Psyllid ID: psy3880
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | 2.2.26 [Sep-21-2011] | |||||||
| Q2KJ16 | 406 | Phosphorylase b kinase ga | yes | N/A | 0.428 | 0.431 | 0.519 | 1e-50 | |
| P15735 | 406 | Phosphorylase b kinase ga | yes | N/A | 0.431 | 0.433 | 0.511 | 1e-49 | |
| Q9DB30 | 406 | Phosphorylase b kinase ga | yes | N/A | 0.431 | 0.433 | 0.505 | 1e-49 | |
| P31325 | 406 | Phosphorylase b kinase ga | yes | N/A | 0.431 | 0.433 | 0.511 | 2e-49 | |
| Q16816 | 387 | Phosphorylase b kinase ga | no | N/A | 0.394 | 0.416 | 0.542 | 1e-47 | |
| P13286 | 388 | Phosphorylase b kinase ga | no | N/A | 0.281 | 0.296 | 0.648 | 1e-47 | |
| P07934 | 388 | Phosphorylase b kinase ga | no | N/A | 0.281 | 0.296 | 0.641 | 3e-47 | |
| P00518 | 387 | Phosphorylase b kinase ga | no | N/A | 0.394 | 0.416 | 0.542 | 7e-47 | |
| Q13555 | 558 | Calcium/calmodulin-depend | no | N/A | 0.379 | 0.277 | 0.424 | 1e-30 | |
| Q923T9 | 529 | Calcium/calmodulin-depend | no | N/A | 0.379 | 0.293 | 0.424 | 1e-30 |
| >sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus GN=PHKG2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 200 bits (509), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 93/179 (51%), Positives = 125/179 (69%), Gaps = 4/179 (2%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+HN+++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHNNNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase (PYGB, PYGL or PYGM). May regulate glycogeneolysis in the testis. In vitro, phosphorylates TNNI3, TNNT2, MAPT/TAU, GAP43 and NRGN/RC3. Bos taurus (taxid: 9913) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 6 |
| >sp|P15735|PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 92/180 (51%), Positives = 124/180 (68%), Gaps = 4/180 (2%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISG 180
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSS 262
|
Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase (PYGB, PYGL or PYGM). May regulate glycogeneolysis in the testis. In vitro, phosphorylates TNNI3, TNNT2, MAPT/TAU, GAP43 and NRGN/RC3. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DB30|PHKG2_MOUSE Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Mus musculus GN=Phkg2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 91/180 (50%), Positives = 124/180 (68%), Gaps = 4/180 (2%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEAGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISG 180
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y F+SPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFTSPEWDDRSN 262
|
Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase (PYGB, PYGL or PYGM). May regulate glycogeneolysis in the testis. In vitro, phosphorylates TNNI3, TNNT2, MAPT/TAU, GAP43 and NRGN/RC3. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P31325|PHKG2_RAT Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Rattus norvegicus GN=Phkg2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (500), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 92/180 (51%), Positives = 124/180 (68%), Gaps = 4/180 (2%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVN 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHVNNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISG 180
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSN 262
|
Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase (PYGB, PYGL or PYGM). May regulate glycogeneolysis in the testis. In vitro, phosphorylates TNNI3, TNNT2, MAPT/TAU, GAP43 and NRGN/RC3. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q16816|PHKG1_HUMAN Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform OS=Homo sapiens GN=PHKG1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 89/164 (54%), Positives = 113/164 (68%), Gaps = 3/164 (1%)
Query: 19 EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75
E + L ++ +GE + + S R IMR L E + +H ++VHRDLKPE
Sbjct: 95 ETNTFFFLVFDLMKRGELFDYLTEKVTLSEKETRKIMRALLEVICTLHKLNIVHRDLKPE 154
Query: 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
NILLDD MN+KLTDFGF+ L+ GE+L ++CGTP YLAPE++ +M ED GYG+ VD+W
Sbjct: 155 NILLDDNMNIKLTDFGFSCQLEPGERLREVCGTPSYLAPEIIECSMNEDHPGYGKEVDMW 214
Query: 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
+ GVIMYTLL G PPFWHRKQM+MLR IM G Y F SPEW+D S
Sbjct: 215 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 258
|
Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 9 |
| >sp|P13286|PHKG1_RAT Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform OS=Rattus norvegicus GN=Phkg1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 85/131 (64%), Positives = 104/131 (79%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R IMR L E + +H ++VHRDLKPENILLDD MN+KLTDFGF+ L+ GEKL ++CGT
Sbjct: 128 RKIMRALLEVVCTLHKLNIVHRDLKPENILLDDNMNIKLTDFGFSCQLQPGEKLREVCGT 187
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P YLAPE+++ +M E GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM+GKY
Sbjct: 188 PSYLAPEIIQCSMDEGHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMDGKY 247
Query: 169 SFSSPEWNDIS 179
F SPEW+D S
Sbjct: 248 QFGSPEWDDYS 258
|
Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 9 |
| >sp|P07934|PHKG1_MOUSE Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform OS=Mus musculus GN=Phkg1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 84/131 (64%), Positives = 104/131 (79%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R IMR L E + +H ++VHRDLKPENILLDD MN+KLTDFGF+ L+ GEKL ++CGT
Sbjct: 128 RKIMRALLEVICTLHKLNIVHRDLKPENILLDDNMNIKLTDFGFSCQLQPGEKLREVCGT 187
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P YLAPE+++ +M + GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM+GKY
Sbjct: 188 PSYLAPEIIQCSMDDGHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMDGKY 247
Query: 169 SFSSPEWNDIS 179
F SPEW+D S
Sbjct: 248 QFGSPEWDDYS 258
|
Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 9 |
| >sp|P00518|PHKG1_RABIT Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform OS=Oryctolagus cuniculus GN=PHKG1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 7e-47, Method: Compositional matrix adjust.
Identities = 89/164 (54%), Positives = 112/164 (68%), Gaps = 3/164 (1%)
Query: 19 EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75
E + L ++ KGE + + S R IMR L E + +H ++VHRDLKPE
Sbjct: 95 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 154
Query: 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
NILLDD MN+KLTDFGF+ L GEKL ++CGTP YLAPE++ +M ++ GYG+ VD+W
Sbjct: 155 NILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 214
Query: 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
+ GVIMYTLL G PPFWHRKQM+MLR IM G Y F SPEW+D S
Sbjct: 215 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 258
|
Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 9 |
| >sp|Q13555|KCC2G_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G PE=1 SV=3 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 73/172 (42%), Positives = 99/172 (57%), Gaps = 17/172 (9%)
Query: 16 VKEEGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRD 71
+ EEG +L +V GE +DI+ S + + Q+ E++ H+H H +VHRD
Sbjct: 80 ISEEG--FHYLVFDLVTGGEL-FEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRD 136
Query: 72 LKPENILLDDQMN---VKLTDFGFA-RVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATG 127
LKPEN+LL + VKL DFG A V + + GTPGYL+PEVLR +
Sbjct: 137 LKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD------P 190
Query: 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
YG+ VD+WACGVI+Y LLVG PPFW Q + + I G Y F SPEW+ ++
Sbjct: 191 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 242
|
Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in sarcoplamic reticulum Ca(2+) transport in skeletal muscle and may function in dendritic spine and synapse formation and neuronal plasticity. In slow-twitch muscles, is involved in regulation of sarcoplamic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of the ryanodine receptor-coupling factor triadin. In neurons, may participate in the promotion of dendritic spine and synapse formation and maintenance of synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q923T9|KCC2G_MOUSE Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Mus musculus GN=Camk2g PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (337), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 73/172 (42%), Positives = 99/172 (57%), Gaps = 17/172 (9%)
Query: 16 VKEEGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRD 71
+ EEG +L +V GE +DI+ S + + Q+ E++ H+H H +VHRD
Sbjct: 80 ISEEG--FHYLVFDLVTGGEL-FEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRD 136
Query: 72 LKPENILLDDQMN---VKLTDFGFA-RVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATG 127
LKPEN+LL + VKL DFG A V + + GTPGYL+PEVLR +
Sbjct: 137 LKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD------P 190
Query: 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
YG+ VD+WACGVI+Y LLVG PPFW Q + + I G Y F SPEW+ ++
Sbjct: 191 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 242
|
Calcium/calmodulin-dependent protein kinase that functions autonomously after Ca(2+)/calmodulin-binding and autophosphorylation, and is involved in sarcoplamic reticulum Ca(2+) transport in skeletal muscle and may function in dendritic spine and synapse formation and neuronal plasticity. In slow-twitch muscles, is involved in regulation of sarcoplamic reticulum (SR) Ca(2+) transport and in fast-twitch muscle participates in the control of Ca(2+) release from the SR through phosphorylation of the ryanodine receptor-coupling factor triadin. In neurons, may participate in the promotion of dendritic spine and synapse formation and maintenance of synaptic plasticity which enables long-term potentiation (LTP) and hippocampus-dependent learning. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | ||||||
| 383847134 | 592 | PREDICTED: phosphorylase b kinase gamma | 0.612 | 0.422 | 0.488 | 2e-66 | |
| 350401267 | 1021 | PREDICTED: hypothetical protein LOC10074 | 0.600 | 0.239 | 0.493 | 2e-65 | |
| 195133216 | 419 | GI16230 [Drosophila mojavensis] gi|19390 | 0.674 | 0.656 | 0.445 | 8e-65 | |
| 195432514 | 419 | GK20076 [Drosophila willistoni] gi|19416 | 0.674 | 0.656 | 0.442 | 2e-64 | |
| 340720649 | 1022 | PREDICTED: hypothetical protein LOC10064 | 0.600 | 0.239 | 0.486 | 5e-64 | |
| 357631494 | 419 | putative cAMP-dependent protein kinase c | 0.615 | 0.599 | 0.443 | 5e-64 | |
| 307172017 | 1068 | Phosphorylase b kinase gamma catalytic c | 0.289 | 0.110 | 0.809 | 9e-64 | |
| 380012898 | 977 | PREDICTED: uncharacterized protein LOC10 | 0.289 | 0.120 | 0.801 | 1e-63 | |
| 328785191 | 1020 | PREDICTED: hypothetical protein LOC55064 | 0.289 | 0.115 | 0.801 | 1e-63 | |
| 242025124 | 418 | cAMP-dependent protein kinase catalytic | 0.301 | 0.294 | 0.801 | 3e-63 |
| >gi|383847134|ref|XP_003699210.1| PREDICTED: phosphorylase b kinase gamma catalytic chain, skeletal muscle isoform-like, partial [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 259 bits (662), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 151/309 (48%), Positives = 182/309 (58%), Gaps = 59/309 (19%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFAR+LK G+KL
Sbjct: 123 SEKKTRYIMRQVFEGVQHVHNQGIVHRDLKPENILLDDSLNVKITDFGFARMLKAGDKLY 182
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
DLCGTPGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNI
Sbjct: 183 DLCGTPGYLAPEVLKCNMFENAEGYGHEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNI 242
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
MEGKYSF+SPEW DI+ AP+ L + LLV P
Sbjct: 243 MEGKYSFTSPEWADITE--APKDL-----------------------IRKLLVVDP---- 273
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
K+ + +++ +E + F + W+ +D L R L T R S
Sbjct: 274 -KKRITIKDALEHSF-FHTVLWD---QDIAPLKRSL--STNSRRLS-------------- 312
Query: 284 FDQDIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDD 343
I + + K S N FQ I+ VRAAVRI RL P LS D
Sbjct: 313 ---RISQLALELKAKS-----FNARKRFQLAIICVRAAVRIKRLHITPEP-LSTQVACTD 363
Query: 344 PYGVKILRQ 352
PY +KILR+
Sbjct: 364 PYRIKILRK 372
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401267|ref|XP_003486104.1| PREDICTED: hypothetical protein LOC100745483 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 255 bits (652), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 150/304 (49%), Positives = 179/304 (58%), Gaps = 59/304 (19%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFARVLK G+KL DLCGT
Sbjct: 128 RYIMRQVFEGVQHVHNQGIVHRDLKPENILLDDNLNVKITDFGFARVLKAGDKLYDLCGT 187
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKY
Sbjct: 188 PGYLAPEVLKCNMFENAEGYGHEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKY 247
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
SF+SPEW DI+ AP+ L + LLV P K+ +
Sbjct: 248 SFTSPEWADITE--APKDL-----------------------IRKLLVVDP-----KKRI 277
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDI 288
++ +E + F + W+ +D L R L T R S I
Sbjct: 278 SIKEALEHSF-FHTMLWD---QDIAPLKRSL--STNSRRLS-----------------RI 314
Query: 289 EPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDDPYGVK 348
+ + K S K QL I+ VRA VRI RL P LS DPY +K
Sbjct: 315 SQLALELKAKSFNARKKFQLA-----IICVRAVVRIKRLHSTPEP-LSTHVACTDPYRIK 368
Query: 349 ILRQ 352
ILR+
Sbjct: 369 ILRK 372
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195133216|ref|XP_002011035.1| GI16230 [Drosophila mojavensis] gi|193907010|gb|EDW05877.1| GI16230 [Drosophila mojavensis] | Back alignment and taxonomy information |
|---|
Score = 254 bits (648), Expect = 8e-65, Method: Compositional matrix adjust.
Identities = 150/337 (44%), Positives = 194/337 (57%), Gaps = 62/337 (18%)
Query: 19 EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75
E D L ++ KGE + S R IMRQ+FE +E++H ++VHRDLKPE
Sbjct: 98 ESDAFVFLVFELCPKGELFDYLTSVVTLSEKKTRTIMRQIFEGVEYIHGKNIVHRDLKPE 157
Query: 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
NILLD+ NVK+TDFGFAR L +GEKL DLCGTPGYLAPE L+ NMFE + GY Q VD+W
Sbjct: 158 NILLDENHNVKITDFGFARQLGEGEKLTDLCGTPGYLAPETLKCNMFEGSPGYSQEVDIW 217
Query: 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDA 195
ACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKYSF+SPEW DIS +++R + D
Sbjct: 218 ACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKYSFTSPEWADISED-PKDLIRKCLVVDP 276
Query: 196 TGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255
A + V+ + PF++ QM+ +NI K S S+
Sbjct: 277 -----AQRITVKEVLRH-------PFFN--QMLFEQNIDGLKRSLSTKS----------- 311
Query: 256 IRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315
R++ +T +I ++K + +RK +FQF I
Sbjct: 312 -RRMSRIT-----------------------EIALLRKQSRFNARK--------KFQFAI 339
Query: 316 LVVRAAVRISRLKYNHVPALSVTQGRDDPYGVKILRQ 352
LV+RA +RI RL+Y P L V + DPY VK+LR+
Sbjct: 340 LVIRAVIRIRRLRYTAEP-LHVEEAIRDPYRVKVLRK 375
|
Source: Drosophila mojavensis Species: Drosophila mojavensis Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195432514|ref|XP_002064268.1| GK20076 [Drosophila willistoni] gi|194160353|gb|EDW75254.1| GK20076 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
Score = 253 bits (645), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 149/337 (44%), Positives = 195/337 (57%), Gaps = 62/337 (18%)
Query: 19 EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75
E D L ++ KGE + S R IMRQ+FE +E++H ++VHRDLKPE
Sbjct: 98 ESDAFVFLVFELCPKGELFDYLTSVVTLSEKKTRTIMRQIFEGVEYIHAKNIVHRDLKPE 157
Query: 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
NILLD+ NVK+TDFGFAR L++GEKL DLCGTPGYLAPE L+ NMFE + GY Q VD+W
Sbjct: 158 NILLDENHNVKITDFGFARQLQEGEKLTDLCGTPGYLAPETLKCNMFEGSPGYSQEVDIW 217
Query: 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDA 195
ACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKYSF+SPEW DIS +++R + D
Sbjct: 218 ACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKYSFTSPEWADISED-PKDLIRKCLVVDP 276
Query: 196 TGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255
A + V+ + PF++ QM+ +NI K S S+
Sbjct: 277 -----AQRITVKEVLRH-------PFFN--QMLFEQNIDGLKRSLSTKS----------- 311
Query: 256 IRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315
R++ +T +I ++K + +RK +FQF I
Sbjct: 312 -RRMSRIT-----------------------EIALLRKQSRFNARK--------KFQFAI 339
Query: 316 LVVRAAVRISRLKYNHVPALSVTQGRDDPYGVKILRQ 352
LV+RA +RI RL++ P L V + DPY VK+LR+
Sbjct: 340 LVIRAMIRIRRLRFTAEP-LHVEEAIRDPYRVKVLRK 375
|
Source: Drosophila willistoni Species: Drosophila willistoni Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340720649|ref|XP_003398746.1| PREDICTED: hypothetical protein LOC100644069 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 251 bits (641), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 148/304 (48%), Positives = 178/304 (58%), Gaps = 59/304 (19%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFAR+LK +KL DLCGT
Sbjct: 128 RYIMRQVFEGVQHVHNQGIVHRDLKPENILLDDNLNVKITDFGFARLLKAEDKLYDLCGT 187
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKY
Sbjct: 188 PGYLAPEVLKCNMFENAEGYGHEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKY 247
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
SF+SPEW DI+ AP+ L + LLV P K+ +
Sbjct: 248 SFTSPEWADITE--APKDL-----------------------IRKLLVVDP-----KKRI 277
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDI 288
++ +E + F + W+ +D L R L T R S I
Sbjct: 278 SIKEALEHSF-FHTMLWD---QDIAPLKRSL--STNSRRLS-----------------RI 314
Query: 289 EPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDDPYGVK 348
+ + K S K QL I+ VRA VRI RL P LS DPY +K
Sbjct: 315 SQLALELKAKSFNARKKFQLA-----IICVRAVVRIKRLHSTPEP-LSTHVACTDPYRIK 368
Query: 349 ILRQ 352
ILR+
Sbjct: 369 ILRK 372
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357631494|gb|EHJ78965.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 137/309 (44%), Positives = 179/309 (57%), Gaps = 58/309 (18%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S RYIMRQ+ E + +H+H +VHRDLKPENILLDDQ+NVK+TDFGFAR+L++GEKL
Sbjct: 125 SEKKTRYIMRQVLEGVRSIHSHGIVHRDLKPENILLDDQLNVKITDFGFARMLQRGEKLF 184
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
+LCGTPGYLAPE L+ANMFEDA GYG VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNI
Sbjct: 185 ELCGTPGYLAPETLKANMFEDAPGYGMEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNI 244
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
MEG+YSF+SPEW DIS ED ++ LLV P
Sbjct: 245 MEGRYSFTSPEWADIS-------------EDPKD------------LIRRLLVVDP---- 275
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
Q + L + + ++ F + W+ +D +K +L+ +
Sbjct: 276 -AQRIALEDALTHQF-FHTKLWD------------------QDMTPLKRSLSGTSRKMSR 315
Query: 284 FDQDIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDD 343
DQ +K T +L + +L V +AVR+ RL + +L + D
Sbjct: 316 IDQIAMSLKSGVCTPRSRL---------RVALLAVLSAVRLRRLPHAAARSLPLVDAETD 366
Query: 344 PYGVKILRQ 352
PY V++LR+
Sbjct: 367 PYSVRLLRK 375
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307172017|gb|EFN63611.1| Phosphorylase b kinase gamma catalytic chain, skeletal muscle isoform [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 106/131 (80%), Positives = 119/131 (90%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFAR+L GEKL DLCGT
Sbjct: 128 RYIMRQVFEGIQHVHNQRIVHRDLKPENILLDDNLNVKITDFGFARILNPGEKLEDLCGT 187
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKY
Sbjct: 188 PGYLAPEVLKCNMFENADGYGFEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKY 247
Query: 169 SFSSPEWNDIS 179
SF+SPEW DI+
Sbjct: 248 SFTSPEWADIT 258
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380012898|ref|XP_003690510.1| PREDICTED: uncharacterized protein LOC100869575 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 105/131 (80%), Positives = 120/131 (91%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFAR+LK G+KL DLCGT
Sbjct: 127 RYIMRQVFEGVQHVHNQGIVHRDLKPENILLDDNLNVKITDFGFARLLKTGDKLYDLCGT 186
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQM+MLRNIMEGKY
Sbjct: 187 PGYLAPEVLKCNMFENAEGYGHEVDIWACGVIMFTLLVGCPPFWHRKQMIMLRNIMEGKY 246
Query: 169 SFSSPEWNDIS 179
SF+SPEW DI+
Sbjct: 247 SFTSPEWADIT 257
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328785191|ref|XP_623113.2| PREDICTED: hypothetical protein LOC550645 isoform 2 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 249 bits (637), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 105/131 (80%), Positives = 120/131 (91%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
RYIMRQ+FE ++HVHN +VHRDLKPENILLDD +NVK+TDFGFAR+LK G+KL DLCGT
Sbjct: 127 RYIMRQVFEGVQHVHNQGIVHRDLKPENILLDDNLNVKITDFGFARLLKTGDKLYDLCGT 186
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPEVL+ NMFE+A GYG VD+WACGVIM+TLLVGCPPFWHRKQM+MLRNIMEGKY
Sbjct: 187 PGYLAPEVLKCNMFENAEGYGHEVDIWACGVIMFTLLVGCPPFWHRKQMIMLRNIMEGKY 246
Query: 169 SFSSPEWNDIS 179
SF+SPEW DI+
Sbjct: 247 SFTSPEWADIT 257
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242025124|ref|XP_002432976.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212518485|gb|EEB20238.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 248 bits (634), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 109/136 (80%), Positives = 124/136 (91%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S RYIMRQ+FEAL+H+H +VVHRDLKPENILLDD MNVK+TDFGFA+VLK+ E+L+
Sbjct: 125 SEKKTRYIMRQIFEALDHIHKKNVVHRDLKPENILLDDCMNVKITDFGFAKVLKENERLV 184
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
+LCGTPGYLAPE L+A+MFEDA GYG+ VD+WACGVIM+TLLVGCPPFWHRKQMVMLRNI
Sbjct: 185 ELCGTPGYLAPETLKASMFEDAPGYGKEVDIWACGVIMFTLLVGCPPFWHRKQMVMLRNI 244
Query: 164 MEGKYSFSSPEWNDIS 179
MEGKYSFSSPEW DIS
Sbjct: 245 MEGKYSFSSPEWADIS 260
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 408 | ||||||
| FB|FBgn0011754 | 560 | PhKgamma "Phosphorylase kinase | 0.394 | 0.287 | 0.652 | 2.3e-66 | |
| UNIPROTKB|Q2KJ16 | 406 | PHKG2 "Phosphorylase b kinase | 0.428 | 0.431 | 0.519 | 3.7e-48 | |
| UNIPROTKB|F1RG75 | 406 | PHKG2 "Uncharacterized protein | 0.428 | 0.431 | 0.513 | 2.6e-47 | |
| UNIPROTKB|P15735 | 406 | PHKG2 "Phosphorylase b kinase | 0.428 | 0.431 | 0.513 | 2.6e-47 | |
| UNIPROTKB|H3BTW6 | 266 | PHKG2 "Phosphorylase b kinase | 0.428 | 0.657 | 0.513 | 2.6e-47 | |
| RGD|620024 | 406 | Phkg2 "phosphorylase kinase, g | 0.428 | 0.431 | 0.513 | 3.3e-47 | |
| MGI|MGI:1916211 | 406 | Phkg2 "phosphorylase kinase, g | 0.428 | 0.431 | 0.508 | 5.4e-47 | |
| UNIPROTKB|E2R3E4 | 406 | PHKG2 "Uncharacterized protein | 0.428 | 0.431 | 0.508 | 1.1e-46 | |
| UNIPROTKB|F1P5T2 | 388 | PHKG1 "Uncharacterized protein | 0.409 | 0.430 | 0.529 | 1e-45 | |
| UNIPROTKB|E2RKP3 | 530 | PHKG1 "Uncharacterized protein | 0.409 | 0.315 | 0.523 | 1e-45 |
| FB|FBgn0011754 PhKgamma "Phosphorylase kinase gamma" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 2.3e-66, Sum P(2) = 2.3e-66
Identities = 107/164 (65%), Positives = 128/164 (78%)
Query: 19 EGDDLKHLAAQVVDKGEAA--VQDIIN-SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75
E D L ++ KGE + ++ S R IMRQ+FE +E++H S+VHRDLKPE
Sbjct: 98 ESDAFVFLVFELCPKGELFDYLTSVVTLSEKKTRTIMRQIFEGVEYIHAKSIVHRDLKPE 157
Query: 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
NILLD+ NVK+TDFGFA+ L++GEKL +LCGTPGYLAPE L+ NMFE + GY Q VD+W
Sbjct: 158 NILLDENHNVKITDFGFAKQLQEGEKLTNLCGTPGYLAPETLKCNMFEGSPGYSQEVDIW 217
Query: 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
ACGVIM+TLLVGCPPFWHRKQMVMLRNIMEGKYSF+SPEW DIS
Sbjct: 218 ACGVIMFTLLVGCPPFWHRKQMVMLRNIMEGKYSFTSPEWADIS 261
|
|
| UNIPROTKB|Q2KJ16 PHKG2 "Phosphorylase b kinase gamma catalytic chain, liver/testis isoform" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
Identities = 93/179 (51%), Positives = 125/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+HN+++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHNNNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| UNIPROTKB|F1RG75 PHKG2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 92/179 (51%), Positives = 124/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGREVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| UNIPROTKB|P15735 PHKG2 "Phosphorylase b kinase gamma catalytic chain, liver/testis isoform" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 92/179 (51%), Positives = 124/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| UNIPROTKB|H3BTW6 PHKG2 "Phosphorylase b kinase gamma catalytic chain, liver/testis isoform" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 92/179 (51%), Positives = 124/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| RGD|620024 Phkg2 "phosphorylase kinase, gamma 2 (testis)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 92/179 (51%), Positives = 124/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVN 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHVNNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| MGI|MGI:1916211 Phkg2 "phosphorylase kinase, gamma 2 (testis)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
Identities = 91/179 (50%), Positives = 124/179 (69%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEAGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y F+SPEW+D S
Sbjct: 203 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFTSPEWDDRS 261
|
|
| UNIPROTKB|E2R3E4 PHKG2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.1e-46, P = 1.1e-46
Identities = 91/179 (50%), Positives = 123/179 (68%)
Query: 5 EMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALE 60
++ H ++ + E L ++ KGE + + S R IMR L EA+
Sbjct: 83 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 142
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGTPGYLAPE+L+ +
Sbjct: 143 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 202
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
M E GY + VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y FSSPEW+D S
Sbjct: 203 MDETHPGYSKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 261
|
|
| UNIPROTKB|F1P5T2 PHKG1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 91/172 (52%), Positives = 120/172 (69%)
Query: 13 VVRVKE--EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSV 67
V+++K+ E L ++ +GE + + S R IM L E +E++H+ +
Sbjct: 86 VIQLKDSYESSTFFFLVFDLMKRGELFDYLTEKVTLSEKETRKIMHALLEVIEYLHSIDI 145
Query: 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATG 127
VHRDLKPENILLDD MN+KLTDFGF+ L + EKL ++CGTPGYLAPE+L+ +M ++ G
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLHENEKLKEICGTPGYLAPEILQCSMDDEHEG 205
Query: 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
YG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM G Y F SPEW+D S
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMNGDYQFGSPEWDDRS 257
|
|
| UNIPROTKB|E2RKP3 PHKG1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 90/172 (52%), Positives = 120/172 (69%)
Query: 13 VVRVKE--EGDDLKHLAAQVVDKGEA---AVQDIINSNPALRYIMRQLFEALEHVHNHSV 67
++++K+ E + L ++ +GE + + S R IMR L E + ++H ++
Sbjct: 230 IIQLKDTYETNTFFFLVFDLMKRGELFDYLTEKVTLSEKETRKIMRALLEVIRNLHKLNI 289
Query: 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATG 127
VHRDLKPENILLDD MN+KLTDFGF+ L+ GEKL ++CGTP YLAPE++ +M +D G
Sbjct: 290 VHRDLKPENILLDDDMNIKLTDFGFSCQLEPGEKLREVCGTPSYLAPEIIECSMNDDHPG 349
Query: 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
YG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM G Y F SPEW+D S
Sbjct: 350 YGKEVDMWSIGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 401
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P31325 | PHKG2_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5111 | 0.4313 | 0.4334 | yes | N/A |
| Q2KJ16 | PHKG2_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5195 | 0.4289 | 0.4310 | yes | N/A |
| P15735 | PHKG2_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5111 | 0.4313 | 0.4334 | yes | N/A |
| Q9DB30 | PHKG2_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.5055 | 0.4313 | 0.4334 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 408 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-43 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-26 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-25 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-24 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-24 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-22 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-20 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-20 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-09 | |
| pfam01585 | 45 | pfam01585, G-patch, G-patch domain | 8e-09 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| smart00443 | 47 | smart00443, G_patch, glycine rich nucleic binding | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.002 | |
| COG0510 | 269 | COG0510, ycfN, Thiamine kinase and related kinases | 0.002 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.002 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.002 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.004 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 3e-55
Identities = 68/143 (47%), Positives = 89/143 (62%), Gaps = 12/143 (8%)
Query: 40 DIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94
D++ L R+ +RQ+ ALE++H+ +VHRDLKPENILLD+ +VKL DFG AR
Sbjct: 86 DLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR 145
Query: 95 VLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154
L GEKL GTP Y+APEVL GYG+AVD+W+ GVI+Y LL G PPF
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGK------GYGKAVDIWSLGVILYELLTGKPPFPGD 199
Query: 155 KQM-VMLRNIMEGKYSFSSPEWN 176
Q+ + + I + K F PEW+
Sbjct: 200 DQLLELFKKIGKPKPPFPPPEWD 222
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 59/136 (43%), Positives = 79/136 (58%), Gaps = 9/136 (6%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLC 106
+ I Q+ LE++H++ ++HRDLKPENILLD+ VK+ DFG A+ L K L
Sbjct: 100 AKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV 159
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNI 163
GTP Y+APEVL GYG VDVW+ GVI+Y LL G PPF Q+ ++R I
Sbjct: 160 GTPWYMAPEVLL-----GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI 214
Query: 164 MEGKYSFSSPEWNDIS 179
+ F P+W+ S
Sbjct: 215 LGPPLEFDEPKWSSGS 230
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 8e-43
Identities = 53/123 (43%), Positives = 76/123 (61%), Gaps = 7/123 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-GEKLMDLCG 107
R+ ++ ALE++H+ +++RDLKPENILLD ++KLTDFG A+ L G + CG
Sbjct: 96 RFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP YLAPEVL GYG+AVD W+ GV++Y +L G PPF+ + + I++
Sbjct: 156 TPEYLAPEVLL------GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209
Query: 168 YSF 170
F
Sbjct: 210 LRF 212
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 57/130 (43%), Positives = 82/130 (63%), Gaps = 8/130 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
P R+ Q+ ALE++H+ +V+RDLKPEN+LLD +K+TDFGFA+ +K +
Sbjct: 99 PEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTY 156
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
LCGTP YLAPE++ + GYG+AVD WA G+++Y +L G PPF+ + + I
Sbjct: 157 TLCGTPEYLAPEIIL------SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 164 MEGKYSFSSP 173
+EGK F S
Sbjct: 211 LEGKVRFPSF 220
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 52/127 (40%), Positives = 75/127 (59%), Gaps = 8/127 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R+ + + A E++HN +++RDLKPEN+LLD VKL DFGFA+ LK G+K CGT
Sbjct: 96 RFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK--QMVMLRNIMEG 166
P Y+APE++ GY +VD W+ G+++Y LL G PPF M + +I++G
Sbjct: 156 PEYVAPEIILNK------GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 167 KYSFSSP 173
P
Sbjct: 210 NGKLEFP 216
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 54/155 (34%), Positives = 84/155 (54%), Gaps = 21/155 (13%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM----- 103
R + ++ ALE++H++ ++HRDLKP+NIL+D ++KLTDFG ++V ++
Sbjct: 96 RIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 104 ----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+ GTP Y+APEV+ G+ + VD W+ G I+Y LVG PPF +
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQ------GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209
Query: 160 LRNIMEGKYSF-----SSPEWND-ISGYLAPEVLR 188
+NI+ GK + S E D IS L P+ +
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEK 244
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 52/120 (43%), Positives = 78/120 (65%), Gaps = 10/120 (8%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
A E++H+ +++RDLKPEN+LLD++ +VK+TDFGFA+ K ++ LCGTP YLAPEV+
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVI 187
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
++ G+G+AVD W GV++Y + G PPF+ + I+ G+ F P W D
Sbjct: 188 QSK------GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF--PNWFD 239
|
Length = 329 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 45/103 (43%), Positives = 65/103 (63%), Gaps = 7/103 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKL 102
S + I+ Q+ E LE++H++ ++HRDLKPENILLD D VKL DFG +++L + L
Sbjct: 90 SEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL 149
Query: 103 M-DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
+ + GTP Y+APEVL Y + D+W+ GVI+Y L
Sbjct: 150 LKTIVGTPAYMAPEVLLGKG-----YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 49/100 (49%), Positives = 63/100 (63%), Gaps = 8/100 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM-VMLRNIMEGKYS 239
Y+APEVL GYG+AVD+W+ GVI+Y LL G PPF Q+ + + I + K
Sbjct: 162 YMAPEVLLGK------GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 215
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F PEW+ IS + KDLIRKLL+ PE R + +EAL H FF
Sbjct: 216 FPPPEWD-ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 56/127 (44%), Positives = 83/127 (65%), Gaps = 8/127 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
SN + ++ ALE++H+ +V+RDLKPENILLD + ++KLTDFGFA+ L+ ++
Sbjct: 99 SNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTW 156
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
LCGTP YLAPEV++ + G+ +AVD WA G+++Y +LVG PPF+ + I
Sbjct: 157 TLCGTPEYLAPEVIQ------SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 164 MEGKYSF 170
+ GK F
Sbjct: 211 LAGKLEF 217
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 17/148 (11%)
Query: 38 VQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
+ ++ L R RQ+ E L ++H++ +VHRD+K NIL+D VKL DFG
Sbjct: 88 LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147
Query: 93 ARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
A+ L E + GTP ++APEV+R YG+A D+W+ G + + G P
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIR------GEEYGRAADIWSLGCTVIEMATGKP 201
Query: 150 PFWHRKQM--VMLRNIMEGKYSFSSPEW 175
P+ + + I PE
Sbjct: 202 PWSELGNPMAALYK-IGSSGEPPEIPEH 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 42/103 (40%), Positives = 61/103 (59%), Gaps = 6/103 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
++ + ++ ALE++H+ ++HRD+KP+NILLD+Q +V +TDF A + GT
Sbjct: 103 KFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT 162
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
PGY+APEVL GY AVD W+ GV Y L G P+
Sbjct: 163 PGYMAPEVLC------RQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-29
Identities = 40/121 (33%), Positives = 64/121 (52%), Gaps = 7/121 (5%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLCGT 108
QL AL+++H+ ++HRD+KP+NI L VKL DFG ++VL + + GT
Sbjct: 107 DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P YL+PE+ + N Y D+W+ G ++Y L PF + + I++G+Y
Sbjct: 167 PYYLSPELCQ-NK-----PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY 220
Query: 169 S 169
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 43/104 (41%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIME 235
Y+APEVL GYG VDVW+ GVI+Y LL G PPF Q+ ++R I+
Sbjct: 162 PWYMAPEVLL-----GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILG 216
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F P+W+ SE+ KDLI+K L P R + +E L H +F
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 27/148 (18%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------- 96
R+ ++ ALE++H+ ++HRDLKPENILLD M++K+TDFG A+VL
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
Query: 97 --KKGEKLMD------------LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
K +D GT Y++PE+L E G + D+WA G I+Y
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN----EKPAGK--SSDLWALGCIIY 213
Query: 143 TLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
+L G PPF + + + I++ +YSF
Sbjct: 214 QMLTGKPPFRGSNEYLTFQKILKLEYSF 241
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 48/223 (21%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
AL+ VH +HRD+KP+NIL+D ++KL DFG + + K + +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY----------YLN 162
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
++ H+++ V + + +P
Sbjct: 163 DSHNLLFRDNVLVRRR------------------DHKQRRVRANSTV------GTP---- 194
Query: 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237
Y+APEVLR T YG D W+ GVI+Y +L G PPF+ I+ K
Sbjct: 195 --DYIAPEVLRG------TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK 246
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-SVKEALNHSFF 279
S P +S + DLI +LL PEDR S +E +H FF
Sbjct: 247 ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 53/123 (43%), Positives = 75/123 (60%), Gaps = 7/123 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ +L ALE++H +V++RDLKPENILLD Q ++ L DFG ++ +K +K CG
Sbjct: 96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP YLAPE+L + GY +AVD W GV++Y +L G PPF+ M R I++
Sbjct: 156 TPEYLAPELLLGH------GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209
Query: 168 YSF 170
F
Sbjct: 210 LRF 212
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 37 AVQDIINSNP------ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+++D++ S + Y+ ++L + LE++H++ ++HRD+K NILL VKL DF
Sbjct: 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDF 142
Query: 91 GFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
G + L + + GTP ++APEV+ Y D+W+ G+ L G PP
Sbjct: 143 GLSAQLSDTKARNTMVGTPYWMAPEVIN------GKPYDYKADIWSLGITAIELAEGKPP 196
Query: 151 FWHRK---QMVMLRNIMEGKYSFSSPEWN 176
+ + + + G +PE
Sbjct: 197 --YSELPPMKALFKIATNGPPGLRNPEKW 223
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 76/243 (31%), Positives = 108/243 (44%), Gaps = 61/243 (25%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK------L 102
RYIM QL +AL+++H+ +V+HRDLKP NILL+ VKL DFG AR L + E+ L
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
D T Y APE+L + T Y + VD+W+ G I+ +L+G P F + L
Sbjct: 170 TDYVATRWYRAPEILLGS-----TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224
Query: 163 IME--GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220
I+E G S E DI +P A M +
Sbjct: 225 IIEVIGP---PSAE--DIESIKSPF--AATMLDSL------------------------- 252
Query: 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF-- 278
+ L ++ S+D DL++KLL+ P R + +EAL H +
Sbjct: 253 --PSRPRKPLDELL-----------PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
Query: 279 -FH 280
FH
Sbjct: 300 QFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 54/129 (41%), Positives = 76/129 (58%), Gaps = 15/129 (11%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-VLKKGEKLMDLCGTPGYLAPEV 116
ALEH+H +++RDLKPENILLD Q +VKLTDFG + + +G CGT Y+APE+
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 176
L +G+G+AVD W+ G +MY +L G PPF + + I++GK +
Sbjct: 172 LM------RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN------- 218
Query: 177 DISGYLAPE 185
+ YL PE
Sbjct: 219 -LPPYLTPE 226
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 64/263 (24%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95
+I S L +Y + Q+ L+++H+ +V+HRDLKP NIL++ ++K+ DFG AR
Sbjct: 93 VIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG 152
Query: 96 L----KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ + L + T Y APE+L ++ Y +A+D+W+ G I LL P F
Sbjct: 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTRKPLF 207
Query: 152 ---WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACG 208
+ Q+ ++ ++ +P D+ + +
Sbjct: 208 PGRDYIDQLNLIVEVL------GTPSEEDLKFITSEKARNY------------------- 242
Query: 209 VIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY 268
L P + + + +SPE DL+ K+L+ P+ R
Sbjct: 243 ------LKSLPKKPKKP--------LSKLFPGASPE-------AIDLLEKMLVFDPKKRI 281
Query: 269 SVKEALNHSFFHPKLFDQDIEPI 291
+ EAL H + L D + EP+
Sbjct: 282 TADEALAHPYLAQ-LHDPEDEPV 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 48/125 (38%), Positives = 67/125 (53%), Gaps = 12/125 (9%)
Query: 51 IMRQLFEALEHVHN-----HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
I+ QL AL HN ++V+HRDLKP NI LD NVKL DFG A++L
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169
Query: 106 C-GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
GTP Y++PE L +++ + D+W+ G ++Y L PPF R Q+ + I
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKS------DIWSLGCLIYELCALSPPFTARNQLQLASKIK 223
Query: 165 EGKYS 169
EGK+
Sbjct: 224 EGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 51/123 (41%), Positives = 71/123 (57%), Gaps = 6/123 (4%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
++ + +L ALEH+H + +V+RDLKPENILLD ++ L DFG ++ L + CG
Sbjct: 99 KFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
T YLAPEVL D GY + VD W+ GV+++ + G PF+ M RNI GK
Sbjct: 159 TTEYLAPEVLL-----DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
Query: 168 YSF 170
F
Sbjct: 214 VRF 216
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 58/246 (23%), Positives = 90/246 (36%), Gaps = 68/246 (27%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKL 102
++ + QL + L H+H ++HRDLKPEN+L++ + +KL DFG AR
Sbjct: 96 PESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
T Y APE+L GY VD+W+ G I +++ R
Sbjct: 156 THYVVTRWYRAPELLLG-----DKGYSTPVDIWSVGCIFA-------------ELLSRRP 197
Query: 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222
+ GK ++I D I TL P W
Sbjct: 198 LFPGK--------SEI------------------------DQLF--KIFRTLGTPDPEVW 223
Query: 223 HRKQMVMLRNIMEGKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEA 273
+ + Y FS P+ + S DL+ ++L P R + ++A
Sbjct: 224 PKFTSLAR------NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277
Query: 274 LNHSFF 279
L H +F
Sbjct: 278 LAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 2e-25
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKG--- 99
S +I+ Q+ ALE++H+ ++HRD+KPENILLD D VKL DFG A++L
Sbjct: 99 SESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
Query: 100 ----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---- 151
GTPGY+APEVL + D+W+ G+ +Y LL G PPF
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAY---ASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLR 188
L+ I+E + + + L +
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAAS 252
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 59/230 (25%), Positives = 88/230 (38%), Gaps = 78/230 (33%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-----GEKLMDLCGT 108
QL E L ++H+H +VHRD+KP NI LD +KL DFG A LK GE++ L GT
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P Y+APEV+ G+G+A D+W+ G ++ + G P W
Sbjct: 167 PAYMAPEVITGG---KGKGHGRAADIWSLGCVVLEMATGKRP-WS--------------- 207
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
+ + + IM+ + G P
Sbjct: 208 -------------------------------ELDNEFQ---IMFHVGAGHKP-------- 225
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
P+ +S + KD + + L P+ R + E L H F
Sbjct: 226 ------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 49/112 (43%), Positives = 69/112 (61%), Gaps = 24/112 (21%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV--------------LKKGEKLM 103
ALE++HN+ +VHRDLKP+N+L+ ++KLTDFG +++ K + +
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 104 D--LCGTPGYLAPEV-LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152
D +CGTP Y+APEV LR GYG+ VD WA G+I+Y LVGC PF+
Sbjct: 173 DKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 49/117 (41%), Positives = 76/117 (64%), Gaps = 8/117 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLA 113
Q+ E++ + ++V+RDLKPEN+LLD +K+TDFGFA+V+ + LCGTP Y+A
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIA 196
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
PE+L G+G+A D W G+ +Y +LVGCPPF+ + +++ + I+EG F
Sbjct: 197 PEILL------NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
|
Length = 340 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 26/116 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++ IM QL L + H+H ++HRDLKP+NIL++ +KL DFG AR G
Sbjct: 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR----------AFG 149
Query: 108 TPG-----------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152
P Y APE+L + Y AVD+W+ G I ++ G P F
Sbjct: 150 IPLRTYTHEVVTLWYRAPEILL-----GSKHYSTAVDIWSVGCIFAEMITGKPLFP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 68/248 (27%), Positives = 100/248 (40%), Gaps = 50/248 (20%)
Query: 40 DIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG 99
D YI + A++ +H +HRD+KP+N+LLD + ++KL+DFG LKK
Sbjct: 96 DTFTEEETRFYIAETIL-AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 100 ---EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
E L + + M + + W R +
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPM--SSKRKAET--------------------WKRNR 192
Query: 157 MVMLRNIMEGKYS-FSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 215
+ YS +P+ Y+APEV TGY + D W+ GVIMY +L
Sbjct: 193 RAL-------AYSTVGTPD------YIAPEVFLQ------TGYNKECDWWSLGVIMYEML 233
Query: 216 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR---YSVKE 272
VG PPF R I+ K + P+ +S + KDLI++L E R V E
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292
Query: 273 ALNHSFFH 280
+H FF
Sbjct: 293 IKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 48/130 (36%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKL 102
S R+ ++ AL ++H+ VV+RDLK EN++LD ++K+TDFG + + G +
Sbjct: 93 SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
CGTP YLAPEVL N YG+AVD W GV+MY ++ G PF+++ +
Sbjct: 153 KTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 163 IMEGKYSFSS 172
I+ + F
Sbjct: 207 ILMEEIRFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 50/122 (40%), Positives = 71/122 (58%), Gaps = 7/122 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKL 102
P R+ ++ A+ ++H+ ++++RDLKPENILLD Q +V LTDFG + ++ E
Sbjct: 94 LEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
CGTP YLAPEVLR Y + VD W G ++Y +L G PPF+ R M N
Sbjct: 154 STFCGTPEYLAPEVLRKE------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN 207
Query: 163 IM 164
I+
Sbjct: 208 IL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 13/113 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ ++ M+QL E L+++H++ ++HRD+K NIL+++ +KL DFG AR K
Sbjct: 98 TESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK-RNSA 156
Query: 104 DLCGTPG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
D T Y PE+L AT YG VD+W+ G I+ L +G P F
Sbjct: 157 DY--TNRVITLWYRPPELLLG-----ATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 42/107 (39%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL--KKGEKLMD 104
+R + ++ AL+H+H +++RD+K ENILLD + +V LTDFG ++ ++ E+
Sbjct: 106 EVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
CGT Y+APEV+R + G+ +AVD W+ GV+ + LL G PF
Sbjct: 166 FCGTIEYMAPEVIRGG----SGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 55/144 (38%), Positives = 77/144 (53%), Gaps = 11/144 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
P R+ ++ AL ++H+ ++++RDLKPENILLD Q +V LTDFG + + K
Sbjct: 94 PEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153
Query: 104 D-LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
CGTP YLAPEVLR Y + VD W G ++Y +L G PPF+ R M N
Sbjct: 154 STFCGTPEYLAPEVLRKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207
Query: 163 IMEG----KYSFSSPEWNDISGYL 182
I+ K + S + + G L
Sbjct: 208 ILNKPLRLKPNISVSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 43/104 (41%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S +R I+ Q+ + L H+H H HRDLKPEN+L+ VK+ DFG AR ++
Sbjct: 97 SESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM---YTL 144
D T Y APE+L + T Y VD+WA G IM YTL
Sbjct: 157 DYVSTRWYRAPEILLRS-----TSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 50/120 (41%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMD 104
P R+ ++ AL ++H+ ++V+RDLKPENILLD Q +V LTDFG + + + +
Sbjct: 96 PRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
CGTP YLAPEV+R Y VD W G ++Y +L G PPF+ R M NI+
Sbjct: 156 FCGTPEYLAPEVIRKQ------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 61/166 (36%), Positives = 86/166 (51%), Gaps = 21/166 (12%)
Query: 20 GDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79
G DLK+ V GE + + Q+ LEH+H +V+RDLKPEN+LL
Sbjct: 77 GGDLKYHIYNV---GEPGFPE-----ARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139
DD NV+++D G A LK G+K+ GTPGY+APEVL+ + Y +VD +A G
Sbjct: 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV------YDFSVDWFALGC 182
Query: 140 IMYTLLVGCPPFWHRKQMVMLRNI------MEGKYSFS-SPEWNDI 178
+Y ++ G PF RK+ V + M +Y SPE D+
Sbjct: 183 TLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDL 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 5e-23
Identities = 56/241 (23%), Positives = 87/241 (36%), Gaps = 72/241 (29%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
M LE++H++ ++HRDLKP N+L+ +KL DFG AR G+P
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS----------FGSPN 156
Query: 111 -----------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
Y APE+L A YG VD+W+ G I LL+ P +
Sbjct: 157 RKMTHQVVTRWYRAPELLFG-----ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
L I E + + W ++ + F+
Sbjct: 212 LGKIFEALGTPTEENWPGVT-----SLPDYVEFKPFPP---------------------T 245
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P F + S+D DL+++LL + P R + ++AL H +F
Sbjct: 246 PLKQI---------------FPA-----ASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
Query: 280 H 280
Sbjct: 286 S 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 49/107 (45%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL--KKGEKLMD 104
A+R + QL +A+ + H+H+++HRD+KPENIL+ + +KL DFGFAR L + L D
Sbjct: 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE+L T YG+ VDVWA G IM LL G P F
Sbjct: 161 YVATRWYRAPELLVG-----DTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 9e-23
Identities = 49/120 (40%), Positives = 69/120 (57%), Gaps = 7/120 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMD 104
P R+ ++ AL ++H+ ++V+RDLKPENILLD Q ++ LTDFG + ++
Sbjct: 96 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
CGTP YLAPEVL Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 156 FCGTPEYLAPEVLHKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 50/131 (38%), Positives = 70/131 (53%), Gaps = 12/131 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG--EKLMDLC 106
R+ M ++FEA++ +H +HRDLKPEN L+D ++KLTDFG L KG +
Sbjct: 104 RFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVV 159
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
G+P Y+APEVLR GY VD W+ G ++Y L G PPF N+
Sbjct: 160 GSPDYMAPEVLR------GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
Query: 167 KYSFSSPEWND 177
K + P ++D
Sbjct: 214 KETLQRPVYDD 224
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 16/128 (12%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
+E +H ++HRD+KPEN+L+D ++KLTDFG +R G + GTP YLAPE +
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETI 165
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG-------KYSF 170
G + D W+ G +++ L G PPF + NI+ F
Sbjct: 166 LGV------GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF 219
Query: 171 SSPEWNDI 178
SPE D+
Sbjct: 220 CSPEAVDL 227
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 51/131 (38%), Positives = 81/131 (61%), Gaps = 10/131 (7%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-VLKKGEKLMDLC 106
+++ + +L AL+H+H+ +++RDLKPENILLD++ ++KLTDFG ++ + +K C
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW--HRKQ-MVMLRNI 163
GT Y+APEV+ + G+ Q+ D W+ GV+M+ +L G PF RK+ M M+
Sbjct: 160 GTVEYMAPEVV------NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 164 MEGKYSFSSPE 174
G F SPE
Sbjct: 214 KLGMPQFLSPE 224
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 16/157 (10%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR--VLKKGEK 101
S +R+ ++ ALEH+H +V+RD+K ENILLD + +V LTDFG ++ + ++ E+
Sbjct: 103 SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQM 157
CGT Y+APE++R G+G+AVD W+ G++++ LL G PF Q
Sbjct: 163 TYSFCGTIEYMAPEIIRGK-----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFED 194
+ R I++ P + G A ++L + +D
Sbjct: 218 EVSRRILK-----CDPPFPSFIGPEAQDLLHKLLRKD 249
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 44/102 (43%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCG 107
+ I+ Q +A+ H H+ +HRD+KPENIL+ Q +KL DFGFAR+L D
Sbjct: 103 KKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
T Y APE+L + T YG VDVWA G + LL G P
Sbjct: 163 TRWYRAPELLVGD-----TQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 50/130 (38%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ ALE++H+ VV+RD+K EN++LD ++K+TDFG + + G + CG
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ +
Sbjct: 158 TPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 168 YSFS---SPE 174
F SPE
Sbjct: 212 IRFPRTLSPE 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
L+ +H +++RDLK +N+LLD + ++K+ DFG + + G CGTP Y+APE+
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
L YG AVD WA GV++Y +L G PF + + ++I+E + + P W
Sbjct: 168 LS------YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY--PRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 21/141 (14%)
Query: 46 PALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
P L YI RQ+ + L+++H ++HRD+KP N+L++ + VK+ DFG ++VL E +D
Sbjct: 99 PVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLD 155
Query: 105 LC----GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ---M 157
C GT Y++PE ++ Y A D+W+ G+ + +G PF Q
Sbjct: 156 QCNTFVGTVTYMSPERIQGES------YSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209
Query: 158 VMLRNIMEGKYSFSSPEWNDI 178
+++ I +G P
Sbjct: 210 ELMQAICDG----PPPSLPAE 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
++ +MRQL ++ +H+H +VHRDLKP+NIL+ VK+ DFG AR+ L
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT 164
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
+ T Y APEVL + Y VD+W+ G I L
Sbjct: 165 SVVVTLWYRAPEVLL------QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 10/137 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC-- 106
R+ ++ AL+ +H+ +HRD+KP+N+LLD ++KL DFG +K M C
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDT 202
Query: 107 --GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
GTP Y++PEVL++ + G YG+ D W+ GV +Y +LVG PF+ + I
Sbjct: 203 AVGTPDYISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
Query: 164 MEGKYSFSSPEWNDISG 180
M+ K S + P+ +IS
Sbjct: 260 MDHKNSLTFPDDIEISK 276
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLM-DLC 106
+ MR L + + ++H + ++HRDLKP N+L+ +K+ DFG AR+ + E +L
Sbjct: 102 KSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE+L A Y VD+WA G I LL G P F
Sbjct: 162 ATRWYRAPELLYG-----ARKYDPGVDLWAVGCIFAELLNGSPLF 201
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 46/105 (43%), Positives = 63/105 (60%), Gaps = 6/105 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-GEKLMDLC 106
+R + Q+ +E H+H+++HRD+KPENIL+ VKL DFGFAR L GE D
Sbjct: 102 VRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV 161
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE+L + T YG+AVD+WA G ++ +L G P F
Sbjct: 162 ATRWYRAPELLVGD-----TKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 41/103 (39%), Positives = 64/103 (62%), Gaps = 7/103 (6%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGT 108
Y+ R++ + LE++H+ +V+HRD+K +NILL +VKL DFGFA L K K + GT
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT 179
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
P ++APEV++ YG VD+W+ G++ + G PP+
Sbjct: 180 PYWMAPEVIKRKD------YGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-EKL 102
P + Q+ LEH+H +++RDLKPEN+LLD+ NV+++D G A LK G K
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT 154
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV---- 158
GTPG++APE+L+ Y +VD +A GV +Y ++ PF R + V
Sbjct: 155 KGYAGTPGFMAPELLQGEE------YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208
Query: 159 MLRNIMEGKYSFS---SPEWNDI-SGYLAPEVLRANMFEDAT 196
+ + I+ ++ SP LA + + F D
Sbjct: 209 LKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGN 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 44/119 (36%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPE++ + GYG+AVD WA G+++Y +L G PPF+ + + I+EGK F
Sbjct: 164 YLAPEIILS------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF 217
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQDIEP 290
S S D KDLIR LL V R V + NH +F L + IE
Sbjct: 218 PSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEA 272
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 72/257 (28%), Positives = 114/257 (44%), Gaps = 55/257 (21%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95
II S+ L +Y + QL L+++H+ +V+HRDLKP N+LL+ ++K+ DFG AR
Sbjct: 98 IIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157
Query: 96 -LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154
+KG+ + + T Y APE+L + + Y A+DVW+ G I LL P F +
Sbjct: 158 TSEKGDFMTEYVVTRWYRAPELLL-----NCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212
Query: 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 214
+ L+ I E SP D+ +R E A Y +++
Sbjct: 213 DYVHQLKLITE---LLGSPSEEDL------GFIRN---EKARRYIRSL------------ 248
Query: 215 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
P+ R+ L + + DL+ K+L+ P R +V+EAL
Sbjct: 249 -----PYTPRQSFARL--------------FPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
Query: 275 NHSFFHPKLFDQDIEPI 291
H + L D EP+
Sbjct: 290 AHPYLAS-LHDPSDEPV 305
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 13/102 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL GYG+AVD W+ GV++Y +L G PPF+ + + I++ F
Sbjct: 159 YLAPEVLLG------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF 212
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR---YSVKEALNHSFF 279
PE +S + +DLI LL P R +E H FF
Sbjct: 213 --PE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 52/141 (36%), Positives = 82/141 (58%), Gaps = 11/141 (7%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENILLDDQMNVKLTDFGFARV-L 96
++ + S R+ ++ AL+++H+ +VV+RDLK EN++LD ++K+TDFG + +
Sbjct: 88 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147
Query: 97 KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
K G + CGTP YLAPEVL N YG+AVD W GV+MY ++ G PF+++
Sbjct: 148 KDGATMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201
Query: 157 MVMLRNIMEGKYSFS---SPE 174
+ I+ + F SPE
Sbjct: 202 EKLFELILMEEIRFPRTLSPE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 42/96 (43%), Positives = 60/96 (62%), Gaps = 6/96 (6%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR--VLKKGEKLMDLCGTPGYLAPE 115
ALEH+H +++RD+K ENILLD +V LTDFG ++ + E+ CGT Y+AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
++R G+ +AVD W+ GV+MY LL G PF
Sbjct: 177 IVRGG----DGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 44/104 (42%), Positives = 62/104 (59%), Gaps = 7/104 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ AL +H H V++RDLK +NILLD + + KL DFG + + G CG
Sbjct: 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y+APE+L+ YG +VD WA GV+MY ++ G PPF
Sbjct: 159 TPDYIAPEILQ------ELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 46/128 (35%), Positives = 64/128 (50%), Gaps = 2/128 (1%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--C 106
++ + +L A+ VH VHRD+KPEN+L+D ++KL DFG A L + +
Sbjct: 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
GTP Y+APEVL + YG D W+ GVI Y ++ G PF NIM
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224
Query: 167 KYSFSSPE 174
+ PE
Sbjct: 225 QRFLKFPE 232
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 42/104 (40%), Positives = 66/104 (63%), Gaps = 7/104 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ AL +H +++RDLK +N+LLD + ++KLTD+G + ++ G+ CG
Sbjct: 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y+APE+LR ED YG +VD WA GV+M+ ++ G PF
Sbjct: 159 TPNYIAPEILRG---ED---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 40/100 (40%), Positives = 60/100 (60%), Gaps = 6/100 (6%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLR 118
LE +H +V+RDLKPENILLDD +++++D G A + +GE + GT GY+APEV++
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK 174
Query: 119 ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
Y + D W G ++Y ++ G PF RK+ V
Sbjct: 175 NER------YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 41/116 (35%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGTPGYL 112
Q+ L H+H+ ++HRD+K N+ LD NVK+ D G A++L + + GTP YL
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYL 168
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
+PE + ED Y + DVWA GV++Y G PF Q ++ I+ G +
Sbjct: 169 SPE-----LCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 8e-20
Identities = 46/121 (38%), Positives = 74/121 (61%), Gaps = 12/121 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ AL+++H+ +V+RDLK EN++LD ++K+TDFG + + + CG
Sbjct: 98 RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW---HRK--QMVMLRN 162
TP YLAPEVL N YG+AVD W GV+MY ++ G PF+ H K +++++ +
Sbjct: 158 TPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 163 I 163
I
Sbjct: 212 I 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 10/121 (8%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-----EKLMDL 105
+++++ + LE++H++ +HRD+K NILL + +VK+ DFG + L G +
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP ++APEV+ E GY D+W+ G+ L G P+ M +L ++
Sbjct: 167 VGTPCWMAPEVM-----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221
Query: 166 G 166
Sbjct: 222 N 222
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 38/237 (16%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R+ M + A+E VH +HRD+KP+NIL+D ++KL+DFG + K +
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD------S 157
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML---RNIME 165
Y ++N AVD I T+ + Q+ R +M
Sbjct: 158 AYYQKLLQGKSNKNRIDNRNSVAVDS-----INLTMS-------SKDQIATWKKNRRLM- 204
Query: 166 GKYS-FSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224
YS +P+ Y+APE+ GYGQ D W+ G IM+ L+G PPF
Sbjct: 205 -AYSTVGTPD------YIAPEIFLQQ------GYGQECDWWSLGAIMFECLIGWPPFCSE 251
Query: 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPE--DRYSVKEALNHSFF 279
R I+ + + P+ +S + +DLIR+L+ R E +H FF
Sbjct: 252 NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 45/134 (33%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDD-QMNVKLTDFGFARVLKKGEKLMDLCGTPGYL 112
Q+ AL HVH ++HRDLK +NILLD +M VK+ DFG +++L K + GTP Y+
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYI 168
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 172
+PE+ + Y Q D+WA G ++Y L F ++ IM G +
Sbjct: 169 SPELC------EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF---- 218
Query: 173 PEWNDISGYLAPEV 186
IS +P++
Sbjct: 219 ---APISDRYSPDL 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 44/119 (36%), Positives = 68/119 (57%), Gaps = 10/119 (8%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
LE +H + V+RDLKPENILLDD +++++D G A + +GE + GT GY+APEVL
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIMEGKYSFSS 172
Y + D W G ++Y ++ G PF RK+ V + R ++E + +S+
Sbjct: 174 NNQR------YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 7/120 (5%)
Query: 38 VQDIINSNPALR-----YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
V+ + L+ YI+R+ L ++H + V+HRD+K +NILL VKL DFG
Sbjct: 100 VKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 93 ARVLKKGEKLMDLC-GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ L + GTP ++APEV+ + DA+ Y DVW+ G+ L G PP
Sbjct: 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDAS-YDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 41/95 (43%), Positives = 60/95 (63%), Gaps = 7/95 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
L+++H + +V+RDLK +N+LLD + VK+ DFG + + G++ CGTP +LAPEV
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L T Y +AVD W GV++Y +LVG PF
Sbjct: 173 LT------ETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 44/106 (41%), Positives = 61/106 (57%), Gaps = 2/106 (1%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMD 104
P +RY+ RQ+ EAL +H+H V+HRDLK NILL +VKL DFG A+ +K
Sbjct: 103 PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
GTP ++APEV+ F+D Y D+W+ G+ + L PP
Sbjct: 163 FIGTPYWMAPEVVACETFKDNP-YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 7/115 (6%)
Query: 52 MRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMDLCGTPG 110
+ Q+ + L ++H V+HRD+K NIL VKL DFG A ++ + + GTP
Sbjct: 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
++APEV+ + G A D+W+ G + LL G PP++ M L I++
Sbjct: 165 WMAPEVIEMS------GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 43/104 (41%), Positives = 67/104 (64%), Gaps = 7/104 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ AL ++H +++RDLK +N+LLD + ++KLTD+G + L+ G+ CG
Sbjct: 99 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y+APE+LR ED YG +VD WA GV+M+ ++ G PF
Sbjct: 159 TPNYIAPEILRG---ED---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 40/102 (39%), Positives = 57/102 (55%), Gaps = 11/102 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEV+ G+ + VD W+ G I+Y LVG PPF + +NI+ GK +
Sbjct: 167 YIAPEVILGQ------GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR---YSVKEALNHSFF 279
PE ++S++ DLI KLL+ PE R S++E NH FF
Sbjct: 221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 34 GEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKL 87
G ++QDI S + Y+ R+ + L ++H +HRD+K NILL + +VKL
Sbjct: 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKL 142
Query: 88 TDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146
DFG + L K GTP ++APEV GY D+WA G+ L
Sbjct: 143 ADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER---KGGYDGKCDIWALGITAIELAE 199
Query: 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
PP + M L + K +F P+ D
Sbjct: 200 LQPPMFDLHPMRAL--FLISKSNFPPPKLKD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 47/128 (36%), Positives = 68/128 (53%), Gaps = 5/128 (3%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--C 106
R+ + ++ A++ VH VHRD+KP+N+LLD +++L DFG L +
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV 164
Query: 107 GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP Y++PE+L+A ED G YG D W+ GV MY +L G PF+ + IM
Sbjct: 165 GTPDYISPEILQA--MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
Query: 166 GKYSFSSP 173
K F P
Sbjct: 223 HKEHFQFP 230
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 77/313 (24%), Positives = 128/313 (40%), Gaps = 76/313 (24%)
Query: 17 KEEGDDLKHLAAQVVDKGEAAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRD 71
+ G D K + V+D E+ + II+S+ L RY + QL L+++H+ +V+HRD
Sbjct: 74 RPPGADFKDVYV-VMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRD 132
Query: 72 LKPENILLDDQMNVKLTDFGFARVL-----KKGEKLMDLCGTPGYLAPEVLRANMFEDAT 126
LKP N+L+++ +++ DFG AR L + + + T Y APE+ +
Sbjct: 133 LKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL----LLS-LP 187
Query: 127 GYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEV 186
Y A+D+W+ VGC A +
Sbjct: 188 EYTTAIDMWS---------VGC--------------------------------IFAEML 206
Query: 187 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP--FWHRKQMVMLRNIMEGKYSFSSPE 244
R +F Q +I+ L G P +R +R ++
Sbjct: 207 GRRQLFPGKNYVHQ------LKLILSVL--GSPSEEVLNRIGSDRVRKYIQNLPRKQPVP 258
Query: 245 WNDI----SEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKK---DYKT 297
W+ I S + DL+ ++L PE+R +V++AL H F + D D EP D+
Sbjct: 259 WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL-AQYHDPDDEPTCPPPFDFDF 317
Query: 298 ASRKLSKINQLTE 310
+ +LS+ QL E
Sbjct: 318 EAIELSR-EQLKE 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 61/251 (24%), Positives = 103/251 (41%), Gaps = 60/251 (23%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
++++ Q+ L+++H+ ++HRDLKP NI +++ +K+ DFG AR +++ T
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVAT 178
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y APE++ M Y Q VD+W+ G IM LL G F + L+ IM
Sbjct: 179 RWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN--- 230
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
+ G E+L+ E A Y Q++ P +K
Sbjct: 231 ---------LVGTPDEELLQKISSESARNYIQSL-----------------PQMPKKD-- 262
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP------- 281
+ + G + DL+ K+L++ P+ R + EAL H +
Sbjct: 263 -FKEVFSGA-----------NPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE 310
Query: 282 ---KLFDQDIE 289
+DQ E
Sbjct: 311 PVAPPYDQSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 51/136 (37%), Positives = 79/136 (58%), Gaps = 10/136 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC-- 106
R+ ++ AL+ +H+ +HRD+KP+N+LLD ++KL DFG +K ++ M C
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDT 202
Query: 107 --GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
GTP Y++PEVL++ + G YG+ D W+ GV +Y +LVG PF+ + I
Sbjct: 203 AVGTPDYISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
Query: 164 MEGKYSFSSPEWNDIS 179
M K S + P+ NDIS
Sbjct: 260 MNHKNSLTFPDDNDIS 275
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 42/132 (31%), Positives = 74/132 (56%), Gaps = 11/132 (8%)
Query: 37 AVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
A+ DI+ + + + + +AL +H V+HRD+K ++ILL VKL+DFGF
Sbjct: 102 ALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF 161
Query: 93 -ARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
A+V K+ + L GTP ++APEV+ YG VD+W+ G+++ ++ G PP+
Sbjct: 162 CAQVSKEVPRRKSLVGTPYWMAPEVI------SRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
Query: 152 WHRKQMVMLRNI 163
++ + ++ I
Sbjct: 216 FNEPPLQAMKRI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 42/124 (33%), Positives = 67/124 (54%), Gaps = 10/124 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK----KG 99
+ R RQ+ E +E++H++ +VHRD+K NIL D NVKL DFG ++ L+ G
Sbjct: 102 TETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+ + GTP +++PEV+ GYG+ DVW+ G + +L PP+ + M
Sbjct: 162 TGMKSVTGTPYWMSPEVISGE------GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215
Query: 160 LRNI 163
+ I
Sbjct: 216 IFKI 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 41/113 (36%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S ++ +M QL L+++H + ++HRDLK N+LL D+ +K+ DFG AR K M
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 104 DLCGTPG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y APE+L T Y A+D+WA G I+ LL P
Sbjct: 166 ----TPKVVTLWYRAPELLLG-----CTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/251 (25%), Positives = 97/251 (38%), Gaps = 66/251 (26%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR--------- 94
+ ++ I+ Q+ L +H +HRDL P NI ++ + K+ DFG AR
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 95 ------VLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
+++ E++ T Y APE+L A Y AVD+W+ G I LL G
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMG-----AEKYHFAVDMWSVGCIFAELLTGK 231
Query: 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACG 208
P F ++ L I E + + W P+ +
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNW--------PQAKK-------------------- 263
Query: 209 VIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY 268
+ +YT F RK + N S+D DL++ LL + P +R
Sbjct: 264 LPLYT------EFTPRK-----------PKDLKTIFPNA-SDDAIDLLQSLLKLNPLERI 305
Query: 269 SVKEALNHSFF 279
S KEAL H +F
Sbjct: 306 SAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 42/119 (35%), Positives = 68/119 (57%), Gaps = 10/119 (8%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
LE +H +V+RDLKPENILLDD +++++D G A + +G+ + GT GY+APEV+
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIMEGKYSFSS 172
+ Y + D WA G ++Y ++ G PF RK+ + + R + E + +S
Sbjct: 174 KNER------YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 52/271 (19%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S+ +++++ QL L+++H+ ++HRDLKP N+ +++ +++ DFG AR + +++
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT 173
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
T Y APE++ M Y Q VD+W+ G IM LL G F + L+ I
Sbjct: 174 GYVATRWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
ME + G +PEVL+ E A Y Q++ P
Sbjct: 229 ME------------VVGTPSPEVLKKISSEHARKYIQSL----------------PHMPQ 260
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
+ L+ I G + DL+ K+L++ + R S EAL H +F +
Sbjct: 261 QD----LKKIFRGANPLAI-----------DLLEKMLVLDSDKRISASEALAHPYF-SQY 304
Query: 284 FDQDIEPIKKDY-KTASRKLSKINQLTEFQF 313
D + EP + Y ++ K I + E +
Sbjct: 305 HDPEDEPEAEPYDESPENKERTIEEWKELTY 335
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 53/234 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK--LMDL 105
++ M+QL E L + H + +HRD+K NILL+++ +KL DFG AR+ E +
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
T Y PE+L YG A+DVW+CG I+ L P F +++ L I
Sbjct: 178 VITLWYRPPELLLGE-----ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI-- 230
Query: 166 GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR- 224
+ + G P VW VI P+++
Sbjct: 231 ----------SRLCGSPCP------------------AVWP-DVIKL-------PYFNTM 254
Query: 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
K R + ++SF I DL+ +L + P R + +EALN +
Sbjct: 255 KPKKQYRRRLREEFSF-------IPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 45/125 (36%), Positives = 69/125 (55%), Gaps = 10/125 (8%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP 109
+ Q+ + H+H+ +V+RD+KPEN+LLDDQ N +L+D G A LK G+ + GT
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 165
GY+APE+L+ Y VD +A G +Y ++ G PF K+ V + R +E
Sbjct: 159 GYMAPEILKEEP------YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 166 GKYSF 170
+ F
Sbjct: 213 DEVKF 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 7/119 (5%)
Query: 51 IMRQLFEALEHVHNHS-VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP 109
I Q+ AL ++H +VHRDL P NI+L + V +TDFG A+ + KL + GT
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y PE+++ YG+ DVWA G I+Y + PPF+ + + I+E Y
Sbjct: 178 LYSCPEIVK------NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 66/253 (26%), Positives = 95/253 (37%), Gaps = 89/253 (35%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP 109
+I+R++ LE++H +HRD+K NILL ++ +VKL DFG +
Sbjct: 102 FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS---------------- 145
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 169
G L + + N F VG P FW
Sbjct: 146 GQLTSTMSKRNTF-----------------------VGTP-FW----------------- 164
Query: 170 FSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229
+APEV++ +GY + D+W+ G+ L G PP M +
Sbjct: 165 ------------MAPEVIKQ------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206
Query: 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIE 289
L I K + S E N S+ KD + L P++R S KE L H F
Sbjct: 207 LFLIP--KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF----------- 253
Query: 290 PIKKDYKTASRKL 302
IKK KT+ L
Sbjct: 254 -IKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 37/104 (35%), Positives = 61/104 (58%), Gaps = 7/104 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCG 107
R+ ++ L+ +H +++RDLK +N+LLD ++K+ DFG + GE CG
Sbjct: 99 RFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y+APE+L+ Y ++VD W+ GV++Y +L+G PF
Sbjct: 159 TPDYIAPEILKGQK------YNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 61/240 (25%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNV-KLTDFGFAR-----VLKKG 99
++ M QL + + H H H V+HRDLKP+N+L+D Q + K+ D G R V
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+++ L Y APEVL +T Y VD+W+ G I + P F ++
Sbjct: 170 HEIVTLW----YRAPEVLLG-----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ 220
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
L +I + + + W P V + D +
Sbjct: 221 LLHIFKLLGTPTEQVW--------PGVSK---LRDWHEF--------------------- 248
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P W + + + D+S + DL++K+L P R S K AL H +F
Sbjct: 249 PQWKPQDL---------SRAVP-----DLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 42/104 (40%), Positives = 64/104 (61%), Gaps = 7/104 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCG 107
R+ ++ AL +H +++RDLK +N+LLD ++KLTD+G + L G+ CG
Sbjct: 99 RFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
TP Y+APE+LR E+ YG +VD WA GV+M+ ++ G PF
Sbjct: 159 TPNYIAPEILRG---EE---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 40/153 (26%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK------------------- 98
ALE++H +V+RDLKPENILL + ++ L+DF ++
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 99 -----------GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147
+ GT Y+APEV+ + G+G AVD W G+++Y +L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD------GHGSAVDWWTLGILLYEMLYG 228
Query: 148 CPPFW-HRKQMVMLRNIMEGKYSFSSPEWNDIS 179
PF + NI++ + +F P +S
Sbjct: 229 TTPFKGSNRDET-FSNILKKEVTF--PGSPPVS 258
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 41/113 (36%), Positives = 62/113 (54%), Gaps = 6/113 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P +R RQ+ LE++H+ + VHRD+K NIL+D VKL DFG A+ + +
Sbjct: 102 PVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
G+P ++APEV+ GYG A D+W+ G + + G PP W + + V
Sbjct: 162 KGSPYWMAPEVIAQQ-----GGYGLAADIWSLGCTVLEMATGKPP-WSQLEGV 208
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 12/152 (7%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMD 104
R+ ++ AL +H+ +++RDLK +N+LLD + + KL DFG + + G+
Sbjct: 96 ARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
CGTP Y+APE+L+ + YG +VD WA GV++Y +L G PF + + I+
Sbjct: 156 FCGTPDYIAPEILQEML------YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
Query: 165 EGKYSFSSPEWNDISGYLAPEVLRANMFEDAT 196
+ + P W A ++L+A M ++ T
Sbjct: 210 NDEVVY--PTW---LSQDAVDILKAFMTKNPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 48/147 (32%), Positives = 67/147 (45%), Gaps = 50/147 (34%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA--------------- 93
R+ + +L A+E VH +HRD+KP+NIL+D ++KLTDFG
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 94 ---------------------------RVLKKGEKLM--DLCGTPGYLAPEVLRANMFED 124
R ++ ++ + L GTP Y+APEVL
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL------L 217
Query: 125 ATGYGQAVDVWACGVIMYTLLVGCPPF 151
TGY Q D W+ GVI+Y +LVG PPF
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 7e-18
Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 15/145 (10%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLA 113
QL L+ +H ++HRDLK NILL VK+ D G ++VLKK GTP Y+A
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMA 169
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN-IMEGKYSFSS 172
PEV + Y D+W+ G ++Y + PPF + M LR + GKY
Sbjct: 170 PEVWK------GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIP 222
Query: 173 PEWND-----ISGYLAPE-VLRANM 191
P ++ I L + LR N
Sbjct: 223 PIYSQDLQNFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-18
Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTP 109
+ R+ +ALE +H++ V+HRD+K +NILL +VKLTDFGF A++ + K + GTP
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKY 168
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 181 YWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 169 SFSSPE 174
+PE
Sbjct: 235 ELQNPE 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTP 109
+ R+ +ALE +H++ V+HRD+K +NILL +VKLTDFGF A++ + K + GTP
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKY 168
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 180 YWMAPEVVTRKA------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 169 SFSSPE 174
+PE
Sbjct: 234 ELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 47/128 (36%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMDLC- 106
R+ + ++ A++ VH VHRD+KP+NIL+D +++L DFG ++++ G +
Sbjct: 105 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 164
Query: 107 GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP Y++PE+L+A ED G YG D W+ GV MY +L G PF+ + IM
Sbjct: 165 GTPDYISPEILQA--MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
Query: 166 GKYSFSSP 173
K F P
Sbjct: 223 HKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 38/102 (37%), Positives = 60/102 (58%), Gaps = 6/102 (5%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTP 109
I+R++ AL+++H V+HRD+K NIL+ + NVKL DFG A +L + K GTP
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
++APEV+ + Y D+W+ G+ +Y + G PP+
Sbjct: 166 YWMAPEVIT-----EGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 49/138 (35%), Positives = 80/138 (57%), Gaps = 10/138 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC-- 106
++ ++ AL+ +H+ ++HRD+KP+N+LLD ++KL DFG +K E M C
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVRCDT 202
Query: 107 --GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
GTP Y++PEVL++ + G YG+ D W+ GV ++ +LVG PF+ + I
Sbjct: 203 AVGTPDYISPEVLKS---QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
Query: 164 MEGKYSFSSPEWNDISGY 181
M+ K S + PE +IS +
Sbjct: 260 MDHKNSLNFPEDVEISKH 277
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 6/104 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++ M QL ++L+H+H + + HRD+KPENIL+ D +KL DFG R + +
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS 160
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE L + + YG +D+WA G + + +L P F
Sbjct: 161 TRWYRAPECLLTDGY-----YGPKMDIWAVGCVFFEILSLFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 17/120 (14%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD------LCGTPG 110
L +H+ +++RDLK +N++LD + ++K+ DFG + E + CGTP
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPD 166
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
Y+APE++ YG++VD WA GV++Y +L G PPF + + ++IME S+
Sbjct: 167 YIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 41/112 (36%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 55 LFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTPGYLA 113
+ AL ++HN V+HRD+K ++ILL +KL+DFGF A+V K+ K L GTP ++A
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
PEV+ YG VD+W+ G+++ ++ G PP+++ + +R I +
Sbjct: 187 PEVI------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 44/126 (34%), Positives = 71/126 (56%), Gaps = 8/126 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTP 109
+ R+ +ALE +H + V+HRD+K +N+LL +VKLTDFGF A++ + K + GTP
Sbjct: 120 VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKY 168
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 180 YWMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 169 SFSSPE 174
+PE
Sbjct: 234 ELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 39/100 (39%), Positives = 59/100 (59%), Gaps = 6/100 (6%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLR 118
LE + +V+RDLKPENILLDD+ +++++D G A + +GE + GT GY+APEV+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174
Query: 119 ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
Y + D W G ++Y ++ G PF RK+ V
Sbjct: 175 NE------KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 42/126 (33%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 34 GEAAVQDIINSNPA-------LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVK 86
G +V D++ + + YI R++ L H+H H V+HRD+K +N+LL + VK
Sbjct: 102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161
Query: 87 LTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
L DFG + L + + GTP ++APEV+ + DAT Y D+W+ G+ +
Sbjct: 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT-YDYRSDIWSLGITAIEMA 220
Query: 146 VGCPPF 151
G PP
Sbjct: 221 EGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 53/265 (20%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
+++++ Q+ + L+++H ++HRDLKP N+ +++ +K+ DFG AR + ++
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV 177
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
T Y APEV+ M Y Q VD+W+ G IM +L G P F + L IM+
Sbjct: 178 TRWYRAPEVILNWMH-----YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK-- 230
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
++G + E ++ EDA Y + P F +
Sbjct: 231 ----------VTGTPSKEFVQKLQSEDAKNY----------------VKKLPRFRKKDFR 264
Query: 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF---HPKLF 284
+L N +P +++ K+L++ E R + EAL H +F H
Sbjct: 265 SLLPNA--------NPL-------AVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309
Query: 285 DQDIEPIKKDYKTASRKLSKINQLT 309
+ + P + + L + +LT
Sbjct: 310 ETEAPPYDDSFDEVDQSLEEWKRLT 334
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 44/128 (34%), Positives = 68/128 (53%), Gaps = 5/128 (3%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD--LC 106
R+ + ++ A+ +H VHRD+KP+N+LLD +++L DFG + + +
Sbjct: 105 RFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 107 GTPGYLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP Y++PE+L+A ED G YG D W+ GV MY +L G PF+ + IM
Sbjct: 165 GTPDYISPEILQA--MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
Query: 166 GKYSFSSP 173
+ F P
Sbjct: 223 HEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 67/279 (24%), Positives = 106/279 (37%), Gaps = 91/279 (32%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM--DL 105
+ Y++ Q+ ++H+H+ ++HRDLKP NI++ +K+ DFG AR G M
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY 177
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
T Y APEV+ GY + VD+W+ G IM +M+ +
Sbjct: 178 VVTRYYRAPEVIL------GMGYKENVDIWSVGCIM-------------GEMIRGTVLFP 218
Query: 166 GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP--FWH 223
G +WN I +G P F
Sbjct: 219 GTDHID--QWNKI----------------------------------IEQLGTPSDEFMS 242
Query: 224 RKQMVMLRNIMEGK-----YSFS-----------SPEWNDI-SEDPKDLIRKLLIVTPED 266
R Q +RN +E + YSF S N + + +DL+ K+L++ PE
Sbjct: 243 RLQP-TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301
Query: 267 RYSVKEALNHSFFH------------PKLFDQDIEPIKK 293
R SV +AL H + + P +D I+ +
Sbjct: 302 RISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREH 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 71/248 (28%), Positives = 102/248 (41%), Gaps = 62/248 (25%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S A ++ + + A++ +H +HRD+KP+N+LLD + +VKL+DFG LKK +
Sbjct: 99 SEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP----FWH----RK 155
Y L PP F + RK
Sbjct: 159 -------------------------------------FYRNLTHNPPSDFSFQNMNSKRK 181
Query: 156 QMVMLRNIMEGKYS-FSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 214
+N + YS +P+ Y+APEV TGY + D W+ GVIMY +
Sbjct: 182 AETWKKNRRQLAYSTVGTPD------YIAPEVFMQ------TGYNKLCDWWSLGVIMYEM 229
Query: 215 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVK 271
L+G PPF R +M K + P ISE KDLI + E+R V+
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVE 288
Query: 272 EALNHSFF 279
E +H FF
Sbjct: 289 EIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTP 109
+ R+ +AL+ +H++ V+HRD+K +NILL +VKLTDFGF A++ + K + GTP
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKY 168
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 180 YWMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 169 SFSSPE 174
+PE
Sbjct: 234 ELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 12/105 (11%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR----VLKKGEKLMDLC 106
+M QL + H+H++ ++HRDLK N+LL+++ +K+ DFG AR LK L
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---PYTQLV 167
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE+L A Y A+D+W+ G I LL P F
Sbjct: 168 VTLWYRAPELLL-----GAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-17
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 13/113 (11%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
P +Q+ + + ++HN+ VVHRD+K N++L +KL DFG AR L
Sbjct: 102 PVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 99 GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L + GTP ++APEV+ +GYG+ D+W+ G ++ + G PP
Sbjct: 162 SNMLKSMHGTPYWMAPEVIN------ESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 14/104 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIMEGKYS 239
Y+APEV+ + G+G AVD W G+++Y +L G PF + NI++ + +
Sbjct: 198 YIAPEVISGD------GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-FSNILKKEVT 250
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDR----YSVKEALNHSFF 279
F P +S +DLIRKLL+ P R E H FF
Sbjct: 251 F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 39/110 (35%), Positives = 65/110 (59%), Gaps = 7/110 (6%)
Query: 62 VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEVLRAN 120
+H +++RDLK +N++LD + ++K+ DFG + + G CGTP Y+APE++
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
YG++VD WA GV++Y +L G PPF + + ++IME S+
Sbjct: 177 ------PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 44/137 (32%), Positives = 73/137 (53%), Gaps = 15/137 (10%)
Query: 36 AAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+++D + S AL R RQ+ E + ++H++ +VHRD+K NIL D NVKL DF
Sbjct: 91 GSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF 150
Query: 91 GFARVLK----KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146
G ++ L+ G + + GTP +++PEV+ GYG+ D+W+ G + +L
Sbjct: 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE------GYGRKADIWSVGCTVVEMLT 204
Query: 147 GCPPFWHRKQMVMLRNI 163
PP+ + M + I
Sbjct: 205 EKPPWAEFEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 55/286 (19%)
Query: 18 EEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77
EE D+ +L +++D V + + + Y++ Q+ ++H+H+ ++HRDLKP NI
Sbjct: 96 EEFQDV-YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154
Query: 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137
++ +K+ DFG AR + T Y APEV+ GY + VD+W+
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL------GMGYKENVDIWSV 208
Query: 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATG 197
G IM L+ G F + ++E +P + L P V N E+
Sbjct: 209 GCIMGELVKGSVIFQGTDHIDQWNKVIE---QLGTPSA-EFMNRLQPTV--RNYVENRPQ 262
Query: 198 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND--ISEDPKDL 255
Y G+ L P W F S D + +DL
Sbjct: 263 YP--------GISFEELF----PDW----------------IFPSESERDKLKTSQARDL 294
Query: 256 IRKLLIVTPEDRYSVKEALNHSFFH------------PKLFDQDIE 289
+ K+L++ P+ R SV EAL H + P+++D +E
Sbjct: 295 LSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLE 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 61/237 (25%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLCG 107
+ QL + + H + V+HRDLKP+N+L++ + +KL DFG AR +
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRNIM 164
T Y AP+VL + Y ++D+W+ G IM ++ G P F Q++ + IM
Sbjct: 163 TLWYRAPDVLLG-----SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217
Query: 165 EGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224
G + S+ W IS PE P + +
Sbjct: 218 -GTPTEST--WPGIS--QLPEYKPT----------------------------FPRYPPQ 244
Query: 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPK--DLIRKLLIVTPEDRYSVKEALNHSFF 279
+ + DP DL+ +LL + PE R S +AL H +F
Sbjct: 245 DLQQLFPHA-----------------DPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 9e-17
Identities = 44/112 (39%), Positives = 64/112 (57%), Gaps = 6/112 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S +R+ ++ LEH+HN VV+RDLKP NILLD+ +V+++D G A K +K
Sbjct: 95 SEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH 153
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
GT GY+APEVL + T Y + D ++ G +++ LL G PF K
Sbjct: 154 ASVGTHGYMAPEVL-----QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 9e-17
Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 9/126 (7%)
Query: 34 GEAAVQDIINSNPA-------LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVK 86
G +V D+I + + YI R++ L H+H H V+HRD+K +N+LL + VK
Sbjct: 92 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151
Query: 87 LTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
L DFG + L + + GTP ++APEV+ + DAT Y D+W+ G+ +
Sbjct: 152 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT-YDFKSDLWSLGITAIEMA 210
Query: 146 VGCPPF 151
G PP
Sbjct: 211 EGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 72/252 (28%), Positives = 109/252 (43%), Gaps = 36/252 (14%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R+ + +L A+E VH +HRD+KP+NIL+D ++KLTDFG + +
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD------S 157
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIMEG 166
Y + + +R + + + +G + CG + P R+ L + + G
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANC-RCGDRLK------PLERRAARQHQRCLAHSLVG 210
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226
+P Y+APEVL TGY Q D W+ GVI+Y +LVG PPF +
Sbjct: 211 -----TPN------YIAPEVLLR------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
Query: 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHPKL 283
+ ++ + S P +S + DLI K L PEDR E H FF
Sbjct: 254 LETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID 312
Query: 284 FDQDIEPIKKDY 295
F D+ Y
Sbjct: 313 FSSDLRQQSAPY 324
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 66/259 (25%), Positives = 115/259 (44%), Gaps = 57/259 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
+++++ Q+ L+++H+ ++HRDLKP N+ +++ +K+ DFG AR +++
Sbjct: 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA 179
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
T Y APE++ M Y Q VD+W+ G IM LL G F + L+ I+
Sbjct: 180 TRWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR-- 232
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
+ G E+L+ E A Y Q++ QM
Sbjct: 233 ----------LVGTPGAELLKKISSESARNYIQSL----------------------TQM 260
Query: 228 VMLRNIMEGKYSFSSPEWNDISEDPK--DLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285
K +F++ I +P DL+ K+L++ + R + +AL H++F + D
Sbjct: 261 --------PKMNFANVF---IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-AQYHD 308
Query: 286 QDIEPIKKDYKTA--SRKL 302
D EP+ Y + SR L
Sbjct: 309 PDDEPVADPYDQSFESRDL 327
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 45/137 (32%), Positives = 73/137 (53%), Gaps = 15/137 (10%)
Query: 36 AAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+V+D + + AL R RQ+ E + ++H++ +VHRD+K NIL D NVKL DF
Sbjct: 91 GSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150
Query: 91 GFARVLK----KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146
G ++ L+ G + + GTP +++PEV+ GYG+ DVW+ G + +L
Sbjct: 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE------GYGRKADVWSLGCTVVEMLT 204
Query: 147 GCPPFWHRKQMVMLRNI 163
PP+ + M + I
Sbjct: 205 EKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 37/110 (33%), Positives = 65/110 (59%), Gaps = 7/110 (6%)
Query: 62 VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEVLRAN 120
+H+ +++RDLK +N++LD + ++K+ DFG + + G CGTP Y+APE++
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
YG++VD WA GV++Y +L G PF + + ++IME ++
Sbjct: 177 ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVL 117
L+ +H+ +V+RDLK +NILLD ++K+ DFG + G+ K CGTP Y+APE+L
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y +VD W+ GV++Y +L+G PF
Sbjct: 169 LGQK------YNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 63/258 (24%), Positives = 100/258 (38%), Gaps = 77/258 (29%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEK-L 102
++ ++ Q+ + ++H++ V+HRDLKP NIL+ ++ VK+ D G AR+ K L
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 103 MDLCG---TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF-------- 151
DL T Y APE+L A Y +A+D+WA G I LL P F
Sbjct: 170 ADLDPVVVTIWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
Query: 152 ----WHRKQMVMLRNIMEGKYSFSSPE-WNDISGYLAPEVLRANMFEDATGYGQAVDVWA 206
+ R Q+ + ++ + + W DI
Sbjct: 225 KSNPFQRDQLERIFEVL----GTPTEKDWPDIKKM------------------------- 255
Query: 207 CGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS-PEWND--ISEDPK--DLIRKLLI 261
P + + Y +S +W + D + DL+RKLL
Sbjct: 256 -------------PEYDTLMK----DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298
Query: 262 VTPEDRYSVKEALNHSFF 279
P R + +EAL H +F
Sbjct: 299 YDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 49/178 (27%), Positives = 73/178 (41%), Gaps = 42/178 (23%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---- 102
++ + + A++ +H +HRD+KP+N+LLD + +VKL+DFG LKK +
Sbjct: 102 ETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 103 --------------------------------MDLCGTPGYLAPEVLRANMFEDATGYGQ 130
GTP Y+APEV GY +
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT------GYNK 215
Query: 131 AVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLR 188
D W+ GVIMY +L+G PPF + +M K + P IS +LR
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 40/124 (32%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLCG 107
+Y + QL ALEH+H+ ++HRD+KP N+ + VKL D G R K L G
Sbjct: 110 KYFV-QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ--MVMLRNIME 165
TP Y++PE + N GY D+W+ G ++Y + PF+ K + + I +
Sbjct: 169 TPYYMSPERIHEN------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
Query: 166 GKYS 169
Y
Sbjct: 223 CDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 42/120 (35%), Positives = 64/120 (53%), Gaps = 10/120 (8%)
Query: 42 INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK 101
I L + RQ+ + ++H +VHRD+KP N+L++ NVK+ DFG +R+L +
Sbjct: 164 IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---Q 220
Query: 102 LMDLC----GTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
MD C GT Y++PE R N + Y G A D+W+ GV + +G PF +Q
Sbjct: 221 TMDPCNSSVGTIAYMSPE--RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 43/112 (38%), Positives = 63/112 (56%), Gaps = 6/112 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S +R+ ++ LEH+HN VV+RDLKP NILLD+ +V+++D G A K +K
Sbjct: 95 SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH 153
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
GT GY+APEVL + Y + D ++ G +++ LL G PF K
Sbjct: 154 ASVGTHGYMAPEVL-----QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 6e-16
Identities = 31/128 (24%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S L Q+ +E++ + + +HRDL N L+ + + VK++DFG +R L +
Sbjct: 100 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YY 158
Query: 104 DLCGTPG---YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVM 159
G ++APE L+ F DVW+ GV+++ + P+ +
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKF------TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 212
Query: 160 LRNIMEGK 167
L + G
Sbjct: 213 LEYLKNGY 220
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 34 GEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLT 88
G ++QDI + S + Y+ R+ + L ++H+ +HRD+K NILL D +VKL
Sbjct: 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLA 148
Query: 89 DFGF-ARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147
DFG A++ K GTP ++APEV E GY Q D+WA G+ L
Sbjct: 149 DFGVAAKITATIAKRKSFIGTPYWMAPEVAAV---EKNGGYNQLCDIWAVGITAIELAEL 205
Query: 148 CPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
PP + M L + K +F P+ D
Sbjct: 206 QPPMFDLHPMRAL--FLMSKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 34 GEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLT 88
G ++QDI + S + Y+ R+ + L ++H+ +HRD+K NILL D +VKL
Sbjct: 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLA 148
Query: 89 DFGF-ARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147
DFG A++ K GTP ++APEV E GY Q D+WA G+ L
Sbjct: 149 DFGVSAQITATIAKRKSFIGTPYWMAPEVAAV---ERKGGYNQLCDIWAVGITAIELAEL 205
Query: 148 CPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
PP + M L + K +F P+ D
Sbjct: 206 QPPMFDLHPMRAL--FLMTKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 58/254 (22%)
Query: 35 EAAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTD 89
EA + II S L + + Q+ L+++H+ +V+HRDLKP N+L++ +K+ D
Sbjct: 89 EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICD 148
Query: 90 FGFARVLKKG-----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
FG AR + + + T Y APE++ + Y +A+DVW+ G I+ L
Sbjct: 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-----QSYTKAIDVWSVGCILAEL 203
Query: 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDV 204
L P F + + L I++ + G E L A Y +++
Sbjct: 204 LGRKPVFKGKDYVDQLNQILQ------------VLGTPDEETLSRIGSPKAQNYIRSL-- 249
Query: 205 WACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTP 264
P +K + + ++P DL+ KLL P
Sbjct: 250 ---------------PNIPKKPFESI-------FPNANPL-------ALDLLEKLLAFDP 280
Query: 265 EDRYSVKEALNHSF 278
R SV+EAL H +
Sbjct: 281 TKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 39/112 (34%), Positives = 65/112 (58%), Gaps = 9/112 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-- 101
SN ++Y + Q+ L+++H+ +V+HRDLKP N+LL+ ++K+ DFG AR+
Sbjct: 104 SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 102 --LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L + T Y APE+ M ++ GY +A+D+W+ G I+ +L P F
Sbjct: 164 GFLTEYVATRWYRAPEI----ML-NSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 8/141 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKL 102
+ P ++ I RQ+ EAL+++H+ ++HRDLK N+LL ++KL DFG A+ +K ++
Sbjct: 108 TEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
GTP ++APEV+ +D T Y D+W+ G+ + + PP M +L
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKD-TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
Query: 163 IMEGK------YSFSSPEWND 177
I + + S S E+ D
Sbjct: 227 IAKSEPPTLSQPSKWSMEFRD 247
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPG 110
Q+ AL+ VH+ ++HRDLK NI L +KL DFGF++ L CGTP
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS- 169
YLAPE+ + Y + D+W+ GVI+Y LL PF Q +++ ++ GKY
Sbjct: 237 YLAPELW------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 170 FSSPEWNDISGYLAP 184
F P + + L P
Sbjct: 291 FPCPVSSGMKALLDP 305
|
Length = 478 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 44/128 (34%), Positives = 66/128 (51%), Gaps = 7/128 (5%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
I + L ++H+H +HRD+K NILL + VKL DFG A ++ + GTP
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---GTPY 176
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-S 169
++APEV+ A D Y VDVW+ G+ L PP ++ M L +I + +
Sbjct: 177 WMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233
Query: 170 FSSPEWND 177
SS +W+D
Sbjct: 234 LSSNDWSD 241
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC-GTPGYL 112
Q+ AL+HVH+ ++HRD+K +NI L +KL DFG ARVL +L C GTP YL
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
+PE+ + Y D+WA G ++Y +
Sbjct: 169 SPEIC------ENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 41/112 (36%), Positives = 68/112 (60%), Gaps = 10/112 (8%)
Query: 55 LFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTPGYLA 113
+ +AL +H V+HRD+K ++ILL VKL+DFGF A+V K+ + L GTP ++A
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRN 162
PE++ YG VD+W+ G+++ ++ G PP+++ K M M+R+
Sbjct: 185 PELI------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 40/104 (38%), Positives = 54/104 (51%), Gaps = 6/104 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++ +MRQ L+ +H + +VHRDLKPENIL+ VKL DFG AR+ L +
Sbjct: 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APEVL + Y VD+W+ G I + P F
Sbjct: 170 TLWYRAPEVLLQST------YATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 66/286 (23%)
Query: 35 EAAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTD 89
E+ + +I +N L ++ + QL AL+++H +V HRDLKP+NIL + +K+ D
Sbjct: 87 ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICD 146
Query: 90 FGFARV--LKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
FG ARV + D T Y APE L + F + Y A+D+W+ G I +L
Sbjct: 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF---SKYTPAIDIWSIGCIFAEVL 202
Query: 146 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVW 205
G P F K +V +++ D+ G +PE + E A Y ++
Sbjct: 203 TGKPLF-PGKNVVHQLDLI-----------TDLLGTPSPETISRVRNEKARRYLSSM--- 247
Query: 206 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPK--DLIRKLLIVT 263
+KQ V K+ + DP L+ +LL
Sbjct: 248 -----------------RKKQPVPF----SQKFP---------NADPLALRLLERLLAFD 277
Query: 264 PEDRYSVKEALNHSFFHPKLFDQDIEP-----IKKDYKTASRKLSK 304
P+DR + +EAL +F L + EP K +++ R+L+K
Sbjct: 278 PKDRPTAEEALADPYFK-GLAKVEREPSAQPITKLEFEFERRRLTK 322
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 39/103 (37%), Positives = 64/103 (62%), Gaps = 7/103 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKLMDLCGTP 109
+ + +AL ++H+ V+HRD+K ++ILL VKL+DFGF A++ K K L GTP
Sbjct: 122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152
++APEV+ T YG VD+W+ G+++ ++ G PP++
Sbjct: 182 YWMAPEVI------SRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 43/123 (34%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 56 FEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPE 115
+ L ++H+H+++HRD+K NILL + VKL DFG A + + GTP ++APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---GTPYWMAPE 191
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-SFSSPE 174
V+ A D Y VDVW+ G+ L PP ++ M L +I + + + S E
Sbjct: 192 VILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 175 WND 177
W+D
Sbjct: 249 WSD 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 17/136 (12%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGTP 109
I+ Q + LE++H++ +HRD+K NILL+++ KL DFG + L + + GTP
Sbjct: 104 ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH---RKQMVMLRNIMEG 166
++APEV++ GY D+W+ G+ + G PP+ + + M+ N +
Sbjct: 164 FWMAPEVIQEI------GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--KP 215
Query: 167 KYSFS-----SPEWND 177
+ S SPE+ND
Sbjct: 216 PPTLSDPEKWSPEFND 231
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 51/252 (20%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S ++Y++ Q+ L+++H+ ++HRDLKP N+ +++ +K+ DFG AR ++
Sbjct: 115 SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT 172
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
T Y APEV+ M Y Q VD+W+ G IM +L G F + + L I
Sbjct: 173 GYVVTRWYRAPEVILNWMH-----YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
++ ++G PE ++ + A Y +++ P +
Sbjct: 228 LK------------VTGVPGPEFVQKLEDKAAKSYIKSL-----------------PKYP 258
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
RK L + S DL+ K+L + + R + EAL H +F
Sbjct: 259 RKDFSTL--------------FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS-F 303
Query: 284 FDQDIEPIKKDY 295
D D E ++ Y
Sbjct: 304 RDADEETEQQPY 315
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 37/104 (35%), Positives = 59/104 (56%), Gaps = 7/104 (6%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++Y + Q+ L++VH+ VVHRDLKP NIL+++ ++K+ DFG AR+ + ++
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVS 167
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE++ Y VD+W+ G I +L G P F
Sbjct: 168 TRYYRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++ +M QL L+ +H+H VVHRDLKP+NIL+ +KL DFG AR+ L +
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 171
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APEVL + Y VD+W+ G I + P F
Sbjct: 172 TLWYRAPEVLL------QSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 9/128 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S L Q+ +E++ + + +HRDL N L+ + + VK++DFG +R L +
Sbjct: 101 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160
Query: 104 DLCGT-P-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVML 160
G P ++APE L+ F DVW+ GV+++ + P+ +L
Sbjct: 161 VKGGKLPIRWMAPESLKEGKF------TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL 214
Query: 161 RNIMEGKY 168
+ +G
Sbjct: 215 EYLKKGYR 222
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 48 LRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC 106
L I + + L ++H H ++HRD+KP NIL++ + +KL DFG + L
Sbjct: 102 LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFV 160
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152
GT Y+APE ++ N Y D+W+ G+ + L G P+
Sbjct: 161 GTSSYMAPERIQGN------DYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 54/151 (35%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF---------ARVLKKG 99
R+ + +L A+E VH +HRD+KP+NIL+D ++KLTDFG ++ +KG
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163
Query: 100 -----------------------EKLM----------------DLCGTPGYLAPEVLRAN 120
++L L GTP Y+APEVL
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GY Q D W+ GVI++ +LVG PPF
Sbjct: 224 ------GYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 68/253 (26%), Positives = 96/253 (37%), Gaps = 69/253 (27%)
Query: 44 SNPALRY-------IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-- 94
SN +++ +M+ L L ++H + ++HRD+K NIL+ +KL DFG AR
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169
Query: 95 VLKKGEKLMDLCG---TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L K K T Y PE+L YG +D+W G IM
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE-----RDYGPPIDMWGAGCIM-------AEM 217
Query: 152 WHRKQMVMLRNIMEGKYSFSSPEWNDIS---GYLAPEVLRANMFEDATGYGQAVDVWACG 208
W R IM+G + + IS G + PE VW G
Sbjct: 218 WTRSP------IMQG--NTEQHQLTLISQLCGSITPE------------------VWP-G 250
Query: 209 VIMYTLL--VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPED 266
V L + P RK L+ ++ ++ DLI KLL++ P
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHAL-------------DLIDKLLVLDPAK 297
Query: 267 RYSVKEALNHSFF 279
R ALNH FF
Sbjct: 298 RIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 42/137 (30%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLC-GTPGY 111
Q+ L+H+H+ ++HRD+K +NI L + M KL DFG AR L +L C GTP Y
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171
L+PE+ + + + T D+W+ G ++Y L PF ++ I +G ++
Sbjct: 169 LSPEICQNRPYNNKT------DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI 222
Query: 172 SPEWNDISGYLAPEVLR 188
SP ++ L ++ +
Sbjct: 223 SPNFSRDLRSLISQLFK 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 50/234 (21%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDL 105
+R + QL +A+ H + +VHRD+KPEN+L+ +KL DFGFAR L +G +
Sbjct: 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
T Y +PE+L YG+AVD+W+ G I+ L G P F ++ L I +
Sbjct: 162 VATRWYRSPELLL------GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215
Query: 166 GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225
+ G L E ++ + + +G + V P R+
Sbjct: 216 ------------VLGPLPAEQMKL-FYSNPRFHG-----------LRFPAVNHPQSLERR 251
Query: 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ +L ++ DL++ LL + P DRY ++ LNH F
Sbjct: 252 YLGILSGVL------------------LDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 38/119 (31%), Positives = 64/119 (53%), Gaps = 10/119 (8%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK----KGEKLMD 104
R RQ+ + + ++H++ +VHRD+K NIL D NVKL DFG ++ ++ G +
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
+ GTP +++PEV+ GYG+ DVW+ + +L PP+ + M + I
Sbjct: 169 VTGTPYWMSPEVI------SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 1e-14
Identities = 31/128 (24%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ L + Q+ + +E++ + + VHRDL N L+ + + VK++DFG +R + + +
Sbjct: 100 TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR 159
Query: 104 DLCGTPG---YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159
G ++APE L+ F DVW+ GV+++ + +G P+ +
Sbjct: 160 KRGGGKLPIKWMAPESLKDGKF------TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 213
Query: 160 LRNIMEGK 167
L + +G
Sbjct: 214 LELLEDGY 221
|
Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 43/123 (34%), Positives = 63/123 (51%), Gaps = 7/123 (5%)
Query: 56 FEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPE 115
+ L ++H+H+++HRD+K NILL + VKL DFG A + GTP ++APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---GTPYWMAPE 187
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-SFSSPE 174
V+ A D Y VDVW+ G+ L PP ++ M L +I + + S E
Sbjct: 188 VILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 175 WND 177
W D
Sbjct: 245 WTD 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 26/111 (23%)
Query: 52 MRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP-- 109
+ QL + + + H+H V+HRDLKP+N+L+D + +KL DFG AR G P
Sbjct: 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF----------GVPVR 154
Query: 110 ---------GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y APE+L + Y VD+W+ G I ++ P F
Sbjct: 155 TYTHEVVTLWYRAPEILLG-----SRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 34/94 (36%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVL 117
L+ +H+ +++RDLK +N++LD ++K+ DFG + G+ + CGTP Y+APE+L
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ Y +VD W+ GV++Y +L+G PF
Sbjct: 169 Q------GLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ-MNVKLTDFGFA-----RVLKKGEK 101
+ Y QL L ++H + ++HRD+K N+L+D +++ DFG A + GE
Sbjct: 106 INYT-EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L GT ++APEVLR YG++ DVW+ G ++ + PP+
Sbjct: 165 QGQLLGTIAFMAPEVLRGE------QYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 67/300 (22%), Positives = 121/300 (40%), Gaps = 83/300 (27%)
Query: 18 EEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77
EE D+ +L +++D V + + + Y++ Q+ ++H+H+ ++HRDLKP NI
Sbjct: 92 EEFQDV-YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137
++ +K+ DFG AR + T Y APEV+ GY + VD+W+
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL------GMGYKENVDIWSV 204
Query: 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATG 197
G IM +MV + + G+ +WN
Sbjct: 205 GCIM-------------GEMVRHKILFPGRDYID--QWNK-------------------- 229
Query: 198 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF---------------SS 242
++ L CP F + Q +RN +E + + +
Sbjct: 230 ------------VIEQLGTPCPEFMKKLQPT-VRNYVENRPKYAGLTFPKLFPDSLFPAD 276
Query: 243 PEWNDI-SEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH------------PKLFDQDIE 289
E N + + +DL+ K+L++ P R SV EAL H + + P+++D+ ++
Sbjct: 277 SEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLD 336
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 181 YLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y++PEVL++ + G YG+ D W+ GV +Y +LVG PF+ + IM+ K S
Sbjct: 209 YISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPE--DRYSVKEALNHSFF 279
+ P+ +IS+ KDLI L R V E +H FF
Sbjct: 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 36/119 (30%), Positives = 65/119 (54%), Gaps = 13/119 (10%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
+R +RQ+ + L ++HN ++HRD+K NIL+D++ +K++DFG ++ L K
Sbjct: 106 TLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 99 GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157
L G+ ++APEV++ T Y + D+W+ G ++ +L G PF Q+
Sbjct: 166 NGARPSLQGSVFWMAPEVVK------QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 43/127 (33%), Positives = 68/127 (53%), Gaps = 14/127 (11%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTP 109
I+R++ + L+++H+ +HRD+K N+LL +Q +VKL DFG A L + K GTP
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI------ 163
++APEV++ + Y D+W+ G+ L G PP M +L I
Sbjct: 166 FWMAPEVIK------QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP 219
Query: 164 -MEGKYS 169
+EG+YS
Sbjct: 220 TLEGQYS 226
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 41/123 (33%), Positives = 65/123 (52%), Gaps = 7/123 (5%)
Query: 56 FEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPE 115
+ L ++H+H+++HRD+K NILL + VKL DFG A ++ + GTP ++APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAPE 181
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS-FSSPE 174
V+ A D Y VDVW+ G+ L PP ++ M L +I + + S
Sbjct: 182 VILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 175 WND 177
W++
Sbjct: 239 WSE 241
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYL 112
QL A+EH+H+ V+HRD+KP N+ + VKL D G R K L GTP Y+
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
+PE + N GY D+W+ G ++Y + PF+ K
Sbjct: 174 SPERIHEN------GYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 39/114 (34%), Positives = 61/114 (53%), Gaps = 12/114 (10%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLK----- 97
S R M QL L+++H+ +V+HRDLKP N+ ++ + + +K+ DFG AR++
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 98 KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
KG L T Y +P +L + Y +A+D+WA G I +L G P F
Sbjct: 172 KGYLSEGLV-TKWYRSPRLLLS-----PNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 15/105 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEV+++ G+G+AVD W GV++Y + G PPF+ + I+ G+ F
Sbjct: 181 YLAPEVIQSK------GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFH 280
P W D +DL++ LL R V + NH +FH
Sbjct: 235 --PNWFD--GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 16/169 (9%)
Query: 2 EKGEMVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEH 61
E E H +V+ + GD ++ + Q +G+ +D I L++ + Q+ ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQ---RGKLFPEDTI-----LQWFV-QMCLGVQH 115
Query: 62 VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRAN 120
+H V+HRD+K +NI L VKL DFG AR+L G GTP Y+ PE+ N
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE-N 174
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 169
M Y D+W+ G I+Y L PF ++ + +G Y
Sbjct: 175 M-----PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYL 112
QL ALEH+H+ V+HRD+KP N+ + VKL D G R K L GTP Y+
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
+PE + N GY D+W+ G ++Y + PF+ K
Sbjct: 174 SPERIHEN------GYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 18/148 (12%)
Query: 34 GEAAVQDIINSNP----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTD 89
G + D++ P + I+R++ + L+++H+ +HRD+K N+LL + VKL D
Sbjct: 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLAD 144
Query: 90 FGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
FG A L + K GTP ++APEV++ + Y D+W+ G+ L G
Sbjct: 145 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIK------QSAYDSKADIWSLGITAIELAKGE 198
Query: 149 PPFWHRKQMVMLRNI-------MEGKYS 169
PP M +L I +EG YS
Sbjct: 199 PPHSELHPMKVLFLIPKNNPPTLEGNYS 226
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 2/109 (1%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF-ARVLKKGEKL 102
P + YI+ + L+H+H + +HRD+K NILL + VKL DFG A++ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GTP ++APEV+ D+T Y DVW+ G+ L G PP
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 44/132 (33%), Positives = 67/132 (50%), Gaps = 13/132 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK---KGEKLMDLCGTPG 110
Q+ A+ HVH+ ++HRD+K NILL VKL DFGF+++ + CGTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-- 168
Y+APE+ R Y + D+++ GV++Y LL PF ++ + G+Y
Sbjct: 211 YVAPEIWR------RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264
Query: 169 --SFSSPEWNDI 178
SPE +I
Sbjct: 265 LPPSISPEMQEI 276
|
Length = 496 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 32/116 (27%), Positives = 64/116 (55%), Gaps = 8/116 (6%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK---GEKL 102
+R+ Q+ E L ++H+ ++HRDLK +N+L+D K++DFG ++ ++
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
M + G+ ++APEV+ + + GY VD+W+ G ++ + G P W ++ +
Sbjct: 168 MSMQGSVFWMAPEVIHS----YSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 14/103 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE+L E G + D+WA G I+Y +L G PPF + + + I++ +YSF
Sbjct: 188 YVSPELLN----EKPAGK--SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL----NHSFF 279
+ D KDLI KLL++ P+DR V E H FF
Sbjct: 242 P----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 32/122 (26%), Positives = 59/122 (48%), Gaps = 14/122 (11%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP- 109
Q+ + +E++ + VHRDL N L+ + + VK++DFG +R + + G
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169
Query: 110 --GYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHRKQMVMLRNIM 164
++APE L+ +F + DVW+ GV+++ TL G P+ +L +
Sbjct: 170 PIRWMAPESLKDGIFTSKS------DVWSFGVLLWEIFTL--GATPYPGLSNEEVLEYLR 221
Query: 165 EG 166
+G
Sbjct: 222 KG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 2/107 (1%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMD 104
+ YI+ L+H+HN+ ++HRD+K NILL + VKL DFG + L +
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GTP ++APEV+ D + Y DVW+ G+ L G PP
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYS-YDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA----RVLKKG 99
+ P +R + +Q EAL ++H + ++HRDLK NIL ++KL DFG + R +++
Sbjct: 101 TEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+ + GTP ++APEV+ +D Y DVW+ G+ + + PP M +
Sbjct: 161 DSFI---GTPYWMAPEVVMCETSKDRP-YDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216
Query: 160 LRNIME------GKYSFSSPEWND 177
L I + + S S E+ D
Sbjct: 217 LLKIAKSEPPTLAQPSRWSSEFKD 240
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 34/108 (31%), Positives = 61/108 (56%), Gaps = 6/108 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNV-KLTDFGFARVLKKGEKLMD 104
+ + +Q+ E L+++H++ +VHRD+K +N+L++ V K++DFG ++ L +
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 105 -LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GT Y+APEV+ + GYG D+W+ G + + G PPF
Sbjct: 168 TFTGTLQYMAPEVID----KGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 45/122 (36%), Positives = 62/122 (50%), Gaps = 12/122 (9%)
Query: 46 PALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-EKLM 103
L I + +ALE++H SV+HRD+KP N+L++ VKL DFG + L K +
Sbjct: 103 DILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF--WHR-----KQ 156
D G Y+APE R N + GY DVW+ G+ M L G P+ W KQ
Sbjct: 163 D-AGCKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219
Query: 157 MV 158
+V
Sbjct: 220 VV 221
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 37/122 (30%), Positives = 66/122 (54%), Gaps = 11/122 (9%)
Query: 34 GEAAVQDIINSNP----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTD 89
G + D++ + P + +++++ + L+++H+ +HRD+K N+LL +Q +VKL D
Sbjct: 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLAD 144
Query: 90 FGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
FG A L + K GTP ++APEV++ + Y D+W+ G+ L G
Sbjct: 145 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ------QSAYDSKADIWSLGITAIELAKGE 198
Query: 149 PP 150
PP
Sbjct: 199 PP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLC 106
++ M QL L + H ++HRDLKP+N+L++++ +KL DFG AR K +
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y P+VL +T Y +D+W G I+Y + G P F
Sbjct: 165 VTLWYRPPDVLLG-----STEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
I +Q+ E L ++H ++HRD+K ENI ++D V + D G A+ + L GT
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 111 YLAPEVL-RANMFEDATGYGQAVDVWACGVIMYTLL 145
APEVL R Y D+W+ G++++ +L
Sbjct: 222 TNAPEVLARDK-------YNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 20/116 (17%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95
II S L + + Q+ L+++H+ ++HRD+KP N+L++ +K+ DFG ARV
Sbjct: 93 IIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
Query: 96 LKKGEKLMDLCG------TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
E+ + T Y APE+L + Y AVD+W+ G I LL
Sbjct: 153 ----EEPDESKHMTQEVVTQYYRAPEILMG-----SRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 17/119 (14%)
Query: 40 DIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN-VKLTDFGFA 93
D++ L + I+RQL EAL +H H+++H D+K EN+L D + + L D+G
Sbjct: 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
Query: 94 RVLKKGEKLMDLCGTPGYLAPE-VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
++ D GT Y +PE + N Y + D WA GV+ Y LL G PF
Sbjct: 158 KI-IGTPSCYD--GTLDYFSPEKIKGHN-------YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 11/101 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM--VMLRNIMEGKY 238
++APEV+R YG+A D+W+ G + + G PP+ + + I
Sbjct: 169 WMAPEVIRG------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSGE 221
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
PE +SE+ KD +RK L P+ R + E L H F
Sbjct: 222 PPEIPEH--LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 161 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 214
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFH----PKLFDQDIEP 290
+S + K L+ LL P+ R KE + H FF + + +EP
Sbjct: 215 PR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 33/88 (37%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFE 123
H V+HRD+KP NILLD NVKL DFG + L + G Y+APE +
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 124 DATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y DVW+ G+ + L G P+
Sbjct: 193 PK--YDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 41/198 (20%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQD--IINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76
EG LK L V K E+ ++ S A I ++ +E+VH+ V+HRDLKP+N
Sbjct: 85 EGYTLKSLLKSVWQK-ESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDN 143
Query: 77 ILLDDQMNVKLTDFGFARVLKKGEK--LMDL------------------CGTPGYLAPEV 116
ILL V + D+G A + KK E+ L+D+ GTP Y+APE
Sbjct: 144 ILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-QMVMLRNIMEGKYSFSSPE- 174
L ++T D++A GVI+Y +L P+ +K + + R+ SP
Sbjct: 203 LLGVPASEST------DIYALGVILYQMLTLSFPYRRKKGRKISYRD------VILSPIE 250
Query: 175 ---WNDISGYLAPEVLRA 189
+ +I +L+ ++A
Sbjct: 251 VAPYREIPPFLSQIAMKA 268
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 28/69 (40%), Positives = 49/69 (71%), Gaps = 2/69 (2%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDL 105
A++YI ++ AL+++H H ++HRDLKP+N+L+ ++ ++KLTDFG ++V L + +MD+
Sbjct: 106 AVKYI-SEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDI 164
Query: 106 CGTPGYLAP 114
TP P
Sbjct: 165 LTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 71/279 (25%)
Query: 18 EEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77
EE D+ ++ +++D V + + + Y++ Q+ ++H+H+ ++HRDLKP NI
Sbjct: 99 EEFQDV-YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137
++ +K+ DFG AR + T Y APEV+ GY + VD+W+
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL------GMGYKENVDIWSV 211
Query: 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATG 197
G IM ++ G G L P T
Sbjct: 212 GCIMGEMIKG--------------------------------GVLFP----------GTD 229
Query: 198 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK-----YSF----------SS 242
+ +D W ++ L CP F + Q +R +E + YSF +
Sbjct: 230 H---IDQW--NKVIEQLGTPCPEFMKKLQPT-VRTYVENRPKYAGYSFEKLFPDVLFPAD 283
Query: 243 PEWNDI-SEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
E N + + +DL+ K+L++ R SV EAL H + +
Sbjct: 284 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 26/98 (26%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---- 109
QL + L H+H V+HRDLKP+N+L++ + +KL DFG AR G P
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------GVPVRTY 157
Query: 110 -------GYLAPEVLRANMFEDATGYGQAVDVWACGVI 140
Y APE+L + Y AVD+W+ G I
Sbjct: 158 THEVVTLWYRAPEILLGCKY-----YSTAVDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 26/107 (24%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
++ M QL + L H+H+V+HRDLKP+N+L++ +KL DFG AR
Sbjct: 99 EIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF--------- 149
Query: 106 CGTP-----------GYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141
G P Y P+VL A Y ++D+W+ G I
Sbjct: 150 -GIPVRCYSAEVVTLWYRPPDVLFG-----AKLYSTSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 17/111 (15%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-------LKKG---- 99
M QL E + ++H + ++HRD+K NIL+D+Q +K+ DFG AR K G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 100 -EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
K +L T Y PE+L Y AVD+W G + + P
Sbjct: 180 TRKYTNLVVTRWYRPPELLLG-----ERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 39/115 (33%), Positives = 55/115 (47%), Gaps = 18/115 (15%)
Query: 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231
SP+ Y+APEVLR GY VD W+ G ++Y L G PPF
Sbjct: 161 SPD------YMAPEVLRG------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208
Query: 232 NIMEGKYSFSSPEWND----ISEDPKDLIRKLLIVTPEDRY-SVKEALNHSFFHP 281
N+ K + P ++D +S++ DLI K LI P R+ S+++ NH FF
Sbjct: 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 36/122 (29%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM--DLCG 107
+ + Q+ A+ ++H ++HRD+K NI L +KL DFG +++L E M + G
Sbjct: 105 WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVG 163
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP Y++PE+ + Y D+WA G ++Y LL F + ++ I++G
Sbjct: 164 TPYYMSPELCQ------GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217
Query: 168 YS 169
Y+
Sbjct: 218 YT 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 51/160 (31%), Positives = 73/160 (45%), Gaps = 42/160 (26%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGF------------ARV 95
+M Q+ +AL HN +VHRDLKP+NI++ + + K+ DFG A +
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 96 LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
+ E L GTP Y APE LR E T D++A G+I L G
Sbjct: 144 TRTTEVL----GTPTYCAPEQLRG---EPVTP---NSDLYAWGLIFLECLTG-------- 185
Query: 156 QMVM----LRNIMEGKYS---FSSPEWNDISGYLAPEVLR 188
Q V+ + I+ + S S P W I+G+ +VLR
Sbjct: 186 QRVVQGASVAEILYQQLSPVDVSLPPW--IAGHPLGQVLR 223
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 58 ALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPE 115
AL ++ ++HRD+KP NILLD N+KL DFG + L K D G Y+APE
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 177
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ + + GY DVW+ G+ +Y + G P+
Sbjct: 178 RIDPSARD---GYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 66.7 bits (161), Expect = 5e-12
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 12/126 (9%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF----WHRKQMVMLRNIME 235
GY+APEVL + D+W+ G+ +Y LL G PPF L+ I+E
Sbjct: 173 GYMAPEVLLGLSLAY---ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
Query: 236 GKYSFSSPEWND-----ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEP 290
+ + IS+ DL++KLL P++R S L+H +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 291 IKKDYK 296
Sbjct: 290 DLLKPD 295
|
Length = 384 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLC 106
++ + QL L + H V+HRDLKP+N+L++++ +KL DFG AR K +
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y P++L +T Y +D+W G I Y + G P F
Sbjct: 166 VTLWYRPPDILLG-----STDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 6/99 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMN-VKLTDFGFARVLKKGEKLMDLCGTPGYL 112
QL AL ++H+ + HRDLKP+N+L+D + +KL DFG A+ L G++ + + Y
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
APE++ AT Y +D+W+ G I+ +++G P F
Sbjct: 238 APELMLG-----ATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 38/105 (36%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLC 106
+R M QL L ++H ++HRDLKP+N+L+ +KL DFG AR +
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV 164
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y P+VL AT Y A+D+W G I +L G P F
Sbjct: 165 VTLWYRPPDVLLG-----ATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 11/119 (9%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
+D IN L + Q+ + ++++ + +HRDL NIL++ + VK++DFG A+VL +
Sbjct: 103 RDQINLKRLLLFSS-QICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161
Query: 99 GE---KLMDLCGTPG-YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153
+ + + +P + APE LR + F A+ DVW+ GV +Y L P
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSAS------DVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--C 106
R IM+QL A+E++H+ ++HRD+K ENI L+ + L DFG A +K + D
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
GT +PE+L + GY + D+W+CG+I+ +L
Sbjct: 330 GTVATNSPEILAGD------GYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 41/117 (35%), Positives = 55/117 (47%), Gaps = 17/117 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPE+L + GY +AVD W GV++Y +L G PPF+ M R I++ F
Sbjct: 159 YLAPELLLGH------GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF 212
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSV---KEALNHSFFH----PKLFDQDIEP 290
+ D KDL+ LL P R +E NH FF KL + I+P
Sbjct: 213 P----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQP 265
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 32/124 (25%), Positives = 49/124 (39%), Gaps = 30/124 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y APE+L + Y AVD+W+ G I ++ G P F ++ L I +
Sbjct: 164 YRAPEILL-----GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218
Query: 236 -----------GKYSFSSPEW---------NDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
Y + P++ + + DL+ K+L P R S KEAL
Sbjct: 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278
Query: 276 HSFF 279
H +F
Sbjct: 279 HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 39/118 (33%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEVL TGY Q D W+ GVI+Y +LVG PPF ++ + +
Sbjct: 210 YIAPEVL------LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR---YSVKEALNHSFFHPKLFDQDIEPIKKDY 295
P +S + DLI + L EDR E H FF F I K Y
Sbjct: 264 HIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPY 320
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 26/109 (23%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---- 109
Q+ + + H+ V+HRDLKP+N+L+D++ +KL DFG AR G P
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVY 158
Query: 110 -------GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y APEVL + Y VD+W+ G I + P F
Sbjct: 159 THEVVTLWYRAPEVLLG-----SPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 10/103 (9%)
Query: 53 RQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTP 109
+Q+ E + ++H+ +HRDL N+LLD+ VK+ DFG A+ + +G ++ + +P
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 110 GY-LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ A E L+ N F A+ DVW+ GV +Y LL C
Sbjct: 174 VFWYAVECLKENKFSYAS------DVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL+PE+ + N Y D+W+ G ++Y L PF + + I++G+Y
Sbjct: 169 YLSPELCQ-NK-----PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP 222
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
++ S + ++L+ LL PE+R S+ + L
Sbjct: 223 IPSQY---SSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARV----LKKG 99
++ ++ Q+ + + ++H + V+HRDLKP NIL+ ++ VK+ D GFAR+ LK
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
L + T Y APE+L A Y +A+D+WA G I LL P F R++ +
Sbjct: 170 ADLDPVVVTFWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
Query: 160 LRN 162
N
Sbjct: 225 TSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 13/123 (10%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARV----LKKG 99
++ ++ Q+ + + ++H + V+HRDLKP NIL+ ++ VK+ D GFAR+ LK
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
L + T Y APE+L A Y +A+D+WA G I LL P F R++ +
Sbjct: 170 ADLDPVVVTFWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224
Query: 160 LRN 162
N
Sbjct: 225 TSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
EG DL H + KG+ ++ N + + + Q+ AL+++H ++HRDLK +N+
Sbjct: 83 EGGDLYHKLKE--QKGK-----LLPENQVVEWFV-QIAMALQYLHEKHILHRDLKTQNVF 134
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLMD-LCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137
L +K+ D G ARVL+ + L GTP Y++PE +F + Y DVWA
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-----LFSNKP-YNYKSDVWAL 188
Query: 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
G +Y + F + ++ I+EGK
Sbjct: 189 GCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA--RVLKKGEKLMDLCGT 108
I R + A++++H + ++HRD+K ENI ++ +V L DFG A V K GT
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147
APE+L + YG AVD+W+ G++++ +
Sbjct: 247 IATNAPELLARD------PYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLCG 107
R + QL L + H V+HRDLKP+N+L+ ++ +KL DFG AR K +
Sbjct: 106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV 165
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y P+VL +T Y ++D+W G I Y + G P F
Sbjct: 166 TLWYRPPDVLLG-----STEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFG---FARVLKKGE 100
+ + RQL A++++H ++HRD+K EN+L++ ++ L DFG FAR
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ GT APEVL + Y +VD+W+ G++++
Sbjct: 318 FHYGIAGTVDTNAPEVLAGD------PYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 35/104 (33%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIMEGK 237
GY+APEVL GY AVD W+ GV Y L G P+ R +R E
Sbjct: 164 GYMAPEVLCR------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDR--YSVKEALNHSFF 279
W S + D I KLL P+ R ++K+ NH +F
Sbjct: 218 DVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 34/82 (41%), Positives = 49/82 (59%), Gaps = 10/82 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEV+++ G+ +AVD WA G+++Y +LVG PPF+ + I+ GK F
Sbjct: 164 YLAPEVIQS------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF 217
Query: 241 SSPEWNDISEDPKDLIRKLLIV 262
P D+ KDLI+KLL+V
Sbjct: 218 --PRHLDLY--AKDLIKKLLVV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-11
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 8/114 (7%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL-MDLCGTPGYL 112
QL + ++H ++HRDLK +NI L + + +K+ DFG +R+L L GTP Y+
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
+PE L+ GY D+W+ G I+Y + F + + ++ I+EG
Sbjct: 173 SPEALKHQ------GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 36/119 (30%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L YG AVD WA GV++Y +L G PF + + ++I+E + +
Sbjct: 162 YIAPEILSY------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFH----PKLFDQDIEP 290
P W +S++ K +++ L PE R ++ H FF KL ++I+P
Sbjct: 216 --PRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAP 114
L ++H+ ++HRD+KP NILL + VKL DFG + GE + GT Y+AP
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAP 172
Query: 115 EVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
E ++ Y DVW+ G+ + + PF
Sbjct: 173 ERIQGK------PYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 2/107 (1%)
Query: 46 PALRYIMRQLFEALEHV-HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
LR I + + L+ + H+++HRD+KP N+L++ VKL DFG + L +
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ G Y+APE +++ Y DVW+ G+ + + +G P+
Sbjct: 162 I-GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLC 106
++ + Q+ L + H V+HRDLKP+N+L++++ +KL DFG AR K +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y P+VL ++ Y +D+W G I + + G P F
Sbjct: 166 VTLWYRPPDVLLG-----SSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 55/244 (22%), Positives = 92/244 (37%), Gaps = 58/244 (23%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-VLKKGEKLMDL 105
A+ +I++ + AL+++H+ +HR +K +ILL V L+ ++ ++K G++ +
Sbjct: 102 AIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161
Query: 106 CGTPGY-------LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
P L+PEVL+ N+ GY + D+++ G+ L G PF
Sbjct: 162 HDFPKSSVKNLPWLSPEVLQQNL----QGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANM---FEDATGYGQAVDVWACGVIMYTLL 215
ML + G + P D S Y E + E +VD YT
Sbjct: 218 MLLEKVRG----TVPCLLDKSTYPLYEDSMSQSRSSNEHPNN-RDSVDH------PYTRT 266
Query: 216 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
F ++ + R+ PE R S + LN
Sbjct: 267 FS-EHFHQFVELCLQRD-------------------------------PESRPSASQLLN 294
Query: 276 HSFF 279
HSFF
Sbjct: 295 HSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 15/104 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L +G+G+AVD W+ G +MY +L G PPF + + I++GK +
Sbjct: 166 YMAPEILMR------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
P + ++ + +DL++KLL P R E +H FF
Sbjct: 220 --PPY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 56/245 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLC 106
++ + QL L ++H ++HRDLKP+N+L+ D +KL DFG AR +
Sbjct: 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV 164
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
T Y P+VL +T Y +D+W VGC + +++G
Sbjct: 165 VTLWYRPPDVLLG-----STEYSTCLDMWG---------VGC----------IFVEMIQG 200
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRK 225
+F P DI L L + D W GV ++L P F R
Sbjct: 201 VAAF--PGMKDIQDQLERIFLVLGTPNE--------DTWP-GV--HSL----PHFKPERF 243
Query: 226 QMVMLRNIMEGKYSFSSPEWNDIS--EDPKDLIRKLLIVTPEDRYSVKEALNHSFFH--- 280
+ +N+ + WN +S +DL KLL P++R S + AL+H +F
Sbjct: 244 TLYSPKNLRQA--------WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295
Query: 281 PKLFD 285
P+L++
Sbjct: 296 PRLWE 300
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 28/122 (22%)
Query: 43 NSNPAL-RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN-VKLTDFGFARVLKKGE 100
NP L + + Q+ + + H+H V+HRDLKP+N+L+D + N +KL DFG AR
Sbjct: 98 AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---- 153
Query: 101 KLMDLCGTP-----------GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
G P Y APE+L + Y VD+W+ G I ++ P
Sbjct: 154 ------GIPVRTFTHEVVTLWYRAPEILLG-----SRHYSTPVDIWSVGCIFAEMVNQKP 202
Query: 150 PF 151
F
Sbjct: 203 LF 204
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 42/125 (33%), Positives = 54/125 (43%), Gaps = 28/125 (22%)
Query: 51 IMRQLFEALEHVHN-------HSVVHRDLKPENILLDD----------QMN-------VK 86
I RQL AL + HN V+HRDLKP+NI L Q N K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 87 LTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146
+ DFG ++ + GTP Y +PE+L + Y D+WA G I+Y L
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELL----LHETKSYDDKSDMWALGCIIYELCS 238
Query: 147 GCPPF 151
G PF
Sbjct: 239 GKTPF 243
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL D GY + VD W+ GV+++ + G PF+ M RNI GK F
Sbjct: 162 YLAPEVLL-----DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY----SVKEALNHSFF 279
N +S++ + ++ LL P+ R E H FF
Sbjct: 217 PK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 20/126 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L G+G+A D W G+ +Y +LVGCPPF+ + +++ + I+EG F
Sbjct: 194 YIAPEILLN------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-SVKEALNHSFFHP--------KLFDQDIE-P 290
P++ D + K L++KLL RY ++K+ + HP L +++E P
Sbjct: 248 --PKFLD--NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVP 303
Query: 291 IKKDYK 296
K YK
Sbjct: 304 YKPKYK 309
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 181 YLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y++PE+L+A ED G YG D W+ GV MY +L G PF+ + IM +
Sbjct: 169 YISPEILQA--MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226
Query: 240 FSSPEW-NDISEDPKDLIRKLLIVTPEDR---YSVKEALNHSFF 279
F P D+SE+ KDLI++ LI + E R +++ H+FF
Sbjct: 227 FQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 38/104 (36%), Positives = 50/104 (48%), Gaps = 15/104 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ F
Sbjct: 161 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF 214
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
+S D K L+ LLI P R KE + HSFF
Sbjct: 215 P----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 15/122 (12%)
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220
RN +E K +P+ YLAPE + G + D W+ G +++ L G PP
Sbjct: 145 RNGLENKKFVGTPD------YLAPETILGV------GDDKMSDWWSLGCVIFEFLFGYPP 192
Query: 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHS 277
F + NI+ + ++ S + DLI +LL + P R +E +H
Sbjct: 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 278 FF 279
FF
Sbjct: 253 FF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 9/109 (8%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP 109
I R+L EAL ++H ++HRD+K ENI LD+ N L DFG A L G
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 110 GYL---APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
G L +PE+L + Y D+W+ G++++ + V + ++
Sbjct: 249 GTLETNSPELLALDP------YCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTP-G 110
Q+ + ++H V+H+D+ N ++D+++ VK+TD +R L + L D P
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
++A E L + A+ DVW+ GV+++ L
Sbjct: 185 WMALESLVNKEYSSAS------DVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 27/141 (19%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG--- 110
Q+ + +E++ + VHRDL NIL++ + VK+ DFG +VL + +K PG
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESP 174
Query: 111 --YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-----PP--FWHR----KQM 157
+ APE L + F A+ DVW+ GV++Y L PP F KQ
Sbjct: 175 IFWYAPESLTESKFSVAS------DVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228
Query: 158 VM----LRNIMEGKYSFSSPE 174
M L +++ +P
Sbjct: 229 QMIVYHLIELLKNNGRLPAPP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE L +++ + D+W+ G ++Y L PPF R Q+ + I EGK+
Sbjct: 176 YMSPEQLNHMSYDEKS------DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-- 227
Query: 241 SSPEWNDI-SEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
S + ++I+ +L V P+ R S +E L
Sbjct: 228 --RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 16/106 (15%)
Query: 51 IMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC--- 106
I + E L +++N H ++HRD+KP NIL++ + +KL DFG + GE + +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 107 -GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GT Y++PE ++ Y DVW+ G+ + L +G PF
Sbjct: 163 VGTSTYMSPERIQGG------KYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 11/121 (9%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTP 109
++R + ++++ + + VHRDL NIL++ + K++DFG +RVL+ E G
Sbjct: 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK 171
Query: 110 ---GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIME 165
+ APE + F A+ DVW+ G++M+ ++ G P+W +++ I +
Sbjct: 172 IPIRWTAPEAIAYRKFTSAS------DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225
Query: 166 G 166
G
Sbjct: 226 G 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 18/108 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIMEG 236
Y+APE++R G+G+AVD W+ G++++ LL G PF Q + R I++
Sbjct: 172 YMAPEIIRGK-----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFF 279
F S I + +DL+ KLL P+ R E H FF
Sbjct: 227 DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 30/78 (38%), Positives = 45/78 (57%), Gaps = 11/78 (14%)
Query: 45 NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM-NVKLTDFGFARVLKKG---- 99
N ++ IMRQ+ AL+ +H+ +VHRD+KP+NI+ + + K+ D G A L+ G
Sbjct: 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313
Query: 100 --EKLMDLCGTPGYLAPE 115
E L+D P Y APE
Sbjct: 314 PKEFLLD----PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|144978 pfam01585, G-patch, G-patch domain | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 8e-09
Identities = 17/32 (53%), Positives = 23/32 (71%)
Query: 374 EDNVGFKMLQKLGWQEGSGLGTDGGGIQEPVN 405
N+GFK+LQK+GW+ G GLG + GI EP+
Sbjct: 1 TSNIGFKLLQKMGWKPGQGLGKNEQGITEPIE 32
|
This domain is found in a number of RNA binding proteins, and is also found in proteins that contain RNA binding domains. This suggests that this domain may have an RNA binding function. This domain has seven highly conserved glycines. Length = 45 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 13/102 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIMEG 236
++APEV+ Y D+W+ G+ L G PP + + + + G
Sbjct: 162 YWMAPEVING------KPYDYKADIWSLGITAIELAEGKPP--YSELPPMKALFKIATNG 213
Query: 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+PE S++ KD ++K L PE R + ++ L H F
Sbjct: 214 PPGLRNPEKW--SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 34/182 (18%)
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
+D + G++ +V NM D +G+ + D C + +V C
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-------------- 200
Query: 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPF 221
+ +P+ Y++PEVL++ + GY G+ D W+ GV +Y +LVG PF
Sbjct: 201 ----DTAVGTPD------YISPEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 222 WHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPED----RYSVKEALNHS 277
+ + IM K S + P+ NDIS++ K+LI L T + R V+E H
Sbjct: 248 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL--TDREVRLGRNGVEEIKRHL 305
Query: 278 FF 279
FF
Sbjct: 306 FF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 15/115 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ Y ++VD W+ GV++Y +L+G PF + + +I+ + F
Sbjct: 162 YIAPEILKGQK------YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL-NHSFFHP----KLFDQDIEP 290
P W IS++ KD + KL P R V + H FF +L ++I P
Sbjct: 216 --PRW--ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 16/130 (12%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
++R + ++++ + VHRDL NIL++ + K++DFG +RVL+ + T G
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRG 168
Query: 111 ------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNI 163
+ APE + F A+ DVW+ G++M+ ++ G P+W +++ I
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSAS------DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
Query: 164 MEGKYSFSSP 173
EG Y +P
Sbjct: 223 EEG-YRLPAP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 11/111 (9%)
Query: 42 INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK 101
IN L+Y + Q+ + ++++ + VHRDL N+L++ + VK+ DFG + ++ ++
Sbjct: 106 INLKQQLKYAV-QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
Query: 102 LM----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
DL + APE L + F A+ DVW+ GV +Y LL C
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIAS------DVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP-GYLAPE 115
E +E++ + +VHRDL NIL+ + K++DFG ARV G +D P + APE
Sbjct: 111 EGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPE 167
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMY 142
L+ F + DVW+ GV+++
Sbjct: 168 ALKHKKFSSKS------DVWSYGVLLW 188
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 29/97 (29%), Positives = 36/97 (37%), Gaps = 40/97 (41%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVL Y + D+W+ GVI+Y L
Sbjct: 158 AYMAPEVLLGKG-----YYSEKSDIWSLGVILYEL------------------------- 187
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ KDLIRK+L PE R S KE L H
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN-IMEGKYS 239
Y+APEV + Y D+W+ G ++Y + PPF + M LR + GKY
Sbjct: 167 YMAPEVWKG------RPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKY- 218
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277
P S+D ++ IR +L V P+ R + + L
Sbjct: 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 15/133 (11%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
+L + Q+ E + ++ + +HRDL NIL+ + + K+ DFG AR++K+ L
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163
Query: 106 CGTP-GYLAPEVLRANMFEDATGYG---QAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 160
P + APE A +G DVW+ G+++Y + G P+ +
Sbjct: 164 KKIPYKWTAPE---------AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 161 RNIMEGKYSFSSP 173
I G Y P
Sbjct: 215 DQITAG-YRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P L + Q+ E + ++ + + +HRDL NIL+ + + K+ DFG AR+++ E
Sbjct: 103 PQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----Y 158
Query: 106 CGTPG------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
G + APE F DVW+ G+++ +
Sbjct: 159 TAREGAKFPIKWTAPEAANYGRFT------IKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 37/118 (31%), Positives = 49/118 (41%), Gaps = 18/118 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVLR Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 162 YLAPEVLRKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL----NHSFFHP----KLFDQDIEP 290
+IS + L+ LL R K+ NH FF L ++ I P
Sbjct: 216 KP----NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 15/104 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 161 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 214
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
+S + K L+ LL P+ R KE + H FF
Sbjct: 215 P----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 15/115 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L Y +VD W+ GV++Y +L+G PF + + ++I +
Sbjct: 162 YIAPEILLGQK------YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL-NHSFFH----PKLFDQDIEP 290
P W ++ + KD++ KL + PE R VK + H FF L +++IEP
Sbjct: 216 --PRW--LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 32/110 (29%), Positives = 56/110 (50%), Gaps = 10/110 (9%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
+D I S L + Q+ + + ++ +VHRDL N+L+ +VK+TDFG A++L
Sbjct: 103 KDNIGSQYLLNW-CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161
Query: 99 GEKLMDLCG--TP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
EK G P ++A E + ++ + DVW+ GV ++ L+
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKS------DVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC 106
L Y+ Q+ A+E++ + +HRDL N L+ + VK+ DFG +R L G+
Sbjct: 105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHA 163
Query: 107 GTP---GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
G + APE L N F + DVWA GV+++ + G P+
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKS------DVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---GYLA 113
E + ++ + +HRDL N L+DDQ VK++DFG +R + E + G+ +
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSP 169
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMY 142
PEVL + F + DVWA GV+M+
Sbjct: 170 PEVLLYSKFSSKS------DVWAFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 17/91 (18%)
Query: 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-----LCGTPGYLAPEVLRA 119
H ++HRD+KP NIL++ + +KL DFG + +L+D GT Y++PE L+
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYMSPERLQ- 175
Query: 120 NMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
T Y D+W+ G+ + L +G P
Sbjct: 176 -----GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 14/93 (15%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK---GEKLMDLCGTPGYLAP 114
AL+ +H +V RDL P NILLDD+ +++LT F ++ GE + ++ Y AP
Sbjct: 97 ALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 115 EVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147
EV + E+ +A D W+ G I++ LL G
Sbjct: 152 EV--GGISEET----EACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 11/115 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL----MDLCGTP 109
Q+ + ++ + +HRDL NILL VK+ DFG R L + E L
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNI 163
+ APE LR F A+ DVW GV ++ + G P+ +L+ I
Sbjct: 165 AWCAPESLRTRTFSHAS------DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 10/87 (11%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP-GYLAPE 115
E +E++ + VHRDL N+L+ + + K++DFG A K+ + D P + APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPE 169
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMY 142
LR F + DVW+ G++++
Sbjct: 170 ALREKKFSTKS------DVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/118 (32%), Positives = 49/118 (41%), Gaps = 18/118 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVLR Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 162 YLAPEVLRKE------PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVK----EALNHSFFHP----KLFDQDIEP 290
+ + DL+ LL R K E NH FF P L+ + I P
Sbjct: 216 PGGK----TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 36/126 (28%), Positives = 49/126 (38%), Gaps = 32/126 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y PE+L AT YG VD+W+ G I+ L +G P F ++ L I E G
Sbjct: 167 YRPPELLLG-----ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 237 ----KYSFSSPEWND-------------------ISEDPKDLIRKLLIVTPEDRYSVKEA 273
S W + I DL+ KLL + P+ R S +A
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
Query: 274 LNHSFF 279
L H +F
Sbjct: 282 LQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 15/103 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ---MVMLRNIMEGK 237
Y++PE ++ Y A D+W+ G+ + +G PF Q +++ I +G
Sbjct: 166 YMSPERIQGES------YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG- 218
Query: 238 YSFSSPEWND--ISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
P S + +D I L P+ R S E L H F
Sbjct: 219 ---PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 15/104 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 162 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
+S + K L+ LL P+ R KE + H FF
Sbjct: 216 P----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPE+L +G AVD WA GV ++ L G PPF + +NI+
Sbjct: 546 YLAPELLLGK------PHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL--NRDI 597
Query: 241 SSPEWND-ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
PE + +S + ++ I LL + P R +KE H FH
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFH 638
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|197727 smart00443, G_patch, glycine rich nucleic binding domain | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-07
Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 372 LKEDNVGFKMLQKLGWQEGSGLGTDGGGIQEPV 404
+ N+G K+L+K+GW+EG GLG + GI EP+
Sbjct: 1 ISTSNIGAKLLRKMGWKEGQGLGKNEQGIVEPI 33
|
A predicted glycine rich nucleic binding domain found in the splicing factor 45, SON DNA binding protein and D-type Retrovirus- polyproteins. Length = 47 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 18/124 (14%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
++R + ++++ + VHRDL NIL++ + K++DFG +R L+ E T G
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT---TKG 167
Query: 111 ------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH-RKQMVMLRN 162
+ APE + F A DVW+ G++M+ ++ G P+W Q V+ +
Sbjct: 168 GKIPIRWTAPEAIAYRKFT------SASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KA 220
Query: 163 IMEG 166
+ +G
Sbjct: 221 VEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 35/125 (28%), Positives = 48/125 (38%), Gaps = 31/125 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--GKY 238
Y APE+L A Y VD+WA G I LL G P F + L + G
Sbjct: 166 YRAPELLYG-----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 239 SFSS-------PEWNDISEDPK-----------------DLIRKLLIVTPEDRYSVKEAL 274
+ + P++N I+ DL++ LL+ P R S EAL
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280
Query: 275 NHSFF 279
H +F
Sbjct: 281 RHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L I + + L ++ + ++HRD+KP N+L++ + VKL DFG + L
Sbjct: 95 HVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA-KTY 153
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GT Y+APE + YG DVW+ G+ L +G P+
Sbjct: 154 VGTNAYMAPERISGEQ------YGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 9/97 (9%)
Query: 52 MRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP-- 109
M + +E++ + + +HRDL N +L++ M V + DFG ++ + G+ C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 110 -GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
+LA E L N+ Y DVWA GV M+ ++
Sbjct: 179 VKWLALESLADNV------YTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 16/131 (12%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
++R + ++++ + VHRDL NIL++ + K++DFG +R L+ + G
Sbjct: 111 MLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 111 ------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH-RKQMVMLRN 162
+ APE + F A+ DVW+ G++M+ ++ G P+W Q V+ N
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSAS------DVWSYGIVMWEVMSYGERPYWDMSNQDVI--N 222
Query: 163 IMEGKYSFSSP 173
+E Y P
Sbjct: 223 AIEQDYRLPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 35/109 (32%), Positives = 46/109 (42%), Gaps = 14/109 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 162 YLAPEVLHKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVK----EALNHSFFHPKLFD 285
+I+ + L+ LL R K E NH FF P +D
Sbjct: 216 KP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 21/124 (16%)
Query: 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIM 234
+GY+APE+L+ Y VD +A G +Y ++ G PF K+ V + R +
Sbjct: 158 NGYMAPEILKEEP------YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211
Query: 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN----HSFFH----PKLFDQ 286
E + F E + +E+ KD+ R L PEDR +E + H FF P+L
Sbjct: 212 EDEVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAG 268
Query: 287 DIEP 290
I P
Sbjct: 269 LIPP 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 17/142 (11%)
Query: 18 EEGDDLKHLAAQVVDKGEA--------AVQDIINSNPALRYIMRQLFEALEHVHNHSVVH 69
E GD + L++ +D E A S +L ++ Q+ ++++ + + VH
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTP-GYLAPEVLRANMFEDAT 126
RDL N L+ + + +K+ DFG +R L G+ ++ P ++A E + F A+
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 127 GYGQAVDVWACGVIMYTLLVGC 148
DVWA GV ++ +L+ C
Sbjct: 222 ------DVWAFGVTLWEILMLC 237
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 24/110 (21%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL----------KKGEKLM 103
Q+ + +E++ + VHRDL N +LD+ VK+ DFG AR + G KL
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL- 164
Query: 104 DLCGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
P ++A E L+ F + DVW+ GV+++ L+ G PP+
Sbjct: 165 -----PVKWMALESLQTQKFTTKS------DVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 17/91 (18%)
Query: 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-----LCGTPGYLAPEVLRA 119
H ++HRD+KP NIL++ + +KL DFG + +L+D GT Y++PE L+
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYMSPERLQ- 175
Query: 120 NMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
T Y D+W+ G+ + + +G P
Sbjct: 176 -----GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE++ YG++VD WA GV++Y +L G PPF + + ++IME S+
Sbjct: 167 YIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHP----KLFDQDIEP 290
+S++ + + LL P R ++ H+FF KL ++I+P
Sbjct: 221 P----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 2/72 (2%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++ +MRQ+ L +H +VHRD+KPEN+L+ VK+ DFG A + G L G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 108 T--PGYLAPEVL 117
P Y PE L
Sbjct: 371 MLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 31/110 (28%), Positives = 58/110 (52%), Gaps = 10/110 (9%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLM 103
+I+ Q+ +E + +H VVH+DL N+L+ D++NVK++D G R + + KLM
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 104 DLCGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
P +++PE + F + D+W+ GV+++ + G P+
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDS------DIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 27/106 (25%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGT 108
I Q+ +E++ +H VHRDL N L+ + + VK++DFG +R + + ++
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 109 P-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFW 152
P ++ PE + F + D+W+ GV+++ + G P++
Sbjct: 189 PVRWMPPEAILYGKFTTES------DIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 17/92 (18%)
Query: 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-----LCGTPGYLAPEVLR 118
H ++HRD+KP NIL++ + +KL DFG + G+ L+D GT Y++PE L+
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQ-LIDSMANSFVGTRSYMSPERLQ 171
Query: 119 ANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
T Y D+W+ G+ + + +G P
Sbjct: 172 ------GTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 18/106 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLC 106
Q+ + +E + + +HRDL NILL + VK+ DFG AR ++KG+ + L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE + F+ Y DVW+ GV+++ + +G P+
Sbjct: 246 ---KWMAPETI----FDRV--YTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 36/107 (33%), Positives = 51/107 (47%), Gaps = 21/107 (19%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-------KLMDLC 106
QL AL ++ + VHRD+ N+L+ VKL DFG +R L+ KL
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL---- 170
Query: 107 GTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
P ++APE + F A+ DVW GV M+ +L+ G PF
Sbjct: 171 --PIKWMAPESINFRRFTSAS------DVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 34/122 (27%), Positives = 45/122 (36%), Gaps = 29/122 (23%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y APEVL + Y VD+W+ G I L P F + L I +
Sbjct: 172 YRAPEVLLQ------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225
Query: 241 SSPEW-----------------------NDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277
S EW +I E+ DL++K+L P R S EAL H
Sbjct: 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 278 FF 279
+F
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 11/114 (9%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---GYLA 113
E +E++ +S +HRDL N L+ VK++DFG R + E G +
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSP 169
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEG 166
PEV + + + DVW+ GV+M+ + G PF + ++ I G
Sbjct: 170 PEVFNFSKYSSKS------DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 17/106 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+ E GY D+W+ G+ L G P+ M +L +
Sbjct: 172 WMAPEVM-----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL-----Q 221
Query: 241 SSPEWNDISEDPK-------DLIRKLLIVTPEDRYSVKEALNHSFF 279
+ P + D K +I L P R + +E L H FF
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 29/108 (26%), Positives = 47/108 (43%), Gaps = 15/108 (13%)
Query: 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231
+P W +APEV+ + G A D+W+ G + LL G PP++ M L
Sbjct: 162 TPYW------MAPEVIEMS------GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209
Query: 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
I++ + P IS + KD + + P R + K+ L H +
Sbjct: 210 RIVQDDH---PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y++PEVL++ + GY G+ D W+ GV ++ +LVG PF+ + IM+ K S
Sbjct: 209 YISPEVLKS---QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPED----RYSVKEALNHSFFHPKLFDQD 287
+ PE +IS+ K+LI L T + R V+E H FF ++ D
Sbjct: 266 LNFPEDVEISKHAKNLICAFL--TDREVRLGRNGVEEIKQHPFFKNDQWNWD 315
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 22/45 (48%), Positives = 26/45 (57%), Gaps = 6/45 (13%)
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GTP YLAPE+L +G AVD WA GV ++ L G PPF
Sbjct: 542 GTPDYLAPELLLGK------PHGPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 23/146 (15%)
Query: 41 IINSNPALRYI-----MRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR- 94
+IN +PAL Y+ Q+ +E + + + VHRDL N+L+ + VK+ DFG AR
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 95 ------VLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VG 147
+ KG + L ++APE + N+ Y DVW+ G++++ + +G
Sbjct: 289 IMRDSNYISKGSTFLPL----KWMAPESIFNNL------YTTLSDVWSFGILLWEIFTLG 338
Query: 148 CPPFWHRKQMVMLRNIMEGKYSFSSP 173
P+ N ++ Y + P
Sbjct: 339 GTPYPELPMNEQFYNAIKRGYRMAKP 364
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---G 110
+ EA+E++ ++ +HRDL N L+ + VK++DFG AR + + GT
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVK 166
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEG 166
+ PEV + F + DVW+ GV+M+ + G P+ ++ ++ G
Sbjct: 167 WAPPEVFDYSRFSSKS------DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 39/122 (31%), Positives = 58/122 (47%), Gaps = 25/122 (20%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW--HRKQ-MVMLRNIMEGK 237
Y+APEV+ + G+ Q+ D W+ GV+M+ +L G PF RK+ M M+ G
Sbjct: 164 YMAPEVV------NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQDI 288
F SPE + L+R L P +R V+E H FF KL+ ++I
Sbjct: 218 PQFLSPE-------AQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREI 270
Query: 289 EP 290
+P
Sbjct: 271 KP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 33/127 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y APE+L A Y A+D+W+ G I LL P F + ++ L I +
Sbjct: 172 YRAPELLL-----GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 236 --------------GKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKE 272
K +F+ +N +S++ DL+ +LL P R S ++
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286
Query: 273 ALNHSFF 279
AL H +F
Sbjct: 287 ALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 17/118 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE++ YG++VD WA GV++Y +L G PPF + + ++IME S+
Sbjct: 167 YIAPEIIAYQ------PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY 220
Query: 241 SSPEWNDISEDPKDLIRKL----LIVTPEDRYSVKEALNHSFFH----PKLFDQDIEP 290
+ K L+ K L PE ++E H+FF KL +++I+P
Sbjct: 221 PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIRE---HAFFRRIDWDKLENREIQP 275
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 33/138 (23%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---WHRKQMVMLRNI---- 233
Y APE+ M ++ GY +A+D+W+ G I+ +L P F + Q+ ++ +
Sbjct: 175 YRAPEI----ML-NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229
Query: 234 -MEGKYSFSSPE---------------WNDI--SEDPK--DLIRKLLIVTPEDRYSVKEA 273
E S WN + + DPK DL+ K+L P R +V+EA
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 274 LNHSFFHPKLFDQDIEPI 291
L H + D EP+
Sbjct: 290 LAHPYLEQ-YHDPSDEPV 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 16/98 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG--- 110
Q+ + ++ + +HRDL N+L+ + K+ DFG ARV+K+ G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI----YEAREGAKF 166
Query: 111 ---YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
+ APE N F + DVW+ G+++ ++
Sbjct: 167 PIKWTAPEAALYNRFSIKS------DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP-GYLAPE 115
EA+E++ ++ VHRDL N+L+ + K++DFG K+ D P + APE
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 169
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTL 144
LR F + DVW+ G++++ +
Sbjct: 170 ALREKKFSTKS------DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMD 104
P L Q+ E + ++ + +HRDL+ N+L+ + + K+ DFG ARV++ E +
Sbjct: 103 PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162
Query: 105 LCGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
P + APE + F + DVW+ G+++Y ++
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKS------DVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 37/126 (29%), Positives = 52/126 (41%), Gaps = 27/126 (21%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI------ 233
GY+APEVL+ + Y +VD +A G +Y ++ G PF RK+ V +
Sbjct: 159 GYMAPEVLQGEV------YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFH----PKLF 284
M +Y + S + KDL LL PE R S E H F +L
Sbjct: 213 MAVEYP------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266
Query: 285 DQDIEP 290
+EP
Sbjct: 267 AGMLEP 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 9/87 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL+PE + ED Y + DVWA GV++Y G PF Q ++ I+ G +
Sbjct: 167 YLSPE-----LCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-- 218
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR 267
P S+ LI + L R
Sbjct: 219 -PPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 8/99 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
+++PEV+ GYG+ DVW+ G + +L PP+ + M + I +
Sbjct: 173 WMSPEVISGE------GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 226
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P +S D ++ +R+ + + R S +E L H F
Sbjct: 227 QLPS--HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 20/120 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ + YG +VD WA GV++Y +L G PF + + I+ + +
Sbjct: 162 YIAPEILQEML------YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSV------KEALNHSFFH----PKLFDQDIEP 290
P W +S+D D+++ + P R + L H FF KL + IEP
Sbjct: 216 --PTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 30/144 (20%), Positives = 64/144 (44%), Gaps = 18/144 (12%)
Query: 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNH 65
+ VV+ + +GD +L ++ + ++ ++ + + ++
Sbjct: 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA-EIADGMAYLAAK 138
Query: 66 SVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KKGEKLMDLCGTPGYLAPEVLR 118
VHRDL N ++ + + VK+ DFG R + K G+ L+ + ++APE L+
Sbjct: 139 KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV----RWMAPESLK 194
Query: 119 ANMFEDATGYGQAVDVWACGVIMY 142
+F + DVW+ GV+++
Sbjct: 195 DGVFTTKS------DVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
+D I S L + + Q+ + + ++ +VHRDL N+L+ +VK+TDFG AR+L+
Sbjct: 103 KDNIGSQLLLNWCV-QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161
Query: 99 GEKLMDLCGTP---GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
EK + G ++A E + F + DVW+ GV ++ L+ G P+
Sbjct: 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQS------DVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 18/106 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLC 106
Q+ +E + + +HRDL NILL + VK+ DFG AR ++KG + L
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL- 240
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE ++F+ Y DVW+ GV+++ + +G P+
Sbjct: 241 ---KWMAPE----SIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 14/97 (14%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
GY+APEVL Y + D W G ++Y ++ G PF RK+ V + R ++E
Sbjct: 166 GYMAPEVLNNQR------YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE 219
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKE 272
+ +S+ SE+ K + + LL P+ R +E
Sbjct: 220 TEEVYSA----KFSEEAKSICKMLLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH---RKQMVMLRNIMEGK 237
++APEV++ GY D+W+ G+ + G PP+ + + M+ N +
Sbjct: 165 WMAPEVIQEI------GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--KPP 216
Query: 238 YSFSSPE-WNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ S PE W S + D ++K L+ PE+R S + L H F
Sbjct: 217 PTLSDPEKW---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 19/116 (16%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
GY+APEV++ Y + D W G ++Y ++ G PF RK+ V + R + E
Sbjct: 166 GYMAPEVVKNER------YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE 219
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK-----EALNHSFFHPKLFDQ 286
+ +S SE + + R+LL P R + E H FF F +
Sbjct: 220 DQEEYSE----KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 10/88 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y PE+++ YG+ DVWA G I+Y + PPF+ + + I+E Y
Sbjct: 179 YSCPEIVKN------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY-- 230
Query: 241 SSPEWNDI-SEDPKDLIRKLLIVTPEDR 267
P + SED D+I L E R
Sbjct: 231 -EPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 7e-06
Identities = 31/125 (24%), Positives = 47/125 (37%), Gaps = 31/125 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y APE+L + T Y VD+WA G IM L P F ++ L I +
Sbjct: 164 YRAPEILLRS-----TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218
Query: 241 SSPEWND--------------------------ISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+ +W + S + DLI+ +L P+ R + +AL
Sbjct: 219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
Query: 275 NHSFF 279
H +F
Sbjct: 279 QHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 33/104 (31%), Positives = 43/104 (41%), Gaps = 16/104 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEV+R Y VD W G ++Y +L G PPF+ R M NI+
Sbjct: 162 YLAPEVIRKQ------PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL 215
Query: 241 ----SSPEWNDISE-DPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
S W+ + E KD R+L + E H FF
Sbjct: 216 RPGASLTAWSILEELLEKDRQRRL-----GAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 29/101 (28%), Positives = 41/101 (40%), Gaps = 8/101 (7%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV GY D+WA G+ L PP + M L + K +F
Sbjct: 167 WMAPEVAAVER---KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FLISKSNF 221
Query: 241 SSPEWND---ISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
P+ D S D I+K L P+ R + + L H F
Sbjct: 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 33/138 (23%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF-----WHRKQMV--ML--- 230
Y APE+L T Y A+D+WA G I+ LL P + ++ +L
Sbjct: 174 YRAPELLLG-----CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 231 -RNIMEG--------KYSFSSPEWND-------ISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+I G K++ +N+ +SE L+ LL+ P+ R + +EAL
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
Query: 275 NHSFF--HPKLFDQDIEP 290
S+F P + ++ P
Sbjct: 289 ESSYFKEKPLPCEPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 37/127 (29%), Positives = 49/127 (38%), Gaps = 33/127 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM------ 234
Y APE+L T YG+ VDVWA G IM LL G P F + L I
Sbjct: 167 YRAPELLVG-----DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221
Query: 235 --EGKYSFSS---------PEWNDI-----------SEDPKDLIRKLLIVTPEDRYSVKE 272
+ FSS PE + S D ++ L + P++R + E
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 273 ALNHSFF 279
L H +F
Sbjct: 282 LLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 17/118 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE++ YG++VD WA GV++Y +L G PF + + ++IME ++
Sbjct: 167 YIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 220
Query: 241 SSPEWNDISEDPKDLIR----KLLIVTPEDRYSVKEALNHSFFH----PKLFDQDIEP 290
+ K L+ K L PE +KE H+FF KL ++++P
Sbjct: 221 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE---HAFFRYIDWEKLERKEVQP 275
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 10/96 (10%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP- 109
++ Q+ ++++ + VHRDL N+LL Q K++DFG ++ L E
Sbjct: 100 LVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159
Query: 110 ---GYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ APE + F + DVW+ GV+M+
Sbjct: 160 WPVKWYAPECMNYYKFSSKS------DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 53/256 (20%), Positives = 109/256 (42%), Gaps = 54/256 (21%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
+D I S L + + Q+ + + ++ +VHRDL N+L+ +VK+TDFG A++L
Sbjct: 103 KDNIGSQYLLNWCV-QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161
Query: 99 GEKLMDLCGTP---GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
EK G ++A E + + Y DVW+ GV ++ L+
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRI------YTHQSDVWSYGVTVWELM---------- 205
Query: 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 215
+F S ++ I A E+ +++ E Q C + +Y ++
Sbjct: 206 -------------TFGSKPYDGIP---ASEI--SSILEKGERLPQPP---ICTIDVYMIM 244
Query: 216 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
V C W M+ K+ E++ ++ DP+ + L++ ++R + +
Sbjct: 245 VKC---W------MIDADSRPKFRELIIEFSKMARDPQ----RYLVIQGDERMHLPSPTD 291
Query: 276 HSFFHPKLFDQDIEPI 291
+F+ + ++D++ +
Sbjct: 292 SNFYRALMDEEDMDDV 307
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 18/106 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLC 106
Q+ +E + + +HRDL NILL + VK+ DFG AR ++KG+ + L
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 239
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE ++F+ Y DVW+ GV+++ + +G P+
Sbjct: 240 ---KWMAPE----SIFDKV--YTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 9/134 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--K 101
S + Q+ ++H+ N VHRDL N L+ Q VK++ ++ + E K
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 160
L + +LAPE ++ + F + DVW+ GV+M+ + G PF+ +L
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKS------DVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
Query: 161 RNIMEGKYSFSSPE 174
+ GK PE
Sbjct: 229 NRLQAGKLELPVPE 242
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 29/119 (24%), Positives = 64/119 (53%), Gaps = 13/119 (10%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCG 107
+I Q+ +E++ +H VH+DL NIL+ +Q++VK++D G +R + + ++
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 108 TP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFW---HRKQMVMLR 161
P ++ PE + F + D+W+ GV+++ + G P++ +++ + M+R
Sbjct: 188 LPIRWMPPEAIMYGKFSSDS------DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 10/124 (8%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL-MDLCGTP-GY 111
Q+ E + + + +HRDL+ NIL+ + + K+ DFG AR+++ E + P +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSF 170
APE + F + DVW+ G+++ ++ G P+ +++N+ G Y
Sbjct: 170 TAPEAINYGTFTIKS------DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRM 222
Query: 171 SSPE 174
P+
Sbjct: 223 PRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 17/106 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ YG +VD WA GV+MY ++ G PPF + + +I+ +
Sbjct: 162 YIAPEILQE------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSV-------KEALNHSFF 279
P W +S++ +++ + P R H FF
Sbjct: 216 --PVW--LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+ YG VD+W+ G+++ ++ G PP+++ + ++ I +
Sbjct: 181 WMAPEVI------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ +S + + ++L+ P R + E LNH F
Sbjct: 235 LK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 38/166 (22%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 12 VVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMR---QLFEALEHVHNHSVV 68
V++ + GD +L + + VQ + P+L+ +++ ++ + + +++ + V
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQ----APPSLKKMIQMAGEIADGMAYLNANKFV 141
Query: 69 HRDLKPENILLDDQMNVKLTDFGFARVL-------KKGEKLMDLCGTPGYLAPEVLRANM 121
HRDL N ++ + VK+ DFG R + K G+ L+ + +++PE L+ +
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV----RWMSPESLKDGV 197
Query: 122 FEDATGYGQAVDVWACGVIMYTL-LVGCPPFWHRKQMVMLRNIMEG 166
F + DVW+ GV+++ + + P+ +LR +MEG
Sbjct: 198 FTTYS------DVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 17/48 (35%), Positives = 29/48 (60%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA 93
++ IM+ + LE++H H + H D+KPENI++D + D+G A
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDL 105
L Y+ Q+ ++++ + + VHRDL N L+ + +K+ DFG +R L G+ ++
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 106 CGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
P ++A E + F A+ DVWA GV ++ + C
Sbjct: 191 AVLPIRWMAWESILLGKFTTAS------DVWAFGVTLWEMFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 12/131 (9%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF-GFARVLKKGEKL 102
S A+ YI++ + +AL+++H+ VHR +K +IL+ V L+ ++ G++L
Sbjct: 99 SELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158
Query: 103 MDLCGTPGY-------LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
+ P Y L+PEVL+ N+ GY D+++ G+ L G PF
Sbjct: 159 RVVHDFPKYSVKVLPWLSPEVLQQNL----QGYDAKSDIYSVGITACELANGHVPFKDMP 214
Query: 156 QMVMLRNIMEG 166
ML + G
Sbjct: 215 ATQMLLEKLNG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 20/59 (33%), Positives = 27/59 (45%), Gaps = 6/59 (10%)
Query: 51 IMRQLFEALEHVHNHS---VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC 106
I QL E L +H + H DL P NIL+DD + + D+ +A G DL
Sbjct: 91 IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY---GPPAFDLA 146
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 11/117 (9%)
Query: 166 GKYSFSSPEWNDISG---YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222
G S +SP N G ++APEV+ A D Y VDVW+ G+ L PP +
Sbjct: 170 GSASIASPA-NSFVGTPYWMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLF 225
Query: 223 HRKQMVMLRNIMEGKY-SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+ M L +I + + + S EW+D ++ + L P+DR + +E L H F
Sbjct: 226 NMNAMSALYHIAQNESPTLQSNEWSDYF---RNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ Y +VD W+ GV++Y +L+G PF + + +I +
Sbjct: 162 YIAPEILQG------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY 215
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN-HSFF 279
P W I+++ KD++ KL P R V + H FF
Sbjct: 216 --PRW--ITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 20/127 (15%)
Query: 31 VDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+ E V D+ + Q+ + ++ + VHRDL N+LL ++ K++DF
Sbjct: 87 KKRREIPVSDLKE-------LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 91 GFARVLKKGEKLMDLCGTPG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
G +R L G T G + APE + F + DVW+ GV ++
Sbjct: 140 GMSRALGAGSDYYR-ATTAGRWPLKWYAPECINYGKFSSKS------DVWSYGVTLWEAF 192
Query: 146 -VGCPPF 151
G P+
Sbjct: 193 SYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---GYLAPE 115
+E++ N + +HRDL N +L + M V + DFG ++ + G+ ++A E
Sbjct: 126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLL 145
L ++ + DVWA GV M+ +
Sbjct: 186 SLADRVYTSKS------DVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---G 110
Q+ + + ++ +VHRDL N+L+ +VK+TDFG AR+L E G
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
++A E + F + DVW+ GV ++ L+ G P+
Sbjct: 177 WMALESILHRRFTHQS------DVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 26/121 (21%)
Query: 59 LEHVHNHSVVHRDLKPENILL-----DDQMNVKLTDFGFARVL-------KKGEKLMDLC 106
LE +H +HRDL N L+ D VK+ DFG AR + K+GE L+ +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY-TLLVGCPPFWHRKQMVMLRNIME 165
++APE L F + DVW+ GV+M+ L +G P+ +L+++
Sbjct: 178 ---RWMAPESLLDGKFTTQS------DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
Query: 166 G 166
G
Sbjct: 229 G 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-D 104
P L Q+ E + + + +HRDL+ NIL+ + K+ DFG ARV++ E +
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161
Query: 105 LCGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141
P + APE + F + DVW+ G+++
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKS------DVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 19/109 (17%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
GY+APEV++ Y + D WA G ++Y ++ G PF RK+ + + R + E
Sbjct: 166 GYMAPEVVKNER------YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 219
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
+ +S S D + L + LL P++R +E H F
Sbjct: 220 VQEEYSE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GY+APEV+ Y + D W G ++Y ++ G PF RK+ V R ++ +
Sbjct: 166 GYMAPEVINNE------KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVK 218
Query: 240 FSSPEWND-ISEDPKDLIRKLLIVTPEDRYSVKE 272
E+++ SED K + R LL P++R +
Sbjct: 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRG 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS- 239
YLAPE+ + Y + D+W+ GVI+Y LL PF Q +++ ++ GKY
Sbjct: 237 YLAPELW------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F P +S K L+ LL P R + ++ L+ F
Sbjct: 291 FPCP----VSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 26/100 (26%), Positives = 41/100 (41%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIMEGKY 238
Y+APEV+ + GYG D+W+ G + + G PPF Q M + G +
Sbjct: 175 YMAPEVID----KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMF 227
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+S + K+ I + P+ R S + L F
Sbjct: 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 33/129 (25%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLC 106
Q+ +E + + + VHRDL N+LL VK+ DFG AR + KG + +
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV- 303
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIME 165
++APE + N+ Y DVW+ G++++ + +G P+ N ++
Sbjct: 304 ---KWMAPESIFDNL------YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354
Query: 166 GKYSFSSPE 174
Y + P+
Sbjct: 355 SGYRMAKPD 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKYS 239
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 182 WMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+PE +S +D + + L + E R S KE L H F
Sbjct: 236 LQNPE--KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 36/127 (28%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL---------------------VGCP 219
Y APE L + + YG +D+WA G + + +L +G P
Sbjct: 164 YRAPECLLTDGY-----YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP 218
Query: 220 PFWHRKQMVMLR--NIMEGKYSFSSPEW-----NDISEDPKDLIRKLLIVTPEDRYSVKE 272
+ + R M + + S + DL++KLL P++R + K+
Sbjct: 219 D---AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275
Query: 273 ALNHSFF 279
AL H +F
Sbjct: 276 ALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 14/126 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFG-FARVLKKGEKL 102
S + I+ L ++H + +HR++K +IL+ V L+ +++ G+K
Sbjct: 99 SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158
Query: 103 MDLCGTPGY-------LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF--WH 153
+ P + L+PE+LR +D GY D+++ G+ L G PF
Sbjct: 159 KVVYDFPQFSTSVLPWLSPELLR----QDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
Query: 154 RKQMVM 159
R QM++
Sbjct: 215 RTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL+PE+ + + + T D+W+ G ++Y L PF ++ I +G ++
Sbjct: 168 YLSPEICQNRPYNNKT------DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP 221
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
SP + S D + LI +L V+P DR S+ L F
Sbjct: 222 ISPNF---SRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRNIMEGK 237
++APE++ YG VD+W+ G+++ ++ G PP+++ K M M+R+ + K
Sbjct: 182 WMAPELI------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK 235
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ +S K + +LL+ P R + E L H F
Sbjct: 236 LK----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 35/127 (27%), Positives = 47/127 (37%), Gaps = 34/127 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH----------------- 223
Y APE+L + T YG VDVWA G + LL G P W
Sbjct: 166 YRAPELLVGD-----TQYGPPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGD 219
Query: 224 ---RKQMVMLRNIMEGKYSFSSPE--------WNDISEDPKDLIRKLLIVTPEDRYSVKE 272
R Q + N S PE + +IS ++ L + P +R S +E
Sbjct: 220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279
Query: 273 ALNHSFF 279
L H +F
Sbjct: 280 LLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/133 (26%), Positives = 57/133 (42%), Gaps = 46/133 (34%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---------WH-------- 223
Y APE+L + T YG+AVD+WA G ++ +L G P F +H
Sbjct: 166 YRAPELLVGD-----TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 224 --RKQMVMLRNI---------------MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPED 266
R Q + +N +E ++ P+ + + DL ++ L + P+D
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF----PKLSGLV---LDLAKQCLRIDPDD 273
Query: 267 RYSVKEALNHSFF 279
R S + L+H FF
Sbjct: 274 RPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKYS 239
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 181 WMAPEVVTRKA------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+PE +S +D + + L + E R S KE L H F
Sbjct: 235 LQNPE--KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKYS 239
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 181 WMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+PE +S +D + + L + E R S KE L H F
Sbjct: 235 LQNPE--KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 30/124 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM------ 234
Y APE+L + Y VD+W+ G I ++ P F ++ L I
Sbjct: 165 YRAPEILLG-----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP 219
Query: 235 ------------EGKYSF---SSPEWNDI----SEDPKDLIRKLLIVTPEDRYSVKEALN 275
+ K +F + + + + ED DL+ K+L+ P R S K AL
Sbjct: 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279
Query: 276 HSFF 279
H +F
Sbjct: 280 HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 35/124 (28%), Positives = 49/124 (39%), Gaps = 30/124 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y APEVL + Y VD+W+ G I + P F ++ L I
Sbjct: 167 YRAPEVLLG-----SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221
Query: 236 -----------GKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALN 275
Y + P+W ++ ED DL+ K+LI P R S K+ALN
Sbjct: 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281
Query: 276 HSFF 279
H +F
Sbjct: 282 HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 32/127 (25%), Positives = 56/127 (44%), Gaps = 25/127 (19%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLCGTPGY 111
+E++ + + +HRDL N L+ + +K++DFG +R + G K + + T
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT--- 162
Query: 112 LAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVG--CP-PFWHRKQMVMLRNIMEGK 167
APE L G Y DVW+ G++++ P P +Q R +E
Sbjct: 163 -APEALN-------YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIESG 211
Query: 168 YSFSSPE 174
Y +P+
Sbjct: 212 YRMPAPQ 218
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 14/104 (13%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P L + Q+ + +V + VHRDL+ NIL+ + + K+ DFG AR+++ E
Sbjct: 102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161
Query: 106 CGT--PGYLAPEVLRANMFEDATGYGQAV---DVWACGVIMYTL 144
+ APE A YG+ DVW+ G+++ L
Sbjct: 162 GAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 34/134 (25%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIIN-SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77
E DL ++ + A D++ S L ++ Q+ ++++ + + VHRDL N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 78 LLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTP-GYLAPEVLRANMFEDATGYGQAVDV 134
L+ +K+ DFG +R L G+ ++ P +++ E + F A+ DV
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS------DV 215
Query: 135 WACGVIMYTLLVGC 148
WA GV ++ +L C
Sbjct: 216 WAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP---GYLA 113
E + ++ + +V+HRDL N L+ + VK++DFG R + ++ GT + +
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSS 169
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEG 166
PEV + Y DVW+ GV+M+ + G P+ +R ++ I G
Sbjct: 170 PEVFS------FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 27/96 (28%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 52 MRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTP 109
M + +E++ + S +HRDL N +L++ MNV + DFG ++ + G+ + + P
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 110 -GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144
++A E L + Y DVW+ GV M+ +
Sbjct: 178 VKWIAIESLADRV------YTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 28/102 (27%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPG 110
Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + + K +
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK 204
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE L + Y DVW+ GV+M+ + +G P+
Sbjct: 205 WMAPEALFDRV------YTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 6/41 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
Y+APE+LR ED YG +VD WA GV+M+ ++ G PF
Sbjct: 162 YIAPEILRG---ED---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 7/98 (7%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+ +GYG+ D+W+ G ++ + G PP ++ + I +
Sbjct: 174 WMAPEVINE------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-GL 226
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+ S D + L +R S + L H F
Sbjct: 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 14/105 (13%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P L + Q+ + + ++ + +HRDL+ NIL+ D + K+ DFG AR+++ E
Sbjct: 102 PQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161
Query: 106 CGT--PGYLAPEVLRANMFEDATGYGQAV---DVWACGVIMYTLL 145
+ APE A YG+ DVW+ G+++ L+
Sbjct: 162 GAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 9/114 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S L Y+ Q+ + ++ + + VHRDL N L+ +K+ DFG +R L
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS---- 183
Query: 104 DLCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGC--PPFWH 153
D G AP +R +E + DVWA GV ++ +L C P+ H
Sbjct: 184 DYYRVQGR-APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
+++PEV+ GYG+ DVW+ G + +L PP+ + M + I +
Sbjct: 175 WMSPEVISGE------GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
P + ISE +D + + V R S +E L H F
Sbjct: 229 QLP--SHISEHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 26/103 (25%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+ T YG VD+W+ G+++ ++ G PP++ + ++ + +
Sbjct: 183 WMAPEVI------SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----- 231
Query: 241 SSP----EWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
S P + IS +D + ++L P++R + +E L+H F
Sbjct: 232 SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 11/118 (9%)
Query: 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
N + K + + P ++APEV++ T Y + D+W+ G ++ +L G PF
Sbjct: 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ------TSYTRKADIWSLGCLVVEMLTGKHPF 212
Query: 222 WHRKQMVMLRNIMEGKYSFSSPEW-NDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
Q+ + I E +SPE ++IS + D + K + R + E L H F
Sbjct: 213 PDCTQLQAIFKIGE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 33/124 (26%), Positives = 47/124 (37%), Gaps = 30/124 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG---- 236
Y APE+L + Y AVD+W+ G I ++ F ++ L I
Sbjct: 166 YRAPEILLGCKY-----YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 220
Query: 237 ------------KYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALN 275
Y S P+W + ED +DL+ ++L P R S K AL
Sbjct: 221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
Query: 276 HSFF 279
H FF
Sbjct: 281 HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 25/106 (23%), Positives = 55/106 (51%), Gaps = 18/106 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-------VLKKGEKLMDLC 106
Q+ ++++ +VHRDL N+L+ + +K++DFG +R +K+ + + +
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV- 193
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++A E L ++ Y DVW+ GV+++ ++ +G P+
Sbjct: 194 ---KWMAIESLFDHI------YTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 12/97 (12%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
+M Q+ ++++ + VHRDL N+LL +Q K++DFG ++ L + + G
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-ARSAG 158
Query: 111 -----YLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ APE + F + DVW+ G+ M+
Sbjct: 159 KWPLKWYAPECINFRKFSSRS------DVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 26/116 (22%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+ YG VD+W+ G+++ ++ G PP+++ + +R I +
Sbjct: 184 WMAPEVI------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPP 236
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYK 296
+ + +S + + +L+ P R + +E L H F I P+ + Y+
Sbjct: 237 RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQYR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 15/143 (10%)
Query: 43 NSNPALRYIMRQLFE---ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG 99
P + R E L H+H ++ +H DL N LL + VK+ D+G + K
Sbjct: 94 LMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153
Query: 100 EKLM--DLCGTP-GYLAPEVL---RANMF-EDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
+ + D P ++APE++ N+ D T +VW+ GV ++ L +G P+
Sbjct: 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKES---NVWSLGVTIWELFELGSQPY 210
Query: 152 WH-RKQMVMLRNIMEGKYSFSSP 173
H + V+ + E + P
Sbjct: 211 RHLSDEQVLTYTVREQQLKLPKP 233
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 32/134 (23%), Positives = 66/134 (49%), Gaps = 21/134 (15%)
Query: 46 PALRYIMR---QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------ 96
P L+ +++ ++ + + +++ VHRDL N ++ VK+ DFG R +
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175
Query: 97 -KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL-LVGCPPFWHR 154
K G+ L+ + ++APE L+ +F T D+W+ GV+++ + + P+
Sbjct: 176 RKGGKGLLPV----RWMAPESLKDGVF---TTSS---DMWSFGVVLWEITSLAEQPYQGL 225
Query: 155 KQMVMLRNIMEGKY 168
+L+ +M+G Y
Sbjct: 226 SNEQVLKFVMDGGY 239
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI-MEGKYS 239
++APEV+ YG VD+W+ G++ ++ G PP+ + + L I G
Sbjct: 181 WMAPEVVTRK------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+PE +S +D + + L + + R S KE L H F
Sbjct: 235 LQNPE--RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 10/102 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR---VLKKGEKLMDLCGTPG 110
Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + +K +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE L F+ Y DVW+ GV+++ + +G P+
Sbjct: 202 WMAPEAL----FDRV--YTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P L + Q+ + ++ + +HRDL+ NIL+ D + K+ DFG AR+++ E
Sbjct: 102 PNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 106 CGT--PGYLAPEVLRANMFEDATGYGQAV---DVWACGVIMYTLL 145
+ APE A YG+ DVW+ G+++ L+
Sbjct: 162 GAKFPIKWTAPE---------AALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 36/117 (30%), Positives = 51/117 (43%), Gaps = 11/117 (9%)
Query: 166 GKYSFSSPEWNDISG---YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222
G S SSP N G ++APEV+ A D Y VDVW+ G+ L PP +
Sbjct: 166 GSASKSSPA-NSFVGTPYWMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLF 221
Query: 223 HRKQMVMLRNIMEGKY-SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+ M L +I + + S EW D + + L P++R + E L H F
Sbjct: 222 NMNAMSALYHIAQNDSPTLQSNEWTD---SFRGFVDYCLQKIPQERPASAELLRHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 18/106 (16%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-------KGEKLMDLC 106
Q+ + + + + + +HRDL N+LL VK+ DFG AR + KG + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV- 207
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE + + Y DVW+ G++++ + +G P+
Sbjct: 208 ---KWMAPESIFNCV------YTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 20/41 (48%), Positives = 27/41 (65%), Gaps = 6/41 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
Y+APE+LR ED YG +VD WA GV+M+ ++ G PF
Sbjct: 162 YIAPEILRG---ED---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 14/146 (9%)
Query: 162 NIMEGKYSF-SSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220
+IM F +P W +APEV+ A D Y VDVW+ G+ L PP
Sbjct: 163 SIMAPANXFVGTPYW------MAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPP 213
Query: 221 FWHRKQMVMLRNIMEGKYS-FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
++ M L +I + + S W SE ++ + L P+DR + + L H F
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
Query: 280 HPKLFDQDIEPIKKDYKTASRKLSKI 305
+ I + + K A R+L +
Sbjct: 271 LRERPPTVIMDLIQRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/126 (22%), Positives = 59/126 (46%), Gaps = 18/126 (14%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-------GEKL 102
+I +Q+ + ++ + VHRDL N L+ + + VK+ DFG +R + G +
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLR 161
+ + ++ PE + F + DVW+ GV+++ + G P++ ++
Sbjct: 184 LPI----RWMPPESIMYRKFTTES------DVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
Query: 162 NIMEGK 167
I +G+
Sbjct: 234 CITQGR 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 25/100 (25%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------KKGEKLMDLCG 107
Q+ +E + + +HRDL N+L+ + +K+ DFG AR + +K
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK--------T 191
Query: 108 TPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
T G L APE L ++ + DVW+ GV+++
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQS------DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTP-G 110
Q+ + + ++ H +VHR+L NILL V++ DFG A +L +K TP
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151
++A E + Y DVW+ GV ++ ++ G P+
Sbjct: 177 WMALESILFGR------YTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 19/41 (46%), Positives = 27/41 (65%), Gaps = 6/41 (14%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
Y+APE+LR E+ YG +VD WA GV+M+ ++ G PF
Sbjct: 162 YIAPEILRG---EE---YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 24/100 (24%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
+++PEV+ GYG+ D+W+ G + +L PP+ + M + I +
Sbjct: 175 WMSPEVISGE------GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
P +S+ +D ++++ + + R S E L H+F H
Sbjct: 229 VLPP--HVSDHCRDFLKRIFVEA-KLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 27/126 (21%), Positives = 50/126 (39%), Gaps = 33/126 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRNIM--- 234
Y APE+L + Y AVD+W+ G I LL F + +Q+ ++ +++
Sbjct: 170 YRAPEILMG-----SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 235 ---------EG--KYSFSSPE-----------WNDISEDPKDLIRKLLIVTPEDRYSVKE 272
EG + P + + + L+ ++L+ P+ R S +
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284
Query: 273 ALNHSF 278
AL H +
Sbjct: 285 ALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 36/128 (28%), Positives = 50/128 (39%), Gaps = 34/128 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-MLRNIME---- 235
Y P+VL AT Y A+D+W G I +L G P F + L I
Sbjct: 169 YRPPDVLLG-----ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223
Query: 236 ---------GKYSFSSPEW-------------NDISEDPK--DLIRKLLIVTPEDRYSVK 271
K PEW +S PK DL ++L++ P+DR S +
Sbjct: 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283
Query: 272 EALNHSFF 279
+AL H +F
Sbjct: 284 DALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE +F + Y DVWA G +Y + F + ++ I+EGK
Sbjct: 168 YMSPE-----LFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP- 220
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
P D S + +LI +L PE R SVK L +
Sbjct: 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 7/112 (6%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC---PPFWHRKQMVMLRNIMEGK 237
Y+APE +++ Y DVW+ G+ + + +G PP + L I++G
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIE 289
+ S+D +D + K L P R + + L H + K + D++
Sbjct: 227 PPTLPSGY---SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL-VKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 18/110 (16%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
I +Q+ + ++ VHRDL N L+ + M VK+ DFG +R + D
Sbjct: 135 IAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI----YSADYYKASE 190
Query: 111 -------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFW 152
++ PE + N + + DVWA GV+++ + G P++
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTES------DVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 27/102 (26%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPG 110
Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + + K +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
++APE L + Y DVW+ GV+++ + +G P+
Sbjct: 208 WMAPEALFDRI------YTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|223584 COG0510, ycfN, Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 12 VVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNH--SVVH 69
+ R + K + + A +D N LR +++L ALE V H
Sbjct: 102 QLPRSGSSFIEPKDYLELLWQQNSRAYRD----NHLLRKKLKELRRALEEVPKDDLVPCH 157
Query: 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
DL P N+LL D+ + L D+ +A + + DL
Sbjct: 158 NDLNPGNLLLTDKGGLFLIDWEYAGL---NDPAFDL 190
|
Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KL 102
L Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + + K
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
+ ++APE L F+ Y DVW+ G++M+ + +G P+
Sbjct: 194 SNGRLPVKWMAPEAL----FDRV--YTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 29/126 (23%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK-------GEKL 102
+I Q+ + ++ + VHRDL N L+ + VK+ DFG +R + G +
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLR 161
+ + ++ PE + F + DVW+ GVI++ + G P++ ++
Sbjct: 187 LPI----RWMPPESIMYRKFTTES------DVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
Query: 162 NIMEGK 167
I +G+
Sbjct: 237 CITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 10/94 (10%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPE 115
+ H+H H+ +H DL N L + VK+ D+G K + + D C +LAPE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 116 VLRAN----MFEDATGYGQAVDVWACGVIMYTLL 145
++ + + T +VWA GV ++ L
Sbjct: 172 LVGEFHGGLITAEQTKPS---NVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 13/106 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GY+APEVL + Y + D ++ G +++ LL G PF R+ ++ ++
Sbjct: 160 GYMAPEVL-----QKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTL 212
Query: 240 FSSPEW-NDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFF 279
+ E + S + + L+ LL R +E H FF
Sbjct: 213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 24/104 (23%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L + R L A +H H V D+ + L+ D V L D ++ G +
Sbjct: 117 DFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCP 176
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAV--DVWACGVIMYTLLVG 147
G + PE+ F G+ + D + V+++ LL G
Sbjct: 177 VGVSEFTPPELQTLPSF---VGFERTANHDNFGLAVLIFHLLFG 217
|
Length = 637 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0603|consensus | 612 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201|consensus | 467 | 99.98 | ||
| KOG0696|consensus | 683 | 99.98 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG0579|consensus | 1187 | 99.98 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG0192|consensus | 362 | 99.97 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0671|consensus | 415 | 99.97 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG0668|consensus | 338 | 99.97 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0584|consensus | 632 | 99.97 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| KOG4721|consensus | 904 | 99.97 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0574|consensus | 502 | 99.96 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0197|consensus | 468 | 99.96 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0664|consensus | 449 | 99.96 | ||
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1027|consensus | 903 | 99.96 | ||
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG1989|consensus | 738 | 99.96 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| KOG1035|consensus | 1351 | 99.95 | ||
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| KOG0670|consensus | 752 | 99.95 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1151|consensus | 775 | 99.95 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0695|consensus | 593 | 99.94 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| KOG0193|consensus | 678 | 99.94 | ||
| KOG0587|consensus | 953 | 99.94 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| KOG2345|consensus | 302 | 99.94 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG1167|consensus | 418 | 99.93 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| KOG0194|consensus | 474 | 99.93 | ||
| KOG1026|consensus | 774 | 99.93 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| KOG1006|consensus | 361 | 99.92 | ||
| KOG4250|consensus | 732 | 99.92 | ||
| KOG1095|consensus | 1025 | 99.91 | ||
| KOG0590|consensus | 601 | 99.91 | ||
| KOG4257|consensus | 974 | 99.91 | ||
| KOG1187|consensus | 361 | 99.9 | ||
| KOG0196|consensus | 996 | 99.9 | ||
| KOG0984|consensus | 282 | 99.89 | ||
| KOG0199|consensus | 1039 | 99.89 | ||
| KOG0576|consensus | 829 | 99.89 | ||
| KOG1290|consensus | 590 | 99.88 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG0603|consensus | 612 | 99.87 | ||
| KOG4278|consensus | 1157 | 99.87 | ||
| KOG1094|consensus | 807 | 99.86 | ||
| KOG0606|consensus | 1205 | 99.85 | ||
| KOG0200|consensus | 609 | 99.85 | ||
| KOG1152|consensus | 772 | 99.84 | ||
| KOG1345|consensus | 378 | 99.83 | ||
| KOG1025|consensus | 1177 | 99.83 | ||
| KOG3653|consensus | 534 | 99.82 | ||
| KOG2052|consensus | 513 | 99.81 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG0965|consensus | 988 | 99.75 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.74 | |
| KOG1024|consensus | 563 | 99.74 | ||
| KOG1033|consensus | 516 | 99.7 | ||
| KOG1240|consensus | 1431 | 99.69 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.66 | |
| KOG4158|consensus | 598 | 99.64 | ||
| KOG0590|consensus | 601 | 99.63 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.63 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.57 | |
| KOG0606|consensus | 1205 | 99.49 | ||
| KOG1164|consensus | 322 | 99.45 | ||
| KOG1165|consensus | 449 | 99.43 | ||
| KOG1023|consensus | 484 | 99.38 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.38 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.36 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.35 | |
| KOG1163|consensus | 341 | 99.33 | ||
| KOG0605|consensus | 550 | 99.23 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.21 | |
| KOG0195|consensus | 448 | 99.16 | ||
| KOG1166|consensus | 974 | 99.12 | ||
| PF01585 | 45 | G-patch: G-patch domain; InterPro: IPR000467 The D | 99.1 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.1 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.08 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.07 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.06 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.06 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.01 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.95 | |
| smart00443 | 47 | G_patch glycine rich nucleic binding domain. A pre | 98.92 | |
| KOG0610|consensus | 459 | 98.91 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.9 | |
| KOG1266|consensus | 458 | 98.84 | ||
| KOG0601|consensus | 524 | 98.79 | ||
| KOG0599|consensus | 411 | 98.72 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.64 | |
| KOG2137|consensus | 700 | 98.6 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.55 | |
| KOG0591|consensus | 375 | 98.46 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.41 | |
| KOG0033|consensus | 355 | 98.38 | ||
| KOG0601|consensus | 524 | 98.35 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.31 | |
| KOG0660|consensus | 359 | 98.26 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.21 | |
| KOG0600|consensus | 560 | 98.2 | ||
| KOG0607|consensus | 463 | 98.14 | ||
| KOG0667|consensus | 586 | 98.13 | ||
| KOG0616|consensus | 355 | 98.11 | ||
| KOG0663|consensus | 419 | 98.09 | ||
| KOG0659|consensus | 318 | 98.07 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 98.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.06 | |
| KOG0604|consensus | 400 | 98.0 | ||
| KOG1243|consensus | 690 | 98.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 97.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 97.97 | |
| KOG0593|consensus | 396 | 97.95 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 97.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 97.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 97.91 | |
| KOG0615|consensus | 475 | 97.91 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.9 | |
| KOG0598|consensus | 357 | 97.88 | ||
| KOG0592|consensus | 604 | 97.88 | ||
| KOG0658|consensus | 364 | 97.86 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 97.85 | |
| KOG0589|consensus | 426 | 97.85 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 97.84 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 97.81 | |
| KOG0588|consensus | 786 | 97.8 | ||
| KOG0582|consensus | 516 | 97.8 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 97.79 | |
| KOG0695|consensus | 593 | 97.78 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 97.78 | |
| KOG2384|consensus | 223 | 97.77 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 97.77 | |
| KOG0578|consensus | 550 | 97.76 | ||
| KOG0594|consensus | 323 | 97.76 | ||
| KOG0612|consensus | 1317 | 97.73 | ||
| KOG0201|consensus | 467 | 97.71 | ||
| KOG3087|consensus | 229 | 97.71 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 97.7 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 97.69 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 97.69 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 97.69 | |
| KOG0696|consensus | 683 | 97.68 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 97.66 |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-67 Score=481.35 Aligned_cols=274 Identities=49% Similarity=0.839 Sum_probs=244.1
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
..||++| .+.+ +.+.+.++|+|+|..|| |||++++ ++++|.+|+|+++|++|||.++||||||||||||+
T Consensus 80 ~GHP~II-~l~D~yes~sF~FlVFdl~prGE--LFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 80 MGHPYII-DLQDVYESDAFVFLVFDLMPRGE--LFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred cCCCcEE-EeeeeccCcchhhhhhhhcccch--HHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 4688755 5554 67788999999999999 9999975 58999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+++.++||+|||+|..+.+++.+...||||+|+|||.+.++++++++
T Consensus 157 ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~p--------------------------------- 203 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHP--------------------------------- 203 (411)
T ss_pred ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCC---------------------------------
Confidence 99999999999999999999999999999999999999987765443
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+|+.++|+|+||||||+||.|+||||++.+..|++.|++|+|+
T Consensus 204 -------------------------------------GYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 204 -------------------------------------GYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred -------------------------------------CccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 4666899999999999999999999999999999999999999
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHHHHHH
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFIILVVR 319 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (408)
|.+|+|.++|+++||||++||++||.+|+|++|+|.||||.+....+.....+.......+++..++++.+|+.||++|+
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~~~~~~k~qt~~~aRkrFk~ail~vr 326 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVVEVELVKDQTSERARKRFKVAILTVR 326 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCcchhhhhhhhhHHhhhheeeeeehHH
Confidence 99999999999999999999999999999999999999996543222222222222344667788999999999999999
Q ss_pred HHHHHhhhcccCCccccccccccCCcchHHHHHHH
Q psy3880 320 AAVRISRLKYNHVPALSVTQGRDDPYGVKILRQYN 354 (408)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (408)
+..|+.+.++...| +..+...+|||+.|.+|+.-
T Consensus 327 a~~Ria~~~~~~~p-l~re~l~rdPyr~r~lRh~i 360 (411)
T KOG0599|consen 327 AFQRIAKYKYRVTP-LTREVLIRDPYRLRDLRHLI 360 (411)
T ss_pred HHHHHHHHhhcccc-ccHHHHhcCchhhhHHHHHH
Confidence 99999999999999 99999999999999988754
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=397.24 Aligned_cols=240 Identities=37% Similarity=0.663 Sum_probs=209.0
Q ss_pred ccccCCcEEEEeccC--CcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEG--DDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
||.||+ |+++.++. +.+.|||||+|+||+ |+.-|. ++..+..+++|||+||.|||.+||||||+||+|+|
T Consensus 66 ~LqHP~-IvrL~~ti~~~~~~ylvFe~m~G~d--l~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 66 KLQHPN-IVRLHDSIQEESFHYLVFDLVTGGE--LFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred hcCCCc-EeehhhhhcccceeEEEEecccchH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 788997 66888754 456799999999999 766554 55889999999999999999999999999999999
Q ss_pred Eec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+.+ ...+||+|||+|..++.+.......|||+|||||+++..
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkd----------------------------------- 187 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKD----------------------------------- 187 (355)
T ss_pred eeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcC-----------------------------------
Confidence 964 347999999999999866666679999999999998642
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
+|+.++|||+||||+|.||.|++|||+.++..+++.|+.
T Consensus 188 -----------------------------------------py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~ 226 (355)
T KOG0033|consen 188 -----------------------------------------PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA 226 (355)
T ss_pred -----------------------------------------CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 356689999999999999999999999999999999999
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.|.+++++|+.+|++|+|||++||..||++|+||.|+|+|||+.... .............++++||+++++|.++
T Consensus 227 g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~----~~As~~H~~dtvd~lrkfNarRKLKgav 302 (355)
T KOG0033|consen 227 GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE----RVASAIHRQDTVDCLKKFNARRKLKGAI 302 (355)
T ss_pred cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH----HHHHHhhhHHHHHHHHHhhHHHHHHHHH
Confidence 999999999999999999999999999999999999999999997642 1122344556677899999999999999
Q ss_pred HHHHHHHHHhhhc
Q psy3880 316 LVVRAAVRISRLK 328 (408)
Q Consensus 316 ~~~~~~~~~~~~~ 328 (408)
++...+.|+....
T Consensus 303 Ltav~s~r~~s~~ 315 (355)
T KOG0033|consen 303 LTTVIATRNLSTT 315 (355)
T ss_pred HHHHHhccccccC
Confidence 9998888876643
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=405.46 Aligned_cols=200 Identities=38% Similarity=0.720 Sum_probs=178.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
|.||+ ||++++ +.++..|+||||+.||| |++.+.. +..-+.+++|||.||.|||++||+||||||+|||+
T Consensus 233 L~HP~-IV~~~d~f~~~ds~YmVlE~v~GGe--Lfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 233 LSHPN-IVRIKDFFEVPDSSYMVLEYVEGGE--LFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred cCCCC-EEEEeeeeecCCceEEEEEEecCcc--HHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 67998 557776 55677799999999999 9999864 47789999999999999999999999999999999
Q ss_pred ecC---CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQ---MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~---~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+.+ ..+||+|||+|+......-+.+.||||.|.|||++...- +
T Consensus 310 ~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg------~---------------------------- 355 (475)
T KOG0615|consen 310 SNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG------V---------------------------- 355 (475)
T ss_pred ccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC------e----------------------------
Confidence 876 689999999999998888888999999999999996421 1
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH-HHHHHHh
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-MLRNIME 235 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~-~~~~i~~ 235 (408)
..|+.++|+||+||++|.+|+|+|||....+.. +.++|.+
T Consensus 356 ---------------------------------------~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 356 ---------------------------------------EYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred ---------------------------------------ecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 123448999999999999999999998876555 8999999
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
|.|.|.++.|..+|++++|||.+||++||++|||++|||+||||+..
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 99999999999999999999999999999999999999999999864
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.88 Aligned_cols=197 Identities=39% Similarity=0.692 Sum_probs=170.7
Q ss_pred ccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 8 AHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 8 ~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.|++ ||.+.+. +..+..+|||.++||| ||.+|.+ +.++..|++||..|+.|||+.+|.||||||
T Consensus 113 ~h~~-iV~IidVyeNs~~~rkcLLiVmE~meGGe--Lfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp 189 (400)
T KOG0604|consen 113 GHPH-IVSIIDVYENSYQGRKCLLIVMECMEGGE--LFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP 189 (400)
T ss_pred CCCc-eEEeehhhhhhccCceeeEeeeecccchH--HHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh
Confidence 5776 5565553 3445679999999999 9999864 378999999999999999999999999999
Q ss_pred CcEEEec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 75 ENILLDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 75 ~NILl~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|+.. |..+||+|||+|+.-.....+.+.|.||+|.|||++...
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~e------------------------------- 238 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPE------------------------------- 238 (400)
T ss_pred hheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCch-------------------------------
Confidence 9999975 457999999999987777778899999999999998421
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch----hH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK----QM 227 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~----~~ 227 (408)
.|+..||+||+|||||+||||+|||++.. ..
T Consensus 239 ---------------------------------------------KydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp 273 (400)
T KOG0604|consen 239 ---------------------------------------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273 (400)
T ss_pred ---------------------------------------------hcCCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence 35568899999999999999999997653 24
Q ss_pred HHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 228 ~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
-|-++|..|.|.|+.++|+.+|+++||||++||..+|.+|+|++|+++|||+....
T Consensus 274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 57889999999999999999999999999999999999999999999999998753
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=370.81 Aligned_cols=194 Identities=39% Similarity=0.726 Sum_probs=174.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+| ||.++. |+.+..|||+|+|..|+ |-..+. +++++|++++||+.||.|||+++|||||||..|++
T Consensus 74 ~L~Hpn-IV~f~~~FEDs~nVYivLELC~~~s--L~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlf 150 (592)
T KOG0575|consen 74 SLKHPN-IVQFYHFFEDSNNVYIVLELCHRGS--LMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLF 150 (592)
T ss_pred hcCCCc-EEeeeeEeecCCceEEEEEecCCcc--HHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhee
Confidence 578998 557765 77888999999999998 766554 45999999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++++.++||+|||||..+... +.-.+.||||.|.|||++.. .
T Consensus 151 L~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k------~------------------------------- 193 (592)
T KOG0575|consen 151 LNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK------S------------------------------- 193 (592)
T ss_pred ecCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc------C-------------------------------
Confidence 999999999999999998844 77789999999999999853 1
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+++.++||||+||+||+||+|.|||..++-.+++..|....
T Consensus 194 ---------------------------------------gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 194 ---------------------------------------GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE 234 (592)
T ss_pred ---------------------------------------CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence 23458999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
|.++. .+|.+|+|||.+||..||.+|||++++|.|+||+..
T Consensus 235 Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 235 YSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99986 689999999999999999999999999999999654
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=372.23 Aligned_cols=195 Identities=34% Similarity=0.664 Sum_probs=173.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+| |+++++ +.....|+|.||+.||| ||+++.++ .+++.+++||+.||.|||..+|+||||||||+|
T Consensus 68 Li~Hpn-Vl~LydVwe~~~~lylvlEyv~gGE--LFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 68 LIEHPN-VLRLYDVWENKQHLYLVLEYVPGGE--LFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred HhcCCC-eeeeeeeeccCceEEEEEEecCCch--hHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 578998 557666 55567799999999999 99998764 789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++..++|||+|||+|..-.++..+.+.||+|.|.|||++.+..|.
T Consensus 145 Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYd----------------------------------- 189 (786)
T KOG0588|consen 145 LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYD----------------------------------- 189 (786)
T ss_pred hhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCC-----------------------------------
Confidence 999999999999999887788888899999999999999864321
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
|.++|+||||||+|.||+|+.||.+++-..++.+++.|.|
T Consensus 190 ----------------------------------------G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 190 ----------------------------------------GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF 229 (786)
T ss_pred ----------------------------------------CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc
Confidence 3378888888888888888888888888888889999998
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+ ..+|++|+|||++||.+||++|+|.+|+++|||+...
T Consensus 230 ~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 230 EMP----SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred cCC----CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 887 4799999999999999999999999999999999864
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.59 Aligned_cols=196 Identities=34% Similarity=0.645 Sum_probs=159.6
Q ss_pred cccCCcEEEEeccCCc--HHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKEEGDD--LKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~--~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|| +||.+.+..++ ..|||+||+.||| |+..|.+ +..+++|+.+|+.||.|||++|||||||||||||+
T Consensus 82 v~hP-Fiv~l~ysFQt~~kLylVld~~~GGe--Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL 158 (357)
T KOG0598|consen 82 IKHP-FIVKLIYSFQTEEKLYLVLDYLNGGE--LFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL 158 (357)
T ss_pred CCCC-cEeeeEEecccCCeEEEEEeccCCcc--HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee
Confidence 5555 78888876654 5799999999999 9998874 47899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.+|+++|+|||+|+... .+....+.|||+.|||||++... +|+
T Consensus 159 d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~------gy~----------------------------- 203 (357)
T KOG0598|consen 159 DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK------GYD----------------------------- 203 (357)
T ss_pred cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC------CCC-----------------------------
Confidence 999999999999998644 34455668999999999999752 344
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
..||+||+||++|+||+|.|||.+.+...+.++|..++.
T Consensus 204 -----------------------------------------~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~ 242 (357)
T KOG0598|consen 204 -----------------------------------------KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL 242 (357)
T ss_pred -----------------------------------------cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC
Confidence 456666666666666666666666666677777777774
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC----CHHHHHcCCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY----SVKEALNHSFFHPKLF 284 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~----ta~e~L~Hpwf~~~~~ 284 (408)
.+.. ..+|.+++|||+++|++||++|+ .++++.+||||.+..+
T Consensus 243 ~~~p---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 243 PLPP---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred CCCC---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 4332 23799999999999999999996 5899999999987644
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=332.16 Aligned_cols=193 Identities=38% Similarity=0.719 Sum_probs=166.0
Q ss_pred cccCCcEEEEecc--CCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|| +++.+..+ +.+..|+||||+.||| ||.++.+ ++.+|+|+.||+.||+|||+++|++|||||||||+
T Consensus 101 v~~P-Flv~l~~t~~d~~~lymvmeyv~GGE--lFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl 177 (355)
T KOG0616|consen 101 VSHP-FLVKLYGTFKDNSNLYMVMEYVPGGE--LFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL 177 (355)
T ss_pred ccCc-eeEEEEEeeccCCeEEEEEeccCCcc--HHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee
Confidence 4566 56677754 4456799999999999 9998854 58999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
|.+|.+||+|||+|+.+... ..+.||||.|+|||++.. .
T Consensus 178 D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s------k--------------------------------- 216 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS------K--------------------------------- 216 (355)
T ss_pred ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhc------C---------------------------------
Confidence 99999999999999987654 567999999999999864 2
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+|+.++|+||+||+.|+|++|+|||...+...++++|+++++.
T Consensus 217 -------------------------------------~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 217 -------------------------------------GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK 259 (355)
T ss_pred -------------------------------------CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc
Confidence 3455677777777777778888888888888899999999999
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPKLF 284 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~~~ 284 (408)
|++ .+|++++|||+++|++|-.+|. ...++.+||||....+
T Consensus 260 fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 260 FPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred CCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 986 5799999999999999999995 4789999999987543
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=350.89 Aligned_cols=197 Identities=44% Similarity=0.801 Sum_probs=177.9
Q ss_pred cc-cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VA-HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~-~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
|. |+| ||.+++ +..+..|+|||+|.||+ |+|.|. ++.++..+++|++.|++|||+.||+||||||||+|+
T Consensus 92 l~~hpn-iv~l~~~~e~~~~~~lvmEL~~GGe--Lfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~ 168 (382)
T KOG0032|consen 92 LSGHPN-IVQLKDAFEDPDSVYLVMELCEGGE--LFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLL 168 (382)
T ss_pred ccCCCC-EEEEEEEEEcCCeEEEEEEecCCch--HHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeee
Confidence 45 887 556665 56667899999999999 999874 468999999999999999999999999999999999
Q ss_pred ecC----CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 80 DDQ----MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 80 ~~~----~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
... +.+|++|||+|.....+......||||+|+|||++..
T Consensus 169 ~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~------------------------------------ 212 (382)
T KOG0032|consen 169 ASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG------------------------------------ 212 (382)
T ss_pred ccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC------------------------------------
Confidence 643 4799999999999888777888999999999999853
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+|+..+||||+|||+|.||+|.+||++.+.......|..
T Consensus 213 ----------------------------------------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 213 ----------------------------------------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred ----------------------------------------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 1356689999999999999999999999999999999999
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.|..+.|+.+|..|+|||++||.+||.+|+||.++|+|||++..
T Consensus 253 ~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 253 GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999999999999999999875
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.33 Aligned_cols=196 Identities=36% Similarity=0.636 Sum_probs=170.2
Q ss_pred ccc-cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVA-HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~-~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+. |+| |+++.+ +..+..|+|||||.||+ |++.+.+ +.+++.+++|++.||+|||++||+|||||||||
T Consensus 75 ~~~~Hpn-I~~l~ev~~t~~~~~ivmEy~~gGd--L~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi 151 (370)
T KOG0583|consen 75 RLRSHPN-IIRLLEVFATPTKIYIVMEYCSGGD--LFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI 151 (370)
T ss_pred HhccCCC-EeEEEEEEecCCeEEEEEEecCCcc--HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 355 776 667776 44556899999999999 9999865 479999999999999999999999999999999
Q ss_pred EEecC-CCEEEeccccchhc-ccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDDQ-MNVKLTDFGFARVL-KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~~-~~iKl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++.+ +++||+|||++... ..+..+.+.||||.|+|||++.+.. .|.
T Consensus 152 lld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~-----~Y~-------------------------- 200 (370)
T KOG0583|consen 152 LLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKG-----TYS-------------------------- 200 (370)
T ss_pred EecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCC-----CcC--------------------------
Confidence 99999 99999999999988 5667788999999999999997531 021
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
|.++|+|||||++|.|++|+.||...+...+++.|..
T Consensus 201 -------------------------------------------g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 201 -------------------------------------------GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK 237 (370)
T ss_pred -------------------------------------------CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 3478999999999999999999998888889999999
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.+.++. |-. |+++++||++||+.||.+|+|+.++++||||+.
T Consensus 238 ~~~~~p~--~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 GEFKIPS--YLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCccCCC--CcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9888754 333 999999999999999999999999999999997
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=348.75 Aligned_cols=197 Identities=33% Similarity=0.634 Sum_probs=164.2
Q ss_pred cccCCcEEEEeccCCc--HHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKEEGDD--LKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~--~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
|.+++.|++++.+++| ..|+|+||+.+|| |++.|.. +..+|+|+.||+.||+|||++|||||||||||||+
T Consensus 130 L~~hPgivkLy~TFQD~~sLYFvLe~A~nGd--ll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL 207 (604)
T KOG0592|consen 130 LSGHPGIVKLYFTFQDEESLYFVLEYAPNGD--LLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL 207 (604)
T ss_pred hhCCCCeEEEEEEeecccceEEEEEecCCCc--HHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE
Confidence 4344467799987766 4699999999999 9999864 47899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc--------------ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL--------------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~--------------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
+.++++||+|||.|+.+.+.... .+++||..|.+||+|..+
T Consensus 208 d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~------------------------- 262 (604)
T KOG0592|consen 208 DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS------------------------- 262 (604)
T ss_pred cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-------------------------
Confidence 99999999999999987643211 235666666666666432
Q ss_pred hCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 146 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 146 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
..+..+|+|++|||+|.|+.|.|||.+.+
T Consensus 263 ---------------------------------------------------~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 263 ---------------------------------------------------PAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred ---------------------------------------------------CCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 12446788888888888888888888888
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
+..++++|+.-.|.|+. ..+++++|||+|+|+.||.+|+|++|+.+||||....++
T Consensus 292 eyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 292 EYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 88899999999999875 578999999999999999999999999999999876554
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=339.30 Aligned_cols=248 Identities=29% Similarity=0.486 Sum_probs=182.7
Q ss_pred ccCCcEEEEeccCCc--HHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKEEGDD--LKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~~~~~--~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.-+++||.+++.++| ..||||||+.||+ +-..|. ++..+|+|+.+++.|++.||+.|+|||||||+|+|||
T Consensus 198 ~ds~~vVKLyYsFQD~~~LYLiMEylPGGD--~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD 275 (550)
T KOG0605|consen 198 VDSPWVVKLYYSFQDKEYLYLIMEYLPGGD--MMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID 275 (550)
T ss_pred cCCCcEEEEEEEecCCCeeEEEEEecCCcc--HHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec
Confidence 346789999986654 5789999999999 665553 5689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
..|++||+|||||..+....... .|.--+....... .....|.=+. ..|....+..+++
T Consensus 276 ~~GHiKLSDFGLs~gl~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~~~----------~~~~~~~~~~~~~ 334 (550)
T KOG0605|consen 276 AKGHIKLSDFGLSTGLDKKHRIE------SYRLDEQMQINLS-----EAKPSDFPKF----------NTPRSTMSRREQL 334 (550)
T ss_pred CCCCEeeccccccchhhhhhhhh------hhcchhhhhhhhc-----cCCCcccccc----------ccccchhhHHHHH
Confidence 99999999999996654322111 0110000000000 0000000000 1223333344444
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
+........+. -...+++.|||||++..+ +|+..||+||+|||||+||.|+|||.+.++.++.++|+.....+
T Consensus 335 ~~w~~nrr~~a-~StVGTPDYiAPEVll~k------gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l 407 (550)
T KOG0605|consen 335 QTWKRNRRQLA-YSTVGTPDYIAPEVLLGK------GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL 407 (550)
T ss_pred HHHHhhhhhhh-hcccCCccccchHHHhcC------CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc
Confidence 43333222111 114577889999999875 78999999999999999999999999999999999999998766
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPKLFDQ 286 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~~~~~ 286 (408)
..|.-..+|++|+|||.+||+ ||++|+. ++|+..||||....++.
T Consensus 408 ~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 408 KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 666667899999999999999 9999995 99999999999876543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=329.07 Aligned_cols=225 Identities=30% Similarity=0.451 Sum_probs=178.3
Q ss_pred ccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
+|+|+| .+.| +.+...|+|||||+-.-+.|... +.++..++.||+||++||+|+|++|+.|||+||||||+..
T Consensus 67 ~hpnii-kL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 67 PHPNII-KLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG 145 (538)
T ss_pred CCCcch-hhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc
Confidence 489855 6666 33337899999998775444332 3456999999999999999999999999999999999998
Q ss_pred CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
+..+||+|||+|+.+......++++.|++|+|||++... ..|+.++|+||+|||++|+.+-++.|.|.++.+++.
T Consensus 146 ~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs-----~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 146 NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRS-----GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred cceeEecccccccccccCCCcchhhhcccccchHHhhhc-----cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 889999999999999888888899999999999999864 569999999999999999999999999999999999
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
+|++--.++.. +.|--|--+..-+.=..|+........+
T Consensus 221 KIc~VLGtP~~------------------------------~~~~eg~~La~~mnf~~P~~~~~~l~~L----------- 259 (538)
T KOG0661|consen 221 KICEVLGTPDK------------------------------DSWPEGYNLASAMNFRFPQVKPSPLKDL----------- 259 (538)
T ss_pred HHHHHhCCCcc------------------------------ccchhHHHHHHHhccCCCcCCCCChHHh-----------
Confidence 99875444333 3333332222222222233222211111
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....|+++.+||.+||.+||.+||||.|||+||||+..
T Consensus 260 ---~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 260 ---LPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ---CcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 13479999999999999999999999999999999753
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.46 Aligned_cols=229 Identities=30% Similarity=0.456 Sum_probs=180.6
Q ss_pred ccCCcEEEEec--cC--CcHHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EG--DDLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~--~~~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
-|+| ||++.+ .+ -|..|+|||||+..-.+|.+-.. +..+++.++.|+|.||+|||++.|+||||||+|+|++
T Consensus 133 ~H~N-IV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~ 211 (419)
T KOG0663|consen 133 RHPN-IVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS 211 (419)
T ss_pred CCCC-eeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec
Confidence 3676 667776 23 35589999999988666666543 3489999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.|.+||+|||+|+.+... ..++..+.|.+|+|||++.+ +..|++++|+||+|||+.||+++++.|.+..+.++
T Consensus 212 ~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG-----~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 212 HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG-----AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ 286 (419)
T ss_pred cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC-----CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH
Confidence 9999999999999998754 34556788999999999987 47899999999999999999999999999999999
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.+|..-...++...|.+++..-+--.+ -.-..|+ +.....
T Consensus 287 l~~If~llGtPte~iwpg~~~lp~~k~~---------------------------~f~~~py----------n~lr~k-- 327 (419)
T KOG0663|consen 287 LDKIFKLLGTPSEAIWPGYSELPAVKKM---------------------------TFSEHPY----------NNLRKK-- 327 (419)
T ss_pred HHHHHHHhCCCccccCCCccccchhhcc---------------------------ccCCCCc----------hhhhhh--
Confidence 9999887777777777665432110000 0000011 111111
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
|. +..+|+.+.||+.++|.+||.+|+||+|+|+|.||.....
T Consensus 328 F~---~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 328 FG---ALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cc---ccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 11 1227899999999999999999999999999999987543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=319.66 Aligned_cols=227 Identities=31% Similarity=0.464 Sum_probs=173.4
Q ss_pred ccccCCcEEEEeccCC--cHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKEEGD--DLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~--~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
+|.|+|+| .+.|... ...|||||||+..-....+. -.....++.+++|++.|+.|||+++||||||||||||++
T Consensus 57 qLkH~NLV-nLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 57 QLKHENLV-NLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT 135 (396)
T ss_pred hcccchHH-HHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence 57788844 7777543 45699999998764111221 124478999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||||||+|+.+. +++..++++.|.+|+|||.+.+. ..|++++||||+||++.||++|.+.|.+.++.++
T Consensus 136 ~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGD-----tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 136 QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGD-----TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhccc-----CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 99999999999999998 77777889999999999999864 7899999999999999999999999999999999
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+..|...-.. +.|+.. -+.+..||++.-.... + ....
T Consensus 211 Ly~I~ktLG~------------L~prhq--------------------------~iF~~N~~F~Gv~lP~---~--~~~e 247 (396)
T KOG0593|consen 211 LYLIRKTLGN------------LIPRHQ--------------------------SIFSSNPFFHGVRLPE---P--EHPE 247 (396)
T ss_pred HHHHHHHHcc------------cCHHHH--------------------------HHhccCCceeeeecCC---C--CCcc
Confidence 9888653222 122211 1222333332110000 0 0000
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.....+..+|.-+.||+++||..||++|+|++|+|+||||+.
T Consensus 248 pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 248 PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred chhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 001124578889999999999999999999999999999944
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.28 Aligned_cols=225 Identities=28% Similarity=0.480 Sum_probs=172.1
Q ss_pred cccCCcEEEEecc-----CC--cHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 7 VAHSRVVVRVKEE-----GD--DLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 7 ~~~~~~i~~~~~~-----~~--~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
+.|+|+| .+.+. .+ +..|+|+|+|+. + |...+.+ +..++++++|||.||.|+|+.+|+||||||
T Consensus 78 ~~HeNIi-~l~di~~p~~~~~f~DvYiV~elMet-D--L~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKP 153 (359)
T KOG0660|consen 78 LRHENII-GLLDIFRPPSRDKFNDVYLVFELMET-D--LHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKP 153 (359)
T ss_pred hcCCCcc-eEEeecccccccccceeEEehhHHhh-H--HHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccch
Confidence 4599866 43331 11 346999999943 3 7666643 478999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhccc---CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKK---GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
.|+|++.++.+||+|||+|+.... ...++.++.|.+|+|||++.. ...|++++||||+|||++||++|++.|
T Consensus 154 sNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-----~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 154 SNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN-----SSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred hheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc-----cccccchhhhhhhhHHHHHHHcCCCCC
Confidence 999999999999999999998864 344567899999999999975 367999999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.|.+...++..|+.--.++ ++|.+..-..+ -.+
T Consensus 229 pG~d~v~Ql~lI~~~lGtP------------~~e~l~~i~s~-----------------------------------~ar 261 (359)
T KOG0660|consen 229 PGKDYVHQLQLILELLGTP------------SEEDLQKIRSE-----------------------------------KAR 261 (359)
T ss_pred CCCchHHHHHHHHHhcCCC------------CHHHHHHhccH-----------------------------------HHH
Confidence 9999999999998754333 22222211000 000
Q ss_pred HHHhcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCC
Q psy3880 232 NIMEGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287 (408)
Q Consensus 232 ~i~~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~ 287 (408)
..++.....+. ..++.++++|.||+.|||++||.+|+||+|||+|||+.+...+.+
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 11111111111 124678999999999999999999999999999999987654433
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.70 Aligned_cols=217 Identities=32% Similarity=0.565 Sum_probs=166.7
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|.|++ .+.+ |+++.+|||||-+.||. |..+|. ++.+++.+++.|+.||.|||.+||.||||||||||..
T Consensus 134 gh~nil-qLiefFEdd~~FYLVfEKm~GGp--lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 134 GHKNIL-QLIEFFEDDTRFYLVFEKMRGGP--LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCE 210 (463)
T ss_pred CCccHH-HHHHHhcccceEEEEEecccCch--HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeec
Confidence 477754 5554 77888999999999998 777765 4479999999999999999999999999999999997
Q ss_pred cC---CCEEEeccccchhcccCc--------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 81 DQ---MNVKLTDFGFARVLKKGE--------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 81 ~~---~~iKl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
+. ..+|||||.++..+.... .+.+.||+..|||||+...- ..++..|++++|.||||||+|.|++|++
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~f-v~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVF-VDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhh-ccccccccccccHHHHHHHHHHHHhCCC
Confidence 54 468999998876543221 34567888899999986431 2234556666666666666666666666
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+... +---|+-|-.. ..-+..+
T Consensus 290 PFvG~Cg--------------------------------------------~dCGWdrGe~C-----------r~CQ~~L 314 (463)
T KOG0607|consen 290 PFVGHCG--------------------------------------------ADCGWDRGEVC-----------RVCQNKL 314 (463)
T ss_pred CccCccC--------------------------------------------CcCCccCCCcc-----------HHHHHHH
Confidence 6654321 11134333211 1136678
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
++.|.+|.|.|+..+|..+|.+++|||+++|..|+.+|.+|.+.|+|||++...
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 999999999999999999999999999999999999999999999999998754
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.10 Aligned_cols=226 Identities=27% Similarity=0.456 Sum_probs=176.0
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHh---hhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQD---IINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~---~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
-|.|+|+| .+.+ .....+|||||||+....-|.. .-.++++++.||+||+.||+|||++||+|||||.+|||
T Consensus 172 ~l~HpNIi-kL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiL 250 (560)
T KOG0600|consen 172 RLDHPNII-KLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNIL 250 (560)
T ss_pred hcCCCccc-ceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceE
Confidence 37899855 6554 2235689999999876322222 23466999999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|+++|.+||+|||||+.+.... .++..+.|.+|+|||+|++ .+.|+.++|+||+|||+.||++|++.|.+.++
T Consensus 251 idn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG-----~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 251 IDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG-----ATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred EcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC-----CcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 9999999999999999776544 4567889999999999997 47899999999999999999999999999999
Q ss_pred HHHHHHHHhccccCCCCCCc--cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 157 MVMLRNIMEGKYSFSSPEWN--DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~--~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.+++.+|..-..++....|. ++..+ ...-|... ....+
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~----------------------------------~~~kp~~~------y~r~l 365 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHA----------------------------------TIFKPQQP------YKRRL 365 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcc----------------------------------cccCCCCc------ccchH
Confidence 99999998766665544444 11100 01111110 01111
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
. +.+..+++.+.+|+.+||.+||.+|.||.++|+|+||.....
T Consensus 366 ~-------E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 366 R-------ETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred H-------HHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 1 113467999999999999999999999999999999965443
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.82 Aligned_cols=197 Identities=35% Similarity=0.640 Sum_probs=157.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+| ||++.+ +.+|+.|||||||+||+ |.++|.+ ++.+|.++.||+.||++||+++||||||||+|||+
T Consensus 66 l~H~n-IV~l~d~~~~~~~i~lVMEyC~gGD--Ls~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 66 LKHPN-IVRLLDCIEDDDFIYLVMEYCNGGD--LSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL 142 (429)
T ss_pred cCCcc-eeeEEEEEecCCeEEEEEEeCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence 67998 457665 67889999999999999 8888754 48999999999999999999999999999999999
Q ss_pred ecC------CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 80 DDQ------MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 80 ~~~------~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+.. -.+||+|||+|+.+.++....+.||||.|||||++.. ..|+.|+|+||+|+|+|++++|++|
T Consensus 143 s~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~------~~YdAKADLWSiG~Ilyq~l~g~~P--- 213 (429)
T KOG0595|consen 143 STTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS------QQYDAKADLWSIGTILYQCLTGKPP--- 213 (429)
T ss_pred ccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh------ccccchhhHHHHHHHHHHHHhCCCC---
Confidence 764 4589999999999999888889999999999999974 3455555555555555555555555
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
|...+..+++..+
T Consensus 214 -------------------------------------------------------------------f~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 214 -------------------------------------------------------------------FDAETPKELLLYI 226 (429)
T ss_pred -------------------------------------------------------------------ccccCHHHHHHHH
Confidence 4444555555555
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+....+... ..+|+...+|+..+|+.||.+|.+..+-+.|++.....
T Consensus 227 ~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 227 KKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccccccCchh-hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 55554433322 35788888999999999999999999999999998754
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=312.64 Aligned_cols=197 Identities=24% Similarity=0.480 Sum_probs=157.7
Q ss_pred ccCCcEEEEecc--CCc-HHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEE
Q psy3880 8 AHSRVVVRVKEE--GDD-LKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENIL 78 (408)
Q Consensus 8 ~~~~~i~~~~~~--~~~-~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NIL 78 (408)
.|| +||.++.. .+. ..+|+||||+||. |-+.+. .++.+..++.+|++||.|||. ++||||||||+|||
T Consensus 135 ~sp-yIV~~ygaF~~~~~~isI~mEYMDgGS--Ld~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 135 QSP-YIVGFYGAFYSNGEEISICMEYMDGGS--LDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL 211 (364)
T ss_pred CCC-CeeeEeEEEEeCCceEEeehhhcCCCC--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence 455 57787753 233 4789999999998 666553 568899999999999999995 99999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++..|.|||||||.++.+.++ ...+++||..|||||.+.+ ..|+.++||||||+.+.|+++|+.||....
T Consensus 212 vNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--- 281 (364)
T KOG0581|consen 212 VNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG------ESYSVKSDIWSLGLSLLELAIGRFPYPPPN--- 281 (364)
T ss_pred eccCCCEEeccccccHHhhhh-hcccccccccccChhhhcC------CcCCcccceecccHHHHHHhhCCCCCCCcC---
Confidence 999999999999999988776 4567999999999999976 468899999999999999999999984320
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.. ..|+ .+++..|+.+..
T Consensus 282 --------------------~~--------------------~~~~----------------------~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 282 --------------------PP--------------------YLDI----------------------FELLCAIVDEPP 299 (364)
T ss_pred --------------------CC--------------------CCCH----------------------HHHHHHHhcCCC
Confidence 00 1111 123334443322
Q ss_pred -CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 -SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 -~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+.. ..|+++++||.+||++||.+|+|++|+|+|||+...
T Consensus 300 P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 300 PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 22221 369999999999999999999999999999999764
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.39 Aligned_cols=244 Identities=30% Similarity=0.497 Sum_probs=183.6
Q ss_pred cccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 5 EMVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 5 ~~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.|++|| ++..++. +.+++.+||||||.||+ |....+ ++..+|+|+.+|+.||+|||-.|||+||||||
T Consensus 132 ~~lDHP-FlPTLYa~fet~~~~cl~meyCpGGd--L~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE 208 (459)
T KOG0610|consen 132 SLLDHP-FLPTLYASFETDKYSCLVMEYCPGGD--LHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE 208 (459)
T ss_pred HhcCCC-ccchhhheeeccceeEEEEecCCCcc--HHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence 468998 6888887 44566789999999999 766554 44899999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCccccc-----------CCCC--CcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMD-----------LCGT--PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~-----------~~gt--~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
|||+.++|+|+|+||.|+......-.+.. .|-+ +....|..+..... ..+.|.
T Consensus 209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~------~~k~~~-------- 274 (459)
T KOG0610|consen 209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKK------RKKKDE-------- 274 (459)
T ss_pred eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccc------cccccc--------
Confidence 99999999999999999865421111100 0000 11112221111000 000000
Q ss_pred HHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 143 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 143 ~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
. ....+..+........+..+.++.+|+|||+++++ +.|.++|||++||.+|+||.|..||.
T Consensus 275 ----------~--~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~------GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 275 ----------S--ASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE------GHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred ----------c--ccccchhhhcCCCCccccccccccccccceeeecC------CCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 0 00111122222334556778899999999999874 67889999999999999999999999
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC----HHHHHcCCCCCCCCCC
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS----VKEALNHSFFHPKLFD 285 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t----a~e~L~Hpwf~~~~~~ 285 (408)
+.+..+++.+|+.....|+.. ..+|.+|+|||+++|++||++|+. |.|+.+||||.+..|.
T Consensus 337 G~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 337 GSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred CCCchhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 999999999999999998654 478999999999999999999998 9999999999987654
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.36 Aligned_cols=226 Identities=25% Similarity=0.409 Sum_probs=178.6
Q ss_pred cccCCcEEEEecc--CCcHHHHHHHHHhhchhhHH---hhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 7 VAHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQ---DIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~---~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
+.|+| |+.+.+. ..+..+||+||+...-+.+- ..+.+..+++.++.++++||+|||++.|+||||||.|+|++.
T Consensus 58 l~h~n-Ii~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 58 LKHPN-IIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred ccCcc-hhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 35776 5577764 45678999999987632221 123455899999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
+|.+||+|||+|+.+..... ....+.|.+|+|||++.+ +..|+..+|+||.|||++||+.|.+-|.+.++.+++
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG-----sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG-----SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred CCcEEeecccchhccCCCCcccccceeeeeccChHHhcc-----chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 99999999999998875433 334578999999999986 468999999999999999999999999999999999
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
..|...-.++....|.+.....+--.++ ..|- ..
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~-----------------------------~~P~-----------------~~ 245 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQ-----------------------------QFPK-----------------PP 245 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHh-----------------------------cCCC-----------------Cc
Confidence 9999888888777776655432211111 0000 00
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
....+...|+++.||+.+||.+||.+|+||.|+|+|+||.....
T Consensus 246 ~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 246 LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 01124567999999999999999999999999999999986543
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=320.51 Aligned_cols=196 Identities=36% Similarity=0.605 Sum_probs=175.9
Q ss_pred ccccCCcEEEEeccCC--cHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEEGD--DLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~--~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+|-|+| ||++++..| ...|||+|+=++|+ |+|+|... ..++.|+.||+.|+.|||+..+|||||||||+
T Consensus 73 LVQHpN-iVRLYEViDTQTKlyLiLELGD~GD--l~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 73 LVQHPN-IVRLYEVIDTQTKLYLILELGDGGD--LFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred HhcCcC-eeeeeehhcccceEEEEEEecCCch--HHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 477887 669998544 56799999999999 99999754 67899999999999999999999999999998
Q ss_pred EEe-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLD-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
.+- .-|-+||+||||+-.+.+++.+.+.||+..|-|||++.+..+ +
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsY------D--------------------------- 196 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSY------D--------------------------- 196 (864)
T ss_pred EEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCcc------C---------------------------
Confidence 774 568999999999999999999999999999999999986422 1
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+++||||+|||+|.|+||.+||...+..+++..|+.+
T Consensus 197 ------------------------------------------APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC 234 (864)
T KOG4717|consen 197 ------------------------------------------APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC 234 (864)
T ss_pred ------------------------------------------CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc
Confidence 13789999999999999999999999999999999999
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+|..++ .+|.+|+|||..||+.||.+|.|.+|+.+|+|++...
T Consensus 235 KYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 235 KYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 999875 6899999999999999999999999999999998753
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=306.75 Aligned_cols=228 Identities=29% Similarity=0.415 Sum_probs=178.0
Q ss_pred ccccCCcEEEEeccCC--c------HHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKEEGD--D------LKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~--~------~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.|.|+|.||++.+... + ..|+||||++..-...-|.+. +...++.+|+||+.||+|||+++|+|||
T Consensus 66 ~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRD 145 (323)
T KOG0594|consen 66 RLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRD 145 (323)
T ss_pred HhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 4788886777776322 2 567899998766322333322 1247999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+|||++++|.+||+|||+|+... +.......++|.+|+|||++.+. ..|+..+||||+|||++||+++++.
T Consensus 146 LKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs-----~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 146 LKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGS-----TSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred CCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCC-----CcCCCCcchHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999877 44456678899999999999874 5699999999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.++.+++..|.+--.++....|+..... ...+++|........+
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~---------------------------------~~~k~~f~~~~~~~~l 267 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL---------------------------------PDYKAPFPKWPGPKDL 267 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCcccc---------------------------------ccccccCcCCCCccch
Confidence 9999999999999887777777667654321 1112233222111111
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...++..++++.||+.+||++||.+|+||+.+|.||||...
T Consensus 268 -----------~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 268 -----------SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred -----------HHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11234567899999999999999999999999999999875
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.42 Aligned_cols=200 Identities=32% Similarity=0.532 Sum_probs=166.1
Q ss_pred ccccCCcEEEEecc----CCcHHHHHHHHHhhchhhHHhh----h-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKEE----GDDLKHLAAQVVDKGEAAVQDI----I-NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~~~~~~lv~e~~~~g~~~l~~~----~-~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
-+.|+| ||++.|- ..+..|||+|||.+|+ +... - .++.++|.|++.++.||+|||.+|||||||||+|
T Consensus 164 kl~H~n-VV~LiEvLDDP~s~~~YlVley~s~G~--v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 164 KLHHPN-VVKLIEVLDDPESDKLYLVLEYCSKGE--VKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred hcCCcC-eeEEEEeecCcccCceEEEEEeccCCc--cccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 367876 6677764 3456799999999998 4322 1 3558999999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcc------cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLK------KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|++++|.+||+|||.+.... ....+...+|||.|+|||.+....- .
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~---~------------------------ 293 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS---F------------------------ 293 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC---c------------------------
Confidence 999999999999999987652 2223455789999999999864210 0
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
...|.+.||||+||.+|.|+.|..||.+....+++
T Consensus 294 ---------------------------------------------~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 294 ---------------------------------------------SYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred ---------------------------------------------cccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 01244789999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+|++....|+. ..+++++++|||.+||.+||++|+|+.++..|||....
T Consensus 329 ~KIvn~pL~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVNDPLEFPE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcCcccCCC--cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999999988865 45789999999999999999999999999999999865
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.26 Aligned_cols=197 Identities=30% Similarity=0.570 Sum_probs=163.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
+.|+|+| .+.+ -..+....||||++||. |.|.+. ++.+++.|++++|.||+|||.+||+|||||.+|||++
T Consensus 327 ~~H~NiV-nfl~Sylv~deLWVVMEym~ggs--LTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 327 LHHPNIV-NFLDSYLVGDELWVVMEYMEGGS--LTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT 403 (550)
T ss_pred ccchHHH-HHHHHhcccceeEEEEeecCCCc--hhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence 3577644 5554 23467889999999999 888764 4689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.+|.+||+|||||..+.... .-.+.+|||+|||||++.. ..|+.++||||||++++||+.|.+||..++....
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA 477 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 477 (550)
T ss_pred cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh------cccCccccchhhhhHHHHHhcCCCCccCCChHHH
Confidence 99999999999998877554 4567899999999999975 4689999999999999999999999987766655
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+..|... |.|+
T Consensus 478 lyLIa~n--------------------------------------------------g~P~------------------- 488 (550)
T KOG0578|consen 478 LYLIATN--------------------------------------------------GTPK------------------- 488 (550)
T ss_pred HHHHhhc--------------------------------------------------CCCC-------------------
Confidence 5544321 2222
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+ ..+..+|++++|||.+||++|+.+|+||.|+|+||||+...
T Consensus 489 l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 489 L--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred c--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 1 22457999999999999999999999999999999996543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=308.98 Aligned_cols=193 Identities=34% Similarity=0.628 Sum_probs=170.7
Q ss_pred cccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 5 EMVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 5 ~~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|.||++| .+++ |..|...|||||..||| |+|+|. ++.++|.+++||+.|+.|||+++++|||||.+||
T Consensus 108 SsLNHPhII-~IyEVFENkdKIvivMEYaS~Ge--LYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI 184 (668)
T KOG0611|consen 108 SSLNHPHII-QIYEVFENKDKIVIVMEYASGGE--LYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI 184 (668)
T ss_pred hhcCCCcee-ehhhhhcCCceEEEEEEecCCcc--HHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence 468999866 6766 66678899999999999 999985 4589999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++++||+|||++-.+..+.-+.++||+|.|.+||++.+..+
T Consensus 185 LLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY----------------------------------- 229 (668)
T KOG0611|consen 185 LLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPY----------------------------------- 229 (668)
T ss_pred eecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCC-----------------------------------
Confidence 999999999999999999988888899999999999999865321
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
-|+++|.||+||++|+|+.|..||.+++...++++|..|.
T Consensus 230 ----------------------------------------~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 230 ----------------------------------------KGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred ----------------------------------------CCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 1447888888999999999999998888888999999988
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
|.-+ ..+.+|.-||+.||.+||++|.|++++-+|=|.+
T Consensus 270 YrEP-----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 YREP-----ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ccCC-----CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 7643 3477899999999999999999999999998885
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.93 Aligned_cols=225 Identities=29% Similarity=0.444 Sum_probs=169.9
Q ss_pred ccccCCcEEEEec-----cC-CcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy3880 6 MVAHSRVVVRVKE-----EG-DDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHR 70 (408)
Q Consensus 6 ~~~~~~~i~~~~~-----~~-~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHR 70 (408)
+++|+|+|.-++. +. ..+..|||||+... |.+.+. ..-+++.|++||++||.|||+.||+||
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~t---L~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR 149 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPET---LYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR 149 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHH---HHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC
Confidence 7899996633332 22 12567999999865 455443 115789999999999999999999999
Q ss_pred cCCCCcEEEecC-CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 71 DLKPENILLDDQ-MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 71 DLKp~NILl~~~-~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
||||.|+|+|.+ |.+||||||.|+.+..++...++..|++|+|||.+.+ +..|+.++||||.||++.||+-|++
T Consensus 150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg-----a~~Yt~~IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVMAELLKGQP 224 (364)
T ss_pred CCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC-----ccccCceeEEhhhhHHHHHHhcCCc
Confidence 999999999965 8999999999999999888888999999999999986 5789999999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
.|.|.+..+++..|..--..++..+ + ..|.|+-. ...|
T Consensus 225 lFpG~s~~dQL~eIik~lG~Pt~e~---I-~~mn~~y~------------------------------~~~~-------- 262 (364)
T KOG0658|consen 225 LFPGDSSVDQLVEIIKVLGTPTRED---I-KSMNPNYT------------------------------EFKF-------- 262 (364)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCHHH---H-hhcCcccc------------------------------cccC--------
Confidence 9999998888888876432221110 0 00010000 0000
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.+|....+ ..-....+++++.||+.++|+++|.+|.|+.|+|.||||+...
T Consensus 263 -p~ik~~~~--~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 263 -PQIKAHPW--HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred -cccccccc--eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 01111110 0011246899999999999999999999999999999997643
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.16 Aligned_cols=193 Identities=30% Similarity=0.568 Sum_probs=159.8
Q ss_pred CCcEEEEeccCC--cHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 10 SRVVVRVKEEGD--DLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 10 ~~~i~~~~~~~~--~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
+++++.+....+ +..|+||||+.||+ +..++. +++.+++|+..|+.||+|||++||||||||.+|||+|.+|
T Consensus 428 HPFL~~L~~~fQT~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 428 HPFLVNLFSCFQTKEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG 505 (694)
T ss_pred CCeEeecccccccCCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC
Confidence 458889998655 56789999999999 766654 5689999999999999999999999999999999999999
Q ss_pred CEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHH
Q psy3880 84 NVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162 (408)
Q Consensus 84 ~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~ 162 (408)
.+||+|||+|+..- .+....+.||||.|+|||++.+. .|
T Consensus 506 h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~------~Y---------------------------------- 545 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ------SY---------------------------------- 545 (694)
T ss_pred cEEecccccccccCCCCCccccccCChhhcChhhhccC------cc----------------------------------
Confidence 99999999998654 55566789999999999999752 34
Q ss_pred HHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCC
Q psy3880 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 242 (408)
Q Consensus 163 i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~ 242 (408)
+..+|+||+||+||+||.|.+||.+++..+.+..|+...+.++.
T Consensus 546 ------------------------------------t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~ 589 (694)
T KOG0694|consen 546 ------------------------------------TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 589 (694)
T ss_pred ------------------------------------cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 44566666666666666666666666777777788877777653
Q ss_pred CcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCC
Q psy3880 243 PEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPKLF 284 (408)
Q Consensus 243 ~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~~~ 284 (408)
.+|.|+.+++++||.+||++|+. ++++..||||....+
T Consensus 590 ----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 590 ----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred ----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 58999999999999999999996 689999999987544
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=301.44 Aligned_cols=197 Identities=31% Similarity=0.549 Sum_probs=151.5
Q ss_pred cccCCcEEEEecc--CC-c-HHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 7 VAHSRVVVRVKEE--GD-D-LKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~-~-~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
|.|+| ||+.+.. .. + ..++.|||+.||. |.+.+. +++.++.+.+||++||+|||++|||||||||+|
T Consensus 71 l~~p~-IV~~~G~~~~~~~~~~~i~mEy~~~Gs--L~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 71 LNHPN-IVQYYGSSSSRENDEYNIFMEYAPGGS--LSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred CCCCC-EEeeCCccccccCeeeEeeeeccCCCc--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence 55787 5566652 22 2 4789999999999 877653 568999999999999999999999999999999
Q ss_pred EEEec-CCCEEEeccccchhccc----CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 77 ILLDD-QMNVKLTDFGFARVLKK----GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 77 ILl~~-~~~iKl~DFGla~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||++. ++.+||+|||++..... ........|||.|||||++... ...+.++||||+||++.||+||++||
T Consensus 148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g-----~~~~~~sDiWSlGCtVvEM~Tg~~PW 222 (313)
T KOG0198|consen 148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNG-----EVARRESDIWSLGCTVVEMLTGKPPW 222 (313)
T ss_pred EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCC-----CcCCccchhhhcCCEEEeccCCCCcc
Confidence 99999 79999999999987663 1223457899999999999731 11235999999999999999999998
Q ss_pred CCc-hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 152 WHR-KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 152 ~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
... .....+..|
T Consensus 223 ~~~~~~~~~~~~i------------------------------------------------------------------- 235 (313)
T KOG0198|consen 223 SEFFEEAEALLLI------------------------------------------------------------------- 235 (313)
T ss_pred hhhcchHHHHHHH-------------------------------------------------------------------
Confidence 652 111111111
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
........-| ..+|++++|||.+||.+||++||||+++|+|||.....
T Consensus 236 ---g~~~~~P~ip--~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 236 ---GREDSLPEIP--DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ---hccCCCCCCC--cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1111000111 34899999999999999999999999999999997653
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=284.97 Aligned_cols=154 Identities=30% Similarity=0.608 Sum_probs=132.4
Q ss_pred ccccCCcEEEEec-c---CCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHH--CC--Ce
Q psy3880 6 MVAHSRVVVRVKE-E---GDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHN--HS--VV 68 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~---~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~--~~--Iv 68 (408)
+|.|+|+| +++. . +..-.+||||||.+|+ |...|. .++++..++.|++.||.+||+ .+ |+
T Consensus 74 QL~HpNIV-qYy~~~f~~~~evlnivmE~c~~GD--LsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 74 QLNHPNIV-QYYAHSFIEDNEVLNIVMELCDAGD--LSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred hcCCchHH-HHHHHhhhccchhhHHHHHhhcccC--HHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 68999966 5554 2 2233799999999999 776653 458999999999999999999 55 99
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCccc-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
||||||.||+++.+|.+||+|||+++.+...... .+++|||+||+||.+.. .+|+.++||||+||++|||..-
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~------~~Y~~kSDiWslGCllyEMcaL 224 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE------SGYNFKSDIWSLGCLLYEMCAL 224 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc------CCCCcchhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998876544 35899999999999986 5799999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccc
Q psy3880 148 CPPFWHRKQMVMLRNIMEGKY 168 (408)
Q Consensus 148 ~~pf~~~~~~~~~~~i~~~~~ 168 (408)
++||.+.+-.++.++|.+|.+
T Consensus 225 ~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 225 QSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred CCCcccccHHHHHHHHHcCCC
Confidence 999999888888888877644
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.33 Aligned_cols=206 Identities=28% Similarity=0.499 Sum_probs=164.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
...||| |+.+.. ..+...++||.||.+|. +++++. ++..++.+++++|+||.|||.+|.||||||+.|
T Consensus 80 l~~HPN-Iv~~~~sFvv~~~LWvVmpfMa~GS--~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgn 156 (516)
T KOG0582|consen 80 LIDHPN-IVTYHCSFVVDSELWVVMPFMAGGS--LLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGN 156 (516)
T ss_pred hcCCCC-cceEEEEEEecceeEEeehhhcCCc--HHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccccc
Confidence 467887 446665 45677899999999999 888874 458899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||++++|.|||+|||++..+..+. .+.+.+|||+|||||++..+ ..+|+.|+||||||++..||.+|..||
T Consensus 157 ILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~----~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 157 ILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ----LHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred EEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhc----ccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 999999999999999876654322 12457899999999998664 578999999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.......++..-+++ .||+....
T Consensus 233 ~k~pPmkvLl~tLqn---------------------------------------------------~pp~~~t~------ 255 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQN---------------------------------------------------DPPTLLTS------ 255 (516)
T ss_pred ccCChHHHHHHHhcC---------------------------------------------------CCCCcccc------
Confidence 877666655544443 33321100
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.++..+....+...+.+|..||++||.+||||+++|+|+||+..
T Consensus 256 -------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 256 -------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred -------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 01111223456689999999999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=298.82 Aligned_cols=194 Identities=33% Similarity=0.581 Sum_probs=148.3
Q ss_pred ccccCCcEEEEe--ccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~--~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+. .+.++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 51 ~l~hp~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIl 127 (323)
T cd05571 51 NTRHPFLT-ALKYSFQTHDRLCFVMEYANGGE--LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLM 127 (323)
T ss_pred hCCCCCCC-CEEEEEEcCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEE
Confidence 35788755 443 355667899999999998 777653 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++... ........+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||
T Consensus 128 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~Pf------ 195 (323)
T cd05571 128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPF------ 195 (323)
T ss_pred ECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC------CCCCccccCcccchhhhhhhcCCCCC------
Confidence 9999999999999987532 2233345789999999999853 23455555555555555555555555
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...+...+...+..+.
T Consensus 196 ----------------------------------------------------------------~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 196 ----------------------------------------------------------------YNQDHEKLFELILMEE 211 (323)
T ss_pred ----------------------------------------------------------------CCCCHHHHHHHHHcCC
Confidence 4433344444454444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||++||+.||++|| ++.++++||||...
T Consensus 212 ~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 212 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 4443 35799999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.29 Aligned_cols=202 Identities=32% Similarity=0.538 Sum_probs=169.4
Q ss_pred cCCcEEEEeccC--CcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 9 HSRVVVRVKEEG--DDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 9 ~~~~i~~~~~~~--~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
-+.||+.+.+.+ ++..|+||||+.||+ |...+ .+++-+|+|+..|+.||.-||+.|+|||||||+|||++.
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD--lltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGD--LLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCch--HHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 367888877654 456789999999999 65544 456899999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.|+|||+|||.|-.+..+... ...+|||-|.+||++....- +
T Consensus 211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~------~------------------------------ 254 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGD------G------------------------------ 254 (1317)
T ss_pred cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcC------C------------------------------
Confidence 999999999999888744333 34789999999999975310 0
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...||..||+||+||++|+||+|..||+..+-.+++.+|++-+-.
T Consensus 255 -----------------------------------~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 255 -----------------------------------KGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred -----------------------------------ccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 013788999999999999999999999999999999999988544
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPKLF 284 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~~~ 284 (408)
|..|.-.+||++++|||+++|+ +|+.|+. ++++.+||||.+..|
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 4444445699999999999986 8999998 999999999988765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=300.53 Aligned_cols=197 Identities=31% Similarity=0.529 Sum_probs=142.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.+ ++.+..|+||||+.||+ |.+.+. ++.+++.++.|++.||+|||++||+||||||+|||
T Consensus 57 ~~~~~~iv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NIL 133 (363)
T cd05628 57 EADSLWVV-KMFYSFQDKLNLYLIMEFLPGGD--MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133 (363)
T ss_pred hCCCCCcc-eEEEEEecCCeEEEEEcCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE
Confidence 45788755 5443 45567899999999998 888764 35889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc------------------------------------cccCCCCCcccChhhhhhccc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK------------------------------------LMDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~------------------------------------~~~~~gt~~y~aPE~l~~~~~ 122 (408)
++.++.+||+|||+|+.+..... ....+||+.|+|||++..
T Consensus 134 i~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--- 210 (363)
T cd05628 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--- 210 (363)
T ss_pred ECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC---
Confidence 99999999999999876532110 012345555555555432
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAV 202 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~ 202 (408)
. .|+.++
T Consensus 211 ---~----------------------------------------------------------------------~~~~~~ 217 (363)
T cd05628 211 ---T----------------------------------------------------------------------GYNKLC 217 (363)
T ss_pred ---C----------------------------------------------------------------------CCCCch
Confidence 1 234456
Q ss_pred cccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCC---CCCHHHHHcCCCC
Q psy3880 203 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPED---RYSVKEALNHSFF 279 (408)
Q Consensus 203 DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~---R~ta~e~L~Hpwf 279 (408)
|+||+||++|+|++|.+||.+.+..+....+.........+.+..+|++++|||.+||. +|.+ |||++|+++||||
T Consensus 218 DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f 296 (363)
T cd05628 218 DWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296 (363)
T ss_pred hhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCC
Confidence 66666666666666666666655556666666544333334445689999999999886 5555 5799999999999
Q ss_pred CCC
Q psy3880 280 HPK 282 (408)
Q Consensus 280 ~~~ 282 (408)
+..
T Consensus 297 ~~~ 299 (363)
T cd05628 297 EGV 299 (363)
T ss_pred CCC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.54 Aligned_cols=221 Identities=27% Similarity=0.441 Sum_probs=159.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.+ . |.+.+ .+...++.++.||+.||+|||++||+||||||+||
T Consensus 59 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~-~--l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (288)
T cd07871 59 NLKHANIV-TLHDIIHTERCLTLVFEYLDS-D--LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134 (288)
T ss_pred hCCCCCEe-eEEEEEcCCCeEEEEEeCCCc-C--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 46898855 6554 345567899999986 4 55544 24578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+++...... ......+|+.|+|||++.+. ..++.++|+||+||++|+|++|.+||.+.+.
T Consensus 135 l~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS-----TEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred EECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCC-----cccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987643222 23346789999999998642 4578899999999999999999999998887
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+...........|..+. ..+.+... ..|-+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---------------------------~~~~~~~~----------- 248 (288)
T cd07871 210 KEELHLIFRLLGTPTEETWPGIT---SNEEFRSY---------------------------LFPQYRAQ----------- 248 (288)
T ss_pred HHHHHHHHHHhCCCChHHhhccc---cchhhhcc---------------------------ccCccCCC-----------
Confidence 77766665543332222222110 00000000 00000000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
........++++++|||++||++||.+||||+|+|+||||
T Consensus 249 ---~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 249 ---PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ---chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0001124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=302.53 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=166.5
Q ss_pred CcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 11 RVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 11 ~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
..+|++++ ...+..+||+|++.-. |++.|.. -..+|.++.|||.||.+||+.||||+|||||||||.+
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~N---LYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLSTN---LYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhhh---HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 34667776 5678889999999765 6777643 3899999999999999999999999999999999975
Q ss_pred C--CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 82 Q--MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 82 ~--~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
- ..|||+|||.|...... ..+++-+++|+|||+|.+ .+|+.++||||||||++||++|.+.|.+.++.++
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILG------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILG------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred CCcCceeEEecccccccCCc--ceeeeeccccccchhhcc------CCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 3 47999999999876543 347889999999999986 5789999999999999999999999999999999
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhh-----cccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH--H
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRAN-----MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR--N 232 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~-----~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~--~ 232 (408)
+..|++-- +..+++.|... .|.....+..-+..|+. ++.. ...+..+ .
T Consensus 397 l~~I~e~l------------G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~------------~~~~-k~~~~~~~~~ 451 (586)
T KOG0667|consen 397 LARIIEVL------------GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSA------------PRGT-KSPEVRKYYR 451 (586)
T ss_pred HHHHHHHh------------CCCCHHHHHhccccceehhccCCceeeeeeecc------------cccc-cchhhhhhhh
Confidence 99998732 22222332211 11100111111222221 1111 0011111 1
Q ss_pred HHhcCCCC--CCCcCCC-----CCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 233 IMEGKYSF--SSPEWND-----ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 233 i~~~~~~f--~~~~~~~-----iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
........ ....|.. -.....|||++||.+||.+|+|+.|+|+||||....
T Consensus 452 ~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 452 KARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 11111111 1122221 123568999999999999999999999999998653
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.36 Aligned_cols=188 Identities=33% Similarity=0.500 Sum_probs=149.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE-
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILL- 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl- 79 (408)
..|+| |+.+.+ ++....|+|||++.||+ +.+.+... .+++.|+.||+.|+.|||++|||||||||+|||+
T Consensus 373 ~~h~n-iv~~~~v~~~~~~~~~v~e~l~g~e--ll~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 373 RDHPN-IVKSHDVYEDGKEIYLVMELLDGGE--LLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred cCCCc-ceeecceecCCceeeeeehhccccH--HHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 46777 546655 45556799999999999 88887654 4778899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
++.++++|+|||+++.+... ..+.|-|..|.|||++.. .+|+.+|||||||+++|+||+|+.||......
T Consensus 450 ~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-- 519 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-- 519 (612)
T ss_pred CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhcc------CCCCcchhhHHHHHHHHHHHhCCCccccCCch--
Confidence 58899999999999887665 455678889999999863 45677777777777777777777766443221
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.++...|..+.+.
T Consensus 520 -------------------------------------------------------------------~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 520 -------------------------------------------------------------------IEIHTRIQMPKFS 532 (612)
T ss_pred -------------------------------------------------------------------HHHHHhhcCCccc
Confidence 2333334333322
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
..+|++|||||++||++||.+|+|+.+++.||||.
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 46899999999999999999999999999999993
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=291.83 Aligned_cols=194 Identities=37% Similarity=0.636 Sum_probs=148.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ ..++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 49 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nil 125 (312)
T cd05585 49 QVNCPFIV-PLKFSFQSPEKLYLVLAFINGGE--LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125 (312)
T ss_pred hCCCCcEe-ceeeEEecCCeEEEEEcCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeE
Confidence 35788755 5443 45567899999999999 887763 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++..... ......+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||
T Consensus 126 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~pf------ 193 (312)
T cd05585 126 LDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG------HGYTKAVDWWTLGVLLYEMLTGLPPF------ 193 (312)
T ss_pred ECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC------CCCCCccceechhHHHHHHHhCCCCc------
Confidence 999999999999999754322 22345689999999998854 23455555555555555555555555
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...+..++.+.+..+.
T Consensus 194 ----------------------------------------------------------------~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 194 ----------------------------------------------------------------YDENVNEMYRKILQEP 209 (312)
T ss_pred ----------------------------------------------------------------CCCCHHHHHHHHHcCC
Confidence 4444444455555554
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~---ta~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||.+||..||++|+ +|.|+|+||||...
T Consensus 210 ~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 210 LRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 4443 35789999999999999999997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=286.88 Aligned_cols=191 Identities=34% Similarity=0.619 Sum_probs=159.5
Q ss_pred cEEEEecc--CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCC
Q psy3880 12 VVVRVKEE--GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN 84 (408)
Q Consensus 12 ~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~ 84 (408)
++..+++. ..|...+||||+.||| ||-++. +++.+|+|-.+|+.||.|||+++||+||||.+|+|++.+|+
T Consensus 229 FLt~LKYsFQt~drlCFVMeyanGGe--Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH 306 (516)
T KOG0690|consen 229 FLTSLKYSFQTQDRLCFVMEYANGGE--LFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH 306 (516)
T ss_pred HHHHhhhhhccCceEEEEEEEccCce--EeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc
Confidence 44455553 3466789999999999 887765 44889999999999999999999999999999999999999
Q ss_pred EEEeccccchh-cccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHH
Q psy3880 85 VKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163 (408)
Q Consensus 85 iKl~DFGla~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i 163 (408)
|||+|||+++. +..+....++||||.|+|||++..+
T Consensus 307 IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn------------------------------------------- 343 (516)
T KOG0690|consen 307 IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN------------------------------------------- 343 (516)
T ss_pred eEeeecccchhcccccceeccccCChhhcCchhhccc-------------------------------------------
Confidence 99999999975 4456667889999999999998532
Q ss_pred HhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCC
Q psy3880 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSP 243 (408)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~ 243 (408)
.||.++|+|.+||+||+|.||+.||+.+....++..|+-+...|+.
T Consensus 344 ---------------------------------DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr- 389 (516)
T KOG0690|consen 344 ---------------------------------DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR- 389 (516)
T ss_pred ---------------------------------cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc-
Confidence 2555677777777777777777777777777777788888878864
Q ss_pred cCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCC
Q psy3880 244 EWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPKLF 284 (408)
Q Consensus 244 ~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~~~ 284 (408)
.+|++|+.|+..+|.+||.+|+. |.|+.+|+||....+
T Consensus 390 ---~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 390 ---TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred ---cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 68999999999999999999985 899999999987643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=285.86 Aligned_cols=216 Identities=30% Similarity=0.455 Sum_probs=159.6
Q ss_pred cccCCcEEEEec-------cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKE-------EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~-------~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
+.|+|++ ++.+ +.....++|||++.++ |.+.+ .+...+..++.||+.||.|||++||+||||
T Consensus 61 ~~hpniv-~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dl 136 (290)
T cd07862 61 FEHPNVV-RLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 136 (290)
T ss_pred cCCCCcc-eEEEEEecccCCCCCcEEEEEccCCCC---HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 4688855 5443 1334578999999754 44444 245788999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
||+|||++.++.+||+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|.+||.
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 137 KPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ------SSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred CHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC------CCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 99999999999999999999987655444455789999999999864 357889999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+..+.+.+|...........|...... . .. .+...++ ..+..
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~------------------~~----------~~~~~~~-------~~~~~ 254 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVAL-P------------------RQ----------AFHSKSA-------QPIEK 254 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcc-c------------------ch----------hccCCCC-------CCHHH
Confidence 99888888888764322221111110000 0 00 0000000 00001
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+++.+++||.+||+.||++|||+.|+|+||||
T Consensus 255 -----------~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 255 -----------FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred -----------HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=294.37 Aligned_cols=192 Identities=34% Similarity=0.660 Sum_probs=147.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 74 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 74 ELSHPFIV-NMMCSFQDENRVYFLLEFVVGGE--LFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150 (329)
T ss_pred hCCCCCCC-cEEEEEEcCCEEEEEEcCCCCCh--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence 46798866 4443 45677899999999998 877764 44788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++...... ....+||+.|+|||++... .++.++|+|||||++|+|++|..|
T Consensus 151 l~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~p-------- 214 (329)
T PTZ00263 151 LDNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSK------GHGKAVDWWTMGVLLYEFIAGYPP-------- 214 (329)
T ss_pred ECCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCC------CCCCcceeechHHHHHHHHcCCCC--------
Confidence 999999999999999866432 2356899999999998642 344555555555555555555554
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
|.+.+.....+.+..+..
T Consensus 215 --------------------------------------------------------------f~~~~~~~~~~~i~~~~~ 232 (329)
T PTZ00263 215 --------------------------------------------------------------FFDDTPFRIYEKILAGRL 232 (329)
T ss_pred --------------------------------------------------------------CCCCCHHHHHHHHhcCCc
Confidence 444444445555666554
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.++. .++.++++||++||+.||.+|++ ++++++||||...
T Consensus 233 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 KFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 4432 37889999999999999999997 7999999999764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=297.80 Aligned_cols=202 Identities=29% Similarity=0.513 Sum_probs=157.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~~h~~iv-~~~~~~~~~~~~~lv~Ey~~gg~--L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 99 HANSEWIV-QLHYAFQDDKYLYMVMEYMPGGD--LVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred hCCCCCcc-eEEEEEecCCEEEEEEcCCCCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 46788755 5443 55667899999999998 877663 357889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+.++.+||+|||++........ ....+||+.|+|||++..... ..
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~------------------------------- 222 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG--DG------------------------------- 222 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCC--CC-------------------------------
Confidence 9999999999999986643321 234679999999999864210 01
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.|+.++|+||+||++|+|++|.+||.+.+....+..|....
T Consensus 223 ---------------------------------------~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05596 223 ---------------------------------------YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ---------------------------------------CCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 13345666666666666667777776666666677777765
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
.....+.+..+|.++++||++||+.+|.+ |+|++|+++||||...
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 55555556678999999999999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=293.85 Aligned_cols=194 Identities=34% Similarity=0.596 Sum_probs=147.6
Q ss_pred ccccCCcEEEEe--ccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~--~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+. .+.++..|+||||+.+|. |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 51 ~l~hp~iv-~~~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl 127 (328)
T cd05593 51 NTRHPFLT-SLKYSFQTKDRLCFVMEYVNGGE--LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127 (328)
T ss_pred hCCCCCCc-ceEEEEEcCCEEEEEEeCCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeE
Confidence 35788755 443 356677899999999998 776653 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+
T Consensus 128 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltG~~Pf~~---- 197 (328)
T cd05593 128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPFYN---- 197 (328)
T ss_pred ECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC------CCCCccCCccccchHHHHHhhCCCCCCC----
Confidence 99999999999999875432 223345689999999999854 2345666666666666666666666543
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.+.......+....
T Consensus 198 ------------------------------------------------------------------~~~~~~~~~~~~~~ 211 (328)
T cd05593 198 ------------------------------------------------------------------QDHEKLFELILMED 211 (328)
T ss_pred ------------------------------------------------------------------CCHHHHHHHhccCC
Confidence 33333333444444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+|+++++||++||+.||++|+ |++|+++||||...
T Consensus 212 ~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 212 IKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 3333 35799999999999999999998 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=296.63 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=156.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+++| .+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~~hp~iv-~~~~~~~~~~~~~lv~Ey~~gg~--L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl 175 (370)
T cd05621 99 FANSPWVV-QLFCAFQDDKYLYMVMEYMPGGD--LVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175 (370)
T ss_pred hCCCCCEe-eEEEEEEcCCEEEEEEcCCCCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 46788755 5554 45567899999999998 877764 357899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+.++.+||+|||+|..+..... ....+||+.|+|||++..... ..
T Consensus 176 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~--~~------------------------------- 222 (370)
T cd05621 176 DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG--DG------------------------------- 222 (370)
T ss_pred CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCC--CC-------------------------------
Confidence 9999999999999987643322 235689999999999864210 01
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.|+.++|+||+||++|+|++|.+||.+.+.......|....
T Consensus 223 ---------------------------------------~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 223 ---------------------------------------YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ---------------------------------------CCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 13346677777777777777777777666666677777665
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
..+..+.+..+|.++++||.+||+.+|.+ |+|++|+++||||+..
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 44544555678999999999999866544 8899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.09 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=155.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| ++.+ .+++..|+|||||.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 57 ~~~h~~iv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 57 EADNEWVV-RLYYSFQDKDNLYFVMDYIPGGD--MMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred hCCCCcCC-eEEEEEEeCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 35788755 5554 45567899999999998 777653 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccccc-CCCCCcccChhhhhhccccCcCCCC-cchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMD-LCGTPGYLAPEVLRANMFEDATGYG-QAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~~~-~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||+|..+........ ..+.. ......-..... ...+. ...+.+....-.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--------------- 195 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH-VRQDSMDFSNEW--GDPANCRCGDRLKPLERR--------------- 195 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccc-cccccccccccc--cccccccccccccchhhh---------------
Confidence 99999999999999864321100000 00000 000000000000 00000 000000000000
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.......-......++..|++||++... +|+.++|+||+||++|+|++|.+||.+.+..+....+...
T Consensus 196 ------~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 263 (382)
T cd05625 196 ------AARQHQRCLAHSLVGTPNYIAPEVLLRT------GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263 (382)
T ss_pred ------hccccccccccccccCcccCCHHHhcCC------CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHcc
Confidence 0000000000112234557777766532 4566788888888888888888888877776666677665
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~ 282 (408)
......+.+..+|++++|||.+|+ .||.+|++ ++|+++||||...
T Consensus 264 ~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 264 QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 555555666789999999999987 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=295.64 Aligned_cols=192 Identities=34% Similarity=0.632 Sum_probs=147.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.+ +..+..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 87 ~l~hp~Iv-~~~~~~~~~~~~~lv~Ey~~~g~--L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 163 (340)
T PTZ00426 87 YINHPFCV-NLYGSFKDESYLYLVLEFVIGGE--FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL 163 (340)
T ss_pred hCCCCCCc-ceEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 35788755 5543 45567899999999998 887764 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++..+... ....+||+.|+|||++.+ ..++.++|+
T Consensus 164 l~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~Di------------------------ 211 (340)
T PTZ00426 164 LDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN------VGHGKAADW------------------------ 211 (340)
T ss_pred ECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC------CCCCccccc------------------------
Confidence 999999999999999865432 245689999999999853 223444454
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
||+||++|+|++|.+||...+...+...+..+..
T Consensus 212 ----------------------------------------------wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 212 ----------------------------------------------WTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred ----------------------------------------------cchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 5555555555555555555444455556666655
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..+++++++||++||+.||++|+ |++|+++||||...
T Consensus 246 ~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 246 YFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 443 24789999999999999999996 89999999999764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=295.88 Aligned_cols=235 Identities=27% Similarity=0.464 Sum_probs=152.1
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ .+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 l~h~~iv-~~~~~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~ 134 (364)
T cd05599 58 ADNPWVV-KLYYSFQDENYLYLIMEYLPGGD--MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL 134 (364)
T ss_pred CCCCCCc-ceEEEEEcCCeEEEEECCCCCcH--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence 5688755 5443 55677899999999998 887764 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++..+..............+..+........ ..........|...
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--------------------- 191 (364)
T cd05599 135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK--PMSSKRKAETWKRN--------------------- 191 (364)
T ss_pred CCCCCEEEeecccceeccccccccccccccccccccccccccc--cccccccccchhhc---------------------
Confidence 9999999999999876532211000000000000000000000 00000000000000
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+ ........++..|++||++... +|+.++|+||+||++|+|++|.+||...+.......+......
T Consensus 192 -------~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~ 257 (364)
T cd05599 192 -------R-RALAYSTVGTPDYIAPEVFLQT------GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKET 257 (364)
T ss_pred -------c-cccccccccCccccCHHHHcCC------CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCc
Confidence 0 0000001123345666655332 3556777777777777777788887777766667777665555
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~ 282 (408)
+..+....+|+++++||++||. ||.+|++ ++|+|+||||...
T Consensus 258 ~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 258 LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 5445555789999999999997 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=298.54 Aligned_cols=193 Identities=31% Similarity=0.572 Sum_probs=155.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
-|.|+|+| ++.+ |.....++|.|||.| + |+.++. .++.++.+..+++.||.|||+++|+|||+||.|||
T Consensus 57 ~lkHpniv-~m~esfEt~~~~~vVte~a~g-~--L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniL 132 (808)
T KOG0597|consen 57 SLKHPNIV-EMLESFETSAHLWVVTEYAVG-D--LFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNIL 132 (808)
T ss_pred hcCCcchh-hHHHhhcccceEEEEehhhhh-h--HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceee
Confidence 37899855 6555 455667899999998 6 888774 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++..+.+|+||||+|+.+..++.. ....|||.|||||++.++ .|+..+|+||+||
T Consensus 133 l~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~------pyd~~sDlWslGc------------------ 188 (808)
T KOG0597|consen 133 LEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQ------PYDHTSDLWSLGC------------------ 188 (808)
T ss_pred ecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCC------CccchhhHHHHHH------------------
Confidence 999999999999999998876654 457899999999998753 3555555555555
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
|+|++..|.|||+.++-..+.+.|....
T Consensus 189 ----------------------------------------------------ilYE~~~G~PPF~a~si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 189 ----------------------------------------------------ILYELYVGQPPFYARSITQLVKSILKDP 216 (808)
T ss_pred ----------------------------------------------------HHHHHhcCCCCchHHHHHHHHHHHhcCC
Confidence 5555555555555555566777777776
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+++ .+|.++++||..+|++||.+|+|-.++|.|||++..
T Consensus 217 v~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 217 VKPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred CCCcc----cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 66554 689999999999999999999999999999999754
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=294.52 Aligned_cols=197 Identities=34% Similarity=0.596 Sum_probs=160.5
Q ss_pred cccCCcEEEEeccCCc--HHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKEEGDD--LKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~--~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
-.|+++||+++.+..| ..|+.||-|-||| |...+..+ .++++|+..+++|++|||++|||+|||||||+++
T Consensus 476 ~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE--lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL 553 (732)
T KOG0614|consen 476 ECRSDFIVRLYRTFRDSKYVYMLMEACLGGE--LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL 553 (732)
T ss_pred hcCchHHHHHHHHhccchhhhhhHHhhcCch--hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee
Confidence 3578999999987655 5689999999999 88887543 7999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.+|.+||.|||+|+.+..+....++||||.|.|||++.. .+++.++|.||||+++|||++|.+||.
T Consensus 554 d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn------KGHD~avDyWaLGIli~ELL~G~pPFs------- 620 (732)
T KOG0614|consen 554 DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN------KGHDRAVDYWALGILIYELLTGSPPFS------- 620 (732)
T ss_pred ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhc------cCcchhhHHHHHHHHHHHHHcCCCCCC-------
Confidence 9999999999999999999998899999999999999974 345555555555555555555555554
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.+++.++..|++|--.
T Consensus 621 ---------------------------------------------------------------~~dpmktYn~ILkGid~ 637 (732)
T KOG0614|consen 621 ---------------------------------------------------------------GVDPMKTYNLILKGIDK 637 (732)
T ss_pred ---------------------------------------------------------------CCchHHHHHHHHhhhhh
Confidence 44455555555554333
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~~ 283 (408)
...| ..++..|.+||+++...+|..|+. +.++.+|.||.+..
T Consensus 638 i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 638 IEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred hhcc--cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 2222 468999999999999999999996 89999999998754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.46 Aligned_cols=240 Identities=27% Similarity=0.461 Sum_probs=155.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++| .+.+ ++++..|+||||+.||+ |.+.+. ++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 58 l~hp~iv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll 134 (377)
T cd05629 58 SDSPWVV-SLYYSFQDAQYLYLIMEFLPGGD--LMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134 (377)
T ss_pred CCCCCcc-eEEEEEEcCCeeEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 6788755 5554 45667899999999998 877763 357899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc---c-CCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM---D-LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~---~-~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+.++.+||+|||+|+.+....... . ..+... ..+ ... ......+.+++- .....
T Consensus 135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~-~~~--~~~-------~~~~~~~~~~~~------------~~~~~ 192 (377)
T cd05629 135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN-KNR--IDN-------RNSVAVDSINLT------------MSSKD 192 (377)
T ss_pred CCCCCEEEeeccccccccccccccccccccccccc-ccc--ccc-------cccccccccccc------------ccchh
Confidence 999999999999997443211000 0 000000 000 000 000000000000 00000
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
...... ... ........+...|++||++... .|+.++|+||+||++|+|++|.+||.+.+....+..+..
T Consensus 193 ~~~~~~---~~~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 193 QIATWK---KNR-RLMAYSTVGTPDYIAPEIFLQQ------GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhhhh---hcc-cccccccCCCccccCHHHHccC------CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 000000 000 0000012234567888877542 467788999999999999999999988777777777776
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCC---CCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR---YSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R---~ta~e~L~Hpwf~~~ 282 (408)
.......+.+..+|.+++|||++||. +|.+| +|+.|+|+||||...
T Consensus 263 ~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 263 WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 54444444555789999999999998 77776 599999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.09 Aligned_cols=198 Identities=31% Similarity=0.497 Sum_probs=152.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +.++..++||||+.+|. |.+.+ .++..+..++.|++.||+|||++||+||||||+|
T Consensus 56 ~l~~~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05631 56 KVNSRFVV-SLAYAYETKDALCLVLTIMNGGD--LKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPEN 132 (285)
T ss_pred hcCCCcEE-EEEEEEccCCeEEEEEEecCCCc--HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 35788755 5443 45667899999999998 65443 2457889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
||+++++.+||+|||++.............||+.|+|||++.. ..|+.++|+||+||++|+|++|+.||.+.+.
T Consensus 133 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 133 ILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred EEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC------CCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999987655444456789999999999864 3467788888888888888888888855322
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
... .......+...
T Consensus 207 ~~~------------------------------------------------------------------~~~~~~~~~~~ 220 (285)
T cd05631 207 RVK------------------------------------------------------------------REEVDRRVKED 220 (285)
T ss_pred chh------------------------------------------------------------------HHHHHHHhhcc
Confidence 110 00111122222
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
... ....+|+++++||++||+.||.+|+| ++++++||||...
T Consensus 221 ~~~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 221 QEE----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred ccc----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 222 22467999999999999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.16 Aligned_cols=192 Identities=39% Similarity=0.680 Sum_probs=149.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ++++..|+||||+.+|. |.+++. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 57 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIl 133 (291)
T cd05612 57 EVSHPFII-RLFWTEHDQRFLYMLMEYVPGGE--LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL 133 (291)
T ss_pred hCCCCcHh-hhHhhhccCCeEEEEEeCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 46788755 5554 34566789999999998 877763 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++...... ....+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+.+
T Consensus 134 i~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--- 202 (291)
T cd05612 134 LDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS------KGHNKAVDWWALGILIYEMLVGYPPFFDDN--- 202 (291)
T ss_pred ECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999876432 234679999999999864 345667777777777777777776664433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.......+..+..
T Consensus 203 -------------------------------------------------------------------~~~~~~~i~~~~~ 215 (291)
T cd05612 203 -------------------------------------------------------------------PFGIYEKILAGKL 215 (291)
T ss_pred -------------------------------------------------------------------HHHHHHHHHhCCc
Confidence 2333444444444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.++. .+++++++||++||+.||.+|++ ++|+++||||...
T Consensus 216 ~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 216 EFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 4432 46889999999999999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.49 Aligned_cols=226 Identities=25% Similarity=0.405 Sum_probs=158.3
Q ss_pred ccccCCcEEEEec----------cCCcHHHHHHHHHhhchhhHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKE----------EGDDLKHLAAQVVDKGEAAVQDI------INSNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~----------~~~~~~~lv~e~~~~g~~~l~~~------~~~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|+|+| .+.+ +.....++||||+.++...+... ..+...++.++.||+.||+|||++||+|
T Consensus 115 ~l~h~niv-~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiH 193 (440)
T PTZ00036 115 NLNHINII-FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICH 193 (440)
T ss_pred hcCCCCCc-ceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 46799866 4322 11123568999998764222211 1234788999999999999999999999
Q ss_pred ccCCCCcEEEecCC-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 70 RDLKPENILLDDQM-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 70 RDLKp~NILl~~~~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
|||||+|||++.++ .+||+|||+|+.+.........+||+.|+|||++.+ ...|+.++|+||+||++|+|++|.
T Consensus 194 rDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-----ATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred CCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-----CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999998654 799999999987765555556789999999999864 245889999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
+||.+.+..+.+.++......+. .+.+.... ..| .++ ..++.. ...
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~------------~~~~~~~~----~~~---~~~------------~~~~~~---~~~ 314 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPT------------EDQLKEMN----PNY---ADI------------KFPDVK---PKD 314 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCC------------HHHHHHhc----hhh---hcc------------cCCccC---chh
Confidence 99999887777777655322211 11110000 000 000 000000 000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.. .++ ...|+++++||++||++||.+|+|+.|+|+||||...
T Consensus 315 -l~~------~~p----~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 315 -LKK------VFP----KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred -HHH------Hhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000 011 2468899999999999999999999999999999753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.56 Aligned_cols=192 Identities=29% Similarity=0.549 Sum_probs=146.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++ +.+.+ +..+..|+||||+.||. |.+.+. ++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 54 ~h~~i-v~~~~~~~~~~~~~iv~Ey~~~g~--L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~ 130 (320)
T cd05590 54 NHPFL-TQLYCCFQTPDRLFFVMEFVNGGD--LMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130 (320)
T ss_pred CCCch-hceeeEEEcCCEEEEEEcCCCCch--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 57764 45554 45567899999999998 776653 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++..... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~Pf~------- 197 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE------MLYGPSVDWWAMGVLLYEMLCGHAPFE------- 197 (320)
T ss_pred CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC------CCCCCccchhhhHHHHHHHhhCCCCCC-------
Confidence 999999999999875432 223345689999999998853 234555666666666666666655554
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
..+...+...+..+...
T Consensus 198 ---------------------------------------------------------------~~~~~~~~~~i~~~~~~ 214 (320)
T cd05590 198 ---------------------------------------------------------------AENEDDLFEAILNDEVV 214 (320)
T ss_pred ---------------------------------------------------------------CCCHHHHHHHHhcCCCC
Confidence 33344444455544443
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV------KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta------~e~L~Hpwf~~~ 282 (408)
++ ..+++++++||++||+.||++|+|+ +++++||||...
T Consensus 215 ~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 215 YP----TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CC----CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 32 2478999999999999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=289.39 Aligned_cols=194 Identities=27% Similarity=0.555 Sum_probs=150.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++|+.+.. ...+..|+||||+.||+ |.+.+. +++.++.++.||+.||+|||++||+||||||+|||+
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~--L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 134 (324)
T cd05587 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD--LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (324)
T ss_pred cCCCCceeeeEEEEEcCCEEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 457887877764 45567899999999998 777663 458889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++.... ........+||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltG~~pf~~~---- 204 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY------QPYGKSVDWWAFGVLLYEMLAGQPPFDGE---- 204 (324)
T ss_pred cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC------CCCCcccchhhhHHHHHHHHhCCCCCCCC----
Confidence 999999999999987532 2223345689999999999864 23556666666666666666666666443
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+..+....+.....
T Consensus 205 ------------------------------------------------------------------~~~~~~~~i~~~~~ 218 (324)
T cd05587 205 ------------------------------------------------------------------DEDELFQSIMEHNV 218 (324)
T ss_pred ------------------------------------------------------------------CHHHHHHHHHcCCC
Confidence 33334444544444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-----~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||..||.+|+++ +++++||||...
T Consensus 219 ~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 219 SYP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 433 3579999999999999999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=294.27 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=153.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++ |+++.. ++++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 57 ~l~h~~-iv~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 57 EADNEW-VVKLYYSFQDKDNLYFVMDYIPGGD--MMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred hcCCCC-eeeeEEEEecCCEEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 356776 556554 45667899999999998 877763 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccC-----CCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDL-----CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~-----~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
++.++.+||+|||++..+......... ..+.. +.|+.+....- ....+.. .-.+-......
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~-- 199 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS-MEPSDLWDDVS--NCRCGDR---------LKTLEQRATKQ-- 199 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccc-cCccccccccc--ccccccc---------cchhhcccccc--
Confidence 999999999999998654321100000 00000 01111000000 0000000 00000000000
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.. .-......++..|++||.+... .|+.++|+||+||++|+|++|.+||...+..+....+
T Consensus 200 ------------~~-~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 200 ------------HQ-RCLAHSLVGTPNYIAPEVLLRK------GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred ------------cc-ccccccccCCccccCHHHHcCC------CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 00 0000011234567777776432 3566788888888888888888888777666666666
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCC--CCCCHHHHHcCCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPE--DRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~--~R~ta~e~L~Hpwf~~~~ 283 (408)
.........+.+..+|++++|||.+||..+++ .|+|++|+++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 261 INWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 65444444455667899999999998766554 499999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=272.36 Aligned_cols=193 Identities=31% Similarity=0.551 Sum_probs=158.0
Q ss_pred cccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 5 EMVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 5 ~~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
+-|-|||++ +++. -++...||++||..+|| ++..+. ++..+..|++|++.||.|||.++||||||||+
T Consensus 77 s~L~hpnil-rlY~~fhd~~riyLilEya~~ge--l~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe 153 (281)
T KOG0580|consen 77 SHLRHPNIL-RLYGYFHDSKRIYLILEYAPRGE--LYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE 153 (281)
T ss_pred cccCCccHH-hhhhheeccceeEEEEEecCCch--HHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence 457899866 5554 34456799999999999 888776 33678899999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+|++..+.+|++|||-+..-. ...-.+.|||.-|++||...+ ..++.
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~------~~hd~------------------------- 201 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG------RGHDK------------------------- 201 (281)
T ss_pred HhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCC------CCccc-------------------------
Confidence 9999999999999999886543 445578999999999998754 33444
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+|+|++||++|++|.|.|||...+..++++.|.+
T Consensus 202 ---------------------------------------------~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 202 ---------------------------------------------FVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred ---------------------------------------------hhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 45555556666666666666666666778888888
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..+.++ ..+|.+|+|||.+||.++|.+|++..|++.|||+..
T Consensus 237 ~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 237 VDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ccccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 887776 479999999999999999999999999999999854
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.37 Aligned_cols=234 Identities=28% Similarity=0.450 Sum_probs=152.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ++++..|+||||+.||+ |.+.+. ++..++.++.|++.||+|||++||+||||||+|||
T Consensus 57 ~l~~~~iv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIl 133 (360)
T cd05627 57 EADGAWVV-KMFYSFQDKRNLYLIMEFLPGGD--MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133 (360)
T ss_pred hCCCCCEe-eEEEEEEcCCEEEEEEeCCCCcc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 45788755 5443 45567899999999998 887764 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++..+....... .........|........ ......+.|.
T Consensus 134 i~~~~~vkL~DfG~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------------------- 186 (360)
T cd05627 134 LDAKGHVKLSDFGLCTGLKKAHRTE-FYRNLTHNPPSDFSFQNM----NSKRKAETWK---------------------- 186 (360)
T ss_pred ECCCCCEEEeeccCCcccccccccc-cccccccCCccccccccc----cccccccccc----------------------
Confidence 9999999999999987553221100 000000000000000000 0000000000
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...........++..|+|||++... +|+.++|+||+||++|+|++|.+||...+.......+.....
T Consensus 187 -------~~~~~~~~~~~gt~~Y~APE~~~~~------~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~ 253 (360)
T cd05627 187 -------KNRRQLAYSTVGTPDYIAPEVFMQT------GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE 253 (360)
T ss_pred -------ccccccccccCCCccccCHHHHcCC------CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCC
Confidence 0000000011233456666665432 356678888888888888888888887777777777765443
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~---ta~e~L~Hpwf~~~~ 283 (408)
....+....+|++++|||.+|+. ||.+|+ +++|+++||||....
T Consensus 254 ~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 254 TLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred ceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 33333344589999999999874 999998 489999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.23 Aligned_cols=194 Identities=34% Similarity=0.579 Sum_probs=152.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.. +.++..|+||||+.+|. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~~p~-i~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~ 130 (330)
T cd05586 54 ESPF-IVGLKFSFQTDSDLYLVTDYMSGGE--LFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130 (330)
T ss_pred CCCc-CcceEEEEecCCeEEEEEcCCCCCh--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 5666 445554 45667899999999998 776653 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++..... .......+||+.|+|||++... ..+
T Consensus 131 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~------------------------------- 174 (330)
T cd05586 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE-----KGY------------------------------- 174 (330)
T ss_pred CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCC-----CCC-------------------------------
Confidence 999999999999875432 2233457899999999988531 112
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.++|+||+||++|+|++|..||...+..++...+..+...
T Consensus 175 ---------------------------------------~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 215 (330)
T cd05586 175 ---------------------------------------TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215 (330)
T ss_pred ---------------------------------------CCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC
Confidence 33566777777777777777777666666666777766665
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCC----CHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRY----SVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~----ta~e~L~Hpwf~~~ 282 (408)
++. ..+++++++||++||..||++|| +++|+++||||...
T Consensus 216 ~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 216 FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 543 24789999999999999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=291.98 Aligned_cols=237 Identities=23% Similarity=0.388 Sum_probs=164.8
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+... .....|+||||+.++.......-.+...+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~l~h~~ii-~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI 157 (364)
T cd07875 79 CVNHKNII-GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157 (364)
T ss_pred hcCCCCcc-ccceeecccccccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence 46788865 44321 1123589999998764222222235678899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+++............||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+..
T Consensus 158 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred EECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999987655444455789999999999864 45788999999999999999999999998888
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
....++......+ .|+....- . ..........+.+.......... ...
T Consensus 232 ~~~~~~~~~~~~~------------~~~~~~~~---------------~--~~~~~~~~~~~~~~~~~~~~~~~---~~~ 279 (364)
T cd07875 232 DQWNKVIEQLGTP------------CPEFMKKL---------------Q--PTVRTYVENRPKYAGYSFEKLFP---DVL 279 (364)
T ss_pred HHHHHHHHhcCCC------------CHHHHHhh---------------h--HHHHHHHhhCCCcCCCChHhhCc---ccc
Confidence 8777776532221 11211100 0 00001111222222221111111 011
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+......+...+.+++|||.+||+.||.+|||++|+|+||||..
T Consensus 280 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 280 FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred ccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 11122223345778999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=288.26 Aligned_cols=238 Identities=24% Similarity=0.370 Sum_probs=161.4
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+. .....|+||||+.++.........+...++.++.|++.||+|||++||+||||||+||
T Consensus 72 ~l~h~niv-~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni 150 (355)
T cd07874 72 CVNHKNII-SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150 (355)
T ss_pred HhCCCchh-ceeeeeeccccccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 46799865 44431 1123589999998764222222245678899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+++............||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 151 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred EECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999987655444455789999999999864 35788999999999999999999999988876
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+....... .||...... -.+ -..+...+.+....... ......
T Consensus 225 ~~~~~~~~~~~~~------------~~~~~~~~~---------------~~~--~~~~~~~~~~~~~~~~~---~~~~~~ 272 (355)
T cd07874 225 DQWNKVIEQLGTP------------CPEFMKKLQ---------------PTV--RNYVENRPKYAGLTFPK---LFPDSL 272 (355)
T ss_pred HHHHHHHHHhCCC------------CHHHHHhhc---------------HHH--HHHHhcCCccccccchh---hccccc
Confidence 6666655432211 111110000 000 00000011110000000 000011
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+..........+.++++||.+||+.||++|||+.|+|+||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 111112223457789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.26 Aligned_cols=193 Identities=33% Similarity=0.596 Sum_probs=145.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.. +.++..|+||||+.||. |.+.+. ++.+++.++.||+.||+|||+ +||+||||||+|||
T Consensus 52 ~~hp~i~-~~~~~~~~~~~~~lv~E~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIl 128 (325)
T cd05594 52 SRHPFLT-ALKYSFQTHDRLCFVMEYANGGE--LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128 (325)
T ss_pred CCCCCCC-ceEEEEEcCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEE
Confidence 5688755 4433 55667899999999998 776653 457899999999999999997 89999999999999
Q ss_pred EecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++.... ........+||+.|+|||++.. ..++.++|+||+||++|+|++
T Consensus 129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~t----------- 191 (325)
T cd05594 129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMC----------- 191 (325)
T ss_pred ECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc------CCCCCccccccccceeeeecc-----------
Confidence 9999999999999987533 2233345689999999998853 234454555555555555544
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
|.+||...+.......+....
T Consensus 192 -----------------------------------------------------------G~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 192 -----------------------------------------------------------GRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred -----------------------------------------------------------CCCCCCCCCHHHHHHHHhcCC
Confidence 445554444444444454444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||++||+.||++|+ |+.++|+||||...
T Consensus 213 ~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 213 IRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 4443 25789999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=301.36 Aligned_cols=195 Identities=33% Similarity=0.613 Sum_probs=171.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+|.|||+| +++. +.....|+||||+.+|| +++++.. +.+++.++.|++.|++|||+++|||||||++|||
T Consensus 111 ~l~HPnIv-kl~~v~~t~~~lylV~eya~~ge--~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNil 187 (596)
T KOG0586|consen 111 SLNHPNIV-KLFSVIETEATLYLVMEYASGGE--LFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENIL 187 (596)
T ss_pred hcCCccee-eeeeeeeecceeEEEEEeccCch--hHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcc
Confidence 68999855 5554 55678999999999999 9999853 4899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
|+.+.++||+|||++..+..+..+.+.||++.|.|||++.+.. |
T Consensus 188 L~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~------y------------------------------ 231 (596)
T KOG0586|consen 188 LDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKK------Y------------------------------ 231 (596)
T ss_pred cccccceeeeccccceeecccccccccCCCCCccChHhhcCcc------c------------------------------
Confidence 9999999999999999999888888999999999999986421 1
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
-|+++|+||+||++|.|++|..||.+.+-.++-...+.++|
T Consensus 232 ---------------------------------------~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 232 ---------------------------------------DGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY 272 (596)
T ss_pred ---------------------------------------CCcceehhhhhhhheeeeecccccCCcccccccchheeeee
Confidence 14478899999999999999999988887777778888888
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+. .+|.++++||+++|++||.+|+++++++.|.|....
T Consensus 273 rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 273 RIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred cccc----eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 7654 479999999999999999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=283.13 Aligned_cols=226 Identities=25% Similarity=0.445 Sum_probs=153.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++||||+.++ |.+.+. ..++++.++.||+.||+|||++||+||||||+||
T Consensus 59 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 134 (303)
T cd07869 59 GLKHANIV-LLHDIIHTKETLTLVFEYVHTD---LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL 134 (303)
T ss_pred hCCCCCcC-eEEEEEecCCeEEEEEECCCcC---HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 46899865 4443 4456789999999754 444442 3478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++..... .......+||+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+...
T Consensus 135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS-----TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999875432 2223446789999999998642 3578899999999999999999999987543
Q ss_pred -HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 157 -MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 157 -~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
...+..+...........|..... .|. + ..+-|. ...| .+ +...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------~--~~~~~~----------~~~~---~~----~~~~-- 254 (303)
T cd07869 210 IQDQLERIFLVLGTPNEDTWPGVHS--LPH------------F--KPERFT----------LYSP---KN----LRQA-- 254 (303)
T ss_pred HHHHHHHHHHHhCCCChhhccchhh--ccc------------c--cccccc----------ccCC---cc----HHHH--
Confidence 233333322111111111110000 000 0 000000 0000 00 0000
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+. ....+++++|||++||+.||++|||++|+|+||||...
T Consensus 255 ----~~---~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 255 ----WN---KLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ----hh---ccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 01356889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=294.34 Aligned_cols=236 Identities=26% Similarity=0.420 Sum_probs=153.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ ++.+ ++++..|+|||||.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 57 ~l~h~~iv-~~~~~~~~~~~~~lv~E~~~~g~--L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 133 (376)
T cd05598 57 EADNEWVV-KLYYSFQDKDNLYFVMDYIPGGD--MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 133 (376)
T ss_pred hCCCCCcc-eEEEEEEcCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEE
Confidence 36788755 5443 45677899999999998 887763 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCC--CC---CcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLC--GT---PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~--gt---~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
++.++.+||+|||+|..+.......... .. .....+..... ...+.. .+...
T Consensus 134 l~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~--------------~~~~~ 190 (376)
T cd05598 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE---------IDRCRL--------------KPLER 190 (376)
T ss_pred ECCCCCEEEEeCCCCccccccccccccccccccccccccccccccc---------cccccc--------------cchhh
Confidence 9999999999999986432110000000 00 00000000000 000000 00000
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
. .. ............++..|++||++... .|+.++|+||+||++|+|++|.+||.+.+..+....+
T Consensus 191 ~-------~~-~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 191 R-------RK-RQHQRCLAHSLVGTPNYIAPEVLLRT------GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred h-------hh-hhcccccccccCCCccccCHHHHcCC------CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH
Confidence 0 00 00000001112334456677766432 3566788888888888888888888777766666666
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~---ta~e~L~Hpwf~~~ 282 (408)
.........+.+..+|+++++||.+|+ .||.+|+ |+.|+++||||...
T Consensus 257 ~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 257 INWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 655544555556779999999999976 5999999 99999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=288.06 Aligned_cols=226 Identities=26% Similarity=0.412 Sum_probs=157.3
Q ss_pred ccccCCcEEEEecc-----CC--cHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE-----GD--DLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-----~~--~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.+. .. ...|+|||||.+ . |.+.+. +...++.++.||+.||.|||++||+|||||
T Consensus 55 ~l~hpniv-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 130 (338)
T cd07859 55 LLRHPDIV-EIKHIMLPPSRREFKDIYVVFELMES-D--LHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK 130 (338)
T ss_pred hCCCCCEe-eecceEeccCCCCCceEEEEEecCCC-C--HHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 46799854 54431 11 235899999964 4 665543 458899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
|+|||++.++.+||+|||+++...... .....+||+.|+|||++... ...++.++|+||+||++|+|++|++
T Consensus 131 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 131 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred HHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcc----ccccCchhHHHHHHHHHHHHHcCCC
Confidence 999999999999999999997643221 12346799999999998641 1357889999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+.+....+..+...... ..++.+..-. .......
T Consensus 207 pf~~~~~~~~~~~~~~~~~~------------~~~~~~~~i~-------------------------------~~~~~~~ 243 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGT------------PSPETISRVR-------------------------------NEKARRY 243 (338)
T ss_pred CCCCCChHHHHHHHHHHhCC------------CCHHHHHHhh-------------------------------hhhHHHH
Confidence 99887765554444321110 0111110000 0000011
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+..+...........+..+++++++||.+||..||++|||++|+|+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 11111111111112345678999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.30 Aligned_cols=199 Identities=34% Similarity=0.572 Sum_probs=149.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++|+.+.+ +.++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili 138 (332)
T cd05614 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGE--MFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138 (332)
T ss_pred ccCCCCcccEEEEEecCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE
Confidence 333444656654 45567789999999998 877663 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+.++.+||+|||+++...... .....+||+.|+|||++.+. ..++.++||||+||++|+|++|..||......
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK-----GGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCC-----CCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 999999999999997654322 22346899999999998642 23567788888888888888888777432100
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.........+....
T Consensus 214 ------------------------------------------------------------------~~~~~~~~~~~~~~ 227 (332)
T cd05614 214 ------------------------------------------------------------------NTQSEVSRRILKCD 227 (332)
T ss_pred ------------------------------------------------------------------CCHHHHHHHHhcCC
Confidence 01112222333333
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..+ ...+++++++||.+||..||++|+ +++++++||||+..
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 228 PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 222 235789999999999999999999 88999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=287.93 Aligned_cols=195 Identities=33% Similarity=0.590 Sum_probs=148.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ ++.+ +..+..|+||||+.||. |.+.+. ++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 58 ~~h~~iv-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 134 (333)
T cd05600 58 TKSEWLV-KLLYAFQDDEYLYLAMEYVPGGD--FRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134 (333)
T ss_pred CCCCCCc-cEEEEEEcCCEEEEEEeCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 4588755 4443 45667899999999998 888763 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++..... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+
T Consensus 135 ~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~---- 202 (333)
T cd05600 135 DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG------KGYDFTVDYWSLGCMLYEFLCGFPPFSGST---- 202 (333)
T ss_pred CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcC------CCCCCccceecchHHHhhhhhCCCCCCCCC----
Confidence 9999999999999976543 2345789999999999864 245566666666666666666666664433
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
..+....+......
T Consensus 203 ------------------------------------------------------------------~~~~~~~i~~~~~~ 216 (333)
T cd05600 203 ------------------------------------------------------------------PNETWENLKYWKET 216 (333)
T ss_pred ------------------------------------------------------------------HHHHHHHHHhcccc
Confidence 22333333322222
Q ss_pred CCCCcC----CCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEW----NDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~----~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+..+.+ ..+|+++++||.+||..+|.+|+|++|+++||||...
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 222222 2579999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=283.94 Aligned_cols=141 Identities=31% Similarity=0.511 Sum_probs=111.1
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh--------------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII--------------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~--------------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|+| .+.+ ..+...++||||+.++ |.+.+ .+...++.++.||+.||+|||++||
T Consensus 54 ~l~h~niv-~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 129 (317)
T cd07868 54 ELKHPNVI-SLQKVFLSHADRKVWLLFDYAEHD---LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 129 (317)
T ss_pred hcCCCCCc-ceeeeEecCCCcEEEEEEeccCCC---HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 46799865 4433 3344568999998764 43332 3457789999999999999999999
Q ss_pred eeccCCCCcEEEe----cCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 68 VHRDLKPENILLD----DQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 68 vHRDLKp~NILl~----~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
+||||||+|||+. .++.+||+|||+|+...... .....+||+.|+|||++.+. ..|+.++|+||+||
T Consensus 130 vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~ 204 (317)
T cd07868 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGC 204 (317)
T ss_pred EcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCC-----CCcCchhhHHHHHH
Confidence 9999999999994 55789999999998764321 22346789999999998642 35788999999999
Q ss_pred HHHHHHhCCCCCCCch
Q psy3880 140 IMYTLLVGCPPFWHRK 155 (408)
Q Consensus 140 il~~ll~G~~pf~~~~ 155 (408)
++|+|++|.+||....
T Consensus 205 il~el~~g~~~f~~~~ 220 (317)
T cd07868 205 IFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHHHhCCCCccCCc
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.19 Aligned_cols=194 Identities=32% Similarity=0.590 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ..++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 51 ~l~hp~i~-~~~~~~~~~~~~~lv~E~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl 127 (323)
T cd05595 51 NTRHPFLT-ALKYAFQTHDRLCFVMEYANGGE--LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127 (323)
T ss_pred hCCCCCCc-ceeeEEecCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 35788755 4443 55567899999999998 766553 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++..... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+
T Consensus 128 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-- 199 (323)
T cd05595 128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-- 199 (323)
T ss_pred EcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC------CCCCchhchhhhHHHHHHHHhCCCCCCCCC--
Confidence 99999999999999875322 223345789999999999854 245666777777777777777666664432
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.......+....
T Consensus 200 --------------------------------------------------------------------~~~~~~~~~~~~ 211 (323)
T cd05595 200 --------------------------------------------------------------------HERLFELILMEE 211 (323)
T ss_pred --------------------------------------------------------------------HHHHHHHHhcCC
Confidence 233333444444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||.+||..||.+|+ ++.++++||||...
T Consensus 212 ~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 212 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 3333 35799999999999999999998 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=281.24 Aligned_cols=225 Identities=30% Similarity=0.416 Sum_probs=157.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|++ .+.+ +.++..|+||||+.+|...+... -.+...++.++.|++.||+|||++||+||||||+||+++
T Consensus 56 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 56 TLKQENIV-ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134 (287)
T ss_pred hCCCcccc-chhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 46788855 5554 45567799999999986222211 134578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
.++.+||+|||++....... ......||+.|+|||++.. ..++.++|+||+||++|+|++|++||.+.+...
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG------APYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred CCCcEEEeeccCcccccccccccccccccccccCCcHHHcC------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999998764332 2234679999999999864 347889999999999999999999999877666
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+...... .+++.+..- . .+.+- .....|......
T Consensus 209 ~~~~~~~~~~~------------~~~~~~~~~-~---------~~~~~--------~~~~~~~~~~~~------------ 246 (287)
T cd07848 209 QLFTIQKVLGP------------LPAEQMKLF-Y---------SNPRF--------HGLRFPAVNHPQ------------ 246 (287)
T ss_pred HHHHHHHhhCC------------CCHHHHHhh-h---------ccchh--------cccccCcccCcc------------
Confidence 55554432111 111111100 0 00000 000001000000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
......+..+|++++|||++||++||++|||++|+|+||||
T Consensus 247 ~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00011124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=287.04 Aligned_cols=193 Identities=24% Similarity=0.486 Sum_probs=146.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++ +.+.+ +.++..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||+
T Consensus 53 ~~~~~i-~~~~~~~~~~~~~~lv~E~~~~g~--L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 53 WENPFL-THLYCTFQTKEHLFFVMEFLNGGD--LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129 (316)
T ss_pred cCCCCc-cCeeEEEEeCCEEEEEECCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 467764 45543 45567899999999998 766653 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~el~~g~~Pf~~~~--- 200 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--- 200 (316)
T ss_pred CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC------CCCCcccchhhhHHHHHHHHhCCCCCCCCC---
Confidence 9999999999999875322 222345789999999999864 345666777777777777777766664433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...+.+.+.....
T Consensus 201 -------------------------------------------------------------------~~~~~~~~~~~~~ 213 (316)
T cd05620 201 -------------------------------------------------------------------EDELFESIRVDTP 213 (316)
T ss_pred -------------------------------------------------------------------HHHHHHHHHhCCC
Confidence 2233333333333
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCH-HHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-KEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-~e~L~Hpwf~~~ 282 (408)
.++ ..+|.++++||++||..||++|+|+ +++++||||...
T Consensus 214 ~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 HYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 332 1378999999999999999999997 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=287.06 Aligned_cols=193 Identities=26% Similarity=0.530 Sum_probs=148.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++|+.+.. +..+..|+||||+.+|+ |.+.+. ++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~--L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 135 (323)
T cd05616 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD--LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135 (323)
T ss_pred cCCCeEeeEEEEEecCCEEEEEEcCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC
Confidence 45666766654 45567899999999998 776653 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~elltg~~Pf~~------ 203 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY------QPYGKSVDWWAFGVLLYEMLAGQAPFEG------ 203 (323)
T ss_pred CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC------CCCCCccchhchhHHHHHHHhCCCCCCC------
Confidence 999999999999875432 223345789999999999864 2355666666666666666666555543
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+...+...+......
T Consensus 204 ----------------------------------------------------------------~~~~~~~~~i~~~~~~ 219 (323)
T cd05616 204 ----------------------------------------------------------------EDEDELFQSIMEHNVA 219 (323)
T ss_pred ----------------------------------------------------------------CCHHHHHHHHHhCCCC
Confidence 3334444555555544
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
++ ..+|+++++||.+||+.||++|++ ..++++||||...
T Consensus 220 ~p----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 220 YP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred CC----CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 43 257999999999999999999998 4899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=286.36 Aligned_cols=192 Identities=30% Similarity=0.553 Sum_probs=145.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +.++..|+||||+.||. |.+.+. ++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 54 ~hp~-i~~~~~~~~~~~~~~lv~E~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 54 KHPF-LTALHCCFQTKDRLFFVMEYVNGGD--LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred CCCC-ccceeeEEEcCCeEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 5776 556554 45567899999999998 766653 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++..... .......+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~Pf-------- 196 (321)
T cd05591 131 AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE------LEYGPSVDWWALGVLMYEMMAGQPPF-------- 196 (321)
T ss_pred CCCCEEEeecccceecccCCccccccccCccccCHHHHcC------CCCCCccceechhHHHHHHhcCCCCC--------
Confidence 999999999999875432 222345679999999998853 23455555555555555555555555
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...+....+..+..+...
T Consensus 197 --------------------------------------------------------------~~~~~~~~~~~i~~~~~~ 214 (321)
T cd05591 197 --------------------------------------------------------------EADNEDDLFESILHDDVL 214 (321)
T ss_pred --------------------------------------------------------------CCCCHHHHHHHHHcCCCC
Confidence 444444445555555444
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCC-------CHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRY-------SVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~-------ta~e~L~Hpwf~~~ 282 (408)
++. .+|.++++||++||+.||++|+ +++++++||||...
T Consensus 215 ~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 215 YPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 332 3689999999999999999999 99999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=286.97 Aligned_cols=194 Identities=35% Similarity=0.578 Sum_probs=146.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 52 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl 128 (323)
T cd05575 52 NVKHPFLV-GLHYSFQTADKLYFVLDYVNGGE--LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL 128 (323)
T ss_pred hCCCCCCC-CeeEEEEeCCEEEEEEcCCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence 36788765 4443 45567899999999998 777653 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++..... .......+||+.|+|||++.. ..++.++|+|||||++|+|++|..||
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf------ 196 (323)
T cd05575 129 LDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK------QPYDRTVDWWCLGAVLYEMLYGLPPF------ 196 (323)
T ss_pred ECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC------CCCCccccccccchhhhhhhcCCCCC------
Confidence 99999999999999875432 223345689999999998753 23445555555555555555555554
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...+..++...+..+.
T Consensus 197 ----------------------------------------------------------------~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 197 ----------------------------------------------------------------YSRDTAEMYDNILNKP 212 (323)
T ss_pred ----------------------------------------------------------------CCCCHHHHHHHHHcCC
Confidence 4444444455555544
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf~~~ 282 (408)
.... ..+++++++||++||+.||++|+|+ .|+++||||...
T Consensus 213 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 213 LRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 4332 3579999999999999999999997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=285.52 Aligned_cols=194 Identities=35% Similarity=0.604 Sum_probs=147.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..|+||||+.||. |++.+. .+..++.++.||+.||+|||++||+||||||+|||
T Consensus 56 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 132 (323)
T cd05584 56 AVKHPFIV-DLIYAFQTGGKLYLILEYLSGGE--LFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENIL 132 (323)
T ss_pred hCCCCchh-ceeeEEecCCeEEEEEeCCCCch--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 46898865 4433 45567899999999998 887763 34788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~G~~pf~----- 201 (323)
T cd05584 133 LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR------SGHGKAVDWWSLGALMYDMLTGAPPFT----- 201 (323)
T ss_pred ECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC------CCCCCcceecccHHHHHHHhcCCCCCC-----
Confidence 99999999999999875332 222334689999999998854 234555666666666666655555554
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+.......+..+.
T Consensus 202 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 216 (323)
T cd05584 202 -----------------------------------------------------------------AENRKKTIDKILKGK 216 (323)
T ss_pred -----------------------------------------------------------------CCCHHHHHHHHHcCC
Confidence 333333444455444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||++||+.||++|+ +++++++||||...
T Consensus 217 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 LNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 4332 35789999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.62 Aligned_cols=198 Identities=33% Similarity=0.560 Sum_probs=163.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
..++++||.+.+ +..|-..||+.+|+||+ |..+| .+++.+++|+.+|+.||++||+.+||+|||||+||
T Consensus 241 kV~s~FiVslaYAfeTkd~LClVLtlMNGGD--LkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNI 318 (591)
T KOG0986|consen 241 KVSSPFIVSLAYAFETKDALCLVLTLMNGGD--LKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENI 318 (591)
T ss_pred HhccCcEEEEeeeecCCCceEEEEEeecCCc--eeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhe
Confidence 357889998776 66678899999999999 65554 35689999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|+|+.|+|+|+|+|+|..+..++.....+||.+|||||++... .|+..+|+||+||++|+|+.|+.||......
T Consensus 319 LLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne------~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 319 LLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNE------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred eeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCC------cccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 9999999999999999999888888888999999999999753 3777778888777777777777777543321
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
. ...+.-+.+++..
T Consensus 393 v------------------------------------------------------------------k~eEvdrr~~~~~ 406 (591)
T KOG0986|consen 393 V------------------------------------------------------------------KREEVDRRTLEDP 406 (591)
T ss_pred h------------------------------------------------------------------hHHHHHHHHhcch
Confidence 1 1123444555555
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
..++ +..|+++++|.+.+|++||++|+. ++++.+||||+..
T Consensus 407 ~ey~----~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 407 EEYS----DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred hhcc----cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 5554 468999999999999999999985 7899999999865
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=286.56 Aligned_cols=194 Identities=35% Similarity=0.591 Sum_probs=146.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ +.++..|+||||+.||. |.+.+. .+..++.++.||+.||+|||++||+||||||+|||
T Consensus 52 ~~~h~~Iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil 128 (325)
T cd05602 52 NVKHPFLV-GLHFSFQTADKLYFVLDYINGGE--LFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128 (325)
T ss_pred hCCCCCCC-ceeEEEEcCCeEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 46788755 4443 45667899999999998 777663 35788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||++|+|++|
T Consensus 129 i~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g---------- 192 (325)
T cd05602 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK------QPYDRTVDWWCLGAVLYEMLYG---------- 192 (325)
T ss_pred ECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC------CCCCCccccccccHHHHHHhcC----------
Confidence 99999999999999875432 223345789999999998864 2344455555555555555555
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.+||...+..+++..+....
T Consensus 193 ------------------------------------------------------------~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 193 ------------------------------------------------------------LPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred ------------------------------------------------------------CCCCCCCCHHHHHHHHHhCC
Confidence 44554444444555555444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH----HHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK----EALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~----e~L~Hpwf~~~ 282 (408)
..+. ..+++++++||++||+.||.+|+++. ++++|+||...
T Consensus 213 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 213 LQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred cCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 3332 36899999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=286.05 Aligned_cols=202 Identities=30% Similarity=0.470 Sum_probs=151.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.+ +.++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 58 ~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIl 134 (330)
T cd05601 58 SNSPWIP-QLQYAFQDKDNLYLVMEYQPGGD--LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134 (330)
T ss_pred CCCCCCc-ceeeEEecCCeEEEEECCCCCCC--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheE
Confidence 5677654 5543 45567899999999998 777663 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++..+...... ...+||+.|+|||++..........
T Consensus 135 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~----------------------------- 185 (330)
T cd05601 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT----------------------------- 185 (330)
T ss_pred ECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCC-----------------------------
Confidence 999999999999999876543322 2357999999999986321110112
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
|+.++|+||+||++|+|++|.+||...+....+.++...
T Consensus 186 -----------------------------------------~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 224 (330)
T cd05601 186 -----------------------------------------YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224 (330)
T ss_pred -----------------------------------------CCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 344566666666666666666666655555555555544
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
......+....+|+++++||++||. ||++|||++++++||||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 3222233345689999999999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.31 Aligned_cols=202 Identities=31% Similarity=0.521 Sum_probs=155.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ ++.. ..++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~~hp~iv-~~~~~~~~~~~~~lv~Ey~~gg~--L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 99 FANSPWVV-QLFYAFQDDRYLYMVMEYMPGGD--LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred hCCCCCCC-eEEEEEEcCCEEEEEEcCCCCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 45788755 5543 45567899999999998 777663 357889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+.++.+||+|||+|..+..... ....+||+.|+|||++..... ..
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~------------------------------- 222 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG--DG------------------------------- 222 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCC--Cc-------------------------------
Confidence 9999999999999987653321 235679999999999864210 01
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.|+.++|+||+||++|+|++|.+||...+.......|....
T Consensus 223 ---------------------------------------~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 223 ---------------------------------------YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred ---------------------------------------cCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 13346677777777777777777777766666777777766
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
..+..+.+..+|.++++||.+||..++.+ |++++|+++||||...
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 264 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 55555566789999999999999844433 7799999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.92 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=158.9
Q ss_pred ccccCCcEEEEeccC---C-----cHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEEG---D-----DLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~---~-----~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+.. + ...|+||||+.++.......-.+...++.++.||+.||+|||++||+||||||+||
T Consensus 76 ~l~h~niv-~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI 154 (359)
T cd07876 76 CVNHKNII-SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154 (359)
T ss_pred hCCCCCEe-eeeeeeccCCCccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 46788855 554421 1 23589999998764212111235688899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+++............||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 155 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred EECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999986554444455788999999999864 35788999999999999999999999988776
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+........ .+.. ... --.........+.+.+....+..... .
T Consensus 229 ~~~~~~~~~~~~~~------------~~~~-~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 276 (359)
T cd07876 229 DQWNKVIEQLGTPS------------AEFM-NRL----------------QPTVRNYVENRPQYPGISFEELFPDW---I 276 (359)
T ss_pred HHHHHHHHhcCCCc------------HHHH-HHH----------------HHHHHHHHhhCCCCCCcchhhhcccc---c
Confidence 66555544211100 0000 000 00000001111111111111110000 0
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+..........++++++||.+||+.||++|||+.|+|+||||..
T Consensus 277 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 277 FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred cccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00011112245788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.49 Aligned_cols=216 Identities=30% Similarity=0.441 Sum_probs=156.6
Q ss_pred cccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
+.|+|++ ++.+. ..+..++|+|++.++ |.+.+ .+.++++.++.||+.||+|||++||+||||
T Consensus 59 ~~h~ni~-~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~di 134 (288)
T cd07863 59 FDHPNIV-RLMDVCATSRTDRETKVTLVFEHVDQD---LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 134 (288)
T ss_pred cCCCCee-eeeeeeccccCCCCceEEEEEcccccC---HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4688755 55432 123468999999864 44433 245889999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
||+|||++.++.+||+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|.+||.
T Consensus 135 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 135 KPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ------STYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred CHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhC------CCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 99999999999999999999987655444445678999999999864 357889999999999999999999998
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+....+.++...........|..... . ....|...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~--~~~~~~~~-------- 245 (288)
T cd07863 209 GNSEADQLGKIFDLIGLPPEDDWPRDVT---------------------------------L--PRGAFSPR-------- 245 (288)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCccccc---------------------------------c--cccccCCC--------
Confidence 8877776666654321111111110000 0 00000000
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
........+..++.+++|||.+||+.||++|||+.|+|+||||
T Consensus 246 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 246 ----GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ----CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000011123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.41 Aligned_cols=194 Identities=30% Similarity=0.534 Sum_probs=149.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++ .+.+ +..+..|+||||+.||+ |...+. +++++..++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~l~hp~i~-~~~~~~~~~~~~~lv~E~~~~~~--L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill 134 (324)
T cd05589 58 SERHPFLV-NLFACFQTEDHVCFVMEYAAGGD--LMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134 (324)
T ss_pred ccCCCChh-ceeeEEEcCCEEEEEEcCCCCCc--HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence 45798855 5443 45567899999999998 766653 457899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++..... .......+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~G~~pf~~~~--- 205 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE------TSYTRAVDWWGLGVLIYEMLVGESPFPGDD--- 205 (324)
T ss_pred CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC------CCCCcccchhhHHHHHHHHHhCCCCCCCCC---
Confidence 9999999999999875332 223345789999999999864 235566677777777776666666664433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
..+.+..+..+..
T Consensus 206 -------------------------------------------------------------------~~~~~~~i~~~~~ 218 (324)
T cd05589 206 -------------------------------------------------------------------EEEVFDSIVNDEV 218 (324)
T ss_pred -------------------------------------------------------------------HHHHHHHHHhCCC
Confidence 3333444444444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++.+||++||+.||.+|| +++++++||||...
T Consensus 219 ~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 333 25789999999999999999999 69999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=287.20 Aligned_cols=196 Identities=33% Similarity=0.613 Sum_probs=145.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ .+.+ +.++..|+||||+.||. |.+.+. +...++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll 134 (350)
T cd05573 58 ADSPWIV-KLYYSFQDEEHLYLVMEYMPGGD--LMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134 (350)
T ss_pred cCCCCcc-chhhheecCCeEEEEEcCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 5577644 5554 45567899999999998 777653 457899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc------------------------------ccccCCCCCcccChhhhhhccccCcCCCC
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE------------------------------KLMDLCGTPGYLAPEVLRANMFEDATGYG 129 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~ 129 (408)
+.++.+||+|||++..+.... ......||+.|+|||++.
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------- 203 (350)
T cd05573 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR----------- 203 (350)
T ss_pred CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc-----------
Confidence 999999999999997654332 111233455555555443
Q ss_pred cchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhh
Q psy3880 130 QAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGV 209 (408)
Q Consensus 130 ~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gv 209 (408)
.. .|+.++|+||+||
T Consensus 204 -----------------------------------------------------------~~------~~~~~~DiwSlG~ 218 (350)
T cd05573 204 -----------------------------------------------------------GT------PYGLECDWWSLGV 218 (350)
T ss_pred -----------------------------------------------------------CC------CCCCceeeEecch
Confidence 22 2445666666777
Q ss_pred hHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-HHHHHcCCCCCCC
Q psy3880 210 IMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-VKEALNHSFFHPK 282 (408)
Q Consensus 210 ily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-a~e~L~Hpwf~~~ 282 (408)
++|+|++|.+||...+.......+......+..+....+|+++++||.+||. ||.+|++ ++|+|+||||...
T Consensus 219 il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 219 ILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred hhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777777777776666555566666533333333444589999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.69 Aligned_cols=194 Identities=33% Similarity=0.545 Sum_probs=145.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 52 ~~~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl 128 (325)
T cd05604 52 NVKHPFLV-GLHYSFQTTEKLYFVLDFVNGGE--LFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128 (325)
T ss_pred hCCCCCCc-cEEEEEecCCEEEEEEcCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 36788765 5443 55677899999999998 776653 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|
T Consensus 129 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el------------- 189 (325)
T cd05604 129 LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK------QPYDNTVDWWCLGAVLYEM------------- 189 (325)
T ss_pred ECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC------CCCCCcCccccccceehhh-------------
Confidence 99999999999999875322 223345689999999999854 2344445555555555554
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
++|.+||...+..++...+....
T Consensus 190 ---------------------------------------------------------~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 190 ---------------------------------------------------------LYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred ---------------------------------------------------------hcCCCCCCCCCHHHHHHHHHcCC
Confidence 44555554444444555555544
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf~~~ 282 (408)
..+. ..+|.++.+||++||..||.+||++ .++++||||...
T Consensus 213 ~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 213 LVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 3332 2478899999999999999999986 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=283.18 Aligned_cols=194 Identities=26% Similarity=0.537 Sum_probs=149.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++|+.+.. +.++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~--L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill 134 (323)
T cd05615 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGD--LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134 (323)
T ss_pred ccCCCchhheeeEEecCCEEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 457777776654 45567899999999998 877653 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltG~~pf~~----- 203 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY------QPYGKSVDWWAYGVLLYEMLAGQPPFDG----- 203 (323)
T ss_pred CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC------CCCCCccchhhhHHHHHHHHhCCCCCCC-----
Confidence 99999999999998754322 22345679999999999864 2355666666666666666666666544
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+...+...+.....
T Consensus 204 -----------------------------------------------------------------~~~~~~~~~i~~~~~ 218 (323)
T cd05615 204 -----------------------------------------------------------------EDEDELFQSIMEHNV 218 (323)
T ss_pred -----------------------------------------------------------------CCHHHHHHHHHhCCC
Confidence 333334445555444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.++ ..+|.++++||.+||..||.+|++ .+++++||||...
T Consensus 219 ~~p----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 219 SYP----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CCC----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 433 357899999999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=288.09 Aligned_cols=196 Identities=34% Similarity=0.615 Sum_probs=165.8
Q ss_pred ccccCCcEEEEe--ccCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~--~~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.||. ||.+. -|..+..+.|||.+.|.. |-=++.++ ...++++.|||.||.|||.+||||+||||||+
T Consensus 619 ~l~HPG-iV~le~M~ET~ervFVVMEKl~GDM--LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENV 695 (888)
T KOG4236|consen 619 NLHHPG-IVNLECMFETPERVFVVMEKLHGDM--LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENV 695 (888)
T ss_pred hcCCCC-eeEEEEeecCCceEEEEehhhcchH--HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchhe
Confidence 356776 55655 467788899999998875 43334333 57899999999999999999999999999999
Q ss_pred EEecC---CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 78 LLDDQ---MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 78 Ll~~~---~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|+.+. -.+||||||+|+++....--.+.+|||.|+|||+++..
T Consensus 696 LLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk---------------------------------- 741 (888)
T KOG4236|consen 696 LLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK---------------------------------- 741 (888)
T ss_pred eeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc----------------------------------
Confidence 99754 36999999999999877666778999999999999742
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+|+..-||||.|||+|.-|+|..||... .++-.+|.
T Consensus 742 ------------------------------------------GyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 742 ------------------------------------------GYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred ------------------------------------------cccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 3455778888999999999999998654 24556789
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
++.+-|+...|.++|++|.|||.++|++.-.+|+|++..|.|||++..
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999999999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=282.35 Aligned_cols=193 Identities=28% Similarity=0.562 Sum_probs=146.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
..|++++ ++.+ +..+..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 53 ~~hp~i~-~~~~~~~~~~~~~lv~e~~~gg~--L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill 129 (316)
T cd05592 53 WEHPFLT-HLFCTFQTKEHLFFVMEYLNGGD--LMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129 (316)
T ss_pred cCCCCcc-ceeeEEEcCCEEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE
Confidence 4677755 5554 34567899999999998 777653 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|...... ......+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-- 201 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-- 201 (316)
T ss_pred CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC------CCCCCcccchhHHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999754322 22345689999999999864 2356677777777777777777777654433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
..++..+.....
T Consensus 202 --------------------------------------------------------------------~~~~~~i~~~~~ 213 (316)
T cd05592 202 --------------------------------------------------------------------DELFDSILNDRP 213 (316)
T ss_pred --------------------------------------------------------------------HHHHHHHHcCCC
Confidence 223333333322
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCH-HHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-KEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-~e~L~Hpwf~~~ 282 (408)
.++ ..++.++++||++||..||++|+|+ .++++||||...
T Consensus 214 ~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 HFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 222 2478899999999999999999986 588999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.63 Aligned_cols=198 Identities=29% Similarity=0.502 Sum_probs=150.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|++ |+.+.+ +.++..|+||||+.||. |.+.+ .++..+..++.||+.||+|||++||+||||||
T Consensus 49 ~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~g~--L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 125 (280)
T cd05608 49 KVHSRF-IVSLAYAFQTKTDLCLVMTIMNGGD--LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKP 125 (280)
T ss_pred hCCCCc-EeeeeEEEcCCCeEEEEEeCCCCCC--HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 456766 555543 44566789999999998 65543 24578899999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+||+++.++.+||+|||++..+..... .....||+.|+|||++.. ..++.++|+||+||++|+|++|..||..
T Consensus 126 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG------EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred HHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC------CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999976654322 234679999999999864 3467788999999999999888888854
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
...... .......+
T Consensus 200 ~~~~~~------------------------------------------------------------------~~~~~~~~ 213 (280)
T cd05608 200 RGEKVE------------------------------------------------------------------NKELKQRI 213 (280)
T ss_pred CCcchh------------------------------------------------------------------HHHHHHhh
Confidence 321100 00111122
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
...... ....+|+++++|+.+||+.||++|+ |++++++||||+..
T Consensus 214 ~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 214 LNDSVT----YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cccCCC----CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 222211 1245799999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.87 Aligned_cols=194 Identities=34% Similarity=0.556 Sum_probs=145.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +..+..|+||||+.||+ |.+.+. .+.+++.++.||+.||+|||++||+||||||+|||
T Consensus 52 ~~~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl 128 (321)
T cd05603 52 NLKHPFLV-GLHYSFQTAEKLYFVLDYVNGGE--LFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL 128 (321)
T ss_pred hCCCCCcc-ceeeEEEcCCEEEEEEcCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence 46788755 5543 45667899999999998 766553 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++.... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf------ 196 (321)
T cd05603 129 LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK------EPYDRTVDWWCLGAVLYEMLYGLPPF------ 196 (321)
T ss_pred ECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC------CCCCCcCcccccchhhhhhhcCCCCC------
Confidence 99999999999999875322 222345689999999998853 23445555555555555555555555
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...+...+...+....
T Consensus 197 ----------------------------------------------------------------~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 197 ----------------------------------------------------------------YSRDVSQMYDNILHKP 212 (321)
T ss_pred ----------------------------------------------------------------CCCCHHHHHHHHhcCC
Confidence 4444344444555444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf~~~ 282 (408)
..++ ...+.++.+||.+||+.||.+|+++ .|+++||||...
T Consensus 213 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 213 LQLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CCCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 4333 2468899999999999999999975 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=282.89 Aligned_cols=194 Identities=31% Similarity=0.580 Sum_probs=149.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ ++.+ +.++..|+||||+.+|+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 54 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 130 (318)
T cd05582 54 EVNHPFIV-KLHYAFQTEGKLYLILDFLRGGD--LFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 130 (318)
T ss_pred hCCCCCcc-cEEEEEEcCCEEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeE
Confidence 46798855 5543 45567799999999998 877763 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++...... ......+||+.|+|||++... .++.
T Consensus 131 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~--------------------------- 177 (318)
T cd05582 131 LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR------GHTQ--------------------------- 177 (318)
T ss_pred ECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC------CCCC---------------------------
Confidence 999999999999998765443 233457899999999988532 2333
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
++|+||+||++|+|++|..||...........+....
T Consensus 178 -------------------------------------------~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~ 214 (318)
T cd05582 178 -------------------------------------------SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214 (318)
T ss_pred -------------------------------------------ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 4555555555555555666665555555555666555
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
..++ ..+++++++||++||+.||++||| ++++++||||...
T Consensus 215 ~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 215 LGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 5443 247899999999999999999999 7789999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=281.75 Aligned_cols=201 Identities=27% Similarity=0.536 Sum_probs=153.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++++ .+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~hp~Iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~ 130 (329)
T cd05588 54 NHPFLV-GLHSCFQTESRLFFVIEFVSGGD--LMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCCC-ceEEEEEcCCEEEEEEeCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC
Confidence 577755 5554 45567799999999998 776653 4588999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhc-ccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+++.. .........+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||......
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-- 202 (329)
T cd05588 131 AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS-- 202 (329)
T ss_pred CCCCEEECcCccccccccCCCccccccCCccccCHHHHcC------CCCCCccceechHHHHHHHHHCCCCccccccc--
Confidence 9999999999998753 23333445789999999999864 35678899999999999999999998431100
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
. .|. ........+.+......
T Consensus 203 -----------~-----------------------------------------------~~~-~~~~~~~~~~~~~~~~~ 223 (329)
T cd05588 203 -----------D-----------------------------------------------NPD-QNTEDYLFQVILEKQIR 223 (329)
T ss_pred -----------c-----------------------------------------------ccc-ccchHHHHHHHHcCCCC
Confidence 0 000 00111223344444444
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC------HHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS------VKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t------a~e~L~Hpwf~~~ 282 (408)
++ ..+|.++++||++||+.||.+|+| ++++++||||...
T Consensus 224 ~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 224 IP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred CC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 33 247899999999999999999997 7899999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.61 Aligned_cols=193 Identities=28% Similarity=0.546 Sum_probs=148.3
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ .+.+ +.++..|+||||+.||. |.+.+. +..++..++.|++.||+|||++||+||||||+|||+
T Consensus 53 ~~hp~iv-~~~~~~~~~~~~~lv~ey~~~g~--L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~ 129 (316)
T cd05619 53 WEHPFLT-HLYCTFQTKENLFFVMEYLNGGD--LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129 (316)
T ss_pred cCCCcCc-ceEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 4788755 5443 45567889999999998 777663 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++..... .......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~G~~pf~~~~~-- 201 (316)
T cd05619 130 DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-- 201 (316)
T ss_pred CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--
Confidence 9999999999999875322 223345689999999999864 3466777777777777777777777754332
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.++.+.+.....
T Consensus 202 --------------------------------------------------------------------~~~~~~i~~~~~ 213 (316)
T cd05619 202 --------------------------------------------------------------------EELFQSIRMDNP 213 (316)
T ss_pred --------------------------------------------------------------------HHHHHHHHhCCC
Confidence 222333333322
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK-EALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~-e~L~Hpwf~~~ 282 (408)
.++ ..++.++++||.+||+.||++|+|+. ++++||||...
T Consensus 214 ~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 214 CYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 222 13688999999999999999999996 99999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=255.33 Aligned_cols=231 Identities=25% Similarity=0.445 Sum_probs=174.2
Q ss_pred ccccCCcEEEEec------cCC----cHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKE------EGD----DLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~~~----~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.|.|+|++ .+.+ +.. ..+|+||++|... |+..+. +-.+++.+|++++.||.|+|.+.|+|
T Consensus 72 ~lkHenv~-nliEic~tk~Tp~~r~r~t~ylVf~~cehD---LaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilH 147 (376)
T KOG0669|consen 72 LLKHENVV-NLIEICRTKATPTNRDRATFYLVFDFCEHD---LAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILH 147 (376)
T ss_pred HhcchhHH-HHHHHHhhccCCcccccceeeeeHHHhhhh---HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHh
Confidence 46788743 4443 222 3479999999875 444443 23799999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
||+||+|+||+.++.+||+|||+|+.+...+. ....+.|.+|++||.+.+. ..|+++.|+|+.|||+.+|
T Consensus 148 RDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-----r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 148 RDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-----REYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred hcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcc-----cccCCcchhHhHHHHHHHH
Confidence 99999999999999999999999987654332 2345679999999999874 6799999999999999999
Q ss_pred HhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 145 l~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
++|.+.|.+++++.++..|..-..++....|+....+ -+|.-+.- +| ...
T Consensus 223 wtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l----------------------------pL~~sie~-eP-l~~ 272 (376)
T KOG0669|consen 223 WTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL----------------------------PLYQSIEL-EP-LPK 272 (376)
T ss_pred HccCccccCChHHHHHHHHHHHhccCCcccCCCcccc----------------------------hHHHhccC-CC-CCc
Confidence 9999999999999999988776666666666543221 11111111 22 223
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
.+...+.++++ .| .-.+++.||+.+||.+||.+|++++++|+|.||..+..
T Consensus 273 ~~~rkv~n~~k---p~------~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 273 GQKRKVKNRLK---PY------VKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred chhhhhhhhcc---cc------cCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 33333333332 11 12678999999999999999999999999999987653
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=282.92 Aligned_cols=203 Identities=28% Similarity=0.514 Sum_probs=150.2
Q ss_pred ccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCCH----H--HHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINSN----P--ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~~----~--~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|.++|.-+++ .++++.|+|||+ |+..|..+|... + .+++|.+|||.|+.++|.+||||.||||.|+|+-
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~---Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV 494 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMEC---GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV 494 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeec---ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE
Confidence 46776644444 467789999996 555588887654 3 7999999999999999999999999999999986
Q ss_pred cCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
. |.+||+|||+|..+..++. -.+.+||+.||+||.+.........+ .
T Consensus 495 k-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~--~--------------------------- 544 (677)
T KOG0596|consen 495 K-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENG--K--------------------------- 544 (677)
T ss_pred e-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCC--C---------------------------
Confidence 4 7899999999988876542 23589999999999997643211000 0
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch-hHHHHHHHHhc
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-QMVMLRNIMEG 236 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~-~~~~~~~i~~~ 236 (408)
+ --..+.++||||||||+|.|+.|++||..-. ...-+..|..-
T Consensus 545 ---------------~---------------------k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 545 ---------------S---------------------KIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred ---------------c---------------------ceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 0 0123557888888888888888888886543 33444555443
Q ss_pred CCCCCCCcCCCCC--ccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDIS--EDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS--~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... .+++.++ .++.|+++.||.+||.+|||+.|+|+|||.+..
T Consensus 589 ~~~---Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 NHE---IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred Ccc---ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 221 1233333 238999999999999999999999999999874
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.49 Aligned_cols=232 Identities=29% Similarity=0.476 Sum_probs=167.0
Q ss_pred ccCCcEEEEecc--CCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
+.++|||++++. ++|..|+||||+.||+ +-..| ..+..+|+|+.++.+|+++.|+.|+|||||||+|||||
T Consensus 686 ADn~WVVrLyySFQDkdnLYFVMdYIPGGD--mMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID 763 (1034)
T KOG0608|consen 686 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGD--MMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 763 (1034)
T ss_pred cCCcceEEEEEEeccCCceEEEEeccCCcc--HHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc
Confidence 458899999985 5578999999999998 55543 46689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc--ccccCCCCC---ccc--ChhhhhhccccCcCCCCcchhhhh-hhHHHHHHHhCCCCCC
Q psy3880 81 DQMNVKLTDFGFARVLKKGE--KLMDLCGTP---GYL--APEVLRANMFEDATGYGQAVDVWA-CGVIMYTLLVGCPPFW 152 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~--~~~~~~gt~---~y~--aPE~l~~~~~~~~~~~~~~~DiwS-lGvil~~ll~G~~pf~ 152 (408)
.+|+|||+|||||..+.-.. .... -|.. --| +||.- |+-+ +-++.
T Consensus 764 rdGHIKLTDFGLCTGfRWTHdskYYq-~gdH~RqDSmep~~e~~---------------d~~~~lkvL~----------- 816 (1034)
T KOG0608|consen 764 RDGHIKLTDFGLCTGFRWTHDSKYYQ-EGDHHRQDSMEPSPEWA---------------DISKCLKVLE----------- 816 (1034)
T ss_pred cCCceeeeeccccccceecccccccc-CCCccccccCCCchhhc---------------cccccchHHH-----------
Confidence 99999999999997653211 1111 1110 001 11110 0000 00100
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..-+...-+.......++..|++||++.. .+|++.||+||.|||||+|+.|.+||...+.-++..+
T Consensus 817 --------~ra~~~h~r~~ahslvgt~nyiapevl~r------~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~k 882 (1034)
T KOG0608|consen 817 --------RRAMRQHQRILAHSLVGTPNYIAPEVLAR------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYK 882 (1034)
T ss_pred --------HHHHhhhhhhhhhhhcCCCcccChHHhcc------cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence 00001111111223345677999999865 4788899999999999999999999998887777666
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPKL 283 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~~ 283 (408)
|.+-.-....+.-.++|.||.|||.+|. -+++.|+. ++|+.+||||+...
T Consensus 883 v~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 883 VINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred eeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence 6655444444555689999999999975 58999995 88899999998754
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.90 Aligned_cols=225 Identities=28% Similarity=0.462 Sum_probs=175.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH---HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN---PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~---~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
|.|-| ||++.+ ..+...-+|+|+|+..-...||-++-. +.+|.+|.|++.||.|||++++.||||||.|+|++.
T Consensus 58 lkhkn-ivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ 136 (292)
T KOG0662|consen 58 LKHKN-IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR 136 (292)
T ss_pred hhhcc-eeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc
Confidence 56777 668776 345566799999998766677777644 788999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH-hCCCCCCCchhHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll-~G~~pf~~~~~~~~ 159 (408)
+|.+|++|||+|+.+.-.- ..+..+.|.+|++|.++.+ +.-|++..|+||.|||+.|+. .|.+.|.+.+-.++
T Consensus 137 ngelkladfglarafgipvrcysaevvtlwyrppdvlfg-----akly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 137 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred CCcEEecccchhhhcCCceEeeeceeeeeeccCcceeee-----eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 9999999999999876443 3445678999999999875 456899999999999999999 59999999999999
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.+|..--.++....|+.+...-+ -..| |.+... ....+|+
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpd-----------yk~y---------------------p~ypat--tswsqiv----- 252 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPD-----------YKPY---------------------PIYPAT--TSWSQIV----- 252 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCC-----------Cccc---------------------CCcccc--chHHHHh-----
Confidence 999987766666666655432100 0000 111000 0011111
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.++...+||++++|.-+|.+|++|+++|+||||...
T Consensus 253 ------p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 253 ------PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ------hhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 3467788999999999999999999999999999764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.09 Aligned_cols=199 Identities=32% Similarity=0.522 Sum_probs=152.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +.++..++||||+.||. |.+.+ .+.+.+..++.|++.||+|||++||+||||||+|
T Consensus 49 ~l~hp~i~-~~~~~~~~~~~~~lv~e~~~g~~--L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N 125 (277)
T cd05607 49 KVNSPFIV-NLAYAFESKTHLCLVMSLMNGGD--LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPEN 125 (277)
T ss_pred hcCCCcEE-EEEEEEecCCeEEEEEecCCCCC--HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHh
Confidence 47898855 4443 45567899999999998 76655 2346778899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|+++.++.++|+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+...
T Consensus 126 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 126 VLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred EEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999999999999987655444445679999999999864 3477889999999999999999999854322
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.... ....+.+...
T Consensus 200 ~~~~------------------------------------------------------------------~~~~~~~~~~ 213 (277)
T cd05607 200 KVAK------------------------------------------------------------------EELKRRTLED 213 (277)
T ss_pred hhhH------------------------------------------------------------------HHHHHHhhcc
Confidence 1100 0111112212
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf~~~ 282 (408)
...+. ...++++++|||++||+.||++|||+ +++++||||...
T Consensus 214 ~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 214 EVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred ccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 21111 13578899999999999999999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=276.33 Aligned_cols=224 Identities=24% Similarity=0.402 Sum_probs=159.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.++ |.+.+ .+...++.++.||+.||+|||++||+||||||+||
T Consensus 60 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 60 DLKHANIV-TLHDIVHTDKSLTLVFEYLDKD---LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred hCCCCCcc-eEEEEEeeCCeEEEEEeCCCCC---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 36788855 5544 4456788999999864 44443 34578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++....... ......+|+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 136 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS-----SEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred EECCCCCEEECccccceecCCCccccccccccccccCCHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999987643322 22345789999999998642 3578899999999999999999999998877
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+...........|..+.. .... .....+++...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~------------ 249 (309)
T cd07872 211 EDELHLIFRLLGTPTEETWPGISS---NDEF--------------------------KNYNFPKYKPQ------------ 249 (309)
T ss_pred HHHHHHHHHHhCCCCHHHHhhhcc---hhhh--------------------------hhhhcCccCCC------------
Confidence 666666554322222111111100 0000 00000111000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........+|++++|||.+||+.||.+|+|++|+|+||||...
T Consensus 250 ---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 250 ---PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred ---chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0001124578999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=284.31 Aligned_cols=194 Identities=28% Similarity=0.466 Sum_probs=165.5
Q ss_pred cccCCcEEEEec--cCCcH-HHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 7 VAHSRVVVRVKE--EGDDL-KHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~-~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
+-||| ||.+++ +.++. .+|||+||+||+ +.+.|. .++.+..++.|++.||+|||+++|+|||||+.|
T Consensus 60 ~~hP~-iv~y~ds~~~~~~~l~Ivm~Y~eGg~--l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N 136 (426)
T KOG0589|consen 60 LLHPN-IVEYKDSFEEDGQLLCIVMEYCEGGD--LAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN 136 (426)
T ss_pred ccCCC-eeeeccchhcCCceEEEEEeecCCCC--HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence 56887 556665 34455 899999999998 766653 457899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+++.++.|||.|||+|+.+.+.. ...+..|||.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD------IPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC------CCCCccCcchhhcchHHHHHhcccccCccc
Confidence 999999999999999999998776 5567899999999999975 579999999999999999999999998888
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
-..++.+|..+.+.+-
T Consensus 211 m~~Li~ki~~~~~~Pl---------------------------------------------------------------- 226 (426)
T KOG0589|consen 211 MSELILKINRGLYSPL---------------------------------------------------------------- 226 (426)
T ss_pred hHHHHHHHhhccCCCC----------------------------------------------------------------
Confidence 8777777766542211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
-...|.+.+.||+.||..+|..||||.++|.+|.....
T Consensus 227 ---------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 ---------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred ---------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 12348899999999999999999999999999988643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=280.56 Aligned_cols=202 Identities=27% Similarity=0.514 Sum_probs=153.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+++| .+.+ ..++..|+||||+.+|+ |.+.+ .++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 53 ~~hp~iv-~~~~~~~~~~~~~lv~E~~~~~~--L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili 129 (329)
T cd05618 53 SNHPFLV-GLHSCFQTESRLFFVIEYVNGGD--LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129 (329)
T ss_pred CCCCcCC-ceeeEEEeCCEEEEEEeCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 3677755 5554 45567899999999998 76654 3457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||......
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~- 202 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS- 202 (329)
T ss_pred CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC------CCCCCccceecccHHHHHHhhCCCCCccCCCc-
Confidence 999999999999987532 2233345789999999999864 35678899999999999999999988421100
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. .| ...........+.....
T Consensus 203 ------------~-----------------------------------------------~~-~~~~~~~~~~~i~~~~~ 222 (329)
T cd05618 203 ------------D-----------------------------------------------NP-DQNTEDYLFQVILEKQI 222 (329)
T ss_pred ------------C-----------------------------------------------Cc-ccccHHHHHHHHhcCCC
Confidence 0 00 00111123334444444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC------HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS------VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t------a~e~L~Hpwf~~~ 282 (408)
.++ ..++.++++||++||+.||++|+| ++++++||||...
T Consensus 223 ~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 223 RIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred CCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 443 357899999999999999999998 4799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=280.08 Aligned_cols=192 Identities=29% Similarity=0.590 Sum_probs=148.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +..+..|+||||+.||. |.+.+. ++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 54 ~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~ 130 (318)
T cd05570 54 KHPF-LTQLHSCFQTKDRLFFVMEYVNGGD--LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD 130 (318)
T ss_pred CCCC-ccceeeEEEcCCEEEEEEcCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC
Confidence 5776 556554 45667899999999998 766653 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++.... ........+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--- 201 (318)
T cd05570 131 SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--- 201 (318)
T ss_pred CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---
Confidence 99999999999986532 2222344679999999999864 3456677777777777777777777754332
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
......+......
T Consensus 202 -------------------------------------------------------------------~~~~~~i~~~~~~ 214 (318)
T cd05570 202 -------------------------------------------------------------------DELFQSILEDEVR 214 (318)
T ss_pred -------------------------------------------------------------------HHHHHHHHcCCCC
Confidence 2233334333333
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-----~e~L~Hpwf~~~ 282 (408)
++ ..+++++++||++||+.||++|||+ .++++||||...
T Consensus 215 ~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 215 YP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 32 2478999999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=280.52 Aligned_cols=224 Identities=27% Similarity=0.446 Sum_probs=157.5
Q ss_pred ccccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+.. ....|++++++ ++. |.+.+ .+..+++.++.||+.||+|||++||+|||||
T Consensus 70 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik 145 (343)
T cd07878 70 HMKHENVI-GLLDVFTPATSIENFNEVYLVTNLM-GAD--LNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK 145 (343)
T ss_pred hcCCCchh-hhhhhhcccccccccCcEEEEeecC-CCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 46788755 544311 13357888887 555 55554 3568899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||++.++.+||+|||++...... ....+||+.|+|||++... ..++.++|+||+||++|+|++|..||.+
T Consensus 146 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 146 PSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred hhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCC-----ccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999865432 3456899999999998642 3578899999999999999999999998
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..+....... .++.+..- .+-..--+ + ...|..... .+
T Consensus 219 ~~~~~~~~~~~~~~~~~------------~~~~~~~~--------------~~~~~~~~--~-~~~~~~~~~---~~--- 263 (343)
T cd07878 219 NDYIDQLKRIMEVVGTP------------SPEVLKKI--------------SSEHARKY--I-QSLPHMPQQ---DL--- 263 (343)
T ss_pred CCHHHHHHHHHHHhCCC------------CHHHHHhc--------------chhhHHHH--h-hccccccch---hH---
Confidence 87777666665432111 11111100 00000000 0 000000000 00
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
...+...++.++|||.+||+.||++|||+.|+|+||||....
T Consensus 264 --------~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 264 --------KKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred --------HHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 011235678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=265.64 Aligned_cols=226 Identities=25% Similarity=0.413 Sum_probs=163.8
Q ss_pred ccccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|.|+| .+.... -...|+|||+|+.. |...+. ....+++++.|++.|++|||+.||+||||||
T Consensus 71 ~v~~~nii-~l~n~ftP~~~l~~~~e~y~v~e~m~~n---l~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkP 146 (369)
T KOG0665|consen 71 CVNHKNII-SLLNVFTPQKTLEEFQEVYLVMELMDAN---LCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKP 146 (369)
T ss_pred hhccccee-eeeeccCccccHHHHHhHHHHHHhhhhH---HHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCc
Confidence 46788866 444321 12369999999876 333332 3489999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+||++..++.+||.|||+|+.-...-..+.++.|.+|+|||++.+ .+|...+||||+||++.||++|+..|.+.
T Consensus 147 snivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~------~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 147 SNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccceecchhheeeccchhhcccCcccccCchhheeeccCchheec------cCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 999999999999999999987666555677899999999999986 34889999999999999999999999999
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..++..+|.+....++. .+...+. +.|-+... ..+-+...+-.+
T Consensus 221 d~idQ~~ki~~~lgtpd~-------------~F~~qL~-------------~~~r~yv~---~~~~y~~~~f~~------ 265 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDP-------------SFMKQLQ-------------PTVRNYVE---NRPQYQAISFSE------ 265 (369)
T ss_pred hHHHHHHHHHHHhcCCCH-------------HHHHHhh-------------HHHHHHhh---cChHhhccchhh------
Confidence 999998888764333221 1111110 00101000 000000000000
Q ss_pred hcCCCCCCCcCC-------CCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 235 EGKYSFSSPEWN-------DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 235 ~~~~~f~~~~~~-------~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.|+...|. .-+..|+||+.+||+.||++|+|+++||+||||+
T Consensus 266 ----~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 266 ----LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ----hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 12222221 2245789999999999999999999999999996
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=266.33 Aligned_cols=227 Identities=30% Similarity=0.447 Sum_probs=169.2
Q ss_pred cccCCcE--EEEeccCCcHHHHHHHHHhhchhhHHhhhC----------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 7 VAHSRVV--VRVKEEGDDLKHLAAQVVDKGEAAVQDIIN----------SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 7 ~~~~~~i--~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~----------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
+.|+|+| |++.-+.+...++++||++.. |..+|. ...-++.+++||+.|++|||++=|+||||||
T Consensus 84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhD---L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLSHDKKVWLLFDYAEHD---LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred hcCCcchhHHHHHhccCceEEEEehhhhhh---HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 5688866 233345577789999999765 555542 1257899999999999999999999999999
Q ss_pred CcEEEecC----CCEEEeccccchhcccCc-c---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 75 ENILLDDQ----MNVKLTDFGFARVLKKGE-K---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 75 ~NILl~~~----~~iKl~DFGla~~~~~~~-~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
.|||+..+ |.+||+|||+|+.+...- . ....+.|.+|+|||.+.+ +..|++++|+||.|||+.||++
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-----a~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-----ARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-----cccccchhhhHHHHHHHHHHHc
Confidence 99999877 899999999999876432 2 223677999999999986 4789999999999999999999
Q ss_pred CCCCCCCch---------hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 147 GCPPFWHRK---------QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 147 G~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
-.+.|.+.. +.+++.+|.+--..++...|+++..+ ||--
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~--Pe~q------------------------------ 283 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKM--PEYQ------------------------------ 283 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhC--cchH------------------------------
Confidence 999998753 34677777776666666666655432 2210
Q ss_pred CCCCCCchhHHHHHHHHhcCCCCC-----CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 218 CPPFWHRKQMVMLRNIMEGKYSFS-----SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 218 ~~Pf~~~~~~~~~~~i~~~~~~f~-----~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+..+....+.-- ...|..-|+.+.||+.+||++||.+|+||++||+|+||....
T Consensus 284 ----------~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 284 ----------TLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred ----------HHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 00000000000000 012344577799999999999999999999999999998764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=278.99 Aligned_cols=199 Identities=27% Similarity=0.517 Sum_probs=151.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +..+..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 54 ~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~ 130 (327)
T cd05617 54 SNPF-LVGLHSCFQTTSRLFLVIEYVNGGD--LMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130 (327)
T ss_pred CCCC-EeeEEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence 4554 666665 44566899999999998 766553 4588999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++.... ........+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||......
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-- 202 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-- 202 (327)
T ss_pred CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC------CCCCchheeehhHHHHHHHHhCCCCCCccCCC--
Confidence 99999999999987532 2333445789999999999864 35678899999999999999998888432100
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+. ..........+......
T Consensus 203 ------------------------------------------------------------~~-~~~~~~~~~~~~~~~~~ 221 (327)
T cd05617 203 ------------------------------------------------------------PD-MNTEDYLFQVILEKPIR 221 (327)
T ss_pred ------------------------------------------------------------cc-cccHHHHHHHHHhCCCC
Confidence 00 00111223334444333
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC------HHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS------VKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t------a~e~L~Hpwf~~~ 282 (408)
++ ..+|.++++||++||..||++|+| .+++++||||...
T Consensus 222 ~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 222 IP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 32 357899999999999999999998 4699999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=292.99 Aligned_cols=194 Identities=31% Similarity=0.498 Sum_probs=156.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| ++.+ +.++..||||||+.||. |.+.+ .++.++..++.||+.||+|||++||+||||||
T Consensus 121 ~l~Hpniv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp 197 (478)
T PTZ00267 121 ACDHFGIV-KHFDDFKSDDKLLLIMEYGSGGD--LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197 (478)
T ss_pred hCCCCCEe-EEEEEEEECCEEEEEEECCCCCC--HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCH
Confidence 47899855 5554 45567899999999998 76544 24578899999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
+|||++.++.+||+|||+++.+..... ....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||
T Consensus 198 ~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~Pf 271 (478)
T PTZ00267 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER------KRYSKKADMWSLGVILYELLTLHRPF 271 (478)
T ss_pred HhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC------CCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999987654322 234679999999999864 45788999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+..+.+..+..+.
T Consensus 272 ~~~~~~~~~~~~~~~~---------------------------------------------------------------- 287 (478)
T PTZ00267 272 KGPSQREIMQQVLYGK---------------------------------------------------------------- 287 (478)
T ss_pred CCCCHHHHHHHHHhCC----------------------------------------------------------------
Confidence 7665554444443321
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+. +....+|+++++||.+||..||++|||++++|+|||+..
T Consensus 288 ------~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 288 ------YD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ------CC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 11 001246889999999999999999999999999999854
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.77 Aligned_cols=203 Identities=29% Similarity=0.520 Sum_probs=156.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++ |+.+.+ +..+..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 58 ~~~~~-i~~~~~~~~~~~~~~lv~ey~~~g~--L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nil 134 (332)
T cd05623 58 GDNQW-ITTLHYAFQDENNLYLVMDYYVGGD--LLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134 (332)
T ss_pred CCCCC-EeeEEEEEecCCEEEEEEeccCCCc--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 45665 556554 45567899999999998 877763 34688999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++..+..... ....+||+.|+|||++.... .....++.++|+||+||++|+|++|..||...+.
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccc-cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999876543222 22367999999999986421 1123578899999999999999999999987766
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+...++......
T Consensus 214 ~~~~~~i~~~~~~------------------------------------------------------------------- 226 (332)
T cd05623 214 VETYGKIMNHKER------------------------------------------------------------------- 226 (332)
T ss_pred HHHHHHHhCCCcc-------------------------------------------------------------------
Confidence 5555554432110
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
..++ ..+..+|++++|||++||+.+|.+ |+|++|+++||||...
T Consensus 227 -~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 227 -FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 0111 112457999999999999876655 6899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.87 Aligned_cols=226 Identities=25% Similarity=0.414 Sum_probs=158.3
Q ss_pred ccccCCcEEEEec--cCCc-----HHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE--EGDD-----LKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~-----~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+ ...+ ..|+|+||+.++ |.+.+. +...++.++.||+.||+|||++||+|||||
T Consensus 55 ~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk 130 (372)
T cd07853 55 FFKHDNVL-SALDILQPPHIDPFEEIYVVTELMQSD---LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK 130 (372)
T ss_pred hCCCCCcC-CHhheecCCCccccceEEEEeeccccC---HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 46788865 4433 1222 468999999754 555442 457899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|+|||++.++.+||+|||++....... ......+|+.|+|||++.+. ..|+.++|+||+||++|+|++|+.||
T Consensus 131 p~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 131 PGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS-----RHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred hHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCC-----CCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 999999999999999999997654322 22345689999999998642 34788999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+....+..|....... .++.+... .. +. ...++.. |.......
T Consensus 206 ~~~~~~~~~~~i~~~~g~~------------~~~~~~~~-----------~~----~~-~~~~~~~--~~~~~~~~---- 251 (372)
T cd07853 206 QAQSPIQQLDLITDLLGTP------------SLEAMRSA-----------CE----GA-RAHILRG--PHKPPSLP---- 251 (372)
T ss_pred CCCCHHHHHHHHHHHcCCC------------CHHHHHHh-----------hH----HH-HHHHHhC--CCCCCchH----
Confidence 9988877777765422111 11111100 00 00 0001110 00000000
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+ ......++++++||.+||+.||++|||++|+|+||||...
T Consensus 252 ----~~~----~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 252 ----VLY----TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred ----Hhc----ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000 1123468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=276.57 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=163.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|.|||.| .++. -.+...+||||||-|--..|.+... .+-++..|..+.|.||.|||+++.||||||..|||++
T Consensus 82 ~l~HPnti-eYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs 160 (948)
T KOG0577|consen 82 QLRHPNTI-EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS 160 (948)
T ss_pred hccCCCcc-cccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec
Confidence 47899855 5553 3355789999999987544555543 2468899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
+.|.|||+|||.|....+. .+++|||+|||||++... +...|+-++||||||+++.+|...++|.++.+-...+
T Consensus 161 e~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAM---DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL 234 (948)
T KOG0577|consen 161 EPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 234 (948)
T ss_pred CCCeeeeccccchhhcCch---hcccCCccccchhHheec---cccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence 9999999999999887653 468999999999999753 2357899999999999999999999998887766665
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
..|.+.. .+..
T Consensus 235 YHIAQNe---------------------------------------------------------------------sPtL 245 (948)
T KOG0577|consen 235 YHIAQNE---------------------------------------------------------------------SPTL 245 (948)
T ss_pred HHHHhcC---------------------------------------------------------------------CCCC
Confidence 5554421 1223
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
.+++| |+..+.|+..||++-|.+|||++++|.|+|......+
T Consensus 246 qs~eW---S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 246 QSNEW---SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred CCchh---HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 44555 7789999999999999999999999999999876443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.43 Aligned_cols=198 Identities=31% Similarity=0.513 Sum_probs=151.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +.++..++||||+.||. |.+.+ .+++.+..++.|++.||+|||++||+||||||+|
T Consensus 56 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 132 (285)
T cd05605 56 KVNSRFVV-SLAYAYETKDALCLVLTLMNGGD--LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPEN 132 (285)
T ss_pred hcCCCCEe-eeeeeecCCCeEEEEEeccCCCc--HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 46788755 5543 45567899999999998 65544 2457889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++++++.++|+|||++..+.........+|++.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 133 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 133 ILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred EEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC------CCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 9999999999999999987654444445689999999999864 3466778888888888888888888854332
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
..... .....+...
T Consensus 207 ~~~~~------------------------------------------------------------------~~~~~~~~~ 220 (285)
T cd05605 207 KVKRE------------------------------------------------------------------EVERRVKED 220 (285)
T ss_pred hhHHH------------------------------------------------------------------HHHHHhhhc
Confidence 11110 111122222
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
...+ ...+++.+++||.+||..||++|+ |++++++||||...
T Consensus 221 ~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 221 QEEY----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred cccc----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 2222 235789999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=282.77 Aligned_cols=222 Identities=22% Similarity=0.375 Sum_probs=153.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+|+| .+.+ +.++..++|+|++. |+ |.+.+. +..+++.++.||+.||+|||++|||||||||+|||
T Consensus 139 ~l~HpnIv-~~~~~~~~~~~~~lv~e~~~-~~--L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 139 AINHPSII-QLKGTFTYNKFTCLILPRYK-TD--LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred hCCCCCCC-CEeEEEEECCeeEEEEecCC-CC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 47899865 5544 44566789999986 44 555543 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC--cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG--EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK- 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~- 155 (408)
++.++.+||+|||+|...... ......+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||....
T Consensus 215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~elltg~~p~~~~~~ 288 (391)
T PHA03212 215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288 (391)
T ss_pred EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC------CCCCcHHHHHHHHHHHHHHHHCCCCcCCccc
Confidence 999999999999999754321 22335689999999999864 357899999999999999999998886532
Q ss_pred ------hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh-HH
Q psy3880 156 ------QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MV 228 (408)
Q Consensus 156 ------~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~-~~ 228 (408)
....+..+......... ++ |+..... ..
T Consensus 289 ~~~~~~~~~~l~~i~~~~g~~p~-~~--------------------------------------------~~~~~~~~~~ 323 (391)
T PHA03212 289 LDGDCDSDRQIKLIIRRSGTHPN-EF--------------------------------------------PIDAQANLDE 323 (391)
T ss_pred ccccCchhHHHHHHHHHhcCChh-hc--------------------------------------------CcchhHHHHH
Confidence 12223333222111100 00 0000000 00
Q ss_pred HHHHHHhcCC--CCCCCcCC---CCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKY--SFSSPEWN---DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~--~f~~~~~~---~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+........ ....+.|. .++.++++||.+||++||++||||+|+|+||||+..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000000000 01112222 357789999999999999999999999999999764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.28 Aligned_cols=220 Identities=23% Similarity=0.281 Sum_probs=147.1
Q ss_pred CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEecCC----------
Q psy3880 20 GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQM---------- 83 (408)
Q Consensus 20 ~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NILl~~~~---------- 83 (408)
.....++|||++ ||. |.+.+. ...+++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~--l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPC--LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 344567899887 555 666553 457899999999999999998 5999999999999998665
Q ss_pred ------CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 84 ------NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 84 ------~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG------LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 2345789999999999975 45789999999999999999999999988877
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+..+......+. ..|..... .+| ..++ +.......|... .. .+..+....
T Consensus 352 ~~~~~i~~~~g~~p-~~~~~~~~--~~~---------------~~~~-------~~~~~~~~~~~~--~~-~~~~~~~~~ 403 (467)
T PTZ00284 352 EHLHLMEKTLGRLP-SEWAGRCG--TEE---------------ARLL-------YNSAGQLRPCTD--PK-HLARIARAR 403 (467)
T ss_pred HHHHHHHHHcCCCC-HHHHhhcc--chh---------------HHHH-------hhhcccccccCC--HH-HHHhhhccc
Confidence 76666554322211 01100000 000 0000 000000011110 00 111111110
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. +.. ...++.+.|||++||++||++||||+|+|+||||...
T Consensus 404 ~-~~~---~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 404 P-VRE---VIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred c-hhh---hhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0 000 0125678899999999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=272.83 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=161.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++||||+.||. |.+.+. ++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 59 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni 135 (331)
T cd06649 59 ECNSPYIV-GFYGAFYSDGEISICMEHMDGGS--LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135 (331)
T ss_pred HCCCCCCC-eEEEEEEECCEEEEEeecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence 46788855 5443 44566899999999998 877763 4578899999999999999986 699999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++..+... ......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||...+..
T Consensus 136 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 136 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred EEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999998765432 2344679999999999864 35788999999999999999999999876654
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
++...+...........+........ .++..... .+...............+....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPR-------------PPGRPVSG-----------HGMDSRPAMAIFELLDYIVNEP 264 (331)
T ss_pred HHHHHhcccccccccCCccccCcccc-------------cccccccc-----------cccccccchhHHHHHHHHHhCC
Confidence 43322211000000000000000000 00000000 0000000111222333333322
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... .....+++++++||++||++||++|||++|+|+||||+..
T Consensus 265 ~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 265 PPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred CcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 211 1123578999999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.68 Aligned_cols=204 Identities=26% Similarity=0.451 Sum_probs=148.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ 82 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~ 82 (408)
.+.|+|+| .+.+ +.++..|+||||+.+|. |.+.. ..+..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 128 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 204 (353)
T PLN00034 128 DVNHPNVV-KCHDMFDHNGEIQVLLEFMDGGS--LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204 (353)
T ss_pred hCCCCCcc-eeeeEeccCCeEEEEEecCCCCc--ccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 46798855 5443 44566789999999998 65543 4567788999999999999999999999999999999999
Q ss_pred CCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 83 MNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 83 ~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
+.+||+|||++..+.... ......||+.|+|||++..... ....++.++|||||||++|+|++|+.||.....
T Consensus 205 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----- 278 (353)
T PLN00034 205 KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN-HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----- 278 (353)
T ss_pred CCEEEcccccceecccccccccccccCccccCccccccccc-cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 999999999998765332 2234679999999998753211 112234578888888888888888887742110
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
.+ | ......+... ..
T Consensus 279 ----------------------------------------~~-~---------------------~~~~~~~~~~---~~ 293 (353)
T PLN00034 279 ----------------------------------------GD-W---------------------ASLMCAICMS---QP 293 (353)
T ss_pred ----------------------------------------cc-H---------------------HHHHHHHhcc---CC
Confidence 00 0 0111111111 11
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
......++.++++||.+||..||++|||+.|+|+||||....
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 122346789999999999999999999999999999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=274.50 Aligned_cols=203 Identities=29% Similarity=0.545 Sum_probs=154.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|+++ +.+.+ +.++..|+||||+.||+ |.+++. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 58 ~~~~~i-~~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (331)
T cd05597 58 GDRRWI-TNLHYAFQDENNLYLVMDYYVGGD--LLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134 (331)
T ss_pred CCCCCC-CceEEEEecCCeEEEEEecCCCCc--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEE
Confidence 457764 45543 45667899999999998 777663 34789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++..+...... ...+||+.|+|||++.... .....++.++|+||+||++|+|++|..||.+.+.
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhcc-ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 999999999999998765443322 2257999999999986421 0123467899999999999999999999977665
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+....+......
T Consensus 214 ~~~~~~i~~~~~~------------------------------------------------------------------- 226 (331)
T cd05597 214 VETYGKIMNHKEH------------------------------------------------------------------- 226 (331)
T ss_pred HHHHHHHHcCCCc-------------------------------------------------------------------
Confidence 5544444321100
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
+.++ +.+..+|+++++||++||..++++ |++++++|+||||...
T Consensus 227 -~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 227 -FQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -ccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0111 123357999999999999875554 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=272.08 Aligned_cols=141 Identities=31% Similarity=0.520 Sum_probs=110.8
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh--------------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII--------------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~--------------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|+| .+.. ..+...++|+||+.++ |.+.+ .++..++.++.||+.||+|||++||
T Consensus 54 ~l~h~niv-~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 129 (317)
T cd07867 54 ELKHPNVI-ALQKVFLSHSDRKVWLLFDYAEHD---LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV 129 (317)
T ss_pred hCCCCCee-eEEEEEeccCCCeEEEEEeeeCCc---HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 46799865 4433 3445678999998765 33332 2346788999999999999999999
Q ss_pred eeccCCCCcEEE----ecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 68 VHRDLKPENILL----DDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 68 vHRDLKp~NILl----~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
+||||||+|||+ +.++.+||+|||+|+...... ......||+.|+|||++.+. ..++.++|+||+||
T Consensus 130 vH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~ 204 (317)
T cd07867 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGC 204 (317)
T ss_pred EcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCC-----CccCcHHHHHhHHH
Confidence 999999999999 456789999999998664322 12345789999999998642 34788999999999
Q ss_pred HHHHHHhCCCCCCCch
Q psy3880 140 IMYTLLVGCPPFWHRK 155 (408)
Q Consensus 140 il~~ll~G~~pf~~~~ 155 (408)
++|+|++|.+||....
T Consensus 205 il~el~tg~~~f~~~~ 220 (317)
T cd07867 205 IFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHHHhCCCCccccc
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=265.60 Aligned_cols=220 Identities=27% Similarity=0.460 Sum_probs=155.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ ++.+ ..++..|+||||+.+ . |.+.+ .+...++.++.||+.||+|||++||+||||||+
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~-~--l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ 130 (285)
T cd07861 55 ELQHPNIV-CLQDVLMQESRLYLIFEFLSM-D--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQ 130 (285)
T ss_pred hcCCCCEe-eeEEEEeeCCeEEEEEecCCC-C--HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence 46788855 5554 345677999999985 3 44433 245788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|||++.++.+||+|||++........ .....+++.|+|||++... ..++.++|+||+||++|+|++|.+||.+.
T Consensus 131 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 131 NLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS-----PRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred HEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCC-----CCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999876543221 2234678899999988642 34678999999999999999999999887
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
........+.+.........|...... . .|....+.|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--------~~~~~~~~~----------------------------- 242 (285)
T cd07861 206 SEIDQLFRIFRILGTPTEDVWPGVTSL------P--------DYKNTFPKW----------------------------- 242 (285)
T ss_pred CHHHHHHHHHHHhCCCChhhhhcchhh------H--------HHHhhcccc-----------------------------
Confidence 766555444332222111111110000 0 000000000
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
........+..+|+++++||++||+.||++|||+.++++||||
T Consensus 243 --~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 243 --KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred --CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000111234589999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.88 Aligned_cols=200 Identities=31% Similarity=0.547 Sum_probs=164.2
Q ss_pred cccccCCcEEEEe--ccCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 5 EMVAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 5 ~~~~~~~~i~~~~--~~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+++.|+|+| +++ +-.++..||-||||+||. |.+.+ ..+--.+.|..|++.|+.|||++|||||||||+||
T Consensus 1289 E~lnHpNlV-~YyGVEvHRekv~IFMEyC~~Gs--La~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1289 EGLNHPNLV-RYYGVEVHREKVYIFMEYCEGGS--LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred HhccCcccc-ccCceeecHHHHHHHHHHhccCc--HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccce
Confidence 578999855 655 456778899999999997 65543 23356789999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
+++.+|.+|++|||.|..+..+. .+....|||.|||||++.+.. ..+.+.+.||||+||++.||+||+.||.
T Consensus 1366 ~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~---~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1366 LLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK---GKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred eeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc---cCCCCcchhhhcccceEEEeecCCCchh
Confidence 99999999999999998776542 345689999999999998742 3567889999999999999999999994
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..+. =| -|||-.-.|..|-
T Consensus 1443 ~~dn-----------------------------------------------e~---aIMy~V~~gh~Pq----------- 1461 (1509)
T KOG4645|consen 1443 ELDN-----------------------------------------------EW---AIMYHVAAGHKPQ----------- 1461 (1509)
T ss_pred hccc-----------------------------------------------hh---HHHhHHhccCCCC-----------
Confidence 3221 12 2677777776662
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
++ ..+|.+.+|||.+||+.||++|+||.|+|.|.|-+..
T Consensus 1462 -------~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1462 -------IP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -------Cc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 21 2389999999999999999999999999999997654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=273.74 Aligned_cols=202 Identities=26% Similarity=0.492 Sum_probs=147.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++ |+.+.+ +.++..|+||||+.||+ |.+.+. ++..++.++.|++.||+|||++||+||||||+|||
T Consensus 58 ~~~~~-i~~l~~~~~~~~~~~lv~Ey~~gg~--L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nil 134 (331)
T cd05624 58 GDCQW-ITTLHYAFQDENYLYLVMDYYVGGD--LLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134 (331)
T ss_pred CCCCC-EeeEEEEEEcCCEEEEEEeCCCCCc--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEE
Confidence 46776 545554 45677899999999998 877663 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++......... ...+||+.|+|||++..... ....+
T Consensus 135 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~---------------------------- 185 (331)
T cd05624 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED-GMGKY---------------------------- 185 (331)
T ss_pred EcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcccc-CCCCC----------------------------
Confidence 999999999999999766543322 23579999999998853110 00112
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
+.++|+||+||++|+|++|.+||...+..+.+..+...
T Consensus 186 ------------------------------------------~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 186 ------------------------------------------GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred ------------------------------------------CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 33556666666666666666666655555555555544
Q ss_pred CCCCCC-CcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSS-PEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~-~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~ 282 (408)
...++. ..+..+|++++|||.+||..++++ |++++++++||||...
T Consensus 224 ~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 224 EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 332221 234568999999999999976655 5689999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=270.16 Aligned_cols=224 Identities=26% Similarity=0.435 Sum_probs=158.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ +.++..++||||+.+ . |.+.+. +...++.++.||+.||+|||++||+||||||+||
T Consensus 60 ~l~h~nI~-~~~~~~~~~~~~~lv~e~~~~-~--l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 60 DLKHANIV-TLHDIIHTEKSLTLVFEYLDK-D--LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred hcCCCCcc-eEEEEEecCCeEEEEEecccc-C--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 46798855 5554 445667899999985 3 554442 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++....... ......+++.|+|||++... ..++.++|+||+||++|+|++|++||.+.+.
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred EECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCC-----CCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987644322 22345678999999998642 3567899999999999999999999988877
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+....+...........|... +....+. .-..|...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~----------------------~~~~~~~~------------- 247 (301)
T cd07873 211 EEQLHFIFRILGTPTEETWPGI--------LSNEEFK----------------------SYNYPKYR------------- 247 (301)
T ss_pred HHHHHHHHHHcCCCChhhchhh--------hcccccc----------------------ccccCccc-------------
Confidence 6666555443222222212110 0000000 00000000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..........++++++|||.+||+.||.+|||++|+|+||||...
T Consensus 248 -~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 248 -ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred -cccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000001124678999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=269.03 Aligned_cols=199 Identities=29% Similarity=0.491 Sum_probs=150.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++..+.. ..++..++||||+.||. |.+.+ .++.++..++.|++.||.|||++||+||||||+||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05630 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGGD--LKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133 (285)
T ss_pred hCCCCCeeeeeEEEecCCEEEEEEEecCCCc--HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 4678875533332 45567899999999998 76655 24478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++.++.++|+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|..||......
T Consensus 134 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 134 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred EECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcC------CCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999876654444445689999999999864 34678899999999999999999988543210
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
... .....+....
T Consensus 208 ~~~-------------------------------------------------------------------~~~~~~~~~~ 220 (285)
T cd05630 208 IKR-------------------------------------------------------------------EEVERLVKEV 220 (285)
T ss_pred chH-------------------------------------------------------------------HHHHhhhhhh
Confidence 000 0000000000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.......+++++++||++||+.||++|+| ++|+++||||...
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 221 ---QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ---hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 00112457889999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=273.55 Aligned_cols=193 Identities=29% Similarity=0.482 Sum_probs=153.1
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.++|+. +++. -.+...+++||||.||. +.+.+. .+.++..++++++.||.|||+++.+|||||+.|||+
T Consensus 68 ~~~~~it-~yygsyl~g~~LwiiMey~~gGs--v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~ 144 (467)
T KOG0201|consen 68 CDSPNIT-EYYGSYLKGTKLWIIMEYCGGGS--VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL 144 (467)
T ss_pred cCcchHH-hhhhheeecccHHHHHHHhcCcc--hhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE
Confidence 3455433 4443 34567899999999998 766653 557889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
..+|.+|++|||++..+...... .+++|||+|||||++.+ .+|+.++||||||++.+||++|.+|+.......
T Consensus 145 s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 145 SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred eccCcEEEEecceeeeeechhhccccccccccccchhhhcc------ccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 99999999999999887755433 67899999999999984 579999999999999999999999985543211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. +|.+.-..||-
T Consensus 219 v---------------------------------------------------lflIpk~~PP~----------------- 230 (467)
T KOG0201|consen 219 V---------------------------------------------------LFLIPKSAPPR----------------- 230 (467)
T ss_pred E---------------------------------------------------EEeccCCCCCc-----------------
Confidence 1 01111112221
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.-...|+.+++||..||.+||+.||||.++|+|+|++.
T Consensus 231 -----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 231 -----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11246889999999999999999999999999999976
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-34 Score=272.49 Aligned_cols=195 Identities=28% Similarity=0.545 Sum_probs=154.3
Q ss_pred ccCCcEEEEeccCC--cHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKEEGD--DLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~~~~--~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
..+++++.+..-.+ |..|+||||++||+ |-..|+ .++.+.+|+.+|+-||-|||++|||+||||.+|+|++
T Consensus 407 ~kppFL~qlHScFQTmDRLyFVMEyvnGGD--LMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd 484 (683)
T KOG0696|consen 407 GKPPFLVQLHSCFQTMDRLYFVMEYVNGGD--LMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 484 (683)
T ss_pred CCCchHHHHHHHhhhhhheeeEEEEecCch--hhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec
Confidence 45666666666443 67899999999999 655554 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhc-ccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.+|++||+|||+++.- ..+....+.||||-|+|||++..+ +|+.
T Consensus 485 ~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Yq------PYgk----------------------------- 529 (683)
T KOG0696|consen 485 SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQ------PYGK----------------------------- 529 (683)
T ss_pred cCCceEeeecccccccccCCcceeeecCCCcccccceEEec------cccc-----------------------------
Confidence 9999999999999753 344455679999999999998753 3444
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
++|+||.||++|+||.|.|||.+.+..++++.|++.+..
T Consensus 530 -----------------------------------------svDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs 568 (683)
T KOG0696|consen 530 -----------------------------------------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS 568 (683)
T ss_pred -----------------------------------------chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc
Confidence 455555555555555555555566666677777777777
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHPKLF 284 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-----~e~L~Hpwf~~~~~ 284 (408)
++. .+|.+|.++++.+|.+.|.+|+.+ .++-.||||....+
T Consensus 569 yPK----slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 569 YPK----SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred Ccc----cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 764 689999999999999999999863 58999999986543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=277.29 Aligned_cols=224 Identities=23% Similarity=0.350 Sum_probs=154.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| ++.+ ..+...++|||++.+ + |.+.+. +..++..++.||+.||+|||++|||||||||+|||
T Consensus 142 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~-~--l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 142 TISHRAII-NLIHAYRWKSTVCMVMPKYKC-D--LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred hcCCCCcc-ceeeeEeeCCEEEEEehhcCC-C--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 46798855 5543 344567899999865 3 555542 44789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||++..+..... .....||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+..
T Consensus 218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC------CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999976554321 224679999999999864 357889999999999999999999998754
Q ss_pred h---HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHH-h-hcCCCCCCCchhHHHH
Q psy3880 156 Q---MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT-L-LVGCPPFWHRKQMVML 230 (408)
Q Consensus 156 ~---~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~-l-l~g~~Pf~~~~~~~~~ 230 (408)
. ...+..+....... ..++.. -..+... .-+. . ....+|+.
T Consensus 292 ~~~~~~~l~~i~~~~~~~-~~~~~~---~~~~~~~----------------------~~~~~~~~~~~~~~~-------- 337 (392)
T PHA03207 292 VKSSSSQLRSIIRCMQVH-PLEFPQ---NGSTNLC----------------------KHFKQYAIVLRPPYT-------- 337 (392)
T ss_pred CCCcHHHHHHHHHHhccC-ccccCC---ccchhHH----------------------HHHHhhcccccCCcc--------
Confidence 2 23333333321100 000000 0000000 0000 0 00111110
Q ss_pred HHHHhcCCCCCC-CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSS-PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~-~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+. ......+.++++||++||++||++|||+.|+|+||||...
T Consensus 338 ---------~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 338 ---------IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ---------ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000 0012457789999999999999999999999999999764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=276.23 Aligned_cols=136 Identities=26% Similarity=0.461 Sum_probs=109.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ ...+..++|+|++.+. |.+.+. +..++..++.||+.||.|||++|||||||||+||
T Consensus 113 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni 188 (357)
T PHA03209 113 NVNHPSVI-RMKDTLVSGAITCMVLPHYSSD---LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188 (357)
T ss_pred hCCCCCCc-ChhheEEeCCeeEEEEEccCCc---HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 47898855 5554 3445678999998654 555542 3578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|++.++.+||+|||+++............||+.|+|||++.. ..|+.++|+||+||++|+|+++..|+
T Consensus 189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR------DKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EECCCCCEEEecCccccccccCcccccccccccccCCeecCC------CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999976443333445679999999999864 35788999999999999999865554
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=281.09 Aligned_cols=221 Identities=22% Similarity=0.394 Sum_probs=151.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|.|+|+| ++.+ ...+..++|||++.+ + |.+.+ .+..++..++.||+.||+|||++|||||||||+||
T Consensus 216 ~L~HpnIv-~l~~~~~~~~~~~lv~e~~~~-~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NI 291 (461)
T PHA03211 216 RLSHPAVL-ALLDVRVVGGLTCLVLPKYRS-D--LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV 291 (461)
T ss_pred HCCCCCCC-cEEEEEEECCEEEEEEEccCC-C--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHE
Confidence 46899865 5443 345567899999864 4 55544 24578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|++.++.+||+|||+++.+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..|+...
T Consensus 292 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG------DPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred EECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC------CCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 999999999999999976543221 124679999999999864 35788999999999999999988766442
Q ss_pred hh-------HHHHHHHH-hccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 155 KQ-------MVMLRNIM-EGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 155 ~~-------~~~~~~i~-~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
.. ...+.+++ ...... ++ .+++.....
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~--~~-------------------------------------------~~~~~~~~l 400 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHV--DE-------------------------------------------FPQHAGSRL 400 (461)
T ss_pred CcccccCCcHHHHHHHHHhhcccc--cc-------------------------------------------CCCCcchHH
Confidence 21 12222222 111110 00 001100000
Q ss_pred HHHHHHHH--hcCCCCCCCcCC---CCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 227 MVMLRNIM--EGKYSFSSPEWN---DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 227 ~~~~~~i~--~~~~~f~~~~~~---~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...+.... .....+..+.|. .++.++++||.+||++||.+|||+.|+|+||||+.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00000000 011112223343 57789999999999999999999999999999975
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=278.93 Aligned_cols=202 Identities=24% Similarity=0.454 Sum_probs=159.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhh--H--HhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAA--V--QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~--l--~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
+||++| .+.. ..++...+..|||.||-.. . .++...+++++.+++|+|.||.|||+++|||||||+.|||++.
T Consensus 87 dHP~iv-kLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl 165 (1187)
T KOG0579|consen 87 DHPVIV-KLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL 165 (1187)
T ss_pred CChHHH-HHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe
Confidence 588644 5443 4566778899999999611 1 2234567999999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 82 QMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
+|.|+|+|||++..... -..-.++.|||+|||||++.|..+. ..+|+.++||||||+++.+|..+.+|-..-+....+
T Consensus 166 dGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~K-D~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl 244 (1187)
T KOG0579|consen 166 DGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFK-DQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 244 (1187)
T ss_pred cCcEeeecccccccchhHHhhhccccCCcccccchheeecccc-CCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence 99999999998765432 2233468999999999999987765 468999999999999999999999987766666666
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
.+|.... ||-. .
T Consensus 245 lKiaKSe---------------------------------------------------PPTL-----------------l 256 (1187)
T KOG0579|consen 245 LKIAKSE---------------------------------------------------PPTL-----------------L 256 (1187)
T ss_pred HHHhhcC---------------------------------------------------CCcc-----------------c
Confidence 6554321 1100 0
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.. ...|...+||+.+||++||..||++.++|+||||+..
T Consensus 257 qP---S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 257 QP---SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred Cc---chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11 1336789999999999999999999999999999854
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=283.53 Aligned_cols=177 Identities=30% Similarity=0.513 Sum_probs=145.3
Q ss_pred HHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 24 KHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
.++||||+.+|+ |.+.+. ++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 114 i~lV~Ey~~~gs--L~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 114 IALVLDYANAGD--LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEEeCCCCCc--HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 579999999999 877663 346889999999999999999999999999999999999999999999997
Q ss_pred hcccC---cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 95 VLKKG---EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 95 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
.+... ......+||+.|+|||++.. ..|+.++||||+||++|+|++|..||.+.+....+.++..+.
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~---- 261 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRR------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---- 261 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC----
Confidence 65432 12235789999999999864 357899999999999999999999997765544444433221
Q ss_pred CCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCcc
Q psy3880 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISED 251 (408)
Q Consensus 172 ~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~ 251 (408)
+. +....++++
T Consensus 262 ------------------------------------------------------------------~~---~~~~~~~~~ 272 (496)
T PTZ00283 262 ------------------------------------------------------------------YD---PLPPSISPE 272 (496)
T ss_pred ------------------------------------------------------------------CC---CCCCCCCHH
Confidence 11 011346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 252 PKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 252 ~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+++||.+||..||.+|||+.++|+|||+..
T Consensus 273 l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 273 MQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=251.91 Aligned_cols=192 Identities=29% Similarity=0.469 Sum_probs=150.4
Q ss_pred ccccCCcEEEEecc---CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKEE---GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~~---~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|++++ .+.+. .+...|+++||+.+|. |.+.+. +.+++..++.|++.||++||++||+||||||+
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~~lv~e~~~~~~--l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~ 131 (257)
T cd08223 55 QLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGD--LYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ 131 (257)
T ss_pred hCCCCCee-eeeeeecCCCCEEEEEecccCCCc--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCch
Confidence 46788855 44432 3345689999999998 776653 34788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||+++.++.++|+|||++..+.... ......+++.|+|||++.. ..++.++|+||+||+++++++|..||...
T Consensus 132 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN------KPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred hEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC------CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999987664322 2234678999999999864 34678999999999999999999998765
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+
T Consensus 206 ~~~~~~~~~~~~-------------------------------------------------------------------- 217 (257)
T cd08223 206 DMNSLVYRIIEG-------------------------------------------------------------------- 217 (257)
T ss_pred CHHHHHHHHHhc--------------------------------------------------------------------
Confidence 433332222221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... +....+++++.+||.+||..||++|||+.++++||||
T Consensus 218 --~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 218 --KLP---PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --CCC---CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 100 0112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=261.56 Aligned_cols=199 Identities=31% Similarity=0.498 Sum_probs=151.5
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
++.|++++.... ...++..++||||+.+|. |.+.+ .+...+..++.|++.||.|||++||+||||||+||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05632 56 KVNSQFVVNLAYAYETKDALCLVLTIMNGGD--LKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133 (285)
T ss_pred HcCCcCceeEEEEEecCCEEEEEEEeccCcc--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 567887664332 245567899999999998 65544 23578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++++++.+||+|||++.............|++.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 134 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 134 LLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred EECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999876554443445689999999999864 34677888888888888888888888554322
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..... +...+....
T Consensus 208 ~~~~~------------------------------------------------------------------~~~~~~~~~ 221 (285)
T cd05632 208 VKREE------------------------------------------------------------------VDRRVLETE 221 (285)
T ss_pred HHHHH------------------------------------------------------------------HHHhhhccc
Confidence 11111 111122111
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.. ....+++++.+||.+||+.||++||| +.++++||||...
T Consensus 222 ~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 EV----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred cc----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 11 22457889999999999999999999 8899999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=265.47 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=157.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++.. ..++..++||||+.+|. |.+.+. +...++.++.|++.||+|||++||+||||||+|
T Consensus 55 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N 131 (327)
T cd08227 55 LFNHPNIV-PYRATFIADNELWVVTSFMAYGS--AKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131 (327)
T ss_pred hcCCCCee-eEEEEEEECCEEEEEEeccCCCc--HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhh
Confidence 36898855 5543 45567899999999998 766652 457889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccC-cc-------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKG-EK-------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~-~~-------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
||++.++.++++||+.+...... .. .....++..|+|||++... ...|+.++|+||+||++|+|++|.
T Consensus 132 il~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~DiwslG~il~el~~g~ 207 (327)
T cd08227 132 ILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN----LQGYDAKSDIYSVGITACELANGH 207 (327)
T ss_pred EEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcc----cCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999865433211 10 1123567789999998642 235789999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||..............+...... + .....+|.+...... .+ .|.+-+ .+........
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~----~~--~~~~~~--------~~~~~~~~~~--- 265 (327)
T cd08227 208 VPFKDMPATQMLLEKLNGTVPCLL----D-TTTIPAEELTMKPSR----SG--ANSGLG--------ESTTVSTPRP--- 265 (327)
T ss_pred CCCCCcchhHHHHHHhcCCccccc----c-ccchhhhhcccCCcc----cC--CcCCCC--------cccccCCcCc---
Confidence 999876655544444433221100 0 001112211110000 00 000000 0000000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
........+....+++++++||++||+.||++|||++|+|+||||+.
T Consensus 266 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 266 ------SNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred ------cccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 00000111122456889999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=266.65 Aligned_cols=145 Identities=26% Similarity=0.465 Sum_probs=121.8
Q ss_pred cccCCcEEEEecc-CC-c-HHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCC-CeeccCCCC
Q psy3880 7 VAHSRVVVRVKEE-GD-D-LKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHS-VVHRDLKPE 75 (408)
Q Consensus 7 ~~~~~~i~~~~~~-~~-~-~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~-IvHRDLKp~ 75 (408)
|.|+|+| .+... .+ . ...|||||+.+|. |.+++.. ...+..++.||+.|++|||+++ ||||||||+
T Consensus 96 l~HpNIV-~f~G~~~~~~~~~~iVtEy~~~Gs--L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~ 172 (362)
T KOG0192|consen 96 LRHPNIV-QFYGACTSPPGSLCIVTEYMPGGS--LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSD 172 (362)
T ss_pred CCCCCee-eEEEEEcCCCCceEEEEEeCCCCc--HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChh
Confidence 8899855 66652 22 2 4789999999999 8888855 1677889999999999999999 999999999
Q ss_pred cEEEecCC-CEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDDQM-NVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~~~-~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|||++.++ ++||+|||+++..... .......||+.|||||++... ...|+.++||||||+++|||+||..||.+
T Consensus 173 NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 173 NILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE----KSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred hEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC----CCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 99999997 9999999999876654 334447899999999999743 35689999999999999999999999977
Q ss_pred chhHH
Q psy3880 154 RKQMV 158 (408)
Q Consensus 154 ~~~~~ 158 (408)
....+
T Consensus 249 ~~~~~ 253 (362)
T KOG0192|consen 249 LAPVQ 253 (362)
T ss_pred CCHHH
Confidence 65533
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=255.51 Aligned_cols=193 Identities=30% Similarity=0.505 Sum_probs=150.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ +.++..++|+|++.||. |.+.+. ++..++.++.|++.||.|||++||+||||||+||+
T Consensus 60 ~l~~~~i~-~~~~~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil 136 (263)
T cd06625 60 NLQHERIV-QYYGCLRDDETLSIFMEYMPGGS--VKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL 136 (263)
T ss_pred hCCCCCee-eeEEEEccCCeEEEEEEECCCCc--HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 46798865 5443 45567899999999997 766553 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++.++|+|||++........ .....|++.|+|||.+.+ ..++.++|+||+||++|++++|+.||...
T Consensus 137 v~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG------EGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred EcCCCCEEEeecccceeccccccccccccCCCcCccccCcceecc------CCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999876543211 123568889999999865 23778999999999999999999999654
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+......++..
T Consensus 211 ~~~~~~~~~~~--------------------------------------------------------------------- 221 (263)
T cd06625 211 EAMAAIFKIAT--------------------------------------------------------------------- 221 (263)
T ss_pred chHHHHHHHhc---------------------------------------------------------------------
Confidence 33322222111
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
..... .....++.++.+||++||..||.+|||+.|+|+||||
T Consensus 222 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -QPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -cCCCC--CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 10000 0113468899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=242.86 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=161.6
Q ss_pred cc-CCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEe
Q psy3880 8 AH-SRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~-~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NILl~ 80 (408)
.| +++||+-.. ..+....+.||+|..+-+.|..++. .+.-+-.+...++.||.||- ++||||||+||+|||+|
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD 226 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD 226 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc
Confidence 45 778888654 4566789999999998766776664 23556677788999999997 57999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-hHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-QMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~-~~~~ 159 (408)
+.|++|+||||++..+.++.......|-+.|||||.+.-. +...|+.++||||||++++||.||+.||.+.+ +.++
T Consensus 227 e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~---~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ 303 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPP---DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV 303 (391)
T ss_pred cCCCEEeecccccceeecccccccccCCccccCccccCCC---CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence 9999999999999988887777778899999999988632 35679999999999999999999999997754 4555
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.+|+... +.
T Consensus 304 ltkvln~e----------------------------------------------------------------------PP 313 (391)
T KOG0983|consen 304 LTKVLNEE----------------------------------------------------------------------PP 313 (391)
T ss_pred HHHHHhcC----------------------------------------------------------------------CC
Confidence 55554421 11
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. -+.-...|++.++|+..||++|+.+||.-.++|+|||+...
T Consensus 314 ~-L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 L-LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred C-CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0 01112379999999999999999999999999999999764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=263.29 Aligned_cols=237 Identities=20% Similarity=0.314 Sum_probs=158.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ +.++..++||||+.||. |.+++. ....+..++.|++.||.|||++ +|+||||||+||
T Consensus 59 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni 135 (333)
T cd06650 59 ECNSPYIV-GFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 135 (333)
T ss_pred HCCCCccc-ceeEEEEECCEEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence 46788855 5443 45567899999999998 887763 3477889999999999999975 799999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++..+... .....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||......
T Consensus 136 li~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 136 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred EEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9999999999999998765432 2234679999999999864 35778999999999999999999999876543
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC--chhHHHHHHHHh
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIME 235 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~--~~~~~~~~~i~~ 235 (408)
.... +......-... .... .++ ....+.. +....|-.. .........+.+
T Consensus 209 ~~~~-~~~~~~~~~~~-~~~~----~~~---------------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 260 (333)
T cd06650 209 ELEL-MFGCPVEGDPA-ESET----SPR---------------PRPPGRP-------LSSYGPDSRPPMAIFELLDYIVN 260 (333)
T ss_pred HHHH-HhcCcccCCcc-cccc----Ccc---------------cCCccch-------hhhhcccccccccHHHHHHHHhc
Confidence 3322 22111100000 0000 000 0000000 000011100 011112222322
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....... -...+.++++||.+||++||++|||++|+|+||||+..
T Consensus 261 ~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 261 EPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 2211111 12467899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=258.26 Aligned_cols=220 Identities=26% Similarity=0.425 Sum_probs=151.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ .+.+..++|+||+.++ |.+.+ .+.+.++.++.||+.||.|||++||+||||||+||
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 55 ELKHKNIV-RLYDVLHSDKKLTLVFEYCDQD---LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred hcCCCCee-eHHHHhccCCceEEEEecCCCC---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 36788744 5554 3456678999999864 44433 24578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC-Cch
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRK 155 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~-~~~ 155 (408)
+++.++.+||+|||++....... ......+++.|+|||.+.+. ..++.++|+||+||++|+|++|..||. +.+
T Consensus 131 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 131 LINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred EEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCC-----cccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 99999999999999998654332 22335678999999998642 346789999999999999999888864 444
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....+..+........ .+.|+... . +.....+.......
T Consensus 206 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~---~-~~~~~~~~~~~~~~------- 244 (284)
T cd07839 206 VDDQLKRIFRLLGTPT------------------------------EESWPGVS---K-LPDYKPYPMYPATT------- 244 (284)
T ss_pred HHHHHHHHHHHhCCCC------------------------------hHHhHHhh---h-cccccccCCCCCcc-------
Confidence 4444444433211110 01111000 0 00000000000000
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+ ......+|++++|||++||..||.+|||++|+|+||||
T Consensus 245 ---~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 245 ---SL-VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ---hh-hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=259.67 Aligned_cols=195 Identities=29% Similarity=0.464 Sum_probs=147.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++++ .+.+ ..++..++||||+.||. |.+.+. ++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 55 ~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~ 131 (279)
T cd05633 55 DCPFIV-CMTYAFHTPDKLCFILDLMNGGD--LHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131 (279)
T ss_pred CCCcEe-EEEEEEecCCeEEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence 566654 4443 34567899999999998 766653 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
.++.++|+|||++....... .....||+.|+|||.+.. ...++.++|+||+||++|+|++|..||........
T Consensus 132 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~- 204 (279)
T cd05633 132 EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK- 204 (279)
T ss_pred CCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcC-----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-
Confidence 99999999999987554332 233578999999998753 23467889999999999999999999854321000
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
+. ...... ..
T Consensus 205 ------------------------~~------------------------------------------~~~~~~----~~ 214 (279)
T cd05633 205 ------------------------HE------------------------------------------IDRMTL----TV 214 (279)
T ss_pred ------------------------HH------------------------------------------HHHHhh----cC
Confidence 00 000000 00
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.......+++++++||++||..||++|+ |++|+++||||...
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 1111235788999999999999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=261.58 Aligned_cols=228 Identities=29% Similarity=0.406 Sum_probs=159.8
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ...+..|+||||+.++...+.... .+..++..++.||+.||+|||++|++||||||+||+
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 62 NLRHPNIV-ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred hCCCCCCc-ceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 46788855 4443 222457899999986432233322 345788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++....... ......+++.|+|||++.+. ..++.++|+||+||++|+|++|.+||.+.+..
T Consensus 141 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 141 LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC-----TTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred ECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCC-----CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999998765432 22234467889999998642 34678999999999999999999999998888
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+..+...........|.... .+- ..+.... ....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~--~~~~~~~------------~~~~ 251 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFS------------------------------DLP--LVGKFTL------------PKQP 251 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhh------------------------------ccc--ccccccc------------cCCC
Confidence 8777776543322211111100 000 0000000 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+......+...|++++|||++||+.||++|||++|+|+||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 252 YNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred CCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0000111233688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=254.48 Aligned_cols=195 Identities=28% Similarity=0.514 Sum_probs=148.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
..|+|++ ++.+ +.++..|+|+||+.||. |.+.+. +...+..++.|++.||.|||+++++||||+|+||++
T Consensus 54 ~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~ 130 (260)
T cd05611 54 GESPYVA-KLYYSFQSKDYLYLVMEYLNGGD--CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130 (260)
T ss_pred CCCCCee-eeeeeEEcCCeEEEEEeccCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 4677754 5554 45567899999999998 777663 447889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++..... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.
T Consensus 131 ~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--- 198 (260)
T cd05611 131 DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGV------GDDKMSDWWSLGCVIFEFLFGYPPFHAETP--- 198 (260)
T ss_pred CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCC------CCcchhhhHHHHHHHHHHHHCCCCCCCCCH---
Confidence 9999999999999875433 2235688899999988642 256777888888888887777777744322
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
..+...+..+...
T Consensus 199 -------------------------------------------------------------------~~~~~~~~~~~~~ 211 (260)
T cd05611 199 -------------------------------------------------------------------DAVFDNILSRRIN 211 (260)
T ss_pred -------------------------------------------------------------------HHHHHHHHhcccC
Confidence 2222333333333
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~~ 283 (408)
++......+++++.++|.+||+.||++||| ++|+|+||||....
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 333333467899999999999999999995 57999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=257.57 Aligned_cols=221 Identities=27% Similarity=0.468 Sum_probs=159.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.+ ..++..|+|+||+ ++. |.+.+ .++.+++.++.||+.||+|||++||+|+||||+||+
T Consensus 56 ~~~~~i~-~~~~~~~~~~~~~~v~e~~-~~~--L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (286)
T cd07832 56 CQHPYVV-KLLDVFPHGSGFVLVMEYM-PSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131 (286)
T ss_pred CCCCCCc-ceeeEEecCCeeEEEeccc-CCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence 4688755 4444 4556789999999 888 77665 245889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.++|+|||++....... ......|+..|+|||.+... ..++.++|+||+||++|+|++|.+||.+.+.
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA-----RKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred EcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecc-----ccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 9999999999999988765432 23346789999999987532 3467899999999999999999999988877
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+..+...........|..... ..-|+- ..|...... .+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~-----------~~~~~~~~~-~~~----- 248 (286)
T cd07832 207 IEQLAIVFRTLGTPNEETWPGLTS---------------------LPDYNK-----------ITFPESKPI-PLE----- 248 (286)
T ss_pred HHHHHHHHHHcCCCChHHHhhccC---------------------cchhhc-----------ccCCCCCcc-hHH-----
Confidence 766666654322211111111100 000000 000000000 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
..+.+.+.++.+||.+||..||++|||++++|+||||.
T Consensus 249 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 249 ------EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ------HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11235678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=265.08 Aligned_cols=235 Identities=24% Similarity=0.399 Sum_probs=158.8
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|++++ .+.+. +....|+||||+.+. |.+.+ .+.+++..++.|++.||+|||++||+||||||
T Consensus 71 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (353)
T cd07850 71 LVNHKNII-GLLNVFTPQKSLEEFQDVYLVMELMDAN---LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146 (353)
T ss_pred hcCCCCCc-ceeeeeccCCCccccCcEEEEEeccCCC---HHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 46788855 44331 112358999999764 44433 46688999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+||+++.++.+||+|||++.............+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...
T Consensus 147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 147 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred HHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC------CCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999987655443345678999999999864 45788999999999999999999999888
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+......++....... .++.... +...+.. .....+.+...........
T Consensus 221 ~~~~~~~~~~~~~~~~------------~~~~~~~---------------~~~~~~~--~~~~~~~~~~~~~~~~~~~-- 269 (353)
T cd07850 221 DHIDQWNKIIEQLGTP------------SDEFMSR---------------LQPTVRN--YVENRPKYAGYSFEELFPD-- 269 (353)
T ss_pred CHHHHHHHHHHhcCCC------------CHHHHHH---------------hhhhhhH--HhhcCCCCCCcchhhhCcc--
Confidence 7766666664421110 0010000 0000000 0011111111110011000
Q ss_pred hcCCCC-CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSF-SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f-~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+.. ....+...++++++||.+||+.||++|||+.|+|+||||...
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 270 -VLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred -cccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 00000 001123457789999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=257.56 Aligned_cols=191 Identities=26% Similarity=0.491 Sum_probs=147.1
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++++ .+.+ ..++..|+||||+.+|. |.+.+. +++++..++.|++.||.|||++|++||||||+||+++
T Consensus 67 ~h~~iv-~~~~~~~~~~~~~iv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 67 DNPNFI-KLYYSVTTLKGHVLIMDYIKDGD--LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred cCCCEE-EEEEEEecCCeeEEEEEcCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 677755 5554 45567899999999998 877653 4588999999999999999999999999999999999
Q ss_pred cCC-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQM-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++ .++|+|||++...... ....+++.|+|||++.. ..++.++|+||+||++|+|++|..||........
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 888 9999999998765432 23568899999999864 3467889999999999999999988853221100
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+ .... ... .
T Consensus 215 -----------------------~~------------------------------------------~~~~-~~~----~ 224 (267)
T PHA03390 215 -----------------------DL------------------------------------------ESLL-KRQ----Q 224 (267)
T ss_pred -----------------------hH------------------------------------------HHHH-Hhh----c
Confidence 00 0000 111 1
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC-HHHHHcCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS-VKEALNHSFFH 280 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-a~e~L~Hpwf~ 280 (408)
...+.++.+|+.+++||.+||+.||.+|++ ++|+|+||||.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 111223468999999999999999999996 59999999995
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=254.26 Aligned_cols=223 Identities=29% Similarity=0.476 Sum_probs=156.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.++. |...+ .++..++.++.||+.||+|||++||+||||||+||+
T Consensus 56 ~~~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil 132 (286)
T cd07847 56 QLKHPNLV-NLIEVFRRKRKLHLVFEYCDHTV--LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENIL 132 (286)
T ss_pred hCCCCCEe-eeeeEEeeCCEEEEEEeccCccH--HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEE
Confidence 46788755 5444 44556789999999986 55443 245789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++....... ......++..|+|||++.+. ..++.++|+||+||++|+|++|.+||.+.+..
T Consensus 133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 133 ITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD-----TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred EcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCC-----CCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999998765433 22345678899999998642 34678999999999999999999999887765
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+..+.........+ ...+|+.....-.+ ..++-.....
T Consensus 208 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~--~~~~~~~~~~----------- 247 (286)
T cd07847 208 DQLYLIRKTLGDLIPR---------------------------HQQIFSTNQFFKGL--SIPEPETREP----------- 247 (286)
T ss_pred HHHHHHHHHhCCCChH---------------------------Hhhhcccccccccc--cCCCcccccC-----------
Confidence 5554443321111000 00000000000000 0000000000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+..++.++.+||.+||..||++|||+.|+|.||||
T Consensus 248 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 248 ---LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001134578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=256.32 Aligned_cols=189 Identities=14% Similarity=0.211 Sum_probs=148.0
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHH-CCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHN-HSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~-~~IvHRDLK 73 (408)
.+.|+| |+++... .....++||||+.||. |.+.+.+ ......++.|++.||.|||+ .+++|||||
T Consensus 74 ~l~h~n-Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk 150 (283)
T PHA02988 74 RIDSNN-ILKIYGFIIDIVDDLPRLSLILEYCTRGY--LREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150 (283)
T ss_pred hcCCCC-EEEEeeeEEecccCCCceEEEEEeCCCCc--HHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence 467986 5566642 2245689999999998 8888753 36778899999999999998 499999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||+++++.+||+|||+++.+.... ....||+.|+|||++... ...|+.++|||||||++|+|++|..||.+
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~----~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDI----FSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhc----cccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998764322 345788999999998641 14578999999999999999999999977
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....+..+.
T Consensus 225 ~~~~~~~~~i~~~~------------------------------------------------------------------ 238 (283)
T PHA02988 225 LTTKEIYDLIINKN------------------------------------------------------------------ 238 (283)
T ss_pred CCHHHHHHHHHhcC------------------------------------------------------------------
Confidence 65544444433221
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+..+ ...++++++||.+||+.||++|||+.|+++
T Consensus 239 ----~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 239 ----NSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----CCCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111111 145788999999999999999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=251.09 Aligned_cols=198 Identities=36% Similarity=0.656 Sum_probs=151.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ++++..|+|+||+.+|. |.+.+. +...+..++.||+.||+|||+++++|+||||+||+
T Consensus 49 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nil 125 (262)
T cd05572 49 ECNHPFIV-KLYRTFKDKKYIYMLMEYCLGGE--LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL 125 (262)
T ss_pred hCCCCCEe-eeeeeEEcCCccEEEEecCCCCc--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 46788855 4443 45567899999999998 877764 44788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.++|+|||++.............+++.|+|||.+.. ..++.++|+||+||++|++++|..||.....
T Consensus 126 v~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-- 197 (262)
T cd05572 126 LDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN------KGYDFSVDYWSLGILLYELLTGRPPFGEDDE-- 197 (262)
T ss_pred EcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--
Confidence 99999999999999987765433344678999999998753 3456778888888888888888877744321
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+.......+..+..
T Consensus 198 ------------------------------------------------------------------~~~~~~~~~~~~~~ 211 (262)
T cd05572 198 ------------------------------------------------------------------DPMEIYNDILKGNG 211 (262)
T ss_pred ------------------------------------------------------------------CHHHHHHHHhccCC
Confidence 02223333432222
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
....+ ...+++++++|.+||..||++|+| ++|+++||||+..
T Consensus 212 ~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 212 KLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCCCC--cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 22112 234889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=254.00 Aligned_cols=202 Identities=25% Similarity=0.432 Sum_probs=151.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..|+|+||+.+|. |.+.+ .+++.+..++.|++.||.|||+.||+||||||+||
T Consensus 58 ~l~h~~ii-~~~~~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ni 134 (282)
T cd06643 58 SCDHPNIV-KLLDAFYYENNLWILIEFCAGGA--VDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134 (282)
T ss_pred HCCCCCee-eEEEEEeeCCEEEEEEEecCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 46899865 4443 44566789999999998 65544 24578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++...... .......+++.|+|||++..... ....++.++|+||+||++|+|++|.+||...+.
T Consensus 135 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred EEccCCCEEEccccccccccccccccccccccccccCHhhccccCC-CCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 9999999999999998765332 12234678999999999853321 123466788888888888888888888865544
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....++..+
T Consensus 214 ~~~~~~~~~~---------------------------------------------------------------------- 223 (282)
T cd06643 214 MRVLLKIAKS---------------------------------------------------------------------- 223 (282)
T ss_pred HHHHHHHhhc----------------------------------------------------------------------
Confidence 3333322211
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... .......++.++++||.+||..||.+|||++++++||||...
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 224 EPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 100 001113467899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=252.84 Aligned_cols=196 Identities=27% Similarity=0.470 Sum_probs=146.6
Q ss_pred ccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 8 AHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 8 ~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.|+|++ .+.... ++..|+||||+.+|. |.+.+. ++..+..++.|++.||+|||+++|+||||
T Consensus 61 ~h~~i~-~~~~~~~~~~~~~~~~~~~iv~e~~~~~~--L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 61 HHRNIA-TYYGAFIKKNPPGMDDQLWLVMEFCGAGS--VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred CCCCee-eEeeEEeecCCCCCCcEEEEEEEcCCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 577755 544321 245689999999998 766543 34778889999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+||+++.++.+||+|||++....... ......|++.|+|||++..... ....|+.++|+||+||++|+|++|..||
T Consensus 138 ~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 138 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN-PDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred CHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccC-cCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999987654322 2234678999999999864321 1235778899999999999999999998
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
...........+
T Consensus 217 ~~~~~~~~~~~~-------------------------------------------------------------------- 228 (272)
T cd06637 217 CDMHPMRALFLI-------------------------------------------------------------------- 228 (272)
T ss_pred cccCHHHHHHHH--------------------------------------------------------------------
Confidence 543322111110
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .........++.++++||.+||..||.+|||+.|++.||||
T Consensus 229 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 229 --PRN--PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --hcC--CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 00111123467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=254.14 Aligned_cols=196 Identities=28% Similarity=0.467 Sum_probs=145.9
Q ss_pred ccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 8 AHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 8 ~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.|+|+ +.+... ..+..+++|||+.+|. |.+.+. ++..+..++.||+.||.|||++||+||||
T Consensus 71 ~h~~i-~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl 147 (282)
T cd06636 71 HHRNI-ATYYGAFIKKSPPGHDDQLWLVMEFCGAGS--VTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDI 147 (282)
T ss_pred CCCcE-EEEeeehhcccccCCCCEEEEEEEeCCCCc--HHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 57764 455432 2356689999999987 766553 34668889999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+||+++.++.++|+|||++...... .......|++.|+|||.+..... ....++.++|+||+||++|+|++|..||
T Consensus 148 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~-~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 148 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN-PDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred CHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccC-cCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 999999999999999999998765422 12234678999999998863211 1245778899999999999999999988
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
........+..+
T Consensus 227 ~~~~~~~~~~~~-------------------------------------------------------------------- 238 (282)
T cd06636 227 CDMHPMRALFLI-------------------------------------------------------------------- 238 (282)
T ss_pred cccCHHhhhhhH--------------------------------------------------------------------
Confidence 543322111110
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.... ........++.++.+||++||..||.+|||+.|+|+||||
T Consensus 239 --~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 239 --PRNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --hhCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0000 0011123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=275.86 Aligned_cols=223 Identities=23% Similarity=0.328 Sum_probs=147.9
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----------SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
+.|+|+| .+.+ +..+..|+|++++.+. +++.+. ...+++.++.||+.||+|||++|||||||||
T Consensus 220 l~HpnIv-~l~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 220 LNHENIL-KIEEILRSEANTYMITQKYDFD---LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred CCCCCcC-cEeEEEEECCeeEEEEeccccC---HHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 5798855 5543 4455678888877543 333321 1256788999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
+|||++.++.+||+|||++..+..... ....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..++.
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG------DGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC------CCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999999987654322 224679999999999864 457889999999999999999876544
Q ss_pred Cc---hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC-CCCCCchhHH
Q psy3880 153 HR---KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMV 228 (408)
Q Consensus 153 ~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~-~Pf~~~~~~~ 228 (408)
.. +....+.++...... ...++.+. ..++|. .+... .+........
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~-~~~~~p~~----------------------~~~~~~-------~i~~~~~~~~~~~~~~ 419 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSV-CDEEFPDP----------------------PCKLFD-------YIDSAEIDHAGHSVPP 419 (501)
T ss_pred cCCCCCHHHHHHHHHHhccc-ChhhcCCc----------------------HHHHHH-------HhhhhhcccCccchhh
Confidence 32 223333333322110 00001000 000000 00000 0000000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+. ...++.++.++|.+||++||++||||.|+|+||||...
T Consensus 420 ~~~-------------~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 420 LIR-------------NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHH-------------hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 010 01357788999999999999999999999999999764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=251.89 Aligned_cols=202 Identities=32% Similarity=0.536 Sum_probs=155.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ ++.+ ..++..|+||||+.+|. |.+.+. ++++++.++.|++.||.|||++||+|+||||+||
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 134 (280)
T cd06611 58 ECKHPNIV-GLYEAYFYENKLWILIEFCDGGA--LDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI 134 (280)
T ss_pred hCCCCcee-EEEEEEecCCeEEEEeeccCCCc--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 46788755 5543 45567799999999998 666542 4578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||++....... ......+++.|+|||.+...... ...++.++|+||+||++|+|++|.+||...+.
T Consensus 135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 135 LLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK-DNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred EECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccC-CCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 99999999999999987654321 22335689999999998643221 23467899999999999999999999976554
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+.++..+ .+|.
T Consensus 214 ~~~~~~~~~~---------------------------------------------------~~~~--------------- 227 (280)
T cd06611 214 MRVLLKILKS---------------------------------------------------EPPT--------------- 227 (280)
T ss_pred HHHHHHHhcC---------------------------------------------------CCCC---------------
Confidence 4333333221 0110
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+. ....++.++.+||.+||..||.+|||++++|+||||...
T Consensus 228 ---~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 ---LD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---cC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 012467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.68 Aligned_cols=197 Identities=28% Similarity=0.444 Sum_probs=143.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ..++..|+|+||+.+|. |.+.+. ++.++..++.|++.||+|||++||+||||||+||+
T Consensus 62 ~l~h~~ii-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 138 (267)
T cd06645 62 DCKHSNIV-AYFGSYLRRDKLWICMEFCGGGS--LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred hCCCCCee-eEEEEEEeCCEEEEEEeccCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 46788865 4443 44567799999999998 877653 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++....... ......|++.|+|||++... ....++.++|+||+||++|+|++|..||....
T Consensus 139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~-- 213 (267)
T cd06645 139 LTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE---RKGGYNQLCDIWAVGITAIELAELQPPMFDLH-- 213 (267)
T ss_pred ECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccc---cCCCCCchhhhHHHHHHHHHHhcCCCCccccc--
Confidence 9999999999999987654321 12346789999999987421 11345667788888888777777777764321
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.......+....
T Consensus 214 --------------------------------------------------------------------~~~~~~~~~~~~ 225 (267)
T cd06645 214 --------------------------------------------------------------------PMRALFLMTKSN 225 (267)
T ss_pred --------------------------------------------------------------------chhhHHhhhccC
Confidence 111111111111
Q ss_pred CCCCC-CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 238 YSFSS-PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 238 ~~f~~-~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
+..+. ..-..++..+++||.+||..||++|||++++++|||
T Consensus 226 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 11110 011246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=255.28 Aligned_cols=197 Identities=28% Similarity=0.481 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++ .+.+ ..++..|+||||+.||. |.+++. +..++..++.|++.||+|||++||+||||||+||++
T Consensus 73 ~~~h~~v~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 73 ENKNPNIV-NYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred hCCCCCEe-eEEEEEEeCCEEEEeecccCCCC--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 46799855 5543 34557899999999998 877763 447889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++........ .....|++.|+|||.+.. ..++.++|+||+||++|+|++|..||.......
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred cCCCCEEECccccchhccccccccCcccCCccccCHHHHcC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999876543322 233578899999998864 335678888888888888888888885533211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.. ..+....
T Consensus 224 ~~----------------------------------------------------------------------~~~~~~~- 232 (296)
T cd06654 224 AL----------------------------------------------------------------------YLIATNG- 232 (296)
T ss_pred hH----------------------------------------------------------------------HHHhcCC-
Confidence 00 0000000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....+....++..+++||.+||..||++|||+.|+++||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00001123578889999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=254.79 Aligned_cols=221 Identities=28% Similarity=0.472 Sum_probs=156.6
Q ss_pred ccccCCcEEEEec--cCC--cHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGD--DLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~--~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.. .++ +..|+|+||+.+ . |.+.+ .+..+++.++.||+.||+|||++||+|+||||+
T Consensus 60 ~l~h~ni~-~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ 135 (293)
T cd07843 60 KLQHPNIV-TVKEVVVGSNLDKIYMVMEYVEH-D--LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135 (293)
T ss_pred hcCCCCEE-EEEEEEEecCCCcEEEEehhcCc-C--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 45688855 5443 333 678999999985 3 44433 245789999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||+++.++.+||+|||++...... .......+++.|+|||.+... ..++.++|+||+||++|+|++|.+||...
T Consensus 136 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA-----KEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred HEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCC-----ccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998876543 223345678899999988642 23578999999999999999999999988
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+.++...........|..... +..... . .+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~-------~--~~~~----------- 247 (293)
T cd07843 211 SEIDQLNKIFKLLGTPTEKIWPGFSE-----------------------LPGAKK-------K--TFTK----------- 247 (293)
T ss_pred ChHHHHHHHHHHhCCCchHHHHHhhc-----------------------cchhcc-------c--cccc-----------
Confidence 87777766654332221111111100 000000 0 0000
Q ss_pred hcCCCCCCCcCCC--CCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWND--ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~--iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
..+......+.. +++.+++||++||+.||++|||++|+|+||||
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 248 -YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred -ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000000011122 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=249.18 Aligned_cols=198 Identities=28% Similarity=0.522 Sum_probs=153.5
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++..+. .+.++..|+|+|++.||. |.+.+. ++..++.++.|++.||.|||++||+||||||+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGS--LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred hcCCCCEEEEEEEEeeCCEEEEEEeccCCCc--HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 468888653332 245566789999999997 766652 346789999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccc-----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKL-----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|++++++.++|+|||++..+...... ....|++.|+|||++... ..++.++|+||+||++++|++|..||
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~p~ 207 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-----HGYDFKADIWSFGITAIELATGAAPY 207 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccc-----cCcCcccchHhHhHHHHHHHhCCCCc
Confidence 99999999999999998876543221 235689999999998642 25678999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
...+....+.++.... +|
T Consensus 208 ~~~~~~~~~~~~~~~~---------------------------------------------------~~----------- 225 (267)
T cd06610 208 SKYPPMKVLMLTLQND---------------------------------------------------PP----------- 225 (267)
T ss_pred cccChhhhHHHHhcCC---------------------------------------------------CC-----------
Confidence 7654433333322210 00
Q ss_pred HHHhcCCCCC-CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 232 NIMEGKYSFS-SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 232 ~i~~~~~~f~-~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+. ...+..+++++++||.+||..||++|||++|+++||||
T Consensus 226 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 -------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000 01135678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=254.07 Aligned_cols=197 Identities=28% Similarity=0.456 Sum_probs=148.7
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
..|++++ .+.+ +..+..++||||+.||. |.+.+. ++.+++.++.|++.||+|||+++|+||||||+||++
T Consensus 54 ~~~~~i~-~~~~~~~~~~~~~~v~e~~~g~~--L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili 130 (278)
T cd05606 54 GDCPFIV-CMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130 (278)
T ss_pred CCCCcEe-eeeeeeecCCEEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE
Confidence 3567644 5544 45567899999999998 766652 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++....... ....+|+..|+|||++... ..++.++|+||+||++|+|++|..||......
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-- 202 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-- 202 (278)
T ss_pred CCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCC-----CCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--
Confidence 999999999999987654322 2346799999999998632 34677888888888888888888888542110
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
........+......
T Consensus 203 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 217 (278)
T cd05606 203 -----------------------------------------------------------------DKHEIDRMTLTMAVE 217 (278)
T ss_pred -----------------------------------------------------------------chHHHHHHhhccCCC
Confidence 000011111111111
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~~ 283 (408)
+ +..+|.++++||++||..||.+|+ |++++++||||....
T Consensus 218 ~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 218 L----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred C----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 1 234689999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=254.44 Aligned_cols=203 Identities=29% Similarity=0.444 Sum_probs=144.7
Q ss_pred HHHHHHHHhhchhhHHhhh----------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-CCCEEEecccc
Q psy3880 24 KHLAAQVVDKGEAAVQDII----------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-QMNVKLTDFGF 92 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~----------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-~~~iKl~DFGl 92 (408)
.|+||||+.++ |.+.+ .++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSD---LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcC---HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 68999999864 44433 245788999999999999999999999999999999998 88999999999
Q ss_pred chhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 93 ARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 93 a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
+..+... .......+++.|+|||++... ..++.++|+||+||++|+|++|..||.+.+....+.++........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGS-----THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 8765332 122234678899999988542 3467899999999999999999999998877666666544221111
Q ss_pred CCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCcc
Q psy3880 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISED 251 (408)
Q Consensus 172 ~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~ 251 (408)
...|.... -+... .-.+.+... ........++++
T Consensus 233 ~~~~~~~~------------------------------~~~~~-~~~~~~~~~---------------~~~~~~~~~~~~ 266 (295)
T cd07837 233 EQVWPGVS------------------------------KLRDW-HEFPQWKPQ---------------DLSRAVPDLSPE 266 (295)
T ss_pred hhhCcchh------------------------------hccch-hhcCcccch---------------hHHHhccccCHH
Confidence 11110000 00000 000000000 000111357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 252 PKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 252 ~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
+++||.+||..||++|||++|+|+||||+
T Consensus 267 ~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 267 GLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 99999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=257.30 Aligned_cols=142 Identities=29% Similarity=0.469 Sum_probs=112.6
Q ss_pred EEEEeccCC--cHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec--
Q psy3880 13 VVRVKEEGD--DLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-- 81 (408)
Q Consensus 13 i~~~~~~~~--~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-- 81 (408)
+|.+.+..+ ....||+|++. -. ++|.+.+. +.+|.+.+|++++++|||+.+++|-||||||||+.+
T Consensus 153 cv~m~~wFdyrghiCivfellG-~S--~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLG-LS--TFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred EEeeehhhhccCceEEEEeccC-hh--HHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccc
Confidence 344444333 33445888772 13 77877552 799999999999999999999999999999999943
Q ss_pred ------------------CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 82 ------------------QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 82 ------------------~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
+..|+|+|||.|+.-... ..+.+.|..|+|||++.+ .+++.+|||||+|||++|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg------LGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG------LGWSQPCDVWSIGCILVE 301 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec------cCcCCccCceeeeeEEEE
Confidence 234899999999865443 356788999999999985 789999999999999999
Q ss_pred HHhCCCCCCCchhHH---HHHHHHh
Q psy3880 144 LLVGCPPFWHRKQMV---MLRNIME 165 (408)
Q Consensus 144 ll~G~~pf~~~~~~~---~~~~i~~ 165 (408)
+.+|...|+..+..+ +.+.|++
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhC
Confidence 999999999887555 5555544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=258.95 Aligned_cols=103 Identities=29% Similarity=0.478 Sum_probs=86.3
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~ 122 (408)
.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... ....+++.|+|||++..
T Consensus 174 ~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 250 (338)
T cd05102 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD--- 250 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc---
Confidence 456778999999999999999999999999999999999999999999865432211 12345678999999864
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
..|+.++||||+||++|+|++ |..||.+.
T Consensus 251 ---~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 251 ---KVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ---CCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 357889999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.43 Aligned_cols=195 Identities=29% Similarity=0.473 Sum_probs=149.7
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHC-------
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNH------- 65 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~------- 65 (408)
.|.|+++| .+.+ ......||||||+.+|+ |.+.|. ++..+..|+.||+.||.|||+.
T Consensus 68 ~L~HPNIV-rl~d~f~de~~~~lyIVMEY~~gGS--L~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 68 ELKHKNIV-RYIDRFLNKANQKLYILMEFCDAGD--LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HcCCCCcC-eEEEEEEecCCCEEEEEEeCCCCCc--HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 47799865 5443 34456899999999998 776653 4578899999999999999984
Q ss_pred CCeeccCCCCcEEEecC-----------------CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCC
Q psy3880 66 SVVHRDLKPENILLDDQ-----------------MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGY 128 (408)
Q Consensus 66 ~IvHRDLKp~NILl~~~-----------------~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~ 128 (408)
+||||||||+|||++.. ..+||+|||++..+.........+||+.|+|||++... ...+
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge----~~~~ 220 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE----TKSY 220 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc----CCCC
Confidence 49999999999999642 34899999999876544444456899999999998642 2357
Q ss_pred CcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchh
Q psy3880 129 GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACG 208 (408)
Q Consensus 129 ~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~G 208 (408)
+.++|||||||++|+|++|..||...+....+...+
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~l-------------------------------------------- 256 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL-------------------------------------------- 256 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHH--------------------------------------------
Confidence 889999999999999999999996543322111111
Q ss_pred hhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 209 VIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 209 vily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
... ..++ ....|.++.+||.+||.+||.+|||+.|+|.|||+.
T Consensus 257 -------------------------k~~-p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 257 -------------------------KRG-PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred -------------------------hcC-CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 000 0111 123578899999999999999999999999999996
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=256.58 Aligned_cols=201 Identities=27% Similarity=0.497 Sum_probs=152.6
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
++.|+|++..+.. ...+..++||||+.+|. |.+++. +..++..++.||+.||+|||++||+||||||+||+++
T Consensus 75 ~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~ 152 (292)
T cd06658 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGA--LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152 (292)
T ss_pred hCCCCcHHHHHHheecCCeEEEEEeCCCCCc--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 4678886633322 34567799999999998 776652 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.++|+|||++....... ......|++.|+|||.+.. ..++.++|+||+||++|+|++|+.||...+....
T Consensus 153 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred CCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999987653322 2234578999999998854 3467889999999999999999999866543332
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+..+... ..
T Consensus 227 ~~~~~~~-----------------------------------------------------------------------~~ 235 (292)
T cd06658 227 MRRIRDN-----------------------------------------------------------------------LP 235 (292)
T ss_pred HHHHHhc-----------------------------------------------------------------------CC
Confidence 2221110 00
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
...+....+++.+++||.+||..||++|||++|+|+||||.....+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 236 PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0001112468889999999999999999999999999999865433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=248.20 Aligned_cols=192 Identities=28% Similarity=0.500 Sum_probs=147.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ...+..++|+||+.++. |.+++. +...++.++.|++.||+|||++|++||||||+||+
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil 138 (267)
T cd06628 62 ELQHENIV-QYLGSSLDADHLNIFLEYVPGGS--VAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138 (267)
T ss_pred hcCCCCee-eEEEEEEeCCccEEEEEecCCCC--HHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence 36788865 4443 45567889999999987 776663 34778899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
+++++.++|+|||+++...... ......|++.|+|||.+.. ..++.++|+||+||++|+|++|..||
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ------TSYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc------CCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 9999999999999988665211 1123468899999999864 34567889999999999999999888
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
...+....+.++..
T Consensus 213 ~~~~~~~~~~~~~~------------------------------------------------------------------ 226 (267)
T cd06628 213 PDCTQLQAIFKIGE------------------------------------------------------------------ 226 (267)
T ss_pred CCccHHHHHHHHhc------------------------------------------------------------------
Confidence 65443222222111
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.. .......++.++++||++||+.||++|||+.|+++||||
T Consensus 227 ----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 ----NA---SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----cC---CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 000112467899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=259.44 Aligned_cols=228 Identities=27% Similarity=0.439 Sum_probs=141.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +.++..|+||||+.||. |.+.+. .+..++.++.|++.||+|||++|++|+||||+|
T Consensus 57 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 133 (316)
T cd05574 57 TLDHPFLP-TLYASFQTETYLCLVMDYCPGGE--LFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133 (316)
T ss_pred hCCCCCch-hheeeeecCCEEEEEEEecCCCC--HHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHH
Confidence 56788755 4443 45566799999999998 777653 346788899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|+++.++.++|+|||++.............. .......... .+.
T Consensus 134 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~--------------------------- 177 (316)
T cd05574 134 ILLHESGHIMLSDFDLSKQSDVEPPPVSKAL-RKGSRRSSVN--------SIP--------------------------- 177 (316)
T ss_pred eEEcCCCCEEEeecchhhccccccccccccc-cccccccccc--------ccc---------------------------
Confidence 9999999999999999875432211000000 0000000000 000
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
................+...|++||.+... .++.++|+||+||++|+|++|..||...+....+..+...
T Consensus 178 ----~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 247 (316)
T cd05574 178 ----SETFSEEPSFRSNSFVGTEEYIAPEVISGD------GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK 247 (316)
T ss_pred ----hhhhcccccCCCCCCcCccCCcCHHHHcCC------CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcC
Confidence 000000000000111122334555544321 2334555666666666666666666555544555555544
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC----HHHHHcCCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS----VKEALNHSFFHPKLF 284 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t----a~e~L~Hpwf~~~~~ 284 (408)
...++. ...++++++++|.+||..||++||| ++|+|+||||+...+
T Consensus 248 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 248 EVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred CccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 444332 2337899999999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=253.85 Aligned_cols=220 Identities=28% Similarity=0.468 Sum_probs=154.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ ++.+ ++++..++||||+.+ . |...+. +...+..++.|++.||+|||+++++||||+|+|
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~-~--l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~n 130 (284)
T cd07860 55 ELNHPNIV-KLLDVIHTENKLYLVFEFLHQ-D--LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 130 (284)
T ss_pred hcCCCCCc-chhhhcccCCcEEEEeecccc-C--HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 46788855 5554 455678999999964 4 554432 347889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+++.++.+||+|||++..+.... ......+++.|+|||.+.+. ..++.++|+||+||++|+|++|+.||.+.+
T Consensus 131 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred EEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999987654322 22334578899999987542 335788999999999999999999998877
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....+.++.+...... ..+|+- +..........|.+.... +..+
T Consensus 206 ~~~~~~~~~~~~~~~~------------------------------~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~-- 249 (284)
T cd07860 206 EIDQLFRIFRTLGTPD------------------------------EVVWPG-VTSLPDYKPSFPKWARQD---FSKV-- 249 (284)
T ss_pred HHHHHHHHHHHhCCCC------------------------------hhhhhh-hhHHHHHHhhcccccccC---HHHH--
Confidence 6655555443221111 111110 000000000001110000 0000
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
...+++++++||.+||..||++|||++|+|+||||
T Consensus 250 ---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 250 ---------VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ---------cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 13478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=254.26 Aligned_cols=199 Identities=35% Similarity=0.545 Sum_probs=149.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +.++..|+|+||+.+|. |.+.+ .++.++..++.|++.||.|||++|++||||+|+|
T Consensus 49 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~N 125 (277)
T cd05577 49 KVSSRFIV-SLAYAFETKDDLCLVMTLMNGGD--LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPEN 125 (277)
T ss_pred hCCCCCEe-eeeeEEecCCeEEEEEecCCCCc--HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 35677755 4443 45567899999999998 76554 2447888999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|+++.++.+||+|||++.............++..|+|||++.+. .++.++|+||+||++|+|++|..||.....
T Consensus 126 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 126 VLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE------VYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred EEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCC------CCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999876544444456788899999998642 366788888888888888888888854321
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.. ....+...+...
T Consensus 200 ~~------------------------------------------------------------------~~~~~~~~~~~~ 213 (277)
T cd05577 200 KV------------------------------------------------------------------EKEELKRRTLEM 213 (277)
T ss_pred cc------------------------------------------------------------------cHHHHHhccccc
Confidence 00 000111111111
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~~ 283 (408)
+.......++++++||++||+.||++|| |+.++++||||....
T Consensus 214 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 214 ----AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ----cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 1122245689999999999999999999 899999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=251.68 Aligned_cols=221 Identities=25% Similarity=0.437 Sum_probs=151.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ +.++..|+||||+.+ + |.+.+. +...++.++.|++.||.|||++||+||||||+||
T Consensus 59 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni 134 (291)
T cd07844 59 DLKHANIV-TLHDIIHTKKTLTLVFEYLDT-D--LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL 134 (291)
T ss_pred hCCCccee-eEEEEEecCCeEEEEEecCCC-C--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence 46788755 5543 455678999999985 5 665542 4478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK- 155 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~- 155 (408)
+++.++.+||+|||+++...... ......+++.|+|||++.+. ..++.++|+||+||++|+|++|..||.+..
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 135 LISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS-----TEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred EEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcC-----cccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999999999987543211 12234568899999988642 346789999999999999999999997665
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+.+..+...........|... ...........++..... +.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~------~~- 252 (291)
T cd07844 210 VEDQLHKIFRVLGTPTEETWPGV------------------------------SSNPEFKPYSFPFYPPRP------LI- 252 (291)
T ss_pred HHHHHHHHHHhcCCCChhhhhhh------------------------------hhccccccccccccCChh------HH-
Confidence 33333333222111111111110 000000000001111000 00
Q ss_pred cCCCCCCCcCCCCC--ccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDIS--EDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS--~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
..+..++ .++.+||.+||..||++|||+.|+|+||||
T Consensus 253 -------~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 253 -------NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred -------HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0111234 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=236.03 Aligned_cols=226 Identities=23% Similarity=0.425 Sum_probs=159.3
Q ss_pred ccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC-
Q psy3880 8 AHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ- 82 (408)
Q Consensus 8 ~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~- 82 (408)
.|+|+| .+.+ .......||+|+++.-+....-...+..++++++.|+|.||.||||+||+|||+||.|++++..
T Consensus 91 gg~NIi-~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 91 GGPNII-KLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred CCCCee-ehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh
Confidence 478755 5544 3334568999999988733333334568999999999999999999999999999999999854
Q ss_pred CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC-chhHHHHH
Q psy3880 83 MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLR 161 (408)
Q Consensus 83 ~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~-~~~~~~~~ 161 (408)
-.++|+|+|+|..+.++....-.+.+.+|--||.+.. ...|+...|+||+||.++.|+..+.||.. .+..+++-
T Consensus 170 rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd-----y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred ceeeeeecchHhhcCCCceeeeeeehhhcCCchheee-----chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 5799999999999999887777889999999999874 35688999999999999999999999864 34444444
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC----
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK---- 237 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~---- 237 (408)
+|..--. .+.+.. -...|.-.- +| .+..|+...
T Consensus 245 kIakVLG---------------t~el~~----Yl~KY~i~L----------------dp--------~~~~i~~~~~rk~ 281 (338)
T KOG0668|consen 245 KIAKVLG---------------TDELYA----YLNKYQIDL----------------DP--------QFEDILGRHSRKP 281 (338)
T ss_pred HHHHHhC---------------hHHHHH----HHHHHccCC----------------Ch--------hHhhHhhcccccc
Confidence 4432100 000000 000000000 00 001111000
Q ss_pred -CCCCCCcC-CCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 -YSFSSPEW-NDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 -~~f~~~~~-~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..|..++. .-+|+++.|||.++|.+|-.+|+||.||+.||||.+.
T Consensus 282 w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 282 WSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 01222222 2367999999999999999999999999999999753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=258.78 Aligned_cols=226 Identities=26% Similarity=0.484 Sum_probs=154.4
Q ss_pred ccccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+. .....|+|+||+.+ + +.+.+. ++..++.++.|++.||+|||++||+||||||
T Consensus 59 ~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp 134 (336)
T cd07849 59 RFKHENII-GILDIIRPPSFESFNDVYIVQELMET-D--LYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP 134 (336)
T ss_pred hCCCCCcC-chhheeecccccccceEEEEehhccc-C--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 45688754 54431 12345899999975 4 555543 4578999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|||++.++.+||+|||++....... .....+||+.|+|||.+... ..++.++|+||+||++|+|++|+.|
T Consensus 135 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslGvil~el~~G~~~ 209 (336)
T cd07849 135 SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-----KGYTKAIDIWSVGCILAEMLSNRPL 209 (336)
T ss_pred HHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCC-----CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999987654322 12235789999999987532 3568899999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+.......+....... .+|.+.... +....+ + + ...|+.....
T Consensus 210 f~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~-----------~~~~~~---~--~-~~~~~~~~~~---- 256 (336)
T cd07849 210 FPGKDYLHQLNLILGVLGTP------------SQEDLNCII-----------SLRARN---Y--I-KSLPFKPKVP---- 256 (336)
T ss_pred CCCCCHHHHHHHHHHHcCCC------------CHHHHHHhh-----------chhhhh---H--H-hhcCcCCccc----
Confidence 98876555444443221110 111110000 000000 0 0 0011100000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+ ......+|+++.|||.+||..||++|||+.|+++||||....
T Consensus 257 ---------~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 257 ---------W-NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred ---------H-HHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000134688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=250.19 Aligned_cols=217 Identities=29% Similarity=0.469 Sum_probs=152.4
Q ss_pred ccCCcEEEEec--cCC--cHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 8 AHSRVVVRVKE--EGD--DLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~--~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|+|++ .+.+ .++ +..++|+||+.++ +.+.+. +..++..++.|++.||+|||++||+||||||+||
T Consensus 56 ~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni 131 (282)
T cd07831 56 PHPNIL-RLIEVLFDRKTGRLALVFELMDMN---LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENI 131 (282)
T ss_pred CCCCcc-ceEEEEecCCCCcEEEEEecCCcc---HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence 488755 4443 223 5679999999754 454442 4578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++. +.+||+|||++..+..........+++.|+|||.+... ..++.++|+||+||++|+|++|.+||.+.+..
T Consensus 132 ~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~ 205 (282)
T cd07831 132 LIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD-----GYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205 (282)
T ss_pred EEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcC-----CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence 9999 99999999999876554444456788999999987532 34578999999999999999999999888776
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+..+....... .+++ ....... .. ....+...... .+..+
T Consensus 206 ~~~~~~~~~~~~~------------~~~~-~~~~~~~------~~--------------~~~~~~~~~~~-~~~~~---- 247 (282)
T cd07831 206 DQIAKIHDVLGTP------------DAEV-LKKFRKS------RH--------------MNYNFPSKKGT-GLRKL---- 247 (282)
T ss_pred HHHHHHHHHcCCC------------CHHH-HHhhccc------cc--------------ccccCcccccc-cHHHH----
Confidence 6665554321110 0011 0000000 00 00000000000 00000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
-..+|.++++||.+||..||++|||++++|+||||
T Consensus 248 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 248 -------LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred -------cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 12468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=254.25 Aligned_cols=192 Identities=41% Similarity=0.704 Sum_probs=148.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ...+..|+||||+.+|. |.+.+. +...+..++.||+.||.|||++||+|+||+|.|||
T Consensus 57 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nil 133 (290)
T cd05580 57 SIRHPFLV-NLYGSFQDDSNLYLVMEYVPGGE--LFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLL 133 (290)
T ss_pred hCCCCCcc-ceeeEEEcCCeEEEEEecCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 35688755 5544 45567789999999998 877763 45788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++...... ....+|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 134 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 202 (290)
T cd05580 134 LDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS------KGYGKAVDWWALGILIYEMLAGYPPFFDDN--- 202 (290)
T ss_pred ECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC------CCCCccccHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999876543 345678999999998753 234566777777777777777777764432
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.......+..+..
T Consensus 203 -------------------------------------------------------------------~~~~~~~~~~~~~ 215 (290)
T cd05580 203 -------------------------------------------------------------------PIQIYEKILEGKV 215 (290)
T ss_pred -------------------------------------------------------------------HHHHHHHHhcCCc
Confidence 2223333333333
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..++++++++|.+||..||.+|+ +++|+++||||...
T Consensus 216 ~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 216 RFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred cCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 332 23588999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=253.01 Aligned_cols=223 Identities=26% Similarity=0.470 Sum_probs=159.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ .+.+..++||||+ +|. |.+.+. +..++..++.||++||.|||++||+|+||||+||
T Consensus 58 ~~~h~~i~-~~~~~~~~~~~~~lv~e~~-~~~--L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni 133 (298)
T cd07841 58 ELKHPNII-GLLDVFGHKSNINLVFEFM-ETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133 (298)
T ss_pred hcCCCCCh-hhhheeecCCEEEEEEccc-CCC--HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence 35688755 5444 3345679999999 777 766653 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||++....... ......+++.|+|||.+... ..++.++|+||+||++|+|++|.+||.+.+.
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 134 LIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA-----RHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred EEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCC-----CCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 99999999999999997665432 22334568899999988532 3467899999999999999999999988877
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+.++...........|...... .+ +......++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~--------~~~~~~~~~~~-------------- 246 (298)
T cd07841 209 IDQLGKIFEALGTPTEENWPGVTSL--------------------PD--------YVEFKPFPPTP-------------- 246 (298)
T ss_pred HHHHHHHHHHcCCCchhhhhhcccc--------------------cc--------cccccccCCcc--------------
Confidence 6666666542111111111000000 00 00000000000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
....+..++.++++||.+||..||++|||+.|+|+||||....
T Consensus 247 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 247 ----LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ----hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0011245688999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=252.64 Aligned_cols=203 Identities=23% Similarity=0.360 Sum_probs=150.1
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII-NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~-~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
.+.|+|++..+.. +.++..++|+||+.+|. |.... .+++.+..++.|++.||+|||++||+|+||||+|||++.++
T Consensus 55 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~ 132 (279)
T cd06619 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGS--LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG 132 (279)
T ss_pred hCCCCCeeeEEEEEEECCEEEEEEecCCCCC--hHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC
Confidence 3678886633332 45566789999999997 43322 35678899999999999999999999999999999999999
Q ss_pred CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHH
Q psy3880 84 NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163 (408)
Q Consensus 84 ~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i 163 (408)
.++|+|||++..+... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.......
T Consensus 133 ~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~----- 200 (279)
T cd06619 133 QVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ----- 200 (279)
T ss_pred CEEEeeCCcceecccc-cccCCCCChhhcCceeecC------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccc-----
Confidence 9999999999765432 2334689999999998864 346789999999999999999999985421100
Q ss_pred HhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCC
Q psy3880 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSP 243 (408)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~ 243 (408)
....++ .....+..... ...
T Consensus 201 ----------------~~~~~~------------------------------------------~~~~~~~~~~~--~~~ 220 (279)
T cd06619 201 ----------------GSLMPL------------------------------------------QLLQCIVDEDP--PVL 220 (279)
T ss_pred ----------------cccchH------------------------------------------HHHHHHhccCC--CCC
Confidence 000000 00111111100 001
Q ss_pred cCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 244 EWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 244 ~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....++++++||.+||+.||++|||++|+++||||...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 123468899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=251.24 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=153.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ..+...++||||+.||. |...+ .+...+..++.|++.||+|||++||+||||||+||
T Consensus 65 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 141 (292)
T cd06644 65 TCNHPYIV-KLLGAFYWDGKLWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141 (292)
T ss_pred hCCCCcEe-eeEEEEEeCCeEEEEEecCCCCc--HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence 57898855 5544 45567899999999997 65443 24588899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.+||+|||++...... .......+++.|+|||++...... ...++.++|+||+||++|+|++|..||...+.
T Consensus 142 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 142 LLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK-DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred EEcCCCCEEEccCccceeccccccccceecCCccccCceeecccccc-CCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 9999999999999998654322 122345688999999998543211 24477899999999999999999999966544
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....++..+. +|
T Consensus 221 ~~~~~~~~~~~---------------------------------------------------~~---------------- 233 (292)
T cd06644 221 MRVLLKIAKSE---------------------------------------------------PP---------------- 233 (292)
T ss_pred HHHHHHHhcCC---------------------------------------------------Cc----------------
Confidence 33322221110 00
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. .....++.++.+||++||..||++|||++|+++||||....
T Consensus 234 --~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 234 --TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred --cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 01124678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=265.71 Aligned_cols=192 Identities=26% Similarity=0.507 Sum_probs=155.5
Q ss_pred cccCCcEEEEec-c-C--CcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCC--CeeccCCCC
Q psy3880 7 VAHSRVVVRVKE-E-G--DDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHS--VVHRDLKPE 75 (408)
Q Consensus 7 ~~~~~~i~~~~~-~-~--~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~--IvHRDLKp~ 75 (408)
|.|+|+| ++++ . + .....+|.|++++|. |..++... +.++.|++|||+||.|||++. |||||||.+
T Consensus 98 L~H~NIi-rfy~SW~d~~n~~in~iTEL~TSGt--Lr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCD 174 (632)
T KOG0584|consen 98 LKHPNII-RFYDSWVDTDNKTINFITELFTSGT--LREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCD 174 (632)
T ss_pred CCCCcee-eeeeheecCCCceeeeeeecccCCc--HHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccc
Confidence 8999855 6664 2 2 234679999999999 87776443 789999999999999999986 999999999
Q ss_pred cEEEec-CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDD-QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~-~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||+++. .|.|||+|+|||..+..... ....|||.|||||+.. ..|+..+||||||+++.||+|+.+||.--
T Consensus 175 NIFinG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE-------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 175 NIFVNGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE-------ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred eEEEcCCcCceeecchhHHHHhhcccc-ceeccCccccChHHHh-------hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 999985 48999999999998776543 4489999999999885 46999999999999999999999999654
Q ss_pred h-hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 155 K-QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 155 ~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
. ..++.+++.+|. -|+.|
T Consensus 247 ~n~AQIYKKV~SGi---------------KP~sl---------------------------------------------- 265 (632)
T KOG0584|consen 247 TNPAQIYKKVTSGI---------------KPAAL---------------------------------------------- 265 (632)
T ss_pred CCHHHHHHHHHcCC---------------CHHHh----------------------------------------------
Confidence 3 445555555542 11111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. +--.+++++||.+||.. .+.|+||.|+|+||||+.+
T Consensus 266 -------~----kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 -------S----KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -------h----ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1 11267899999999998 9999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=257.68 Aligned_cols=223 Identities=26% Similarity=0.437 Sum_probs=156.6
Q ss_pred ccccCCcEEEEec------cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE------EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|++++ .+.+ ......|+|+||+.+ . |.+.+. +..+++.++.||+.||.|||++||+||||||
T Consensus 60 ~l~h~~iv-~~~~~~~~~~~~~~~~~lv~e~~~~-~--l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 135 (334)
T cd07855 60 HFKHDNII-AIRDILRPPGADFKDVYVVMDLMES-D--LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP 135 (334)
T ss_pred hcCCCCcc-CHHHhccccCCCCceEEEEEehhhh-h--HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 45688754 5443 123456899999964 4 666553 4588999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
+||+++.++.+||+|||++....... ......|+..|+|||.+... ..++.++|+||+||++|+|++|+.
T Consensus 136 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL-----PEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCC-----cccccccchHHHHHHHHHHHcCCC
Confidence 99999999999999999987654321 11235788999999998542 347889999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+.+....+..+...... ..++.+.. +|+ ..
T Consensus 211 pf~~~~~~~~~~~~~~~~g~------------~~~~~~~~--------------~~~---------------------~~ 243 (334)
T cd07855 211 LFPGKNYVHQLKLILSVLGS------------PSEEVLNR--------------IGS---------------------DR 243 (334)
T ss_pred ccCCCChHHHHHHHHHHhCC------------ChhHhhhh--------------hch---------------------hh
Confidence 99887665554444331110 00111000 000 00
Q ss_pred HHHHHhcCCCCCCC----cCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSP----EWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 230 ~~~i~~~~~~f~~~----~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
+............. .+..+++++++||++||+.||++|||++++++||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00000000001111 12457899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=255.54 Aligned_cols=197 Identities=27% Similarity=0.485 Sum_probs=149.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++ .+.+ ...+..|+|+||+.+|. |.+.+. +..++..++.|++.||+|||++|++||||||+||++
T Consensus 72 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili 148 (296)
T cd06655 72 ELKNPNIV-NFLDSFLVGDELFVVMEYLAGGS--LTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148 (296)
T ss_pred hcCCCcee-eeeeeEecCceEEEEEEecCCCc--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 46788855 5554 44567899999999998 666543 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++........ .....+++.|+|||.+.. ..++.++|+||+||++|++++|..||.+.+...
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~ 222 (296)
T cd06655 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (296)
T ss_pred CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999886654322 233578899999998754 335677888888888888888888775543221
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. ...+.....
T Consensus 223 ~----------------------------------------------------------------------~~~~~~~~~ 232 (296)
T cd06655 223 A----------------------------------------------------------------------LYLIATNGT 232 (296)
T ss_pred H----------------------------------------------------------------------HHHHHhcCC
Confidence 1 111111110
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........+++.+++||++||..||++|||+.++++||||...
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 233 -PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0011224578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=251.00 Aligned_cols=230 Identities=21% Similarity=0.314 Sum_probs=157.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.. ..++..++|+||+.||. |.+++. ++..++.++.|++.||.|||+ ++++||||||+||
T Consensus 55 ~l~h~~iv-~~~~~~~~~~~~~lv~ey~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~ni 131 (308)
T cd06615 55 ECNSPYIV-GFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131 (308)
T ss_pred hCCCCCCC-eEEEEEeeCCEEEEEeeccCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHE
Confidence 36788865 4443 45567899999999998 887763 347889999999999999997 6999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++..+... .....+|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 132 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred EEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcC------CCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 9999999999999998765432 2245678999999998754 34678999999999999999999999776543
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC-chhHHHHHHHHhc
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLRNIMEG 236 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~-~~~~~~~~~i~~~ 236 (408)
.....+.........+... +.. .....+... ....+....+...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~--------~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~ 249 (308)
T cd06615 205 ELEAMFGRPVSEGEAKESH--------RPV---------------------------SGHPPDSPRPMAIFELLDYIVNE 249 (308)
T ss_pred hHHHhhcCccccccccCCc--------ccc---------------------------cCCCCCccchhhHHHHHHHHhcC
Confidence 3222221110000000000 000 000000000 0011122222221
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... ...+..+++++++||.+||..||++|||+.|+++||||...
T Consensus 250 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 250 PPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111 11122478899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.37 Aligned_cols=194 Identities=27% Similarity=0.473 Sum_probs=149.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.. ...+..++|+||+.||. |.+.+. +++.+..++.|++.||+|||+.+|+|+||||+||+
T Consensus 58 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 134 (265)
T cd06631 58 SLKHVNIV-QYLGTCLDDNTISIFMEFVPGGS--ISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVM 134 (265)
T ss_pred hcCCCCEe-eEeeEeecCCeEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEE
Confidence 46788855 5443 34567899999999998 777663 34788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-------cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-------EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
++.++.++|+|||++...... .......|+..|+|||.+.. ..++.++|+||+||++|+|++|..||
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Dv~slG~~~~~l~~g~~p~ 208 (265)
T cd06631 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE------SGYGRKSDIWSIGCTVFEMATGKPPL 208 (265)
T ss_pred ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC------CCCcchhhHHHHHHHHHHHHhCCCcc
Confidence 999999999999998764321 11234568999999999864 34678999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
...+.......+...
T Consensus 209 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 223 (265)
T cd06631 209 ASMDRLAAMFYIGAH----------------------------------------------------------------- 223 (265)
T ss_pred ccCChHHHHHHhhhc-----------------------------------------------------------------
Confidence 654432222111110
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+ +....++.++++||++||..||++|||+.|+|+||||
T Consensus 224 -----~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 224 -----RGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----cCCCC-CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 0112468899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=273.03 Aligned_cols=201 Identities=26% Similarity=0.514 Sum_probs=156.8
Q ss_pred cccccCCcEEEEeccCC-cHHHHHHHHHhhchhhHHhhhCC--------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 5 EMVAHSRVVVRVKEEGD-DLKHLAAQVVDKGEAAVQDIINS--------NPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 5 ~~~~~~~~i~~~~~~~~-~~~~lv~e~~~~g~~~l~~~~~~--------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
..|-|-|+|..+-.-+. .++-|.||-+.||. |.+.+.+ +.++.+|.+|||+||.|||++.|||||||-+
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS--LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGD 704 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGS--LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGD 704 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCc--HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCC
Confidence 35678886644444333 35568899999999 8877754 3789999999999999999999999999999
Q ss_pred cEEEe-cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLD-DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~-~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|++ -.|.+||+|||-++.+..-. ...++.||..|||||++..+ ..+|++++|||||||++.||.||++||..
T Consensus 705 NVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG----~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 705 NVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQG----PRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccC----CcCCCchhhhhhccceeEeeccCCCCeee
Confidence 99997 57899999999988765433 23468899999999999764 57899999999999999999999999842
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
--. +.+.|+..
T Consensus 781 lgs-------------------------------------------pqAAMFkV-------------------------- 791 (1226)
T KOG4279|consen 781 LGS-------------------------------------------PQAAMFKV-------------------------- 791 (1226)
T ss_pred cCC-------------------------------------------hhHhhhhh--------------------------
Confidence 110 01111111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
|-|....+-...+|.+|+.||.+|+..||.+||+|.++|..||++..
T Consensus 792 --GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 --GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 22222233334689999999999999999999999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=256.05 Aligned_cols=230 Identities=24% Similarity=0.343 Sum_probs=155.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.. ..++..|++|||+.+|. |.+.+. ++..++.+++|++.||+|||+++|+||||||+|
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~~~~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~N 131 (314)
T cd08216 55 QLQHPNIL-PYVTSFIVDSELYVVSPLMAYGS--CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASH 131 (314)
T ss_pred hcCCcchh-hhhheeecCCeEEEEEeccCCCC--HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcce
Confidence 46788755 4443 44566799999999997 766653 347889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
|+++.++.+||+|||.+..+..... .....++..|+|||++... ...|+.++|+||+||++|+|++|.
T Consensus 132 ili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN----LQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred EEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC----CCCCCcchhHHHHHHHHHHHHhCC
Confidence 9999999999999998865432211 1234577789999998642 235788999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+......+.....+..... -+.. ..| .+.+...-. ..++.......
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~----~~~~--~~~-----------------~~~~~~~~~-------~~~~~~~~~~~ 257 (314)
T cd08216 208 VPFKDMPATQMLLEKVRGTVPCL----LDKS--TYP-----------------LYEDSMSQS-------RSSNEHPNNRD 257 (314)
T ss_pred CCCCCCCHHHHHHHHHhccCccc----cccC--chh-----------------hhcCCcCcc-------cccccccchhh
Confidence 99987655443322222211100 0000 000 000000000 00000000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
......-..+|.++++||.+||+.||++|||++|+|+||||...
T Consensus 258 ----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 258 ----------SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ----------hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00001112357789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=255.19 Aligned_cols=198 Identities=36% Similarity=0.621 Sum_probs=148.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ ++.+ ..++..++|||++.+|. |.+.+. +..++..++.||+.||.+||++||+||||||+||++
T Consensus 55 l~~~~i~-~~~~~~~~~~~~~~v~~~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~ 131 (260)
T PF00069_consen 55 LRHPNIV-QILDVFQDDNYLYIVMEYCPGGS--LQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL 131 (260)
T ss_dssp HTBTTBC-HEEEEEEESSEEEEEEEEETTEB--HHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE
T ss_pred ccccccc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4788865 4443 33566789999999987 776654 348899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhc-ccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||.+... ..........+|+.|+|||++.. ...++.++|+||+|+++++|++|..||...+...
T Consensus 132 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 132 DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQ-----GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTT-----TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-----cccccccccccccccccccccccccccccccchh
Confidence 99999999999998753 22334456789999999999861 2456788999999999999999888886542111
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. ...+........
T Consensus 207 ~-------------------------------------------------------------------~~~~~~~~~~~~ 219 (260)
T PF00069_consen 207 Q-------------------------------------------------------------------LEIIEKILKRPL 219 (260)
T ss_dssp H-------------------------------------------------------------------HHHHHHHHHTHH
T ss_pred h-------------------------------------------------------------------hhhhhhcccccc
Confidence 1 111122222111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
......+...+.++.+||++||..||++|||+.++++||||
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 11111122234789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=249.29 Aligned_cols=195 Identities=30% Similarity=0.503 Sum_probs=152.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
+.|+|++ .+.+ .++...|+|+||+.+|. |.+.+. +...+..++.|++.||.|||+++++||||+|+||+++
T Consensus 56 l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 132 (274)
T cd06609 56 CRSPYIT-KYYGSFLKGSKLWIIMEYCGGGS--CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS 132 (274)
T ss_pred cCCCCee-eeeEEEEECCeEEEEEEeeCCCc--HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 5799855 4443 44566789999999998 777764 3478999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+++.++|+|||++..+... .......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+....
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~ 206 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS------GYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206 (274)
T ss_pred CCCCEEEcccccceeecccccccccccCCccccChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCcccCchHHH
Confidence 9999999999999876543 223346788999999998642 367889999999999999999999865433222
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...+..+ .+| .
T Consensus 207 ~~~~~~~---------------------------------------------------~~~------------------~ 217 (274)
T cd06609 207 LFLIPKN---------------------------------------------------NPP------------------S 217 (274)
T ss_pred HHHhhhc---------------------------------------------------CCC------------------C
Confidence 2211110 000 0
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. + ...+++++.++|.+||..||++|||++++++||||...
T Consensus 218 ~--~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 218 L--E-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred C--c-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0 1 11267889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=253.53 Aligned_cols=197 Identities=32% Similarity=0.578 Sum_probs=142.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.. +.++..++||||+.||. |.+.+. ++..+..++.|++.||+|||++|++||||||+||+
T Consensus 57 ~~~~~~i~-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIl 133 (305)
T cd05609 57 FAENPFVV-SMFCSFETKRHLCMVMEYVEGGD--CATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133 (305)
T ss_pred hCCCCCee-eeEEEEecCCEEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEE
Confidence 46788755 5554 44556799999999998 776663 44778889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc----------------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE----------------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
++.++.+||+|||+++...... ......++..|+|||.+.. ..++.++|+||+||++|
T Consensus 134 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~vl~ 207 (305)
T cd05609 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR------QGYGKPVDWWAMGIILY 207 (305)
T ss_pred ECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC------CCCCchhhHHHHHHHHH
Confidence 9999999999999886421100 0012356677888887643 23455666666666666
Q ss_pred HHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 143 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 143 ~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
++++|..||.+
T Consensus 208 el~~g~~pf~~--------------------------------------------------------------------- 218 (305)
T cd05609 208 EFLVGCVPFFG--------------------------------------------------------------------- 218 (305)
T ss_pred HHHhCCCCCCC---------------------------------------------------------------------
Confidence 66666666543
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPK 282 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~ 282 (408)
....+....+..+...++...+ .++++++++|.+||..||++||| +.++|+||||...
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 219 -DTPEELFGQVISDDIEWPEGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -CCHHHHHHHHHhcccCCCCccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 3333344444444433333332 57889999999999999999998 7999999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.82 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=155.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ +..+..++|+||+.+|. +.+.+. ++..++.++.|++.||+|||++||+||||||+|
T Consensus 55 ~l~h~niv-~~~~~~~~~~~~~~v~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~N 131 (328)
T cd08226 55 FFRHPNIM-TSWTVFTTGSWLWVISPFMAYGS--ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131 (328)
T ss_pred hCCCCCcc-eEeeeEecCCceEEEEecccCCC--HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 36798855 5544 45567899999999988 666553 447788999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-cc-------ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-KL-------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-~~-------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
||++.++.++++||+.+....... .. ....++..|+|||++... ...++.++|+||+||++|+|++|.
T Consensus 132 ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD----LYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred EEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC----CCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999998654332111 00 012345679999998653 234788999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+......+..+..+....... ....|..... ... ...-+..++.--.+..+...+
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~------- 266 (328)
T cd08226 208 VPFQDMLRTQMLLQKLKGPPYSPLD------ITTFPCEESR-MKN-------SQSGVDSGIGESVVAAGMTQT------- 266 (328)
T ss_pred CCCCCcChHHHHHHHhcCCCCCCcc------ccccchhhhh-hcc-------chhhhhcccccchhccccccc-------
Confidence 9998877666555554432210000 0000000000 000 000000000000000000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.. .....+.+...++++++||++||+.||++|||++|+|+||||..
T Consensus 267 ----~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 267 ----MTS--ERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ----ccc--ccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000 00111223456789999999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.44 Aligned_cols=193 Identities=25% Similarity=0.432 Sum_probs=145.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++.-+.. ..++..|+|+||+.|+. |.+.+.+ ...+..++.|++.||.|||++||+|+||||+||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni 132 (256)
T cd08529 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGD--LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132 (256)
T ss_pred hcCCCCeehheeeeccCCEEEEEEEeCCCCc--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 4679986633322 44566799999999998 7776633 367788999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||++..+..... ....+|++.|+|||++.. ..++.++|+|||||++++|++|..||...+.
T Consensus 133 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 133 FLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED------KPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred EEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC------CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999887654332 234578899999998864 2356677777777777777777777754432
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
. .....+..+
T Consensus 207 ~----------------------------------------------------------------------~~~~~~~~~ 216 (256)
T cd08529 207 G----------------------------------------------------------------------ALILKIIRG 216 (256)
T ss_pred H----------------------------------------------------------------------HHHHHHHcC
Confidence 2 222233332
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
...... ..++.+++++|.+||+.||++||++.++++|||+
T Consensus 217 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 217 VFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 221111 1467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=251.55 Aligned_cols=202 Identities=23% Similarity=0.387 Sum_probs=147.3
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPE 75 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~ 75 (408)
+.|+|++ .+.+ ..++..|+||||+.|+. |...+. ++..++.++.|++.||.|||+ +||+||||||+
T Consensus 56 ~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 56 AVSPYIV-DFYGAFFIEGAVYMCMEYMDAGS--LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred cCCCcHH-hhhhheecCCeEEEEEeecCCCC--HHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 5687754 5554 34567899999999998 655432 457899999999999999997 59999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
||+++.++.+||+|||++..+... ......+++.|+|||.+..........++.++|+||+||++|+|++|..||....
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 133 NVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred HEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999998765432 2234568889999999865432222345667777777777777777777774322
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..... ..+..+..
T Consensus 212 ~~~~~-------------------------------------------------------------------~~~~~~~~ 224 (286)
T cd06622 212 YANIF-------------------------------------------------------------------AQLSAIVD 224 (286)
T ss_pred hhhHH-------------------------------------------------------------------HHHHHHhh
Confidence 11110 01112222
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.. ......+++++++||.+||+.||++|||++++++||||...
T Consensus 225 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 225 GDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred cCC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 211 11223578999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=246.43 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=148.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NI 77 (408)
+.|+|+| ++.. ..++..|+||||+.|.-..++... .++..+..++.||+.||+|||++ +++||||||+||
T Consensus 57 ~~~~~iv-~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ni 135 (283)
T cd06617 57 VDCPYTV-TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135 (283)
T ss_pred cCCCCee-eeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 5678755 5443 445668999999986532233321 24578899999999999999998 999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-h
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-Q 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~-~ 156 (408)
|++.++.+||+|||++.............|+..|+|||.+..... ...++.++|+||+||++|+|++|..||.... .
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (283)
T cd06617 136 LINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN--QKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213 (283)
T ss_pred EECCCCCEEEeecccccccccccccccccCCccccChhhcCCccc--ccccCccccchhhHHHHHHHHhCCCCCCccccC
Confidence 999999999999999987644332233568899999998864321 2457789999999999999999999985321 1
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+ ..+
T Consensus 214 ~~~~~~~----------------------------------------------------------------------~~~ 223 (283)
T cd06617 214 FQQLKQV----------------------------------------------------------------------VEE 223 (283)
T ss_pred HHHHHHH----------------------------------------------------------------------Hhc
Confidence 1111111 111
Q ss_pred -CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 -KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 -~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...++. ..+|.++++||.+||..||++|||++++++||||...
T Consensus 224 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 224 PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 001111 2368899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=245.42 Aligned_cols=199 Identities=22% Similarity=0.444 Sum_probs=150.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.. +..+..++|+||+.||. |.+.+. +...++.++.|++.||.|||++|++||||+|+||+
T Consensus 64 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil 140 (272)
T cd06629 64 DLDHLNIV-QYLGFETTEEYLSIFLEYVPGGS--IGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL 140 (272)
T ss_pred hcCCCCcc-eEEEEeccCCceEEEEecCCCCc--HHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEE
Confidence 35788865 4443 55677899999999998 777653 34778899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.++++|||++....... ......|+..|+|||.+.... ..++.++|+||+|++++++++|..||...+
T Consensus 141 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 141 VDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS----QGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred EcCCCeEEEeeccccccccccccccccccccCCccccCHHHhcccc----CCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 9999999999999987654221 123456889999999986431 246788999999999999999999986543
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....+.++... .
T Consensus 217 ~~~~~~~~~~~--------------------------------------------------------------------~ 228 (272)
T cd06629 217 AIAAMFKLGNK--------------------------------------------------------------------R 228 (272)
T ss_pred hHHHHHHhhcc--------------------------------------------------------------------c
Confidence 32222111100 0
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....++...+..++.++++||.+||..||++|||++++|+||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00111222234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=253.81 Aligned_cols=202 Identities=27% Similarity=0.506 Sum_probs=152.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.. +.++..|+|+||+.+|. |.+.+. +...+..++.|++.||+|||++||+||||||+||++
T Consensus 74 ~l~hp~i~-~~~~~~~~~~~~~iv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill 150 (297)
T cd06659 74 DYQHQNVV-EMYKSYLVGEELWVLMEFLQGGA--LTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150 (297)
T ss_pred hCCCCchh-hhhhheeeCCeEEEEEecCCCCC--HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE
Confidence 46798855 4443 34567799999999987 666543 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++....... .....+|++.|+|||++.. ..++.++|+||+||++|+|++|..||.......
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 224 (297)
T cd06659 151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224 (297)
T ss_pred ccCCcEEEeechhHhhcccccccccceecCccccCHHHHcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999987654322 2234678999999999864 245678888888888888888888875433222
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+ ..+.....
T Consensus 225 ~~----------------------------------------------------------------------~~~~~~~~ 234 (297)
T cd06659 225 AM----------------------------------------------------------------------KRLRDSPP 234 (297)
T ss_pred HH----------------------------------------------------------------------HHHhccCC
Confidence 11 11111111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~ 287 (408)
. ....+..++.++.++|++||+.||++|||++++++||||.....+..
T Consensus 235 ~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 235 P-KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred C-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 1 11123457889999999999999999999999999999986644433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=246.47 Aligned_cols=220 Identities=26% Similarity=0.441 Sum_probs=157.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|+ +++.+ .+.+..++||||+.++ |.+.+ .+.+.+..++.|++.||+|||++||+||||||+
T Consensus 54 ~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ 129 (284)
T cd07836 54 ELKHENI-VRLHDVIHTENKLMLVFEYMDKD---LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ 129 (284)
T ss_pred hhcCCCE-eeeeeeEeeCCcEEEEEecCCcc---HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 4678874 46554 4456679999999864 44443 245788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||++++++.++|+|||++....... ......+++.|++||.+... ..++.++|+||+||++|++++|..||.+.
T Consensus 130 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS-----RTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred HEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999997654322 12335678899999988642 34678999999999999999999999988
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+...++...........|... . ....+....|.... .....+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~-~~~~~~~~~~~~~~---~~~~~~- 249 (284)
T cd07836 205 NNEDQLLKIFRIMGTPTESTWPGI------------------------------S-QLPEYKPTFPRYPP---QDLQQL- 249 (284)
T ss_pred CcHHHHHHHHHHhCCCChhhHHHH------------------------------h-cCchhcccccCCCh---HHHHHH-
Confidence 877776666554322211111110 0 00000011111100 000111
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
...++.+++++|.+||+.||.+|||+.|+++||||
T Consensus 250 ----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 250 ----------FPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ----------hhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 12358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=247.40 Aligned_cols=197 Identities=32% Similarity=0.514 Sum_probs=146.1
Q ss_pred ccCCcEEEEec-------cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 8 AHSRVVVRVKE-------EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 8 ~~~~~i~~~~~-------~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.|+|++ ++.. ..++..++||||+.||. |.+.+ .++..+..++.|++.||.|||+++|+|||
T Consensus 73 ~h~~i~-~~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 149 (286)
T cd06638 73 DHPNVV-KFYGMYYKKDVKNGDQLWLVLELCNGGS--VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149 (286)
T ss_pred cCCCee-eeeeeeeecccCCCCeEEEEEeecCCCC--HHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 688755 5443 23456799999999998 66543 23467888999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+||+++.++.+||+|||++..+.... ......|++.|+|||++..... ....++.++|+||+||++|+|++|..|
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slGvi~~el~~g~~p 228 (286)
T cd06638 150 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ-LDSTYDARCDVWSLGITAIELGDGDPP 228 (286)
T ss_pred CCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhh-ccccccchhhhhhHHHHHHHHhcCCCC
Confidence 99999999999999999999987654322 2233568999999999864211 124477889999999999999999998
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|...+....+.++.. +.+|
T Consensus 229 ~~~~~~~~~~~~~~~---------------------------------------------------~~~~---------- 247 (286)
T cd06638 229 LADLHPMRALFKIPR---------------------------------------------------NPPP---------- 247 (286)
T ss_pred CCCCchhHHHhhccc---------------------------------------------------cCCC----------
Confidence 865433221111100 0000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+ ...+.++++||.+||..||++|||+.|+|+|+||
T Consensus 248 --------~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 --------TLHQP--ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------cccCC--CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00000 1246789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=247.35 Aligned_cols=198 Identities=28% Similarity=0.462 Sum_probs=148.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.. ..++..|+||||+.+|. |.+.+. ++..+..++.|++.||+|||++||+||||||+||+
T Consensus 62 ~~~h~~ii-~~~~~~~~~~~~~iv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 138 (267)
T cd06646 62 ECKHCNIV-AYFGSYLSREKLWICMEYCGGGS--LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL 138 (267)
T ss_pred hcCCCCee-eeeEEEEeCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 45788866 4443 44556789999999998 777653 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++..+.... ......|++.|+|||.+... ....++.++|+||+||++|+|++|..||...+..
T Consensus 139 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 139 LTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE---KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ECCCCCEEECcCccceeecccccccCccccCccccCHhHcccc---cCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 9999999999999998664322 22345788999999987532 1234678999999999999999999998544322
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+....+ .+|.
T Consensus 216 ~~~~~~~~~~~-------------------------------------------------~~~~---------------- 230 (267)
T cd06646 216 RALFLMSKSNF-------------------------------------------------QPPK---------------- 230 (267)
T ss_pred hhheeeecCCC-------------------------------------------------CCCC----------------
Confidence 11111000000 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
+ ..-..+|.++++||++||..||++|||++++|+|+|
T Consensus 231 --~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 --L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0 001235789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=252.71 Aligned_cols=197 Identities=28% Similarity=0.506 Sum_probs=151.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.+ ..++..|+||||+.||. |.+++. +..++..++.|++.||.|||+.||+||||||+|||+
T Consensus 72 ~~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili 148 (297)
T cd06656 72 ENKNPNIV-NYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148 (297)
T ss_pred hCCCCCEe-eEEEEEecCCEEEEeecccCCCC--HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 36788755 5443 45567899999999998 777653 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||++........ .....+++.|+|||.+.. ..++.++|+||+||++|++++|..||.+.+...
T Consensus 149 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 9999999999999876544322 234578899999999864 346788999999999999999999996543211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+. ..+.++.
T Consensus 223 ~~~~~~--------------------------------------------------~~~~~~~----------------- 235 (297)
T cd06656 223 ALYLIA--------------------------------------------------TNGTPEL----------------- 235 (297)
T ss_pred heeeec--------------------------------------------------cCCCCCC-----------------
Confidence 100000 0011110
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....++..+++||.+||..||++|||++++|+||||...
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 236 ----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 0112467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=256.84 Aligned_cols=103 Identities=24% Similarity=0.459 Sum_probs=86.3
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~ 122 (408)
+++..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.+...... ....+++.|+|||++..
T Consensus 212 ~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 288 (374)
T cd05106 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD--- 288 (374)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC---
Confidence 467889999999999999999999999999999999999999999999765433221 12234567999999864
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
..++.++|+||+||++|+|++ |..||...
T Consensus 289 ---~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 289 ---CVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred ---CCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 357889999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=248.84 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=140.5
Q ss_pred ccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 8 AHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 8 ~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.|+|++ .+... ..+..++|+||+.||. |.+.+. ++..++.++.|++.||+|||++||+|||
T Consensus 77 ~h~ni~-~~~~~~~~~~~~~~~~~~lv~ey~~~~s--L~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 153 (291)
T cd06639 77 NHPNVV-KFYGMFYKADKLVGGQLWLVLELCNGGS--VTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRD 153 (291)
T ss_pred CCCCeE-EEEEEEEeccccCCCeeEEEEEECCCCc--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 688755 44431 1235789999999998 766542 4478899999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+||+++.++.+||+|||++....... ......|++.|+|||++..... ....++.++|+||+||++|+|++|.+|
T Consensus 154 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 154 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ-YDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCC-cccccCCccchHHHHHHHHHHhhCCCC
Confidence 99999999999999999999988654322 1223568899999998754210 012345667777777777777777666
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|...+. ...+
T Consensus 233 ~~~~~~----------------------------------------------------------------------~~~~ 242 (291)
T cd06639 233 LFDMHP----------------------------------------------------------------------VKTL 242 (291)
T ss_pred CCCCcH----------------------------------------------------------------------HHHH
Confidence 643322 1222
Q ss_pred HHHHhcCC-CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 231 RNIMEGKY-SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 231 ~~i~~~~~-~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
..+..... .... -...+.++++||.+||..||++|||+.|+|+||||+
T Consensus 243 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 243 FKIPRNPPPTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHhcCCCCCCCc--ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22222111 1111 123567899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=248.64 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=146.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENI 77 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NI 77 (408)
.|+++| .+.. ..++..+++|||+.+....+...+ .++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 61 ~~~~iv-~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 139 (288)
T cd06616 61 DCPYIV-KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI 139 (288)
T ss_pred CCCCEe-eeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHE
Confidence 477744 5543 334556788999876432343322 34578899999999999999974 999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh-
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ- 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~- 156 (408)
+++.++.+||+|||++..+..........|++.|+|||++.... ...++.++|+||+||++|+|++|..||.....
T Consensus 140 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 216 (288)
T cd06616 140 LLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA---RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216 (288)
T ss_pred EEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhcccc---ccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence 99999999999999998765443334457899999999986421 13577889999999999999999988854321
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.++. .+.+|
T Consensus 217 ~~~~~~~~---------------------------------------------------~~~~~---------------- 229 (288)
T cd06616 217 FDQLTQVV---------------------------------------------------KGDPP---------------- 229 (288)
T ss_pred HHHHhhhc---------------------------------------------------CCCCC----------------
Confidence 01111110 01111
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
......+..+|.++.+||++||+.||++|||++|+++||||...
T Consensus 230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 230 --ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred --cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 11112234578999999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=246.26 Aligned_cols=193 Identities=30% Similarity=0.515 Sum_probs=145.2
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.. ..++..++++||+.++. |.+.+. +...+..++.|++.||+|||+++|+||||||+|
T Consensus 60 ~l~h~~i~-~~~~~~~~~~~~~~~l~~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n 136 (266)
T cd06651 60 NLQHERIV-QYYGCLRDRAEKTLTIFMEYMPGGS--VKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN 136 (266)
T ss_pred HcCCCCee-eEEEEEEcCCCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 46788865 4443 22456789999999987 776653 457788899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccC----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKG----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|+++.++.+||+|||++..+... .......++..|+|||.+.. ..++.++|+||+||++|++++|..||.
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG------EGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred EEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC------CCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999998765321 11223568889999999864 346789999999999999999999996
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
.......+.++... +.
T Consensus 211 ~~~~~~~~~~~~~~--------------------------------------------------~~-------------- 226 (266)
T cd06651 211 EYEAMAAIFKIATQ--------------------------------------------------PT-------------- 226 (266)
T ss_pred ccchHHHHHHHhcC--------------------------------------------------CC--------------
Confidence 54332222211100 00
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
...++ ..+++.+++|| +||..||++|||++|+++||||+
T Consensus 227 ----~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----NPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----CCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00010 23578889999 46668999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=257.89 Aligned_cols=225 Identities=29% Similarity=0.416 Sum_probs=155.0
Q ss_pred ccccCCcEEEEeccC-------CcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEEG-------DDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~-------~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.+.. ....|+|+||+.+ . |.+.+. ++..+..++.|++.||.|||+++++|||||
T Consensus 60 ~l~h~ni~-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk 135 (337)
T cd07858 60 HLDHENVI-AIKDIMPPPHREAFNDVYIVYELMDT-D--LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK 135 (337)
T ss_pred hcCCCCcc-chHHheecccccccCcEEEEEeCCCC-C--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 46788754 544311 1236899999964 4 555542 457899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|+||+++.++.+||+|||++...... .......++..|+|||.+... ..++.++|+||+||++|+|++|.+||.
T Consensus 136 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 136 PSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC-----SEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred HHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcC-----CCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999866443 222345788999999988642 247789999999999999999999998
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+....+..+........ ++.+.. ..+. ........
T Consensus 211 ~~~~~~~~~~~~~~~~~~~------------~~~~~~-----------~~~~--------------------~~~~~~~~ 247 (337)
T cd07858 211 GKDYVHQLKLITELLGSPS------------EEDLGF-----------IRNE--------------------KARRYIRS 247 (337)
T ss_pred CCChHHHHHHHHHHhCCCC------------hHHhhh-----------cCch--------------------hhhHHHHh
Confidence 8765544444432211110 010000 0000 00000000
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+...........++.+|+++++||++||+.||++|||++|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000001234689999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=249.03 Aligned_cols=223 Identities=25% Similarity=0.404 Sum_probs=150.8
Q ss_pred ccccCCcEEEEecc----------CCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKEE----------GDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----------~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|++++ ++.+. ..+..++||||+.++ +.+.+ .+.+++..++.||+.||+|||++|++|
T Consensus 67 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 142 (310)
T cd07865 67 LLKHENVV-NLIEICRTKATPYNRYKGSFYLVFEFCEHD---LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142 (310)
T ss_pred hCCCCCcc-ceEEEEecccccccCCCceEEEEEcCCCcC---HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 56788865 44431 123348999999764 44332 355889999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||||+||+++.++.+||+|||++..+..... .....++..|+|||.+.+. ..++.++|+||+|+++|+|
T Consensus 143 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-----RDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred cCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC-----cccCchhhhHHHHHHHHHH
Confidence 99999999999999999999999976543221 1234678899999988542 3467899999999999999
Q ss_pred HhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 145 l~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
++|..||.+.+.......+......+..+.+.... ..+.|.. ..+...
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~-----------~~~~~~ 265 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD---------------------KLELFKK-----------MELPQG 265 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc---------------------chhhhhh-----------ccCCCc
Confidence 99999998877655555444322111111111100 0011100 000000
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .+. ... .....++.++|||.+||..||++|||++|+|+||||
T Consensus 266 -~~~---~~~-~~l-----~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 266 -QKR---KVK-ERL-----KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred -cch---hhH-Hhc-----ccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 000 000 001246789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=251.57 Aligned_cols=145 Identities=30% Similarity=0.406 Sum_probs=112.1
Q ss_pred ccccCCcEEEEec--cCC--cHHHHHHHHHhhchhhHHhh-------hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGD--DLKHLAAQVVDKGEAAVQDI-------INSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~--~~~~lv~e~~~~g~~~l~~~-------~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|++++ .+.+ ... +..++||||+.++...+... -.++..++.++.||+.||+|||+++|+||||||
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp 136 (316)
T cd07842 58 ELKHENVV-SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136 (316)
T ss_pred hcCCCCcc-ceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 46898865 4443 222 56789999997653222111 124578899999999999999999999999999
Q ss_pred CcEEEec----CCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 75 ENILLDD----QMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 75 ~NILl~~----~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
+||+++. ++.+||+|||++........ ....++|+.|+|||++.+. ..++.++|+||+||++|+|++
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-----RHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCC-----CCCCcHHHHHHHHHHHHHHHh
Confidence 9999998 89999999999886543221 2235788999999987642 356789999999999999999
Q ss_pred CCCCCCCchh
Q psy3880 147 GCPPFWHRKQ 156 (408)
Q Consensus 147 G~~pf~~~~~ 156 (408)
|.+||.+...
T Consensus 212 ~~~~~~~~~~ 221 (316)
T cd07842 212 LEPIFKGREA 221 (316)
T ss_pred cCCCCcCCcc
Confidence 9999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=247.44 Aligned_cols=222 Identities=24% Similarity=0.410 Sum_probs=154.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.. ..++..|+||||+.++ +.+.+. +...++.++.||+.||+|||++||+||||||+|
T Consensus 57 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~n 132 (294)
T PLN00009 57 EMQHGNIV-RLQDVVHSEKRLYLVFEYLDLD---LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN 132 (294)
T ss_pred hccCCCEe-eEEEEEecCCeEEEEEeccccc---HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcce
Confidence 46798855 4443 4456778999999653 544432 346788899999999999999999999999999
Q ss_pred EEEec-CCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 77 ILLDD-QMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 77 ILl~~-~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|+++. ++.+||+|||++....... ......+++.|+|||.+.+. ..++.++|+||+||++|+|++|.+||.+.
T Consensus 133 ill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS-----RHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred EEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99985 4579999999997653321 22335678899999988542 34678999999999999999999999887
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+.++......... .+|.-..-+-......+.+....
T Consensus 208 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~--------- 248 (294)
T PLN00009 208 SEIDELFKIFRILGTPNE------------------------------ETWPGVTSLPDYKSAFPKWPPKD--------- 248 (294)
T ss_pred CHHHHHHHHHHHhCCCCh------------------------------hhccccccchhhhhhcccCCCCC---------
Confidence 776666655432211111 11110000000000000000000
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.......+|++++++|.+||..||++|||++++|+||||..
T Consensus 249 ------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 249 ------LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred ------HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00012357889999999999999999999999999999975
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=247.99 Aligned_cols=199 Identities=26% Similarity=0.509 Sum_probs=148.8
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|++++..+.. ...+..++|+||+.|+. |.+.+. +..++..++.|++.||+|||++||+||||||+||+++
T Consensus 72 ~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~ 149 (285)
T cd06648 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGA--LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149 (285)
T ss_pred HcCCCChheEEEEEEcCCeEEEEEeccCCCC--HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc
Confidence 4678886644432 45567799999999998 777653 4478889999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.++|+|||++....... ......|++.|+|||.+.. ..++.++|+||+||++|+|++|..||...+..
T Consensus 150 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-- 221 (285)
T cd06648 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-- 221 (285)
T ss_pred CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--
Confidence 99999999999887554322 1223568999999998754 23567788888888888888887777543322
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.....+......
T Consensus 222 --------------------------------------------------------------------~~~~~~~~~~~~ 233 (285)
T cd06648 222 --------------------------------------------------------------------QAMKRIRDNLPP 233 (285)
T ss_pred --------------------------------------------------------------------HHHHHHHhcCCC
Confidence 122222222111
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
. ......++.++.+||++||..||++|||+.++++||||....
T Consensus 234 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 234 K-LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred C-CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 1 111124788999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=242.67 Aligned_cols=193 Identities=29% Similarity=0.498 Sum_probs=149.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.+ ..+...|+++|++.++. |.+.+. +...++.++.|++.||.|||+.+|+|+||+|+||+
T Consensus 55 l~~~~i~-~~~~~~~~~~~~~l~~e~~~~~~--L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~ 131 (256)
T cd06612 55 CDSPYIV-KYYGSYFKNTDLWIVMEYCGAGS--VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL 131 (256)
T ss_pred CCCCcEe-eeeeeeecCCcEEEEEecCCCCc--HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 4788755 5554 34466789999999998 777653 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.++|+|||++....... ......++..|+|||++.+ ..++.++|+||+||++|+|++|..||......
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 132 LNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred ECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 9999999999999998765433 2233568899999999864 35678999999999999999999999654332
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+.. ..++
T Consensus 206 ~~~~~~~~---------------------------------------------------~~~~----------------- 217 (256)
T cd06612 206 RAIFMIPN---------------------------------------------------KPPP----------------- 217 (256)
T ss_pred hhhhhhcc---------------------------------------------------CCCC-----------------
Confidence 21111100 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+. ....++.++.+||.+||+.||++|||+.|+|.||||
T Consensus 218 -~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 -TLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -CCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000 012357789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=260.53 Aligned_cols=190 Identities=24% Similarity=0.463 Sum_probs=156.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
|.|+|+| .|.. +..-++.||||||..|- |+..+.+. ..+..+..+|+.|++|||.+.|||||||.-||||
T Consensus 169 LkH~NII-~FkGVCtqsPcyCIiMEfCa~Gq--L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI 245 (904)
T KOG4721|consen 169 LKHPNII-TFKGVCTQSPCYCIIMEFCAQGQ--LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI 245 (904)
T ss_pred ccCccee-eEeeeecCCceeEEeeecccccc--HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence 7899865 7776 44456789999999999 99888654 5678889999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.+..|||+|||-++.+........++||..|||||+|+. .+.+.|+|||||||++||||||..||.+-+.
T Consensus 246 s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--- 316 (904)
T KOG4721|consen 246 SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--- 316 (904)
T ss_pred eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc------CCcccccceehhHHHHHHHHhcCCCccccch---
Confidence 9999999999999998877666678999999999999985 4567899999999999999999999854321
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+=||-.|-=. ..
T Consensus 317 -----------------------------------------sAIIwGVGsNs--------------------------L~ 329 (904)
T KOG4721|consen 317 -----------------------------------------SAIIWGVGSNS--------------------------LH 329 (904)
T ss_pred -----------------------------------------heeEEeccCCc--------------------------cc
Confidence 34455544210 01
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hp 277 (408)
. +.....++-++-||+.|+.-.|.+|||..++|.|-
T Consensus 330 L--pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 L--PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred c--cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 1 11134567788999999999999999999999994
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=252.86 Aligned_cols=225 Identities=28% Similarity=0.469 Sum_probs=160.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ...+..++||||+.| . |.+.+. +.+.+..++.|++.||+|||++||+|+||||+||+
T Consensus 76 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~-~--l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil 151 (335)
T PTZ00024 76 EIKHENIM-GLVDVYVEGDFINLVMDIMAS-D--LKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF 151 (335)
T ss_pred hCCCccee-eeeEEEecCCcEEEEEecccc-C--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE
Confidence 46788755 4443 455677899999975 4 666553 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC---------------cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG---------------EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
++.++.++|+|||++...... .......+++.|+|||.+.+. ..++.++|+||+||++|+
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-----EKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-----CCCCcHHHHHHHHHHHHH
Confidence 999999999999998765411 111234568899999988542 346789999999999999
Q ss_pred HHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 144 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 144 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
|++|.+||.+.+....+..+...........|.... .+....|+..
T Consensus 227 l~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~ 272 (335)
T PTZ00024 227 LLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAK----------------------------------KLPLYTEFTP 272 (335)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchh----------------------------------hcccccccCc
Confidence 999999999888777766665432222111111100 0000011111
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
..... .. ......+.++.+||.+||..||++|||++|+|.||||+.....
T Consensus 273 ~~~~~-~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 273 RKPKD-LK-----------TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CCccc-HH-----------HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 00000 00 0113468899999999999999999999999999999876544
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=246.16 Aligned_cols=197 Identities=31% Similarity=0.530 Sum_probs=147.8
Q ss_pred ccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy3880 8 AHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHR 70 (408)
Q Consensus 8 ~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHR 70 (408)
.|+|++ .+.+. ..+..|+||||+.++. |.+.+. ++..++.++.|++.||.|||++|++|+
T Consensus 61 ~h~~i~-~~~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 61 NHPNIA-TFYGAFIKKNPPGNDDQLWLVMELCGGGS--VTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred CCCChh-eEEEEEEecCCCCcceEEEEEEEcCCCCc--HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 688755 44432 1334689999999987 655432 347889999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 71 DLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 71 DLKp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
||+|+||+++.++.+||+|||++....... ......|++.|+|||++...... ...++.++|+||+||++|+|++|..
T Consensus 138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP-DASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred CCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccc-cCCccccccHHHhHHHHHHHHhCCC
Confidence 999999999999999999999987654322 22346789999999998643221 3457789999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||........+.++..+ .+|
T Consensus 217 p~~~~~~~~~~~~~~~~---------------------------------------------------~~~--------- 236 (275)
T cd06608 217 PLCDMHPMRALFKIPRN---------------------------------------------------PPP--------- 236 (275)
T ss_pred CccccchHHHHHHhhcc---------------------------------------------------CCC---------
Confidence 99654433332222211 000
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+ ...+.++++||.+||..||++|||++|+++|||+
T Consensus 237 ---------~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 ---------TLKSP--ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------CCCch--hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00000 1257789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=241.77 Aligned_cols=192 Identities=25% Similarity=0.453 Sum_probs=151.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ .+.+..+++|||+.+|. |.+.+. +...+..++.|++.||.|||+.|++|+||||+|
T Consensus 55 ~~~h~~i~-~~~~~~~~~~~~~~~~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n 131 (256)
T cd08221 55 LLQHPNII-AYYNHFMDDNTLLIEMEYANGGT--LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN 131 (256)
T ss_pred hCCCCCee-EEEeEEecCCeEEEEEEecCCCc--HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHh
Confidence 35688744 5543 44567789999999998 777663 346888999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+++.++.+||+|||++....... ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+
T Consensus 132 i~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 132 IFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG------VKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred EEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC------CCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999987664433 2334678999999998864 245678999999999999999999987655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..+.
T Consensus 206 ~~~~~~~~~~~~-------------------------------------------------------------------- 217 (256)
T cd08221 206 PLNLVVKIVQGN-------------------------------------------------------------------- 217 (256)
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 444444333221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
+... -..++.+++++|.+||..||.+|||++|+|+|||+
T Consensus 218 --~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 218 --YTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --CCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 1110 03467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=242.82 Aligned_cols=192 Identities=28% Similarity=0.511 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ ..++..++|+||+.||. |.+.+. ++..+..++.|++.||+|||++||+|+||||+|
T Consensus 55 ~~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~n 131 (256)
T cd08220 55 LLSHPNII-EYYENFLEDKALMIVMEYAPGGT--LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQN 131 (256)
T ss_pred hCCCCchh-heeeeEecCCEEEEEEecCCCCC--HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 45788755 4443 44566799999999998 777653 347888999999999999999999999999999
Q ss_pred EEEecCC-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQM-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+++.++ .+||+|||++.............|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 132 il~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 132 ILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG------KPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred EEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC------CCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 9998554 589999999987665444445678999999998864 346778999999999999999999886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..
T Consensus 206 ~~~~~~~~~~---------------------------------------------------------------------- 215 (256)
T cd08220 206 LPALVLKIMS---------------------------------------------------------------------- 215 (256)
T ss_pred hHHHHHHHHh----------------------------------------------------------------------
Confidence 3333222221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
+... +....++.++++||.+||..||++|||+.|+|+||||
T Consensus 216 ~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 GTFA---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCCC---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1100 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=280.69 Aligned_cols=126 Identities=25% Similarity=0.400 Sum_probs=97.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.. ...+..|+||||+.||. |.+++. .+..++.++.||+.||+|||++|||||||||+|||
T Consensus 60 ~l~hp~Iv-~~~~~~~~~~~~~lVmEy~~g~~--L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL 136 (669)
T cd05610 60 LSKSPFIV-HLYYSLQSANNVYLVMEYLIGGD--VKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML 136 (669)
T ss_pred hcCCCCcC-eEEEEEEECCEEEEEEeCCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence 35788765 4443 44567899999999998 877764 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
++.++.+||+|||+++...... ......+|+.|++||..... .+-...+++|++|+
T Consensus 137 l~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~-----~~~~~~s~~~s~g~ 193 (669)
T cd05610 137 ISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR-----TPGQVLSLISSLGF 193 (669)
T ss_pred EcCCCCEEEEeCCCCccccCCcccccccccCccccCccccccC-----CCCceeeeeeecCc
Confidence 9999999999999998765432 33457899999999865321 11233455666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=252.00 Aligned_cols=220 Identities=25% Similarity=0.433 Sum_probs=152.8
Q ss_pred ccccCCcEEEEecc----------CCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKEE----------GDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----------~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|++++ ++.+. .....++|+||+.+. +...+ .+..+++.++.||++||+|||++||+|
T Consensus 63 ~l~h~~i~-~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~---l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H 138 (311)
T cd07866 63 KLKHPNVV-PLIDMAVERPDKSKRKRGSVYMVTPYMDHD---LSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILH 138 (311)
T ss_pred hcCCCCcc-chhhheecccccccccCceEEEEEecCCcC---HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 46788755 54431 122458899998764 33332 345889999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCcc------------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhh
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEK------------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~~------------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSl 137 (408)
|||||+||++++++.+||+|||++........ .....+++.|+|||.+.+. ..++.++|+||+
T Consensus 139 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~sl 213 (311)
T cd07866 139 RDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-----RRYTTAVDIWGI 213 (311)
T ss_pred CCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-----CccCchhHhHHH
Confidence 99999999999999999999999976543211 1223568889999987642 346789999999
Q ss_pred hHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 138 Gvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
||++|+|++|++||.+.+.......+.........+.+.... .+..
T Consensus 214 G~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~ 259 (311)
T cd07866 214 GCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWR----------------------------------SLPG 259 (311)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhh----------------------------------hccc
Confidence 999999999999999888777666665432222211111100 0000
Q ss_pred CCC-CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 218 CPP-FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 218 ~~P-f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .........+ ...+...++++.+||.+||..||.+|||+.|+++||||
T Consensus 260 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 260 CEGVHSFTNYPRTL-----------EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ccccccCCCCCccH-----------HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 0000000000 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=241.79 Aligned_cols=192 Identities=30% Similarity=0.491 Sum_probs=150.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ +..+..++|+||+.+|. |.+.+. ++.++..++.|++.||.|||++|++|+||+|+|
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~n 131 (256)
T cd08218 55 NMKHPNIV-QYQESFEENGNLYIVMDYCEGGD--LYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQN 131 (256)
T ss_pred hCCCCCee-eeEeeecCCCeEEEEEecCCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 46788755 5554 45567789999999998 776653 346788899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+++.++.++|+|||++........ .....|++.|+|||++.. ..++.++|+||+||+++++++|..||...+
T Consensus 132 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 132 IFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN------RPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred EEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC------CCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 9999999999999999876544322 223568889999999864 345678999999999999999999986554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
......++..+
T Consensus 206 ~~~~~~~~~~~--------------------------------------------------------------------- 216 (256)
T cd08218 206 MKNLVLKIIRG--------------------------------------------------------------------- 216 (256)
T ss_pred HHHHHHHHhcC---------------------------------------------------------------------
Confidence 44333333221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.... .-...+.+++++|.+||..||++|||+.|+|+||||
T Consensus 217 -~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 -SYPP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -CCCC---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1100 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=248.67 Aligned_cols=195 Identities=29% Similarity=0.524 Sum_probs=154.6
Q ss_pred cCCcEEEEeccC--CcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 9 HSRVVVRVKEEG--DDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 9 ~~~~i~~~~~~~--~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.+||.++... ....++|||||-.|. +.|++. ++.++..+++..|.||+|||...-||||||..|||++
T Consensus 86 ~S~yVVKYYGSYFK~sDLWIVMEYCGAGS--iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN 163 (502)
T KOG0574|consen 86 KSKYVVKYYGSYFKHSDLWIVMEYCGAGS--ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN 163 (502)
T ss_pred CCchhhhhhhhhccCCceEeehhhcCCCc--HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc
Confidence 355677766432 345689999998888 888763 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.+|..||+|||+|..+.+... -.+..|||.|||||++.. -+|++++||||||++..||..|++||.+-.....
T Consensus 164 T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA 237 (502)
T KOG0574|consen 164 TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA 237 (502)
T ss_pred ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHH------hccchhhhHhhhcchhhhhhcCCCCcccccccce
Confidence 999999999999988875432 346889999999999975 5799999999999999999999999854322110
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+ | |+-..||- .
T Consensus 238 I---------------------------------------------------F-MIPT~PPP-----------------T 248 (502)
T KOG0574|consen 238 I---------------------------------------------------F-MIPTKPPP-----------------T 248 (502)
T ss_pred e---------------------------------------------------E-eccCCCCC-----------------C
Confidence 0 0 11112221 2
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
|..|+ ..|.+..|||++||+++|++|-||-++++|||+...
T Consensus 249 F~KPE--~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 249 FKKPE--EWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCChH--hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 32221 237899999999999999999999999999999753
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=240.66 Aligned_cols=192 Identities=32% Similarity=0.569 Sum_probs=150.5
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHH-----HCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVH-----NHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH-----~~~I 67 (408)
.+.|++++ .+.+ ......|+++||+.+|. |.+.+. +..++..++.||+.||.||| +.+|
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~~~~~~e~~~~~~--L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i 131 (265)
T cd08217 55 ELKHPNIV-RYYDRIIDRSNQTLYIVMEYCEGGD--LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV 131 (265)
T ss_pred hcCCCccc-eeeeeeecCCCCEEEEEehhccCCC--HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcc
Confidence 35788755 4433 23445689999999998 766653 33688999999999999999 9999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
+|+||||+||+++.++.+||+|||++........ .....+++.|+|||.+.. ..++.++|+||+|+++++|++
T Consensus 132 ~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~------~~~~~~~Dv~slG~il~~l~~ 205 (265)
T cd08217 132 LHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH------MSYDEKSDIWSLGCLIYELCA 205 (265)
T ss_pred eecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcC------CCCCchhHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987765433 334678999999999864 346788999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|+.||...+.......+..+
T Consensus 206 g~~p~~~~~~~~~~~~~~~~------------------------------------------------------------ 225 (265)
T cd08217 206 LSPPFTARNQLQLASKIKEG------------------------------------------------------------ 225 (265)
T ss_pred CCCcccCcCHHHHHHHHhcC------------------------------------------------------------
Confidence 99999766544333333221
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+... -...+.++.+|+.+||..||++|||++++|+|||+
T Consensus 226 ----------~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ----------KFRRI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------CCCCC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 11000 01357889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=244.44 Aligned_cols=183 Identities=26% Similarity=0.408 Sum_probs=141.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+| |+.+.+ ...+..++||||+.||. |.+.+. +.+.+..++.|++.||+|||++||+||||||+||+++
T Consensus 43 ~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~ 119 (237)
T cd05576 43 CVPN-MVCLHKYIVSEDSVFLVLQHAEGGK--LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119 (237)
T ss_pred CCCc-eeehhhheecCCeEEEEEecCCCCC--HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 4676 446665 34466789999999998 877763 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
.++.++++|||++..+... .....+++.|+|||.+.. ..++.++|+||+||++|+|++|..||......
T Consensus 120 ~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--- 188 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI------SEETEACDWWSLGAILFELLTGKTLVECHPSG--- 188 (237)
T ss_pred CCCCEEEecccchhccccc--cccCCcCccccCCcccCC------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---
Confidence 9999999999988665432 234556778999998753 34677899999999999999998776321100
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
+ .....+
T Consensus 189 ------------------------------------------------------------------------~-~~~~~~ 195 (237)
T cd05576 189 ------------------------------------------------------------------------I-NTHTTL 195 (237)
T ss_pred ------------------------------------------------------------------------c-cccccc
Confidence 0 000000
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCH-----HHHHcCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFF 279 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-----~e~L~Hpwf 279 (408)
..+ ..+++++++||++||+.||++|+|+ +|+++||||
T Consensus 196 ~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 111 2368899999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=244.34 Aligned_cols=196 Identities=23% Similarity=0.483 Sum_probs=145.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.. ..++..++|+||+.++. |.+.+. ....+..++.||+.||+|||++||+||||||+
T Consensus 61 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ 137 (268)
T cd06624 61 YLKHRNIV-QYLGSDSENGFFKIFMEQVPGGS--LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137 (268)
T ss_pred hcCCCCee-eeeeeeccCCEEEEEEecCCCCC--HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 35788855 5543 44567889999999998 776653 34677889999999999999999999999999
Q ss_pred cEEEec-CCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDD-QMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~-~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
||+++. ++.++|+|||++....... ......|++.|+|||++... ...++.++|+||+||++|+|++|..||..
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG----PRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccc----cccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 999976 6789999999987654322 22335688999999998542 23467889999999999999999988843
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
..... ..+|.. ..
T Consensus 214 ~~~~~-------------------------------------------~~~~~~------------------------~~ 226 (268)
T cd06624 214 LGEPQ-------------------------------------------AAMFKV------------------------GM 226 (268)
T ss_pred ccChh-------------------------------------------hhHhhh------------------------hh
Confidence 21100 000000 00
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
. .........+++++++||++||..||++|||+.|++.||||
T Consensus 227 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 227 F----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred h----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0 00001123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=247.30 Aligned_cols=223 Identities=30% Similarity=0.466 Sum_probs=157.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ +.++..|+|+||+.++. +.+.. .+..++..++.||+.||.|||++||+|+||+|+||+
T Consensus 56 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~ 132 (286)
T cd07846 56 QLRHENLV-NLIEVFRRKKRLYLVFEFVDHTV--LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENIL 132 (286)
T ss_pred hcCCcchh-hHHHhcccCCeEEEEEecCCccH--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 46788755 5544 45566799999999886 54443 245889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++++.++|+|||++..+.... ......++..|+|||++.+. ..++.++|+||+||++|+|++|.+||...+..
T Consensus 133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 133 VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD-----TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred ECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccc-----cccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 9999999999999987654432 22345688899999998642 34678899999999999999999999887766
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+....+......+..... + .+....+.-.+. .|-.... ...
T Consensus 208 ~~~~~~~~~~~~~~~~~~---------~------------------~~~~~~~~~~~~---~~~~~~~--~~~------- 248 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQ---------E------------------IFQKNPLFAGMR---LPEVKEI--EPL------- 248 (286)
T ss_pred HHHHHHHHHhCCCchhhH---------H------------------HhccchHhhccc---cccccCc--chH-------
Confidence 655555443221110000 0 000000000000 0000000 000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
...+..++.++++||.+||..||++|||+.++|+||||
T Consensus 249 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 249 ----EKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ----HHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 01134678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=267.14 Aligned_cols=183 Identities=22% Similarity=0.352 Sum_probs=118.7
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-CCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-QMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~ 122 (408)
..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+|+.+..+. .....++|+.|+|||.+.....
T Consensus 255 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~ 334 (566)
T PLN03225 255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ 334 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCC
Confidence 346789999999999999999999999999999985 5789999999998654332 2245789999999997643221
Q ss_pred cC----------------cCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHh-ccccCCCCCCccCCCCCchH
Q psy3880 123 ED----------------ATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME-GKYSFSSPEWNDISGYLAPE 185 (408)
Q Consensus 123 ~~----------------~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~PE 185 (408)
.. ...++.++||||+||++|+|+++..++. +....+..++. ..+. ..
T Consensus 335 ~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~--~~------------ 398 (566)
T PLN03225 335 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD--LV------------ 398 (566)
T ss_pred CCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc--HH------------
Confidence 10 0124456789999999888887655532 22222222221 1000 00
Q ss_pred HHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCC
Q psy3880 186 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPE 265 (408)
Q Consensus 186 ~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~ 265 (408)
.|. ..+... +.. + +.. .| ...+..+.++.|||++||++||+
T Consensus 399 ------------------~~~------~~~~~~--~~~----~----~~~---~~--~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 399 ------------------AWR------KLVEPR--ASP----D----LRR---GF--EVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ------------------HHH------Hhhccc--cch----h----hhh---hh--hhccccchHHHHHHHHHccCCcc
Confidence 000 000000 000 0 000 00 01122345677999999999999
Q ss_pred CCCCHHHHHcCCCCCCCC
Q psy3880 266 DRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 266 ~R~ta~e~L~Hpwf~~~~ 283 (408)
+|||+.|+|+||||+...
T Consensus 440 kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 440 QRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCCHHHHhCCcCcCCCC
Confidence 999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=247.57 Aligned_cols=142 Identities=27% Similarity=0.465 Sum_probs=112.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++|+||+.++ +.+.+. ....++.++.|++.||+|||++||+||||||+||
T Consensus 59 ~l~h~ni~-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 59 GLKHANIV-LLHDIIHTKETLTFVFEYMHTD---LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred hcCCCCEe-EEEEEEecCCeEEEEEecccCC---HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 46899855 5554 3445678999999644 444332 3467889999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+++..... .......+++.|+|||.+.+. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA-----TDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 9999999999999998754322 222335678999999987532 3467889999999999999999999976553
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=255.95 Aligned_cols=186 Identities=25% Similarity=0.462 Sum_probs=151.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
|.|++ ||+++. +.+...|||||||..|. |.+++... +++..++.||++|++||+++++|||||.+.||
T Consensus 258 L~H~~-lV~l~gV~~~~~piyIVtE~m~~Gs--Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi 334 (468)
T KOG0197|consen 258 LRHEK-LVKLYGVCTKQEPIYIVTEYMPKGS--LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI 334 (468)
T ss_pred CcccC-eEEEEEEEecCCceEEEEEecccCc--HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence 67998 557776 44457899999999999 99998762 78899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCC--CCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCG--TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++++..+||+|||+|+...++.......+ ...|.|||.+..+ .|+.+||||||||++||++| |+.|+.+.
T Consensus 335 LV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~------~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 335 LVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG------KFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred eeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC------CcccccceeehhhhHHHHhccCCCCCCCC
Confidence 999999999999999996555443222222 2369999999864 47889999999999999997 88888887
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+.+|.
T Consensus 409 sn~ev~~~le~Gy------------------------------------------------------------------- 421 (468)
T KOG0197|consen 409 SNEEVLELLERGY------------------------------------------------------------------- 421 (468)
T ss_pred CHHHHHHHHhccC-------------------------------------------------------------------
Confidence 7777777766553
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHH
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L 274 (408)
..+.| ...+++.-+++..|...+|++|||.+.+.
T Consensus 422 ----Rlp~P--~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 422 ----RLPRP--EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----cCCCC--CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 12222 35788899999999999999999987543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=252.41 Aligned_cols=222 Identities=26% Similarity=0.418 Sum_probs=155.5
Q ss_pred ccCCcEEEEec------cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 8 AHSRVVVRVKE------EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 8 ~~~~~i~~~~~------~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.|+|++ .+.. ......|+++|++.+ . |.+.+. ++++++.++.||+.||+|||++||+||||||+|
T Consensus 60 ~h~~iv-~~~~~~~~~~~~~~~~~~~~e~~~~-~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~N 135 (332)
T cd07857 60 GHKNIT-CLYDMDIVFPGNFNELYLYEELMEA-D--LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGN 135 (332)
T ss_pred CCCChh-eeeeeeeeccccCCcEEEEEecccC-C--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 588755 5443 122345788888864 4 666553 458899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|+++.++.+||+|||++..+.... ......||+.|+|||.+... ..++.++|+||+||++|++++|.+||
T Consensus 136 ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Di~slGv~l~~l~~g~~pf 210 (332)
T cd07857 136 LLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-----QSYTKAIDVWSVGCILAELLGRKPVF 210 (332)
T ss_pred eEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence 999999999999999997654321 12335789999999987542 35788999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+....+..+........ ++.+..-. + ........
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~-----------~--------------------~~~~~~~~ 247 (332)
T cd07857 211 KGKDYVDQLNQILQVLGTPD------------EETLSRIG-----------S--------------------PKAQNYIR 247 (332)
T ss_pred CCCCHHHHHHHHHHHhCCCC------------HHHHHhhh-----------h--------------------hhHHHHHH
Confidence 98887777766665432111 01100000 0 00000000
Q ss_pred HHHhcC-CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 232 NIMEGK-YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~-~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...... ..+. ..+..++.++++||.+||+.||++|||+.|++.||||...
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 248 SLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000000 0011 1234568899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=244.49 Aligned_cols=221 Identities=25% Similarity=0.433 Sum_probs=157.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ...+..++|+||+.+ . +.+.+. +...+..++.|++.||.|||+++|+|+||||+||
T Consensus 54 ~l~~~~i~-~~~~~~~~~~~~~~v~e~~~~-~--l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 129 (283)
T cd05118 54 ELNHPNII-KLLDVFRHKGDLYLVFEFMDT-D--LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129 (283)
T ss_pred HhcCCCcc-hHHHhhccCCCEEEEEeccCC-C--HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence 35677644 5554 345677899999976 3 444432 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||.+....... ......++..|+|||.+... ..++.++|+||+||++|+|++|+.||.+.+.
T Consensus 130 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 130 LINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD-----KGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred EECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987765443 22335678899999998642 3568899999999999999999999988887
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.++.+.........|...... .+..+ ..|. ..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~----------~~~~------------~~ 240 (283)
T cd05118 205 IDQLFKIFRTLGTPDPEVWPKFTSL----------------------ARNYK----------FSFP------------KK 240 (283)
T ss_pred HHHHHHHHHHcCCCchHhcccchhh----------------------hhhhh----------hhhc------------cc
Confidence 7776666543222111111111000 00000 0000 00
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
........+..++.++++||.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000011234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=242.45 Aligned_cols=216 Identities=31% Similarity=0.480 Sum_probs=154.6
Q ss_pred cccCCcEEEEecc--CCc-----HHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKEE--GDD-----LKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~~-----~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
+.|++++ .+.+. ..+ ..+++||++.+ . |.+.+ .+...+..++.|++.||.|||+++++|+||
T Consensus 58 ~~h~~i~-~~~~~~~~~~~~~~~~~~l~~e~~~~-~--l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l 133 (287)
T cd07838 58 FEHPNIV-RLLDVCHGPRTDRELKLTLVFEHVDQ-D--LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDL 133 (287)
T ss_pred cCCCCcc-eEEEEEeeccCCCCceeEEEehhccc-C--HHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 3588755 54432 222 27899999975 3 44433 245788999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
+|+||+++.++.+||+|||++..+..........+++.|+|||++.. ..++.++|+||+||++|+|++|.+||.
T Consensus 134 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 134 KPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ------SSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred ChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhcc------CCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 99999999999999999999987755544445568889999999864 346789999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+..+.+.++...........|..... ... ..|.....
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~--------------~~~~~~~~------ 246 (287)
T cd07838 208 GTSEADQLDKIFDVIGLPSEEEWPRNVS---------------------LPR--------------SSFPSYTP------ 246 (287)
T ss_pred CCChHHHHHHHHHHcCCCChHhcCCCcc---------------------cch--------------hhcccccc------
Confidence 9888777777654221111010000000 000 00000000
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.........+++++.+||.+||..||++|||++|+|+||||
T Consensus 247 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 247 ------RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ------cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00001113467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=251.28 Aligned_cols=222 Identities=23% Similarity=0.434 Sum_probs=155.2
Q ss_pred ccccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.+.. .+..|++++++ |+. |.+.+ .+...++.++.|++.||+|||++||+|||||
T Consensus 72 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~lv~~~~-~~~--L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 147 (345)
T cd07877 72 HMKHENVI-GLLDVFTPARSLEEFNDVYLVTHLM-GAD--LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 147 (345)
T ss_pred HcCCCccc-ceeeeeeecccccccccEEEEehhc-ccC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 35788754 544321 13357888887 555 65544 3457889999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+||+++.++.+||+|||++..... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|..||..
T Consensus 148 p~NIll~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 148 PSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLN-----WMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred hHHEEEcCCCCEEEecccccccccc--cccccccCCCccCHHHHhC-----ccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999876533 2234678999999998854 23577899999999999999999999988
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..+....... .|+.+..- ++ .........+
T Consensus 221 ~~~~~~~~~~~~~~~~~------------~~~~~~~~----------------------------~~---~~~~~~~~~~ 257 (345)
T cd07877 221 TDHIDQLKLILRLVGTP------------GAELLKKI----------------------------SS---ESARNYIQSL 257 (345)
T ss_pred CCHHHHHHHHHHHhCCC------------CHHHHhhc----------------------------cc---HhHHHHHHHh
Confidence 77766666665433211 11111000 00 0000000000
Q ss_pred Hhc-CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEG-KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~-~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... ...+ ...+...+++++|||.+||+.||.+|+|+.++|+||||...
T Consensus 258 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 258 TQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 0000 01123468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=241.32 Aligned_cols=198 Identities=30% Similarity=0.468 Sum_probs=150.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ...+..|++|||+.++. |.+.+. ++.++..++.|++.||.|||++||+|+||||+||
T Consensus 56 ~~~h~~i~-~~~~~~~~~~~~~l~~e~~~~~~--l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 132 (262)
T cd06613 56 ECRHPNIV-AYFGSYLRRDKLWIVMEYCGGGS--LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132 (262)
T ss_pred hCCCCChh-ceEEEEEeCCEEEEEEeCCCCCc--HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence 46788865 4443 44566789999999987 665542 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.+||+|||++....... ......++..|+|||.+.... ...++.++|+||+||++|+|++|.+||...+.
T Consensus 133 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~---~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER---KGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred EECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccc---cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987665432 223467889999999986421 12567899999999999999999999976554
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
......+....+. ++.
T Consensus 210 ~~~~~~~~~~~~~-------------------------------------------------~~~--------------- 225 (262)
T cd06613 210 MRALFLISKSNFP-------------------------------------------------PPK--------------- 225 (262)
T ss_pred HHHHHHHHhccCC-------------------------------------------------Ccc---------------
Confidence 3333222211000 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
. .....++.++++||++||..||.+|||+.+++.|||
T Consensus 226 ---~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ---L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 001234678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=241.28 Aligned_cols=193 Identities=27% Similarity=0.478 Sum_probs=146.0
Q ss_pred ccccCCcEEEEecc----CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKEE----GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+... ..+..|++|||+.||. |.+++. +...+..++.|++.||+|||+++|+|+||||+|
T Consensus 60 ~l~h~~i~-~~~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (265)
T cd06652 60 NLLHERIV-QYYGCLRDPMERTLSIFMEHMPGGS--IKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN 136 (265)
T ss_pred hcCCCCee-eEEeEeccCCCceEEEEEEecCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 46788865 44431 2345679999999998 777652 446788899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccC----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKG----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|+++.++.++|+|||++...... .......|+..|+|||.+.. ..++.++|+||+||++|+|++|..||.
T Consensus 137 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 137 ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG------EGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred EEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC------CCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999998765321 11233568899999998864 346789999999999999999999996
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
.......+.++...
T Consensus 211 ~~~~~~~~~~~~~~------------------------------------------------------------------ 224 (265)
T cd06652 211 EFEAMAAIFKIATQ------------------------------------------------------------------ 224 (265)
T ss_pred ccchHHHHHHHhcC------------------------------------------------------------------
Confidence 54332222211100
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.... .....++..+.++|++||. +|++|||++|+++|||+.
T Consensus 225 ----~~~~--~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 225 ----PTNP--VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----CCCC--CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0000 0012467889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=253.07 Aligned_cols=219 Identities=25% Similarity=0.413 Sum_probs=154.6
Q ss_pred ccccCCcEEEEeccCC--------cHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEEGD--------DLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~--------~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+... ...|+|+||+.. . +... ..+.+.+..++.|++.||+|||++||+||||||
T Consensus 70 ~l~h~niv-~~~~~~~~~~~~~~~~~~~lv~e~~~~-~--l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp 145 (342)
T cd07879 70 HMQHENVI-GLLDVFTSAVSGDEFQDFYLVMPYMQT-D--LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP 145 (342)
T ss_pred hcCCCCcc-chhheecccccCCCCceEEEEeccccc-C--HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 46788755 5544211 124789998864 3 4443 235688999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+|||++.++.+||+|||+++.... ......+++.|+|||.+... ..++.++|+||+||++|+|++|+.||.+.
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNW-----MHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCc-----cccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999876432 22345778999999998642 34678999999999999999999999988
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+..+...... ..|+....- +.. ......
T Consensus 219 ~~~~~~~~~~~~~~~------------~~~~~~~~~------------~~~-----------------------~~~~~~ 251 (342)
T cd07879 219 DYLDQLTQILKVTGV------------PGPEFVQKL------------EDK-----------------------AAKSYI 251 (342)
T ss_pred CHHHHHHHHHHhcCC------------CCHHHHHHh------------ccc-----------------------chHHHH
Confidence 766666665543210 111111000 000 000000
Q ss_pred hcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....+.. ..+..+++++++||++||+.||++|||++|+|.||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000110 1124578899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=238.27 Aligned_cols=193 Identities=30% Similarity=0.508 Sum_probs=150.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ .+.. +.++..|+++||+.++. |.+.+ .+...+..++.||+.||+|||+.||+|+||+|+||++
T Consensus 59 ~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~ 135 (258)
T cd06632 59 LQHPNIV-QYLGTEREEDNLYIFLELVPGGS--LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135 (258)
T ss_pred cCCCCch-heeeeEecCCeEEEEEEecCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 5788755 4443 44566789999999988 77665 2457788899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++.............|++.|+|||.+... ..++.++|+||+||++|++++|..||........
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-----~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ-----GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCC-----CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 99999999999998776544333456789999999998542 1367899999999999999999999965432222
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
..++... ..
T Consensus 211 ~~~~~~~---------------------------------------------------------------------~~-- 219 (258)
T cd06632 211 VFKIGRS---------------------------------------------------------------------KE-- 219 (258)
T ss_pred HHHHHhc---------------------------------------------------------------------cc--
Confidence 1111100 00
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.......+++++++||++||..||++|||+.++|.|||+
T Consensus 220 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123468899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=254.69 Aligned_cols=207 Identities=27% Similarity=0.499 Sum_probs=149.7
Q ss_pred HHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccC
Q psy3880 24 KHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG 99 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~ 99 (408)
.++|+|++ |+. |.+.+ .+.+++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~lv~e~~-~~~--L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 95 VYLVTHLM-GAD--LNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEEEecC-CCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 68999998 455 66654 345889999999999999999999999999999999999999999999999865432
Q ss_pred cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCC
Q psy3880 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179 (408)
Q Consensus 100 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 179 (408)
.....+++.|+|||.+... ..++.++|+||+||++|++++|..||.+.+....+..+.+.....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~--------- 235 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP--------- 235 (343)
T ss_pred --ccCCcccccccCHHHHhCC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---------
Confidence 3456788999999998642 246789999999999999999999999888777777666542111
Q ss_pred CCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHh
Q psy3880 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKL 259 (408)
Q Consensus 180 ~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~kl 259 (408)
.++.+ ... ..+ ..+. + ....|..... .+. ..+...|+++.|||++|
T Consensus 236 ---~~~~~-~~~---------~~~--~~~~--~---~~~~~~~~~~-------------~~~-~~~~~~s~~l~dli~~~ 281 (343)
T cd07851 236 ---DEELL-QKI---------SSE--SARN--Y---IQSLPQMPKK-------------DFK-EVFSGANPLAIDLLEKM 281 (343)
T ss_pred ---CHHHH-hhc---------cch--hHHH--H---HHhccccCCC-------------CHH-HHhccCCHHHHHHHHHh
Confidence 11111 000 000 0000 0 0000110000 000 11234688999999999
Q ss_pred cccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 260 LIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 260 L~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
|..||++|||+.|+|+||||....
T Consensus 282 l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 282 LVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred CCCChhhCCCHHHHhcCCCccccC
Confidence 999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=244.51 Aligned_cols=221 Identities=29% Similarity=0.443 Sum_probs=154.1
Q ss_pred ccccCCcEEEEeccC------------CcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKEEG------------DDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~------------~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|++ .+.+.. ....++|+||+.++. .+.+ .+.+.++.++.|++.||+|||++||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l---~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 137 (302)
T cd07864 62 QLNHRNIV-NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDL---MGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNF 137 (302)
T ss_pred hCCCCCee-eeeheecCcchhhhccccCCcEEEEEcccCccH---HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35788755 544321 125689999998753 3333 2458899999999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
+||||||+||++++++.+||+|||++..+.... ......+++.|+|||.+... ..++.++|+||+||++++|+
T Consensus 138 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Di~slG~~~~el~ 212 (302)
T cd07864 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE-----ERYGPAIDVWSCGCILGELF 212 (302)
T ss_pred ecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCC-----CCCCchhHHHHHHHHHHHHH
Confidence 999999999999999999999999998664432 11223567889999987532 34578999999999999999
Q ss_pred hCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 146 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 146 ~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
+|++||...+....+..+...........|...... +.|....
T Consensus 213 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~ 255 (302)
T cd07864 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL-------------------------------------PYFNTMK 255 (302)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc-------------------------------------ccccccc
Confidence 999999887776666665543222221111111000 0000000
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .........+..++.++++||.+||..||++|||+++++.||||
T Consensus 256 ~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 256 PKK-------QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccc-------ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000 00000112234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=244.45 Aligned_cols=219 Identities=27% Similarity=0.430 Sum_probs=153.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|++++ .+.+ ...+..|+++||+.+ . |.+.+ .+...+..++.|++.||+|||+++++||||+|+||
T Consensus 55 l~~~~iv-~~~~~~~~~~~~~iv~e~~~~-~--l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~ni 130 (283)
T cd07835 55 LNHPNIV-RLLDVVHSENKLYLVFEFLDL-D--LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNL 130 (283)
T ss_pred cCCCCcc-CHhheeccCCeEEEEEeccCc-C--HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHE
Confidence 5688755 4433 445677899999954 4 55544 24578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||++..+.... ......+++.|+|||++... ..++.++|+||+||++|+|++|++||...+.
T Consensus 131 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 131 LIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS-----RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred EEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecC-----cccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987654322 22234568899999987542 3467899999999999999999999988776
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+.++.......... .|..-..+..... .....
T Consensus 206 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~---------------~~~~~ 240 (283)
T cd07835 206 IDQLFRIFRTLGTPDED------------------------------VWPGVTSLPDYKP---------------TFPKW 240 (283)
T ss_pred HHHHHHHHHHhCCCChH------------------------------Hhhhhhhchhhhh---------------hcccc
Confidence 66655554432211111 1100000000000 00000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
...........++.++.+||.+||..||++|||++|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000011123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=242.61 Aligned_cols=190 Identities=18% Similarity=0.330 Sum_probs=146.3
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCC---------------------HHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINS---------------------NPALRYIMRQLFEALEHVH 63 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~---------------------~~~~r~i~~qil~aL~~LH 63 (408)
.+.|++++.-+.. ..+...+++|||+.+|. |.+.+.. ..++..++.|++.||.|||
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD--LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred hcCCcccceEEEEEcCCCceEEEEecCCCCc--HHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3678886533332 34556789999999998 7776632 3567889999999999999
Q ss_pred HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 64 ~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
++||+||||||+||++++++.+||+|||++........ .....+++.|+|||.+.. ..++.++|+||+||+
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDv~slG~i 215 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY------GKFTTESDIWSFGVV 215 (283)
T ss_pred hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc------CcCchhhhHHHHHHH
Confidence 99999999999999999999999999999876533221 223456788999998864 346789999999999
Q ss_pred HHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 141 MYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 141 l~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
+|+|++ |..||.+.+..+....+..+
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~----------------------------------------------------- 242 (283)
T cd05048 216 LWEIFSYGLQPYYGFSNQEVIEMIRSR----------------------------------------------------- 242 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcC-----------------------------------------------------
Confidence 999997 99998776554443333221
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
... .. -..+++++.+|+++||..||++|||+.|+++|
T Consensus 243 -----------------~~~-~~--~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 -----------------QLL-PC--PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -----------------CcC-CC--cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 00 12468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=253.20 Aligned_cols=223 Identities=35% Similarity=0.521 Sum_probs=156.6
Q ss_pred ccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|+|++ .+.. ......|+||||+.+ . |...+ .+...+..++.||+.||+|||++||+||||||+||++
T Consensus 65 ~h~ni~-~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill 140 (337)
T cd07852 65 DHPNIV-KLLNVIKAENDKDIYLVFEYMET-D--LHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140 (337)
T ss_pred CCCCcc-ceeeeeccCCCceEEEEeccccc-C--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 788754 5544 223356899999975 4 65554 3457788899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+.++.+||+|||++..+.... ......||+.|+|||.+... ..++.++|+||+||++|+|++|..||.+
T Consensus 141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS-----TRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc-----ccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999987654322 22335689999999987542 3467899999999999999999999988
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
........++........ .+.+ ..+.. ++ ...++..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~------------~~~~-----------------~~~~~----------~~----~~~~~~~~ 252 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPS------------AEDI-----------------ESIKS----------PF----AATMLDSL 252 (337)
T ss_pred CChHHHHHHHHHHhCCCC------------HHHH-----------------HHHHh----------hh----HHHhhhhc
Confidence 877766666654321110 0000 00000 00 00011111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..............++.++.+||.+||+.||++|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 253 PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred ccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 1111111111123478899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=242.53 Aligned_cols=195 Identities=21% Similarity=0.376 Sum_probs=148.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------HHHHHHHHHHHHHHHHHHHHCCCe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------NPALRYIMRQLFEALEHVHNHSVV 68 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------~~~~r~i~~qil~aL~~LH~~~Iv 68 (408)
.+.|++++ ++.. ...+..|+||||+.+|. |.+++.. ...+..++.|++.||.|||+++|+
T Consensus 65 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 141 (288)
T cd05061 65 GFTCHHVV-RLLGVVSKGQPTLVVMELMAHGD--LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV 141 (288)
T ss_pred hCCCCCee-eEEEEEcCCCCcEEEEeCCCCCC--HHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence 46788755 5543 45567899999999998 8887742 246788999999999999999999
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
||||||+|||++.++.+||+|||+++........ ....++..|+|||.+.. ..++.++|+||+||++|+|+
T Consensus 142 H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~------~~~~~~~DvwslG~~l~el~ 215 (288)
T cd05061 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD------GVFTTSSDMWSFGVVLWEIT 215 (288)
T ss_pred CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc------CCCChHhHHHHHHHHHHHHH
Confidence 9999999999999999999999998765432211 12345678999999864 34678999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 146 V-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 146 ~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+ |..||.+....+....+..+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~---------------------------------------------------------- 237 (288)
T cd05061 216 SLAEQPYQGLSNEQVLKFVMDG---------------------------------------------------------- 237 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcC----------------------------------------------------------
Confidence 8 78888665443333322211
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc------CCCCCCC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN------HSFFHPK 282 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~------Hpwf~~~ 282 (408)
.... .+ ...+++++++|.+||+.||++|||+.++++ ||||.+.
T Consensus 238 ------------~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 ------------GYLD-QP--DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred ------------CCCC-CC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 1000 00 134678999999999999999999999987 9999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=243.38 Aligned_cols=194 Identities=30% Similarity=0.509 Sum_probs=147.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ++.+..++|+||+.|+. |.+.+. ++.++..++.||++||.|||++|++|+||||+||+
T Consensus 56 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 56 ELNHPFLV-NLWYSFQDEENMYLVVDLLLGGD--LRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred hCCCCChH-HHHHhhcCCCeEEEEEeCCCCCC--HHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 56888744 5543 45567899999999998 766653 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+++++.++|+|||++.............|+..|+|||.+... .++.++|+||+|+++|+|++|..||...+...
T Consensus 133 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 133 LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ------GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred EcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHccc------CCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 999999999999998876554334456788899999998642 35677888888888888888887775432100
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...+.........
T Consensus 207 -------------------------------------------------------------------~~~~~~~~~~~~~ 219 (258)
T cd05578 207 -------------------------------------------------------------------RDQIRAKQETADV 219 (258)
T ss_pred -------------------------------------------------------------------HHHHHHHhccccc
Confidence 0111111111111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCH--HHHHcCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV--KEALNHSFF 279 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta--~e~L~Hpwf 279 (408)
.+ ...++.++.++|++||..||.+|+|+ +|+++||||
T Consensus 220 ~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 LY----PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cC----cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 11 13467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=242.79 Aligned_cols=199 Identities=29% Similarity=0.461 Sum_probs=149.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|++ .+.. ..++..|+|+||+.|+...+... -.+..++..++.|++.||.|||++||+||||+|+||+++
T Consensus 71 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~ 149 (307)
T cd06607 71 QLRHPNTI-EYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT 149 (307)
T ss_pred hCCCCCEE-EEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC
Confidence 46788855 5443 45567789999998653222221 124578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
+++.+||+|||++...... ....+++.|+|||++... ....++.++|+||+||++|+|++|..||.+.+.....
T Consensus 150 ~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~---~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~ 223 (307)
T cd06607 150 EPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (307)
T ss_pred CCCCEEEeecCcceecCCC---CCccCCccccCceeeecc---CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence 9999999999998765432 245788899999987431 1234778999999999999999999999776544433
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
..+.... +| ..
T Consensus 224 ~~~~~~~---------------------------------------------------~~------------------~~ 234 (307)
T cd06607 224 YHIAQND---------------------------------------------------SP------------------TL 234 (307)
T ss_pred HHHhcCC---------------------------------------------------CC------------------CC
Confidence 3221110 00 01
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. ...+.++++||.+||..||++|||+.+++.||||....
T Consensus 235 ~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 235 SS---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred Cc---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 01 12467899999999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=243.20 Aligned_cols=195 Identities=26% Similarity=0.464 Sum_probs=149.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
.|++++ .+.+ +.++..++||||+.||. |.+.+. +...+..++.|++.||.|||+.||+|+||+|+||+++.
T Consensus 60 ~~~~vi-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~ 136 (277)
T cd06917 60 QPPNIT-KYYGSYLKGPRLWIIMEYAEGGS--VRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136 (277)
T ss_pred CCCCee-eEeeeeeeCCEEEEEEecCCCCc--HHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC
Confidence 488765 4443 44556789999999997 766653 34788999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
++.++|+|||++..+..... .....|+..|+|||.+... ..++.++|+||+||++|+|++|..||.+.......
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 137 TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG-----KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred CCCEEEccCCceeecCCCccccccccCCcceeCHHHhccC-----CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 99999999999877654332 2345789999999998542 34678999999999999999999998654322111
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
..+.. ..+
T Consensus 212 ~~~~~---------------------------------------------------~~~--------------------- 219 (277)
T cd06917 212 MLIPK---------------------------------------------------SKP--------------------- 219 (277)
T ss_pred hcccc---------------------------------------------------CCC---------------------
Confidence 10000 000
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+...+...+.++.++|.+||..||++|||+.|+++||||...
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 001112367889999999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=239.51 Aligned_cols=189 Identities=28% Similarity=0.469 Sum_probs=148.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ ++++..|+|+||+.+|. |.+.+. +++.+..++.|++.||.|||++||+|+||||+|
T Consensus 54 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~n 130 (255)
T cd08219 54 KMKHPNIV-AFKESFEADGHLYIVMEYCDGGD--LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKN 130 (255)
T ss_pred hCCCCCcc-eEEEEEEECCEEEEEEeeCCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 46798865 4443 55667899999999998 766542 457888999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++++++.++++|||++........ .....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+
T Consensus 131 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 131 IFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN------MPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred EEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc------CCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 9999999999999999876643222 234678899999999864 346789999999999999999999997655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+.
T Consensus 205 ~~~~~~~~~~~~-------------------------------------------------------------------- 216 (255)
T cd08219 205 WKNLILKVCQGS-------------------------------------------------------------------- 216 (255)
T ss_pred HHHHHHHHhcCC--------------------------------------------------------------------
Confidence 443333332221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+.. ....++.++++||.+||..||++|||+.|+++-
T Consensus 217 --~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --YKP---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCC---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 110 012357789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=243.75 Aligned_cols=224 Identities=32% Similarity=0.466 Sum_probs=156.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ..++..++|+||+.++. +.... .+..++..++.||+.||.|||+++++||||+|+||+
T Consensus 56 ~l~~~~i~-~~~~~~~~~~~~~iv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~ 132 (288)
T cd07833 56 QLRHENIV-NLKEAFRRKGRLYLVFEYVERTL--LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENIL 132 (288)
T ss_pred hcCCCCee-ehhheEEECCEEEEEEecCCCCH--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 46788754 5554 33456789999999876 44333 235788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++++.+||+|||++....... ......+++.|+|||++... ..++.++|+||+|+++|+|++|.+||.+.+.
T Consensus 133 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 133 VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD-----TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred ECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCC-----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999988765443 23346788999999998642 2577899999999999999999999988776
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+.........+..... ..+-+..+. ..|-. ........
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~--------~~~~~--~~~~~~~~---- 251 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELF----------------------SSNPRFAGV--------AFPEP--SQPESLER---- 251 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhc----------------------ccCcccccc--------ccCCC--CCcHHHHH----
Confidence 6555554432222111100000 000000000 00000 00000000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+ -..+++++++||++||..||++|||++++++||||
T Consensus 252 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 252 --RY----PGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred --hc----CCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 02358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=250.85 Aligned_cols=103 Identities=25% Similarity=0.477 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~ 122 (408)
+.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......... ...++..|+|||++..
T Consensus 214 ~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 290 (375)
T cd05104 214 EDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--- 290 (375)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC---
Confidence 4567889999999999999999999999999999999999999999997654332211 2334567999999864
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
..++.++|+|||||++|+|++ |..||...
T Consensus 291 ---~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 291 ---CVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ---CCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 357889999999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=239.83 Aligned_cols=190 Identities=21% Similarity=0.329 Sum_probs=142.7
Q ss_pred ccccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|++..+... .....++++||+.+|+ |.+.+ .+...+..++.||+.||+|||+++|
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 133 (272)
T cd05075 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD--LHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF 133 (272)
T ss_pred hCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc--HHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 46899866433211 1234679999999998 66554 2347788999999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||||||+|||++.++.+||+|||+++.+...... ....+++.|+|||.+.. ..++.++|+||+||++|+|
T Consensus 134 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slG~il~el 207 (272)
T cd05075 134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD------RVYTTKSDVWSFGVTMWEI 207 (272)
T ss_pred eccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC------CCcChHHHHHHHHHHHHHH
Confidence 99999999999999999999999999876543221 12345678999998864 4578899999999999999
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+.........+..+
T Consensus 208 ~~~g~~p~~~~~~~~~~~~~~~~--------------------------------------------------------- 230 (272)
T cd05075 208 ATRGQTPYPGVENSEIYDYLRQG--------------------------------------------------------- 230 (272)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcC---------------------------------------------------------
Confidence 98 78888665443333322211
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
... +....++++++++|.+||..||++|||+.+++++
T Consensus 231 -------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 231 -------------NRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 100 0112457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=238.46 Aligned_cols=192 Identities=30% Similarity=0.522 Sum_probs=149.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ +.++..|+|+||+.++. |.+.+. ++..+..++.|++.||.|||+++++|+||||+|
T Consensus 55 ~~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n 131 (257)
T cd08225 55 KMKHPNIV-TFFASFQENGRLFIVMEYCDGGD--LMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN 131 (257)
T ss_pred hCCCCChh-hhhheeccCCeEEEEEecCCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 45788755 5544 45566799999999998 777653 457889999999999999999999999999999
Q ss_pred EEEecCC-CEEEeccccchhcccCccc-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 77 ILLDDQM-NVKLTDFGFARVLKKGEKL-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 77 ILl~~~~-~iKl~DFGla~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|++++++ .+||+|||.+......... ....|++.|+|||.+.. ..++.++|+||+||+++++++|..||...
T Consensus 132 il~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 132 IFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN------RPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred EEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998876 4699999999876543322 23568899999998754 34678999999999999999999999765
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+.
T Consensus 206 ~~~~~~~~~~~~~------------------------------------------------------------------- 218 (257)
T cd08225 206 NLHQLVLKICQGY------------------------------------------------------------------- 218 (257)
T ss_pred cHHHHHHHHhccc-------------------------------------------------------------------
Confidence 5433333222110
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.. +.-..++.+++++|.+||..||++|||+.|+++||||
T Consensus 219 ---~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ---FA---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---CC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00 0012457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=242.38 Aligned_cols=218 Identities=31% Similarity=0.487 Sum_probs=157.0
Q ss_pred cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 9 HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 9 ~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
|++++ .+.. +.++..|+||||+ +|. |.+.+. +..++..++.|++.||.|||++|++|+||+|+||++
T Consensus 57 h~~i~-~~~~~~~~~~~~~lv~e~~-~~~--l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i 132 (283)
T cd07830 57 HPNIV-KLKEVFRENDELYFVFEYM-EGN--LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV 132 (283)
T ss_pred CCCch-hHHHHhhcCCcEEEEEecC-CCC--HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 77744 5554 4466789999999 665 555432 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.++|+|||++.............++..|+|||++... ..++.++|+||+|+++++|++|++||...+....
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~ 207 (283)
T cd07830 133 SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS-----TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207 (283)
T ss_pred cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecC-----cCcCCccchhhHHHHHHHHHhCCCccCCCChHHH
Confidence 99999999999999876554444456788999999987542 3467899999999999999999999988887777
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.++......... +.|.-+.-+........|..... . +
T Consensus 208 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~--~-~--------- 245 (283)
T cd07830 208 LYKICSVLGTPTK------------------------------QDWPEGYKLASKLGFRFPQFAPT--S-L--------- 245 (283)
T ss_pred HHHHHHhcCCCCh------------------------------hhhhhHhhhhccccccccccccc--c-H---------
Confidence 6666553222211 12221111110000000000000 0 0
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.......++++++||++||+.||++|||++|++.||||
T Consensus 246 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 246 --HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred --HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00112347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=250.64 Aligned_cols=226 Identities=27% Similarity=0.458 Sum_probs=160.3
Q ss_pred ccccCCcEEEEecc--CC-----cHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE--GD-----DLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--~~-----~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|++++ .+.+. .. ...|+||||+.+ . |.+.+. +...+..++.||+.||+|||++||+|||||
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlk 130 (330)
T cd07834 55 HLRHENII-GLLDILRPPSPEDFNDVYIVTELMET-D--LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLK 130 (330)
T ss_pred hcCCcchh-hhhhhhcccCcccccceEEEecchhh-h--HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 35688754 44431 11 256899999985 3 555543 457889999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
|+|||++.++.++|+|||++....... ......+++.|+|||.+... ..++.++|+||+||++|+|++|.+
T Consensus 131 p~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~sDi~slG~il~~l~~g~~ 205 (330)
T cd07834 131 PSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS-----SRYTKAIDIWSVGCIFAELLTRKP 205 (330)
T ss_pred HHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecc-----cCCCcchhHHHHHHHHHHHHcCCC
Confidence 999999999999999999998765442 23446788999999998652 257889999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+.+....+..+...........+.......+.+ .+.+..+.....
T Consensus 206 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~---- 253 (330)
T cd07834 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN----------------------------YLKSLPKKPKKP---- 253 (330)
T ss_pred CcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhh----------------------------HHhhcccCCcch----
Confidence 999998887777776543222211111000000000 000000000000
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
. ......+++++.+||.+||..||.+|||++++|+||||....
T Consensus 254 ~-----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 254 L-----------SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred h-----------HHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0 001134788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=243.36 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=150.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.+ .+++..++||||+.||. |.+.+. +..++..++.|++.||+|||+++++|+||+|+||++
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~ 134 (277)
T cd06640 58 QCDSPYVT-KYYGSYLKGTKLWIIMEYLGGGS--ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL 134 (277)
T ss_pred hCCCCCEe-eEEEEEEECCEEEEEEecCCCCc--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE
Confidence 46788755 5444 45567899999999998 887764 347788899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||++........ .....++..|+|||++.. ..++.++|+||+||++|+|++|..||...+...
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred cCCCCEEEcccccceeccCCccccccccCcccccCHhHhcc------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 9999999999999876544321 223568889999999864 346778999999999999999999986543322
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+. .+.+|
T Consensus 209 ~~~~~~---------------------------------------------------~~~~~------------------ 219 (277)
T cd06640 209 VLFLIP---------------------------------------------------KNNPP------------------ 219 (277)
T ss_pred Hhhhhh---------------------------------------------------cCCCC------------------
Confidence 111110 00011
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....++.++.+||.+||..||++|||++++++||||...
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 220 ----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0112356788999999999999999999999999999664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=241.96 Aligned_cols=188 Identities=19% Similarity=0.344 Sum_probs=145.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------------------CHHHHHHHHHHHHHHHHHHHHC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------------------SNPALRYIMRQLFEALEHVHNH 65 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------------------~~~~~r~i~~qil~aL~~LH~~ 65 (408)
.+.|++++ ++.+ ...+..++|+||+.+|. |.+.+. +...+..++.|++.||+|||++
T Consensus 63 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~ 139 (288)
T cd05093 63 NLQHEHIV-KFYGVCVEGDPLIMVFEYMKHGD--LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139 (288)
T ss_pred hCCCCCcc-eEEEEEecCCccEEEEEcCCCCC--HHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46798755 5543 45577899999999998 777663 4468889999999999999999
Q ss_pred CCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 66 SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 66 ~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
|++||||||+|||+++++.+||+|||++........ .....+++.|+|||.+.. ..++.++|+|||||++|
T Consensus 140 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~il~ 213 (288)
T cd05093 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY------RKFTTESDVWSLGVVLW 213 (288)
T ss_pred CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc------CCCCchhhHHHHHHHHH
Confidence 999999999999999999999999999876543221 112345778999998864 35678999999999999
Q ss_pred HHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 143 TLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 143 ~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
+|++ |..||...+....+..+..+
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~------------------------------------------------------- 238 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQG------------------------------------------------------- 238 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-------------------------------------------------------
Confidence 9998 88888765544444443322
Q ss_pred CCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 222 WHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 222 ~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.... .-...+.++++||.+||+.||.+|||++|++.
T Consensus 239 ---------------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 ---------------RVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ---------------CcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1100 01235778999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=250.11 Aligned_cols=223 Identities=24% Similarity=0.412 Sum_probs=156.7
Q ss_pred ccccCCcEEEEecc---CCc-----HHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE---GDD-----LKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~---~~~-----~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.+. +.. ..++|+|++ |+. |.+.+. +...++.++.||+.||+|||++||+|||||
T Consensus 70 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~lv~e~~-~~~--l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk 145 (343)
T cd07880 70 HMKHENVI-GLLDVFTPDLSLDRFHDFYLVMPFM-GTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK 145 (343)
T ss_pred hcCCCCcc-ceeeeecCCccccccceEEEEEecC-CCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 46788855 44432 111 237899998 555 655543 458899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+||+++.++.+||+|||++...... .....+++.|+|||.+... ..++.++|+||+||++|++++|..||.+
T Consensus 146 p~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 146 PGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNW-----MHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred HHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998765432 2345778999999998642 3467899999999999999999999998
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+......+++...... |+.+..... ..+. .......+.+... .+
T Consensus 219 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~--------~~~~-------~~~~~~~~~~~~~----~~--- 263 (343)
T cd07880 219 HDHLDQLMEIMKVTGTP-------------SKEFVQKLQ--------SEDA-------KNYVKKLPRFRKK----DF--- 263 (343)
T ss_pred CCHHHHHHHHHHhcCCC-------------CHHHHHhhc--------chhH-------HHHHHhccccCcc----hH---
Confidence 87766666665432211 111110000 0000 0000000111000 00
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+..+++++.+||.+||..||++|||+.++++||||+..
T Consensus 264 --------~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 264 --------RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred --------HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 01134678899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=244.71 Aligned_cols=194 Identities=27% Similarity=0.449 Sum_probs=149.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++ .+.. ..++..|+|+||+.+|. |.+.+. ++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i 134 (277)
T cd06642 58 QCDSPYIT-RYYGSYLKGTKLWIIMEYLGGGS--ALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL 134 (277)
T ss_pred cCCCCccH-hhhcccccCCceEEEEEccCCCc--HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE
Confidence 46788755 4443 45667899999999998 777663 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++++|||++..+..... .....|+..|+|||.+.. ..++.++|+||+||++|+|++|..||.......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 9999999999999876654321 123568889999999864 346789999999999999999999985432211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+ ..+.+|
T Consensus 209 ~~~~~---------------------------------------------------~~~~~~------------------ 219 (277)
T cd06642 209 VLFLI---------------------------------------------------PKNSPP------------------ 219 (277)
T ss_pred HHhhh---------------------------------------------------hcCCCC------------------
Confidence 11110 000001
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.. -...+.++.+||.+||..||++|||+.++++||||..
T Consensus 220 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 TL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00 0135778999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=241.43 Aligned_cols=194 Identities=35% Similarity=0.637 Sum_probs=144.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+|++ ++.+ +..+..|+++|++.||. |.+.+. ++..+..++.||+.||+|||++|++|+||+|+||++
T Consensus 50 ~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~ 126 (265)
T cd05579 50 AQSPYVV-KLYYSFQGKKNLYLVMEYLPGGD--LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI 126 (265)
T ss_pred CCCcchh-HHHHheecCcEEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE
Confidence 5688755 4443 44566789999999987 766543 457888999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc---------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE---------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+.++.++|+|||++....... ......+++.|+|||.+... .++.++|+||+|+++|++++|..|
T Consensus 127 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~Dv~slG~~~~~l~~g~~p 200 (265)
T cd05579 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ------GHSKTVDWWSLGCILYEFLVGIPP 200 (265)
T ss_pred cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC------CCCcchhhHHHHHHHHHHHhCCCC
Confidence 999999999999987643321 11235677889999987542 245667777777777777777666
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|... ......
T Consensus 201 ~~~~----------------------------------------------------------------------~~~~~~ 210 (265)
T cd05579 201 FHGE----------------------------------------------------------------------TPEEIF 210 (265)
T ss_pred CCCC----------------------------------------------------------------------CHHHHH
Confidence 6433 222333
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH---HHHHcCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV---KEALNHSFFHP 281 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta---~e~L~Hpwf~~ 281 (408)
..+..+.+.++.. ..+++++.+||++||+.||++|||+ .++|+||||..
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 211 QNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 3344333333221 2358899999999999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=240.33 Aligned_cols=197 Identities=27% Similarity=0.468 Sum_probs=146.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
++.|+++| .+.+ ...+..++|+||+.||. |.+.+. ++..+..++.||+.||+|||++|++||||||+||+
T Consensus 59 ~l~h~~iv-~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil 135 (268)
T cd06630 59 RLNHPHII-RMLGATCEDSHFNLFVEWMAGGS--VSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLL 135 (268)
T ss_pred HcCCCcee-hhhceeccCCeEEEEEeccCCCc--HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 36788855 5554 34456789999999997 766652 34788899999999999999999999999999999
Q ss_pred EecCC-CEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 79 LDDQM-NVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 79 l~~~~-~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++.++ .+||+|||++..+..... .....||..|+|||.+.. ..++.++|+||+||++|++++|..||.
T Consensus 136 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG------EQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred EcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc------CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 98765 599999999876653211 123468889999999854 346789999999999999999999985
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..........+ ..
T Consensus 210 ~~~~~~~~~~~-------------------------------------------------------------------~~ 222 (268)
T cd06630 210 AEKHSNHLALI-------------------------------------------------------------------FK 222 (268)
T ss_pred CCCCcchHHHH-------------------------------------------------------------------HH
Confidence 43211110000 00
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
+...... ......++++++++|.+||..||++|||+.|+|+||||.
T Consensus 223 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 223 IASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HhccCCC--CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0000000 011124688999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=239.32 Aligned_cols=198 Identities=30% Similarity=0.547 Sum_probs=147.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ...+..++|+||+.++. |.+.+. +...++.++.|++.||.|||++||+|+||+|+||+
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil 131 (264)
T cd06626 55 LLKHPNLV-KYYGVEVHREKVYIFMEYCSGGT--LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131 (264)
T ss_pred hCCCCChh-heeeeEecCCEEEEEEecCCCCc--HHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 35788755 5443 45567899999999998 777653 44788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+++++.+||+|||++........ .....+++.|+|||++.... ...++.++|+||+||+++++++|..||..
T Consensus 132 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK---GKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred ECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCC---CCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 99999999999999887643322 12356788999999986431 12356778888888888888888877743
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.... | .+.+....+.
T Consensus 209 ~~~~-----------------------------------------------~---~~~~~~~~~~--------------- 223 (264)
T cd06626 209 LDNE-----------------------------------------------F---QIMFHVGAGH--------------- 223 (264)
T ss_pred Ccch-----------------------------------------------H---HHHHHHhcCC---------------
Confidence 2100 0 0111111111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....+.+..+++.+++||.+||+.||.+|||+.|+++|||+
T Consensus 224 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 224 -----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11223445678999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=245.55 Aligned_cols=187 Identities=22% Similarity=0.352 Sum_probs=139.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|++++ .+.. +.++..|+||||+.+|. |.+.+. +.+++..++.||+.||+|||+
T Consensus 66 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 66 HHPNII-NLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred CCCCcc-eEEEEECCCCCceEEEEeCCCCc--HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 677754 5543 55667899999999998 777653 346789999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||+||||||+|||++.++.+||+|||++.............++..|+|||.+.. ..++.++|+||+||++|+|
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el 216 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY------SVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc------cCCcccccchhhhhHHHHH
Confidence 9999999999999999999999999999864321111111234567999998854 3467788999999999998
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+.+..+....+..
T Consensus 217 lt~g~~p~~~~~~~~~~~~~~~---------------------------------------------------------- 238 (303)
T cd05088 217 VSLGGTPYCGMTCAELYEKLPQ---------------------------------------------------------- 238 (303)
T ss_pred HhcCCCCcccCChHHHHHHHhc----------------------------------------------------------
Confidence 87 8888865443332222211
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+ +.. +.+..+++++.+||.+||..||++|||++++|++
T Consensus 239 ------------~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 ------------G-YRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------------C-CcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 000 1123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=246.69 Aligned_cols=198 Identities=30% Similarity=0.516 Sum_probs=151.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++ |+.+.+ ..++..|+|+||+.+|. |.+.+. +..++..++.|++.||.|||++|++||||||+||++
T Consensus 72 ~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili 148 (293)
T cd06647 72 ENKHPN-IVNYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148 (293)
T ss_pred hcCCCC-eeehhheeeeCCcEEEEEecCCCCc--HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence 357887 446554 34567799999999998 777654 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||++....... ......|++.|+|||.+.. ..++.++|+||+||++|++++|..||...+...
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred cCCCCEEEccCcceecccccccccccccCChhhcCchhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 999999999999987654332 2233568899999998854 346788999999999999999999996644321
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+. ..+.++
T Consensus 223 ~~~~~~--------------------------------------------------~~~~~~------------------ 234 (293)
T cd06647 223 ALYLIA--------------------------------------------------TNGTPE------------------ 234 (293)
T ss_pred heeehh--------------------------------------------------cCCCCC------------------
Confidence 111000 000011
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+ ..+..++..+++||++||..||++|||+.+++.||||....
T Consensus 235 -~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 -L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 1 12335678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=239.74 Aligned_cols=188 Identities=19% Similarity=0.333 Sum_probs=145.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.+.|++++ .+.. ......++||||+.||. |.+++. +...+..++.|++.||.|||+
T Consensus 64 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 64 NFQHENIV-KFYGVCTEGDPPIMVFEYMEHGD--LNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred hcCCCCch-heeeEEecCCCeEEEEecCCCCC--HHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 46788755 4443 44467899999999998 877763 235778899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+|++||||||+||+++.++.+||+|||++..+..... .....+++.|+|||++.. ..++.++|+||+||++
T Consensus 141 ~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il 214 (280)
T cd05049 141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY------RKFTTESDVWSFGVVL 214 (280)
T ss_pred CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc------CCcchhhhHHHHHHHH
Confidence 9999999999999999999999999999875433221 122345678999999864 3578899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+.......+..+
T Consensus 215 ~e~~~~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 240 (280)
T cd05049 215 WEIFTYGKQPWYGLSNEEVIECITQG------------------------------------------------------ 240 (280)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC------------------------------------------------------
Confidence 99998 99998765554443333221
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..... ...++.++++||++||..||++|||++|+++
T Consensus 241 ----------------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 ----------------RLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ----------------CcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11110 1246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=242.27 Aligned_cols=145 Identities=21% Similarity=0.398 Sum_probs=113.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC------------------------HHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS------------------------NPALRYIMRQLFEAL 59 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~------------------------~~~~r~i~~qil~aL 59 (408)
.+.|+|+| .+.+ ..++..++||||+.+|. |.+++.. ...+..++.||+.||
T Consensus 75 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 75 RLKDPNII-RLLGVCVDEDPLCMITEYMENGD--LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred hcCCCCee-EEEEEEecCCceEEEEecCCCCc--HHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 46798855 5543 44567899999999998 8776632 245778999999999
Q ss_pred HHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhh
Q psy3880 60 EHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWA 136 (408)
Q Consensus 60 ~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwS 136 (408)
.|||++||+||||||+|||++.++.+||+|||+++.+..... .....++..|+|||++.. ..++.++|+||
T Consensus 152 ~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~s 225 (304)
T cd05096 152 KYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM------GKFTTASDVWA 225 (304)
T ss_pred HHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc------CCCCchhhhHH
Confidence 999999999999999999999999999999999986544322 122455788999999864 34788999999
Q ss_pred hhHHHHHHHh--CCCCCCCchhHHH
Q psy3880 137 CGVIMYTLLV--GCPPFWHRKQMVM 159 (408)
Q Consensus 137 lGvil~~ll~--G~~pf~~~~~~~~ 159 (408)
|||++|+|++ +..||.+.+..+.
T Consensus 226 lG~~l~el~~~~~~~p~~~~~~~~~ 250 (304)
T cd05096 226 FGVTLWEILMLCKEQPYGELTDEQV 250 (304)
T ss_pred HHHHHHHHHHccCCCCCCcCCHHHH
Confidence 9999999986 5567765544433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=258.72 Aligned_cols=201 Identities=27% Similarity=0.359 Sum_probs=144.1
Q ss_pred HHHHHHHHHhhchhhHHhhhCC-----------------------------HHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 23 LKHLAAQVVDKGEAAVQDIINS-----------------------------NPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~~~-----------------------------~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
..+||+||+.+|. |.+.+.. ...++.++.|++.||.|||+++|+|||||
T Consensus 259 ~~~LV~Ey~~~gs--L~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 259 SQWLVWKFESDAT--LGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred ceEEEEEcCCCCc--HHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 4578888888877 6655431 24578899999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccC--CCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDL--CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|+|||++.++.+||+|||++..+..+...... .+|+.|+|||.+... .....++.++++.++.......
T Consensus 337 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~------~~~~~~~~~~~~~~l~~~~~~y--- 407 (507)
T PLN03224 337 PENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP------QSCPRAPAPAMAALLSPFAWLY--- 407 (507)
T ss_pred hHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC------CCCCccchhhhhhhhhhhHHhc---
Confidence 99999999999999999999765443322222 347899999998642 2234445555444433322110
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC-CCCCchh----
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP-PFWHRKQ---- 226 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~-Pf~~~~~---- 226 (408)
+.....|+||+||++|+|++|.. ||.....
T Consensus 408 ---------------------------------------------g~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~ 442 (507)
T PLN03224 408 ---------------------------------------------GRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE 442 (507)
T ss_pred ---------------------------------------------CCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH
Confidence 01125799999999999999875 7653211
Q ss_pred -------HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCC---CCCCCHHHHHcCCCCCC
Q psy3880 227 -------MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTP---EDRYSVKEALNHSFFHP 281 (408)
Q Consensus 227 -------~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP---~~R~ta~e~L~Hpwf~~ 281 (408)
....+.+....+.| +.|+.+|++++|||.+||..+| .+|+||+|+|+||||.+
T Consensus 443 ~~~~~~~~~~~r~~~~~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 443 LRQYDNDLNRWRMYKGQKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HhhccchHHHHHhhcccCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11122233344444 3578899999999999999876 68999999999999965
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=242.46 Aligned_cols=187 Identities=19% Similarity=0.336 Sum_probs=139.8
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+++| .+.+ ...+..|+|+||+.+|. |.+.+. +.+.++.++.|++.||+|||+
T Consensus 61 ~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 61 HHPNII-NLLGACENRGYLYIAIEYAPYGN--LLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred CCCchh-heEEEEccCCcceEEEEecCCCc--HHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 577755 5543 44567899999999998 777763 236788999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||+||||||+|||++.++.+||+|||++..............+..|+|||.+.. ..++.++|+|||||++|+|
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY------SVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc------CCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999864322111111223457999998854 3467889999999999999
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+........++..+
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~--------------------------------------------------------- 234 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQG--------------------------------------------------------- 234 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcC---------------------------------------------------------
Confidence 87 88888665443333322211
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+.. +....++.++++||.+||..||.+|||++++++.
T Consensus 235 --------------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 --------------YRM--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------CCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001 1113468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=250.32 Aligned_cols=206 Identities=26% Similarity=0.448 Sum_probs=144.2
Q ss_pred HHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-CCCEEEeccccchhccc
Q psy3880 24 KHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-QMNVKLTDFGFARVLKK 98 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-~~~iKl~DFGla~~~~~ 98 (408)
.|+|+||+.+ . |.+.+ .++..++.++.||+.||+|||++||+||||||+||+++. ++.+|++|||++..+..
T Consensus 91 ~~lv~e~~~~-~--L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 91 VYIVQEYMET-D--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred EEEEeecccc-c--HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 5799999974 4 65554 345899999999999999999999999999999999974 55789999999876543
Q ss_pred Ccc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCC
Q psy3880 99 GEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPE 174 (408)
Q Consensus 99 ~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 174 (408)
... .....++..|+|||.+... ..++.++|+||+||++|+|++|..||.+.+.......+........
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 239 (342)
T cd07854 168 HYSHKGYLSEGLVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR--- 239 (342)
T ss_pred ccccccccccccccccccCHHHHhCc-----cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC---
Confidence 211 1224678899999987542 3577899999999999999999999998877766666554321100
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhh-cCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPK 253 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll-~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~ 253 (408)
++... ..++ +.. ..+. ....+... ... .-..++.+++
T Consensus 240 ---------~~~~~--------------~~~~-~~~-~~~~~~~~~~~~~------~~~-----------~~~~~~~~~~ 277 (342)
T cd07854 240 ---------EEDRN--------------ELLN-VIP-SFVRNDGGEPRRP------LRD-----------LLPGVNPEAL 277 (342)
T ss_pred ---------hHHhh--------------hhhh-hhh-hhhhhcccccCCC------HHH-----------HccCCCHHHH
Confidence 00000 0000 000 0000 00000000 000 0124788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 254 DLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 254 dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+||++||+.||.+|||++|+|+||||+..
T Consensus 278 ~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 278 DFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 99999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=244.57 Aligned_cols=199 Identities=32% Similarity=0.576 Sum_probs=147.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.. +.+...|+|+||+.+|. |.+.+. ....++.++.|++.||.|||++|++||||||+|||++
T Consensus 63 ~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~ 139 (290)
T cd05613 63 QSPF-LVTLHYAFQTDTKLHLILDYINGGE--LFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139 (290)
T ss_pred cCCC-hhceeeEeecCCeEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC
Confidence 3555 556553 44566789999999998 887763 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
.++.+||+|||++....... ......|+..|+|||.+... ...++.++|+||+||++|+|++|..||.....
T Consensus 140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-- 213 (290)
T cd05613 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG----DGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-- 213 (290)
T ss_pred CCCCEEEeeCccceecccccccccccccCCcccCChhhccCC----CCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--
Confidence 99999999999987654322 22346789999999988542 12356678888888888888888877732110
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
......+...+.....
T Consensus 214 ----------------------------------------------------------------~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 214 ----------------------------------------------------------------KNSQAEISRRILKSEP 229 (290)
T ss_pred ----------------------------------------------------------------cccHHHHHHHhhccCC
Confidence 0011122223332222
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~~ 283 (408)
.++ ..+++.+.+||++||..||++|+ +++++++||||+...
T Consensus 230 ~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 230 PYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 221 34688899999999999999997 899999999997753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=236.71 Aligned_cols=189 Identities=19% Similarity=0.287 Sum_probs=144.5
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|++++..+....++..++||||+.+|. |.+.+. +++.+..++.|++.||+|||++||+||||||.||+++
T Consensus 52 ~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~ 129 (257)
T cd05116 52 QLDNPYIVRMIGICEAESWMLVMELAELGP--LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV 129 (257)
T ss_pred hCCCCCcceEEEEEcCCCcEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc
Confidence 468998664443334456689999999997 777663 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
.++.+||+|||++..+...... ....+++.|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+
T Consensus 130 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 130 TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999876543221 12234578999998753 346789999999999999997 999997655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+.
T Consensus 204 ~~~~~~~i~~~~-------------------------------------------------------------------- 215 (257)
T cd05116 204 GNEVTQMIESGE-------------------------------------------------------------------- 215 (257)
T ss_pred HHHHHHHHHCCC--------------------------------------------------------------------
Confidence 444433332211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .+ ....++++++|||.+||+.||++|||+.++..
T Consensus 216 --~-~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 --R-ME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --C-CC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 00 01246889999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=238.50 Aligned_cols=221 Identities=30% Similarity=0.522 Sum_probs=156.7
Q ss_pred ccccCCcEEEEec--cCC--cHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGD--DLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~--~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|++++ .+.+ ..+ +..++|+||+.++ |.+.+ .+.+.+..++.||+.||+|||++|++|+||||+
T Consensus 54 ~l~~~~i~-~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ 129 (287)
T cd07840 54 KLRHPNIV-RLKEIVTSKGKGSIYMVFEYMDHD---LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS 129 (287)
T ss_pred hccCCCee-eheeeEecCCCCcEEEEecccccc---HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 35688755 4443 222 5689999999863 55444 345788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
||++++++.+||+|||++....... ......++..|+|||.+.+. ..++.++|+||+||++|+|++|..||..
T Consensus 130 nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 130 NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA-----TRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred HeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcc-----ccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998665432 12335678899999987542 3467899999999999999999999998
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..+...........|...... +.|. ......++ ...+...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~-------~~~~~~~~-----~~~~~~~ 251 (287)
T cd07840 205 STELEQLEKIFELCGSPTDENWPGVSKL---------------------PWFE-------NLKPKKPY-----KRRLREF 251 (287)
T ss_pred CChHHHHHHHHHHhCCCchhhccccccc---------------------hhhh-------hccccccc-----hhHHHHH
Confidence 8877777766554332222222211100 0000 00000000 0011111
Q ss_pred HhcCCCCCCCcCCC-CCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 234 MEGKYSFSSPEWND-ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 234 ~~~~~~f~~~~~~~-iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .++++.++|++||..||.+|||+.++++||||
T Consensus 252 -----------~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 252 -----------FKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred -----------hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 112 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=231.74 Aligned_cols=209 Identities=29% Similarity=0.469 Sum_probs=155.6
Q ss_pred HHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhccc
Q psy3880 24 KHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~ 98 (408)
.|.+.|++... |-.+|.+. +.++-+++||+.||.|||+.||.||||||.|+|++++..+||||||+|+..+.
T Consensus 132 iYV~TELmQSD---LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELMQSD---LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHhh---hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 48999999765 66777654 78999999999999999999999999999999999999999999999998765
Q ss_pred Cc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCc
Q psy3880 99 GE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 176 (408)
Q Consensus 99 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 176 (408)
.+ .+...+.|.+|+|||++.+ +..|+.++||||.|||+.|++..+..|...+..+++..|..--.+++.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG-----aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~---- 279 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG-----ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ---- 279 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc-----chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH----
Confidence 43 3344667899999999987 467999999999999999999999999999998888888654332221
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
|..+.. |. |.-...|-.+ ++|-.. --|...++ .+...++.++
T Consensus 280 --------EaMr~A-----------CE----GAk~H~LR~~~k~Ps~~------------vLYtlsS~--~~~~heav~~ 322 (449)
T KOG0664|consen 280 --------EAMKYA-----------CE----GAKNHVLRAGLRAPDTQ------------RLYKIASP--DDKNHEAVDL 322 (449)
T ss_pred --------HHHHHH-----------hh----hhHHHhhccCCCCCCcc------------ceeeecCC--cccchHHHHH
Confidence 111110 00 0001111111 111000 00111221 2345678899
Q ss_pred HHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 256 IRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 256 I~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.+||.+||.+|++.++++.|+|...
T Consensus 323 ~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 323 LQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHHhCCCCcccccHhhhcccccccc
Confidence 99999999999999999999999854
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=240.12 Aligned_cols=189 Identities=19% Similarity=0.337 Sum_probs=145.0
Q ss_pred cccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHH
Q psy3880 5 EMVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEH 61 (408)
Q Consensus 5 ~~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~ 61 (408)
..+.|++++ .+.. ..++..++||||+.+|. |.+++. +...+..++.||+.||+|
T Consensus 62 ~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 138 (291)
T cd05094 62 TNLQHEHIV-KFYGVCGDGDPLIMVFEYMKHGD--LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 138 (291)
T ss_pred hcCCCCCcc-eEEEEEccCCceEEEEecCCCCc--HHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357898855 4443 45567899999999998 877763 346789999999999999
Q ss_pred HHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhh
Q psy3880 62 VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACG 138 (408)
Q Consensus 62 LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlG 138 (408)
||++||+||||||+|||++.++.++|+|||++........ .....+++.|+|||.+.. ..++.++|+||+|
T Consensus 139 lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG 212 (291)
T cd05094 139 LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY------RKFTTESDVWSFG 212 (291)
T ss_pred HHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc------CCCCchhhHHHHH
Confidence 9999999999999999999999999999999876543221 123456788999998864 3467889999999
Q ss_pred HHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 139 VIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 139 vil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
|++|+|++ |..||...+.......+..+
T Consensus 213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~--------------------------------------------------- 241 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTEVIECITQG--------------------------------------------------- 241 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhCC---------------------------------------------------
Confidence 99999998 99998665544333322211
Q ss_pred CCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 218 CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 218 ~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.... .....+.++.+||.+||+.||++|||+.++++
T Consensus 242 -------------------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 -------------------RVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -------------------CCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1100 01235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=235.85 Aligned_cols=189 Identities=21% Similarity=0.402 Sum_probs=142.3
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
++.|+|++..+. ...++..++++||+.+|. |.+.+.+ .+.+..++.|++.||+|||+++++||||||+||
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGS--LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred hCCCCCeeeEEEEEcCCCCcEEEEecCCCCc--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 578998664332 355567899999999998 8777632 367788999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+++.++.+||+|||++......... ....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF------GSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc------CCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 9999999999999999876543211 12345668999998854 346678888888888888887 88887654
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
........+..
T Consensus 209 ~~~~~~~~~~~--------------------------------------------------------------------- 219 (261)
T cd05072 209 SNSDVMSALQR--------------------------------------------------------------------- 219 (261)
T ss_pred CHHHHHHHHHc---------------------------------------------------------------------
Confidence 43333222211
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +. .+....++.++.+||.+||..||++|||++++++
T Consensus 220 -~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 -G-YR--MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -C-CC--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1 11 1122356888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=235.41 Aligned_cols=189 Identities=22% Similarity=0.374 Sum_probs=143.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+....++..++||||+.+|. |.+++. +.+.+..++.|++.||+|||++||+||||||+||+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nil 134 (260)
T cd05069 57 KLRHDKLVPLYAVVSEEPIYIVTEFMGKGS--LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL 134 (260)
T ss_pred hCCCCCeeeEEEEEcCCCcEEEEEcCCCCC--HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 468998664444455566789999999998 777763 33678899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+++++.++|+|||++......... ....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||.+..
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 135 VGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------GRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred EcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999765433211 12345678999998754 346778899999999999988 888886654
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..
T Consensus 209 ~~~~~~~~~~---------------------------------------------------------------------- 218 (260)
T cd05069 209 NREVLEQVER---------------------------------------------------------------------- 218 (260)
T ss_pred HHHHHHHHHc----------------------------------------------------------------------
Confidence 4333332221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +. .+.....+..+++||++||..||++|||++++++
T Consensus 219 ~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 G-YR--MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred C-CC--CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1 00 1112346788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=238.58 Aligned_cols=189 Identities=20% Similarity=0.350 Sum_probs=143.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------HHHHHHHHHHHHHHHHHHHHCCCe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------NPALRYIMRQLFEALEHVHNHSVV 68 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------~~~~r~i~~qil~aL~~LH~~~Iv 68 (408)
.+.|+|++ ++.+ ......++||||+.+|. |.+++.+ ...+..++.|++.||+|||++|++
T Consensus 65 ~l~~~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~v 141 (277)
T cd05062 65 EFNCHHVV-RLLGVVSQGQPTLVIMELMTRGD--LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFV 141 (277)
T ss_pred hCCCCCee-eEEEEEcCCCCeEEEEecCCCCC--HHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 46788755 5554 34456789999999998 8777642 246778899999999999999999
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
||||||+|||+++++.++|+|||++......... ....+++.|+|||++.. ..++.++|+|||||++|+|+
T Consensus 142 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD------GVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc------CCcCchhHHHHHHHHHHHHH
Confidence 9999999999999999999999998765432211 12345778999999864 34678999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 146 V-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 146 ~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+ |..||.+.+.......+..+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~---------------------------------------------------------- 237 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEG---------------------------------------------------------- 237 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcC----------------------------------------------------------
Confidence 8 68888665544333332221
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..... + ...+++++++|.+||+.||++|||+.|++++
T Consensus 238 ------------~~~~~-~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 ------------GLLDK-P--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ------------CcCCC-C--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10000 0 2356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=240.74 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=148.3
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..... ..++..++|+||+.|. +.+.+ ....++..++.|++.||.|||+++++||||||+|||
T Consensus 71 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 147 (308)
T cd06634 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGS---ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147 (308)
T ss_pred hCCCCCcccEEEEEEcCCeeEEEEEccCCC---HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEE
Confidence 4678876633322 4556778999999754 44333 245788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.++|+|||++...... ....+++.|+|||.+.... ...++.++|+||+||++|+|++|..||...+...
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 148 LSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred ECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcc---cCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 999999999999998765432 3457889999999985321 1346779999999999999999999986544332
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+..+ ..|.
T Consensus 222 ~~~~~~~~---------------------------------------------------~~~~----------------- 233 (308)
T cd06634 222 ALYHIAQN---------------------------------------------------ESPA----------------- 233 (308)
T ss_pred HHHHHhhc---------------------------------------------------CCCC-----------------
Confidence 22222111 0000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. -...+..+++||++||..+|++|||++++++|||+....
T Consensus 234 -~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 234 -LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred -cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 00 124577899999999999999999999999999997753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=234.97 Aligned_cols=189 Identities=22% Similarity=0.368 Sum_probs=142.9
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+....++..|++|||+.+|. |.+.+. +.+++..++.|++.||+|||++||+||||||+||+
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil 134 (260)
T cd05070 57 KLRHDKLVQLYAVVSEEPIYIVTEYMSKGS--LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134 (260)
T ss_pred hcCCCceEEEEeEECCCCcEEEEEecCCCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 478998664444445566789999999998 877663 34778999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+++++.++|+|||++..+...... ....++..|+|||.+.. ..++.++|+|||||++|+|++ |.+||.+.+
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 135 VGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------GRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred EeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999765443211 12334567999998754 346678899999999999888 778886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..
T Consensus 209 ~~~~~~~~~~---------------------------------------------------------------------- 218 (260)
T cd05070 209 NREVLEQVER---------------------------------------------------------------------- 218 (260)
T ss_pred HHHHHHHHHc----------------------------------------------------------------------
Confidence 4333332221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ ... +.....+.++++||.+||..||++|||+.++++
T Consensus 219 ~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 219 G-YRM--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred C-CCC--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1 001 112356788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.69 Aligned_cols=200 Identities=27% Similarity=0.485 Sum_probs=148.3
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|++++..+. ....+..++||||+.++. |.+.+ .+...++.++.|++.||+|||++|++|+||||+||+++
T Consensus 73 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~ 150 (292)
T cd06657 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGA--LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150 (292)
T ss_pred hcCCcchhheeeEEEeCCEEEEEEecCCCCc--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 467887653332 244567789999999997 76664 24578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.++|+|||++....... ......|++.|+|||.+.. ..++.++|+||+||++|+|++|..||.+......
T Consensus 151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~ 224 (292)
T cd06657 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224 (292)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCHHHhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999887554322 1233578899999998753 2356678888888888888888887754332211
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...+......
T Consensus 225 ----------------------------------------------------------------------~~~~~~~~~~ 234 (292)
T cd06657 225 ----------------------------------------------------------------------MKMIRDNLPP 234 (292)
T ss_pred ----------------------------------------------------------------------HHHHHhhCCc
Confidence 1111111100
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
.......+++++.++|.+||..||.+|||+.++|+||||.....
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 235 -KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 01112356889999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=239.98 Aligned_cols=220 Identities=28% Similarity=0.435 Sum_probs=156.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ .+.+..++|+|++.+ . |.+.+. +...+..++.|++.||+|||++||+||||+|+||
T Consensus 54 ~~~~~~i~-~~~~~~~~~~~~~~v~e~~~~-~--l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni 129 (282)
T cd07829 54 ELKHPNIV-KLLDVIHTERKLYLVFEYCDM-D--LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129 (282)
T ss_pred hcCCCCHH-HHHhhhhcCCceEEEecCcCc-C--HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence 34688755 4443 344678899999975 4 655553 4578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++++++.++|+|||++....... ......++..|+|||.+... ..++.++|+||+||+++++++|.+||.+.+.
T Consensus 130 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 204 (282)
T cd07829 130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS-----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204 (282)
T ss_pred EEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCC-----cCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 99999999999999987664432 22334567889999998642 3567899999999999999999999999887
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+.++.+.........|.... -+. -.....|.+...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~-~~~~~~~~~~~~----------- 242 (282)
T cd07829 205 IDQLFKIFQILGTPTEESWPGVT------------------------------KLP-DYKPTFPKFPPK----------- 242 (282)
T ss_pred HHHHHHHHHHhCCCcHHHHHhhc------------------------------ccc-cccccccccCcc-----------
Confidence 77777665432222111111100 000 000000100000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.....+..++.+++++|++||..||++|||++++++||||
T Consensus 243 ---~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 243 ---DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ---chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011123458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=243.55 Aligned_cols=190 Identities=23% Similarity=0.304 Sum_probs=145.0
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+.....+..++|+||+.+|. |.+.+.. ...+..++.||+.||+|||++||+||||||+|||+
T Consensus 65 ~l~h~niv~~~g~~~~~~~~~v~e~~~~g~--l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill 142 (316)
T cd05108 65 SVDNPHVCRLLGICLTSTVQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142 (316)
T ss_pred hCCCCCCCeEEEEEcCCCceeeeecCCCCC--HHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe
Confidence 568998765444444456789999999998 8887643 35678889999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+++.+....... ...++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+..
T Consensus 143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999998765433221 2334668999999864 457889999999999999997 999986644
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+... +..
T Consensus 217 ~~~~~~-~~~---------------------------------------------------------------------- 225 (316)
T cd05108 217 ASEISS-ILE---------------------------------------------------------------------- 225 (316)
T ss_pred HHHHHH-HHh----------------------------------------------------------------------
Confidence 332211 111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
....++.+ ...+.++.++|.+||..||++|||+.+++.+
T Consensus 226 ~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 KGERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11111111 2356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=238.23 Aligned_cols=189 Identities=18% Similarity=0.307 Sum_probs=144.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHV 62 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~L 62 (408)
.+.|+++| .+.. +..+..++++||+.++. |.+.+. +...+..++.|++.||+||
T Consensus 64 ~l~h~~iv-~~~~~~~~~~~~~~~~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l 140 (283)
T cd05091 64 RLQHPNIV-CLLGVVTKEQPLSMIFSYCSHSD--LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL 140 (283)
T ss_pred cCCCCCcC-eEEEEEcCCCceEEEEEcCCCCc--HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 57799855 5443 44456788999998887 666652 3356788999999999999
Q ss_pred HHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 63 HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 63 H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
|++||+||||||+|||+++++.+||+|||+++.+..... .....+++.|+|||.+.. ..++.++|+||+||
T Consensus 141 H~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~ 214 (283)
T cd05091 141 SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY------GKFSIDSDIWSYGV 214 (283)
T ss_pred HHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc------CCCCcchhHHHHHH
Confidence 999999999999999999999999999999886543321 123445778999999864 34678999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC
Q psy3880 140 IMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218 (408)
Q Consensus 140 il~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~ 218 (408)
++|+|++ |..||.+....+....+..+
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~---------------------------------------------------- 242 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNR---------------------------------------------------- 242 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcC----------------------------------------------------
Confidence 9999998 88888665544444443322
Q ss_pred CCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.... .-.+.+.++.+|+.+||+.||++|||+.++++.
T Consensus 243 ------------------~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 243 ------------------QVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ------------------CcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 1110 012467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=234.22 Aligned_cols=188 Identities=23% Similarity=0.376 Sum_probs=146.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ +.++..++||||+.+|. |.+.+. +.+.+..++.|++.||+|||++||+||||||+||
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~iv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05114 55 KLSHPKLV-QLYGVCTQQKPLYIVTEFMENGC--LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC 131 (256)
T ss_pred HCCCCCce-eEEEEEccCCCEEEEEEcCCCCc--HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceE
Confidence 35788755 4443 45567899999999998 777663 3477899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+++.++.+||+|||+++......... ...++..|+|||.+.. ..++.++|+||+||++|+|++ |..||...
T Consensus 132 ~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 132 LVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred EEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc------CccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999987654332221 2234567999999864 346789999999999999999 89999776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+..+..
T Consensus 206 ~~~~~~~~i~~~~~------------------------------------------------------------------ 219 (256)
T cd05114 206 SNYEVVEMISRGFR------------------------------------------------------------------ 219 (256)
T ss_pred CHHHHHHHHHCCCC------------------------------------------------------------------
Confidence 66555555433210
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... + ...+.++.+||.+||..||++|||++|+++
T Consensus 220 ----~~~-~--~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ----LYR-P--KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----CCC-C--CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 0 124667899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=238.01 Aligned_cols=189 Identities=18% Similarity=0.360 Sum_probs=144.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------------------CHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----------------------SNPALRYIMRQLFEALEH 61 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----------------------~~~~~r~i~~qil~aL~~ 61 (408)
.+.|+|+| .+.. ...+..++||||+.+|+ |.+++. +..++..++.|++.||.|
T Consensus 63 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 63 ELHHPNIV-CLLGVVTQEQPVCMLFEYLNQGD--LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred hCCCCCee-eEEEEEecCCceEEEEEcCCCCc--HHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 46788865 4443 45567899999999998 877762 335678899999999999
Q ss_pred HHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhh
Q psy3880 62 VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACG 138 (408)
Q Consensus 62 LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlG 138 (408)
||++||+||||||+|||++.++.+||+|||+++...... ......++..|+|||.+.. ..++.++|+||+|
T Consensus 140 lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG 213 (283)
T cd05090 140 LSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY------GKFSSDSDIWSFG 213 (283)
T ss_pred HHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc------CCCCchhhhHHHH
Confidence 999999999999999999999999999999997654322 1223455678999998864 3467899999999
Q ss_pred HHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 139 VIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 139 vil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
|++|+|++ |..||.+.+.......+..+
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~~~~--------------------------------------------------- 242 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMVRKR--------------------------------------------------- 242 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------------------------------------------------
Confidence 99999998 88888665443333322211
Q ss_pred CCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 218 CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 218 ~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .. +.+..++++++++|.+||+.||++||++.+++++
T Consensus 243 -------------------~-~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 243 -------------------Q-LL--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -------------------C-cC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0 00 1123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=240.42 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=146.9
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|+|++ .+.+ +..+..|+||||+.||. |.+.+. +...+..++.||+.||.|||+.|++|+||
T Consensus 55 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl 131 (287)
T cd06621 55 SCKSPYIV-KYYGAFLDESSSSIGIAMEYCEGGS--LDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDI 131 (287)
T ss_pred hCCCCCee-eeeeEEEccCCCeEEEEEEecCCCC--HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 46888855 5433 34456799999999997 655432 34678899999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
+|+||+++.++.++|+|||++....... .....++..|+|||.+.. ..++.++|+||+||++|+|++|..||.
T Consensus 132 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 132 KPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG------KPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred CHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcC------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999987654322 224567889999998864 346788999999999999999999985
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..... .. ...+....
T Consensus 205 ~~~~~---------------------------------------------~~--------------------~~~~~~~~ 219 (287)
T cd06621 205 PEGEP---------------------------------------------PL--------------------GPIELLSY 219 (287)
T ss_pred cccCC---------------------------------------------CC--------------------ChHHHHHH
Confidence 43210 00 00011111
Q ss_pred HHhcCC-CCCC--CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 233 IMEGKY-SFSS--PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 233 i~~~~~-~f~~--~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+..... .... ..-...++++++||.+||..||++|||+.|++.||||...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 111000 0000 0001246789999999999999999999999999999543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=240.91 Aligned_cols=195 Identities=26% Similarity=0.418 Sum_probs=145.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ .+++..|+||||+.|. +.+.+ .+..++..++.||+.||.|||++||+|+||||+||
T Consensus 77 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni 152 (313)
T cd06633 77 QLKHPNTI-EYKGCYLKEHTAWLVMEYCLGS---ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152 (313)
T ss_pred hCCCCCCc-cEEEEEEeCCEEEEEEecCCCC---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence 45788765 4443 4556678999999754 33333 24478888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++.++.+||+|||++..... .....|+..|+|||++.... ...++.++|+||+||++|+|++|..||.+.+..
T Consensus 153 li~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 153 LLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred EECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999864322 23467889999999974311 134677889999999999998888888665443
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+... .
T Consensus 227 ~~~~~~~~~----------------------------------------------------------------------~ 236 (313)
T cd06633 227 SALYHIAQN----------------------------------------------------------------------D 236 (313)
T ss_pred HHHHHHHhc----------------------------------------------------------------------C
Confidence 333322211 0
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. +.......+..+++||.+||+.||.+|||+.++++||||...
T Consensus 237 ~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 237 S--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 001112356779999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=234.13 Aligned_cols=189 Identities=21% Similarity=0.351 Sum_probs=143.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ +..+..|+||||+.||. |.+.+. +.+.+..++.||+.||.|||++||+||||||+||
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05059 55 KLSHPNLV-QLYGVCTKQRPIFIVTEYMANGC--LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131 (256)
T ss_pred hCCCCCEE-EEEEEEcCCCceEEEEecCCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhE
Confidence 47898855 4443 45567899999999998 877763 3468899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+++.++.+||+|||+++......... ...++..|+|||.+.. ..++.++|+||+||++|++++ |..||...
T Consensus 132 ~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 132 LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY------SRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred EECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc------CCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 99999999999999987654332111 1223347999999864 346788999999999999998 78888654
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....+..
T Consensus 206 ~~~~~~~~~~~--------------------------------------------------------------------- 216 (256)
T cd05059 206 SNSEVVESVSA--------------------------------------------------------------------- 216 (256)
T ss_pred CHHHHHHHHHc---------------------------------------------------------------------
Confidence 44333322211
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+ ... +.....|+++.+++.+||..||++|||+.|+++.
T Consensus 217 -~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 -G-YRL--YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -C-CcC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1 000 1112468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=272.13 Aligned_cols=141 Identities=17% Similarity=0.233 Sum_probs=101.9
Q ss_pred ccccccccCCcEEEEec---------cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 2 EKGEMVAHSRVVVRVKE---------EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 2 ~~~~~~~~~~~i~~~~~---------~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
+|-..+.|.++|+.+.+ ..++.+.+++|++ ++. |.+++. +..+++.+++||+.||+|||++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g 100 (793)
T PLN00181 24 DGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVS--LRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG 100 (793)
T ss_pred CccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-Ccc--HHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 34456778666765443 2345678888876 445 888773 34789999999999999999999
Q ss_pred CeeccCCCCcEEEec-------------------CCCEEEeccccchhcccCc-----------------ccccCCCCCc
Q psy3880 67 VVHRDLKPENILLDD-------------------QMNVKLTDFGFARVLKKGE-----------------KLMDLCGTPG 110 (408)
Q Consensus 67 IvHRDLKp~NILl~~-------------------~~~iKl~DFGla~~~~~~~-----------------~~~~~~gt~~ 110 (408)
||||||||+|||++. ++.+|++|||+++...... .....+||++
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 3456677777765421100 0012468888
Q ss_pred ccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 111 y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|+|||++.+ ..|+.++|||||||++|||++|.+|+
T Consensus 181 Y~APE~~~~------~~~~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 181 YTSPEEDNG------SSSNCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred eEChhhhcc------CCCCchhhhhhHHHHHHHHhhCCCch
Confidence 999998864 34677888888888888888877765
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=235.67 Aligned_cols=188 Identities=22% Similarity=0.362 Sum_probs=142.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ ++.. ..++..++||||+.+|. |.+.+. +...+..++.|++.||+|||++|++||||||+|
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~n 134 (263)
T cd05052 58 EIKHPNLV-QLLGVCTREPPFYIITEFMTYGN--LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 134 (263)
T ss_pred hCCCCChh-heEEEEcCCCCcEEEEEeCCCCc--HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence 36788765 4443 45567889999999998 777653 236778899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
||+++++.+||+|||++.......... ...+++.|+|||.+.. ..++.++|+|||||++|+|++ |..||.+
T Consensus 135 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY------NKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred EEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999998765432211 2234567999998864 346778999999999999997 8888866
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....+..+
T Consensus 209 ~~~~~~~~~~~~~------------------------------------------------------------------- 221 (263)
T cd05052 209 IDLSQVYELLEKG------------------------------------------------------------------- 221 (263)
T ss_pred CCHHHHHHHHHCC-------------------------------------------------------------------
Confidence 5443332222111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+.. +.-..++.++.+||.+||..||++|||+.++++
T Consensus 222 ----~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 ----YRM--ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----CCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011 111346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=262.01 Aligned_cols=191 Identities=34% Similarity=0.537 Sum_probs=141.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH---------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN---------PALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~---------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
+|+|+| |++- .++.+.||+.|+|.-. |.|.+... -..+.++.|++.||++||+.+||||||||.|
T Consensus 561 ~H~Nvi-Ryyc~E~d~qF~YIalELC~~s---L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVI-RYYCSEQDRQFLYIALELCACS---LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQN 636 (903)
T ss_pred CCCceE-EEEeeccCCceEEEEehHhhhh---HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCce
Confidence 689855 7663 4556789999999743 77777551 3458899999999999999999999999999
Q ss_pred EEEec---C--CCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 77 ILLDD---Q--MNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 77 ILl~~---~--~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
|||+. + ..++|+|||+++.+..+.. ..+..||-+|+|||++.... -..++||+|+||++|+.++|
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~------~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR------KTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc------cCcccchhhcCceEEEEecC
Confidence 99976 3 3689999999998876542 34578999999999997642 23467777777777776664
Q ss_pred -CCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 148 -CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 148 -~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
..||-+..
T Consensus 711 G~HpFGd~~----------------------------------------------------------------------- 719 (903)
T KOG1027|consen 711 GSHPFGDSL----------------------------------------------------------------------- 719 (903)
T ss_pred CccCCCchH-----------------------------------------------------------------------
Confidence 55663322
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+...+|+.+++....-+- .-..+|+|||.+||..||..||||.++|+||+|-.
T Consensus 720 -~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 720 -ERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -HhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 122345555554322110 00118999999999999999999999999999964
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=235.43 Aligned_cols=189 Identities=20% Similarity=0.328 Sum_probs=144.2
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
++.|+++|..+.....+..++||||+.+|. |.+.+. +..++..++.|++.||+|||++|++||||||+|||+
T Consensus 51 ~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 128 (257)
T cd05115 51 QLDNPYIVRMIGVCEAEALMLVMEMASGGP--LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128 (257)
T ss_pred hcCCCCeEEEEEEEcCCCeEEEEEeCCCCC--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE
Confidence 478998664443334456789999999998 777653 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+.++.+||+|||++..+...... ....+++.|+|||.+.. ..++.++|+|||||++|++++ |..||.+.
T Consensus 129 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF------RKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc------CCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999765433221 11223568999998864 346789999999999999996 99999765
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+. .
T Consensus 203 ~~~~~~~~~~~~~---------------------------------------------------~--------------- 216 (257)
T cd05115 203 KGPEVMSFIEQGK---------------------------------------------------R--------------- 216 (257)
T ss_pred CHHHHHHHHHCCC---------------------------------------------------C---------------
Confidence 5444333332221 0
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..++ ...++++++||.+|+..||++|||+.++.+
T Consensus 217 ---~~~~----~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---LDCP----AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011 235789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=239.20 Aligned_cols=207 Identities=24% Similarity=0.359 Sum_probs=151.4
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NIL 78 (408)
.+.|++++..+.. ...+..++|+||+.+|. |.+.+. +...++.++.|++.||.|||+ ++++||||||+||+
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGS--LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred HcCCCCcceEeeeEecCCEEEEEEecCCCCC--HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 4678886644432 34466789999999998 766553 347889999999999999997 69999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+++++.++|+|||++....... ....+|+..|+|||++.. ..++.++|+||+||++|++++|..||.......
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQG------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred ECCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHcc------CCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 9999999999999987553321 234678999999999864 356789999999999999999999997644321
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.... .+ .........+.....
T Consensus 210 ~~~~--------------------~~---------------------------------------~~~~~~~~~~~~~~~ 230 (284)
T cd06620 210 DGQD--------------------DP---------------------------------------MGILDLLQQIVQEPP 230 (284)
T ss_pred hhhh--------------------hh---------------------------------------hHHHHHHHHHhhccC
Confidence 0000 00 000011111211110
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. ...+..++.++.+||.+||+.||++|||++|+++||||...
T Consensus 231 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 231 P--RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred C--CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 01112367889999999999999999999999999999664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=238.59 Aligned_cols=195 Identities=28% Similarity=0.453 Sum_probs=148.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ ..++..++||||+.|. +.+.+ .+..++..++.|++.||.|||++||+||||+|+||
T Consensus 81 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~g~---l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 81 RIKHPNSI-EYKGCYLREHTAWLVMEYCLGS---ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred hCCCCCEE-EEEEEEeeCCeEEEEEeCCCCC---HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 35788755 4443 3556678999999764 44433 23478888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++.++.+||+|||++...... ....|++.|+|||.+... ....++.++|+||+||++|+|++|..||...+..
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~---~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 230 (317)
T cd06635 157 LLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230 (317)
T ss_pred EECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcC---CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 9999999999999998754332 345788999999997531 1234678999999999999999999998765443
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+..+..+. .
T Consensus 231 ~~~~~~~~~~---------------------------------------------------------------------~ 241 (317)
T cd06635 231 SALYHIAQNE---------------------------------------------------------------------S 241 (317)
T ss_pred HHHHHHHhcc---------------------------------------------------------------------C
Confidence 3333332210 0
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... .....++.+++||.+||+.||.+|||+.++++|||+...
T Consensus 242 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 242 PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 001 112357789999999999999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=239.49 Aligned_cols=199 Identities=26% Similarity=0.427 Sum_probs=148.1
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NI 77 (408)
+.|+|++ .+.. ..++..++++|++.++. |.+.+. ++..+..++.|++.||+|||+ .|++|+||||+||
T Consensus 56 ~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni 132 (265)
T cd06605 56 CNSPYIV-GFYGAFYNNGDISICMEYMDGGS--LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNI 132 (265)
T ss_pred CCCCchh-hhheeeecCCEEEEEEEecCCCc--HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHE
Confidence 4688755 4433 34467789999999887 777664 347788899999999999999 9999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++.++.++|+|||++........ ....++..|+|||.+.. ..++.++|+||+||++|++++|..||......
T Consensus 133 ~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 205 (265)
T cd06605 133 LVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQG------NDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205 (265)
T ss_pred EECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcC------CCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999999876643322 22678899999999864 35678899999999999999998888542210
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
........+.+....
T Consensus 206 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 220 (265)
T cd06605 206 -----------------------------------------------------------------PDGIFELLQYIVNEP 220 (265)
T ss_pred -----------------------------------------------------------------cccHHHHHHHHhcCC
Confidence 000111222222221
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..- .....+|+++++||.+||..||++|||+.|++.||||+..
T Consensus 221 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 PPR--LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCC--CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 110 0111278899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=236.03 Aligned_cols=186 Identities=22% Similarity=0.354 Sum_probs=139.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+++| ++.+ +.++..|+||||+.+|. |.+.+. +.+++..++.|++.||+|||+
T Consensus 54 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~ 130 (270)
T cd05047 54 HHPNII-NLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130 (270)
T ss_pred cCCCee-eEEEEEecCCCceEEEEeCCCCc--HHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 577744 5543 45567899999999998 877663 346789999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+|++||||||+|||++.++.+||+|||++..............++.|+|||++.. ..++.++|+|||||++|+|
T Consensus 131 ~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Di~slG~il~el 204 (270)
T cd05047 131 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY------SVYTTNSDVWSYGVLLWEI 204 (270)
T ss_pred CCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc------CCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999864322111112234567999998854 3467889999999999999
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+.+.......+..
T Consensus 205 ~~~g~~pf~~~~~~~~~~~~~~---------------------------------------------------------- 226 (270)
T cd05047 205 VSLGGTPYCGMTCAELYEKLPQ---------------------------------------------------------- 226 (270)
T ss_pred HcCCCCCccccCHHHHHHHHhC----------------------------------------------------------
Confidence 96 8888865543333322211
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +.. +....++.++.+||.+||..||.+|||+.|+++
T Consensus 227 ------------~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 ------------G-YRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------C-CCC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 000 111246778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=237.00 Aligned_cols=189 Identities=22% Similarity=0.292 Sum_probs=141.2
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++..+....+...++++|++.+|. |.+.+. +..++..++.||+.||+|||+++|+||||||+|||+
T Consensus 65 ~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~--l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~ 142 (279)
T cd05109 65 GVGSPYVCRLLGICLTSTVQLVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142 (279)
T ss_pred hcCCCCCceEEEEEcCCCcEEEEEcCCCCC--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 356887654443344456789999999998 777763 336788899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++++.+||+|||+++.+....... ...+++.|+|||.+.. ..++.++|+||+||++|+|++ |..||....
T Consensus 143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999998765332211 2234678999999854 346788999999999999987 888875543
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+. .
T Consensus 217 ~~~~~~~~~----------------------------------------------------------------------~ 226 (279)
T cd05109 217 AREIPDLLE----------------------------------------------------------------------K 226 (279)
T ss_pred HHHHHHHHH----------------------------------------------------------------------C
Confidence 322211111 1
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+. .. +.....+.++.++|.+||..||++|||+.+++.
T Consensus 227 ~~-~~--~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 GE-RL--PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CC-cC--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 01 112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=234.54 Aligned_cols=189 Identities=21% Similarity=0.334 Sum_probs=141.6
Q ss_pred ccccCCcEEEEec---cCC-----cHHHHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 6 MVAHSRVVVRVKE---EGD-----DLKHLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~-----~~~~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
.+.|++++ .+.. +.+ ...++++||+.+|+ |.+.+ .+...+..++.|++.||.|||+++
T Consensus 57 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~~v~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~ 133 (273)
T cd05035 57 DFDHPNVM-KLIGVCFEASSLQKIPKPMVILPFMKHGD--LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133 (273)
T ss_pred hCCCCCee-eEEeeeccCCccccCcccEEEEeccCCCC--HHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36798855 4443 111 23589999999998 65554 234678889999999999999999
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|+||||||+||++++++.+||+|||+++.+...... ....++..|+|||.+.. ..++.++|+||+||++|+
T Consensus 134 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD------RVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc------CCCCcccchHHHHHHHHH
Confidence 999999999999999999999999999866433211 11335678999998853 346789999999999999
Q ss_pred HHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 144 LLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 144 ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
|++ |.+||.+.+..+.+..+..+.
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~------------------------------------------------------- 232 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHGN------------------------------------------------------- 232 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCC-------------------------------------------------------
Confidence 998 888886655443333322110
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .. .....++++.++|.+||+.||++|||+.|++++
T Consensus 233 ---------------~-~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ---------------R-LK--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------------C-CC--CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 012457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=245.53 Aligned_cols=153 Identities=25% Similarity=0.386 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 122 (408)
+.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .....++..|+|||++..
T Consensus 173 ~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 249 (337)
T cd05054 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD--- 249 (337)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC---
Confidence 56788999999999999999999999999999999999999999999987643221 112345678999999864
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQA 201 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~ 201 (408)
..++.++|+||+||++|+|++ |..||.+....+.+....
T Consensus 250 ---~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~------------------------------------- 289 (337)
T cd05054 250 ---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL------------------------------------- 289 (337)
T ss_pred ---CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-------------------------------------
Confidence 457889999999999999997 999986533211111111
Q ss_pred ccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 202 VDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 202 ~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+. ....+ ...++++.+++.+||+.+|++|||++|+++|
T Consensus 290 --------------------------------~~~~-~~~~~--~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 290 --------------------------------KEGT-RMRAP--EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --------------------------------hccC-CCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 00001 2357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=242.10 Aligned_cols=224 Identities=24% Similarity=0.462 Sum_probs=153.7
Q ss_pred ccccCCcEEEEecc---CCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEE---GDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~---~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+. .....|+|+||+. +. |.+.+. ....++.++.|+++||+|||++||+||||||.|||
T Consensus 65 ~l~hpniv-~~~~~~~~~~~~~~lv~e~~~-~~--L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil 140 (328)
T cd07856 65 HLRHENII-SLSDIFISPLEDIYFVTELLG-TD--LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140 (328)
T ss_pred hcCCCCee-eEeeeEecCCCcEEEEeehhc-cC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence 46798855 55542 2446789999984 44 655543 34678889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++..... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|..||.+.....
T Consensus 141 i~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 141 INENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred ECCCCCEEeCccccccccCC--CcCCCcccccccCceeeec-----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999875432 2234567889999998753 2357889999999999999999999998776544
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+...... .|+.+..... ..+.............
T Consensus 214 ~~~~~~~~~~~-------------~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~ 250 (328)
T cd07856 214 QFSIITDLLGT-------------PPDDVINTIC------------------------------SENTLRFVQSLPKREP 250 (328)
T ss_pred HHHHHHHHhCC-------------CCHHHHHhcc------------------------------chhhHHHHhhccccCC
Confidence 33333221000 0111110000 0000000101000000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.........++++++++|++||+.||++|||+++++.||||....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred CcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000011235788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=262.15 Aligned_cols=189 Identities=30% Similarity=0.504 Sum_probs=139.9
Q ss_pred ccCCcEEEEec------cCCc--H-HHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCC--Cee
Q psy3880 8 AHSRVVVRVKE------EGDD--L-KHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHS--VVH 69 (408)
Q Consensus 8 ~~~~~i~~~~~------~~~~--~-~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~--IvH 69 (408)
.|+|+| .+.+ .++. + ..|.||||.||. |.|.++ ++.++..||.|+++||.+||... |||
T Consensus 93 gh~nIV-~yidss~~~~~~~~~~~EvllLmEyC~gg~--Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH 169 (738)
T KOG1989|consen 93 GHKNIV-SYIDSSAINRSSNNGVWEVLLLMEYCKGGS--LVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH 169 (738)
T ss_pred CCCcee-eEeccccccccCCCceeEEEeehhhccCCc--HHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence 488855 5554 1222 2 368999999877 777765 35899999999999999999998 999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCc-c---------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGE-K---------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~-~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
||||-||+||+.++..||||||.|..-...- . .....-|+.|+|||++.-- ...+.+.|+|||||||
T Consensus 170 RDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly---sg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 170 RDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY---SGLPIGEKSDIWALGC 246 (738)
T ss_pred hhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh---cCCCCcchhHHHHHHH
Confidence 9999999999999999999999886422111 0 0123568999999998531 1234456666666666
Q ss_pred HHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 140 IMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 140 il~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
+||-|+..+.||.+
T Consensus 247 lLYkLCy~t~PFe~------------------------------------------------------------------ 260 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEE------------------------------------------------------------------ 260 (738)
T ss_pred HHHHHHHhCCCcCc------------------------------------------------------------------
Confidence 66666666666633
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
..+ ..|++++|.|+. ++..|..+++||+.||+.||.+||++-|++.+-+
T Consensus 261 ----sg~----laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 261 ----SGK----LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ----Ccc----eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 211 146778888754 4678999999999999999999999998876543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=235.52 Aligned_cols=188 Identities=16% Similarity=0.316 Sum_probs=142.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.. ..++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++|++||||||+||
T Consensus 62 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 62 QFDHSNIV-RLEGVITRGNTMMIVTEYMSNGA--LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred cCCCCCcC-eEEEEEecCCCcEEEEEeCCCCc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 36799855 5554 45567899999999998 766553 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+|++|||.+.......... ...++..|+|||++.. ..++.++|+||+||++|++++ |..||.+.
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 139 LVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY------HHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred EEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh------CCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999876543222111 2335678999999864 356788999999999999764 88888766
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+..+..+.
T Consensus 213 ~~~~~~~~~~~~~------------------------------------------------------------------- 225 (266)
T cd05064 213 SGQDVIKAVEDGF------------------------------------------------------------------- 225 (266)
T ss_pred CHHHHHHHHHCCC-------------------------------------------------------------------
Confidence 5544443332211
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. +.....+..+.+++.+|+..||.+|||++|+++
T Consensus 226 ----~~--~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 ----RL--PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ----CC--CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01 112346778999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=234.52 Aligned_cols=152 Identities=19% Similarity=0.282 Sum_probs=113.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC----------HHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS----------NPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~----------~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.. ...+..|+||||+.+|. |.+++.+ ...+..++.||+.||+|||++||+|||||
T Consensus 51 ~l~h~nii-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 127 (269)
T cd05042 51 ELNHPNVL-QCLGQCIESIPYLLVLEFCPLGD--LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA 127 (269)
T ss_pred hCCCCCcc-eEEEEECCCCceEEEEEeCCCCc--HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEeccccc
Confidence 36799866 4443 44567899999999998 8777632 35678899999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhcccc-CcCCCCcchhhhhhhHHHHHHHh-CC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFE-DATGYGQAVDVWACGVIMYTLLV-GC 148 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~-~~~~~~~~~DiwSlGvil~~ll~-G~ 148 (408)
|+|||++.++.+||+|||++......... ....+++.|+|||++...... ....++.++|+||+||++|+|++ |.
T Consensus 128 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (269)
T cd05042 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207 (269)
T ss_pred HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999998654332211 223456789999998642110 12345778889998888888888 67
Q ss_pred CCCCCchhHHHH
Q psy3880 149 PPFWHRKQMVML 160 (408)
Q Consensus 149 ~pf~~~~~~~~~ 160 (408)
.||......+.+
T Consensus 208 ~p~~~~~~~~~~ 219 (269)
T cd05042 208 QPYPDLSDEQVL 219 (269)
T ss_pred CCCCcCCHHHHH
Confidence 777655444333
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=235.44 Aligned_cols=190 Identities=18% Similarity=0.309 Sum_probs=142.9
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhC------------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIIN------------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~------------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|++++..+. ....+..++||||+.||. |.+.+. +...+..++.||+.||+|||+++++||||
T Consensus 65 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~--L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGD--LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred hCCCCCEeeEEEEEccCCCcEEEEecCCCCC--HHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 467887653333 245566789999999998 777652 33677889999999999999999999999
Q ss_pred CCCcEEEecCC---CEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 73 KPENILLDDQM---NVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 73 Kp~NILl~~~~---~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
||+|||++.++ .+||+|||+++.+...... .....++.|+|||++.. ..++.++|+||+||++|+|++
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD------GIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc------CCcCchhHHHHHHHHHHHHHc
Confidence 99999998654 5899999999876332211 12233467999999864 347889999999999999996
Q ss_pred -CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 147 -GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 147 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
|..||.+.+.......+..+.
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~---------------------------------------------------------- 238 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGG---------------------------------------------------------- 238 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCC----------------------------------------------------------
Confidence 999997655443333222110
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
...+ -..++.++.++|.+||+.||++|||+.++|+|
T Consensus 239 -----------~~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 -----------RLDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -----------cCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0001 02457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.46 Aligned_cols=189 Identities=21% Similarity=0.343 Sum_probs=145.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
++.|++++ .+.+ ...+..++||||+.+|. |.+.+. +...+..++.||+.||+|||++|++|+||||+||
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05113 55 KLSHEKLV-QLYGVCTKQRPIYIVTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131 (256)
T ss_pred cCCCCCee-eEEEEEccCCCcEEEEEcCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence 57898755 5553 45566799999999997 776653 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+++.++.+||+|||+++......... ...++..|+|||.+.. ..++.++|+|||||++|+|++ |..||...
T Consensus 132 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY------SKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred EEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc------CcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999987654432211 2234567999999864 347789999999999999998 98898655
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+.
T Consensus 206 ~~~~~~~~~~~~~------------------------------------------------------------------- 218 (256)
T cd05113 206 NNSETVEKVSQGL------------------------------------------------------------------- 218 (256)
T ss_pred CHHHHHHHHhcCC-------------------------------------------------------------------
Confidence 5444333332211
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+.. ...+..+++++.+||..||.+|||+.+++.+
T Consensus 219 ---~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 219 ---RLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---CCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 11100 1247789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=232.07 Aligned_cols=189 Identities=21% Similarity=0.343 Sum_probs=143.0
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+++|--+.....+..++||||+.+|. |.+.+. ++..+..++.|++.||+|||+++++||||||+|||++
T Consensus 52 ~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~ 129 (257)
T cd05060 52 QLDHPCIVRLIGVCKGEPLMLVMELAPLGP--LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129 (257)
T ss_pred hcCCCCeeeEEEEEcCCceEEEEEeCCCCc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence 467988654333344456789999999998 887773 4578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccc-c---CCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLM-D---LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~-~---~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
.++.+||+|||+++.+....... . ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||...+
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC------CCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999998765433221 1 123457999998854 346788999999999999997 888886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+.++
T Consensus 204 ~~~~~~~~~~~--------------------------------------------------------------------- 214 (257)
T cd05060 204 GAEVIAMLESG--------------------------------------------------------------------- 214 (257)
T ss_pred HHHHHHHHHcC---------------------------------------------------------------------
Confidence 43333332211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. .+....++..++++|.+||..||++|||+.++++
T Consensus 215 -~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 -ER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0111346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=233.88 Aligned_cols=191 Identities=37% Similarity=0.663 Sum_probs=145.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.. +.++..++|||++.++. |.+.+. ++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 49 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~ 125 (250)
T cd05123 49 RINHPFIV-KLHYAFQTEEKLYLVLEYAPGGE--LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENIL 125 (250)
T ss_pred HcCCCcHH-HHHHHeecCCeeEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEE
Confidence 35688755 4433 45667899999999888 777663 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.++|+|||++...... .......++..|+|||.+... .++.++|+||+|+++|++++|..||...+.
T Consensus 126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~------~~~~~~D~~slG~~~~~l~~g~~p~~~~~~- 198 (250)
T cd05123 126 LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK------GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR- 198 (250)
T ss_pred EcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC------CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-
Confidence 999999999999998765443 223346788899999987542 245667777777777777777777644322
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+...+....
T Consensus 199 ---------------------------------------------------------------------~~~~~~~~~~~ 209 (250)
T cd05123 199 ---------------------------------------------------------------------KEIYEKILKDP 209 (250)
T ss_pred ---------------------------------------------------------------------HHHHHHHhcCC
Confidence 22233333332
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH---HHHHcCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV---KEALNHSFF 279 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta---~e~L~Hpwf 279 (408)
..++ ..++.+++++|++||..||++|||+ +++++||||
T Consensus 210 ~~~~----~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 LRFP----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCC----CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 2222 2458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=234.06 Aligned_cols=187 Identities=19% Similarity=0.356 Sum_probs=137.1
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------HHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------NPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
+.|++++ .+.. +..+..++||||+.+|. |.+++.+ ...+..++.|++.||.|||+++|+|
T Consensus 66 ~~~~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 66 FNCHHVV-RLLGVVSTGQPTLVVMELMAKGD--LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred CCCCcee-EEEEEEcCCCCcEEEEecCCCCC--HHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5788755 5554 55577899999999998 8777632 3467889999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|||||+|||++.++.+||+|||+++.+..... .....++..|+|||.+.. ..++.++|+|||||++|++++
T Consensus 143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~t 216 (277)
T cd05032 143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD------GVFTTKSDVWSFGVVLWEMAT 216 (277)
T ss_pred cccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc------CCCCcccchHHHHHHHHHhhc
Confidence 99999999999999999999999876544321 123456778999998753 235566777777777777665
Q ss_pred -CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 147 -GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 147 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
|..||.+. +
T Consensus 217 ~g~~p~~~~----------------------------------------------------------------------~ 226 (277)
T cd05032 217 LAEQPYQGL----------------------------------------------------------------------S 226 (277)
T ss_pred cCCCCCccC----------------------------------------------------------------------C
Confidence 66665432 2
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.......+..+.. ...+ ...+.++++||.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 227 NEEVLKFVIDGGH-LDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2223333332221 1111 235889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=234.81 Aligned_cols=191 Identities=26% Similarity=0.445 Sum_probs=146.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ ++.+ ...+..++|+||+.++. |.+.+ .++.++..++.|++.||.|||++|++|+||||
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~ 134 (260)
T cd08222 58 KLDHPAIV-KFHASFLERDAFCIITEYCEGRD--LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKA 134 (260)
T ss_pred hCCCCcHH-HHHHHHhcCCceEEEEEeCCCCC--HHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCCh
Confidence 35688755 5544 34456789999999987 66544 24578899999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+||++++ +.+||+|||++........ .....|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||..
T Consensus 135 ~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 135 KNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH------QGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred hheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999975 5699999999876644322 234668899999998753 3467789999999999999999999865
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.........+..+. .|
T Consensus 208 ~~~~~~~~~~~~~~---------------------------------------------------~~------------- 223 (260)
T cd08222 208 QNFLSVVLRIVEGP---------------------------------------------------TP------------- 223 (260)
T ss_pred ccHHHHHHHHHcCC---------------------------------------------------CC-------------
Confidence 54333322222110 00
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+ -...+.++.+||.+||..||++|||+.|+++||||
T Consensus 224 -----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 -----SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00 12457789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=233.44 Aligned_cols=187 Identities=20% Similarity=0.321 Sum_probs=141.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++..+.. ..++..|+|+||+.+|. |.+.+. +.+.+..++.|++.||+|||++||+||||||+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 132 (256)
T cd05082 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS--LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN 132 (256)
T ss_pred hCCCCCeeeEEEEEEcCCCceEEEEECCCCCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchhe
Confidence 4679886644432 34456799999999998 777653 236788999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
|++++++.+||+|||++....... ....++..|+|||++.. ..++.++|+||+||++|+|++ |..||...+
T Consensus 133 il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 133 VLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred EEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987544322 23445678999998854 346778999999999999987 888886544
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..
T Consensus 205 ~~~~~~~~~~---------------------------------------------------------------------- 214 (256)
T cd05082 205 LKDVVPRVEK---------------------------------------------------------------------- 214 (256)
T ss_pred HHHHHHHHhc----------------------------------------------------------------------
Confidence 3332222211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +. ....+.+++.++++|.+||..||++|||+.++++
T Consensus 215 ~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 G-YK--MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred C-CC--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 00 0111346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=231.01 Aligned_cols=191 Identities=30% Similarity=0.481 Sum_probs=144.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
++.|++++ .+.+ ..++..|+|+||+.++. |.+.+ .+++.+..++.|++.||+|||++|++|+||+|
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~ 131 (256)
T cd08530 55 SVNHPNII-SYKEAFLDGNKLCIVMEYAPFGD--LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKS 131 (256)
T ss_pred hCCCCCch-hhhhhhccCCEEEEEehhcCCCC--HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCc
Confidence 45688755 5543 34466789999999987 66554 23467889999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+||+++.++.+||+|||++...... ......+++.|+|||.+.. ..++.++|+||+|+++++|++|+.||...
T Consensus 132 ~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~------~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 132 ANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG------RPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876554 2334568899999999854 33566778888888888888877777543
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.. .....+.
T Consensus 205 ~~~----------------------------------------------------------------------~~~~~~~ 214 (256)
T cd08530 205 SMQ----------------------------------------------------------------------DLRYKVQ 214 (256)
T ss_pred CHH----------------------------------------------------------------------HHHHHHh
Confidence 321 1222222
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+.+.-.. ...+.+++++|.+||..||++|||+.|+|+||+.
T Consensus 215 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 215 RGKYPPIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred cCCCCCCc---hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 22221111 2467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=238.74 Aligned_cols=198 Identities=33% Similarity=0.566 Sum_probs=146.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ...+..|+|+||+.|+. |.+.+.. ..++..++.|++.||.|||++||+|+||+|+||
T Consensus 71 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni 147 (286)
T cd06614 71 DCKHPNIV-DYYDSYLVGDELWVVMEYMDGGS--LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147 (286)
T ss_pred HCCCCCee-EEEEEEEECCEEEEEEeccCCCc--HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhE
Confidence 45788755 5544 34567899999999987 7777543 367888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.++|+|||++....... ......+++.|+|||.+.. ..++.++|+||+||++|+|++|..||...+.
T Consensus 148 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 148 LLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred EEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC------CCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999987654322 1223457889999998753 2356777888888777777777777644322
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
. .....+...
T Consensus 222 ~----------------------------------------------------------------------~~~~~~~~~ 231 (286)
T cd06614 222 L----------------------------------------------------------------------RALFLITTK 231 (286)
T ss_pred H----------------------------------------------------------------------HHHHHHHhc
Confidence 1 111122111
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
... .......++.++++||++||..||.+|||+.++|+||||....
T Consensus 232 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 232 GIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 111 1112234678999999999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=231.09 Aligned_cols=189 Identities=23% Similarity=0.392 Sum_probs=147.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------------CHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------------SNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------------~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+.+. ++.++..++.|++.||+|||++||+|
T Consensus 52 ~~~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H 128 (262)
T cd00192 52 KLGHPNVV-RLLGVCTEEEPLYLVLEYMEGGD--LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH 128 (262)
T ss_pred hcCCCChh-eeeeeecCCCceEEEEEeccCCc--HHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCccc
Confidence 35688755 4443 34567899999999998 777664 34788999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|||||+||+++.++.+||+|||.+....... ......+++.|+|||.+.. ..++.++|+||+||++|+|++
T Consensus 129 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD------GIFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred CccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc------CCcchhhccHHHHHHHHHHHh
Confidence 9999999999999999999999998765432 1233567889999998864 257889999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 147 -GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 147 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
|..||.+....+....+..+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~----------------------------------------------------------- 223 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKG----------------------------------------------------------- 223 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcC-----------------------------------------------------------
Confidence 68898765444333333221
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. ... .-..+|+++.++|.+||..||++|||++|+++|
T Consensus 224 -----------~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -----------Y-RLP--KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------C-CCC--CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 000 112458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=235.50 Aligned_cols=189 Identities=16% Similarity=0.305 Sum_probs=143.6
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC--------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN--------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~--------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.+.|+|++.-+.. ...+..+++|||+.+|. |.+.+. +...+..++.||+.||+|||+
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGD--LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred cCCCCCCceEEEEEecCCceEEEEecCCCCC--HHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 4689986533322 44567899999999998 776652 346788999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||+++++.+||+|||++........ .....+++.|+|||.+.. ..++.++|+|||||++
T Consensus 141 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il 214 (280)
T cd05092 141 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY------RKFTTESDIWSFGVVL 214 (280)
T ss_pred CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc------CCcCchhhHHHHHHHH
Confidence 9999999999999999999999999999875533221 112335678999998864 3467899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |.+||........+..+..+.
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------------------------------- 241 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGR----------------------------------------------------- 241 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCc-----------------------------------------------------
Confidence 99998 888886654443333322211
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. . .....+++++.+||.+||+.||++|||++|+++
T Consensus 242 -----------------~-~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 -----------------E-L--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -----------------c-C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0 011246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=232.17 Aligned_cols=193 Identities=28% Similarity=0.480 Sum_probs=143.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|++++..+.. ...+..++|+|++.++. |.+.+. +..++..++.|++.||.|||++|++|+||+|+
T Consensus 55 ~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~ 132 (258)
T cd08215 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGD--LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132 (258)
T ss_pred hcCCCChhheEEEEecCCEEEEEEEecCCCc--HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 3568886533322 33467789999999987 766553 34788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||+++.++.++|+|||++....... ......|++.|+|||.+.. ..++.++|+||+|+++++|++|..||...
T Consensus 133 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN------KPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred HeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhcc------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999987665433 2234578899999998753 23566777777777777777777776443
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+. ......+.
T Consensus 207 ~~----------------------------------------------------------------------~~~~~~~~ 216 (258)
T cd08215 207 NL----------------------------------------------------------------------LELALKIL 216 (258)
T ss_pred cH----------------------------------------------------------------------HHHHHHHh
Confidence 22 22222222
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....... -...+.+++++|.+||..||++|||+.|+|+||||
T Consensus 217 ~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 KGQYPPI---PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 2221111 12567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=230.64 Aligned_cols=140 Identities=21% Similarity=0.393 Sum_probs=109.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ...+..++||||+.+|. |.+.+. +..++..++.|++.||+|||++||+||||||+||
T Consensus 49 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 125 (252)
T cd05084 49 QYSHPNIV-RLIGVCTQKQPIYIVMELVQGGD--FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125 (252)
T ss_pred hCCCCCcc-eEEEEEcCCCCeEEEEeeccCCc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence 57899866 4443 45567889999999998 777763 3477899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
+++.++.+||+|||++.......... ...++..|+|||.+.. ..++.++|+||+||++|+|++ |..||..
T Consensus 126 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 126 LVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY------GRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred EEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC------CCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999987654322111 1122356999998854 346778999999999999997 8777754
Q ss_pred c
Q psy3880 154 R 154 (408)
Q Consensus 154 ~ 154 (408)
.
T Consensus 200 ~ 200 (252)
T cd05084 200 L 200 (252)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=236.79 Aligned_cols=188 Identities=36% Similarity=0.705 Sum_probs=148.2
Q ss_pred cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 9 HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 9 ~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
|++ |+.+.+ ++++..++|||++.+|. |.+.+. +..++..++.|++.||.|||++|++|+||+|+||+++.
T Consensus 61 ~~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~ 137 (280)
T cd05581 61 HPG-IIKLYYTFQDEENLYFVLEYAPNGE--LLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK 137 (280)
T ss_pred CCC-chhHHHHhcCCceEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 887 446554 45567789999999998 777663 44789999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCc---------------------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 82 QMNVKLTDFGFARVLKKGE---------------------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~---------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
++.++++|||++....... ......++..|+|||.+.. ..++.++|+||+||+
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~------~~~~~~~Di~slG~~ 211 (280)
T cd05581 138 DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE------KPAGKSSDLWALGCI 211 (280)
T ss_pred CCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC------CCCChhhhHHHHHHH
Confidence 9999999999987654322 1123457889999998764 236778999999999
Q ss_pred HHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 141 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 141 l~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
++++++|..||...+....+..+.
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~-------------------------------------------------------- 235 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKIL-------------------------------------------------------- 235 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHH--------------------------------------------------------
Confidence 999999999986654333322222
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFF 279 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf 279 (408)
.....++ ..+++++.+||.+||..||++|||+ +++|+||||
T Consensus 236 --------------~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 --------------KLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred --------------hcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2222222 2357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=234.49 Aligned_cols=143 Identities=24% Similarity=0.370 Sum_probs=114.9
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|.-+........++++||+.+|. |.+.+. +.+.+..++.||+.||+|||++|++||||||+|||+
T Consensus 65 ~l~h~~iv~~~~~~~~~~~~~i~e~~~~gs--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili 142 (279)
T cd05111 65 SLDHAYIVRLLGICPGASLQLVTQLSPLGS--LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL 142 (279)
T ss_pred cCCCCCcceEEEEECCCccEEEEEeCCCCc--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE
Confidence 468998654343444455789999999998 887764 346889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+++.+..... .....++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+..
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999976543321 123456778999999864 347889999999999999998 988886654
Q ss_pred h
Q psy3880 156 Q 156 (408)
Q Consensus 156 ~ 156 (408)
.
T Consensus 217 ~ 217 (279)
T cd05111 217 P 217 (279)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=232.11 Aligned_cols=189 Identities=23% Similarity=0.345 Sum_probs=142.8
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+....++..++||||+.+|. |.+.+. +.+.+..++.|++.||+|||+++|+||||||+||+
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 57 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGS--LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred hCCCCCcceEEEEECCCCcEEEEEcCCCCc--HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 467888664443344556789999999998 777764 33678899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||++..+...... ....++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+..
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------GRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred EcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999766543321 12345678999998753 346788999999999999998 777886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+
T Consensus 209 ~~~~~~~~~~~--------------------------------------------------------------------- 219 (262)
T cd05071 209 NREVLDQVERG--------------------------------------------------------------------- 219 (262)
T ss_pred hHHHHHHHhcC---------------------------------------------------------------------
Confidence 43333322211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .. +.-..++.++.+||.+||..||++|||+.++++
T Consensus 220 -~-~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 -Y-RM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -C-CC--CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 00 001245778999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=229.53 Aligned_cols=193 Identities=30% Similarity=0.501 Sum_probs=149.4
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++..+. ...+...++++|++.++. |.+.+. +...+..++.|++.||.|||++||+||||||+||++
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i 132 (254)
T cd06627 55 NLKHPNIVKYIGSIETSDSLYIILEYAENGS--LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132 (254)
T ss_pred hCCCCCccEEEEEEEeCCEEEEEEecCCCCc--HHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence 357887553332 244567789999999987 777653 457888999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||++........ .....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||...+...
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999987654332 234578899999998754 236789999999999999999999986543222
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...++.. ....
T Consensus 207 ~~~~~~~---------------------------------------------------------------------~~~~ 217 (254)
T cd06627 207 ALFRIVQ---------------------------------------------------------------------DDHP 217 (254)
T ss_pred HHHHHhc---------------------------------------------------------------------cCCC
Confidence 1111110 0000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.....++++++++|.+||..||++|||+.++++||||
T Consensus 218 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 ----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 1113568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=236.30 Aligned_cols=195 Identities=28% Similarity=0.468 Sum_probs=150.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.. ..++..|+|+||+.+|. |.+++. +...+..++.|++.|+.|||++|++|+||||+||++
T Consensus 58 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i 134 (277)
T cd06641 58 QCDSPYVT-KYYGSYLKDTKLWIIMEYLGGGS--ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 134 (277)
T ss_pred hcCCCCEe-EEEEEEEeCCeEEEEEEeCCCCc--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE
Confidence 56788755 5543 45567899999999988 777663 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.++|+|||++..+.... ......++..|+|||.+.. ..++.++|+||+||++|+|++|..||.......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ------SAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred CCCCCEEEeecccceecccchhhhccccCCccccChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 999999999999987654322 1223568889999998864 345678999999999999999999986543322
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+.. +.+|
T Consensus 209 ~~~~~~~---------------------------------------------------~~~~------------------ 219 (277)
T cd06641 209 VLFLIPK---------------------------------------------------NNPP------------------ 219 (277)
T ss_pred HHHHHhc---------------------------------------------------CCCC------------------
Confidence 2221111 0000
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+ -..++.++.++|.+||..||.+||++.++++||||...
T Consensus 220 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 02357889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=233.56 Aligned_cols=193 Identities=25% Similarity=0.458 Sum_probs=146.0
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++..+.. ......++++||+.++. |.+.+. +...++.++.|++.||.|||++|++||||||+||
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni 137 (264)
T cd06653 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS--IKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI 137 (264)
T ss_pred HcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 4689886633322 12345678999999987 766653 3578889999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+++.++.++|+|||+++..... .......|+..|+|||.+.. ..++.++|+||+||++|++++|..||..
T Consensus 138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG------EGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC------CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999765321 11234568899999999864 3467899999999999999999999965
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
......+.++..
T Consensus 212 ~~~~~~~~~~~~-------------------------------------------------------------------- 223 (264)
T cd06653 212 YEAMAAIFKIAT-------------------------------------------------------------------- 223 (264)
T ss_pred cCHHHHHHHHHc--------------------------------------------------------------------
Confidence 433322222111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
... .......++++++++|.+||+ +|.+|||+.++|+|||.
T Consensus 224 --~~~--~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 224 --QPT--KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --CCC--CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 000 001123578899999999999 68999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=235.28 Aligned_cols=187 Identities=20% Similarity=0.377 Sum_probs=134.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|++++ .+.. ..++..+++|||+.+|. |.+++. +...+..++.|++.||+|||+
T Consensus 74 ~h~~i~-~~~~~~~~~~~~~li~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 150 (293)
T cd05053 74 KHKNII-NLLGVCTQEGPLYVVVEYAAHGN--LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150 (293)
T ss_pred CCCCee-eEEEEEcCCCCeEEEEEeCCCCc--HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 688755 5443 45566899999999998 776652 336778899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+++.+...... ....++..|+|||.+.. ..++.++|+||+||++
T Consensus 151 ~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il 224 (293)
T cd05053 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD------RVYTHQSDVWSFGVLL 224 (293)
T ss_pred CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc------CCcCcccceeehhhHH
Confidence 99999999999999999999999999999876543211 12234567999998753 2345566666666666
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|++++ |..||.
T Consensus 225 ~el~~~g~~p~~-------------------------------------------------------------------- 236 (293)
T cd05053 225 WEIFTLGGSPYP-------------------------------------------------------------------- 236 (293)
T ss_pred HHHhcCCCCCCC--------------------------------------------------------------------
Confidence 66654 555553
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+....+....+..+. ... .....+.++.+||.+||..||++|||++|++++
T Consensus 237 --~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 237 --GIPVEELFKLLKEGY-RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred --CCCHHHHHHHHHcCC-cCC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333333333333221 111 123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=228.48 Aligned_cols=192 Identities=28% Similarity=0.519 Sum_probs=143.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ..++..++++||+.|+. |.+.+. +...+..++.|++.||.+||++|++|+||+|+||
T Consensus 53 ~l~~~~i~-~~~~~~~~~~~~~l~~e~~~~~~--L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni 129 (253)
T cd05122 53 KCKHPNIV-KYYGSYLKKDELWIVMEFCSGGS--LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129 (253)
T ss_pred hCCCCCEe-EEEEEEecCCeEEEEEecCCCCc--HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHE
Confidence 45688755 5444 44567789999999887 766543 4478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+++.++.++|+|||++.............++..|+|||.+... .++.++|+||+|+++|+|++|..||...+..
T Consensus 130 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK------PYDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred EEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCC------CCCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 9999999999999999876654333456788999999988642 2566788888888888888877777443211
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc-
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG- 236 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~- 236 (408)
.....+...
T Consensus 204 ----------------------------------------------------------------------~~~~~~~~~~ 213 (253)
T cd05122 204 ----------------------------------------------------------------------KALFKIATNG 213 (253)
T ss_pred ----------------------------------------------------------------------HHHHHHHhcC
Confidence 111111111
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
..... ....++.++.++|.+||+.||++|||+.|+|+|||
T Consensus 214 ~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 214 PPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 11111 11124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=232.10 Aligned_cols=197 Identities=27% Similarity=0.513 Sum_probs=150.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.+ ..++..++|+||+.++. |.+.+. ++..+..++.|++.||+|||+ ++++||||+|+||+
T Consensus 56 l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~ 132 (264)
T cd06623 56 CESPYVV-KCYGAFYKEGEISIVLEYMDGGS--LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132 (264)
T ss_pred cCCCCee-eEEEEEccCCeEEEEEEecCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEE
Confidence 4588755 5543 45567899999999998 877764 457889999999999999999 99999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccc-cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLM-DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.++|+|||++.......... ...++..|+|||.+.. ..++.++|+||||+++|+|++|..||......
T Consensus 133 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 206 (264)
T cd06623 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG------ESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206 (264)
T ss_pred ECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC------CCCCchhhHHHHHHHHHHHHhCCCCCcccccc
Confidence 9999999999999988765433222 4567889999998754 35678999999999999999999998654210
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
. .......+....
T Consensus 207 ~-------------------------------------------------------------------~~~~~~~~~~~~ 219 (264)
T cd06623 207 S-------------------------------------------------------------------FFELMQAICDGP 219 (264)
T ss_pred C-------------------------------------------------------------------HHHHHHHHhcCC
Confidence 0 001111111111
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
... .....++..+.++|.+||..+|++|||+.|+++||||+.
T Consensus 220 ~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 220 PPS--LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred CCC--CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 000 001126788999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=236.47 Aligned_cols=186 Identities=20% Similarity=0.362 Sum_probs=141.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+++| .+.+ ..++..|+||||+.+|. |.+++. +..++..++.||+.||.|||+
T Consensus 76 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 152 (314)
T cd05099 76 KHKNII-NLLGVCTQEGPLYVIVEYAAKGN--LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152 (314)
T ss_pred CCCCee-eEEEEEccCCceEEEEecCCCCc--HHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 588755 5554 44566789999999998 777663 235678899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+++....... .....+++.|+|||.+.. ..++.++|+||+||++
T Consensus 153 ~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l 226 (314)
T cd05099 153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD------RVYTHQSDVWSFGILM 226 (314)
T ss_pred CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc------CCcCccchhhHHHHHH
Confidence 9999999999999999999999999999986543221 112234467999998864 3577899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|++++ |..||.+.+..+....+..+
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 252 (314)
T cd05099 227 WEIFTLGGSPYPGIPVEELFKLLREG------------------------------------------------------ 252 (314)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC------------------------------------------------------
Confidence 99998 88888665443333332211
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. ... ....++.++++||.+||..||++|||+.|+++
T Consensus 253 ----------------~-~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 253 ----------------H-RMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ----------------C-CCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 000 01245778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=237.06 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=142.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NILl~~ 81 (408)
.|++++ .+.+ ..+...|+||||+.+....+.... .+...+..++.|++.||+|||+ +||+||||+|+||++++
T Consensus 72 ~~~~i~-~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~ 150 (296)
T cd06618 72 DCPYIV-KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA 150 (296)
T ss_pred CCCchH-hhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC
Confidence 577754 5544 344567899999865322233332 2456778899999999999997 69999999999999999
Q ss_pred CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
++.+||+|||++..+..........+++.|+|||.+..... ...++.++|+||+||++|+|++|..||......
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 224 (296)
T cd06618 151 SGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDP--NPKYDIRADVWSLGISLVELATGQFPYKNCKTE---- 224 (296)
T ss_pred CCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCC--ccccccchhHHHHHHHHHHHHhCCCCCCcchhH----
Confidence 99999999999977654333334567889999999864311 134567788888888888888888777442111
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
.+.+..+.......
T Consensus 225 -----------------------------------------------------------------~~~~~~~~~~~~~~- 238 (296)
T cd06618 225 -----------------------------------------------------------------FEVLTKILQEEPPS- 238 (296)
T ss_pred -----------------------------------------------------------------HHHHHHHhcCCCCC-
Confidence 11111222111110
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+....++.++++||.+||..||++|||++++++||||...
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 11112468889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=230.04 Aligned_cols=188 Identities=22% Similarity=0.397 Sum_probs=142.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ .+.+..++||||+.+|. |.+.+. +.+.+..++.||+.||+|||++||+||||||+|
T Consensus 58 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~n 134 (261)
T cd05148 58 RLRHKHLI-SLFAVCSVGEPVYIITELMEKGS--LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARN 134 (261)
T ss_pred cCCCcchh-heeeeEecCCCeEEEEeecccCC--HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcce
Confidence 45788765 4443 45567899999999998 888764 347789999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccc-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKL-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|+++.++.+||+|||++......... ....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 135 ilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH------GTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred EEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999776433211 12345668999998854 346678899998888888887 77887655
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+..
T Consensus 209 ~~~~~~~~~~~--------------------------------------------------------------------- 219 (261)
T cd05148 209 NNHEVYDQITA--------------------------------------------------------------------- 219 (261)
T ss_pred CHHHHHHHHHh---------------------------------------------------------------------
Confidence 44333333221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +.. +.....++++.++|.+||+.||.+|||+.++++
T Consensus 220 -~-~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 220 -G-YRM--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -C-CcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 111 112356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=229.92 Aligned_cols=189 Identities=21% Similarity=0.355 Sum_probs=140.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+|..+.. ..++..++|+||+.+|. |.+.+. +...+..++.|++.||+|||+++|+||||||+||
T Consensus 52 ~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~ni 129 (262)
T cd05058 52 DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGD--LRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNC 129 (262)
T ss_pred cCCCCCcceEEEEeecCCCCcEEEEecCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 5789986643332 34556789999999998 877763 2356778889999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC-CCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPF 151 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G-~~pf 151 (408)
|++.++.+||+|||+++.+..... .....+++.|+|||.+.. ..++.++|+|||||++|+|++| .+||
T Consensus 130 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT------QKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred EEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc------CccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999876543211 112345678999998854 3577899999999999999994 5666
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
...+.......+..+
T Consensus 204 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 218 (262)
T cd05058 204 PDVDSFDITVYLLQG----------------------------------------------------------------- 218 (262)
T ss_pred CCCCHHHHHHHHhcC-----------------------------------------------------------------
Confidence 544333322222111
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. ...+ ..+++.+++++.+||..||++|||+.|+++
T Consensus 219 -----~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 219 -----RR-LLQP--EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----CC-CCCC--CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0001 235778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=231.11 Aligned_cols=136 Identities=19% Similarity=0.299 Sum_probs=108.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.. ..++..++||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+||
T Consensus 55 ~~~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni 131 (258)
T cd05078 55 QLSHKHLV-LNYGVCVCGDESIMVQEYVKFGS--LDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV 131 (258)
T ss_pred hCCCCChh-heeeEEEeCCCcEEEEecCCCCc--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 46899866 4443 34466789999999998 777663 3467788999999999999999999999999999
Q ss_pred EEecCCC--------EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC-
Q psy3880 78 LLDDQMN--------VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC- 148 (408)
Q Consensus 78 Ll~~~~~--------iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~- 148 (408)
|++.++. ++++|||++...... ....+++.|+|||++.. ...++.++|+||+||++|+|++|.
T Consensus 132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 132 LLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIEN-----PQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred EEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccC-----CCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9987654 699999998765432 23568889999999864 234678999999999999999985
Q ss_pred CCCC
Q psy3880 149 PPFW 152 (408)
Q Consensus 149 ~pf~ 152 (408)
.||.
T Consensus 204 ~~~~ 207 (258)
T cd05078 204 KPLS 207 (258)
T ss_pred CChh
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=231.42 Aligned_cols=138 Identities=22% Similarity=0.337 Sum_probs=108.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.. ..+...++||||+.+|. |...+ .+...+..++.||+.||+|||++||+||||||+||
T Consensus 60 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 136 (262)
T cd05077 60 QVSHKHIV-LLYGVCVRDVENIMVEEFVEFGP--LDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136 (262)
T ss_pred hCCCCCEe-eEEEEEecCCCCEEEEecccCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence 46899855 5543 45566789999999997 43333 24478889999999999999999999999999999
Q ss_pred EEecCCC-------EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH-hCCC
Q psy3880 78 LLDDQMN-------VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149 (408)
Q Consensus 78 Ll~~~~~-------iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll-~G~~ 149 (408)
|++.++. +|++|||++...... ....++..|+|||.+.. ...++.++||||+||++|+|+ .|..
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~el~~~~~~ 208 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVED-----SKNLSIAADKWSFGTTLWEICYNGEI 208 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcC-----CCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 9986653 899999998654322 23567889999998753 245788999999999999998 5877
Q ss_pred CCCCc
Q psy3880 150 PFWHR 154 (408)
Q Consensus 150 pf~~~ 154 (408)
||...
T Consensus 209 p~~~~ 213 (262)
T cd05077 209 PLKDK 213 (262)
T ss_pred CCCCc
Confidence 77543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=228.51 Aligned_cols=193 Identities=33% Similarity=0.548 Sum_probs=148.8
Q ss_pred ccccCCcEEEEec--cCC--cHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGD--DLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~--~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ ... +..++|+|++.++. |.+.+. +..++..++.|++.||+|||++|++|+||+|+|
T Consensus 55 ~l~~~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~n 131 (260)
T cd06606 55 SLQHPNIV-RYYGSERDEEKNTLNIFLEYVSGGS--LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN 131 (260)
T ss_pred HcCCCCEe-eEEEEEecCCCCeEEEEEEecCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 35688755 4443 333 56789999999887 776653 447888999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+++.++.++|+|||.+........ .....++..|+|||.+... .++.++|+||+|++++++++|..||..
T Consensus 132 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE------EYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred EEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999887665442 3446788999999988642 367899999999999999999999965
Q ss_pred chh-HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 154 RKQ-MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 154 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
... ......+
T Consensus 206 ~~~~~~~~~~~--------------------------------------------------------------------- 216 (260)
T cd06606 206 LGNPMAALYKI--------------------------------------------------------------------- 216 (260)
T ss_pred CCchHHHHHhc---------------------------------------------------------------------
Confidence 431 1110000
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
....... .....++.++++||.+||..||++|||+.|+++||||
T Consensus 217 -~~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 -GSSGEPP--EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -cccCCCc--CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0000000 0112457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=230.36 Aligned_cols=189 Identities=22% Similarity=0.392 Sum_probs=142.3
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+....++..+++||++.+|. |.+.+. +.+++..++.|++.||+|||++|++||||||+||+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~ 134 (260)
T cd05067 57 QLQHPRLVRLYAVVTQEPIYIITEYMENGS--LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134 (260)
T ss_pred hcCCcCeeeEEEEEccCCcEEEEEcCCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence 467888654443444566899999999998 877753 33678889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+++++.++|+|||++........ .....++..|+|||++.. ..++.++|+||+||++|++++ |.+||.+.+
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred EcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc------CCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999876553221 112345678999998854 346778899998888888887 888886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+
T Consensus 209 ~~~~~~~~~~~--------------------------------------------------------------------- 219 (260)
T cd05067 209 NPEVIQNLERG--------------------------------------------------------------------- 219 (260)
T ss_pred hHHHHHHHHcC---------------------------------------------------------------------
Confidence 43333322111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+.. +.....+.++++||.+||..||++|||++++++
T Consensus 220 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 220 --YRM--PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=236.51 Aligned_cols=187 Identities=20% Similarity=0.358 Sum_probs=142.8
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------------HHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------------NPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------------~~~~r~i~~qil~aL~~LH~ 64 (408)
.|++++ .+.. ..+...|+||||+.+|. |.+++.+ ..++..++.||+.||.|||+
T Consensus 79 ~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 155 (304)
T cd05101 79 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155 (304)
T ss_pred cCCCch-heeEEEecCCceEEEEecCCCCc--HHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence 688755 5443 45567799999999998 7776642 24678899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+++.+..... .....+++.|+|||++.. ..++.++|+|||||++
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l 229 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD------RVYTHQSDVWSFGVLM 229 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc------CCCCchhhHHHHHHHH
Confidence 9999999999999999999999999999986643221 112345678999998864 3477899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|++++ |..||.+.+..+....+..+
T Consensus 230 ~el~~~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 255 (304)
T cd05101 230 WEIFTLGGSPYPGIPVEELFKLLKEG------------------------------------------------------ 255 (304)
T ss_pred HHHHcCCCCCcccCCHHHHHHHHHcC------------------------------------------------------
Confidence 99998 77888665444333333211
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. ... .....+.++++||.+||..+|++|||+.|+++.
T Consensus 256 ----------------~-~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 256 ----------------H-RMD--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ----------------C-cCC--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 0 000 112467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=228.24 Aligned_cols=190 Identities=22% Similarity=0.331 Sum_probs=145.4
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++|..+....++..++|+||+.+|. |.+.+. +...+..++.|++.||+|||++|++||||||+||+
T Consensus 52 ~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 52 SLDHENLIRLYGVVLTHPLMMVTELAPLGS--LLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred hcCCCCccceeEEEcCCeEEEEEEecCCCc--HHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 478998664333333367789999999998 777653 33678889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
++.++.+||+|||++..+..... .....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||..
T Consensus 130 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~------~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT------RTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred EecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc------cCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999987654221 112456788999998864 347789999999999999998 9999876
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....+...
T Consensus 204 ~~~~~~~~~~~~~------------------------------------------------------------------- 216 (257)
T cd05040 204 LSGSQILKKIDKE------------------------------------------------------------------- 216 (257)
T ss_pred CCHHHHHHHHHhc-------------------------------------------------------------------
Confidence 5554444333210
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
......+ ...+.++.+|+.+||..+|++|||+.|+++
T Consensus 217 ---~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ---GERLERP--EACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---CCcCCCC--ccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000001 235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=237.95 Aligned_cols=198 Identities=34% Similarity=0.561 Sum_probs=145.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +.++..|+||||+.+|. |.+.+. +...++.++.|++.||.|||+.+++||||||.||+++
T Consensus 63 ~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~ 139 (288)
T cd05583 63 RCPF-LVTLHYAFQTDTKLHLILDYVNGGE--LFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139 (288)
T ss_pred CCcc-hhhhheeeecCCEEEEEEecCCCCc--HHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 3555 445543 44456789999999998 776653 3478889999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
.++.++|+|||++........ ....+|++.|+|||.+.+. ...++.++|+||+|+++|+|++|..||.......
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 215 (288)
T cd05583 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215 (288)
T ss_pred CCCCEEEEECccccccccccccccccccCCccccCHHHhcCC----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc
Confidence 999999999999876543322 1235688999999987642 1235678899999999999999988874321100
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. ..+..+.+.....
T Consensus 216 ~------------------------------------------------------------------~~~~~~~~~~~~~ 229 (288)
T cd05583 216 S------------------------------------------------------------------QSEISRRILKSKP 229 (288)
T ss_pred h------------------------------------------------------------------HHHHHHHHHccCC
Confidence 0 0011112222211
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a~e~L~Hpwf~~~ 282 (408)
.. ...++.++++||.+||+.||++||| +.++|+||||+..
T Consensus 230 ~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 230 PF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 11 1346889999999999999999998 6788999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=235.04 Aligned_cols=187 Identities=18% Similarity=0.314 Sum_probs=142.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|+|+| ++.. ...+..|+||||+.+|. |.+.+. +..++..++.|++.||+|||+++|+|+||||+|||
T Consensus 97 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil 173 (302)
T cd05055 97 NHENIV-NLLGACTIGGPILVITEYCCYGD--LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173 (302)
T ss_pred CCCCcc-eEEEEEecCCceEEEEEcCCCCc--HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEE
Confidence 688755 5443 45567899999999998 776653 34788899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
++.++.++++|||++..+..... .....+++.|+|||.+.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 174 LTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN------CVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred EcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 99999999999999976543221 112345678999998864 346789999999999999998 99998654
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.....+.+...
T Consensus 248 ~~~~~~~~~~~--------------------------------------------------------------------- 258 (302)
T cd05055 248 PVDSKFYKLIK--------------------------------------------------------------------- 258 (302)
T ss_pred CchHHHHHHHH---------------------------------------------------------------------
Confidence 33222111111
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...... ....+++++.+||.+||..||++|||+.|+++
T Consensus 259 -~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -EGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -cCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111111 11245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=231.40 Aligned_cols=189 Identities=24% Similarity=0.340 Sum_probs=143.0
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+....++..|+||||+.+|. |.+.+. +...+..++.|++.||+|||++|++||||||+|||+
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili 140 (270)
T cd05056 63 QFDHPHIVKLIGVITENPVWIVMELAPLGE--LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140 (270)
T ss_pred hCCCCchhceeEEEcCCCcEEEEEcCCCCc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence 467988664443344566789999999998 877763 347788899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~ 156 (408)
+.++.+||+|||++.......... ...+++.|+|||.+.. ..++.++|+|||||++|++++ |..||.+.+.
T Consensus 141 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 141 SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999987654432211 2234467999998753 346788999999999999885 8888866554
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+....+..+
T Consensus 215 ~~~~~~~~~~---------------------------------------------------------------------- 224 (270)
T cd05056 215 NDVIGRIENG---------------------------------------------------------------------- 224 (270)
T ss_pred HHHHHHHHcC----------------------------------------------------------------------
Confidence 4333332211
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... +....++.+++++|.+||..||++|||+.+++.
T Consensus 225 ~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 225 ERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 100 112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=235.83 Aligned_cols=187 Identities=20% Similarity=0.358 Sum_probs=140.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------------HHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------------NPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------------~~~~r~i~~qil~aL~~LH~ 64 (408)
.|++++ .+.. ..++..|+||||+.+|+ |.+++.. ..++..++.|++.||+|||+
T Consensus 82 ~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 82 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred CCCCEe-eEEEEEecCCceEEEEecCCCCc--HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 588754 5543 45567899999999998 8777642 35778899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+|++||||||+|||++.++.+||+|||++......... ....+++.|+|||.+.. ..++.++|+||+||++
T Consensus 159 ~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l 232 (307)
T cd05098 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD------RIYTHQSDVWSFGVLL 232 (307)
T ss_pred CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc------CCCCcHHHHHHHHHHH
Confidence 99999999999999999999999999998765432211 11234568999998864 3467889999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+..+....+..
T Consensus 233 ~el~~~g~~p~~~~~~~~~~~~~~~------------------------------------------------------- 257 (307)
T cd05098 233 WEIFTLGGSPYPGVPVEELFKLLKE------------------------------------------------------- 257 (307)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHc-------------------------------------------------------
Confidence 99987 7777755443332222211
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+. .. +....++.++++||.+||..||++|||+.|++++
T Consensus 258 ---------------~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 258 ---------------GH-RM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ---------------CC-CC--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11 01 1113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.43 Aligned_cols=188 Identities=19% Similarity=0.335 Sum_probs=143.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.. +..+..++|||++.+|. |.+.+. +..++..++.|++.||.|||++||+||||||+|
T Consensus 57 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 133 (261)
T cd05068 57 KLRHPKLI-QLYAVCTLEEPIYIVTELMKYGS--LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN 133 (261)
T ss_pred HCCCCCcc-ceeEEEecCCCeeeeeecccCCc--HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcce
Confidence 36788765 4443 45567899999999998 777753 347889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|+++.++.+||+|||++.......... ....+..|+|||.+.. ..++.++|+||+||++|+|++ |..||.+
T Consensus 134 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 134 VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY------NRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred EEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc------CCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999998765322111 1222357999998864 346789999999999999998 9999876
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+.......+..+
T Consensus 208 ~~~~~~~~~~~~~------------------------------------------------------------------- 220 (261)
T cd05068 208 MTNAEVLQQVDQG------------------------------------------------------------------- 220 (261)
T ss_pred CCHHHHHHHHHcC-------------------------------------------------------------------
Confidence 5544433333221
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+..+. -...+.+++++|.+||..||++|||+.++++
T Consensus 221 ----~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ----YRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----CCCCC--CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 00000 1245788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=226.13 Aligned_cols=189 Identities=19% Similarity=0.292 Sum_probs=141.0
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++..+. ....+..++||||+.+|. |.+.+. +...+..++.|++.||.|||++|++||||||+||+
T Consensus 48 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nil 125 (250)
T cd05085 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGD--FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCL 125 (250)
T ss_pred hCCCCCcCeEEEEEecCCccEEEEECCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEE
Confidence 367998663332 245567889999999998 777653 34778889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||++.....+... ....+++.|+|||++.. ..++.++|+||+||++|++++ |..||.+..
T Consensus 126 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 126 VGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY------GRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred EcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 999999999999998754432211 11234567999999864 345678899999999999887 888886554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..
T Consensus 200 ~~~~~~~~~~---------------------------------------------------------------------- 209 (250)
T cd05085 200 NQQAREQVEK---------------------------------------------------------------------- 209 (250)
T ss_pred HHHHHHHHHc----------------------------------------------------------------------
Confidence 3332222211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +.. .....++.++.+|+.+||..||++|||+.|+++
T Consensus 210 ~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 210 G-YRM--SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred C-CCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1 000 111346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=229.24 Aligned_cols=150 Identities=21% Similarity=0.356 Sum_probs=108.1
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCC---------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINS---------NPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~---------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|+|..+.. ...+..|+||||+.+|. |.+++.. ...+..++.||+.||+|||+++|+||||||+
T Consensus 51 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 128 (268)
T cd05086 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGD--LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128 (268)
T ss_pred ccCCcchhheEEEecCCCccEEEEecCCCCc--HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence 4689986644432 44566799999999998 8877642 1456788999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhcccc-CcCCCCcchhhhhhhHHHHHHHh-CCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFE-DATGYGQAVDVWACGVIMYTLLV-GCPP 150 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-~~~~~~~~~DiwSlGvil~~ll~-G~~p 150 (408)
|||++.++.+||+|||++....... .....++++.|+|||++...... ....++.++|+||+||++|+|++ |..|
T Consensus 129 nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred eEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999986432211 11245788899999987532100 01234567777777777777775 4556
Q ss_pred CCCchhH
Q psy3880 151 FWHRKQM 157 (408)
Q Consensus 151 f~~~~~~ 157 (408)
|...+..
T Consensus 209 ~~~~~~~ 215 (268)
T cd05086 209 YSHLSDR 215 (268)
T ss_pred CCCCCHH
Confidence 6544433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=228.32 Aligned_cols=147 Identities=22% Similarity=0.363 Sum_probs=111.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC----------HHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS----------NPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~----------~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.. ...+..++||||+.+|. |.+++.+ ...++.++.|++.||+|||+++++|||||
T Consensus 51 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlk 127 (269)
T cd05087 51 SLQHSNLL-QCLGQCTEVTPYLLVMEFCPLGD--LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLA 127 (269)
T ss_pred hCCCCCEe-eEEEEEcCCCCcEEEEECCCCCc--HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence 46799865 5443 44566789999999998 8777632 24667889999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhcccc-CcCCCCcchhhhhhhHHHHHHHh-CC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFE-DATGYGQAVDVWACGVIMYTLLV-GC 148 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~-~~~~~~~~~DiwSlGvil~~ll~-G~ 148 (408)
|+||+++.++.+||+|||++........ .....+++.|+|||++...... ....++.++|+||+||++|+|++ |.
T Consensus 128 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 9999999999999999999875433221 1234577889999998532100 01235678899999988888885 88
Q ss_pred CCCCCch
Q psy3880 149 PPFWHRK 155 (408)
Q Consensus 149 ~pf~~~~ 155 (408)
.||....
T Consensus 208 ~p~~~~~ 214 (269)
T cd05087 208 QPYRHLS 214 (269)
T ss_pred CCCCCCC
Confidence 8886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=255.16 Aligned_cols=183 Identities=30% Similarity=0.530 Sum_probs=136.5
Q ss_pred cHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
...||-||||+... +.+++... ..+..+++||++||.|+|++|||||||||.||+++.++.|||+|||+|..
T Consensus 669 ~~LYIQMEyCE~~l--l~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTL--LRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred eEEEEEHhhhhhhH--HHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchh
Confidence 34689999999876 77766432 67889999999999999999999999999999999999999999999986
Q ss_pred cc----c---------------CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 96 LK----K---------------GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 96 ~~----~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
.. . ....++.+||.-|+|||++.... ...|+.|+|+||||||++||+. ||...-+
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~---~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS---SNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc---cccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 21 0 11334578999999999987532 1358888888888888888863 3432211
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
. ...+.++.++
T Consensus 821 R---------------------------------------------------------------------a~iL~~LR~g 831 (1351)
T KOG1035|consen 821 R---------------------------------------------------------------------ASILTNLRKG 831 (1351)
T ss_pred H---------------------------------------------------------------------HHHHHhcccC
Confidence 1 1122233333
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...++...|..--+..+.+|+.||..||++||||.|+|++.||.+
T Consensus 832 ~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 832 SIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred CCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 333332233344456678999999999999999999999999976
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=231.94 Aligned_cols=191 Identities=26% Similarity=0.490 Sum_probs=142.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.. ..++..++++||+.||. |.+.+. ++..+..++.||+.||.|||++|++|+||||
T Consensus 58 ~~~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p 134 (267)
T cd08229 58 QLNHPNVI-KYYASFIEDNELNIVLELADAGD--LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP 134 (267)
T ss_pred HccCCchh-hhhheeEeCCeEEEEEEecCCCC--HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 46788855 4443 34567789999999988 766542 4477889999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+||+++.++.++|+|||++........ ....+|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||.+
T Consensus 135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred HHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC------CCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999877654322 234578999999998864 3456788999999999999888888754
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.... .....+.+
T Consensus 209 ~~~~--------------------------------------------------------------------~~~~~~~~ 220 (267)
T cd08229 209 DKMN--------------------------------------------------------------------LYSLCKKI 220 (267)
T ss_pred ccch--------------------------------------------------------------------HHHHhhhh
Confidence 2210 00111122
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.... ++...+...++++++||.+||..||++|||+.++++
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 221 EQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 2211 122223457889999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=232.07 Aligned_cols=139 Identities=22% Similarity=0.378 Sum_probs=108.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh----------------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII----------------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~----------------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|++++ .+.. ..++..++|+|++.+|. |.+.+ .+...+..++.|++.||+|||++||
T Consensus 75 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i 151 (296)
T cd05051 75 RLSDPNIA-RLLGVCTVDPPLCMIMEYMENGD--LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF 151 (296)
T ss_pred hcCCCCEe-EEEEEEecCCCcEEEEecCCCCC--HHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence 46788855 4443 34467899999999987 76654 2346788999999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||||||+||+++.++.++|+|||+++....... .....+++.|+|||.+.. ..++.++|+||+||++|+|
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el 225 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL------GKFTTKSDVWAFGVTLWEI 225 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc------CCCCccchhhhhHHHHHHH
Confidence 9999999999999999999999999876543321 123456778999998864 2467788888888888888
Q ss_pred Hh--CCCCCCC
Q psy3880 145 LV--GCPPFWH 153 (408)
Q Consensus 145 l~--G~~pf~~ 153 (408)
++ |..||..
T Consensus 226 ~~~~~~~p~~~ 236 (296)
T cd05051 226 LTLCREQPYEH 236 (296)
T ss_pred HhcCCCCCCCC
Confidence 87 5556543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=230.95 Aligned_cols=192 Identities=24% Similarity=0.471 Sum_probs=142.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|++++ .+.+ ...+..|+|+||+.+|. |.+.+ .++..+..++.|++.||.|||++||+|+||||
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~ 134 (267)
T cd08228 58 QLNHPNVI-KYLDSFIEDNELNIVLELADAGD--LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP 134 (267)
T ss_pred hCCCccee-eeeeeEEECCeEEEEEEecCCCc--HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCH
Confidence 45788855 4443 34567789999999998 66554 24477889999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+||+++.++.++|+|||++........ .....|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||..
T Consensus 135 ~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred HHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhcc------CCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 999999999999999999876643322 224578899999998864 3456788999999999999988888743
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.... .......+
T Consensus 209 ~~~~--------------------------------------------------------------------~~~~~~~~ 220 (267)
T cd08228 209 DKMN--------------------------------------------------------------------LFSLCQKI 220 (267)
T ss_pred cccc--------------------------------------------------------------------HHHHHHHH
Confidence 2110 00111112
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.... ++.......+.++++||++||..||++|||+.++|+.
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 221 EQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 1111 1111123467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=230.99 Aligned_cols=188 Identities=20% Similarity=0.317 Sum_probs=141.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----------------------------CHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----------------------------SNPALRYIMRQ 54 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----------------------------~~~~~r~i~~q 54 (408)
.+.|+++| ++.+ ..++..++++||+.+|. |.+++. +...+..++.|
T Consensus 59 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 59 QVNHPHVI-KLYGACSQDGPLLLIVEYAKYGS--LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred hCCCCCEe-eEEEEEecCCCcEEEEEecCCCC--HHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence 46799855 5554 45567889999999998 776653 23567899999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcc
Q psy3880 55 LFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQA 131 (408)
Q Consensus 55 il~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~ 131 (408)
++.||+|||+++|+||||||+|||+++++.+||+|||+++....... .....++..|+|||.+.. ..++.+
T Consensus 136 i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~ 209 (290)
T cd05045 136 ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD------HIYTTQ 209 (290)
T ss_pred HHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc------CCcchH
Confidence 99999999999999999999999999999999999999976533221 122345678999998754 346788
Q ss_pred hhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhh
Q psy3880 132 VDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVI 210 (408)
Q Consensus 132 ~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvi 210 (408)
+|+||+||++|+|++ |..||.+.........+.
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------------------------------------------- 243 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK---------------------------------------------- 243 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh----------------------------------------------
Confidence 999999999999998 888886544332221111
Q ss_pred HHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 211 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 211 ly~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+... .....+.++.+||.+||..||++|||+.|+++
T Consensus 244 -------------------------~~~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 244 -------------------------TGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -------------------------CCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 111111 11346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=228.69 Aligned_cols=189 Identities=20% Similarity=0.407 Sum_probs=142.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.. +..+..++||||+.+|. |.+++. +..++..++.|++.||+|||+++|+||||||+||
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~iv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 61 QFDHPNII-RLEGVVTKSRPVMIITEYMENGS--LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred hCCCCCcc-eEeEEEecCCceEEEEEcCCCCC--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 45788755 5543 44566789999999998 877763 3478889999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|++.++.++|+|||++..+.... ... ...+++.|+|||.+.. ..++.++|+|||||++|++++ |..||..
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY------RKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc------CCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 99999999999999998765211 111 2334578999998864 346778888888888888886 8777755
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.........+..
T Consensus 212 ~~~~~~~~~~~~-------------------------------------------------------------------- 223 (266)
T cd05033 212 MSNQDVIKAVED-------------------------------------------------------------------- 223 (266)
T ss_pred CCHHHHHHHHHc--------------------------------------------------------------------
Confidence 443333322221
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+ +..+ .....++++.+|+.+||..||++|||+.|++++
T Consensus 224 --~-~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 --G-YRLP--PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred --C-CCCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 1111 112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=226.99 Aligned_cols=188 Identities=20% Similarity=0.336 Sum_probs=141.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------------CHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------------SNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------------~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+.+. +..++..++.|++.||+|||+++++|+|
T Consensus 55 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d 131 (269)
T cd05044 55 NFNHPNIV-KLLGVCLLNEPQYIIMELMEGGD--LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRD 131 (269)
T ss_pred hcCCCCee-eEeeeecCCCCeEEEEeccCCCc--HHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 46799866 4443 45567899999999998 877763 2367788999999999999999999999
Q ss_pred CCCCcEEEecCC-----CEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 72 LKPENILLDDQM-----NVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 72 LKp~NILl~~~~-----~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|||+||+++.++ .++++|||++......... ....++..|+|||.+.. ..++.++|+|||||++|+
T Consensus 132 l~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~e 205 (269)
T cd05044 132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD------GKFTTQSDVWSFGVLMWE 205 (269)
T ss_pred CChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc------CCcccchhHHHHHHHHHH
Confidence 999999999877 8999999998765432211 12345678999999864 346788999999999999
Q ss_pred HHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 144 LLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 144 ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
|++ |..||...+.......+..+
T Consensus 206 llt~g~~p~~~~~~~~~~~~~~~~-------------------------------------------------------- 229 (269)
T cd05044 206 ILTLGQQPYPALNNQEVLQHVTAG-------------------------------------------------------- 229 (269)
T ss_pred HHHcCCCCCcccCHHHHHHHHhcC--------------------------------------------------------
Confidence 987 88888655443333322111
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .+ ..+..+++++.+||.+||..||++|||++++++
T Consensus 230 --------------~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 --------------G-RL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------------C-cc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 00 112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=227.61 Aligned_cols=189 Identities=22% Similarity=0.396 Sum_probs=140.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++.......+...+++|||+.+|. |.+++.+ ..++..++.|++.||+|||++|++||||||+||+
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~ 134 (260)
T cd05073 57 TLQHDKLVKLHAVVTKEPIYIITEFMAKGS--LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134 (260)
T ss_pred hcCCCCcceEEEEEcCCCeEEEEEeCCCCc--HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 467887653333333466789999999998 8777643 3677889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||++......... ....++..|+|||++.. ..++.++|+||+||++|++++ |..||.+.+
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc------CCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999998765443221 12335567999999864 345678888888888888887 788876554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+.+
T Consensus 209 ~~~~~~~~~~---------------------------------------------------------------------- 218 (260)
T cd05073 209 NPEVIRALER---------------------------------------------------------------------- 218 (260)
T ss_pred HHHHHHHHhC----------------------------------------------------------------------
Confidence 4333322221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +.. +.....+.++.+++.+||..||++|||+.++++
T Consensus 219 ~-~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 G-YRM--PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred C-CCC--CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1 111 112356788999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=230.14 Aligned_cols=139 Identities=29% Similarity=0.496 Sum_probs=112.4
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.. ......++||||+.+|. |.+.+. +..++..++.|++.||+|||++||+||||||+||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 62 TLYHENIV-KYKGCCSEQGGKGLQLIMEYVPLGS--LRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred hCCCCCEe-eEEEEEecCCCceEEEEecCCCCCC--HHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 46899866 4443 22345789999999998 777654 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|++.++.+||+|||++..+...... ....++..|+|||.+.. ..++.++|+||+||++|+|++|+.||..
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE------NKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc------cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999866543221 12345667999998864 3467899999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=231.76 Aligned_cols=179 Identities=18% Similarity=0.218 Sum_probs=129.6
Q ss_pred HHHHHHHhhchhhHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc--
Q psy3880 25 HLAAQVVDKGEAAVQDII--NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-- 100 (408)
Q Consensus 25 ~lv~e~~~~g~~~l~~~~--~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~-- 100 (408)
++++|++......+...+ .+++.++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||+|+.+....
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~ 182 (294)
T PHA02882 103 FILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182 (294)
T ss_pred EEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcc
Confidence 456666543322244433 2457788999999999999999999999999999999999999999999998654221
Q ss_pred ------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCC
Q psy3880 101 ------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPE 174 (408)
Q Consensus 101 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 174 (408)
......||+.|+|||+..+ ..|+.++|+||+||++|+|++|..||.+......+.....
T Consensus 183 ~~~~~~~~~~~~gt~~y~ape~~~~------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~--------- 247 (294)
T PHA02882 183 IEYSKEQKDLHRGTLYYAGLDAHNG------ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK--------- 247 (294)
T ss_pred cccccccccccCCCccccCHHHhCC------CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH---------
Confidence 1123579999999998864 4578899999999999999999999976532111111000
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKD 254 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~d 254 (408)
......+..+...+ ...++++.+
T Consensus 248 ----------------------------------------------------~~~~~~~~~~~~~~-----~~~~~~~~~ 270 (294)
T PHA02882 248 ----------------------------------------------------CDFIKRLHEGKIKI-----KNANKFIYD 270 (294)
T ss_pred ----------------------------------------------------HHHHHHhhhhhhcc-----CCCCHHHHH
Confidence 01112222222222 234778999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy3880 255 LIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 255 LI~klL~~dP~~R~ta~e~L~ 275 (408)
+++.|+..||++||+.+++++
T Consensus 271 ~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 271 FIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.43 Aligned_cols=187 Identities=19% Similarity=0.354 Sum_probs=141.5
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++.-+.. ...+..++|||++.+|. |.+.+. +...+..++.|++.||.|||++||+||||||+||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Ni 133 (256)
T cd05039 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS--LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133 (256)
T ss_pred hcCCcceeeeEEEEcCCCCeEEEEEecCCCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceE
Confidence 4678886533322 44677899999999998 777652 4578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~ 156 (408)
+++.++.+||+|||+++...... ....++..|+|||.+.. ..++.++|+||+||++|++++ |..||...+.
T Consensus 134 li~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 134 LVSEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALRE------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred EEeCCCCEEEccccccccccccc--ccCCCcccccCchhhcC------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999998764322 23344567999998854 346778999999999999987 8888855443
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
......+.. +
T Consensus 206 ~~~~~~~~~----------------------------------------------------------------------~ 215 (256)
T cd05039 206 KDVVPHVEK----------------------------------------------------------------------G 215 (256)
T ss_pred HHHHHHHhc----------------------------------------------------------------------C
Confidence 332222211 1
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+.... -...++++.+||.+||..||++|||++|+++
T Consensus 216 -~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 -YRMEA--PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -CCCCC--ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01111 1245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=245.13 Aligned_cols=211 Identities=29% Similarity=0.422 Sum_probs=145.9
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC-CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccC
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ-MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFED 124 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~-~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 124 (408)
..+|.|+.|++.||..|-..||+|.||||.|||+++. ..+||||||.|.....++ .+.+..+..|.|||++.+
T Consensus 536 kaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG----- 609 (752)
T KOG0670|consen 536 KAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILG----- 609 (752)
T ss_pred hHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeec-----
Confidence 7899999999999999999999999999999999865 468999999998776554 345666789999999986
Q ss_pred cCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhccccccc-CCCccc
Q psy3880 125 ATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATG-YGQAVD 203 (408)
Q Consensus 125 ~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~-y~~~~D 203 (408)
..|+...|+||.||++|||.||+..|.+.+..+|+.-.+..+..|+..-.. .-++.+..|.+... |-..+|
T Consensus 610 -~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR-------KgqF~dqHFD~d~nf~~~e~D 681 (752)
T KOG0670|consen 610 -LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR-------KGQFKDQHFDQDLNFLYIEVD 681 (752)
T ss_pred -CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh-------hcchhhhhcccccceEEEecc
Confidence 578999999999999999999999999999999998887765544321100 01111222221110 111111
Q ss_pred ccchhhhHHHhhcCCC---CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 204 VWACGVIMYTLLVGCP---PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 204 iWs~Gvily~ll~g~~---Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
- +++.. +...-.+..-+...+.+...++..+ ..+-..++|||.+||.+||++|+|+.|||.||||+
T Consensus 682 ~----------vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq-~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 682 K----------VTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ-PKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred c----------cccceeEEEecccCcchhHHHHHhccCCCCchh-HHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 1 11110 0000011111222333332232222 23445789999999999999999999999999997
Q ss_pred C
Q psy3880 281 P 281 (408)
Q Consensus 281 ~ 281 (408)
.
T Consensus 751 ~ 751 (752)
T KOG0670|consen 751 E 751 (752)
T ss_pred C
Confidence 4
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=235.64 Aligned_cols=187 Identities=20% Similarity=0.357 Sum_probs=140.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---------------------HHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---------------------NPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---------------------~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|++ .+.. ..++..++++||+.+|. |.+++.+ ..++..++.|++.||.|||+
T Consensus 76 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 152 (334)
T cd05100 76 KHKNII-NLLGACTQDGPLYVLVEYASKGN--LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152 (334)
T ss_pred CCCCee-eeeEEEccCCceEEEEecCCCCc--HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 688755 5554 44556789999999998 8777632 25667789999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+++........ ....++..|+|||++.. ..++.++|+||+||++
T Consensus 153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il 226 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD------RVYTHQSDVWSFGVLL 226 (334)
T ss_pred CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc------CCcCchhhhHHHHHHH
Confidence 99999999999999999999999999999765432211 12234567999999864 3467789999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+.......+..+
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 252 (334)
T cd05100 227 WEIFTLGGSPYPGIPVEELFKLLKEG------------------------------------------------------ 252 (334)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC------------------------------------------------------
Confidence 99887 77787665444333332211
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .. +.....+.++.+||.+||..+|++|||+.|++++
T Consensus 253 ----------------~-~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 253 ----------------H-RM--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ----------------C-CC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0 00 0112457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=229.47 Aligned_cols=188 Identities=22% Similarity=0.376 Sum_probs=142.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------------CHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------------SNPALRYIMRQLF 56 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------------~~~~~r~i~~qil 56 (408)
.+.|++++ ++.. +.++..++|+||+.+|. |.+.+. +..++..++.|++
T Consensus 64 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 140 (288)
T cd05050 64 EFDHPNIV-KLLGVCAVGKPMCLLFEYMAYGD--LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140 (288)
T ss_pred hcCCCchh-eEEEEEcCCCccEEEEecCCCCC--HHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence 46798765 4443 44567899999999998 776663 2356788999999
Q ss_pred HHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchh
Q psy3880 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVD 133 (408)
Q Consensus 57 ~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~D 133 (408)
.||+|||+++++||||||+||+++.++.++|+|||++..+..... .....++..|+|||.+.+ ..++.++|
T Consensus 141 ~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~D 214 (288)
T cd05050 141 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY------NRYTTESD 214 (288)
T ss_pred HHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc------CCCCchhH
Confidence 999999999999999999999999999999999999876533221 112334667999998864 35788999
Q ss_pred hhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHH
Q psy3880 134 VWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 212 (408)
Q Consensus 134 iwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily 212 (408)
+|||||++|+|++ |..||.+.+..+....+..
T Consensus 215 v~slG~il~el~~~~~~p~~~~~~~~~~~~~~~----------------------------------------------- 247 (288)
T cd05050 215 VWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD----------------------------------------------- 247 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------------------------------------------
Confidence 9999999999997 8788865544333332221
Q ss_pred HhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 213 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 213 ~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+... +.+ ...+.++.+||.+||+.||++|||+.|+++
T Consensus 248 -----------------------~~~~-~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 248 -----------------------GNVL-SCP--DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -----------------------CCCC-CCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1110 001 235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=226.23 Aligned_cols=187 Identities=22% Similarity=0.339 Sum_probs=140.3
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+.....+..++||||+.+|. |.+.+. ....+..++.|++.||.|||++|++||||||+||+
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil 132 (254)
T cd05083 55 KLHHKNLVRLLGVILHNGLYIVMELMSKGN--LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132 (254)
T ss_pred hCCCCCcCeEEEEEcCCCcEEEEECCCCCC--HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 467888765544444556799999999998 777653 23677889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~ 157 (408)
++.++.+||+|||++...... ......+..|+|||.+.. ..++.++|+||+||++|+|++ |..||...+..
T Consensus 133 i~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 133 VSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred EcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 999999999999998754322 122334568999998854 346778899999999999887 88887654433
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+....+ ..+
T Consensus 205 ~~~~~~----------------------------------------------------------------------~~~- 213 (254)
T cd05083 205 EVKECV----------------------------------------------------------------------EKG- 213 (254)
T ss_pred HHHHHH----------------------------------------------------------------------hCC-
Confidence 222222 111
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+... ....+++++++||++||..||++|||+++++.
T Consensus 214 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 YRME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 11356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=234.52 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=153.6
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhH---HhhhCCHHHHHHHHHHHHHHHHHHHHC--CCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAV---QDIINSNPALRYIMRQLFEALEHVHNH--SVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l---~~~~~~~~~~r~i~~qil~aL~~LH~~--~IvHRDLKp~NI 77 (408)
-|+|+++| .+++ -+.+.+.-|+|||.|.+..+ +..+.+++++|.|+-||+.||.||... -|||-||||.||
T Consensus 523 eLDHpRIV-KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNI 601 (775)
T KOG1151|consen 523 ELDHPRIV-KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNI 601 (775)
T ss_pred ccCcceee-eeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccE
Confidence 48999965 5554 45677889999999998322 234568899999999999999999976 499999999999
Q ss_pred EEec---CCCEEEeccccchhcccCcc-------c-ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 78 LLDD---QMNVKLTDFGFARVLKKGEK-------L-MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 78 Ll~~---~~~iKl~DFGla~~~~~~~~-------~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|+.+ .|.|||+|||+++++..... + ....||.+|++||.+.... +.+.
T Consensus 602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk--ePPK------------------- 660 (775)
T KOG1151|consen 602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK--EPPK------------------- 660 (775)
T ss_pred EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCC--CCCc-------------------
Confidence 9964 47899999999999875332 2 2367999999999875321 0111
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc-h
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR-K 225 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~-~ 225 (408)
.+.++|+||+|||+|..+.|+-||-+. +
T Consensus 661 ---------------------------------------------------IsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 661 ---------------------------------------------------ISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ---------------------------------------------------cccceeeEeeehhhhhhhccCCCCCCchh
Confidence 234778888888888888888888654 2
Q ss_pred hHHHHH--HHHh-cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 226 QMVMLR--NIME-GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 226 ~~~~~~--~i~~-~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+..++. .|++ ....|+. -+.+|++|++||++||.+--++|+.+.++-.||||.+..
T Consensus 690 QQdILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 690 QQDILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred HHHHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 333332 2333 3345543 357999999999999999999999999999999998753
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=229.49 Aligned_cols=195 Identities=21% Similarity=0.316 Sum_probs=142.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----------------CHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----------------SNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----------------~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+.+. +...+..++.|++.||+|||++|
T Consensus 73 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 73 RLKNPNII-RLLGVCVSDDPLCMITEYMENGD--LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred hCCCCCcC-eEEEEEcCCCccEEEEecCCCCc--HHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 46798855 4443 45667899999999998 777652 23567789999999999999999
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
++||||||+||+++.++.+||+|||++..+...... ....+++.|+|||++.. ..++.++|+|||||++|+
T Consensus 150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwSlG~~l~e 223 (295)
T cd05097 150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL------GKFTTASDVWAFGVTLWE 223 (295)
T ss_pred eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc------CCcCchhhHHHHHHHHHH
Confidence 999999999999999999999999998765433211 12345678999998864 346789999999999999
Q ss_pred HHh--CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 144 LLV--GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 144 ll~--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
|++ |..||...+....+..+..-.
T Consensus 224 l~~~~~~~p~~~~~~~~~~~~~~~~~------------------------------------------------------ 249 (295)
T cd05097 224 MFTLCKEQPYSLLSDEQVIENTGEFF------------------------------------------------------ 249 (295)
T ss_pred HHHcCCCCCCcccChHHHHHHHHHhh------------------------------------------------------
Confidence 987 566776554444333321100
Q ss_pred CCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 222 WHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 222 ~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... +...+. ......++.+++||.+||..||++|||++++++
T Consensus 250 ---------~~~--~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 250 ---------RNQ--GRQIYL-SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ---------hhc--cccccC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 000000 112246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=224.05 Aligned_cols=188 Identities=22% Similarity=0.330 Sum_probs=140.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ...+..++|+||+.|+. |.+.+. +...+..++.|++.||+|||+++++||||||+||
T Consensus 48 ~l~~~~i~-~~~~~~~~~~~~~~v~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni 124 (251)
T cd05041 48 QYDHPNIV-KLIGVCVQKQPIYIVMELVPGGS--LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124 (251)
T ss_pred hCCCCCeE-EEEEEEecCCCeEEEEEcCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence 46798855 4433 45567799999999998 777662 3367788999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|++.++.+||+|||++.......... ...++..|+|||.+.. ..++.++|+||+||++|+|++ |..||.+
T Consensus 125 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 125 LVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY------GRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred EEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc------CCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 99999999999999987654222111 1233557999998864 346788999999999999998 7777755
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.........+..
T Consensus 199 ~~~~~~~~~~~~-------------------------------------------------------------------- 210 (251)
T cd05041 199 MSNQQTRERIES-------------------------------------------------------------------- 210 (251)
T ss_pred CCHHHHHHHHhc--------------------------------------------------------------------
Confidence 443222222111
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. ... +.....+.++.++|.+||+.||++|||++|+|+
T Consensus 211 --~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 --G-YRM--PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --C-CCC--CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 011 112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=223.48 Aligned_cols=187 Identities=22% Similarity=0.388 Sum_probs=137.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|++++ .+.+ ..++..+++||++.+|. |.+.+ .++..+..++.|++.||+|||++|++||||||+||
T Consensus 58 l~~~~i~-~~~~~~~~~~~~~~i~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ni 134 (258)
T smart00219 58 LDHPNIV-KLLGVCTEEEPLMIVMEYMEGGD--LLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC 134 (258)
T ss_pred cCCCchh-eEEEEEcCCCeeEEEEeccCCCC--HHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceE
Confidence 5788754 5553 34467899999999987 76655 34577899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc--cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
++++++.++|+|||++.......... ...+++.|+|||.+.. ..++.++|+||+||++++|++ |.+||..
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~Di~slG~i~~~l~~~g~~p~~~- 207 (258)
T smart00219 135 LVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD------GKFTSKSDVWSFGVLLWEIFTLGESPYPG- 207 (258)
T ss_pred EEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc------CCCCcchhHHHHHHHHHHHHhCCCCCCCC-
Confidence 99999999999999997665432211 1236678999998743 335566777777777777766 5555533
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.+.......+.
T Consensus 208 ---------------------------------------------------------------------~~~~~~~~~~~ 218 (258)
T smart00219 208 ---------------------------------------------------------------------MSNEEVLEYLK 218 (258)
T ss_pred ---------------------------------------------------------------------CCHHHHHHHHh
Confidence 22233333333
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.+.... .+ ...+.++.+++.+||..||++|||+.|+++
T Consensus 219 ~~~~~~-~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 219 KGYRLP-KP--ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred cCCCCC-CC--CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 332211 11 237889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=227.19 Aligned_cols=188 Identities=21% Similarity=0.427 Sum_probs=141.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.. +.++..++||||+.||. |.+++. +..++..++.|++.||+|||++|++||||||+||
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 61 QFDHPNII-HLEGVVTKSKPVMIVTEYMENGS--LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred hCCCCCcc-eEEEEEecCCccEEEEEcCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 36798855 5543 45567899999999998 777763 3467889999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc-cc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK-LM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~-~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
|++.++.++++|||++..+..... .. ...++..|+|||.+.. ..++.++|+||+||++|++++ |..||.
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~------~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY------RKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc------CccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 999999999999999987653321 11 1223467999999864 346778899999999998775 888886
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..+..+....+.+
T Consensus 212 ~~~~~~~~~~~~~------------------------------------------------------------------- 224 (267)
T cd05066 212 EMSNQDVIKAIEE------------------------------------------------------------------- 224 (267)
T ss_pred cCCHHHHHHHHhC-------------------------------------------------------------------
Confidence 5544333333221
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+ +.+ +....+++++++++.+||+.||.+|||+.++++
T Consensus 225 ---~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 225 ---G-YRL--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---C-CcC--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1 111 111246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=226.09 Aligned_cols=188 Identities=21% Similarity=0.396 Sum_probs=140.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.. ...+..|+||||+.+|. |.+.+. +..++..++.|++.||+|||++|++||||||+||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 62 QFSHHNII-RLEGVVTKFKPAMIITEYMENGA--LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred cCCCCCee-EEEEEEccCCCcEEEEEcCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 46788755 5544 44567799999999998 766653 3467888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc--cc--CCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL--MD--LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~--~~--~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
+++.++.+||+|||++......... .. ...++.|+|||++.. ..++.++|+||+||++|++++ |..||.
T Consensus 139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY------RKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc------CCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999998765432211 11 123457999998864 346778899999999998886 888886
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..+.......+..
T Consensus 213 ~~~~~~~~~~i~~------------------------------------------------------------------- 225 (268)
T cd05063 213 DMSNHEVMKAIND------------------------------------------------------------------- 225 (268)
T ss_pred cCCHHHHHHHHhc-------------------------------------------------------------------
Confidence 5544333333321
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+. ..+...+.+.++.+||.+||..||++||++.++++
T Consensus 226 ---~~---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 226 ---GF---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---CC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10 00111246778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=224.17 Aligned_cols=190 Identities=24% Similarity=0.382 Sum_probs=144.0
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++..+.. +.....++|+||+.+|. |.+++. +.+.+..++.|++.||+|||+++++||||||+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~ 132 (256)
T cd05112 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGC--LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCL 132 (256)
T ss_pred hCCCCCeeeEEEEEccCCceEEEEEcCCCCc--HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEE
Confidence 4678885533332 44566789999999998 777663 34678899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||++........ .....++..|+|||.+.. ..++.++|+||+||++|+|++ |..||....
T Consensus 133 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 133 VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred EcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999875533211 112334568999998864 346789999999999999998 899987655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....+..+..+.
T Consensus 207 ~~~~~~~~~~~~-------------------------------------------------------------------- 218 (256)
T cd05112 207 NSEVVETINAGF-------------------------------------------------------------------- 218 (256)
T ss_pred HHHHHHHHhCCC--------------------------------------------------------------------
Confidence 444443332210
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+. + ...+.++.+|+.+||..||++|||++|++++
T Consensus 219 --~~~~-~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 --RLYK-P--RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --CCCC-C--CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0000 0 1247789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.80 Aligned_cols=103 Identities=27% Similarity=0.450 Sum_probs=85.8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 122 (408)
.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .....+++.|+|||.+..
T Consensus 237 ~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 313 (400)
T cd05105 237 LDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--- 313 (400)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC---
Confidence 44577999999999999999999999999999999999999999999976543221 122456788999998864
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
..++.++|||||||++|+|++ |..||.+.
T Consensus 314 ---~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 314 ---NLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 346789999999999999997 88888653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=229.37 Aligned_cols=142 Identities=25% Similarity=0.374 Sum_probs=112.1
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+........++++||+.+|. |.+.+.+ .+.+..++.|++.||.|||++||+||||||+|||+
T Consensus 65 ~l~h~niv~~~~~~~~~~~~~v~e~~~~g~--l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill 142 (303)
T cd05110 65 SMDHPHLVRLLGVCLSPTIQLVTQLMPHGC--LLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV 142 (303)
T ss_pred hCCCCCcccEEEEEcCCCceeeehhcCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee
Confidence 367988664443333445679999999998 8777643 36788999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+++.+...... ....++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+..
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999866433221 12345678999998854 346788999999999999987 888886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=225.23 Aligned_cols=140 Identities=28% Similarity=0.575 Sum_probs=113.4
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|++++..+.. ..++..++||||+.+|. |.+.+. +..++..++.|++.||.|||++||+||||||+
T Consensus 58 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 58 QLDHPNVIKYLASFIENNELNIVLELADAGD--LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred hCCCCCeeeeeeeeecCCeEEEEEecCCCCC--HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 3578875533322 44566799999999998 766552 44788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
||+++.++.++|+|||++..+.... ......+++.|+|||.+.. ..++.++|+||+||++|+|++|..||..
T Consensus 136 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc------CCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999987654332 2234578899999998864 3467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=228.13 Aligned_cols=138 Identities=25% Similarity=0.439 Sum_probs=110.8
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.. .+....++||||+.||. |.+++. +..++..++.|++.||+|||++||+||||||+
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 62 NLYHENIV-KYKGICTEDGGNGIKLIMEFLPSGS--LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred hCCCCCee-eeeeEEecCCCCceEEEEEccCCCC--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 46798865 4432 22356789999999998 777653 34778899999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+++.++.++|+|||++..+..... .....++..|+|||++.. ..++.++|+||+||++|+|++++.|+
T Consensus 139 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ------SKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred eEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc------CCCCccccchhhhhhhhhhhcCCCCC
Confidence 99999999999999999987654322 123456778999998864 34678999999999999999987765
Q ss_pred C
Q psy3880 152 W 152 (408)
Q Consensus 152 ~ 152 (408)
.
T Consensus 213 ~ 213 (284)
T cd05079 213 S 213 (284)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=224.68 Aligned_cols=188 Identities=22% Similarity=0.394 Sum_probs=142.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|++++ .+.. +.+...++|||++.+|. |.+.+. +.+++..++.|++.||.|||++||+|+||||+|
T Consensus 57 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~n 133 (261)
T cd05034 57 KLRHDKLV-QLYAVCSEEEPIYIVTEYMSKGS--LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARN 133 (261)
T ss_pred hCCCCCEe-eeeeeeecCCceEEEEeccCCCC--HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchhe
Confidence 46788855 5543 34467899999999998 777763 347889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|++++++.+||+|||++..+...... ....++..|+|||.+.+ ..++.++|+||+||++|++++ |..||.+
T Consensus 134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 134 ILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY------GRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred EEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc------CCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999998766432211 12234568999998864 346778999999999999998 8888866
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+.++..+
T Consensus 208 ~~~~~~~~~~~~~------------------------------------------------------------------- 220 (261)
T cd05034 208 MTNREVLEQVERG------------------------------------------------------------------- 220 (261)
T ss_pred CCHHHHHHHHHcC-------------------------------------------------------------------
Confidence 5544443333221
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+. .+.....+.++.+++.+||..||++|||++++++
T Consensus 221 ----~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 221 ----YR--MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----CC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 0111234778999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=228.33 Aligned_cols=138 Identities=21% Similarity=0.292 Sum_probs=108.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.. ..++..++||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+||
T Consensus 72 ~l~h~niv-~~~~~~~~~~~~~lv~ey~~~g~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Ni 148 (274)
T cd05076 72 QVSHIHLA-FVHGVCVRGSENIMVEEFVEHGP--LDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNI 148 (274)
T ss_pred cCCCCCee-eEEEEEEeCCceEEEEecCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccE
Confidence 46798855 5554 44567889999999998 666653 3477888999999999999999999999999999
Q ss_pred EEecCC-------CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH-hCCC
Q psy3880 78 LLDDQM-------NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149 (408)
Q Consensus 78 Ll~~~~-------~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll-~G~~ 149 (408)
|++..+ .+|++|||++...... ....+++.|+|||.+... ..++.++|+|||||++|+++ +|..
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-----NSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-----CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 997543 4899999987644322 234578889999988642 35788999999999999985 6888
Q ss_pred CCCCc
Q psy3880 150 PFWHR 154 (408)
Q Consensus 150 pf~~~ 154 (408)
||...
T Consensus 221 p~~~~ 225 (274)
T cd05076 221 PLKER 225 (274)
T ss_pred Ccccc
Confidence 88553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=226.03 Aligned_cols=190 Identities=24% Similarity=0.409 Sum_probs=144.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------------CHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------------SNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------------~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|++++ .+.. .+.+..++||||+.+|. |.+.+. +...+..++.||+.||+|||+++|+|
T Consensus 64 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H 140 (275)
T cd05046 64 KLSHKNVV-RLLGLCREAEPHYMILEYTDLGD--LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH 140 (275)
T ss_pred hcCCccee-eeEEEECCCCcceEEEEecCCCc--HHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 46788855 5543 44567899999999998 776652 35778999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV- 146 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~- 146 (408)
|||||+|||++.++.++++|||++....... ......+++.|+|||.+.. ..++.++|+||+||++|++++
T Consensus 141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE------DDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred CcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc------CCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999986543221 1223456678999998864 235688999999999999998
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|..||........+..+.
T Consensus 215 ~~~p~~~~~~~~~~~~~~-------------------------------------------------------------- 232 (275)
T cd05046 215 GELPFYGLSDEEVLNRLQ-------------------------------------------------------------- 232 (275)
T ss_pred CCCCccccchHHHHHHHH--------------------------------------------------------------
Confidence 777885544333322222
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.+...+.. ....+..++++|.+||+.||++|||+.|++++
T Consensus 233 --------~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 --------AGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------cCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11111111 12467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=224.48 Aligned_cols=139 Identities=21% Similarity=0.269 Sum_probs=108.1
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++..+.....+..++||||+.+|. |.+++. +...+..++.||+.||+|||++||+||||||+|||+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill 134 (259)
T cd05037 57 QLSHKHLVKLYGVCVRDENIMVEEYVKFGP--LDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV 134 (259)
T ss_pred cCCCcchhheeeEEecCCcEEEEEcCCCCc--HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE
Confidence 467998663333222256789999999998 777664 336788899999999999999999999999999999
Q ss_pred ecCC-------CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCC
Q psy3880 80 DDQM-------NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151 (408)
Q Consensus 80 ~~~~-------~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf 151 (408)
+.++ .+||+|||++..+... ....++..|+|||++... ...++.++|+||+||++|++++ |..||
T Consensus 135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~----~~~~~~~~Di~slG~~~~~l~~~~~~p~ 207 (259)
T cd05037 135 ARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNG----QASLTIAADKWSFGTTLLEICSNGEEPL 207 (259)
T ss_pred ecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcCC----CCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence 9877 7999999999865432 234567789999998642 1356788899999999999888 45666
Q ss_pred CC
Q psy3880 152 WH 153 (408)
Q Consensus 152 ~~ 153 (408)
..
T Consensus 208 ~~ 209 (259)
T cd05037 208 ST 209 (259)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=225.48 Aligned_cols=191 Identities=28% Similarity=0.464 Sum_probs=145.5
Q ss_pred ccccCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCC
Q psy3880 6 MVAHSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHN-HSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp 74 (408)
.+.|+|++..+. ...++..++||||+.|+. |.+.+ .+...+..++.|++.||.|||+ .+++|+||||
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~ 142 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTP 142 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCc--HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCH
Confidence 367888654333 245667899999999987 65554 2346788999999999999996 7899999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+||+++.++.+||+|||++.............|+..|+|||.+.. ..++.++|+||+|+++|+|++|..||...
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN------EPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred HHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC------CCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999999999999999987655444445678999999999864 33678899999999999999998888654
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..
T Consensus 217 ~~~~~~~~~~~--------------------------------------------------------------------- 227 (269)
T cd08528 217 NMLSLATKIVE--------------------------------------------------------------------- 227 (269)
T ss_pred CHHHHHHHHhh---------------------------------------------------------------------
Confidence 43332222221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+.+. .......++++.+||.+||+.||++|||+.|+..+
T Consensus 228 -~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 228 -AVYE--PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -ccCC--cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1111 11112467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=228.23 Aligned_cols=143 Identities=20% Similarity=0.394 Sum_probs=112.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC----------------HHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS----------------NPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~----------------~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+++.. ..++..++.|++.||+|||++||
T Consensus 75 ~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 151 (296)
T cd05095 75 RLKDPNII-RLLAVCITSDPLCMITEYMENGD--LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF 151 (296)
T ss_pred hCCCCCcc-eEEEEEecCCccEEEEEeCCCCc--HHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 46788765 4443 44567899999999998 8777643 24789999999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||||||+|||++.++.++|+|||++..+...... ....+++.|+|||.... ..++.++|+||+||++|+|
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL------GKFTTASDVWAFGVTLWEI 225 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc------CCccchhhhhHHHHHHHHH
Confidence 99999999999999999999999998765433211 12334568999998754 3477899999999999999
Q ss_pred Hh--CCCCCCCchhH
Q psy3880 145 LV--GCPPFWHRKQM 157 (408)
Q Consensus 145 l~--G~~pf~~~~~~ 157 (408)
++ |..||...+..
T Consensus 226 ~~~~~~~p~~~~~~~ 240 (296)
T cd05095 226 LTLCKEQPYSQLSDE 240 (296)
T ss_pred HHhCCCCCccccChH
Confidence 98 66788654433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=226.18 Aligned_cols=189 Identities=25% Similarity=0.347 Sum_probs=143.4
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+....+...++|+||+.+|. |.+.+.+ +..+..++.||+.||+|||++||+||||||+|||+
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~ 142 (279)
T cd05057 65 SVDHPHVVRLLGICLSSQVQLITQLMPLGC--LLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142 (279)
T ss_pred hCCCCCcceEEEEEecCceEEEEecCCCCc--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence 467998664443333467789999999998 8777643 57889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+++.+....... ...++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+.+
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 999999999999998765432211 1223567999998753 356789999999999999998 999986654
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..+
T Consensus 217 ~~~~~~~~~~~--------------------------------------------------------------------- 227 (279)
T cd05057 217 AVEIPDLLEKG--------------------------------------------------------------------- 227 (279)
T ss_pred HHHHHHHHhCC---------------------------------------------------------------------
Confidence 43333322211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .++.+ ...+.++.+++.+||..||++|||+.++++
T Consensus 228 -~-~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 228 -E-RLPQP--PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -C-CCCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 01111 134678899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=225.26 Aligned_cols=188 Identities=19% Similarity=0.390 Sum_probs=139.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.. ..++..++||||+.+|. |.+.+. +..++..++.|++.||+|||++|++||||||+||
T Consensus 61 ~l~h~ni~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 61 QFDHPNII-HLEGVVTKSRPVMIITEFMENGA--LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred hCCCcCcc-eEEEEECCCCceEEEEecCCCCc--HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 46799866 4443 44556789999999997 766653 3367899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc---ccCC---CCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL---MDLC---GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPP 150 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~---~~~~---gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~p 150 (408)
+++.++.+||+|||++..+...... .... .+..|+|||.+.. ..++.++|+||+||++|++++ |..|
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~DvwslG~~l~e~l~~g~~p 211 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY------RKFTSASDVWSYGIVMWEVMSYGERP 211 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc------CcccchhhhhhhHHHHHHHhcCCCCC
Confidence 9999999999999998765432211 1111 2347999999864 346778899999988888775 8888
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|...+.......+..
T Consensus 212 ~~~~~~~~~~~~i~~----------------------------------------------------------------- 226 (269)
T cd05065 212 YWDMSNQDVINAIEQ----------------------------------------------------------------- 226 (269)
T ss_pred CCCCCHHHHHHHHHc-----------------------------------------------------------------
Confidence 766544333333211
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. ... +.....+.++.+++.+||..||++|||+++++.
T Consensus 227 -----~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 227 -----D-YRL--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----C-CcC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 111 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=226.65 Aligned_cols=189 Identities=20% Similarity=0.338 Sum_probs=141.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------------CHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------------SNPALRYIMRQLFEALEHVHNHSVVHR 70 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------------~~~~~r~i~~qil~aL~~LH~~~IvHR 70 (408)
.+.|+|++..+.. +.+...++++|++.+|. |.+.+. +..++..++.|++.||+|||+++++||
T Consensus 64 ~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~--L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGN--LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred hCCCCCCCeEEEEEecCCCCCEEEEEcCCCCc--HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 3589987643332 33467789999999887 766653 346788999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-
Q psy3880 71 DLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV- 146 (408)
Q Consensus 71 DLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~- 146 (408)
||||+||++++++.+||+|||+++.+...... ....++..|+|||.+.. ..++.++|+||+||++|++++
T Consensus 142 di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~------~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN------KEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred ccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc------CCCCchhhHHHhHHHHHHHhcC
Confidence 99999999999999999999999866433211 12345668999998864 346788999999999999988
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|..||...+..+....+.
T Consensus 216 g~~p~~~~~~~~~~~~~~-------------------------------------------------------------- 233 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLK-------------------------------------------------------------- 233 (280)
T ss_pred CCCCcCcCCHHHHHHHHH--------------------------------------------------------------
Confidence 888886544333222111
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .+.+ +.+..+++++++++.+||..||++|||+.|+++
T Consensus 234 --------~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 --------D-GYRL--AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------c-CCCC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 1111 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=234.90 Aligned_cols=103 Identities=30% Similarity=0.483 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 122 (408)
..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ .....+++.|+|||.+..
T Consensus 179 ~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--- 255 (343)
T cd05103 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--- 255 (343)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC---
Confidence 45677899999999999999999999999999999999999999999876533211 112345667999999854
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
..++.++|+||+||++|++++ |..||.+.
T Consensus 256 ---~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 256 ---RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred ---CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 357789999999999999997 88888553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-28 Score=226.35 Aligned_cols=200 Identities=27% Similarity=0.528 Sum_probs=154.0
Q ss_pred CCcEEEEecc--CCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC
Q psy3880 10 SRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ 82 (408)
Q Consensus 10 ~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~ 82 (408)
.+++|-+..- .....++|.||++||+ |-... ..++.+|+|..+|..||.|||++|||+||||.+|+|++..
T Consensus 310 ~pflvglhscfqtesrlffvieyv~ggd--lmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae 387 (593)
T KOG0695|consen 310 NPFLVGLHSCFQTESRLFFVIEYVNGGD--LMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE 387 (593)
T ss_pred CCeEEehhhhhcccceEEEEEEEecCcc--eeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC
Confidence 3466777653 3456788999999998 53333 3558999999999999999999999999999999999999
Q ss_pred CCEEEeccccchh-cccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 83 MNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 83 ~~iKl~DFGla~~-~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
|.+||+|+|.++. +.++...+++||||.|.|||++++ ..|+..+|+|+|||+++||+.|+.||.-.-
T Consensus 388 ghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg------eeygfsvdwwalgvlmfemmagrspfdivg------ 455 (593)
T KOG0695|consen 388 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG------EEYGFSVDWWALGVLMFEMMAGRSPFDIVG------ 455 (593)
T ss_pred CceeecccchhhcCCCCCcccccccCCCcccchhhhcc------cccCceehHHHHHHHHHHHHcCCCCcceec------
Confidence 9999999999875 456667778999999999999986 468888899999999999999988884210
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
...|+ ..+..-+++-|++.....+
T Consensus 456 -------------------m~n~d-------------------------------------~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 456 -------------------MDNPD-------------------------------------MNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred -------------------CCCcc-------------------------------------cchhHHHHHHHhhhccccc
Confidence 00000 0011123444555554443
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCC------HHHHHcCCCCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYS------VKEALNHSFFHPKL 283 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~t------a~e~L~Hpwf~~~~ 283 (408)
..+|-.|...++..|.+||..|+. ..++..|+||....
T Consensus 480 ----rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 480 ----RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ----ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 246778889999999999999985 67999999998543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=258.93 Aligned_cols=139 Identities=31% Similarity=0.456 Sum_probs=110.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC----------------HHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS----------------NPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~----------------~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|++ .+.. +.++..|+||||+.||. |.+.+.+ ...+..++.||+.||+|||++||
T Consensus 58 ~L~HPNIV-kl~~v~~d~~~lyLVMEY~eGGS--L~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GI 134 (932)
T PRK13184 58 DLIHPGIV-PVYSICSDGDPVYYTMPYIEGYT--LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV 134 (932)
T ss_pred hCCCcCcC-eEEEEEeeCCEEEEEEEcCCCCC--HHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 46799866 4443 45567899999999998 7766532 13567789999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCc-------------------ccccCCCCCcccChhhhhhccccCcCCC
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-------------------KLMDLCGTPGYLAPEVLRANMFEDATGY 128 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~ 128 (408)
+||||||+|||++.++.+||+|||+|....... .....+||+.|+|||++.+ ..+
T Consensus 135 IHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g------~~~ 208 (932)
T PRK13184 135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG------VPA 208 (932)
T ss_pred cccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC------CCC
Confidence 999999999999999999999999997652110 0112469999999998864 346
Q ss_pred CcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 129 GQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 129 ~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+.++|+||+||++|+|++|..||..
T Consensus 209 S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 209 SESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred CcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 7889999999999999999988855
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=240.24 Aligned_cols=144 Identities=26% Similarity=0.443 Sum_probs=117.8
Q ss_pred cCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 9 HSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 9 ~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
|.|++ -+. +--.+...||..+|+|-. |+.++.-. .+++.|++||++|+.|||.++|||||||..||++.+
T Consensus 447 H~NIl-LFMG~~~~p~~AIiTqwCeGsS--LY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 447 HENIL-LFMGACMNPPLAIITQWCEGSS--LYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE 523 (678)
T ss_pred hhhhe-eeehhhcCCceeeeehhccCch--hhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc
Confidence 77755 444 333334489999999988 88887532 578999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcc---cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 82 QMNVKLTDFGFARVLK---KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.|||+|||++..-. ....+....|+..|||||+++.+ +..+|+..+|||||||++|||++|..||...+..+
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmq---d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ---DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhc---ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 9999999999986432 23344556788899999999843 35789999999999999999999999997555443
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=249.66 Aligned_cols=199 Identities=30% Similarity=0.489 Sum_probs=155.8
Q ss_pred ccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 8 AHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 8 ~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.|+| ++.++.. .+|-..||||||.||. +-|.+. +++.+.+|++.++.|+.+||.+.++|||+|
T Consensus 74 ~hpn-v~~fyg~~~k~~~~~~DqLWLVMEfC~gGS--VTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDik 150 (953)
T KOG0587|consen 74 HHPN-VATFYGAFIKKDPGNGDQLWLVMEFCGGGS--VTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIK 150 (953)
T ss_pred CCCC-cceEEEEEEEecCCCCCeEEEEeeccCCcc--HHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeeccc
Confidence 4555 6566652 4677899999999998 555542 458899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
-.|||++.++.||++|||++..++... .-.+..|||+|||||++.+..-. ...|+..+|+||||++..||..|.+|+.
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~-d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESP-DATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCC-CCCcccccchhhccceeehhcCCCCCcc
Confidence 999999999999999999998876432 23467899999999999876433 3467889999999999999999998886
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.-....+-+|- ..||-
T Consensus 230 DmHPmraLF~Ip----------------------------------------------------RNPPP----------- 246 (953)
T KOG0587|consen 230 DMHPMRALFLIP----------------------------------------------------RNPPP----------- 246 (953)
T ss_pred CcchhhhhccCC----------------------------------------------------CCCCc-----------
Confidence 544322221111 11111
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
....|..-|.+..|||..||.+|-.+||+..++|.|||+..
T Consensus 247 --------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 --------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred --------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11234556889999999999999999999999999999973
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=236.09 Aligned_cols=152 Identities=22% Similarity=0.355 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhcccc
Q psy3880 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFE 123 (408)
Q Consensus 47 ~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~ 123 (408)
.+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++....... .....+++.|+|||.+..
T Consensus 240 ~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---- 315 (401)
T cd05107 240 DLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN---- 315 (401)
T ss_pred HHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC----
Confidence 4567889999999999999999999999999999999999999999976533221 123456788999999864
Q ss_pred CcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcc
Q psy3880 124 DATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAV 202 (408)
Q Consensus 124 ~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~ 202 (408)
..++.++|+||+||++|+|++ |..||......+.+.....
T Consensus 316 --~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~------------------------------------- 356 (401)
T cd05107 316 --NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK------------------------------------- 356 (401)
T ss_pred --CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH-------------------------------------
Confidence 346789999999999999998 8888855432222111111
Q ss_pred cccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 203 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 203 DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.+ ... +....++.++.+||.+|+..||.+|||+.|+++.
T Consensus 357 --------------------------------~~-~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 357 --------------------------------RG-YRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred --------------------------------cC-CCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 011 1113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=218.09 Aligned_cols=180 Identities=27% Similarity=0.409 Sum_probs=136.1
Q ss_pred cHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEecCCCEEEecc
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHS--VVHRDLKPENILLDDQMNVKLTDF 90 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~--IvHRDLKp~NILl~~~~~iKl~DF 90 (408)
...||++.|...|. |.|.+. ++.++..++.+|++||++||+.. ..||||||.|||+++++.+++.||
T Consensus 96 ~~~yll~Pyy~~Gs--l~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGS--LLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhcccc--HHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 34689999999998 777664 45789999999999999999999 999999999999999999999999
Q ss_pred ccchhccc----Cc---cc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 91 GFARVLKK----GE---KL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 91 Gla~~~~~----~~---~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
|.+....- .. .+ .....|..|+|||.+.... ....+.++|||||||++|+|+.|..||...-+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~---~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---- 246 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS---HCTITERTDIWSLGCTLYAMMFGESPFERIYQ---- 246 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc---CcccccccchhhhhHHHHHHHHcCCcchHHhh----
Confidence 99865421 11 01 1234688999999997643 23356788999999999999988888832110
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
+.|--++ .+.++++.+
T Consensus 247 ----------------------------------------~GgSlaL------------------------Av~n~q~s~ 262 (302)
T KOG2345|consen 247 ----------------------------------------QGGSLAL------------------------AVQNAQISI 262 (302)
T ss_pred ----------------------------------------cCCeEEE------------------------eeecccccc
Confidence 0010011 233444555
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+.. ...|+....||+.||++||.+|||+.+++++
T Consensus 263 P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 263 PNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 432 3489999999999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=222.15 Aligned_cols=139 Identities=27% Similarity=0.450 Sum_probs=110.2
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.. .++...++|+||+.+|. |.+.+. +...+..++.|++.||+|||++||+||||||+
T Consensus 61 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 61 SLQHDNIV-KYKGVCYSAGRRNLRLVMEYLPYGS--LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred hCCCCCee-EEEEEEccCCCCceEEEEEecCCCC--HHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 47899855 5433 33456789999999998 877763 34778899999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccc----cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLM----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+++.++.+||+|||++..+....... ...++..|+|||.+.. ..++.++|+||+||++|+|++|..|+
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE------SKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc------CCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 9999999999999999998764432211 1223446999998864 34678999999999999999988776
Q ss_pred CC
Q psy3880 152 WH 153 (408)
Q Consensus 152 ~~ 153 (408)
..
T Consensus 212 ~~ 213 (284)
T cd05081 212 CS 213 (284)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=218.96 Aligned_cols=189 Identities=22% Similarity=0.383 Sum_probs=138.8
Q ss_pred ccccCCcEEEEeccC-----Cc---HHHHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 6 MVAHSRVVVRVKEEG-----DD---LKHLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~-----~~---~~~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
.+.|++++ .+.+.. .+ ..+++++|+.+|. |.+.+ .+...+..++.|++.||+|||++|
T Consensus 57 ~l~h~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 57 EFDHPNVI-KLIGVSLRSRAKGRLPIPMVILPFMKHGD--LHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred cCCCCCcc-eEEEEEccCCCCCcccceEEEEecCCCCc--HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46888755 555421 11 2357788998887 65443 234678999999999999999999
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|+||||||+||+++.++.+||+|||+++........ ....+++.|++||.+.. ..++.++|+|||||++|+
T Consensus 134 i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~sDi~slG~il~e 207 (273)
T cd05074 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD------NVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc------CccchhhhhHHHHHHHHH
Confidence 999999999999999999999999999866433211 12345678999998864 346789999999999999
Q ss_pred HHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 144 LLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 144 ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
|++ |.+||.+.+.......+..+
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~-------------------------------------------------------- 231 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKG-------------------------------------------------------- 231 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcC--------------------------------------------------------
Confidence 998 88888665443332222211
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. ...+ ...+.++.+++.+||..+|++|||+.|++.+
T Consensus 232 --------------~~-~~~~--~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 --------------NR-LKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------Cc-CCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0000 2357789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=226.36 Aligned_cols=225 Identities=28% Similarity=0.449 Sum_probs=144.6
Q ss_pred CCcHHHHHHHHHhhchhhHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-CCCEEEeccccchhc
Q psy3880 20 GDDLKHLAAQVVDKGEAAVQDII--NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-QMNVKLTDFGFARVL 96 (408)
Q Consensus 20 ~~~~~~lv~e~~~~g~~~l~~~~--~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-~~~iKl~DFGla~~~ 96 (408)
..|...+|+||....+ .-++. .+-++++.|++.++.||.++|++|||||||||.|+|.+. .+.-.|+|||+|...
T Consensus 106 nnd~v~ivlp~~~H~~--f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDR--FRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred cCCeeEEEecccCccC--HHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 3455678888887776 43333 345899999999999999999999999999999999984 456789999998721
Q ss_pred c-----------------c--Cc--------------------------ccccCCCCCcccChhhhhhccccCcCCCCcc
Q psy3880 97 K-----------------K--GE--------------------------KLMDLCGTPGYLAPEVLRANMFEDATGYGQA 131 (408)
Q Consensus 97 ~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~ 131 (408)
+ + +. ......||++|+|||++..- ...+++
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-----~~Qtta 258 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-----PRQTTA 258 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-----cCcCCc
Confidence 1 0 00 00124699999999999752 445789
Q ss_pred hhhhhhhHHHHHHHhCCCCCCCch-hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCC-----ccccc
Q psy3880 132 VDVWACGVIMYTLLVGCPPFWHRK-QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQ-----AVDVW 205 (408)
Q Consensus 132 ~DiwSlGvil~~ll~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~-----~~DiW 205 (408)
+|+||.|||+..++++..||.... +...+..|..... ++.++.- +.-+|. ++-+-
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG---------------~~~mrk~----A~l~g~~~l~~ksn~~ 319 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG---------------SAEMRKC----AALPGRILLWQKSNIP 319 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhC---------------hHHHHHH----hhcCCceeeecccccc
Confidence 999999999999999999997654 3344444432111 0000000 000000 00011
Q ss_pred chhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC-CCCCCcCCCC-CccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 206 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-SFSSPEWNDI-SEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 206 s~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~-~f~~~~~~~i-S~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+++.+.. .|.... ...+.++.. ......|.++ +..+.||++|||..||.+|+||+|+|+||||..
T Consensus 320 ~~~e~~~-------~f~s~~----~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 320 TIPELRV-------NFETLH----IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccHHHHh-------chhccC----hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1111110 011000 112222111 1223345444 458999999999999999999999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=213.85 Aligned_cols=194 Identities=46% Similarity=0.789 Sum_probs=145.9
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ .+.+ ..++..++++|++.++. |.+.+ .+...+..++.+++.++.+||+.+|+|+||+|.||++
T Consensus 44 l~~~~i~-~~~~~~~~~~~~~l~~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 44 LKHPNIV-RLYDVFEDEDKLYLVMEYCDGGD--LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL 120 (244)
T ss_pred CCCCcHH-HHHhheeeCCEEEEEEeCCCCCC--HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE
Confidence 4677654 4443 23356789999999887 77665 3557888999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.++++|||++.............++..|++||.+.. ..++.++|+||+|++++++++|..||....
T Consensus 121 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---- 190 (244)
T smart00220 121 DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG------KGYGKAVDVWSLGVILYELLTGKPPFPGDD---- 190 (244)
T ss_pred CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999987765444456778899999998853 345667888888888888888877774421
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
........+......
T Consensus 191 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 205 (244)
T smart00220 191 -----------------------------------------------------------------QLLELFKKIGKPKPP 205 (244)
T ss_pred -----------------------------------------------------------------cHHHHHHHHhccCCC
Confidence 111122222222222
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.. ..+..++.++.+++.+||..||++|||+.++++||||
T Consensus 206 ~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 206 FP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred Cc-cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 21 2222378899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=203.81 Aligned_cols=94 Identities=24% Similarity=0.367 Sum_probs=82.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhcccc
Q psy3880 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFE 123 (408)
Q Consensus 44 ~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 123 (408)
++++++.++.||+.||+|||+++ ||+|||++.++.+|+ ||++...... ...||+.|+|||++.+
T Consensus 15 ~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~---- 78 (176)
T smart00750 15 NEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQG---- 78 (176)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcccccChHHhcC----
Confidence 56889999999999999999999 999999999999999 9998765442 2368999999999965
Q ss_pred CcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 124 DATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 124 ~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
..|+.++||||+||++|+|++|..||....
T Consensus 79 --~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 79 --QSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred --CCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 357889999999999999999999996543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=220.71 Aligned_cols=188 Identities=29% Similarity=0.462 Sum_probs=137.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.. ...+..++|+||+.+|. |.+.+.. ......++.||+.||.|||+++|+|++|++.|
T Consensus 57 ~l~h~ni~-~~~g~~~~~~~~~lv~e~~~~g~--L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~n 133 (259)
T PF07714_consen 57 KLRHPNIV-KLYGFCIENEPLFLVMEYCPGGS--LDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSN 133 (259)
T ss_dssp THSBTTBE--EEEEEESSSSEEEEEE--TTEB--HHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred cccccccc-ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 35899866 4443 23445789999999997 7766533 37788899999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
||+++++.+||+|||++......... ....+...|+|||.+... .++.++||||||+++||+++ |..||.
T Consensus 134 ill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~ksDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 134 ILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG------EYTKKSDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp EEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS------EESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccccccccccccccccc
Confidence 99999999999999998776322211 224456789999998763 36889999999999999999 778887
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+..+...++..+..
T Consensus 208 ~~~~~~~~~~~~~~~~---------------------------------------------------------------- 223 (259)
T PF07714_consen 208 DYDNEEIIEKLKQGQR---------------------------------------------------------------- 223 (259)
T ss_dssp TSCHHHHHHHHHTTEE----------------------------------------------------------------
T ss_pred cccccccccccccccc----------------------------------------------------------------
Confidence 6655554444432211
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. .-...+.+..++|.+|+..||++|||+.++++
T Consensus 224 -------~~--~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 -------LP--IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------TT--SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------ce--eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 01245778999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=233.66 Aligned_cols=189 Identities=23% Similarity=0.365 Sum_probs=147.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
++.|+| ||+++. ..+...|||||+|.||. |.+++... .+-..++.+.+.||+|||++++|||||...|+
T Consensus 217 ~l~H~N-VVr~yGVa~~~~Pl~ivmEl~~gGs--L~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc 293 (474)
T KOG0194|consen 217 QLNHPN-VVRFYGVAVLEEPLMLVMELCNGGS--LDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC 293 (474)
T ss_pred hCCCCC-EEEEEEEEcCCCccEEEEEecCCCc--HHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence 489998 568886 66678899999999998 99998653 56677889999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCC-CCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLC-GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~-gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
|++.++.+||+|||+++.-..-......+ -...|+|||.+.. .-|+.++||||+||++||+++ |..||.+..
T Consensus 294 L~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred eecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc------CccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 99999999999999987543111111122 2347999999974 368899999999999999997 788887776
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+...+|....
T Consensus 368 ~~~v~~kI~~~~-------------------------------------------------------------------- 379 (474)
T KOG0194|consen 368 NYEVKAKIVKNG-------------------------------------------------------------------- 379 (474)
T ss_pred HHHHHHHHHhcC--------------------------------------------------------------------
Confidence 666555553322
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+..+.+ ...+++...++.+|...||++|+|+.++.+
T Consensus 380 --~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 --YRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --ccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 222211 134667788999999999999999887754
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=236.94 Aligned_cols=186 Identities=23% Similarity=0.443 Sum_probs=151.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-------------------HHHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-------------------NPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-------------------~~~~r~i~~qil~aL~~LH~ 64 (408)
.+.|+| ||++.. ..++..++|||||..|+ |-++|.. ..+...|+.||+.|++||-+
T Consensus 545 ~l~H~n-IVrLlGVC~~~~P~~MvFEYm~~GD--L~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 545 ELQHPN-IVRLLGVCREGDPLCMVFEYMDHGD--LHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred hccCCC-eEEEEEEEccCCeeEEEEEeccccc--HHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 478998 557665 56678999999999999 8777642 25778899999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCC---CcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT---PGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt---~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+.+|||||...|+|+.++..|||+|||+++..-..+.......| ..|||||.|..+ .|+++|||||+||++
T Consensus 622 ~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~------kFTteSDVWs~GVvL 695 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG------KFTTESDVWSFGVVL 695 (774)
T ss_pred CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC------cccchhhhhhhhhhh
Confidence 99999999999999999999999999999876544433222122 479999999864 578999999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
||+++ |..|+.+.+.++.+..|.+|..
T Consensus 696 WEIFsyG~QPy~glSn~EVIe~i~~g~l---------------------------------------------------- 723 (774)
T KOG1026|consen 696 WEIFSYGKQPYYGLSNQEVIECIRAGQL---------------------------------------------------- 723 (774)
T ss_pred hhhhccccCcccccchHHHHHHHHcCCc----------------------------------------------------
Confidence 99996 8888888888887777766542
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA 273 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~ 273 (408)
.+-| .+.+.++.+|+..|.+.+|++|||..|+
T Consensus 724 -------------------L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 724 -------------------LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred -------------------ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1111 2567889999999999999999998886
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=213.63 Aligned_cols=139 Identities=27% Similarity=0.464 Sum_probs=110.9
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|++++ .+.. .+....++||||+.+|. |.+++. +...+..++.|++.||+|||++||+||||||+
T Consensus 62 ~l~~~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ 138 (284)
T cd05038 62 TLDHENIV-KYKGVCEKPGGRSLRLIMEYLPSGS--LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR 138 (284)
T ss_pred hCCCCChh-eEEeeeecCCCCceEEEEecCCCCC--HHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 46788865 4432 23457899999999998 777763 34678899999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+++.++.++|+|||++......... ....++..|+|||.+.. ..++.++|+||+||++++|++|..||
T Consensus 139 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~------~~~~~~~Di~slG~~l~el~tg~~p~ 212 (284)
T cd05038 139 NILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT------SKFSSASDVWSFGVTLYELFTYGDPS 212 (284)
T ss_pred hEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc------CCCCcccchHHHhhhhheeeccCCCc
Confidence 999999999999999999876532211 11234557999998864 34678899999999999999999887
Q ss_pred CC
Q psy3880 152 WH 153 (408)
Q Consensus 152 ~~ 153 (408)
..
T Consensus 213 ~~ 214 (284)
T cd05038 213 QS 214 (284)
T ss_pred cc
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=210.08 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=146.2
Q ss_pred CcEEEEecc-C-CcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEe
Q psy3880 11 RVVVRVKEE-G-DDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLD 80 (408)
Q Consensus 11 ~~i~~~~~~-~-~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NILl~ 80 (408)
++||+++.. + ....++.||+|+---..|+.++- .+.-+-.+....+.||.||- ...|||||+||+|||++
T Consensus 123 p~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld 202 (361)
T KOG1006|consen 123 PNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD 202 (361)
T ss_pred cHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe
Confidence 345555531 1 12346788888765433444332 23445556666789999997 46899999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh-HHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~-~~~ 159 (408)
..|.+||||||++..+..+-..+.-.|...|||||.+..+ ..+|+-++|+||||+++||+.||..|+..-+. .++
T Consensus 203 r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq 278 (361)
T KOG1006|consen 203 RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ 278 (361)
T ss_pred cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCc----cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH
Confidence 9999999999999888766544556788999999998643 34799999999999999999999999865432 233
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+..+ ..|.||-...+
T Consensus 279 l~~V---------------------------------------------------v~gdpp~l~~~-------------- 293 (361)
T KOG1006|consen 279 LCQV---------------------------------------------------VIGDPPILLFD-------------- 293 (361)
T ss_pred HHHH---------------------------------------------------HcCCCCeecCc--------------
Confidence 3332 23444421110
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+--+.|...+.+|.-||.+|-.+||+-.+++.|||+...
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 1112468899999999999999999999999999999765
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-26 Score=230.17 Aligned_cols=142 Identities=34% Similarity=0.563 Sum_probs=120.9
Q ss_pred cccCCcEEEEeccCCc-------HHHHHHHHHhhchhhHHhhhCCH--------HHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 7 VAHSRVVVRVKEEGDD-------LKHLAAQVVDKGEAAVQDIINSN--------PALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~-------~~~lv~e~~~~g~~~l~~~~~~~--------~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
|.|+|+|.-+.-++++ ...+|||||.||+ |...+.+. .++..++..+..||.|||.+||||||
T Consensus 68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGs--L~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRD 145 (732)
T KOG4250|consen 68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGS--LRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRD 145 (732)
T ss_pred cCchhhhhhcccCCccccCcccccceEEEeecCCCc--HHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceecc
Confidence 6699876544433333 3568999999999 99988753 68899999999999999999999999
Q ss_pred CCCCcEEEe--cCC--CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 72 LKPENILLD--DQM--NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 72 LKp~NILl~--~~~--~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
|||.||++. .+| --||+|||.|+.+.+++...+.+||+.|++||+...+ ..|+..+|.||+||++|+.+||
T Consensus 146 lKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q-----~~y~~tVDLWS~GvtlY~caTG 220 (732)
T KOG4250|consen 146 LKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQ-----KKYTATVDLWSFGVTLYECATG 220 (732)
T ss_pred CCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhc-----cCcCceeehhhhhhHHHHHhcc
Confidence 999999984 334 3599999999999999988899999999999998642 4688999999999999999999
Q ss_pred CCCCCCch
Q psy3880 148 CPPFWHRK 155 (408)
Q Consensus 148 ~~pf~~~~ 155 (408)
..||...-
T Consensus 221 ~lPF~p~~ 228 (732)
T KOG4250|consen 221 ELPFIPFG 228 (732)
T ss_pred CCCCCcCC
Confidence 99996543
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=234.22 Aligned_cols=187 Identities=22% Similarity=0.414 Sum_probs=148.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH------------HHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN------------PALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~------------~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
++|+|+| .+.. -.....+|++|||.||+ |..+|.+. .++..++.||++|++||++++.|||||
T Consensus 752 f~HpNiv-~liGv~l~~~~~~i~leyM~gGD--L~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 752 FDHPNIV-SLIGVCLDSGPPLILLEYMEGGD--LLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred CCCccee-eEEEeecCCCCcEEEehhcccCc--HHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 6899965 4443 22456789999999999 98887543 688899999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCccccc-CCCC--CcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGT--PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GC 148 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~-~~gt--~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~ 148 (408)
...|+|++....+||+|||+|+.+...+.... -.+. ..|||||.+... .|+.++|||||||++||+++ |.
T Consensus 829 AaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~------iFtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 829 AARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG------IFTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred hhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc------ccccccchhhhHHHHHHHHhCCC
Confidence 99999999999999999999995544332221 1122 379999999863 46899999999999999997 88
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+.+..+.+..+++|. +...|
T Consensus 903 ~PY~~~~n~~v~~~~~~gg-RL~~P------------------------------------------------------- 926 (1025)
T KOG1095|consen 903 TPYPSRSNFEVLLDVLEGG-RLDPP------------------------------------------------------- 926 (1025)
T ss_pred CCCCCcchHHHHHHHHhCC-ccCCC-------------------------------------------------------
Confidence 8888877766665554442 22211
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...++...+++..|+.-||++||+...+++
T Consensus 927 -----------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 -----------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 235667789999999999999999999987
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=234.98 Aligned_cols=203 Identities=23% Similarity=0.413 Sum_probs=143.4
Q ss_pred ccccccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 2 EKGEMVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 2 ~~~~~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.++..+.|++++-.+.- ...+..+-+||||.+ + |+..+.+. .++..+++|++.||+|+|++||.|||+||+
T Consensus 373 ~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-D--lf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~e 449 (601)
T KOG0590|consen 373 CIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-D--LFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLE 449 (601)
T ss_pred eecccccCCchhhhHHHHhhcccchhhhhcccH-H--HHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccc
Confidence 35778899986533222 122233344999999 8 88888763 789999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccC-----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKG-----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|+++..+|.+||+|||.+...... ......+|+..|+|||++....++ ...+||||+|++++.|.+|+.|
T Consensus 450 nll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-----pr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 450 NLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-----PRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred cEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccC-----cchhhhhhccceEEEEecCCCc
Confidence 999999999999999998765432 123468999999999998754322 2345555555555555555555
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.- ..+.+..
T Consensus 525 Wk~----------------------------------------------------------------------a~~~~~~ 534 (601)
T KOG0590|consen 525 WKV----------------------------------------------------------------------AKKSDNS 534 (601)
T ss_pred ccc----------------------------------------------------------------------ccccccc
Confidence 532 2111100
Q ss_pred -HHHH--hc--CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 -RNIM--EG--KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 -~~i~--~~--~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.... .. ...-+..-|..++.+.+.+|.+||++||.+|+|++++++.+||+..
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0000 00 0001112356788899999999999999999999999999999764
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=220.68 Aligned_cols=151 Identities=27% Similarity=0.471 Sum_probs=124.9
Q ss_pred cccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
++||++| ++.. -.+....||||++.-|| |..++..+ ..+..|+.||+.||.|||+.+.|||||...|||+
T Consensus 448 fdHphIi-kLIGv~~e~P~WivmEL~~~GE--Lr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV 524 (974)
T KOG4257|consen 448 FDHPHII-KLIGVCVEQPMWIVMELAPLGE--LREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV 524 (974)
T ss_pred CCCcchh-heeeeeeccceeEEEecccchh--HHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee
Confidence 6899866 4443 44557899999999999 98888644 5778899999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCC--cccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTP--GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~--~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~ 156 (408)
.+...+||+|||+++.+.+........|.. .|||||.+.. ..++.++|||-|||++||++. |..||.+-..
T Consensus 525 sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 525 SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred cCcceeeecccchhhhccccchhhccccccceeecCccccch------hcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 999999999999999998776655544543 6999999865 457889999999999999985 9999988766
Q ss_pred HHHHHHHHhc
Q psy3880 157 MVMLRNIMEG 166 (408)
Q Consensus 157 ~~~~~~i~~~ 166 (408)
.+.+..|..|
T Consensus 599 sDVI~~iEnG 608 (974)
T KOG4257|consen 599 SDVIGHIENG 608 (974)
T ss_pred cceEEEecCC
Confidence 5555555444
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=215.48 Aligned_cols=140 Identities=27% Similarity=0.428 Sum_probs=113.2
Q ss_pred ccccCCcEEEEec-cCCc-HHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCC---CeeccCC
Q psy3880 6 MVAHSRVVVRVKE-EGDD-LKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHS---VVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~-~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~---IvHRDLK 73 (408)
++.|+|+|.-+-. .+.+ ...||+||+..|. |.+++... ..-..|+.+++.||+|||... |||||||
T Consensus 127 ~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGs--L~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 127 RLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGS--LEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred cCCCcCcccEEEEEecCCceEEEEEEccCCCC--HHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 5679986633333 3333 4799999999998 98887543 456789999999999999854 9999999
Q ss_pred CCcEEEecCCCEEEeccccchhccc-CcccccC-CCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKK-GEKLMDL-CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~-~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|+|||+|++.+.||+|||+|+.... .....+. .||.+|+|||++.. ...+.++|||||||++.|+++|+.|.
T Consensus 205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~------g~lt~KsDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 205 SSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST------GKLTEKSDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred HHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc------CCcCcccccccchHHHHHHHhCCccc
Confidence 9999999999999999999965543 3333333 89999999999864 23578999999999999999999877
Q ss_pred CC
Q psy3880 152 WH 153 (408)
Q Consensus 152 ~~ 153 (408)
..
T Consensus 279 d~ 280 (361)
T KOG1187|consen 279 DQ 280 (361)
T ss_pred CC
Confidence 54
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=220.91 Aligned_cols=189 Identities=22% Similarity=0.451 Sum_probs=150.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.+|||+| ++.. +-.....||.|||+.|. |-.+|... -++..+++.|+.|++||-++|+|||||.+.||
T Consensus 686 QFdHPNII-rLEGVVTks~PvMIiTEyMENGs--LDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 686 QFDHPNII-RLEGVVTKSKPVMIITEYMENGS--LDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNI 762 (996)
T ss_pred cCCCCcEE-EEEEEEecCceeEEEhhhhhCCc--HHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence 47899855 7776 33455689999999998 65555332 57888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-c-cccCCCC--CcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-K-LMDLCGT--PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~-~~~~~gt--~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
|++.+..||++|||+++.+.++. . ..+..|. ..|.|||.|.. ..++.++||||+||++||.++ |..|++
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~------RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY------RKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh------cccCchhhccccceEEEEecccCCCccc
Confidence 99999999999999999886554 2 2223333 37999999975 457889999999999999774 888988
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+.++.+..|.+|.
T Consensus 837 dmSNQdVIkaIe~gy----------------------------------------------------------------- 851 (996)
T KOG0196|consen 837 DMSNQDVIKAIEQGY----------------------------------------------------------------- 851 (996)
T ss_pred ccchHHHHHHHHhcc-----------------------------------------------------------------
Confidence 888888888877652
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+.| .+.+..+..|+..|.++|-++||+..|++++
T Consensus 852 ------RLPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 852 ------RLPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ------CCCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 11111 2456677889999999999999998887663
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=187.23 Aligned_cols=156 Identities=25% Similarity=0.397 Sum_probs=122.2
Q ss_pred ccCCcEEEEecc--CCcHHHHHHHHHhhchhhHHhh------hCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEE
Q psy3880 8 AHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDI------INSNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENIL 78 (408)
Q Consensus 8 ~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~------~~~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NIL 78 (408)
+.++++|+++.. .....++.||.|+--...+... ...+.-+-.++-.++.||.|||+ ..|||||+||+|||
T Consensus 102 ~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiL 181 (282)
T KOG0984|consen 102 VDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNIL 181 (282)
T ss_pred CCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEE
Confidence 356788898852 2234678899887543223222 22446677888899999999997 47999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC-chhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~-~~~~ 157 (408)
++.+|++|+||||.+..+.++-..+--.|...|||||.+..+. +..+|+.++||||||+++.||.+++.|+.. .+..
T Consensus 182 In~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~--n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 182 INYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL--NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred EccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCccc--CcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 9999999999999999887765444467888999999987543 234899999999999999999999999965 4567
Q ss_pred HHHHHHHh
Q psy3880 158 VMLRNIME 165 (408)
Q Consensus 158 ~~~~~i~~ 165 (408)
+++.++.+
T Consensus 260 ~qLkqvVe 267 (282)
T KOG0984|consen 260 QQLKQVVE 267 (282)
T ss_pred HHHHHHhc
Confidence 77777765
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=207.61 Aligned_cols=186 Identities=25% Similarity=0.421 Sum_probs=150.3
Q ss_pred cccCCcEEEEecc-CCcHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKEE-GDDLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~~-~~~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
|.|+++| +++.- -+...-+|||++..|. |.+.+... ..+..|+.||+.|+.||.+++.|||||...|+|
T Consensus 168 L~H~hli-RLyGvVl~qp~mMV~ELaplGS--LldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 168 LQHPHLI-RLYGVVLDQPAMMVFELAPLGS--LLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred ccCccee-EEeeeeccchhhHHhhhcccch--HHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 6899855 77764 3356789999999999 99988652 577899999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCC----CCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCG----TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
+.....|||+||||.+-+..++......+ ...|.|||.|.. ..|+.++|+|++||++|||++ |..||.+
T Consensus 245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh------~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH------RKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc------ccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 99988999999999998877665443222 236999999975 467899999999999999997 7778877
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+++++|-.+.
T Consensus 319 ~~g~qIL~~iD~~e------------------------------------------------------------------ 332 (1039)
T KOG0199|consen 319 CRGIQILKNIDAGE------------------------------------------------------------------ 332 (1039)
T ss_pred CCHHHHHHhccccc------------------------------------------------------------------
Confidence 77766666664321
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHH
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L 274 (408)
..+. -+..|++..+++..|...+|++|||...+.
T Consensus 333 -----rLpR--Pk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 333 -----RLPR--PKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred -----cCCC--CCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 1111 134688899999999999999999987664
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=215.41 Aligned_cols=200 Identities=28% Similarity=0.445 Sum_probs=154.0
Q ss_pred ccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
.|+|+|..+.. -.++...++||||.||. |+|+- .++.++.++.+..+.||+|||++|-+|||||-.|||+++
T Consensus 70 ~h~nivay~gsylr~dklwicMEycgggs--lQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd 147 (829)
T KOG0576|consen 70 RHPNIVAYFGSYLRRDKLWICMEYCGGGS--LQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD 147 (829)
T ss_pred CCcChHHHHhhhhhhcCcEEEEEecCCCc--ccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc
Confidence 58886644443 34566789999999998 88863 467899999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
.|.+|++|||.+..+... .+-.+..|||+|||||+-... ...+|+..||+|++|+...|+..-++|..+.-+...+
T Consensus 148 ~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaave---rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l 224 (829)
T KOG0576|consen 148 EGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE---RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL 224 (829)
T ss_pred cCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHH---hcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence 999999999998776532 233568999999999987543 3567889999999998888888777776554433322
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
.... +..|..
T Consensus 225 ~LmT----------------------------------------------------------------------kS~~qp 234 (829)
T KOG0576|consen 225 FLMT----------------------------------------------------------------------KSGFQP 234 (829)
T ss_pred HHhh----------------------------------------------------------------------ccCCCC
Confidence 2221 111111
Q ss_pred CC-CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 241 SS-PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 241 ~~-~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+. .+-..-|+...+|++.+|.++|++|||++.+|.|||.+..
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 10 1112347788999999999999999999999999999754
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=203.45 Aligned_cols=140 Identities=21% Similarity=0.369 Sum_probs=86.4
Q ss_pred CCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc------hhHHHHHHHHhccccCCCCCCccCCC
Q psy3880 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR------KQMVMLRNIMEGKYSFSSPEWNDISG 180 (408)
Q Consensus 107 gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~ 180 (408)
.|..|+|||++.+ .+|+..+||||++|+++||+||...|.-. .+.+-+..|++--.
T Consensus 413 QTRQYRapEVllG------sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG------------ 474 (590)
T KOG1290|consen 413 QTRQYRAPEVLLG------SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLG------------ 474 (590)
T ss_pred hhhhccCcceeec------CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHh------------
Confidence 4667999999986 57999999999999999999999999543 23455555544211
Q ss_pred CCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhc
Q psy3880 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLL 260 (408)
Q Consensus 181 ~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL 260 (408)
-|++-......+... -|....+ +.. ..+.-|| -+..++..+|.|+..+ ..+.-|||.-||
T Consensus 475 ~iPr~ia~~Gk~SRd-FFnr~G~------Lrh---I~~LK~W------pL~~VL~eKY~~s~e~----A~~fsdFL~PmL 534 (590)
T KOG1290|consen 475 KIPRKIALGGKYSRD-FFNRRGE------LRH---IRRLKPW------PLYEVLIEKYEWSEED----AQQFSDFLSPML 534 (590)
T ss_pred hccHHHHhcCcchHh-hhccccc------eec---ccccCCC------cHHHHHHHHhCCCHHH----HHHHHHHHHHHH
Confidence 111111111000000 0000000 000 0011111 1345666677775432 456679999999
Q ss_pred ccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 261 IVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 261 ~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
+++|++|+||.++|+|||+.+...
T Consensus 535 ef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred hcCccccccHHHHhcCccccCCCC
Confidence 999999999999999999987643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=234.35 Aligned_cols=134 Identities=22% Similarity=0.362 Sum_probs=109.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--CHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--SNPALRYIMRQLFEALEHVH---NHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--~~~~~r~i~~qil~aL~~LH---~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ ..++..|+||||+.+|. |.+.+. +..+...++.|++.||+||| +.+|+||||||+||+
T Consensus 739 ~l~HpnIv-~~~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 739 KLQHPNIV-KLIGLCRSEKGAYLIHEYIEGKN--LSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred hCCCCCcc-eEEEEEEcCCCCEEEEeCCCCCc--HHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 46799855 5554 44567799999999999 888774 45788899999999999999 679999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++.++..++. ||.+...... ....||+.|+|||++.. ..|+.++||||+||++|||++|+.||.
T Consensus 816 ~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~------~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 816 IDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET------KDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ECCCCceEEE-eccccccccC---CCccccccccCcccccC------CCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 9988887775 6655443221 23468899999998864 457889999999999999999999984
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=205.33 Aligned_cols=183 Identities=29% Similarity=0.510 Sum_probs=146.1
Q ss_pred CcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 11 RVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 11 ~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
.++|++.+ +.+...|+++++..||+ ++..+... ...+.+...++.|++++|+.+|+|||+|++||+++.+|
T Consensus 57 ~f~v~lhyafqt~~kl~l~ld~~rgg~--lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G 134 (612)
T KOG0603|consen 57 PFLVKLHYAFQTDGKLYLILDFLRGGD--LFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG 134 (612)
T ss_pred CceeeeeeeeccccchhHhhhhcccch--hhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC
Confidence 35667665 56678899999999999 88877543 67888999999999999999999999999999999999
Q ss_pred CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHH
Q psy3880 84 NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163 (408)
Q Consensus 84 ~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i 163 (408)
.+++.|||+++..-..+. .|||..|||||++.+ +..
T Consensus 135 hi~~tdfglske~v~~~~---~cgt~eymApEI~~g--------h~~--------------------------------- 170 (612)
T KOG0603|consen 135 HIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIING--------HLS--------------------------------- 170 (612)
T ss_pred ccccCCchhhhHhHhhhh---cccchhhhhhHhhhc--------cCC---------------------------------
Confidence 999999999987654432 299999999999852 233
Q ss_pred HhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCC
Q psy3880 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSP 243 (408)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~ 243 (408)
.+|+||+||++|+|++|..||.. ++.+.|+.....++.
T Consensus 171 -------------------------------------a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~- 208 (612)
T KOG0603|consen 171 -------------------------------------AADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR- 208 (612)
T ss_pred -------------------------------------cccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch-
Confidence 45555666666666666666655 455667766665553
Q ss_pred cCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCC
Q psy3880 244 EWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPKLF 284 (408)
Q Consensus 244 ~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~~~ 284 (408)
.++.++++++..|+..+|.+|.. +.|+++|+||+...+
T Consensus 209 ---~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 209 ---ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred ---hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 57899999999999999999986 589999999987543
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=202.95 Aligned_cols=184 Identities=24% Similarity=0.428 Sum_probs=142.9
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|+|+| ++-. +..-.+|||.|||..|. |.|++... --+.+++.||..|++||..+++|||||...|+
T Consensus 320 ikHpNLV-qLLGVCT~EpPFYIiTEfM~yGN--LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC 396 (1157)
T KOG4278|consen 320 IKHPNLV-QLLGVCTHEPPFYIITEFMCYGN--LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 396 (1157)
T ss_pred hcCccHH-HHhhhhccCCCeEEEEecccCcc--HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence 5688866 4433 44557899999999999 99998543 24577889999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCC---CcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGT---PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt---~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|+.++..+|++|||+++.+..+.. ....|. ..|.|||.+..+ .++.++|||+|||++||+.| |-.||.+
T Consensus 397 LVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyN------tFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 397 LVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYN------TFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cccccceEEeeccchhhhhcCCce-ecccCccCcccccCccccccc------ccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999876543 333443 369999999764 46789999999999999997 8788866
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
-+..+.. . +
T Consensus 470 idlSqVY-~----------------------------------------------------------------------L 478 (1157)
T KOG4278|consen 470 IDLSQVY-G----------------------------------------------------------------------L 478 (1157)
T ss_pred ccHHHHH-H----------------------------------------------------------------------H
Confidence 5433222 1 2
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA 273 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~ 273 (408)
++..|....| ...++.+..|++.|.+++|.+||+..|+
T Consensus 479 LEkgyRM~~P--eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 479 LEKGYRMDGP--EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HhccccccCC--CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 2223333333 2467778899999999999999997765
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=196.13 Aligned_cols=149 Identities=22% Similarity=0.396 Sum_probs=119.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.|.|||+| ++.. ..|+...+|+||++.|+ |..++... +....++.||+.|++||.+.++|||||.+.|
T Consensus 591 qLkhPNIv-eLvGVC~~DePicmI~EYmEnGD--LnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 591 RLKHPNIV-ELLGVCVQDDPLCMITEYMENGD--LNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred ccCCCCee-EEEeeeecCCchHHHHHHHhcCc--HHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 57899854 6665 57788999999999999 88877544 2345599999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccccc---CCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh--CCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMD---LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV--GCPPF 151 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~--G~~pf 151 (408)
+|++.++++||+|||.++.+-.+..... .+-...|||+|.+..+ .+++++|+|++|+++||+++ ...||
T Consensus 668 cLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg------kFttaSDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 668 CLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG------KFTTASDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred eeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc------cccchhhhhhhHHHHHHHHHHHhhCch
Confidence 9999999999999999997665543221 2233589999998764 46899999999999999874 66788
Q ss_pred CCchhHHHHHHH
Q psy3880 152 WHRKQMVMLRNI 163 (408)
Q Consensus 152 ~~~~~~~~~~~i 163 (408)
....+.+...+.
T Consensus 742 ~~lt~e~vven~ 753 (807)
T KOG1094|consen 742 SQLTDEQVVENA 753 (807)
T ss_pred hhhhHHHHHHhh
Confidence 776665555443
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-22 Score=209.20 Aligned_cols=154 Identities=35% Similarity=0.680 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccC--------------cc--cccCCCCCcccChhhh
Q psy3880 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG--------------EK--LMDLCGTPGYLAPEVL 117 (408)
Q Consensus 54 qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~--------------~~--~~~~~gt~~y~aPE~l 117 (408)
+++.+++|||+.||+|||+||+|.|+..-|.+|++|||+++..... .. -...||||.|.|||++
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 3478999999999999999999999999999999999998642110 01 1246899999999988
Q ss_pred hhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhccccccc
Q psy3880 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATG 197 (408)
Q Consensus 118 ~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~ 197 (408)
.. . +
T Consensus 231 lr------q----------------------------------------------------------------------g 234 (1205)
T KOG0606|consen 231 LR------Q----------------------------------------------------------------------G 234 (1205)
T ss_pred hh------h----------------------------------------------------------------------c
Confidence 64 2 3
Q ss_pred CCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCC---CHHHHH
Q psy3880 198 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEAL 274 (408)
Q Consensus 198 y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~---ta~e~L 274 (408)
||+++|||++|+|+|+.|.|+.||.++++.+++..++.....|+...| .+.+|++|+|.+||+.+|..|. .+-++.
T Consensus 235 ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk 313 (1205)
T KOG0606|consen 235 YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVK 313 (1205)
T ss_pred cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhh
Confidence 555666666666666666666777777777777777776666766543 4789999999999999999997 478999
Q ss_pred cCCCCCCCCC
Q psy3880 275 NHSFFHPKLF 284 (408)
Q Consensus 275 ~Hpwf~~~~~ 284 (408)
+|+||+...+
T Consensus 314 ~h~ff~~LDw 323 (1205)
T KOG0606|consen 314 QHGFFQLLDW 323 (1205)
T ss_pred hccceeeccc
Confidence 9999987644
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=207.17 Aligned_cols=187 Identities=24% Similarity=0.421 Sum_probs=138.9
Q ss_pred ccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHHC
Q psy3880 8 AHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHNH 65 (408)
Q Consensus 8 ~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~~ 65 (408)
.|+|+|-.+-. ..+...++|.|||..|+ |.+++. ...++-.+..||+.|++||++.
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~--L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGD--LLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCc--HHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 47776533433 23567789999999998 766553 2246788999999999999999
Q ss_pred CCeeccCCCCcEEEecCCCEEEeccccchhcccCccccc--CCCCC--cccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 66 SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD--LCGTP--GYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 66 ~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~--~~gt~--~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
.+|||||.+.|||+..+..+||+|||+|+.......... ..|+. .|||||.+.. ..|+.++||||+||++
T Consensus 438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~------~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD------RVFTSKSDVWSFGILL 511 (609)
T ss_pred CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc------CcccccchhhHHHHHH
Confidence 999999999999999999999999999986554443321 22222 4999999974 4578999999999999
Q ss_pred HHHHh-CCCCCCCch-hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 142 YTLLV-GCPPFWHRK-QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
||+++ |..|+.+-. ..+.+..+
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l-------------------------------------------------------- 535 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFL-------------------------------------------------------- 535 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHH--------------------------------------------------------
Confidence 99997 778875522 22222222
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..| +....| ...+++..++++.|...+|++|||..|+..
T Consensus 536 --------------~~G-~r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 536 --------------KEG-NRMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred --------------hcC-CCCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 111 222223 245889999999999999999999888764
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-22 Score=199.44 Aligned_cols=138 Identities=33% Similarity=0.633 Sum_probs=118.8
Q ss_pred cCCcEEEEe-ccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC
Q psy3880 9 HSRVVVRVK-EEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ 82 (408)
Q Consensus 9 ~~~~i~~~~-~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~ 82 (408)
|+|+|..+. .|+++..||+||-=.-| ..|||+|. ++++++.|++||+.|+++||+.||||||||-||+.++.+
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~g-IDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEG-IDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCC-cchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 999775555 38888999999965445 45999985 458999999999999999999999999999999999999
Q ss_pred CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 83 MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 83 ~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|-+||+|||.|..... .....+.||..|.|||++.++.+ -++.-|||++|+++|.+.....||++
T Consensus 707 g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y-----~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKY-----LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCcc-----CCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999876554 35667899999999999987644 36788999999999999999888864
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=180.89 Aligned_cols=143 Identities=27% Similarity=0.465 Sum_probs=99.5
Q ss_pred cccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhCC----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 5 EMVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIINS----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 5 ~~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~~----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+-|.|++.|+.-++ +..|...+++||+..|+ |..-+.. +...+.++.|+++|+.|+|++++||||||.+||
T Consensus 75 ~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gd--L~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNi 152 (378)
T KOG1345|consen 75 FFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGD--LRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENI 152 (378)
T ss_pred eeeccchhhhHHHHHHhhcCceEEEeeccCccch--hhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceE
Confidence 34556665655443 44456668999999999 7665543 467899999999999999999999999999999
Q ss_pred EEe--cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 78 LLD--DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 78 Ll~--~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|+- +...+||||||+.+..+.. ....--+..|-+||++..- .++.....+.+|+|.||+++|..++|++||+
T Consensus 153 Lif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~-~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 153 LIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTV-VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred EEecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhc-cccceEecccccchheeeeeeeeecCCCcch
Confidence 994 3458999999988654322 1222334568899887542 2222333555666666666666666666664
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=193.66 Aligned_cols=145 Identities=26% Similarity=0.410 Sum_probs=118.3
Q ss_pred cccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 5 EMVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 5 ~~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|+|+|++.-+.---.+..-||++|+.+|. |.|++..+ +.+..+..||++|+.|||.+++|||||...|+|
T Consensus 753 asldHpnl~RLLgvc~~s~~qlvtq~mP~G~--LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL 830 (1177)
T KOG1025|consen 753 ASLDHPNLLRLLGVCMLSTLQLVTQLMPLGC--LLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL 830 (1177)
T ss_pred hcCCCchHHHHhhhcccchHHHHHHhcccch--HHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee
Confidence 3589999774444333445889999999999 99987544 678889999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccC-CC--CCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDL-CG--TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~-~g--t~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+..-..+||.|||+|+.+......... .| .+.|||-|.+.. ..|+.++||||+||++||++| |..|+.+.
T Consensus 831 VksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~------~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 831 VKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI------RKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred ecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc------cCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 999999999999999988765543332 22 246888888864 568899999999999999997 88888765
Q ss_pred hhH
Q psy3880 155 KQM 157 (408)
Q Consensus 155 ~~~ 157 (408)
...
T Consensus 905 ~~~ 907 (1177)
T KOG1025|consen 905 PAE 907 (1177)
T ss_pred CHH
Confidence 543
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-21 Score=186.84 Aligned_cols=143 Identities=27% Similarity=0.474 Sum_probs=113.0
Q ss_pred cccCCcEEEEecc-CCc----HHHHHHHHHhhchhhHHhhhCCH----HHHHHHHHHHHHHHHHHHH---------CCCe
Q psy3880 7 VAHSRVVVRVKEE-GDD----LKHLAAQVVDKGEAAVQDIINSN----PALRYIMRQLFEALEHVHN---------HSVV 68 (408)
Q Consensus 7 ~~~~~~i~~~~~~-~~~----~~~lv~e~~~~g~~~l~~~~~~~----~~~r~i~~qil~aL~~LH~---------~~Iv 68 (408)
+.|+|++.-+-.+ ..+ ...||++|-..|. |.+++... .++..++..|+.||+|||+ ..|+
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGs--L~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGS--LCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCc--HHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 5688865333332 222 3459999999999 99998543 8999999999999999995 4699
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
|||||..|||+.+|+++-|+|||||..+.++... ...+||..|||||++.+..--.....-++.||||+|.++||++
T Consensus 339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988765432 3478999999999997643111122235799999999999999
Q ss_pred hCCCCC
Q psy3880 146 VGCPPF 151 (408)
Q Consensus 146 ~G~~pf 151 (408)
+++.-+
T Consensus 419 SRC~~~ 424 (534)
T KOG3653|consen 419 SRCTDA 424 (534)
T ss_pred hhcccc
Confidence 988755
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-20 Score=182.23 Aligned_cols=141 Identities=24% Similarity=0.404 Sum_probs=112.4
Q ss_pred cccccCCcEEEEeccC-Cc-----HHHHHHHHHhhchhhHHhhhCCH----HHHHHHHHHHHHHHHHHHH--------CC
Q psy3880 5 EMVAHSRVVVRVKEEG-DD-----LKHLAAQVVDKGEAAVQDIINSN----PALRYIMRQLFEALEHVHN--------HS 66 (408)
Q Consensus 5 ~~~~~~~~i~~~~~~~-~~-----~~~lv~e~~~~g~~~l~~~~~~~----~~~r~i~~qil~aL~~LH~--------~~ 66 (408)
-||-|+|++ .+.+.+ .+ ..+||.||=+.|. |+|++++. ..+..++..++.||+|||. -.
T Consensus 260 vmLRHENIL-gFIaaD~~~~gs~TQLwLvTdYHe~GS--L~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 260 VMLRHENIL-GFIAADNKDNGSWTQLWLVTDYHEHGS--LYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred HHhccchhh-hhhhccccCCCceEEEEEeeecccCCc--HHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 489999965 555422 11 2589999999999 99999765 7788899999999999994 35
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
|.|||||..|||+..++.+-|+|+|||....... .....+||..|||||++...+-.+...--+.+||||||.++
T Consensus 337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999999999999999999997654432 23457999999999999765433222233579999999999
Q ss_pred HHHHhCC
Q psy3880 142 YTLLVGC 148 (408)
Q Consensus 142 ~~ll~G~ 148 (408)
||++..+
T Consensus 417 WEiarRc 423 (513)
T KOG2052|consen 417 WEIARRC 423 (513)
T ss_pred HHHHHHh
Confidence 9998654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=166.40 Aligned_cols=154 Identities=41% Similarity=0.620 Sum_probs=122.3
Q ss_pred cccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++..+.. ..++..++++|++.++. |.+.+ .+...+..++.|++.++.+||+++++|+|++|.||++
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v 131 (225)
T smart00221 54 LKHPNIVKLYGVFEDPEPLYLVMEYCEGGD--LFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL 131 (225)
T ss_pred CCCCChhhheeeeecCCceEEEEeccCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 467765533332 34467789999999987 76665 3446788999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC--ch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~--~~ 155 (408)
+.++.++|+|||++....... ......++..|++||.+. ....++.++|+||+|+++++|++|+.||.+ ++
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~ 206 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-----GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEF 206 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-----CCCCCCchhhHHHHHHHHHHHHHCCCCccccchh
Confidence 999999999999988765442 334567888999999884 124567799999999999999999999988 44
Q ss_pred hHHHHHHHHhcc
Q psy3880 156 QMVMLRNIMEGK 167 (408)
Q Consensus 156 ~~~~~~~i~~~~ 167 (408)
..++.+.|..+.
T Consensus 207 ~~~~~~~~~~~~ 218 (225)
T smart00221 207 TSLLSDVWSFGV 218 (225)
T ss_pred HHHHHHHHhcCC
Confidence 446667776654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=162.80 Aligned_cols=109 Identities=38% Similarity=0.675 Sum_probs=84.8
Q ss_pred cccCCcEEEEecc--CCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++ |+.+... ..+..++++|++.|+. |.+.+ .+...+..++.+++.++++||++|++|+||+|.||+
T Consensus 48 l~~~~-i~~~~~~~~~~~~~~~~~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~ 124 (215)
T cd00180 48 LNHPN-IVKLYGVFEDENHLYLVMEYCEGGS--LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL 124 (215)
T ss_pred cCCCC-eeeEeeeeecCCeEEEEEecCCCCc--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEE
Confidence 46665 4455543 3357789999999887 66655 344788999999999999999999999999999999
Q ss_pred Eec-CCCEEEeccccchhcccCc-ccccCCCCCcccChhhhh
Q psy3880 79 LDD-QMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLR 118 (408)
Q Consensus 79 l~~-~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~ 118 (408)
++. ++.++|+|||.+....... ......+...|++||.+.
T Consensus 125 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 166 (215)
T cd00180 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL 166 (215)
T ss_pred EeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhc
Confidence 998 8999999999987654432 123355777889998774
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0965|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-19 Score=180.61 Aligned_cols=61 Identities=57% Similarity=0.993 Sum_probs=59.5
Q ss_pred hHHHHHHHhhhcCCCCCccccccccccccchhHHHHHhcCCCCCCCCCCCCCCcccccccc
Q psy3880 347 VKILRQYNALKEGREPDLSDYKEFKLKEDNVGFKMLQKLGWQEGSGLGTDGGGIQEPVNKI 407 (408)
Q Consensus 347 ~~~~~~~~a~k~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (408)
-+||+++++++++++||+|+|+++||+++||||||||||||+||+|||++|.||++|||+.
T Consensus 878 ~KFme~~~a~k~~rkpd~sdyke~KLt~dNiGfQMLqKMGWKEGeGLGS~gkGI~dPVnkg 938 (988)
T KOG0965|consen 878 AKFMERGRAMKKKRKPDDSDYKEQKLTDDNIGFQMLQKMGWKEGEGLGSLGKGIRDPVNKG 938 (988)
T ss_pred HHHHHhhhhhhhccCCChHHHHHhhccccchHHHHHHHhCccccccccccCcccccchhhc
Confidence 4899999999999999999999999999999999999999999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-18 Score=162.46 Aligned_cols=141 Identities=38% Similarity=0.636 Sum_probs=106.2
Q ss_pred cccCCcEEEEeccC--CcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 7 VAHSRVVVRVKEEG--DDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 7 ~~~~~~i~~~~~~~--~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
+.|++.|+.+.... ....+++++++.++. +.+.+ .....+..++.|++.++.|+|+.+++|||+||+|
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~n 131 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS--LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPEN 131 (384)
T ss_pred ccCCcceeeEEEEEecCCEEEEEEecCCCCc--HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 45553354555433 223589999999998 54433 3347899999999999999999999999999999
Q ss_pred EEEecCC-CEEEeccccchhcccCc-------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDDQM-NVKLTDFGFARVLKKGE-------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~~~-~iKl~DFGla~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
|+++..+ .++++|||++..+.... .....+||+.|+|||.+.... ...+....|+||+|++++++++|.
T Consensus 132 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~---~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 132 ILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS---LAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred eeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC---CCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999888 79999999998654432 235678999999999986420 024566788888888888877777
Q ss_pred CCCC
Q psy3880 149 PPFW 152 (408)
Q Consensus 149 ~pf~ 152 (408)
.||.
T Consensus 209 ~p~~ 212 (384)
T COG0515 209 PPFE 212 (384)
T ss_pred CCCC
Confidence 7753
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-18 Score=161.47 Aligned_cols=151 Identities=30% Similarity=0.496 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc--cccC-CCCCcccChhhhhhccc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK--LMDL-CGTPGYLAPEVLRANMF 122 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~--~~~~-~gt~~y~aPE~l~~~~~ 122 (408)
-++..++.|+..|++|||++||||.||...|++|++...+||+|=.+++-+.+... +.+. -....||+||.+..
T Consensus 396 ~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--- 472 (563)
T KOG1024|consen 396 IQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--- 472 (563)
T ss_pred HHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh---
Confidence 56778899999999999999999999999999999999999999999987766542 2221 12347999999975
Q ss_pred cCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQA 201 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~ 201 (408)
..|+.++|+|||||++|||++ |+.|+..-+..++..-+
T Consensus 473 ---~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-------------------------------------- 511 (563)
T KOG1024|consen 473 ---SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-------------------------------------- 511 (563)
T ss_pred ---hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--------------------------------------
Confidence 457899999999999999997 87777544433333222
Q ss_pred ccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 202 VDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 202 ~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+. .|....| .+.++++-..+.-|...+|++|||.+|+..
T Consensus 512 --------------------------------kd-GyRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 512 --------------------------------KD-GYRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred --------------------------------hc-cceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22 2222222 256888999999999999999999988753
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-17 Score=166.03 Aligned_cols=113 Identities=31% Similarity=0.561 Sum_probs=97.7
Q ss_pred HHHHHHHHHhhchhhHHhhhCCH--------HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 23 LKHLAAQVVDKGEAAVQDIINSN--------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~~~~--------~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
..||.|++|..+. |.|+|... -.+..++.|+..|++| ++.+|||+||.||....+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~t--ledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKET--LEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhh--HHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 4789999999888 99998632 5788999999999999 999999999999999999999999999987
Q ss_pred hcccCc-------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 95 VLKKGE-------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 95 ~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
...... ......||+.||+||.+.++ .|+.++||||||++++|++.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~------~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ------QYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhh------hhhhhcchhhHHHHHHHHHH
Confidence 665444 34457899999999999864 57889999999999999886
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=169.72 Aligned_cols=130 Identities=28% Similarity=0.407 Sum_probs=90.4
Q ss_pred cCCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccc
Q psy3880 19 EGDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA 93 (408)
Q Consensus 19 ~~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla 93 (408)
+.+.-.|||=+|+... |+|++..+ -+-++|+.||+.||.-||..||+|+|||.||||++.-..+.|+||..-
T Consensus 91 ~t~kAAylvRqyvkhn---LyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 91 VTDKAAYLVRQYVKHN---LYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred HhhHHHHHHHHHHhhh---hhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc
Confidence 4445579999999876 89999776 477999999999999999999999999999999999999999999643
Q ss_pred hh--cccCc--cc----ccCCCCCcccChhhhhhcc-----ccCcCCCCcchhhhhhhHHHHHHHh-CCCCC
Q psy3880 94 RV--LKKGE--KL----MDLCGTPGYLAPEVLRANM-----FEDATGYGQAVDVWACGVIMYTLLV-GCPPF 151 (408)
Q Consensus 94 ~~--~~~~~--~~----~~~~gt~~y~aPE~l~~~~-----~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf 151 (408)
+- +..+. .. .+...-..|.|||.+.... ........++-||+|+||+++|+++ |.+||
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 31 11111 01 1111223699999886421 0001113445666666666666664 55555
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-17 Score=162.72 Aligned_cols=124 Identities=21% Similarity=0.265 Sum_probs=92.2
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEEecCCC
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDL-KPENILLDDQMN 84 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDL-Kp~NILl~~~~~ 84 (408)
.|.|+++|..+.+.+ ..||||||+.|+. |... .... ...++.|++.||.|||++||+|||| ||+|||++.++.
T Consensus 77 ~L~h~~iv~~l~~~~--~~~LVmE~~~G~~--L~~~-~~~~-~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 77 TVRGIGVVPQLLATG--KDGLVRGWTEGVP--LHLA-RPHG-DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred hccCCCCCcEEEEcC--CcEEEEEccCCCC--HHHh-Cccc-hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC
Confidence 467998876666543 4699999999998 6532 2222 2568899999999999999999999 999999998899
Q ss_pred EEEeccccchhcccCcc---------cccCCCCCcccChhhhhhccccCcCCCCcchhhh
Q psy3880 85 VKLTDFGFARVLKKGEK---------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135 (408)
Q Consensus 85 iKl~DFGla~~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~Diw 135 (408)
+||+|||+|+.+..... +...++++.|+|||.+...........+...|-|
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999999986654321 2346788899999998654322223334456666
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.3e-16 Score=149.51 Aligned_cols=161 Identities=32% Similarity=0.533 Sum_probs=101.7
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe--cCC--CEEEeccccchhccc-------CcccccCCCCCcccCh
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD--DQM--NVKLTDFGFARVLKK-------GEKLMDLCGTPGYLAP 114 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~--~~~--~iKl~DFGla~~~~~-------~~~~~~~~gt~~y~aP 114 (408)
...+-++.|+|+|+.|||++||.|||+|.+|||+. +++ .+.|+|||+|---+. .....+..|.-.-|||
T Consensus 341 r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 341 RTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence 56788899999999999999999999999999995 333 578999998743211 1112235577778999
Q ss_pred hhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccc
Q psy3880 115 EVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFED 194 (408)
Q Consensus 115 E~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~ 194 (408)
|+.....-..+.
T Consensus 421 Ei~ta~PGp~av-------------------------------------------------------------------- 432 (598)
T KOG4158|consen 421 EIATAVPGPNAV-------------------------------------------------------------------- 432 (598)
T ss_pred hhhhcCCCCcee--------------------------------------------------------------------
Confidence 987532100000
Q ss_pred cccCCCcccccchhhhHHHhhcCCCCCCCchhHHH-HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC---H
Q psy3880 195 ATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM-LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---V 270 (408)
Q Consensus 195 ~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~-~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t---a 270 (408)
..|+ ++|.|++|-+.|+++....||+++..+.+ .+...+.+.. +--+.+++.+++|+..+|+.||++|+| |
T Consensus 433 -vny~-kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 433 -VNYE-KADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred -eccc-hhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 0011 44555555555555555555554332211 1111222211 122468899999999999999999999 4
Q ss_pred HHHHcCCCC
Q psy3880 271 KEALNHSFF 279 (408)
Q Consensus 271 ~e~L~Hpwf 279 (408)
..+|+-.-|
T Consensus 508 ANvl~LsLw 516 (598)
T KOG4158|consen 508 ANVLNLSLW 516 (598)
T ss_pred HhHHHHHHh
Confidence 556654433
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-17 Score=173.06 Aligned_cols=196 Identities=31% Similarity=0.508 Sum_probs=147.6
Q ss_pred cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-CCH------HHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEE
Q psy3880 9 HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-NSN------PALRYIMRQLFEALEHVH-NHSVVHRDLKPENIL 78 (408)
Q Consensus 9 ~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-~~~------~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NIL 78 (408)
|+|.+ .+.+ ......++++++..||+ +++.+ ... ..+..++.|+..++.|+| ..++.|||+||+|.+
T Consensus 80 h~n~~-~~~~~~~~~~~~~~~~~~s~g~~--~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 80 HSNTV-HMIEPSSSPRSYLLSLSYSDGGS--LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccccc-ccCCccCCCcccccccCcccccc--cccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 78755 5554 45567889999999999 99888 332 678999999999999999 999999999999999
Q ss_pred EecCC-CEEEeccccchhccc-Cc---ccccCCC-CCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 79 LDDQM-NVKLTDFGFARVLKK-GE---KLMDLCG-TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 79 l~~~~-~iKl~DFGla~~~~~-~~---~~~~~~g-t~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++..+ .+|++|||+|..+.. .. .+...+| ++.|+|||...+. ...+...|+||+|+++..+++|..|+.
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-----~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-----AYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccch-----hhcCCCcccccccccccccccCCCCcc
Confidence 99999 999999999987765 22 2345789 9999999987642 123455666666666666666666653
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
...... .....
T Consensus 232 ~~~~~~---------------------------------------------------------------------~~~~~ 242 (601)
T KOG0590|consen 232 FPSRKD---------------------------------------------------------------------GRYSS 242 (601)
T ss_pred cccccc---------------------------------------------------------------------cccee
Confidence 211100 00001
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.......+....|..++..+.+++.++|..+|..|.|.+++-.+||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1111123345668999999999999999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.6e-16 Score=148.15 Aligned_cols=101 Identities=28% Similarity=0.414 Sum_probs=70.1
Q ss_pred HHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccc--cCcCCC
Q psy3880 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMF--EDATGY 128 (408)
Q Consensus 51 i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~ 128 (408)
+..|++..+++||+.|+||+||||+|++++.+|.+.|+||+.....+. .......+..|.+||....... .....+
T Consensus 150 lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~ 227 (288)
T PF14531_consen 150 LTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPY 227 (288)
T ss_dssp HHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE
T ss_pred HHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCccccee
Confidence 348999999999999999999999999999999999999986654332 2222344578999998754210 012346
Q ss_pred CcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 129 GQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 129 ~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+.+.|.|++|+++|.+++|..||..
T Consensus 228 t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 228 TFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeccCHHHHHHHHHHHHHccCCCCC
Confidence 7788999999999999999888854
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-15 Score=138.82 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=101.3
Q ss_pred cccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEEecCCCE
Q psy3880 7 VAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDL-KPENILLDDQMNV 85 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDL-Kp~NILl~~~~~i 85 (408)
|.|+..|..+.+. +..+++|||+.|++ |...+... ...++.|++.+|++||++||+|||| ||+|||++.++.+
T Consensus 58 L~~~~~vP~ll~~--~~~~lvmeyI~G~~--L~~~~~~~--~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i 131 (218)
T PRK12274 58 LDGLPRTPRLLHW--DGRHLDRSYLAGAA--MYQRPPRG--DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSP 131 (218)
T ss_pred cCCCCCCCEEEEE--cCEEEEEeeecCcc--HHhhhhhh--hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCE
Confidence 5554555565543 23589999999988 76544222 2457889999999999999999999 7999999999999
Q ss_pred EEeccccchhcccCccc----c----------cCCCCCcccChhhhhhccccCcCCCC-cchhhhhhhHHHHHHHhCCCC
Q psy3880 86 KLTDFGFARVLKKGEKL----M----------DLCGTPGYLAPEVLRANMFEDATGYG-QAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 86 Kl~DFGla~~~~~~~~~----~----------~~~gt~~y~aPE~l~~~~~~~~~~~~-~~~DiwSlGvil~~ll~G~~p 150 (408)
+|+|||+|......... . -...++.|++|+.-..- ...+ ...++.+.|+-+|.++|+..+
T Consensus 132 ~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-----~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 132 AVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-----KRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred EEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-----ccchhHHHHHHHhcchHHHHHhccCC
Confidence 99999999854433211 0 02367889999754321 1112 456788999999999999999
Q ss_pred CCCchh
Q psy3880 151 FWHRKQ 156 (408)
Q Consensus 151 f~~~~~ 156 (408)
++++++
T Consensus 207 ~~~~~~ 212 (218)
T PRK12274 207 HWEDNE 212 (218)
T ss_pred ccccCC
Confidence 877653
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-14 Score=152.05 Aligned_cols=228 Identities=26% Similarity=0.408 Sum_probs=154.7
Q ss_pred cccCCcEEEEecc--CCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKEE--GDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~~--~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
..|++++++.... -.+..+|+++|+.||. |+..+.. .+-+|.++..+..++++||+..++|||++|.|+|.
T Consensus 860 ~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~--~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 860 TPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD--LPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI 937 (1205)
T ss_pred cCCCCceecccCCCCCCCCcchhhHHhccCC--chhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh
Confidence 3677888877765 5567899999999988 8777543 24678888889999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccc-----cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLM-----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~-----~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
..++..+++|||.......-.... ...|++...++-.-..+ ... |
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~-------l~~--~--------------------- 987 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQ-------LSA--D--------------------- 987 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccc-------ccc--c---------------------
Confidence 999999999998544322110000 01122222111100000 000 0
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
... ..-.......|.+||.+... .-+..+|+|+.|+++++.++|.+||........+++|.
T Consensus 988 ------~~~-------~~~~~~~t~~~laPe~~lg~------~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 988 ------EAR-------RKHAVVGTPDYLAPEILLGR------RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENIL 1048 (1205)
T ss_pred ------hhh-------ccccccCCCcccCCcccccc------cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccc
Confidence 000 00001223345566655432 23557788888888888888888888888778888887
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH---HHHcCCCCCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK---EALNHSFFHPKLFDQ 286 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~---e~L~Hpwf~~~~~~~ 286 (408)
.+...++... ...++++++++.++|.-+|.+|.++. +.-.||||++..++.
T Consensus 1049 ~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1049 NRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred cCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 7766554322 35789999999999999999999877 999999999876543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.2e-13 Score=132.76 Aligned_cols=138 Identities=24% Similarity=0.335 Sum_probs=103.5
Q ss_pred EEEEeccC---CcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC---
Q psy3880 13 VVRVKEEG---DDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ--- 82 (408)
Q Consensus 13 i~~~~~~~---~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~--- 82 (408)
+..+...+ .++.|+||+++-..-..|.... .+..++..++.|++.+|++||+.|++||||||+|+++...
T Consensus 82 ~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 82 FPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred CCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCc
Confidence 43444433 4567889888754433333222 2458899999999999999999999999999999999754
Q ss_pred --CCEEEeccccchhcc---cCc-------c-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 83 --MNVKLTDFGFARVLK---KGE-------K-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 83 --~~iKl~DFGla~~~~---~~~-------~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
..+.|.|||+|+... ... . .....||..|.++..-.+ ...+.+-|+||++-++.++..|..
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~------~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG------IEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC------CccCCchhhhhHHHHHHHHhcCCC
Confidence 468999999998322 111 0 122459999999997654 346789999999999999999999
Q ss_pred CCCCchh
Q psy3880 150 PFWHRKQ 156 (408)
Q Consensus 150 pf~~~~~ 156 (408)
||.+...
T Consensus 236 PW~~~~~ 242 (322)
T KOG1164|consen 236 PWEALEM 242 (322)
T ss_pred CCccccc
Confidence 9977653
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.1e-13 Score=128.43 Aligned_cols=153 Identities=22% Similarity=0.328 Sum_probs=116.4
Q ss_pred cccCCcEEEEeccCCcHH--HHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 7 VAHSRVVVRVKEEGDDLK--HLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~~~--~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
|.+..-|-.+++-+..-. .||+|++---.+.|||+-. +.+++.-++.|++.-++|+|++..|.|||||+|+||..
T Consensus 80 L~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 80 LGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred HcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 344445655666554434 4999998555566777643 45899999999999999999999999999999999964
Q ss_pred C-----CCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 82 Q-----MNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 82 ~-----~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
. ..|.++|||+|+.+.+... ..+..||..||+--.-.+ ...+.+-|+=|||-++.+.|.|.
T Consensus 160 p~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG------rEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 160 PGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG------REQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred CCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc------chhhhhhhHHHhhhhhhhhccCC
Confidence 3 3589999999998765432 245789999998765443 23467899999999999999999
Q ss_pred CCCCCch---hHHHHHHHHh
Q psy3880 149 PPFWHRK---QMVMLRNIME 165 (408)
Q Consensus 149 ~pf~~~~---~~~~~~~i~~ 165 (408)
.||.+-+ ..+-.++|-.
T Consensus 234 LPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 234 LPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred CccccccCcchHHHHHHhcc
Confidence 9998753 4555556543
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-13 Score=136.76 Aligned_cols=145 Identities=24% Similarity=0.390 Sum_probs=104.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH------HHHHHHHHHHHHHHHHHHHCCC-eeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN------PALRYIMRQLFEALEHVHNHSV-VHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~------~~~r~i~~qil~aL~~LH~~~I-vHRDLKp~N 76 (408)
.+.|+|+. .+.. -.......|-+||..|. |+|.+..+ -=.-.+++.|+.||+|||+-.| .|..|+..|
T Consensus 3 ~l~h~n~~-~f~g~~~~~~~~~~i~~~c~rGs--l~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 3 QLDHDNLN-KFIGASVDGPEMIVIWEYCSRGS--LLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred ccchhhhh-hheeeEecCCceEEEEeeecCcc--HHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 36788744 5544 22355678899999999 99988653 2235567889999999998877 999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCc-CCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDA-TGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~-~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++++..-.+|++|||+........ ......-..-|.|||.+........ ..-+.+.|+||+|++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 999999999999999987654210 0011122346899999976422110 113567899999999999999888886
Q ss_pred C
Q psy3880 153 H 153 (408)
Q Consensus 153 ~ 153 (408)
.
T Consensus 160 ~ 160 (484)
T KOG1023|consen 160 L 160 (484)
T ss_pred c
Confidence 5
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=7e-14 Score=129.97 Aligned_cols=99 Identities=13% Similarity=0.220 Sum_probs=74.2
Q ss_pred HHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc
Q psy3880 23 LKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~ 102 (408)
..+|||||++|.. |.+.....+ ..+.+++.+|..||+.|++|||+||+||+++.++ ++|+|||...........
T Consensus 117 ~~~lvmEyi~G~t--L~~~~~~~~---~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~ 190 (232)
T PRK10359 117 TYIMLIEYIEGVE--LNDMPEISE---DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK 190 (232)
T ss_pred CeEEEEEEECCcc--HHHhhhccH---HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH
Confidence 4679999999987 766533222 3466999999999999999999999999999888 999999987654322111
Q ss_pred ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 103 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
..++.. ..|+.++|+||||+++...
T Consensus 191 -----------d~~vle------r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 191 -----------DRIDLE------RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -----------HHHHHH------hHhcccccccceeEeehHH
Confidence 012222 3466789999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-13 Score=125.66 Aligned_cols=69 Identities=16% Similarity=0.182 Sum_probs=58.7
Q ss_pred HHHHHHHhhchhhHHh-----hhCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCcEEEecCCCEEEeccccchhc
Q psy3880 25 HLAAQVVDKGEAAVQD-----IINSNPALRYIMRQLFEALEHV-HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96 (408)
Q Consensus 25 ~lv~e~~~~g~~~l~~-----~~~~~~~~r~i~~qil~aL~~L-H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~ 96 (408)
+|||||+.|+. +.. ...+..++..++.|++.+|.++ |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus 93 ~iVmE~i~g~~--l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDG--WAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCC--CcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 79999999875 322 2234578999999999999999 799999999999999998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-13 Score=123.10 Aligned_cols=73 Identities=19% Similarity=0.257 Sum_probs=60.1
Q ss_pred HHHHHHHHhhchhh---HHhhhCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEecCCCEEEeccccchhcc
Q psy3880 24 KHLAAQVVDKGEAA---VQDIINSNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLK 97 (408)
Q Consensus 24 ~~lv~e~~~~g~~~---l~~~~~~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~ 97 (408)
.+|||||+.|+... +.+.-.+..++..++.|++.+|.++|+ +||+||||||+|||++ ++.++|+|||+|..+.
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 37999999987411 112123456889999999999999999 9999999999999998 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.7e-12 Score=117.38 Aligned_cols=141 Identities=21% Similarity=0.311 Sum_probs=103.9
Q ss_pred cHHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC---CCEEEeccccchh
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ---MNVKLTDFGFARV 95 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~---~~iKl~DFGla~~ 95 (408)
+.-.+|||++----+.||..-. +-+++.-++-|++.-++|+|.++.|||||||+|+|..-+ ..+-++|||+|+.
T Consensus 84 ~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 84 DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 3445788877444344544432 236777888999999999999999999999999999643 4688999999987
Q ss_pred cccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch---hHHHHHHHH
Q psy3880 96 LKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIM 164 (408)
Q Consensus 96 ~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~---~~~~~~~i~ 164 (408)
+.+... -....||..|.+--...+ ...+.+-|+=|+|-++.+...|..||++-. ..+-..+|.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLG------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhh------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 654321 134679999988765543 123568899999999999999999998854 455556666
Q ss_pred hccc
Q psy3880 165 EGKY 168 (408)
Q Consensus 165 ~~~~ 168 (408)
+.+.
T Consensus 238 EkK~ 241 (341)
T KOG1163|consen 238 EKKM 241 (341)
T ss_pred Hhhc
Confidence 6543
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.9e-12 Score=124.63 Aligned_cols=69 Identities=42% Similarity=0.768 Sum_probs=60.7
Q ss_pred ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCcc
Q psy3880 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177 (408)
Q Consensus 103 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 177 (408)
...+|||-|+|||++.+ .+|+..||+||||||+||||.|.+||.+++..+..++|...+-.+..|.-..
T Consensus 346 ~StVGTPDYiAPEVll~------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~ 414 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLG------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD 414 (550)
T ss_pred hcccCCccccchHHHhc------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc
Confidence 34789999999999986 5799999999999999999999999999999999999999886665555433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.4e-12 Score=116.94 Aligned_cols=84 Identities=18% Similarity=0.141 Sum_probs=60.4
Q ss_pred cccCCcEEEEeccCCc-----HHH-HHHHH--HhhchhhHHhhhCCH--HHHHHHHHHHHHHH-HHHHHCCCeeccCCCC
Q psy3880 7 VAHSRVVVRVKEEGDD-----LKH-LAAQV--VDKGEAAVQDIINSN--PALRYIMRQLFEAL-EHVHNHSVVHRDLKPE 75 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~-----~~~-lv~e~--~~~g~~~l~~~~~~~--~~~r~i~~qil~aL-~~LH~~~IvHRDLKp~ 75 (408)
..|+| |+++++...+ ..+ +|+|| +.+|. |.+.+... ++...++.|++.++ +|||+++||||||||+
T Consensus 58 ~~h~n-Ivr~yg~~et~~g~g~v~~~I~e~~G~~~~t--L~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 58 IDWSG-IPRYYGTVETDCGTGYVYDVIADFDGKPSIT--LTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCCcc-cceeeEEEEeCCCCeEEEEEEecCCCCcchh--HHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 36787 5577653222 223 78999 44677 88887532 22245688888888 9999999999999999
Q ss_pred cEEEecC----CCEEEeccccc
Q psy3880 76 NILLDDQ----MNVKLTDFGFA 93 (408)
Q Consensus 76 NILl~~~----~~iKl~DFGla 93 (408)
|||++.. ..++|+||+.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 9999743 37999995433
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.1e-11 Score=110.68 Aligned_cols=143 Identities=13% Similarity=0.293 Sum_probs=101.1
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCCH-------HHHHHHHHHHHHHHHHHHHCC--CeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINSN-------PALRYIMRQLFEALEHVHNHS--VVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~~-------~~~r~i~~qil~aL~~LH~~~--IvHRDLKp~ 75 (408)
..+|||+...+.+ ...-...++.+||.-|. |+..+... .++..++-.++.|+.|||+.. |.---|...
T Consensus 243 ifshpnilpvlgacnsppnlv~isq~mp~gs--lynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNSPPNLVIISQYMPFGS--LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred eecCCchhhhhhhccCCCCceEeeeeccchH--HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 4679986655544 33345668889999998 88877543 677888999999999999864 444467778
Q ss_pred cEEEecCCCEEE--eccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDDQMNVKL--TDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~~~~iKl--~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
.++++++.+.+| +|--++. ......-+|.||+||.+....-+ .--.++|+|||.+++||+-|...||.+
T Consensus 321 hvmidedltarismad~kfsf------qe~gr~y~pawmspealqrkped---~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 321 HVMIDEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPED---LNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred eEEecchhhhheecccceeee------eccccccCcccCCHHHHhcCchh---cchhhhhHHHHHHHHHHhhcccccccc
Confidence 899988876554 3432221 11234557899999999764321 123579999999999999999999976
Q ss_pred chhHHH
Q psy3880 154 RKQMVM 159 (408)
Q Consensus 154 ~~~~~~ 159 (408)
-+..+.
T Consensus 392 lspmec 397 (448)
T KOG0195|consen 392 LSPMEC 397 (448)
T ss_pred CCchhh
Confidence 554443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.7e-11 Score=129.52 Aligned_cols=122 Identities=24% Similarity=0.375 Sum_probs=103.7
Q ss_pred CCcHHHHHHHHHhhchhhHHhhhCCH-----HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-------CCCEEE
Q psy3880 20 GDDLKHLAAQVVDKGEAAVQDIINSN-----PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-------QMNVKL 87 (408)
Q Consensus 20 ~~~~~~lv~e~~~~g~~~l~~~~~~~-----~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-------~~~iKl 87 (408)
+.|--+||+||-+-|. |.|.++.. --+.++..|+|.-|++||..+|||.||||+|+||.. +..++|
T Consensus 765 ~~~~S~lv~ey~~~Gt--lld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGT--LLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cCCcceeeeecccccc--HHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 4555678999999998 99998754 567889999999999999999999999999999942 346999
Q ss_pred eccccchhcc---cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 88 TDFGFARVLK---KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 88 ~DFGla~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
+|||.+.-+. ++..+...++|-.+-++|+..+ .+++..+|.+.+..+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g------rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG------RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcC------CCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999986543 4556778899999999999864 578899999999999999999964
|
|
| >PF01585 G-patch: G-patch domain; InterPro: IPR000467 The D111/G-patch domain [] is a short conserved region of about 40 amino acids which occurs in a number of putative RNA-binding proteins, including tumor suppressor and DNA-damage-repair proteins, suggesting that this domain may have an RNA binding function | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.3e-11 Score=81.78 Aligned_cols=32 Identities=47% Similarity=1.165 Sum_probs=30.7
Q ss_pred cchhHHHHHhcCCCCCCCCCCCCCCccccccc
Q psy3880 375 DNVGFKMLQKLGWQEGSGLGTDGGGIQEPVNK 406 (408)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (408)
+|+|++||++|||++|+|||++.+||++||+.
T Consensus 2 ~~~g~~lm~kmGw~~G~GLGk~~~G~~~pi~~ 33 (45)
T PF01585_consen 2 SSIGFKLMKKMGWKPGQGLGKNGQGIAEPIEV 33 (45)
T ss_pred CcHHHHHHHHCCCCCCcCCCcCCccCCcceEE
Confidence 68999999999999999999999999999975
|
This domain has seven highly conserved glycines. A multiple alignment of a small subset of D111/G-patch domains is shown in Fig. 2b of [].; GO: 0003676 nucleic acid binding, 0005622 intracellular |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-11 Score=114.34 Aligned_cols=71 Identities=17% Similarity=0.215 Sum_probs=59.5
Q ss_pred HHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCcEEEecCCCEEEeccccchhcc
Q psy3880 24 KHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHS-VVHRDLKPENILLDDQMNVKLTDFGFARVLK 97 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~-IvHRDLKp~NILl~~~~~iKl~DFGla~~~~ 97 (408)
.+|||||+.|+. +.... ....+++.++.||+.+|.+||++| |+||||||+||+++ ++.++|+|||.|....
T Consensus 123 ~~lV~E~~~g~~--L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 123 NVLVMEFIGGDG--LPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ceEEEEEecCCc--ccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 479999999976 43332 223567889999999999999999 99999999999999 7899999999887543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-11 Score=113.62 Aligned_cols=69 Identities=20% Similarity=0.349 Sum_probs=56.0
Q ss_pred HHHHHHHhhc-hhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 25 HLAAQVVDKG-EAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 25 ~lv~e~~~~g-~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
++|+|+++|+ . |.+.+...+.....+.||+.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~--L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARD--LVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3999999874 5 6666543221223467999999999999999999999999999888999999998765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.5e-11 Score=125.50 Aligned_cols=85 Identities=18% Similarity=0.354 Sum_probs=69.0
Q ss_pred ccccCCcEEE-EeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCC
Q psy3880 6 MVAHSRVVVR-VKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN 84 (408)
Q Consensus 6 ~~~~~~~i~~-~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~ 84 (408)
.+.|+++++. ++....+..++||||+.|+. |.+.+. ....++.|++.+|.+||++||+||||||+|||+ +++.
T Consensus 392 ~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~--L~~~l~---~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 392 EARRAGVPTPVIYDVDPEEKTIVMEYIGGKD--LKDVLE---GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred hhcccCCCeeEEEEEeCCCCEEEEEecCCCc--HHHHHH---HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCc
Confidence 3567775543 33344455689999999998 877664 467789999999999999999999999999999 5778
Q ss_pred EEEeccccchhc
Q psy3880 85 VKLTDFGFARVL 96 (408)
Q Consensus 85 iKl~DFGla~~~ 96 (408)
++|+|||+|+..
T Consensus 466 ~~liDFGla~~~ 477 (535)
T PRK09605 466 LYLIDFGLGKYS 477 (535)
T ss_pred EEEEeCcccccC
Confidence 999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.5e-11 Score=109.45 Aligned_cols=76 Identities=22% Similarity=0.432 Sum_probs=63.0
Q ss_pred EEeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 15 RVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 15 ~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
.+....++..++||||+.|+. |.+.+..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++.
T Consensus 63 ~~~~~~~~~~~lv~e~~~g~~--l~~~~~~~~~--~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 63 VVYDVDPDNKTIVMEYIEGKP--LKDVIEEGND--ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred EEEEEECCCCEEEEEEECCcc--HHHHHhhcHH--HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 334444555689999999998 7776644322 7899999999999999999999999999999 7899999999886
Q ss_pred h
Q psy3880 95 V 95 (408)
Q Consensus 95 ~ 95 (408)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.2e-11 Score=108.62 Aligned_cols=72 Identities=18% Similarity=0.278 Sum_probs=61.3
Q ss_pred HHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcc
Q psy3880 23 LKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK 97 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~ 97 (408)
..++||||+.|+. |.+... .+....++.+++.++.++|+.||+||||||+||+++.++.++|+|||.+....
T Consensus 105 ~~~lv~e~~~g~~--L~~~~~-~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 105 RHAVVMEYIDGVE--LYRVRV-LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CceEEEEEeCCcc--hhhccc-cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 3478999999987 655433 24567788999999999999999999999999999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=9.6e-11 Score=107.43 Aligned_cols=73 Identities=23% Similarity=0.397 Sum_probs=62.5
Q ss_pred CCcHHHHHHHHHhhchhhHHhhhCCH-HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 20 GDDLKHLAAQVVDKGEAAVQDIINSN-PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 20 ~~~~~~lv~e~~~~g~~~l~~~~~~~-~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
+.+..+++|||+.|+. |.+.+... .+...++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 70 ~~~~~~lv~e~~~G~~--L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 70 DPENFIIVMEYIEGEP--LKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCCCEEEEEEeCCcC--HHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 4455789999999988 77766432 36778899999999999999999999999999999 78899999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.1e-10 Score=103.08 Aligned_cols=72 Identities=21% Similarity=0.260 Sum_probs=57.9
Q ss_pred HHHHHHHHhhch---hhHHhhhCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEecCCCEEEeccccchhcc
Q psy3880 24 KHLAAQVVDKGE---AAVQDIINSNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLK 97 (408)
Q Consensus 24 ~~lv~e~~~~g~---~~l~~~~~~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~ 97 (408)
.++||||+.||. ..|.+... ..+++.++.+++.++.++|+ +||+||||||+||+++ ++.++++|||.+....
T Consensus 90 ~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 90 HVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 367888888853 01322222 16788999999999999999 9999999999999999 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >smart00443 G_patch glycine rich nucleic binding domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=8e-10 Score=76.89 Aligned_cols=35 Identities=46% Similarity=1.082 Sum_probs=32.4
Q ss_pred ccccchhHHHHHhcCCCCCCCCCCCCCCccccccc
Q psy3880 372 LKEDNVGFKMLQKLGWQEGSGLGTDGGGIQEPVNK 406 (408)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (408)
++.+|+|++||++|||++|+|||++.+||++||..
T Consensus 1 ~~~~~~g~~~l~~mGw~~G~GLG~~~~g~~~pi~~ 35 (47)
T smart00443 1 ISTSNIGYKLLRKMGWKEGQGLGKNEQGIVEPISA 35 (47)
T ss_pred CCcccHHHHHHHHcCCCCCCcCCCCCCcCccceeE
Confidence 46789999999999999999999999999999854
|
A predicted glycine rich nucleic binding domain found in the splicing factor 45, SON DNA binding protein and D-type Retrovirus- polyproteins. |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-09 Score=107.24 Aligned_cols=64 Identities=41% Similarity=0.734 Sum_probs=57.7
Q ss_pred ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCC
Q psy3880 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 172 (408)
Q Consensus 103 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~ 172 (408)
...+||..|+|||++.+ .+++.++|+|+|||++|||+.|..||.+.+..+.+.+|+.....|..
T Consensus 293 nSFVGThEYlAPEvI~G------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 293 NSFVGTHEYLAPEVIRG------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE 356 (459)
T ss_pred cccccccccccceeeec------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC
Confidence 45889999999999986 57899999999999999999999999999999999999987766543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.3e-09 Score=115.54 Aligned_cols=138 Identities=28% Similarity=0.498 Sum_probs=106.1
Q ss_pred eeccCCCC-cEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 68 VHRDLKPE-NILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 68 vHRDLKp~-NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
.|++.+|. |++++..+..++.|||.++....+.. ....+||+.|+|||++.+ ..|+.++||||+||++|+
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~------~~~~~~~DiwSlG~il~E 572 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLG------KPHGPAVDWWALGVCLFE 572 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCC------CCCCcHHHHHHHHHHHHH
Confidence 34566666 56666666778899998877654322 234689999999999874 457899999999999999
Q ss_pred HHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 144 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 144 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
|++|..||.+......+..++...+.+... .
T Consensus 573 lltG~~pf~~~~~~~~~~~il~~~~~~p~~------------------------------~------------------- 603 (669)
T cd05610 573 FLTGIPPFNDETPQQVFQNILNRDIPWPEG------------------------------E------------------- 603 (669)
T ss_pred HHHCCCCCCCCCHHHHHHHHHhcCCCCCcc------------------------------c-------------------
Confidence 999999999988888888876644321100 0
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..++.++.+++.+||..||.+|||+.|+|+||||...
T Consensus 604 ----------------------~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~ 640 (669)
T cd05610 604 ----------------------EKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGV 640 (669)
T ss_pred ----------------------ccCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCC
Confidence 0235678899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.3e-10 Score=105.30 Aligned_cols=134 Identities=19% Similarity=0.281 Sum_probs=91.9
Q ss_pred ccccCCcEEEEeccCCcHH-------HHHHHHHhhchhhHHhhhCCH---------HHHHHHHHHHHHHHHHHHHCC--C
Q psy3880 6 MVAHSRVVVRVKEEGDDLK-------HLAAQVVDKGEAAVQDIINSN---------PALRYIMRQLFEALEHVHNHS--V 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~-------~lv~e~~~~g~~~l~~~~~~~---------~~~r~i~~qil~aL~~LH~~~--I 67 (408)
.+.|.| +|.+...-+|.+ .++.||+..|. +...+.+- ...+.++.||+.||.|||+.. |
T Consensus 123 qlvHsn-lvkfH~yw~d~K~~e~~rviFiteymssgs--~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 123 QLVHSN-LVKFHKYWTDKKYEEKPRVIFITEYMSSGS--LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHH-HHHHHHhhcccccccccceEEEEecccchh--HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 356777 445554333333 47889999987 66655432 566889999999999999875 9
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccC-----c-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKG-----E-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~-----~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+|.++....|.+..+|-||+.---.. ..... + ...-..+-++|-|||.=. ....+.++|||++|.+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~------~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGT------TTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCc------ccccccchhhhhhhHHH
Confidence 99999999999999888887532110 00000 0 001134568899998532 34456789999999999
Q ss_pred HHHHhCCC
Q psy3880 142 YTLLVGCP 149 (408)
Q Consensus 142 ~~ll~G~~ 149 (408)
.+|..+..
T Consensus 273 lemailEi 280 (458)
T KOG1266|consen 273 LEMAILEI 280 (458)
T ss_pred HHHHHhee
Confidence 88887643
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=4e-09 Score=107.74 Aligned_cols=181 Identities=23% Similarity=0.341 Sum_probs=132.4
Q ss_pred cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCcEEEecC-CCEEE
Q psy3880 19 EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFE----ALEHVHNHSVVHRDLKPENILLDDQ-MNVKL 87 (408)
Q Consensus 19 ~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~----aL~~LH~~~IvHRDLKp~NILl~~~-~~iKl 87 (408)
++.+..|+-+|+|. .. ++.+.. ....+...+.+... ||.++|+.+|+|-|+||+||....+ ..+++
T Consensus 188 e~~~~lfiqtE~~~-~s--l~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ES--LQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred ccCCcceeeecccc-ch--hHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence 56778899999886 22 555533 33788888899988 9999999999999999999999988 88999
Q ss_pred eccccchhcccCccc------ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 88 TDFGFARVLKKGEKL------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 88 ~DFGla~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
+|||+...+..+.-. ...-|..-|++||++.. -++...|++|+|.+..+..++..+....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-------l~~~~~di~sl~ev~l~~~l~~~~~~~g------- 330 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-------LATFASDIFSLGEVILEAILGSHLPSVG------- 330 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-------ccchHhhhcchhhhhHhhHhhcccccCC-------
Confidence 999998877654311 12356678999999863 4788999999999999888876654221
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
..+.|. ++... | .+
T Consensus 331 ---------------------------------------~~~~W~-------------~~r~~-------------~-ip 344 (524)
T KOG0601|consen 331 ---------------------------------------KNSSWS-------------QLRQG-------------Y-IP 344 (524)
T ss_pred ---------------------------------------CCCCcc-------------ccccc-------------c-Cc
Confidence 112221 00000 0 01
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.......|.+....+..|+.-||..|++++.+++|+++...
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 11112345566669999999999999999999999999754
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.7e-09 Score=96.86 Aligned_cols=51 Identities=80% Similarity=1.538 Sum_probs=48.7
Q ss_pred cchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCC
Q psy3880 130 QAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISG 180 (408)
Q Consensus 130 ~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 180 (408)
..+|+||+|||+|.|+.|++||++..+..+++.|++|+|.|.+|+|.+++.
T Consensus 207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc
Confidence 368999999999999999999999999999999999999999999998876
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.9e-09 Score=87.66 Aligned_cols=71 Identities=28% Similarity=0.427 Sum_probs=59.6
Q ss_pred CcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 21 DDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNH---SVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 21 ~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~---~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
.+..++++||+.|+. +... +......++.+++.+|.++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 65 ~~~~~~v~e~~~g~~--~~~~--~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 65 DGWSYLLMEWIEGET--LDEV--SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCccEEEEEecCCee--cccC--CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 357899999999887 4432 4455677889999999999985 799999999999999988999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-07 Score=98.26 Aligned_cols=151 Identities=24% Similarity=0.361 Sum_probs=96.1
Q ss_pred HHHHHHHHHH-HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCccc----c----c--CCCCCcccChhhhhhccc
Q psy3880 54 QLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL----M----D--LCGTPGYLAPEVLRANMF 122 (408)
Q Consensus 54 qil~aL~~LH-~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~----~----~--~~gt~~y~aPE~l~~~~~ 122 (408)
++..|+.|+| +.++||++|.|++|.++.++..||+.|+++......... . . ..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence 4558899999 568999999999999999999999999987654432210 0 0 112335677776643
Q ss_pred cCcCCCCcchhhhhhhHHHHHHH-hCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCc
Q psy3880 123 EDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQA 201 (408)
Q Consensus 123 ~~~~~~~~~~DiwSlGvil~~ll-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~ 201 (408)
...+.++|++|+||.+|.+. .|+..+..
T Consensus 184 ---~~~~~~sd~fSlG~li~~i~~~gk~i~~a------------------------------------------------ 212 (700)
T KOG2137|consen 184 ---TTNTPASDVFSLGVLIYTIYNGGKSIIAA------------------------------------------------ 212 (700)
T ss_pred ---ccccccccceeeeeEEEEEecCCcchhhc------------------------------------------------
Confidence 12244555566665555554 23332211
Q ss_pred ccccchhhhHHHhhcCCCCCCCchhHHHHH--HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 202 VDVWACGVIMYTLLVGCPPFWHRKQMVMLR--NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 202 ~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~--~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.+...... .-..+...+... ..++.+.++=|.++|..|+.-||++.+++.-|||
T Consensus 213 ----------------------~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff 268 (700)
T KOG2137|consen 213 ----------------------NGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFF 268 (700)
T ss_pred ----------------------cCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCcccCcchhhhhccccc
Confidence 11000000 000000111111 4688999999999999999999999999999999
Q ss_pred CCC
Q psy3880 280 HPK 282 (408)
Q Consensus 280 ~~~ 282 (408)
++.
T Consensus 269 ~D~ 271 (700)
T KOG2137|consen 269 SDP 271 (700)
T ss_pred CCc
Confidence 865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-08 Score=103.03 Aligned_cols=80 Identities=23% Similarity=0.276 Sum_probs=60.6
Q ss_pred EeccCCcHHHHHHHHHhhchhhHHhhhCCH---HHHHHHHHHHHH-HHHHHHHCCCeeccCCCCcEEEecCCCEEEeccc
Q psy3880 16 VKEEGDDLKHLAAQVVDKGEAAVQDIINSN---PALRYIMRQLFE-ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFG 91 (408)
Q Consensus 16 ~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~---~~~r~i~~qil~-aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFG 91 (408)
++.+..+..+|||||+.|+. |.+..... .....++.+++. .+..+|..|++|+|++|.||+++.++.++++|||
T Consensus 225 v~~~~~~~~vLvmE~i~G~~--L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG 302 (437)
T TIGR01982 225 VYWDRTSERVLTMEWIDGIP--LSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFG 302 (437)
T ss_pred EehhhcCCceEEEEeECCcc--cccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCC
Confidence 44455566799999999987 65543211 122345555555 4788999999999999999999999999999999
Q ss_pred cchhcc
Q psy3880 92 FARVLK 97 (408)
Q Consensus 92 la~~~~ 97 (408)
++..+.
T Consensus 303 ~~~~l~ 308 (437)
T TIGR01982 303 IVGRLS 308 (437)
T ss_pred CeeECC
Confidence 987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.4e-08 Score=90.95 Aligned_cols=72 Identities=15% Similarity=0.239 Sum_probs=56.5
Q ss_pred HHHHHHHHHhhch---hhHHhhhCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 23 LKHLAAQVVDKGE---AAVQDIINSNPALRYIMRQLFEALEHV-HNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 23 ~~~lv~e~~~~g~---~~l~~~~~~~~~~r~i~~qil~aL~~L-H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
..+|||||+.+++ ..|.+...+.+++..++.|++.+|..| |+.||||+||++.|||+. ++.+.|+|||.|..
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 3467888887652 124444445566778889999999999 899999999999999997 46799999997754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-08 Score=89.71 Aligned_cols=75 Identities=20% Similarity=0.305 Sum_probs=56.5
Q ss_pred EEeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCcEEEecCCCEEEec
Q psy3880 15 RVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSV-----VHRDLKPENILLDDQMNVKLTD 89 (408)
Q Consensus 15 ~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~I-----vHRDLKp~NILl~~~~~iKl~D 89 (408)
++...+.+..++|||+++|.. +.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|
T Consensus 57 ~~~~~~~~~~~lv~e~i~G~~--l~~~---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liD 130 (170)
T cd05151 57 KLYYFDPETGVLITEFIEGSE--LLTE---DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLID 130 (170)
T ss_pred ceEEEeCCCCeEEEEecCCCc--cccc---cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEe
Confidence 333333334579999999986 4432 11224567899999999999986 9999999999999 66899999
Q ss_pred cccchh
Q psy3880 90 FGFARV 95 (408)
Q Consensus 90 FGla~~ 95 (408)
||.+..
T Consensus 131 f~~a~~ 136 (170)
T cd05151 131 WEYAGM 136 (170)
T ss_pred cccccC
Confidence 998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-07 Score=88.68 Aligned_cols=88 Identities=25% Similarity=0.499 Sum_probs=78.1
Q ss_pred CCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcC-CCCCccH
Q psy3880 174 EWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW-NDISEDP 252 (408)
Q Consensus 174 ~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~-~~iS~~~ 252 (408)
.+.+++.||+||.+... +|+.++|+||+||++|+|..-.+||.+++-.++.++|.++.++. -| ...|.++
T Consensus 187 S~VGTPyYMSPE~i~~~------~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~---~p~~~YS~~l 257 (375)
T KOG0591|consen 187 SLVGTPYYMSPERIHES------GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP---LPDEHYSTDL 257 (375)
T ss_pred hhcCCCcccCHHHHhcC------CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC---CcHHHhhhHH
Confidence 35677889999999875 68899999999999999999999999999999999999997752 23 4579999
Q ss_pred HHHHHHhcccCCCCCCCH
Q psy3880 253 KDLIRKLLIVTPEDRYSV 270 (408)
Q Consensus 253 ~dLI~klL~~dP~~R~ta 270 (408)
..||..|+.+||+.||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999984
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.7e-06 Score=84.30 Aligned_cols=108 Identities=22% Similarity=0.313 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDA 125 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 125 (408)
+-+..+.+.++.+..-||..|.+-.|+.++|+|+++++.+.|.|-..-..-.++......+|.+.|++||.-.-..+..
T Consensus 117 ~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g- 195 (637)
T COG4248 117 DFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVG- 195 (637)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccc-
Confidence 4567788999999999999999999999999999999999999854322223444455678999999999865443332
Q ss_pred CCCCcchhhhhhhHHHHHHHhC-CCCCCCc
Q psy3880 126 TGYGQAVDVWACGVIMYTLLVG-CPPFWHR 154 (408)
Q Consensus 126 ~~~~~~~DiwSlGvil~~ll~G-~~pf~~~ 154 (408)
..-+...|.+.||+++++++.| ..||.+-
T Consensus 196 ~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 196 FERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2335678999999999999976 8999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-07 Score=81.72 Aligned_cols=98 Identities=19% Similarity=0.325 Sum_probs=72.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh-HHHHHHHHhcCCCCCC---CcCCCCCc--
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MVMLRNIMEGKYSFSS---PEWNDISE-- 250 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~-~~~~~~i~~~~~~f~~---~~~~~iS~-- 250 (408)
....|++||++... .|+.++||||+||++|+|++|.+||..... ...+..+......... +....+++
T Consensus 66 g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 66 VDPYFMAPEVIQGQ------SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred CcccccChHHhcCC------CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 34679999999754 467899999999999999999999976543 2333333332222110 11223444
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
++++||.+||..||.+|||+.|+++|+|+.
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 699999999999999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.8e-07 Score=84.17 Aligned_cols=49 Identities=51% Similarity=1.217 Sum_probs=46.7
Q ss_pred chhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCC
Q psy3880 131 AVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179 (408)
Q Consensus 131 ~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 179 (408)
.+||||+|||+|.|+.|++||++.++..+..+|..|.|.+.+|+|..++
T Consensus 192 pvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 192 PVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred cchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 6899999999999999999999999999999999999999999998764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.2e-07 Score=95.24 Aligned_cols=121 Identities=21% Similarity=0.303 Sum_probs=87.6
Q ss_pred cHHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC-CCEEEeccccchhcc
Q psy3880 22 DLKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ-MNVKLTDFGFARVLK 97 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~-~~iKl~DFGla~~~~ 97 (408)
+..|+-.|||.++..+|...+ ..+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||++..+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 345799999999985555533 2346778889999999999999999999999999999876 788999999886532
Q ss_pred cCcccccCCCCCccc-ChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 98 KGEKLMDLCGTPGYL-APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 98 ~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
... ......-++. ..|++.. ...+..++|++|+|..+.+.+++..
T Consensus 419 ~~~--~~~~~~~r~~p~~~~~~e-----~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FSS--GVFHHIDRLYPIAEILLE-----DYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred eec--ccccccccccccchhhcc-----ccccccccccccccccccccccCcc
Confidence 211 1112222334 3555543 2456778888998888877777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.3e-07 Score=82.69 Aligned_cols=75 Identities=20% Similarity=0.372 Sum_probs=60.8
Q ss_pred EeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 16 VKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 16 ~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
+++.+.+...|+|||+.|-. |.|.+.+. .-.+++.+-.-+.-||..||||.||.++||++.... +.++|||++..
T Consensus 66 v~dvD~~~~~I~me~I~G~~--lkd~l~~~--~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 66 VYDVDPDNGLIVMEYIEGEL--LKDALEEA--RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEcCCCCEEEEEEeCChh--HHHHHHhc--chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 45556667789999998877 77777655 245667777778899999999999999999998655 89999999875
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.9e-07 Score=86.39 Aligned_cols=82 Identities=29% Similarity=0.444 Sum_probs=58.6
Q ss_pred CCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCC-CCccH
Q psy3880 174 EWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND-ISEDP 252 (408)
Q Consensus 174 ~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~-iS~~~ 252 (408)
++..+..|.|||++..- ..|++++||||+|||+.+||+|+|-|-+.+....+..|+.--...+...... -|+.+
T Consensus 186 eYVaTRWYRAPElll~~-----~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 186 EYVATRWYRAPELLLNS-----SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred cceeeeeecCHHHHhcc-----ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34456669999998543 4699999999999999999999999999998888888776543332221222 23456
Q ss_pred HHHHHHhc
Q psy3880 253 KDLIRKLL 260 (408)
Q Consensus 253 ~dLI~klL 260 (408)
+..|+.+=
T Consensus 261 r~yi~slp 268 (359)
T KOG0660|consen 261 RPYIKSLP 268 (359)
T ss_pred HHHHHhCC
Confidence 66666543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.21 E-value=4e-07 Score=94.92 Aligned_cols=75 Identities=19% Similarity=0.254 Sum_probs=55.6
Q ss_pred EEeccCCcHHHHHHHHHhhchhhHHhh--hCC---------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 15 RVKEEGDDLKHLAAQVVDKGEAAVQDI--INS---------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 15 ~~~~~~~~~~~lv~e~~~~g~~~l~~~--~~~---------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
.++.+..+..+|||||+.|+. +.+. +.. +..+..++.|+ ...|++|+|+||.||+++.++
T Consensus 227 ~v~~d~st~~VLvmE~i~G~~--l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g 297 (537)
T PRK04750 227 EVYWDYCSETVMVMERMYGIP--VSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDP 297 (537)
T ss_pred eeecccCCCceEEEeeecCcc--HHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCC
Confidence 355566677899999999998 5542 211 12344445554 469999999999999999887
Q ss_pred ----CEEEeccccchhccc
Q psy3880 84 ----NVKLTDFGFARVLKK 98 (408)
Q Consensus 84 ----~iKl~DFGla~~~~~ 98 (408)
.++++|||++..+..
T Consensus 298 ~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 298 PENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCCCeEEEEecceEEECCH
Confidence 899999999876654
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-06 Score=88.19 Aligned_cols=64 Identities=33% Similarity=0.526 Sum_probs=53.8
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 246 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~ 246 (408)
+..|.+||.|.+. +.||.++|+||+||||.+|+.|+|.|.+++..+.++.|-+---......|.
T Consensus 282 TLWYRpPELLLG~-----t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 282 TLWYRPPELLLGA-----TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred EeeccChHHhcCC-----cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 4559999999874 679999999999999999999999999999999888886644444455676
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.5e-06 Score=83.08 Aligned_cols=25 Identities=40% Similarity=0.803 Sum_probs=20.8
Q ss_pred hHHHHHHHHhccccCCCCCCccCCC
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISG 180 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~ 180 (408)
+..++..|.+|+|.|...+|..++.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~ 335 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISS 335 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhH
Confidence 5677888999999999999987753
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-06 Score=89.48 Aligned_cols=50 Identities=36% Similarity=0.586 Sum_probs=45.3
Q ss_pred CCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 181 ~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
|.|||++.+- +|+.++||||+|||+++|.+|.|-|-+.+..+.+..|++-
T Consensus 354 YRAPEVILGl------pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 354 YRAPEVILGL------PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred cccchhhccC------CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 8999999874 6888999999999999999999999999998888888764
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.7e-06 Score=80.47 Aligned_cols=42 Identities=43% Similarity=0.942 Sum_probs=39.6
Q ss_pred cchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 130 QAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 130 ~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
+++|+|||||++|||+.|.+||.+.+...+..+|++|++.|.
T Consensus 220 kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP 261 (355)
T KOG0616|consen 220 KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP 261 (355)
T ss_pred cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC
Confidence 479999999999999999999999999999999999998765
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-06 Score=81.42 Aligned_cols=68 Identities=31% Similarity=0.415 Sum_probs=55.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 249 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS 249 (408)
.+..|.+||.|.+. ..|+.++||||+|||+.+++.+.|-|.+.+..+.+..|..---......|+.++
T Consensus 239 VTLWYRaPELLLG~-----~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 239 VTLWYRAPELLLGA-----KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred EEeeecCHHHhcCC-----cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 35569999999864 569999999999999999999999999999888888877654444455677665
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.1e-06 Score=78.25 Aligned_cols=68 Identities=29% Similarity=0.508 Sum_probs=57.1
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 249 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS 249 (408)
-+..|.|||.+.+. ..||..+||||.|||+.+|+-|.|=|-+.+..+.+..|...--......|++++
T Consensus 163 ~TRWYRAPELLfGs-----r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 163 VTRWYRAPELLFGS-----RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred eeeeccChHHhccc-----hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 34569999998764 569999999999999999999999999999988888887766666667788765
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.9e-06 Score=87.56 Aligned_cols=55 Identities=24% Similarity=0.419 Sum_probs=44.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
..+..|++||++... .|+.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 306 ~gt~~Y~APE~~~~~------~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 306 VSTRHYRSPEVVLGL------GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred cCCccccCcHHhhcC------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 345679999998653 4788999999999999999999999887776666655544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-06 Score=79.63 Aligned_cols=70 Identities=24% Similarity=0.440 Sum_probs=56.9
Q ss_pred HHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC---CEEEeccccchh
Q psy3880 25 HLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM---NVKLTDFGFARV 95 (408)
Q Consensus 25 ~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~---~iKl~DFGla~~ 95 (408)
+||+|.++|-. .|.+.+.. ....+.++.++...+.-||++||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 93 ~lite~l~~~~-~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 93 YLITEALPGAQ-DLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEEEeCCCcc-cHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 57777777642 25555543 567789999999999999999999999999999999876 799999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.3e-06 Score=81.11 Aligned_cols=101 Identities=33% Similarity=0.547 Sum_probs=71.2
Q ss_pred HCCCeeccCCCCcEE-EecCCCEEEec--cccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 64 NHSVVHRDLKPENIL-LDDQMNVKLTD--FGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 64 ~~~IvHRDLKp~NIL-l~~~~~iKl~D--FGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
=.++...+-.+.-+| +.+-|-.|..+ -++- ......+...|.-+-||-.. +.+|+||+||+
T Consensus 189 pENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~-----TPc~TPyYvaPevlg~eKyd-----------kscdmwSlgVi 252 (400)
T KOG0604|consen 189 PENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM-----TPCFTPYYVAPEVLGPEKYD-----------KSCDMWSLGVI 252 (400)
T ss_pred hhheeeecCCCCcceEecccccccccCCCcccc-----CCcccccccCHHHhCchhcC-----------CCCCccchhHH
Confidence 356676666655444 34556677665 2221 11233344455666777644 47899999999
Q ss_pred HHHHHhCCCCCCCchh----HHHHHHHHhccccCCCCCCccCCC
Q psy3880 141 MYTLLVGCPPFWHRKQ----MVMLRNIMEGKYSFSSPEWNDISG 180 (408)
Q Consensus 141 l~~ll~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 180 (408)
+|.|++|.+||++... ..+-.+|..|.|.|..|+|..+++
T Consensus 253 mYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 253 MYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred HHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 9999999999998763 568889999999999999987753
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.9e-06 Score=85.97 Aligned_cols=132 Identities=15% Similarity=0.265 Sum_probs=91.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEecCC
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NILl~~~~ 83 (408)
+|-||+++..+.- +.++..|||+|-+.-=+..| +.+ ....+..-++||+.||.||| +.+++|.+|--..+.++..|
T Consensus 65 tlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~l-k~l-~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G 142 (690)
T KOG1243|consen 65 TLRHPNILSYLDTTEEEGTLYLVTERVRPLETVL-KEL-GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG 142 (690)
T ss_pred hccCchhhhhhhhhcccCceEEEeeccccHHHHH-HHh-HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC
Confidence 5789987744443 44567899988775422112 111 24678888999999999997 78899999999999999999
Q ss_pred CEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 84 NVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 84 ~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
..||.+|-++........ .....---.|..|+.+..+ .-..|.|-|||++++++.|
T Consensus 143 eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s--------~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS--------EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc--------ccchhhhhHHHHHHHHhCc
Confidence 999999977643322111 1111112246667654321 2357999999999999999
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.1e-06 Score=78.48 Aligned_cols=54 Identities=30% Similarity=0.473 Sum_probs=44.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
....|++||.+... .|+.++|+||+||++|+|++|.+||.+.+..+.+..|...
T Consensus 171 ~~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 171 VTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred ccccccChHHHhCC------CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 45569999998643 4677999999999999999999999988877777666654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.1e-06 Score=79.87 Aligned_cols=58 Identities=33% Similarity=0.645 Sum_probs=44.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.+...|++||++.... .....|+.++|+||+||++|+|++|.+||...+..+.+..+.
T Consensus 164 ~gt~~y~aPE~~~~~~-~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 164 VGTPDYISPEILQAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred ccCccccCHHHHhccc-cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 3566799999986421 112357889999999999999999999998777666555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.8e-06 Score=78.56 Aligned_cols=56 Identities=36% Similarity=0.547 Sum_probs=47.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
..+..|.|||.+.+. ++||.++||||+||++.+|++|.|-|-+++..+.+..|...
T Consensus 162 VATRWYRaPELLvGD-----tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 162 VATRWYRAPELLVGD-----TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT 217 (396)
T ss_pred hhhhhccChhhhccc-----CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence 345679999999874 57999999999999999999999999999888777666553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.1e-05 Score=77.56 Aligned_cols=49 Identities=18% Similarity=0.410 Sum_probs=38.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
+...|++||++.... ..|+.++|+||+||++|+|++|..||.+.+..++
T Consensus 182 ~~~~y~aPE~~~~~~----~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 182 NFMVYFSYKMLNDIF----SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred CcccccCHHHhhhcc----ccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 345699999986521 3578899999999999999999999976554433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.3e-06 Score=85.82 Aligned_cols=55 Identities=27% Similarity=0.500 Sum_probs=43.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|+|||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+..
T Consensus 231 ~~t~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 231 ICSRFYRAPELMLGA-----TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred CCCcCccCHHHhcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 345669999997542 3578899999999999999999999998877666655543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.2e-05 Score=74.09 Aligned_cols=70 Identities=14% Similarity=0.252 Sum_probs=55.7
Q ss_pred HHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec-------CCCEEEec
Q psy3880 24 KHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD-------QMNVKLTD 89 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~-------~~~iKl~D 89 (408)
.+||+|++.+- .+|.+.+. +....+.++.++...+.-||+.||+|+|+++.|||++. +..+.++|
T Consensus 110 s~LVte~l~~~-~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 110 SFIITEDLAPT-ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eEEEEeeCCCC-ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 46888888764 12544442 22467789999999999999999999999999999975 45789999
Q ss_pred cccch
Q psy3880 90 FGFAR 94 (408)
Q Consensus 90 FGla~ 94 (408)
|+.++
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99775
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.8e-06 Score=78.90 Aligned_cols=64 Identities=27% Similarity=0.447 Sum_probs=46.9
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 246 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~ 246 (408)
...|++||.+... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+...........|+
T Consensus 166 ~~~y~aPE~~~~~-----~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 166 TLWYRPPDVLLGS-----TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred cccccChHHhcCC-----cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 4569999988542 346789999999999999999999998877766666655443333333343
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.4e-06 Score=85.57 Aligned_cols=51 Identities=31% Similarity=0.781 Sum_probs=46.3
Q ss_pred cchhhhhhhHHHHHHHhCCCCCCCchhHH-HHHHHHhccccCCCCCCccCCC
Q psy3880 130 QAVDVWACGVIMYTLLVGCPPFWHRKQMV-MLRNIMEGKYSFSSPEWNDISG 180 (408)
Q Consensus 130 ~~~DiwSlGvil~~ll~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 180 (408)
.++|+||+||++|.+++|.+||.+..... +..+|..|+|.|.++.|..++.
T Consensus 360 ~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 360 SKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred chheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 58999999999999999999999988666 8899999999999999987753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.4e-06 Score=76.42 Aligned_cols=71 Identities=25% Similarity=0.396 Sum_probs=48.0
Q ss_pred HHHHHHHHh--hch-hhHHhhhCCHHHHHHHHHHHHHHHHH-HHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 24 KHLAAQVVD--KGE-AAVQDIINSNPALRYIMRQLFEALEH-VHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 24 ~~lv~e~~~--~g~-~~l~~~~~~~~~~r~i~~qil~aL~~-LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
..|||||+. |.. ..|.+...+.++...++.+++..+.. +|+.||||+||.+.|||++++ .+.++|||.|..
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 358999998 543 11222221235677888899886665 579999999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.3e-05 Score=77.87 Aligned_cols=37 Identities=35% Similarity=0.849 Sum_probs=34.9
Q ss_pred hhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q psy3880 133 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 169 (408)
Q Consensus 133 DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~ 169 (408)
|+||+||++|+|++|.+||.+.+...+.++|..++..
T Consensus 207 DWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 207 DWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP 243 (357)
T ss_pred chHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC
Confidence 8999999999999999999999999999999998833
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.1e-05 Score=81.88 Aligned_cols=42 Identities=33% Similarity=0.784 Sum_probs=39.1
Q ss_pred chhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCC
Q psy3880 131 AVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 172 (408)
Q Consensus 131 ~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~ 172 (408)
.+|+|+||||+|.|+.|.+||.+.++-..+++|+...|.|..
T Consensus 267 ~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 267 SSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred ccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 689999999999999999999999999999999998887653
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.2e-05 Score=78.00 Aligned_cols=56 Identities=32% Similarity=0.482 Sum_probs=46.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
....-|.|||.+.+ ++.|+.++|+||+||++++|+-|.|=|.+++....+..|.+-
T Consensus 186 icSRyYRaPELifg-----a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 186 ICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred EEeccccCHHHHcC-----ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 34445999999875 467999999999999999999999999999887777776653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.5e-05 Score=76.00 Aligned_cols=51 Identities=31% Similarity=0.501 Sum_probs=41.0
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
...|++||++... .|+.++|+||+||++|+|++|.+||.+......+..+.
T Consensus 170 ~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 170 TLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred cccccCchHhhCC------CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 4569999998643 46789999999999999999999998776655555444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.6e-05 Score=79.90 Aligned_cols=55 Identities=22% Similarity=0.420 Sum_probs=46.9
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+++.||.||.+.+. +|+.++||||+||++|+|++-+++|.+.+...+..+|..
T Consensus 166 vvGTp~YmcPEil~d~------pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~ 220 (426)
T KOG0589|consen 166 VVGTPYYMCPEILSDI------PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR 220 (426)
T ss_pred ecCCCcccCHHHhCCC------CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence 4577889999999774 688999999999999999999999988877776666654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.3e-05 Score=79.68 Aligned_cols=55 Identities=29% Similarity=0.469 Sum_probs=45.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.+.+.......+...
T Consensus 186 ~~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 186 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cccCCcCCHHHHhCC------CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 345679999998653 4678999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=97.81 E-value=1.7e-05 Score=75.63 Aligned_cols=52 Identities=35% Similarity=0.525 Sum_probs=40.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+...|++||++... .|+.++|+||+||++|+|++|.+||.+.+....+..+.
T Consensus 163 ~~~~y~aPE~~~~~------~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 163 ATRWYRSPELLLGA------PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred cccccCCcHHHcCC------CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45569999998643 46779999999999999999999998776555444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=97.80 E-value=1.6e-05 Score=82.52 Aligned_cols=40 Identities=38% Similarity=0.801 Sum_probs=37.5
Q ss_pred hhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 132 VDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 132 ~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
+||||||||+|.||+|+.||.+.+-..++.++..|.|...
T Consensus 193 sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 193 SDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred cccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence 4999999999999999999999999999999999998654
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.1e-05 Score=78.21 Aligned_cols=63 Identities=25% Similarity=0.467 Sum_probs=51.7
Q ss_pred CCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 173 PEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 173 ~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
..+.++..||+||++. ++..+|+.++||||+|+...+|.+|..||..-.++.++..-+++.+.
T Consensus 188 ~tfvgtp~wmAPEvl~----q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 188 NTFVGTPCWMAPEVLM----QQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred ccccCcccccChHHhh----hcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 4566778899999984 45679999999999999999999999999988777766555555443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=3.4e-05 Score=77.92 Aligned_cols=44 Identities=27% Similarity=0.734 Sum_probs=36.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+.++..|++||++... .|+.++|+||+||++|+|++|.+||+..
T Consensus 243 ~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 243 WAGTIATNAPELLARD------PYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccCccCCCChhhhcCC------CCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 3456779999998643 4788999999999999999999988754
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=97.78 E-value=1.1e-05 Score=77.56 Aligned_cols=43 Identities=42% Similarity=0.884 Sum_probs=38.4
Q ss_pred CCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 174 EWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 174 ~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
.+.+++.|++||++++. .||..+|+|++||+|++|..|+.||.
T Consensus 410 tfcgtpnyiapeilrge------eygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGE------EYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cccCCCcccchhhhccc------ccCceehHHHHHHHHHHHHcCCCCcc
Confidence 35677789999999975 58999999999999999999999994
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=97.78 E-value=1.7e-05 Score=78.59 Aligned_cols=54 Identities=30% Similarity=0.429 Sum_probs=43.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.+.........+..
T Consensus 179 ~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 179 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred cccCCccCHHHHcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 345679999998653 467899999999999999999999998876665555544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG2384|consensus | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.4e-05 Score=69.26 Aligned_cols=44 Identities=25% Similarity=0.728 Sum_probs=39.8
Q ss_pred ccccccccccccchhHHHHHhcCCCCCCCCCCCCCCcccccccc
Q psy3880 364 LSDYKEFKLKEDNVGFKMLQKLGWQEGSGLGTDGGGIQEPVNKI 407 (408)
Q Consensus 364 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (408)
-.-+..+.|+..|+|||.|-+-||+++.|||.+++|-+.||+.+
T Consensus 117 a~k~~p~~i~pks~GyrLl~~~GW~pe~GLGp~~~Grr~PvrTv 160 (223)
T KOG2384|consen 117 ANKFQPHLIKPKSLGYRLLSQYGWSPEAGLGPENQGRRAPVRTV 160 (223)
T ss_pred CCCCCCCcCCCCCchHHHHHhcCCCcccCCCccccCcccchhHH
Confidence 34466889999999999999999999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.2e-05 Score=76.02 Aligned_cols=56 Identities=32% Similarity=0.613 Sum_probs=41.8
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
+...|++||++....- ....++.++|+||+||++|+|++|..||...+..+....+
T Consensus 165 gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 165 GTPDYISPEILQAMED-GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred ccccccCHHHHhhccc-cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 4567999999864211 1234678999999999999999999999876655554443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=97.76 E-value=2.4e-05 Score=79.84 Aligned_cols=52 Identities=29% Similarity=0.633 Sum_probs=43.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.++..|||||++..+ .||.++||||||+..-+|+-|.|||..+++..-+..|
T Consensus 430 VGTPYWMAPEVvtrk------~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRK------PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred cCCCCccchhhhhhc------ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 467779999999765 5899999999999999999999999987765544444
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=97.76 E-value=3.6e-05 Score=74.50 Aligned_cols=67 Identities=28% Similarity=0.449 Sum_probs=54.0
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 249 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS 249 (408)
+..|.+||+|.+. ..|+..+||||+|||+++|.++.+=|.+.+..+.+..|-+---......|+.++
T Consensus 183 TlWYRaPEvLlGs-----~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 183 TLWYRAPEVLLGS-----TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred EeeccCHHHhcCC-----CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 3449999998764 358999999999999999999999999999888888877655455556676654
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=97.73 E-value=2.9e-05 Score=84.85 Aligned_cols=51 Identities=37% Similarity=0.689 Sum_probs=44.8
Q ss_pred CCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccC
Q psy3880 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDI 178 (408)
Q Consensus 128 ~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 178 (408)
||..||+||+||++|||+.|..||+..+-.+...+|+.-+-++..|.-.++
T Consensus 258 yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 258 YGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred cCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 788999999999999999999999999999999999998777766644343
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=97.71 E-value=1.5e-05 Score=78.96 Aligned_cols=129 Identities=21% Similarity=0.218 Sum_probs=76.5
Q ss_pred HHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchh
Q psy3880 56 FEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVD 133 (408)
Q Consensus 56 l~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~D 133 (408)
+-.+-.-|.-|.+|..||+.|++-.....+.+.++..+..+...+ ...+.-++.....-+ ..+-
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~--------------g~vk 151 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES--------------GDVK 151 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc--------------CcEE
Confidence 344445567899999999999984445567777776554332211 111111111111100 1223
Q ss_pred hhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHH
Q psy3880 134 VWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 213 (408)
Q Consensus 134 iwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ 213 (408)
+|-|||-.---.+ ......+.++.-|||||++.. .+|+.++||||||++.++
T Consensus 152 l~DfgVa~ql~~~----------------------~~rr~tfvGTPfwMAPEVI~~------~~Y~~KADIWSLGITaiE 203 (467)
T KOG0201|consen 152 LADFGVAGQLTNT----------------------VKRRKTFVGTPFWMAPEVIKQ------SGYDTKADIWSLGITAIE 203 (467)
T ss_pred EEecceeeeeech----------------------hhccccccccccccchhhhcc------ccccchhhhhhhhHHHHH
Confidence 3444442110000 001123456677999999974 478999999999999999
Q ss_pred hhcCCCCCCCchh
Q psy3880 214 LLVGCPPFWHRKQ 226 (408)
Q Consensus 214 ll~g~~Pf~~~~~ 226 (408)
|+.|.||+....+
T Consensus 204 la~GePP~s~~hP 216 (467)
T KOG0201|consen 204 LAKGEPPHSKLHP 216 (467)
T ss_pred HhcCCCCCcccCc
Confidence 9999999976554
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00013 Score=65.21 Aligned_cols=50 Identities=32% Similarity=0.545 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC---CEEEeccccchh
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM---NVKLTDFGFARV 95 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~---~iKl~DFGla~~ 95 (408)
+....+++.|-+.+.-||.++|||.||..+||++..++ .+.++|||++..
T Consensus 113 ~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 113 EGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 33478899999999999999999999999999997655 358999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=3.4e-05 Score=75.96 Aligned_cols=54 Identities=37% Similarity=0.543 Sum_probs=42.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+..
T Consensus 177 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 177 ATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred ccccccCchHhcCC-----ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 45669999998642 2477899999999999999999999988776666655544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.9e-05 Score=77.57 Aligned_cols=53 Identities=32% Similarity=0.466 Sum_probs=43.3
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
...|++||.+... ..|+.++|+||+||++|+|++|.+||.+.+....+..|..
T Consensus 167 ~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 167 TQYYRAPEILMGS-----RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred CCCcCCHHHHcCC-----CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 4569999998642 2367789999999999999999999998887776666654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.9e-05 Score=76.24 Aligned_cols=49 Identities=22% Similarity=0.445 Sum_probs=39.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.....|++||.+... .|+.++|+||+||++|+|++|..||......++.
T Consensus 163 ~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 163 VGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred CCCcCcCCHhHhcCC------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 345679999998643 4677999999999999999999999776655443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.5e-05 Score=77.49 Aligned_cols=53 Identities=32% Similarity=0.534 Sum_probs=42.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....|++||++... .|+.++|+||+||++|+|++|.+||.+.+.......+.+
T Consensus 184 ~t~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 184 VTRYYRAPEVILGM------GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred ccCCCCCchhccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 34569999998653 467799999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=97.68 E-value=4e-05 Score=75.63 Aligned_cols=38 Identities=37% Similarity=0.744 Sum_probs=35.2
Q ss_pred hhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 134 VWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 134 iwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
+||+||++|||+.|++||.++++.++++.|++...+|.
T Consensus 533 WWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 533 WWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP 570 (683)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc
Confidence 79999999999999999999999999999998876653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=97.66 E-value=3.5e-05 Score=73.05 Aligned_cols=42 Identities=21% Similarity=0.628 Sum_probs=34.9
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
..|++||.+... .++.++|+||+||++|+|++ |..||.....
T Consensus 188 ~~y~aPE~~~~~------~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 188 IRWMPPESIMYR------KFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ceecChhhhccC------CcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 459999988653 46778999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 408 | ||||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-51 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-34 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-48 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-33 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-48 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-33 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-48 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-33 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-23 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-28 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-28 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-28 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-28 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-28 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-28 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-26 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-26 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-26 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-26 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-25 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-25 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-23 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-23 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-23 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-23 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-23 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-23 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-23 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-23 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-23 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-23 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-23 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-23 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-22 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-22 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-22 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-16 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 |
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-74
Identities = 83/131 (63%), Positives = 101/131 (77%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R IMR L E + +H ++VHRDLKPENILLDD MN+KLTDFGF+ L GEKL ++CGT
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P YLAPE++ +M ++ GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM G Y
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 169 SFSSPEWNDIS 179
F SPEW+D S
Sbjct: 247 QFGSPEWDDYS 257
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-50
Identities = 58/108 (53%), Positives = 78/108 (72%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
YLAPE++ +M ++ GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM G Y
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287
F SPEW+D S+ KDL+ + L+V P+ RY+ +EAL H FF + ++
Sbjct: 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-73
Identities = 85/131 (64%), Positives = 108/131 (82%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R IMR L EA+ +H +++VHRDLKPENILLDD M ++L+DFGF+ L+ GEKL +LCGT
Sbjct: 203 RSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGT 262
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
PGYLAPE+L+ +M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322
Query: 169 SFSSPEWNDIS 179
FSSPEW+D S
Sbjct: 323 QFSSPEWDDRS 333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 62/100 (62%), Positives = 78/100 (78%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GYLAPE+L+ +M E GYG+ VD+WACGVI++TLL G PPFWHR+Q++MLR IMEG+Y
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
FSSPEW+D S KDLI +LL V PE R + ++AL H FF
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 9e-65
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 85/300 (28%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+ MRQ+ EAL + H+++++HRD+KP +LL ++ VKL FG
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV------------- 179
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
A+ + G++ VG P
Sbjct: 180 -------------------------AIQLGESGLVAGGR-VGTP---------------- 197
Query: 166 GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225
++APEV++ YG+ VDVW CGVI++ LL GC PF+ K
Sbjct: 198 --------------HFMAPEVVKRE------PYGKPVDVWGCGVILFILLSGCLPFYGTK 237
Query: 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285
+ + I++GKY + +W+ ISE KDL+R++L++ P +R +V EALNH + +
Sbjct: 238 ER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK----E 292
Query: 286 QDIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDDPY 345
+D K +L K N + + +L ++ + + + P + +DP
Sbjct: 293 RDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGD--PPEELPDFSEDPT 350
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-64
Identities = 57/134 (42%), Positives = 82/134 (61%), Gaps = 9/134 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN---VKLTDFGFARVLKKGEKLMDL 105
+ ++Q+ E++ + H++ +VHR+LKPEN+LL + VKL DFG A + E
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTPGYL+PEVL+ + Y + VD+WACGVI+Y LLVG PPFW Q + I
Sbjct: 168 AGTPGYLSPEVLKKD------PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
Query: 166 GKYSFSSPEWNDIS 179
G Y + SPEW+ ++
Sbjct: 222 GAYDYPSPEWDTVT 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 42/100 (42%), Positives = 59/100 (59%), Gaps = 6/100 (6%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GYL+PEVL+ + Y + VD+WACGVI+Y LLVG PPFW Q + I G Y
Sbjct: 172 GYLSPEVLKKD------PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ SPEW+ ++ + K LI +L V P+ R + +AL +
Sbjct: 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-63
Identities = 57/134 (42%), Positives = 81/134 (60%), Gaps = 9/134 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+ ++Q+ E++ + H++ +VHR+LKPEN+LL VKL DFG A + E
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTPGYL+PEVL+ + Y + VD+WACGVI+Y LLVG PPFW Q + I
Sbjct: 191 AGTPGYLSPEVLKKD------PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
Query: 166 GKYSFSSPEWNDIS 179
G Y + SPEW+ ++
Sbjct: 245 GAYDYPSPEWDTVT 258
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 55/135 (40%), Positives = 84/135 (62%), Gaps = 7/135 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+ Q+ A++++H + ++HRDLKPEN+LL ++ +K+TDFG +++L + + L
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIM 164
CGTP YLAPEVL + GY +AVD W+ GVI++ L G PPF HR Q+ + I
Sbjct: 177 CGTPTYLAPEVLVSV---GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 165 EGKYSFSSPEWNDIS 179
GKY+F W ++S
Sbjct: 234 SGKYNFIPEVWAEVS 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-61
Identities = 50/139 (35%), Positives = 76/139 (54%), Gaps = 14/139 (10%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLK-KGEKLM 103
++ + + +E++H VVHRDLKP NIL + ++++ DFGFA+ L+ + LM
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVML 160
C T ++APEVL GY A D+W+ GV++YT+L G PF + +L
Sbjct: 179 TPCYTANFVAPEVLERQ------GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 161 RNIMEGKYSFSSPEWNDIS 179
I GK+S S WN +S
Sbjct: 233 ARIGSGKFSLSGGYWNSVS 251
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 21/147 (14%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIMEG 236
++APEVL GY A D+W+ GV++YT+L G PF + +L I G
Sbjct: 185 NFVAPEVLERQ------GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYK 296
K+S S WN +S+ KDL+ K+L V P R + L H + I +
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW------------IVHWDQ 286
Query: 297 TASRKLSKINQLTEFQFIILVVRAAVR 323
+L++ + + + +A+
Sbjct: 287 LPQYQLNRQDAPHLVKGAMAATYSALN 313
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 7e-61
Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 9/134 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+++Q+ E + ++H +++VH DLKP+NILL ++K+ DFG +R + +L ++
Sbjct: 134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI 193
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP YLAPE+L + A D+W G+I Y LL PF NI +
Sbjct: 194 MGTPEYLAPEILNYD------PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 166 GKYSFSSPEWNDIS 179
+S ++ +S
Sbjct: 248 VNVDYSEETFSSVS 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-44
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 6/129 (4%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
YLAPE+L + A D+W G+I Y LL PF NI +
Sbjct: 198 EYLAPEILNYD------PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
+S ++ +S+ D I+ LL+ PE R + + L+HS+ F+ P + + +
Sbjct: 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311
Query: 300 RKLSKINQL 308
+ S +
Sbjct: 312 QDHSVRSSE 320
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-60
Identities = 55/134 (41%), Positives = 83/134 (61%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
I++Q+F + ++H H++VHRDLKPENILL + ++K+ DFG + ++ K+ D
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEVLR Y + DVW+ GVI+Y LL G PPF+ + + +L+ +
Sbjct: 184 IGTAYYIAPEVLRGT-------YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 166 GKYSFSSPEWNDIS 179
GKY+F P+W IS
Sbjct: 237 GKYAFDLPQWRTIS 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 42/97 (43%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVLR Y + DVW+ GVI+Y LL G PPF+ + + +L+ + GKY+
Sbjct: 188 YYIAPEVLRGT-------YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
F P+W IS+D KDLIRK+L P R + + L H
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-59
Identities = 55/135 (40%), Positives = 84/135 (62%), Gaps = 7/135 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+ Q+ A++++H + ++HRDLKPEN+LL ++ +K+TDFG +++L + + L
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIM 164
CGTP YLAPEVL + GY +AVD W+ GVI++ L G PPF HR Q+ + I
Sbjct: 302 CGTPTYLAPEVLVSVGTA---GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
Query: 165 EGKYSFSSPEWNDIS 179
GKY+F W ++S
Sbjct: 359 SGKYNFIPEVWAEVS 373
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 44/113 (38%), Positives = 66/113 (58%), Gaps = 4/113 (3%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIMEGKY 238
YLAPEVL + GY +AVD W+ GVI++ L G PPF HR Q+ + I GKY
Sbjct: 306 TYLAPEVLVSVGTA---GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
+F W ++SE DL++KLL+V P+ R++ +EAL H + + + + +
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-59
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMD 104
++Q+ + + ++H + H DLKPENI+L ++KL DFG A ++ G + +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
+ GTP ++APE++ G D+W+ GVI Y LL G PF + L NI
Sbjct: 178 IFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 165 EGKYSFSSPEWNDIS 179
Y F ++ S
Sbjct: 232 AVSYDFDEEFFSQTS 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 11/186 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE++ G D+W+ GVI Y LL G PF + L NI Y
Sbjct: 183 EFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F ++ SE KD IRKLL+ R +++EAL H + D ++++
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI--TPVDTQQAMVRRESVVNL 294
Query: 300 RKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPALSVTQGRDDPYGVKILRQYNALKEG 359
K ++ +V ++R V + R+ + + A ++
Sbjct: 295 ENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTE---ENIARRKA 351
Query: 360 REPDLS 365
P
Sbjct: 352 LHPRRR 357
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-59
Identities = 62/135 (45%), Positives = 83/135 (61%), Gaps = 10/135 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLM-D 104
+ ++Q+ EA+ H H VVHR+LKPEN+LL VKL DFG A ++ ++
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
GTPGYL+PEVLR + YG+ VD+WACGVI+Y LLVG PPFW Q + + I
Sbjct: 173 FAGTPGYLSPEVLRKD------PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226
Query: 165 EGKYSFSSPEWNDIS 179
G Y F SPEW+ ++
Sbjct: 227 AGAYDFPSPEWDTVT 241
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-59
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMD 104
++Q+ + + ++H + H DLKPENI+L ++KL DFG A ++ G + +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
+ GTP ++APE++ G D+W+ GVI Y LL G PF + L NI
Sbjct: 178 IFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 165 EGKYSFSSPEWNDIS 179
Y F ++ S
Sbjct: 232 SVSYDFDEEFFSHTS 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 8/147 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE++ G D+W+ GVI Y LL G PF + L NI Y
Sbjct: 183 EFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F ++ SE KD IRKLL+ R +++EAL H + D ++++
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI--TPVDNQQAMVRRESVVNL 294
Query: 300 RKLSKINQLTEFQFIILVVRAAVRISR 326
K ++ +V ++R
Sbjct: 295 ENFRKQYVRRRWKLSFSIVSLCNHLTR 321
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 7e-59
Identities = 55/142 (38%), Positives = 82/142 (57%), Gaps = 17/142 (11%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLK-KGEKLMD 104
YIMR+L A+ H+H+ VVHRDLKPEN+L +D + +K+ DFGFAR+ + L
Sbjct: 109 SYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV------ 158
C T Y APE+L N GY ++ D+W+ GVI+YT+L G PF + +
Sbjct: 169 PCFTLHYAAPELLNQN------GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 159 -MLRNIMEGKYSFSSPEWNDIS 179
+++ I +G +SF W ++S
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVS 244
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 27/158 (17%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-------MLRN 232
Y APE+L N GY ++ D+W+ GVI+YT+L G PF + + +++
Sbjct: 174 HYAAPELLNQN------GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK 227
Query: 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIK 292
I +G +SF W ++S++ KDLI+ LL V P R + + + ++
Sbjct: 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW------------LQ 275
Query: 293 KDYKTASRKLSKINQLTEFQFIILV-VRAAVR-ISRLK 328
+ +S L + L + V+A ++ K
Sbjct: 276 DGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYK 313
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 49/134 (36%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
IM+ + A+ + H +V HRDLKPEN L +KL DFG A K G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GTP Y++P+VL YG D W+ GV+MY LL G PPF ++ I E
Sbjct: 169 VGTPYYVSPQVLEGL-------YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
Query: 166 GKYSFSSPEWNDIS 179
G ++F +W ++S
Sbjct: 222 GTFTFPEKDWLNVS 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y++P+VL YG D W+ GV+MY LL G PPF ++ I EG ++
Sbjct: 173 YYVSPQVLEGL-------YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDI 288
F +W ++S + LIR+LL +P+ R + +AL H +F +L
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMD 104
++Q+ + + ++H+ + H DLKPENI+L +KL DFG A ++ G + +
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
+ GTP ++APE++ G D+W+ GVI Y LL G PF + L NI
Sbjct: 171 IFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 165 EGKYSFSSPEWNDIS 179
Y F +++ S
Sbjct: 225 AVNYDFDEEYFSNTS 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE++ G D+W+ GVI Y LL G PF + L NI Y
Sbjct: 176 EFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
F +++ SE KD IR+LL+ P+ R ++ ++L H
Sbjct: 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 27/157 (17%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGE----- 100
+++ + AL+ +HN + HRDLKPENIL + VK+ DF +K
Sbjct: 114 SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 101 ---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-- 155
+L+ CG+ Y+APEV+ A E+A+ Y + D+W+ GVI+Y LL G PPF R
Sbjct: 174 STPELLTPCGSAEYMAPEVVEA-FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232
Query: 156 -------------QMVMLRNIMEGKYSFSSPEWNDIS 179
Q ++ +I EGKY F +W IS
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHIS 269
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 43/115 (37%), Positives = 59/115 (51%), Gaps = 16/115 (13%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-------------- 225
Y+APEV+ A E+A+ Y + D+W+ GVI+Y LL G PPF R
Sbjct: 186 EYMAPEVVEA-FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 226 -QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
Q ++ +I EGKY F +W IS KDLI KLL+ + R S + L H +
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-58
Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 11/138 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL--DDQMNVKLTDFGFARVLKK-----GEK 101
IMRQ+F AL ++HN + HRD+KPEN L + +KL DFG ++ K
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
+ GTP ++APEVL YG D W+ GV+++ LL+G PF +
Sbjct: 231 MTTKAGTPYFVAPEVLNTT----NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS 286
Query: 162 NIMEGKYSFSSPEWNDIS 179
++ K F +P +N +S
Sbjct: 287 QVLNKKLCFENPNYNVLS 304
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APEVL YG D W+ GV+++ LL+G PF + ++ K
Sbjct: 239 YFVAPEVLNTT----NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F +P +N +S +DL+ LL ++R+ AL H +
Sbjct: 295 FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-58
Identities = 52/133 (39%), Positives = 80/133 (60%), Gaps = 10/133 (7%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDLCG 107
++Q+ EA+ ++H + +VHRDLKPEN+L +K+ DFG +++++ + +CG
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIMEG 166
TPGY APE+LR YG VD+W+ G+I Y LL G PF+ R M R I+
Sbjct: 213 TPGYCAPEILR------GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266
Query: 167 KYSFSSPEWNDIS 179
+Y F SP W+++S
Sbjct: 267 EYYFISPWWDEVS 279
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIMEGKY 238
GY APE+LR YG VD+W+ G+I Y LL G PF+ R M R I+ +Y
Sbjct: 215 GYCAPEILRG------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTA 298
F SP W+++S + KDL+RKL+++ P+ R + +AL H + TA
Sbjct: 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV------TGKAANFVHMDTA 322
Query: 299 SRKLSKINQLTEFQFIILVVRAAVRI 324
+KL + N + + + V A+ R+
Sbjct: 323 QKKLQEFNARRKLKAAVKAVVASSRL 348
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-57
Identities = 54/138 (39%), Positives = 78/138 (56%), Gaps = 13/138 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
IM+ + EA++++H+ ++ HRD+KPEN+L +KLTDFGFA+ L
Sbjct: 164 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLR 161
C TP Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ M
Sbjct: 224 CYTPYYVAPEVLG------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 162 NIMEGKYSFSSPEWNDIS 179
I G+Y F +PEW+++S
Sbjct: 278 RIRMGQYEFPNPEWSEVS 295
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 46/138 (33%), Positives = 64/138 (46%), Gaps = 22/138 (15%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIME 235
Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ M I
Sbjct: 228 YYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDY 295
G+Y F +PEW+++SE+ K LIR LL P R ++ E +NH + I +
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW------------IMQST 329
Query: 296 KTASRKLSKINQLTEFQF 313
K L L E +
Sbjct: 330 KVPQTPLHTSRVLKEDKE 347
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 55/134 (41%), Positives = 82/134 (61%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+++Q+ A++++H + +VHRDLKPEN+L ++ + +TDFG +++ + G +
Sbjct: 109 SLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTA 167
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
CGTPGY+APEVL Y +AVD W+ GVI Y LL G PPF+ + + I E
Sbjct: 168 CGTPGYVAPEVLAQK------PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
Query: 166 GKYSFSSPEWNDIS 179
G Y F SP W+DIS
Sbjct: 222 GYYEFESPFWDDIS 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-56
Identities = 56/138 (40%), Positives = 80/138 (57%), Gaps = 14/138 (10%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
IMR + A++ +H+H++ HRD+KPEN+L + +KLTDFGFA+ + L
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTP 189
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLR 161
C TP Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ M R
Sbjct: 190 CYTPYYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
Query: 162 NIMEGKYSFSSPEWNDIS 179
I G+Y F +PEW+++S
Sbjct: 244 RIRLGQYGFPNPEWSEVS 261
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 42/101 (41%), Positives = 58/101 (57%), Gaps = 10/101 (9%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIME 235
Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ M R I
Sbjct: 194 YYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
G+Y F +PEW+++SED K LIR LL P +R ++ + +NH
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-56
Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMDLC 106
++Q+ + ++H+ + H DLKPENI+L + +K+ DFG A + G + ++
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
GTP ++APE++ G D+W+ GVI Y LL G PF + L N+
Sbjct: 179 GTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
Query: 167 KYSFSSPEWNDIS 179
Y F +++ S
Sbjct: 233 NYEFEDEYFSNTS 245
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE++ G D+W+ GVI Y LL G PF + L N+ Y
Sbjct: 182 EFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F +++ S KD IR+LL+ P+ R +++++L H + PK D +K
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK--DTQQALSRKASAVNM 293
Query: 300 RKLSKIN 306
K K
Sbjct: 294 EKFKKFA 300
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-56
Identities = 44/131 (33%), Positives = 72/131 (54%), Gaps = 8/131 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN--VKLTDFGFARVLKKGEKLMDLCGT 108
+ Q+ EAL+ +H+H++ H D++PENI+ + + +K+ +FG AR LK G+ L
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P Y APEV + + A D+W+ G ++Y LL G PF ++ NIM +Y
Sbjct: 167 PEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 169 SFSSPEWNDIS 179
+F + +IS
Sbjct: 221 TFDEEAFKEIS 231
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 13/148 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y APEV + + A D+W+ G ++Y LL G PF ++ NIM +Y+
Sbjct: 168 EYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F + +IS + D + +LL+ + R + EAL H + Q IE +
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK-----QKIERVSTKVIRTL 276
Query: 300 RKLSKINQLTEFQFIILVVRAAVRISRL 327
+ + L + + +V +A RIS
Sbjct: 277 KHRRYYHTL--IKKDLNMVVSAARISCG 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-55
Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
+M+Q+ AL + H+ VVH+DLKPENIL +K+ DFG A + K E +
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEV + + D+W+ GV+MY LL GC PF + +
Sbjct: 187 AGTALYMAPEVFKRD-------VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
Query: 166 GKYSFSSPEWNDIS 179
+ +++ E ++
Sbjct: 240 KEPNYAV-ECRPLT 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEV + + D+W+ GV+MY LL GC PF + + + +
Sbjct: 191 LYMAPEVFKRD-------VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
++ E ++ DL++++L PE R S + L+H
Sbjct: 244 YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-55
Identities = 51/133 (38%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL--DDQMNVKLTDFGFARVLKKGEKLMDLC 106
M+Q+ E + H+H ++H DLKPENIL D +K+ DFG AR K EKL
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
GTP +LAPEV+ + D+W+ GVI Y LL G PF L NI+
Sbjct: 250 GTPEFLAPEVVNYD------FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303
Query: 167 KYSFSSPEWNDIS 179
++ E+ DIS
Sbjct: 304 RWDLEDEEFQDIS 316
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 40/127 (31%), Positives = 55/127 (43%), Gaps = 8/127 (6%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+LAPEV+ + D+W+ GVI Y LL G PF L NI+ ++
Sbjct: 253 EFLAPEVVNYD------FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKD--YKT 297
E+ DISE+ K+ I KLLI R S EAL H + + KK
Sbjct: 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366
Query: 298 ASRKLSK 304
A ++K
Sbjct: 367 AQDFVTK 373
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 45/133 (33%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL--DDQMNVKLTDFGFARVLKKGEKLMDLC 106
MRQ E L+H+H HS+VH D+KPENI+ +VK+ DFG A L E +
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
T + APE++ G D+WA GV+ Y LL G PF + L+N+
Sbjct: 212 ATAEFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
Query: 167 KYSFSSPEWNDIS 179
+ F ++ +S
Sbjct: 266 DWEFDEDAFSSVS 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 34/149 (22%), Positives = 58/149 (38%), Gaps = 11/149 (7%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+ APE++ G D+WA GV+ Y LL G PF + L+N+ +
Sbjct: 215 EFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 268
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F ++ +S + KD I+ LL P R +V +AL H + D + ++
Sbjct: 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK-----GDHSNLTSRIPSSR 323
Query: 300 RKLSKINQLTEFQFIILVVRAAVRISRLK 328
+ ++ A RI+
Sbjct: 324 YNKIRQKIKEKYADWPAPQPAIGRIANFS 352
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 55/134 (41%), Positives = 83/134 (61%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
I++Q+F + ++H H++VHRDLKPENILL + ++K+ DFG + ++ K+ D
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEVLR Y + DVW+ GVI+Y LL G PPF+ + + +L+ +
Sbjct: 184 IGTAYYIAPEVLRGT-------YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 166 GKYSFSSPEWNDIS 179
GKY+F P+W IS
Sbjct: 237 GKYAFDLPQWRTIS 250
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVLR Y + DVW+ GVI+Y LL G PPF+ + + +L+ + GKY+
Sbjct: 188 YYIAPEVLRGT-------YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F P+W IS+D KDLIRK+L P R + + L H + + ++A
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM 300
Query: 300 RKLSKINQLTEFQFIILVVRA 320
+ + + L+ A
Sbjct: 301 TNIRQFQAEKKLAQAALLYMA 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 56/134 (41%), Positives = 81/134 (60%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
IM+Q+ + ++H H++VHRD+KPENILL + +N+K+ DFG + K KL D
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEVL+ Y + DVW+CGVIMY LL G PPF + +++ + +
Sbjct: 209 LGTAYYIAPEVLKKK-------YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 166 GKYSFSSPEWNDIS 179
GKY F +W +IS
Sbjct: 262 GKYYFDFNDWKNIS 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 8/141 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVL+ Y + DVW+CGVIMY LL G PPF + +++ + +GKY
Sbjct: 213 YYIAPEVLKKK-------YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F +W +IS++ K+LI+ +L R + +EALN + + + K S
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325
Query: 300 RKLSKINQLTEFQFIILVVRA 320
+ K + ++
Sbjct: 326 N-MRKFEGSQKLAQAAILFIG 345
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-53
Identities = 52/134 (38%), Positives = 79/134 (58%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
I+RQ+ + ++H + +VHRDLKPEN+LL N+++ DFG + + +K+ D
Sbjct: 129 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEVL Y + DVW+ GVI+Y LL GCPPF + +L+ + +
Sbjct: 189 IGTAYYIAPEVLHGT-------YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
Query: 166 GKYSFSSPEWNDIS 179
GKY+F P+W +S
Sbjct: 242 GKYTFELPQWKKVS 255
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 8/141 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVL Y + DVW+ GVI+Y LL GCPPF + +L+ + +GKY+
Sbjct: 193 YYIAPEVLHGT-------YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F P+W +SE KDLIRK+L P R S ++AL+H + + I A
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ-TYTKEQISVDVPSLDNAI 304
Query: 300 RKLSKINQLTEFQFIILVVRA 320
+ + + L+
Sbjct: 305 LNIRQFQGTQKLAQAALLYMG 325
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-53
Identities = 54/128 (42%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMDLCG 107
RY +RQ+ +++H + V+HRDLK N+ L++ + VK+ DFG A +V GE+ LCG
Sbjct: 118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP Y+APEVL G+ VDVW+ G IMYTLLVG PPF I + +
Sbjct: 178 TPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
Query: 168 YSFSSPEW 175
YS P+
Sbjct: 232 YSI--PKH 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 39/99 (39%), Positives = 50/99 (50%), Gaps = 10/99 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEVL G+ VDVW+ G IMYTLLVG PPF I + +YS
Sbjct: 181 YIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 234
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P+ I+ LI+K+L P R ++ E LN FF
Sbjct: 235 --PKH--INPVAASLIQKMLQTDPTARPTINELLNDEFF 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 54/134 (40%), Positives = 83/134 (61%), Gaps = 10/134 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
I++Q+ + ++H H++VHRDLKPEN+LL + +K+ DFG + V + +K+ +
Sbjct: 139 AVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT Y+APEVLR Y + DVW+ GVI++ LL G PPF + +LR + +
Sbjct: 199 LGTAYYIAPEVLRKK-------YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 166 GKYSFSSPEWNDIS 179
GKY+F SPEW ++S
Sbjct: 252 GKYTFDSPEWKNVS 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 7/141 (4%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEVLR Y + DVW+ GVI++ LL G PPF + +LR + +GKY+
Sbjct: 203 YYIAPEVLRKK-------YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F SPEW ++SE KDLI+++L + R S ++AL H + ++ A
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315
Query: 300 RKLSKINQLTEFQFIILVVRA 320
+ K + L+ A
Sbjct: 316 ENMRKFQNSQKLAQAALLYMA 336
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 54/128 (42%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMDLCG 107
RY +RQ+ +++H + V+HRDLK N+ L++ + VK+ DFG A +V GE+ LCG
Sbjct: 144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP Y+APEVL G+ VDVW+ G IMYTLLVG PPF I + +
Sbjct: 204 TPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257
Query: 168 YSFSSPEW 175
YS P+
Sbjct: 258 YSI--PKH 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 44/131 (33%), Positives = 57/131 (43%), Gaps = 14/131 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEVL G+ VDVW+ G IMYTLLVG PPF I + +YS
Sbjct: 207 YIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF----HPKLFDQDIEPIKKDYK 296
P+ I+ LI+K+L P R ++ E LN FF P I +
Sbjct: 261 --PKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFS 316
Query: 297 TASRKLSKINQ 307
A L N+
Sbjct: 317 IAPSSLDPSNR 327
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 43/131 (32%), Positives = 62/131 (47%), Gaps = 8/131 (6%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQM--NVKLTDFGFARVLKKGEKLMDLCGT 108
MRQ+ + L H+H ++ VH DLKPENI+ + +KL DFG L + + GT
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
+ APEV G D+W+ GV+ Y LL G PF LRN+ +
Sbjct: 320 AEFAAPEVAEG------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
Query: 169 SFSSPEWNDIS 179
+ ++ IS
Sbjct: 374 NMDDSAFSGIS 384
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 16/162 (9%)
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226
K + + E + APEV G D+W+ GV+ Y LL G PF
Sbjct: 314 KVTTGTAE------FAAPEVAEG------KPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQ 286
LRN+ ++ ++ ISED KD IRKLL+ P R ++ +AL HP L
Sbjct: 362 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE----HPWLTPG 417
Query: 287 DIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLK 328
+ ++ + + T++ + RIS
Sbjct: 418 NAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYS 459
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 48/259 (18%), Positives = 89/259 (34%), Gaps = 66/259 (25%)
Query: 44 SNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
++ I++ + + ++HN ++ HRD+KP NIL+D VKL+DFG + +K+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKI 207
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLR 161
GT ++ PE ++ G VD+W+ G+ +Y + PF + +
Sbjct: 208 KGSRGTYEFMPPEFFSNE----SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
NI + P
Sbjct: 264 NIRTKNIEY------------------------------------------------PLD 275
Query: 222 WHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF-- 279
+ + +F +S + D ++ L P +R + ++AL H +
Sbjct: 276 RNHFLYPLTNKKSTCSNNF-------LSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 280 --HPKLFDQDIEPIKKDYK 296
L + E KK K
Sbjct: 329 TNIEDLREFSKELYKKRKK 347
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-51
Identities = 47/128 (36%), Positives = 69/128 (53%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLCG 107
R+ M Q+ + ++H+H ++HRDL N+LL MN+K+ DFG A LK EK LCG
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
TP Y++PE+ + +G DVW+ G + YTLL+G PPF L ++
Sbjct: 175 TPNYISPEIATRS------AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
Query: 168 YSFSSPEW 175
Y P +
Sbjct: 229 YEM--PSF 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 14/110 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE+ + +G DVW+ G + YTLL+G PPF L ++ Y
Sbjct: 178 YISPEIATRS------AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF----HPKLFDQ 286
P + +S + KDLI +LL P DR S+ L+H F K D+
Sbjct: 232 --PSF--LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-50
Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 29/174 (16%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMD 104
++R + + H+ + +VHR++KP NI+ D Q KLTDFG AR L+ E+ +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 105 LCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPFWH----RKQMV 158
L GT YL P++ + YG VD+W+ GV Y G PF R+
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 159 MLRNIMEGKY-----------------SFSSPEWNDISGYLAPEV--LRANMFE 193
++ I+ GK S P +S L + + AN+ E
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 27/127 (21%)
Query: 180 GYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPFWH----RKQMVMLRNI 233
YL P++ + YG VD+W+ GV Y G PF R+ ++ I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 234 MEGKY-----------------SFSSPEWNDISEDPKD----LIRKLLIVTPEDRYSVKE 272
+ GK S P +S + ++ +L E + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 273 ALNHSFF 279
+
Sbjct: 300 FFAETSD 306
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-49
Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 29/174 (16%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL----DDQMNVKLTDFGFARVLKKGEKLMD 104
++R + + H+ + +VHR++KP NI+ D Q KLTDFG AR L+ E+ +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 105 LCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPFWH----RKQMV 158
L GT YL P++ + YG VD+W+ GV Y G PF R+
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 159 MLRNIMEGKY-----------------SFSSPEWNDISGYLAPEV--LRANMFE 193
++ I+ GK S P +S L + + AN+ E
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 27/125 (21%)
Query: 180 GYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPFWH----RKQMVMLRNI 233
YL P++ + YG VD+W+ GV Y G PF R+ ++ I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 234 MEGKY-----------------SFSSPEWNDISEDPKD----LIRKLLIVTPEDRYSVKE 272
+ GK S P +S + ++ +L E + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 273 ALNHS 277
+
Sbjct: 300 FFAET 304
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 43/132 (32%), Positives = 68/132 (51%), Gaps = 9/132 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ +L AL + H+ V+HRD+KPEN+LL +K+ DFG++ V +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT 165
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
DLCGT YL PE++ + + VD+W+ GV+ Y LVG PPF + I
Sbjct: 166 DLCGTLDYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219
Query: 164 MEGKYSFSSPEW 175
+++F P++
Sbjct: 220 SRVEFTF--PDF 229
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 14/117 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL PE++ + + VD+W+ GV+ Y LVG PPF + I +++F
Sbjct: 173 YLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 226
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF----HPKLFDQDIEPIKK 293
P++ ++E +DLI +LL P R ++E L H + Q+ E K
Sbjct: 227 --PDF--VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 9/132 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
M +L +AL + H V+HRD+KPEN+L+ + +K+ DFG++ V +
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR 170
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
+CGT YL PE++ + + VD+W GV+ Y LVG PPF R I
Sbjct: 171 TMCGTLDYLPPEMIEGK------THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224
Query: 164 MEGKYSFSSPEW 175
+ F P +
Sbjct: 225 VNVDLKF--PPF 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 12/110 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL PE++ + + VD+W GV+ Y LVG PPF R I+ F
Sbjct: 178 YLPPEMIEGK------THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 231
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEP 290
P + +S+ KDLI KLL P R +K + H + K + + P
Sbjct: 232 --PPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV--KANSRRVLP 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 4e-47
Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD---DQMNVKLTDFGFARVLKKGEKLMDL 105
R ++ + AL ++H + ++HRDLKPENI+L ++ K+ D G+A+ L +GE +
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT YLAPE+L Y VD W+ G + + + G PF Q V +
Sbjct: 184 VGTLQYLAPELLEQ------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 166 GKYSFSSPEWNDISG 180
K + ++D++G
Sbjct: 238 EKSNEHIVVYDDLTG 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-47
Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 22/146 (15%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK---------- 98
+ RQ+ EAL ++H+ ++HRDLKP NI +D+ NVK+ DFG A+ + +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 99 -----GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153
+ L GT Y+A EVL + Y + +D+++ G+I + ++ P
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVL-----DGTGHYNEKIDMYSLGIIFFEMI--YPFSTG 231
Query: 154 RKQMVMLRNIMEGKYSFSSPEWNDIS 179
+++ +L+ + F ++
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKM 257
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 23/109 (21%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+A EVL + Y + +D+++ G+I + ++ P +++ +L+ + F
Sbjct: 196 YVATEVL-----DGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEF 248
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIE 289
++ + K +IR L+ P R + LN + K D+ I+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
+ + + EA+ +H H +VH DLKP N L+ D +KL DFG A ++ +
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 106 CGTPGYLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVM 159
GT Y+ PE ++ + + DVW+ G I+Y + G PF Q+
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 160 LRNIMEGKYSFSSPEW 175
L I++ + P+
Sbjct: 249 LHAIIDPNHEIEFPDI 264
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 27/126 (21%), Positives = 52/126 (41%), Gaps = 13/126 (10%)
Query: 181 YLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLRNIM 234
Y+ PE ++ + + DVW+ G I+Y + G PF Q+ L I+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKD 294
+ + P+ +D +D+++ L P+ R S+ E L H + + P+ +
Sbjct: 254 DPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ-----THPVNQM 306
Query: 295 YKTASR 300
K +
Sbjct: 307 AKGTTE 312
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 8/146 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ A + Q+ L +H++ +VH L+P +I+LD + V LT F + +
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGARV 260
Query: 104 DLCGTPGYLAPEVL-----RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
+ G+ PE+ + + T + D WA G+++Y + P +
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320
Query: 159 MLRNIMEGKYSFSSPEWNDISGYLAP 184
I + P + G+L
Sbjct: 321 GSEWIFRSCKNIPQPVRALLEGFLRY 346
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-26
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 13/106 (12%)
Query: 180 GYLAPEVL-----RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234
G+ PE+ + + T + D WA G+++Y + P + I
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF 326
Query: 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
+I + + L+ L EDR +A+ +
Sbjct: 327 RSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-45
Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 30 VVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD--------- 80
V K + + ++RQ+ + H+H+ ++HRDLKP+NIL+
Sbjct: 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 81 ----DQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLR-ANMFEDATGYGQ 130
+ + + ++DFG + L G+ L + GT G+ APE+L +N + +
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
Query: 131 AVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFS---SPEWNDIS 179
++D+++ G + Y +L G PF + NI+ G +S +
Sbjct: 219 SIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLI 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 26/106 (24%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 179 SGYLAPEVLR-ANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEG 236
SG+ APE+L +N + +++D+++ G + Y +L G PF + NI+ G
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRG 253
Query: 237 KYSFS---SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+S + + DLI +++ P R + + L H F
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 16/156 (10%)
Query: 31 VDKGEAAVQDIINSNP-----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNV 85
V++G V ++ P A Y + L + +E++H ++HRD+KP N+L+ + ++
Sbjct: 120 VNQGP--VMEVPTLKPLSEDQARFY-FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI 176
Query: 86 KLTDFGFARVLKKGEKLMD-LCGTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYT 143
K+ DFG + K + L+ GTP ++APE L + G+A+DVWA GV +Y
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET----RKIFSGKALDVWAMGVTLYC 232
Query: 144 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
+ G PF + M + I F P+ DI+
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEF--PDQPDIA 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE L + G+A+DVWA GV +Y + G PF + M + I
Sbjct: 203 FMAPESLSET----RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F P+ DI+ED KDLI ++L PE R V E H +
Sbjct: 259 F--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
+ + + EA+ +H H +VH DLKP N L+ D +KL DFG A ++ +
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 106 CGTPGYLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVM 159
GT Y+ PE ++ + + DVW+ G I+Y + G PF Q+
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 160 LRNIMEGKYSFSSPEW 175
L I++ + P+
Sbjct: 230 LHAIIDPNHEIEFPDI 245
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 10/135 (7%)
Query: 181 YLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLRNIM 234
Y+ PE ++ + + DVW+ G I+Y + G PF Q+ L I+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL--FDQDIEPIK 292
+ + P+ +D +D+++ L P+ R S+ E L H + + +Q +
Sbjct: 235 DPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 292
Query: 293 KDYKTASRKLSKINQ 307
++ K +L +N
Sbjct: 293 EEMKYVLGQLVGLNS 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-45
Identities = 45/130 (34%), Positives = 74/130 (56%), Gaps = 9/130 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
R+ ++ ALE++H ++HRDLKPENILL++ M++++TDFG A+VL K
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 104 D---LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
GT Y++PE+L ++ D+WA G I+Y L+ G PPF + ++
Sbjct: 188 RANSFVGTAQYVSPELLTEK------SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241
Query: 161 RNIMEGKYSF 170
+ I++ +Y F
Sbjct: 242 QKIIKLEYDF 251
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 20/122 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE+L ++ D+WA G I+Y L+ G PPF + ++ + I++ +Y F
Sbjct: 198 YVSPELLTEK------SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 251
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY------SVKEALNHSFFHP----KLFDQDIEP 290
PE +DL+ KLL++ R H FF L Q
Sbjct: 252 --PEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 307
Query: 291 IK 292
+
Sbjct: 308 LT 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-44
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ-----MNVKLTDFGFARVLKK 98
+++Q L H+H+ ++VHRDLKP NIL+ + ++DFG + L
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 99 GE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153
G + + GT G++APE+L + E VD+++ G + Y ++ G PF
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKE---NPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 154 RKQMVMLRNIMEGKYSFSSPE-WNDIS 179
Q NI+ G S
Sbjct: 233 SLQRQA--NILLGACSLDCLHPEKHED 257
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 33/124 (26%), Positives = 56/124 (45%), Gaps = 12/124 (9%)
Query: 161 RNIMEGKYSFSSPEWNDI---SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV- 216
+ + G++SFS + + G++APE+L + E VD+++ G + Y ++
Sbjct: 171 KKLAVGRHSFS--RRSGVPGTEGWIAPEMLSEDCKE---NPTYTVDIFSAGCVFYYVISE 225
Query: 217 GCPPFWHRKQMVMLRNIMEGKYSFSSPE-WNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
G PF Q NI+ G S ++LI K++ + P+ R S K L
Sbjct: 226 GSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
Query: 276 HSFF 279
H FF
Sbjct: 284 HPFF 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 51/127 (40%), Positives = 72/127 (56%), Gaps = 7/127 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R RQ+ A+++ H +VHRDLK EN+LLD MN+K+ DFGF+ G KL CG
Sbjct: 117 RSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
P Y APE+ + ++ G VDVW+ GVI+YTL+ G PF + + ++ GKY
Sbjct: 177 PPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231
Query: 169 SFSSPEW 175
P +
Sbjct: 232 RI--PFY 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 29/111 (26%), Positives = 60/111 (54%), Gaps = 9/111 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y APE+ + ++ G VDVW+ GVI+YTL+ G PF + + ++ GKY
Sbjct: 179 YAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 233
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
P + +S D ++L+++ L++ P R ++++ + + + + +++P
Sbjct: 234 --PFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 36/136 (26%), Positives = 60/136 (44%), Gaps = 10/136 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
+ + + EA+ +H H +VH DLKP N L+ D +KL DFG A ++ +
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 106 CGTPGYLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVM 159
G Y+ PE ++ + + DVW+ G I+Y + G PF Q+
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 160 LRNIMEGKYSFSSPEW 175
L I++ + P+
Sbjct: 277 LHAIIDPNHEIEFPDI 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 10/135 (7%)
Query: 181 YLAPEVLR-----ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLRNIM 234
Y+ PE ++ + + DVW+ G I+Y + G PF Q+ L I+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL--FDQDIEPIK 292
+ + P+ +D +D+++ L P+ R S+ E L H + + +Q +
Sbjct: 282 DPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339
Query: 293 KDYKTASRKLSKINQ 307
++ K +L +N
Sbjct: 340 EEMKYVLGQLVGLNS 354
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-44
Identities = 24/142 (16%), Positives = 46/142 (32%), Gaps = 6/142 (4%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC 106
AL + QL ++ + +VH P+N+ + + L D K G +
Sbjct: 195 ALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS 252
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
Y E L A+ + A++ W G+ +Y + PF +
Sbjct: 253 VPVTYAPREFLNAS----TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 167 KYSFSSPEWNDISGYLAPEVLR 188
+ S P+ ++
Sbjct: 309 LRVPGTDSLAFGSCTPLPDFVK 330
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 18/104 (17%), Positives = 31/104 (29%), Gaps = 9/104 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y E L A+ + A++ W G+ +Y + PF +
Sbjct: 257 YAPREFLNAS----TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
Query: 241 SSPEWN-----DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ + + K LI + L R EA+ F
Sbjct: 313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 54/128 (42%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R + +Q+ A+++ H H VVHRDLKPEN+LLD MN K+ DFG + ++ GE L CG+
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 173
Query: 109 PGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
P Y APEV+ Y G VD+W+CGVI+Y LL G PF + + I G
Sbjct: 174 PNYAAPEVISGR------LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 168 YSFSSPEW 175
+ PE+
Sbjct: 228 FYI--PEY 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-23
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y APEV+ Y G VD+W+CGVI+Y LL G PF + + I G +
Sbjct: 176 YAAPEVISGR------LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
PE+ ++ L+ +L V P R ++K+ H +F
Sbjct: 230 I--PEY--LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 51/128 (39%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R +Q+ A+E+ H H +VHRDLKPEN+LLDD +NVK+ DFG + ++ G L CG+
Sbjct: 111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170
Query: 109 PGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
P Y APEV+ Y G VDVW+CG+++Y +LVG PF + + +
Sbjct: 171 PNYAAPEVINGK------LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224
Query: 168 YSFSSPEW 175
Y P++
Sbjct: 225 YVM--PDF 230
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y APEV+ Y G VDVW+CG+++Y +LVG PF + + + Y
Sbjct: 173 YAAPEVINGK------LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV 226
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P++ +S + LIR++++ P R +++E +F
Sbjct: 227 M--PDF--LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 43/127 (33%), Positives = 64/127 (50%), Gaps = 13/127 (10%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
YI RQL A+ ++ ++HRD+K ENI++ + +KL DFG A L++G+ CGT
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT 192
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y APEVL N + G +++W+ GV +YTL+ PF L +E
Sbjct: 193 IEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI 241
Query: 169 SFSSPEW 175
P
Sbjct: 242 HP--PYL 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-43
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 34/138 (24%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLMDL 105
IM+ + EA++++H+ ++ HRD+KPEN+L +KLTDFGFA
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------ 167
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLR 161
E Y ++ D+W+ GVIMY LL G PPF+ M
Sbjct: 168 --------KETTG-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 162 NIMEGKYSFSSPEWNDIS 179
I G+Y F +PEW+++S
Sbjct: 213 RIRMGQYEFPNPEWSEVS 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 42/136 (30%), Positives = 59/136 (43%), Gaps = 23/136 (16%)
Query: 182 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIMEGK 237
A E Y ++ D+W+ GVIMY LL G PPF+ M I G+
Sbjct: 166 FAKETTG-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKT 297
Y F +PEW+++SE+ K LIR LL P R ++ E +NH + I + K
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW------------IMQSTKV 266
Query: 298 ASRKLSKINQLTEFQF 313
L L E +
Sbjct: 267 PQTPLHTSRVLKEDKE 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL---KKGEKLM 103
A Y QL + LE++H+ +VH+D+KP N+LL +K++ G A L +
Sbjct: 111 AHGY-FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 104 DLCGTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
G+P + PE+ + G VD+W+ GV +Y + G PF + N
Sbjct: 170 TSQGSPAFQPPEIAN-----GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224
Query: 163 IMEGKYSFSSPEW 175
I +G Y+ P
Sbjct: 225 IGKGSYAI--PGD 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 33/132 (25%), Positives = 54/132 (40%), Gaps = 13/132 (9%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+ PE+ + G VD+W+ GV +Y + G PF + NI +G Y+
Sbjct: 177 FQPPEIAN-----GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF---HPKLFDQDIEPIKKDYK 296
P DL++ +L P R+S+++ HS+F HP P D K
Sbjct: 232 I--PGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287
Query: 297 TASRKLSKINQL 308
R ++ + L
Sbjct: 288 DRWRSMTVVPYL 299
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 50/129 (38%), Positives = 78/129 (60%), Gaps = 8/129 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S P R+ Q+ E++H+ +++RDLKPEN+L+D Q +++TDFGFA+ + +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTW 196
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
LCGTP LAPE++ + GY +AVD WA GV++Y + G PPF+ + + + I
Sbjct: 197 TLCGTPEALAPEIILSK------GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 164 MEGKYSFSS 172
+ GK F S
Sbjct: 251 VSGKVRFPS 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 38/119 (31%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
LAPE++ + GY +AVD WA GV++Y + G PPF+ + + + I+ GK F
Sbjct: 204 ALAPEIILSK------GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQDIEP 290
P S D KDL+R LL V R+ V + NH +F ++ + +E
Sbjct: 258 --PSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 17/129 (13%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCG 107
R Q+ EA+ H HN V+HRD+K ENIL+D ++ +KL DFG +LK D G
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDG 210
Query: 108 TPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
T Y PE +R + Y G++ VW+ G+++Y ++ G PF H ++ I+ G
Sbjct: 211 TRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG 258
Query: 167 KYSFSSPEW 175
+ F +
Sbjct: 259 QVFF--RQR 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 17/112 (15%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y PE +R + Y G++ VW+ G+++Y ++ G PF H ++ I+ G+
Sbjct: 214 YSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF 261
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
F + +S + + LIR L + P DR + +E NH + L Q+ I
Sbjct: 262 F--RQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 40/129 (31%), Positives = 60/129 (46%), Gaps = 17/129 (13%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM-NVKLTDFGFARVLKKGEKLMDLCG 107
R Q+ A++H H+ VVHRD+K ENIL+D + KL DFG +L D G
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDG 200
Query: 108 TPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
T Y PE + + Y VW+ G+++Y ++ G PF ++ I+E
Sbjct: 201 TRVYSPPEWISRH------QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA 248
Query: 167 KYSFSSPEW 175
+ F P
Sbjct: 249 ELHF--PAH 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 30/124 (24%), Positives = 49/124 (39%), Gaps = 17/124 (13%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y PE + + Y VW+ G+++Y ++ G PF ++ I+E +
Sbjct: 204 YSPPEWISRH------QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELH 251
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
F P +S D LIR+ L P R S++E L + D + P K +
Sbjct: 252 F--PAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307
Query: 300 RKLS 303
L
Sbjct: 308 WSLL 311
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
+ QL + ++H + HRD+KPEN+LLD++ N+K++DFG A V + + L
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 106 CGTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNI 163
CGT Y+APE+L+ + + VDVW+CG+++ +L G P+ +
Sbjct: 168 CGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 164 MEGKYSFSSPEWNDIS 179
E K W I
Sbjct: 222 KEKKTYL--NPWKKID 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 26/112 (23%), Positives = 47/112 (41%), Gaps = 10/112 (8%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNIMEGKY 238
Y+APE+L+ + + VDVW+CG+++ +L G P+ + E K
Sbjct: 173 YVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEP 290
W I P L+ K+L+ P R ++ + +++ L P
Sbjct: 227 YL--NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 51/128 (39%), Positives = 73/128 (57%), Gaps = 9/128 (7%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
R + +Q+ +++ H H VVHRDLKPEN+LLD MN K+ DFG + ++ GE L CG+
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGS 178
Query: 109 PGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
P Y APEV+ Y G VD+W+ GVI+Y LL G PF + + I +G
Sbjct: 179 PNYAAPEVISGR------LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232
Query: 168 YSFSSPEW 175
+ P++
Sbjct: 233 FYT--PQY 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y APEV+ Y G VD+W+ GVI+Y LL G PF + + I +G +
Sbjct: 181 YAAPEVISGR------LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P++ ++ L++ +L V P R ++K+ H +F
Sbjct: 235 T--PQY--LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 44/119 (36%), Positives = 70/119 (58%), Gaps = 8/119 (6%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLA 113
++ ALE++H+ +++RDLKPENILLD ++K+TDFGFA+ + LCGTP Y+A
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIA 171
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 172
PEV+ Y +++D W+ G+++Y +L G PF+ M I+ + F
Sbjct: 172 PEVVSTK------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 9e-24
Identities = 32/119 (26%), Positives = 55/119 (46%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEV+ Y +++D W+ G+++Y +L G PF+ M I+ + F
Sbjct: 169 YIAPEVVSTK------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 222
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQDIEP 290
P + +ED KDL+ +L+ R ++ NH +F KL ++IE
Sbjct: 223 --PPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIET 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
+ QL + ++H + HRD+KPEN+LLD++ N+K++DFG A V + + L
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 106 CGTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNI 163
CGT Y+APE+L+ + + VDVW+CG+++ +L G P+ +
Sbjct: 168 CGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 164 MEGKYSFSSPEWNDIS 179
E K W I
Sbjct: 222 KEKKTYL--NPWKKID 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 27/129 (20%), Positives = 53/129 (41%), Gaps = 11/129 (8%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNIMEGKY 238
Y+APE+L+ + + VDVW+CG+++ +L G P+ + E K
Sbjct: 173 YVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTA 298
W I P L+ K+L+ P R ++ + +++ K + + +
Sbjct: 227 YL--NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLKKGAKRPRVTSGGV 283
Query: 299 SRKLSKINQ 307
S S ++
Sbjct: 284 SESPSGFSK 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-41
Identities = 41/132 (31%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
++ + +L AL+++ N ++HRD+KP+NILLD+ +V +TDF A +L + ++
Sbjct: 113 KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ---MVML 160
+ GT Y+APE+ + GY AVD W+ GV Y LL G P+ R ++
Sbjct: 173 TMAGTKPYMAPEMFSSR---KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 161 RNIMEGKYSFSS 172
++ S
Sbjct: 230 HTFETTVVTYPS 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 29/118 (24%), Positives = 51/118 (43%), Gaps = 15/118 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ---MVMLRNIMEGK 237
Y+APE+ + GY AVD W+ GV Y LL G P+ R ++
Sbjct: 180 YMAPEMFSSR---KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236
Query: 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-SVKEALNHSFFHP----KLFDQDIEP 290
++ S S++ L++KLL P+ R+ + + N + + +F + + P
Sbjct: 237 VTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 29/140 (20%), Positives = 47/140 (33%), Gaps = 3/140 (2%)
Query: 47 ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-- 104
A + Q+ L +H++ +VH L+P +I+LD + V LT F
Sbjct: 212 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR 271
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
P A +L T A D W G+ +Y + P + I
Sbjct: 272 GFAPPETTAERMLPFGQ-HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330
Query: 165 EGKYSFSSPEWNDISGYLAP 184
+ P + G+L
Sbjct: 331 RSCKNIPQPVRALLEGFLRY 350
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ--MNVKLTDFGFARVLKKGEKLMDLC 106
R+ +QL + + H+ + HRDLK EN LLD +K+ DFG+++ +
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 107 GTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN--- 162
GTP Y+APEVL Y G+ DVW+CGV +Y +LVG PF ++ R
Sbjct: 179 GTPAYIAPEVLLRQ------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
Query: 163 -IMEGKYSFSSPEW 175
I+ KYS
Sbjct: 233 RILSVKYSIPDDIR 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 181 YLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN----IME 235
Y+APEVL Y G+ DVW+CGV +Y +LVG PF ++ R I+
Sbjct: 183 YIAPEVLLRQ------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
KYS P+ IS + LI ++ + P R S+ E HS+F
Sbjct: 237 VKYSI--PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 48/138 (34%), Positives = 74/138 (53%), Gaps = 4/138 (2%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
R+ ++ AL+ +H+ +HRD+KP+N+LLD ++KL DFG + K +
Sbjct: 166 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 104 D--LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
GTP Y++PEVL++ YG+ D W+ GV +Y +LVG PF+ +
Sbjct: 226 CDTAVGTPDYISPEVLKSQ--GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283
Query: 162 NIMEGKYSFSSPEWNDIS 179
IM K S + P+ NDIS
Sbjct: 284 KIMNHKNSLTFPDDNDIS 301
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PEVL++ YG+ D W+ GV +Y +LVG PF+ + IM K S
Sbjct: 235 YISPEVLKSQ--GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHP----KLFDQDIEP 290
+ P+ NDIS++ K+LI L E R V+E H FF +D
Sbjct: 293 TFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVA 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMD-LCGTPGYLAPE 115
A++ VH VHRD+KP+NIL+D +++L DFG ++++ G GTP Y++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
+L+A M YG D W+ GV MY +L G PF+ + IM K F P
Sbjct: 247 ILQA-MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305
Query: 176 ND 177
Sbjct: 306 VT 307
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE+L+A M YG D W+ GV MY +L G PF+ + IM K F
Sbjct: 242 YISPEILQA-MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300
Query: 241 SSPEW-NDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHP 281
P D+SE+ KDLIR+L+ + E R +++ H FF
Sbjct: 301 QFPTQVTDVSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFSG 344
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 36/131 (27%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ Q+ + ++++H+ +++RDLKP NI L D VK+ DFG LK K GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y++PE + + YG+ VD++A G+I+ LL C + + ++ +G
Sbjct: 185 LRYMSPEQISSQ------DYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRDGII 236
Query: 169 SFS-SPEWNDI 178
S + +
Sbjct: 237 SDIFDKKEKTL 247
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 14/107 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE + + YG+ VD++A G+I+ LL C + + ++ +G S
Sbjct: 187 YMSPEQISSQ------DYGKEVDLYALGLILAELLHVCDTAFETSKF--FTDLRDGIIS- 237
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287
+ + K L++KLL PEDR + E L K +++
Sbjct: 238 -----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 34/117 (29%), Positives = 50/117 (42%), Gaps = 7/117 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
+ +R AL H+H+ +VH D+KP NI L + KL DFG L
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
G P Y+APE+L+ YG A DV++ G+ + + + LR
Sbjct: 217 EGDPRYMAPELLQG-------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 18/99 (18%), Positives = 36/99 (36%), Gaps = 12/99 (12%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ YG A DV++ G+ + + + LR
Sbjct: 222 YMAPELLQG-------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG-----YL 269
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+S + + ++ +L P+ R + + L
Sbjct: 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 45/123 (36%), Positives = 62/123 (50%), Gaps = 3/123 (2%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD--LCGTPGYLAPE 115
A++ VH VHRD+KP+NILLD +++L DFG L+ + GTP YL+PE
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 116 VLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPE 174
+L+A TG YG D WA GV Y + G PF+ I+ K S P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293
Query: 175 WND 177
++
Sbjct: 294 VDE 296
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 181 YLAPEVLRANMFEDATG-YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
YL+PE+L+A TG YG D WA GV Y + G PF+ I+ K
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
Query: 240 FSSPEWND-ISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHP 281
S P ++ + E+ +D I++LL PE R + H FF
Sbjct: 289 LSLPLVDEGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFFFG 333
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 44/232 (18%), Positives = 79/232 (34%), Gaps = 68/232 (29%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+I Q+ EA+E +H+ ++HRDLKP NI VK+ DFG +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM------------ 168
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
D Q V +T VG
Sbjct: 169 ---------------DQDEEEQTVLTPMPAYARHTGQVGTKL------------------ 195
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
Y++PE + N Y VD+++ G+I++ LL P +++
Sbjct: 196 ------------YMSPEQIHGN------SYSHKVDIFSLGLILFELL--YPFSTQMERVR 235
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
L ++ K+ P + +++ +L +P +R + ++ F
Sbjct: 236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 11/133 (8%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGTP 109
Q+ AL+HVH+ ++HRD+K +NI L V+L DFG ARVL +L GTP
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY- 168
YL+PE+ Y D+WA G ++Y L F ++ I+ G +
Sbjct: 190 YYLSPEICENK------PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 169 ---SFSSPEWNDI 178
S + +
Sbjct: 244 PVSLHYSYDLRSL 256
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 29/127 (22%), Positives = 48/127 (37%), Gaps = 10/127 (7%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YL+PE+ Y D+WA G ++Y L F ++ I+ G +
Sbjct: 191 YLSPEICENK------PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-- 242
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASR 300
P S D + L+ +L P DR SV L F ++ ++ + P + +
Sbjct: 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI-EKFLSPQLIAEEFCLK 300
Query: 301 KLSKINQ 307
SK
Sbjct: 301 TFSKFGS 307
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 46/119 (38%), Positives = 69/119 (57%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
AL H+H +++RDLKPENI+L+ Q +VKLTDFG + + G CGT Y+APE+
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
L + G+ +AVD W+ G +MY +L G PPF + + I++ K + P +
Sbjct: 193 LMRS------GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--PPY 243
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L + G+ +AVD W+ G +MY +L G PPF + + I++ K +
Sbjct: 187 YMAPEILMRS------GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P + ++++ +DL++KLL R E H FF +L + +EP
Sbjct: 241 --PPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEP 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 47/119 (39%), Positives = 71/119 (59%), Gaps = 10/119 (8%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR--VLKKGEKLMDLCGTPGYLAPE 115
ALEH+H +++RD+K ENILLD +V LTDFG ++ V + E+ D CGT Y+AP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIMEGKYSF 170
++R +G+ +AVD W+ GV+MY LL G PF Q + R I++ + +
Sbjct: 231 IVR----GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 21/123 (17%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMVMLRNIMEG 236
Y+AP+++R +G+ +AVD W+ GV+MY LL G PF Q + R I++
Sbjct: 226 YMAPDIVR----GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQD 287
+ + P+ +S KDLI++LL+ P+ R E H FF L +
Sbjct: 282 EPPY--PQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 337
Query: 288 IEP 290
+
Sbjct: 338 VPA 340
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 47/134 (35%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 48 LRYIMRQLFEALEHVH-----NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
+ +M QL AL+ H H+V+HRDLKP N+ LD + NVKL DFG AR+L
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 103 MD-LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
GTP Y++PE + Y + D+W+ G ++Y L PPF Q +
Sbjct: 173 AKTFVGTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226
Query: 162 NIMEGKYSFSSPEW 175
I EGK+ +
Sbjct: 227 KIREGKFRRIPYRY 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 9/103 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE + Y + D+W+ G ++Y L PPF Q + I EGK+
Sbjct: 182 YMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
S++ ++I ++L + R SV+E L +
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 44/119 (36%), Positives = 73/119 (61%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
AL+H+H+ +++RDLKPENILLD++ ++KLTDFG ++ + +K CGT Y+APEV
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
+ G+ Q+ D W+ GV+M+ +L G PF + + + I++ K P++
Sbjct: 198 VNRR------GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--PQF 248
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APEV+ G+ Q+ D W+ GV+M+ +L G PF + + + I++ K
Sbjct: 192 YMAPEVVNRR------GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM 245
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P++ +S + + L+R L P +R V+E HSFF KL+ ++I P
Sbjct: 246 --PQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHP 300
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 47/114 (41%), Positives = 63/114 (55%), Gaps = 7/114 (6%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFA-RVLKKGEKLMDLCGTPGYLAPEV 116
AL ++H+ ++V+RDLKPENILLD Q ++ LTDFG ++ CGTP YLAPEV
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
L Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 211 LHKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 258
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 34/118 (28%), Positives = 46/118 (38%), Gaps = 18/118 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL Y + VD W G ++Y +L G PPF+ R M NI+
Sbjct: 205 YLAPEVLHKQ------PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 258
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY----SVKEALNHSFFHP----KLFDQDIEP 290
I+ + L+ LL R E +H FF L ++ I P
Sbjct: 259 --KPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP 312
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 45/131 (34%), Positives = 65/131 (49%), Gaps = 12/131 (9%)
Query: 54 QLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLA 113
++ LEH+HN VV+RDLKP NILLD+ +V+++D G A K K GT GY+A
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMA 358
Query: 114 PEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM---VMLRNIMEGKYSF 170
PEVL+ Y + D ++ G +++ LL G PF K + R +
Sbjct: 359 PEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413
Query: 171 S---SPEWNDI 178
SPE +
Sbjct: 414 PDSFSPELRSL 424
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 29/123 (23%), Positives = 45/123 (36%), Gaps = 21/123 (17%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM---VMLRNIMEG 236
GY+APEVL+ Y + D ++ G +++ LL G PF K + R +
Sbjct: 355 GYMAPEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQD 287
P+ S + + L+ LL R +E FF +F Q
Sbjct: 410 AVEL--PDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 465
Query: 288 IEP 290
P
Sbjct: 466 YPP 468
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 13/128 (10%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVL 117
LE +H +V+RDLKPENILLDD +++++D G A + +G+ + GT GY+APEV+
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIMEGKYSFS-- 171
+ Y + D WA G ++Y ++ G PF RK+ + + R + E +S
Sbjct: 358 K------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 172 -SPEWNDI 178
SP+ +
Sbjct: 412 FSPQARSL 419
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 23/124 (18%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
GY+APEV++ Y + D WA G ++Y ++ G PF RK+ + + R + E
Sbjct: 350 GYMAPEVVKN------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQ 286
+ E S + L +LL P +R S +E H F +L
Sbjct: 404 VPEEY--SER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459
Query: 287 DIEP 290
+EP
Sbjct: 460 MLEP 463
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 40/119 (33%), Positives = 64/119 (53%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-VLKKGEKLMDLCGTPGYLAPEV 116
L+ +H+ +V+RDLK +NILLD ++K+ DFG + + K CGTP Y+APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
L Y +VD W+ GV++Y +L+G PF + + + +I + P W
Sbjct: 190 LLGQ------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRW 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 15/115 (13%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L Y +VD W+ GV++Y +L+G PF + + + +I +
Sbjct: 184 YIAPEILLGQ------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 237
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRY-SVKEALNHSFFHP----KLFDQDIEP 290
P W + ++ KDL+ KL + PE R + H F +L ++I+P
Sbjct: 238 --PRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP 288
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 46/114 (40%), Positives = 69/114 (60%), Gaps = 7/114 (6%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
ALE++H+ VV+RD+K EN++LD ++K+TDFG + + G + CGTP YLAPEV
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170
L N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 177 LEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 171 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P +S + K L+ LL P+ R KE + H FF + + + P
Sbjct: 225 --PRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 46/129 (35%), Positives = 71/129 (55%), Gaps = 14/129 (10%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGTPGYLAPEV 116
LEH+H ++++RDLKPEN+LLDD NV+++D G A LK G+ GTPG++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIMEGKYSFS- 171
L Y +VD +A GV +Y ++ PF R + V + + ++E ++
Sbjct: 361 LL------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414
Query: 172 --SPEWNDI 178
SP D
Sbjct: 415 KFSPASKDF 423
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 23/124 (18%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
G++APE+L Y +VD +A GV +Y ++ PF R + V + + ++E
Sbjct: 354 GFMAPELLLG------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQ 286
++ P+ S KD LL PE R S H F +L
Sbjct: 408 QAVTY--PDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAG 463
Query: 287 DIEP 290
+ P
Sbjct: 464 MLTP 467
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 34/147 (23%), Positives = 62/147 (42%), Gaps = 25/147 (17%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK----------- 97
+I Q+ EA+E +H+ ++HRDLKP NI VK+ DFG +
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 98 --KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
GT Y++PE + Y VD+++ G+I++ LL R
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIH------GNNYSHKVDIFSLGLILFELLYSFSTQMERV 280
Query: 156 QMVMLRNIMEGKY----SFSSPEWNDI 178
+ ++ ++ K+ + P+ + +
Sbjct: 281 R--IITDVRNLKFPLLFTQKYPQEHMM 305
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 16/100 (16%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y++PE + Y VD+++ G+I++ LL R ++ + ++ K+
Sbjct: 242 YMSPEQIHG------NNYSHKVDIFSLGLILFELLYSFSTQMERVRI--ITDVRNLKFP- 292
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
+ +++ +L +P +R + + ++ F
Sbjct: 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 43/119 (36%), Positives = 65/119 (54%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
AL +H+ +++RDLK +N+LLD + + KL DFG + + G CGTP Y+APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
L+ YG AVD WA GV++Y +L G PF + + I+ + + P W
Sbjct: 196 LQEM------LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 20/120 (16%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE+L+ YG AVD WA GV++Y +L G PF + + I+ + +
Sbjct: 190 YIAPEILQEM------LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 243
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR------YSVKEALNHSFFHP----KLFDQDIEP 290
P W + ED +++ + P R L H FF +L + IEP
Sbjct: 244 --PTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 20/144 (13%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG--------- 99
+++ + LE +H HRDLKP NILL D+ L D G
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 100 -EKLMDLCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPF-WHRK 155
+ T Y APE +F + + DVW+ G ++Y ++ G P+ +
Sbjct: 197 LQDWAAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 156 QMVMLRNIMEGKYSFSSPEWNDIS 179
+ + ++ + S P+ S
Sbjct: 252 KGDSVALAVQNQLSI--PQSPRHS 273
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 38/119 (31%), Positives = 67/119 (56%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
L + + +++RDLK +N++LD + ++K+ DFG + + G CGTP Y+APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
+ YG++VD WA GV++Y +L G PF + + ++IME ++ P+
Sbjct: 193 IAYQ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKS 243
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE++ YG++VD WA GV++Y +L G PF + + ++IME ++
Sbjct: 187 YIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P+ +S++ + + L+ P R ++ H+FF KL ++I+P
Sbjct: 241 --PKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 28/148 (18%)
Query: 49 RYIMRQLFEALEHVHNHS--VVHRDLKPENILLDDQMNVKLTDFGFARVLKKG------- 99
I Q A++H+H ++HRDLK EN+LL +Q +KL DFG A +
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 100 ------EKLMDLCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPF 151
E+ + TP Y PE + + + G+ D+WA G I+Y L PF
Sbjct: 199 QRRALVEEEITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 152 WHRKQMVMLRNIMEGKYSFSSPEWNDIS 179
+ I+ GKYS P +
Sbjct: 254 ----EDGAKLRIVNGKYSI--PPHDTQY 275
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 43/128 (33%), Positives = 68/128 (53%), Gaps = 18/128 (14%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
AL ++H +++RDLK +N+LLD + ++KLTD+G + L+ G+ CGTP Y+APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV---------MLRNIMEGK 167
LR YG +VD WA GV+M+ ++ G PF + + I+E +
Sbjct: 182 LRGE------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235
Query: 168 YSFSSPEW 175
P
Sbjct: 236 IRI--PRS 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 29/129 (22%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV---------MLR 231
Y+APE+LR YG +VD WA GV+M+ ++ G PF + +
Sbjct: 176 YIAPEILRGE------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229
Query: 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR------YSVKEALNHSFFHP---- 281
I+E + P +S +++ L P++R + H FF
Sbjct: 230 VILEKQIRI--PRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285
Query: 282 KLFDQDIEP 290
+ + + P
Sbjct: 286 MMEQKQVVP 294
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 39/121 (32%), Positives = 57/121 (47%), Gaps = 9/121 (7%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLCGTP 109
QL ALEH+H+ V+HRD+KP N+ + VKL D G R K L GTP
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIMEGK 167
Y++PE + N GY D+W+ G ++Y + PF+ + + I +
Sbjct: 201 YYMSPERIHEN------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 168 Y 168
Y
Sbjct: 255 Y 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 23/111 (20%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH--RKQMVMLRNIMEGKY 238
Y++PE + N GY D+W+ G ++Y + PF+ + + I + Y
Sbjct: 202 YMSPERIHEN------GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 255
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIE 289
P + SE+ + L+ + PE R V + + +E
Sbjct: 256 P-PLPS-DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 27/145 (18%), Positives = 50/145 (34%), Gaps = 23/145 (15%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILL-----------DDQMNVKLTDFGFARVLK 97
++ +E VH+ ++H D+KP+N +L D + L D G + +K
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 98 ---KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF-WH 153
KG C T G+ E+L + +D + +Y +L G +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNK------PWNYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 154 RKQMVMLRNIMEGKYSFSSPEWNDI 178
+ + WN+
Sbjct: 289 EGGECKPEGLF--RRLPHLDMWNEF 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 15/131 (11%), Positives = 34/131 (25%), Gaps = 18/131 (13%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNIMEGKY 238
G+ E+L + +D + +Y +L G + + +
Sbjct: 250 GFQCVEMLSNK------PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF--RR 301
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTA 298
WN+ +L + + L K+F Q + +
Sbjct: 302 LPHLDMWNEF-------FHVMLNIPDCHHLPSLDLLRQKLK--KVFQQHYTNKIRALRNR 352
Query: 299 SRKLSKINQLT 309
L + +
Sbjct: 353 LIVLLLECKRS 363
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 49/126 (38%), Positives = 74/126 (58%), Gaps = 11/126 (8%)
Query: 58 ALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPE 115
AL+++H+ +VV+RDLK EN++LD ++K+TDFG + +K G + CGTP YLAPE
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS---S 172
VL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 320 VLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373
Query: 173 PEWNDI 178
PE +
Sbjct: 374 PEAKSL 379
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
YLAPEVL N YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 315 YLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P + + K L+ LL P+ R KE + H FF ++++ + P
Sbjct: 369 --PRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSP 423
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 43/128 (33%), Positives = 68/128 (53%), Gaps = 18/128 (14%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV-LKKGEKLMDLCGTPGYLAPEV 116
AL ++H +++RDLK +N+LLD + ++KLTD+G + L+ G+ CGTP Y+APE+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV---------MLRNIMEGK 167
LR YG +VD WA GV+M+ ++ G PF + + I+E +
Sbjct: 225 LRGE------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 168 YSFSSPEW 175
P
Sbjct: 279 IRI--PRS 284
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 29/129 (22%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV---------MLR 231
Y+APE+LR YG +VD WA GV+M+ ++ G PF + +
Sbjct: 219 YIAPEILRGE------DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR------YSVKEALNHSFFHP---- 281
I+E + P +S +++ L P++R + H FF
Sbjct: 273 VILEKQIRI--PRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328
Query: 282 KLFDQDIEP 290
+ + + P
Sbjct: 329 MMEQKQVVP 337
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 38/119 (31%), Positives = 67/119 (56%), Gaps = 9/119 (7%)
Query: 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-VLKKGEKLMDLCGTPGYLAPEV 116
L + + +++RDLK +N++LD + ++K+ DFG + + G CGTP Y+APE+
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 513
Query: 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
+ YG++VD WA GV++Y +L G PF + + ++IME ++ P+
Sbjct: 514 IAYQ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--PKS 564
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 19/119 (15%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
Y+APE++ YG++VD WA GV++Y +L G PF + + ++IME ++
Sbjct: 508 YIAPEIIAYQ------PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR-----YSVKEALNHSFFHP----KLFDQDIEP 290
P+ +S++ + + L+ P R ++ H+FF KL ++I+P
Sbjct: 562 --PKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP 616
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 52/257 (20%), Positives = 87/257 (33%), Gaps = 47/257 (18%)
Query: 38 VQDIINSN-------PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+D+I ++ A+ YI++ + +AL+++H+ VHR +K +IL+ V L+
Sbjct: 113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 91 GFARVLKK--------GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ + +L+PEVL+ ++ GY D+++ G+
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ----QNLQGYDAKSDIYSVGITAC 228
Query: 143 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAV 202
L G PF ML + G P D S A E+ + A
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGT----VPCLLDTSTIPAEELTMSPSRSVANSGLS-- 282
Query: 203 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIV 262
+ S S P S + + L
Sbjct: 283 ----------------------DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320
Query: 263 TPEDRYSVKEALNHSFF 279
P+ R S LNHSFF
Sbjct: 321 NPDARPSASTLLNHSFF 337
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 52/244 (21%), Positives = 92/244 (37%), Gaps = 39/244 (15%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
+ Y++ Q+ ++H+H+ ++HRDLKP NI++ +K+ DFG AR +
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
T Y APEV+ GY + VD+W+ G IM ++ G F + ++E
Sbjct: 189 TRYYRAPEVIL------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-- 240
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
+P + + Y + P +
Sbjct: 241 -QLGTPCPEFMK----------KLQPTVRTYVENR-----------------PKYAGYSF 272
Query: 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287
L + + S + +DL+ K+L++ R SV EAL H + + +D
Sbjct: 273 EKL--FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV-WYDPS 329
Query: 288 IEPI 291
Sbjct: 330 EAEA 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 56/257 (21%), Positives = 83/257 (32%), Gaps = 54/257 (21%)
Query: 41 IINSNPA------LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94
+I+ ++Y M + L +H VVHRDL P NILL D ++ + DF AR
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 95 VLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154
Y APE++ G+ + VD+W+ G +M + F
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFK-----GFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 214
L I+E + G E + A Y
Sbjct: 238 TFYNQLNKIVE------------VVGTPKIEDVVMFSSPSARDY---------------- 269
Query: 215 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
L + + P DLI K+L P+ R S ++AL
Sbjct: 270 LRNSLSNVPARA-------WTAVVPTADPV-------ALDLIAKMLEFNPQRRISTEQAL 315
Query: 275 NHSFFHPKLFDQDIEPI 291
H +F LFD
Sbjct: 316 RHPYFES-LFDPLDLTE 331
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 46/237 (19%), Positives = 93/237 (39%), Gaps = 48/237 (20%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCG 107
R+ M ++ +AL++ H+ ++HRD+KP N+++D + ++L D+G A G++
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-MLRNIME- 165
+ + PE+L D Y ++D+W+ G ++ +++ PF+H L I +
Sbjct: 193 SRYFKGPELLV-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 166 -GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224
G + + D E+ R
Sbjct: 248 LG-----TEDLYDYIDKYNIELDPR-------------------------FNDILGRHSR 277
Query: 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281
K+ S + +S + D + KLL + R + +EA+ H +F+
Sbjct: 278 KRWERF---------VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 39/250 (15%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM--NVKLTDFGFARVLKKGEK 101
S P +R + + L+ +H + ++H DLKPENILL Q +K+ DFG + + ++
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQR 255
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
+ + Y APEV+ YG +D+W+ G I+ LL G P + L
Sbjct: 256 VYTYIQSRFYRAPEVIL------GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
Query: 162 NIME--GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
++E G S L RA F + GY + V
Sbjct: 310 CMIELLGM----------PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV------- 352
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDP-----KDLIRKLLIVTPEDRYSVKEAL 274
R + + S EW + + D +++ L P R + +AL
Sbjct: 353 ---VLNGGRSRRGKL--RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 275 NHSFFHPKLF 284
H + +L
Sbjct: 408 RHPWLRRRLP 417
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 55/255 (21%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
I+ +++++ Q+ L+++H+ ++HRDLKP N+ +++ +K+ DFG AR
Sbjct: 123 IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182
Query: 97 KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
+++ T Y APE++ M Y Q VD+W+ G IM LL G F
Sbjct: 183 --ADEMTGYVATRWYRAPEIMLNWM-----HYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235
Query: 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 216
+ L+ I+ + G E+L+ E A Y Q++
Sbjct: 236 IDQLKLILR------------LVGTPGAELLKKISSESARNYIQSL-------------- 269
Query: 217 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ + ++P DL+ K+L++ + R + +AL H
Sbjct: 270 ---TQMPKMN-------FANVFIGANPL-------AVDLLEKMLVLDSDKRITAAQALAH 312
Query: 277 SFFHPKLFDQDIEPI 291
++F D D EP+
Sbjct: 313 AYFAQ-YHDPDDEPV 326
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 51/243 (20%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+Y++ Q+ + L+++H+ VVHRDLKP N+ +++ +K+ DFG AR ++ T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVT 186
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y APEV+ + M Y Q VD+W+ G IM +L G F + + L I++
Sbjct: 187 RWYRAPEVILSWM-----HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK--- 238
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
++G E ++ + A Y Q++ P RK
Sbjct: 239 ---------VTGVPGTEFVQKLNDKAAKSYIQSL-----------------PQTPRKD-- 270
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDI 288
+ +SP+ DL+ K+L + + R + +AL H FF P D +
Sbjct: 271 -----FTQLFPRASPQ-------AADLLEKMLELDVDKRLTAAQALTHPFFEP-FRDPEE 317
Query: 289 EPI 291
E
Sbjct: 318 ETE 320
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 23/133 (17%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
G LK Q + EA + ++ AL ++H+ +V+ DLKPENI+
Sbjct: 167 GGQSLKRSKGQKLPVAEAIA------------YLLEILPALSYLHSIGLVYNDLKPENIM 214
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACG 138
L ++ +KL D G + L GTPG+ APE++R TG A D++ G
Sbjct: 215 LTEE-QLKLIDLGAVSRINSFGYLY---GTPGFQAPEIVR-------TGPTVATDIYTVG 263
Query: 139 VIMYTLLVGCPPF 151
+ L + P
Sbjct: 264 RTLAALTLDLPTR 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 23/92 (25%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
G+ APE++R TG A D++ G + L + P G+Y
Sbjct: 242 GFQAPEIVR-------TGPTVATDIYTVGRTLAALTLDLPTR-------------NGRYV 281
Query: 240 FSSPEWN---DISEDPKDLIRKLLIVTPEDRY 268
PE + + L+R+ + P R+
Sbjct: 282 DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/253 (20%), Positives = 97/253 (38%), Gaps = 50/253 (19%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
Y++ Q+ ++H+H+ ++HRDLKP NI++ +K+ DFG AR + T
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y APEV+ GY + VD+W+ G IM ++ F R + ++E
Sbjct: 227 RYYRAPEVIL------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE--- 277
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
+P + + Y + P +
Sbjct: 278 QLGTPCPEFMK----------KLQPTVRNYVENR-----------------PKYAGLTFP 310
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF--------- 279
L + + S + +DL+ K+L++ P R SV +AL H +
Sbjct: 311 KL--FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 368
Query: 280 ---HPKLFDQDIE 289
P+++D+ ++
Sbjct: 369 EAPPPQIYDKQLD 381
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 55/255 (21%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
++ +++++ Q+ + L ++H ++HRDLKP N+ +++ +K+ DFG AR
Sbjct: 119 LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178
Query: 97 KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
++ T Y APEV+ M Y Q VD+W+ G IM ++ G F
Sbjct: 179 --DSEMTGYVVTRWYRAPEVILNWM-----RYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231
Query: 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 216
+ L+ IM+ ++G E ++ ++A Y + +
Sbjct: 232 LDQLKEIMK------------VTGTPPAEFVQRLQSDEAKNYMKGL-------------- 265
Query: 217 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
P +K + +SP +L+ K+L++ E R + EAL H
Sbjct: 266 ---PELEKKD-------FASILTNASPL-------AVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 277 SFFHPKLFDQDIEPI 291
+F L D + EP
Sbjct: 309 PYFES-LHDTEDEPQ 322
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 15/121 (12%)
Query: 40 DIINSNPALRY-----IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94
DI+++ + ++ +AL H + ++HRD+KP NI++ VK+ DFG AR
Sbjct: 105 DIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 95 VLKKGEKLM----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150
+ + + GT YL+PE R + DV++ G ++Y +L G PP
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDA---RSDVYSLGCVLYEVLTGEPP 218
Query: 151 F 151
F
Sbjct: 219 F 219
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 29/156 (18%), Positives = 57/156 (36%), Gaps = 34/156 (21%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-------------------DQMNVK 86
L+ ++ Q+ L ++H+ S+VH D+KP NI + +++ K
Sbjct: 115 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 87 LTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146
+ D G + G +LA EVL+ N + D++A + +
Sbjct: 175 IGDLGHVTRIS---SPQVEEGDSRFLANEVLQENY-----THLPKADIFALALTVVCAAG 226
Query: 147 GCPPFWHRKQMVMLRNIMEGKY----SFSSPEWNDI 178
P + I +G+ S E+ ++
Sbjct: 227 AEPLP---RNGDQWHEIRQGRLPRIPQVLSQEFTEL 259
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 11/101 (10%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
+LA EVL+ N + D++A + + P + I +G+
Sbjct: 196 FLANEVLQENY-----THLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGRLPR 247
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281
S++ +L++ ++ PE R S + HS
Sbjct: 248 IPQVL---SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 42/104 (40%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEKLMDLCG 107
+ I Q +A+ H H+ +HRD+KPENIL+ +KL DFGFAR+L + D
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y +PE+L T YG VDVWA G + LL G P +
Sbjct: 165 TRWYRSPELLVG-----DTQYGPPVDVWAIGCVFAELLSGVPLW 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 30/127 (23%), Positives = 47/127 (37%), Gaps = 32/127 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI------- 233
Y +PE+L T YG VDVWA G + LL G P + + + L I
Sbjct: 168 YRSPELLVG-----DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222
Query: 234 ----------MEGKYSFSSPEWND----------ISEDPKDLIRKLLIVTPEDRYSVKEA 273
+ P+ D IS L++ L + P +R + ++
Sbjct: 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282
Query: 274 LNHSFFH 280
L+H +F
Sbjct: 283 LHHPYFE 289
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLCGTPGYLAPEVLRA 119
H N +VHR+LK N+L+D + VK+ DFG +R+ GTP ++APEVLR
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 120 NMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ DV++ GVI++ L P+
Sbjct: 214 EP------SNEKSDVYSFGVILWELATLQQPW 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 58/278 (20%), Positives = 103/278 (37%), Gaps = 61/278 (21%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
+I +N +Y++ QL + ++++H+ ++HRD+KP NILL+ + +VK+ DFG +R
Sbjct: 100 VIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 97 KKGEKLMDLCGTPG----------------------YLAPEVLRANMFEDATGYGQAVDV 134
++ + Y APE+L + Y + +D+
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST-----KYTKGIDM 214
Query: 135 WACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFED 194
W+ G I+ +L G P F M L I+ + + + E + +
Sbjct: 215 WSLGCILGEILCGKPIFPGSSTMNQLERIIG------------VIDFPSNEDVESIQSPF 262
Query: 195 ATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN-DISEDPK 253
A + +Q + K D +E+
Sbjct: 263 AKTM----------------IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 254 DLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
DL+ KLL P R S +AL H F + + EP
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSI-FHNPNEEPN 343
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 6/109 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KL 102
L I RQ ++++H S++HRDLK NI L + VK+ DFG A + +
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L G+ ++APEV+R +D+ Y DV+A G+++Y L+ G P+
Sbjct: 180 EQLSGSILWMAPEVIR---MQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 15/41 (36%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
++APEV+R +D+ Y DV+A G+++Y L+ G P+
Sbjct: 188 WMAPEVIR---MQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 43/104 (41%), Positives = 59/104 (56%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKLMDLCG 107
+ + Q+ + H+H+++HRD+KPENIL+ VKL DFGFAR L GE D
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
T Y APE+L YG+AVDVWA G ++ + +G P F
Sbjct: 187 TRWYRAPELLVG-----DVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 39/146 (26%), Positives = 57/146 (39%), Gaps = 37/146 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI------- 233
Y APE+L YG+AVDVWA G ++ + +G P F + L +I
Sbjct: 190 YRAPELLVG-----DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244
Query: 234 ----MEGKYS------FSSPEWN----------DISEDPKDLIRKLLIVTPEDRYSVKEA 273
E PE +SE DL +K L + P+ R E
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 274 LNHSFFH----PKLFDQDI-EPIKKD 294
L+H FF + F Q++ ++KD
Sbjct: 305 LHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 10/113 (8%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK------KGEK 101
R I +++ + + ++H ++H+DLK +N+ D+ V +TDFG + + +K
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDK 190
Query: 102 LMDLCGTPGYLAPEVLR---ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
L G +LAPE++R + ED + + DV+A G I Y L PF
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/44 (36%), Positives = 23/44 (52%), Gaps = 3/44 (6%)
Query: 181 YLAPEVLR---ANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
+LAPE++R + ED + + DV+A G I Y L PF
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 57/259 (22%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
++ + + Y + Q+ L+++H+ +V+HRDLKP N+LL+ ++K+ DFG ARV
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 97 KKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152
L + T Y APE++ + GY +++D+W+ G I+ +L P F
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSK-----GYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 212
+ + L +I+ I G + E L + A Y ++
Sbjct: 234 GKHYLDQLNHILG------------ILGSPSQEDLNCIINLKARNYLLSL---------- 271
Query: 213 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKE 272
P ++ + + + D L+ K+L P R V++
Sbjct: 272 -------PHKNKVP-------WNRLFPNADSKALD-------LLDKMLTFNPHKRIEVEQ 310
Query: 273 ALNHSFFHPKLFDQDIEPI 291
AL H + +D EPI
Sbjct: 311 ALAHPYLEQ-YYDPSDEPI 328
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 13/125 (10%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ-MNVKLTDFGFARVL------KK 98
Y + Q E LE++H ++H D+K +N+LL L DFG A L K
Sbjct: 150 DRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 99 GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
+ GT ++APEV+ VD+W+ +M +L GC P+ +
Sbjct: 210 LLTGDYIPGTETHMAPEVVM------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263
Query: 159 MLRNI 163
+ I
Sbjct: 264 LCLKI 268
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 37/122 (30%), Positives = 64/122 (52%), Gaps = 19/122 (15%)
Query: 40 DIINSNPALRY-----IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94
+ I S+ L Q+ + ++H H+ +VHRD+KP+NIL+D +K+ DFG A+
Sbjct: 100 EYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 95 VLK-----KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
L + ++ GT Y +PE + E + D+++ G+++Y +LVG P
Sbjct: 160 ALSETSLTQTNHVL---GTVQYFSPEQAKG---EATD---ECTDIYSIGIVLYEMLVGEP 210
Query: 150 PF 151
PF
Sbjct: 211 PF 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 40/137 (29%), Positives = 59/137 (43%), Gaps = 22/137 (16%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
G DL + + +G A + I+RQ+ AL+ H HRD+KPENIL
Sbjct: 117 NGVDLAAM---LRRQGPLAPPRAVA-------IVRQIGSALDAAHAAGATHRDVKPENIL 166
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLM----DLCGTPGYLAPEVLRANMFEDATGYGQAVDV 134
+ L DFG A ++ + + GT Y+APE AT D+
Sbjct: 167 VSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSE---SHATY---RADI 218
Query: 135 WACGVIMYTLLVGCPPF 151
+A ++Y L G PP+
Sbjct: 219 YALTCVLYECLTGSPPY 235
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 56/294 (19%), Positives = 97/294 (32%), Gaps = 71/294 (24%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95
+ + L + ++ L +++VH+ ++HRDLKP N L++ +VK+ DFG AR
Sbjct: 146 LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 96 LKKGEKLMDLCGTPG----------------------------YLAPEVLRANMFEDATG 127
+ E Y APE++
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-----QEN 260
Query: 128 YGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK-YSFSSPEWNDISGYLAPEV 186
Y +A+DVW+ G I LL + + G SP+ + +
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKE--NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318
Query: 187 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 246
+ VI L G P + + L +Y P+
Sbjct: 319 GNRDQLN---------------VIFNIL--GTPS---EEDIEALEKEDAKRYIRIFPKRE 358
Query: 247 ---------DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
S D L++++L+ P R ++ E L H FF + ++E
Sbjct: 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE-VRIAEVETN 411
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 5/106 (4%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL-----CGTPGY 111
E ++ HRDLK +NIL+ + D G A + + +D+ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157
+APEVL + D + VD+WA G++++ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 12/47 (25%), Positives = 22/47 (46%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
Y+APEVL + D + VD+WA G++++ + +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 55/248 (22%), Positives = 93/248 (37%), Gaps = 26/248 (10%)
Query: 44 SNPALRYIMRQLFEALEHVHNH--SVVHRDLKPENILLDDQMN--VKLTDFGFARVLKKG 99
S R +Q+ AL + S++H DLKPENILL + +K+ DFG + + G
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC--QLG 212
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+++ + Y +PEVL Y A+D+W+ G I+ + G P F ++
Sbjct: 213 QRIYQYIQSRFYRSPEVLLG------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
+ I+E + G +L W P
Sbjct: 267 MNKIVE------------VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 314
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPK--DLIRKLLIVTPEDRYSVKEALNHS 277
P + ++ + + +++ K DLI ++L P+ R AL HS
Sbjct: 315 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374
Query: 278 FFHPKLFD 285
FF +
Sbjct: 375 FFKKTADE 382
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 53/263 (20%), Positives = 99/263 (37%), Gaps = 59/263 (22%)
Query: 44 SNPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDD------QMNVKLTDFGFARVL 96
++ I +QL L+++H ++H D+KPEN+L++ + +K+ D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW- 187
Query: 97 KKGEKLMDLCGTPGYLAPEV-LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---- 151
E + T Y +PEV L A +G D+W+ +++ L+ G F
Sbjct: 188 -YDEHYTNSIQTREYRSPEVLLGA-------PWGCGADIWSTACLIFELITGDFLFEPDE 239
Query: 152 --WHRKQMVMLRNIME--GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWAC 207
+ K + I+E G+ + YL F ++ G + +
Sbjct: 240 GHSYTKDDDHIAQIIELLGE----------LPSYLLRNGKYTRTFFNSRGLLRNI----- 284
Query: 208 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR 267
+ + L +++ KY FS E +I D + +L + P R
Sbjct: 285 ---------------SKLKFWPLEDVLTEKYKFSKDEAKEI----SDFLSPMLQLDPRKR 325
Query: 268 YSVKEALNHSFFHPKLFDQDIEP 290
+NH + L ++I
Sbjct: 326 ADAGGLVNHPWLKDTLGMEEIRV 348
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 42/129 (32%), Positives = 64/129 (49%), Gaps = 9/129 (6%)
Query: 37 AVQDIINSNPALR-------YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTD 89
+V D+I + YI R++ L H+H H V+HRD+K +N+LL + VKL D
Sbjct: 113 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172
Query: 90 FGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148
FG + L + + GTP ++APEV+ + DA Y D+W+ G+ + G
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA-TYDFKSDLWSLGITAIEMAEGA 231
Query: 149 PPFWHRKQM 157
PP M
Sbjct: 232 PPLCDMHPM 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 63/284 (22%), Positives = 103/284 (36%), Gaps = 43/284 (15%)
Query: 22 DLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81
DL H+ + ++ ++ Q+ + + ++H + V+HRDLKP NIL+
Sbjct: 105 DLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 163
Query: 82 QMN----VKLTDFGFARVLKKGEK-LMDLCG---TPGYLAPEVLRANMFEDATGYGQAVD 133
+ VK+ D GFAR+ K L DL T Y APE+L A Y +A+D
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-----ARHYTKAID 218
Query: 134 VWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFE 193
+WA G I LL P I + + + Y ++ R +F
Sbjct: 219 IWAIGCIFAELLTSEP-------------IFHCR----QEDIKTSNPYHHDQLDR--IFN 259
Query: 194 DATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPK 253
G+ A W + + R I + P
Sbjct: 260 -VMGF-PADKDWE-DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----DSKAF 311
Query: 254 DLIRKLLIVTPEDRYSVKEALNHSFFH--PKLFDQDIEPIKKDY 295
L++KLL + P R + ++A+ +F P + Y
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPY 355
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 42/104 (40%), Positives = 64/104 (61%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCG 107
+ M QLF +L ++H+ + HRD+KP+N+LLD D +KL DFG A+ L +GE +
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ Y APE+ +F AT Y ++DVW+ G ++ LL+G P F
Sbjct: 219 SRYYRAPEL----IF-GATDYTSSIDVWSAGCVLAELLLGQPIF 257
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 36/135 (26%), Positives = 54/135 (40%), Gaps = 31/135 (22%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---WHRKQMVM-------- 229
Y APE+ +F AT Y ++DVW+ G ++ LL+G P F Q+V
Sbjct: 222 YRAPEL----IF-GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 230 ----LRNIMEGKYSFSSPEW----------NDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
+R + F P+ + L +LL TP R + EA
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
Query: 276 HSFFHPKLFDQDIEP 290
HSFF L D +++
Sbjct: 337 HSFFDE-LRDPNVKL 350
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 36/118 (30%), Positives = 65/118 (55%), Gaps = 12/118 (10%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM-NVKLTDFGFARVLKK-GEKLM 103
+ + +Q+ E L+++H++ +VHRD+K +N+L++ +K++DFG ++ L
Sbjct: 122 QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVW--ACGVI-MYTLLVGCPPFWHRKQMV 158
GT Y+APE++ + GYG+A D+W C +I M T G PPF+ +
Sbjct: 182 TFTGTLQYMAPEIID----KGPRGYGKAADIWSLGCTIIEMAT---GKPPFYELGEPQ 232
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 20/124 (16%)
Query: 160 LRNIMEGKYSFS-SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVW--ACGVI-MYTLL 215
L I +F+ + ++ +APE++ + GYG+A D+W C +I M T
Sbjct: 173 LAGINPCTETFTGTLQY------MAPEIID----KGPRGYGKAADIWSLGCTIIEMAT-- 220
Query: 216 VGCPPFWHRKQ-MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
G PPF+ + + + K PE +S + K I K P+ R + L
Sbjct: 221 -GKPPFYELGEPQAAMFKVGMFKVHPEIPE--SMSAEAKAFILKCFEPDPDKRACANDLL 277
Query: 275 NHSF 278
F
Sbjct: 278 VDEF 281
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-24
Identities = 15/91 (16%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRAN 120
H + L ++++D+ M +++ + + P ++APE L+
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQK- 182
Query: 121 MFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ ++ D+W+ V+++ L+ PF
Sbjct: 183 --KPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APE L+ + ++ D+W+ V+++ L+ PF M + +
Sbjct: 174 WVAPEALQK---KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDR 267
+ P IS L++ + P R
Sbjct: 231 TIPP--GISPHVSKLMKICMNEDPAKR 255
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 5/100 (5%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL-----CGTPGY 111
E ++ HRDLK +NIL+ + D G A +D+ GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ PEVL ++ + D+++ G+I++ + C
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 9/41 (21%), Positives = 20/41 (48%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
Y+ PEVL ++ + D+++ G+I++ + C
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 18/135 (13%)
Query: 22 DLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81
DLK + +D ++Y QL + L H + ++HRDLKP+N+L++
Sbjct: 88 DLK----KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143
Query: 82 QMNVKLTDFGFARVLKKGEKLMDLCGTPG-----YLAPEVLRANMFEDATGYGQAVDVWA 136
+ +KL DFG AR + Y AP+VL + Y ++D+W+
Sbjct: 144 RGQLKLGDFGLARAFGIPVNTF----SSEVVTLWYRAPDVLMG-----SRTYSTSIDIWS 194
Query: 137 CGVIMYTLLVGCPPF 151
CG I+ ++ G P F
Sbjct: 195 CGCILAEMITGKPLF 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 35/130 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y AP+VL + Y ++D+W+CG I+ ++ G P F L+ I + G
Sbjct: 174 YRAPDVLMG-----SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228
Query: 237 ------------KYSFSSPEW--------------NDISEDPKDLIRKLLIVTPEDRYSV 270
KY+ + + + + D + LL + P+ R S
Sbjct: 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 271 KEALNHSFFH 280
K+AL+H +F
Sbjct: 289 KQALHHPWFA 298
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 18/145 (12%)
Query: 37 AVQDIINSNP----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
+ D++ P + I+R++ + L+++H+ +HRD+K N+LL + VKL DFG
Sbjct: 106 SALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV 165
Query: 93 ARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
A L K GTP ++APEV++ + Y D+W+ G+ L G PP
Sbjct: 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELARGEPPH 219
Query: 152 WHRKQMVMLRNI-------MEGKYS 169
M +L I +EG YS
Sbjct: 220 SELHPMKVLFLIPKNNPPTLEGNYS 244
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 14/108 (12%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ + QL + H H H ++HRDLKP+N+L++ +KL DFG AR + T
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY----T 177
Query: 109 PG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y AP+VL + Y +VD+W+ G I ++ G P F
Sbjct: 178 HEVVTLWYRAPDVLMG-----SKKYSTSVDIWSIGCIFAEMITGKPLF 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 28/126 (22%), Positives = 45/126 (35%), Gaps = 31/126 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y AP+VL + Y +VD+W+ G I ++ G P F L I
Sbjct: 185 YRAPDVLMG-----SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239
Query: 236 --------------GKYSFSSPEWND-------ISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+ +F E ++ DL+ +L P R S ++A+
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299
Query: 275 NHSFFH 280
NH +F
Sbjct: 300 NHPYFK 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 12/105 (11%)
Query: 51 IMRQLFEALEHVHNH---SVVHRDLKPENILLDDQMNV-KLTDFGFARVLKKGEKLMDLC 106
Q + + ++H+ +++HRDLKP N+LL V K+ DFG A ++ + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNK 164
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
G+ ++APEV + Y + DV++ G+I++ ++ PF
Sbjct: 165 GSAAWMAPEVFEGS------NYSEKCDVFSWGIILWEVITRRKPF 203
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 36/124 (29%), Positives = 62/124 (50%), Gaps = 8/124 (6%)
Query: 37 AVQDIINSNPA------LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
AV I+ ++ + RQ+ EAL +H+ ++HRDLK N+L+ + +++L DF
Sbjct: 102 AVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161
Query: 91 GFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
G + K +K GTP ++APEV+ +D Y D+W+ G+ + + P
Sbjct: 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT-PYDYKADIWSLGITLIEMAQIEP 220
Query: 150 PFWH 153
P
Sbjct: 221 PHHE 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 11/120 (9%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC--- 106
I+R++ E LE++H + +HRD+K NILL + +V++ DFG + L G +
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 107 ---GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
GTP ++APEV+ E GY D+W+ G+ L G P+ M +L
Sbjct: 185 TFVGTPCWMAPEVM-----EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 40/132 (30%), Positives = 73/132 (55%), Gaps = 11/132 (8%)
Query: 37 AVQDIINSNP----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
A+ DI++ + + + +AL ++H V+HRD+K ++ILL VKL+DFGF
Sbjct: 128 ALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 93 -ARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
A++ K K L GTP ++APEV+ + Y VD+W+ G+++ ++ G PP+
Sbjct: 188 CAQISKDVPKRKSLVGTPYWMAPEVIS------RSLYATEVDIWSLGIMVIEMVDGEPPY 241
Query: 152 WHRKQMVMLRNI 163
+ + ++ +
Sbjct: 242 FSDSPVQAMKRL 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-23
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 14/108 (12%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ + QL + + H+ V+HRDLKP+N+L++ + +K+ DFG AR + T
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY----T 158
Query: 109 PG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y AP+VL + Y +D+W+ G I ++ G P F
Sbjct: 159 HEIVTLWYRAPDVLMG-----SKKYSTTIDIWSVGCIFAEMVNGTPLF 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 59.8 bits (146), Expect = 3e-10
Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 30/124 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y AP+VL + Y +D+W+ G I ++ G P F + L I G
Sbjct: 166 YRAPDVLMG-----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220
Query: 237 ------------KYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALN 275
KY + + + E DL+ K+L + P R + K+AL
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 276 HSFF 279
H++F
Sbjct: 281 HAYF 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ + QL L + H V+HRDLKP+N+L++++ +KL DFG AR K
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY----D 158
Query: 109 PG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y P++L +T Y +D+W G I Y + G P F
Sbjct: 159 NEVVTLWYRPPDILLG-----STDYSTQIDMWGVGCIFYEMATGRPLF 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 28/126 (22%), Positives = 42/126 (33%), Gaps = 31/126 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y P++L +T Y +D+W G I Y + G P F L I
Sbjct: 166 YRPPDILLG-----STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP 220
Query: 236 --------------GKYSFSSPEWND-------ISEDPKDLIRKLLIVTPEDRYSVKEAL 274
Y++ + D DL+ KLL +R S ++A+
Sbjct: 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280
Query: 275 NHSFFH 280
H FF
Sbjct: 281 KHPFFL 286
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCG 107
+ M QL +L ++H+ + HRD+KP+N+LLD +KL DFG A++L GE +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ Y APE+ +F AT Y +D+W+ G +M L+ G P F
Sbjct: 204 SRYYRAPEL----IF-GATNYTTNIDIWSTGCVMAELMQGQPLF 242
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 49/187 (26%), Positives = 70/187 (37%), Gaps = 41/187 (21%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---WHRKQMV--------- 228
Y APE+ +F AT Y +D+W+ G +M L+ G P F Q+V
Sbjct: 207 YRAPEL----IF-GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 229 ---MLRNIMEGKYSFSSPEW----------NDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
++ + P+ D DLI +LL TP R + EAL
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 276 HSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPAL 335
H FF L + R+L L + L VR + ISRL H A
Sbjct: 322 HPFFDE-LRTGEARM------PNGRELPP---LFNWTKEELSVRPDL-ISRLVPQHAEAE 370
Query: 336 SVTQGRD 342
+++G D
Sbjct: 371 LLSRGID 377
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 5/102 (4%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL-----CGTPGY 111
E + ++ HRDLK +NIL+ + D G A +D+ GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153
+APEVL ++ + D++A G++ + + C
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 10/43 (23%), Positives = 20/43 (46%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
Y+APEVL ++ + D++A G++ + + C
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 50 YIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTP 109
+ + L ++H+H+++HRD+K NILL + VKL DFG A ++ + GTP
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTP 214
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153
++APEV+ A D Y VDVW+ G+ L PP ++
Sbjct: 215 YWMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 38/148 (25%), Positives = 58/148 (39%), Gaps = 18/148 (12%)
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220
N G +P W +APEV+ A D Y VDVW+ G+ L PP
Sbjct: 207 ANSFVG-----TPYW------MAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPP 252
Query: 221 FWHRKQMVMLRNI-MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
++ M L +I + S W SE ++ + L P+DR + + L H F
Sbjct: 253 LFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309
Query: 280 HPKLFDQDIEPIKKDYKTASRKLSKINQ 307
+ I + + K A R+L +
Sbjct: 310 LRERPPTVIMDLIQRTKDAVRELDNLQY 337
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 10/106 (9%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
+M+ L L ++H + ++HRD+K N+L+ +KL DFG AR + T
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 111 -----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y PE+L YG +D+W G IM + P
Sbjct: 189 VVTLWYRPPELLLG-----ERDYGPPIDLWGAGCIMAEMWTRSPIM 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 34/156 (21%), Positives = 45/156 (28%), Gaps = 40/156 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI------- 233
Y PE+L YG +D+W G IM + P + L I
Sbjct: 194 YRPPELLLG-----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 234 ----------MEGKYSFSSPEW---------NDISEDPK--DLIRKLLIVTPEDRYSVKE 272
E + DP DLI KLL++ P R +
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308
Query: 273 ALNHSFFH-------PKLFDQDIEPIKKDYKTASRK 301
ALNH FF K +Y R+
Sbjct: 309 ALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 38/235 (16%)
Query: 46 PALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
L + + + L ++ H ++HRD+KP NIL++ + +KL DFG + L
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 189
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 164
GT Y++PE L T Y D+W+ G+ + + VG P +
Sbjct: 190 FVGTRSYMSPERL------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 243
Query: 165 EGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224
++ P + ++ ++ PP
Sbjct: 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE---------LLDYIVNEPPP---- 290
Query: 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
S + S + +D + K LI P +R +K+ + H+F
Sbjct: 291 --------------KLPSGVF---SLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 43/132 (32%), Positives = 74/132 (56%), Gaps = 11/132 (8%)
Query: 37 AVQDIINSNP----ALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGF 92
++ D++ + + R+ +ALE +H++ V+HRD+K +NILL +VKLTDFGF
Sbjct: 103 SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 93 -ARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
A++ + K + GTP ++APEV+ YG VD+W+ G++ ++ G PP+
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVT------RKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 152 WHRKQMVMLRNI 163
+ + L I
Sbjct: 217 LNENPLRALYLI 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 39/106 (36%), Positives = 53/106 (50%), Gaps = 14/106 (13%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
M + LE++H H ++HRDLKP N+LLD+ +KL DFG A+ + T
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----THQ 172
Query: 111 -----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y APE+L A YG VD+WA G I+ LL+ P
Sbjct: 173 VVTRWYRAPELLFG-----ARMYGVGVDMWAVGCILAELLLRVPFL 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 31/126 (24%), Positives = 44/126 (34%), Gaps = 33/126 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y APE+L A YG VD+WA G I+ LL+ P + L I E
Sbjct: 178 YRAPELLFG-----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232
Query: 236 ------------GKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+F + +D DLI+ L + P R + +AL
Sbjct: 233 TEEQWPDMCSLPDYVTF--KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 275 NHSFFH 280
+F
Sbjct: 291 KMKYFS 296
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 17/142 (11%)
Query: 46 PALRYIMRQLFEALEHVHNHS--VVHRDLKPENILLDDQM-NVKLTDFGFARVLKKGEKL 102
LR RQ+ + L+ +H + ++HRDLK +NI + +VK+ D G A + +
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFA 187
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM-VMLR 161
+ GTP ++APE+ Y ++VDV+A G+ M + P+ + + R
Sbjct: 188 KAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 162 NIMEGK-----YSFSSPEWNDI 178
+ G + PE +I
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEI 262
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 27/112 (24%), Positives = 51/112 (45%), Gaps = 16/112 (14%)
Query: 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM-VML 230
+PE+ +APE+ Y ++VDV+A G+ M + P+ + +
Sbjct: 193 TPEF------MAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239
Query: 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282
R + G S + + K++I + ++RYS+K+ LNH+FF +
Sbjct: 240 RRVTSGVKPASFDK--VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 11/96 (11%)
Query: 61 HVHNHSVVHRDLKPENILLDDQ-----MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPE 115
N +VHRDL+ NI L + K+ DFG ++ + L G ++APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPE 196
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ A Y + D ++ +I+YT+L G PF
Sbjct: 197 TIGAE----EESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 44/137 (32%), Positives = 62/137 (45%), Gaps = 15/137 (10%)
Query: 46 PALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
L I +AL H+ N ++HRD+KP NILLD N+KL DFG + L
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF--WH--RKQMVM- 159
G Y+APE + + GY DVW+ G+ +Y L G P+ W+ Q+
Sbjct: 185 DAGCRPYMAPERIDPS--ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
Query: 160 -------LRNIMEGKYS 169
L N E ++S
Sbjct: 243 VKGDPPQLSNSEEREFS 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 14/106 (13%)
Query: 59 LEHVHNH----------SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD---L 105
L ++H ++ HRD+K +N+LL + + + DFG A + G+ D
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
GT Y+APEVL + + + D++A G++++ L C
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRI-DMYAMGLVLWELASRCTAA 238
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 11/42 (26%), Positives = 21/42 (50%), Gaps = 1/42 (2%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221
Y+APEVL + + + D++A G++++ L C
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRI-DMYAMGLVLWELASRCTAA 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ +M QL L+ +H+H VVHRDLKP+NIL+ +KL DFG AR+ L + T
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y APEVL + Y VD+W+ G I + P F
Sbjct: 183 LWYRAPEVLL------QSSYATPVDLWSVGCIFAEMFRRKPLF 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 33/125 (26%), Positives = 46/125 (36%), Gaps = 33/125 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y APEVL + Y VD+W+ G I + P F + L I++ G
Sbjct: 185 YRAPEVLLQ------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 237 ------------KYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALN 275
+ +F + DI E KDL+ K L P R S AL+
Sbjct: 239 GEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
Query: 276 HSFFH 280
H +F
Sbjct: 297 HPYFQ 301
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM-NVKLTDFGFARVLKKGEKLMDLCG 107
+ QLF A+ +H+ + HRD+KP+N+L++ + +KL DFG A+ L E +
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC 203
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ Y APE+ M AT Y ++D+W+ G + L++G P F
Sbjct: 204 SRFYRAPEL----ML-GATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 37/177 (20%), Positives = 62/177 (35%), Gaps = 31/177 (17%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---WHRKQMVM-------- 229
Y APE+ M AT Y ++D+W+ G + L++G P F Q+V
Sbjct: 207 YRAPEL----ML-GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261
Query: 230 ----LRNIMEGKYSFSSPEWNDIS-------EDPK---DLIRKLLIVTPEDRYSVKEALN 275
+ + P P DL+ ++L P+ R + EA+
Sbjct: 262 TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
Query: 276 HSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHV 332
H FF L + +K + I QL F L + ++R+ +
Sbjct: 322 HPFFDH-LRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNF 377
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 14/110 (12%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ + QL + L H+ +V+HRDLKP+N+L++ +KL +FG AR + +
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----S 159
Query: 109 PG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153
Y P+VL A Y ++D+W+ G I L P +
Sbjct: 160 AEVVTLWYRPPDVLFG-----AKLYSTSIDMWSAGCIFAELANAGRPLFP 204
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 6e-08
Identities = 28/126 (22%), Positives = 50/126 (39%), Gaps = 31/126 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK----QMVMLRNIM-- 234
Y P+VL A Y ++D+W+ G I L P + Q+ + ++
Sbjct: 167 YRPPDVLFG-----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
Query: 235 --EGKY-SFSS-PEWN----------------DISEDPKDLIRKLLIVTPEDRYSVKEAL 274
E ++ S + P++ ++ +DL++ LL P R S +EAL
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 275 NHSFFH 280
H +F
Sbjct: 282 QHPYFS 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 37 AVQDIINSNPA------LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90
+V DII + I++ + LE++H +HRD+K NILL+ + + KL DF
Sbjct: 110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
Query: 91 GFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149
G A L K + GTP ++APEV++ GY D+W+ G+ + G P
Sbjct: 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI------GYNCVADIWSLGITAIEMAEGKP 223
Query: 150 PFWHRKQMVMLRNI 163
P+ M + I
Sbjct: 224 PYADIHPMRAIFMI 237
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 4/111 (3%)
Query: 46 PALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
L + + +AL ++ H V+HRD+KP NILLD++ +KL DFG + L +
Sbjct: 124 RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF--WH 153
G Y+APE + Y DVW+ G+ + L G P+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKP-DYDIRADVWSLGISLVELATGQFPYKNCK 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 40/101 (39%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
+MRQ L+ +H + +VHRDLKPENIL+ VKL DFG AR+ L + T
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
Y APEVL + Y VD+W+ G I + P F
Sbjct: 185 YRAPEVLL------QSTYATPVDMWSVGCIFAEMFRRKPLF 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 30/125 (24%), Positives = 44/125 (35%), Gaps = 33/125 (26%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y APEVL + Y VD+W+ G I + P F + L I + G
Sbjct: 185 YRAPEVLLQ------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238
Query: 237 ------------KYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALN 275
+ +F P ++ E L+ ++L P R S AL
Sbjct: 239 PEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
Query: 276 HSFFH 280
HS+ H
Sbjct: 297 HSYLH 301
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 3/107 (2%)
Query: 46 PALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104
L I + +ALEH+H SV+HRD+KP N+L++ VK+ DFG + L
Sbjct: 109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI 168
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
G Y+APE + + GY D+W+ G+ M L + P+
Sbjct: 169 DAGCKPYMAPERINPE--LNQKGYSVKSDIWSLGITMIELAILRFPY 213
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 18/112 (16%)
Query: 51 IMRQLFEALEHVHNH---SVVHRDLKPENILLD--------DQMNVKLTDFGFARVLKKG 99
Q+ + ++H+ ++HRDLK NIL+ +K+TDFG AR +
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 100 EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
K M G ++APEV+RA+M + + DVW+ GV+++ LL G PF
Sbjct: 170 TK-MSAAGAYAWMAPEVIRASM------FSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 8/96 (8%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240
++APEV+RA+M + + DVW+ GV+++ LL G PF + + + K +
Sbjct: 180 WMAPEVIRASM------FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
P E L+ P R S L+
Sbjct: 234 PIPS--TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 24/126 (19%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-----DQMNVKLTDF 90
++ NP + + + QL + H+ +HRDLKP+N+LL + +K+ DF
Sbjct: 122 YMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 91 GFARVLKKGEKLMDLCGTPG-----YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
G AR + T Y PE+L + Y +VD+W+ I +L
Sbjct: 182 GLARAFGIPIRQF----THEIITLWYRPPEILLG-----SRHYSTSVDIWSIACIWAEML 232
Query: 146 VGCPPF 151
+ P F
Sbjct: 233 MKTPLF 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 35/136 (25%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--G-- 236
Y PE+L + Y +VD+W+ I +L+ P F ++ L I E G
Sbjct: 203 YRPPEILLG-----SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 237 ------------KYSFSSPEW----------NDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+ S P++ + ++ DL+ +L + P R S K AL
Sbjct: 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 275 NHSFFHPKLFDQDIEP 290
H +F D +P
Sbjct: 318 EHPYFS----HNDFDP 329
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 49 RYIMRQLFEALEHVHNHS--VVHRDLKPENILLDDQMNV-KLTDFGFARVLKKGEKLMDL 105
+ + QL ++ +H S V HRD+KP N+L+++ KL DFG A+ L E +
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ Y APE+ +F Y AVD+W+ G I +++G P F
Sbjct: 192 ICSRYYRAPEL----IF-GNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 32/138 (23%), Positives = 49/138 (35%), Gaps = 34/138 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF---WHRKQMVM-------- 229
Y APE+ +F Y AVD+W+ G I +++G P F Q+
Sbjct: 197 YRAPEL----IF-GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 230 ----LRNIMEGKYSFSSPEW-----------NDISEDPK--DLIRKLLIVTPEDRYSVKE 272
LR + + + + + DL+ LL PE+R E
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311
Query: 273 ALNHSFFHPKLFDQDIEP 290
AL H +F L D +
Sbjct: 312 ALCHPYFDE-LHDPATKL 328
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 20/126 (15%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
+I++ ++Y + Q A++ +H +V+HRDLKP N+L++ ++K+ DFG AR++
Sbjct: 103 VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 97 KKGEKLMDLCGTPG-----------YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145
+ Y APEV+ + Y +A+DVW+CG I+ L
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA-----KYSRAMDVWSCGCILAELF 217
Query: 146 VGCPPF 151
+ P F
Sbjct: 218 LRRPIF 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 35/139 (25%), Positives = 52/139 (37%), Gaps = 34/139 (24%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME--GK- 237
Y APEV+ + Y +A+DVW+CG I+ L + P F R L I G
Sbjct: 188 YRAPEVMLTSA-----KYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 238 ------YSFSSPE---------------WNDI----SEDPKDLIRKLLIVTPEDRYSVKE 272
SP + + DL++++L+ P R + KE
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 273 ALNHSFFHPKLFDQDIEPI 291
AL H + D + EP
Sbjct: 303 ALEHPYLQT-YHDPNDEPE 320
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 41 IINSNPA----LRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARV 95
++ P R M QL L+++H+ +V+HRDLKP N+ ++ + + +K+ DFG AR+
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 96 LKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
+ L + T Y +P +L + Y +A+D+WA G I +L G F
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPN-----NYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 152 WHRKQMVMLRNIME 165
++ ++ I+E
Sbjct: 226 AGAHELEQMQLILE 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 30/137 (21%), Positives = 52/137 (37%), Gaps = 32/137 (23%)
Query: 181 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME----- 235
Y +P +L + Y +A+D+WA G I +L G F ++ ++ I+E
Sbjct: 190 YRSPRLLLSPN-----NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 236 ------------GKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEAL 274
Y + IS + D + ++L +P DR + +EAL
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 275 NHSFFHPKLFDQDIEPI 291
+H + EPI
Sbjct: 305 SHPYMSI-YSFPMDEPI 320
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 50/265 (18%), Positives = 81/265 (30%), Gaps = 69/265 (26%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
++ ++ +AL ++ S+ H DLKPENILLDD K K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 101 -------KLMDLCGTPG-----------------YLAPEVLRANMFEDATGYGQAVDVWA 136
KL+D G Y APEV+ G+ + D+W+
Sbjct: 195 RTKSTGIKLIDF----GCATFKSDYHGSIINTRQYRAPEVIL------NLGWDVSSDMWS 244
Query: 137 CGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDAT 196
G ++ L G F + M L + I + +L + +
Sbjct: 245 FGCVLAELYTGSLLFRTHEHMEHLAMMES------------IIQPIPKNMLYEATKTNGS 292
Query: 197 GYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPK--D 254
Y + + + +I K+ I + D
Sbjct: 293 KY---------------VNKDELKLAWPENASSINSI---KHVKKCLPLYKIIKHELFCD 334
Query: 255 LIRKLLIVTPEDRYSVKEALNHSFF 279
+ +L + P R S E L H F
Sbjct: 335 FLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 27/118 (22%), Positives = 51/118 (43%), Gaps = 19/118 (16%)
Query: 59 LEHVH---------NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL------- 102
L ++H ++ HRDL N+L+ + ++DFG + L +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 103 --MDLCGTPGYLAPEVLRANM-FEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157
+ GT Y+APEVL + D + VD++A G+I + + + C + + +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 50/311 (16%), Positives = 89/311 (28%), Gaps = 113/311 (36%)
Query: 41 IINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95
+ + L + I+ L +H ++HRDLKP N LL+ +VK+ DFG AR
Sbjct: 119 LFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 96 LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155
+ + + P N+ + T +
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH--------------------------- 211
Query: 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 215
V+ R W Y APE++ Y +++D+W+ G I LL
Sbjct: 212 --VVTR-------------W-----YRAPELILLQE-----NYTKSIDIWSTGCIFAELL 246
Query: 216 VG----CPPFWHRKQM------VMLRNIMEGKYSFS---------------SPEWNDI-- 248
+R + L K +P +D+
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN 306
Query: 249 --SEDPKDLIRKL--------------------------LIVTPEDRYSVKEALNHSFFH 280
+ I+ L P R ++ +AL+H +
Sbjct: 307 INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366
Query: 281 PKLFDQDIEPI 291
+ + +E
Sbjct: 367 D-VRKKKLENF 376
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 27/133 (20%), Positives = 58/133 (43%), Gaps = 23/133 (17%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---------- 100
+ + + ++H+ +++HRDL N L+ + NV + DFG AR++ +
Sbjct: 113 FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 101 -----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF--WH 153
K + G P ++APE++ Y + VDV++ G+++ ++ +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRS------YDEKVDVFSFGIVLCEIIGRVNADPDYL 226
Query: 154 RKQMVMLRNIMEG 166
+ M N+
Sbjct: 227 PRTMDFGLNVRGF 239
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 54/269 (20%), Positives = 93/269 (34%), Gaps = 77/269 (28%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
P +R++ QL AL +H + + H DLKPENIL + L + + K +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 101 -KLMDLCGTPG-----------------YLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
++ D G Y PEV+ G+ Q DVW+ G I++
Sbjct: 181 IRVADF----GSATFDHEHHTTIVATRHYRPPEVIL------ELGWAQPCDVWSIGCILF 230
Query: 143 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAV 202
G F + L + + I G + ++ +
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEK------------ILGPIPSHMIHRTRKQK-------- 270
Query: 203 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS--FSSPEWNDISEDPK------D 254
++++ +V N +G+Y P + + +D D
Sbjct: 271 ------------------YFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 255 LIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
L+R++L P R ++ EAL H FF
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 50/261 (19%), Positives = 87/261 (33%), Gaps = 65/261 (24%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
+R + Q+ +++ +H++ + H DLKPENIL + + R +
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 101 -KLMDLCGTPG-----------------YLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
K++D G Y APEV+ A G+ Q DVW+ G I+
Sbjct: 176 IKVVDF----GSATYDDEHHSTLVSTRHYRAPEVIL------ALGWSQPCDVWSIGCILI 225
Query: 143 TLLVGCPPFWHRKQMVMLRNIME--GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQ 200
+G F L + G + ++ + + F
Sbjct: 226 EYYLGFTVFPTHDSKEHLAMMERILGP----------LPKHMIQKTRKRKYFHHDR---- 271
Query: 201 AVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLL 260
+ + + L+ M + + E DLI+K+L
Sbjct: 272 ----------LDWDEHSSAGRYVSRACKPLKEFMLSQ--------DVEHERLFDLIQKML 313
Query: 261 IVTPEDRYSVKEALNHSFFHP 281
P R +++EAL H FF
Sbjct: 314 EYDPAKRITLREALKHPFFDL 334
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 20/133 (15%), Positives = 30/133 (22%), Gaps = 44/133 (33%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
G L+ +A A M+ L A + H V P +
Sbjct: 114 RGGSLQEVADTSPSPVGAI------------RAMQSLAAAADAAHRAGVALSIDHPSRVR 161
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACG 138
+ +V L P + D+ G
Sbjct: 162 VSIDGDVVL-------------------AYPATMPDA-------------NPQDDIRGIG 189
Query: 139 VIMYTLLVGCPPF 151
+Y LLV P
Sbjct: 190 ASLYALLVNRWPL 202
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 16/99 (16%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK------LMDLCGTPGYL 112
+ +H + +HRD+K NILLD+ K++DFG AR +K + ++ GT Y+
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV---GTTAYM 202
Query: 113 APEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151
APE LR + + D+++ GV++ ++ G P
Sbjct: 203 APEALRGEITPKS-------DIYSFGVVLLEIITGLPAV 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 54/306 (17%), Positives = 95/306 (31%), Gaps = 126/306 (41%)
Query: 46 PALRYIMRQLFEALEHVHNH-SVVHRDLKPENILL------------------------- 79
P ++ I++Q+ + L+++H ++H D+KPENILL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 80 ------------------------DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPE 115
+++ VK+ D G A + + + T Y + E
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLE 263
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
VL +GY D+W+ + + L G F E
Sbjct: 264 VL----IG--SGYNTPADIWSTACMAFELATGDYLF----------------------EP 295
Query: 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP------------FWH 223
+ Y E A + E L+G P F+
Sbjct: 296 HSGEEYTRDEDHIALIIE---------------------LLGKVPRKLIVAGKYSKEFFT 334
Query: 224 RK---------QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+K + L ++ KY +S E + D + +L + PE R + E L
Sbjct: 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEE----AAGFTDFLLPMLELIPEKRATAAECL 390
Query: 275 NHSFFH 280
H + +
Sbjct: 391 RHPWLN 396
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 22/63 (34%), Positives = 37/63 (58%), Gaps = 9/63 (14%)
Query: 59 LEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK------LMDLCGTPGYL 112
L ++H +++HRD+K NILLD+ K+TDFG ++ + ++ + GT GY+
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYI 208
Query: 113 APE 115
PE
Sbjct: 209 DPE 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 22/62 (35%), Positives = 39/62 (62%), Gaps = 5/62 (8%)
Query: 59 LEHVHNHS---VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM--DLCGTPGYLA 113
L ++H+H ++HRD+K NILLD++ + DFG A+++ + + + GT G++A
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 114 PE 115
PE
Sbjct: 204 PE 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 9/124 (7%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMD 104
P L + Q+ + +V + VHRDL+ NIL+ + + K+ DFG AR+++ E
Sbjct: 363 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 105 LCGTP-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRN 162
P + APE F + DVW+ G+++ L G P+ +L
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKS------DVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
Query: 163 IMEG 166
+ G
Sbjct: 477 VERG 480
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 10/125 (8%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Q+ + + ++ + +VHRDL N+L+ +VK+TDFG A++L EK
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 CGT--P-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLR 161
G P ++A E + ++ + DVW+ GV ++ L+ G P+ +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQS------DVWSYGVTVWELMTFGSKPYDGIPASEISS 230
Query: 162 NIMEG 166
+ +G
Sbjct: 231 ILEKG 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 9/124 (7%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Y+ Q+ A+E++ + +HR+L N L+ + VK+ DFG +R++
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377
Query: 106 CGTPGY--LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRN 162
APE L N F + DVWA GV+++ + G P+ +
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKS------DVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431
Query: 163 IMEG 166
+ +
Sbjct: 432 LEKD 435
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 9/124 (7%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
P L + Q+ + +V + VHRDL+ NIL+ + + K+ DFG AR+++ E
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 106 CGTPGY--LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRN 162
APE F + DVW+ G+++ L G P+ +L
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKS------DVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
Query: 163 IMEG 166
+ G
Sbjct: 394 VERG 397
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 26/127 (20%), Positives = 53/127 (41%), Gaps = 14/127 (11%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L ++ +E++ + +HRDL N L+ ++ +K++DFG +R G
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS- 271
Query: 106 CGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159
G + APE L + + DVW+ G++++ +G P+ +
Sbjct: 272 -GGLRQVPVKWTAPEALNYGRYSSES------DVWSFGILLWETFSLGASPYPNLSNQQT 324
Query: 160 LRNIMEG 166
+ +G
Sbjct: 325 REFVEKG 331
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 10/125 (8%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Q+ + + ++ + +VHRDL N+L+ +VK+TDFG A++L EK
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 CGT--P-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLR 161
G P ++A E + ++ + DVW+ GV ++ L+ G P+ +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQS------DVWSYGVTVWELMTFGSKPYDGIPASEISS 230
Query: 162 NIMEG 166
+ +G
Sbjct: 231 ILEKG 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 29/125 (23%), Positives = 56/125 (44%), Gaps = 10/125 (8%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Q+ + + ++ H +VHR+L N+LL V++ DFG A +L +K +
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 106 CGT--P-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLR 161
P ++A E + + + DVW+ GV ++ L+ G P+ + +
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQS------DVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 162 NIMEG 166
+ +G
Sbjct: 229 LLEKG 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
L Q+ + ++ + + VHRDL N +LD++ VK+ DFG AR + E
Sbjct: 194 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 108 TPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLR 161
T L A E L+ F + DVW+ GV+++ L+ G PP+ +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKS------DVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
Query: 162 NIMEG 166
+++G
Sbjct: 308 YLLQG 312
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 32/133 (24%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE----- 100
L Y+ Q+ A+E++ + +HRDL N L+ + VK+ DFG +R++
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170
Query: 101 ------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
K APE L N F + DVWA GV+++ + G P+
Sbjct: 171 GAKFPIKWT---------APESLAYNKFSIKS------DVWAFGVLLWEIATYGMSPYPG 215
Query: 154 RKQMVMLRNIMEG 166
+ + +
Sbjct: 216 IDLSQVYELLEKD 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 30/120 (25%), Positives = 47/120 (39%), Gaps = 27/120 (22%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Q+ E + ++ + +HRDL N+LL + VK+ DFG R L + +
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--- 177
Query: 106 CGTPGY------------LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFW 152
Y APE L+ F A+ D W GV ++ + G P+
Sbjct: 178 -----YVMQEHRKVPFAWCAPESLKTRTFSHAS------DTWMFGVTLWEMFTYGQEPWI 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK------ 97
+ L ++R + + ++ + VHRDL N+L+D + K++DFG +RVL+
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 98 ---KGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149
G K+ APE + F A+ DVW+ GV+M+ +L G
Sbjct: 209 YTTTGGKIPIRWT---------APEAIAFRTFSSAS------DVWSFGVVMWEVLAYGER 253
Query: 150 PFWHRKQMVMLRNIMEG 166
P+W+ ++ ++ EG
Sbjct: 254 PYWNMTNRDVISSVEEG 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 6e-11
Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
L + + E + + +H +HRDL N L+D + VK++DFG R +
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
G K APEV + + DVWA G++M+ + +G P+
Sbjct: 164 GTKFPVKWS---------APEVFHYFKYSSKS------DVWAFGILMWEVFSLGKMPYDL 208
Query: 154 RKQMVMLRNIMEG 166
++ + +G
Sbjct: 209 YTNSEVVLKVSQG 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 32/137 (23%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK------ 97
+ L ++R + ++++ + VHRDL NIL++ + K++DFG RVL+
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 98 ---KGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149
+G K+ +PE + F A+ DVW+ G++++ ++ G
Sbjct: 205 YTTRGGKIPIRWT---------SPEAIAYRKFTSAS------DVWSYGIVLWEVMSYGER 249
Query: 150 PFWHRKQMVMLRNIMEG 166
P+W +++ + EG
Sbjct: 250 PYWEMSNQDVIKAVDEG 266
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE----- 100
+L QL AL ++ + VHRD+ N+L+ VKL DFG +R ++
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 101 ------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
K M APE + F A+ DVW GV M+ +L G PF
Sbjct: 176 KGKLPIKWM---------APESINFRRFTSAS------DVWMFGVCMWEILMHGVKPFQG 220
Query: 154 RKQMVMLRNIMEG 166
K ++ I G
Sbjct: 221 VKNNDVIGRIENG 233
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 36/127 (28%), Positives = 54/127 (42%), Gaps = 12/127 (9%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
L Q+ +E++ VHRDL N +LD+ VK+ DFG AR + E
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 106 CGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159
L A E L+ F + DVW+ GV+++ LL G PP+ H +
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKS------DVWSFGVLLWELLTRGAPPYRHIDPFDL 237
Query: 160 LRNIMEG 166
+ +G
Sbjct: 238 THFLAQG 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 29/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK------ 97
S L ++R + ++++ N + VHRDL NIL++ + K++DFG +RVL+
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 98 ---KGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149
G K+ APE + F A+ DVW+ G++M+ ++ G
Sbjct: 205 YTTSGGKIPIRWT---------APEAISYRKFTSAS------DVWSFGIVMWEVMTYGER 249
Query: 150 PFWHRKQMVMLRNIMEG 166
P+W +++ I +G
Sbjct: 250 PYWELSNHEVMKAINDG 266
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 16/127 (12%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
L Q+ + ++++ + VHRDL N +LD++ VK+ DFG AR + E
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 108 TPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIM---YTLLVGCPPFWHRKQMVM 159
T L A E L+ F + DVW+ GV++ T G PP+ +
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKS------DVWSFGVLLWELMTR--GAPPYPDVNTFDI 241
Query: 160 LRNIMEG 166
+++G
Sbjct: 242 TVYLLQG 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 31/137 (22%), Positives = 56/137 (40%), Gaps = 29/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
+ ++ Q+ ++++ + VHRDL N+LL ++ K++DFG ++ L +
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167
Query: 101 ----------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 149
K APE + F + DVW+ GV M+ L G
Sbjct: 168 TARSAGKWPLKWY---------APECINFRKFSSRS------DVWSYGVTMWEALSYGQK 212
Query: 150 PFWHRKQMVMLRNIMEG 166
P+ K ++ I +G
Sbjct: 213 PYKKMKGPEVMAFIEQG 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
L + + E + ++ V+HRDL N L+ + +K++DFG R +
Sbjct: 104 ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
G K +PEV + + + DVW+ GV+M+ + G P+ +
Sbjct: 164 GTKFPVKWA---------SPEVFSFSRYSSKS------DVWSFGVLMWEVFSEGKIPYEN 208
Query: 154 RKQMVMLRNIMEG 166
R ++ +I G
Sbjct: 209 RSNSEVVEDISTG 221
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 30/129 (23%), Positives = 55/129 (42%), Gaps = 23/129 (17%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL---KKGEKL 102
L + EA+E++ ++ VHRDL N+L+ + K++DFG + + KL
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176
Query: 103 ----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQM 157
APE LR F + DVW+ G++++ + G P+
Sbjct: 177 PVKWT---------APEALREKKFSTKS------DVWSFGILLWEIYSFGRVPYPRIPLK 221
Query: 158 VMLRNIMEG 166
++ + +G
Sbjct: 222 DVVPRVEKG 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 33/133 (24%), Positives = 56/133 (42%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
L Q+ +A+ ++ + + VHRD+ NIL+ VKL DFG +R +
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
+L M +PE + F A+ DVW V M+ +L G PF+
Sbjct: 173 VTRLPIKWM---------SPESINFRRFTTAS------DVWMFAVCMWEILSFGKQPFFW 217
Query: 154 RKQMVMLRNIMEG 166
+ ++ + +G
Sbjct: 218 LENKDVIGVLEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/129 (23%), Positives = 55/129 (42%), Gaps = 23/129 (17%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL---KKGEKL 102
L + EA+E++ ++ VHRDL N+L+ + K++DFG + + KL
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 103 ----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQM 157
APE LR F + DVW+ G++++ + G P+
Sbjct: 349 PVKWT---------APEALREKKFSTKS------DVWSFGILLWEIYSFGRVPYPRIPLK 393
Query: 158 VMLRNIMEG 166
++ + +G
Sbjct: 394 DVVPRVEKG 402
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 12/104 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ L Q+ + +E++ +HRDL NIL++++ VK+ DFG +VL + ++
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171
Query: 104 DLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ PG APE L + F A+ DVW+ GV++Y
Sbjct: 172 KV-KEPGESPIFWYAPESLTESKFSVAS------DVWSFGVVLY 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 31/133 (23%), Positives = 59/133 (44%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
L + Q+ E + + + +HRDL+ NIL+ D ++ K+ DFG AR++ ++
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
G K APE + F + DVW+ G+++ ++ G P+
Sbjct: 169 GAKFPIKWT---------APEAINYGTFTIKS------DVWSFGILLTEIVTHGRIPYPG 213
Query: 154 RKQMVMLRNIMEG 166
+++N+ G
Sbjct: 214 MTNPEVIQNLERG 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE----- 100
+L QL AL ++ + VHRD+ N+L+ VKL DFG +R ++
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 101 ------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
K M APE + F A+ DVW GV M+ +L G PF
Sbjct: 551 KGKLPIKWM---------APESINFRRFTSAS------DVWMFGVCMWEILMHGVKPFQG 595
Query: 154 RKQMVMLRNIMEG 166
K ++ I G
Sbjct: 596 VKNNDVIGRIENG 608
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 27/136 (19%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ + ++ Q+ ++++ + VHRDL N+LL Q K++DFG ++ L+ E
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 173
Query: 104 DLCGTPGY------------LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPP 150
Y APE + F + DVW+ GV+M+ G P
Sbjct: 174 -------YKAQTHGKWPVKWYAPECINYYKFSSKS------DVWSFGVLMWEAFSYGQKP 220
Query: 151 FWHRKQMVMLRNIMEG 166
+ K + + +G
Sbjct: 221 YRGMKGSEVTAMLEKG 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 31/136 (22%), Positives = 57/136 (41%), Gaps = 29/136 (21%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE----- 100
+ ++ Q+ ++++ + VHR+L N+LL ++ K++DFG ++ L +
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 101 --------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPF 151
K APE + F + DVW+ GV M+ L G P+
Sbjct: 496 RSAGKWPLKWY---------APECINFRKFSSRS------DVWSYGVTMWEALSYGQKPY 540
Query: 152 WHRKQMVMLRNIMEGK 167
K ++ I +GK
Sbjct: 541 KKMKGPEVMAFIEQGK 556
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 35/133 (26%), Positives = 59/133 (44%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
L + + + EA+E++ + +HRDL N L++DQ VK++DFG +R +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
G K PEVL + F + D+WA GV+M+ + +G P+
Sbjct: 180 GSKFPVRWS---------PPEVLMYSKFSSKS------DIWAFGVLMWEIYSLGKMPYER 224
Query: 154 RKQMVMLRNIMEG 166
+I +G
Sbjct: 225 FTNSETAEHIAQG 237
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 12/104 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ L Q+ + +E++ +HRDL NIL++++ VK+ DFG +VL + ++
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY 202
Query: 104 DLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ PG APE L + F A+ DVW+ GV++Y
Sbjct: 203 KV-KEPGESPIFWYAPESLTESKFSVAS------DVWSFGVVLY 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 24/130 (18%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMD 104
L M + +E++ N + +HRDL N +L D M V + DFG ++ + G+ +
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ--- 205
Query: 105 LCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHRKQ 156
G + A E L ++ + DVWA GV M+ T G P+ +
Sbjct: 206 --GRIAKMPVKWIAIESLADRVYTSKS------DVWAFGVTMWEIATR--GMTPYPGVQN 255
Query: 157 MVMLRNIMEG 166
M ++ G
Sbjct: 256 HEMYDYLLHG 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 32/133 (24%), Positives = 56/133 (42%), Gaps = 27/133 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KK 98
P L Q+ E + + + +HRDL+ NIL+ + K+ DFG ARV+ ++
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 99 GEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWH 153
G K APE + F + DVW+ G+++ ++ G P+
Sbjct: 344 GAKFPIKWT---------APEAINFGSFTIKS------DVWSFGILLMEIVTYGRIPYPG 388
Query: 154 RKQMVMLRNIMEG 166
++R + G
Sbjct: 389 MSNPEVIRALERG 401
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 12/104 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
L +Q+ E + ++H +HRDL N+LLD+ VK+ DFG A+ + +G +
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191
Query: 104 DLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ G APE L+ F A+ DVW+ GV +Y
Sbjct: 192 RV-REDGDSPVFWYAPECLKEYKFYYAS------DVWSFGVTLY 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 12/104 (11%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ Q+ + ++++ + VHRDL N+L++ + VK+ DFG + ++ ++
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 183
Query: 104 DLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ APE L + F A+ DVW+ GV ++
Sbjct: 184 TV-KDDRDSPVFWYAPECLMQSKFYIAS------DVWSFGVTLH 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 24/130 (18%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMD 104
+ + ++ + + +++ + VHRDL N ++ + VK+ DFG R + + + K
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK--- 196
Query: 105 LCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHRKQ 156
G G L +PE L+ +F + DVW+ GV+++ TL P+
Sbjct: 197 --GGKGLLPVRWMSPESLKDGVFTTYS------DVWSFGVVLWEIATL--AEQPYQGLSN 246
Query: 157 MVMLRNIMEG 166
+LR +MEG
Sbjct: 247 EQVLRFVMEG 256
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 33/134 (24%), Positives = 56/134 (41%), Gaps = 24/134 (17%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
L M + +E++ + + +HRDL N +L + M V + DFG +R + G+
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 101 KLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFW 152
+ G L A E L N++ + DVWA GV M+ T G P+
Sbjct: 195 Q-----GCASKLPVKWLALESLADNLYTVHS------DVWAFGVTMWEIMTR--GQTPYA 241
Query: 153 HRKQMVMLRNIMEG 166
+ + ++ G
Sbjct: 242 GIENAEIYNYLIGG 255
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 17/129 (13%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD- 104
L Q+ + +E++ + VHRDL NIL++ + +VK+ DFG A++L + D
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DY 183
Query: 105 -LCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQM 157
+ PG APE L N+F + DVW+ GV++Y L +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQS------DVWSFGVVLYELFTYCDKSCSPSAEF 237
Query: 158 VMLRNIMEG 166
+ +
Sbjct: 238 LRMMGCERD 246
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 17/46 (36%), Positives = 27/46 (58%), Gaps = 2/46 (4%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILL--DDQMNVKLTDFGFAR 94
+ +L +ALE +H + VH ++ ENI + +DQ V L +GFA
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 2/46 (4%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLD--DQMNVKLTDFGFAR 94
+ ++ + LE++H H VH D+K N+LL+ + V L D+G A
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 14/46 (30%), Positives = 26/46 (56%), Gaps = 2/46 (4%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLD--DQMNVKLTDFGFAR 94
+ ++ + LE++H + VH D+K N+LL + V L D+G +
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 17/102 (16%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KKGE 100
L Q+ + +E + + +HRDL NILL ++ VK+ DFG AR + +KG+
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ L APE + ++ + DVW+ GV+++
Sbjct: 255 ARLPLKWM----APETIFDRVYTIQS------DVWSFGVLLW 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 30/137 (21%), Positives = 52/137 (37%), Gaps = 30/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------K 97
L + Q+ + ++ VHRDL N L+ + VK+ DFG +R + +
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 98 KGEKLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCP 149
G + L PE + F + DVW+ GV+++ T G
Sbjct: 216 VGGR--------TMLPIRWMPPESILYRKFTTES------DVWSFGVVLWEIFTY--GKQ 259
Query: 150 PFWHRKQMVMLRNIMEG 166
P++ + I +G
Sbjct: 260 PWYQLSNTEAIDCITQG 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 24/134 (17%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
S+ L Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 101 KLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFW 152
K T G L APE L ++ + DVW+ GV+++ TL G P+
Sbjct: 249 K-----TTNGRLPVKWMAPEALFDRIYTHQS------DVWSFGVLLWEIFTL--GGSPYP 295
Query: 153 HRKQMVMLRNIMEG 166
+ + + EG
Sbjct: 296 GVPVEELFKLLKEG 309
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 31/139 (22%), Positives = 55/139 (39%), Gaps = 30/139 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------K 97
+ +I Q+ + ++ + VHRDL N L+ + VK+ DFG +R + +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 98 KGEKLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCP 149
G L PE + F + DVW+ GVI++ T G
Sbjct: 191 VGGH--------TMLPIRWMPPESIMYRKFTTES------DVWSFGVILWEIFTY--GKQ 234
Query: 150 PFWHRKQMVMLRNIMEGKY 168
P++ ++ I +G+
Sbjct: 235 PWFQLSNTEVIECITQGRV 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 29/131 (22%), Positives = 54/131 (41%), Gaps = 29/131 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR-----VLKKGEKL 102
L + + ++++ +HRDL NIL+ + K+ DFG +R V K +L
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 103 ----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHRK 155
M A E L +++ + DVW+ GV+++ +L G P+
Sbjct: 204 PVRWM---------AIESLNYSVYTTNS------DVWSYGVLLWEIVSL--GGTPYCGMT 246
Query: 156 QMVMLRNIMEG 166
+ + +G
Sbjct: 247 CAELYEKLPQG 257
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 31/137 (22%), Positives = 58/137 (42%), Gaps = 30/137 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------K 97
P +++ Q+ +E++ +H VVH+DL N+L+ D++NVK++D G R + K
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 98 KGEKLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCP 149
L APE + F + D+W+ GV+++ + G
Sbjct: 186 LLGN--------SLLPIRWMAPEAIMYGKFSIDS------DIWSYGVVLWEVFSY--GLQ 229
Query: 150 PFWHRKQMVMLRNIMEG 166
P+ ++ I
Sbjct: 230 PYCGYSNQDVVEMIRNR 246
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 17/102 (16%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-------KKGE 100
L Q+ + +E + + +HRDL NILL ++ VK+ DFG AR + +KG+
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+ L APE + ++ + DVW+ GV+++
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQS------DVWSFGVLLW 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 34/138 (24%), Positives = 56/138 (40%), Gaps = 32/138 (23%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------- 96
+ L QL +E++ + +HRDL N+L+ + +K+ DFG AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 97 KKGEKL-----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGC 148
K M APE L ++ + DVW+ GV+M+ TL G
Sbjct: 215 KTTNGRLPVKWM---------APEALFDRVYTHQS------DVWSFGVLMWEIFTL--GG 257
Query: 149 PPFWHRKQMVMLRNIMEG 166
P+ + + + EG
Sbjct: 258 SPYPGIPVEELFKLLKEG 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 13/104 (12%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
L Q+ + + + + + +HRDL NILL K+ DFG AR +K +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 104 DLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
L APE + ++ + DVW+ G+ ++
Sbjct: 203 V--KGNARLPVKWMAPESIFNCVYTFES------DVWSYGIFLW 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 34/138 (24%), Positives = 56/138 (40%), Gaps = 32/138 (23%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------- 96
+ L QL +E++ + +HRDL N+L+ + +K+ DFG AR +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 97 KKGEKL-----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGC 148
K M APE L ++ + DVW+ GV+M+ TL G
Sbjct: 261 KTTNGRLPVKWM---------APEALFDRVYTHQS------DVWSFGVLMWEIFTL--GG 303
Query: 149 PPFWHRKQMVMLRNIMEG 166
P+ + + + EG
Sbjct: 304 SPYPGIPVEELFKLLKEG 321
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 30/133 (22%), Positives = 57/133 (42%), Gaps = 30/133 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------KKGEK 101
L Q+ + ++++ +VHRDL NIL+ + +K++DFG +R + K +
Sbjct: 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211
Query: 102 LMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWH 153
G + A E L +++ + DVW+ GV+++ TL G P+
Sbjct: 212 --------GRIPVKWMAIESLFDHIYTTQS------DVWSFGVLLWEIVTL--GGNPYPG 255
Query: 154 RKQMVMLRNIMEG 166
+ + G
Sbjct: 256 IPPERLFNLLKTG 268
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 17/49 (34%), Positives = 29/49 (59%), Gaps = 5/49 (10%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN-----VKLTDFGFAR 94
I QL +E+VH+ ++++RD+KPEN L+ N + + DF A+
Sbjct: 110 IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 33/141 (23%), Positives = 53/141 (37%), Gaps = 35/141 (24%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL------K 97
S I RQ+ + ++ VHRDL N L+ + M VK+ DFG +R + K
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 98 KGEKLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCP 149
+ PE + N + + DVWA GV+++ + G
Sbjct: 232 ADGN--------DAIPIRWMPPESIFYNRYTTES------DVWAYGVVLWEIFSY--GLQ 275
Query: 150 PFWHRK-----QMVMLRNIME 165
P++ V NI+
Sbjct: 276 PYYGMAHEEVIYYVRDGNILA 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 13/49 (26%), Positives = 27/49 (55%), Gaps = 5/49 (10%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN-----VKLTDFGFAR 94
+Q+ ++ +H S+V+RD+KP+N L+ + + + DFG +
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 19/107 (17%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKG---E 100
+ L Q+ + +E + S VHRDL N+L+ VK+ DFG AR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 101 KLMDLCGTPGYL-----APEVLRANMFEDATGYGQAVDVWACGVIMY 142
L APE L ++ + DVW+ G++++
Sbjct: 230 V-----RGNARLPVKWMAPESLFEGIYTIKS------DVWSYGILLW 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 2e-07
Identities = 65/436 (14%), Positives = 124/436 (28%), Gaps = 120/436 (27%)
Query: 13 VVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRY--IMRQL--------FEALEHV 62
++ K+ L ++ K E VQ + + Y +M + ++
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 63 HNHSVVHRD---LKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGY----LAPE 115
++ D N+ KL L+ + ++ + G G +A +
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYL-KLRQ--ALLELRPAKNVL-IDGVLGSGKTWVALD 169
Query: 116 VLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW--------HRKQMVMLRNIMEGK 167
V + + + I FW + ML+ +
Sbjct: 170 VCLSYKVQCKMDFK----------I----------FWLNLKNCNSPETVLEMLQKL---- 205
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDA-------TGYGQAV----DVWACGVIMYTLLV 216
P W S + + LR + + Y + +V +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA-FNL 264
Query: 217 GCPPFWHRKQMVMLRNI---------MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDR 267
C K ++ R S ++ K L+ K L P+D
Sbjct: 265 SC------KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD- 317
Query: 268 YSVKEALNHSFFHPKLF---DQDIEPIKKDY--KTASRKLSKI-----NQLT--EFQ--F 313
+E L + + +D D KL+ I N L E++ F
Sbjct: 318 -LPREVLTTNPRRLSIIAESIRD-GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 314 IILVV-RAAVRISRLKYNHVPA--LSVTQGRDDPYGVKI----LRQYNALKEGRE----- 361
L V + I P LS+ V + L +Y+ +++ +
Sbjct: 376 DRLSVFPPSAHI--------PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 362 -PDLSDYKEFKLKEDN 376
P + Y E K+K +N
Sbjct: 428 IPSI--YLELKVKLEN 441
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 5e-05
Identities = 53/423 (12%), Positives = 114/423 (26%), Gaps = 117/423 (27%)
Query: 15 RVKEEGDDLKHLAA--QVVDKGEAAVQDIINSNP----ALRYIMRQLFEALEHVHNHS-V 67
L+ L +D + D ++ +++ +R+L + + + +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK--SKPYENCLL 248
Query: 68 VHRDLKPENILLDDQMNVK----LT--DFGFARVLK----KGEKLMDLCGTPGYLAPEVL 117
V +++ + N+ LT L L + EV
Sbjct: 249 VLLNVQNAKAW--NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH--SMTLTPDEVK 304
Query: 118 RANMFEDATGYG------QAVDV--WACGVIMYTLLVGCPPFWHRKQMVM---LRNIMEG 166
++ + + +I + W + V L I+E
Sbjct: 305 --SLLLKYLDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAV---DVWACGVIMYTLLVGCPPFWH 223
+ L P R MF+ +V I LL W
Sbjct: 362 SLN-----------VLEPAEYRK-MFDRL-----SVFPPSAH----IPTILLS---LIWF 397
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPK-------DLIRKLLIVTPEDRYSV-KEALN 275
+ ++ + +S + + PK + +L + E+ Y++ + ++
Sbjct: 398 DVIKSDVMVVVNKLHKYSL-----VEKQPKESTISIPSIYLELKV-KLENEYALHRSIVD 451
Query: 276 HSFFHPKLFDQDIEPIKKD---YKTASRKLSKINQ----------LTEFQFIILVVRAAV 322
H D+ P D Y L I +F+F+ +
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL----EQKI 507
Query: 323 RISRLKYNHVPALSVTQGRDDPYGVKILRQYNALKEGREPDLSDYKEFKLKEDNVGFKML 382
R +N ++ N L+ L YK + D +++
Sbjct: 508 RHDSTAWNASGSIL-----------------NTLQ-----QLKFYKPYICDNDPKYERLV 545
Query: 383 QKL 385
+
Sbjct: 546 NAI 548
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 25/111 (22%), Positives = 49/111 (44%), Gaps = 27/111 (24%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR--------V 95
S L + Q+ + + + + + +HRD+ N+LL + K+ DFG AR +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 96 LKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142
+K +L M APE + ++ + DVW+ G++++
Sbjct: 222 VKGNARLPVKWM---------APESIFDCVYTVQS------DVWSYGILLW 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 11/72 (15%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN---VKLTDFGFA---RVLKKGEKLM- 103
+ Q+ +E VH+ S +HRD+KP+N L+ V + DFG A R + +
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 104 ----DLCGTPGY 111
+L GT Y
Sbjct: 168 RENKNLTGTARY 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 11/72 (15%)
Query: 51 IMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGEKLM---- 103
+ Q+ +E++H+ + +HRD+KP+N L+ V + DFG A+ +
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 104 ----DLCGTPGY 111
+L GT Y
Sbjct: 170 RENKNLTGTARY 181
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 29/132 (21%), Positives = 53/132 (40%), Gaps = 25/132 (18%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLD---DQMNVKLTDFGFARVL-------K 97
L ++ R + +++ + +HRD+ N LL K+ DFG AR + K
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 98 KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHR 154
G ++ + PE +F T D W+ GV+++ +L G P+ +
Sbjct: 202 GGCAMLPVKWM----PPEAFMEGIFTSKT------DTWSFGVLLWEIFSL--GYMPYPSK 249
Query: 155 KQMVMLRNIMEG 166
+L + G
Sbjct: 250 SNQEVLEFVTSG 261
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 22/148 (14%), Positives = 53/148 (35%), Gaps = 30/148 (20%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD--------DQMNVKLTDFGFARVLK 97
+ +QL A+ + ++++H ++ +NILL + +KL+D G + +
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 98 KGE------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPP 150
+ + PE + + A D W+ G ++ + G P
Sbjct: 173 PKDILQERIPWV---------PPECIE-----NPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDI 178
L+ + + +P+ ++
Sbjct: 219 LSALDSQRKLQFYEDR-HQLPAPKAAEL 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 29/132 (21%), Positives = 53/132 (40%), Gaps = 25/132 (18%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLD---DQMNVKLTDFGFARVL-------K 97
L ++ R + +++ + +HRD+ N LL K+ DFG AR + K
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 98 KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY---TLLVGCPPFWHR 154
G ++ + PE +F T D W+ GV+++ +L G P+ +
Sbjct: 243 GGCAMLPVKWM----PPEAFMEGIFTSKT------DTWSFGVLLWEIFSL--GYMPYPSK 290
Query: 155 KQMVMLRNIMEG 166
+L + G
Sbjct: 291 SNQEVLEFVTSG 302
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 4e-06
Identities = 14/63 (22%), Positives = 23/63 (36%), Gaps = 1/63 (1%)
Query: 38 VQDIINSNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96
++ ++S + I+ QL +L HRDL N+LL KL +
Sbjct: 153 MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
Query: 97 KKG 99
Sbjct: 213 TIP 215
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 17/89 (19%), Positives = 27/89 (30%), Gaps = 13/89 (14%)
Query: 52 MRQLFEALEHV---HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL--- 105
R+L++ L+ H DL NI + D D G + +K D+
Sbjct: 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR---ADKWYDIAFC 223
Query: 106 -CGTPGYLAPEVLRANMFEDATGYGQAVD 133
+ E F+ G D
Sbjct: 224 VRSIREDIGEEQYVELFFD---LLGIKPD 249
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 14/94 (14%), Positives = 32/94 (34%), Gaps = 10/94 (10%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
+ + +++ + L + V H D +N++ D+ + D G + ++ DL
Sbjct: 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI---ADRYQDL 230
Query: 106 ---CGTPGYLAPEVLRANMFEDATGYGQAVDVWA 136
G +P + + YG
Sbjct: 231 AILWNCLGEFSPSLQKR--LFQK--YGIDNPDMN 260
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.98 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.78 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.48 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.23 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.88 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 98.7 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 98.69 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.68 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 98.64 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.49 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.49 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 98.46 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 98.43 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 98.35 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 98.31 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 98.24 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 98.18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 98.15 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 98.1 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 98.09 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 98.08 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 98.07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 98.06 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.06 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 98.06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 98.03 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 98.03 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 98.01 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 98.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 97.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 97.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 97.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 97.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 97.95 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 97.92 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 97.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 97.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 97.89 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.89 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.85 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 97.84 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 97.83 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 97.8 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 97.8 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 97.8 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 97.8 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 97.79 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 97.78 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 97.78 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 97.77 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 97.77 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.74 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 97.74 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 97.74 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 97.74 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 97.73 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 97.73 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 97.72 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 97.71 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 97.69 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 97.69 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 97.69 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 97.68 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 97.68 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.67 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 97.67 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 97.66 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 97.66 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 97.66 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 97.66 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.65 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 97.64 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 97.63 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 97.63 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.63 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 97.61 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 97.6 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 97.6 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 97.6 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 97.59 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 97.59 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 97.59 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 97.59 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 97.59 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 97.57 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 97.57 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 97.56 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 97.56 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 97.56 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 97.55 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 97.55 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 97.55 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 97.55 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 97.54 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 97.54 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 97.54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 97.54 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 97.53 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 97.52 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.52 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 97.52 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 97.51 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 97.51 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 97.5 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 97.5 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 97.5 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 97.49 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 97.48 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 97.48 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 97.48 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 97.48 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 97.47 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 97.47 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 97.47 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 97.46 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 97.45 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 97.45 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 97.45 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 97.44 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 97.44 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 97.44 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 97.43 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 97.43 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 97.42 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 97.41 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 97.41 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 97.4 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 97.4 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 97.4 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 97.4 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 97.4 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 97.39 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 97.39 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 97.39 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 97.39 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 97.39 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 97.38 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 97.38 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 97.37 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 97.37 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 97.37 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 97.36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 97.35 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 97.35 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 97.35 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 97.35 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 97.35 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 97.35 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 97.34 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 97.34 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.34 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 97.34 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 97.33 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 97.33 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 97.33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 97.32 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 97.31 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 97.31 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 97.31 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 97.31 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 97.3 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 97.3 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 97.3 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 97.3 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 97.3 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 97.3 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 97.29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 97.29 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 97.29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 97.28 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 97.28 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 97.28 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 97.28 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 97.27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 97.27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 97.26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 97.26 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 97.26 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 97.25 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 97.25 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 97.25 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 97.25 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 97.25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 97.24 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 97.24 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 97.23 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 97.23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 97.21 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 97.2 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 97.19 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 97.18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 97.18 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 97.15 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 97.15 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 97.13 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 97.12 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 97.12 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 97.12 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 97.1 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 97.1 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 97.1 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 97.1 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 97.09 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 97.09 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 97.08 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 97.08 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 97.07 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 97.06 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 97.05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 97.05 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 97.04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 97.01 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 96.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 96.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 96.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 96.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 96.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 96.9 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 96.9 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 96.87 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 96.87 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 96.87 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 96.8 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 96.8 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 96.77 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 96.76 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 96.76 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 96.74 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 96.72 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 96.71 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 96.7 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 96.66 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 96.65 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 96.6 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 96.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.54 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 96.53 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 96.52 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 96.5 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 96.48 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 96.47 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 96.43 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 96.42 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 96.36 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 96.26 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 96.21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 96.19 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 96.18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 96.14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 96.12 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=389.46 Aligned_cols=197 Identities=30% Similarity=0.601 Sum_probs=158.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+|+| ++++ ++++..|||||||.||+ |++.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 88 ~l~HpnIv-~l~~~~~~~~~~yivmEy~~gG~--L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNIL 164 (311)
T 4aw0_A 88 RLDHPFFV-KLYFTFQDDEKLYFGLSYAKNGE--LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 164 (311)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEEeCCEEEEEEecCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeE
Confidence 57899855 6554 55677899999999999 988874 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC---cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG---EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||+|+.+... ....+.|||+.|||||++.+ ..|+.++||||+||++|+|++
T Consensus 165 l~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~------~~y~~~~DiWSlGvilyeml~--------- 229 (311)
T 4aw0_A 165 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE------KSACKSSDLWALGCIIYQLVA--------- 229 (311)
T ss_dssp ECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH------SCBCHHHHHHHHHHHHHHHHH---------
T ss_pred EcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC------CCCCcHHHHHHHHHHHHHHHh---------
Confidence 999999999999999987533 23456899999999999975 235555555555555555554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
|.+||.+.+..+++.+|.+
T Consensus 230 -------------------------------------------------------------G~~PF~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 230 -------------------------------------------------------------GLPPFRAGNEGLIFAKIIK 248 (311)
T ss_dssp -------------------------------------------------------------SSCSSCCSSHHHHHHHHHH
T ss_pred -------------------------------------------------------------CCCCCCCCCHHHHHHHHHc
Confidence 5555555555566777777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHH------HHcCCCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKE------ALNHSFFHPKLFD 285 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e------~L~Hpwf~~~~~~ 285 (408)
+.+.++ ..+|++++|||++||++||++|+|++| +++||||+...++
T Consensus 249 ~~~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 249 LEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp TCCCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred CCCCCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 777664 368999999999999999999999988 5899999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=387.46 Aligned_cols=198 Identities=27% Similarity=0.515 Sum_probs=163.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|.|+|+| ++++ +.++..|||||||+||+ |++++. ++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 127 ~l~HpnIV-~l~~~~~~~~~~~ivmEy~~gg~--L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 203 (346)
T 4fih_A 127 DYQHENVV-EMYNSYLVGDELWVVMEFLEGGA--LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 203 (346)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEECCCTTEE--HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEeCCCCCc--HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence 46899855 6655 45567899999999999 888763 568999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|+.+... ....+.|||+.|||||++.. ..|+.++||||+||++|+|++|.+||.+.+..+
T Consensus 204 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 204 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999877543 34567899999999999864 457888888888888888888888887766655
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..|..+ .
T Consensus 278 ~~~~i~~~----------------------------------------------------------------------~- 286 (346)
T 4fih_A 278 AMKMIRDN----------------------------------------------------------------------L- 286 (346)
T ss_dssp HHHHHHHS----------------------------------------------------------------------S-
T ss_pred HHHHHHcC----------------------------------------------------------------------C-
Confidence 55544332 1
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
....+.|..+|++++|||.+||++||++|||++|+|+||||+...
T Consensus 287 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 112234567899999999999999999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=375.94 Aligned_cols=194 Identities=36% Similarity=0.689 Sum_probs=143.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+|+| ++++ +.++..|+||||| +|+ |++.+. ++.+++.+++||+.||+|||++|||||||||+|||
T Consensus 69 ~l~HpnIv-~~~~~~~~~~~~~ivmEy~-~g~--L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL 144 (275)
T 3hyh_A 69 LLRHPHII-KLYDVIKSKDEIIMVIEYA-GNE--LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL 144 (275)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECC-CEE--HHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred HCCCCCCC-eEEEEEEECCEEEEEEeCC-CCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence 47899855 6554 5567789999999 666 777763 56899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|+.........+.+||+.|||||++.+. ..++.++||||+||++|+|++|+.||
T Consensus 145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~y~~~~~DiwSlGvily~lltg~~PF------- 212 (275)
T 3hyh_A 145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK-----LYAGPEVDVWSCGVILYVMLCRRLPF------- 212 (275)
T ss_dssp ECTTCCEEECCSSCC---------------CTTSCHHHHSSS-----SCCCTHHHHHHHHHHHHHHHHSSCSS-------
T ss_pred ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCC-----CCCCChhhhHHHHHHHHHHHHCCCCC-------
Confidence 999999999999999987766666778999999999998642 11245566666666665555555555
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+.+..++++.|.++.+
T Consensus 213 ---------------------------------------------------------------~~~~~~~~~~~i~~~~~ 229 (275)
T 3hyh_A 213 ---------------------------------------------------------------DDESIPVLFKNISNGVY 229 (275)
T ss_dssp ---------------------------------------------------------------CCSSHHHHHHHHHHTCC
T ss_pred ---------------------------------------------------------------CCCCHHHHHHHHHcCCC
Confidence 44444455566666665
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 230 ~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 230 TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 553 3589999999999999999999999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=377.39 Aligned_cols=194 Identities=31% Similarity=0.579 Sum_probs=154.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+| ||++++ +.++..|||||||+||+ |++++. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 82 ~l~Hpn-Iv~l~~~~~~~~~~~ivmEy~~gg~--L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 82 EVNHPF-IVKLHYAFQTEGKLYLILDFLRGGD--LFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 158 (304)
T ss_dssp CCCCTT-EECEEEEEEETTEEEEEECCCTTCE--EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred HCCCCC-CCeEEEEEEECCEEEEEEEcCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeE
Confidence 578997 556665 45567899999999999 888774 55899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+|+..... ....+.+||+.|||||++.+ ..|+.++||||+||++|+|++|.+||.
T Consensus 159 l~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~------~~y~~~~DiwSlGvilyemltG~~PF~----- 227 (304)
T 3ubd_A 159 LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR------RGHTQSADWWSFGVLMFEMLTGTLPFQ----- 227 (304)
T ss_dssp ECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT------SCCCTHHHHHHHHHHHHHHHHSSCSSC-----
T ss_pred EcCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc------CCCCCCCcccchHHHHHHHHhCCCCCC-----
Confidence 999999999999999865443 34456899999999999864 345666666666666666666655554
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+..+++..|.++.
T Consensus 228 -----------------------------------------------------------------~~~~~~~~~~i~~~~ 242 (304)
T 3ubd_A 228 -----------------------------------------------------------------GKDRKETMTMILKAK 242 (304)
T ss_dssp -----------------------------------------------------------------CSSHHHHHHHHHHCC
T ss_pred -----------------------------------------------------------------CcCHHHHHHHHHcCC
Confidence 444445556666666
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
+.++ ..+|++++|||++||++||++||| ++|+|+||||+..
T Consensus 243 ~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 243 LGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 5553 468999999999999999999998 5899999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=390.11 Aligned_cols=198 Identities=27% Similarity=0.510 Sum_probs=159.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|.|+|+| ++++ +.++..|||||||.||+ |++++ .++.+++.|+.||+.||+|||++|||||||||+|||+
T Consensus 204 ~l~HpnIV-~l~~~~~~~~~~~iVmEy~~gG~--L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl 280 (423)
T 4fie_A 204 DYQHENVV-EMYNSYLVGDELWVVMEFLEGGA--LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 280 (423)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE
T ss_pred hCCCCCCC-ceEEEEEECCEEEEEEeCCCCCc--HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence 46899855 6655 45567899999999999 88876 3568999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|+.+... ....+.|||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 281 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 281 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999877543 34557899999999999864 356777777777777777777777765544433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
++..|....
T Consensus 355 ----------------------------------------------------------------------~~~~i~~~~- 363 (423)
T 4fie_A 355 ----------------------------------------------------------------------AMKMIRDNL- 363 (423)
T ss_dssp ----------------------------------------------------------------------HHHHHHHSC-
T ss_pred ----------------------------------------------------------------------HHHHHHcCC-
Confidence 333333322
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
....+.|..+|++++|||.+||++||++|+||+|+|+||||+...
T Consensus 364 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 364 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 223345678999999999999999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.16 Aligned_cols=195 Identities=30% Similarity=0.489 Sum_probs=163.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.|.|+|+| ++++ +.++..|||||||.||+ |+++|. ++.+++.|+.||+.||+|||++|||||||||+|
T Consensus 79 ~l~HpnIV-~~~~~~~~~~~~yiVmEy~~gg~--L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 155 (350)
T 4b9d_A 79 NMKHPNIV-QYRESFEENGSLYIVMDYCEGGD--LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155 (350)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGG
T ss_pred HCCCCCCC-cEEEEEEECCEEEEEEeCCCCCc--HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 47899855 6655 45567899999999999 988873 457899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
||++.++.+||+|||+|+.+..... ..+.+||+.|||||++.+ ..|+.++||||+||++|+|++|.+||.+.+
T Consensus 156 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~------~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 156 IFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN------KPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp EEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999988765432 345789999999999975 468899999999999999999998887776
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+++.+|..+.
T Consensus 230 ~~~~~~~i~~~~-------------------------------------------------------------------- 241 (350)
T 4b9d_A 230 MKNLVLKIISGS-------------------------------------------------------------------- 241 (350)
T ss_dssp HHHHHHHHHHTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 666555554432
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+. +.+..+|++++|||.+||++||++|||++|+|+||||+..
T Consensus 242 --~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 242 --FP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp --CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred --CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 21 1234679999999999999999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.96 Aligned_cols=193 Identities=27% Similarity=0.510 Sum_probs=154.0
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCC--CeeccC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHS--VVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~--IvHRDL 72 (408)
.|.|||+| ++++. +++..|||||||.||+ |.+++. ++.+++.++.||+.||+|||++| ||||||
T Consensus 81 ~l~HpnIV-~~~~~~~~~~~~~~~~~lvmEy~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDl 157 (290)
T 3fpq_A 81 GLQHPNIV-RFYDSWESTVKGKKCIVLVTELMTSGT--LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp TCCCTTBC-CEEEEEEEEETTEEEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCC
T ss_pred hCCCCCCC-cEEEEEeeccCCCcEEEEEEeCCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEeccc
Confidence 47899855 65542 2455799999999999 888774 45889999999999999999999 999999
Q ss_pred CCCcEEEec-CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLDD-QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~~-~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|||++. ++.+||+|||+|+.... ....+.+|||.|||||++.+ .|+.++||||+||++|+|++|.+||
T Consensus 158 Kp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-------~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 158 KCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-------CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999974 78999999999986433 34557899999999998852 4889999999999999999999999
Q ss_pred CCchhHH-HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 152 WHRKQMV-MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 152 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.+.+... +...+..+ ..|
T Consensus 230 ~~~~~~~~~~~~i~~~---------------------------------------------------~~~---------- 248 (290)
T 3fpq_A 230 SECQNAAQIYRRVTSG---------------------------------------------------VKP---------- 248 (290)
T ss_dssp TTCSSHHHHHHHHTTT---------------------------------------------------CCC----------
T ss_pred CCCCcHHHHHHHHHcC---------------------------------------------------CCC----------
Confidence 6644322 22222211 111
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 249 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1112356889999999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=374.72 Aligned_cols=242 Identities=31% Similarity=0.501 Sum_probs=161.6
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC-
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ- 82 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~- 82 (408)
.|+| |+++.+ +.++..|||||||.||+ |++.+. ++.+++.+++||+.||+|||++|||||||||+|||++.+
T Consensus 78 ~h~n-Iv~l~~~~~~~~~~~lvmE~~~g~~--L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~ 154 (361)
T 4f9c_A 78 GQDN-VMGVKYCFRKNDHVVIAMPYLEHES--FLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL 154 (361)
T ss_dssp SBTT-BCCCSEEEEETTEEEEEEECCCCCC--HHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred CCCC-CceEEEEEEECCEEEEEEeCCCccc--HHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC
Confidence 5776 556655 45567899999999999 888874 568999999999999999999999999999999999876
Q ss_pred CCEEEeccccchhcccC-----------------------------cccccCCCCCcccChhhhhhccccCcCCCCcchh
Q psy3880 83 MNVKLTDFGFARVLKKG-----------------------------EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVD 133 (408)
Q Consensus 83 ~~iKl~DFGla~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~D 133 (408)
+.+||+|||+|+..... ....+.+||++|+|||++.+. ..|+.++|
T Consensus 155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~y~~~~D 229 (361)
T 4f9c_A 155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-----PNQTTAID 229 (361)
T ss_dssp TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-----SCCCTHHH
T ss_pred CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-----CCCCCccc
Confidence 79999999999754321 122346899999999999752 45899999
Q ss_pred hhhhhHHHHHHHhCCCCCCC-chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhh-cccccc---cCCCcccccchh
Q psy3880 134 VWACGVIMYTLLVGCPPFWH-RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRAN-MFEDAT---GYGQAVDVWACG 208 (408)
Q Consensus 134 iwSlGvil~~ll~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~-~~~~~~---~y~~~~DiWs~G 208 (408)
|||+||++|+|++|+.||.. .++.+++.+|.....+ |+..... .+.... ...+..+.+...
T Consensus 230 iWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~--------------~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 295 (361)
T 4f9c_A 230 MWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS--------------RETIQAAKTFGKSILCSKEVPAQDLRKLC 295 (361)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH--------------HHHHHHHHHTTEEEEESSCCCCCCHHHHH
T ss_pred hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCC--------------ccchhhhhhccccccccccCcchhhhHHH
Confidence 99999999999999999965 4566677776542211 1110000 000000 000001111100
Q ss_pred hhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 209 VIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 209 vily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
-.+...-...|.+. ..+. ......+.|..+|++++|||++||++||++|+||+|||+||||+.
T Consensus 296 ~~~~~~~~~~p~~~--------~~~~--~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 296 ERLRGMDSSTPKLT--------SDIQ--GHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHC--------------------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred Hhhccccccccccc--------cccc--cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00000000000000 0000 011223568899999999999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.89 Aligned_cols=226 Identities=24% Similarity=0.381 Sum_probs=170.8
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.|.|+|+| .+++. ..+..|||||||. |+ |++.+. ++.+++.+++||+.||+|||++|||||||
T Consensus 109 ~l~HpnIv-~l~~~~~~~~~~~~~~~~~ivmE~~~-g~--L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDl 184 (398)
T 4b99_A 109 HFKHDNII-AIKDILRPTVPYGEFKSVYVVLDLME-SD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDL 184 (398)
T ss_dssp HCCCTTBC-CEEEECCCSSCTTTCCCEEEEEECCS-EE--HHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred hcCCCCcc-eEeeeeecccccccCCEEEEEEeCCC-CC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCc
Confidence 46899855 65542 2345699999996 55 777774 45899999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccC-----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKG-----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
||+|||++.++.+||+|||+|+.+... ....+.+||+.|+|||++.+. ..|+.++||||+||++|+|++|
T Consensus 185 KP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-----~~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 185 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-----HEYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHHHT
T ss_pred CccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCC-----CCCCChhheehhHHHHHHHHHC
Confidence 999999999999999999999876432 234568999999999998753 4578999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 148 CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 148 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
.+||.+.+..+++..|......+....+....... ....+...++.....-
T Consensus 260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~- 310 (398)
T 4b99_A 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER----------------------------VRAYIQSLPPRQPVPW- 310 (398)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----C----------------------------HHHHHHSSCCCCCCCH-
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh----------------------------hhhhhhcCCCcCCCCH-
Confidence 99999999999999998876554433222111000 0011111122111100
Q ss_pred HHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 228 ~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
. ..+..+|++++|||++||++||++||||+|||+||||+...
T Consensus 311 ---~-----------~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 311 ---E-----------TVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---H-----------HHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred ---H-----------HhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 11356899999999999999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=366.22 Aligned_cols=197 Identities=23% Similarity=0.338 Sum_probs=157.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+|+| ++++ +.++..|||||||+||+ |++++. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 106 ~l~HpnIV-~l~~~~~~~~~~~ivmEy~~gg~--L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 182 (336)
T 4g3f_A 106 GLSSPRIV-PLYGAVREGPWVNIFMELLEGGS--LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182 (336)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEECCCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEeccCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence 47899855 6655 44567899999999999 988874 55899999999999999999999999999999999
Q ss_pred EecCC-CEEEeccccchhcccCcc------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 79 LDDQM-NVKLTDFGFARVLKKGEK------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 79 l~~~~-~iKl~DFGla~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
++.++ .+||+|||+|+.+..... ....+||+.|||||++.+ ..|+.++||||+||++|+|++|.+||
T Consensus 183 l~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~------~~y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG------KPCDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp ECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC------CCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99887 699999999987754321 123689999999999975 46889999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+...++.+|..+ .+|+
T Consensus 257 ~~~~~~~~~~~i~~~---------------------------------------------------~~~~---------- 275 (336)
T 4g3f_A 257 TQYFRGPLCLKIASE---------------------------------------------------PPPI---------- 275 (336)
T ss_dssp TTTCCSCCHHHHHHS---------------------------------------------------CCGG----------
T ss_pred CCCCHHHHHHHHHcC---------------------------------------------------CCCc----------
Confidence 765543333333321 1111
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH-------------HcCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA-------------LNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~-------------L~Hpwf~~~ 282 (408)
. ..+..+|+++++||.+||++||++|||+.|+ |+|||+...
T Consensus 276 ---------~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 276 ---------R-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp ---------G-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred ---------h-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 0 1235689999999999999999999999997 689999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=385.72 Aligned_cols=200 Identities=32% Similarity=0.556 Sum_probs=166.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|.|+|+| ++++ +.++..|||||||.||+ |++++.. +.+++.+++||+.||+|||++||+||||||+||
T Consensus 210 ~l~hpnIv-~l~~~~~~~~~~~iv~E~~~gg~--L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Ni 286 (573)
T 3uto_A 210 VLRHPTLV-NLHDAFEDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286 (573)
T ss_dssp HTCCTTBC-CEEEEEECSSEEEEEEECCCCCB--HHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-eEEEEEEECCEEEEEEeecCCCc--HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhc
Confidence 46899855 6655 55677899999999999 9988753 479999999999999999999999999999999
Q ss_pred EEecC--CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDDQ--MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~~--~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++.+ +.+||+|||+|+.+.........|||+.|||||++.+ ..|+.++
T Consensus 287 ll~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~------~~y~~~~----------------------- 337 (573)
T 3uto_A 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG------KPVGYYT----------------------- 337 (573)
T ss_dssp EESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT------CCBCHHH-----------------------
T ss_pred cccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC------CCCCcHH-----------------------
Confidence 99854 7999999999999887777778899999999999864 2345544
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
||||+|||+|+|++|.+||.+.+..+++..|..
T Consensus 338 -----------------------------------------------DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~ 370 (573)
T 3uto_A 338 -----------------------------------------------DMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370 (573)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence 555555555555555556666666677778888
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
+.+.++.+.|..+|++++|||++||++||++|||++|+|+||||+....
T Consensus 371 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 8888888889999999999999999999999999999999999987644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=375.19 Aligned_cols=197 Identities=28% Similarity=0.454 Sum_probs=159.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.||++| .+++ ++++..|||||||.||+ |+++|. ++.++++|+.||+.||+|||++|||||||||+|||
T Consensus 248 ~~~HP~IV-~l~~~f~~~~~lylVmEy~~GGd--L~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL 324 (689)
T 3v5w_A 248 TGDCPFIV-CMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324 (689)
T ss_dssp SSCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hCCCCCEe-EEEEEEEECCEEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE
Confidence 35788755 6554 55677899999999999 988873 56899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.+|.+||+|||+|+.+... ...+.||||.|||||++.. ..+|+.++|+||+||++|+|++|.+||.+.+..
T Consensus 325 ld~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~-----~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~- 397 (689)
T 3v5w_A 325 LDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK-----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK- 397 (689)
T ss_dssp ECTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHST-----TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-
T ss_pred EeCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhC-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 999999999999999876544 3456899999999999863 245788888888888888888888888543211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+.+.+....+
T Consensus 398 ------------------------------------------------------------------~~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 398 ------------------------------------------------------------------DKHEIDRMTLTMAV 411 (689)
T ss_dssp ------------------------------------------------------------------CHHHHHHHHHHCCC
T ss_pred ------------------------------------------------------------------HHHHHHHhhcCCCC
Confidence 11223344444444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.+ |..+|++++|||++||++||++|+| |+|+++||||+..
T Consensus 412 ~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 412 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred CC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 43 3468999999999999999999998 8999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.00 Aligned_cols=247 Identities=29% Similarity=0.511 Sum_probs=169.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.||+ |++++. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 71 ~l~hpnIv-~l~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIl 147 (361)
T 2yab_A 71 QVLHPNII-TLHDVYENRTDVVLILELVSGGE--LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147 (361)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCcCCC-cEEEEEEeCCEEEEEEEcCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 46799865 5544 45567899999999999 998875 45899999999999999999999999999999999
Q ss_pred EecCC----CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQM----NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~----~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++ .+||+|||++..+.........+||+.|+|||++.. ..|+.++|+||+||++|+
T Consensus 148 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~~----------- 210 (361)
T 2yab_A 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY------EPLGLEADMWSIGVITYI----------- 210 (361)
T ss_dssp ESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHH-----------
T ss_pred EeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC------CCCCccccHHHHHHHHHH-----------
Confidence 98776 799999999988776666667899999999999864 234555555555555555
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
|++|.+||.+.+..+++..|.
T Consensus 211 -----------------------------------------------------------ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 211 -----------------------------------------------------------LLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp -----------------------------------------------------------HHHSCCSSCCSSHHHHHHHHH
T ss_pred -----------------------------------------------------------HHhCCCCCCCCCHHHHHHHHH
Confidence 455555555555556667777
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHH
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFI 314 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (408)
.+.+.++.+.|..+|+++++||++||+.||++|||++|+|+||||+....... ............++++....+++.+
T Consensus 232 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (361)
T 2yab_A 232 AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA--MVRRESVVNLENFKKQYVRRRWKLS 309 (361)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHH--HHHHTCBCCHHHHHHHTC-------
T ss_pred hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhh--hhcccchhhHHHHHHHHHHhHHHHH
Confidence 77888877778899999999999999999999999999999999986432110 0111111224456677788999999
Q ss_pred HHHHHHHHHHhhhcccCCc
Q psy3880 315 ILVVRAAVRISRLKYNHVP 333 (408)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~ 333 (408)
+..+.+..++.++.....+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~ 328 (361)
T 2yab_A 310 FSIVSLCNHLTRSLMKKVH 328 (361)
T ss_dssp -------------------
T ss_pred HHHHHHHHHHHHHHhcccC
Confidence 9999999999887655444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=340.42 Aligned_cols=193 Identities=25% Similarity=0.428 Sum_probs=141.6
Q ss_pred ccccCCcEEEEeccC--C------------cHHHHHHHHHhhchhhHHhhhCC--------HHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKEEG--D------------DLKHLAAQVVDKGEAAVQDIINS--------NPALRYIMRQLFEALEHVH 63 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--~------------~~~~lv~e~~~~g~~~l~~~~~~--------~~~~r~i~~qil~aL~~LH 63 (408)
.|.|+|+| ++++.. . ...|+|||||.||+ |.+.+.. ...++.++.||+.||+|||
T Consensus 59 ~l~HpnIV-~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~--L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH 135 (299)
T 4g31_A 59 KLEHPGIV-RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKEN--LKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135 (299)
T ss_dssp TCCCTTBC-CEEEEEEEEC----------CEEEEEEEECCCSCC--HHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCC-eEEEEEEecCccccccccCCCcEEEEEEecCCCCc--HHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH
Confidence 47899855 555421 1 12589999999999 8887743 2458899999999999999
Q ss_pred HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc-------------cccCCCCCcccChhhhhhccccCcCCCCc
Q psy3880 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-------------LMDLCGTPGYLAPEVLRANMFEDATGYGQ 130 (408)
Q Consensus 64 ~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~ 130 (408)
++|||||||||+|||++.++.+||+|||+|+.+..... ..+.+||+.|||||++.+ ..|+.
T Consensus 136 ~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~------~~y~~ 209 (299)
T 4g31_A 136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG------NSYSH 209 (299)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT------CCCCT
T ss_pred HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC------CCCCC
Confidence 99999999999999999999999999999987654321 234689999999999975 46889
Q ss_pred chhhhhhhHHHHHHHhCCCCCCCchhH-HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhh
Q psy3880 131 AVDVWACGVIMYTLLVGCPPFWHRKQM-VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGV 209 (408)
Q Consensus 131 ~~DiwSlGvil~~ll~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gv 209 (408)
++||||+||++|+|++ ||.+..+. ..+..+..
T Consensus 210 ~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~-------------------------------------------- 242 (299)
T 4g31_A 210 KVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN-------------------------------------------- 242 (299)
T ss_dssp HHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT--------------------------------------------
T ss_pred HHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc--------------------------------------------
Confidence 9999999999999985 77553321 11111111
Q ss_pred hHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 210 IMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 210 ily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. ++ +.+...++++++||++||+.||++|||+.|+|+||||+...
T Consensus 243 --------------------------~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 243 --------------------------LK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp --------------------------TC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred --------------------------CC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 11 00 11233577889999999999999999999999999998643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.24 Aligned_cols=196 Identities=23% Similarity=0.376 Sum_probs=149.3
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|.|+|+|.-+....++..|||||||.||+ |.+++. +..++..++.||+.||+|||+++||||||||+|||+
T Consensus 88 ~l~HpNIV~l~g~~~~~~~~iVmEy~~gGs--L~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl 165 (307)
T 3omv_A 88 KTRHVNILLFMGYMTKDNLAIVTQWCEGSS--LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL 165 (307)
T ss_dssp TCCCTTBCCEEEEECSSSCEEEEECCSSCB--HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE
T ss_pred hCCCCCEeeEEEEEECCeEEEEEEcCCCCC--HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE
Confidence 578998663333344456799999999999 988873 347899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC---cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKG---EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++++.+||+|||+|+..... ......+||+.|||||++... ....|+.++|||||||++|||++|+.||.+.+.
T Consensus 166 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~---~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 166 HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ---DNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCC---SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhcc---CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999876432 233457999999999999753 124589999999999999999999999977654
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+..+....+.. |
T Consensus 243 ~~~~~~~~~~~~~~-------------------------------------------------p---------------- 257 (307)
T 3omv_A 243 RDQIIFMVGRGYAS-------------------------------------------------P---------------- 257 (307)
T ss_dssp HHHHHHHHHTTCCC-------------------------------------------------C----------------
T ss_pred HHHHHHHHhcCCCC-------------------------------------------------C----------------
Confidence 44333332211100 0
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHH
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L 274 (408)
.....+.++|+++++||.+||+.||++|||+.|++
T Consensus 258 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 258 ---DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp ---CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred ---CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 00122356789999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.65 Aligned_cols=237 Identities=35% Similarity=0.637 Sum_probs=183.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.++..|+||||+.||+ |++.+. ++.++..++.||+.||+|||++||+||||||+|||
T Consensus 84 ~l~hpnIv-~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIl 160 (362)
T 2bdw_A 84 KLQHPNIV-RLHDSIQEESFHYLVFDLVTGGE--LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 160 (362)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEEeCCEEEEEEecCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence 36799865 5543 45567799999999999 888774 45899999999999999999999999999999999
Q ss_pred EecC---CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQ---MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~---~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.+ +.+||+|||++............+||+.|+|||++.. ..|+.++||||+||++|+|++
T Consensus 161 l~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~--------- 225 (362)
T 2bdw_A 161 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK------DPYSKPVDIWACGVILYILLV--------- 225 (362)
T ss_dssp ESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT------CCCCTHHHHHHHHHHHHHHHH---------
T ss_pred EecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc------CCCCchhhHHHHHHHHHHHHH---------
Confidence 9765 4599999999988776555566899999999999864 234555555555555555554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
|.+||++.+...+...+..
T Consensus 226 -------------------------------------------------------------g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 226 -------------------------------------------------------------GYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp -------------------------------------------------------------SSCSSCCSSHHHHHHHHHH
T ss_pred -------------------------------------------------------------CCCCCCCCCHHHHHHHHHh
Confidence 5555555555566777888
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.++.+.|..+|+++++||.+||+.||++|||+.|+|+||||....... ...........+++++...+++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~~~~ 320 (362)
T 2bdw_A 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA----SAIHRQDTVDCLKKFNARRKLKGAI 320 (362)
T ss_dssp TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHS----CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccc----cccchhhHHHHHHHHHHHHHHHHHH
Confidence 888888899999999999999999999999999999999999996421000 0011223456778899999999998
Q ss_pred HHHHHHHHHh
Q psy3880 316 LVVRAAVRIS 325 (408)
Q Consensus 316 ~~~~~~~~~~ 325 (408)
+.+++..+..
T Consensus 321 ~~~~~~~~~~ 330 (362)
T 2bdw_A 321 LTTMIATRNL 330 (362)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhc
Confidence 8887766544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.95 Aligned_cols=231 Identities=39% Similarity=0.691 Sum_probs=178.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.++..|+|||||.||+ |++.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 66 ~l~hpnIv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIl 142 (444)
T 3soa_A 66 LLKHPNIV-RLHDSISEEGHHYLIFDLVTGGE--LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLL 142 (444)
T ss_dssp HCCBTTBC-CEEEEEECSSEEEEEECCCBCCB--HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEE
T ss_pred hCCCcCCC-eEEEEEEECCEEEEEEEeCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 46899865 5544 45567899999999999 888763 56899999999999999999999999999999999
Q ss_pred Ee---cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LD---DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~---~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++ .++.+||+|||+|....... .....+||+.|+|||++.. ..|+.++
T Consensus 143 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~~~~~---------------------- 194 (444)
T 3soa_A 143 LASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK------DPYGKPV---------------------- 194 (444)
T ss_dssp ESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT------CCBCTHH----------------------
T ss_pred EeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC------CCCCCcc----------------------
Confidence 98 45789999999998765433 3345789999999999864 2344444
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
||||+||++|+|++|.+||.+.+...+...+.
T Consensus 195 ------------------------------------------------DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 195 ------------------------------------------------DLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp ------------------------------------------------HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ------------------------------------------------ccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 55555555555555555565666666777888
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHH
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFI 314 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (408)
.+.+.++.+.|..+|+++++||.+||+.||++|||+.|+|+||||+...... ...........++++++.++++.+
T Consensus 227 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~----~~~~~~~~~~~l~~~~~~~klk~~ 302 (444)
T 3soa_A 227 AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA----SCMHRQETVDCLKKFNARRKLKGA 302 (444)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHS----CCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred hCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCcccc----ccchhhHHHHHHHHHHHHHHHHHH
Confidence 8889999999999999999999999999999999999999999996431100 001112345677888888888887
Q ss_pred HHHHH
Q psy3880 315 ILVVR 319 (408)
Q Consensus 315 ~~~~~ 319 (408)
++.++
T Consensus 303 ~~~~~ 307 (444)
T 3soa_A 303 ILTVM 307 (444)
T ss_dssp CSCEE
T ss_pred HHHHH
Confidence 65544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.93 Aligned_cols=187 Identities=18% Similarity=0.342 Sum_probs=153.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------------------CHHHHHHHHHHHHHHHHHHHHC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------------------SNPALRYIMRQLFEALEHVHNH 65 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------------------~~~~~r~i~~qil~aL~~LH~~ 65 (408)
.|.|+|+| +++. ..++..|||||||.||+ |.+++. ++.++..++.||+.||+|||++
T Consensus 71 ~l~HpnIV-~l~g~~~~~~~~~lV~Ey~~~G~--L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 71 NLQHEHIV-KFYGVCVEGDPLIMVFEYMKHGD--LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEEECCTTCB--HHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCc-cEEEEEeeCCEEEEEEEcCCCCc--HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47899855 6654 45567899999999999 888772 4578999999999999999999
Q ss_pred CCeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 66 SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 66 ~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
+||||||||+|||++.++.+||+|||+|+........ ...+||+.|||||++.. ..|+.++|||||||++|
T Consensus 148 ~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~------~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 148 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY------RKFTTESDVWSLGVVLW 221 (299)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH------CCCCHHHHHHHHHHHHH
T ss_pred CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC------CCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999999876543322 23568999999999975 35889999999999999
Q ss_pred HHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 143 TLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 143 ~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
||+| |+.||.+.+..+.+..|..+..
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~----------------------------------------------------- 248 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRV----------------------------------------------------- 248 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCC-----------------------------------------------------
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCC-----------------------------------------------------
Confidence 9998 8999977766655555544321
Q ss_pred CCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHH
Q psy3880 222 WHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274 (408)
Q Consensus 222 ~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L 274 (408)
. +....+|+++++||.+||+.||++|||++|++
T Consensus 249 -----------------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 249 -----------------L---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp -----------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----------------C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 0 11135788999999999999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.79 Aligned_cols=189 Identities=19% Similarity=0.330 Sum_probs=146.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------------------CHHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------------------SNPALRYIMRQLFEALEHVH 63 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------------------~~~~~r~i~~qil~aL~~LH 63 (408)
.|.|+|+| +++. ..++..|||||||.+|+ |.+++. +..++..++.||+.||+|||
T Consensus 99 ~l~HpnIV-~l~g~~~~~~~~~lV~Ey~~~G~--L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 99 MLQHQHIV-RFFGVCTEGRPLLMVFEYMRHGD--LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEEECCTTCB--HHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEEcCCCCc--HHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899855 6654 44567899999999999 888763 34678999999999999999
Q ss_pred HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 64 ~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
+++||||||||+|||++.++.+||+|||+|+.+..... ....+||+.|||||++.. ..|+.++|||||||+
T Consensus 176 ~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~------~~~~~~sDvwS~Gvv 249 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY------RKFTTESDVWSFGVV 249 (329)
T ss_dssp HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT------CCCCHHHHHHHHHHH
T ss_pred cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC------CCCCccccccchHHH
Confidence 99999999999999999999999999999987654322 234689999999999975 458899999999999
Q ss_pred HHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 141 MYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 141 l~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
+|||+| |+.||.+.+..+.+..|..+..
T Consensus 250 l~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--------------------------------------------------- 278 (329)
T 4aoj_A 250 LWEIFTYGKQPWYQLSNTEAIDCITQGRE--------------------------------------------------- 278 (329)
T ss_dssp HHHHHTTSCCTTCSSCHHHHHHHHHHTCC---------------------------------------------------
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCC---------------------------------------------------
Confidence 999998 8999877666555555544310
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. +....+|+++++||.+||+.||++|||++|++++
T Consensus 279 --------------------~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 --------------------L--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp --------------------C--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred --------------------C--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0 1113578999999999999999999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=331.27 Aligned_cols=190 Identities=23% Similarity=0.335 Sum_probs=150.6
Q ss_pred cccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHH
Q psy3880 7 VAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHV 62 (408)
Q Consensus 7 ~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~L 62 (408)
+.|+++||++.. +.++..|||||||.+|+ |.++|. +..++..++.||+.||+||
T Consensus 124 l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~--L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp HCCCTTBCCEEEEECCTTSCCEEEEECCTTEE--HHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcEEEEEEEEEecCCEEEEEEEcCCCCC--HHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 567655667664 23356799999999999 888772 4578899999999999999
Q ss_pred HHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 63 HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 63 H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
|+++||||||||+|||+++++.+||+|||+|+.+..... ....+||+.|||||++.. ..|+.++|||||||
T Consensus 202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~------~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD------RVYTIQSDVWSFGV 275 (353)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH------CCCCHHHHHHHHHH
T ss_pred hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc------CCCCCcccEeehHH
Confidence 999999999999999999999999999999987654322 234679999999999975 45889999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC
Q psy3880 140 IMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218 (408)
Q Consensus 140 il~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~ 218 (408)
++|||+| |..||.+.+..+.+.++
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~~~~~~------------------------------------------------------- 300 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDEEFCRR------------------------------------------------------- 300 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHH-------------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHH-------------------------------------------------------
Confidence 9999998 89999765422221111
Q ss_pred CCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+..+ ..++.| +.+|+++++||.+||+.||++|||+.|+++|
T Consensus 301 --------------i~~g-~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 301 --------------LKEG-TRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp --------------HHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------HHcC-CCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1111 111111 3578999999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=322.01 Aligned_cols=189 Identities=21% Similarity=0.359 Sum_probs=155.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHV 62 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~L 62 (408)
.|.|+|+| ++.. ..++..+||||||.+|+ |.++| .+..++..++.||+.||+||
T Consensus 85 ~l~HpNIV-~l~g~~~~~~~~~lV~Ey~~~G~--L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 85 RLQHPNVV-CLLGVVTKDQPLSMIFSYCSHGD--LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCSSCB--HHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCC-CcceEEEECCEEEEEEEcCCCCc--HHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 47899865 5554 45567899999999999 98887 23478899999999999999
Q ss_pred HHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 63 HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 63 H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
|+++||||||||+|||+++++.+||+|||+|+.+.... .....+||+.|||||++.. ..|+.++|||||||
T Consensus 162 H~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~------~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 162 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY------GKFSIDSDIWSYGV 235 (308)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH------CCCCHHHHHHHHHH
T ss_pred HhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC------CCCCccchhhhHHH
Confidence 99999999999999999999999999999998765432 2334689999999999975 35889999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC
Q psy3880 140 IMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218 (408)
Q Consensus 140 il~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~ 218 (408)
++|||+| |..||.+.+..+.+..|..+..
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~-------------------------------------------------- 265 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-------------------------------------------------- 265 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------
Confidence 9999998 8999987776665555543321
Q ss_pred CCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. +...++++++.+||.+|+..||++|||+.|++++
T Consensus 266 ---------------------~--~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 ---------------------L--PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp ---------------------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------C--CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 1123578899999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.57 Aligned_cols=237 Identities=33% Similarity=0.611 Sum_probs=179.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..|+|||||.||+ |++.+. ++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 153 (486)
T 3mwu_A 77 KLDHPNIM-KLFEILEDSSSFYIVGELYTGGE--LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153 (486)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hCCCCCcC-eEEEEEEcCCEEEEEEEcCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence 36799865 5444 45567899999999998 877663 55889999999999999999999999999999999
Q ss_pred Ee---cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LD---DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~---~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++ .++.+||+|||+|............+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||
T Consensus 154 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf---- 222 (486)
T 3mwu_A 154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-------TYDEKCDVWSAGVILYILLSGTPPF---- 222 (486)
T ss_dssp ESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-------CCCHHHHHHHHHHHHHHHHHSSCSS----
T ss_pred EecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-------CCCchhhHHHHHHHHHHHHhCCCCC----
Confidence 95 456799999999988776666667889999999999853 2556666666666666665555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+.+..+..
T Consensus 223 ------------------------------------------------------------------~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 223 ------------------------------------------------------------------YGKNEYDILKRVET 236 (486)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHh
Confidence 44444556667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.+..+.|..+|+++++||++||+.||++|||+.|+|+||||+.....................++++....+++.++
T Consensus 237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (486)
T 3mwu_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316 (486)
T ss_dssp TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHH
T ss_pred CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHH
Confidence 78888888899999999999999999999999999999999999765332211111122234455667777777888777
Q ss_pred HHHHHHH
Q psy3880 316 LVVRAAV 322 (408)
Q Consensus 316 ~~~~~~~ 322 (408)
+.+.+..
T Consensus 317 l~~ia~~ 323 (486)
T 3mwu_A 317 LLYMASK 323 (486)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7766644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.19 Aligned_cols=235 Identities=35% Similarity=0.660 Sum_probs=174.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +..+..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 104 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 180 (349)
T 2w4o_A 104 RLSHPNII-KLKEIFETPTEISLVLELVTGGE--LFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180 (349)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hCCCCCCc-ceeeeEecCCeEEEEEEeCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEE
Confidence 36788865 4443 44566789999999998 888774 45889999999999999999999999999999999
Q ss_pred Eec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++. ++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+..
T Consensus 181 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG------CAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ESSSSTTCCEEECCCC----------------CGGGSCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred EecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC------CCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 975 78999999999987765544556789999999999864 346778888888888888888888875433
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
... .++..+..
T Consensus 255 ~~~---------------------------------------------------------------------~~~~~i~~ 265 (349)
T 2w4o_A 255 GDQ---------------------------------------------------------------------FMFRRILN 265 (349)
T ss_dssp CHH---------------------------------------------------------------------HHHHHHHT
T ss_pred ccH---------------------------------------------------------------------HHHHHHHh
Confidence 221 23344555
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.+..+.|..+|.++++||++||..||++|||+.|+|+||||........ ......++++++++..+++.++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 339 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV------HMDTAQKKLQEFNARRKLKAAV 339 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh------hhcchHHHHHHHHHHHHHHHHH
Confidence 5555566667889999999999999999999999999999999987543221 1234566789999999999999
Q ss_pred HHHHHHHHH
Q psy3880 316 LVVRAAVRI 324 (408)
Q Consensus 316 ~~~~~~~~~ 324 (408)
..+.+..++
T Consensus 340 ~~~~~~~~l 348 (349)
T 2w4o_A 340 KAVVASSRL 348 (349)
T ss_dssp HHHHHCC--
T ss_pred HHHHHHhhc
Confidence 888776543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.01 Aligned_cols=236 Identities=33% Similarity=0.600 Sum_probs=181.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 82 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 158 (484)
T 3nyv_A 82 QLDHPNIM-KLYEFFEDKGYFYLVGEVYTGGE--LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158 (484)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCCCC-cEEEEEEeCCEEEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 46899865 5444 45567899999999999 887763 35889999999999999999999999999999999
Q ss_pred E---ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 L---DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l---~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+ +.++.+||+|||+|..+.........+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||
T Consensus 159 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf---- 227 (484)
T 3nyv_A 159 LESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-------TYDEKCDVWSTGVILYILLSGCPPF---- 227 (484)
T ss_dssp ESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-------CCCTHHHHHHHHHHHHHHHHSSCSS----
T ss_pred EecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-------CCCCcceeHHHHHHHHHHHHCCCCC----
Confidence 9 4578999999999998876666667789999999999853 3556666666666666665555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+.+..+..
T Consensus 228 ------------------------------------------------------------------~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 228 ------------------------------------------------------------------NGANEYDILKKVEK 241 (484)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHc
Confidence 44444556667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.+..+.|..+|+++++||++||+.||++|||+.|+|+||||+....... .............++++....+++.++
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~kl~qa~ 320 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI-SVDVPSLDNAILNIRQFQGTQKLAQAA 320 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC------CCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccc-cccccchHHHHHHHHHHhhhhHHHHHH
Confidence 8888888899999999999999999999999999999999999975432111 001112234455677788888888887
Q ss_pred HHHHHHH
Q psy3880 316 LVVRAAV 322 (408)
Q Consensus 316 ~~~~~~~ 322 (408)
+.+++..
T Consensus 321 l~~i~~~ 327 (484)
T 3nyv_A 321 LLYMGSK 327 (484)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 7766644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=316.76 Aligned_cols=196 Identities=33% Similarity=0.614 Sum_probs=163.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.||+ |.+.+ .++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 70 ~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 70 ILNHPNIV-KLFEVIETEKTLYLIMEYASGGE--VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCTTCB--HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCCEe-eEEEEEEECCEEEEEEECCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 36799865 5444 45567899999999998 88876 355899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++............+||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.+...
T Consensus 147 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 147 LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK-----KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp ECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTC-----CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCC-----CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999887776667778999999999999753 223578999999999999999999997766555
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...++..+ .+
T Consensus 222 ~~~~i~~~----------------------------------------------------------------------~~ 231 (328)
T 3fe3_A 222 LRERVLRG----------------------------------------------------------------------KY 231 (328)
T ss_dssp HHHHHHHC----------------------------------------------------------------------CC
T ss_pred HHHHHHhC----------------------------------------------------------------------CC
Confidence 55444433 22
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.++ ..+|+++++||++||+.||.+|||++|+|+||||+...
T Consensus 232 ~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 232 RIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 222 13688999999999999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=325.96 Aligned_cols=238 Identities=34% Similarity=0.620 Sum_probs=167.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| ++.+ +.++..|+|||||.||+ |.+.+ .++..++.++.||+.||+|||++||+||||||
T Consensus 82 ~l~hpnIv-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp 158 (351)
T 3c0i_A 82 MLKHPHIV-ELLETYSSDGMLYMVFEFMDGAD--LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP 158 (351)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCSSCB--HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hCCCCCCC-cEEEEEEeCCEEEEEEeCCCCCC--HHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCh
Confidence 46799865 5444 44566799999999998 76554 35678999999999999999999999999999
Q ss_pred CcEEEecCCC---EEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 75 ENILLDDQMN---VKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 75 ~NILl~~~~~---iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|||++.++. +||+|||++........ ....+||+.|+|||++.. ..|+.++||||+||++|+|++|..|
T Consensus 159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR------EPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp GGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC------CCCCchHhhHHHHHHHHHHHHCCCC
Confidence 9999986554 99999999987665432 345789999999999864 3467788888888888888888877
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+. .+.
T Consensus 233 f~~~~~-----------------------------------------------------------------------~~~ 241 (351)
T 3c0i_A 233 FYGTKE-----------------------------------------------------------------------RLF 241 (351)
T ss_dssp SCSSHH-----------------------------------------------------------------------HHH
T ss_pred CCCcHH-----------------------------------------------------------------------HHH
Confidence 755321 223
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHH
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTE 310 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (408)
..+..+.+.+....|..+|+++++||++||..||++|||+.|+|+||||+..... ...........++++++..++
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~ 317 (351)
T 3c0i_A 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRY----AYKIHLPETVEQLRKFNARRK 317 (351)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHH----SCCSCCHHHHHHHHHHHHHHC
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccc----cccccchHHHHHHHHHHHHHH
Confidence 3344444444445567889999999999999999999999999999999753110 001112234567788888999
Q ss_pred HHHHHHHHHHHHHHhhh
Q psy3880 311 FQFIILVVRAAVRISRL 327 (408)
Q Consensus 311 ~~~~~~~~~~~~~~~~~ 327 (408)
++.+++...+..++..+
T Consensus 318 ~~~~~~~~~~~~~~~~~ 334 (351)
T 3c0i_A 318 LKGAVLAAVSSHKFNSF 334 (351)
T ss_dssp -----------------
T ss_pred HHHHHHHHHHHhhcccC
Confidence 99888887776666544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=341.75 Aligned_cols=236 Identities=32% Similarity=0.594 Sum_probs=176.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.....|+|||||.||+ |++.+. ++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 168 (494)
T 3lij_A 92 LLDHPNIM-KLYDFFEDKRNYYLVMECYKGGE--LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLL 168 (494)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEEeCCEEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEE
Confidence 46899865 5444 45566799999999998 877663 45789999999999999999999999999999999
Q ss_pred EecC---CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQ---MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~---~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.. +.+||+|||+|............+||+.|+|||++.. .|+.++||||+||++|+|++|.+||
T Consensus 169 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwslG~il~~ll~g~~pf---- 237 (494)
T 3lij_A 169 LESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-------KYDEKCDVWSIGVILFILLAGYPPF---- 237 (494)
T ss_dssp ESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-------CBCTHHHHHHHHHHHHHHHHSSCSS----
T ss_pred EeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-------cCCCchhHHHHHHHHHHHHhCCCCC----
Confidence 9764 4599999999988776666667899999999998742 3556666666666666666555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+++..+..
T Consensus 238 ------------------------------------------------------------------~~~~~~~~~~~i~~ 251 (494)
T 3lij_A 238 ------------------------------------------------------------------GGQTDQEILRKVEK 251 (494)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHh
Confidence 44444556667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.+..+.|..+|+++++||++||+.||++|||++|+|+||||+.....................++++....+++.++
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~ 331 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAA 331 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHH
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHH
Confidence 88888889999999999999999999999999999999999999653110000000011122344556666666666666
Q ss_pred HHHHHH
Q psy3880 316 LVVRAA 321 (408)
Q Consensus 316 ~~~~~~ 321 (408)
+.+.+.
T Consensus 332 l~~ia~ 337 (494)
T 3lij_A 332 LLYMAS 337 (494)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 655543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.18 Aligned_cols=235 Identities=31% Similarity=0.578 Sum_probs=180.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.....|+|||||.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 102 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 102 SLDHPNII-KLFDVFEDKKYFYLVTEFYEGGE--LFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178 (504)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEEcCCEEEEEEecCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence 46799865 5544 45567799999999998 877763 56889999999999999999999999999999999
Q ss_pred EecCC---CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQM---NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~---~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++ .+||+|||+|............+||+.|+|||++.. .|+.++||||+||++|+|++|.+||
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf---- 247 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-------KYNEKCDVWSCGVIMYILLCGYPPF---- 247 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-------CBCTHHHHHHHHHHHHHHHHSSCSS----
T ss_pred EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-------CCCchHHHHHHHHHHHHHHhCCCCC----
Confidence 98765 699999999988776666667889999999998752 3556666666666666666555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+++..+..
T Consensus 248 ------------------------------------------------------------------~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 248 ------------------------------------------------------------------GGQNDQDIIKKVEK 261 (504)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHc
Confidence 44444555666777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCCcchhhhhhhHHHHHhhhhhHHHHHHHHH
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTASRKLSKINQLTEFQFII 315 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (408)
+.+.++.+.|..+|+++++||++||+.||.+|||++|+|+||||+........ ...........++++++...+++.++
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~kl~~a~ 340 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK-SDQKTLCGALSNMRKFEGSQKLAQAA 340 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCG-GGHHHHHHHHHHHHHCCCCSHHHHHH
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccc-cchhhHHHHHHHHHHHHHHHHHHHHH
Confidence 77777777889999999999999999999999999999999999765432211 11122334455667777777777777
Q ss_pred HHHHHH
Q psy3880 316 LVVRAA 321 (408)
Q Consensus 316 ~~~~~~ 321 (408)
+.+.+.
T Consensus 341 l~~i~~ 346 (504)
T 3q5i_A 341 ILFIGS 346 (504)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 666553
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=321.73 Aligned_cols=198 Identities=29% Similarity=0.565 Sum_probs=160.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ +..+..|+|||||.||+ |++.+. ++.++..++.||+.||+|||++||+||||||+||
T Consensus 57 ~l~hpnIv-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NI 133 (321)
T 1tki_A 57 IARHRNIL-HLHESFESMEELVMIFEFISGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HSCCTTBC-CEEEEEEETTEEEEEECCCCCCB--HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-eEeEEEecCCEEEEEEEeCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 36799865 5544 44567799999999999 888774 3478999999999999999999999999999999
Q ss_pred EEec--CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDD--QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~--~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++. ++.+||+|||++..+..+......+||+.|+|||++... .++.++|+||+||++|+|++|..||
T Consensus 134 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~pf---- 203 (321)
T 1tki_A 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSGINPF---- 203 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC------EECHHHHHHHHHHHHHHHHHSSCTT----
T ss_pred EEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC------CCCchhhHHHHHHHHHHHHhCCCCC----
Confidence 9987 789999999999887766666667899999999998642 2455566666666665555555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+....+..+..
T Consensus 204 ------------------------------------------------------------------~~~~~~~~~~~i~~ 217 (321)
T 1tki_A 204 ------------------------------------------------------------------LAETNQQIIENIMN 217 (321)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------cCCCHHHHHHHHHc
Confidence 44444455666777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.++...|..+|+++++||++||..||++|||+.|+|+||||+..
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 77777777788999999999999999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.09 Aligned_cols=205 Identities=30% Similarity=0.512 Sum_probs=160.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+++| ++.+ .+++..|+|||||.||+ |.+.+ .++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 125 ~l~hp~Iv-~l~~~~~~~~~~~lV~E~~~gg~--L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 201 (410)
T 3v8s_A 125 FANSPWVV-QLFYAFQDDRYLYMVMEYMPGGD--LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201 (410)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCCC-eEEEEEEECCEEEEEEeCCCCCc--HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence 35788755 5554 45567899999999999 87766 3568899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
+.++.+||+|||+|+.+..... ..+.+||+.|+|||++..... ...|+.
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~~~--------------------------- 252 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG--DGYYGR--------------------------- 252 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTT--TCEEET---------------------------
T ss_pred CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCC--CcCCCC---------------------------
Confidence 9999999999999987654432 336789999999999864210 001334
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
++|+||+||++|+|++|.+||.+.+...++..|..+.
T Consensus 253 -------------------------------------------~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 253 -------------------------------------------ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp -------------------------------------------HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred -------------------------------------------cceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 4555555555555566666666666667777887766
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~~~~ 285 (408)
..+..+.+..+|+++++||++||+.+|.+ |+|++|+++||||+...++
T Consensus 290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 55555667789999999999999999988 9999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=329.25 Aligned_cols=238 Identities=23% Similarity=0.372 Sum_probs=159.9
Q ss_pred ccccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+.. ....|+||||+.++.......-.++.+++.++.||+.||+|||++||+||||||+||
T Consensus 117 ~l~hpnIv-~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI 195 (464)
T 3ttj_A 117 CVNHKNII-SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195 (464)
T ss_dssp HCCCTTBC-CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred hCCCCCCC-cEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence 36798855 554421 133589999999875222222246689999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+|+...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+..
T Consensus 196 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp EECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999988776655667899999999999975 35889999999999999999999999999998
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+.+|......+. |+.+..- .-..-..+...+.+........+ ....
T Consensus 270 ~~~~~i~~~lg~p~------------~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 317 (464)
T 3ttj_A 270 DQWNKVIEQLGTPC------------PEFMKKL-----------------QPTVRNYVENRPKYAGLTFPKLF---PDSL 317 (464)
T ss_dssp HHHHHHHHHHCSCC------------HHHHTTS-----------------CHHHHHHHTTSCCCCCCCHHHHS---CGGG
T ss_pred HHHHHHHHhcCCCC------------HHHHHHc-----------------chhhhhHhhcccccCCCChHHhC---cccc
Confidence 88888876543321 1111100 00000011111111111100000 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+......+...+++++|||++||++||++|||++|+|+||||+..
T Consensus 318 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 318 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000000011136789999999999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=319.83 Aligned_cols=192 Identities=29% Similarity=0.551 Sum_probs=147.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++| .+.+ ...+..|+|||||.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~hp~Iv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~ 158 (353)
T 3txo_A 82 NHPFLT-QLFCCFQTPDRLFFVMEFVNGGD--LMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158 (353)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCcee-eEEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC
Confidence 577755 5554 45567899999999999 877663 5689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|+... ........+||+.|+|||++... .|+.++|+||+||++|+|++|..||.
T Consensus 159 ~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~G~~Pf~------- 225 (353)
T 3txo_A 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM------LYGPAVDWWAMGVLLYEMLCGHAPFE------- 225 (353)
T ss_dssp TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH------HCTTHHHHHHHHHHHHHHHHSSCSSC-------
T ss_pred CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC------CcCCccCCCcchHHHHHHHhCCCCCC-------
Confidence 99999999999997643 23334567999999999998653 35566666666666666666655554
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.+..+++..|..+.+.
T Consensus 226 ---------------------------------------------------------------~~~~~~~~~~i~~~~~~ 242 (353)
T 3txo_A 226 ---------------------------------------------------------------AENEDDLFEAILNDEVV 242 (353)
T ss_dssp ---------------------------------------------------------------CSSHHHHHHHHHHCCCC
T ss_pred ---------------------------------------------------------------CCCHHHHHHHHHcCCCC
Confidence 44444555666666665
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV------KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta------~e~L~Hpwf~~~ 282 (408)
++. .+|+++++||++||+.||++|+|+ +|+++||||+..
T Consensus 243 ~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 243 YPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 543 479999999999999999999998 899999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=312.33 Aligned_cols=198 Identities=31% Similarity=0.607 Sum_probs=159.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..++||||+.||+ |.+.+. ++.++..++.||+.||.|||++||+||||||+|||
T Consensus 70 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl 146 (326)
T 2y0a_A 70 EIQHPNVI-TLHEVYENKTDVILILELVAGGE--LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146 (326)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCC-cEEEEEEeCCEEEEEEEcCCCCC--HHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEE
Confidence 36798865 5443 45567899999999999 888874 45889999999999999999999999999999999
Q ss_pred EecCC----CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQM----NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~----~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++ .+||+|||++............+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+.
T Consensus 147 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY------EPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp ESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred EecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC------CCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 98877 799999999988766555567889999999999854 34566777777777777777766666443
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
...+.+..+.
T Consensus 221 ----------------------------------------------------------------------~~~~~~~~~~ 230 (326)
T 2y0a_A 221 ----------------------------------------------------------------------TKQETLANVS 230 (326)
T ss_dssp ----------------------------------------------------------------------SHHHHHHHHH
T ss_pred ----------------------------------------------------------------------CHHHHHHHHH
Confidence 3333444555
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+.++...|..+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 555555555667889999999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=313.93 Aligned_cols=194 Identities=32% Similarity=0.590 Sum_probs=153.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ...+..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 61 ~l~hp~iv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 137 (337)
T 1o6l_A 61 NTRHPFLT-ALKYAFQTHDRLCFVMEYANGGE--LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred hCCCCcCc-ceEEEEEeCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence 35788755 4443 45567899999999999 877663 56899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+|+... ........+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+.
T Consensus 138 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~--- 208 (337)
T 1o6l_A 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--- 208 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS------SCBCTTHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred ECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC------CCCCchhhcccchhHHHHHhcCCCCCCCC---
Confidence 9999999999999998643 3334556889999999999864 34566777777777777766666666443
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+...+...|..+.
T Consensus 209 -------------------------------------------------------------------~~~~~~~~i~~~~ 221 (337)
T 1o6l_A 209 -------------------------------------------------------------------DHERLFELILMEE 221 (337)
T ss_dssp -------------------------------------------------------------------SHHHHHHHHHHCC
T ss_pred -------------------------------------------------------------------CHHHHHHHHHcCC
Confidence 3334445555555
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+|+++++||++||+.||++|| |++|+++||||...
T Consensus 222 ~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 5554 25799999999999999999999 89999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=316.21 Aligned_cols=199 Identities=32% Similarity=0.557 Sum_probs=160.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ +.++..++||||+.||+ |.+.+. ++.++..++.||+.||+|||++||+||||||+||
T Consensus 104 ~l~hpnIv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 180 (387)
T 1kob_A 104 QLHHPKLI-NLHDAFEDKYEMVLILEFLSGGE--LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180 (387)
T ss_dssp TCCSTTBC-CEEEEEECSSEEEEEEECCCCCB--HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCcCCC-eEEEEEEeCCEEEEEEEcCCCCc--HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHe
Confidence 46788866 4444 45567899999999999 888774 3578999999999999999999999999999999
Q ss_pred EEec--CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDD--QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~--~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++. ++.+||+|||+|..+.........+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+
T Consensus 181 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~Pf~~-- 252 (387)
T 1kob_A 181 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR------EPVGFYTDMWAIGVLGYVLLSGLSPFAG-- 252 (387)
T ss_dssp EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT------CCBCHHHHHHHHHHHHHHHHHSCCSSCC--
T ss_pred EEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC------CCCCCcccEeeHhHHHHHHHhCCCCCCC--
Confidence 9974 46799999999988766555556789999999999864 2456666777777666666666666644
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+....+..+..
T Consensus 253 --------------------------------------------------------------------~~~~~~~~~i~~ 264 (387)
T 1kob_A 253 --------------------------------------------------------------------EDDLETLQNVKR 264 (387)
T ss_dssp --------------------------------------------------------------------SSHHHHHHHHHH
T ss_pred --------------------------------------------------------------------CCHHHHHHHHHh
Confidence 333444555666
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+.++...|..+|+++++||++||..||++|||++|+|+||||....
T Consensus 265 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 666777777888999999999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=314.44 Aligned_cols=192 Identities=26% Similarity=0.521 Sum_probs=151.8
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +..+..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~hp~-iv~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~ 155 (353)
T 2i0e_A 79 KPPF-LTQLHSCFQTMDRLYFVMEYVNGGD--LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155 (353)
T ss_dssp CCTT-BCCEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCE-EeeEEEEEEcCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc
Confidence 4554 556554 45567899999999999 877764 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|+... ........+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+
T Consensus 156 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~G~~Pf~~------ 223 (353)
T 2i0e_A 156 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY------QPYGKSVDWWAFGVLLYEMLAGQAPFEG------ 223 (353)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT------CCBSTHHHHHHHHHHHHHHHHSSCSSCC------
T ss_pred CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC------CCcCCcccccchHHHHHHHHcCCCCCCC------
Confidence 99999999999998643 2334456899999999999864 3456666666666666666666665544
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+..+++..|..+.+.
T Consensus 224 ----------------------------------------------------------------~~~~~~~~~i~~~~~~ 239 (353)
T 2i0e_A 224 ----------------------------------------------------------------EDEDELFQSIMEHNVA 239 (353)
T ss_dssp ----------------------------------------------------------------SSHHHHHHHHHHCCCC
T ss_pred ----------------------------------------------------------------CCHHHHHHHHHhCCCC
Confidence 4444555666666655
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
++ ..+|+++++||++||+.||++||+ ++|+++||||+..
T Consensus 240 ~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 240 YP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp CC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred CC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 54 358999999999999999999994 7999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.81 Aligned_cols=201 Identities=27% Similarity=0.523 Sum_probs=160.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++| .+.+ ..++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 111 ~hp~Iv-~l~~~~~~~~~~~lV~E~~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~ 187 (396)
T 4dc2_A 111 NHPFLV-GLHSCFQTESRLFFVIEYVNGGD--LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187 (396)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCcC-eeEEEEEECCEEEEEEEcCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC
Confidence 688755 5554 45567899999999999 877663 5689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhc-ccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVL-KKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|+.. .........+||+.|+|||++.+ ..|+.++|+||+||++|+|++|..||........
T Consensus 188 ~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~ 261 (396)
T 4dc2_A 188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261 (396)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---
T ss_pred CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccc
Confidence 9999999999999863 34445567899999999999975 4578899999999999999999999954221000
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
| .......+...|....+.
T Consensus 262 ------------------------------------------------------------~-~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 262 ------------------------------------------------------------P-DQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp ----------------------------------------------------------------CCHHHHHHHHHHCCCC
T ss_pred ------------------------------------------------------------c-chhhHHHHHHHHhccccC
Confidence 0 011223355667777666
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV------KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta------~e~L~Hpwf~~~ 282 (408)
++. .+|+++++||++||+.||++|+|+ +|+++||||+..
T Consensus 281 ~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 281 IPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 543 589999999999999999999995 799999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.67 Aligned_cols=194 Identities=27% Similarity=0.515 Sum_probs=153.0
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|++++ ++.+ ...+..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~hp~iv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 151 (345)
T 1xjd_A 75 WEHPFLT-HMFCTFQTKENLFFVMEYLNGGD--LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151 (345)
T ss_dssp TTCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred CCCCCCC-cEEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE
Confidence 3788755 5554 44567899999999999 887764 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|+.... .......+||+.|+|||++.+ ..|+.++|+||+||++|+|++|..||.+.
T Consensus 152 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~---- 221 (345)
T 1xjd_A 152 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---- 221 (345)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC------CCCCChhhhHHHHHHHHHHhcCCCCCCCC----
Confidence 9999999999999986432 233456899999999999864 34566677777776666666666666443
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+..+++..|..+..
T Consensus 222 ------------------------------------------------------------------~~~~~~~~i~~~~~ 235 (345)
T 1xjd_A 222 ------------------------------------------------------------------DEEELFHSIRMDNP 235 (345)
T ss_dssp ------------------------------------------------------------------SHHHHHHHHHHCCC
T ss_pred ------------------------------------------------------------------CHHHHHHHHHhCCC
Confidence 33444555555554
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK-EALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~-e~L~Hpwf~~~~ 283 (408)
.++ ..+|+++++||++||+.||++|||+. |+++||||+...
T Consensus 236 ~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 236 FYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred CCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 443 24799999999999999999999998 999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=306.16 Aligned_cols=192 Identities=32% Similarity=0.657 Sum_probs=153.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| ++.+ ...+..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 62 ~l~hp~Iv-~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 62 IVTHPFII-RMWGTFQDAQQIFMIMDYIEGGE--LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SCCBTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred hCCCCCCc-eEeEEEEeCCEEEEEEeCCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 46788755 5544 44567899999999999 888763 46889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+++.... .....+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+
T Consensus 139 l~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~----- 205 (318)
T 1fot_A 139 LDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVST------KPYNKSIDWWSFGILIYEMLAGYTPFYD----- 205 (318)
T ss_dssp ECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTT------CCBCTTHHHHHHHHHHHHHHHSSCTTCC-----
T ss_pred EcCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcC------CCCCcccchhhhHHHHHHHHhCCCCCCC-----
Confidence 99999999999999986543 2346789999999999864 3456666666666666666666666644
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+...+...|..+..
T Consensus 206 -----------------------------------------------------------------~~~~~~~~~i~~~~~ 220 (318)
T 1fot_A 206 -----------------------------------------------------------------SNTMKTYEKILNAEL 220 (318)
T ss_dssp -----------------------------------------------------------------SSHHHHHHHHHHCCC
T ss_pred -----------------------------------------------------------------CCHHHHHHHHHhCCC
Confidence 334445555666655
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||+.||++|+ |++|+++||||+..
T Consensus 221 ~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 221 RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 554 25799999999999999999999 89999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=321.77 Aligned_cols=201 Identities=36% Similarity=0.653 Sum_probs=157.7
Q ss_pred cccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 7 VAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 7 ~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
+.|+|++ ++.+. +++..|||||||.||+ |.+++. ++.+++.++.||+.||+|||++||+|||||
T Consensus 112 ~~hp~iv-~l~~~~~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 188 (400)
T 1nxk_A 112 SQCPHIV-RIVDVYENLYAGRKCLLIVMECLDGGE--LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 188 (400)
T ss_dssp TTSTTBC-CEEEEEEEEETTEEEEEEEEECCCSEE--HHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred cCCCCcc-eEeEEEeecccCCcEEEEEEEeCCCCc--HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 4677755 44431 2456799999999999 888773 457899999999999999999999999999
Q ss_pred CCcEEEec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 74 PENILLDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 74 p~NILl~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|+|||++. ++.+||+|||+++...........+||+.|+|||++.. ..|+.++||||+||++|+|++|..|
T Consensus 189 p~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p 262 (400)
T 1nxk_A 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_dssp GGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC------CCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred cceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC------CCCCCcccHHHHHHHHHHHHhCCCC
Confidence 99999987 78899999999987665555567899999999999853 4578899999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+... ....+.
T Consensus 263 f~~~~~~~------------------------------------------------------------------~~~~~~ 276 (400)
T 1nxk_A 263 FYSNHGLA------------------------------------------------------------------ISPGMK 276 (400)
T ss_dssp CCCCTTCS------------------------------------------------------------------SCCSHH
T ss_pred CCCCcccc------------------------------------------------------------------ccHHHH
Confidence 86532100 000123
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+..+.+.++.+.|..+|+++++||++||+.||++|||++|+|+||||...
T Consensus 277 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 277 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 4566778888888899999999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.78 Aligned_cols=198 Identities=34% Similarity=0.609 Sum_probs=158.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 71 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl 147 (321)
T 2a2a_A 71 QVLHHNVI-TLHDVYENRTDVVLILELVSGGE--LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147 (321)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCcc-eEEEEEecCCEEEEEEEcCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEE
Confidence 36799866 4443 45566899999999998 888764 35789999999999999999999999999999999
Q ss_pred EecCC----CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQM----NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~----~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++ .+||+|||++............+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.
T Consensus 148 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY------EPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp ESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred EecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC------CCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 99887 799999999987766555566789999999999864 34667778888887777777777777554
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.. +.+..+.
T Consensus 222 ~~~----------------------------------------------------------------------~~~~~i~ 231 (321)
T 2a2a_A 222 TKQ----------------------------------------------------------------------ETLANIT 231 (321)
T ss_dssp SHH----------------------------------------------------------------------HHHHHHH
T ss_pred CHH----------------------------------------------------------------------HHHHHHH
Confidence 333 3333444
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+.++...+..+|+++++||++||..||++|||++|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 232 SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 444444444456789999999999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=313.11 Aligned_cols=194 Identities=33% Similarity=0.563 Sum_probs=153.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.+ ..++..|+||||+.||+ |++.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 95 ~~~hp~Iv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 171 (373)
T 2r5t_A 95 NVKHPFLV-GLHFSFQTADKLYFVLDYINGGE--LFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 171 (373)
T ss_dssp CCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hCCCCCCC-CEEEEEEeCCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 36788755 5543 45567899999999999 877663 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+|+... ........+||+.|+|||++.+ ..|+.++|+||+||++|+|++|..||.+
T Consensus 172 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~G~~Pf~~---- 241 (373)
T 2r5t_A 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK------QPYDRTVDWWCLGAVLYEMLYGLPPFYS---- 241 (373)
T ss_dssp ECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCTTCC----
T ss_pred ECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC------CCCCchhhhHHHHHHHHHHHcCCCCCCC----
Confidence 9999999999999998643 3334456899999999999864 3456666666666666666666665544
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.+..++...|....
T Consensus 242 ------------------------------------------------------------------~~~~~~~~~i~~~~ 255 (373)
T 2r5t_A 242 ------------------------------------------------------------------RNTAEMYDNILNKP 255 (373)
T ss_dssp ------------------------------------------------------------------SBHHHHHHHHHHSC
T ss_pred ------------------------------------------------------------------CCHHHHHHHHHhcc
Confidence 44444555666665
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH----HHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV----KEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta----~e~L~Hpwf~~~ 282 (408)
..++ ..+|+++++||++||+.||.+|+++ +|+++||||+..
T Consensus 256 ~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 LQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp CCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred cCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 5543 3589999999999999999999986 699999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=310.90 Aligned_cols=198 Identities=34% Similarity=0.637 Sum_probs=160.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+|+| .+.+ ++++..|+|||||.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+.
T Consensus 74 ~hp~iv-~~~~~~~~~~~~~lv~E~~~gg~--L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 74 QHPNII-TLKDVYDDGKYVYVVTELMKGGE--LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp TSTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred CCCCcC-eEEEEEEcCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 688755 5554 45567899999999999 888763 5689999999999999999999999999999999985
Q ss_pred cC----CCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 81 DQ----MNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 81 ~~----~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+. +.+||+|||++...... ......+||+.|+|||++... .|+.++|+||+||++|+|++|..||.+..
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ------GYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH------HHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred cCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC------CCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 43 35999999999876543 334567899999999998753 35667788888888777777777774311
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....+++..+..
T Consensus 225 -------------------------------------------------------------------~~~~~~~~~~i~~ 237 (342)
T 2qr7_A 225 -------------------------------------------------------------------DDTPEEILARIGS 237 (342)
T ss_dssp -------------------------------------------------------------------TSCHHHHHHHHHH
T ss_pred -------------------------------------------------------------------cCCHHHHHHHHcc
Confidence 1123456677888
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.+.+....|..+|+++++||++||..||++|||+.|+|+||||..
T Consensus 238 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 8888888889999999999999999999999999999999999954
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.94 Aligned_cols=205 Identities=29% Similarity=0.505 Sum_probs=153.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|+++| .+.+ ..++..|||||||.||+ |.+.+. ++..++.++.||+.||+|||++|||||||||+|||
T Consensus 131 ~~hp~Iv-~l~~~~~~~~~~~lV~Ey~~gg~--L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 131 GDSKWIT-TLHYAFQDDNNLYLVMDYYVGGD--LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207 (437)
T ss_dssp SCTTTBC-CEEEEEECSSEEEEEECCCTTCB--HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CCCCCEE-EEEEEEeeCCEEEEEEecCCCCc--HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence 5677755 5544 45567899999999999 887764 35889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||+|+....... ....+||+.|+|||++..... ....|+.++||||+||++|+|++|..||.+.
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-- 284 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG-GKGRYGPECDWWSLGVCMYEMLYGETPFYAE-- 284 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHT-SCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred EcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhccc-CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--
Confidence 99999999999999976654332 234789999999999863210 0123556666666666666666666665444
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
+..+++..|...
T Consensus 285 --------------------------------------------------------------------~~~~~~~~i~~~ 296 (437)
T 4aw2_A 285 --------------------------------------------------------------------SLVETYGKIMNH 296 (437)
T ss_dssp --------------------------------------------------------------------SHHHHHHHHHTH
T ss_pred --------------------------------------------------------------------ChhHHHHhhhhc
Confidence 344444444443
Q ss_pred CCCCCCC-cCCCCCccHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q psy3880 237 KYSFSSP-EWNDISEDPKDLIRKLLIVTPED--RYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 237 ~~~f~~~-~~~~iS~~~~dLI~klL~~dP~~--R~ta~e~L~Hpwf~~~~~~ 285 (408)
...+..+ .+..+|++++|||++||+.+|++ |++++|+++||||+...++
T Consensus 297 ~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 297 KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 2222222 23678999999999999999998 9999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=311.41 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=160.1
Q ss_pred ccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|+|+| .+.+ ++....|+|||||.++ |.+.+ .+...++.++.||+.||+|||++||+||||||+|||+
T Consensus 67 ~h~niv-~l~~~~~~~~~~~~~lv~e~~~~~---L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 67 GHENIV-NLLNVLRADNDRDVYLVFDYMETD---LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TCTTBC-CEEEEEECTTSSCEEEEEECCSEE---HHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCC-eeeeEEecCCCCEEEEEecccCcC---HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 488865 4443 2334579999999864 55444 4568899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc----------------------CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhh
Q psy3880 80 DDQMNVKLTDFGFARVLKK----------------------GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~----------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSl 137 (408)
+.++.+||+|||+|+.+.. .......+||++|+|||++.+. ..|+.++||||+
T Consensus 143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSl 217 (388)
T 3oz6_A 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-----TKYTKGIDMWSL 217 (388)
T ss_dssp CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-----CCCCTHHHHHHH
T ss_pred cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-----CCCCChhhHHHH
Confidence 9999999999999976532 1123447899999999998642 468899999999
Q ss_pred hHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 138 Gvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
||++|+|++|.+||.+.+....+..|......+....+..+..-.+...+..- ....-..
T Consensus 218 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~ 277 (388)
T 3oz6_A 218 GCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESL--------------------KEKVEIR 277 (388)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHH--------------------HHHCC--
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC--------------------ccccccc
Confidence 99999999999999999998888888753221111000000000000000000 0000000
Q ss_pred CCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 218 CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 218 ~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..++...- ......... ...+..+|++++|||++||++||++|||++|+|+||||+..
T Consensus 278 ~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 278 QSNKRDIF--TKWKNLLLK-----INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp ---CCCCH--HHHHHHHHH-----HCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred CCCHHHhC--cchhhhccc-----ccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 00000000 000000000 01234689999999999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.53 Aligned_cols=218 Identities=30% Similarity=0.450 Sum_probs=156.5
Q ss_pred ccCCcEEEEec---cCCc----HHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 8 AHSRVVVRVKE---EGDD----LKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 8 ~~~~~i~~~~~---~~~~----~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.|+|++ ++.+ .... ..++|||++.+ . |.+.+ .++.+++.++.||+.||+|||++||+|||||
T Consensus 72 ~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 147 (308)
T 3g33_A 72 EHPNVV-RLMDVCATSRTDREIKVTLVFEHVDQ-D--LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147 (308)
T ss_dssp CCTTBC-CEEEEEEECCSSSEEEEEEEEECCCC-B--HHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred CCCCeE-EeeeeeeccCCCCceeEEEEehhhhc-C--HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 588865 4443 1111 46899999975 4 65554 3568999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||++.++.+||+|||+|............+||+.|+|||++.. ..|+.++||||+||++|+|++|.+||.+
T Consensus 148 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 148 PENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ------STYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp TTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT------SCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred HHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcC------CCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999988766555566889999999999875 3478899999999999999999999988
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+.++... ......+.|.-.+-+- .+..|-....
T Consensus 222 ~~~~~~~~~i~~~------------------------------~~~~~~~~~~~~~~~~---~~~~~~~~~~-------- 260 (308)
T 3g33_A 222 NSEADQLGKIFDL------------------------------IGLPPEDDWPRDVSLP---RGAFPPRGPR-------- 260 (308)
T ss_dssp SSHHHHHHHHHHH------------------------------HCCCCTTTSCSSCSSC---GGGSCCCCCC--------
T ss_pred CCHHHHHHHHHHH------------------------------hCCCChhhccchhhcc---ccccCCCCCC--------
Confidence 7766655554320 0011111121100000 0000000000
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....+..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus 261 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 261 ------PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp ------CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ------cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0001124689999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=311.39 Aligned_cols=201 Identities=54% Similarity=1.004 Sum_probs=158.8
Q ss_pred ccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
.|++++..+.. +..+..|+||||+.||. |.+.+. +...++.++.||+.||.|||++||+||||||+|||++.
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGE--LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 68886643332 45667899999999998 777653 45889999999999999999999999999999999999
Q ss_pred CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHH
Q psy3880 82 QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~ 161 (408)
++.+||+|||++..+.........+||+.|+|||++.+........|+.++|||||||++|+|++|..||
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf---------- 305 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF---------- 305 (365)
T ss_dssp TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS----------
T ss_pred CCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC----------
Confidence 9999999999998877666666789999999999987542222223455555555555555555555555
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
...+...++..+..+.+.+.
T Consensus 306 ------------------------------------------------------------~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 306 ------------------------------------------------------------WHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp ------------------------------------------------------------CCSSHHHHHHHHHHTCCCCC
T ss_pred ------------------------------------------------------------CCCCHHHHHHHHHhCCCCCC
Confidence 44444455556666666666
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.+.|..+|+++++||++||..||++|||++|+|+||||+
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 677888999999999999999999999999999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.26 Aligned_cols=224 Identities=25% Similarity=0.459 Sum_probs=164.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ +.++..++||||+.++ |.+.+ .++.+++.++.||+.||+|||++||+||||||+||
T Consensus 75 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 75 ELHHPNIV-SLIDVIHSERCLTLVFEFMEKD---LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp HCCCTTBC-CEEEEECCSSCEEEEEECCSEE---HHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HcCCCCEe-eeeeEEccCCEEEEEEcCCCCC---HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 35788865 5444 4556678999999975 44433 34588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+|...... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.+.+.
T Consensus 151 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----KKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp EECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred EECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCC-----CCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999876533 233456899999999998642 4578999999999999999999999998887
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+...........|...... ..|.- .....+..... .
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~~~~~----~----- 267 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQEL---------------------PLWKQ--------RTFQVFEKKPW----S----- 267 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGTTS---------------------HHHHS--------CCCCCCCCCCH----H-----
T ss_pred HHHHHHHHHHHCCCChHHhhhhhcc---------------------chhhh--------cccccccCCcH----H-----
Confidence 7777777664444333333221110 00000 00000000000 0
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 268 ------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 268 ------SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp ------HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ------HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123578999999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.24 Aligned_cols=197 Identities=28% Similarity=0.489 Sum_probs=158.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+| ++.+ ...+..|+||||+.||. |.+.+ .++.+++.++.|++.||+|||++||+||||||+|||+
T Consensus 73 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 149 (297)
T 3fxz_A 73 ENKNPNIV-NYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (297)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred cCCCCCCC-eEeEEEEECCEEEEEEECCCCCC--HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 36798865 5444 34556799999999998 87776 4568999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++....... .....+||+.|+|||++.. ..|+.++||||+||++|+|++|..||.+.+...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999998765433 2345789999999999864 357889999999999999999999997765544
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+.... ..
T Consensus 224 ~~~~~~~~~---------------------------------------------------------------------~~ 234 (297)
T 3fxz_A 224 ALYLIATNG---------------------------------------------------------------------TP 234 (297)
T ss_dssp HHHHHHHHC---------------------------------------------------------------------SC
T ss_pred HHHHHHhCC---------------------------------------------------------------------CC
Confidence 433332210 00
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+ .....+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 235 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 EL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 11 1123578899999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=314.23 Aligned_cols=197 Identities=37% Similarity=0.584 Sum_probs=158.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ +..+..+|||||+.||. |.+.+ .++.++..++.||+.||+|||++||+||||||+||
T Consensus 142 ~l~hpnIv-~~~~~~~~~~~~~lv~E~~~~~~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 218 (373)
T 2x4f_A 142 QLDHANLI-QLYDAFESKNDIVLVMEYVDGGE--LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218 (373)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCE--EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-eEEEEEEECCEEEEEEeCCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 46799866 4443 44567799999999998 76655 34578899999999999999999999999999999
Q ss_pred EE--ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LL--DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll--~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|+ +.++.+||+|||+++.+.........+||+.|+|||++.. ..++.++||||+||++|+|++|..||.+.+
T Consensus 219 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 219 LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp EEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99 4567899999999988776665666789999999999864 345667777777777777777766665443
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+.+..+..
T Consensus 293 ----------------------------------------------------------------------~~~~~~~i~~ 302 (373)
T 2x4f_A 293 ----------------------------------------------------------------------DAETLNNILA 302 (373)
T ss_dssp ----------------------------------------------------------------------HHHHHHHHHH
T ss_pred ----------------------------------------------------------------------HHHHHHHHHh
Confidence 3344455555
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..+.++...|..+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 6666666677889999999999999999999999999999999965
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=306.04 Aligned_cols=145 Identities=22% Similarity=0.342 Sum_probs=114.4
Q ss_pred ccccCCcEEEEecc---CC---cHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHC--------CC
Q psy3880 6 MVAHSRVVVRVKEE---GD---DLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNH--------SV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~---~~---~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~--------~I 67 (408)
.+.|+|+| ++... .+ ...|||||||+||+ |.+++. +.+++..++.|++.||+|||++ +|
T Consensus 53 ~l~HpNIv-~l~g~~~~~~~~~~~~~lV~Ey~~~gs--L~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~I 129 (303)
T 3hmm_A 53 MLRHENIL-GFIAADNKDNGTWTQLWLVSDYHEHGS--LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129 (303)
T ss_dssp TCCCTTBC-CEEEEEEEECSSSEEEEEEEECCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCE
T ss_pred cCCCCCCC-cEEEEEEecCCCceEEEEEecCCCCCc--HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCE
Confidence 57899866 55432 11 23689999999999 888874 3478888999999999999987 99
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
|||||||+|||++.++.+||+|||+|+....... ....+||+.|||||++.+........|+.++|||||||++|
T Consensus 130 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~ 209 (303)
T 3hmm_A 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred eeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence 9999999999999999999999999987654322 22468999999999997542222234678999999999999
Q ss_pred HHHhCCCCCCC
Q psy3880 143 TLLVGCPPFWH 153 (408)
Q Consensus 143 ~ll~G~~pf~~ 153 (408)
||++|.+||..
T Consensus 210 El~tg~~~~~~ 220 (303)
T 3hmm_A 210 EIARRCSIGGI 220 (303)
T ss_dssp HHHHTBCBTTB
T ss_pred HHHHCCCCCCc
Confidence 99999998854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.41 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=148.6
Q ss_pred ccccCCcEEEEec-------cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE-------EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~-------~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+ +..+..|+||||+.+ + |.+.+ .++..++.++.||+.||+|||++||||||||
T Consensus 108 ~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK 183 (458)
T 3rp9_A 108 RLNHDHVV-KVLDIVIPKDVEKFDELYVVLEIADS-D--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183 (458)
T ss_dssp HCCCTTBC-CEEEECCCSCTTTCCCEEEEECCCSE-E--HHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred hCCCCCCC-ceEEEEecCCcccCceEEEEEecccc-c--hhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 35788866 5443 222457999999854 4 65554 3558999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc----------------------------ccccCCCCCcccChhhhhhccccCc
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE----------------------------KLMDLCGTPGYLAPEVLRANMFEDA 125 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~ 125 (408)
|+|||++.++.+||+|||+|+...... .....+||++|+|||++.. .
T Consensus 184 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~ 258 (458)
T 3rp9_A 184 PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-----Q 258 (458)
T ss_dssp GGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-----C
T ss_pred hhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-----C
Confidence 999999999999999999998764221 2345689999999998753 2
Q ss_pred CCCCcchhhhhhhHHHHHHHh-----------CCCCCCCchhHHHHHHHH-hccccCCCCCCccCCCCCchHHHhhhccc
Q psy3880 126 TGYGQAVDVWACGVIMYTLLV-----------GCPPFWHRKQMVMLRNIM-EGKYSFSSPEWNDISGYLAPEVLRANMFE 193 (408)
Q Consensus 126 ~~~~~~~DiwSlGvil~~ll~-----------G~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~PE~l~~~~~~ 193 (408)
..|+.++||||+||++|+|++ |.++|.+.+......... .+.+.
T Consensus 259 ~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~------------------------ 314 (458)
T 3rp9_A 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFK------------------------ 314 (458)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------------------------------------
T ss_pred CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccc------------------------
Confidence 468999999999999999999 556665543210000000 00000
Q ss_pred ccccCCCcccccchhhhHHHhhcCCCCCCCc--hhHHHHHHHHhcCC----CCCCCcCCCCCccHHHHHHHhcccCCCCC
Q psy3880 194 DATGYGQAVDVWACGVIMYTLLVGCPPFWHR--KQMVMLRNIMEGKY----SFSSPEWNDISEDPKDLIRKLLIVTPEDR 267 (408)
Q Consensus 194 ~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~--~~~~~~~~i~~~~~----~f~~~~~~~iS~~~~dLI~klL~~dP~~R 267 (408)
+......-.+-.|+ -+.|.++.... .............. ......|..+|++++|||++||++||++|
T Consensus 315 ----~~~~~~~~~l~~i~--~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 388 (458)
T 3rp9_A 315 ----FHTRGNRDQLNVIF--NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKR 388 (458)
T ss_dssp ------CHHHHHHHHHHH--HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ----ccccCCHHHHHHHH--HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCcccc
Confidence 00000000000000 01122221000 00000011111000 01112356789999999999999999999
Q ss_pred CCHHHHHcCCCCCCCC
Q psy3880 268 YSVKEALNHSFFHPKL 283 (408)
Q Consensus 268 ~ta~e~L~Hpwf~~~~ 283 (408)
||++|+|+||||+...
T Consensus 389 ~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 389 ITINECLAHPFFKEVR 404 (458)
T ss_dssp CCHHHHHHSGGGTTTC
T ss_pred CCHHHHhcCHhhhhcC
Confidence 9999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.30 Aligned_cols=201 Identities=27% Similarity=0.519 Sum_probs=159.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++| .+.+ ..++..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 ~hp~iv-~l~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 144 (345)
T 3a8x_A 68 NHPFLV-GLHSCFQTESRLFFVIEYVNGGD--LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144 (345)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCccC-eEEEEEEeCCEEEEEEeCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence 688755 5554 45567899999999998 877663 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|+... ........+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.......
T Consensus 145 ~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 217 (345)
T 3a8x_A 145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD- 217 (345)
T ss_dssp TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---
T ss_pred CCCCEEEEeccccccccCCCCcccccCCCccccCccccCC------CCCChHHhHHHHHHHHHHHHhCCCCcCCccccc-
Confidence 99999999999998633 3334556899999999999864 357889999999999999999999985321100
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.| .......+...+....+.
T Consensus 218 -----------------------------------------------------------~~-~~~~~~~~~~~i~~~~~~ 237 (345)
T 3a8x_A 218 -----------------------------------------------------------NP-DQNTEDYLFQVILEKQIR 237 (345)
T ss_dssp -----------------------------------------------------------------CHHHHHHHHHHCCCC
T ss_pred -----------------------------------------------------------cc-ccccHHHHHHHHHcCCCC
Confidence 00 001223445566666665
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV------KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta------~e~L~Hpwf~~~ 282 (408)
++ ..+|+++++||++||+.||++|||+ +|+++||||...
T Consensus 238 ~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 238 IP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 54 3579999999999999999999995 899999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=333.62 Aligned_cols=193 Identities=25% Similarity=0.529 Sum_probs=153.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+++|+.+.+ +..+..||||||+.||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 399 ~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~ 476 (674)
T 3pfq_A 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD--LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476 (674)
T ss_dssp TCCTTBCCEEEECBCSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC
T ss_pred cCCCeEEEEEEEEEeCCEEEEEEeCcCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc
Confidence 35556666665 44567899999999999 887764 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|+... ........+||+.|+|||++.. ..|+.++|+|||||++|+|++|.+||.+
T Consensus 477 ~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~~~~~DvwSlGvilyelltG~~Pf~~------ 544 (674)
T 3pfq_A 477 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY------QPYGKSVDWWAFGVLLYEMLAGQAPFEG------ 544 (674)
T ss_dssp SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC------CCBSTHHHHHHHHHHHHHHHHSSCSSCC------
T ss_pred CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC------CCCCccceEechHHHHHHHHcCCCCCCC------
Confidence 99999999999998643 3334556899999999999864 3456666666666666666666655544
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+..+++..|....+.
T Consensus 545 ----------------------------------------------------------------~~~~~~~~~i~~~~~~ 560 (674)
T 3pfq_A 545 ----------------------------------------------------------------EDEDELFQSIMEHNVA 560 (674)
T ss_dssp ----------------------------------------------------------------SSHHHHHHHHHSSCCC
T ss_pred ----------------------------------------------------------------CCHHHHHHHHHhCCCC
Confidence 4444556666666665
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCH-----HHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta-----~e~L~Hpwf~~~ 282 (408)
++. .+|+++++||++||+.||++|+++ +|+++||||+..
T Consensus 561 ~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 561 YPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred CCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 543 589999999999999999999997 999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.91 Aligned_cols=192 Identities=36% Similarity=0.656 Sum_probs=153.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ .+.+ ..++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 97 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 97 AVNFPFLV-KLEFSFKDNSNLYMVMEYVAGGE--MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEEcCCEEEEEEcCCCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 45788755 4443 45567899999999998 887764 56899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+++..... ....+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+
T Consensus 174 l~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~----- 240 (350)
T 1rdq_E 174 IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS------KGYNKAVDWWALGVLIYEMAAGYPPFFA----- 240 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCC-----
T ss_pred ECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcC------CCCCCcCCEecccHhHhHHhhCCCCCCC-----
Confidence 999999999999999876443 345789999999999864 3456666666666666666666666544
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+...+...|..+..
T Consensus 241 -----------------------------------------------------------------~~~~~~~~~i~~~~~ 255 (350)
T 1rdq_E 241 -----------------------------------------------------------------DQPIQIYEKIVSGKV 255 (350)
T ss_dssp -----------------------------------------------------------------SSHHHHHHHHHHCCC
T ss_pred -----------------------------------------------------------------CCHHHHHHHHHcCCC
Confidence 344445556666665
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||+.||++||+ ++|+++||||...
T Consensus 256 ~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 554 257999999999999999999998 9999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.94 Aligned_cols=204 Identities=35% Similarity=0.662 Sum_probs=146.7
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+|+| ++.+ +.++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 64 ~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~ 140 (325)
T 3kn6_A 64 GHPNIV-KLHEVFHDQLHTFLVMELLNGGE--LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140 (325)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCCee-EEEEEEEcCCEEEEEEEccCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence 388755 5544 45566799999999998 887763 5689999999999999999999999999999999998
Q ss_pred cCC---CEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 81 DQM---NVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 81 ~~~---~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
.++ .+||+|||++...... ......+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+.+.
T Consensus 141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ------NGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp C----CEEEECCCTTCEECCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC------CCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 665 7999999999865443 23345789999999999864 4578899999999999999999999965432
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.. ......+.+..+..+
T Consensus 215 ~~---------------------------------------------------------------~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 215 SL---------------------------------------------------------------TCTSAVEIMKKIKKG 231 (325)
T ss_dssp ------------------------------------------------------------------CCCHHHHHHHHTTT
T ss_pred cc---------------------------------------------------------------ccccHHHHHHHHHcC
Confidence 10 011223455666777
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.+.+..+.|..+|+++++||++||..||++|||++|+|+||||+...
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 77777777888999999999999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.24 Aligned_cols=206 Identities=28% Similarity=0.486 Sum_probs=161.6
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|++++ .+.+ .+++..||||||+.||+ |.+++. ++..++.++.||+.||+|||++|||||||||+|||
T Consensus 118 ~~hp~Iv-~l~~~~~~~~~~~lVmE~~~gg~--L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 118 GDRRWIT-QLHFAFQDENYLYLVMEYYVGGD--LLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194 (412)
T ss_dssp SCTTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCCCee-eEEEEEeeCCEEEEEEcCCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee
Confidence 4677644 5554 45567899999999998 877763 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccc-cCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMF-EDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||+|+.+..... ....+||+.|+|||++..... .....|+.++|+||+||++|+|++|..||.+.+
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 99999999999999987654432 234689999999999974210 012357899999999999999999999998877
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+...+|......+
T Consensus 275 ~~~~~~~i~~~~~~~----------------------------------------------------------------- 289 (412)
T 2vd5_A 275 TAETYGKIVHYKEHL----------------------------------------------------------------- 289 (412)
T ss_dssp HHHHHHHHHTHHHHC-----------------------------------------------------------------
T ss_pred HHHHHHHHHhcccCc-----------------------------------------------------------------
Confidence 776666665422110
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY---SVKEALNHSFFHPKLFD 285 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~---ta~e~L~Hpwf~~~~~~ 285 (408)
.++ ..+..+|++++|||++||+ ||.+|+ |++|+++||||+...++
T Consensus 290 ---~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 290 ---SLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ---CCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred ---CCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 111 0123579999999999999 999985 89999999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.56 Aligned_cols=194 Identities=32% Similarity=0.585 Sum_probs=152.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ +..+..|+||||+.||+ |.+.+. +...++.++.||+.||+|||+ +|||||||||+||
T Consensus 204 ~l~h~~iv-~l~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NI 280 (446)
T 4ejn_A 204 NSRHPFLT-ALKYSFQTHDRLCFVMEYANGGE--LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280 (446)
T ss_dssp CCSCTTSC-CEEEEEEETTEEEEEECCCSSCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGE
T ss_pred hCCCCeEe-eEEEEEeeCCEEEEEEeeCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHE
Confidence 46788866 4443 44556799999999998 777663 568899999999999999998 9999999999999
Q ss_pred EEecCCCEEEeccccchhcc-cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLK-KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+|+... ........+||+.|+|||++.. ..|+.++||||+||++|+|++|..||.+.+.
T Consensus 281 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp EECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC------CCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 99999999999999998643 3334456899999999999864 3467777777777777777777777754433
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
..+...+...
T Consensus 355 ----------------------------------------------------------------------~~~~~~i~~~ 364 (446)
T 4ejn_A 355 ----------------------------------------------------------------------EKLFELILME 364 (446)
T ss_dssp ----------------------------------------------------------------------HHHHHHHHHC
T ss_pred ----------------------------------------------------------------------HHHHHHHHhC
Confidence 3334444445
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.+.++ ..+|+++++||.+||..||++|| |++|+|+||||+..
T Consensus 365 ~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 EIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 44443 35799999999999999999999 99999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=291.62 Aligned_cols=222 Identities=26% Similarity=0.464 Sum_probs=161.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ +..+..++|||++.++ |.+.+ .+..+++.++.||+.||+|||++||+||||||+||
T Consensus 56 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 131 (288)
T 1ob3_A 56 ELKHSNIV-KLYDVIHTKKRLVLVFEHLDQD---LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (288)
T ss_dssp GCCCTTBC-CEEEEEECSSCEEEEEECCSEE---HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hcCCCCEe-eeeeEEccCCeEEEEEEecCCC---HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 46798865 5444 4456779999999874 44443 24578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++...... ......+||+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEcCCCCEEEeECccccccCccccccccccccccccCchheeCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999876532 233456899999999998642 3578999999999999999999999999888
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+...........|...... ..+......+ .|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-------------~~~--------------- 244 (288)
T 1ob3_A 207 ADQLMRIFRILGTPNSKNWPNVTEL--------------PKYDPNFTVY-------------EPL--------------- 244 (288)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGS--------------TTCCTTCCCC-------------CCC---------------
T ss_pred HHHHHHHHHHHCCCChhhchhhhcc--------------cccccccccc-------------cCc---------------
Confidence 8877777664433333333221100 0000000000 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.....+..+++++++||++||+.||++|||++|+|+||||+.
T Consensus 245 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 245 ---PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp ---CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ---cHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000112468999999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=296.86 Aligned_cols=229 Identities=26% Similarity=0.506 Sum_probs=166.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|+|+| ++.+ +.++..|+||||+.| . |.+.+ .+...++.++.||+.||+|||++||+||||
T Consensus 59 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~-~--L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T 2pmi_A 59 ELKHENIV-RLYDVIHTENKLTLVFEFMDN-D--LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134 (317)
T ss_dssp TCCBTTBC-CEEEEECCTTEEEEEEECCCC-B--HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hcCCCCcc-eEEEEEEECCeEEEEEEecCC-C--HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 46798865 5544 445667999999985 4 55543 345789999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|||++.++.+||+|||++...... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||
T Consensus 135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS-----RTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999876532 233456899999999998642 35789999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+..+.+..+...........|...... ..|... ....+| .. +.
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~-------------~~~~~~---~~----~~ 255 (317)
T 2pmi_A 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKL--------------PKYNPN-------------IQQRPP---RD----LR 255 (317)
T ss_dssp CCSSHHHHHHHHHHHHCSCCTTTCGGGGGC--------------TTCCTT-------------CCCCCC---CC----SH
T ss_pred CCCChHHHHHHHHHHhCCCChhHhhhhhhh--------------hhcccc-------------cccccc---hh----HH
Confidence 999888888877664433332222211100 000000 000000 00 00
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.... ......+|++++|||++||+.||++|||++|+|+||||+...
T Consensus 256 ~~~~------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 256 QVLQ------PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp HHHG------GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred Hhhc------ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 1111 011235789999999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=308.41 Aligned_cols=194 Identities=32% Similarity=0.639 Sum_probs=155.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..++||||+ +|+ |++.+ .++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 65 ~l~hpnIv-~l~~~~~~~~~~~lv~E~~-~g~--l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 140 (336)
T 3h4j_B 65 LLRHPHII-KLYDVITTPTDIVMVIEYA-GGE--LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140 (336)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCC-CEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred hCCCCCCC-eEEEEEEeCCEEEEEEECC-CCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence 46799865 5544 4455678999999 666 77766 356899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++.....+......+||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.....
T Consensus 141 l~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK-----LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp ECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCS-----GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred EcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCC-----CCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 999999999999999887776666778999999999998643 223679999999999999999999996532111
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...+ +..+.+
T Consensus 216 ~~~~----------------------------------------------------------------------i~~~~~ 225 (336)
T 3h4j_B 216 LFKK----------------------------------------------------------------------VNSCVY 225 (336)
T ss_dssp CBCC----------------------------------------------------------------------CCSSCC
T ss_pred HHHH----------------------------------------------------------------------HHcCCC
Confidence 0000 001111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||+.||.+|||++|+++||||+..
T Consensus 226 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 226 VMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 111 2478999999999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=293.30 Aligned_cols=226 Identities=24% Similarity=0.364 Sum_probs=164.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|+| .+.+ +.++..++||||+.++....... -.++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 57 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 57 ELKHKNIV-RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCCCEe-eEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 46788855 5544 34556789999999875222211 235689999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC-CCCchhHH
Q psy3880 81 DQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP-FWHRKQMV 158 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p-f~~~~~~~ 158 (408)
.++.+||+|||++...... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..| |.+.+...
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCC-----CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 9999999999999876533 233456899999999998642 3478999999999999999987777 55666667
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+......+....|...... ....|+.... ..
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~-----------~~ 245 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSMTKL----------------------------------PDYKPYPMYP-----------AT 245 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGS----------------------------------TTCCCCCCCC-----------TT
T ss_pred HHHHHHHHhCCCChhhhhhhccc----------------------------------cccccccccc-----------CC
Confidence 77777665444443333221100 0000110000 00
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.........+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00112234689999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=306.36 Aligned_cols=200 Identities=26% Similarity=0.519 Sum_probs=159.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+.+ ...+..|+||||+.||+ |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 71 ~l~hp~Iv-~l~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 147 (384)
T 4fr4_A 71 GLEHPFLV-NLWYSFQDEEDMFMVVDLLLGGD--LRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147 (384)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCCC-cEEEEEEeCCEEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 46788855 5443 44567899999999999 877764 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|..+.........+||+.|+|||++... ....|+.++|+||+||++|+|++|..||...+..
T Consensus 148 l~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~- 223 (384)
T 4fr4_A 148 LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR---KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST- 223 (384)
T ss_dssp ECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCC---SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-
T ss_pred ECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccC---CCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-
Confidence 999999999999999887766666778999999999998642 1235778888888888888888888888543210
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+...+.....
T Consensus 224 ------------------------------------------------------------------~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 224 ------------------------------------------------------------------SSKEIVHTFETTVV 237 (384)
T ss_dssp ------------------------------------------------------------------CHHHHHHHHHHCCC
T ss_pred ------------------------------------------------------------------cHHHHHHHHhhccc
Confidence 11122333333333
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-a~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||..||++||| ++++++||||+..
T Consensus 238 ~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 238 TYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 333 357899999999999999999998 9999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=300.12 Aligned_cols=199 Identities=31% Similarity=0.529 Sum_probs=153.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|++ |+.+.+ +.++..++||||+.||. |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 87 ~~~~-iv~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPR-VINLHEVYENTSEIILILEYAAGGE--IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp TCTT-BCCEEEEEECSSEEEEEEECCTTEE--GGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CCCC-EEEEEEEEEeCCeEEEEEEecCCCc--HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 3465 545554 45566799999999998 887763 34789999999999999999999999999999999
Q ss_pred Eec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++. ++.+||+|||++............+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY------DPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 987 78999999999987766555566789999999999864 345677777777777777777777765433
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
. ......+..
T Consensus 238 ~----------------------------------------------------------------------~~~~~~i~~ 247 (327)
T 3lm5_A 238 N----------------------------------------------------------------------QETYLNISQ 247 (327)
T ss_dssp H----------------------------------------------------------------------HHHHHHHHH
T ss_pred c----------------------------------------------------------------------hHHHHHHHh
Confidence 3 333444555
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
....+..+.+..+++++++||.+||+.||++|||++|+|+||||+...+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 55566666777899999999999999999999999999999999876443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=292.58 Aligned_cols=198 Identities=38% Similarity=0.767 Sum_probs=159.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ..++..++||||+.||. |.+.+ .+..++..++.|++.||+|||++||+||||||+|||
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 137 (284)
T 3kk8_A 61 KLQHPNIV-RLHDSIQEESFHYLVFDLVTGGE--LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 137 (284)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HcCCCCcC-eEEEEEEcCCEEEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence 36788865 4443 44556789999999998 76655 356889999999999999999999999999999999
Q ss_pred EecCCC---EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMN---VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~---iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++. +||+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~--- 208 (284)
T 3kk8_A 138 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK------DPYSKPVDIWACGVILYILLVGYPPFW--- 208 (284)
T ss_dssp ESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSC---
T ss_pred EecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC------CCCCcccchHHHHHHHHHHHHCCCCCC---
Confidence 986654 99999999987766655566789999999999864 235566666666666666666666554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..........+..
T Consensus 209 -------------------------------------------------------------------~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 209 -------------------------------------------------------------------DEDQHRLYAQIKA 221 (284)
T ss_dssp -------------------------------------------------------------------CSSHHHHHHHHHH
T ss_pred -------------------------------------------------------------------CCchhHHHHHHHh
Confidence 3444455566677
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.++.+.|..+++++++||.+||..||++|||++|+|+||||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 77778888888999999999999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=297.83 Aligned_cols=217 Identities=34% Similarity=0.574 Sum_probs=160.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
+.|+|++ .+.+ +.++..|+||||+.||. |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 ~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 144 (316)
T 2ac3_A 68 QGHRNVL-ELIEFFEEEDRFYLVFEKMRGGS--ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144 (316)
T ss_dssp CCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred cCCCCee-eEEEEEeeCCEEEEEEEcCCCCc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 4688855 5444 44567799999999998 877763 558899999999999999999999999999999999
Q ss_pred ecCCC---EEEeccccchhcccCc--------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 80 DDQMN---VKLTDFGFARVLKKGE--------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 80 ~~~~~---iKl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
+.++. +||+|||++....... .....+||+.|+|||++..... ....|+.++||||+||++|+|++|.
T Consensus 145 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE-EASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp SCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH-HHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc-cccCCCcccccHhHHHHHHHHHHCC
Confidence 87765 9999999987654211 1234579999999999864110 0123678999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+..... ..|..+ .........
T Consensus 224 ~pf~~~~~~~--------------------------------------------~~~~~~-----------~~~~~~~~~ 248 (316)
T 2ac3_A 224 PPFVGRCGSD--------------------------------------------CGWDRG-----------EACPACQNM 248 (316)
T ss_dssp CSCCCCCCSC--------------------------------------------SCC---------------CCHHHHHH
T ss_pred CCCccccccc--------------------------------------------cccccc-----------ccchhHHHH
Confidence 9996542110 011100 001112344
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+...+..+.+.++...|..+|+++++||++||..||++|||++|+|+||||+..
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 567778888877777778899999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.43 Aligned_cols=201 Identities=36% Similarity=0.709 Sum_probs=149.0
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+| .+.+ ...+..|+||||+.+|+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 196 ~l~hpniv-~l~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll 272 (419)
T 3i6u_A 196 KLNHPCII-KIKNFFDAEDYYIVLELMEGGE--LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272 (419)
T ss_dssp HCCCTTBC-CCCEEEESSEEEEEEECCTTCB--GGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hCCCCCEe-eEEEEEecCceEEEEEcCCCCc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 36799865 4443 22334689999999999 888774 458899999999999999999999999999999999
Q ss_pred ecCC---CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQM---NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~---~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+.++ .+||+|||+|+...........+||+.|+|||++... ....|+.++|+||+||++|+|++|..||.....
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV---GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC-------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecC---CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 7544 5999999999987765555678999999999998531 124567788888888888888888888854321
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.. .+...+..+
T Consensus 350 ~~---------------------------------------------------------------------~~~~~i~~~ 360 (419)
T 3i6u_A 350 QV---------------------------------------------------------------------SLKDQITSG 360 (419)
T ss_dssp SC---------------------------------------------------------------------CHHHHHHTT
T ss_pred hH---------------------------------------------------------------------HHHHHHhcC
Confidence 10 112233444
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+.+....|..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 444444556788999999999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.43 Aligned_cols=227 Identities=30% Similarity=0.404 Sum_probs=164.6
Q ss_pred ccccCCcEEEEec--------cCCcHHHHHHHHHhhchhhHHh------hhCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE--------EGDDLKHLAAQVVDKGEAAVQD------IINSNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--------~~~~~~~lv~e~~~~g~~~l~~------~~~~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|+|+| .+.+ .+....++||||+.++...... ...+...++.++.||+.||+|||++||+|||
T Consensus 88 ~l~h~niv-~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 166 (394)
T 4e7w_A 88 IVKHPNVV-DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166 (394)
T ss_dssp TCCCTTBC-CEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hCCCCCcc-eEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence 46799866 4332 1122367999999987522211 1234578999999999999999999999999
Q ss_pred CCCCcEEEe-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+|||++ .++.+||+|||+|+.+..+......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..|
T Consensus 167 lkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCC-----CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999 7899999999999887666666678899999999998642 4588999999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+..+.+..|......+. ++.+....- .| .....|-.....
T Consensus 242 f~~~~~~~~l~~i~~~~g~p~------------~~~~~~~~~----~~----------------~~~~~~~~~~~~---- 285 (394)
T 4e7w_A 242 FPGESGIDQLVEIIKVLGTPS------------REQIKTMNP----NY----------------MEHKFPQIRPHP---- 285 (394)
T ss_dssp SCCSSHHHHHHHHHHHHCCCC------------HHHHHHHCG----GG----------------SSSCCCCCCCCC----
T ss_pred CCCCCHHHHHHHHHHHhCCCC------------HHHHHhhCh----hh----------------hhhccccccCCc----
Confidence 999988888877765332211 111111000 00 000000000000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+....+..+|++++|||.+||++||++|||+.|+|+||||+...
T Consensus 286 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 286 ---------FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp ---------HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred ---------HHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00011235799999999999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.34 Aligned_cols=234 Identities=25% Similarity=0.396 Sum_probs=156.7
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh--------------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII--------------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~--------------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.|.|+|+| .+.+ ..+...|+||||+.++ |.+.+ .+...++.++.||+.||+|||++||
T Consensus 74 ~l~hpniv-~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 149 (405)
T 3rgf_A 74 ELKHPNVI-SLQKVFLSHADRKVWLLFDYAEHD---LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 149 (405)
T ss_dssp HCCCTTBC-CCCEEEEETTTTEEEEEEECCSEE---HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hcCCCCee-eEeeEEecCCCCeEEEEEeCCCCC---HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 36798865 4433 3456678999999875 44433 4567899999999999999999999
Q ss_pred eeccCCCCcEEE----ecCCCEEEeccccchhcccC----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 68 VHRDLKPENILL----DDQMNVKLTDFGFARVLKKG----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 68 vHRDLKp~NILl----~~~~~iKl~DFGla~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||++.+. ..|+.++||||+||
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~ 224 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGC 224 (405)
T ss_dssp CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTC-----CSCCHHHHHHHHHH
T ss_pred eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-----CcccchhhhHHHHH
Confidence 999999999999 66789999999999876532 223457899999999998642 35789999999999
Q ss_pred HHHHHHhCCCCCCCchh---------HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhh
Q psy3880 140 IMYTLLVGCPPFWHRKQ---------MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVI 210 (408)
Q Consensus 140 il~~ll~G~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvi 210 (408)
++|+|++|.+||.+... ...+..|......+....|..+........+....
T Consensus 225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~------------------- 285 (405)
T 3rgf_A 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF------------------- 285 (405)
T ss_dssp HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHC-------------------
T ss_pred HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhc-------------------
Confidence 99999999999977654 35555555544333334443332211111110000
Q ss_pred HHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 211 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 211 ly~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
. ...+........ +. ......++++++||++||++||++|||++|+|+||||.....
T Consensus 286 ----~--~~~~~~~~~~~~---~~--------~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 286 ----R--RNTYTNCSLIKY---ME--------KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp ----C--GGGGTTCCHHHH---HH--------TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred ----c--ccCCCcchhhhh---Hh--------hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 0 000000000000 00 011245889999999999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.64 Aligned_cols=195 Identities=32% Similarity=0.627 Sum_probs=156.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..|+||||+.||+ |.+++. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 72 ~l~HpnIv-~l~~~~~~~~~~~lv~E~~~gg~--L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl 148 (476)
T 2y94_A 72 LFRHPHII-KLYQVISTPSDIFMVMEYVSGGE--LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148 (476)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCSSEE--HHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEeCCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence 46799865 5544 44567899999999999 988875 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++.....+......+||+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+.+
T Consensus 149 l~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~--- 220 (476)
T 2y94_A 149 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR-----LYAGPEVDIWSSGVILYALLCGTLPFDDDH--- 220 (476)
T ss_dssp ECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTC-----CBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCC-----CCCCCcceehhhHHHHHHHhhCCCCCCCCC---
Confidence 999999999999999887766666778999999999998653 122566777777777777777777665433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
...+...+..+.+
T Consensus 221 -------------------------------------------------------------------~~~~~~~i~~~~~ 233 (476)
T 2y94_A 221 -------------------------------------------------------------------VPTLFKKICDGIF 233 (476)
T ss_dssp -------------------------------------------------------------------SHHHHHHHHTTCC
T ss_pred -------------------------------------------------------------------HHHHHHHHhcCCc
Confidence 2333444554444
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+ ..+|+++++||++||+.||++|||++|+++||||+..
T Consensus 234 ~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 YTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 332 2478999999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=299.19 Aligned_cols=194 Identities=31% Similarity=0.539 Sum_probs=149.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.++..|+||||+.||. |.+.+. ++..++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nil 153 (327)
T 3a62_A 77 EVKHPFIV-DLIYAFQTGGKLYLILEYLSGGE--LFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM 153 (327)
T ss_dssp HCCCTTBC-CEEEEEECSSCEEEEEECCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred hCCCCCcc-ceeEEEEcCCEEEEEEeCCCCCc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeE
Confidence 36788866 4443 44567899999999998 877663 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+++..... ......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 154 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~- 226 (327)
T 3a62_A 154 LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR------SGHNRAVDWWSLGALMYDMLTGAPPFTGENR- 226 (327)
T ss_dssp ECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred ECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC------CCCCCcccchhHHHHHHHHHHCCCCCCCCCH-
Confidence 999999999999999764432 23345789999999999864 3456777777777777777777777654433
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
......+....
T Consensus 227 ---------------------------------------------------------------------~~~~~~i~~~~ 237 (327)
T 3a62_A 227 ---------------------------------------------------------------------KKTIDKILKCK 237 (327)
T ss_dssp ---------------------------------------------------------------------HHHHHHHHHTC
T ss_pred ---------------------------------------------------------------------HHHHHHHHhCC
Confidence 33344444444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
+.++ ..+++++++||.+||..||++|| |++|+|+||||+..
T Consensus 238 ~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 238 LNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 4443 25789999999999999999999 89999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=303.12 Aligned_cols=201 Identities=33% Similarity=0.558 Sum_probs=145.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ ...+..|+||||+.||. |.+.+ .+..+++.++.||+.||+|||++||+||||||+|||
T Consensus 72 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 72 SLRHPNIV-RFKEVILTPTHLAIIMEYASGGE--LYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred hCCCCCCC-cEEEEEeeCCEEEEEEEeCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 36798865 5544 45566899999999998 87776 356899999999999999999999999999999999
Q ss_pred EecCCC--EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCC-CcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMN--VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGY-GQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~--iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~-~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++. +||+|||+|+...........+||+.|+|||++.+. .+ +.++||||+||++|+|++|..||.+..
T Consensus 149 l~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp ECSSSSCCEEECCCCCC---------------CTTSCHHHHHCS------SCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred EcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCC------CCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 987665 999999999865544444567899999999998753 33 345899999999999999999986533
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.... ....+..+..
T Consensus 223 ~~~~------------------------------------------------------------------~~~~~~~~~~ 236 (361)
T 3uc3_A 223 EPRD------------------------------------------------------------------YRKTIQRILS 236 (361)
T ss_dssp -CCC------------------------------------------------------------------HHHHHHHHHT
T ss_pred cHHH------------------------------------------------------------------HHHHHHHHhc
Confidence 2111 1112233333
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+.+ +.+..+|+++++||++||+.||++|||++|+|+||||....
T Consensus 237 ~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 237 VKYSI--PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp TCCCC--CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCCCC--CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 33333 33446899999999999999999999999999999996643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=303.20 Aligned_cols=220 Identities=24% Similarity=0.414 Sum_probs=163.9
Q ss_pred ccccCCcEEEEecc---CC-----cHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE---GD-----DLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~---~~-----~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+. .. ...|+||||+ |+. |.+.+ .++..++.++.||+.||+|||++||+|||||
T Consensus 80 ~l~hpnIv-~l~~~~~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 155 (367)
T 1cm8_A 80 HMRHENVI-GLLDVFTPDETLDDFTDFYLVMPFM-GTD--LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 155 (367)
T ss_dssp HCCBTTBC-CCSEEECSCSSTTTCCCCEEEEECC-SEE--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hCCCcCCC-CceeeEecCCccccCceEEEEEecC-CCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 35788855 44431 11 2348999999 666 66655 3568899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||++.++.+||+|||+|+.... .....+||+.|+|||++.+. ..|+.++|+||+||++|+|++|..||.+
T Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 156 PGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNW-----MRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTT-----TCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEEcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCC-----CCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987543 24567899999999998752 4588999999999999999999999999
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..|......+. +|.+..- . . ......
T Consensus 229 ~~~~~~l~~i~~~~g~~~------------~~~~~~~-~------------------------------~----~~~~~~ 261 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPP------------AEFVQRL-Q------------------------------S----DEAKNY 261 (367)
T ss_dssp SSHHHHHHHHHHHHCCCC------------HHHHHTC-S------------------------------C----HHHHHH
T ss_pred CCHHHHHHHHHHhcCCCC------------HHHHHHh-h------------------------------h----HHHHHH
Confidence 998888888876432211 1111000 0 0 000111
Q ss_pred HhcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 234 MEGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 234 ~~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
......... ..+..+|++++|||++||+.||++|||++|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 111111111 12356799999999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.72 Aligned_cols=197 Identities=31% Similarity=0.517 Sum_probs=159.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|+++| .+.+ +..+..|+||||+.||+ |.+.+ .++..++.++.||+.||+|||++|||||||||+||
T Consensus 241 l~hp~Iv-~l~~~~~~~~~l~lVmEy~~gg~--L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 241 VNSRFVV-SLAYAYETKDALCLVLTLMNGGD--LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp CCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCCEe-eEEEEEeeCCEEEEEEEcCCCCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 5788755 5443 45567899999999999 87766 45689999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+|..+..+......+||+.|+|||++.. ..|+.++|+||+||++|+|++|..||.+.+..
T Consensus 318 Lld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred EEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcC------CCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 999999999999999988766655667899999999999864 34678888888888888888888888543210
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+...+....
T Consensus 392 ------------------------------------------------------------------~~~~~i~~~i~~~~ 405 (576)
T 2acx_A 392 ------------------------------------------------------------------IKREEVERLVKEVP 405 (576)
T ss_dssp ------------------------------------------------------------------CCHHHHHHHHHHCC
T ss_pred ------------------------------------------------------------------hhHHHHHHHhhccc
Confidence 01122334455444
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
..++ ..+|+++++||++||+.||++|| |++|+++||||+..
T Consensus 406 ~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 EEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 4443 46899999999999999999999 89999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.49 Aligned_cols=226 Identities=24% Similarity=0.435 Sum_probs=160.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.| . |.+.+ .+...++.++.||+.||+|||++||+||||||+|||
T Consensus 89 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl 164 (329)
T 3gbz_A 89 ELQHRNII-ELKSVIHHNHRLHLIFEYAEN-D--LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164 (329)
T ss_dssp GCCCTTBC-CEEEEEEETTEEEEEEECCSE-E--HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HcCCCCcc-eEEEEEecCCEEEEEEecCCC-C--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence 46788865 5443 445667899999986 4 66654 355889999999999999999999999999999999
Q ss_pred Ee-----cCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 79 LD-----DQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 79 l~-----~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++ .++.+||+|||+|...... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.
T Consensus 165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS-----RHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp EEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCC-----CCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 95 4445999999999876533 233456889999999998642 357899999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+....+.++......+....|..... ..-|. ...+-+.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~---------~~~~~~~~~~~~~---- 285 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTA---------------------LPDWK---------QSFPKFRGKTLKR---- 285 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGG---------------------STTCC---------TTCCCCCCCCHHH----
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhh---------------------hhhhh---------hhhhhhccccHhh----
Confidence 9988888888776544333333322110 00000 0001111111111
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
.. ...+++++++||.+||+.||++|||++|+|+||||+...+
T Consensus 286 ~~----------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 286 VL----------GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp HH----------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hc----------ccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11 1236889999999999999999999999999999987644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=309.07 Aligned_cols=248 Identities=22% Similarity=0.378 Sum_probs=154.7
Q ss_pred ccccCCcEEEEecc--CC-----cHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE--GD-----DLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--~~-----~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+. .. +..|+||||+.+ + |.+.+. ++..++.++.||+.||+|||++||+|||||
T Consensus 81 ~l~h~nIv-~l~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 156 (432)
T 3n9x_A 81 RLKSDYII-RLYDLIIPDDLLKFDELYIVLEIADS-D--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLK 156 (432)
T ss_dssp HCCCTTBC-CEEEECCCSCTTTCCCEEEEEECCSE-E--HHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HcCCCCcc-eEEEEEecCCCCcCCeEEEEEecCCc-C--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 35788866 44432 11 346899999875 5 666653 568999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc-----------------------ccccCCCCCcccChhhhhhccccCcCCCCc
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE-----------------------KLMDLCGTPGYLAPEVLRANMFEDATGYGQ 130 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~-----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~ 130 (408)
|+|||++.++.+||+|||+|+...... .....+||++|+|||++... ..|+.
T Consensus 157 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~~~~ 231 (432)
T 3n9x_A 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-----ENYTK 231 (432)
T ss_dssp GGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC-----SCCCT
T ss_pred HHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-----CCCCc
Confidence 999999999999999999998764321 23567899999999997542 45889
Q ss_pred chhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCC-CchHHHhhhcccccccCCCcccccchhh
Q psy3880 131 AVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGY-LAPEVLRANMFEDATGYGQAVDVWACGV 209 (408)
Q Consensus 131 ~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~PE~l~~~~~~~~~~y~~~~DiWs~Gv 209 (408)
++||||+||++|+|++|..||..... .+...|. +...+ .+|....... ....+.-.+-.
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~~~~~--------~~~p~f~-----g~~~~~~~~~~~~~~~-------~~~~~~~ql~~ 291 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHINDPT--------NRFPLFP-----GSSCFPLSPDRNSKKV-------HEKSNRDQLNI 291 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTCSSGG--------GCCCSCC-----CSCSCC-----------------CHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHhcccccccccc--------cccccCC-----CccccccCcccccccc-------cccchHHHHHH
Confidence 99999999999999997766654321 0000000 00000 0000000000 00000000000
Q ss_pred hHHHhhcCCCCCCC---chhHHHHHHHHhcCCCCCC---CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 210 IMYTLLVGCPPFWH---RKQMVMLRNIMEGKYSFSS---PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 210 ily~ll~g~~Pf~~---~~~~~~~~~i~~~~~~f~~---~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
| .-+.|.||... .........+.......+. ..+..+|++++|||++||++||++|||++|+|+||||+...
T Consensus 292 i--~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 292 I--FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp H--HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred H--HHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 0 01123333210 0111122222221111111 12457899999999999999999999999999999998754
Q ss_pred C
Q psy3880 284 F 284 (408)
Q Consensus 284 ~ 284 (408)
.
T Consensus 370 ~ 370 (432)
T 3n9x_A 370 K 370 (432)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=290.36 Aligned_cols=197 Identities=34% Similarity=0.640 Sum_probs=158.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.||. |.+.+ .+..++..++.|++.||+|||++||+||||||+|||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 138 (277)
T 3f3z_A 62 SLDHPNII-RLYETFEDNTDIYLVMELCTGGE--LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138 (277)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCEe-eEEEEEecCCeEEEEEeccCCCc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence 46788865 5443 45566799999999998 77765 356889999999999999999999999999999999
Q ss_pred E---ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 L---DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l---~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+ +.++.+||+|||++............+||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+
T Consensus 139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-------LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp ESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-------CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-------cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 9 7788999999999987776666667889999999998853 25677777777777777777777765433
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
. .+....+..
T Consensus 212 ~----------------------------------------------------------------------~~~~~~~~~ 221 (277)
T 3f3z_A 212 D----------------------------------------------------------------------SEVMLKIRE 221 (277)
T ss_dssp H----------------------------------------------------------------------HHHHHHHHH
T ss_pred H----------------------------------------------------------------------HHHHHHHHh
Confidence 3 334444555
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.++...|..+|+++++||.+||..||++|||+.|+|+||||+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 222 GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 55556555667889999999999999999999999999999999653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=295.54 Aligned_cols=199 Identities=30% Similarity=0.573 Sum_probs=156.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+||||+.||+ |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 61 ~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 137 (323)
T 3tki_A 61 MLNHENVV-KFYGHRREGNIQYLFLEYCSGGE--LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (323)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCTTEE--GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCCC-eEEEEEecCCeEEEEEEcCCCCc--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence 46798866 5443 45566789999999999 888875 35889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||++..+.... .....+||+.|+|||++... ..++.++||||+||++|+|++|..||.+.+
T Consensus 138 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-----EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCS-----SBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred EeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999998664322 23457899999999998753 224678999999999999999999996543
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..... ......
T Consensus 213 ~~~~~---------------------------------------------------------------------~~~~~~ 223 (323)
T 3tki_A 213 DSCQE---------------------------------------------------------------------YSDWKE 223 (323)
T ss_dssp TTSHH---------------------------------------------------------------------HHHHHT
T ss_pred hHHHH---------------------------------------------------------------------HHHHhc
Confidence 21100 000111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. ...+.|..+++++++||.+||..||++|||++|+|+||||+...
T Consensus 224 ~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 224 KK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp TC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cc--ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 11 11123567899999999999999999999999999999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=299.87 Aligned_cols=200 Identities=32% Similarity=0.591 Sum_probs=154.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------------------------------------
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------------------------- 43 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------------------------- 43 (408)
.+.|+|+| ++.+ +.++..++||||+.||. |.+.+.
T Consensus 84 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (345)
T 3hko_A 84 KLHHPNIA-RLYEVYEDEQYICLVMELCHGGH--LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160 (345)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred hCCCCCcc-eeehhhccCCeEEEEEeCCCCCc--HHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 35788865 5443 45566899999999998 888774
Q ss_pred -----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC--CEEEeccccchhcccCc-----ccccCCCCCcc
Q psy3880 44 -----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM--NVKLTDFGFARVLKKGE-----KLMDLCGTPGY 111 (408)
Q Consensus 44 -----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~--~iKl~DFGla~~~~~~~-----~~~~~~gt~~y 111 (408)
++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+.... .....+||+.|
T Consensus 161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 161 LDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 3467889999999999999999999999999999998766 89999999998654321 13456899999
Q ss_pred cChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhc
Q psy3880 112 LAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANM 191 (408)
Q Consensus 112 ~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~ 191 (408)
+|||++... ...|+.++||||+||++|+|++|..||.
T Consensus 241 ~aPE~~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~--------------------------------------- 277 (345)
T 3hko_A 241 VAPEVLNTT----NESYGPKCDAWSAGVLLHLLLMGAVPFP--------------------------------------- 277 (345)
T ss_dssp CCHHHHTCS----SSCCCTHHHHHHHHHHHHHHHHSSCSSC---------------------------------------
T ss_pred cCchhhccC----CCCCCcHHHHHHHHHHHHHHHHCCCCCC---------------------------------------
Confidence 999998632 1345666666666666666666666653
Q ss_pred ccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH
Q psy3880 192 FEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK 271 (408)
Q Consensus 192 ~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~ 271 (408)
+.+..+....+......+..+.+..+|+++++||.+||..||.+|||+.
T Consensus 278 -------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 278 -------------------------------GVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp -------------------------------CSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred -------------------------------CCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 3344445566677777777777888999999999999999999999999
Q ss_pred HHHcCCCCCCC
Q psy3880 272 EALNHSFFHPK 282 (408)
Q Consensus 272 e~L~Hpwf~~~ 282 (408)
|+|+||||+..
T Consensus 327 ~~l~hp~~~~~ 337 (345)
T 3hko_A 327 RALQHPWISQF 337 (345)
T ss_dssp HHHHSHHHHTT
T ss_pred HHhcChhhccC
Confidence 99999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=295.49 Aligned_cols=198 Identities=39% Similarity=0.756 Sum_probs=157.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..|+||||+.||. |.+.+. ++.++..++.||+.||+|||++||+||||||+|||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl 138 (304)
T 2jam_A 62 KIKHENIV-TLEDIYESTTHYYLVMQLVSGGE--LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138 (304)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCE
T ss_pred hCCCCCee-ehhhhcccCCEEEEEEEcCCCcc--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 36788865 4443 45566799999999998 777663 56889999999999999999999999999999999
Q ss_pred E---ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 L---DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l---~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+ +.++.+||+|||++...... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+
T Consensus 139 ~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~-- 209 (304)
T 2jam_A 139 YLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ------KPYSKAVDCWSIGVITYILLCGYPPFYE-- 209 (304)
T ss_dssp ESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS------CSCCHHHHHHHHHHHHHHHHHSSCTTTT--
T ss_pred EecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc------CCCCchhhHHHHHHHHHHHHHCCCCCCC--
Confidence 9 67889999999998764432 2334679999999998853 3456677777777777777777666643
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.........+..
T Consensus 210 --------------------------------------------------------------------~~~~~~~~~i~~ 221 (304)
T 2jam_A 210 --------------------------------------------------------------------ETESKLFEKIKE 221 (304)
T ss_dssp --------------------------------------------------------------------SCHHHHHHHHHH
T ss_pred --------------------------------------------------------------------CCHHHHHHHHHc
Confidence 333344556666
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+.+.++.+.|..+|+++++||.+||..||++|||++|+|+||||+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp CCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 777777777888999999999999999999999999999999997653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=293.11 Aligned_cols=197 Identities=32% Similarity=0.595 Sum_probs=153.2
Q ss_pred ccccCCcEEEEecc----CCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEE----GDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+. .++..|+||||+.+|. |.+.+. +..+++.++.||+.||+|||++||+||||||+||
T Consensus 92 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVV-KLVEVLDDPNEDHLYMVFELVNQGP--VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBC-CEEEEEECSSSSEEEEEEECCTTCB--SCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-eEEEEEEcCCCCEEEEEEecCCCCc--HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 46799865 44432 2456799999999998 766543 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++....... .....+||+.|+|||++.... ...++.++|+||+||++|+|++|..||.+.+.
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR---KIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC---CCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC---CCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999998765433 234578999999999986421 01136778999999999999988888866544
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
......+ ...
T Consensus 246 ~~~~~~~----------------------------------------------------------------------~~~ 255 (298)
T 2zv2_A 246 MCLHSKI----------------------------------------------------------------------KSQ 255 (298)
T ss_dssp HHHHHHH----------------------------------------------------------------------HHC
T ss_pred HHHHHHH----------------------------------------------------------------------hcc
Confidence 3332222 222
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
...+ +....+++++++||.+||..||++|||+.|+|+||||+
T Consensus 256 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 256 ALEF--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cCCC--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 2222 22346889999999999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=297.04 Aligned_cols=224 Identities=25% Similarity=0.433 Sum_probs=161.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ +.++..++||||+.|+ |.+.+ .+..+++.++.||+.||+|||++||+||||||+||
T Consensus 56 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI 131 (324)
T 3mtl_A 56 DLKHANIV-TLHDIIHTEKSLTLVFEYLDKD---LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131 (324)
T ss_dssp CCCCTTBC-CEEEEEECSSCEEEEEECCSEE---HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred hcCCCCCC-eeeeEEeeCCEEEEEecccccC---HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence 46788865 5444 4556678999999864 44443 35588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++...... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.+.+.
T Consensus 132 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 132 LINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp EECTTCCEEECSSSEEECC------------CGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999765433 233456889999999998642 4578999999999999999999999999998
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+......+....|..... .+.... ...+.+.....
T Consensus 207 ~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~--------------------------~~~~~~~~~~~---------- 247 (324)
T 3mtl_A 207 EEQLHFIFRILGTPTEETWPGILS---NEEFKT--------------------------YNYPKYRAEAL---------- 247 (324)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGG---CHHHHH--------------------------TCCCCCCCCCH----------
T ss_pred HHHHHHHHHHhCCCChHhchhhhc---chhhcc--------------------------cccccccchhh----------
Confidence 888888776544444333322110 000000 00111111100
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+..+|++++|||++||+.||++|||++|+|+||||...
T Consensus 248 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 248 -----LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp -----HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred -----hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 01134679999999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=287.14 Aligned_cols=195 Identities=31% Similarity=0.553 Sum_probs=149.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+ +..+..++||||+.+|. |.+.+ .+...+..++.||+.||+|||++||+||||||
T Consensus 76 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp 152 (285)
T 3is5_A 76 SLDHPNII-KIFEVFEDYHNMYIVMETCEGGE--LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152 (285)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCSCCB--HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred hCCCchHH-hHHHheecCCeEEEEEEeCCCCc--HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH
Confidence 36798865 4444 44556799999999998 77765 35578999999999999999999999999999
Q ss_pred CcEEEe---cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 75 ENILLD---DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 75 ~NILl~---~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
+|||++ .++.+||+|||++............+||+.|+|||++.. .++.++|+||+||++|+|++|..||
T Consensus 153 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 153 ENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-------DVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp GGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-------CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-------CCCcccCeehHHHHHHHHHhCCCCC
Confidence 999994 457899999999987766555566789999999999853 4678999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+.......+....
T Consensus 226 ~~~~~~~~~~~~~~~~---------------------------------------------------------------- 241 (285)
T 3is5_A 226 TGTSLEEVQQKATYKE---------------------------------------------------------------- 241 (285)
T ss_dssp CCSSHHHHHHHHHHCC----------------------------------------------------------------
T ss_pred CCCCHHHHHhhhccCC----------------------------------------------------------------
Confidence 7766544433332211
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..+. .....+++++++||++||..||++|||+.|+|+||||+.
T Consensus 242 ------~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 242 ------PNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ------CCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ------cccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 1111 112346889999999999999999999999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.48 Aligned_cols=203 Identities=52% Similarity=0.986 Sum_probs=160.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+|++ .+.+ +.++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+||+++
T Consensus 82 ~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 82 GHPNII-QLKDTYETNTFFFLVFDLMKKGE--LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD 158 (298)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCEe-eeeeeeccCCeEEEEEeccCCCc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc
Confidence 488865 4443 45567899999999998 877763 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
.++.+||+|||++............+||+.|+|||++..........++.++|+||+||++|+|++|..||
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~--------- 229 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------- 229 (298)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS---------
T ss_pred CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC---------
Confidence 99999999999998776665566678999999999986432222233455556666555555555555555
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
...+.......+..+.+.+
T Consensus 230 -------------------------------------------------------------~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 230 -------------------------------------------------------------WHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp -------------------------------------------------------------CCSSHHHHHHHHHHTCCCC
T ss_pred -------------------------------------------------------------cCccHHHHHHHHhcCCccc
Confidence 4444445555666666677
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+.|..+|+++++||.+||..||++|||+.|+|+||||+...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 7777888999999999999999999999999999999998653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=302.81 Aligned_cols=234 Identities=24% Similarity=0.420 Sum_probs=153.2
Q ss_pred ccccCCcEEEEec--cCC------cHHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGD------DLKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~------~~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| .+.+ ... ...|+||||+.++ |.+.+ .+..+++.++.||+.||+|||++||+||||||
T Consensus 80 ~l~hpniv-~~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 80 CVNHKNII-GLLNVFTPQKSLEEFQDVYIVMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp HCCCTTBC-CEEEEECSCCSTTTCCEEEEEEECCSEE---HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred hcCCCCcc-ceEEeeccccccccccceEEEEEcCCCC---HHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 46798866 4443 111 2468999999876 44443 45688999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+|||++.++.+||+|||+|+...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.
T Consensus 156 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 156 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp GGEEECTTSCEEECCCCC----------------CTTCCHHHHTT------CCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC------CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999987765544556789999999999975 35788999999999999999999999999
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+.++....... .|+....- .-.+-......+.+........+...
T Consensus 230 ~~~~~~~~i~~~~~~~------------~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~- 279 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTP------------CPEFMKKL-----------------QPTVRTYVENRPKYAGYSFEKLFPDV- 279 (371)
T ss_dssp SHHHHHHHHHC-CCCC------------CHHHHTTS-----------------CHHHHHHHHSSCCCCCCCHHHHSCGG-
T ss_pred CHHHHHHHHHHHhCCC------------CHHHHHHh-----------------hhHHHHHHhhCccccccchhhhcccc-
Confidence 9888888887643221 12211100 00000111122222221111110000
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+......+...+++++|||++||+.||++|||++|+|+||||+.
T Consensus 280 --~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 280 --LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp --GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --cCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000000001123678999999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.86 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=157.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++.+ ..++..|+|||||.+|. |.+.+ .++..++.++.||+.||+|||++||+||||||+|
T Consensus 82 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 82 LFNHPNIV-PYRATFIADNELWVVTSFMAYGS--AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred hCCCCCCC-cEeEEEEECCEEEEEEEccCCCC--HHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 36798865 5544 44556799999999998 77765 3458899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc--------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE--------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
||++.++.+||+|||++....... .....+||+.|+|||++... ...|+.++||||+||++|+|++|.
T Consensus 159 Ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~el~~g~ 234 (389)
T 3gni_B 159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN----LQGYDAKSDIYSVGITACELANGH 234 (389)
T ss_dssp EEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT----SSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred EEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhcc----CCCCCcHhHHHHHHHHHHHHHHCC
Confidence 999999999999999886543221 11235789999999999752 245889999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+.+....+..+..+........ .. ...+.+... ...+....-+...+....+..
T Consensus 235 ~pf~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~------ 292 (389)
T 3gni_B 235 VPFKDMPATQMLLEKLNGTVPCLLDT----ST-IPAEELTMS-----------PSRSVANSGLSDSLTTSTPRP------ 292 (389)
T ss_dssp CTTTTCCSTTHHHHC-----------------------------------------------------------------
T ss_pred CCCCCCCHHHHHHHHhcCCCCccccc----cc-ccccccccc-----------ccccccccccccccccCcccc------
Confidence 99998877666666555433211000 00 000000000 000000000000000000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........+.+..+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 293 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 293 ------SNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ------ccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000011223456789999999999999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=293.40 Aligned_cols=224 Identities=27% Similarity=0.433 Sum_probs=169.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ +..+..++||||+.++ |.+.+. +..+++.++.|++.||+|||++||+||||||+||
T Consensus 68 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 143 (346)
T 1ua2_A 68 ELSHPNII-GLLDAFGHKSNISLVFDFMETD---LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143 (346)
T ss_dssp HCCCTTBC-CEEEEECCTTCCEEEEECCSEE---HHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred hCCCCCCC-eEEEEEeeCCceEEEEEcCCCC---HHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence 35788865 4443 4456678999999875 444443 3478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+++.+... ......+||+.|+|||++.+. ..|+.++|+||+||++|+|++|.+||.+.+.
T Consensus 144 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCC-----CCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999876533 234457899999999998642 3578899999999999999999999999998
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.++......+....|.+..... +.. .....++. . ..
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~--------------------~~~--------~~~~~~~~---~----~~----- 258 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLP--------------------DYV--------TFKSFPGI---P----LH----- 258 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSST--------------------TCC--------CCCCCCCC---C----HH-----
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCc--------------------ccc--------cccccCCC---C----hH-----
Confidence 88888887765544444443321100 000 00000000 0 00
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
..+..+|+++++||++||+.||++|||++|+|+||||+....
T Consensus 259 ------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 259 ------HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp ------HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ------HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 113567899999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=292.59 Aligned_cols=199 Identities=27% Similarity=0.526 Sum_probs=157.9
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|+|..+.. ...+..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||++
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGA--LTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCB--HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCC--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 4679986633332 34456789999999998 877764 4588999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||++....... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999998765432 2345789999999999864 3577899999999999999999999977655444
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...+.... +|
T Consensus 250 ~~~~~~~~---------------------------------------------------~~------------------- 259 (321)
T 2c30_A 250 MKRLRDSP---------------------------------------------------PP------------------- 259 (321)
T ss_dssp HHHHHHSS---------------------------------------------------CC-------------------
T ss_pred HHHHhcCC---------------------------------------------------CC-------------------
Confidence 44333211 00
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
....+..+|+++++||.+||..||++|||++|+|+||||....
T Consensus 260 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 260 -KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 0011235688999999999999999999999999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=302.98 Aligned_cols=226 Identities=29% Similarity=0.413 Sum_probs=159.6
Q ss_pred ccccCCcEEEEec------c--CCcHHHHHHHHHhhchhhHHhh------hCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE------E--GDDLKHLAAQVVDKGEAAVQDI------INSNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~--~~~~~~lv~e~~~~g~~~l~~~------~~~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|+|+| ++.+ + +....++||||+.++...+... -.+...++.++.||+.||+|||++||+|||
T Consensus 103 ~l~hpniv-~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 181 (420)
T 1j1b_A 103 KLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181 (420)
T ss_dssp TCCCTTBC-CEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred HcCCCCcc-ceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 46799866 4322 1 1123568999998764222221 134578999999999999999999999999
Q ss_pred CCCCcEEEecC-CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLDDQ-MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~~~-~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+|||++.+ +.+||+|||+|+.+.........+||+.|+|||++.+. ..|+.++||||+||++|+|++|++|
T Consensus 182 lkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCC-----CCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999965 56899999999877665555667899999999998642 4588999999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+..+.+.+|....... ..|.+.... ..|. -+ ..|-..... .
T Consensus 257 f~~~~~~~~l~~i~~~lg~p------------~~~~~~~~~----~~~~----~~------------~~p~~~~~~---~ 301 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTP------------TREQIREMN----PNYT----EF------------KFPQIKAHP---W 301 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSC------------CHHHHHHHC----SCCC----CC------------CCCCCCCCC---H
T ss_pred CCCCCHHHHHHHHHHHhCCC------------CHHHHHhhC----hhhh----hh------------ccCccCCCC---H
Confidence 99988887777776532111 011111000 0000 00 000000000 0
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+ + ...++++++|||++||++||++|||+.|+|+||||+..
T Consensus 302 ~~~------~----~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 302 TKV------F----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHH------S----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHh------c----CCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000 0 13568999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=295.61 Aligned_cols=219 Identities=25% Similarity=0.398 Sum_probs=155.6
Q ss_pred ccccCCcEEEEeccC----------CcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKEEG----------DDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~----------~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|+|++ .+.+.. .+..|+||||+.++. .+.+ .+..+++.++.||+.||+|||++||+|
T Consensus 72 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l---~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 147 (351)
T 3mi9_A 72 LLKHENVV-NLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147 (351)
T ss_dssp HCCCTTBC-CEEEEEEEC--------CEEEEEEECCSEEH---HHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hccCCCcc-cHhheeeccccccccCCceEEEEEeccCCCH---HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 36788865 444311 234579999998753 3332 345899999999999999999999999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccC-----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKG-----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
|||||+|||++.++.+||+|||+|..+... ......+||+.|+|||++.+. ..|+.++||||+||++|+|
T Consensus 148 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-----RDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-----CSCCTHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCC-----CCCCcHhHHHHHHHHHHHH
Confidence 999999999999999999999999866421 223456889999999998642 4578899999999999999
Q ss_pred HhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC--
Q psy3880 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-- 222 (408)
Q Consensus 145 l~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~-- 222 (408)
++|.+||.+.+....+..+.. +.|.+|..
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~-------------------------------------------------~~~~~~~~~~ 253 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQ-------------------------------------------------LCGSITPEVW 253 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHH-------------------------------------------------HHCCCCTTTS
T ss_pred HhCCCCCCCCChHHHHHHHHH-------------------------------------------------HhCCCChhhc
Confidence 999999987766554444321 12222211
Q ss_pred Cch-hHHHHHHHHhcCCCCCCCcCC---------CCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCC
Q psy3880 223 HRK-QMVMLRNIMEGKYSFSSPEWN---------DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287 (408)
Q Consensus 223 ~~~-~~~~~~~i~~~~~~f~~~~~~---------~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~ 287 (408)
... ..... ........... ..++++++||.+||+.||++|||++|+|+||||.....+.+
T Consensus 254 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 254 PNVDNYELY-----EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TTGGGCGGG-----TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred cccccchhh-----cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 000 00000 00000000000 13778999999999999999999999999999987655444
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.20 Aligned_cols=197 Identities=30% Similarity=0.532 Sum_probs=157.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
+.|+++| .+.+ +.++..|+||||+.||+ |.+.+ .++..++.++.||+.||+|||++||+||||||+
T Consensus 242 l~hp~Iv-~l~~~~~~~~~l~lVmE~~~gg~--L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~ 318 (543)
T 3c4z_A 242 VHSRFIV-SLAYAFETKTDLCLVMTIMNGGD--IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318 (543)
T ss_dssp CCCTTBC-CEEEEEECSSEEEEEECCCTTCB--HHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred cCCCCEe-eEEEEEeeCCEEEEEEEeccCCC--HHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence 5677755 5443 45567899999999999 77665 345889999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|||++.++.+||+|||+++.+..... ....+||+.|+|||++.+ ..|+.++|+||+||++|+|++|.+||.+.
T Consensus 319 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG------EEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred HEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC------CCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 99999999999999999987665433 234699999999999864 35778888888888888888888888543
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.. .....+...+.
T Consensus 393 ~~~------------------------------------------------------------------~~~~~~~~~i~ 406 (543)
T 3c4z_A 393 GEK------------------------------------------------------------------VENKELKQRVL 406 (543)
T ss_dssp TCC------------------------------------------------------------------CCHHHHHHHHH
T ss_pred ccc------------------------------------------------------------------hhHHHHHHHHh
Confidence 210 01223445566
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
.....++ ..+|+++++||++||+.||++||+ ++|+++||||+..
T Consensus 407 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 407 EQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred hcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 6655554 368999999999999999999996 5899999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=296.72 Aligned_cols=209 Identities=25% Similarity=0.365 Sum_probs=153.3
Q ss_pred HHHHHHHHHhhchhh-HHhh-----hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe-cCCCEEEeccccchh
Q psy3880 23 LKHLAAQVVDKGEAA-VQDI-----INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARV 95 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~-l~~~-----~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~-~~~~iKl~DFGla~~ 95 (408)
..++||||+.|+... +.+. ..+...++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 191 (383)
T 3eb0_A 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191 (383)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcc
Confidence 367999999975211 2221 134578999999999999999999999999999999998 678999999999988
Q ss_pred cccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCC
Q psy3880 96 LKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175 (408)
Q Consensus 96 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 175 (408)
+.........+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.+.+..+.+..+......+.
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~---- 262 (383)
T 3eb0_A 192 LIPSEPSVAYICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT---- 262 (383)
T ss_dssp CCTTSCCCCCCCCSSCCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC----
T ss_pred cCCCCCCcCcccCCCccCHHHhcCC-----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC----
Confidence 7666666678899999999998642 4578999999999999999999999999988888887765332211
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
+|.+..... .|.. -..|-..... ...+ + ...+|++++||
T Consensus 263 --------~~~~~~~~~----~~~~----------------~~~~~~~~~~---~~~~------~----~~~~~~~~~~l 301 (383)
T 3eb0_A 263 --------KEQMIRMNP----HYTE----------------VRFPTLKAKD---WRKI------L----PEGTPSLAIDL 301 (383)
T ss_dssp --------HHHHHHHCT----TC------------------CCCCCCCCCC---HHHH------S----CTTCCHHHHHH
T ss_pred --------HHHHHHhCc----cccc----------------ccCCccCccc---HHhh------C----CCCCCHHHHHH
Confidence 111110000 0000 0000000000 0000 0 12478899999
Q ss_pred HHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 256 IRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 256 I~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
|++||+.||++|||+.|+|+||||+.
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHH
Confidence 99999999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.64 Aligned_cols=220 Identities=24% Similarity=0.433 Sum_probs=150.7
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+. .....|+|+|++ ++. |.+.+. +...++.++.||+.||+|||++||+|||||
T Consensus 84 ~l~hpnIv-~~~~~~~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 159 (367)
T 2fst_X 84 HMKHENVI-GLLDVFTPARSLEEFNDVYLVTHLM-GAD--LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159 (367)
T ss_dssp HCCCTTBC-CCSEEECSCSSGGGCCCCEEEEECC-CEE--CC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hCCCCCCC-cEEEEEecCCccccCCeEEEEeccc-CCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 36788855 44431 123468999998 565 665553 458899999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||++.++.+||+|||+|+.... .....+||+.|+|||++.+. ..|+.++||||+||++|+|++|..||.+
T Consensus 160 p~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 160 PSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp GGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTC-----CSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HhhEEECCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCC-----cCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987543 23457899999999998642 4578999999999999999999999999
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..|......+. +|.+..- .. ......
T Consensus 233 ~~~~~~l~~i~~~~g~p~------------~~~~~~~--------------------------------~~---~~~~~~ 265 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPG------------AELLKKI--------------------------------SS---ESARNY 265 (367)
T ss_dssp SSHHHHHHHHHHHHCSCC------------HHHHTTC--------------------------------CC---HHHHHH
T ss_pred CCHHHHHHHHHHHhCCCC------------HHHHHHh--------------------------------hh---HHHHHH
Confidence 998888888766432221 1111000 00 000011
Q ss_pred HhcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 234 MEGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 234 ~~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.......+. ..+..++++++|||++||++||++|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 111001111 11346789999999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=292.61 Aligned_cols=201 Identities=36% Similarity=0.715 Sum_probs=154.6
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++ .+.+ ..++..|+||||+.+|. |.+.+. ++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 71 ~l~h~~i~-~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 147 (322)
T 2ycf_A 71 KLNHPCII-KIKNFFDAEDYYIVLELMEGGE--LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147 (322)
T ss_dssp HCCCTTBC-CEEEEEESSSEEEEEECCTTEE--THHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCCc-eEeeEEcCCceEEEEecCCCCc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 35799866 4433 22233789999999998 877764 457899999999999999999999999999999999
Q ss_pred ecCCC---EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQMN---VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~---iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+.++. +||+|||++............+||+.|+|||++... ....++.++|+||+||++|+|++|..||.....
T Consensus 148 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV---GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT---TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC---CCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 87654 999999999876654444456899999999998531 124577889999999999999999988854322
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
... +...+..+
T Consensus 225 ~~~---------------------------------------------------------------------~~~~~~~~ 235 (322)
T 2ycf_A 225 QVS---------------------------------------------------------------------LKDQITSG 235 (322)
T ss_dssp SSC---------------------------------------------------------------------HHHHHHHT
T ss_pred HHH---------------------------------------------------------------------HHHHHHhC
Confidence 100 11122233
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+.+....|..+|+++++||.+||..||++|||++|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 333333345678999999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=286.87 Aligned_cols=224 Identities=20% Similarity=0.371 Sum_probs=158.7
Q ss_pred cCCcEEEEecc----CCcHHHHHHHHHhhchhhHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC
Q psy3880 9 HSRVVVRVKEE----GDDLKHLAAQVVDKGEAAVQDII--NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ 82 (408)
Q Consensus 9 ~~~~i~~~~~~----~~~~~~lv~e~~~~g~~~l~~~~--~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~ 82 (408)
|+|++ .+.+. .....++||||+.+|. |.+.+ .+..+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~ 166 (330)
T 3nsz_A 90 GPNII-TLADIVKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166 (330)
T ss_dssp STTBC-CEEEEEECTTTCCEEEEEECCCCCC--HHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCCEE-EeeeeeccCCCCceEEEEeccCchh--HHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC
Confidence 77755 44432 2445689999999998 66655 4568899999999999999999999999999999999977
Q ss_pred C-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc-hhHHHH
Q psy3880 83 M-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR-KQMVML 160 (408)
Q Consensus 83 ~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~-~~~~~~ 160 (408)
+ .+||+|||+|+...........+||+.|+|||++... ..++.++||||+||++|+|++|..||... +....+
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l 241 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY-----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241 (330)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred CCEEEEEeCCCceEcCCCCccccccccccccChhhhcCC-----CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH
Confidence 6 8999999999877666666677899999999998642 45788999999999999999999999543 333444
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC--
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY-- 238 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~-- 238 (408)
..+..... ++.+... +.....++.. . +..+.....
T Consensus 242 ~~~~~~~~---------------~~~~~~~-----------------------~~~~~~~~~~-~----~~~~~~~~~~~ 278 (330)
T 3nsz_A 242 VRIAKVLG---------------TEDLYDY-----------------------IDKYNIELDP-R----FNDILGRHSRK 278 (330)
T ss_dssp HHHHHHHC---------------HHHHHHH-----------------------HHHTTCCCCT-H----HHHHHCCCCCC
T ss_pred HHHHHhcC---------------CchhhhH-----------------------HHHhcccccc-c----hhhhhhhcccc
Confidence 43332110 0000000 0000000000 0 000000000
Q ss_pred ----CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 ----SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ----~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.+....+..+|+++++||++||..||++|||++|+|+||||+...
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 279 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred chhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 011222345899999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=296.91 Aligned_cols=145 Identities=28% Similarity=0.432 Sum_probs=119.2
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+.|+|+| .+.+ ...+..++|||++ +|. |.+.+ .+..+++.++.||+.||+|||++||+||||||+||
T Consensus 93 ~~h~~iv-~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 168 (360)
T 3llt_A 93 INNNNIV-KYHGKFMYYDHMCLIFEPL-GPS--LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENI 168 (360)
T ss_dssp TTGGGBC-CEEEEEEETTEEEEEECCC-CCB--HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCCCCee-cccceeeECCeeEEEEcCC-CCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccE
Confidence 4588755 5544 3456678999999 777 77765 34588999999999999999999999999999999
Q ss_pred EEec-------------------------CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcch
Q psy3880 78 LLDD-------------------------QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAV 132 (408)
Q Consensus 78 Ll~~-------------------------~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~ 132 (408)
|++. ++.+||+|||+|..... .....+||+.|+|||++.+ ..|+.++
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~ 240 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN------LGWDVSS 240 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT------CCCCTTH
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC------CCCCCcc
Confidence 9975 78899999999976443 2345789999999999975 3578999
Q ss_pred hhhhhhHHHHHHHhCCCCCCCchhHHHHHHH
Q psy3880 133 DVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163 (408)
Q Consensus 133 DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i 163 (408)
||||+||++|+|++|..||.+.+..+.+..+
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 9999999999999999999887766555544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.00 Aligned_cols=239 Identities=26% Similarity=0.376 Sum_probs=158.9
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
..|+|++ .+.+ +..+..++||||+.++ |.+.+ .+...++.++.||+.||+|||++|||||||||+||
T Consensus 156 ~~~~~iv-~~~~~~~~~~~~~lv~e~~~~~---L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI 231 (429)
T 3kvw_A 156 DNTMNVI-HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231 (429)
T ss_dssp TSCSCBC-CEEEEEEETTEEEEEECCCCCB---HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGE
T ss_pred cCCcCEE-EEEeecccCCeEEEEEeccCCC---HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 3566755 5444 3445678999999754 55544 35578999999999999999999999999999999
Q ss_pred EEecCCC--EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDDQMN--VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~~~~--iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++.++. +||+|||+|..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+
T Consensus 232 Ll~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 232 LLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILG------ARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHT------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhC------CCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9998887 99999999975433 3446789999999999975 357899999999999999999999999999
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhh----cccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRAN----MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~----~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
..+.+..+......+ .++.+... .+.+..++...+..-. +..+...+.....
T Consensus 304 ~~~~l~~i~~~~~~p------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~----- 359 (429)
T 3kvw_A 304 EGDQLACMIELLGMP------------SQKLLDASKRAKNFVSSKGYPRYCTVTT-------LSDGSVVLNGGRS----- 359 (429)
T ss_dssp HHHHHHHHHHHHCCC------------CHHHHHTBTTHHHHBCTTSCBTTSCEEC-------CCC--CEECCEEC-----
T ss_pred HHHHHHHHHHHcCCC------------CHHHHHhhhhhhhccCCCCCcccccccc-------ccccccccccccc-----
Confidence 888888776532211 11111100 0000000100000000 0000000000000
Q ss_pred HHHhcCC--CCCCCcC-----CCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 232 NIMEGKY--SFSSPEW-----NDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 232 ~i~~~~~--~f~~~~~-----~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+.. ......| ...+++++|||++||++||++|||++|+|+||||+...
T Consensus 360 --~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 360 --RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp --TTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred --chhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 00000 0001111 23578899999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.99 Aligned_cols=225 Identities=28% Similarity=0.455 Sum_probs=157.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.+|. |.+.+ .+...++.++.|++.||+|||++||+||||||+|||
T Consensus 58 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil 134 (311)
T 4agu_A 58 QLKHPNLV-NLLEVFRRKRRLHLVFEYCDHTV--LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENIL 134 (311)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCSEEH--HHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCcc-chhheeecCCeEEEEEEeCCCch--HHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEE
Confidence 36788865 4443 34456789999999997 65554 345889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++...... ......+||+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 135 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 135 ITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD-----TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp ECTTSCEEECCCTTCEECC------------GGGCCHHHHHTC-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999876533 233456899999999998642 45788999999999999999999999998877
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCC-CchhHHHHHHHHh
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFW-HRKQMVMLRNIME 235 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~-~~~~~~~~~~i~~ 235 (408)
+.+..+....... .|+.... +.. .-| ..+ ..|-. .....
T Consensus 210 ~~~~~~~~~~~~~------------~~~~~~~--~~~--------~~~---------~~~~~~~~~~~~~~~-------- 250 (311)
T 4agu_A 210 DQLYLIRKTLGDL------------IPRHQQV--FST--------NQY---------FSGVKIPDPEDMEPL-------- 250 (311)
T ss_dssp HHHHHHHHHHCSC------------CHHHHHH--HHT--------CGG---------GTTCCCCCCSSCCCH--------
T ss_pred HHHHHHHHHhccc------------ccccccc--ccc--------ccc---------cccCcCCCccccchh--------
Confidence 7666654422111 0110000 000 000 000 00000 00000
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
...+..+|+++.+||++||..||++|||++|+|+||||+...
T Consensus 251 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 251 ------ELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp ------HHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ------hhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 011346899999999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=288.23 Aligned_cols=188 Identities=24% Similarity=0.357 Sum_probs=144.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|+|+| ++.+ +.++..++||||+. |. |.+.+ .+...+..++.||+.||+|||++||+||||||+|||+
T Consensus 115 ~h~~iv-~l~~~~~~~~~~~lv~e~~~-~~--L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 115 QHPCCV-RLEQAWEEGGILYLQTELCG-PS--LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp CCTTBC-CEEEEEEETTEEEEEEECCC-CB--HHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCcEE-EEEEEEEeCCEEEEEEeccC-CC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 688755 5443 34556789999994 44 55543 3568899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
+.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+......
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~ 263 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263 (311)
T ss_dssp CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-------CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH
T ss_pred CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-------CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 9999999999999987765554556789999999998853 478899999999999999999777655332111
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
+.. +..|
T Consensus 264 ---~~~---------------------------------------------------~~~~------------------- 270 (311)
T 3p1a_A 264 ---LRQ---------------------------------------------------GYLP------------------- 270 (311)
T ss_dssp ---HTT---------------------------------------------------TCCC-------------------
T ss_pred ---Hhc---------------------------------------------------cCCC-------------------
Confidence 110 0000
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...+..+|+++++||.+||..||++|||++|+|+||||+.
T Consensus 271 --~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 --PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0112357899999999999999999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=294.72 Aligned_cols=225 Identities=26% Similarity=0.447 Sum_probs=161.3
Q ss_pred ccccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+. .....|+|||++.| . |.+.+ .+..+++.++.||+.||+|||++||+||||||
T Consensus 81 ~l~h~niv-~~~~~~~~~~~~~~~~~~iv~e~~~~-~--L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 156 (364)
T 3qyz_A 81 RFRHENII-GINDIIRAPTIEQMKDVYIVQDLMET-D--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP 156 (364)
T ss_dssp HCCCTTBC-CCCEEECCSSTTTCCCEEEEEECCSE-E--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hcCCCCCc-cceeEEecCCccccceEEEEEcccCc-C--HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh
Confidence 36788855 44331 11346899999986 4 55554 35688999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|||++.++.+||+|||++........ ....+||+.|+|||++... ..++.++||||+||++|+|++|..|
T Consensus 157 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~p 231 (364)
T 3qyz_A 157 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-----KGYTKSIDIWSVGCILAEMLSNRPI 231 (364)
T ss_dssp GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB-----CSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred HhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCC-----CCCCcchhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999987654322 2446899999999998642 4578999999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+..+.+..+......+. ++.+... .....--+.. . .|......
T Consensus 232 f~~~~~~~~~~~i~~~~~~~~------------~~~~~~~--------------~~~~~~~~~~--~-~~~~~~~~---- 278 (364)
T 3qyz_A 232 FPGKHYLDQLNHILGILGSPS------------QEDLNCI--------------INLKARNYLL--S-LPHKNKVP---- 278 (364)
T ss_dssp SCCSSGGGHHHHHHHHHCSCC------------HHHHHTC--------------CCHHHHHHHH--T-SCCCCCCC----
T ss_pred CCCCChHHHHHHHHHHhCCCC------------HHHHHHh--------------hhhhHHHHHH--h-cCCccCCC----
Confidence 999888777777765322211 1111000 0000000000 0 00000000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....+..+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 279 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 279 ----------WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp ----------HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred ----------HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 001124678999999999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.45 Aligned_cols=197 Identities=23% Similarity=0.430 Sum_probs=138.7
Q ss_pred cCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 9 HSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 9 ~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
|+| |+++.+ ..++..|+||| +.+|+ |.+++. +..+++.++.||+.||+|||++||+||||||+|||++
T Consensus 115 ~~~-iv~~~~~~~~~~~~~lv~E-~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~- 189 (390)
T 2zmd_A 115 SDK-IIRLYDYEITDQYIYMVME-CGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV- 189 (390)
T ss_dssp CTT-BCCEEEEEECSSEEEEEEE-CCSEE--HHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-
T ss_pred CCe-EEEEEEEEecCCEEEEEEe-cCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-
Confidence 355 556663 45667899999 66777 777663 4468899999999999999999999999999999995
Q ss_pred CCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhcccc-----CcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 82 QMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFE-----DATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 82 ~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~-----~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
++.+||+|||+|+.+.... .....+||+.|+|||++...... ....|+.++|||||||++|+|++|..||
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf-- 267 (390)
T 2zmd_A 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-- 267 (390)
T ss_dssp SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT--
T ss_pred CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc--
Confidence 5889999999998765432 12357899999999998642100 0123455556665555555555555555
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc-hhHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR-KQMVMLRN 232 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~-~~~~~~~~ 232 (408)
... .....+..
T Consensus 268 --------------------------------------------------------------------~~~~~~~~~~~~ 279 (390)
T 2zmd_A 268 --------------------------------------------------------------------QQIINQISKLHA 279 (390)
T ss_dssp --------------------------------------------------------------------TTCCCHHHHHHH
T ss_pred --------------------------------------------------------------------hhhhHHHHHHHH
Confidence 332 12233444
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+......+..+. ..++++++||.+||..||++|||+.|+|+||||+..
T Consensus 280 ~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 280 IIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HhCccccCCCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 554444443333 347889999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=283.56 Aligned_cols=220 Identities=30% Similarity=0.450 Sum_probs=164.7
Q ss_pred cccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
+.|+|++ ++.+. .....++|||++.| . |.+.+ .+..++..++.||+.||+|||++||+||||
T Consensus 71 ~~h~~i~-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 71 FEHPNVV-RLFDVCTVSRTDRETKLTLVFEHVDQ-D--LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp TCCTTBC-CEEEEEEEEECSSEEEEEEEEECCSC-B--HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred cCCCCeE-eeeeeeeecccCCCceEEEEEecCCC-C--HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 3788865 44331 34567899999985 4 55544 356889999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
||+|||++.++.+||+|||++............+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ------SSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhc------CCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999987765555556789999999999864 347889999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+....+.++...........|..... .|. . .|..
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~-----------------~----------------~~~~--------- 256 (326)
T 1blx_A 221 GSSDVDQLGKILDVIGLPGEEDWPRDVA--LPR-----------------Q----------------AFHS--------- 256 (326)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCS--SCG-----------------G----------------GSCC---------
T ss_pred CCCHHHHHHHHHHHcCCCCcccCccccc--cch-----------------h----------------hhcc---------
Confidence 9888888777765432222222211000 000 0 0000
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.........+..+++++++||.+||..||++|||+.|+|+||||+...
T Consensus 257 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 257 ---KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp ---CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ---cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000000112356899999999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.42 Aligned_cols=197 Identities=31% Similarity=0.613 Sum_probs=151.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ...+..++||||+.+|. |.+.+ .+..++..++.||+.||.|||++||+||||||+||+
T Consensus 64 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 140 (283)
T 3bhy_A 64 EIRHPNII-TLHDIFENKTDVVLILELVSGGE--LFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140 (283)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCCCee-ehhheecCCCeEEEEEeecCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEE
Confidence 36788865 4443 44566799999999998 87776 355889999999999999999999999999999999
Q ss_pred EecCC----CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQM----NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~----~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++ .+||+|||++.............||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.
T Consensus 141 ~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY------EPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp ESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC------CCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 98776 799999999987765555556789999999999864 34667788888888888888887777554
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+... ....+.
T Consensus 215 ~~~~----------------------------------------------------------------------~~~~~~ 224 (283)
T 3bhy_A 215 TKQE----------------------------------------------------------------------TLTNIS 224 (283)
T ss_dssp SHHH----------------------------------------------------------------------HHHHHH
T ss_pred chHH----------------------------------------------------------------------HHHHhH
Confidence 4332 333333
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...+.++...+..+++++++||.+||..||++|||+.|+|+||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 44444443445678999999999999999999999999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=289.11 Aligned_cols=223 Identities=23% Similarity=0.362 Sum_probs=153.1
Q ss_pred ccccCCcEEEEec-------cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKE-------EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~-------~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|+|++ .+.+ ......|+||||+.|+ |.+.+ .+...++.++.||+.||+|||++||+||||
T Consensus 85 ~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 160 (362)
T 3pg1_A 85 HFHHPNIL-GLRDIFVHFEEPAMHKLYLVTELMRTD---LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDL 160 (362)
T ss_dssp HCCCTTBC-CCSEEEEECCTTTCCEEEEEEECCSEE---HHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hCCCcCcc-ceeeeEEeccCCCcceEEEEEccCCCC---HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCC
Confidence 35788865 4432 2223568999999865 44443 345889999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
||+|||++.++.+||+|||++............+||+.|+|||++... ..++.++|+||+||++|+|++|..||.
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQF-----KGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTC-----TTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCC-----CCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999866555555567899999999998642 457899999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+....+..+......+..+.+ ..+..+.. ...
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~-------------------------------------------~~~ 269 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDV---VMFSSPSA-------------------------------------------RDY 269 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHH---HHTSCHHH-------------------------------------------HHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHh---hhccchhh-------------------------------------------hHH
Confidence 99888877777653322110000 00000000 000
Q ss_pred HHhcCCCCCCCc----CCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 233 IMEGKYSFSSPE----WNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 233 i~~~~~~f~~~~----~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+.......+... ....++++++||.+||..||++|||++|+|+||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp TTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 000000111111 135688999999999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.53 Aligned_cols=223 Identities=26% Similarity=0.415 Sum_probs=157.0
Q ss_pred ccccCCcEEEEec--cCCcH------HHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDL------KHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~------~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| .+.+ ...+. .|+||||+.+. |.+.+ .+..+++.++.||+.||+|||++||+||||||
T Consensus 97 ~l~h~niv-~~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 172 (371)
T 4exu_A 97 HMQHENVI-GLLDVFTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 172 (371)
T ss_dssp HCCCTTBC-CCSEEECSCSSSTTCCCCEEEEECCCEE---HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred hcCCCCch-hhhhheeccCCcccceeEEEEEcccccc---HHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCH
Confidence 35788855 4443 22222 28999999854 55554 35689999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+|||++.++.+||+|||+++..... ....+||+.|+|||++... ..++.++|+||+||++|+|++|..||.+.
T Consensus 173 ~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 173 GNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSW-----MHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp GGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCC-----SCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCC-----CCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999865432 3457899999999998642 45788999999999999999999999999
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+.++........ ++....- ...........+.
T Consensus 246 ~~~~~~~~i~~~~~~~~------------~~~~~~~-------------------------------~~~~~~~~~~~~~ 282 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPG------------TEFVQKL-------------------------------NDKAAKSYIQSLP 282 (371)
T ss_dssp SHHHHHHHHHHHHCCCC------------HHHHTTC-------------------------------SCHHHHHHHHHSC
T ss_pred ChHHHHHHHHHHhCCCc------------HHHHHHh-------------------------------hhhhhhhhhhccC
Confidence 88888777765322111 1110000 0000000000000
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....-....+..+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000000001234679999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=287.82 Aligned_cols=196 Identities=27% Similarity=0.445 Sum_probs=154.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ ..++..++||||+.|+ +.+.+ .+..++..++.|++.||+|||++||+||||||+||
T Consensus 110 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~g~---l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 110 KLRHPNTI-QYRGCYLREHTAWLVMEYCLGS---ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCSEE---HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred hCCCCCEe-eEEEEEEECCeEEEEEecCCCC---HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 36799865 4443 3456678999999865 33333 35688999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++...... ...+||+.|+|||++... ....|+.++||||+||++|+|++|..||.+.+..
T Consensus 186 ll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 259 (348)
T 1u5q_A 186 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259 (348)
T ss_dssp EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTT---SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccc---cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999999766432 356899999999998632 1245788999999999999999999999776655
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+..+..+. .|
T Consensus 260 ~~~~~~~~~~---------------------------------------------------~~----------------- 271 (348)
T 1u5q_A 260 SALYHIAQNE---------------------------------------------------SP----------------- 271 (348)
T ss_dssp HHHHHHHHSC---------------------------------------------------CC-----------------
T ss_pred HHHHHHHhcC---------------------------------------------------CC-----------------
Confidence 4444433221 00
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.. ....+|+++++||.+||..||++|||++|+|+||||....
T Consensus 272 -~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 272 -AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp -CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred -CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 00 1124688899999999999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=286.77 Aligned_cols=189 Identities=30% Similarity=0.542 Sum_probs=151.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhc-hhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKG-EAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g-~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ +.++..++|||++.+| + |.+.+. ++..++.++.||+.||+|||++||+||||||+||
T Consensus 85 ~l~h~~Iv-~~~~~~~~~~~~~lv~e~~~~g~~--l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 161 (335)
T 3dls_A 85 RVEHANII-KVLDIFENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENI 161 (335)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTSCB--HHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCEe-eEEEEEeeCCEEEEEEEeCCCCcc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHE
Confidence 36788865 5444 4556778999998777 6 776653 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++............+||+.|+|||++... ..++.++||||+||++|+|++|..||......
T Consensus 162 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 236 (335)
T 3dls_A 162 VIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN-----PYRGPELEMWSLGVTLYTLVFEENPFCELEET 236 (335)
T ss_dssp EECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTC-----CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred EEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCC-----CCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence 9999999999999999887766655668899999999998753 22367899999999999999999998542110
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
....
T Consensus 237 ----------------------------------------------------------------------------~~~~ 240 (335)
T 3dls_A 237 ----------------------------------------------------------------------------VEAA 240 (335)
T ss_dssp ----------------------------------------------------------------------------TTTC
T ss_pred ----------------------------------------------------------------------------Hhhc
Confidence 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. .....+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 241 ~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 241 I----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred c----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 0012468899999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=289.92 Aligned_cols=198 Identities=32% Similarity=0.572 Sum_probs=151.1
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|++ |+.+.+ +.++..|+||||+.+|. |.+.+. +..+++.++.||+.||.|||++||+||||||+|||++
T Consensus 117 ~h~~-iv~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 117 QSPF-LVTLHYAFQTETKLHLILDYINGGE--LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193 (355)
T ss_dssp TCTT-BCCEEEEEEETTEEEEEECCCCSCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CCCc-eeEEEEEEeeCceEEEEeecCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 4666 445544 44556789999999998 877763 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
.++.+||+|||+++.+.... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.......
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCC----CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 99999999999998654322 23346899999999998742 2346788999999999999999999985432110
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+...+.....
T Consensus 270 ------------------------------------------------------------------~~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 270 ------------------------------------------------------------------SQAEISRRILKSEP 283 (355)
T ss_dssp ------------------------------------------------------------------CHHHHHHHHHHCCC
T ss_pred ------------------------------------------------------------------hHHHHHHHHhccCC
Confidence 01111222222222
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.+ ...+++.+++||.+||..||++|| |++|+++||||+..
T Consensus 284 ~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 284 PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 22 235789999999999999999999 99999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=286.97 Aligned_cols=229 Identities=27% Similarity=0.401 Sum_probs=162.0
Q ss_pred cccCCcEEEEecc---------CCcHHHHHHHHHhhchhh-HHhhh-----CCHHHHHHHHHHHHHHHHHHH--HCCCee
Q psy3880 7 VAHSRVVVRVKEE---------GDDLKHLAAQVVDKGEAA-VQDII-----NSNPALRYIMRQLFEALEHVH--NHSVVH 69 (408)
Q Consensus 7 ~~~~~~i~~~~~~---------~~~~~~lv~e~~~~g~~~-l~~~~-----~~~~~~r~i~~qil~aL~~LH--~~~IvH 69 (408)
+.|+|+| .+.+. .+...++||||+.++... +...+ .+...++.++.|++.||.||| ++||+|
T Consensus 76 l~h~niv-~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH 154 (360)
T 3e3p_A 76 LHHPNIV-QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154 (360)
T ss_dssp HCCTTBC-CEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBC
T ss_pred cCCCCcc-cHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeec
Confidence 5788866 44321 112367999999987411 22221 244788999999999999999 999999
Q ss_pred ccCCCCcEEEec-CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 70 RDLKPENILLDD-QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 70 RDLKp~NILl~~-~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
|||||+|||++. ++.+||+|||++..+.........+||+.|+|||++.+. ..++.++||||+||++|+|++|.
T Consensus 155 ~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCC-----CCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999996 899999999999887766555667899999999998642 34789999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+.+....+..+....... .++.+..-.- .....+.+. ....|+
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~-----~~~~~~~~~---------~~~~~~------- 276 (360)
T 3e3p_A 230 PIFRGDNSAGQLHEIVRVLGCP------------SREVLRKLNP-----SHTDVDLYN---------SKGIPW------- 276 (360)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCC------------CHHHHHHHCT-----TCCCGGGGC---------CCCCCH-------
T ss_pred CCcCCCChHHHHHHHHHHcCCC------------CHHHHHhccc-----chhhccccc---------cccCCc-------
Confidence 9999998888887776543221 1111111000 000000000 000000
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+ +. ......|+++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 277 --~~~------~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 277 --SNV------FS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp --HHH------TT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred --ccc------cc-hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 00 11124678999999999999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=276.31 Aligned_cols=194 Identities=29% Similarity=0.530 Sum_probs=153.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+|||
T Consensus 65 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 65 HLRHPNIL-RLYGYFHDATRVYLILEYAPLGT--VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred cCCCCCCc-chhheEecCCEEEEEEecCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 46798865 4443 44566799999999998 777653 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++...... .....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||...+...
T Consensus 142 i~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 142 LGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEG------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhcc------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 999999999999998654432 2345689999999999864 346789999999999999999999997665544
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+.. ...
T Consensus 215 ~~~~~~~----------------------------------------------------------------------~~~ 224 (279)
T 3fdn_A 215 TYKRISR----------------------------------------------------------------------VEF 224 (279)
T ss_dssp HHHHHHH----------------------------------------------------------------------TCC
T ss_pred HHHHHHh----------------------------------------------------------------------CCC
Confidence 4444332 222
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.++ ..+++++++||.+||..||++|||++|+|+||||+...
T Consensus 225 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 221 24688999999999999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=285.12 Aligned_cols=223 Identities=25% Similarity=0.465 Sum_probs=159.1
Q ss_pred ccccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ ++.+. .....|+||||+.+ . |.+.+ .+..+++.++.||+.||+|||++||+||||||
T Consensus 65 ~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp 140 (353)
T 2b9h_A 65 HFKHENII-TIFNIQRPDSFENFNEVYIIQELMQT-D--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKP 140 (353)
T ss_dssp HCCCTTBC-CEEEECCCSCSTTCCCEEEEECCCSE-E--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred hCcCCCcC-CeeeeecccccCccceEEEEEeccCc-c--HHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 35788866 44431 12456899999985 3 55544 45689999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc-----------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE-----------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
+|||++.++.+||+|||++....... .....+||+.|+|||++... ..++.++|+||+||++|+
T Consensus 141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~ 215 (353)
T 2b9h_A 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAE 215 (353)
T ss_dssp GGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSC-----CCCCHHHHHHHHHHHHHH
T ss_pred HHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccC-----CCccchhhHHHHHHHHHH
Confidence 99999999999999999998654321 12235789999999988642 457889999999999999
Q ss_pred HHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 144 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 144 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
|++|..||.+.+....+..+......+..... ......+
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--------------------------------------- 254 (353)
T 2b9h_A 216 LFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND--LRCIESP--------------------------------------- 254 (353)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT--TTTCCCH---------------------------------------
T ss_pred HHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc--ccccccc---------------------------------------
Confidence 99999999998877666665442211111000 0000000
Q ss_pred chhHHHHHHHHhcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 224 RKQMVMLRNIMEGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
...........++. ..+..+|+++++||.+||..||++|||++|+|+||||+...
T Consensus 255 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 255 -----RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp -----HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred -----hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00011111111111 12356899999999999999999999999999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=285.59 Aligned_cols=175 Identities=24% Similarity=0.455 Sum_probs=135.0
Q ss_pred HHHHHHHHhhchhhHHhhhCC--------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 24 KHLAAQVVDKGEAAVQDIINS--------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~~~--------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
.++|||||.||. |.+.+.. ...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 136 ~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 136 LYIQMQLCRKEN--LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213 (332)
T ss_dssp EEEEEECCCSSC--HHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCC--HHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccc
Confidence 579999999998 8887643 245889999999999999999999999999999999999999999999987
Q ss_pred cccCc-------------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHH
Q psy3880 96 LKKGE-------------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162 (408)
Q Consensus 96 ~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~ 162 (408)
..... .....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..|+... ......
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~ 285 (332)
T 3qd2_B 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG------NNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITD 285 (332)
T ss_dssp CSCC--------------CCCSCC-CGGGSCHHHHHC------CCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHH
T ss_pred cccchhhccccccccccccccccCCCcCccChHHhcC------CCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHH
Confidence 65432 1234679999999999874 35778899999999999999886654211 111111
Q ss_pred HHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCC
Q psy3880 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSS 242 (408)
Q Consensus 163 i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~ 242 (408)
+ ..... .
T Consensus 286 ~----------------------------------------------------------------------~~~~~---~ 292 (332)
T 3qd2_B 286 V----------------------------------------------------------------------RNLKF---P 292 (332)
T ss_dssp H----------------------------------------------------------------------HTTCC---C
T ss_pred h----------------------------------------------------------------------hccCC---C
Confidence 1 11100 0
Q ss_pred CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 243 PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 243 ~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..+...++++++||.+||..||++|||++|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 111234678899999999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.54 Aligned_cols=205 Identities=28% Similarity=0.483 Sum_probs=151.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------------CCHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------------NSNPALRYIMRQLFEALEHVHNHSVVHR 70 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------------~~~~~~r~i~~qil~aL~~LH~~~IvHR 70 (408)
.+.|+|++ ++.+ ..++..++||||+.||. |.+.+ .+...+..++.||+.||.|||++||+||
T Consensus 69 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 145 (303)
T 2vwi_A 69 QCHHPNIV-SYYTSFVVKDELWLVMKLLSGGS--VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145 (303)
T ss_dssp CCCCTTBC-CEEEEEESSSCEEEEEECCTTCB--HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred hcCCCCEe-eEEEEEeecCCcEEEehhccCCc--hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 46788865 4443 44566789999999998 77665 3568899999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeccccchhcccCc------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 71 DLKPENILLDDQMNVKLTDFGFARVLKKGE------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 71 DLKp~NILl~~~~~iKl~DFGla~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
||||+|||++.++.+||+|||++....... ......||+.|+|||++... ..++.++|+||+||++|+|
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l 220 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-----RGYDFKADIWSFGITAIEL 220 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH-----HCCCTHHHHHHHHHHHHHH
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-----cCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999997764322 12346799999999998642 3468899999999999999
Q ss_pred HhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 145 l~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
++|..||.+.+..........+ .+|....
T Consensus 221 ~~g~~pf~~~~~~~~~~~~~~~---------------------------------------------------~~~~~~~ 249 (303)
T 2vwi_A 221 ATGAAPYHKYPPMKVLMLTLQN---------------------------------------------------DPPSLET 249 (303)
T ss_dssp HHSSCTTTTSCGGGHHHHHHTS---------------------------------------------------SCCCTTC
T ss_pred HhCCCCCccCchhhHHHHHhcc---------------------------------------------------CCCcccc
Confidence 9999999775543333222211 1110000
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. ......+..+++++++||.+||..||++|||+.|+|+||||+..
T Consensus 250 ~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 250 G-------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred c-------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0 00011234678899999999999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=292.42 Aligned_cols=201 Identities=36% Similarity=0.673 Sum_probs=135.3
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|+|++ .+.+. ++...++||||+.||+ |.+.+. ++.+++.++.||+.||.|||++||+||||
T Consensus 78 ~~~h~~i~-~~~~~~~~~~~~~~~~~lv~e~~~gg~--L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dl 154 (336)
T 3fhr_A 78 ASGGPHIV-CILDVYENMHHGKRCLLIIMECMEGGE--LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154 (336)
T ss_dssp HTTSTTBC-CEEEEEEEEETTEEEEEEEEECCTTEE--HHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hcCCCChH-HHHHHHhhccCCCceEEEEEeccCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 35788755 43331 2445789999999998 877763 45789999999999999999999999999
Q ss_pred CCCcEEEec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 73 KPENILLDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 73 Kp~NILl~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
||+|||++. ++.+||+|||++...... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..
T Consensus 155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC------CCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999976 455999999999765432 3345788999999999854 346789999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+........ ..
T Consensus 228 pf~~~~~~~~~~------------------------------------------------------------------~~ 241 (336)
T 3fhr_A 228 PFYSNTGQAISP------------------------------------------------------------------GM 241 (336)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCCCccchhhhh------------------------------------------------------------------hH
Confidence 986543221100 01
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+..+.+.++.+.|..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 12233344556667788899999999999999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.68 Aligned_cols=185 Identities=16% Similarity=0.194 Sum_probs=139.7
Q ss_pred HHHHHHHHHhhchhhHHhhhCCH-----HHH-------HHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEecc
Q psy3880 23 LKHLAAQVVDKGEAAVQDIINSN-----PAL-------RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDF 90 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~~~~-----~~~-------r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DF 90 (408)
..||||||+. |+ |.+.+... ..+ ..++.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus 162 ~~~lv~e~~~-~~--L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DF 238 (371)
T 3q60_A 162 NYLLLMPAAS-VD--LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238 (371)
T ss_dssp EEEEEECCCS-EE--HHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCG
T ss_pred eEEEEecCCC-CC--HHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEec
Confidence 3689999999 66 77776432 222 355699999999999999999999999999999999999999
Q ss_pred ccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccC
Q psy3880 91 GFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 170 (408)
Q Consensus 91 Gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~ 170 (408)
|+|+..... .....+|+.|+|||++... ...|+.++||||+||++|+|++|..||.+.....
T Consensus 239 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------------ 300 (371)
T 3q60_A 239 SALWKVGTR--GPASSVPVTYAPREFLNAS----TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI------------ 300 (371)
T ss_dssp GGEEETTCE--EEGGGSCGGGCCHHHHTCS----EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC------------
T ss_pred ceeeecCCC--ccCccCCcCCcChhhccCC----CCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc------------
Confidence 999865432 2245667999999999641 1357899999999999999999999996643210
Q ss_pred CCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCc
Q psy3880 171 SSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISE 250 (408)
Q Consensus 171 ~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~ 250 (408)
.+.|..- . ........+..+.+..+|+
T Consensus 301 -------------------------------~~~~~~~-----------~-----------~~~~~~~~~~~~~~~~~~~ 327 (371)
T 3q60_A 301 -------------------------------KGSWKRP-----------S-----------LRVPGTDSLAFGSCTPLPD 327 (371)
T ss_dssp -------------------------------TTCCCBC-----------C-----------TTSCCCCSCCCTTSSCCCH
T ss_pred -------------------------------ccchhhh-----------h-----------hhhccccccchhhccCCCH
Confidence 0000000 0 0000111223344567899
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
++++||.+||..||++|||++|+|+||||+.
T Consensus 328 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 328 FVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999999999999999954
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.82 Aligned_cols=198 Identities=29% Similarity=0.569 Sum_probs=154.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ ++.+ ..++..|+||||+.+|. |.+.+.. ..++..++.||+.||+|||++||+||||||+||+
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 137 (276)
T 2yex_A 61 MLNHENVV-KFYGHRREGNIQYLFLEYCSGGE--LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (276)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hcCCCCce-eeeeEEEcCCEEEEEEEecCCCc--HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEE
Confidence 46788865 4443 34456789999999998 8887753 4789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||++....... .....+||+.|+|||++... ..++.++|+||+||++|+|++|..||...+
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-----EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCS-----SBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred EccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999997654332 23457899999999998642 223678999999999999999999996543
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..... ...+..
T Consensus 213 ~~~~~---------------------------------------------------------------------~~~~~~ 223 (276)
T 2yex_A 213 DSCQE---------------------------------------------------------------------YSDWKE 223 (276)
T ss_dssp TTSHH---------------------------------------------------------------------HHHHHT
T ss_pred hHHHH---------------------------------------------------------------------HHHhhh
Confidence 21000 001111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.... .+.|..+++++++||.+||..||++|||++|+++||||+..
T Consensus 224 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 224 KKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp TCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccc--cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 1111 12345679999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.98 Aligned_cols=196 Identities=23% Similarity=0.393 Sum_probs=141.9
Q ss_pred CcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 11 RVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 11 ~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
++|+.+.+ ..++..|+||| +.+|+ |.+.+. +..+++.++.||+.||+|||++||+||||||+|||++ ++
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e-~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~ 144 (343)
T 3dbq_A 69 DKIIRLYDYEITDQYIYMVME-CGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG 144 (343)
T ss_dssp TTBCCEEEEEECSSEEEEEEC-CCSEE--HHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT
T ss_pred CceEEEeeeEeeCCEEEEEEe-CCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC
Confidence 44556554 45567799999 56676 777763 4578999999999999999999999999999999997 57
Q ss_pred CEEEeccccchhcccCcc---cccCCCCCcccChhhhhhcccc-----CcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 84 NVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFE-----DATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 84 ~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~-----~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
.+||+|||+|..+..... ....+||+.|+|||++...... ....|+.++||||+||++|+|++|..||....
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 899999999987654322 2356899999999998642110 11457889999999999999999999996532
Q ss_pred hH-HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 156 QM-VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 156 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.. ..+.. +.
T Consensus 225 ~~~~~~~~----------------------------------------------------------------------~~ 234 (343)
T 3dbq_A 225 NQISKLHA----------------------------------------------------------------------II 234 (343)
T ss_dssp SHHHHHHH----------------------------------------------------------------------HH
T ss_pred hHHHHHHH----------------------------------------------------------------------Hh
Confidence 11 11111 11
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........ ....++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCcccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 11111111 12346789999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=277.21 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=141.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh------hCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI------INSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~------~~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~N 76 (408)
.+.|++++ .+.+ ..++..++||||+.|+...+... -.++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 62 ~~~h~~iv-~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~N 140 (290)
T 3fme_A 62 TVDCPFTV-TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140 (290)
T ss_dssp TCCCTTBC-CEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGG
T ss_pred hCCCCeEE-EEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 46788866 4443 44556789999998753222221 235688999999999999999998 99999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK- 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~- 155 (408)
||++.++.+||+|||++............+||+.|+|||++.... ....++.++|+||+||++|+|++|..||....
T Consensus 141 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 141 VLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL--NQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp CEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCT--TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred EEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhh--cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 999999999999999998776555445568999999999974211 12457889999999999999999999996422
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....+..+. ..
T Consensus 219 ~~~~~~~~~---------------------------------------------------------------------~~ 229 (290)
T 3fme_A 219 PFQQLKQVV---------------------------------------------------------------------EE 229 (290)
T ss_dssp HHHHHHHHH---------------------------------------------------------------------HS
T ss_pred hHHHHHHHh---------------------------------------------------------------------cc
Confidence 111111111 11
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..... ....+|+++++||.+||..||++|||++|+|+||||+.
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 230 PSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 11111 12357889999999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.56 Aligned_cols=174 Identities=20% Similarity=0.260 Sum_probs=134.8
Q ss_pred HHHHHHHHhhchhhHHhhhCC------------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccc
Q psy3880 24 KHLAAQVVDKGEAAVQDIINS------------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFG 91 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~~~------------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFG 91 (408)
.|+||||+ +|+ |.+.+.. ...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 175 ~~lv~E~~-~g~--L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 175 RFFLYPRM-QSN--LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEEECC-SEE--HHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEEecc-CCC--HHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEech
Confidence 67999999 577 8777653 25566799999999999999999999999999999999999999999
Q ss_pred cchhcccCcccccCCCCCcccChhhhhhcc-----ccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q psy3880 92 FARVLKKGEKLMDLCGTPGYLAPEVLRANM-----FEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166 (408)
Q Consensus 92 la~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~ 166 (408)
+|+... ......+| +.|+|||++.... ......|+.++|||||||++|+|++|..||.+.+......
T Consensus 252 ~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----- 323 (377)
T 3byv_A 252 HLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE----- 323 (377)
T ss_dssp GCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG-----
T ss_pred hheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh-----
Confidence 998533 23456778 9999999997530 0001257889999999999999999999985532110000
Q ss_pred cccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCC
Q psy3880 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 246 (408)
Q Consensus 167 ~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~ 246 (408)
.+ ...+.
T Consensus 324 -----------------------------------------------------------------~~--------~~~~~ 330 (377)
T 3byv_A 324 -----------------------------------------------------------------WI--------FRSCK 330 (377)
T ss_dssp -----------------------------------------------------------------GG--------GSSCC
T ss_pred -----------------------------------------------------------------hh--------hhhcc
Confidence 00 01124
Q ss_pred CCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 247 DISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 247 ~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+|+++++||.+||..||++|||+.|+|+||||+.
T Consensus 331 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 67899999999999999999999999999999954
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=277.72 Aligned_cols=194 Identities=34% Similarity=0.619 Sum_probs=132.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ +..+..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 67 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 67 QLKHPSIL-ELYNYFEDSNYVYLVLEMCHNGE--MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp TBCCTTBC-CEEEEEECSSEEEEEEECCTTEE--HHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred hCCCCCeE-eEEEEEccCCeEEEEEecCCCCc--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 46788866 4443 45567799999999998 776653 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.+||+|||++...... ......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+.
T Consensus 144 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 144 LLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp EECTTCCEEECCCTTCEECC----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred EEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 9999999999999999876532 22335689999999999864 3467899999999999999999999965432
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+.++ ...
T Consensus 218 ~~~~~~~----------------------------------------------------------------------~~~ 227 (278)
T 3cok_A 218 KNTLNKV----------------------------------------------------------------------VLA 227 (278)
T ss_dssp C-----C----------------------------------------------------------------------CSS
T ss_pred HHHHHHH----------------------------------------------------------------------hhc
Confidence 1111110 001
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+.. ...+|+++++||.+||..||++|||++|+|+||||...
T Consensus 228 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 1111 12468899999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.79 Aligned_cols=223 Identities=26% Similarity=0.433 Sum_probs=156.7
Q ss_pred ccccCCcEEEEec---cCCc-----HHHHHHHHHhhchhhHHhhhC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE---EGDD-----LKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~-----~~~lv~e~~~~g~~~l~~~~~---~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+ ..+. ..|+||||+.+ . |.+.+. +..+++.++.||+.||+|||++||+||||||
T Consensus 79 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~lv~e~~~~-~--l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 154 (353)
T 3coi_A 79 HMQHENVI-GLLDVFTPASSLRNFYDFYLVMPFMQT-D--LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 154 (353)
T ss_dssp HCCCTTBC-CCSEEECSCSSGGGCCCCEEEEECCSE-E--GGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred hcCCCCcc-cHhheEecccccccceeEEEEeccccC-C--HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 35788855 4443 2221 23899999985 4 666543 5689999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+|||++.++.+||+|||++...... ....+||+.|+|||++... ..++.++|+||+||++|+|++|..||.+.
T Consensus 155 ~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 155 GNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSW-----MHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp GGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCC-----SCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred HHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999865432 3456899999999998642 45788999999999999999999999998
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+..+........ ++.... . ........+..+.
T Consensus 228 ~~~~~~~~i~~~~~~~~------------~~~~~~-~------------------------------~~~~~~~~~~~~~ 264 (353)
T 3coi_A 228 DYLDQLTQILKVTGVPG------------TEFVQK-L------------------------------NDKAAKSYIQSLP 264 (353)
T ss_dssp CHHHHHHHHHHHHCBCC------------HHHHTT-C------------------------------SCHHHHHHHHTSC
T ss_pred CHHHHHHHHHHHhCCCC------------HHHHHH-H------------------------------hhHHHHHHHHhCc
Confidence 88777777765322111 010000 0 0000000000000
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.....-....+..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000000012235679999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.50 Aligned_cols=196 Identities=38% Similarity=0.744 Sum_probs=155.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|++++ ++.+ ...+..++|+|++.+|. |.+.+ .+..++..++.||+.||.|||++||+||||||+||+
T Consensus 77 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl 153 (287)
T 2wei_A 77 KLDHPNIM-KLFEILEDSSSFYIVGELYTGGE--LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153 (287)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hccCCCcc-EEEEEEeCCCeEEEEEEccCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEE
Confidence 46788865 4443 44566789999999998 76655 356889999999999999999999999999999999
Q ss_pred EecC---CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQ---MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~---~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.+ +.+||+|||++.............||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+
T Consensus 154 v~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-------TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp ESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-------CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-------CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9754 4699999999987765544455668899999998753 25677777777777777777777765433
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..
T Consensus 227 ----------------------------------------------------------------------~~~~~~~~~~ 236 (287)
T 2wei_A 227 ----------------------------------------------------------------------EYDILKRVET 236 (287)
T ss_dssp ----------------------------------------------------------------------HHHHHHHHHH
T ss_pred ----------------------------------------------------------------------HHHHHHHHHc
Confidence 3334445556
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.+.++.+.|..+|+++++||++||..||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 6666666778889999999999999999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=275.24 Aligned_cols=195 Identities=33% Similarity=0.640 Sum_probs=147.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ ...+..|+|||++.+|. |.+.+. +..++..++.||+.||.|||++||+||||||+|||
T Consensus 67 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 67 LFRHPHII-KLYQVISTPTDFFMVMEYVSGGE--LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred cCCCCCEe-EEEEEEecCCeEEEEEeccCCCc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 46788865 4443 44566799999999988 877763 55889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++............+||+.|+|||++... ..++.++|+||+||++|+|++|..||...+...
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 144 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR-----LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp ECTTSCEEECCCCGGGCCCC-------------CCTGGGTTS-----CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 999999999999999877665545567899999999998642 223578999999999999999999997655444
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+.. +.+
T Consensus 219 ~~~~~~~----------------------------------------------------------------------~~~ 228 (276)
T 2h6d_A 219 LFKKIRG----------------------------------------------------------------------GVF 228 (276)
T ss_dssp HHHHHHH----------------------------------------------------------------------CCC
T ss_pred HHHHhhc----------------------------------------------------------------------Ccc
Confidence 3333322 222
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.++ ..+++++++||.+||..||++|||++|+|+||||+..
T Consensus 229 ~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 121 2367889999999999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=276.76 Aligned_cols=193 Identities=30% Similarity=0.540 Sum_probs=151.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ ++.+ ..++..|+||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+||+
T Consensus 70 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 70 HLRHPNIL-RMYNYFHDRKRIYLMLEFAPRGE--LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred cCCCCCEe-eEEEEEEcCCEEEEEEEeCCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 46788865 4443 44567799999999998 777663 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||++...... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+..
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 218 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT- 218 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred EcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhcc------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-
Confidence 999999999999998655432 2345689999999999864 34567788888888888888887777544332
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.....+.....
T Consensus 219 ---------------------------------------------------------------------~~~~~~~~~~~ 229 (284)
T 2vgo_A 219 ---------------------------------------------------------------------ETHRRIVNVDL 229 (284)
T ss_dssp ---------------------------------------------------------------------HHHHHHHTTCC
T ss_pred ---------------------------------------------------------------------HHHHHHhcccc
Confidence 22333333333
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||.+||..||.+|||++|+|+||||+..
T Consensus 230 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 KFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 332 3578999999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=274.80 Aligned_cols=194 Identities=27% Similarity=0.508 Sum_probs=150.2
Q ss_pred ccccCCcEEEEec------cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCC--CeeccC
Q psy3880 6 MVAHSRVVVRVKE------EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHS--VVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~--IvHRDL 72 (408)
.+.|+|++ .+.+ .+....++||||+.+|. |.+.+. +...+..++.||+.||.|||++| |+||||
T Consensus 81 ~l~h~~iv-~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~di 157 (290)
T 1t4h_A 81 GLQHPNIV-RFYDSWESTVKGKKCIVLVTELMTSGT--LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp TCCCTTBC-CEEEEEEEESSSCEEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred hCCCCCee-eeeeeeccccCCCceEEEEEEecCCCC--HHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCC
Confidence 46799866 4432 23456789999999998 877763 45789999999999999999999 999999
Q ss_pred CCCcEEEe-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|||++ .++.+||+|||++...... .....+||+.|+|||++.. .++.++|+||+||++|+|++|..||
T Consensus 158 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 158 KCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc-------cCCCcchHHHHHHHHHHHHhCCCCC
Confidence 99999997 7889999999999754433 3345689999999998753 3788999999999999999999999
Q ss_pred CCchhHHHH-HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 152 WHRKQMVML-RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 152 ~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
......... ..+..+ ..|
T Consensus 230 ~~~~~~~~~~~~~~~~---------------------------------------------------~~~---------- 248 (290)
T 1t4h_A 230 SECQNAAQIYRRVTSG---------------------------------------------------VKP---------- 248 (290)
T ss_dssp TTCSSHHHHHHHHTTT---------------------------------------------------CCC----------
T ss_pred CCcCcHHHHHHHHhcc---------------------------------------------------CCc----------
Confidence 664332221 111111 000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.......++++++||.+||..||++|||++|+|+||||+..
T Consensus 249 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -----------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01113457889999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=281.90 Aligned_cols=212 Identities=26% Similarity=0.458 Sum_probs=152.2
Q ss_pred CcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe-cCCCEEEeccccchh
Q psy3880 21 DDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARV 95 (408)
Q Consensus 21 ~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~-~~~~iKl~DFGla~~ 95 (408)
.+..|+||||+.| . |.+.+. +...++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~--L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 94 LNSVYIVQEYMET-D--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp CSEEEEEEECCSE-E--HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred cCceeEEeeccCC-C--HHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 3556899999984 5 777664 4578999999999999999999999999999999997 567899999999987
Q ss_pred cccC----cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCC
Q psy3880 96 LKKG----EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 96 ~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~ 171 (408)
.... .......+|+.|+|||++... ..++.++|+||+||++|+|++|..||.+.+....+..+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCT-----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred cCCCcccccccccccccccccCcHHhcCc-----ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 6432 122345679999999998642 4578899999999999999999999999888887777765432111
Q ss_pred CCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCcc
Q psy3880 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISED 251 (408)
Q Consensus 172 ~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~ 251 (408)
++... .. . ...|. ................+..+|++
T Consensus 246 ------------~~~~~-~~-----------------------~-~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 281 (320)
T 2i6l_A 246 ------------EEDRQ-EL-----------------------L-SVIPV-------YIRNDMTEPHKPLTQLLPGISRE 281 (320)
T ss_dssp ------------HHHHH-HH-----------------------H-TTSCH-------HHHHHTTSCCCCHHHHSTTCCHH
T ss_pred ------------hhhhh-hh-----------------------h-hcCcc-------cccccccCCCCChhHhcchhhHH
Confidence 00000 00 0 00000 00000000000000123468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 252 PKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 252 ~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
+++||++||..||++|||++|+|+||||+...+
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 282 AVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 999999999999999999999999999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.99 Aligned_cols=226 Identities=32% Similarity=0.478 Sum_probs=158.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +..+..++||||+.+|. |.+.+ .+...+..++.||+.||.|||++||+||||||+|||
T Consensus 80 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 80 QLRHENLV-NLLEVCKKKKRWYLVFEFVDHTI--LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCSEEH--HHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hCCCCCEe-eEEEEeecCCEEEEEEecCCcch--HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 36788865 5443 34556789999999997 55543 345889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++..+... ......+||+.|+|||++... ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 157 VSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD-----VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp ECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTC-----TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCC-----CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999876543 233457899999999998642 35788999999999999999999999998887
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..+..+........... .+.+.... .+ .|. ..+.......
T Consensus 232 ~~~~~~~~~~~~~~~~~---------~~~~~~~~------------~~-~~~-------~~~~~~~~~~----------- 271 (331)
T 4aaa_A 232 DQLYHIMMCLGNLIPRH---------QELFNKNP------------VF-AGV-------RLPEIKEREP----------- 271 (331)
T ss_dssp HHHHHHHHHHCSCCHHH---------HHHHHHCG------------GG-TTC-------CCCCCSSCCC-----------
T ss_pred HHHHHHHHHhCCCChhh---------hhHhhhcc------------cc-ccc-------cCccccccch-----------
Confidence 77776654322111000 00000000 00 000 0000000000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....+..+|+++++||.+||..||++|||+.|+|+||||+..
T Consensus 272 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 272 ---LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp ---HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ---hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 001234679999999999999999999999999999999653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=285.16 Aligned_cols=197 Identities=25% Similarity=0.454 Sum_probs=145.5
Q ss_pred ccccCCcEEEEecc--CCc----HHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE--GDD----LKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--~~~----~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| ++.+. ..+ ..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||
T Consensus 68 ~l~hp~iv-~~~~~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 144 (311)
T 3ork_A 68 ALNHPAIV-AVYDTGEAETPAGPLPYIVMEYVDGVT--LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144 (311)
T ss_dssp CCCCTTBC-CEEEEEEEEETTEEEEEEEEECCCEEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred cCCCCCcc-eEEEeeeccCCCCcccEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 46799865 55432 222 2389999999998 877763 5588999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|||++.++.+||+|||++..+.... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~g~~p 218 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG------DSVDARSDVYSLGCVLYEVLTGEPP 218 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHT------CCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC------CCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999998765432 1234679999999999864 3467788888888888888888888
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+.....
T Consensus 219 f~~~~~~~~~---------------------------------------------------------------------- 228 (311)
T 3ork_A 219 FTGDSPVSVA---------------------------------------------------------------------- 228 (311)
T ss_dssp CCCSSHHHHH----------------------------------------------------------------------
T ss_pred CCCCChHHHH----------------------------------------------------------------------
Confidence 8654433222
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..+.......+...+..+|+++++||.+||..||++|||+.++|.|+|+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 222222222222234568999999999999999999999999999999963
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=282.20 Aligned_cols=196 Identities=36% Similarity=0.627 Sum_probs=157.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ ++.+ +.++..|+||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 97 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 173 (335)
T 2owb_A 97 SLAHQHVV-GFHGFFEDNDFVFVVLELCRRRS--LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173 (335)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCTTCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hCCCCCCC-eEEEEEecCCeEEEEEecCCCCC--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence 46799866 4443 45567899999999998 776653 56889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++...... ......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+..
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 999999999999999876532 23345789999999999864 34678999999999999999999999765544
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+....+. ...
T Consensus 248 ~~~~~~~----------------------------------------------------------------------~~~ 257 (335)
T 2owb_A 248 ETYLRIK----------------------------------------------------------------------KNE 257 (335)
T ss_dssp HHHHHHH----------------------------------------------------------------------HTC
T ss_pred HHHHHHh----------------------------------------------------------------------cCC
Confidence 3333322 222
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
+.++ ..+++++++||++||..||++|||++|+|+||||.....
T Consensus 258 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 258 YSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 2221 246889999999999999999999999999999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.28 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=161.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++||||+.||. |.+.+. +...+..++.|++.||+|||++ ||+||||||+||
T Consensus 87 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 163 (360)
T 3eqc_A 87 ECNSPYIV-GFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163 (360)
T ss_dssp GCCCTTBC-CEEEEEEETTEEEEEECCCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred HCCCCCEE-EEeEEEEECCEEEEEEECCCCCC--HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence 36788865 4443 44556789999999998 877763 4578899999999999999996 999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||...+..
T Consensus 164 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp EECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred EECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999765432 2345689999999999864 35789999999999999999999999887655
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+.........+.. ...+..+-.+... +..+.........+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3eqc_A 237 ELELMFGCQVEGDAAETP--------------------------PRPRTPGRPLNKF--GMDSRPPMAIFELLDYIVNEP 288 (360)
T ss_dssp HHHHHHC----------------------------------------------------------CCCHHHHHHHHHHSC
T ss_pred HHHHHhcccccccCCCCC--------------------------CCcccCCCccccc--ccCCCCcccchhhhhHHhccC
Confidence 543332111000000000 0000000000000 000111122334445555443
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... .....+|+++++||++||..||++|||++|+|+||||+..
T Consensus 289 ~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 289 PPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp CCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 322 2234579999999999999999999999999999999653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=273.43 Aligned_cols=197 Identities=36% Similarity=0.623 Sum_probs=157.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 71 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil 147 (294)
T 2rku_A 71 SLAHQHVV-GFHGFFEDNDFVFVVLELCRRRS--LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147 (294)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCEe-eeeeeeccCCEEEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 46798866 4443 44566799999999988 776653 56889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||++...... ......+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+..
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 148 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp ECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999876532 23345689999999999864 34678999999999999999999999765544
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+....+. ...
T Consensus 222 ~~~~~~~----------------------------------------------------------------------~~~ 231 (294)
T 2rku_A 222 ETYLRIK----------------------------------------------------------------------KNE 231 (294)
T ss_dssp HHHHHHH----------------------------------------------------------------------TTC
T ss_pred HHHHHHh----------------------------------------------------------------------hcc
Confidence 3333322 222
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFD 285 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~ 285 (408)
+.++ ..+++++++||.+||..||++|||++|+|+||||.....+
T Consensus 232 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 232 YSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred CCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 2221 2468899999999999999999999999999999876443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=278.83 Aligned_cols=221 Identities=24% Similarity=0.326 Sum_probs=150.2
Q ss_pred cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec----------
Q psy3880 19 EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD---------- 81 (408)
Q Consensus 19 ~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~---------- 81 (408)
+.++..++||||+ +|. |.+.+. +..+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~--l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLS--TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCB--HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCC--HHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 3455678999999 666 666542 45789999999999999999999999999999999987
Q ss_pred ---------CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 82 ---------QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 82 ---------~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
++.+||+|||++..... .....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA------LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT------SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC------CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 66899999999976443 2345789999999999864 357889999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh-HHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MVMLR 231 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~-~~~~~ 231 (408)
+.+..+.+..+......+ +++.+.... ....+. .+...|..... .....
T Consensus 236 ~~~~~~~~~~~~~~~~~~------------p~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~~~~ 285 (339)
T 1z57_A 236 THDSKEHLAMMERILGPL------------PKHMIQKTR---------KRKYFH---------HDRLDWDEHSSAGRYVS 285 (339)
T ss_dssp CSCHHHHHHHHHHHHCSC------------CHHHHHHCS---------CGGGEE---------TTEECCCTTSHHHHHHH
T ss_pred CCChHHHHHHHHHHhCCC------------CHHHHhhcc---------chhHHh---------hccccccccccccchhh
Confidence 887766665554322111 111111100 000000 00001111000 00011
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
........+. ..-...++++++||.+||..||++|||++|+|+||||+.
T Consensus 286 ~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 286 RACKPLKEFM-LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHCCCGGGGC-SCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred hcCcchhhhc-ccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 1110000000 001224677899999999999999999999999999965
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=270.51 Aligned_cols=188 Identities=24% Similarity=0.332 Sum_probs=142.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.|+|++ ++.+ ..++..++||||+.||. |.+.+. ++.+++.++.||+.||+|||++||+||||||+|
T Consensus 69 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVV-RYFSAWAEDDHMLIQNEYCNGGS--LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145 (289)
T ss_dssp SCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCee-eeeeeeecCCeEEEEEEecCCCc--HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence 788755 5444 44567789999999998 877763 557899999999999999999999999999999
Q ss_pred EEEecC-------------------CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhh
Q psy3880 77 ILLDDQ-------------------MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWAC 137 (408)
Q Consensus 77 ILl~~~-------------------~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSl 137 (408)
||++.+ ..+||+|||++...... ....||+.|+|||++... ..++.++||||+
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~Di~sl 217 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQEN-----YTHLPKADIFAL 217 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTC-----CTTHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCC-----CCCCchhhHHHH
Confidence 999843 47999999999876543 235699999999998642 345578888888
Q ss_pred hHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC
Q psy3880 138 GVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 217 (408)
Q Consensus 138 Gvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g 217 (408)
||++|+|++|.+|+......
T Consensus 218 G~il~~l~~~~~~~~~~~~~------------------------------------------------------------ 237 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGDQW------------------------------------------------------------ 237 (289)
T ss_dssp HHHHHHHTTCCCCCSSSHHH------------------------------------------------------------
T ss_pred HHHHHHHhcCCCCCcchhHH------------------------------------------------------------
Confidence 88888888887766433211
Q ss_pred CCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 218 CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 218 ~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+..+... .....+|+++++||.+||..||++|||+.|+|+||||...
T Consensus 238 -------------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 -------------HEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -------------HHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -------------HHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 111111111 1113578999999999999999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=278.82 Aligned_cols=220 Identities=24% Similarity=0.428 Sum_probs=157.5
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+.+ ......++||||+.||. |.+.+ .+..++..++.||+.||+|||++||+|||||
T Consensus 63 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 139 (319)
T 4euu_A 63 KLNHKNIV-KLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139 (319)
T ss_dssp HCCCTTBC-CEEEEEECTTTCCEEEEEECCTTCB--HHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hcCCCCcc-eEEEEeecCCCceEEEEEeCCCCCC--HHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 36788866 4432 22335689999999998 87776 3558899999999999999999999999999
Q ss_pred CCcEEE----ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhcccc--CcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 74 PENILL----DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFE--DATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 74 p~NILl----~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
|+|||+ +.++.+||+|||+|+...........+||+.|+|||++...... ....++.++||||+||++|+|++|
T Consensus 140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp GGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999 66778999999999887766666677899999999998642111 124678899999999999999999
Q ss_pred CCCCCCc----hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 148 CPPFWHR----KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 148 ~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
..||... .....+.++..+............ ....--|+ +..|
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--------------------~~~~~~~~----------~~~~--- 266 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKA--------------------ENGPIDWS----------GDMP--- 266 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECS--------------------TTCCEEEE----------SSCC---
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcc--------------------cCCccccC----------ccCC---
Confidence 9999743 234555555554322111100000 00000111 0001
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hp 277 (408)
........+++.+.+||++||+.||++|||++|+|+||
T Consensus 267 ----------------~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 267 ----------------VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp ----------------TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred ----------------cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 00111123566789999999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=271.70 Aligned_cols=183 Identities=27% Similarity=0.514 Sum_probs=135.4
Q ss_pred CcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 21 DDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 21 ~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
.+..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 87 KSTLFIQMEYCENGT--LYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEEEECCCSCB--HHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred CCceEEEEecCCCCC--HHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 456789999999998 887763 347888999999999999999999999999999999999999999999997
Q ss_pred hcccC---------------cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 95 VLKKG---------------EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 95 ~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
..... ......+||+.|+|||++... ..++.++|+||+||++|+|++ ||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~---p~~~~~~~-- 234 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-----GHYNEKIDMYSLGIIFFEMIY---PFSTGMER-- 234 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSC-----SCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCC-----CCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence 65421 122346789999999998642 346788899999998888887 55322111
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
......+......
T Consensus 235 -------------------------------------------------------------------~~~~~~~~~~~~~ 247 (303)
T 1zy4_A 235 -------------------------------------------------------------------VNILKKLRSVSIE 247 (303)
T ss_dssp -------------------------------------------------------------------HHHHHHHHSTTCC
T ss_pred -------------------------------------------------------------------HHHHHhccccccc
Confidence 1112222222223
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
++.......++.+++||++||..||++|||++|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3333334567889999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.75 Aligned_cols=142 Identities=29% Similarity=0.445 Sum_probs=115.8
Q ss_pred EEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCcEEEe-
Q psy3880 13 VVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVH--NHSVVHRDLKPENILLD- 80 (408)
Q Consensus 13 i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH--~~~IvHRDLKp~NILl~- 80 (408)
|+.+.+ ..++..++||||+.+ . |.+.+ .+...++.++.||+.||.||| +.|||||||||+|||++
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~-~--L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLSY-N--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCCC-B--HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred EEEeeeeeccCCceEEEEecCCC-C--HHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence 545544 344667899999975 4 55554 245889999999999999999 57999999999999995
Q ss_pred -cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 -DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 -~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
.++.+||+|||+|..... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.+..+.
T Consensus 195 ~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCcEEEEeccCceeccc--ccccccCCccccChHHHcC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 467899999999987643 3356789999999999975 3578999999999999999999999998887776
Q ss_pred HHHHHh
Q psy3880 160 LRNIME 165 (408)
Q Consensus 160 ~~~i~~ 165 (408)
+.++..
T Consensus 267 ~~~i~~ 272 (382)
T 2vx3_A 267 MNKIVE 272 (382)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 666643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=288.53 Aligned_cols=228 Identities=23% Similarity=0.382 Sum_probs=149.8
Q ss_pred cCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCC
Q psy3880 9 HSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNH-SVVHRDLKP 74 (408)
Q Consensus 9 ~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp 74 (408)
|++++ .+.+. .....++||||+.++ +.+.+ .+..+++.++.||+.||+|||++ ||+||||||
T Consensus 100 ~~~iv-~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp 175 (397)
T 1wak_A 100 REMVV-QLLDDFKISGVNGTHICMVFEVLGHH---LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP 175 (397)
T ss_dssp GGGBC-CEEEEEEEEETTEEEEEEEECCCCCB---HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSG
T ss_pred cceee-eeecceeecCCCCceEEEEEeccCcc---HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence 66544 54442 345678999999554 44333 34588999999999999999998 999999999
Q ss_pred CcEEEecCC-------------------------------------------------CEEEeccccchhcccCcccccC
Q psy3880 75 ENILLDDQM-------------------------------------------------NVKLTDFGFARVLKKGEKLMDL 105 (408)
Q Consensus 75 ~NILl~~~~-------------------------------------------------~iKl~DFGla~~~~~~~~~~~~ 105 (408)
+|||++.++ .+||+|||+|...... ....
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~ 253 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTED 253 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSC
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccC
Confidence 999998765 7999999999866432 3456
Q ss_pred CCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch------hHHHHHHHHhccccCCCCCCccCC
Q psy3880 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK------QMVMLRNIMEGKYSFSSPEWNDIS 179 (408)
Q Consensus 106 ~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~ 179 (408)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+ ....+..+......
T Consensus 254 ~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 317 (397)
T 1wak_A 254 IQTRQYRSLEVLIG------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK---------- 317 (397)
T ss_dssp CSCGGGCCHHHHHT------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS----------
T ss_pred CCCCcccCChhhcC------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC----------
Confidence 89999999999975 347889999999999999999999997654 23333333221111
Q ss_pred CCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHh
Q psy3880 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKL 259 (408)
Q Consensus 180 ~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~kl 259 (408)
..++.+....+.. .-+....+.-. +....|+ .. ..+....+.++ ...++++++||.+|
T Consensus 318 --~p~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~---~~----~~~~~~~~~~~----~~~~~~~~~li~~~ 375 (397)
T 1wak_A 318 --VPRKLIVAGKYSK-EFFTKKGDLKH--------ITKLKPW---GL----FEVLVEKYEWS----QEEAAGFTDFLLPM 375 (397)
T ss_dssp --CCHHHHHHCTTGG-GTBCTTSSBSS--------CCCCCCC---CH----HHHHHHTSCCC----HHHHHHHHHHHGGG
T ss_pred --CChHHhhcccccc-cccCCcccccc--------ccccCCc---ch----hHhhhhhcccc----hhhHHHHHHHHHHH
Confidence 1111111100000 00000000000 0000011 00 01111122221 23567889999999
Q ss_pred cccCCCCCCCHHHHHcCCCCC
Q psy3880 260 LIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 260 L~~dP~~R~ta~e~L~Hpwf~ 280 (408)
|+.||++|||++|+|+||||+
T Consensus 376 L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 376 LELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp GCSSGGGSCCHHHHHTSGGGG
T ss_pred hccChhhcCCHHHHhhCcccc
Confidence 999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=271.00 Aligned_cols=195 Identities=31% Similarity=0.520 Sum_probs=154.3
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCC-----C
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHS-----V 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~-----I 67 (408)
.+.|+|++ .+.+ +.+...|+||||+.||. |.+.+ .+...+..++.||+.||+|||++| |
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i 137 (279)
T 2w5a_A 61 ELKHPNIV-RYYDRIIDRTNTTLYIVMEYCEGGD--LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137 (279)
T ss_dssp HCCCTTBC-CEEEEEEEGGGTEEEEEEECCTTEE--HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------
T ss_pred hcCCCCCC-eEEEEEecCCCceEEEEEeCCCCCC--HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee
Confidence 35788865 4443 33456789999999998 77766 456789999999999999999999 9
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc-cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.. ..++.++|+||+||++|+|++
T Consensus 138 vH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~ 211 (279)
T 2w5a_A 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR------MSYNEKSDIWSLGCLLYELCA 211 (279)
T ss_dssp CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC------C-CCHHHHHHHHHHHHHHHHH
T ss_pred EEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhcc------CCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654332 234678999999999864 357889999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|..||...+.......+..+.
T Consensus 212 g~~p~~~~~~~~~~~~i~~~~----------------------------------------------------------- 232 (279)
T 2w5a_A 212 LMPPFTAFSQKELAGKIREGK----------------------------------------------------------- 232 (279)
T ss_dssp SSCSSCCSSHHHHHHHHHHTC-----------------------------------------------------------
T ss_pred CCCCCcccCHHHHHHHHhhcc-----------------------------------------------------------
Confidence 999997766554444443321
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... ....+|+++++||.+||..||++|||++|+|+|+|+...
T Consensus 233 -----------~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 233 -----------FRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------ccc---CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 110 012468899999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=280.18 Aligned_cols=222 Identities=23% Similarity=0.329 Sum_probs=149.3
Q ss_pred cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE------------
Q psy3880 19 EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL------------ 79 (408)
Q Consensus 19 ~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl------------ 79 (408)
+..+..++||||+.++ +.+.+ .+..+++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELLGKN---TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECCCCB---HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEeccCCC---hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 3445678999999554 33333 3457899999999999999999999999999999999
Q ss_pred -------ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 80 -------DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 80 -------~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
+.++.+||+|||++..... .....+||+.|+|||++.. ..++.++|+||+||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE------LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeec------CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 5678999999999976433 2345789999999999964 357889999999999999999999999
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh-HHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MVMLR 231 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~-~~~~~ 231 (408)
+.+....+..+......+ +++.+... . ....+ ..+...+..... .....
T Consensus 241 ~~~~~~~~~~~~~~~~~~------------p~~~~~~~-~--------~~~~~---------~~~~~~~~~~~~~~~~~~ 290 (355)
T 2eu9_A 241 THENREHLVMMEKILGPI------------PSHMIHRT-R--------KQKYF---------YKGGLVWDENSSDGRYVK 290 (355)
T ss_dssp CSSHHHHHHHHHHHHCCC------------CHHHHHHC-S--------CGGGE---------ETTEECCCTTSHHHHHHH
T ss_pred CCCHHHHHHHHHHHcCCC------------cHHHhhhc-c--------chhhh---------cccccccccccchhcccc
Confidence 887766665554432111 11111100 0 00000 000001111100 00111
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........+ .......++++++||++||..||++|||+.|+|+||||+..
T Consensus 291 ~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 291 ENCKPLKSY-MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHCCCGGGG-CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred ccCCccccc-ccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 110000000 00112235688999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=271.87 Aligned_cols=203 Identities=27% Similarity=0.458 Sum_probs=153.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++||||+.+|. |.+.+ .+...+..++.||+.||.|||++||+||||||+||
T Consensus 72 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (302)
T 2j7t_A 72 TCDHPYIV-KLLGAYYHDGKLWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNV 148 (302)
T ss_dssp HCCCTTBC-CEEEEEECC-CEEEEEECCTTEE--HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred cCCCCCEe-eeeeeeeeCCeEEEEEEeCCCCc--HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 36788866 4443 34456789999999998 66554 35688999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||++...... .......||+.|+|||++..... ....++.++|+||+||++|+|++|..||...+.
T Consensus 149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 149 LMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM-KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp EECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHT-TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccC-CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999999999999997643321 12234679999999999853221 124578899999999999999999999977665
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+..+..+. +|.
T Consensus 228 ~~~~~~~~~~~---------------------------------------------------~~~--------------- 241 (302)
T 2j7t_A 228 MRVLLKIAKSD---------------------------------------------------PPT--------------- 241 (302)
T ss_dssp HHHHHHHHHSC---------------------------------------------------CCC---------------
T ss_pred HHHHHHHhccC---------------------------------------------------Ccc---------------
Confidence 54444433221 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
. .....+|.++++||.+||..||++|||+.|+|+||||+...
T Consensus 242 ---~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ---L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 0 01124678899999999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=277.14 Aligned_cols=199 Identities=27% Similarity=0.457 Sum_probs=144.4
Q ss_pred ccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 8 AHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 8 ~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.|+|++ .+.+.. ++..++||||+.+|. |.+.+ .+...++.++.||+.||.|||++||+||||
T Consensus 79 ~h~~i~-~~~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 155 (326)
T 2x7f_A 79 HHRNIA-TYYGAFIKKNPPGMDDQLWLVMEFCGAGS--VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155 (326)
T ss_dssp CSTTBC-CEEEEEEECC--CCCCEEEEEEECCTTEE--HHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred CCCCee-eeeeEEeeccCccccceEEEEEEcCCCCc--HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 577755 444321 456799999999988 77665 245788999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|||++.++.+||+|||++....... .....+||+.|+|||++..... ....++.++|+||+||++|+|++|..||
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN-PDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC---------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccc-cCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999988765332 2334679999999999863211 1245778899999999999999999988
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+....+..+..
T Consensus 235 ~~~~~~~~~~~~~~------------------------------------------------------------------ 248 (326)
T 2x7f_A 235 CDMHPMRALFLIPR------------------------------------------------------------------ 248 (326)
T ss_dssp TTSCHHHHHHHHHH------------------------------------------------------------------
T ss_pred CCCcHHHHHHHhhc------------------------------------------------------------------
Confidence 66554333322221
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
... +......+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 249 ----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 ----NPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ----SCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ----Ccc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 110 001123568899999999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=272.65 Aligned_cols=199 Identities=26% Similarity=0.452 Sum_probs=152.4
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ +..+..|+||||+.+|...+.... .+..++..++.||+.||+|||++||+||||||+||
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NI 140 (305)
T 2wtk_C 62 RLRHKNVI-QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140 (305)
T ss_dssp TCCCTTBC-CEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hcCCCCee-EEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 46788866 4443 334467899999999842233332 34578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC---cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG---EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
|++.++.+||+|||++...... .......||+.|+|||++... ...++.++|+||+||++|+|++|..||.+.
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL----DTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC----SCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc----ccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999865432 223456799999999998642 122467899999999999999999999766
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..
T Consensus 217 ~~~~~~~~i~~--------------------------------------------------------------------- 227 (305)
T 2wtk_C 217 NIYKLFENIGK--------------------------------------------------------------------- 227 (305)
T ss_dssp SHHHHHHHHHH---------------------------------------------------------------------
T ss_pred hHHHHHHHHhc---------------------------------------------------------------------
Confidence 54444333332
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+.+.++ ..+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 228 -~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 228 -GSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp -CCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred -CCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 222222 24688999999999999999999999999999997653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=280.12 Aligned_cols=213 Identities=20% Similarity=0.406 Sum_probs=152.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh------hC-------CHHHHHHHHHHHHHHHHHHHH-CCCee
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI------IN-------SNPALRYIMRQLFEALEHVHN-HSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~------~~-------~~~~~r~i~~qil~aL~~LH~-~~IvH 69 (408)
.+.|++++ .+.+ ..++..|+||||+.+|. |.+. +. +...+..++.||+.||+|||+ +||+|
T Consensus 99 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 175 (348)
T 2pml_X 99 DIKNEYCL-TCEGIITNYDEVYIIYEYMENDS--ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175 (348)
T ss_dssp TCCCTTBC-CCSEEEESSSEEEEEEECCTTCB--SSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred hCCCCCcc-eEEEEEeeCCeEEEEEeccCCCc--HHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence 36788855 5443 44567899999999998 7776 43 347899999999999999999 99999
Q ss_pred ccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCc-chhhhhhhHHHHHHHhCC
Q psy3880 70 RDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQ-AVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 70 RDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~-~~DiwSlGvil~~ll~G~ 148 (408)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++... ..++. ++|+||+||++|+|++|.
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNE-----SSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSC-----CCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCC-----CCCCcchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999876443 34567899999999998642 23445 899999999999999998
Q ss_pred CCCCCchh-HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 149 PPFWHRKQ-MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 149 ~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
.||..... ... +..+..+..++......
T Consensus 250 ~pf~~~~~~~~~---------------------------------------------------~~~i~~~~~~~~~~~~~ 278 (348)
T 2pml_X 250 VPFSLKISLVEL---------------------------------------------------FNNIRTKNIEYPLDRNH 278 (348)
T ss_dssp CSSCCSSCSHHH---------------------------------------------------HHHHTSCCCCCCCSSSS
T ss_pred CCCCCCCcHHHH---------------------------------------------------HHHHhccCcCCccchhh
Confidence 88855332 111 11112222222110000
Q ss_pred HHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 228 ~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.. ... ...-....+..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 279 ~~-~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 279 FL-YPL---TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp ST-TTT---CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hh-ccc---cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 00 000 0000001124689999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=271.78 Aligned_cols=197 Identities=28% Similarity=0.475 Sum_probs=154.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ ..++..++||||+.+|. |.+.+. +..++..++.||+.||.|||++||+||||||+||
T Consensus 80 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Ni 156 (314)
T 3com_A 80 QCDSPHVV-KYYGSYFKNTDLWIVMEYCGAGS--VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156 (314)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred hCCCCCCc-cEEEEEEeCCEEEEEeecCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHE
Confidence 36788865 4443 34456789999999998 777653 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+++.++.+||+|||++....... ......||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+.
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 157 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE------IGYNCVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp EECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999997665432 2345679999999999864 3578899999999999999999999976544
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
......+... .+|
T Consensus 231 ~~~~~~~~~~---------------------------------------------------~~~---------------- 243 (314)
T 3com_A 231 MRAIFMIPTN---------------------------------------------------PPP---------------- 243 (314)
T ss_dssp HHHHHHHHHS---------------------------------------------------CCC----------------
T ss_pred HHHHHHHhcC---------------------------------------------------CCc----------------
Confidence 3332222111 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+. ....+|+++++||.+||..||++|||+.|+|+||||+..
T Consensus 244 --~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 --TFR--KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --CCS--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --ccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 011 112358899999999999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=271.95 Aligned_cols=195 Identities=22% Similarity=0.340 Sum_probs=140.0
Q ss_pred ccccCCcEEEEec--cCCcHH------HHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLK------HLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~------~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
.+.|+|++ .+.+ ...+.. ++||||+.+|. |.+.+ .+..++..++.||+.||+|||++|
T Consensus 81 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 157 (323)
T 3qup_A 81 EFDHPHVA-KLVGVSLRSRAKGRLPIPMVILPFMKHGD--LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157 (323)
T ss_dssp TCCCTTBC-CCCEEEECC-------CEEEEEECCTTCB--HHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HCCCCcee-hhhceeeccccccCCCccEEEEEeccCCc--HHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence 46788855 5443 222222 79999999998 77766 455789999999999999999999
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|+||||||+|||++.++.+||+|||+|......... ....+|+.|+|||++.. ..++.++||||+||++|+
T Consensus 158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~e 231 (323)
T 3qup_A 158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD------NLYTVHSDVWAFGVTMWE 231 (323)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC------CCCCCccchhhHHHHHHH
Confidence 999999999999999999999999999876543322 23456788999999875 357889999999999999
Q ss_pred HHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 144 LLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 144 ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
|++ |..||.+.+.......+..+.
T Consensus 232 ll~~g~~p~~~~~~~~~~~~~~~~~------------------------------------------------------- 256 (323)
T 3qup_A 232 IMTRGQTPYAGIENAEIYNYLIGGN------------------------------------------------------- 256 (323)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTC-------------------------------------------------------
T ss_pred HHhCCCCCccccChHHHHHHHhcCC-------------------------------------------------------
Confidence 999 999997655444333332211
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCC-------HHHHHcCCCCCCC
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-------VKEALNHSFFHPK 282 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-------a~e~L~Hpwf~~~ 282 (408)
.. +....+++++++||.+||..||++||| ++++++|||+...
T Consensus 257 ---------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 ---------------RL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ---------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ---------------CC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 00 111356889999999999999999999 7889999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=269.68 Aligned_cols=199 Identities=24% Similarity=0.460 Sum_probs=148.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.+ ..++..++|||++.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+
T Consensus 75 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 151 (295)
T 2clq_A 75 HLKHKNIV-QYLGSFSENGFIKIFMEQVPGGS--LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151 (295)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCSEEE--HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hCCCCCEe-eEeeEEEeCCcEEEEEEeCCCCC--HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChh
Confidence 36788865 4443 34456789999999998 766653 25678889999999999999999999999999
Q ss_pred cEEEec-CCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDD-QMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~-~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|||++. ++.+||+|||++....... ......||+.|+|||++.... ..++.++|+||+||++|+|++|..||..
T Consensus 152 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP----RGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp GEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGG----GGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred hEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCC----CCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 999987 8899999999998665322 233568999999999987531 2367889999999999999999998854
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
....... .....
T Consensus 228 ~~~~~~~--------------------------------------------------------------------~~~~~ 239 (295)
T 2clq_A 228 LGEPQAA--------------------------------------------------------------------MFKVG 239 (295)
T ss_dssp GSSHHHH--------------------------------------------------------------------HHHHH
T ss_pred CCchhHH--------------------------------------------------------------------HHhhc
Confidence 3211100 00000
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.. .........+++++++||.+||..||++|||++|+|+||||+..
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 240 MF---KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HH---CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cc---cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 00 01111124578999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-33 Score=269.75 Aligned_cols=195 Identities=27% Similarity=0.438 Sum_probs=154.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|++++ .+.+ ..++..++||||+.||. |.+.+. +..++..++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 152 (303)
T 3a7i_A 76 QCDSPYVT-KYYGSYLKDTKLWIIMEYLGGGS--ALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152 (303)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--HHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCEe-EEEEEEecCCeEEEEEEeCCCCc--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE
Confidence 35788755 4443 34456789999999998 888775 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||++....... ......||+.|+|||++.. ..++.++|+||+||++|+|++|..||...+...
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 226 (303)
T 3a7i_A 153 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ------SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226 (303)
T ss_dssp CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH
Confidence 999999999999997765432 2345689999999999864 346788999999999999999999886654433
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
....+.. ...
T Consensus 227 ~~~~~~~----------------------------------------------------------------------~~~ 236 (303)
T 3a7i_A 227 VLFLIPK----------------------------------------------------------------------NNP 236 (303)
T ss_dssp HHHHHHH----------------------------------------------------------------------SCC
T ss_pred HHHHhhc----------------------------------------------------------------------CCC
Confidence 3322221 111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
. .....+++++++||.+||..||++|||++|+|+||||...
T Consensus 237 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp C---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred C---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 1123568899999999999999999999999999999653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=268.72 Aligned_cols=194 Identities=20% Similarity=0.321 Sum_probs=143.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHS--VVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~--IvHRDLK 73 (408)
.+.|+|+| .+.+ +.++..++||||+.||. |.+.+ .+...+..++.||+.||+|||++| |+|||||
T Consensus 90 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dik 166 (309)
T 3p86_A 90 RLRHPNIV-LFMGAVTQPPNLSIVTEYLSRGS--LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166 (309)
T ss_dssp HCCCTTBC-CEEEEECSTTCCEEEEECCTTCB--HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCC
T ss_pred hCCCCCEe-eEEEEEEECCceEEEEecCCCCc--HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCC
Confidence 36798866 4443 44456789999999998 87776 345778899999999999999999 9999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|+|||++.++.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus 167 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 167 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD------EPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp GGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTT------CCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred hhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999997654332 2335789999999999875 346889999999999999999999997
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+..+....+....
T Consensus 241 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 255 (309)
T 3p86_A 241 NLNPAQVVAAVGFKC----------------------------------------------------------------- 255 (309)
T ss_dssp TSCHHHHHHHHHHSC-----------------------------------------------------------------
T ss_pred CCCHHHHHHHHHhcC-----------------------------------------------------------------
Confidence 765544443332110
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc--CCCCC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFFH 280 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~--Hpwf~ 280 (408)
... +....+|+++.+||.+||..||++|||++|+++ ++++.
T Consensus 256 -----~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 -----KRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -----CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -----CCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 011357889999999999999999999999987 34443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=276.13 Aligned_cols=187 Identities=21% Similarity=0.361 Sum_probs=146.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|+| ++.+ ..++..|+||||+.||. |.+++. +..++..++.||+.||+|||+
T Consensus 145 ~hpnIv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 221 (370)
T 2psq_A 145 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221 (370)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEe-eEEEEEccCCCEEEEEEcCCCCC--HHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 688755 5544 45567899999999998 877762 447888999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+|+....... .....+|+.|+|||++.. ..|+.++|||||||++
T Consensus 222 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwslG~il 295 (370)
T 2psq_A 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD------RVYTHQSDVWSFGVLM 295 (370)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT------CCCCHHHHHHHHHHHH
T ss_pred CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC------CCCCcHHHHHHHHHHH
Confidence 9999999999999999999999999999986654322 223567889999999874 3578899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+..+....+..+
T Consensus 296 ~ellt~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 321 (370)
T 2psq_A 296 WEIFTLGGSPYPGIPVEELFKLLKEG------------------------------------------------------ 321 (370)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHTT------------------------------------------------------
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHhcC------------------------------------------------------
Confidence 99998 99998665443333322221
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. . +....+++++++||.+||..||++|||+.|++++
T Consensus 322 ----------------~~-~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 322 ----------------HR-M--DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ----------------CC-C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0 1113568899999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=286.75 Aligned_cols=202 Identities=27% Similarity=0.509 Sum_probs=143.5
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH------------HHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN------------PALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~------------~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
..|+|+| ++.+ +.++..|+|||||. |. |.+.+... ..+..++.||+.||+|||++||+||||
T Consensus 66 ~~HpnIv-~~~~~~~~~~~~~lv~E~~~-gs--L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDL 141 (434)
T 2rio_A 66 DDHPNVI-RYYCSETTDRFLYIALELCN-LN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDL 141 (434)
T ss_dssp TTSTTBC-CEEEEEECSSEEEEEECCCS-EE--HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCCCcC-eEEEEEecCCeEEEEEecCC-CC--HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCC
Confidence 4788865 5543 44566799999996 45 77776432 123569999999999999999999999
Q ss_pred CCCcEEEecC-------------CCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccc-cCcCCCCcchh
Q psy3880 73 KPENILLDDQ-------------MNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMF-EDATGYGQAVD 133 (408)
Q Consensus 73 Kp~NILl~~~-------------~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~~~D 133 (408)
||+|||++.+ +.+||+|||+|..+..... ....+||+.|+|||++.+... .....++.++|
T Consensus 142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 221 (434)
T 2rio_A 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221 (434)
T ss_dssp SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence 9999999754 4799999999987654321 234689999999999864210 01245789999
Q ss_pred hhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHH
Q psy3880 134 VWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 212 (408)
Q Consensus 134 iwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily 212 (408)
|||+||++|+|++ |..||.+..... ..+..+.+....
T Consensus 222 iwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~---------------------------------------- 259 (434)
T 2rio_A 222 IFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE---------------------------------------- 259 (434)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCC----------------------------------------
T ss_pred hHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccc----------------------------------------
Confidence 9999999999998 999996543221 122222111100
Q ss_pred HhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 213 TLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 213 ~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.....+..+|+++++||.+||+.||++|||+.|+|+||||..
T Consensus 260 ---------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 260 ---------------------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp ---------------------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred ---------------------------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 000011234678999999999999999999999999999965
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=264.97 Aligned_cols=190 Identities=24% Similarity=0.343 Sum_probs=138.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++.-+....++..|+||||+.+|. |.+.+. +..++..++.|++.||+|||++||+||||||+|||+
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 149 (281)
T 1mp8_A 72 QFDHPHIVKLIGVITENPVWIIMELCTLGE--LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 149 (281)
T ss_dssp TCCCTTBCCEEEEECSSSCEEEEECCTTEE--HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hCCCCccceEEEEEccCccEEEEecCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE
Confidence 367998663333334456789999999998 777653 457889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~ 156 (408)
+.++.+||+|||++......... ....+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.+.+.
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp EETTEEEECC-------------------CCGGGCCHHHHHH------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CCCCCEEECccccccccCcccccccccCCCcccccChhhccc------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 99999999999999876543322 23457789999999865 357889999999999999996 9999976554
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+....+..+
T Consensus 224 ~~~~~~i~~~---------------------------------------------------------------------- 233 (281)
T 1mp8_A 224 NDVIGRIENG---------------------------------------------------------------------- 233 (281)
T ss_dssp GGHHHHHHTT----------------------------------------------------------------------
T ss_pred HHHHHHHHcC----------------------------------------------------------------------
Confidence 4333333221
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. .+....+++++++||.+||..||++|||+.|++++
T Consensus 234 ~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 234 ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10 01123578899999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=270.57 Aligned_cols=190 Identities=22% Similarity=0.328 Sum_probs=146.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|..+....++..++||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+|||+
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 148 (325)
T 3kex_A 71 SLDHAHIVRLLGLCPGSSLQLVTQYLPLGS--LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148 (325)
T ss_dssp TCCCTTBCCEEEEECBSSEEEEEECCTTCB--SHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE
T ss_pred cCCCCCcCeEEEEEcCCccEEEEEeCCCCC--HHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE
Confidence 357998663333333456789999999998 777653 337889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+|+.+..... .....||+.|+|||++.. ..++.++||||+||++|+|++ |..||.+.+
T Consensus 149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc------CCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 9999999999999987654322 234668889999999975 347889999999999999999 999997655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+.
T Consensus 223 ~~~~~~~~~~~~-------------------------------------------------------------------- 234 (325)
T 3kex_A 223 LAEVPDLLEKGE-------------------------------------------------------------------- 234 (325)
T ss_dssp TTHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 443333332211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. ...+ ...++++.+||.+||..||++|||+.|+++|
T Consensus 235 --~-~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 --R-LAQP--QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --B-CCCC--TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --C-CCCC--CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0001 2357788999999999999999999999886
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=278.20 Aligned_cols=193 Identities=18% Similarity=0.275 Sum_probs=152.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------------CHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------------SNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------------~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|+|+| .+.+ ..++..++||||+.||+ |.+.+. +..++..++.||+.||+|||++||+|||
T Consensus 130 ~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 206 (367)
T 3l9p_A 130 KFNHQNIV-RCIGVSLQSLPRFILLELMAGGD--LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206 (367)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred hCCCCCCC-eEEEEEecCCCCEEEEEeCCCCC--HHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 35799866 4443 44556789999999998 877763 3468899999999999999999999999
Q ss_pred CCCCcEEEecCC---CEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 72 LKPENILLDDQM---NVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 72 LKp~NILl~~~~---~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
|||+|||++.++ .+||+|||+|+.+.... ......||+.|+|||++.. ..|+.++|||||||++|+|+
T Consensus 207 lkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DvwslG~il~ell 280 (367)
T 3l9p_A 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME------GIFTSKTDTWSFGVLLWEIF 280 (367)
T ss_dssp CCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHH
T ss_pred CChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC------CCCCcHHHHHHHHHHHHHHH
Confidence 999999998554 59999999998654321 2234568999999999875 35789999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 146 V-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 146 ~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+ |..||.+.+..+....+..+..
T Consensus 281 t~g~~pf~~~~~~~~~~~i~~~~~-------------------------------------------------------- 304 (367)
T 3l9p_A 281 SLGYMPYPSKSNQEVLEFVTSGGR-------------------------------------------------------- 304 (367)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCC--------------------------------------------------------
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC--------------------------------------------------------
Confidence 8 9999977666555554443210
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
. .....+++++.+||.+||..||++|||+.|+++|.++.
T Consensus 305 --------------~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 --------------M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------C---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 01134688899999999999999999999999998763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=286.36 Aligned_cols=195 Identities=27% Similarity=0.478 Sum_probs=137.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|+|+| ++.. ..++..|+|||||.| . |.+.+.. ..++..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~HpnIv-~l~~~~~~~~~~~lv~E~~~g-~--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll 151 (432)
T 3p23_A 76 EHPNVI-RYFCTEKDRQFQYIAIELCAA-T--LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151 (432)
T ss_dssp CCTTBC-CEEEEEEETTEEEEEEECCSE-E--HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEE
T ss_pred CCCCcC-eEEEEEecCCEEEEEEECCCC-C--HHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEE
Confidence 688866 5544 344567999999975 4 7776632 24677899999999999999999999999999999
Q ss_pred ec---C--CCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCC
Q psy3880 80 DD---Q--MNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCP 149 (408)
Q Consensus 80 ~~---~--~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~ 149 (408)
+. + ..+||+|||+|+.+.... .....+||+.|+|||++.... ...++.++||||+||++|+|++ |..
T Consensus 152 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC---KENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp CCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC------CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred ecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhccc---ccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 53 2 358899999998765432 234578999999999986421 2345678999999999999998 888
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.......... + .
T Consensus 229 pf~~~~~~~~~~-~-~---------------------------------------------------------------- 242 (432)
T 3p23_A 229 PFGKSLQRQANI-L-L---------------------------------------------------------------- 242 (432)
T ss_dssp TTBSTTTHHHHH-H-T----------------------------------------------------------------
T ss_pred CcchhhHHHHHH-H-h----------------------------------------------------------------
Confidence 885433221110 0 0
Q ss_pred HHHHHhcCCCCCC-CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 230 LRNIMEGKYSFSS-PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 230 ~~~i~~~~~~f~~-~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+...... ......+..+++||.+||+.||++|||++|+|+||||..
T Consensus 243 ------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 243 ------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0000000 001123556899999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-34 Score=279.95 Aligned_cols=211 Identities=23% Similarity=0.421 Sum_probs=143.9
Q ss_pred HHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEec------CCCEEEe
Q psy3880 23 LKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENILLDD------QMNVKLT 88 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NILl~~------~~~iKl~ 88 (408)
..++|||++ +|. |.+.+ .+...+..++.||+.||+|||++ ||+||||||+|||++. .+.+||+
T Consensus 104 ~~~lv~e~~-~~~--L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~ 180 (373)
T 1q8y_A 104 HVVMVFEVL-GEN--LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180 (373)
T ss_dssp EEEEEECCC-CEE--HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred eEEEEEecC-CCC--HHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEc
Confidence 578999999 666 66654 34578999999999999999998 9999999999999953 3379999
Q ss_pred ccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch------hHHHHHH
Q psy3880 89 DFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK------QMVMLRN 162 (408)
Q Consensus 89 DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~------~~~~~~~ 162 (408)
|||++...... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+ ....+..
T Consensus 181 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 181 DLGNACWYDEH--YTNSIQTREYRSPEVLLG------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp CCTTCEETTBC--CCSCCSCGGGCCHHHHHT------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ccccccccCCC--CCCCCCCccccCcHHHhC------CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 99999766432 345689999999999975 347889999999999999999999998654 2233333
Q ss_pred HHhccccCCCCCCccCCCCCchHHHhhhcc-----cccc--cCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMF-----EDAT--GYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 163 i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~-----~~~~--~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
+...... .+++.+....+ .... ..-.....|. +..+..
T Consensus 253 ~~~~~~~------------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~ 297 (373)
T 1q8y_A 253 IIELLGE------------LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP-----------------------LEDVLT 297 (373)
T ss_dssp HHHHHCS------------CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC-----------------------HHHHHH
T ss_pred HHHhcCC------------CCHHHHhccchhhhhcCCcchhcccccccccc-----------------------hhhhhh
Confidence 3321111 11111111000 0000 0000011111 112222
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
..+.++ ..+++++++||++||+.||++|||++|+|+||||+...
T Consensus 298 ~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 298 EKYKFS----KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HTTCCC----HHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hcccCC----cchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 222222 23577899999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-33 Score=260.68 Aligned_cols=189 Identities=21% Similarity=0.343 Sum_probs=148.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ +.++..++||||+.+|. |.+.+ .+...+..++.|++.||+|||++||+||||||+||
T Consensus 61 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 61 KLSHPKLV-QLYGVCLEQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEEECCTTCB--HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hCCCCCEe-eEEEEEecCCceEEEEEeCCCCc--HHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 46798865 5443 44556789999999998 87776 34578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||++....... ......+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 138 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC------CCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999998664432 2233567788999999865 347789999999999999998 88888766
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+.
T Consensus 212 ~~~~~~~~~~~~~------------------------------------------------------------------- 224 (269)
T 4hcu_A 212 SNSEVVEDISTGF------------------------------------------------------------------- 224 (269)
T ss_dssp CHHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHhcCc-------------------------------------------------------------------
Confidence 5554444443221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. ......|+++++||.+||..||++|||+.|+++|
T Consensus 225 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ---RL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---cC---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 1112468899999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-33 Score=268.60 Aligned_cols=197 Identities=24% Similarity=0.485 Sum_probs=147.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 67 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 143 (294)
T 4eqm_A 67 QLSHQNIV-SMIDVDEEDDCYYLVMEYIEGPT--LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143 (294)
T ss_dssp TCCBTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cCCCCCCc-eEEEeeeeCCeEEEEEeCCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 46899866 4443 45567899999999998 877763 55889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG------EATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp ECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999998765432 2234679999999999875 3467889999999999999999999977665
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....+...... |
T Consensus 218 ~~~~~~~~~~~~---------------------------------------------------~---------------- 230 (294)
T 4eqm_A 218 VSIAIKHIQDSV---------------------------------------------------P---------------- 230 (294)
T ss_dssp HHHHHHHHSSCC---------------------------------------------------C----------------
T ss_pred HHHHHHHhhccC---------------------------------------------------C----------------
Confidence 443333322110 0
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
......+..+++++.++|.+||..||++||+..+.+.+.|..
T Consensus 231 --~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 --NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp --CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred --CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 000012346789999999999999999999666666666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-33 Score=266.23 Aligned_cols=203 Identities=22% Similarity=0.337 Sum_probs=141.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~NILl 79 (408)
.+.|+|++ ++.+ ..++..++||||+.+....+... -.+...+..++.||+.||.|||++ ||+||||||+|||+
T Consensus 80 ~~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~ 158 (318)
T 2dyl_A 80 SHDCPYIV-QCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158 (318)
T ss_dssp TTTCTTBC-CEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE
T ss_pred hcCCCcee-eEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE
Confidence 35788865 4443 44567799999994332222221 135688999999999999999995 99999999999999
Q ss_pred ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc-hhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR-KQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~-~~~~ 158 (408)
+.++.+||+|||++.............||+.|+|||++..... ....++.++||||+||++|+|++|..||... ....
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (318)
T 2dyl_A 159 DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP-TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237 (318)
T ss_dssp CTTSCEEECCCTTC--------------CCTTCCHHHHC---------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccc-cccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH
Confidence 9999999999999987665544456789999999999853211 1245788999999999999999999999653 2222
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+.. +..
T Consensus 238 ~~~~~~~----------------------------------------------------------------------~~~ 247 (318)
T 2dyl_A 238 VLTKVLQ----------------------------------------------------------------------EEP 247 (318)
T ss_dssp HHHHHHH----------------------------------------------------------------------SCC
T ss_pred HHHHHhc----------------------------------------------------------------------cCC
Confidence 2222222 111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
. ..+.+..+++++++||.+||..||.+|||++|+|+||||+.
T Consensus 248 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 248 P-LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp C-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred C-CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 1 11223467899999999999999999999999999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-33 Score=271.92 Aligned_cols=156 Identities=24% Similarity=0.345 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhh
Q psy3880 43 NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRA 119 (408)
Q Consensus 43 ~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~ 119 (408)
.+..++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ......||+.|+|||++..
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence 4557788999999999999999999999999999999999999999999998664332 2234668899999999875
Q ss_pred ccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccC
Q psy3880 120 NMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGY 198 (408)
Q Consensus 120 ~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y 198 (408)
..|+.++||||+||++|+|++ |..||.+.+....+...
T Consensus 270 ------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----------------------------------- 308 (359)
T 3vhe_A 270 ------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------------------- 308 (359)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-----------------------------------
T ss_pred ------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-----------------------------------
Confidence 357899999999999999998 99999664422211111
Q ss_pred CCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 199 GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 199 ~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+..+. ... ....+++++.+||.+||..||++|||+.|+++|
T Consensus 309 ----------------------------------~~~~~-~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 309 ----------------------------------LKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------------------------------HHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------HHcCC-CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11111 111 113468899999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=273.08 Aligned_cols=187 Identities=21% Similarity=0.366 Sum_probs=148.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|+| ++.+ ..++..++||||+.+|. |.+.+ .+..++..++.||+.||+|||+
T Consensus 133 ~hpnIv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 133 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCchhh-hheeeeccCCceEEEEEecCCCc--HHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 788865 5444 45566899999999998 88776 4568899999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||+|+...... ......+|+.|+|||++.+ ..++.++||||+||++
T Consensus 210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il 283 (382)
T 3tt0_A 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD------RIYTHQSDVWSFGVLL 283 (382)
T ss_dssp TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS------CCCCHHHHHHHHHHHH
T ss_pred CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC------CCCCchhHHHHHHHHH
Confidence 999999999999999999999999999998765432 2233567889999999864 3577899999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+..+....+..+.
T Consensus 284 ~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------------------------------------- 310 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPVEELFKLLKEGH----------------------------------------------------- 310 (382)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTC-----------------------------------------------------
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------------------------------------------
Confidence 99998 888887665544444333221
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. . .....+++++++||++||..||++|||++|+++|
T Consensus 311 -----------------~-~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 311 -----------------R-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -----------------C-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------C-C--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0 1113578899999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-33 Score=268.96 Aligned_cols=187 Identities=34% Similarity=0.553 Sum_probs=146.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhh-chhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDK-GEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~-g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|++++ ++.+ +.++..++|+|++.+ |. |.+.+. +...++.++.||+.||+|||++||+||||||+|||+
T Consensus 106 ~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~~--L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll 182 (320)
T 3a99_A 106 GFSGVI-RLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182 (320)
T ss_dssp SSCSBC-CEEEEEECSSEEEEEEECCSSEEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCce-EEEEEEecCCcEEEEEEcCCCCcc--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE
Confidence 357755 4443 445667899999976 66 776653 457899999999999999999999999999999999
Q ss_pred e-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 D-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+ +++.+||+|||++...... ......||+.|+|||++... ..++.++|+|||||++|+|++|..||.....
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 254 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH-----RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-- 254 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHS-----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred eCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccC-----CCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence 9 7789999999999876543 33457899999999998753 2235778999999999999888888854321
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+..+..
T Consensus 255 --------------------------------------------------------------------------~~~~~~ 260 (320)
T 3a99_A 255 --------------------------------------------------------------------------IIRGQV 260 (320)
T ss_dssp --------------------------------------------------------------------------HHHCCC
T ss_pred --------------------------------------------------------------------------hhcccc
Confidence 011111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.++ ..+++++++||.+||..||++|||++|+++||||+...
T Consensus 261 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 261 FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 111 35788999999999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=265.00 Aligned_cols=189 Identities=20% Similarity=0.306 Sum_probs=147.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----------------------------CCHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----------------------------NSNPALRYIMRQ 54 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----------------------------~~~~~~r~i~~q 54 (408)
.+.|+|+| ++.+ ..++..++||||+.||. |.+.+ .+..++..++.|
T Consensus 82 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 82 QVNHPHVI-KLYGACSQDGPLLLIVEYAKYGS--LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred hCCCCcee-eEEEEEecCCceEEEEeecCCCC--HHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 46799866 4443 45567899999999998 87766 345788999999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcc
Q psy3880 55 LFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQA 131 (408)
Q Consensus 55 il~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~ 131 (408)
|+.||+|||++||+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++... .++.+
T Consensus 159 i~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~ 232 (314)
T 2ivs_A 159 ISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH------IYTTQ 232 (314)
T ss_dssp HHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC------EECHH
T ss_pred HHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC------CcCch
Confidence 99999999999999999999999999999999999999986644322 1235678899999998753 46789
Q ss_pred hhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhh
Q psy3880 132 VDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVI 210 (408)
Q Consensus 132 ~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvi 210 (408)
+|+||+||++|+|++ |..||.+.+.......+..
T Consensus 233 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--------------------------------------------- 267 (314)
T 2ivs_A 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT--------------------------------------------- 267 (314)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---------------------------------------------
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhc---------------------------------------------
Confidence 999999999999998 9888866543332222221
Q ss_pred HHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 211 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 211 ly~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+.. .+....+++++++||.+||..||++|||+.|+++|
T Consensus 268 -------------------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 268 -------------------------GHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp -------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 110 01123578999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=261.45 Aligned_cols=196 Identities=24% Similarity=0.389 Sum_probs=142.7
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++.-+....++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||+
T Consensus 76 ~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~ 153 (289)
T 3og7_A 76 KTRHVNILLFMGYSTAPQLAIVTQWCEGSS--LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153 (289)
T ss_dssp TCCCTTBCCEEEEECSSSCEEEEECCCEEE--HHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hCCCCcEEEEEeeccCCccEEEEEecCCCc--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 467998774444455566789999999998 887773 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhccc---CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKK---GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+.++.+||+|||++..... ........||+.|+|||++... ....++.++||||+||++|+|++|..||.+.+.
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ---DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ETTTEEEECCCC------------------CCCTTCCHHHHC-------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCEEEccceeccccccccccccccccCCCccccCchhhccc---CCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 9999999999999976543 2223446799999999998632 124578899999999999999999999977544
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+..+.. .+
T Consensus 231 ~~~~~~~~~---------------------------------------------------------------------~~ 241 (289)
T 3og7_A 231 RDQIIEMVG---------------------------------------------------------------------RG 241 (289)
T ss_dssp HHHHHHHHH---------------------------------------------------------------------HT
T ss_pred HHHHHHHhc---------------------------------------------------------------------cc
Confidence 333322221 11
Q ss_pred CCCCC-CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 237 KYSFS-SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 237 ~~~f~-~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..... ......+++++++||.+||..||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11110 1112357889999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=257.52 Aligned_cols=189 Identities=20% Similarity=0.349 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.+|. |.+.+ .+..++..++.|++.||+|||++||+||||||+||
T Consensus 59 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 135 (268)
T 3sxs_A 59 KLSHPKLV-KFYGVCSKEYPIYIVTEYISNGC--LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135 (268)
T ss_dssp HCCCTTBC-CEEEEECSSSSEEEEEECCTTCB--HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred hCCCCCEe-eEEEEEccCCceEEEEEccCCCc--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence 36788865 5444 44556789999999998 77665 35588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||++......... ....+|+.|+|||++... .++.++|+||+||++|+|++ |..||...
T Consensus 136 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 136 LVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF------KYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp EECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS------EEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred EECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc------CCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 9999999999999999866544322 234567789999998753 46789999999999999998 99999776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+.
T Consensus 210 ~~~~~~~~~~~~~------------------------------------------------------------------- 222 (268)
T 3sxs_A 210 TNSEVVLKVSQGH------------------------------------------------------------------- 222 (268)
T ss_dssp CHHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred ChHHHHHHHHcCC-------------------------------------------------------------------
Confidence 6554444433221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.... ....|+++.+||.+||..||++|||+.|+++|
T Consensus 223 ---~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ---RLYR---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---CCCC---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CCCC---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0110 12357889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-33 Score=272.54 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=133.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh-------hCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI-------INSNPALRYIMRQLFEALEHVHNH-SVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~-------~~~~~~~r~i~~qil~aL~~LH~~-~IvHRDLKp~ 75 (408)
.+.|+|++ ++.+ ..++..++||||+.++...+... ..+...+..++.|++.||.|||++ ||+||||||+
T Consensus 77 ~~~h~niv-~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 155 (327)
T 3aln_A 77 SSDCPYIV-QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155 (327)
T ss_dssp SCCCTTBC-CEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG
T ss_pred cCCCCcEe-eeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH
Confidence 45788865 5443 34566789999999863223322 235578899999999999999999 9999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|||++.++.+||+|||++.............||+.|+|||++.... ....++.++|+||+||++|+|++|..||.+.+
T Consensus 156 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 156 NILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA--SRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp GEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred HEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeecccc--CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998766544444568999999999984321 12457889999999999999999999996532
Q ss_pred hH-HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 156 QM-VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 156 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.. ..+.. ...+.+|
T Consensus 234 ~~~~~~~~---------------------------------------------------~~~~~~~-------------- 248 (327)
T 3aln_A 234 SVFDQLTQ---------------------------------------------------VVKGDPP-------------- 248 (327)
T ss_dssp ------CC---------------------------------------------------CCCSCCC--------------
T ss_pred hHHHHHHH---------------------------------------------------HhcCCCC--------------
Confidence 11 00000 0011111
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+....+..+++++++||.+||..||++|||+.|+|+||||..
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 249 ----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1222334568999999999999999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=263.04 Aligned_cols=187 Identities=30% Similarity=0.488 Sum_probs=144.2
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHH-HhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQV-VDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~-~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|+|++ ++.+ ..++..++|+|+ +.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~~--L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 96 GHPGVI-RLLDWFETQEGFMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172 (312)
T ss_dssp CCSSBC-CEEEEC-----CEEEEECCSSEEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE
T ss_pred CCCCee-eEEEEEecCCeEEEEEEecCCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE
Confidence 688865 5444 344567899999 78888 877763 568899999999999999999999999999999999
Q ss_pred e-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 D-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+ .++.+||+|||++...... ......||+.|+|||++... ..++.++|+||+||++|+|++|..||.....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 244 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRH-----QYHALPATVWSLGILLYDMVCGDIPFERDQE-- 244 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHS-----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred eCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecC-----CCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence 9 7899999999999876543 34557899999999998753 2234578888888888888888888854211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+.....
T Consensus 245 --------------------------------------------------------------------------~~~~~~ 250 (312)
T 2iwi_A 245 --------------------------------------------------------------------------ILEAEL 250 (312)
T ss_dssp --------------------------------------------------------------------------HHHTCC
T ss_pred --------------------------------------------------------------------------Hhhhcc
Confidence 111111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.++ ..+++++++||.+||..||++|||++|+|+||||+...
T Consensus 251 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 251 HFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 121 35788999999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=268.24 Aligned_cols=189 Identities=19% Similarity=0.270 Sum_probs=147.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------------------------CHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----------------------------SNPALRYIMRQLFE 57 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----------------------------~~~~~r~i~~qil~ 57 (408)
.|+|++ ++.+ ..++..++||||+.+|. |.+.+. +..++..++.||+.
T Consensus 107 ~hp~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (344)
T 1rjb_A 107 SHENIV-NLLGACTLSGPIYLIFEYCCYGD--LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183 (344)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred CCCCee-eEEEEEeeCCccEEEEecCCCCc--HHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHH
Confidence 788865 4443 45567899999999998 877763 45678899999999
Q ss_pred HHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhh
Q psy3880 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDV 134 (408)
Q Consensus 58 aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~Di 134 (408)
||+|||++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.. ..++.++||
T Consensus 184 aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di 257 (344)
T 1rjb_A 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE------GIYTIKSDV 257 (344)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH------CCCCHHHHH
T ss_pred HHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc------CCCChhHhH
Confidence 99999999999999999999999999999999999986654322 223567889999999875 347889999
Q ss_pred hhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHH
Q psy3880 135 WACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 213 (408)
Q Consensus 135 wSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ 213 (408)
|||||++|+|++ |..||.+......+..+..
T Consensus 258 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------------------------------------------ 289 (344)
T 1rjb_A 258 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ------------------------------------------------ 289 (344)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH------------------------------------------------
T ss_pred HHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh------------------------------------------------
Confidence 999999999998 9999966543222222211
Q ss_pred hhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy3880 214 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277 (408)
Q Consensus 214 ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hp 277 (408)
...... ....+++++.+||.+||..||.+|||+.|+++|.
T Consensus 290 ----------------------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 290 ----------------------NGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ----------------------TTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----------------------cCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 111111 1134688999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=257.09 Aligned_cols=189 Identities=25% Similarity=0.435 Sum_probs=141.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHS---VVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~---IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ ..++..++||||+.||. |.+.+. +...+..++.|++.||+|||++| |+||||||+|
T Consensus 62 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 62 MLKHPNII-ALRGVCLKEPNLCLVMEFARGGP--LNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp HCCCTTBC-CEEEEECCC--CEEEEECCTTEE--HHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred hcCCCCEe-eEEEEEecCCceEEEEEcCCCCC--HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 36788865 5444 44556789999999998 777763 45889999999999999999999 9999999999
Q ss_pred EEEec--------CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 77 ILLDD--------QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 77 ILl~~--------~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
||++. ++.+||+|||++....... .....||+.|+|||++.. ..++.++|+||+||++|+|++|.
T Consensus 139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 139 ILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA------SMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp EEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH------CCCSHHHHHHHHHHHHHHHHHCC
T ss_pred EEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhcc------CCCCchhhHHHHHHHHHHHHhCC
Confidence 99985 6789999999998765433 235689999999999875 34788999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+.+.......+....
T Consensus 212 ~p~~~~~~~~~~~~~~~~~------------------------------------------------------------- 230 (271)
T 3dtc_A 212 VPFRGIDGLAVAYGVAMNK------------------------------------------------------------- 230 (271)
T ss_dssp CTTTTSCHHHHHHHHHTSC-------------------------------------------------------------
T ss_pred CCCCCCCHHHHHHhhhcCC-------------------------------------------------------------
Confidence 9997765544433332211
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
...+ ....+++++++||.+||..||++|||+.|+++|
T Consensus 231 ---------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 ---------LALP--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1111 113568899999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=266.99 Aligned_cols=188 Identities=21% Similarity=0.407 Sum_probs=145.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| .+.+ +..+..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 106 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 182 (325)
T 3kul_A 106 QFDHPNII-RLEGVVTRGRLAMIVTEYMENGS--LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182 (325)
T ss_dssp TCCCTTBC-CEEEEECGGGCCEEEEECCTTCB--HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCCC-cEEEEEEeCCccEEEeeCCCCCc--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 46798865 5544 34456789999999998 877763 3478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
|++.++.+||+|||++........ .....+|+.|+|||++... .++.++||||+||++|+|++ |..||.
T Consensus 183 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR------TFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp EECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC------CCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999987654321 1224567789999999753 46788999999999999988 888887
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+.......+..+.
T Consensus 257 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 271 (325)
T 3kul_A 257 NMTNRDVISSVEEGY----------------------------------------------------------------- 271 (325)
T ss_dssp TSCHHHHHHHHHTTC-----------------------------------------------------------------
T ss_pred cCCHHHHHHHHHcCC-----------------------------------------------------------------
Confidence 665555444443221
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. +....+++++.+||.+||..||++|||+.|+++
T Consensus 272 ------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ------RL--PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CC--CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01 112357889999999999999999999999886
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=266.52 Aligned_cols=187 Identities=21% Similarity=0.327 Sum_probs=145.1
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|++ ++.+ +.++..|+||||+.+|. |.+++ .+..++..++.||+.||+|||+
T Consensus 84 ~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 160 (327)
T 1fvr_A 84 HHPNII-NLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160 (327)
T ss_dssp CCTTBC-CEEEEEEETTEEEEEECCCTTCB--HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCchh-hhceeeeeCCceEEEEecCCCCC--HHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 688755 5544 44566789999999998 87766 3457889999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||+||||||+|||++.++.+||+|||+++............+++.|+|||++... .++.++|+||+||++|+|
T Consensus 161 ~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el 234 (327)
T 1fvr_A 161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEI 234 (327)
T ss_dssp TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC------EECHHHHHHHHHHHHHHH
T ss_pred CCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccc------cCCchhcchHHHHHHHHH
Confidence 99999999999999999999999999998754433333345678899999998653 467899999999999999
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+.+.......+..+.
T Consensus 235 lt~g~~pf~~~~~~~~~~~~~~~~-------------------------------------------------------- 258 (327)
T 1fvr_A 235 VSLGGTPYCGMTCAELYEKLPQGY-------------------------------------------------------- 258 (327)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTC--------------------------------------------------------
T ss_pred HcCCCCCCCCCcHHHHHHHhhcCC--------------------------------------------------------
Confidence 98 999987765544444332210
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. .....+++++++||.+||..||++|||++|+++|
T Consensus 259 ---------------~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 ---------------RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---------------CC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 1112468899999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=265.44 Aligned_cols=189 Identities=21% Similarity=0.322 Sum_probs=148.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----------------------------CHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----------------------------SNPALRYIMRQ 54 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----------------------------~~~~~r~i~~q 54 (408)
.+.|+|++ .+.+ +.++..++||||+.+|. |.+++. +..++..++.|
T Consensus 106 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 182 (343)
T 1luf_A 106 EFDNPNIV-KLLGVCAVGKPMCLLFEYMAYGD--LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182 (343)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred hCCCCCEE-EEEEEEccCCceEEEEecCCCCc--HHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence 46798866 5443 45567899999999998 777652 34678889999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcc
Q psy3880 55 LFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQA 131 (408)
Q Consensus 55 il~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~ 131 (408)
|+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.. ..++.+
T Consensus 183 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~ 256 (343)
T 1luf_A 183 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY------NRYTTE 256 (343)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH------CCCCHH
T ss_pred HHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc------CCcCcc
Confidence 9999999999999999999999999999999999999998764332 1234568899999999875 347889
Q ss_pred hhhhhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhh
Q psy3880 132 VDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVI 210 (408)
Q Consensus 132 ~DiwSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvi 210 (408)
+|+||+||++|+|++ |..||.+.+..+....+..+.
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------------------------------------- 293 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN------------------------------------------- 293 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------------------------------------------
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-------------------------------------------
Confidence 999999999999998 999997766555444443321
Q ss_pred HHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 211 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 211 ly~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
... ....+++++.+||++||..||++|||+.|++++
T Consensus 294 ---------------------------~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 294 ---------------------------ILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp ---------------------------CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------cCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 100 012468899999999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=266.38 Aligned_cols=190 Identities=22% Similarity=0.298 Sum_probs=145.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|..+....++..++|+|++.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+|||+
T Consensus 73 ~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll 150 (327)
T 3poz_A 73 SVDNPHVCRLLGICLTSTVQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150 (327)
T ss_dssp HCCBTTBCCEEEEEESSSEEEEEECCTTCB--HHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEecCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE
Confidence 367988663333322334678999999998 777653 347889999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
+.++.+||+|||+|+.+...... ....+|+.|+|||++.. ..|+.++||||+||++|+|++ |..||.+.+
T Consensus 151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc------CCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 99999999999999876543322 23456889999999975 357889999999999999999 999997654
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+
T Consensus 225 ~~~~~~~~~~~--------------------------------------------------------------------- 235 (327)
T 3poz_A 225 ASEISSILEKG--------------------------------------------------------------------- 235 (327)
T ss_dssp GGGHHHHHHTT---------------------------------------------------------------------
T ss_pred HHHHHHHHHcC---------------------------------------------------------------------
Confidence 43322222211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .. +.....+.++.+||.+||+.||++|||+.|+++|
T Consensus 236 -~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 -E-RL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -C-CC--CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -C-CC--CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 01 1113467889999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=258.56 Aligned_cols=189 Identities=22% Similarity=0.341 Sum_probs=150.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 75 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 151 (283)
T 3gen_A 75 NLSHEKLV-QLYGVCTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151 (283)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEECCCTTCB--HHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred cCCCCCEe-eEEEEEecCCCeEEEEeccCCCc--HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceE
Confidence 46788865 5444 44556789999999998 877764 3478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||++....... ......+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||...
T Consensus 152 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 152 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY------SKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp EECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred EEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998664332 1223556788999999875 347889999999999999998 99999776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+.
T Consensus 226 ~~~~~~~~~~~~~------------------------------------------------------------------- 238 (283)
T 3gen_A 226 TNSETAEHIAQGL------------------------------------------------------------------- 238 (283)
T ss_dssp CHHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred ChhHHHHHHhccc-------------------------------------------------------------------
Confidence 6555444443321
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
... .....++++.+||.+||..||++|||++|+++|
T Consensus 239 ---~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 239 ---RLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---CCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CCC---CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000 112457889999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=258.34 Aligned_cols=189 Identities=21% Similarity=0.312 Sum_probs=144.3
Q ss_pred cccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 7 VAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 7 ~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
+.|+|++.-+....++..|+|||++.+|. |.+.+ .+...+..++.||+.||+|||++||+||||||+|||++
T Consensus 70 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 147 (281)
T 3cc6_A 70 LDHPHIVKLIGIIEEEPTWIIMELYPYGE--LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA 147 (281)
T ss_dssp HCCTTBCCEEEEECSSSCEEEEECCTTCB--HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred CCCCCcceEEEEEcCCCCEEEEecCCCCC--HHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC
Confidence 57888663333333445689999999998 77766 34578899999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchhH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 157 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~~ 157 (408)
.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||......
T Consensus 148 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 148 SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc------CCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 999999999999987654322 223567889999999864 357889999999999999998 99999654433
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....+..+ .
T Consensus 222 ~~~~~~~~~----------------------------------------------------------------------~ 231 (281)
T 3cc6_A 222 DVIGVLEKG----------------------------------------------------------------------D 231 (281)
T ss_dssp GHHHHHHHT----------------------------------------------------------------------C
T ss_pred HHHHHHhcC----------------------------------------------------------------------C
Confidence 322222211 0
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. . +....+++++.+||.+||..||++|||+.|+++|
T Consensus 232 ~-~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 R-L--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp C-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-C--CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0 0 1113468899999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=262.46 Aligned_cols=189 Identities=20% Similarity=0.329 Sum_probs=150.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------CHHHHHHHHHHHHHHHHHHHHCCCe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------SNPALRYIMRQLFEALEHVHNHSVV 68 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------~~~~~r~i~~qil~aL~~LH~~~Iv 68 (408)
.+.|+|++ ++.+ ..++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+
T Consensus 84 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 160 (322)
T 1p4o_A 84 EFNCHHVV-RLLGVVSQGQPTLVIMELMTRGD--LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160 (322)
T ss_dssp GCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred hcCCCCEe-eeEEEEccCCccEEEEEeCCCCc--HHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 46788865 4443 44566789999999998 877764 4467888999999999999999999
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|+
T Consensus 161 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el~ 234 (322)
T 1p4o_A 161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD------GVFTTYSDVWSFGVVLWEIA 234 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc------CCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999986644322 123457889999999875 34788999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 146 V-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 146 ~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+ |..||.+.+.......+..+.
T Consensus 235 ~~g~~p~~~~~~~~~~~~~~~~~--------------------------------------------------------- 257 (322)
T 1p4o_A 235 TLAEQPYQGLSNEQVLRFVMEGG--------------------------------------------------------- 257 (322)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTC---------------------------------------------------------
T ss_pred hcCCCccccCCHHHHHHHHHcCC---------------------------------------------------------
Confidence 9 888987765554444443321
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. +....+++++++||.+||..||++|||+.|+++|
T Consensus 258 -------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 -------------LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------cC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10 0113568899999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=276.49 Aligned_cols=188 Identities=22% Similarity=0.408 Sum_probs=148.0
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.. ..++..|+||||+.+|. |.+++.. ..++..++.||+.||+|||++||+||||||+||
T Consensus 239 ~l~h~~iv-~l~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 239 TLQHDKLV-KLHAVVTKEPIYIITEFMAKGS--LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp TCCCTTBC-CEEEEECSSSCEEEECCCTTCB--HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred hCCCCCEe-eEEEEEeCCccEEEEeecCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 46799866 4443 33556789999999998 8887753 367888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||+|+....... .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||.+.
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF------GSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654321 123456788999999975 347889999999999999998 99998776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....+..+
T Consensus 390 ~~~~~~~~i~~~-------------------------------------------------------------------- 401 (454)
T 1qcf_A 390 SNPEVIRALERG-------------------------------------------------------------------- 401 (454)
T ss_dssp CHHHHHHHHHHT--------------------------------------------------------------------
T ss_pred CHHHHHHHHHcC--------------------------------------------------------------------
Confidence 555444444322
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+..+ ....+++++.+||.+||..||++|||++++++
T Consensus 402 ---~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 402 ---YRMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---CCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1111 12356889999999999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=262.03 Aligned_cols=188 Identities=19% Similarity=0.293 Sum_probs=146.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----------------------CCHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----------------------NSNPALRYIMRQLFEALEHV 62 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----------------------~~~~~~r~i~~qil~aL~~L 62 (408)
.|+|++ ++.+ +.++..++||||+.+|. |.+.+ .+..++..++.||+.||+||
T Consensus 85 ~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 161 (313)
T 1t46_A 85 NHMNIV-NLLGACTIGGPTLVITEYCCYGD--LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (313)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCee-eEEEEEecCCCcEEEEecCCCCC--HHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 688865 4443 45567799999999998 77765 35578999999999999999
Q ss_pred HHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 63 HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 63 H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
|++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.. ..++.++|+||+||
T Consensus 162 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~ 235 (313)
T 1t46_A 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN------CVYTFESDVWSYGI 235 (313)
T ss_dssp HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH------CCCCHHHHHHHHHH
T ss_pred HHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC------CCCChHHHHHHHHH
Confidence 999999999999999999999999999999987654332 123557889999999875 35788999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC
Q psy3880 140 IMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218 (408)
Q Consensus 140 il~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~ 218 (408)
++|+|++ |..||.+......+..+..
T Consensus 236 il~ellt~g~~p~~~~~~~~~~~~~~~----------------------------------------------------- 262 (313)
T 1t46_A 236 FLWELFSLGSSPYPGMPVDSKFYKMIK----------------------------------------------------- 262 (313)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHH-----------------------------------------------------
T ss_pred HHHHHHhCCCCCCCcccchhHHHHHhc-----------------------------------------------------
Confidence 9999998 9999866443222211111
Q ss_pred CCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..... .....+++++++||.+||..||.+|||+.|++++
T Consensus 263 -----------------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 -----------------EGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp -----------------HTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------cCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11111 1123578899999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=258.92 Aligned_cols=191 Identities=20% Similarity=0.282 Sum_probs=150.3
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+....++..++|||++.+|. |.+.+. +..++..++.||+.||.|||++||+||||||+|||+
T Consensus 66 ~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili 143 (287)
T 1u59_A 66 QLDNPYIVRLIGVCQAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143 (287)
T ss_dssp HCCCTTBCCEEEEEESSSEEEEEECCTTEE--HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCEeEEEEEecCCCcEEEEEeCCCCC--HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE
Confidence 357888663333334455789999999998 888763 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 144 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF------RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH------CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc------CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999987653322 123456889999999865 346789999999999999998 99999766
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....+..+.
T Consensus 218 ~~~~~~~~i~~~~------------------------------------------------------------------- 230 (287)
T 1u59_A 218 KGPEVMAFIEQGK------------------------------------------------------------------- 230 (287)
T ss_dssp CTHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHhcCC-------------------------------------------------------------------
Confidence 5544443333221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hp 277 (408)
.. +....+++++++||.+||..||++|||+.|+++|.
T Consensus 231 ---~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ---RM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ---CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ---cC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 01135788999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=262.62 Aligned_cols=142 Identities=24% Similarity=0.407 Sum_probs=112.6
Q ss_pred ccccCCcEEEEec------cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHH--------HCCC
Q psy3880 6 MVAHSRVVVRVKE------EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVH--------NHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH--------~~~I 67 (408)
++.|+|++ ++.. ...+..++||||+.+|. |.+.+. +...+..++.||+.||+||| ++||
T Consensus 58 ~l~h~niv-~~~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 58 MLRHENIL-GFIASDMTSRHSSTQLWLITHYHEMGS--LYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp CCCCTTBC-CEEEEEEEEETTEEEEEEEECCCTTCB--HHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred hccCcCee-eEEEeeccccCCCceeEEehhhccCCC--HHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 37899866 4432 22345789999999998 888874 34788999999999999999 9999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
+||||||+|||++.++.+||+|||+|+....... ....+||+.|+|||++..........++.++||||+||++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 9999999999999999999999999976654322 12358999999999997542211113457899999999999
Q ss_pred HHHhCCCC
Q psy3880 143 TLLVGCPP 150 (408)
Q Consensus 143 ~ll~G~~p 150 (408)
+|++|..|
T Consensus 215 el~tg~~~ 222 (301)
T 3q4u_A 215 EVARRMVS 222 (301)
T ss_dssp HHHTTBCB
T ss_pred HHHhhhcC
Confidence 99999433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=257.37 Aligned_cols=191 Identities=21% Similarity=0.312 Sum_probs=145.9
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHS--VVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~--IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+...+..++||||+.+|. |.+.+. +...+..++.|++.||+|||++| |+||||||+||
T Consensus 79 ~l~h~~i~-~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Ni 155 (287)
T 4f0f_A 79 NLNHPNIV-KLYGLMHNPPRMVMEFVPCGD--LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155 (287)
T ss_dssp TCCCTTBC-CEEEEETTTTEEEEECCTTCB--HHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGE
T ss_pred hCCCCCch-hhheeecCCCeEEEEecCCCC--HHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceE
Confidence 35788755 666554455589999999998 777652 44788999999999999999999 99999999999
Q ss_pred EEecCCC-----EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 78 LLDDQMN-----VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 78 Ll~~~~~-----iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|++.++. +||+|||+++.... ......||+.|+|||++... ...++.++|+||+||++|+|++|..||.
T Consensus 156 l~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 156 FLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAE----EESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp EESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCS----SCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccC----CCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9987776 99999999975433 34457899999999998432 2346789999999999999999999996
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..+.... .....
T Consensus 230 ~~~~~~~--------------------------------------------------------------------~~~~~ 241 (287)
T 4f0f_A 230 EYSYGKI--------------------------------------------------------------------KFINM 241 (287)
T ss_dssp TCCCCHH--------------------------------------------------------------------HHHHH
T ss_pred cccccHH--------------------------------------------------------------------HHHHH
Confidence 5432111 00111
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+....... .....+++++++||.+||..||++|||++|+++
T Consensus 242 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCC--CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11111111 122457899999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=273.01 Aligned_cols=146 Identities=21% Similarity=0.401 Sum_probs=114.0
Q ss_pred ccccCCcEEEE------eccCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHC---------C
Q psy3880 6 MVAHSRVVVRV------KEEGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNH---------S 66 (408)
Q Consensus 6 ~~~~~~~i~~~------~~~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~---------~ 66 (408)
.+.|+|++..+ ..++....++||||+.+|. |.+.+. +...+..++.||+.||+|||++ |
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ 140 (336)
T 3g2f_A 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS--LXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140 (336)
T ss_dssp TCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred hccCcchhhheecccccccCCCceEEEEEecCCCCc--HHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence 47899866333 2233445689999999998 887763 4478889999999999999999 9
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCc---------ccccCCCCCcccChhhhhhcccc-CcCCCCcchhhhh
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---------KLMDLCGTPGYLAPEVLRANMFE-DATGYGQAVDVWA 136 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~-~~~~~~~~~DiwS 136 (408)
|+||||||+|||++.++.+||+|||+|..+.... .....+||+.|+|||++.+.... ....++.++||||
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 9999999999999999999999999998664321 12346799999999998652110 0124567899999
Q ss_pred hhHHHHHHHhCCCCCCC
Q psy3880 137 CGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 137 lGvil~~ll~G~~pf~~ 153 (408)
+||++|+|++|..||..
T Consensus 221 lG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 221 LGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp HHHHHHHHHTTBGGGST
T ss_pred HHHHHHHHHhcCCcCCC
Confidence 99999999999877643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=261.44 Aligned_cols=196 Identities=23% Similarity=0.414 Sum_probs=140.1
Q ss_pred CCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecC
Q psy3880 10 SRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ 82 (408)
Q Consensus 10 ~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~ 82 (408)
++ |+++.+ ..++..|+||| +.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+|||+++
T Consensus 88 ~~-iv~~~~~~~~~~~~~lv~e-~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 88 DK-IIRLYDYEITDQYIYMVME-CGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD- 162 (313)
T ss_dssp TT-BCCEEEEEECSSEEEEEEC-CCSEE--HHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-
T ss_pred Cc-eEEEEEEeecCCEEEEEEe-cCCCc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-
Confidence 55 555554 45566789999 56666 776653 45788999999999999999999999999999999964
Q ss_pred CCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhcccc-----CcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 83 MNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFE-----DATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 83 ~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~-----~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+.+||+|||++..+..... ....+||+.|+|||++...... ....++.++|+||+||++|+|++|..||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 8899999999987654322 2346799999999998642100 1135788999999999999999999999653
Q ss_pred hh-HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 155 KQ-MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 155 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.. ...+.. +
T Consensus 243 ~~~~~~~~~----------------------------------------------------------------------~ 252 (313)
T 3cek_A 243 INQISKLHA----------------------------------------------------------------------I 252 (313)
T ss_dssp CSHHHHHHH----------------------------------------------------------------------H
T ss_pred HHHHHHHHH----------------------------------------------------------------------H
Confidence 21 111111 1
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
......... ....++++++||.+||..||++|||++|+|+||||+..
T Consensus 253 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 IDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 111111111 12347789999999999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=262.28 Aligned_cols=140 Identities=20% Similarity=0.354 Sum_probs=115.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+++|..+.. ..++..++||||+ +|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 136 (296)
T 4hgt_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS--LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCB--HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HhcCCCCCCeeeeecCCCCceEEEEEcc-CCC--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 4567777755443 4556678999999 777 766653 5589999999999999999999999999999999
Q ss_pred EE---ecCCCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 78 LL---DDQMNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 78 Ll---~~~~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|+ +.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 137 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~ 210 (296)
T 4hgt_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG------IEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT------CCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC------CCCCchhHHHHHHHHHHHHhc
Confidence 99 7889999999999987654322 234689999999999875 347889999999999999999
Q ss_pred CCCCCCCc
Q psy3880 147 GCPPFWHR 154 (408)
Q Consensus 147 G~~pf~~~ 154 (408)
|..||.+.
T Consensus 211 g~~pf~~~ 218 (296)
T 4hgt_A 211 GSLPWQGL 218 (296)
T ss_dssp SSCTTSSC
T ss_pred CCCCCccc
Confidence 99999653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=257.51 Aligned_cols=186 Identities=17% Similarity=0.235 Sum_probs=142.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.||. |.+.+ .+...+..++.||+.||+|||++||+||||||+||
T Consensus 68 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 144 (289)
T 4fvq_A 68 KLSHKHLV-LNYGVCVCGDENILVQEFVKFGS--LDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI 144 (289)
T ss_dssp TSCCTTBC-CEEEEECCTTCCEEEEECCTTCB--HHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred hCCCCCEe-EEEEEEEeCCCCEEEEECCCCCC--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceE
Confidence 46799866 4443 44556789999999998 87776 34578899999999999999999999999999999
Q ss_pred EEecCCC--------EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 78 LLDDQMN--------VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 78 Ll~~~~~--------iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
|++.++. +||+|||++...... ....||+.|+|||++... ..++.++||||+||++|+|++|..
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~ 216 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENP-----KNLNLATDKWSFGTTLWEICSGGD 216 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCG-----GGCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCC-----CCCCchhHHHHHHHHHHHHHcCCC
Confidence 9998876 999999998765432 234578899999998742 347889999999999999999655
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
|+...........
T Consensus 217 ~~~~~~~~~~~~~------------------------------------------------------------------- 229 (289)
T 4fvq_A 217 KPLSALDSQRKLQ------------------------------------------------------------------- 229 (289)
T ss_dssp CTTTTSCHHHHHH-------------------------------------------------------------------
T ss_pred CCccccchHHHHH-------------------------------------------------------------------
Confidence 4433221111111
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+......++ ...++++++||.+||..||++|||+.|+++|
T Consensus 230 ---~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 230 ---FYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---HHHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---HhhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111111111 2357889999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=263.33 Aligned_cols=188 Identities=23% Similarity=0.332 Sum_probs=140.1
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ ++.+ ..++..++|+|++.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+|||
T Consensus 73 ~l~hp~iv-~~~~~~~~~~~~~v~~~~~~g~--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 149 (327)
T 3lzb_A 73 SVDNPHVC-RLLGICLTSTVQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp TCCBTTBC-CCCEEEESSSEEEEECCCSSCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCCee-EEEEEEecCCceEEEEecCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence 46788865 4443 22334678999999998 777663 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
++.++.+||+|||++........ .....+|+.|+|||++.+ ..|+.++||||+||++|+|++ |..||.+.
T Consensus 150 ~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH------RIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp EEETTEEEECCTTC----------------CCCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC------CCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999987654322 223456788999999975 357889999999999999999 99999765
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+
T Consensus 224 ~~~~~~~~~~~~-------------------------------------------------------------------- 235 (327)
T 3lzb_A 224 PASEISSILEKG-------------------------------------------------------------------- 235 (327)
T ss_dssp CGGGHHHHHHTT--------------------------------------------------------------------
T ss_pred CHHHHHHHHHcC--------------------------------------------------------------------
Confidence 443332222211
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .. +....+++++.+||++||..||.+|||+.|+++
T Consensus 236 --~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 --E-RL--PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --C-CC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --C-CC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 01 111346889999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=259.40 Aligned_cols=139 Identities=20% Similarity=0.361 Sum_probs=114.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+++|..+.. ..++..++||||+ +|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI 136 (296)
T 3uzp_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS--LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhhcCCCCCccccccCCCCceEEEEEec-CCC--HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHe
Confidence 3567776644433 4455678999999 777 766653 4588999999999999999999999999999999
Q ss_pred EEe---cCCCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 78 LLD---DQMNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 78 Ll~---~~~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|++ .++.+||+|||++........ ....+||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG------IEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC------CCCCcchhhHHHHHHHHHHHh
Confidence 994 788999999999987654322 234689999999999875 347889999999999999999
Q ss_pred CCCCCCC
Q psy3880 147 GCPPFWH 153 (408)
Q Consensus 147 G~~pf~~ 153 (408)
|..||.+
T Consensus 211 g~~pf~~ 217 (296)
T 3uzp_A 211 GSLPWQG 217 (296)
T ss_dssp SSCTTSS
T ss_pred CCCCCCC
Confidence 9999965
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=253.25 Aligned_cols=189 Identities=22% Similarity=0.369 Sum_probs=147.4
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINS-------NPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~-------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++..+....++..++||||+.||. |.+.+.. ..++..++.|++.||+|||++||+||||||+|||
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGS--LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp HCCCTTBCCEEEEECSSSCEEEEECCTTCB--HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hCCCcCcceEEEEEcCCCcEEEEecCCCCC--HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 467888664333334456789999999998 8887753 3678999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||++........ .....+|+.|+|||++... .++.++|+||+||++|+|++ |..||.+.+
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC------CCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 99999999999999987654332 1235577899999998653 46788999999999999998 888887655
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..+.
T Consensus 216 ~~~~~~~~~~~~-------------------------------------------------------------------- 227 (279)
T 1qpc_A 216 NPEVIQNLERGY-------------------------------------------------------------------- 227 (279)
T ss_dssp HHHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHhccc--------------------------------------------------------------------
Confidence 544444332210
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. .....+++++++||.+||..||++|||++++++
T Consensus 228 ---~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 ---RM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CC--CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 111356889999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=258.97 Aligned_cols=137 Identities=20% Similarity=0.345 Sum_probs=111.4
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|++++ .+.. +.++..++||||+ +|. |.+.+. +..++..++.||+.||+|||++||+||||||+|||+
T Consensus 64 ~~~~i~-~~~~~~~~~~~~~lv~e~~-~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 139 (298)
T 1csn_A 64 GCTGIP-NVYYFGQEGLHNVLVIDLL-GPS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139 (298)
T ss_dssp TCTTCC-CEEEEEEETTEEEEEEECC-CCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred cCCCCC-eEEeecCCCceeEEEEEec-CCC--HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 455433 4333 3445678999999 887 777653 458899999999999999999999999999999999
Q ss_pred ecCCC-----EEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 80 DDQMN-----VKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 80 ~~~~~-----iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
+.++. +||+|||++........ ....+||+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 140 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~ 213 (298)
T 1csn_A 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG------REQSRRDDLEALGHVFMYFLR 213 (298)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC------CCCChHHHHHHHHHHHHHHHc
Confidence 87765 99999999987654321 234679999999999864 357889999999999999999
Q ss_pred CCCCCCCc
Q psy3880 147 GCPPFWHR 154 (408)
Q Consensus 147 G~~pf~~~ 154 (408)
|..||.+.
T Consensus 214 g~~pf~~~ 221 (298)
T 1csn_A 214 GSLPWQGL 221 (298)
T ss_dssp SSCTTSSC
T ss_pred CCCCcchh
Confidence 99999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=251.34 Aligned_cols=189 Identities=21% Similarity=0.369 Sum_probs=147.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|++++ .+.+ ..++..++||||+.+|. |.+.+. +...+..++.|++.||+|||++||+||||||+||
T Consensus 59 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 59 KLSHPKLV-QLYGVCLEQAPICLVTEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEECCCTTCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred hCCCCCEe-eEEEEEccCCCeEEEEeCCCCCc--HHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 46788865 4443 44567899999999998 777653 4578899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+++.++.+||+|||++....... ......+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.+.
T Consensus 136 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 136 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EECCCCCEEEcccccccccccccccccccccccccccChhhhcC------CCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 99999999999999998664322 1223567889999999865 346788999999999999998 88888765
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......+..+
T Consensus 210 ~~~~~~~~i~~~-------------------------------------------------------------------- 221 (267)
T 3t9t_A 210 SNSEVVEDISTG-------------------------------------------------------------------- 221 (267)
T ss_dssp CHHHHHHHHHTT--------------------------------------------------------------------
T ss_pred CHHHHHHHHhcC--------------------------------------------------------------------
Confidence 554444443322
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.... .....++++++||.+||..||++|||+.|++++
T Consensus 222 --~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 --FRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CcCC---CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1000 112457889999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=263.71 Aligned_cols=137 Identities=23% Similarity=0.338 Sum_probs=112.7
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.|++++ .+.+ ..++..++||||+ +|. |.+.+. +..++..++.||+.||+|||++||+||||||+|||+
T Consensus 63 ~h~~i~-~~~~~~~~~~~~~lv~e~~-~~~--L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 63 SGDGIP-QVYYFGPCGKYNAMVLELL-GPS--LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp SCTTSC-CEEEEEEETTEEEEEEECC-CCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCC-EEEEEEecCCccEEEEEeC-CCC--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 677755 4443 3445678999999 777 666543 458999999999999999999999999999999999
Q ss_pred ecCCC-----EEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 80 DDQMN-----VKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 80 ~~~~~-----iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
+.++. +||+|||+|+.+..... ....+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 139 ~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~ell~ 212 (330)
T 2izr_A 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG------KEQSRRDDLEALGHMFMYFLR 212 (330)
T ss_dssp CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC------CCCCchhHHHHHHHHHHHHhc
Confidence 98876 99999999987644321 235789999999999875 357889999999999999999
Q ss_pred CCCCCCCc
Q psy3880 147 GCPPFWHR 154 (408)
Q Consensus 147 G~~pf~~~ 154 (408)
|..||.+.
T Consensus 213 g~~Pf~~~ 220 (330)
T 2izr_A 213 GSLPWQGL 220 (330)
T ss_dssp SSCTTTTC
T ss_pred CCCCcccc
Confidence 99999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.72 Aligned_cols=190 Identities=21% Similarity=0.310 Sum_probs=146.7
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|++..+....+...++|+|++.+|. |.+.+ .+..++..++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili 154 (291)
T 1u46_A 77 SLDHRNLIRLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154 (291)
T ss_dssp HCCCTTBCCEEEEECSSSCEEEEECCTTCB--HHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred hCCCCCcccEEEEEccCCceeeEecccCCC--HHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 357888664333333344789999999998 77765 3457899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+.++.+||+|||++........ .....+|+.|+|||++... .++.++|+||+||++|+|++ |..||.+.
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 9999999999999987654322 1235678899999998753 46789999999999999999 99999776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+....+..+...
T Consensus 229 ~~~~~~~~~~~~-------------------------------------------------------------------- 240 (291)
T 1u46_A 229 NGSQILHKIDKE-------------------------------------------------------------------- 240 (291)
T ss_dssp CHHHHHHHHHTS--------------------------------------------------------------------
T ss_pred CHHHHHHHHHcc--------------------------------------------------------------------
Confidence 655444444321
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...+ +....+|+++++||.+||..||++|||+.++++
T Consensus 241 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 --GERL--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --CCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCC--CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 112357889999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=250.75 Aligned_cols=188 Identities=14% Similarity=0.233 Sum_probs=147.1
Q ss_pred ccccCCcEEEEecc--C--CcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCC--CeeccC
Q psy3880 6 MVAHSRVVVRVKEE--G--DDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHS--VVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--~--~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~--IvHRDL 72 (408)
.+.|+|+| ++.+. . .+..++||||+.||. |.+.+. +..++..++.||+.||+|||++| |+||||
T Consensus 63 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 63 IFSHPNVL-PVLGACQSPPAPHPTLITHWMPYGS--LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp CCSCTTEE-CEEEEECTTTSSSCEEEEECCTTCB--HHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred hcCCCchh-heEEEEccCCCCCeEeeecccCCCc--HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 46798855 55542 2 256789999999998 888763 55889999999999999999999 999999
Q ss_pred CCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 73 Kp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
||+|||++.++.++|+|||++..... ....||+.|+|||++..... ..++.++||||+||++|+|++|..||.
T Consensus 140 kp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 140 NSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE---DTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp SGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGG---GSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred ccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCC---CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999988754322 34678999999999975321 233458999999999999999999997
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+.......+....
T Consensus 213 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 227 (271)
T 3kmu_A 213 DLSNMEIGMKVALEG----------------------------------------------------------------- 227 (271)
T ss_dssp TSCHHHHHHHHHHSC-----------------------------------------------------------------
T ss_pred ccChHHHHHHHHhcC-----------------------------------------------------------------
Confidence 765544433332211
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... .....+++++.+||.+||..||++|||++|+++
T Consensus 228 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 228 -----LRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 112357889999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=263.60 Aligned_cols=187 Identities=17% Similarity=0.305 Sum_probs=145.3
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------------------CHHHHHHHHHHHHHHHHHHHHCC
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------------------SNPALRYIMRQLFEALEHVHNHS 66 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------------------~~~~~r~i~~qil~aL~~LH~~~ 66 (408)
.|+|++ ++.+ +.++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++|
T Consensus 108 ~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 108 QHENIV-NLLGACTHGGPVLVITEYCCYGD--LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCee-eEEEEEecCCceEEEEecCCCCc--HHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 688865 5443 45567899999999998 877663 45678899999999999999999
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.. ..++.++||||+||++|+
T Consensus 185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD------CVYTVQSDVWSYGILLWE 258 (333)
T ss_dssp EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH------CCCCHHHHHHHHHHHHHH
T ss_pred cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc------CCCChHHHHHHHHHHHHH
Confidence 99999999999999999999999999986644322 123456789999999875 347889999999999999
Q ss_pred HHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 144 LLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 144 ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
|++ |..||.+......+..+..
T Consensus 259 l~t~g~~p~~~~~~~~~~~~~~~--------------------------------------------------------- 281 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNSKFYKLVK--------------------------------------------------------- 281 (333)
T ss_dssp HTTTSCCSSTTCCSSHHHHHHHH---------------------------------------------------------
T ss_pred HHcCCCCCCcccchhHHHHHHHh---------------------------------------------------------
Confidence 998 9899865433222222111
Q ss_pred CchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 223 ~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...... .....++++.+||.+||..||.+|||+.|+++
T Consensus 282 -------------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 282 -------------DGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp -------------HTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------cCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 111111 11345788999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=256.15 Aligned_cols=174 Identities=29% Similarity=0.488 Sum_probs=139.6
Q ss_pred cHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
...++||||+.+|. |.+.+. +...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 93 KCLFIQMEFCDKGT--LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEECCCCSCB--HHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEeccCCCC--HHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 34689999999998 877762 457889999999999999999999999999999999999999999999998
Q ss_pred hcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCC
Q psy3880 95 VLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPE 174 (408)
Q Consensus 95 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 174 (408)
............||+.|+|||++.. ..++.++|+||+||++|+|++|..||.....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------------------ 226 (284)
T 2a19_B 171 SLKNDGKRTRSKGTLRYMSPEQISS------QDYGKEVDLYALGLILAELLHVCDTAFETSK------------------ 226 (284)
T ss_dssp ESSCCSCCCCCCSCCTTSCHHHHHC------SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------------------
T ss_pred eccccccccccCCcccccChhhhcc------CCCcchhhhHHHHHHHHHHHhcCCcchhHHH------------------
Confidence 7766555556789999999999864 3467889999999999999888877632110
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKD 254 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~d 254 (408)
....+..+.. ...+++++++
T Consensus 227 ------------------------------------------------------~~~~~~~~~~------~~~~~~~~~~ 246 (284)
T 2a19_B 227 ------------------------------------------------------FFTDLRDGII------SDIFDKKEKT 246 (284)
T ss_dssp ------------------------------------------------------HHHHHHTTCC------CTTSCHHHHH
T ss_pred ------------------------------------------------------HHHHhhcccc------cccCCHHHHH
Confidence 1111111111 1246888999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 255 LIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 255 LI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
||.+||..||++|||+.|+++|+|.-.
T Consensus 247 li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 247 LLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=271.72 Aligned_cols=138 Identities=21% Similarity=0.258 Sum_probs=113.2
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|++ .+... +....||||||+ ||. |.+.+ .+..++..++.||+.||+|||++||+|||||
T Consensus 104 ~l~h~~iv-~~~~~~~~~~~~~~~~~lv~e~~-g~~--L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk 179 (364)
T 3op5_A 104 KLKYLGVP-KYWGSGLHDKNGKSYRFMIMDRF-GSD--LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179 (364)
T ss_dssp TCSCCCSC-CEEEEEEEEETTEEEEEEEEECE-EEE--HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hccCCCCC-eEEeeeeeccCCcceEEEEEeCC-CCC--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence 46788865 44432 124578999999 887 77765 2558999999999999999999999999999
Q ss_pred CCcEEEe--cCCCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 74 PENILLD--DQMNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 74 p~NILl~--~~~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
|+|||++ .++.+||+|||+|+.+..... ....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~e 253 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG------VAPSRRGDLEILGYCMIQ 253 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHH
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC------CCCCchhhHHHHHHHHHH
Confidence 9999999 889999999999977654321 123569999999999864 347889999999999999
Q ss_pred HHhCCCCCCC
Q psy3880 144 LLVGCPPFWH 153 (408)
Q Consensus 144 ll~G~~pf~~ 153 (408)
|++|..||.+
T Consensus 254 l~~g~~Pf~~ 263 (364)
T 3op5_A 254 WLTGHLPWED 263 (364)
T ss_dssp HHHSCCTTGG
T ss_pred HHhCCCCccc
Confidence 9999999964
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=257.49 Aligned_cols=139 Identities=22% Similarity=0.442 Sum_probs=114.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 63 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni 139 (310)
T 3s95_A 63 CLEHPNVL-KFIGVLYKDKRLNFITEYIKGGT--LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139 (310)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred hCCCcCcc-cEEEEEecCCeeEEEEEecCCCc--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeE
Confidence 46799866 5444 34556789999999998 877763 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc---------------ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL---------------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~---------------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
|++.++.+||+|||++......... ...+||+.|+|||++.+ ..++.++||||+||++|
T Consensus 140 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING------RSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp EECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT------CCCCTHHHHHHHHHHHH
T ss_pred EECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC------CCCCcHHHHHHHHHHHH
Confidence 9999999999999999765432211 14679999999999864 45788999999999999
Q ss_pred HHHhCCCCCCC
Q psy3880 143 TLLVGCPPFWH 153 (408)
Q Consensus 143 ~ll~G~~pf~~ 153 (408)
+|++|..||..
T Consensus 214 el~~g~~~~~~ 224 (310)
T 3s95_A 214 EIIGRVNADPD 224 (310)
T ss_dssp HHHHTCCSSTT
T ss_pred HHhcCCCCCcc
Confidence 99999998854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=266.31 Aligned_cols=188 Identities=19% Similarity=0.302 Sum_probs=144.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ ..++..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 168 ~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 244 (377)
T 3cbl_A 168 QYSHPNIV-RLIGVCTQKQPIYIVMELVQGGD--FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC 244 (377)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCEE-EEEEEEecCCCcEEEEEcCCCCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHE
Confidence 46799865 5544 44566799999999998 777653 4478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccc---cCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|++.++.+||+|||+++......... ...+++.|+|||++... .|+.++|||||||++|+|++ |..||.+
T Consensus 245 l~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG------RYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp EECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999997654332111 12346679999998753 46789999999999999998 8888876
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....+..+
T Consensus 319 ~~~~~~~~~~~~~------------------------------------------------------------------- 331 (377)
T 3cbl_A 319 LSNQQTREFVEKG------------------------------------------------------------------- 331 (377)
T ss_dssp SCHHHHHHHHHTT-------------------------------------------------------------------
T ss_pred CCHHHHHHHHHcC-------------------------------------------------------------------
Confidence 5544433333221
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...+. ...+++++.+||.+||..||++|||++++++
T Consensus 332 ----~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 ----GRLPC--PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11111 1246788999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=267.26 Aligned_cols=189 Identities=21% Similarity=0.348 Sum_probs=137.3
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++.+ +.++..++||||+.+|. |.+++.. ..++..++.||+.||+|||++||+||||||+|
T Consensus 146 ~l~hpnIv-~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 222 (373)
T 3c1x_A 146 DFSHPNVL-SLLGICLRSEGSPLVVLPYMKHGD--LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222 (373)
T ss_dssp TCCCTTBC-CCCEEECCCSSCCEEEEECCTTCB--HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred hCCCCCcc-eEEEEEEcCCCCeEEEEECCCCCC--HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence 46799866 4443 34456789999999998 8887743 37889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPP 150 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~p 150 (408)
||++.++.+||+|||+++.+..... .....+|+.|+|||++.. ..++.++||||+||++|+|++ |.+|
T Consensus 223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT------QKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp EEECTTCCEEECCC---------------------CCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC------CCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 9999999999999999986643321 123567789999999875 357889999999999999999 6777
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+..+....+..
T Consensus 297 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 311 (373)
T 3c1x_A 297 YPDVNTFDITVYLLQ----------------------------------------------------------------- 311 (373)
T ss_dssp CTTSCSSCHHHHHHT-----------------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHc-----------------------------------------------------------------
Confidence 755433222222211
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
+..... ...+++++.+||.+||..||++|||+.|++++
T Consensus 312 -----~~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 -----GRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111111 12468889999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=271.55 Aligned_cols=159 Identities=30% Similarity=0.572 Sum_probs=124.4
Q ss_pred ccccCCcEEEEec--c--CCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKE--E--GDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~--~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| .+.+ + .....++||||+.||. |.+.+. +..++..++.||+.||+|||++||+|||||
T Consensus 63 ~l~hpnIv-~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 139 (396)
T 4eut_A 63 KLNHKNIV-KLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139 (396)
T ss_dssp HCCCTTBC-CEEEEEECTTTCCEEEEECCCTTEE--HHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCCCC-eEEEeeccCCCCeeEEEEecCCCCC--HHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC
Confidence 36798866 4432 2 2235689999999998 888764 457899999999999999999999999999
Q ss_pred CCcEEE----ecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccC--cCCCCcchhhhhhhHHHHHHHhC
Q psy3880 74 PENILL----DDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFED--ATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 74 p~NILl----~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~~~~~~~DiwSlGvil~~ll~G 147 (408)
|+|||+ +.++.+||+|||+|+...........+||+.|+|||++....... ...|+.++|+||+||++|+|++|
T Consensus 140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp GGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 999999 666779999999998876666566788999999999986421110 12467899999999999999999
Q ss_pred CCCCCCc----hhHHHHHHHHhcc
Q psy3880 148 CPPFWHR----KQMVMLRNIMEGK 167 (408)
Q Consensus 148 ~~pf~~~----~~~~~~~~i~~~~ 167 (408)
..||... ...+.+.++..+.
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSC
T ss_pred CCCCCCCCcccchHHHHHHHhcCC
Confidence 9999643 3345555555543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=263.43 Aligned_cols=140 Identities=24% Similarity=0.371 Sum_probs=116.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ ++.+ ..++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||
T Consensus 91 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp 167 (321)
T 2qkw_B 91 FCRHPHLV-SLIGFCDERNEMILIYKYMENGN--LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167 (321)
T ss_dssp SCCCTTBC-CEEEECCCTTCCEEEEECCTTCB--TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS
T ss_pred hCCCCCEe-eEEEEEcCCCeEEEEEEcCCCCc--HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH
Confidence 46798865 5444 44556789999999998 888763 4478899999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
+|||++.++.+||+|||++....... ......||+.|+|||++.. ..++.++||||+||++|+|++|..||
T Consensus 168 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK------GRLTEKSDVYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp TTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH------CBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred HHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC------CCCCcccchHhHHHHHHHHHhCCCcc
Confidence 99999999999999999997644221 1233568999999999875 34788999999999999999999999
Q ss_pred CCc
Q psy3880 152 WHR 154 (408)
Q Consensus 152 ~~~ 154 (408)
.+.
T Consensus 242 ~~~ 244 (321)
T 2qkw_B 242 VQS 244 (321)
T ss_dssp SCS
T ss_pred ccc
Confidence 654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=258.96 Aligned_cols=188 Identities=23% Similarity=0.319 Sum_probs=144.3
Q ss_pred ccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVH 63 (408)
Q Consensus 8 ~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH 63 (408)
.|+|++ .+.+ ..+...++||||+.||. |.+.+ .+..++..++.||+.||+|||
T Consensus 89 ~hp~iv-~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 165 (316)
T 2xir_A 89 HHLNVV-NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165 (316)
T ss_dssp CCTTBC-CEEEEECCTTSCCEEEEECCTTEE--HHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCee-eEEEEEecCCCceEEEEEcCCCCc--HHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH
Confidence 467655 5544 23345789999999998 87776 345788999999999999999
Q ss_pred HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 64 ~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.. ..++.++|+||+||+
T Consensus 166 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~i 239 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD------RVYTIQSDVWSFGVL 239 (316)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH------CCCCHHHHHHHHHHH
T ss_pred hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc------ccccchhHHHHHHHH
Confidence 99999999999999999999999999999986643322 223567889999999875 357889999999999
Q ss_pred HHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 141 MYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 141 l~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
+|+|++ |..||.+.+....+.
T Consensus 240 l~~l~t~g~~p~~~~~~~~~~~---------------------------------------------------------- 261 (316)
T 2xir_A 240 LWEIFSLGASPYPGVKIDEEFC---------------------------------------------------------- 261 (316)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHH----------------------------------------------------------
T ss_pred HHHHHhCCCCCCcccchhHHHH----------------------------------------------------------
Confidence 999998 999986543211111
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+..+.. .. ....+++++++||.+||..||.+|||+.|+++|
T Consensus 262 -----------~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 -----------RRLKEGTR-MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp -----------HHHHHTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------HHhccCcc-CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111110 11 113468899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=253.27 Aligned_cols=204 Identities=21% Similarity=0.298 Sum_probs=145.3
Q ss_pred ccccCCcEEEEecc----CCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKEE----GDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ ++.+. +....++||||+.+|. |.+.+ .+..++..++.||+.||+|||++||+||||||+
T Consensus 67 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 143 (295)
T 3ugc_A 67 SLQHDNIV-KYKGVCYSAGRRNLKLIMEYLPYGS--LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143 (295)
T ss_dssp TCCCTTBC-CEEEEECHHHHTSCEEEEECCTTCB--HHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred hCCCCCEe-eEEEEEecCCCCceEEEEEeCCCCC--HHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh
Confidence 46798865 54432 2234689999999998 87776 345788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|||++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++||||+||++|+|++|..||
T Consensus 144 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE------SKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp GEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC------CCCChHHHHHHHHHHHHHHHhccccc
Confidence 99999999999999999987654322 123457778999999875 35788999999999999999999998
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
....... ...+ +..+...........
T Consensus 218 ~~~~~~~-~~~~-----------------------------------------------------~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 218 KSPPAEF-MRMI-----------------------------------------------------GNDKQGQMIVFHLIE 243 (295)
T ss_dssp CSHHHHH-HHHH-----------------------------------------------------CTTCCTHHHHHHHHH
T ss_pred CCChHHH-Hhhh-----------------------------------------------------cCccccchhHHHHHH
Confidence 6533211 0000 111111111112222
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.+..+. .. +....+++++.+||.+||..||++|||+.|+++
T Consensus 244 ~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 244 LLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhccC-cC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 232221 22 223467899999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=254.20 Aligned_cols=188 Identities=21% Similarity=0.348 Sum_probs=144.0
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ +.++..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+|
T Consensus 82 ~l~h~~iv-~~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 82 DFSHPNVL-SLLGICLRSEGSPLVVLPYMKHGD--LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp TCCCTTBC-CCCEEECCSSSCCEEEEECCTTCB--HHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hCCCCCEe-eeeeEEEcCCCceEEEEeCCCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 36798866 4433 34556789999999998 888763 347889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPP 150 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~p 150 (408)
||++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|++ |.+|
T Consensus 159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT------QKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC------CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999986643321 223567889999999975 357889999999999999999 5566
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+.......+..
T Consensus 233 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 247 (298)
T 3f66_A 233 YPDVNTFDITVYLLQ----------------------------------------------------------------- 247 (298)
T ss_dssp STTSCTTTHHHHHHT-----------------------------------------------------------------
T ss_pred CccCCHHHHHHHHhc-----------------------------------------------------------------
Confidence 654433222222221
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+..... ...+++++.+||.+||..||++|||+.|+++
T Consensus 248 -----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 248 -----GRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -----TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111111 1246788999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=271.05 Aligned_cols=195 Identities=22% Similarity=0.343 Sum_probs=146.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+|..+....++..|+||||+.+|. |.+++. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 235 ~l~hp~iv~~~~~~~~~~~~iv~e~~~~gs--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 312 (452)
T 1fmk_A 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312 (452)
T ss_dssp HCCCTTBCCEEEEECSSSCEEEECCCTTCB--HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hCCCCCEeeEEEEEcCCceEEEehhhcCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 367998664333333456789999999998 888775 34688999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||+++....... .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+
T Consensus 313 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------GRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc------CCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987654321 123456788999999875 347889999999999999998 888887765
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+.+..+..+.
T Consensus 387 ~~~~~~~i~~~~-------------------------------------------------------------------- 398 (452)
T 1fmk_A 387 NREVLDQVERGY-------------------------------------------------------------------- 398 (452)
T ss_dssp HHHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 555444443221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc--CCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~--Hpwf~~ 281 (408)
..+ ....+++++.+||.+||..||++|||++++++ +.++..
T Consensus 399 ---~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 ---RMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---CCC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111 11246889999999999999999999999876 356644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=260.95 Aligned_cols=192 Identities=17% Similarity=0.274 Sum_probs=149.4
Q ss_pred cccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------------CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 7 VAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------------SNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------------~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
+.|+|++ ++.+ ..++..|+||||+.||. |.+++. +..++..++.||+.||.|||++||+||||
T Consensus 90 l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dl 166 (327)
T 2yfx_A 90 FNHQNIV-RCIGVSLQSLPRFILMELMAGGD--LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 166 (327)
T ss_dssp CCCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCCCC-eEEEEEcCCCCcEEEEecCCCCc--HHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcC
Confidence 5788866 4443 44456789999999998 777662 34678999999999999999999999999
Q ss_pred CCCcEEEec---CCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 73 KPENILLDD---QMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 73 Kp~NILl~~---~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
||+|||++. +..+||+|||++........ .....||+.|+|||++.. ..++.++|+||+||++|+|++
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME------GIFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHT
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC------CCCCchhhHHHHHHHHHHHHc
Confidence 999999984 44699999999986543321 223567899999999875 347889999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 147 -GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 147 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
|..||.+.+.......+..+.
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~---------------------------------------------------------- 262 (327)
T 2yfx_A 241 LGYMPYPSKSNQEVLEFVTSGG---------------------------------------------------------- 262 (327)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTC----------------------------------------------------------
T ss_pred CCCCCCCCcCHHHHHHHHhcCC----------------------------------------------------------
Confidence 999997665544444433221
Q ss_pred hHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 226 ~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.. .....+++++.+||.+||..||.+|||+.|+++|.|+.
T Consensus 263 ------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 ------------RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 01134688999999999999999999999999998863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=259.57 Aligned_cols=187 Identities=21% Similarity=0.353 Sum_probs=146.5
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|++ ++.+ ..++..|+||||+.+|. |.+++ .+..++..++.||+.||+|||+
T Consensus 99 ~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 175 (334)
T 2pvf_A 99 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175 (334)
T ss_dssp CCTTBC-CEEEEECSSSCCEEEEECCTTCB--HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCEe-eEEEEEccCCceEEEEECCCCCc--HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 688755 5443 44567799999999998 87776 2447889999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
+||+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++... .++.++||||+||++
T Consensus 176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il 249 (334)
T 2pvf_A 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR------VYTHQSDVWSFGVLM 249 (334)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC------EECHHHHHHHHHHHH
T ss_pred CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC------CcChHHHHHHHHHHH
Confidence 9999999999999999999999999999986654322 2234678899999998753 467889999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |..||.+.+..+....+..+
T Consensus 250 ~ellt~g~~p~~~~~~~~~~~~~~~~------------------------------------------------------ 275 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVEELFKLLKEG------------------------------------------------------ 275 (334)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHT------------------------------------------------------
T ss_pred HHHHhCCCCCcCcCCHHHHHHHHhcC------------------------------------------------------
Confidence 99998 88888765544433333221
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
... +....+++++++||.+||..||++|||+.|++++
T Consensus 276 ----------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 276 ----------------HRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 1113568899999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=257.38 Aligned_cols=189 Identities=21% Similarity=0.298 Sum_probs=139.0
Q ss_pred ccccCCcEEEEecc--CCc-----HHHHHHHHHhhchhhHHhhh-----------CCHHHHHHHHHHHHHHHHHHHHCCC
Q psy3880 6 MVAHSRVVVRVKEE--GDD-----LKHLAAQVVDKGEAAVQDII-----------NSNPALRYIMRQLFEALEHVHNHSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--~~~-----~~~lv~e~~~~g~~~l~~~~-----------~~~~~~r~i~~qil~aL~~LH~~~I 67 (408)
.+.|+|++ ++.+. ..+ ..++||||+.+|. |.+.+ .+..++..++.||+.||.|||++||
T Consensus 92 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~v~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (313)
T 3brb_A 92 DFSHPNVI-RLLGVCIEMSSQGIPKPMVILPFMKYGD--LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF 168 (313)
T ss_dssp TCCCTTBC-CCCEEEEC-------CEEEEEECCTTCB--HHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCCee-eeeEEEeeccccCCcccEEEEecccCCC--HHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 36788865 44431 111 2389999999998 77766 3458899999999999999999999
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+||||||+|||++.++.+||+|||++........ .....+++.|+|||++.. ..++.++|+||+||++|+|
T Consensus 169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~el 242 (313)
T 3brb_A 169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD------RVYTSKSDVWAFGVTMWEI 242 (313)
T ss_dssp CCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS------SCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC------CCccchhhhHHHHHHHHHH
Confidence 9999999999999999999999999987654321 123567889999999864 3578899999999999999
Q ss_pred Hh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++ |..||.+.+.......+..+
T Consensus 243 ~~~g~~p~~~~~~~~~~~~~~~~--------------------------------------------------------- 265 (313)
T 3brb_A 243 ATRGMTPYPGVQNHEMYDYLLHG--------------------------------------------------------- 265 (313)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTT---------------------------------------------------------
T ss_pred HhcCCCCCccCCHHHHHHHHHcC---------------------------------------------------------
Confidence 99 88888665443333322221
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. ......+++++.+||.+||..||++|||+.++++|
T Consensus 266 -------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 -------------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 01123578899999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=254.49 Aligned_cols=189 Identities=19% Similarity=0.282 Sum_probs=147.5
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|++++..+....++..++|||++.+|. |.+.+ .+..++..++.||+.||+|||++||+||||||+|||++
T Consensus 74 ~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~ 151 (291)
T 1xbb_A 74 QLDNPYIVRMIGICEAESWMLVMEMAELGP--LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 151 (291)
T ss_dssp TCCCTTBCCEEEEEESSSEEEEEECCTTEE--HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred hCCCCCEEEEEEEECCCCcEEEEEeCCCCC--HHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe
Confidence 467888663333334455789999999998 87776 35688999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
.++.+||+|||++......... ....+|+.|+|||++... .++.++|+||+||++|+|++ |..||.+.+
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC------CCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999876543321 224567899999998753 46789999999999999999 999997765
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+.
T Consensus 226 ~~~~~~~~~~~~-------------------------------------------------------------------- 237 (291)
T 1xbb_A 226 GSEVTAMLEKGE-------------------------------------------------------------------- 237 (291)
T ss_dssp HHHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 544443333211
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. . .....+++++.+||.+||..||++|||+.|+++
T Consensus 238 --~-~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 --R-M--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --C-C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --C-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0 011356889999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=253.98 Aligned_cols=188 Identities=23% Similarity=0.355 Sum_probs=146.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ ..++..++||||+.||. |.+.+ .+...+..++.||+.||+|||++||+||||||+|
T Consensus 65 ~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N 141 (288)
T 3kfa_A 65 EIKHPNLV-QLLGVCTREPPFYIITEFMTYGN--LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 141 (288)
T ss_dssp HCCCTTBC-CEEEEECSSSSEEEEEECCTTEE--HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGG
T ss_pred hCCCCCEe-eEEEEEccCCCEEEEEEcCCCCc--HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcce
Confidence 46788866 4443 44556789999999998 87776 3457889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
|+++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.+
T Consensus 142 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 142 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY------NKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp EEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987654332 223456789999999875 347789999999999999998 8888865
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+.......+..
T Consensus 216 ~~~~~~~~~~~~-------------------------------------------------------------------- 227 (288)
T 3kfa_A 216 IDLSQVYELLEK-------------------------------------------------------------------- 227 (288)
T ss_dssp CCGGGHHHHHHT--------------------------------------------------------------------
T ss_pred CCHHHHHHHHhc--------------------------------------------------------------------
Confidence 443322222211
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. ... +....+|+++++||++||..||.+|||++|+++
T Consensus 228 --~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 228 --D-YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --T-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --c-CCC--CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1 111 112457889999999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=255.47 Aligned_cols=202 Identities=22% Similarity=0.365 Sum_probs=148.5
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.+ .+.+..++||||+.+|. |.+.+ .+..++..++.||+.||+|||++||+||||||+
T Consensus 79 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 155 (302)
T 4e5w_A 79 NLYHENIV-KYKGICTEDGGNGIKLIMEFLPSGS--LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 155 (302)
T ss_dssp TCCCTTBC-CEEEEEEC---CCEEEEEECCTTCB--HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred hCCCCCee-eeeeEEecCCCceEEEEEEeCCCCc--HHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh
Confidence 46788865 4433 22355689999999998 88776 345789999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|||++.++.+||+|||++........ .....||+.|+|||++... .++.++|+||+||++|+|++|..|+
T Consensus 156 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS------KFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp GEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred eEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC------CCCcchhHHHHHHHHHHHHHccCCC
Confidence 99999999999999999987654432 2346788899999998753 4678999999999999999999886
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch-hHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-QMVML 230 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~-~~~~~ 230 (408)
...... ..... .|+.... .....
T Consensus 230 ~~~~~~--~~~~~------------------------------------------------------~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 230 SSPMAL--FLKMI------------------------------------------------------GPTHGQMTVTRLV 253 (302)
T ss_dssp GSHHHH--HHHHH------------------------------------------------------CSCCGGGHHHHHH
T ss_pred cchhhH--Hhhcc------------------------------------------------------CCcccccCHHHHH
Confidence 432111 00100 0111111 12222
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+..+. .. +....+|+++.+||.+||..||++|||+.|+++
T Consensus 254 ~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGK-RL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTC-CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccC-CC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2333222 22 223468999999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=265.15 Aligned_cols=181 Identities=34% Similarity=0.645 Sum_probs=136.5
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhh-------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDII-------NSNPALRYIMRQLFEALEHVHNHSVVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~-------~~~~~~r~i~~qil~aL~~LH~~~IvHRDL 72 (408)
.+.|+|++ .+.+. ++...++||||+.||. |.+.+ .+..++..++.||+.||+|||++||+||||
T Consensus 67 ~~~h~~i~-~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 143 (299)
T 3m2w_A 67 ASQCPHIV-RIVDVYENLYAGRKCLLIVMECLDGGE--LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143 (299)
T ss_dssp HTTSTTBC-CEEEEEEEEETTEEEEEEEECCCCSCB--HHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hccCCCch-hHHhhhhhhcCCCceEEEEEeecCCCc--HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 34788755 44331 2456799999999998 77765 345889999999999999999999999999
Q ss_pred CCCcEEEec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 73 KPENILLDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 73 Kp~NILl~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
||+|||++. ++.+||+|||++..... ..|+.++|+||+||++|+|++|..
T Consensus 144 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------------------~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 144 KPENLLYTSKRPNAILKLTDFGFAKETTG---------------------------EKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECTT---------------------------CGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEecCCCCCcEEEecccccccccc---------------------------ccCCchhhHHHHHHHHHHHHHCCC
Confidence 999999997 78899999999864321 235679999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+.+.......+..
T Consensus 197 pf~~~~~~~~~~~~~~---------------------------------------------------------------- 212 (299)
T 3m2w_A 197 PFYSNHGLAISPGMKT---------------------------------------------------------------- 212 (299)
T ss_dssp SCCC-------CCSCC----------------------------------------------------------------
T ss_pred CCCCCcchhhhHHHHH----------------------------------------------------------------
Confidence 9976543211000000
Q ss_pred HHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 230 ~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.+..+.+.++.+.|..+|+++++||.+||..||++|||++|+|+||||...
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 213 --RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp --SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred --HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 001111223333456789999999999999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=255.58 Aligned_cols=188 Identities=21% Similarity=0.397 Sum_probs=139.3
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHH---CCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHN---HSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~---~~IvHRDLKp 74 (408)
.+.|+|+| ++.+...+..++||||+.||. |.+.+. +...+..++.|++.||+|||+ +||+||||||
T Consensus 57 ~l~hp~iv-~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp 133 (307)
T 2eva_A 57 RVNHPNIV-KLYGACLNPVCLVMEYAEGGS--LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133 (307)
T ss_dssp HCCCTTBC-CEEEBCTTTTEEEEECCTTCB--HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred cCCCCCcC-eEEEEEcCCcEEEEEcCCCCC--HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence 35788855 666665566899999999998 888764 346788899999999999999 8999999999
Q ss_pred CcEEEecCCC-EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMN-VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~-iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+|||++.++. +||+|||++...... .....||+.|+|||++.. ..++.++||||+||++|+|++|..||..
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG------SNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp GGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC------CCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred hHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC------CCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 9999998886 799999999765432 234579999999999864 3578899999999999999999999954
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
...... .....+
T Consensus 206 ~~~~~~--------------------------------------------------------------------~~~~~~ 217 (307)
T 2eva_A 206 IGGPAF--------------------------------------------------------------------RIMWAV 217 (307)
T ss_dssp TCSSHH--------------------------------------------------------------------HHHHHH
T ss_pred hCccHH--------------------------------------------------------------------HHHHHH
Confidence 221000 000011
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+. ..+....+++++++||.+||..||++|||++|+++
T Consensus 218 ~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 218 HNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 11122457889999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.34 Aligned_cols=155 Identities=23% Similarity=0.292 Sum_probs=123.5
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhcc--cc
Q psy3880 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANM--FE 123 (408)
Q Consensus 46 ~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~ 123 (408)
..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.... +.
T Consensus 211 ~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccc
Confidence 567788899999999999999999999999999999999999999998765433 455788 9999999995321 00
Q ss_pred --CcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCc
Q psy3880 124 --DATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQA 201 (408)
Q Consensus 124 --~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~ 201 (408)
....|+.++|||||||++|+|++|+.||.+.+......
T Consensus 288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------------------------------- 327 (413)
T 3dzo_A 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------------------------------- 327 (413)
T ss_dssp GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------------------------------
T ss_pred cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------------------------------
Confidence 12346789999999999999999999996543211000
Q ss_pred ccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 202 VDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 202 ~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+ ...+..+|+++++||.+||..||++|||+.|+|+||||+.
T Consensus 328 ------------------------------~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 328 ------------------------------WI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp ------------------------------GG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ------------------------------HH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 00 0123457899999999999999999999999999999953
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=266.40 Aligned_cols=138 Identities=19% Similarity=0.267 Sum_probs=114.1
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ .+.+. +++..|+||||+ ||. |.+.+. +..++..++.||+.||+|||++||+||||||
T Consensus 104 ~l~h~ni~-~~~~~~~~~~~~~~~~~lv~e~~-~~~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 179 (345)
T 2v62_A 104 QLDYLGIP-LFYGSGLTEFKGRSYRFMVMERL-GID--LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA 179 (345)
T ss_dssp TCSCCCCC-CEEEEEEEESSSCEEEEEEEECE-EEE--HHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred cccccCcc-eeecccccccCCCcEEEEEEecc-CCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCH
Confidence 35788865 44431 256789999999 888 888775 4589999999999999999999999999999
Q ss_pred CcEEEecCC--CEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 75 ENILLDDQM--NVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 75 ~NILl~~~~--~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
+|||++.++ .+||+|||+|+.+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG------VALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT------CCCCHHHHHHHHHHHHHHH
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC------CCCCchhhHHHHHHHHHHH
Confidence 999999877 999999999987643221 134689999999999875 3578899999999999999
Q ss_pred HhCCCCCCC
Q psy3880 145 LVGCPPFWH 153 (408)
Q Consensus 145 l~G~~pf~~ 153 (408)
++|..||.+
T Consensus 254 l~g~~pf~~ 262 (345)
T 2v62_A 254 LCGKLPWEQ 262 (345)
T ss_dssp HHSSCTTGG
T ss_pred HhCCCCccc
Confidence 999999854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=250.86 Aligned_cols=187 Identities=20% Similarity=0.311 Sum_probs=138.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++..+.. +.++..|+||||+.+|. |.+.+. +...+..++.|++.||+|||++||+||||||+|
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS--LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp TCCCTTBCCEEEEECCC--CCEEEECCCTTEE--HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hCCCCCEeeEEEEEEcCCCceEEEEecCCCCC--HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 4679986633332 33345789999999998 877763 446789999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
||++.++.+||+|||++...... .....+++.|+|||++.. ..++.++|+||+||++|+|++ |..||...+
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp EEECTTSCEEECCCCC--------------CCTTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred EEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCC------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998765432 223567899999999865 356789999999999999998 999986554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.......+..+
T Consensus 220 ~~~~~~~~~~~--------------------------------------------------------------------- 230 (278)
T 1byg_A 220 LKDVVPRVEKG--------------------------------------------------------------------- 230 (278)
T ss_dssp GGGHHHHHTTT---------------------------------------------------------------------
T ss_pred HHHHHHHHhcC---------------------------------------------------------------------
Confidence 33332222111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. .......+++++++||++||..||++|||+.|+++
T Consensus 231 --~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 --Y--KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --C--CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 01112357889999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=269.70 Aligned_cols=187 Identities=20% Similarity=0.326 Sum_probs=144.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+|..+.. +.+...|+||||+.+|. |.+++. +...+..++.||+.||+|||++||+||||||+|
T Consensus 242 ~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS--LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp TCCCTTBCCEEEEEECTTSCEEEEEECCTTCB--HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred hccCCCEEEEEEEEEcCCCceEEEEEecCCCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 4689986633332 33346799999999998 877763 457789999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
||++.++.+||+|||+++..... .....+++.|+|||++.. ..|+.++|||||||++|+|++ |..||.+.+
T Consensus 320 ill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHS------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred EEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999854332 223467889999999864 357889999999999999998 999986654
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..+
T Consensus 392 ~~~~~~~i~~~--------------------------------------------------------------------- 402 (450)
T 1k9a_A 392 LKDVVPRVEKG--------------------------------------------------------------------- 402 (450)
T ss_dssp TTTHHHHHHTT---------------------------------------------------------------------
T ss_pred HHHHHHHHHcC---------------------------------------------------------------------
Confidence 33333332221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+... ....+++++.+||.+||..||++|||+.++++
T Consensus 403 --~~~~--~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 --YKMD--APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 12357889999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=263.73 Aligned_cols=188 Identities=19% Similarity=0.402 Sum_probs=136.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ ..++..++||||+.+|. |.+++. +..++..++.||+.||+|||++||+||||||+||
T Consensus 102 ~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~s--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 178 (373)
T 2qol_A 102 QFDHPNII-RLEGVVTKSKPVMIVTEYMENGS--LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 178 (373)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hCCCCCCC-eEEEEEeeCCceEEEEeCCCCCc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 46799865 5544 44566789999999998 887763 3478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
|++.++.+||+|||+++........ ....+|+.|+|||++.. ..++.++|||||||++|++++ |..||.
T Consensus 179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY------RKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp EECTTCCEEECCC----------------------CTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred EEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc------CCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999876543211 12345678999999875 357789999999999999887 888887
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+.......+..+.
T Consensus 253 ~~~~~~~~~~i~~~~----------------------------------------------------------------- 267 (373)
T 2qol_A 253 EMSNQDVIKAVDEGY----------------------------------------------------------------- 267 (373)
T ss_dssp TCCHHHHHHHHHTTE-----------------------------------------------------------------
T ss_pred CCCHHHHHHHHHcCC-----------------------------------------------------------------
Confidence 665544444333211
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. +....+++++.+||.+||..||++|||+.|+++
T Consensus 268 ------~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 ------RL--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------EC--CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CC--CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11 111246788999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=261.90 Aligned_cols=181 Identities=19% Similarity=0.279 Sum_probs=139.6
Q ss_pred CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC--CEEEecc
Q psy3880 20 GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM--NVKLTDF 90 (408)
Q Consensus 20 ~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~--~iKl~DF 90 (408)
.++..|+||||+ +|. |.+++. +..++..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 129 ~~~~~~lv~e~~-~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Df 205 (352)
T 2jii_A 129 QDKYRFLVLPSL-GRS--LQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY 205 (352)
T ss_dssp TTTEEEEEEECC-CEE--HHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred CCcEEEEEecCC-CcC--HHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecC
Confidence 356779999999 887 777653 4588999999999999999999999999999999999988 8999999
Q ss_pred ccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch-hHHHHH
Q psy3880 91 GFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK-QMVMLR 161 (408)
Q Consensus 91 Gla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~-~~~~~~ 161 (408)
|+++.+..... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.. ....+.
T Consensus 206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG------CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred cceeeccCCCccccccccccccccCCccccCHHHHcc------CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 99976653321 133589999999999864 357889999999999999999999997643 111111
Q ss_pred HHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC--C
Q psy3880 162 NIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY--S 239 (408)
Q Consensus 162 ~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~--~ 239 (408)
.... .+..... .
T Consensus 280 ~~~~------------------------------------------------------------------~~~~~~~~~~ 293 (352)
T 2jii_A 280 KQKQ------------------------------------------------------------------KFVDKPGPFV 293 (352)
T ss_dssp HHHH------------------------------------------------------------------HHHHSCCCEE
T ss_pred HHHH------------------------------------------------------------------hccCChhhhh
Confidence 1110 0001111 1
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.....|..+++++++||.+||..||++|||++|+++
T Consensus 294 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 294 GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 112335678999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=256.99 Aligned_cols=189 Identities=21% Similarity=0.397 Sum_probs=141.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ +..+..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 102 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 178 (333)
T 1mqb_A 102 QFSHHNII-RLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 178 (333)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEEECCTTEE--HHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hCCCCCCC-cEEEEEecCCCcEEEEeCCCCCc--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheE
Confidence 46798865 4443 44566789999999998 777663 4578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~ 152 (408)
|++.++.+||+|||++........ .....+|+.|+|||++.. ..++.++|+||+||++|+|++ |..||.
T Consensus 179 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 179 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY------RKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS------CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc------CCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999987654321 122356788999999864 357788999999999999988 888886
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
+.+..+....+..+.
T Consensus 253 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 267 (333)
T 1mqb_A 253 ELSNHEVMKAINDGF----------------------------------------------------------------- 267 (333)
T ss_dssp TCCHHHHHHHHHTTC-----------------------------------------------------------------
T ss_pred cCCHHHHHHHHHCCC-----------------------------------------------------------------
Confidence 655444433332210
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. +....+++++.+||.+||..||++|||+.|++++
T Consensus 268 ------~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 ------RL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------CC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------cC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01 1123568899999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=273.12 Aligned_cols=188 Identities=23% Similarity=0.362 Sum_probs=146.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++.+ ..++..|+||||+.+|. |.+++. +...+..++.||+.||+|||++||+||||||+|
T Consensus 272 ~l~hpniv-~l~~~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 348 (495)
T 1opk_A 272 EIKHPNLV-QLLGVCTREPPFYIITEFMTYGN--LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARN 348 (495)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred hcCCCCEe-eEEEEEecCCcEEEEEEccCCCC--HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 36799866 5443 44567899999999998 887763 347888999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
||++.++.+||+|||+++....... .....+++.|+|||++... .|+.++|||||||++|+|++ |..||.+
T Consensus 349 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 349 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp EEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC------CCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987654322 1234567789999999753 46789999999999999998 8888866
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....+..
T Consensus 423 ~~~~~~~~~~~~-------------------------------------------------------------------- 434 (495)
T 1opk_A 423 IDLSQVYELLEK-------------------------------------------------------------------- 434 (495)
T ss_dssp CCGGGHHHHHHT--------------------------------------------------------------------
T ss_pred CCHHHHHHHHHc--------------------------------------------------------------------
Confidence 543322222211
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.+.. +....+++++++||.+||..||++|||+.|+++
T Consensus 435 ---~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ---DYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---TCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1111 112457889999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=280.64 Aligned_cols=189 Identities=19% Similarity=0.284 Sum_probs=146.7
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|+|.-+....++..++||||+.+|+ |.+++. +..++..++.||+.||+|||++|||||||||+|||++
T Consensus 426 ~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~ 503 (635)
T 4fl3_A 426 QLDNPYIVRMIGICEAESWMLVMEMAELGP--LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 503 (635)
T ss_dssp HCCCTTBCCEEEEEESSSEEEEEECCTTEE--HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred hCCCCCEeeEEEEEecCCEEEEEEccCCCC--HHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe
Confidence 367988663333333344689999999998 887763 4578999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 81 DQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
.++.+||+|||+|+.+..... .....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||.+.+
T Consensus 504 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 504 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999987754332 123456788999999965 357899999999999999998 999998776
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+....+..+..
T Consensus 578 ~~~~~~~i~~~~~------------------------------------------------------------------- 590 (635)
T 4fl3_A 578 GSEVTAMLEKGER------------------------------------------------------------------- 590 (635)
T ss_dssp HHHHHHHHHTTCC-------------------------------------------------------------------
T ss_pred HHHHHHHHHcCCC-------------------------------------------------------------------
Confidence 6555554443210
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. +....+++++.+||.+||..||++|||++++++
T Consensus 591 ----~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ----M--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----C--CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 011246889999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.09 Aligned_cols=143 Identities=20% Similarity=0.340 Sum_probs=110.2
Q ss_pred ccccCCcEEEEec--cCC----cHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHC--------CC
Q psy3880 6 MVAHSRVVVRVKE--EGD----DLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNH--------SV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~----~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~--------~I 67 (408)
.+.|+|++ .+.. ... ...|+||||+.+|. |.+.+. +..++..++.|++.||+|||++ ||
T Consensus 87 ~~~h~~i~-~~~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 87 LMRHENIL-GFIAADIKGTGSWTQLYLITDYHENGS--LYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp TCCCTTBC-CEEEEEEESCGGGCEEEEEECCCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred hhcCCCee-eEEEEEccCCCCCCceEEEEeccCCCc--HHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 35798866 4432 111 45689999999998 887763 4588999999999999999999 99
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCccc-----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL-----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
+||||||+|||++.++.+||+|||+|..+...... ...+||+.|+|||++..........++.++||||+||++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 99999999999999999999999999765433221 2468999999999997543221111122599999999999
Q ss_pred HHHhCCCCC
Q psy3880 143 TLLVGCPPF 151 (408)
Q Consensus 143 ~ll~G~~pf 151 (408)
+|++|..|+
T Consensus 244 el~tg~~~~ 252 (337)
T 3mdy_A 244 EVARRCVSG 252 (337)
T ss_dssp HHHTTBCBT
T ss_pred HHHhccCcc
Confidence 999997665
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=261.72 Aligned_cols=145 Identities=25% Similarity=0.404 Sum_probs=116.5
Q ss_pred ccccCCcEEEEeccC------CcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHC----------
Q psy3880 6 MVAHSRVVVRVKEEG------DDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNH---------- 65 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~------~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~---------- 65 (408)
.+.|+|+| ++.+.. ....++||||+.+|. |.+.+. +..++..++.||+.||+|||++
T Consensus 74 ~l~hpniv-~~~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~ 150 (322)
T 3soc_A 74 GMKHENIL-QFIGAEKRGTSVDVDLWLITAFHEKGS--LSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150 (322)
T ss_dssp TCCCTTBC-CEEEEEEEECSSSEEEEEEEECCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC
T ss_pred cCCCCCch-hhcceeccCCCCCceEEEEEecCCCCC--HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC
Confidence 46799865 444321 223589999999998 877763 4588999999999999999999
Q ss_pred CCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 66 SVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 66 ~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
||+||||||+|||++.++.+||+|||+|+.+..... ....+||+.|+|||++.+... ....++.++||||+||++|
T Consensus 151 ~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DiwslG~il~ 229 (322)
T 3soc_A 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN-FQRDAFLRIDMYAMGLVLW 229 (322)
T ss_dssp EEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC-CCHHHHHHHHHHHHHHHHH
T ss_pred CEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccc-cCcCCCccchhHHHHHHHH
Confidence 999999999999999999999999999987654332 234689999999999875211 0124567899999999999
Q ss_pred HHHhCCCCCCCc
Q psy3880 143 TLLVGCPPFWHR 154 (408)
Q Consensus 143 ~ll~G~~pf~~~ 154 (408)
+|++|..||.+.
T Consensus 230 el~tg~~pf~~~ 241 (322)
T 3soc_A 230 ELASRCTAADGP 241 (322)
T ss_dssp HHHTTBTTSSSC
T ss_pred HHHhCCCCCCCC
Confidence 999999999764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=250.90 Aligned_cols=188 Identities=22% Similarity=0.359 Sum_probs=142.6
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|++ .+.+ ..+...++|||++.+|. |.+.+.. ..++..++.|++.||+|||++||+||||||+|
T Consensus 78 ~l~h~~iv-~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 154 (298)
T 3pls_A 78 GLNHPNVL-ALIGIMLPPEGLPHVLLPYMCHGD--LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN 154 (298)
T ss_dssp TCCCTTBC-CCCEEECCSSSCCEEEECCCTTCB--HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hCCCCCee-eEEEEEecCCCCcEEEEecccCCC--HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 35788865 5443 23344589999999998 8887643 47889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC-
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP- 150 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p- 150 (408)
||++.++.+||+|||++....... ......+|+.|+|||.+.. ..++.++|+||+||++|+|++|..|
T Consensus 155 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 155 CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT------YRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp EEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT------CCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred EEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc------CCCChhhchhhHHHHHHHHhhCCCCC
Confidence 999999999999999997654322 2234567889999999864 3578899999999999999995554
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|...+.......+..
T Consensus 229 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 243 (298)
T 3pls_A 229 YRHIDPFDLTHFLAQ----------------------------------------------------------------- 243 (298)
T ss_dssp TTTSCGGGHHHHHHT-----------------------------------------------------------------
T ss_pred CccCCHHHHHHHhhc-----------------------------------------------------------------
Confidence 433322222222211
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+.. . +....+++++++||.+||..||.+|||++|+++
T Consensus 244 -----~~~-~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 244 -----GRR-L--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -----TCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC-C--CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110 1 111346889999999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=277.85 Aligned_cols=189 Identities=20% Similarity=0.291 Sum_probs=145.5
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|.-+....++..|+|||||.+|. |.+++. +..++..++.||+.||+|||++|||||||||+|||+
T Consensus 392 ~l~hpniv~l~~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 469 (613)
T 2ozo_A 392 QLDNPYIVRLIGVCQAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469 (613)
T ss_dssp TCCCTTBCCEEEEEESSSEEEEEECCTTCB--HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hCCCCCEeeEEEEeccCCeEEEEEeCCCCc--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE
Confidence 467998663333323345789999999999 888773 457899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc----ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL----MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+.++.+||+|||+|+.+...... ....+|+.|+|||++.. ..|+.++|||||||++|+|++ |..||.+.
T Consensus 470 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF------RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999876543221 12345689999999975 357899999999999999998 99999776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....+..+..
T Consensus 544 ~~~~~~~~i~~~~~------------------------------------------------------------------ 557 (613)
T 2ozo_A 544 KGPEVMAFIEQGKR------------------------------------------------------------------ 557 (613)
T ss_dssp CSHHHHHHHHTTCC------------------------------------------------------------------
T ss_pred CHHHHHHHHHcCCC------------------------------------------------------------------
Confidence 65555444433210
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. +....+++++.+||.+||..||++|||+.++++
T Consensus 558 -----~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -----M--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----C--CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----C--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 011246889999999999999999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.51 Aligned_cols=217 Identities=27% Similarity=0.453 Sum_probs=153.1
Q ss_pred ccccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCee
Q psy3880 6 MVAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVH 69 (408)
Q Consensus 6 ~~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvH 69 (408)
.+.|+|++ .+.+. ..+..++||||+.||. |.+.+. ++..++.++.||+.||+|||++||+|
T Consensus 68 ~L~HpnIV-~l~~v~~~~~~~~~~~~~~LVmEy~~ggs--L~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVH 144 (676)
T 3qa8_A 68 KLNHPNVV-SAREVPDGLQKLAPNDLPLLAMEYCEGGD--LRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH 144 (676)
T ss_dssp HCCBTTBC-CEEECCTTTCCCCTTSSCCCEEECCSSCB--HHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCC
T ss_pred hCCCCCCC-ceeeeecccccccCCCeEEEEEEeCCCCC--HHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 36799865 44332 1456789999999998 877763 34788999999999999999999999
Q ss_pred ccCCCCcEEEecCCC---EEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 70 RDLKPENILLDDQMN---VKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 70 RDLKp~NILl~~~~~---iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|||||+|||++.++. +||+|||++............+||+.|+|||++.+ ..++.++|+||+||++|+|++
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ------KKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC------SCCSTTHHHHHHHHHHHHHHS
T ss_pred CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc------CCCCchhHHHHHHHHHHHHHH
Confidence 999999999997664 89999999988766655566789999999999864 457889999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|..||.+............... ..++ ..+..+.|...|...
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~--------------------------------~~~~-----~~~~~l~g~~~~~~~-- 259 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKS--------------------------------NEHI-----VVYDDLTGAVKFSSV-- 259 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC--------------------------------------C-----CSCCCCSSSCCCCSS--
T ss_pred CCCCCCcccchhhhhhhhhccc--------------------------------chhh-----hhhhhhccccccccc--
Confidence 9999977543221100000000 0000 000001111111110
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
...+...+..+++++.+||.+||..||++|||+.|+|+||||+.
T Consensus 260 -----------lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 260 -----------LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -----------SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred -----------cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 01111123346788999999999999999999999999999963
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=268.13 Aligned_cols=118 Identities=18% Similarity=0.208 Sum_probs=96.3
Q ss_pred CcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEecCC------------
Q psy3880 21 DDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQM------------ 83 (408)
Q Consensus 21 ~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NILl~~~~------------ 83 (408)
++..|||||||.+|. +.+.+ .++.+++.++.||+.||+||| ++|||||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~--ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TTCEEEEEEEECCCE--ETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred cCeEEEEEEecCCCc--cHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 567799999999996 55554 356899999999999999999 99999999999999999887
Q ss_pred --------CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH-HHHHHhCCCCC
Q psy3880 84 --------NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI-MYTLLVGCPPF 151 (408)
Q Consensus 84 --------~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi-l~~ll~G~~pf 151 (408)
.+||+|||+|+..... ..+||+.|+|||++.+. .+.++||||++++ .+++++|..||
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~-------~~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD-------GDYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC-------SSHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred ccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC-------CccceehhhhhCCCCcccccccCCC
Confidence 8999999999876543 35899999999998642 2567888887665 55555566555
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-31 Score=257.51 Aligned_cols=204 Identities=23% Similarity=0.352 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ .+.. ++++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+
T Consensus 80 ~l~h~~i~-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 80 ALHSDFIV-KYRGVSYGPGRQSLRLVMEYLPSGC--LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp TCCCTTBC-CEEEEEECSSSCEEEEEEECCTTCB--HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred hcCCCcee-EEEEEEecCCCceEEEEEeecCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 35788755 4432 35566789999999998 777653 45889999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|||++.++.+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||
T Consensus 157 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~~p~ 230 (327)
T 3lxl_A 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN------IFSRQSDVWSFGVVLYELFTYCDKS 230 (327)
T ss_dssp GEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred hEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC------CCChHHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999987654322 2235688889999998753 4678999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
............. ..+. ........
T Consensus 231 ~~~~~~~~~~~~~------------------------------------~~~~-------------------~~~~~~~~ 255 (327)
T 3lxl_A 231 CSPSAEFLRMMGC------------------------------------ERDV-------------------PALSRLLE 255 (327)
T ss_dssp GSHHHHHHHHCC----------------------------------------C-------------------CHHHHHHH
T ss_pred ccccchhhhhccc------------------------------------cccc-------------------ccHHHHHH
Confidence 7644321110000 0000 01111222
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.+..+. .. +....+++++++||.+||..||++|||+.|+++|
T Consensus 256 ~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQ-RL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhhccc-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222221 11 2234689999999999999999999999999553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=252.33 Aligned_cols=194 Identities=21% Similarity=0.306 Sum_probs=145.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ ++.+ ..++..++||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 85 ~l~h~~iv-~~~~~~~~~~~~~iv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NI 161 (319)
T 2y4i_B 85 QTRHENVV-LFMGACMSPPHLAIITSLCKGRT--LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161 (319)
T ss_dssp TCCCTTBC-CCCEEEECSSCEEEECBCCCSEE--HHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTE
T ss_pred cCCCCCEe-EEEEEEecCCceEEEeecccCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhE
Confidence 46788865 4443 34456789999999998 888774 3478999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhccc------CcccccCCCCCcccChhhhhhcccc---CcCCCCcchhhhhhhHHHHHHHhCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKK------GEKLMDLCGTPGYLAPEVLRANMFE---DATGYGQAVDVWACGVIMYTLLVGC 148 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~---~~~~~~~~~DiwSlGvil~~ll~G~ 148 (408)
|++ ++.+||+|||++..... ........||+.|+|||++...... ....++.++||||+||++|+|++|.
T Consensus 162 l~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 240 (319)
T 2y4i_B 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240 (319)
T ss_dssp EEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 998 67999999999875432 1122345689999999998642111 1235788999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 149 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 149 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.||.+.+.......+..+. .|
T Consensus 241 ~p~~~~~~~~~~~~~~~~~---------------------------------------------------~~-------- 261 (319)
T 2y4i_B 241 WPFKTQPAEAIIWQMGTGM---------------------------------------------------KP-------- 261 (319)
T ss_dssp CSSSSCCHHHHHHHHHTTC---------------------------------------------------CC--------
T ss_pred CCCCCCCHHHHHHHhccCC---------------------------------------------------CC--------
Confidence 9997766554444433221 00
Q ss_pred HHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 229 ~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
......+++++++||.+||..||++|||+.++++
T Consensus 262 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 -------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0111246889999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-31 Score=257.83 Aligned_cols=138 Identities=28% Similarity=0.466 Sum_probs=115.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHC---CCeecc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNH---SVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~---~IvHRD 71 (408)
.+.|+|++ ++.+ ..++..++||||+.+|. |.+.+ .+...+..++.|++.||+|||++ ||+|||
T Consensus 83 ~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D 159 (326)
T 3uim_A 83 MAVHRNLL-RLRGFCMTPTERLLVYPYMANGS--VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159 (326)
T ss_dssp TCCCTTBC-CCCEEECCSSCCEEEEECCTTCB--HHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred hccCCCcc-ceEEEEecCCceEEEEEeccCCC--HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence 46788855 5544 34556689999999998 87776 34478899999999999999999 999999
Q ss_pred CCCCcEEEecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 72 LKPENILLDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 72 LKp~NILl~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
|||+|||++.++.+||+|||++....... .....+||+.|+|||++... .++.++||||+||++|+|++|..
T Consensus 160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 160 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS------EECHHHHHHHHHHHHHHHHHCCC
T ss_pred CchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC------CCCccccchhHHHHHHHHHhCCC
Confidence 99999999999999999999998765332 23346799999999998753 46789999999999999999999
Q ss_pred CCC
Q psy3880 150 PFW 152 (408)
Q Consensus 150 pf~ 152 (408)
||.
T Consensus 234 pf~ 236 (326)
T 3uim_A 234 AFD 236 (326)
T ss_dssp SBC
T ss_pred ccc
Confidence 995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-31 Score=272.92 Aligned_cols=195 Identities=22% Similarity=0.345 Sum_probs=151.1
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.|.|+|+|..+....+...||||||+.+|. |.+++. +..++..++.||+.||+|||++|||||||||+|||
T Consensus 318 ~l~hpniv~~~~~~~~~~~~lv~e~~~~gs--L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 395 (535)
T 2h8h_A 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395 (535)
T ss_dssp HCCCTTBCCEEEEECSSSCEEEECCCTTEE--HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hCCCCCEeeEEEEEeeccceEeeehhcCCc--HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence 367998663333333456789999999998 888775 34688999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||+++.+..... .....++..|+|||++... .|+.++|||||||++|+|++ |..||.+..
T Consensus 396 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp ECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred EcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987653221 1234567889999998753 47889999999999999998 888887765
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+.+..+..+.
T Consensus 470 ~~~~~~~i~~~~-------------------------------------------------------------------- 481 (535)
T 2h8h_A 470 NREVLDQVERGY-------------------------------------------------------------------- 481 (535)
T ss_dssp HHHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 555444443221
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC--CCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH--SFFHP 281 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H--pwf~~ 281 (408)
..+ ....+++++.+||.+||..||++|||++++++. .+|..
T Consensus 482 ---~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 ---RMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 111 113568899999999999999999999998764 55543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-31 Score=253.73 Aligned_cols=190 Identities=26% Similarity=0.383 Sum_probs=135.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|++ .+.+ +.++..|+||||+.||. |.+.+. +..++..++.||+.||+|||++||+||||||+|||
T Consensus 90 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl 166 (309)
T 2h34_A 90 RLQEPHVV-PIHDFGEIDGQLYVDMRLINGVD--LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166 (309)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCCCEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hcCCCCee-EEEEEEeeCCeEEEEEEecCCCC--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE
Confidence 46788865 4443 34566789999999998 777663 45789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc--ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||++....... ......||+.|+|||++.. ..++.++|+||+||++|+|++|..||.+.+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE------SHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp ECTTSCEEECSCCC----------------CCGGGCCGGGTCC----------CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred EcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC------CCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 9999999999999997665432 2234679999999999864 3456778888888888888888888765433
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
..+ . .....
T Consensus 241 ~~~----------------------------------------------------------------------~-~~~~~ 249 (309)
T 2h34_A 241 SVM----------------------------------------------------------------------G-AHINQ 249 (309)
T ss_dssp HHH----------------------------------------------------------------------H-HHHHS
T ss_pred HHH----------------------------------------------------------------------H-HHhcc
Confidence 211 1 11111
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-CHHHHHc
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-SVKEALN 275 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-ta~e~L~ 275 (408)
........+..+|+++++||.+||..||++|| |++++++
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11112223457899999999999999999999 7887765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-31 Score=262.72 Aligned_cols=137 Identities=20% Similarity=0.368 Sum_probs=115.1
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.|++++ .+.. ..++..|+|||||.||+ |.+.+. +..++..++.||+.||+|||++|||||||||+
T Consensus 125 ~~~~iv-~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFM-KFYSAHLFQNGSVLVGELYSYGT--LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201 (365)
T ss_dssp GGGGBC-CEEEEEECSSCEEEEECCCCSCB--HHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred hhhhhh-hhheeeecCCCcEEEEeccCCCc--HHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence 377755 4443 35567789999999998 888763 44789999999999999999999999999999
Q ss_pred cEEEec-----------CCCEEEeccccchhcc---cCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 76 NILLDD-----------QMNVKLTDFGFARVLK---KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 76 NILl~~-----------~~~iKl~DFGla~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
|||++. ++.+||+|||+|+.+. ........+||+.|+|||++.+ ..|+.++||||+||++
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il 275 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN------KPWNYQIDYFGVAATV 275 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT------CCBSTHHHHHHHHHHH
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC------CCCCccccHHHHHHHH
Confidence 999988 8999999999996543 3334456789999999999975 3478999999999999
Q ss_pred HHHHhCCCCCCC
Q psy3880 142 YTLLVGCPPFWH 153 (408)
Q Consensus 142 ~~ll~G~~pf~~ 153 (408)
|+|++|..||..
T Consensus 276 ~elltg~~pf~~ 287 (365)
T 3e7e_A 276 YCMLFGTYMKVK 287 (365)
T ss_dssp HHHHHSSCCCEE
T ss_pred HHHHhCCCcccc
Confidence 999999999854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-31 Score=253.22 Aligned_cols=141 Identities=27% Similarity=0.452 Sum_probs=116.5
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC--------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN--------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~--------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ ++.+ ..++..++||||+.+|. |.+.+. +...+..++.||+.||+|||++||+||||||+
T Consensus 86 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLV-ELLGFSSDGDDLCLVYVYMPNGS--LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred hcCCCCeE-EEEEEEecCCceEEEEEecCCCc--HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHH
Confidence 46798866 4443 44567789999999998 777653 45788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 152 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~ 152 (408)
|||++.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|+||+||++|+|++|..||.
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-------EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-------CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 9999999999999999987654322 1234679999999998864 36789999999999999999999997
Q ss_pred Cchh
Q psy3880 153 HRKQ 156 (408)
Q Consensus 153 ~~~~ 156 (408)
+.+.
T Consensus 236 ~~~~ 239 (307)
T 2nru_A 236 EHRE 239 (307)
T ss_dssp TTBS
T ss_pred cCcc
Confidence 6543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=275.97 Aligned_cols=189 Identities=24% Similarity=0.343 Sum_probs=146.6
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|.-+....++..|+||||+.+|+ |.+++. +...+..++.||+.||+|||++||+||||||+|||+
T Consensus 447 ~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl 524 (656)
T 2j0j_A 447 QFDHPHIVKLIGVITENPVWIIMELCTLGE--LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524 (656)
T ss_dssp HCCCTTBCCEEEEECSSSCEEEEECCTTCB--HHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hCCCCCCCeEEEEEecCceEEEEEcCCCCc--HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE
Confidence 357998663333334456789999999998 877663 347888999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~~ 156 (408)
+.++.+||+|||+++........ ....+|+.|+|||++.. ..|+.++||||+||++|+|++ |..||.+.+.
T Consensus 525 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999876543322 23457789999999865 357889999999999999997 9999977665
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+..+..+..
T Consensus 599 ~~~~~~i~~~~~-------------------------------------------------------------------- 610 (656)
T 2j0j_A 599 NDVIGRIENGER-------------------------------------------------------------------- 610 (656)
T ss_dssp HHHHHHHHHTCC--------------------------------------------------------------------
T ss_pred HHHHHHHHcCCC--------------------------------------------------------------------
Confidence 555444433210
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
. +....+++++.+||.+||..||++|||+.|+++
T Consensus 611 --~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 --L---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --C---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 011356889999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-31 Score=253.07 Aligned_cols=191 Identities=27% Similarity=0.492 Sum_probs=135.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|++ ++.+ ..++..++||||+.+|. |.+.+ .+..++..++.||+.||.|||++||+||||||
T Consensus 88 ~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p 164 (310)
T 2wqm_A 88 QLNHPNVI-KYYASFIEDNELNIVLELADAGD--LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164 (310)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCCSCB--HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred hCCCCCEe-eEEEEEEcCCcEEEEEecCCCCC--HHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH
Confidence 46788865 4443 34556789999999998 76665 35578899999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
+|||++.++.+||+|||++....... ......||+.|+|||++.. ..++.++|+|||||++|+|++|..||.+
T Consensus 165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE------NGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp GGEEECTTSCEEECCC------------------CCSSCCHHHHTT------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred HHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC------CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999998765432 2234679999999999864 3467889999999999999999888854
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
... ........+
T Consensus 239 ~~~--------------------------------------------------------------------~~~~~~~~~ 250 (310)
T 2wqm_A 239 DKM--------------------------------------------------------------------NLYSLCKKI 250 (310)
T ss_dssp --C--------------------------------------------------------------------CHHHHHHHH
T ss_pred cch--------------------------------------------------------------------hHHHHHHHh
Confidence 211 001122223
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
....+ +...+..+++++++||.+||..||++|||+.++++
T Consensus 251 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 251 EQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HTTCS--CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccC--CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 32222 22223567899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-31 Score=254.53 Aligned_cols=188 Identities=30% Similarity=0.481 Sum_probs=124.7
Q ss_pred ccCCcEEEEec----------cCCcHHHHHHHHHhhchhhHHhhh--------CCHHHHHHHHHHHHHHHHHHHHCC--C
Q psy3880 8 AHSRVVVRVKE----------EGDDLKHLAAQVVDKGEAAVQDII--------NSNPALRYIMRQLFEALEHVHNHS--V 67 (408)
Q Consensus 8 ~~~~~i~~~~~----------~~~~~~~lv~e~~~~g~~~l~~~~--------~~~~~~r~i~~qil~aL~~LH~~~--I 67 (408)
.|+|+| .+.. +.+...++||||+.|. |.+.+ .+..++..++.||+.||+|||++| |
T Consensus 84 ~h~~iv-~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~---L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i 159 (337)
T 3ll6_A 84 GHPNIV-QFCSAASIGKEESDTGQAEFLLLTELCKGQ---LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI 159 (337)
T ss_dssp TSTTBC-CEEEEEEECTTTSTTSSEEEEEEEECCSEE---HHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred cCCChh-hccccccccccccccCCceEEEEEEecCCC---HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE
Confidence 488865 4432 2334568999999754 44443 355889999999999999999999 9
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCccc-------------ccCCCCCcccChhhhhhccccCcCCCCcchhh
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL-------------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDV 134 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~-------------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~Di 134 (408)
+||||||+|||++.++.+||+|||++......... ...+||+.|+|||++... ....++.++||
T Consensus 160 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~Dv 236 (337)
T 3ll6_A 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY---SNFPIGEKQDI 236 (337)
T ss_dssp BCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CC---TTSCSSHHHHH
T ss_pred EEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc---ccCCCChHHhH
Confidence 99999999999999999999999999876542211 145699999999998421 12457789999
Q ss_pred hhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHh
Q psy3880 135 WACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 214 (408)
Q Consensus 135 wSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~l 214 (408)
|||||++|+|++|..||.+......
T Consensus 237 ~slG~il~el~~g~~p~~~~~~~~~------------------------------------------------------- 261 (337)
T 3ll6_A 237 WALGCILYLLCFRQHPFEDGAKLRI------------------------------------------------------- 261 (337)
T ss_dssp HHHHHHHHHHHHSSCCC---------------------------------------------------------------
T ss_pred HHHHHHHHHHHhCCCCCcchhHHHh-------------------------------------------------------
Confidence 9999999999999999854322110
Q ss_pred hcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCC
Q psy3880 215 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278 (408)
Q Consensus 215 l~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpw 278 (408)
..+.+.. +.....++++++||++||..||++|||+.|+++|-+
T Consensus 262 -------------------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 -------------------VNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----------------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred -------------------hcCcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0111111 112356788999999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=255.29 Aligned_cols=140 Identities=23% Similarity=0.391 Sum_probs=110.6
Q ss_pred cccCCcEEEEec--cCCc----HHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHH--------HCCCe
Q psy3880 7 VAHSRVVVRVKE--EGDD----LKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVH--------NHSVV 68 (408)
Q Consensus 7 ~~~~~~i~~~~~--~~~~----~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH--------~~~Iv 68 (408)
+.|+|++ .+.+ ..++ ..++||||+.+|. |.+.+. +..++..++.|++.||+||| ++||+
T Consensus 93 l~h~ni~-~~~~~~~~~~~~~~~~~lv~e~~~~g~--L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 93 LRHENIL-GFIAADNKDNGTWTQLWLVSDYHEHGS--LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp CCCTTBC-CEEEEEECCCSSCCCEEEEECCCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred cCCCcEE-EEEeeecccCCccceeEEEEeecCCCc--HHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 7899866 4433 2222 5789999999998 888763 45789999999999999999 99999
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 143 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ 143 (408)
||||||+|||++.++.+||+|||++........ ....+||+.|+|||++..........++.++||||+||++|+
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 999999999999999999999999987654332 234689999999999875321111123468999999999999
Q ss_pred HHhCCC
Q psy3880 144 LLVGCP 149 (408)
Q Consensus 144 ll~G~~ 149 (408)
|++|..
T Consensus 250 l~tg~~ 255 (342)
T 1b6c_B 250 IARRCS 255 (342)
T ss_dssp HHTTBC
T ss_pred HHhccC
Confidence 999943
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=250.57 Aligned_cols=203 Identities=22% Similarity=0.339 Sum_probs=148.1
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|++ .+.+ .+....++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 89 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni 165 (318)
T 3lxp_A 89 TLYHEHII-KYKGCCEDAGAASLQLVMEYVPLGS--LRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV 165 (318)
T ss_dssp HCCCTTBC-CEEEEEEETTTTEEEEEECCCTTCB--HHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCcchh-hEEEEEecCCCceEEEEEecccCCc--HHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence 36788865 4443 22356789999999998 888774 4588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|++.++.+||+|||++........ .....+|+.|+|||++... .++.++|+||+||++|+|++|..||..
T Consensus 166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY------KFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC------CCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 999999999999999987654332 2335688899999999753 467899999999999999999999865
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
......... . | +............+
T Consensus 240 ~~~~~~~~~--~---------------------------------------~--------------~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 240 PPTKFLELI--G---------------------------------------I--------------AQGQMTVLRLTELL 264 (318)
T ss_dssp HHHHHHHHH--C---------------------------------------S--------------CCHHHHHHHHHHHH
T ss_pred cchhhhhhh--c---------------------------------------c--------------cccchhHHHHHHHH
Confidence 432111000 0 0 00000011111222
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+ ... +....+++++.+||++||..||++|||++|+++
T Consensus 265 ~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERG-ERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcc-cCC--CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222 111 223467899999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=265.48 Aligned_cols=140 Identities=24% Similarity=0.382 Sum_probs=114.0
Q ss_pred cccCCcEEEEe--ccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~--~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
|.|+++|..+. ....+..+|||||+ +|. |.+.+. +..++..++.||+.||+|||++|||||||||+|||
T Consensus 59 L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s--L~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 135 (483)
T 3sv0_A 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS--LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (483)
T ss_dssp TTTSTTCCCEEEEEEETTEEEEEEECC-CCB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hcCCCCCCeEEEEEeeCCEEEEEEECC-CCC--HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEE
Confidence 55655553333 34556678999999 777 766653 45899999999999999999999999999999999
Q ss_pred E---ecCCCEEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 79 L---DDQMNVKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 79 l---~~~~~iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
+ +.++.+||+|||+|+.+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDvwSlGvil~elltG 209 (483)
T 3sv0_A 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG------IEQSRRDDLESLGYVLMYFLRG 209 (483)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC------CCCChHHHHHHHHHHHHHHHhC
Confidence 9 5788999999999987654322 125789999999999875 3578899999999999999999
Q ss_pred CCCCCCch
Q psy3880 148 CPPFWHRK 155 (408)
Q Consensus 148 ~~pf~~~~ 155 (408)
..||.+..
T Consensus 210 ~~Pf~~~~ 217 (483)
T 3sv0_A 210 SLPWQGLK 217 (483)
T ss_dssp SCTTSSCC
T ss_pred CCCCcccc
Confidence 99997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=252.32 Aligned_cols=194 Identities=23% Similarity=0.353 Sum_probs=142.0
Q ss_pred ccccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC---------CHHHHHHHHHHHHHHHHHHHHCCCeec
Q psy3880 6 MVAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN---------SNPALRYIMRQLFEALEHVHNHSVVHR 70 (408)
Q Consensus 6 ~~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~---------~~~~~r~i~~qil~aL~~LH~~~IvHR 70 (408)
.+.|+|++ ++.+. ..+..++||||+.+|. |.+.+. +..++..++.||+.||+|||++||+||
T Consensus 82 ~l~h~~iv-~~~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 158 (317)
T 2buj_A 82 LFNHPNIL-RLVAYCLRERGAKHEAWLLLPFFKRGT--LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR 158 (317)
T ss_dssp TCCCTTBC-CCCEEEEEEETTEEEEEEEEECCTTCB--HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred hcCCCCee-eEEEEEEeccCCCceeEEEEEeCCCCc--HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 46788855 44331 2346789999999998 766552 458899999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeccccchhcccCc----------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 71 DLKPENILLDDQMNVKLTDFGFARVLKKGE----------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 71 DLKp~NILl~~~~~iKl~DFGla~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.... ...++.++||||+||+
T Consensus 159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS---HCVIDERTDVWSLGCV 235 (317)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS---EEEECTHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC---CcCCCchhhHHHHHHH
Confidence 999999999999999999999887543211 112346799999999986421 1235778999999999
Q ss_pred HHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 141 MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 141 l~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
+|+|++|..||....... +
T Consensus 236 l~el~~g~~p~~~~~~~~--------------------------------------------~----------------- 254 (317)
T 2buj_A 236 LYAMMFGEGPYDMVFQKG--------------------------------------------D----------------- 254 (317)
T ss_dssp HHHHHHSSCTTHHHHHTT--------------------------------------------S-----------------
T ss_pred HHHHHhCCCChhhhhccc--------------------------------------------c-----------------
Confidence 999999999883211000 0
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. .........+ +....+|+++++||.+||..||++|||++|+++|
T Consensus 255 -------~~-~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 255 -------SV-ALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------CH-HHHHHCC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------hh-hHHhhccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 0001111111 2234678999999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=243.73 Aligned_cols=139 Identities=26% Similarity=0.415 Sum_probs=112.0
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|++ ++.+ .+....++||||+.+|. |.+.+ .+..++..++.||+.||+|||++||+||||||+
T Consensus 98 ~l~h~~iv-~~~~~~~~~~~~~~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 174 (326)
T 2w1i_A 98 SLQHDNIV-KYKGVCYSAGRRNLKLIMEYLPYGS--LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174 (326)
T ss_dssp TCCCTTBC-CEEEEECC----CCEEEECCCTTCB--HHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred hCCCCCee-eEEEEEEecCCCceEEEEECCCCCC--HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence 35788865 4433 22235689999999998 87765 345788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|||++.++.+||+|||++........ .....+++.|+|||++... .++.++|+||+||++|+|++|..||
T Consensus 175 NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES------KFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp GEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred eEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC------CCCchhhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999987654332 1234577889999998753 4678999999999999999999988
Q ss_pred CC
Q psy3880 152 WH 153 (408)
Q Consensus 152 ~~ 153 (408)
..
T Consensus 249 ~~ 250 (326)
T 2w1i_A 249 KS 250 (326)
T ss_dssp GS
T ss_pred CC
Confidence 54
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-29 Score=266.41 Aligned_cols=134 Identities=27% Similarity=0.388 Sum_probs=108.0
Q ss_pred ccccCCcEEEEec--cCCcH-----HHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDL-----KHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~-----~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|+| .+.+ +..+. .||||||+.||. |.+.+ .+..++..++.||+.||.|||++|||||||||+
T Consensus 135 ~l~hp~iv-~~~~~~~~~~~~~~~~~~lv~E~~~g~~--L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~ 211 (681)
T 2pzi_A 135 EVVHPSIV-QIFNFVEHTDRHGDPVGYIVMEYVGGQS--LKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE 211 (681)
T ss_dssp GCCCTTBC-CEEEEEEEECTTSCEEEEEEEECCCCEE--CC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCcC-eEeeeEeecCCCCCceeEEEEEeCCCCc--HHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChH
Confidence 46799865 4443 11222 589999999998 76665 356889999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|||++.+ .+||+|||+++..... ...+||+.|+|||++... ++.++||||+||++|+|++|.+||.+
T Consensus 212 NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-------~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 212 NIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-------PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp GEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-------SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred HeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC-------CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 9999875 8999999999876543 456899999999998642 46799999999999999999888743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-28 Score=231.30 Aligned_cols=115 Identities=18% Similarity=0.189 Sum_probs=95.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC---HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS---NPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~---~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+|++ ++.+ +.++..|+||||+.||. |.+.+.. ..++..++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~l~hp~iv-~~~~~~~~~~~~~lv~e~~~g~~--L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~ 163 (286)
T 3uqc_A 87 RIDKPGVA-RVLDVVHTRAGGLVVAEWIRGGS--LQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163 (286)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCCEEE--HHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE
T ss_pred cCCCCCcc-eeeEEEEECCcEEEEEEecCCCC--HHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc
Confidence 46899855 5544 34566799999999998 8887753 367888999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
.++.+||+++| |++| ++.++|||||||++|+|++|..||.+.+
T Consensus 164 ~~g~~kl~~~~-------------------~~~~-------------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 164 IDGDVVLAYPA-------------------TMPD-------------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp TTSCEEECSCC-------------------CCTT-------------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CCCCEEEEecc-------------------ccCC-------------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 99999998543 3332 4679999999999999999999997643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-28 Score=254.58 Aligned_cols=130 Identities=17% Similarity=0.169 Sum_probs=92.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCCH--HHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINSN--PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM 83 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~~--~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~ 83 (408)
.|+| |+++.+ +++...|||||||+||+ |.+.|... -..+.|+.||+.||+|||++|||||||||+|||++.++
T Consensus 300 ~~~~-i~~~~~~~ed~~~~yLVMEyv~G~~--L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 300 AGFD-APAVLAHGENAQSGWLVMEKLPGRL--LSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp TTCC-CCCEEEEEECSSEEEEEEECCCSEE--HHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS
T ss_pred CCCC-eeEEEEEEEECCEEEEEEecCCCCc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC
Confidence 4666 555554 55667899999999999 99998654 23456899999999999999999999999999999999
Q ss_pred CEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhC
Q psy3880 84 NVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG 147 (408)
Q Consensus 84 ~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G 147 (408)
.+||+|||+|+..... ....+.+||++|+|||++.+. +..++|+||+|++++.+.++
T Consensus 377 ~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-------~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-------KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------------CCCCTT
T ss_pred CEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-------CCCcccccccccchhhhccc
Confidence 9999999999876543 334567899999999998642 45567888888776655444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-21 Score=200.32 Aligned_cols=135 Identities=18% Similarity=0.280 Sum_probs=109.9
Q ss_pred ccccCCcEE-EEeccCCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCC
Q psy3880 6 MVAHSRVVV-RVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN 84 (408)
Q Consensus 6 ~~~~~~~i~-~~~~~~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~ 84 (408)
.+.|+|+|. .+++.+.+..||||||+.||+ |.+.+.. +..++.||+.||+|||++||+||||||+|||++. .
T Consensus 395 ~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggs--L~~~l~~---~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 395 LVKDFGIPAPYIFDVDLDNKRIMMSYINGKL--AKDVIED---NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp HGGGGTCCCCCEEEEETTTTEEEEECCCSEE--HHHHSTT---CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S
T ss_pred hcCCCCcCceEEEEEeCCccEEEEECCCCCC--HHHHHHH---HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e
Confidence 367998661 455555666799999999999 9998876 7789999999999999999999999999999998 9
Q ss_pred EEEeccccchhcccCcc--------cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 85 VKLTDFGFARVLKKGEK--------LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 85 iKl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
+||+|||+|+....... ....+||+.|+|||++.... .+|+..+|+||..+-..+...++.+|
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~----~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL----EGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH----HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH----HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999987754322 13578999999999997521 35778899999988777776665544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-15 Score=143.59 Aligned_cols=81 Identities=16% Similarity=0.229 Sum_probs=69.7
Q ss_pred cHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK 101 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~ 101 (408)
+..|+||||+.||. |.+ + ...++..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+.
T Consensus 173 ~~~~lvmE~~~g~~--L~~-l-~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------ 241 (282)
T 1zar_A 173 EGNAVLMELIDAKE--LYR-V-RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------ 241 (282)
T ss_dssp ETTEEEEECCCCEE--GGG-C-CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE------
T ss_pred cceEEEEEecCCCc--HHH-c-chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE------
Confidence 45689999999998 887 4 3345668999999999999999999999999999999 99999999999853
Q ss_pred cccCCCCCcccChhhhhh
Q psy3880 102 LMDLCGTPGYLAPEVLRA 119 (408)
Q Consensus 102 ~~~~~gt~~y~aPE~l~~ 119 (408)
+..++|||++..
T Consensus 242 ------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ------VGEEGWREILER 253 (282)
T ss_dssp ------TTSTTHHHHHHH
T ss_pred ------CCCCCHHHHHHH
Confidence 345789998864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=7.7e-13 Score=124.31 Aligned_cols=72 Identities=21% Similarity=0.289 Sum_probs=58.2
Q ss_pred HHHHHHHHHhh-ch--hhHHhhhCC--HHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEecCCCEEEeccccchhc
Q psy3880 23 LKHLAAQVVDK-GE--AAVQDIINS--NPALRYIMRQLFEALEHVH-NHSVVHRDLKPENILLDDQMNVKLTDFGFARVL 96 (408)
Q Consensus 23 ~~~lv~e~~~~-g~--~~l~~~~~~--~~~~r~i~~qil~aL~~LH-~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~ 96 (408)
..+|||||+.+ |. ..|.+...+ ..++..++.|++.||.||| ++|||||||||+|||++. .++|+|||+|...
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 45799999932 31 125555433 3478899999999999999 999999999999999988 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.3e-10 Score=115.33 Aligned_cols=66 Identities=18% Similarity=0.313 Sum_probs=55.7
Q ss_pred HHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCC----------CEEEeccccc
Q psy3880 25 HLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQM----------NVKLTDFGFA 93 (408)
Q Consensus 25 ~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~----------~iKl~DFGla 93 (408)
+|||||+.|+. |.+.. ..++++.++.||+.+|.+||++|||||||||.|||+++++ .+.|+||+-+
T Consensus 187 ~LVME~i~G~~--L~~l~-~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 187 TIVMSLVDALP--MRQVS-SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp EEEEECCSCEE--GGGCC-CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred eEEEEecCCcc--Hhhhc-ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence 58999999887 65543 3455678899999999999999999999999999998776 3789999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=5.3e-09 Score=102.52 Aligned_cols=51 Identities=25% Similarity=0.456 Sum_probs=42.6
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
++..|||||++.+. .|+.++||||+||++|+|++|.+||.+.+..+++.+|
T Consensus 187 GT~~YmAPE~l~~~------~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 187 GTPYYLSPEICENK------PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp SCCTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCccccCHHHHCCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 46679999999763 5788999999999999999999999887766555444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.69 E-value=7.3e-09 Score=103.40 Aligned_cols=69 Identities=25% Similarity=0.302 Sum_probs=56.3
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCC
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDI 248 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~i 248 (408)
..++..|+|||++.+. ..|+.++||||+|||+|+|++|.+||.+.+..+++..|......++...|..+
T Consensus 222 ~~GT~~Y~APEv~~~~-----~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 222 YVATRWYRAPELMLSL-----HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp SCCCCTTCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred ceeChHhcCHHHhcCC-----CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 4567789999998653 24788999999999999999999999999999999999887776665555443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=6.6e-09 Score=101.71 Aligned_cols=49 Identities=24% Similarity=0.672 Sum_probs=40.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.++..|||||++... +|+.++||||+||++|+|++|.+||.+.+..+++
T Consensus 231 ~GTp~YmAPEvl~~~------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 231 VGTPYWMAPELISRL------PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279 (346)
T ss_dssp CSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ccCcCcCCHHHHCCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 467779999998653 5889999999999999999999999876654433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.3e-09 Score=103.45 Aligned_cols=54 Identities=24% Similarity=0.434 Sum_probs=43.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.++..|||||++.+. .|+.++||||+||++|+|++|.+||.+.+...++..|..
T Consensus 217 ~GT~~YmAPE~~~~~------~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 217 PGTETHMAPEVVMGK------PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp CCCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred ccCccccCHHHHCCC------CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 467789999999764 578899999999999999999999987665544544443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.49 E-value=4.2e-08 Score=93.70 Aligned_cols=43 Identities=26% Similarity=0.488 Sum_probs=37.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.++..|||||++.. +|+.++||||+||++|+|++|.+||.+.+
T Consensus 191 ~GTp~YmAPE~~~~-------~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 191 IGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ccCccccCHHHcCC-------CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 46778999998753 48899999999999999999999997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=6.2e-08 Score=93.28 Aligned_cols=54 Identities=26% Similarity=0.496 Sum_probs=42.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
.++..|||||++... ....|+.++||||+||++|+|++|.+||.+.+....+..
T Consensus 195 ~GT~~ymAPE~l~~~---~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQ---DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248 (307)
T ss_dssp CCCTTSCCHHHHHCC---SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred ccCCCccCHHHhhcc---CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 456789999999743 123588899999999999999999999987655444333
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=6.5e-08 Score=95.27 Aligned_cols=54 Identities=37% Similarity=0.698 Sum_probs=42.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc-hhHHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR-KQMVMLRNIM 234 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~-~~~~~~~~i~ 234 (408)
.++..|+|||++... ..|+.++||||+|||+|+|++|.+||... +..+.+..|.
T Consensus 207 ~GT~~Y~APE~l~~~-----~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~ 261 (361)
T 4f9c_A 207 AGTPGFRAPEVLTKC-----PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIM 261 (361)
T ss_dssp CCCGGGCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred ccCccccCHHHHcCC-----CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 467789999998653 34788999999999999999999999764 3445555554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=8.1e-08 Score=92.14 Aligned_cols=51 Identities=20% Similarity=0.506 Sum_probs=41.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~~~i 233 (408)
.+..|||||++... .|+.++||||+||++|+|++ |.+||.+.+..+++..+
T Consensus 192 gt~~ymAPE~~~~~------~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 192 LPIRWMPPESIMYR------KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp ECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cChhhcCHHHHcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 45679999999864 57889999999999999998 99999876655544433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=98.35 E-value=1.8e-07 Score=90.12 Aligned_cols=52 Identities=19% Similarity=0.449 Sum_probs=41.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~~~i 233 (408)
..+..|||||++... .|+.++||||+||++|+|++ |.+||.+.+..+++..|
T Consensus 208 ~gt~~ymAPE~l~~~------~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 208 LLPIRWMAPEAIMYG------KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp CBCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred ccCCcccCHHHHhCC------CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 345569999999764 47889999999999999998 89999876655544433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=98.31 E-value=1.5e-07 Score=99.36 Aligned_cols=46 Identities=35% Similarity=0.691 Sum_probs=38.8
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
..++..|||||++... .+|+.++||||+||++|+|++|.+||.+.+
T Consensus 350 ~~GTp~YmAPEvl~~~-----~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 350 SVGTHGYMAPEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp CCSCGGGCCHHHHSTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred ccCCcCccCHHHHhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3567889999998532 368999999999999999999999997643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.24 E-value=3.9e-07 Score=88.56 Aligned_cols=48 Identities=19% Similarity=0.516 Sum_probs=39.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
.+..|||||++... .|+.++||||+||++|+|++ |.+||.+.+..+.+
T Consensus 222 gt~~ymAPE~~~~~------~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 222 LPIRWMPPESILYR------KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp CCGGGCCHHHHTTC------CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred ccccccChhhhcCC------CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 45579999998764 57889999999999999998 99999876654443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.4e-07 Score=89.03 Aligned_cols=40 Identities=28% Similarity=0.620 Sum_probs=34.9
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
+..|||||++... .|+.++||||+||++|+|++ |.+||.+
T Consensus 250 t~~ymAPE~l~~~------~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 250 PLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cccccCHHHHhcC------CCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 4569999999864 57889999999999999997 9999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=8.2e-07 Score=90.16 Aligned_cols=75 Identities=21% Similarity=0.291 Sum_probs=56.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
..+..|++||++... .|+.++||||+||++|+|++|.+||.+.+..+.+..|.+.........|..+.+.+++.
T Consensus 224 ~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 224 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp -CCCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred cccccccCHHHHcCC------CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 456679999999753 57889999999999999999999999998888888877654333333345555555444
Q ss_pred H
Q psy3880 256 I 256 (408)
Q Consensus 256 I 256 (408)
+
T Consensus 298 ~ 298 (464)
T 3ttj_A 298 V 298 (464)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-06 Score=86.06 Aligned_cols=56 Identities=32% Similarity=0.551 Sum_probs=46.9
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
...+..|+|||++... ..|+.++||||+|||+|+|++|.+||.+.+....+..|..
T Consensus 190 ~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 190 YVATRWYRAPEILLGS-----TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcccCCcCCHHHhcCC-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3456679999998642 3578899999999999999999999999888887777764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=98.09 E-value=1.8e-06 Score=81.24 Aligned_cols=65 Identities=26% Similarity=0.420 Sum_probs=48.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWN 246 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~ 246 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+...........|.
T Consensus 162 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 162 VTLWYRAPDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp CCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccCchheeCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence 45679999998642 247889999999999999999999999887776666665543333333443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=98.08 E-value=1.9e-06 Score=83.36 Aligned_cols=46 Identities=39% Similarity=0.730 Sum_probs=37.2
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
.....|++||++....+ ++.++|+||+||++|+|++|.+||.+.+.
T Consensus 174 ~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKY-----DGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp SSSGGGCCHHHHHTCCC-----CSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCcceeCcccccCCCc-----CCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 35667999999976432 35689999999999999999999976543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=98.07 E-value=2.1e-06 Score=82.60 Aligned_cols=21 Identities=24% Similarity=0.580 Sum_probs=14.7
Q ss_pred CCCCchhHHHHHHHHhccccC
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSF 170 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~ 170 (408)
||.+.+..+++.+|..+.+.+
T Consensus 233 PF~~~~~~~~~~~i~~~~~~~ 253 (311)
T 4aw0_A 233 PFRAGNEGLIFAKIIKLEYDF 253 (311)
T ss_dssp SSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCCCCHHHHHHHHHcCCCCC
Confidence 566677777777887776544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.9e-06 Score=82.50 Aligned_cols=57 Identities=28% Similarity=0.518 Sum_probs=46.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
.....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+....
T Consensus 169 ~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 225 (317)
T 2pmi_A 169 VVTLWYRAPDVLMGS-----RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225 (317)
T ss_dssp CSCCTTCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccCchHhhCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 346679999998642 247889999999999999999999999888777777665543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=4.9e-07 Score=86.68 Aligned_cols=100 Identities=17% Similarity=0.242 Sum_probs=69.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc---------------hhHHHHHHHHhcCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---------------KQMVMLRNIMEGKYSF 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~---------------~~~~~~~~i~~~~~~f 240 (408)
.++..|||||++..........|+.++||||+||++|+|++|.+||... ....+...+.......
T Consensus 173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp 252 (303)
T 3hmm_A 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 252 (303)
T ss_dssp -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCC
Confidence 4677899999997654333345778999999999999999998876321 1223444444444332
Q ss_pred CCCc-CC--CCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 241 SSPE-WN--DISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 241 ~~~~-~~--~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+. |. ..+.++.+||.+||..||++|||+.|+++
T Consensus 253 ~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 253 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2221 11 12346789999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.6e-06 Score=86.69 Aligned_cols=59 Identities=31% Similarity=0.557 Sum_probs=46.6
Q ss_pred ccCCCCCchHHHhhhccc-ccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFE-DATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~-~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.++..|+|||++...... ....|+.++|+||+||++|+|++|.+||.+.+..++...|.
T Consensus 224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 456779999999753111 12357889999999999999999999999888777776665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=98.03 E-value=3.2e-06 Score=82.98 Aligned_cols=79 Identities=29% Similarity=0.396 Sum_probs=56.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCC-ccHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDIS-EDPKD 254 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS-~~~~d 254 (408)
..+..|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..|...........+..++ ..+++
T Consensus 190 ~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 190 VATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp -CCCTTCCHHHHTTC-----CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred CcCcCccChHHHcCC-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 456679999998652 357889999999999999999999999988877777776643333222333333 34556
Q ss_pred HHHHh
Q psy3880 255 LIRKL 259 (408)
Q Consensus 255 LI~kl 259 (408)
++..+
T Consensus 265 ~~~~~ 269 (367)
T 2fst_X 265 YIQSL 269 (367)
T ss_dssp HHHTS
T ss_pred HHhcc
Confidence 66554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-06 Score=83.68 Aligned_cols=74 Identities=22% Similarity=0.311 Sum_probs=51.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.+.+....+..+.+.........+..+.+....+
T Consensus 187 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 187 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp ---CTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred eecCCccCHHHhcCC------CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 345679999998753 47889999999999999999999999988888887777654332222333444444333
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=3.6e-06 Score=80.74 Aligned_cols=11 Identities=36% Similarity=0.151 Sum_probs=5.7
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++-+.+-|-.+
T Consensus 164 ~vKl~DFGla~ 174 (304)
T 3ubd_A 164 HIKLTDFGLSK 174 (304)
T ss_dssp CEEEESSEEEE
T ss_pred CEEecccccce
Confidence 45565555443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.00 E-value=3.4e-06 Score=81.74 Aligned_cols=67 Identities=31% Similarity=0.457 Sum_probs=51.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 247 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~ 247 (408)
.....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+...........|..
T Consensus 173 ~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 173 VVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CCCCTTCCHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cccccccCchHhhCC-----CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 346679999998642 2467899999999999999999999999888877777776544444445544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.6e-06 Score=81.33 Aligned_cols=54 Identities=30% Similarity=0.473 Sum_probs=42.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+......+..+..
T Consensus 181 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 181 VTLWYRAPDVLMGS-----KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp CCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred ccCCcCCHHHhcCC-----CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 45679999998642 3478899999999999999999999987665555555444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=97.97 E-value=4.1e-06 Score=83.75 Aligned_cols=55 Identities=31% Similarity=0.506 Sum_probs=44.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|++||++... ..|+.++||||+||++|+|++|.+||.+.+..+.+..|.+
T Consensus 217 ~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 217 ICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp CSCTTSCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCcCCHHHHcCC-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 446679999998642 3578899999999999999999999998877666666554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.7e-06 Score=80.65 Aligned_cols=66 Identities=24% Similarity=0.415 Sum_probs=49.6
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 247 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~ 247 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+...........|..
T Consensus 162 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 162 VTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp -CGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred CcccccChhhhcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 35669999998642 3478899999999999999999999998887777776665444444444443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.96 E-value=4.8e-06 Score=81.63 Aligned_cols=80 Identities=26% Similarity=0.387 Sum_probs=57.1
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCC-CCccHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND-ISEDPK 253 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~-iS~~~~ 253 (408)
...+..|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..|.......+...+.. .+..++
T Consensus 185 ~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 185 YVVTRWYRAPEVILNW-----MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SCSCGGGCCTHHHHTT-----TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CcCCCCcCCHHHHhCC-----CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 3456679999998752 3478899999999999999999999999888887777766543333222222 244556
Q ss_pred HHHHHh
Q psy3880 254 DLIRKL 259 (408)
Q Consensus 254 dLI~kl 259 (408)
+++..+
T Consensus 260 ~~~~~~ 265 (367)
T 1cm8_A 260 NYMKGL 265 (367)
T ss_dssp HHHHHS
T ss_pred HHHHhC
Confidence 666654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=4.4e-06 Score=80.32 Aligned_cols=55 Identities=27% Similarity=0.420 Sum_probs=44.8
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+....
T Consensus 200 t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 254 (329)
T 3gbz_A 200 TLWYRPPEILLGS-----RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254 (329)
T ss_dssp CCTTCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CccccCHHHhcCC-----CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence 5679999998652 247889999999999999999999999887777666665543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.4e-06 Score=79.95 Aligned_cols=39 Identities=33% Similarity=0.718 Sum_probs=32.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
.++..|||||++... .|+.++||||+||++|+|++ ||.+
T Consensus 191 ~GT~~YmAPE~~~~~------~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 191 VGTKLYMSPEQIHGN------SYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp -CCCTTSCHHHHTTC------CCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ccCccccCHHHHcCC------CCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 467789999999753 58889999999999999995 7754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=97.91 E-value=6.9e-06 Score=77.65 Aligned_cols=12 Identities=17% Similarity=-0.000 Sum_probs=6.0
Q ss_pred CcEEEecCCCEE
Q psy3880 75 ENILLDDQMNVK 86 (408)
Q Consensus 75 ~NILl~~~~~iK 86 (408)
.++-+.+-|..+
T Consensus 149 ~~vkl~DFGla~ 160 (275)
T 3hyh_A 149 LNVKIADFGLSN 160 (275)
T ss_dssp CCEEECCSSCC-
T ss_pred CCEEEeecCCCe
Confidence 356666555444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5e-06 Score=83.36 Aligned_cols=55 Identities=31% Similarity=0.469 Sum_probs=45.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....|+|||++... .|+.++||||+||++|+|++|.+||.+.+..+.+..+.+.
T Consensus 260 ~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 260 IQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp CSCGGGCCHHHHHTB------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCCCCccChHHHhCC------CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 345669999999754 4788999999999999999999999998887777766553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.8e-06 Score=81.35 Aligned_cols=55 Identities=29% Similarity=0.483 Sum_probs=45.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|+|||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..|.+
T Consensus 202 ~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 202 ICSRYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp CSCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCcCccCHHHHcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 345669999998542 3478899999999999999999999999887776666654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.89 E-value=8.9e-06 Score=77.59 Aligned_cols=62 Identities=27% Similarity=0.597 Sum_probs=44.4
Q ss_pred ccCCCCCchHHHhhhcccc--cccCCCcccccchhhhHHHhhcCCCCCCCc----hhHHHHHHHHhcC
Q psy3880 176 NDISGYLAPEVLRANMFED--ATGYGQAVDVWACGVIMYTLLVGCPPFWHR----KQMVMLRNIMEGK 237 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~--~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~----~~~~~~~~i~~~~ 237 (408)
.....|++||++....... ...|+.++|+||+||++|+|++|.+||... ...+.+..+..+.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 3556799999987543322 346888999999999999999999999632 2334444554443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1.4e-06 Score=80.97 Aligned_cols=72 Identities=19% Similarity=0.222 Sum_probs=57.1
Q ss_pred CcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q psy3880 21 DDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHN------------------------------------ 64 (408)
Q Consensus 21 ~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~------------------------------------ 64 (408)
....|+|||++.|.. +.+.+.+......++.++..+|..||+
T Consensus 82 ~~~~~lv~e~i~G~~--l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 82 DGWSNLLMSEADGVL--CSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp TTEEEEEEECCSSEE--HHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred CCceEEEEEecCCee--hhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 345689999999987 666543333445788899999999998
Q ss_pred -----------------------CCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 65 -----------------------HSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 65 -----------------------~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
..++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=7.4e-06 Score=77.64 Aligned_cols=47 Identities=28% Similarity=0.704 Sum_probs=38.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||...+...
T Consensus 177 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp CSCGGGCCHHHHHCS------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cCCcCccChhhhcCC------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 356679999998754 46789999999999999999999997665443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.83 E-value=6.9e-06 Score=81.38 Aligned_cols=45 Identities=38% Similarity=0.602 Sum_probs=36.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
.+..|+|||++... ..|+.++||||+||++|+|++|.+||.+...
T Consensus 197 gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 197 VTFWYRAPELLLGA-----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCCTTCCHHHHTTC-----CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ecCcccCchhhcCC-----CcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 45679999998652 2478899999999999999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.80 E-value=1.4e-05 Score=78.64 Aligned_cols=55 Identities=27% Similarity=0.478 Sum_probs=44.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+..
T Consensus 202 ~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 202 ICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp CCCSSCCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCccCHHHhcCC-----CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 345669999998643 2478899999999999999999999998887776666654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=1.2e-05 Score=74.09 Aligned_cols=52 Identities=23% Similarity=0.433 Sum_probs=39.1
Q ss_pred CCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 173 PEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 173 ~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
........|++||++..... ..++.++|+||+||++|+|++|.+||...+..
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPE---DTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGG---GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred cCccCCccccChhhhccCCC---CCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 33445677999999976432 22344799999999999999999999765543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.80 E-value=1.4e-05 Score=77.48 Aligned_cols=56 Identities=32% Similarity=0.474 Sum_probs=45.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 184 ~~t~~y~aPE~~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 184 VVTRWYRAPEVILSW-----MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp CCSBCCSCHHHHSCC-----SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred ccCcCcCCHHHHhCc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 345679999998642 34778999999999999999999999988877777766653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=97.79 E-value=1.5e-05 Score=77.96 Aligned_cols=56 Identities=32% Similarity=0.474 Sum_probs=46.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 202 ~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 202 VVTRWYRAPEVILSW-----MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp TCCCTTSCHHHHSCC-----SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccCccccCHHHhcCC-----CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 346679999998642 34788999999999999999999999998887777776654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=97.78 E-value=1.1e-05 Score=78.09 Aligned_cols=55 Identities=31% Similarity=0.508 Sum_probs=44.8
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 193 gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 193 CSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp SCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcceeCHHHHcCC-----CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 45669999998543 24788999999999999999999999988877777666553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=97.77 E-value=1.4e-05 Score=83.34 Aligned_cols=42 Identities=26% Similarity=0.505 Sum_probs=36.7
Q ss_pred hhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCcc
Q psy3880 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177 (408)
Q Consensus 136 SlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 177 (408)
|+||++|+|++|.+||.+.+..+.+.+|..+.+.+..+.+..
T Consensus 341 SlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp HHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 799999999999999999999999999999887776655543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=97.77 E-value=1.3e-05 Score=76.32 Aligned_cols=55 Identities=29% Similarity=0.451 Sum_probs=45.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 180 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 180 VVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CCCCTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccceeCHHHHhcC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 345679999998653 4678999999999999999999999988777766666553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.3e-05 Score=79.36 Aligned_cols=100 Identities=22% Similarity=0.421 Sum_probs=70.7
Q ss_pred ccCCCCCchHHHhhhcccc--cccCCCcccccchhhhHHHhhcCCCCCCC----chhHHHHHHHHhcCCCCCC-------
Q psy3880 176 NDISGYLAPEVLRANMFED--ATGYGQAVDVWACGVIMYTLLVGCPPFWH----RKQMVMLRNIMEGKYSFSS------- 242 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~--~~~y~~~~DiWs~Gvily~ll~g~~Pf~~----~~~~~~~~~i~~~~~~f~~------- 242 (408)
.....|++||++....... ...|+.++|+||+||++|+|++|.+||.. ....+.+..+..+...-..
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 255 (396)
T 4eut_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255 (396)
T ss_dssp SSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECST
T ss_pred cCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheecc
Confidence 3567799999987543222 13467799999999999999999999964 3344556666665432100
Q ss_pred ----------Cc----CCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 243 ----------PE----WNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 243 ----------~~----~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+. ...+++.+.+||++||..||++|+|++|+++
T Consensus 256 ~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 00 1224456789999999999999999998855
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=1.7e-05 Score=76.17 Aligned_cols=52 Identities=27% Similarity=0.474 Sum_probs=42.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||........+..+
T Consensus 200 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 200 VATRHYRPPEVILEL------GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp CSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCcccCCeeeecC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456679999999653 4778999999999999999999999887665544443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.3e-05 Score=76.62 Aligned_cols=48 Identities=19% Similarity=0.486 Sum_probs=38.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|++||++... .|+.++|+||+||++|+|++ |.+||......+..
T Consensus 248 ~t~~y~aPE~~~~~------~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 248 LPVKWMPPEAFMEG------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp SCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CcccEECHHHhcCC------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 34569999998754 46789999999999999998 99999776554443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=2e-05 Score=75.11 Aligned_cols=47 Identities=28% Similarity=0.447 Sum_probs=37.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.....|++||++... .++.++|+||+||++|+|++|.+||...+...
T Consensus 200 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 200 AGTPEWMAPEVLRDE------PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp --CCTTSCHHHHTTC------CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred CCCccccChhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 456779999998754 46779999999999999999999997655433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=97.73 E-value=1.3e-05 Score=78.14 Aligned_cols=55 Identities=27% Similarity=0.553 Sum_probs=44.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+..|++||++... ..|+.++|+||+||++|+|++|.+||.+.+..+.+..+..
T Consensus 192 ~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 192 VATRWYRAPEIMLNS-----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp CSCGGGCCHHHHHTB-----CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred ccccCCCCCHHhcCC-----CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 456679999987643 3478899999999999999999999988877666666654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=1.7e-05 Score=73.83 Aligned_cols=45 Identities=29% Similarity=0.603 Sum_probs=36.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
....|++||++... .|+.++|+||+||++|+|++|.+||...+..
T Consensus 178 ~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 222 (279)
T 2w5a_A 178 GTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222 (279)
T ss_dssp SCCTTCCHHHHHCC-------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCccccChHHhccC------CCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence 34569999998653 4677899999999999999999999765443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=1.1e-05 Score=77.35 Aligned_cols=95 Identities=11% Similarity=0.029 Sum_probs=72.1
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc---hhHHHHHHHHhcCCCCCCCcCCCCCcc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRNIMEGKYSFSSPEWNDISED 251 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~---~~~~~~~~i~~~~~~f~~~~~~~iS~~ 251 (408)
..++..|++||++... .|+.++|+||+||++|+|++|.+||.+. ...+.+..+.......+........++
T Consensus 177 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 250 (330)
T 2izr_A 177 LTGTARYMSINTHLGK------EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPE 250 (330)
T ss_dssp CCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHH
T ss_pred cCCCccccChHHHcCC------CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChH
Confidence 4466789999998763 4678999999999999999999999873 344555566555444432222222349
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 252 PKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 252 ~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+++||.+||..||.+|||++++++
T Consensus 251 ~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999888765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=2.2e-05 Score=74.81 Aligned_cols=52 Identities=31% Similarity=0.486 Sum_probs=42.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||...+..+....+
T Consensus 195 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 195 VSTRHYRAPEVILAL------GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp CSCGGGCCHHHHTTS------CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred cCCccccChHHhhCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 456679999998653 4778999999999999999999999887665554444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=2e-05 Score=75.55 Aligned_cols=49 Identities=24% Similarity=0.634 Sum_probs=39.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.+...|++||++... .|+.++|+||+||++|+|++|.+||...+.....
T Consensus 202 ~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 202 VGTPYWMAPEVISRS------LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp CSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cCCccccCHhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 456679999998653 4677999999999999999999999876554443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.69 E-value=1.1e-05 Score=78.58 Aligned_cols=87 Identities=13% Similarity=0.156 Sum_probs=62.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
.++..|++||++... .|+.++|+||+||++|+|++|.+||........ .-...+.. . ..++...++
T Consensus 246 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~-~--~~~~~~~~~ 311 (365)
T 3e7e_A 246 CETSGFQCVEMLSNK------PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFRR-L--PHLDMWNEF 311 (365)
T ss_dssp SCTTSCCCHHHHTTC------CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCTT-C--SSHHHHHHH
T ss_pred cCCCCCCChHHhcCC------CCCccccHHHHHHHHHHHHhCCCccccCCCCce-----eechhccc-c--CcHHHHHHH
Confidence 357789999999764 478899999999999999999999975432100 00001111 1 236778999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q psy3880 256 IRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 256 I~klL~~dP~~R~ta~e~L~H 276 (408)
+.+||..+|.+|++..+.|.+
T Consensus 312 ~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 312 FHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHCCCCTTCCCCHHHHHH
T ss_pred HHHHcCCCCCCcchHHHHHHH
Confidence 999999999999765555443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.68 E-value=2e-05 Score=73.99 Aligned_cols=45 Identities=38% Similarity=0.733 Sum_probs=36.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
.....|++||++.. .++.++|+||+||++|+|++|.+||.+.+..
T Consensus 187 ~~t~~y~aPE~~~~-------~~~~~~Di~slG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 187 AGTALYMAPEVFKR-------DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp CTTGGGCCHHHHTT-------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccCcCChHHhcc-------CCCcccCeehHHHHHHHHHhCCCCCCCCCHH
Confidence 34566999999853 3677999999999999999999999766543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=2.4e-05 Score=76.12 Aligned_cols=54 Identities=31% Similarity=0.520 Sum_probs=41.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
.....|++||++... ....|+.++|+||+||++|+|++|.+||...+....+..
T Consensus 211 ~gt~~y~aPE~~~~~---~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 264 (348)
T 1u5q_A 211 VGTPYWMAPEVILAM---DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264 (348)
T ss_dssp CSCGGGCCHHHHHTT---SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cCCcceeCHhhhccc---cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 456679999998632 123578899999999999999999999987665444433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.67 E-value=2.3e-05 Score=78.52 Aligned_cols=14 Identities=14% Similarity=-0.033 Sum_probs=8.2
Q ss_pred CcEEEecCCCEEEe
Q psy3880 75 ENILLDDQMNVKLT 88 (408)
Q Consensus 75 ~NILl~~~~~iKl~ 88 (408)
.++-|.+-|-.+..
T Consensus 284 g~vKl~DFGla~~~ 297 (423)
T 4fie_A 284 GRVKLSDFGFCAQV 297 (423)
T ss_dssp CCEEECCCTTCEEC
T ss_pred CCEEEecCccceEC
Confidence 35667666655543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=97.67 E-value=9.4e-06 Score=79.83 Aligned_cols=56 Identities=29% Similarity=0.493 Sum_probs=42.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|++||++... ...|+.++|+||+||++|+|++|.+||.+.+....+..+..
T Consensus 196 ~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 196 VKVLPWLSPEVLQQN----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp TTTGGGSCHHHHSTT----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccccccCHHHHhcc----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 345569999998753 13578899999999999999999999987665555444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=73.34 Aligned_cols=95 Identities=13% Similarity=0.041 Sum_probs=72.5
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc---hhHHHHHHHHhcCCCCCC-CcCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---KQMVMLRNIMEGKYSFSS-PEWNDISE 250 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~---~~~~~~~~i~~~~~~f~~-~~~~~iS~ 250 (408)
......|++||++... .|+.++|+||+||++|+|++|.+||.+. .....+..+.......+. .....+++
T Consensus 178 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1csn_A 178 LSGTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 251 (298)
T ss_dssp CCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred CCCCcccCCchhhcCC------CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcH
Confidence 3456779999998653 4677999999999999999999999873 334444445444332221 12346899
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
++++||.+||..||++|||++++++
T Consensus 252 ~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 252 EFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHHH
Confidence 9999999999999999999998875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=2.1e-05 Score=76.92 Aligned_cols=43 Identities=26% Similarity=0.457 Sum_probs=36.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..+..|++||++... .|+.++||||+||++|+|++|.+||...
T Consensus 254 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 254 IQTRQYRSLEVLIGS------GYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CSCGGGCCHHHHHTS------CCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCCCcccCChhhcCC------CCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 346679999999764 4788999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=75.04 Aligned_cols=54 Identities=37% Similarity=0.610 Sum_probs=43.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....|++||.+... ..|+.++|+||+||++|+|++|.+||.+.+....+..+..
T Consensus 186 ~t~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 186 ATRWYRAPELLVGD-----VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp CCCTTCCHHHHTTC-----TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCccccCcccccCC-----CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 45669999998653 2467899999999999999999999998877666655544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=72.36 Aligned_cols=46 Identities=35% Similarity=0.718 Sum_probs=37.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
.....|++||.+... .|+.++|+||+||++|+|++|.+||.+.+..
T Consensus 175 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 175 AGAYAWMAPEVIRAS------MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp -CCGGGSCHHHHHHC------CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred CCccceeCHHHhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 345679999998754 4677999999999999999999999765543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.65 E-value=4.7e-06 Score=79.35 Aligned_cols=127 Identities=16% Similarity=0.289 Sum_probs=76.3
Q ss_pred HHHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q psy3880 23 LKHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHN----------------------------------- 64 (408)
Q Consensus 23 ~~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~----------------------------------- 64 (408)
..|+||+++.|.. +.+.. .+.++...++.|+...|..||+
T Consensus 90 ~~~~vm~~i~G~~--l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 90 MSFAGFTKIKGVP--LTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CSCEEEECCCCEE--CCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cceEEEcccCCeE--CCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 3477888888865 33211 2445667778888888888886
Q ss_pred -----------------------CCCeeccCCCCcEEEec--CCCEEEeccccchhcccCcccccCCCCCcccChhhhhh
Q psy3880 65 -----------------------HSVVHRDLKPENILLDD--QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRA 119 (408)
Q Consensus 65 -----------------------~~IvHRDLKp~NILl~~--~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~ 119 (408)
..++|+|++|.||+++. ...+.|+||+.+..-.+...+........-..|+....
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 24699999999999998 45678999998765322111111111000023322111
Q ss_pred --ccccCcC--C----CCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 120 --NMFEDAT--G----YGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 120 --~~~~~~~--~----~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
..+.... . .....+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000 0 011258899999999999998776
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.64 E-value=2.4e-05 Score=74.09 Aligned_cols=53 Identities=36% Similarity=0.569 Sum_probs=41.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+....+....+.
T Consensus 164 ~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 164 ATRWYRSPELLVGD-----TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp --GGGCCHHHHHTC-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCccccChHHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45569999998642 346889999999999999999999998877666555443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=97.63 E-value=3.4e-05 Score=71.83 Aligned_cols=44 Identities=36% Similarity=0.715 Sum_probs=36.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||.+... .++.++|+||+||++|+|++|.+||....
T Consensus 168 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 168 CGTLDYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp CCCCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCCCccCHhHhccC------CCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 456679999998653 45778999999999999999999996544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=2.5e-05 Score=78.01 Aligned_cols=41 Identities=34% Similarity=0.692 Sum_probs=35.3
Q ss_pred hhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCC
Q psy3880 134 VWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPE 174 (408)
Q Consensus 134 iwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 174 (408)
+||+||++|+|++|..||.+.+......+|..+...+..|.
T Consensus 256 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred EecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 79999999999999999999999999999988765444443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=3e-06 Score=77.88 Aligned_cols=69 Identities=19% Similarity=0.147 Sum_probs=52.0
Q ss_pred cHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q psy3880 22 DLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHS----------------------------------- 66 (408)
Q Consensus 22 ~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~----------------------------------- 66 (408)
+..++|||++.|.. + + ... .....++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~--l-~-~~~-~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 88 GRDWLLLGEVPGQD--L-L-SSH-LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp SCEEEEEECCSSEE--T-T-TSC-CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred CCCEEEEEecCCcc--c-C-cCc-CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 44689999999887 5 2 221 122356778888888888754
Q ss_pred -----------------------CeeccCCCCcEEEecCCCEEEeccccchh
Q psy3880 67 -----------------------VVHRDLKPENILLDDQMNVKLTDFGFARV 95 (408)
Q Consensus 67 -----------------------IvHRDLKp~NILl~~~~~iKl~DFGla~~ 95 (408)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=97.61 E-value=4.3e-05 Score=74.65 Aligned_cols=28 Identities=39% Similarity=1.009 Sum_probs=19.3
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCcc
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWND 177 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 177 (408)
||.+.+.......+..+.+.+..+.|..
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 229 PFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 5666677777788888877766665543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.60 E-value=1.7e-05 Score=78.52 Aligned_cols=47 Identities=38% Similarity=0.720 Sum_probs=37.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..++..|+|||++... ...+|+.++|+||+||++|+|++|.+||...
T Consensus 174 ~~gt~~Y~aPE~~~~~---~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSR---KGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCSCGGGCCGGGTCCC---SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cCCCccccCCeeeccC---CCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 3456679999998642 1235788999999999999999999999654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=97.60 E-value=2.2e-05 Score=74.10 Aligned_cols=46 Identities=26% Similarity=0.645 Sum_probs=38.0
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
....|++||.+... .++.++|+||+||++|+|++|.+||.+.+...
T Consensus 174 gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 174 GTVQYFSPEQAKGE------ATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp -CCSSCCHHHHHTC------CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred cCccccCHhHhcCC------CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 56679999998764 46778999999999999999999998765543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=2.8e-05 Score=74.91 Aligned_cols=54 Identities=35% Similarity=0.556 Sum_probs=42.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.....|++||++... ..++.++|+||+||++|+|++|.+||.+.+....+..+.
T Consensus 183 ~gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 183 VATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp CCCGGGCCHHHHHSC-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCCeeeccC-----CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 345669999988542 346789999999999999999999999887665555444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.59 E-value=3e-05 Score=74.30 Aligned_cols=47 Identities=26% Similarity=0.562 Sum_probs=37.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVM 229 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~ 229 (408)
....|++||++... .|+.++|+||+||++|+|++ |.+||.+....+.
T Consensus 238 ~t~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 238 IPIRWMPPESIFYN------RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp BCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ccceecChhhhccC------CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 34569999998754 46789999999999999998 9999976554433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.59 E-value=5.3e-05 Score=76.37 Aligned_cols=43 Identities=53% Similarity=1.199 Sum_probs=38.6
Q ss_pred hhhHHHHHHHhCCCCCCCchhHHHHHHHHhccccCCCCCCccC
Q psy3880 136 ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDI 178 (408)
Q Consensus 136 SlGvil~~ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 178 (408)
|+||++|+|++|.+||.+.+.......+..+.+.+..+.|..+
T Consensus 198 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 6999999999999999999999999999999988887776543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.59 E-value=3.1e-05 Score=73.20 Aligned_cols=55 Identities=27% Similarity=0.509 Sum_probs=45.0
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...|++||++... ..|+.++|+||+||++|+|++|.+||.+.+.......+....
T Consensus 187 ~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 187 TKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCTTCCHHHHHCT-----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred cccccCcHHhcCc-----ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 5569999988642 246789999999999999999999999888777777776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.59 E-value=3.1e-05 Score=73.47 Aligned_cols=56 Identities=27% Similarity=0.348 Sum_probs=41.7
Q ss_pred cCCCCCchHHHhhhccc---ccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFE---DATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~---~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
....|++||++...... ....|+.++|+||+||++|+|++|..||...........
T Consensus 196 g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp GGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45569999998753221 233578899999999999999999999987665444433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=2.9e-05 Score=74.37 Aligned_cols=43 Identities=26% Similarity=0.549 Sum_probs=35.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~ 225 (408)
....|++||++... .|+.++|+||+||++|+|++ |.+||.+.+
T Consensus 179 ~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 179 TPIKWMALESIHFG------KYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccChHHhccC------CCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 34479999999754 46789999999999999999 999997543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.57 E-value=2.7e-05 Score=72.92 Aligned_cols=43 Identities=30% Similarity=0.561 Sum_probs=35.5
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
...|++||++... .++.++|+||+||++|+|++ |.+||.....
T Consensus 176 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 176 PLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cccccCHHHhccC------CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 3569999998653 36779999999999999998 9999976543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=97.57 E-value=3.7e-05 Score=72.15 Aligned_cols=46 Identities=33% Similarity=0.634 Sum_probs=35.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.....|++||++... ....|+.++|+||+||++|+|++|.+||...
T Consensus 183 ~gt~~y~aPE~~~~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 183 SGSILWMAPEVIRMQ---DSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -CCCTTCCHHHHC-------CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CCCccccCchhhccc---CCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 356679999998632 1235677999999999999999999999654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=2.6e-05 Score=72.78 Aligned_cols=41 Identities=37% Similarity=0.703 Sum_probs=34.2
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCch
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 225 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~ 225 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+..
T Consensus 181 ~~y~aPE~~~~~------~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 181 IKWMAPESINFR------RFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp GGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccChhhcccC------CCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 469999998653 46779999999999999996 999996543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=97.56 E-value=2.7e-05 Score=72.94 Aligned_cols=95 Identities=12% Similarity=0.039 Sum_probs=71.3
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch---hHHHHHHHHhcCCCCCC-CcCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIMEGKYSFSS-PEWNDISE 250 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~---~~~~~~~i~~~~~~f~~-~~~~~iS~ 250 (408)
......|++||.+... .++.++|+||+||++|+|++|.+||...+ ....+..+......++. ..+..+|+
T Consensus 175 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T 3uzp_A 175 LTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 248 (296)
T ss_dssp CCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred cccccccCChhhhcCC------CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCH
Confidence 3466779999998754 36779999999999999999999997632 22233344433333321 12346789
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
++.+||.+||..||++|||++++++
T Consensus 249 ~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 249 EFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 9999999999999999999998875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.56 E-value=4.2e-05 Score=73.82 Aligned_cols=48 Identities=25% Similarity=0.517 Sum_probs=35.8
Q ss_pred ccCCCCCchHHHhhhcccc-----cccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFED-----ATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~-----~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
..+..|++||++....... ...|+.++||||+||++|+|++|.+||..
T Consensus 170 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 4567899999987522111 14578899999999999999999999953
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=3.5e-05 Score=74.71 Aligned_cols=55 Identities=25% Similarity=0.397 Sum_probs=44.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
....|++||++... ..++.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 195 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 195 THRWYRAPELVMQF-----KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp -CGGGCCHHHHTTC-----TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccceecCcHHhcCC-----CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 34569999998642 24778999999999999999999999988877777666553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.55 E-value=2.7e-05 Score=74.19 Aligned_cols=42 Identities=36% Similarity=0.582 Sum_probs=35.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
..|++||.+... .|+.++|+||+||++|+|++ |.+||.+...
T Consensus 203 ~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 203 VKWLALESLADN------LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccccCchhhcCC------CCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 469999998764 46779999999999999999 9999976543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=97.55 E-value=2.6e-05 Score=73.00 Aligned_cols=95 Identities=12% Similarity=0.033 Sum_probs=70.8
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh---HHHHHHHHhcCCCCCC-CcCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ---MVMLRNIMEGKYSFSS-PEWNDISE 250 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~---~~~~~~i~~~~~~f~~-~~~~~iS~ 250 (408)
......|++||++... .|+.++|+||+||++|+|++|.+||.+.+. ...+..+.......+. ..+..+|+
T Consensus 175 ~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T 4hgt_A 175 LTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 248 (296)
T ss_dssp CCSCGGGCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred cCCCccccchHHhcCC------CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCH
Confidence 3456779999998754 467799999999999999999999976432 1223333333322221 12246789
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
++++||.+||..||++|||++++++
T Consensus 249 ~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 249 EFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 9999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=4.1e-05 Score=70.77 Aligned_cols=43 Identities=30% Similarity=0.560 Sum_probs=35.4
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
..|++||.+... .|+.++|+||+||++|+|++ |.+||......
T Consensus 169 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 169 VKWSAPEVFHYF------KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp GGGCCHHHHHHS------EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred cccCCHHHHhcc------CCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 359999998754 35779999999999999998 99999765543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=97.54 E-value=2.8e-05 Score=74.54 Aligned_cols=41 Identities=27% Similarity=0.496 Sum_probs=35.0
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
...|++||.+... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 182 t~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 182 PIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccChHHhccC------CCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 4479999999764 46789999999999999999 99999654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=5e-05 Score=73.02 Aligned_cols=44 Identities=52% Similarity=0.857 Sum_probs=36.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||++... .++.++|+||+||++|+|++|.+||....
T Consensus 202 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 202 CGTPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CSCCSSCCHHHHHTS------CBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCccccCHHHhccC------CCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 345679999998754 46778999999999999999999996543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=97.54 E-value=3.6e-05 Score=74.67 Aligned_cols=44 Identities=25% Similarity=0.509 Sum_probs=35.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.+..
T Consensus 196 ~~t~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 196 IQTREYRSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp CSCGGGCCHHHHHTC------CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCCccccCcHHHhCC------CCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 456679999999764 46789999999999999999999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=5.2e-05 Score=71.17 Aligned_cols=44 Identities=52% Similarity=0.857 Sum_probs=36.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||++... .++.++|+||+||++|+|++|.+||....
T Consensus 176 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 176 CGTPNYIAPEVLSKK------GHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CSCCSSCCHHHHTTS------CBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCCCcCCcchhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 345669999998653 46779999999999999999999996544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=97.53 E-value=3.5e-05 Score=72.00 Aligned_cols=43 Identities=26% Similarity=0.573 Sum_probs=35.5
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
..|++||++... .++.++|+||+||++|+|++ |.+||.+.+..
T Consensus 188 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 188 FAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp GGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ceeeCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 359999998764 35678999999999999999 99999765543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=3e-05 Score=74.37 Aligned_cols=44 Identities=32% Similarity=0.746 Sum_probs=36.5
Q ss_pred CCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHH
Q psy3880 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVM 229 (408)
Q Consensus 180 ~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~ 229 (408)
.|++||++... .|+.++|+||+||++|+|++ |.+||........
T Consensus 219 ~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 219 RWTAPEAIAFR------TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp GGSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred cccCHhHhcCC------CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 59999999754 36779999999999999998 9999977655443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.52 E-value=8e-06 Score=79.57 Aligned_cols=70 Identities=16% Similarity=0.257 Sum_probs=56.2
Q ss_pred HHHHHHHHhhchhhHHhhh---CCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q psy3880 24 KHLAAQVVDKGEAAVQDII---NSNPALRYIMRQLFEALEHVHN------------------------------------ 64 (408)
Q Consensus 24 ~~lv~e~~~~g~~~l~~~~---~~~~~~r~i~~qil~aL~~LH~------------------------------------ 64 (408)
.|+|||++.|.. +.+.. .+..+...++.++..+|..||+
T Consensus 116 ~~~vme~v~G~~--l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRV--LWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBC--CCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCee--cCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 678999999876 43321 2456778889999999999997
Q ss_pred ----------------------CCCeeccCCCCcEEEecCCC--EEEeccccchh
Q psy3880 65 ----------------------HSVVHRDLKPENILLDDQMN--VKLTDFGFARV 95 (408)
Q Consensus 65 ----------------------~~IvHRDLKp~NILl~~~~~--iKl~DFGla~~ 95 (408)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46899999999999987653 68999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=3.7e-05 Score=71.19 Aligned_cols=45 Identities=29% Similarity=0.623 Sum_probs=36.8
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVM 229 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~ 229 (408)
..|++||.+... .|+.++|+||+||++|+|++ |.+||........
T Consensus 171 ~~y~aPE~~~~~------~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 171 VKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred cccCCHHHhcCC------CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 459999998654 46779999999999999999 9999976655443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=97.51 E-value=4.3e-05 Score=71.23 Aligned_cols=44 Identities=27% Similarity=0.533 Sum_probs=36.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 228 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~ 228 (408)
..|++||.+... .|+.++|+||+||++|+|++ |.+||.......
T Consensus 185 ~~y~aPE~~~~~------~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 185 VRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp GGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccCCHHHhccC------CCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 459999998754 46779999999999999998 999997655443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=6.7e-05 Score=75.16 Aligned_cols=63 Identities=27% Similarity=0.535 Sum_probs=43.4
Q ss_pred ccCCCCCchHHHhhhcc-cccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 176 NDISGYLAPEVLRANMF-EDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~-~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
.++..|+|||++..... .....++.++||||+||++|+|++ |.+||....... ..+..+.+.+
T Consensus 193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~ 257 (434)
T 2rio_A 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL 257 (434)
T ss_dssp --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCC
T ss_pred CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCc
Confidence 45677999999975221 112457889999999999999998 999997654332 3455554444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=4.5e-05 Score=72.91 Aligned_cols=44 Identities=18% Similarity=0.532 Sum_probs=36.2
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||......
T Consensus 208 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 208 PVKWMPPEAFMEG------IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CcceeCHhHhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 4569999998754 46779999999999999998 99999765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=97.50 E-value=2.2e-05 Score=76.97 Aligned_cols=45 Identities=22% Similarity=0.386 Sum_probs=34.9
Q ss_pred CCCCchHHHhhh-----cccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 179 SGYLAPEVLRAN-----MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 179 ~~~~~PE~l~~~-----~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
..|++||++... .......|+.++|+||+||++|+|++|.+||.+
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence 779999999865 011112578899999999999999999999954
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.50 E-value=3.4e-05 Score=74.09 Aligned_cols=42 Identities=26% Similarity=0.480 Sum_probs=35.2
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCch
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 225 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~ 225 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||.+..
T Consensus 182 t~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 182 PIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp CGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccCHHHHcCC------CCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 3469999999764 46789999999999999999 999996543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.49 E-value=4e-05 Score=72.21 Aligned_cols=45 Identities=29% Similarity=0.522 Sum_probs=35.6
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
....|++||++.... ..++.++|+||+||++|+|++|..||.+.+
T Consensus 173 ~~~~y~aPE~~~~~~----~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 173 GSPAFQPPEIANGLD----TFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp SCGGGCCHHHHTCCS----CEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCCcChhhccCcc----cCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 456799999986421 123568999999999999999999997654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=4.4e-05 Score=74.78 Aligned_cols=27 Identities=30% Similarity=0.503 Sum_probs=22.3
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCC
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSP 173 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~ 173 (408)
|..||.+.+..+.+.+|..+.+.+..+
T Consensus 214 g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 214 GASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp SCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 889999999999999998887765543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=97.48 E-value=3.2e-05 Score=75.79 Aligned_cols=40 Identities=33% Similarity=0.668 Sum_probs=34.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 269 ~~y~aPE~~~~~------~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 269 VKWMAPEALFDR------VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGGCCHHHHHTC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceECHhHhcCC------CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 459999998753 47789999999999999998 99999654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=97.48 E-value=5.1e-05 Score=72.13 Aligned_cols=44 Identities=20% Similarity=0.498 Sum_probs=36.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 228 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~ 228 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+.+...
T Consensus 204 ~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 204 VRWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred CCccChhhhccC------CCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 459999998754 46779999999999999999 899997655433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.48 E-value=2.2e-05 Score=76.18 Aligned_cols=44 Identities=41% Similarity=0.921 Sum_probs=35.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.+...|++||++....+ ++.++|+||+||++|+|++|.+||...
T Consensus 168 ~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLY-----AGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTSTTTSCGGGSCCSGG-----GCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cCCcCcCCHHHHcCCCC-----CCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 35667999999865422 366899999999999999999999653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=4.7e-05 Score=70.16 Aligned_cols=43 Identities=30% Similarity=0.645 Sum_probs=35.6
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
...|++||++... .++.++|+||+||++|+|++ |.+||...+.
T Consensus 168 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 168 PVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccChhhhcCC------CccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 3469999998753 46778999999999999999 8999976544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=4e-05 Score=71.44 Aligned_cols=40 Identities=30% Similarity=0.641 Sum_probs=33.8
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||..
T Consensus 177 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 177 PIKWMSPESINFR------RFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceeCchhhccC------CCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 3469999998653 46779999999999999998 9999964
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.47 E-value=3.2e-05 Score=72.83 Aligned_cols=46 Identities=35% Similarity=0.618 Sum_probs=35.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.....|++||++..... ..++.++|+||+||++|+|++|.+||...
T Consensus 198 ~gt~~y~aPE~~~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 198 VGTPAFMAPESLSETRK---IFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CSCGGGCCGGGCCTTCC---CEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCccccChhhhccCCC---CCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 35667999998864321 11366889999999999999999999654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.46 E-value=4.3e-05 Score=73.40 Aligned_cols=40 Identities=28% Similarity=0.610 Sum_probs=34.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 238 ~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 238 VKWMAPESLFEG------IYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cCccCHHHhccC------CCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 459999998754 46789999999999999998 99999653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=7.5e-05 Score=70.17 Aligned_cols=56 Identities=23% Similarity=0.426 Sum_probs=41.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
.....|++||.+..... ....++.++|+||+||++|+|++|.+||...+.......
T Consensus 178 ~~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 233 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETM-KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233 (302)
T ss_dssp -CCGGGCCHHHHHHHHT-TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cCChhhcCCeeeccccC-CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 34567999999864322 123577899999999999999999999977655444333
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=4.3e-05 Score=71.68 Aligned_cols=44 Identities=27% Similarity=0.548 Sum_probs=36.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 228 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~ 228 (408)
..|++||.+... .++.++|+||+||++|+|++ |.+||...+...
T Consensus 184 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 184 VKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp GGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ceeeChHHhccC------CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 459999998754 35678999999999999999 999997655433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=2.1e-05 Score=73.90 Aligned_cols=100 Identities=21% Similarity=0.406 Sum_probs=68.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC----------CCCCCCch----hHHHHHHHHhcCCCC-
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG----------CPPFWHRK----QMVMLRNIMEGKYSF- 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g----------~~Pf~~~~----~~~~~~~i~~~~~~f- 240 (408)
.....|++||++......+...++.++|+||+||++|+|++| .+||.... .......+.......
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 257 (301)
T 3q4u_A 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP 257 (301)
T ss_dssp CCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred ccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC
Confidence 456679999999765433322456789999999999999999 89996532 122233322222111
Q ss_pred CCC-cC--CCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 241 SSP-EW--NDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 241 ~~~-~~--~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+ .| ...++++.+||.+||..||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 258 NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 111 11 224567999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=4.1e-05 Score=73.98 Aligned_cols=40 Identities=28% Similarity=0.620 Sum_probs=34.1
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||.+
T Consensus 258 t~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 258 PLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CceeEChhhhcCC------CCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 3469999998753 46789999999999999998 9999854
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=97.44 E-value=2.3e-05 Score=75.36 Aligned_cols=42 Identities=45% Similarity=0.884 Sum_probs=24.7
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
...|++||++... .|+.++|+||+||++|+|++|.+||....
T Consensus 172 t~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 172 TLHYAAPELLNQN------GYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------C------CCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CcCccCHHHhcCC------CCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 5679999998653 47789999999999999999999997644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0001 Score=70.64 Aligned_cols=11 Identities=36% Similarity=0.054 Sum_probs=6.0
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
.+.+.+-|..+
T Consensus 208 ~~kl~Dfg~a~ 218 (345)
T 3hko_A 208 EIKLVDFGLSK 218 (345)
T ss_dssp CEEECCCTTCE
T ss_pred eEEEeeccccc
Confidence 46665555444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.43 E-value=9.3e-05 Score=72.13 Aligned_cols=9 Identities=22% Similarity=-0.067 Sum_probs=4.5
Q ss_pred cEEEecCCC
Q psy3880 76 NILLDDQMN 84 (408)
Q Consensus 76 NILl~~~~~ 84 (408)
++-|.+-|.
T Consensus 162 ~ikL~DFG~ 170 (353)
T 3txo_A 162 HCKLADFGM 170 (353)
T ss_dssp CEEECCCTT
T ss_pred CEEEccccc
Confidence 455555443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.43 E-value=6.1e-05 Score=79.04 Aligned_cols=45 Identities=29% Similarity=0.536 Sum_probs=37.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVM 229 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~ 229 (408)
..|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..+.
T Consensus 503 ~~y~APE~~~~~------~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 548 (613)
T 2ozo_A 503 LKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548 (613)
T ss_dssp CTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH
T ss_pred cceeCHhhhcCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 469999998754 47789999999999999998 9999976554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=5e-05 Score=72.58 Aligned_cols=44 Identities=25% Similarity=0.502 Sum_probs=36.2
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||.+....
T Consensus 204 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 204 PVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp CTTTCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CccccChhhhccc------cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 4569999998654 35779999999999999998 99999765543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=97.41 E-value=2.3e-05 Score=76.62 Aligned_cols=44 Identities=43% Similarity=0.866 Sum_probs=32.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..+..|++||++....+ ++.++|+||+||++|+|++|.+||.+.
T Consensus 178 ~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 178 VGTPAYIAPEVLLRQEY-----DGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---CTTSCHHHHHCSSC-----CHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred cCCCCcCChhhhcCCCC-----CCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 35667999999875422 234589999999999999999999653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=7.4e-05 Score=70.05 Aligned_cols=46 Identities=26% Similarity=0.593 Sum_probs=37.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
.....|++||++... ..++.++|+||+||++|+|++|.+||.....
T Consensus 187 ~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 187 VGTPCWMAPEVMEQV-----RGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp -CCCTTCCHHHHHHH-----HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred CCCccccCHHHhccc-----cCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 355679999998652 2367799999999999999999999976544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.40 E-value=5e-05 Score=76.37 Aligned_cols=45 Identities=33% Similarity=0.491 Sum_probs=33.2
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-----------CCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-----------GCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-----------g~~Pf~~~~ 225 (408)
..+..|+|||++... ..|+.++||||+|||+|+|++ |.++|.+.+
T Consensus 244 ~gt~~Y~aPE~~~~~-----~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 244 VVTRWYRAPELILLQ-----ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp -CCCTTCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred cccccccChHHhhCC-----CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 346679999987432 358889999999999999998 666665543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=97.40 E-value=7e-05 Score=72.57 Aligned_cols=48 Identities=23% Similarity=0.467 Sum_probs=39.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
.....|++||++... .|+.++|+||+||++|+|++|..||.......+
T Consensus 191 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 191 VGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp CCCCTTCCHHHHTTC------CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred CCCCCeECHHHHcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 456679999998653 467899999999999999999999987665443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.40 E-value=6e-05 Score=72.29 Aligned_cols=13 Identities=8% Similarity=0.005 Sum_probs=6.7
Q ss_pred CcEEEecCCCEEE
Q psy3880 75 ENILLDDQMNVKL 87 (408)
Q Consensus 75 ~NILl~~~~~iKl 87 (408)
.++.+.+-|..+.
T Consensus 141 ~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 141 STIKIIEFGQARQ 153 (321)
T ss_dssp CCEEECCCTTCEE
T ss_pred CCEEEEECCCCeE
Confidence 4566655554433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.40 E-value=4.4e-05 Score=76.00 Aligned_cols=46 Identities=26% Similarity=0.427 Sum_probs=36.3
Q ss_pred CCCCchHHHhhhc--cc--ccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 179 SGYLAPEVLRANM--FE--DATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~--~~--~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..|++||++.... +. ....|+.++|+||+||++|+|++|.+||...
T Consensus 271 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 7899999996431 00 2235778999999999999999999999654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=97.40 E-value=7.1e-05 Score=70.08 Aligned_cols=42 Identities=26% Similarity=0.488 Sum_probs=35.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.....|++||++.. .++.++|+||+||++|+|++|.+||...
T Consensus 191 ~~t~~y~aPE~~~~-------~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 191 IGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCcCcCCHHHHhc-------cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 35677999998753 3678999999999999999999999653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=7.6e-05 Score=71.01 Aligned_cols=48 Identities=23% Similarity=0.502 Sum_probs=35.0
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
....|++||++..... ....|+.++|+||+||++|+|++|.+||....
T Consensus 191 ~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 191 GTPYWMAPEVIACDEN-PDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCGGGCCHHHHC---------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCccccChhhhccccc-cCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 4567999999863211 12357889999999999999999999996544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=4.5e-05 Score=72.70 Aligned_cols=95 Identities=20% Similarity=0.287 Sum_probs=66.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH-------HHHHhcCCC-C-----CCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML-------RNIMEGKYS-F-----SSP 243 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~-f-----~~~ 243 (408)
....|++||++... .|+.++|+||+||++|+|++|.+||......... .....+... . ...
T Consensus 203 gt~~y~aPE~~~~~------~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 203 GTLGYIDPEYFIKG------RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp EETTTCCHHHHHHC------BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred CCccccCHHHhcCC------CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 45679999998754 4678999999999999999999999765332111 111111111 0 000
Q ss_pred cCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCC
Q psy3880 244 EWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHS 277 (408)
Q Consensus 244 ~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hp 277 (408)
.....+.++.+||.+||..||++|||+.|+++|.
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1122345688999999999999999999999763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=7.9e-05 Score=72.09 Aligned_cols=43 Identities=16% Similarity=0.260 Sum_probs=36.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||...
T Consensus 229 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 229 EGDLEFISMDLHKGC------GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp CSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCccccCHHHHccC------CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 456689999998753 4678999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=4.8e-05 Score=72.94 Aligned_cols=43 Identities=33% Similarity=0.671 Sum_probs=35.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
.....|++||++.... .++.++|+||+||++|+|++|.+||..
T Consensus 168 ~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 168 CGTLPYVAPELLKRRE-----FHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp CSCGGGSCHHHHHCSS-----BCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccCcCccCcHHhccCC-----CCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 4566799999987542 235689999999999999999999954
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=97.39 E-value=6.6e-05 Score=69.76 Aligned_cols=45 Identities=20% Similarity=0.411 Sum_probs=36.3
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHH
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 228 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~ 228 (408)
...|++||++... .++.++|+||+||++|+|++ |.+||.+.+..+
T Consensus 173 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 173 PIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp CTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccCccChhhhccC------CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 3469999999754 35678999999999999999 999997655433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=97.38 E-value=6.5e-05 Score=75.66 Aligned_cols=42 Identities=21% Similarity=0.519 Sum_probs=35.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
..|+|||++... .|+.++|+||+||++|+|++ |.+||.+.+.
T Consensus 349 ~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 349 IKWTAPEAINFG------SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccccCHHHhccC------CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 459999999754 46789999999999999999 9999976543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=97.38 E-value=6.9e-05 Score=73.51 Aligned_cols=44 Identities=23% Similarity=0.671 Sum_probs=35.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 228 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~ 228 (408)
..|++||++... .|+.++|+||+||++|++++ |.+||...+...
T Consensus 214 ~~y~aPE~~~~~------~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~ 258 (373)
T 2qol_A 214 IRWTSPEAIAYR------KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258 (373)
T ss_dssp CTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH
T ss_pred CCccChhhhccC------CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 469999998754 46779999999999999997 999997665443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=5.9e-05 Score=71.17 Aligned_cols=40 Identities=28% Similarity=0.599 Sum_probs=33.9
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||++... .++.++|+||+||++|+|++ |.+||.+.
T Consensus 211 ~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 211 VKWMAPESIFNC------VYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceeeChHHhcCC------CCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 459999998754 46789999999999999998 99998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00011 Score=74.39 Aligned_cols=14 Identities=7% Similarity=0.026 Sum_probs=8.3
Q ss_pred cccCCCCCCCHHHH
Q psy3880 260 LIVTPEDRYSVKEA 273 (408)
Q Consensus 260 L~~dP~~R~ta~e~ 273 (408)
+..|.+..++.+|+
T Consensus 344 ~D~d~dG~I~~~El 357 (484)
T 3nyv_A 344 MDKNGDGQLDRAEL 357 (484)
T ss_dssp HCTTCSSEEEHHHH
T ss_pred hCcCCCceEeHHHH
Confidence 34455666666665
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=9.4e-05 Score=69.70 Aligned_cols=44 Identities=27% Similarity=0.569 Sum_probs=36.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||.+... .++.++|+||+||++|+|++|.+||....
T Consensus 180 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQS------AYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCcCccCHHHHhcC------CCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 345669999998653 46779999999999999999999996543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=7.9e-05 Score=78.55 Aligned_cols=46 Identities=26% Similarity=0.527 Sum_probs=37.7
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
..|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..+..
T Consensus 536 ~~y~APE~~~~~------~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 536 VKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred eeeeChhhhcCC------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 459999999653 47789999999999999998 99999876554433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=6.3e-05 Score=71.90 Aligned_cols=39 Identities=26% Similarity=0.617 Sum_probs=33.5
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+
T Consensus 230 ~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 230 VKWMAPESIFDC------VYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccccCHHHhccC------CCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 469999998754 46779999999999999998 9999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=6e-05 Score=69.89 Aligned_cols=44 Identities=43% Similarity=0.939 Sum_probs=31.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
....|++||.+....+ ++.++|+||+||++|+|++|.+||....
T Consensus 172 ~~~~y~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 172 GSPNYAAPEVISGRLY-----AGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----CCTGGGTTSCC-----CHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccccCHHHHcCCCC-----CCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 3456999999865421 2468999999999999999999996543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=7.3e-05 Score=69.51 Aligned_cols=41 Identities=27% Similarity=0.622 Sum_probs=34.5
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
...|++||++... .++.++|+||+||++|+|++ |.+||...
T Consensus 177 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 177 PVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp CTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccCHHHhCCC------CCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 4569999998753 46779999999999999998 99998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00012 Score=74.19 Aligned_cols=14 Identities=14% Similarity=0.057 Sum_probs=8.4
Q ss_pred cccCCCCCCCHHHH
Q psy3880 260 LIVTPEDRYSVKEA 273 (408)
Q Consensus 260 L~~dP~~R~ta~e~ 273 (408)
+..|.+-.+|.+|+
T Consensus 340 ~D~d~dG~I~~~El 353 (486)
T 3mwu_A 340 LDTNNDGMLDRDEL 353 (486)
T ss_dssp HCTTCSSSBCHHHH
T ss_pred hCCCCCceeeHHHH
Confidence 34556666776665
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.35 E-value=4.5e-05 Score=74.19 Aligned_cols=45 Identities=40% Similarity=0.772 Sum_probs=35.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..+..|++||++.... ..++.++|+||+||++|+|++|.+||...
T Consensus 221 ~gt~~y~aPE~~~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 221 CGTIEYMAPDIVRGGD----SGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GSCCTTCCHHHHTTCC-------CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ccCcCccChhhhcCCC----CCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 3567799999987421 24677899999999999999999999643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.35 E-value=9.5e-05 Score=69.94 Aligned_cols=47 Identities=28% Similarity=0.568 Sum_probs=38.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~ 228 (408)
.....|++||.+... .|+.++|+||+||++|+|++|.+||.......
T Consensus 186 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 186 IGTPFWMAPEVIQEI------GYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp CSCGGGCCHHHHSSS------CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCCccChhhcCCC------CCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 345669999998653 46789999999999999999999997655433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00011 Score=69.49 Aligned_cols=46 Identities=26% Similarity=0.495 Sum_probs=33.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
....|++||++..... ....|+.++|+||+||++|+|++|.+||..
T Consensus 186 ~~~~y~aPE~~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 186 GCAAYMAPERIDPPDP-TKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -CCTTCCHHHHC---------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccChhhcccccc-cccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 4567999999854211 123477899999999999999999999964
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=9.9e-05 Score=72.41 Aligned_cols=43 Identities=28% Similarity=0.567 Sum_probs=35.6
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
...|++||++... .++.++|+||+||++|+|++ |.+||.+...
T Consensus 256 t~~y~aPE~~~~~------~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 256 PVKWMAPEALFDR------IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CcceeCHHHhcCC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3459999998753 46789999999999999999 9999966543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00013 Score=74.16 Aligned_cols=14 Identities=7% Similarity=0.071 Sum_probs=8.9
Q ss_pred ccCCCCCCCHHHHH
Q psy3880 261 IVTPEDRYSVKEAL 274 (408)
Q Consensus 261 ~~dP~~R~ta~e~L 274 (408)
..|-+-.++.+|+.
T Consensus 356 D~d~dG~I~~~El~ 369 (494)
T 3lij_A 356 DKNGDGQLDRQELI 369 (494)
T ss_dssp CTTCSSEECHHHHH
T ss_pred CcCCCCeEcHHHHH
Confidence 44566667777764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.34 E-value=8.1e-05 Score=71.57 Aligned_cols=43 Identities=28% Similarity=0.733 Sum_probs=35.5
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||...+..
T Consensus 214 ~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 257 (333)
T 1mqb_A 214 IRWTAPEAISYR------KFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257 (333)
T ss_dssp GGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccccCchhcccC------CCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence 459999998653 46779999999999999998 99999765543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.33 E-value=5.4e-05 Score=74.36 Aligned_cols=39 Identities=31% Similarity=0.749 Sum_probs=32.6
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||..
T Consensus 260 ~~y~aPE~~~~~------~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 260 VKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccccChHHhcCC------CCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 459999998754 46789999999999999999 6777743
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=5.5e-05 Score=71.43 Aligned_cols=40 Identities=28% Similarity=0.537 Sum_probs=33.9
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 216 ~~y~aPE~~~~~------~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 216 VKWMAIESLFDH------IYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccChhhhcCC------CcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 459999999764 36779999999999999999 99999643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00015 Score=70.72 Aligned_cols=11 Identities=27% Similarity=0.160 Sum_probs=5.4
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++.+.+-|..+
T Consensus 159 ~vkL~DFG~a~ 169 (353)
T 2i0e_A 159 HIKIADFGMCK 169 (353)
T ss_dssp CEEECCCTTCB
T ss_pred cEEEEeCCccc
Confidence 45555544433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0001 Score=70.61 Aligned_cols=42 Identities=31% Similarity=0.619 Sum_probs=35.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+...
T Consensus 223 ~~y~aPE~~~~~------~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 223 VKWMAPEALFDR------VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeChHHhcCC------CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 459999998754 36778999999999999999 9999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00018 Score=68.95 Aligned_cols=12 Identities=25% Similarity=0.133 Sum_probs=6.3
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++.+.+-|..+.
T Consensus 144 ~~kL~Dfg~a~~ 155 (318)
T 1fot_A 144 HIKITDFGFAKY 155 (318)
T ss_dssp CEEECCCSSCEE
T ss_pred CEEEeecCccee
Confidence 455655554443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00012 Score=73.54 Aligned_cols=10 Identities=30% Similarity=0.209 Sum_probs=5.3
Q ss_pred cEEEecCCCE
Q psy3880 76 NILLDDQMNV 85 (408)
Q Consensus 76 NILl~~~~~i 85 (408)
++-|.+-|..
T Consensus 213 ~vkL~DFGla 222 (437)
T 4aw2_A 213 HIRLADFGSC 222 (437)
T ss_dssp CEEECCCTTC
T ss_pred CEEEcchhhh
Confidence 4556555544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00013 Score=68.05 Aligned_cols=39 Identities=18% Similarity=0.389 Sum_probs=31.2
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
...|++||++... ..++.++|+||+||++|+|++|..|+
T Consensus 180 ~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 180 RIPWVPPECIENP-----KNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp TTTTSCHHHHHCG-----GGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCcccCHHHhCCC-----CCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 4569999998752 24678999999999999999965544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=97.30 E-value=7.9e-05 Score=70.42 Aligned_cols=39 Identities=28% Similarity=0.658 Sum_probs=33.4
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+
T Consensus 214 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 214 LKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeecCchhhccc------cccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 459999998754 46779999999999999998 9999854
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=3.7e-05 Score=73.56 Aligned_cols=99 Identities=18% Similarity=0.137 Sum_probs=66.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch----------------hHHHHHHHHhcCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK----------------QMVMLRNIMEGKYS 239 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~----------------~~~~~~~i~~~~~~ 239 (408)
.....|++||++...... ...++.++|+||+||++|+|++|.+||.+.. ...+...+......
T Consensus 194 ~gt~~y~aPE~~~~~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (322)
T 3soc_A 194 VGTRRYMAPEVLEGAINF-QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR 272 (322)
T ss_dssp CCCGGGCCHHHHTTCCCC-CHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC
T ss_pred ccCccccCHhhccccccc-CcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCC
Confidence 356679999998753211 1235668899999999999999999996532 12222233222222
Q ss_pred CCC-CcCC--CCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 240 FSS-PEWN--DISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 240 f~~-~~~~--~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... ..|. ..++++.+||.+||..||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 273 PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1111 12345899999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=4.8e-05 Score=72.54 Aligned_cols=97 Identities=21% Similarity=0.216 Sum_probs=66.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh----HHHHHHHHhcCCCC-----------C
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ----MVMLRNIMEGKYSF-----------S 241 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~----~~~~~~i~~~~~~f-----------~ 241 (408)
....|++||++... .++.++|+||+||++|+|++|.+||..... .........+...- .
T Consensus 197 gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 3uim_A 197 GTIGHIAPEYLSTG------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270 (326)
T ss_dssp SCGGGCCHHHHHHS------EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT
T ss_pred CCcCccCHHHhccC------CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc
Confidence 56679999998764 357799999999999999999999952211 00111111111100 0
Q ss_pred CCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 242 SPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 242 ~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
.......++++.+||.+||..||++|||+.|+++|-.-
T Consensus 271 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00111234678899999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=3.7e-05 Score=72.60 Aligned_cols=94 Identities=17% Similarity=0.285 Sum_probs=65.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH----HHHHHHhcCCCC-------CCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIMEGKYSF-------SSPE 244 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~----~~~~i~~~~~~f-------~~~~ 244 (408)
.....|++||++... ++.++|+||+||++|+|++|.+||....... ....+......+ ....
T Consensus 196 ~g~~~y~aPE~~~~~-------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 196 VGTTAYMAPEALRGE-------ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp CSCGGGCCHHHHTTE-------ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred CCCcCcCChHHhcCC-------CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 346679999988642 5779999999999999999999997654322 122222211100 0001
Q ss_pred CCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 245 WNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 245 ~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
....++++.+||.+||..||.+|||+.|+++|
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12235678899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=9e-05 Score=74.11 Aligned_cols=43 Identities=26% Similarity=0.425 Sum_probs=33.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
...+..|+|||++... ..|+.++||||+|||+|+|++|..||.
T Consensus 211 ~~gt~~Y~APE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 211 HVVTRWYRAPELILLQ-----ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CCCCCTTCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCCCccccCHHHHhcC-----CCCCcccccchHHHHHHHHHhcccccc
Confidence 3456779999987432 357889999999999999998655554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.30 E-value=3.4e-05 Score=71.76 Aligned_cols=42 Identities=38% Similarity=0.812 Sum_probs=22.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
....|++||.+... .++.++|+||+||++|+|++|.+||...
T Consensus 174 ~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 174 GTPNYISPEIATRS------AHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCCcCCcchhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 45569999988653 3577999999999999999999999653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.29 E-value=7.9e-05 Score=70.86 Aligned_cols=41 Identities=27% Similarity=0.463 Sum_probs=34.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+...|++||++.. .|+.++|+||+||++|+|++|..||+..
T Consensus 218 gt~~y~aPE~~~~-------~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 218 GDPRYMAPELLQG-------SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp CCGGGCCGGGGGT-------CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred CCccccCHhHhcC-------CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4667999998764 3788999999999999999998777654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00015 Score=67.61 Aligned_cols=46 Identities=26% Similarity=0.562 Sum_probs=34.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
.....|++||++.... ....|+.++|+||+||++|+|++|.+||..
T Consensus 170 ~~t~~y~aPE~~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 170 AGCKPYMAPERINPEL--NQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp CCCCCCSCHHHHSCCT--TC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCCccccChhhcChhh--cCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 3456799999974221 123477899999999999999999999954
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00012 Score=69.65 Aligned_cols=43 Identities=23% Similarity=0.559 Sum_probs=35.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
....|++||++... ..|+.++|+||+||++|+|++|..||...
T Consensus 192 ~~~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 192 ASRYFKGPELLVDY-----QMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp SCGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccChhhhcCC-----CcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 45569999998642 34788999999999999999999999654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=97.28 E-value=9.6e-05 Score=69.34 Aligned_cols=39 Identities=31% Similarity=0.749 Sum_probs=31.8
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
..|++||.+... .|+.++|+||+||++|+|++ |.+||..
T Consensus 196 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 196 VKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccChHHhcCC------CCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 469999998764 46779999999999999999 5666643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.28 E-value=7.7e-05 Score=70.78 Aligned_cols=41 Identities=27% Similarity=0.657 Sum_probs=34.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+||.
T Consensus 164 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~g~~p~~ 204 (307)
T 2eva_A 164 KGSAAWMAPEVFEGS------NYSEKCDVFSWGIILWEVITRRKPFD 204 (307)
T ss_dssp -CCTTSSCHHHHTCC------CCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred CCCCceEChhhhCCC------CCCcHHHHHHHHHHHHHHHHCCCCch
Confidence 356679999998653 46789999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=7.8e-05 Score=73.08 Aligned_cols=41 Identities=27% Similarity=0.658 Sum_probs=34.4
Q ss_pred CCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 180 ~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
.|+|||++... .|+.++|+||+||++|+|++ |.+||.+.+.
T Consensus 280 ~y~aPE~~~~~------~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 280 KWTAPEALNYG------RYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp GGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred CcCCHhHhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 49999999754 36779999999999999998 9999976543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00025 Score=65.87 Aligned_cols=10 Identities=20% Similarity=-0.054 Sum_probs=4.9
Q ss_pred EEEecCCCEE
Q psy3880 77 ILLDDQMNVK 86 (408)
Q Consensus 77 ILl~~~~~iK 86 (408)
+.+.+-|...
T Consensus 147 ~kl~Dfg~~~ 156 (284)
T 3kk8_A 147 VKLADFGLAI 156 (284)
T ss_dssp EEECCCTTCE
T ss_pred EEEeeceeeE
Confidence 5555544443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0002 Score=69.06 Aligned_cols=13 Identities=15% Similarity=-0.069 Sum_probs=7.1
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
++.+.+-|..+..
T Consensus 162 ~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 162 VLKLADFGLARAF 174 (351)
T ss_dssp CEEECCCTTCEEC
T ss_pred CEEEccchhcccc
Confidence 5666665555443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00021 Score=70.52 Aligned_cols=23 Identities=9% Similarity=0.021 Sum_probs=10.7
Q ss_pred CCCeeccCCCCcEEEecCCCEEE
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKL 87 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl 87 (408)
.+|+-..-+..++.+.+-|..+.
T Consensus 178 ~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 178 ENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp GGEEESSTTCCCEEECCCTTCEE
T ss_pred HHeEEecCCCCceEEEeccccee
Confidence 34443222334566665554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=97.26 E-value=8.7e-05 Score=69.19 Aligned_cols=40 Identities=33% Similarity=0.615 Sum_probs=33.8
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||.+... .++.++|+||+||++|+|++ |.+||...
T Consensus 176 ~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 176 IKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCcCChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 359999998754 46779999999999999999 99998543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00024 Score=66.95 Aligned_cols=13 Identities=23% Similarity=0.194 Sum_probs=6.5
Q ss_pred CCcEEEecCCCEE
Q psy3880 74 PENILLDDQMNVK 86 (408)
Q Consensus 74 p~NILl~~~~~iK 86 (408)
..++.+.+-|..+
T Consensus 145 ~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 145 NSKIMITDFGLSK 157 (304)
T ss_dssp TCCEEBCSCSTTC
T ss_pred CCCEEEccCCcce
Confidence 3456665544433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0002 Score=69.63 Aligned_cols=12 Identities=25% Similarity=-0.014 Sum_probs=6.1
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++.+.+-|..+.
T Consensus 179 ~~kL~DFg~a~~ 190 (350)
T 1rdq_E 179 YIQVTDFGFAKR 190 (350)
T ss_dssp CEEECCCTTCEE
T ss_pred CEEEccccccee
Confidence 455655554443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00019 Score=70.34 Aligned_cols=13 Identities=15% Similarity=-0.023 Sum_probs=7.1
Q ss_pred CcEEEecCCCEEE
Q psy3880 75 ENILLDDQMNVKL 87 (408)
Q Consensus 75 ~NILl~~~~~iKl 87 (408)
.++.+.+-|..+.
T Consensus 226 ~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 226 KQIKIIDFGLARR 238 (373)
T ss_dssp TEEEECCCSSCEE
T ss_pred CcEEEEeCCCcee
Confidence 3566665555444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=7.3e-05 Score=69.77 Aligned_cols=43 Identities=30% Similarity=0.551 Sum_probs=34.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
.....|++||++... ...|+.++|+||+||++|+|++|.+||.
T Consensus 187 ~g~~~y~aPE~~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~ 229 (287)
T 4f0f_A 187 LGNFQWMAPETIGAE----EESYTEKADTYSFAMILYTILTGEGPFD 229 (287)
T ss_dssp CCCCTTSCGGGSSCS----SCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCccccCchhhccC----CCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence 345679999987432 2346778999999999999999999984
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00011 Score=73.90 Aligned_cols=43 Identities=23% Similarity=0.398 Sum_probs=35.8
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+....
T Consensus 345 ~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 345 IKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccccCHhHHhcC------CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 459999998754 46779999999999999999 99999765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00022 Score=69.00 Aligned_cols=10 Identities=20% Similarity=0.052 Sum_probs=4.9
Q ss_pred cEEEecCCCE
Q psy3880 76 NILLDDQMNV 85 (408)
Q Consensus 76 NILl~~~~~i 85 (408)
++-+.+-|..
T Consensus 143 ~vkL~DFG~a 152 (337)
T 1o6l_A 143 HIKITDFGLC 152 (337)
T ss_dssp CEEECCCTTC
T ss_pred CEEEeeccch
Confidence 4555554433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00021 Score=70.26 Aligned_cols=8 Identities=38% Similarity=0.401 Sum_probs=4.0
Q ss_pred cEEEecCC
Q psy3880 76 NILLDDQM 83 (408)
Q Consensus 76 NILl~~~~ 83 (408)
++.|.+-|
T Consensus 177 ~ikL~DFG 184 (373)
T 2r5t_A 177 HIVLTDFG 184 (373)
T ss_dssp CEEECCCC
T ss_pred CEEEeeCc
Confidence 45555444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=9.1e-05 Score=70.12 Aligned_cols=41 Identities=32% Similarity=0.517 Sum_probs=34.3
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
...|++||.+... .|+.++|+||+||++|+|++ |.+||...
T Consensus 212 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 212 PVKWIAIESLADR------VYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp CGGGSCHHHHHSS------CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccCchhhcCC------CccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 3469999998653 46779999999999999999 89998654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00022 Score=69.33 Aligned_cols=11 Identities=27% Similarity=0.160 Sum_probs=5.5
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++-+.+-|..+
T Consensus 156 ~vkL~DFG~a~ 166 (345)
T 1xjd_A 156 HIKIADFGMCK 166 (345)
T ss_dssp CEEECCCTTCB
T ss_pred CEEEeEChhhh
Confidence 45565544433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00016 Score=68.50 Aligned_cols=47 Identities=26% Similarity=0.549 Sum_probs=35.5
Q ss_pred cCCCCCchHHHhhhccc-----ccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFE-----DATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~-----~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
....|++||++...... ....++.++|+||+||++|+|++|.+||..
T Consensus 190 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 45679999998752211 123578899999999999999999999954
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00011 Score=74.95 Aligned_cols=95 Identities=13% Similarity=0.060 Sum_probs=70.2
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch---hHHHHHHHHhcCCCCCC-CcCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIMEGKYSFSS-PEWNDISE 250 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~---~~~~~~~i~~~~~~f~~-~~~~~iS~ 250 (408)
......|++||++... .|+.++||||+||++|+|++|.+||.+.. ....+..+......... .....+++
T Consensus 173 ~~gt~~Y~aPE~~~~~------~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (483)
T 3sv0_A 173 LTGTARYASVNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPT 246 (483)
T ss_dssp CCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCH
T ss_pred cCCCccccCHHHhcCC------CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcH
Confidence 4466789999998764 46779999999999999999999997643 23334444333322111 11246789
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
++.+||.+||..||++|||++++++
T Consensus 247 ~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 247 EFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999887643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00029 Score=68.21 Aligned_cols=13 Identities=23% Similarity=-0.043 Sum_probs=7.4
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
.+.+.+-|..+..
T Consensus 158 ~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 158 SIRICDFGFAKQL 170 (342)
T ss_dssp GEEECCCTTCEEC
T ss_pred eEEEEECCCcccC
Confidence 3667666655543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00015 Score=76.78 Aligned_cols=47 Identities=32% Similarity=0.606 Sum_probs=37.9
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLR 231 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~~ 231 (408)
..|+|||++... .|+.++|+||+||++|+|++ |.+||.+....+...
T Consensus 556 ~~y~aPE~~~~~------~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~ 603 (656)
T 2j0j_A 556 IKWMAPESINFR------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603 (656)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cceeCHHHhcCC------CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 469999998653 46789999999999999997 999998766544443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00016 Score=67.72 Aligned_cols=39 Identities=28% Similarity=0.466 Sum_probs=31.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
....|++||.+... .|+.++|+||+||++|+|++|..||
T Consensus 190 ~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 190 LPVKWTALESLQTY------RFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp CGGGGSCHHHHTTC------CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCccccChhhhccC------CCChhhchhhHHHHHHHHhhCCCCC
Confidence 34569999998653 4677999999999999999955554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0001 Score=74.19 Aligned_cols=41 Identities=27% Similarity=0.622 Sum_probs=34.6
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
...|++||++... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 349 ~~~y~aPE~~~~~------~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 349 PVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp CTTTSCHHHHHSS------CCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred CcceeCHHHhcCC------CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3569999999753 46789999999999999998 99999643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.18 E-value=7e-05 Score=71.44 Aligned_cols=101 Identities=17% Similarity=0.248 Sum_probs=66.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC----------CCCCCCch-----hHHHHHHHHhcCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG----------CPPFWHRK-----QMVMLRNIMEGKYSF 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g----------~~Pf~~~~-----~~~~~~~i~~~~~~f 240 (408)
.....|++||++..........++.++|+||+||++|+|++| ..||.... .......+.......
T Consensus 207 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (337)
T 3mdy_A 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP 286 (337)
T ss_dssp CSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred ccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCc
Confidence 456679999999765433222222358999999999999999 67775431 122222222222221
Q ss_pred CCCc-C--CCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 241 SSPE-W--NDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 241 ~~~~-~--~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+. | ..+++++.+||.+||..||++|||+.|+++|
T Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 287 SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1111 1 2355678999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.13 E-value=9e-05 Score=70.51 Aligned_cols=43 Identities=30% Similarity=0.543 Sum_probs=24.6
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
....|++||++... ....|+.++|+||+||++|+|++|.+||.
T Consensus 212 ~t~~y~aPE~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 212 TTPMYRTPEIIDLY---SNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp ------------CC---TTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCCCcCChhhhhcc---ccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 45569999998421 12346789999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=5.6e-05 Score=72.88 Aligned_cols=43 Identities=47% Similarity=0.923 Sum_probs=23.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
....|++||++... .|+.++|+||+||++|+|++|.+||....
T Consensus 191 ~t~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 191 YTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp -------------C------HHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCccChhhhCCC------CCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 35669999998543 35678999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00015 Score=68.62 Aligned_cols=88 Identities=15% Similarity=0.178 Sum_probs=65.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHH-----HHHHHHhcCCCCCCCcCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-----MLRNIMEGKYSFSSPEWNDISE 250 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~-----~~~~i~~~~~~f~~~~~~~iS~ 250 (408)
.++..|++||++... .|+.++|+||+||++|+|++|.+||....... ......... ....+++
T Consensus 183 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 250 (310)
T 3s95_A 183 VGNPYWMAPEMINGR------SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY------CPPNCPP 250 (310)
T ss_dssp CSCGGGCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT------CCTTCCT
T ss_pred CCCcceeCHHHhcCC------CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc------CCCCCCH
Confidence 356679999998653 46789999999999999999999986432110 011111110 1245789
Q ss_pred cHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
++.+||.+||..||++|||++|+++
T Consensus 251 ~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 251 SFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp THHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00029 Score=69.73 Aligned_cols=13 Identities=23% Similarity=-0.051 Sum_probs=6.6
Q ss_pred CcEEEecCCCEEE
Q psy3880 75 ENILLDDQMNVKL 87 (408)
Q Consensus 75 ~NILl~~~~~iKl 87 (408)
..+-|.+-|..+.
T Consensus 201 ~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 201 AILKLTDFGFAKE 213 (400)
T ss_dssp CCEEECCCTTCEE
T ss_pred ccEEEEecccccc
Confidence 3455655554443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00019 Score=73.26 Aligned_cols=13 Identities=23% Similarity=0.005 Sum_probs=7.3
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
++.+.+-|..+..
T Consensus 187 ~~kl~Dfg~a~~~ 199 (504)
T 3q5i_A 187 NIKIVDFGLSSFF 199 (504)
T ss_dssp SEEECCCTTCEEC
T ss_pred cEEEEECCCCEEc
Confidence 5666665555443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00011 Score=68.05 Aligned_cols=43 Identities=33% Similarity=0.671 Sum_probs=34.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
.....|++||++.... .++.++|+||+||++|+|++|..||..
T Consensus 168 ~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 168 CGTLPYVAPELLKRRE-----FHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp CSCGGGCCGGGGTCSS-----BCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred ccccCccChHHHhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 3456699999986532 135679999999999999999999954
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.10 E-value=6.3e-05 Score=71.90 Aligned_cols=106 Identities=21% Similarity=0.312 Sum_probs=67.8
Q ss_pred cCCCCCchHHHhhhccc-ccccCCCcccccchhhhHHHhhcCCCCCCCchh-----------------HHHHHH-HHhcC
Q psy3880 177 DISGYLAPEVLRANMFE-DATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-----------------MVMLRN-IMEGK 237 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~-~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~-----------------~~~~~~-i~~~~ 237 (408)
....|++||++...... +...++.++||||+||++|+|++|..||..... ...... +....
T Consensus 190 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (336)
T 3g2f_A 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK 269 (336)
T ss_dssp SCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC
T ss_pred CccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc
Confidence 56679999998753211 123466789999999999999999777643211 011111 11111
Q ss_pred CCCC-CCcC---CCCCccHHHHHHHhcccCCCCCCCHHHH------HcCCCCCCC
Q psy3880 238 YSFS-SPEW---NDISEDPKDLIRKLLIVTPEDRYSVKEA------LNHSFFHPK 282 (408)
Q Consensus 238 ~~f~-~~~~---~~iS~~~~dLI~klL~~dP~~R~ta~e~------L~Hpwf~~~ 282 (408)
.... ...| ..+++++++||.+||..||++|||+.|+ +.|+|-+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 270 QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 1111 1112 2244579999999999999999999999 557776543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0002 Score=73.82 Aligned_cols=43 Identities=23% Similarity=0.398 Sum_probs=35.8
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
..|++||++... .|+.++||||+||++|+|++ |.+||.+....
T Consensus 428 ~~y~aPE~~~~~------~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 428 IKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp GGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred ccccCHHHhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 459999998754 46779999999999999999 99999765443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00022 Score=68.30 Aligned_cols=17 Identities=29% Similarity=0.249 Sum_probs=10.3
Q ss_pred CcEEEecCCCEEEeccc
Q psy3880 75 ENILLDDQMNVKLTDFG 91 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFG 91 (408)
.++.+.+-|..+..+.+
T Consensus 155 ~~~kl~Dfg~a~~~~~~ 171 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFG 171 (326)
T ss_dssp CCEEECCCTTCEECCTT
T ss_pred CCEEEEECCCCeECCCC
Confidence 35777766666665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00038 Score=66.65 Aligned_cols=9 Identities=22% Similarity=0.069 Sum_probs=4.7
Q ss_pred cEEEecCCC
Q psy3880 76 NILLDDQMN 84 (408)
Q Consensus 76 NILl~~~~~ 84 (408)
++.+.+-|.
T Consensus 159 ~~kl~Dfg~ 167 (327)
T 3a62_A 159 HVKLTDFGL 167 (327)
T ss_dssp CEEECCCSC
T ss_pred cEEEEeCCc
Confidence 455555443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00039 Score=64.86 Aligned_cols=8 Identities=25% Similarity=0.073 Sum_probs=4.1
Q ss_pred cEEEecCC
Q psy3880 76 NILLDDQM 83 (408)
Q Consensus 76 NILl~~~~ 83 (408)
++.+.+-+
T Consensus 162 ~~kL~Dfg 169 (287)
T 2wei_A 162 DIKIIDFG 169 (287)
T ss_dssp CEEECSTT
T ss_pred cEEEeccC
Confidence 46565443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00012 Score=70.13 Aligned_cols=101 Identities=17% Similarity=0.262 Sum_probs=69.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC----------CCCCCCch-----hHHHHHHHHhcCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG----------CPPFWHRK-----QMVMLRNIMEGKYSF 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g----------~~Pf~~~~-----~~~~~~~i~~~~~~f 240 (408)
.....|++||++..........++.++|+||+||++|+|++| ..||.... ...+...+.......
T Consensus 212 ~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (342)
T 1b6c_B 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 291 (342)
T ss_dssp CCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC
T ss_pred CcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC
Confidence 456679999998764322222344689999999999999999 78887642 233444444443332
Q ss_pred CCC-cC--CCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 241 SSP-EW--NDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 241 ~~~-~~--~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+ .| ...++.+++||.+||..||++|||++|+++|
T Consensus 292 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 221 12 1234578899999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00017 Score=66.70 Aligned_cols=41 Identities=24% Similarity=0.185 Sum_probs=33.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.....|++||++... ..++.++|+||+||++|+|++|.+|+
T Consensus 191 ~gt~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 191 EGDSRFLANEVLQEN-----YTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp CCCGGGCCHHHHTTC-----CTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCccccChhHhcCC-----CCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 356679999998753 23556899999999999999998875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00015 Score=73.97 Aligned_cols=40 Identities=33% Similarity=0.615 Sum_probs=34.0
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..|++||++... .|+.++|+||+||++|+|++ |.+||.+.
T Consensus 383 ~~y~aPE~~~~~------~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 383 IKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp GGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeCHhHHhcC------CCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 359999999764 36779999999999999998 99998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00011 Score=71.69 Aligned_cols=43 Identities=23% Similarity=0.419 Sum_probs=35.8
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
...|++||++... ...|+.++|+||+||++|+|++|.+||...
T Consensus 254 t~~y~aPE~~~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 254 PVTYAPREFLNAS----TATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp CGGGCCHHHHTCS----EEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCCcChhhccCC----CCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 3679999999541 135788999999999999999999999765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00036 Score=74.05 Aligned_cols=12 Identities=25% Similarity=0.069 Sum_probs=7.4
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++-|.+-|..+.
T Consensus 480 ~ikL~DFGla~~ 491 (674)
T 3pfq_A 480 HIKIADFGMCKE 491 (674)
T ss_dssp CEEECCCTTCEE
T ss_pred cEEEeecceeec
Confidence 566766665554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00059 Score=65.21 Aligned_cols=12 Identities=17% Similarity=0.039 Sum_probs=5.7
Q ss_pred CcEEEecCCCEE
Q psy3880 75 ENILLDDQMNVK 86 (408)
Q Consensus 75 ~NILl~~~~~iK 86 (408)
.++.+.+-|..+
T Consensus 171 ~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 171 GDIKIVDFGMSR 182 (327)
T ss_dssp CCEEECCGGGCE
T ss_pred CcEEEeeCcccc
Confidence 345555444333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00038 Score=68.13 Aligned_cols=33 Identities=39% Similarity=0.486 Sum_probs=30.3
Q ss_pred ccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 250 EDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 250 ~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
++++|||++||+.||++|||++|+|+||||+..
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 478999999999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00057 Score=67.29 Aligned_cols=9 Identities=22% Similarity=-0.126 Sum_probs=4.6
Q ss_pred CcEEEecCC
Q psy3880 75 ENILLDDQM 83 (408)
Q Consensus 75 ~NILl~~~~ 83 (408)
.++-|.+-|
T Consensus 191 ~~~kl~DFG 199 (390)
T 2zmd_A 191 GMLKLIDFG 199 (390)
T ss_dssp SCEEECCCS
T ss_pred CeEEEEecC
Confidence 455565444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00014 Score=68.93 Aligned_cols=42 Identities=26% Similarity=0.589 Sum_probs=33.5
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
...|++||++.... ...|+.++|+||+||++|+|++|.+||.
T Consensus 206 t~~y~aPE~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 206 TISYRAPELFSVQS---HCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp CGGGCCGGGSSCCS---EEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred CcccCCHhHhccCC---CcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 45699999875431 1236779999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00017 Score=68.75 Aligned_cols=43 Identities=30% Similarity=0.536 Sum_probs=35.7
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
...|++||++... .|+.++|+||+||++|+|++|..||.....
T Consensus 193 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 193 PIFWYAPESLSDN------IFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp CGGGSCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred cccccCHHHhccC------CCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 3449999998764 356789999999999999999999976544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00024 Score=66.62 Aligned_cols=41 Identities=29% Similarity=0.462 Sum_probs=34.6
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
..|++||++... .|+.++|+||+||++|+|++|..||....
T Consensus 181 ~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 181 IFWYAPESLTES------KFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp GGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred cceeCcHHhcCC------CCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 349999998764 46789999999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.00042 Score=64.17 Aligned_cols=15 Identities=13% Similarity=-0.175 Sum_probs=7.6
Q ss_pred CCCcEEEecCCCEEE
Q psy3880 73 KPENILLDDQMNVKL 87 (408)
Q Consensus 73 Kp~NILl~~~~~iKl 87 (408)
....+.+.+-|..+.
T Consensus 144 ~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 144 PDSPLKLIDFGLAAR 158 (277)
T ss_dssp TTCCEEECCCTTCEE
T ss_pred CCCcEEEEeccccee
Confidence 334566655554443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.00066 Score=65.51 Aligned_cols=33 Identities=30% Similarity=0.348 Sum_probs=31.0
Q ss_pred CCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 248 ISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 248 iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.++++.+||++||+.||++|||++|+|+||||+
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 467899999999999999999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0007 Score=64.38 Aligned_cols=12 Identities=25% Similarity=-0.086 Sum_probs=6.6
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++.+.+-|..+.
T Consensus 157 ~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 157 HIKLIDFGLAHE 168 (321)
T ss_dssp CEEECCCTTCEE
T ss_pred CEEEccCcccee
Confidence 566665555443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00024 Score=68.43 Aligned_cols=41 Identities=39% Similarity=0.742 Sum_probs=34.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
....|++||++....+ ++.++|+||+||++|+|++|.+||.
T Consensus 191 gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 191 GTIEYCAPEVLMGNPY-----RGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp SCGGGCCHHHHTTCCB-----CSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred CCccccChhhhcCCCC-----CCCcccchhHHHHHHHHHhCCCchh
Confidence 4667999999875422 3678999999999999999999984
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00075 Score=67.57 Aligned_cols=8 Identities=25% Similarity=0.189 Sum_probs=3.9
Q ss_pred cEEEecCC
Q psy3880 76 NILLDDQM 83 (408)
Q Consensus 76 NILl~~~~ 83 (408)
++-|.+-|
T Consensus 287 ~~kl~DFG 294 (446)
T 4ejn_A 287 HIKITDFG 294 (446)
T ss_dssp CEEECCCC
T ss_pred CEEEccCC
Confidence 45555444
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00087 Score=63.40 Aligned_cols=8 Identities=13% Similarity=-0.076 Sum_probs=3.6
Q ss_pred cEEEecCC
Q psy3880 76 NILLDDQM 83 (408)
Q Consensus 76 NILl~~~~ 83 (408)
++.+.+-|
T Consensus 154 ~~kl~Dfg 161 (311)
T 3ork_A 154 AVKVMDFG 161 (311)
T ss_dssp CEEECCCS
T ss_pred CEEEeecc
Confidence 45454443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00045 Score=65.71 Aligned_cols=44 Identities=48% Similarity=0.898 Sum_probs=35.2
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
....|++||++... ....|+.++|+||+||++|+|++|.+||..
T Consensus 178 gt~~y~aPE~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 178 GTPTYLAPEVLVSV---GTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp SCCTTCCHHHHHHT---TTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCcCccCchhhccC---CCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 35579999998532 123577899999999999999999999954
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00021 Score=68.05 Aligned_cols=42 Identities=33% Similarity=0.532 Sum_probs=34.9
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
...|++||++... .++.++|+||+||++|+|++|..||....
T Consensus 200 ~~~y~aPE~~~~~------~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 200 PVFWYAPECLKEY------KFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp CGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CceeeChHHhcCC------CCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 3449999999764 35668999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00059 Score=66.50 Aligned_cols=11 Identities=27% Similarity=-0.037 Sum_probs=5.3
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++.+.+-|..+
T Consensus 238 ~ikl~DfG~~~ 248 (365)
T 2y7j_A 238 QIRLSDFGFSC 248 (365)
T ss_dssp CEEECCCTTCE
T ss_pred CEEEEecCccc
Confidence 45555545433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00029 Score=66.09 Aligned_cols=42 Identities=31% Similarity=0.403 Sum_probs=34.1
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
....|++||++... .++.++|+||+||++|+|++|.+|+...
T Consensus 191 ~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 191 SPVFWYAPECLMQS------KFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCccccCCeeecCC------CCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 33449999999764 3566899999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.001 Score=64.38 Aligned_cols=8 Identities=38% Similarity=0.276 Sum_probs=3.7
Q ss_pred cEEEecCC
Q psy3880 76 NILLDDQM 83 (408)
Q Consensus 76 NILl~~~~ 83 (408)
++.+.+-|
T Consensus 148 ~~kL~DFG 155 (345)
T 3a8x_A 148 HIKLTDYG 155 (345)
T ss_dssp CEEECCGG
T ss_pred CEEEEecc
Confidence 45554433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0011 Score=61.32 Aligned_cols=11 Identities=27% Similarity=-0.031 Sum_probs=5.6
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++.+.+-+..+
T Consensus 150 ~~kl~dfg~~~ 160 (283)
T 3bhy_A 150 RIKLIDFGIAH 160 (283)
T ss_dssp CEEECCCTTCE
T ss_pred ceEEEecccce
Confidence 46665544433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00039 Score=67.37 Aligned_cols=41 Identities=49% Similarity=1.146 Sum_probs=35.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
..+..|++||++... .|+.++|+||+||++|+|++|.+||.
T Consensus 194 ~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 194 VGTPHFMAPEVVKRE------PYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CSCGGGCCHHHHTTC------CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcCccCHHHHcCC------CCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 356679999998753 46789999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0014 Score=60.98 Aligned_cols=9 Identities=11% Similarity=-0.030 Sum_probs=4.5
Q ss_pred cEEEecCCC
Q psy3880 76 NILLDDQMN 84 (408)
Q Consensus 76 NILl~~~~~ 84 (408)
++.+.+-|.
T Consensus 152 ~~kl~Dfg~ 160 (284)
T 2vgo_A 152 ELKIADFGW 160 (284)
T ss_dssp CEEECCCTT
T ss_pred CEEEecccc
Confidence 455554443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0015 Score=60.95 Aligned_cols=12 Identities=33% Similarity=-0.003 Sum_probs=6.0
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++.+.+-+..+.
T Consensus 162 ~~kl~dfg~~~~ 173 (298)
T 1phk_A 162 NIKLTDFGFSCQ 173 (298)
T ss_dssp CEEECCCTTCEE
T ss_pred cEEEecccchhh
Confidence 455655554443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00038 Score=66.30 Aligned_cols=41 Identities=29% Similarity=0.730 Sum_probs=33.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.....|++||++....+ ++.++|+||+||++|+|++|.+||
T Consensus 209 ~gt~~y~aPE~~~~~~~-----~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 209 DGTRVYSPPEWIRYHRY-----HGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CSCGGGSCHHHHHHSCB-----CHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCccCCChHHhccCCC-----CCccchHHhHHHHHHHHHHCCCCC
Confidence 34566999999875432 356789999999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.00026 Score=70.48 Aligned_cols=43 Identities=49% Similarity=0.916 Sum_probs=32.8
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
....|+|||++... ....|+.++|+||+||++|+|++|.+||.
T Consensus 303 gt~~y~aPE~~~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~ 345 (419)
T 3i6u_A 303 GTPTYLAPEVLVSV---GTAGYNRAVDCWSLGVILFICLSGYPPFS 345 (419)
T ss_dssp --CTTCCTTTTC-------CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCccCceeeecC---CCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 45679999987531 12357779999999999999999999994
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0013 Score=66.78 Aligned_cols=13 Identities=15% Similarity=0.028 Sum_probs=6.9
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
++.+.+-|..+..
T Consensus 154 ~vkL~DFG~a~~~ 166 (476)
T 2y94_A 154 NAKIADFGLSNMM 166 (476)
T ss_dssp CEEECCCSSCEEC
T ss_pred CeEEEeccchhhc
Confidence 5666655544443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00064 Score=71.89 Aligned_cols=44 Identities=32% Similarity=0.617 Sum_probs=37.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.....|++||.+.. ..|+.++|+||+||++|+|++|.+||.+..
T Consensus 184 ~gt~~Y~APE~l~~------~~~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 184 VGTLQYLAPELLEQ------KKYTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CSCCTTCSSCSSCC------SCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCcccCChHHhcc------CCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 45667999998754 357889999999999999999999997654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.00039 Score=66.32 Aligned_cols=88 Identities=17% Similarity=0.235 Sum_probs=65.3
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH----------------HHHHHHHhcCCCCCC
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM----------------VMLRNIMEGKYSFSS 242 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~----------------~~~~~i~~~~~~f~~ 242 (408)
..|++||++... .++.++|+||+||++|+|++|..||...... .+...+. .....
T Consensus 212 ~~y~aPE~~~~~------~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-- 282 (326)
T 2w1i_A 212 IFWYAPESLTES------KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRL-- 282 (326)
T ss_dssp GGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCC--
T ss_pred eeEECchhhcCC------CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh-cCCCC--
Confidence 349999998764 3567899999999999999999998643211 1112222 22222
Q ss_pred CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 243 PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 243 ~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+....+++++.+||++||..||++|||+.|+++
T Consensus 283 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 283 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223568999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0017 Score=64.30 Aligned_cols=11 Identities=36% Similarity=0.232 Sum_probs=5.5
Q ss_pred cEEEecCCCEE
Q psy3880 76 NILLDDQMNVK 86 (408)
Q Consensus 76 NILl~~~~~iK 86 (408)
++-|.+-|..+
T Consensus 191 ~ikL~DFGla~ 201 (396)
T 4dc2_A 191 HIKLTDYGMCK 201 (396)
T ss_dssp CEEECCCTTCB
T ss_pred CEEEeecceee
Confidence 45555544433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0018 Score=66.84 Aligned_cols=13 Identities=15% Similarity=-0.026 Sum_probs=7.0
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
++-+.+-|..+..
T Consensus 327 ~vkL~DFGla~~~ 339 (543)
T 3c4z_A 327 NVRISDLGLAVEL 339 (543)
T ss_dssp CEEECCCTTCEEC
T ss_pred CEEEeecceeeec
Confidence 5666655555443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.00068 Score=65.62 Aligned_cols=41 Identities=49% Similarity=1.050 Sum_probs=34.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
+...|++||++... .|+.++|+||+||++|+|++|..||..
T Consensus 212 gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 212 GTPGYCAPEILRGC------AYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp -CGGGSCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCccCHHHhcCC------CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 45679999998753 478899999999999999999999853
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00076 Score=63.04 Aligned_cols=65 Identities=22% Similarity=0.316 Sum_probs=44.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC-CCchhHHHHHHHHhcCCCCCCCcCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF-WHRKQMVMLRNIMEGKYSFSSPEWN 246 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf-~~~~~~~~~~~i~~~~~~f~~~~~~ 246 (408)
....|++||++... ..|+.++|+||+||++|+|++|..|| .+.+....+..+...........|.
T Consensus 163 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 163 VTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCGGGCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred cccCCcChHHHcCC-----CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 35569999998653 23788999999999999999877765 4455555565555544333333443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.001 Score=62.93 Aligned_cols=40 Identities=28% Similarity=0.588 Sum_probs=33.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.....|++||++... .|+.++|+||+||++|+|++|.+|+
T Consensus 237 ~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGN------NYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp C-CGGGSCHHHHHCC------CCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CCCcCccChHHhcCC------CCcchhhHHHHHHHHHHHHHcCCCh
Confidence 356679999998753 4788999999999999999987774
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00076 Score=63.63 Aligned_cols=41 Identities=24% Similarity=0.630 Sum_probs=33.3
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.....|++||++....+ ++.++|+||+||++|+|++|..||
T Consensus 199 ~~~~~y~aPE~~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 199 DGTRVYSPPEWISRHQY-----HALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp CSCTTTSCHHHHHHSCB-----CHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccCceeeecCCC-----CCccchHHHHHHHHHHHHHCCCCC
Confidence 34567999999875432 244799999999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0016 Score=62.27 Aligned_cols=12 Identities=17% Similarity=0.155 Sum_probs=6.0
Q ss_pred cEEEecCCCEEE
Q psy3880 76 NILLDDQMNVKL 87 (408)
Q Consensus 76 NILl~~~~~iKl 87 (408)
++.+.+-|..+.
T Consensus 190 ~~kl~dfg~~~~ 201 (348)
T 2pml_X 190 RVKLSDFGESEY 201 (348)
T ss_dssp CEEECCCTTCEE
T ss_pred cEEEeccccccc
Confidence 455555454443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0046 Score=59.38 Aligned_cols=13 Identities=15% Similarity=0.276 Sum_probs=7.6
Q ss_pred HHHHHHHhccccC
Q psy3880 158 VMLRNIMEGKYSF 170 (408)
Q Consensus 158 ~~~~~i~~~~~~~ 170 (408)
.++..++.|...|
T Consensus 248 ~il~ell~g~~pf 260 (345)
T 2v62_A 248 YCMLRWLCGKLPW 260 (345)
T ss_dssp HHHHHHHHSSCTT
T ss_pred HHHHHHHhCCCCc
Confidence 3555666776554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0019 Score=62.66 Aligned_cols=29 Identities=0% Similarity=0.063 Sum_probs=26.4
Q ss_pred CCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 247 DISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 247 ~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..++++.+||.+||..||++|||++++++
T Consensus 294 ~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 294 NAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 56889999999999999999999988764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=96.19 E-value=0.00075 Score=63.45 Aligned_cols=78 Identities=19% Similarity=0.075 Sum_probs=57.2
Q ss_pred cCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH---HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH
Q psy3880 197 GYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR---NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA 273 (408)
Q Consensus 197 ~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~---~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~ 273 (408)
.++.++|+||+||++|+|++|.+||.+.+....+. ....+........+..+++++++||.+||..||++| |+.|+
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el 256 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTL 256 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence 46779999999999999999999998765322110 111111111112235789999999999999999999 99999
Q ss_pred Hc
Q psy3880 274 LN 275 (408)
Q Consensus 274 L~ 275 (408)
++
T Consensus 257 ~~ 258 (286)
T 3uqc_A 257 LN 258 (286)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0016 Score=60.19 Aligned_cols=40 Identities=33% Similarity=0.651 Sum_probs=33.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.....|++||++... .++.++|+||+||++|+|++|..||
T Consensus 182 ~~~~~y~aPE~~~~~------~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 182 KGTLRYMSPEQISSQ------DYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp CSCCTTSCHHHHHCS------CCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred CCcccccChhhhccC------CCcchhhhHHHHHHHHHHHhcCCcc
Confidence 356679999998653 4678999999999999999998886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0035 Score=59.18 Aligned_cols=38 Identities=26% Similarity=0.470 Sum_probs=0.0
Q ss_pred CcchhhhhhhHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q psy3880 129 GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166 (408)
Q Consensus 129 ~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~~~i~~~ 166 (408)
+.++|+||+||++|+|++|..||.+.+...+...+...
T Consensus 213 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (309)
T 2h34_A 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA 250 (309)
T ss_dssp -CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC
T ss_pred CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0011 Score=70.25 Aligned_cols=38 Identities=26% Similarity=0.494 Sum_probs=0.0
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
++..|++||++... ++.++||||+||++|+|++|.+||
T Consensus 239 gt~~y~aPE~~~~~-------~~~~sDi~slG~~l~~l~~g~~~~ 276 (681)
T 2pzi_A 239 GTPGFQAPEIVRTG-------PTVATDIYTVGRTLAALTLDLPTR 276 (681)
T ss_dssp CCTTTSCTTHHHHC-------SCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred CCccccCHHHHcCC-------CCCceehhhhHHHHHHHHhCCCCC
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 408 | ||||
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-22 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-24 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-19 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-12 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-16 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-12 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-12 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-19 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-10 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-13 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-12 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-11 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-13 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-13 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-09 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-10 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-13 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-10 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-11 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-11 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-11 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-11 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-09 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-09 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-11 |
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 9e-45
Identities = 84/136 (61%), Positives = 102/136 (75%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S R IMR L E + +H ++VHRDLKPENILLDD MN+KLTDFGF+ L GEKL
Sbjct: 108 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 167
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
++CGTP YLAPE++ +M ++ GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR I
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 164 MEGKYSFSSPEWNDIS 179
M G Y F SPEW+D S
Sbjct: 228 MSGNYQFGSPEWDDYS 243
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 118 bits (296), Expect = 3e-31
Identities = 58/100 (58%), Positives = 75/100 (75%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
YLAPE++ +M ++ GYG+ VD+W+ GVIMYTLL G PPFWHRKQM+MLR IM G Y
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F SPEW+D S+ KDL+ + L+V P+ RY+ +EAL H FF
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 49/240 (20%), Positives = 90/240 (37%), Gaps = 44/240 (18%)
Query: 44 SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
L + + + L ++ H ++HRD+KP NIL++ + +KL DFG + L
Sbjct: 102 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 160
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH---RKQMVM 159
GT Y++PE L+ Y D+W+ G+ + + VG P ++ +M
Sbjct: 161 NSFVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
+EG + + P L+ + + P
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSR----------------------------P 246
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
P + + + N K S + +D + K LI P +R +K+ + H+F
Sbjct: 247 PMAIFELLDYIVNEPPPKL-----PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-39
Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ +L AL + H+ V+HRD+KPEN+LL +K+ DFG++ +
Sbjct: 104 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRT 162
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
LCGT YL PE++ + + VD+W+ GV+ Y LVG PPF + I
Sbjct: 163 TLCGTLDYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
Query: 164 MEGKYSFS---SPEWNDI 178
+++F + D+
Sbjct: 217 SRVEFTFPDFVTEGARDL 234
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (239), Expect = 2e-23
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
YL PE++ + + VD+W+ GV+ Y LVG PPF + I +++
Sbjct: 169 DYLPPEMIEGR------MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
F + ++E +DLI +LL P R ++E L H +
Sbjct: 223 F----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-39
Identities = 56/233 (24%), Positives = 86/233 (36%), Gaps = 52/233 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLC 106
++ M + LE++H H ++HRDLKP N+LLD+ +KL DFG A+ +
Sbjct: 102 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 166
T Y APE+L YG VD+WA G I+ LL+ P + L I E
Sbjct: 162 VTRWYRAPELLFGAR-----MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226
+ + +W D+ C + Y P
Sbjct: 217 LGTPTEEQWPDM----------------------------CSLPDYVTFKSFPGIPLHHI 248
Query: 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
++ +D DLI+ L + P R + +AL +F
Sbjct: 249 ------------------FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 54/267 (20%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
SN + Y + Q+ L+++H+ +V+HRDLKP N+LL+ ++K+ DFG ARV
Sbjct: 107 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 104 DL----CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
T Y APE++ + GY +++D+W+ G I+ +L P F + +
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSK-----GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219
L +I+ S S + N I
Sbjct: 222 LNHILGILGSPSQEDLNCII---------------------------------------- 241
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ K L ++ + + + DL+ K+L P R V++AL H +
Sbjct: 242 ---NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 280 --HPKLFDQDIEPIKKDYKTASRKLSK 304
+ D+ I + L K
Sbjct: 299 EQYYDPSDEPIAEAPFKFDMELDDLPK 325
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-38
Identities = 63/246 (25%), Positives = 89/246 (36%), Gaps = 59/246 (23%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
+ +M QL L+ +H+H VVHRDLKP+NIL+ +KL DFG AR+ L + T
Sbjct: 119 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 178
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 168
Y APEVL + Y VD+W+ G I + P F + L I++
Sbjct: 179 LWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 169 SFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 228
+W R +
Sbjct: 233 LPGEEDWP-----------------------------------------------RDVAL 245
Query: 229 MLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDI 288
+ DI E KDL+ K L P R S AL+H +F QD+
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------QDL 299
Query: 289 EPIKKD 294
E K++
Sbjct: 300 ERCKEN 305
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-37
Identities = 51/242 (21%), Positives = 82/242 (33%), Gaps = 52/242 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ ++ +M+ L L ++H + ++HRD+K N+L+ +KL DFG AR +
Sbjct: 115 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 104 -----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158
+ T Y PE+L YG +D+W G IM + P +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGER-----DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218
L I + S + W ++ Y E L +
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK------------------------ 265
Query: 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
+ + DLI KLL++ P R +ALNH F
Sbjct: 266 ------------------RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 279 FH 280
F
Sbjct: 308 FW 309
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-36
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 3/137 (2%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ ++ + +Q +AL ++H++ ++HRDLK NIL ++KL DFG + + +
Sbjct: 108 TESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167
Query: 104 D-LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
D GTP ++APEV+ +D Y DVW+ G+ + + PP M +L
Sbjct: 168 DSFIGTPYWMAPEVVMCETSKD-RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226
Query: 163 IMEGKYSFSSPEWNDIS 179
I + + + + S
Sbjct: 227 IAKSEPPT-LAQPSRWS 242
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 1e-22
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 2/100 (2%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APEV+ +D Y DVW+ G+ + + PP M +L I + +
Sbjct: 175 YWMAPEVVMCETSKD-RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ + S + KD ++K L + R++ + L H F
Sbjct: 234 T-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
L I RQ + ++++H S++HRDLK NI L + + VK+ DFG A V +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
+ L G+ ++APEV+R +D Y DV+A G+++Y L+ G P+ + +
Sbjct: 162 QFEQLSGSILWMAPEVIR---MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLR 188
++ Y P+ + + + R
Sbjct: 219 IFMVGRGYLS--PDLSKVRSNCPKAMKR 244
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 4e-17
Identities = 21/99 (21%), Positives = 43/99 (43%), Gaps = 5/99 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APEV+R +D Y DV+A G+++Y L+ G P+ + + ++ Y
Sbjct: 171 LWMAPEVIR---MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 240 FSSPE--WNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
++ + K L+ + L ++R + L
Sbjct: 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-36
Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 66/268 (24%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCG 107
+ M QLF +L ++H+ + HRD+KP+N+LLD D +KL DFG A+ L +GE +
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
+ Y APE++ Y ++DVW+ G ++ LL+G P F + L I++
Sbjct: 185 SRYYRAPELIFGAT-----DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
+ + + +++ P + +
Sbjct: 240 GTPTREQIREMN----------------------------------------PNYTEFKF 259
Query: 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH------- 280
++ + ++ + L +LL TP R + EA HSFF
Sbjct: 260 PQIK-----AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
Query: 281 --------PKLFDQDIEPIKKDYKTASR 300
P LF+ + + + A+
Sbjct: 315 KLPNGRDTPALFNFTTQELSSNPPLATI 342
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 2e-35
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 8/136 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ + + L ++H+H+++HRD+K NILL + VKL DFG A ++
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
GTP ++APEV+ A D Y VDVW+ G+ L PP ++ M L +I
Sbjct: 170 SFVGTPYWMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 164 MEGKYSFSSPEWNDIS 179
+ + + + S
Sbjct: 227 AQNES--PALQSGHWS 240
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (254), Expect = 5e-25
Identities = 32/127 (25%), Positives = 55/127 (43%), Gaps = 5/127 (3%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APEV+ A D Y VDVW+ G+ L PP ++ M L +I + +
Sbjct: 176 YWMAPEVILA---MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTAS 299
+ + SE ++ + L P+DR + + L H F + I + + K A
Sbjct: 233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
Query: 300 RKLSKIN 306
R+L +
Sbjct: 291 RELDNLQ 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (328), Expect = 4e-35
Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 8/138 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN--VKLTDFGFARVLKKGEK 101
S MRQ+ + L H+H ++ VH DLKPENI+ + + +KL DFG L +
Sbjct: 122 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
+ GT + APEV G D+W+ GV+ Y LL G PF LR
Sbjct: 182 VKVTTGTAEFAAPEVAEGK------PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235
Query: 162 NIMEGKYSFSSPEWNDIS 179
N+ ++ ++ IS
Sbjct: 236 NVKSCDWNMDDSAFSGIS 253
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 107 bits (267), Expect = 1e-26
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 18/147 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+ APEV G D+W+ GV+ Y LL G PF LRN+ ++
Sbjct: 190 EFAAPEVAEGK------PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH------------PKLFDQD 287
++ ISED KD IRKLL+ P R ++ +AL H + + +
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 288 IEPIKKDYKTASRKLSKINQLTEFQFI 314
+ IK Y L + +++ + +
Sbjct: 304 RDSIKTKYDAWPEPLPPLGRISNYSSL 330
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-35
Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-- 101
R+ ++ ALE++H ++HRDLKPENILL++ M++++TDFG A+VL K
Sbjct: 106 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 102 -LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
GT Y++PE+L ++ D+WA G I+Y L+ G PPF + ++
Sbjct: 166 RANSFVGTAQYVSPELLTEK------SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219
Query: 161 RNIMEGKYSFS---SPEWNDI 178
+ I++ +Y F P+ D+
Sbjct: 220 QKIIKLEYDFPEKFFPKARDL 240
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 9e-24
Identities = 41/240 (17%), Positives = 77/240 (32%), Gaps = 36/240 (15%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFG-------FARVLKKGEKLMDLCGTP 109
+ +V V L VKL F K +L+
Sbjct: 50 NKVPYVTRERDVMSRLDHPFF-------VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 102
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML------RNI 163
G R E + I++ L + + + + +
Sbjct: 103 GSFDETCTRFYTAEIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVL 158
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
+ + + Y++PE+L ++ D+WA G I+Y L+ G PPF
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEK------SACKSSDLWALGCIIYQLVAGLPPFRA 212
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF--HP 281
+ ++ + I++ +Y F +DL+ KLL++ R +E + HP
Sbjct: 213 GNEYLIFQKIIKLEYDF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK-- 101
P + QL + ++H + HRD+KPEN+LLD++ N+K++DFG A V + +
Sbjct: 101 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160
Query: 102 -LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
L +CGT Y+APE+L+ F + + VDVW+CG+++ +L G P+
Sbjct: 161 LLNKMCGTLPYVAPELLKRREF-----HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
Query: 161 RNIMEGKYSFSSPEWNDIS 179
+ + K ++ +P W I
Sbjct: 216 YSDWKEKKTYLNP-WKKID 233
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 7e-23
Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 14/114 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APE+L+ F + + VDVW+CG+++ +L G P+ + + K +
Sbjct: 170 PYVAPELLKRREF-----HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKK 293
+ +P W I P L+ K+L+ P R ++ + +++ +P+KK
Sbjct: 225 YLNP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN--------KPLKK 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 2e-34
Identities = 40/242 (16%), Positives = 98/242 (40%), Gaps = 50/242 (20%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKL 102
++ +R+ M ++ +AL++ H+ ++HRD+KP N+++D + ++L D+G A G++
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW----HRKQMV 158
+ + PE + D Y ++D+W+ G ++ +++ PF+ + Q+V
Sbjct: 187 NVRVASRYFKGPE-----LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218
+ ++ + + + +I
Sbjct: 242 RIAKVLGTEDLYDYIDKYNI---------------------------------------- 261
Query: 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
++ + + S + +S + D + KLL + R + +EA+ H +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 279 FH 280
F+
Sbjct: 322 FY 323
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-34
Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD--DQMNVKLTDFGFARVLKKGEK 101
+ + + Q+ EAL+ +H+H++ H D++PENI+ +K+ +FG AR LK G+
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
L P Y APEV + + A D+W+ G ++Y LL G PF ++
Sbjct: 160 FRLLFTAPEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 162 NIMEGKYSFSSPEWNDIS 179
NIM +Y+F + +IS
Sbjct: 214 NIMNAEYTFDEEAFKEIS 231
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-27
Identities = 28/117 (23%), Positives = 52/117 (44%), Gaps = 3/117 (2%)
Query: 197 GYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLI 256
A D+W+ G ++Y LL G PF ++ NIM +Y+F + +IS + D +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 257 RKLLIVTPEDRYSVKEALNHSFFH---PKLFDQDIEPIKKDYKTASRKLSKINQLTE 310
+LL+ + R + EAL H + ++ + I +K + +N +
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (321), Expect = 5e-34
Identities = 46/138 (33%), Positives = 68/138 (49%), Gaps = 8/138 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN--VKLTDFGFARVLKKGEK 101
S + MRQ E L+H+H HS+VH D+KPENI+ + + VK+ DFG A L E
Sbjct: 125 SEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
+ T + APE++ G D+WA GV+ Y LL G PF + L+
Sbjct: 185 VKVTTATAEFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238
Query: 162 NIMEGKYSFSSPEWNDIS 179
N+ + F ++ +S
Sbjct: 239 NVKRCDWEFDEDAFSSVS 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 100 bits (250), Expect = 3e-24
Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 17/144 (11%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+ APE++ G D+WA GV+ Y LL G PF + L+N+ +
Sbjct: 193 EFAAPEIVDRE------PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF---HPKL--------FDQDI 288
F ++ +S + KD I+ LL P R +V +AL H + H L +++
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIR 306
Query: 289 EPIKKDYKTASRKLSKINQLTEFQ 312
+ IK+ Y I ++ F
Sbjct: 307 QKIKEKYADWPAPQPAIGRIANFS 330
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 7e-34
Identities = 48/140 (34%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 44 SNPALRYIMRQLFEALEHVH-----NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
+ +M QL AL+ H H+V+HRDLKP N+ LD + NVKL DFG AR+L
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 99 GEKLM-DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157
GTP Y++PE + Y + D+W+ G ++Y L PPF Q
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220
Query: 158 VMLRNIMEGKYSFSSPEWND 177
+ I EGK+ ++D
Sbjct: 221 ELAGKIREGKFRRIPYRYSD 240
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 2e-20
Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 9/99 (9%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y++PE + Y + D+W+ G ++Y L PPF Q + I EGK+
Sbjct: 179 YYMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 231
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSF 278
S++ ++I ++L + R SV+E L +
Sbjct: 232 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (313), Expect = 1e-33
Identities = 50/237 (21%), Positives = 87/237 (36%), Gaps = 51/237 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKL 102
+ + + QL + + H+ V+HRDLKP+N+L++ + +K+ DFG AR K
Sbjct: 98 ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
T Y AP+VL + Y +D+W+ G I ++ G P F + L
Sbjct: 158 THEIVTLWYRAPDVLMGSK-----KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222
I + +S W +++
Sbjct: 213 IFRILGTPNSKNWPNVT------------------------------------------- 229
Query: 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
+ N + + E DL+ K+L + P R + K+AL H++F
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 53/276 (19%), Positives = 101/276 (36%), Gaps = 38/276 (13%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
E +L +++D V + + + Y++ Q+ ++H+H+ ++HRDLKP NI+
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACG 138
+ +K+ DFG AR + T Y APEV+ GY + VD+W+ G
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM------GYKENVDIWSVG 205
Query: 139 VIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGY 198
IM ++ F R + ++E +
Sbjct: 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK--------------------- 244
Query: 199 GQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRK 258
+ T+ + + + + S + +DL+ K
Sbjct: 245 -----------LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293
Query: 259 LLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKD 294
+L++ P R SV +AL H + + ++E
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-33
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 12/136 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHS--VVHRDLKPENILLDDQ-MNVKLTDFGFARVLKKGE 100
LR RQ+ + L+ +H + ++HRDLK +NI + +VK+ D G A LK+
Sbjct: 110 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRAS 168
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM-VM 159
+ GTP ++APE+ Y ++VDV+A G+ M + P+ + +
Sbjct: 169 FAKAVIGTPEFMAPEMYE-------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221
Query: 160 LRNIMEGKYSFSSPEW 175
R + G S +
Sbjct: 222 YRRVTSGVKPASFDKV 237
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (224), Expect = 3e-21
Identities = 25/101 (24%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM-VMLRNIMEGKY 238
++APE+ Y ++VDV+A G+ M + P+ + + R + G
Sbjct: 178 EFMAPEMYE-------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
S + + K++I + ++RYS+K+ LNH+FF
Sbjct: 231 PASFDKV--AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 5e-33
Identities = 54/252 (21%), Positives = 99/252 (39%), Gaps = 51/252 (20%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+++++ Q+ + L ++H ++HRDLKP N+ +++ +K+ DFG AR ++
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMT 176
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
T Y APEV+ M Y Q VD+W+ G IM ++ G F + L+ I
Sbjct: 177 GYVVTRWYRAPEVILNWM-----RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 164 MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223
M+ + + + A
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKN-------------------------------------- 253
Query: 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283
++ + E + + + S +L+ K+L++ E R + EAL H +F L
Sbjct: 254 -----YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES-L 307
Query: 284 FDQDIEPIKKDY 295
D + EP + Y
Sbjct: 308 HDTEDEPQVQKY 319
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-33
Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 8/135 (5%)
Query: 43 NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLK-KGEK 101
+ + R+ +ALE +H++ V+HRD+K +NILL +VKLTDFGF + + K
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVML 160
+ GTP ++APEV+ YG VD+W+ G++ ++ G PP+ +
Sbjct: 173 RSTMVGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 161 RNIMEGKYSFSSPEW 175
G +PE
Sbjct: 227 LIATNGTPELQNPEK 241
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 1e-22
Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQMVMLRNIMEGKY 238
++APEV+ YG VD+W+ G++ ++ G PP+ + G
Sbjct: 181 YWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKDYKTA 298
+PE +S +D + + L + E R S KE L H F + P+ K A
Sbjct: 235 ELQNPEK--LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
Query: 299 S 299
+
Sbjct: 293 T 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 7e-33
Identities = 58/238 (24%), Positives = 85/238 (35%), Gaps = 51/238 (21%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-KKGEKL 102
P ++ + QL + L H+H V+HRDLKP+N+L++ + +KL DFG AR
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
T Y APE+L + Y AVD+W+ G I ++ F ++ L
Sbjct: 160 THEVVTLWYRAPEILLGCKY-----YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222
I + W GV P W
Sbjct: 215 IFRTLGTPDEVVWP-------------------------------GVTSMPDYKPSFPKW 243
Query: 223 HRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
R+ S + ED + L+ ++L P R S K AL H FF
Sbjct: 244 ARQDF--------------SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-32
Identities = 51/234 (21%), Positives = 85/234 (36%), Gaps = 52/234 (22%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-DLC 106
++ + QL + L H+ +V+HRDLKP+N+L++ +KL +FG AR +
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVMLRNIME 165
T Y P+VL Y ++D+W+ G I L P F L+ I
Sbjct: 163 VTLWYRPPDVLFGAKL-----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
Query: 166 GKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225
+ + +W ++ L P+
Sbjct: 218 LLGTPTEEQWPSMTK----------------------------------LPDYKPYPMYP 243
Query: 226 QMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279
L N+ ++ +DL++ LL P R S +EAL H +F
Sbjct: 244 ATTSLVNV-----------VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 3e-32
Identities = 54/139 (38%), Positives = 82/139 (58%), Gaps = 9/139 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL---DDQMNVKLTDFGFARVLKKGE 100
+ ++ Q+ +A++++H+ +VHRDLKPEN+L D+ + ++DFG +++ G
Sbjct: 105 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
L CGTPGY+APEVL Y +AVD W+ GVI Y LL G PPF+ +
Sbjct: 165 VLSTACGTPGYVAPEVLAQK------PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 161 RNIMEGKYSFSSPEWNDIS 179
I++ +Y F SP W+DIS
Sbjct: 219 EQILKAEYEFDSPYWDDIS 237
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 9e-27
Identities = 47/135 (34%), Positives = 65/135 (48%), Gaps = 11/135 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GY+APEVL Y +AVD W+ GVI Y LL G PPF+ + I++ +Y
Sbjct: 174 GYVAPEVLAQK------PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH-----PKLFDQDIEPIKKD 294
F SP W+DIS+ KD IR L+ PE R++ ++AL H + K Q + K
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287
Query: 295 YKTASRKLSKINQLT 309
S+ N
Sbjct: 288 NFAKSKWKQAFNATA 302
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-32
Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 51/244 (20%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCG 107
+++++ Q+ L+++H+ ++HRDLKP N+ +++ +K+ DFG AR +++
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVA 180
Query: 108 TPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 167
T Y APE++ + Y Q VD+W+ G IM LL G F + L+ I+
Sbjct: 181 TRWYRAPEIML-----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 168 YSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227
+ + IS A
Sbjct: 236 GTPGAELLKKISSESARN------------------------------------------ 253
Query: 228 VMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287
++++ + + + + DL+ K+L++ + R + +AL H++F + D D
Sbjct: 254 -YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA-QYHDPD 311
Query: 288 IEPI 291
EP+
Sbjct: 312 DEPV 315
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (300), Expect = 2e-31
Identities = 47/139 (33%), Positives = 79/139 (56%), Gaps = 11/139 (7%)
Query: 43 NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
NP ++ ++ ALE++H+ +++RDLKPENILLD ++K+TDFGFA+ + +
Sbjct: 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVT 158
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
LCGTP Y+APEV+ Y +++D W+ G+++Y +L G PF+ M
Sbjct: 159 YTLCGTPDYIAPEVVSTK------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212
Query: 163 IMEGKYSFS---SPEWNDI 178
I+ + F + + D+
Sbjct: 213 ILNAELRFPPFFNEDVKDL 231
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.4 bits (221), Expect = 1e-20
Identities = 31/120 (25%), Positives = 53/120 (44%), Gaps = 19/120 (15%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APEV+ Y +++D W+ G+++Y +L G PF+ M I+ +
Sbjct: 166 DYIAPEVVSTK------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----KLFDQDIEP 290
F +ED KDL+ +L+ R ++ NH +F KL ++IE
Sbjct: 220 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIET 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 54/143 (37%), Positives = 81/143 (56%), Gaps = 13/143 (9%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMN---VKLTDFGFARVLKKGE 100
+ IM+ + EA++++H+ ++ HRD+KPEN+L + +KLTDFGFA+
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV-- 158
L C TP Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222
Query: 159 --MLRNIMEGKYSFSSPEWNDIS 179
M I G+Y F +PEW+++S
Sbjct: 223 PGMKTRIRMGQYEFPNPEWSEVS 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 7e-23
Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV----MLRNIME 235
Y+APEVL Y ++ D+W+ GVIMY LL G PPF+ + M I
Sbjct: 178 YYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231
Query: 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF--HPKLFDQDIEPIKK 293
G+Y F +PEW+++SE+ K LIR LL P R ++ E +NH + K+ + +
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
Query: 294 DYKTASRKLSKINQLTEFQFIILVVRAAVRISRLKYNHVPAL 335
+ R ++T + V ++I +++ P L
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLL 333
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-30
Identities = 50/144 (34%), Positives = 80/144 (55%), Gaps = 10/144 (6%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVL-K 97
++ + + R+ ++ ALE++H+ VV+RD+K EN++LD ++K+TDFG +
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 98 KGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157
G + CGTP YLAPEVL N YG+AVD W GV+MY ++ G PF+++
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDN------DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 158 VMLRNIMEGKYSFS---SPEWNDI 178
+ I+ + F SPE +
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKSL 235
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (196), Expect = 3e-17
Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 13/112 (11%)
Query: 188 RANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 247
A + YG+AVD W GV+MY ++ G PF+++ + I+ + F
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRT 227
Query: 248 ISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHP----KLFDQDIEP 290
+S + K L+ LL P+ R KE + H FF + + + P
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 6e-30
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQ----MNVKLTDFGFARVLKKGEKLM 103
++Q+ + ++H+ + H DLKPENI+L D+ +K+ DFG A + G +
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
++ GTP ++APE++ G D+W+ GVI Y LL G PF + L N+
Sbjct: 175 NIFGTPEFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 164 MEGKYSFSSPEWNDIS 179
Y F +++ S
Sbjct: 229 SAVNYEFEDEYFSNTS 244
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 5e-26
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 6/111 (5%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
++APE++ G D+W+ GVI Y LL G PF + L N+ Y
Sbjct: 181 EFVAPEIVNYE------PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEP 290
F +++ S KD IR+LL+ P+ R +++++L H + PK Q +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 3e-28
Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 9 HSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPAL-----RYIMRQLFEALEHVH 63
+ + ++L + + I S + ++ L+ +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD-LCGTPGYLAPEVLRANMF 122
+ +V+RDLK +NILLD ++K+ DFG + G+ + CGTP Y+APE+L
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-- 178
Query: 123 EDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS---SPEWNDI 178
Y +VD W+ GV++Y +L+G PF + + + +I + E D+
Sbjct: 179 ----KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.3 bits (213), Expect = 2e-19
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 15/116 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y+APE+L Y +VD W+ GV++Y +L+G PF + + + +I
Sbjct: 168 DYIAPEILLGQ------KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK-EALNHSFFHP----KLFDQDIEP 290
+ P W + ++ KDL+ KL + PE R V+ + H F +L ++I+P
Sbjct: 222 Y--PRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (278), Expect = 4e-28
Identities = 51/138 (36%), Positives = 80/138 (57%), Gaps = 11/138 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S P R+ Q+ E++H+ +++RDLKPEN+L+D Q +++TDFGFA+ +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW 196
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 163
LCGTP LAPE++ + GY +AVD WA GV++Y + G PPF+ + + + I
Sbjct: 197 TLCGTPEALAPEIILSK------GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 164 MEGKYSFS---SPEWNDI 178
+ GK F S + D+
Sbjct: 251 VSGKVRFPSHFSSDLKDL 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.5 bits (203), Expect = 5e-18
Identities = 46/248 (18%), Positives = 90/248 (36%), Gaps = 32/248 (12%)
Query: 57 EALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEV 116
+ +EH N + + + ++ + ++ G ++ G +
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 117 LRANMFEDATGYGQAVDVWACGVI-----MYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 171
R + + + +I LL+ + + + ++
Sbjct: 143 ARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199
Query: 172 SPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231
LAPE++ + GY +AVD WA GV++Y + G PPF+ + + +
Sbjct: 200 GTPE-----ALAPEIILSK------GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHP----K 282
I+ GK F + S D KDL+R LL V R+ V + NH +F
Sbjct: 249 KIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 283 LFDQDIEP 290
++ + +E
Sbjct: 305 IYQRKVEA 312
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-28
Identities = 41/127 (32%), Positives = 68/127 (53%), Gaps = 7/127 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD-DQMNVKLTDFGFARVLKKGEKL 102
R Q+ EA+ H HN V+HRD+K ENIL+D ++ +KL DFG +L K
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY 166
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
D GT Y PE +R + + +G++ VW+ G+++Y ++ G PF H ++++ +
Sbjct: 167 TDFDGTRVYSPPEWIRYHRY-----HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 221
Query: 163 IMEGKYS 169
+ S
Sbjct: 222 FFRQRVS 228
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.5 bits (211), Expect = 2e-19
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 15/112 (13%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
Y PE +R + + +G++ VW+ G+++Y ++ G PF H + I+ G+
Sbjct: 174 VYSPPEWIRYHRY-----HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF 222
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPI 291
F +S + + LIR L + P DR + +E NH + L Q+ I
Sbjct: 223 FRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 14/179 (7%)
Query: 1 MEKGEMVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALE 60
G+++ + +R K E + + + E + + L Q+ + +E
Sbjct: 123 CCYGDLLNY----LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178
Query: 61 HVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVL 117
+ S VHRDL N+L+ VK+ DFG AR + + ++APE L
Sbjct: 179 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 118 RANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 175
Y DVW+ G++++ + +G P+ +++ + P +
Sbjct: 239 FEG------IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY 291
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 3e-12
Identities = 18/117 (15%), Positives = 40/117 (34%), Gaps = 9/117 (7%)
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCP 219
R+IM ++APE L Y DVW+ G++++ + +G
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEG------IYTIKSDVWSYGILLWEIFSLGVN 265
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
P+ +++ + P + +E+ +++ R S +
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (275), Expect = 1e-27
Identities = 44/134 (32%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL 105
+R+ ++ LEH+HN VV+RDLKP NILLD+ +V+++D G A K K
Sbjct: 107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS 165
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 165
GT GY+APEVL+ + Y + D ++ G +++ LL G PF K I
Sbjct: 166 VGTHGYMAPEVLQKGV-----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR 219
Query: 166 GKYSFSSPEWNDIS 179
+ + + S
Sbjct: 220 MTLTMAVELPDSFS 233
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.2 bits (192), Expect = 2e-16
Identities = 28/120 (23%), Positives = 45/120 (37%), Gaps = 15/120 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
GY+APEVL+ + Y + D ++ G +++ LL G PF K I +
Sbjct: 170 GYMAPEVLQKGV-----AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT 223
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSV-----KEALNHSFFHP----KLFDQDIEP 290
+ + S + + L+ LL R +E FF +F Q P
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 2e-27
Identities = 29/136 (21%), Positives = 58/136 (42%), Gaps = 1/136 (0%)
Query: 43 NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
+ L ++R + ++++ + + VHRDL NIL++ + K++DFG +R L+
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 103 MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLR 161
G P A + A DVW+ G++M+ ++ G P+W ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 162 NIMEGKYSFSSPEWND 177
I + +
Sbjct: 245 AIEQDYRLPPPMDCPS 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.8 bits (157), Expect = 3e-12
Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 4/107 (3%)
Query: 171 SSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 229
S P + G P A + A DVW+ G++M+ ++ G P+W +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 230 LRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ I + + P D L+ R + +N
Sbjct: 243 INAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-27
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--KLM 103
P L + Q+ + +V + VHRDL+ NIL+ + + K+ DFG AR+++ E
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRN 162
+ APE + DVW+ G+++ L G P+ +L
Sbjct: 173 GAKFPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226
Query: 163 IMEGKYSFSSPEWND 177
+ G PE +
Sbjct: 227 VERGYRMPCPPECPE 241
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.3 bits (156), Expect = 4e-12
Identities = 20/103 (19%), Positives = 37/103 (35%), Gaps = 12/103 (11%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
+ APE + DVW+ G+++ L G P+ +L + G
Sbjct: 179 KWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-- 230
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFF 279
+ P + E DL+ + PE+R + + +F
Sbjct: 231 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 106 bits (266), Expect = 4e-27
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
+ ++ +AL H + ++HRD+KP NI++ VK+ DFG AR +
Sbjct: 109 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168
Query: 101 -KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
+ + GT YL+PE R + DV++ G ++Y +L G PPF + +
Sbjct: 169 TQTAAVIGTAQYLSPEQARGD------SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRA 189
+ S +S L VL+A
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKA 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.6 bits (211), Expect = 2e-19
Identities = 33/181 (18%), Positives = 62/181 (34%), Gaps = 9/181 (4%)
Query: 99 GEKLMDLCGTPGYLAPEVLRANMFEDATG--YGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156
G L D+ T G + P+ + + + + V +++
Sbjct: 95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 154
Query: 157 MVMLRNIMEGKYSFSSPEWNDIS-GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 215
+ R I + S + + YL+PE R + DV++ G ++Y +L
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD------SVDARSDVYSLGCVLYEVL 208
Query: 216 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
G PPF + + + S +S D ++ K L PE+RY +
Sbjct: 209 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
Query: 276 H 276
Sbjct: 269 A 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-26
Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL-- 105
+ ++ Q+ ++++ + VHRDL N+LL ++ K++DFG ++ L +
Sbjct: 111 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 106 --CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRN 162
+ APE + + DVW+ GV M+ L G P+ K ++
Sbjct: 171 AGKWPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224
Query: 163 IMEGKYSFSSPEWND 177
I +GK PE
Sbjct: 225 IEQGKRMECPPECPP 239
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 2e-12
Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 13/104 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKY 238
+ APE + + DVW+ GV M+ L G P+ K ++ I +GK
Sbjct: 177 KWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 230
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFF 279
+ + L+ I EDR V++ + ++
Sbjct: 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 2e-26
Identities = 51/260 (19%), Positives = 102/260 (39%), Gaps = 42/260 (16%)
Query: 48 LRYIMRQLFEALEHVH-NHSVVHRDLKPENILLD------DQMNVKLTDFGFARVLKKGE 100
++ I +QL L+++H ++H D+KPEN+L++ + + +K+ D G A E
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--E 184
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160
+ T Y +PEVL +G D+W+ +++ L+ G F +
Sbjct: 185 HYTNSIQTREYRSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220
++ ++ G L +LR + + G
Sbjct: 239 KDDDHIAQII------ELLGELPSYLLRNGKYTRT----------------FFNSRGLLR 276
Query: 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280
+ + L +++ KY FS D +++ D + +L + P R +NH +
Sbjct: 277 NISKLKFWPLEDVLTEKYKFSK----DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
Query: 281 PKLFDQDIE-PIKKDYKTAS 299
L ++I P ++ Y + S
Sbjct: 333 DTLGMEEIRVPDRELYGSGS 352
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 3e-26
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 10/136 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S I RQ+ + ++ VHRDL N L+ + M VK+ DFG +R + +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 104 ---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVM 159
+ ++ PE + N Y DVWA GV+++ + G P++ +
Sbjct: 198 ADGNDAIPIRWMPPESIFYNR------YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 160 LRNIMEGKYSFSSPEW 175
+ + +G
Sbjct: 252 IYYVRDGNILACPENC 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.5 bits (143), Expect = 2e-10
Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 10/115 (8%)
Query: 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCP 219
RNI Y + ++ PE + N Y DVWA GV+++ + G
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNR------YTTESDVWAYGVVLWEIFSYGLQ 241
Query: 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
P++ ++ + +G + + +L+R P DR S
Sbjct: 242 PYYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 9e-26
Identities = 29/139 (20%), Positives = 56/139 (40%), Gaps = 11/139 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
+ + ++ Q+ ++++ + VHRDL N+LL Q K++DFG ++ L+ E
Sbjct: 105 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 104 D----LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMV 158
+ APE + + DVW+ GV+M+ G P+ K
Sbjct: 165 KAQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 159 MLRNIMEGKYSFSSPEWND 177
+ + +G+
Sbjct: 219 VTAMLEKGERMGCPAGCPR 237
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (164), Expect = 2e-13
Identities = 19/104 (18%), Positives = 37/104 (35%), Gaps = 13/104 (12%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKY 238
+ APE + + DVW+ GV+M+ G P+ K + + +G+
Sbjct: 175 KWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS---VKEALNHSFF 279
+ DL+ E+R V+ L + ++
Sbjct: 229 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-25
Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 11/136 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
L Q+ E + ++ + +HRDL N+LL + VK+ DFG R L + +
Sbjct: 109 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 104 DL----CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 158
+ + APE L+ + A D W GV ++ + G P+
Sbjct: 169 VMQEHRKVPFAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
Query: 159 MLRNIMEGKYSFSSPE 174
+L I + PE
Sbjct: 223 ILHKIDKEGERLPRPE 238
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 2e-12
Identities = 21/98 (21%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
+ APE L+ + A D W GV ++ + G P+ +L I +
Sbjct: 179 AWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
PE D +D +++ + PEDR + +
Sbjct: 233 RLPRPE--DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (256), Expect = 1e-25
Identities = 34/194 (17%), Positives = 64/194 (32%), Gaps = 27/194 (13%)
Query: 5 EMVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIINSNPAL-----RYIMRQLFEAL 59
+++A + V G + H + G + + +Q+ +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 60 EHVHNHSVVHRDLKPENILLDDQM-----NVKLTDFGFARVLKKGE--------KLMDLC 106
+ +H S+V+RD+KP+N L+ + + DFG + + + +L
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 107 GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNI 163
GT Y++ + D+ A G + L G P+ K I
Sbjct: 175 GTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 164 MEGKYSFSSPEWND 177
E K S E
Sbjct: 229 GEKKQSTPLRELCA 242
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 32/166 (19%), Positives = 63/166 (37%), Gaps = 12/166 (7%)
Query: 18 EEGDDLKHLAAQVVDKGEAAVQDIINSNPAL-----RYIMRQLFEALEHVHNHSVVHRDL 72
G+ L L V + + A ++ L + + ++++ +HRDL
Sbjct: 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 153
Query: 73 KPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAV 132
NIL+ + K+ DFG +R + K ++A E L + Y
Sbjct: 154 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS------VYTTNS 207
Query: 133 DVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
DVW+ GV+++ ++ G P+ + + +G +D
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 2e-11
Identities = 19/98 (19%), Positives = 41/98 (41%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
++A E L + Y DVW+ GV+++ ++ G P+ + + +G
Sbjct: 191 RWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 242
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ + + ++ DL+R+ P +R S + L
Sbjct: 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-25
Identities = 27/125 (21%), Positives = 53/125 (42%), Gaps = 9/125 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
L + EA+E++ ++ VHRDL N+L+ + K++DFG + +
Sbjct: 101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRN 162
+ APE LR + DVW+ G++++ + G P+ ++
Sbjct: 161 --KLPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
Query: 163 IMEGK 167
+ +G
Sbjct: 213 VEKGY 217
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.5 bits (167), Expect = 1e-13
Identities = 14/98 (14%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKY 238
+ APE LR + DVW+ G++++ + G P+ ++ + +G
Sbjct: 165 KWTAPEALREK------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-- 216
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ + ++++ + R S +
Sbjct: 217 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-25
Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 9/137 (6%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--K 101
L + + + EA+E++ + +HRDL N L++DQ VK++DFG +R + E
Sbjct: 98 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157
Query: 102 LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVML 160
+ + PEVL + + D+WA GV+M+ + +G P+
Sbjct: 158 SVGSKFPVRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
Query: 161 RNIMEGKYSFSSPEWND 177
+I +G + ++
Sbjct: 212 EHIAQGLRLYRPHLASE 228
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 8e-13
Identities = 19/98 (19%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKY 238
+ PEVL + + D+WA GV+M+ + +G P+ +I +G
Sbjct: 166 RWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 219
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ SE ++ ++R + K L++
Sbjct: 220 L---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 9/152 (5%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDL-- 105
+ E + ++ HRDLK +NIL+ + D G A +D+
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 106 ---CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 162
GT Y+APEVL ++ + D++A G++ + + C + +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 163 IMEGKYSFSSPEWNDISGYLAPEVLRANMFED 194
+ S P ++ + + LR N+
Sbjct: 230 DL----VPSDPSVEEMRKVVCEQKLRPNIPNR 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 17/113 (15%), Positives = 36/113 (31%), Gaps = 18/113 (15%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM------------ 227
Y+APEVL ++ + D++A G++ + + C +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 228 ---VMLRNIMEGKYSFSSPEWNDISEDPK---DLIRKLLIVTPEDRYSVKEAL 274
M + + E K + P E + ++R+ R +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-24
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 43 NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKL 102
+ L Q+ + + ++ + +VHRDL N+L+ +VK+TDFG A++L EK
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 103 MDLC---GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159
++A E + Y DVW+ GV ++ L+ +
Sbjct: 168 YHAEGGKVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
Query: 160 LRNIMEGKYSFSSPEW 175
+ +I+E P
Sbjct: 222 ISSILEKGERLPQPPI 237
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 1e-10
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKY 238
++A E + Y DVW+ GV ++ L+ G P+ + + +G+
Sbjct: 178 KWMALESILHR------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
P+ + D ++ K ++ + R +E +
Sbjct: 232 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 1e-24
Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 9/142 (6%)
Query: 39 QDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKK 98
Q + + L + + E + ++ V+HRDL N L+ + +K++DFG R +
Sbjct: 94 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153
Query: 99 GE--KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155
+ + +PEV + Y DVW+ GV+M+ + G P+ +R
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 156 QMVMLRNIMEGKYSFSSPEWND 177
++ +I G + +
Sbjct: 208 NSEVVEDISTGFRLYKPRLAST 229
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.5 bits (159), Expect = 9e-13
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
+ +PEV + Y DVW+ GV+M+ + G P+ +R ++ +I G
Sbjct: 167 KWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-- 218
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
F + S ++ PEDR + L
Sbjct: 219 -FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 2e-24
Identities = 29/133 (21%), Positives = 58/133 (43%), Gaps = 9/133 (6%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD--L 105
L + Q+ E + + + +HRDL+ NIL+ D ++ K+ DFG AR+++ E
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 106 CGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIM 164
+ APE + + DVW+ G+++ ++ G P+ +++N+
Sbjct: 171 KFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 165 EGKYSFSSPEWND 177
G +
Sbjct: 225 RGYRMVRPDNCPE 237
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.9 bits (142), Expect = 2e-10
Identities = 20/103 (19%), Positives = 41/103 (39%), Gaps = 12/103 (11%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
+ APE + + DVW+ G+++ ++ G P+ +++N+ G
Sbjct: 175 KWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-- 226
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFF 279
+ ++ E+ L+R PEDR + + FF
Sbjct: 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 2e-24
Identities = 33/134 (24%), Positives = 57/134 (42%), Gaps = 8/134 (5%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S L Y+ Q+ A+E++ + +HRDL N L+ + VK+ DFG +R++
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 104 D--LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 161
+ APE L N + DVWA GV+++ + + + +
Sbjct: 173 HAGAKFPIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 162 NIMEGKYSFSSPEW 175
++E Y PE
Sbjct: 227 ELLEKDYRMERPEG 240
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.8 bits (152), Expect = 1e-11
Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 10/112 (8%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239
+ APE L N + DVWA GV+++ + + + + ++E Y
Sbjct: 181 KWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234
Query: 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFFHPKLFDQDIE 289
PE E +L+R P DR S E + F ++E
Sbjct: 235 MERPE--GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 4e-24
Identities = 33/137 (24%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
S L ++R + ++++ N + VHRDL NIL++ + K++DFG +RVL+ +
Sbjct: 108 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 104 ----DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMV 158
+ APE + + A DVW+ G++M+ ++ G P+W
Sbjct: 168 YTTSGGKIPIRWTAPEAISYR------KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 159 MLRNIMEGKYSFSSPEW 175
+++ I +G + +
Sbjct: 222 VMKAINDGFRLPTPMDC 238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 4e-11
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 10/97 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
+ APE + + A DVW+ G++M+ ++ G P+W +++ I +G
Sbjct: 178 RWTAPEAISYR------KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-- 229
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
F P D L+ + R + ++
Sbjct: 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-23
Identities = 36/135 (26%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 46 PALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM-- 103
+L QL AL ++ + VHRD+ N+L+ VKL DFG +R ++
Sbjct: 108 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167
Query: 104 DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRN 162
++APE + + A DVW GV M+ +L+ G PF K ++
Sbjct: 168 KGKLPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
Query: 163 IMEGKYSFSSPEWND 177
I G+ P
Sbjct: 222 IENGERLPMPPNCPP 236
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 1e-11
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKY 238
++APE + + A DVW GV M+ +L+ G PF K ++ I G+
Sbjct: 174 KWMAPESINFR------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
P + L+ K P R E
Sbjct: 228 L---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-22
Identities = 31/136 (22%), Positives = 57/136 (41%), Gaps = 12/136 (8%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLC- 106
L Q+ + ++ + + VHRDL N +LD++ VK+ DFG AR + E
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 107 ----GTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVMLR 161
++A E L+ + DVW+ GV+++ L+ PP+ +
Sbjct: 192 TGAKLPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 162 NIMEGKYSFSSPEWND 177
+++G+ D
Sbjct: 246 YLLQGRRLLQPEYCPD 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (151), Expect = 2e-11
Identities = 17/98 (17%), Positives = 39/98 (39%), Gaps = 10/98 (10%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVMLRNIMEGKY 238
++A E L+ + DVW+ GV+++ L+ PP+ + +++G+
Sbjct: 199 KWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276
+ + +++ K E R S E ++
Sbjct: 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 5e-22
Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLM 103
L Q+ + + + + + +HRDL NILL K+ DFG AR +K +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 104 ---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159
+ ++APE + + Y DVW+ G+ ++ L +G P+
Sbjct: 203 VKGNARLPVKWMAPESIFNCV------YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 160 LRNIMEGKYSFSSPEW 175
+++ + SPE
Sbjct: 257 FYKMIKEGFRMLSPEH 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 20/119 (16%), Positives = 43/119 (36%), Gaps = 9/119 (7%)
Query: 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL- 215
+ R+I ++APE + + Y DVW+ G+ ++ L
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV------YTFESDVWSYGIFLWELFS 242
Query: 216 VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEAL 274
+G P+ +++ + SPE + D+++ P R + K+ +
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPE--HAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 1e-21
Identities = 32/132 (24%), Positives = 57/132 (43%), Gaps = 10/132 (7%)
Query: 48 LRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMD 104
L Q+ + +E + + +HRDL NILL ++ VK+ DFG AR + K + D
Sbjct: 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 105 LCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVMLRNI 163
++APE + Y DVW+ GV+++ + P+ K
Sbjct: 196 ARLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 164 MEGKYSFSSPEW 175
++ +P++
Sbjct: 250 LKEGTRMRAPDY 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 2e-09
Identities = 17/121 (14%), Positives = 40/121 (33%), Gaps = 3/121 (2%)
Query: 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 216
+V + + + + P++ P A Y DVW+ GV+++ +
Sbjct: 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
Query: 217 GC-PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275
P+ K ++ +P++ + + + P R + E +
Sbjct: 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 276 H 276
H
Sbjct: 290 H 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.2 bits (228), Expect = 1e-21
Identities = 29/197 (14%), Positives = 66/197 (33%), Gaps = 22/197 (11%)
Query: 6 MVAHSRVVVRVK--EEGDDLKHLAAQVVDKGEAAVQDIIN---SNPALRYIMRQLFEALE 60
M+ + ++ D + +++ + + + S + + Q+ +E
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 61 HVHNHSVVHRDLKPENIL---LDDQMNVKLTDFGFARVLKKGE--------KLMDLCGTP 109
++H+ + +HRD+KP+N L V + DFG A+ + + +L GT
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 110 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 169
Y + + D+ + G ++ +G P+ K +
Sbjct: 178 RYASINTHLGI------EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 170 FSSPEWNDISGYLAPEV 186
S + E
Sbjct: 232 KMSTPIEVLCKGYPSEF 248
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 1e-20
Identities = 31/138 (22%), Positives = 59/138 (42%), Gaps = 10/138 (7%)
Query: 44 SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE--- 100
S+ L Q+ +E++ + +HRDL N+L+ + +K+ DFG AR + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 101 KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL-VGCPPFWHRKQMVM 159
K + ++APE L Y DVW+ GV+++ + +G P+ +
Sbjct: 193 KTTNGRLPVKWMAPEALFDR------IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 160 LRNIMEGKYSFSSPEWND 177
+ + EG +
Sbjct: 247 FKLLKEGHRMDKPSNCTN 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 3e-12
Identities = 23/133 (17%), Positives = 48/133 (36%), Gaps = 10/133 (7%)
Query: 145 LVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDV 204
LV + R+I Y + ++APE L Y DV
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR------IYTHQSDV 220
Query: 205 WACGVIMYTLL-VGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVT 263
W+ GV+++ + +G P+ + + + EG + ++ + + ++R
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAV 277
Query: 264 PEDRYSVKEALNH 276
P R + K+ +
Sbjct: 278 PSQRPTFKQLVED 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 4e-20
Identities = 46/253 (18%), Positives = 83/253 (32%), Gaps = 21/253 (8%)
Query: 52 MRQLFEALEHVHNHSVVHRDLK-PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPG 110
+ Q + EH V ++ ++ T G +L
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 111 YLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM----LRNIMEG 166
++ + E G+I + + +V+ L
Sbjct: 125 RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181
Query: 167 KYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226
+ + ++ Y+AP+++R +G+ +AVD W+ GV+MY LL G PF +
Sbjct: 182 DETERAYDFCGTIEYMAPDIVRGGD----SGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237
Query: 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHP 281
I P ++S KDLI++LL+ P+ R E H FF
Sbjct: 238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
Query: 282 ----KLFDQDIEP 290
L + +
Sbjct: 298 INWDDLAAKKVPA 310
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 4e-19
Identities = 31/163 (19%), Positives = 62/163 (38%), Gaps = 10/163 (6%)
Query: 19 EGDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78
DLK + S + + ++ + + +++ + VHRDL N +
Sbjct: 106 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165
Query: 79 LDDQMNVKLTDFGFARVLKKGEKLM---DLCGTPGYLAPEVLRANMFEDATGYGQAVDVW 135
+ + VK+ DFG R + + + +++PE L+ + DVW
Sbjct: 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG------VFTTYSDVW 219
Query: 136 ACGVIMYTLLVGC-PPFWHRKQMVMLRNIMEGKYSFSSPEWND 177
+ GV+++ + P+ +LR +MEG D
Sbjct: 220 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (136), Expect = 1e-09
Identities = 22/116 (18%), Positives = 49/116 (42%), Gaps = 17/116 (14%)
Query: 180 GYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVMLRNIMEGKY 238
+++PE L+ + DVW+ GV+++ + P+ +LR +MEG
Sbjct: 200 RWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQDIEPIKKD 294
+ ++ + +L+R P+ R S E ++ +++EP ++
Sbjct: 254 L---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS-------IKEEMEPGFRE 299
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.0 bits (147), Expect = 1e-11
Identities = 13/87 (14%), Positives = 32/87 (36%), Gaps = 9/87 (10%)
Query: 49 RYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGT 108
++ + E + ++ +VH DL N+L+ + + + DF + + +
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWRE----- 159
Query: 109 PGYLAPEVLRANMFEDATGYGQAVDVW 135
L +V + + Y D+
Sbjct: 160 --ILERDVRNIITYF-SRTYRTEKDIN 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 408 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.47 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.6 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 98.57 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 98.51 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 98.49 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 98.44 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 98.4 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 98.36 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.36 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.35 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 98.33 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 98.31 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.27 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 98.27 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 98.27 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 98.24 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 98.21 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 98.2 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.19 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.17 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 98.15 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 98.12 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.09 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 98.09 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.07 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.06 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 98.05 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 98.05 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 98.03 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.03 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 97.99 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 97.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 97.96 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 97.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 97.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 97.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 97.94 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 97.93 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 97.92 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 97.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 97.92 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 97.89 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 97.88 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 97.87 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 97.86 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 97.85 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 97.85 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 97.83 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 97.82 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 97.81 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 97.81 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 97.81 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 97.79 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 97.73 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 97.7 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 97.7 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 97.65 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 97.63 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 97.62 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 97.57 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 97.48 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.44 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 97.34 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 84.82 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=368.88 Aligned_cols=198 Identities=37% Similarity=0.739 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.++..|||||||.||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 63 ~l~HpnIv-~l~~~~~~~~~~~lvmE~~~gg~--L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil 139 (307)
T d1a06a_ 63 KIKHPNIV-ALDDIYESGGHLYLIMQLVSGGE--LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 139 (307)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEeccCCCc--HHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccccee
Confidence 57899855 5554 45667899999999999 888873 56899999999999999999999999999999999
Q ss_pred Ee---cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LD---DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~---~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+. .++.+||+|||+|+.........+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+||.
T Consensus 140 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~--- 210 (307)
T d1a06a_ 140 YYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ------KPYSKAVDCWSIGVIAYILLCGYPPFY--- 210 (307)
T ss_dssp ESSSSTTCCEEECCC------------------CTTSCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred ecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC------CCCCcHHHhhhhhHHHHHHHhCCCCCC---
Confidence 95 468999999999998777666677899999999999864 345666666666666666666665554
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
+.+..++...|..
T Consensus 211 -------------------------------------------------------------------~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 211 -------------------------------------------------------------------DENDAKLFEQILK 223 (307)
T ss_dssp -------------------------------------------------------------------CSSHHHHHHHHHT
T ss_pred -------------------------------------------------------------------CCCHHHHHHHHhc
Confidence 4444455667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.++.+.+..+|++++|||.+||++||++|||++|+|+||||+..
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 78888888888999999999999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=353.78 Aligned_cols=198 Identities=29% Similarity=0.568 Sum_probs=158.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhCC-----HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIINS-----NPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~~-----~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ +.++..|||||||+||+ |++.+.+ +++++.++.||+.||+|||++|||||||||+|||
T Consensus 59 ~l~HpnIv-~~~~~~~~~~~~~ivmEy~~gg~--L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NIL 135 (271)
T d1nvra_ 59 MLNHENVV-KFYGHRREGNIQYLFLEYCSGGE--LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 135 (271)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hCCCCCEe-eEeeeeccCceeEEEEeccCCCc--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEE
Confidence 47899855 6654 45567799999999999 9888753 4899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
++.++.+||+|||+|+.+.... .....+||+.|+|||++.+. ..++.++||||+||++|+|++|++||...+
T Consensus 136 l~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-----EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCS-----SBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCC-----CCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998765432 23457899999999999753 224678999999999999999999996543
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
....... .+..
T Consensus 211 ~~~~~~~---------------------------------------------------------------------~~~~ 221 (271)
T d1nvra_ 211 DSCQEYS---------------------------------------------------------------------DWKE 221 (271)
T ss_dssp TTSHHHH---------------------------------------------------------------------HHHT
T ss_pred hHHHHHH---------------------------------------------------------------------HHhc
Confidence 2211111 1111
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.. ...+.|..+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 222 ~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 222 KK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp TC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CC--CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 11 1113356789999999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-45 Score=362.30 Aligned_cols=199 Identities=32% Similarity=0.557 Sum_probs=164.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|.|+|+| ++.+ +.++..|||||||+||+ |++.+. ++.+++.++.||+.||+|||++|||||||||+||
T Consensus 82 ~l~HpnIv-~~~~~~~~~~~~~ivmE~~~gg~--L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NI 158 (352)
T d1koba_ 82 QLHHPKLI-NLHDAFEDKYEMVLILEFLSGGE--LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 158 (352)
T ss_dssp TCCSTTBC-CEEEEEECSSEEEEEEECCCCCB--HHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEEcCCCCh--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccc
Confidence 57899865 5554 45677899999999999 887653 4589999999999999999999999999999999
Q ss_pred EEe--cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLD--DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~--~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++ .++.+||+|||+|..+.........+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||
T Consensus 159 Ll~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvilyelltG~~Pf---- 228 (352)
T d1koba_ 159 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR------EPVGFYTDMWAIGVLGYVLLSGLSPF---- 228 (352)
T ss_dssp EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT------CCBCHHHHHHHHHHHHHHHHHSCCSS----
T ss_pred cccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC------CCCCCccchHHHHHHHHHHHhCCCCC----
Confidence 997 568999999999998877766667899999999999864 34566666666666666655555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+.+..|..
T Consensus 229 ------------------------------------------------------------------~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 229 ------------------------------------------------------------------AGEDDLETLQNVKR 242 (352)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHh
Confidence 44444556667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+.+.++...|..+|++++|||++||+.||++|||++|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 778888788889999999999999999999999999999999998653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=351.04 Aligned_cols=192 Identities=29% Similarity=0.529 Sum_probs=155.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ ++++..|+|||||.||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 62 ~l~hpnIv-~~~~~~~~~~~~~ivmEy~~~g~--L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nil 138 (263)
T d2j4za1 62 HLRHPNIL-RLYGYFHDATRVYLILEYAPLGT--VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 138 (263)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hcCCCCCC-eEEEEEEECCEEEEEEeecCCCc--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccce
Confidence 57899855 5554 55667899999999999 877663 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|...... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+
T Consensus 139 l~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~------~~~~~~~DiwSlGvilyell~G~~Pf~~~~--- 208 (263)
T d2j4za1 139 LGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEG------RMHDEKVDLWSLGVLCYEFLVGKPPFEANT--- 208 (263)
T ss_dssp ECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTT------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---
T ss_pred ecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcC------CCCCchhhhhhHhHHHHHHhcCCCCCCCCC---
Confidence 999999999999999876543 3456789999999999874 346677777777777777777766665443
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
..+++..+.+..+
T Consensus 209 -------------------------------------------------------------------~~~~~~~i~~~~~ 221 (263)
T d2j4za1 209 -------------------------------------------------------------------YQETYKRISRVEF 221 (263)
T ss_dssp -------------------------------------------------------------------HHHHHHHHHTTCC
T ss_pred -------------------------------------------------------------------HHHHHHHHHcCCC
Confidence 3344455555555
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.++ +.+|++++|||.+||+.||++|||++|+|+||||+.
T Consensus 222 ~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 443 358999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=352.16 Aligned_cols=196 Identities=29% Similarity=0.508 Sum_probs=160.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+| ++.+ +.++..|+|||||.||+ |.+.+. ++.+++.+++||+.||+|||++|||||||||+|||+
T Consensus 73 ~l~HpnIv-~~~~~~~~~~~~~ivmEy~~gg~--L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 149 (293)
T d1yhwa1 73 ENKNPNIV-NYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (293)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTCB--HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hCCCCCEe-eEeEEEEECCEEEEEEEecCCCc--HHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE
Confidence 46899855 5554 45567899999999999 777653 568999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|+.+.... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.+...
T Consensus 150 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCcEeeccchhheeeccccccccccccCCCccChhhhcC------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 999999999999998775433 3456789999999999964 357889999999999999999999987766554
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..+..+ +.+
T Consensus 224 ~~~~~~~~---------------------------------------------------------------------~~~ 234 (293)
T d1yhwa1 224 ALYLIATN---------------------------------------------------------------------GTP 234 (293)
T ss_dssp HHHHHHHH---------------------------------------------------------------------CSC
T ss_pred HHHHHHhC---------------------------------------------------------------------CCC
Confidence 44443321 111
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.+ +.+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 235 ~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 11 223468999999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-45 Score=360.35 Aligned_cols=199 Identities=33% Similarity=0.564 Sum_probs=163.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|.|+|+| ++.+ ++++..|||||||.||+ |++.+. ++.+++.++.||+.||+|||++|||||||||+||
T Consensus 79 ~l~HpnIv-~~~~~~~~~~~~~ivmE~~~gg~--L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NI 155 (350)
T d1koaa2 79 VLRHPTLV-NLHDAFEDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155 (350)
T ss_dssp HTCCTTBC-CEEEEEEETTEEEEEECCCCSCB--HHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEEcCCCCC--HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHe
Confidence 46899855 5554 45667899999999999 888773 4589999999999999999999999999999999
Q ss_pred EEec--CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDD--QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~--~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++. ++.+||+|||+|+.+.........+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||
T Consensus 156 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~------~~~~~~~DiwSlGvilyell~G~~Pf---- 225 (350)
T d1koaa2 156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG------KPVGYYTDMWSVGVLSYILLSGLSPF---- 225 (350)
T ss_dssp EESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT------CCBCHHHHHHHHHHHHHHHHHSSCSS----
T ss_pred eeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC------CCCChhHhhhhhhHHHHHHHhCCCCC----
Confidence 9964 57899999999998877666667899999999999874 34566666666666666666665555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+.+..+++..|..
T Consensus 226 ------------------------------------------------------------------~~~~~~~~~~~i~~ 239 (350)
T d1koaa2 226 ------------------------------------------------------------------GGENDDETLRNVKS 239 (350)
T ss_dssp ------------------------------------------------------------------CCSSHHHHHHHHHH
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHh
Confidence 44444556667777
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+.+.++...+..+|++++|||++||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 777777777888999999999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=357.28 Aligned_cols=194 Identities=32% Similarity=0.590 Sum_probs=155.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++| .+++ ++++..|+|||||.||+ |++.+. +++.++.++.||+.||+|||++|||||||||+|||
T Consensus 61 ~l~hp~Iv-~l~~~~~~~~~~~iv~ey~~gg~--L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 61 NTRHPFLT-ALKYAFQTHDRLCFVMEYANGGE--LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred hCCCCCEE-EEEeeeccccccccceeccCCCc--hhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 46788855 5554 56677899999999999 877764 45889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhccc-CcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKK-GEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.+|.+||+|||+|+.... .......+||+.|+|||++.+ .+|+.++|+||+||++|+|++|.+||.
T Consensus 138 l~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~------~~y~~~~DiwSlGvilyeml~G~~pf~----- 206 (337)
T d1o6la_ 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED------NDYGRAVDWWGLGVVMYEMMCGRLPFY----- 206 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS------SCBCTTHHHHHHHHHHHHHHHSSCSSC-----
T ss_pred ecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC------CCCChhhcccchhhHHHHHHHCCCCCC-----
Confidence 99999999999999987643 344556899999999999864 345666666666666666666655554
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+..++++.+..+.
T Consensus 207 -----------------------------------------------------------------~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 207 -----------------------------------------------------------------NQDHERLFELILMEE 221 (337)
T ss_dssp -----------------------------------------------------------------CSSHHHHHHHHHHCC
T ss_pred -----------------------------------------------------------------CcCHHHHHHHHhcCC
Confidence 444445556666666
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
+.++ ..+|++++|||++||++||++|+ |++|+|+||||...
T Consensus 222 ~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 6554 46899999999999999999999 49999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=350.41 Aligned_cols=202 Identities=24% Similarity=0.437 Sum_probs=162.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ +.++..|+|||||.||+ |.+.+ .++.+++.++.||+.||+|||++|||||||||+||
T Consensus 65 ~l~HpnIv-~l~~~~~~~~~~~lvmEy~~~g~--L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI 141 (288)
T d2jfla1 65 SCDHPNIV-KLLDAFYYENNLWILIEFCAGGA--VDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141 (288)
T ss_dssp HCCCTTBC-CEEEEEEETTEEEEEEECCTTEE--HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred hCCCCCCC-eEEEEEeeCCeEEEEEecCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence 46899855 6554 45567899999999998 77664 35588999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
|++.++.+||+|||+|+..... ....+.+||+.|+|||++..... ....|+.++||||+||++|+|++|.+||.+.+.
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCST-TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred eECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhccc-CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 9999999999999999765432 23346789999999999864322 235689999999999999999999999977665
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.++..+. +|.
T Consensus 221 ~~~~~~i~~~~---------------------------------------------------~~~--------------- 234 (288)
T d2jfla1 221 MRVLLKIAKSE---------------------------------------------------PPT--------------- 234 (288)
T ss_dssp GGHHHHHHHSC---------------------------------------------------CCC---------------
T ss_pred HHHHHHHHcCC---------------------------------------------------CCC---------------
Confidence 55554444321 110
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...+..+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 235 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 235 -----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 01224579999999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=350.70 Aligned_cols=197 Identities=30% Similarity=0.610 Sum_probs=153.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ ++++..|+|||||.||+ |++.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 64 ~l~HpnIv-~l~~~~~~~~~~~ivmEy~~gg~--L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIl 140 (288)
T d1uu3a_ 64 RLDHPFFV-KLYFTFQDDEKLYFGLSYAKNGE--LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 140 (288)
T ss_dssp HCCSTTBC-CEEEEEECSSEEEEEECCCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HcCCCCee-EEEEEEEECCEEEEEEEccCCCC--HHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccc
Confidence 46899865 5554 45667899999999999 877654 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
+++++.+||+|||+|+.+.... ...+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+
T Consensus 141 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~~-- 212 (288)
T d1uu3a_ 141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE------KSACKSSDLWALGCIIYQLVAGLPPFRA-- 212 (288)
T ss_dssp ECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT------CCCCHHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred cCCCceEEecccccceecccCCcccccccccCCccccCceeecc------CCCCcccceehhhHHHHHHhhCCCCCCC--
Confidence 9999999999999998765332 2345789999999999864 3456666666666666666666666544
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+..+++.+|.+
T Consensus 213 --------------------------------------------------------------------~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 213 --------------------------------------------------------------------GNEYLIFQKIIK 224 (288)
T ss_dssp --------------------------------------------------------------------SSHHHHHHHHHT
T ss_pred --------------------------------------------------------------------cCHHHHHHHHHc
Confidence 444455566666
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHH------HHcCCCCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKE------ALNHSFFHPKLFD 285 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e------~L~Hpwf~~~~~~ 285 (408)
+.+.++ ..+|++++|||++||+.||++|||++| +++||||+...++
T Consensus 225 ~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 225 LEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TCCCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred CCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 666554 368999999999999999999999987 5899999876443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-45 Score=346.57 Aligned_cols=201 Identities=53% Similarity=0.996 Sum_probs=162.7
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.|+|+| .+.+ ++++..|||||||+||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 68 ~hpnIv-~~~~~~~~~~~~~ivmE~~~~g~--L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 68 GHPNII-QLKDTYETNTFFFLVFDLMKKGE--LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD 144 (277)
T ss_dssp TCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCeE-EEEeecccCcceEEEEEcCCCch--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc
Confidence 488755 5554 55667899999999998 888773 4589999999999999999999999999999999999
Q ss_pred cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHHH
Q psy3880 81 DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 160 (408)
Q Consensus 81 ~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~~ 160 (408)
.++.+||+|||+|+.+.........+||+.|+|||++..........|+.++||||+||++|+|++|
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g------------- 211 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------------- 211 (277)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS-------------
T ss_pred CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC-------------
Confidence 9999999999999987766666678999999999999765433334445555555555555555555
Q ss_pred HHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 161 RNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 161 ~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
.+||.+.+.......|.++.+.+
T Consensus 212 ---------------------------------------------------------~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 212 ---------------------------------------------------------SPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp ---------------------------------------------------------SCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ---------------------------------------------------------CCCCCCCCHHHHHHHHHhCCCCC
Confidence 45555555555666677777777
Q ss_pred CCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 241 SSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 241 ~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
+.+.+..+|++++|||.+||+.||++|||++|+|+||||+.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 77788899999999999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=349.71 Aligned_cols=199 Identities=31% Similarity=0.597 Sum_probs=160.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ ++++..|||||||.||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 69 ~l~HpnIv-~~~~~~~~~~~~~iv~E~~~gg~--L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nil 145 (293)
T d1jksa_ 69 EIQHPNVI-TLHEVYENKTDVILILELVAGGE--LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 145 (293)
T ss_dssp HCCCTTBC-CEEEEEECSSEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEEcCCCcc--ccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEE
Confidence 46899855 6654 56677899999999999 887763 45889999999999999999999999999999999
Q ss_pred EecCC----CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 79 LDDQM----NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 79 l~~~~----~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
++.++ .+|++|||+|.....+....+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+
T Consensus 146 l~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~~- 218 (293)
T d1jksa_ 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY------EPLGLEADMWSIGVITYILLSGASPFLG- 218 (293)
T ss_dssp ESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred EecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC------CCCCCcccchhhhHHHHHHHcCCCCCCC-
Confidence 98766 599999999998877666677899999999999864 2456666666666666666666666544
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.+..+++.+|.
T Consensus 219 ---------------------------------------------------------------------~~~~~~~~~i~ 229 (293)
T d1jksa_ 219 ---------------------------------------------------------------------DTKQETLANVS 229 (293)
T ss_dssp ---------------------------------------------------------------------SSHHHHHHHHH
T ss_pred ---------------------------------------------------------------------CCHHHHHHHHH
Confidence 34444555666
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.+.+.++.+.+..+|++++|||++||+.||++|||++|+|+||||++..
T Consensus 230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 6666666666678999999999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=340.74 Aligned_cols=192 Identities=31% Similarity=0.525 Sum_probs=145.9
Q ss_pred ccccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh---------CCHHHHHHHHHHHHHHHHHHHHCC-----C
Q psy3880 6 MVAHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII---------NSNPALRYIMRQLFEALEHVHNHS-----V 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~---------~~~~~~r~i~~qil~aL~~LH~~~-----I 67 (408)
.+.|+|+| ++++ +.++..|+|||||+||+ |.+.+ .++.+++.++.||+.||+|||++| |
T Consensus 59 ~l~HpnIv-~~~~~~~~~~~~~~~ivmEy~~~g~--L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 59 ELKHPNIV-RYYDRIIDRTNTTLYIVMEYCEGGD--LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp SCCCTTBC-CEEEEEEC----CEEEEEECCTTEE--HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HCCCCCEe-eEEEEEEeCCCCEEEEEEecCCCCc--HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 57899865 5543 23445689999999999 88776 345789999999999999999976 9
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|||||||+|||++.++.+||+|||+|+.+.... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++
T Consensus 136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~~~~~DIwSlGvilyel~t 209 (269)
T d2java1 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR------MSYNEKSDIWSLGCLLYELCA 209 (269)
T ss_dssp ----CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT------CCCCHHHHHHHHHHHHHHHHH
T ss_pred EeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC------CCCChHHHHHhhCHHHHHHhh
Confidence 999999999999999999999999999876543 3345889999999999964 458899999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|..||.+.+..++..+|..+.
T Consensus 210 g~~Pf~~~~~~~~~~~i~~~~----------------------------------------------------------- 230 (269)
T d2java1 210 LMPPFTAFSQKELAGKIREGK----------------------------------------------------------- 230 (269)
T ss_dssp SSCSCCCSSHHHHHHHHHHTC-----------------------------------------------------------
T ss_pred CCCCCCCCCHHHHHHHHHcCC-----------------------------------------------------------
Confidence 999997766655555554432
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
+.. .+..+|+++++||++||+.||++|||++|+|+|||+
T Consensus 231 -----------~~~---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 -----------FRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------CCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 211 123578999999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=349.21 Aligned_cols=196 Identities=25% Similarity=0.381 Sum_probs=157.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ .+++..|+|||||.||. +...+ .++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 71 ~l~HpnIv-~~~~~~~~~~~~~iv~E~~~~g~--l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NIL 147 (309)
T d1u5ra_ 71 KLRHPNTI-QYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147 (309)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCSEEH--HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred HCCCCCEe-eEEEEEEECCEEEEEEEecCCCc--hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEE
Confidence 57899855 6554 44567899999999998 44332 356899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|...... ...+||+.|+|||++.+.. ...|+.++||||+||++|+|++|..||.+.+..+
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~---~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp EETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTT---SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccC---CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999865442 4578999999999996431 2458889999999999999999999987766555
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+.++..+. .
T Consensus 222 ~~~~i~~~~----------------------------------------------------------------------~ 231 (309)
T d1u5ra_ 222 ALYHIAQNE----------------------------------------------------------------------S 231 (309)
T ss_dssp HHHHHHHSC----------------------------------------------------------------------C
T ss_pred HHHHHHhCC----------------------------------------------------------------------C
Confidence 554444321 1
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.. .....+|+++++||++||+.||++|||++|+|+||||...
T Consensus 232 ~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 232 PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CC--CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CC--CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 11 1123578999999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=343.93 Aligned_cols=225 Identities=26% Similarity=0.398 Sum_probs=172.6
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ +.++..|+||||+.||. +..... ++.+++.+++||+.||+|||++|||||||||+|||
T Consensus 56 ~l~hpnIv-~~~~~~~~~~~~~ivmE~~~~~~--~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIl 132 (299)
T d1ua2a_ 56 ELSHPNII-GLLDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 132 (299)
T ss_dssp HCCCTTBC-CEEEEECCTTCCEEEEECCSEEH--HHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hCCCCCEe-EEEeeeccCCceeehhhhhcchH--HhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEE
Confidence 36799855 5554 45566899999999997 554443 34799999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+|+...... .....+||+.|+|||++... ..|+.++||||+||++|+|++|.+||.+.+..
T Consensus 133 i~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 133 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp ECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecCCCccccccCccccccCCCcccccceecChhhccHHHHccC-----CCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 9999999999999998765433 33457899999999998642 45789999999999999999999999999999
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+++.+|.+....+....|.+...... ... . ...| ... +..
T Consensus 208 ~~l~~i~~~~~~~~~~~~~~~~~~~~------------------~~~----------~-~~~~--~~~----~~~----- 247 (299)
T d1ua2a_ 208 DQLTRIFETLGTPTEEQWPDMCSLPD------------------YVT----------F-KSFP--GIP----LHH----- 247 (299)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTT------------------CCC----------C-CCCC--CCC----HHH-----
T ss_pred HHHHHHHHhcCCCChhhccchhccch------------------hhh----------h-ccCC--CCC----hHH-----
Confidence 99999887655544443332211000 000 0 0000 000 000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLF 284 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~ 284 (408)
.+..+|++++|||++||++||++||||+|+|+||||+....
T Consensus 248 ------~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 248 ------IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp ------HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ------hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 12457999999999999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=349.50 Aligned_cols=233 Identities=22% Similarity=0.349 Sum_probs=160.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.+ +.++..|||||||.||+ |.+.+. ++.+++.++.||+.||+|||+ +|||||||||+||
T Consensus 60 ~l~HpnIv-~l~~~~~~~~~~~iVmEy~~gg~--L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 60 ECNSPYIV-GFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136 (322)
T ss_dssp GCCCTTBC-CEEEEEECSSEEEEEEECCTTEE--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred hCCCCCCC-cEEEEEEECCEEEEEEEcCCCCc--HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHe
Confidence 57899855 6665 45566899999999999 887763 558999999999999999997 5999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
|++.++.+||+|||+|+.+... ...+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..
T Consensus 137 Ll~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp EECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred eECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcC------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999999876543 2346799999999999975 45899999999999999999999999876543
Q ss_pred HHHH-HH--HhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 158 VMLR-NI--MEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 158 ~~~~-~i--~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.... .+ ..+......+... ..+...........|. ....+....+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 258 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPR-----------------------------TPGRPLSSYGMDSRPP--MAIFELLDYIV 258 (322)
T ss_dssp HHHHHC-----------------------------------------------------------CC--CCHHHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCcccc-----------------------------cccccccccccccccc--hhHHHHHhhhh
Confidence 2211 11 1111110000000 0000000000011111 11223333343
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
..... ......+|++++|||++||++||++||||+|+|+||||+.
T Consensus 259 ~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 259 NEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp TSCCC--CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCc--cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 33221 1112357899999999999999999999999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=354.19 Aligned_cols=198 Identities=29% Similarity=0.567 Sum_probs=160.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
++.|+|+| ++++ ++++..|||||||+||+ |++.+. ++.+++.++.||+.||+|||++||+||||||+||
T Consensus 57 ~l~HpnIv-~~~~~~~~~~~~~lvmE~~~gg~--L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NI 133 (321)
T d1tkia_ 57 IARHRNIL-HLHESFESMEELVMIFEFISGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HSCCTTBC-CEEEEEEETTEEEEEECCCCCCB--HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred hCCCCCCC-eEEEEEEECCEEEEEEecCCCCc--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccce
Confidence 57899855 6655 45667899999999999 888774 4589999999999999999999999999999999
Q ss_pred EEecC--CCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCch
Q psy3880 78 LLDDQ--MNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 155 (408)
Q Consensus 78 Ll~~~--~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~ 155 (408)
|++.+ ..+||+|||+++...........+||+.|+|||.+... .|+.++||||+||++|+|++|
T Consensus 134 ll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~------~~~~~~DiWSlGvily~ll~G-------- 199 (321)
T d1tkia_ 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD------VVSTATDMWSLGTLVYVLLSG-------- 199 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC------EECHHHHHHHHHHHHHHHHHS--------
T ss_pred eecCCCceEEEEcccchhhccccCCcccccccccccccchhccCC------CCCchhhcccHHHHHHHHHhC--------
Confidence 99854 58999999999887766666678899999999988642 345555555555555555555
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.+||.+.+..+++.+|.+
T Consensus 200 --------------------------------------------------------------~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 200 --------------------------------------------------------------INPFLAETNQQIIENIMN 217 (321)
T ss_dssp --------------------------------------------------------------SCTTCCSSHHHHHHHHHH
T ss_pred --------------------------------------------------------------CCCCCCCCHHHHHHHHHh
Confidence 455555555566777888
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
+.+.++.+.|..+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 88888877888999999999999999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=356.52 Aligned_cols=201 Identities=36% Similarity=0.665 Sum_probs=161.7
Q ss_pred cccCCcEEEEecc------CCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 7 VAHSRVVVRVKEE------GDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 7 ~~~~~~i~~~~~~------~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
+.|+|+| ++++. .++..|||||||.||+ |++.+. ++.+++.++.||+.||+|||++||+|||||
T Consensus 62 ~~hpnIv-~l~~~~~~~~~~~~~~~ivmEy~~gg~--L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiK 138 (335)
T d2ozaa1 62 SQCPHIV-RIVDVYENLYAGRKCLLIVMECLDGGE--LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 138 (335)
T ss_dssp TTSTTBC-CEEEEEEEEETTEEEEEEEEECCCSEE--HHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred cCCCCCC-eEEEEEeecccCCCEEEEEEECCCCCc--HHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence 4688754 65543 2456799999999999 888773 348999999999999999999999999999
Q ss_pred CCcEEEec---CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 74 PENILLDD---QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 74 p~NILl~~---~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|+|||++. ++.+||+|||+|+...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+|
T Consensus 139 p~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~y~~~~DiwSlGvily~lltg~~P 212 (335)
T d2ozaa1 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP------EKYDKSCDMWSLGVIMYILLCGYPP 212 (335)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG------GGGSHHHHHHHHHHHHHHHTTSSCS
T ss_pred ccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC------CCCCHHHHHHhhchhHHHHhhCCCC
Confidence 99999985 45799999999998777666677899999999999865 3578899999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+....... +.
T Consensus 213 f~~~~~~~~~~~------------------------------------------------------------------~~ 226 (335)
T d2ozaa1 213 FYSNHGLAISPG------------------------------------------------------------------MK 226 (335)
T ss_dssp CEETTCC-------------------------------------------------------------------------
T ss_pred CCCCCHHHHHHH------------------------------------------------------------------HH
Confidence 966443221111 11
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+..+.+.++.+.|..+|++++|||++||+.||++|||++|+|+||||...
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 2233445566666777899999999999999999999999999999999654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=335.63 Aligned_cols=192 Identities=27% Similarity=0.493 Sum_probs=152.6
Q ss_pred ccccCCcEEEEec------cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCC--CeeccC
Q psy3880 6 MVAHSRVVVRVKE------EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHS--VVHRDL 72 (408)
Q Consensus 6 ~~~~~~~i~~~~~------~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~--IvHRDL 72 (408)
.+.|+|+| ++++ .++...|+|||||.||. |.+++. ++++++.++.||+.||+|||+++ ||||||
T Consensus 64 ~l~HpnIv-~~~~~~~~~~~~~~~~~ivmE~~~~g~--L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDi 140 (270)
T d1t4ha_ 64 GLQHPNIV-RFYDSWESTVKGKKCIVLVTELMTSGT--LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 140 (270)
T ss_dssp TCCCTTBC-CEEEEEEEESSSCEEEEEEEECCCSCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred hCCCCCee-eEEEEEeeccccCCEEEEEEeCCCCCc--HHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCc
Confidence 57899855 5543 22455799999999999 877763 45889999999999999999999 999999
Q ss_pred CCCcEEEe-cCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 73 KPENILLD-DQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 73 Kp~NILl~-~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+|||++ .++.+||+|||+|+..... ...+.+||+.|+|||++.. .|+.++||||+||++|+|++|..||
T Consensus 141 Kp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-------~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 141 KCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-------CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 99999996 4789999999999865433 3456799999999998853 4789999999999999999999999
Q ss_pred CCchhH-HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 152 WHRKQM-VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 152 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.+.... .+...+..+
T Consensus 213 ~~~~~~~~~~~~i~~~---------------------------------------------------------------- 228 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTSG---------------------------------------------------------------- 228 (270)
T ss_dssp TTCSSHHHHHHHHTTT----------------------------------------------------------------
T ss_pred CCcccHHHHHHHHHcC----------------------------------------------------------------
Confidence 654332 222222221
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFH 280 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~ 280 (408)
.. +...+...|+++++||.+||..||++|||++|+|+||||+
T Consensus 229 ------~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 ------VK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ------CC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ------CC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 10 0011245788999999999999999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-43 Score=344.33 Aligned_cols=192 Identities=32% Similarity=0.655 Sum_probs=154.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +.++..|+|||||.||. |...+. +++.++.++.||+.||+|||++|||||||||+|||
T Consensus 60 ~l~HpnIv-~~~~~~~~~~~~~ivmE~~~gg~--l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIL 136 (316)
T d1fota_ 60 IVTHPFII-RMWGTFQDAQQIFMIMDYIEGGE--LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 136 (316)
T ss_dssp SCCBTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred hccCcChh-heeeeEeeCCeeeeEeeecCCcc--ccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchhee
Confidence 47899865 5554 55677899999999998 666553 45788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|+..... ..+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+
T Consensus 137 l~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~------~~y~~~~DiwSlGvilyemltG~~Pf~~----- 203 (316)
T d1fota_ 137 LDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST------KPYNKSIDWWSFGILIYEMLAGYTPFYD----- 203 (316)
T ss_dssp ECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT------CCBCTTHHHHHHHHHHHHHHHSSCTTCC-----
T ss_pred EcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcC------CCCCchhhccccchhHHHHHhCCCCCCC-----
Confidence 999999999999999876543 346899999999999864 3466667777777766666666666644
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+..++...|..+.+
T Consensus 204 -----------------------------------------------------------------~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 204 -----------------------------------------------------------------SNTMKTYEKILNAEL 218 (316)
T ss_dssp -----------------------------------------------------------------SSHHHHHHHHHHCCC
T ss_pred -----------------------------------------------------------------cCHHHHHHHHHcCCC
Confidence 334445556666655
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|++++|||++||+.||.+|+ |++|+|+||||++.
T Consensus 219 ~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 543 35899999999999999999997 89999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-43 Score=347.54 Aligned_cols=197 Identities=28% Similarity=0.444 Sum_probs=157.0
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ +.++..|+|||||.||+ |.+++. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 63 ~~~hpnIv-~l~~~~~~~~~~~ivmE~~~gg~--L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NIL 139 (364)
T d1omwa3 63 TGDCPFIV-CMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 139 (364)
T ss_dssp SSCCTTBC-CEEEEEECSSEEEEEECCCCSCB--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCCCcEE-EEEEEEEECCEEEEEEEecCCCc--HHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeE
Confidence 35688865 5544 45667899999999999 888763 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|+.+... .....+||+.|+|||++..+ ..|+.++||||+||++|+|++|..||.+.+...
T Consensus 140 l~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 140 LDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp ECSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred EcCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcC-----CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999876554 34567899999999998642 457889999999999999999999986533211
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
. ....+.+ .
T Consensus 214 ~-------------------------------------------------------------------~~~~~~~----~ 222 (364)
T d1omwa3 214 K-------------------------------------------------------------------HEIDRMT----L 222 (364)
T ss_dssp H-------------------------------------------------------------------HHHHHHS----S
T ss_pred H-------------------------------------------------------------------HHHHHhc----c
Confidence 0 0111111 1
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYS-----VKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~t-----a~e~L~Hpwf~~~ 282 (408)
......+..+|++++|||.+||++||++||| |+|+|+||||+..
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 1222234568999999999999999999999 8999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=336.17 Aligned_cols=221 Identities=30% Similarity=0.429 Sum_probs=168.1
Q ss_pred ccCCcEEEEec-------cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 8 AHSRVVVRVKE-------EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 8 ~~~~~i~~~~~-------~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.|+|+| ++.+ +.+...+++||++.+|...+.... .++..++.++.||+.||+|||++|||||||||+|
T Consensus 68 ~HpnIv-~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 68 EHPNVV-RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp CCTTBC-CEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCCcc-eeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 688855 5443 233567899999999973333322 3458899999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
||++.++.+||+|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+.
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC------CCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999987766666677899999999999975 4688999999999999999999999999998
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.+|......+....|...... +. .. +.. .
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~~~-----------------------~~------~~------~~~------------~ 253 (305)
T d1blxa_ 221 VDQLGKILDVIGLPGEEDWPRDVAL-----------------------PR------QA------FHS------------K 253 (305)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSS-----------------------CG------GG------SCC------------C
T ss_pred HHHHHHHHHhhCCCchhcccccccc-----------------------hh------hh------hcc------------c
Confidence 8888888764433222222110000 00 00 000 0
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........+..+|++++|||++||++||++||||+|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0000111235689999999999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-43 Score=343.53 Aligned_cols=192 Identities=36% Similarity=0.656 Sum_probs=154.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..|+||||+.||. |.+.+. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 97 ~l~hpnIv-~~~~~~~~~~~~~~v~e~~~~g~--l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL 173 (350)
T d1rdqe_ 97 AVNFPFLV-KLEFSFKDNSNLYMVMEYVAGGE--MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HcCCCcEe-ecccccccccccccccccccccc--hhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence 56899865 5554 45566789999999998 777763 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+||+|||+|+.+... ....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.
T Consensus 174 l~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~------~~~~~~~DiwSlGvilyemltG~~Pf~~~---- 241 (350)
T d1rdqe_ 174 IDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS------KGYNKAVDWWALGVLIYEMAAGYPPFFAD---- 241 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred cCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcC------CCCCccccccchhHHHHHHHhCCCCCCCc----
Confidence 999999999999999876543 346789999999999875 34666777777777777777666666543
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
+...++..|..+.+
T Consensus 242 ------------------------------------------------------------------~~~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 242 ------------------------------------------------------------------QPIQIYEKIVSGKV 255 (350)
T ss_dssp ------------------------------------------------------------------SHHHHHHHHHHCCC
T ss_pred ------------------------------------------------------------------CHHHHHHHHhcCCC
Confidence 33344555555554
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
.++ ..+|+++++||++||+.||.+|+ |++|+|+||||+..
T Consensus 256 ~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred CCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 443 46899999999999999999995 99999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=340.55 Aligned_cols=194 Identities=27% Similarity=0.530 Sum_probs=155.9
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| .+.+ ++++..|+|||||.||+ |.+++. ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 59 ~~~hp~Iv-~~~~~~~~~~~~yivmEy~~~g~--L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL 135 (320)
T d1xjda_ 59 AWEHPFLT-HMFCTFQTKENLFFVMEYLNGGD--LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135 (320)
T ss_dssp HTTCTTBC-CEEEEEECSSEEEEEEECCTTCB--HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred hCCCCcEE-EEEEEEccCCceeEEEeecCCCc--HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCccccee
Confidence 47888855 5554 55667899999999999 888763 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+||+|||+|+..... ......+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+
T Consensus 136 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvilyemltG~~PF~~~~-- 207 (320)
T d1xjda_ 136 LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-- 207 (320)
T ss_dssp ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred ecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC------CCCCchhhhhhhhHHHHHHHhCCCCCCCCC--
Confidence 999999999999999866543 23345789999999999975 346677777777777777777766665443
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..++...|..+.
T Consensus 208 --------------------------------------------------------------------~~~~~~~i~~~~ 219 (320)
T d1xjda_ 208 --------------------------------------------------------------------EEELFHSIRMDN 219 (320)
T ss_dssp --------------------------------------------------------------------HHHHHHHHHHCC
T ss_pred --------------------------------------------------------------------HHHHHHHHHcCC
Confidence 334445555555
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHH-HHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVK-EALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~-e~L~Hpwf~~~ 282 (408)
+.++ ..+|++++|||++||+.||++|||++ |+++||||+..
T Consensus 220 ~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 220 PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 5443 35899999999999999999999996 89999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=324.19 Aligned_cols=226 Identities=27% Similarity=0.435 Sum_probs=169.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+| ++++ +.++..|+||||+.+|...+.... .++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 57 ~l~Hp~Iv-~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~ 135 (298)
T d1gz8a_ 57 ELNHPNIV-KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135 (298)
T ss_dssp TCCCTTBC-CEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hCCCCcEE-EeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee
Confidence 57899855 5554 445667999999998853333222 3568999999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccC-cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 80 DDQMNVKLTDFGFARVLKKG-EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
+.++.+||+|||+|+..... ......+||+.|+|||++... ..++.++|+||+||++|+|++|+.||.+.+...
T Consensus 136 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~-----~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccCcceeccCCcceeccCCcccceeecccceeeehhhhccc-----cCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 99999999999999877543 334457899999999998653 345789999999999999999999999999888
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKY 238 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~ 238 (408)
.+.++......+....+...... ..+ ....|........
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~--------------~~~-----------------~~~~~~~~~~~~~---------- 249 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSM--------------PDY-----------------KPSFPKWARQDFS---------- 249 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGS--------------TTC-----------------CTTSCCCCCCCHH----------
T ss_pred HHHHHHHhcCCCchhhccccccc--------------ccc-----------------ccccccccccchh----------
Confidence 88888765444332222211100 000 0000111111100
Q ss_pred CCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 239 SFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 239 ~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
..+..+|++++|||++||++||++|||++|+|+||||+..
T Consensus 250 ----~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 250 ----KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp ----HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 1124679999999999999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=321.84 Aligned_cols=233 Identities=26% Similarity=0.396 Sum_probs=167.8
Q ss_pred ccccCCcEEEEec--c-------CCcHHHHHHHHHhhchhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE--E-------GDDLKHLAAQVVDKGEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~-------~~~~~~lv~e~~~~g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|+|+|..+.. . ..+..|+|||++.+|. +.... .++.+++.+++||+.||+|||++||||||
T Consensus 65 ~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~--~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrD 142 (318)
T d3blha1 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 142 (318)
T ss_dssp HCCCTTBCCEEEEEEC----------CEEEEEECCCEEH--HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhcCCCccceEeeeecccccccccCceEEEEEeccCCCc--cchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecC
Confidence 4679886633222 1 1233578999999887 43332 23588999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh
Q psy3880 72 LKPENILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV 146 (408)
Q Consensus 72 LKp~NILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~ 146 (408)
|||+|||++.++.+||+|||+|..+.... .....+||+.|+|||++... ..|+.++||||+||++|+|++
T Consensus 143 lKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-----~~~~~k~DiwSlGvil~el~~ 217 (318)
T d3blha1 143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-----RDYGPPIDLWGAGCIMAEMWT 217 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHH
T ss_pred cCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC-----CCCCcHHHcccCCceeeeHhh
Confidence 99999999999999999999997654321 22346899999999998753 468899999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 147 GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 147 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
|++||.+.+....+..+.....++....+.........+.+.. ..+ .....
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~----~~~~~ 268 (318)
T d3blha1 218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL-------------------------VKG----QKRKV 268 (318)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------C-------------------------CSS----CCBCH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcc-------------------------ccc----ccccc
Confidence 9999999998888888877666655444433322211111100 000 00111
Q ss_pred HHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCC
Q psy3880 227 MVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKLFDQD 287 (408)
Q Consensus 227 ~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~~~~~ 287 (408)
...+... ..+++++|||.+||++||++||||+|+|+||||+....+.+
T Consensus 269 ~~~~~~~-------------~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 269 KDRLKAY-------------VRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp HHHHHHH-------------HCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred hhhhccc-------------cCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 1111111 24789999999999999999999999999999987654443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-41 Score=321.78 Aligned_cols=223 Identities=25% Similarity=0.407 Sum_probs=167.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ +.++..++++|++.++. +..... ++.+++.++.||+.||+|||++|||||||||+|||
T Consensus 56 ~l~hpnIv-~~~~~~~~~~~~~i~~e~~~~~~--~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIl 132 (286)
T d1ob3a_ 56 ELKHSNIV-KLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (286)
T ss_dssp GCCCTTBC-CEEEEEECSSCEEEEEECCSEEH--HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCcEE-eeeeecccCCceeEEEEeehhhh--HHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceee
Confidence 57898865 5554 55667899999999987 554443 45899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 157 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~ 157 (408)
++.++.+|++|||+|....... ......||+.|+|||.+... ..++.++|+||+||++|+|++|+.||.+.+..
T Consensus 133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCCCEEecccccceecccCccccceecccchhhhHHHHhCC-----CCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 9999999999999998765433 23346799999999998753 45789999999999999999999999999988
Q ss_pred HHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 158 VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 158 ~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
+.+.++......+....|....... .+..... ...+
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~-------------~~~~----------------- 243 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELP--------------KYDPNFT-------------VYEP----------------- 243 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGST--------------TCCTTCC-------------CCCC-----------------
T ss_pred HHHHHHHHhhCCCChhhccchhhhh--------------hcccccc-------------cccC-----------------
Confidence 8888887766555544443321100 0000000 0000
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHP 281 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~ 281 (408)
.........+|++++|||++||++||++||||+|+|+||||++
T Consensus 244 -~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 244 -LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0001112457999999999999999999999999999999963
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=320.55 Aligned_cols=185 Identities=34% Similarity=0.532 Sum_probs=146.7
Q ss_pred cCCcEEEEec--cCCcHHHHHHHHHhh-chhhHHhhh-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 9 HSRVVVRVKE--EGDDLKHLAAQVVDK-GEAAVQDII-----NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 9 ~~~~i~~~~~--~~~~~~~lv~e~~~~-g~~~l~~~~-----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
|+|+| ++.+ +.++..|+|||++.+ ++ +++.+ .++.+++.++.||+.||+|||++|||||||||+|||++
T Consensus 68 h~nIv-~~~~~~~~~~~~~lv~e~~~~~~~--l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 68 FSGVI-RLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 144 (273)
T ss_dssp SCSBC-CEEEEEECSSEEEEEEECCSSEEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCCcc-EEEEEEeeCCeEEEEEEeccCcch--HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe
Confidence 78755 6655 555678999999986 45 55544 35689999999999999999999999999999999998
Q ss_pred c-CCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHHH
Q psy3880 81 D-QMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 159 (408)
Q Consensus 81 ~-~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~~ 159 (408)
. ++.+||+|||+|+..... ...+.+||+.|+|||++... ..++.++||||+||++|+|++|..||.+.+
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH-----RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHS-----CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCC-----CCCCcccccccceeeehhHhhCCCCCCCch----
Confidence 5 478999999999865433 34568899999999999753 234567888888888888888888875422
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
.+..+...
T Consensus 215 ------------------------------------------------------------------------~i~~~~~~ 222 (273)
T d1xwsa_ 215 ------------------------------------------------------------------------EIIRGQVF 222 (273)
T ss_dssp ------------------------------------------------------------------------HHHHCCCC
T ss_pred ------------------------------------------------------------------------HHhhcccC
Confidence 12222222
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
++ ..+|++++|||++||+.||++|||++|+|+||||+..
T Consensus 223 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 223 FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 22 3579999999999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=326.90 Aligned_cols=226 Identities=28% Similarity=0.383 Sum_probs=164.9
Q ss_pred ccccCCcEEEEec--------cCCcHHHHHHHHHhhchhhHHh-h-----hCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q psy3880 6 MVAHSRVVVRVKE--------EGDDLKHLAAQVVDKGEAAVQD-I-----INSNPALRYIMRQLFEALEHVHNHSVVHRD 71 (408)
Q Consensus 6 ~~~~~~~i~~~~~--------~~~~~~~lv~e~~~~g~~~l~~-~-----~~~~~~~r~i~~qil~aL~~LH~~~IvHRD 71 (408)
.+.|+|+| ++.+ .+....|||||||.+|...... . -.++.+++.+++||+.||+|||++||||||
T Consensus 69 ~l~h~niv-~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrD 147 (350)
T d1q5ka_ 69 KLDHCNIV-RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 147 (350)
T ss_dssp HCCCTTBC-CEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred hcCCCCCC-cEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 36899866 4432 1223457999999988522221 1 135689999999999999999999999999
Q ss_pred CCCCcEEEecCC-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 72 LKPENILLDDQM-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 72 LKp~NILl~~~~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
|||+|||++.++ .+||+|||+|..+.......+.+||+.|+|||++... ..|+.++||||+||++|+|++|.+|
T Consensus 148 iKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DIwSlG~il~el~~g~~p 222 (350)
T d1q5ka_ 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQPI 222 (350)
T ss_dssp CCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred CCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcc-----cCCCcceeecccceEEEehhhCCCC
Confidence 999999999775 8999999999887776666778999999999998652 4689999999999999999999999
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|...+..+.+.+|........ .+.+...... + .+ ...|-.
T Consensus 223 f~~~~~~~~l~~i~~~~g~~~------------~~~~~~~~~~----~---~~-------------~~~~~~-------- 262 (350)
T d1q5ka_ 223 FPGDSGVDQLVEIIKVLGTPT------------REQIREMNPN----Y---TE-------------FKFPQI-------- 262 (350)
T ss_dssp SCCSSHHHHHHHHHHHHCCCC------------HHHHHHHCC----------C-------------CCCCCC--------
T ss_pred CCCCCHHHHHHHHHHHhCCCh------------HHhhhhhccc----h---hh-------------cccccc--------
Confidence 999988888887765322211 1111110000 0 00 000000
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
....+....+..+|++++|||++||++||++||||.|+|+||||+..
T Consensus 263 -----~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 263 -----KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp -----CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred -----ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00001112234689999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=316.77 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=150.9
Q ss_pred ccccCCcEEEEeccCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKEEGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+|.-+....++..++|||||.||+ |.+.+. +..++..++.||+.||+|||++|||||||||+|||+
T Consensus 60 ~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSS--LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp TCCCTTBCCEEEEECSSSCEEEEECCCEEE--HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred hCCCCCEeeeeEEEeccEEEEEEecCCCCC--HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence 468998663333344556789999999999 888773 347899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 80 DDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
+.++.+||+|||+|+...... .....+||+.|+|||++... ....|+.++|||||||++|||++|+.||.+.+.
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ---DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTC---SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcc---cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 999999999999998765322 33457899999999999653 124588999999999999999999999987655
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
...+..+....+. +|.
T Consensus 215 ~~~~~~~~~~~~~-------------------------------------------------~p~--------------- 230 (276)
T d1uwha_ 215 RDQIIFMVGRGYL-------------------------------------------------SPD--------------- 230 (276)
T ss_dssp HHHHHHHHHHTSC-------------------------------------------------CCC---------------
T ss_pred HHHHHHHHhcCCC-------------------------------------------------CCc---------------
Confidence 4433333221100 000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
....+..+|+++++||.+||..||++|||++|+++|
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 001124578899999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=328.57 Aligned_cols=236 Identities=22% Similarity=0.363 Sum_probs=166.7
Q ss_pred cccCCcEEEEecc--------CCcHHHHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 7 VAHSRVVVRVKEE--------GDDLKHLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 7 ~~~~~~i~~~~~~--------~~~~~~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
+.|+|+| ++.+. ..+..|+|||||.||.........++.+++.+++||+.||+|||++||+||||||+|||
T Consensus 73 l~hpnIv-~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil 151 (355)
T d2b1pa1 73 VNHKNII-SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151 (355)
T ss_dssp CCCTTBC-CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred cCCCCee-EEEEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccc
Confidence 5788754 65542 23566899999998863333233466899999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhHH
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMV 158 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~~ 158 (408)
++.++.+|++|||+++...........+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+...
T Consensus 152 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp ECTTCCEEECCCCC---------------CCTTCCHHHHTT------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccccceeeechhhhhccccccccccccccccccChhhhcC------CCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 99999999999999988776666667889999999999975 457889999999999999999999999998888
Q ss_pred HHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCccccc-chhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 159 MLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVW-ACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 159 ~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiW-s~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
...++....... ..+.| +.+.....+..+.+++.......... ...
T Consensus 226 ~~~~i~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 272 (355)
T d2b1pa1 226 QWNKVIEQLGTP------------------------------CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP---DSL 272 (355)
T ss_dssp HHHHHHHHHCCC------------------------------CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSC---GGG
T ss_pred HHHHHHHhccCC------------------------------CHHHHHHhhhhHHHHhhcCccccccccccccc---ccc
Confidence 888776643221 11222 22333444555555555443322211 111
Q ss_pred CCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 238 YSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 238 ~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.......+..+|++++|||++||++||++||||+|+|+||||+..
T Consensus 273 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 122222233468899999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=321.14 Aligned_cols=188 Identities=19% Similarity=0.273 Sum_probs=152.0
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC----------------------------CHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN----------------------------SNPALRYIMRQLFE 57 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~----------------------------~~~~~r~i~~qil~ 57 (408)
.|+|+| ++++ +.++..|+|||||.||+ |.+++. +..++..++.||+.
T Consensus 99 ~HpnIv-~l~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 99 SHENIV-NLLGACTLSGPIYLIFEYCCYGD--LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred CCCcEe-EEEEEEeeCCeEEEEEEcCCCCc--HHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 688755 6554 45667899999999999 888773 34678999999999
Q ss_pred HHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhh
Q psy3880 58 ALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDV 134 (408)
Q Consensus 58 aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~Di 134 (408)
||+|||++|||||||||+|||++.++.+||+|||+|+....... ..+.+||+.|+|||++.. ..|+.++||
T Consensus 176 gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~Di 249 (325)
T d1rjba_ 176 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE------GIYTIKSDV 249 (325)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH------CCCCHHHHH
T ss_pred HHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC------CCCCcceec
Confidence 99999999999999999999999999999999999987654432 234668999999999975 357899999
Q ss_pred hhhhHHHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHH
Q psy3880 135 WACGVIMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYT 213 (408)
Q Consensus 135 wSlGvil~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ 213 (408)
||+||++|+|++ |.+||.+.+....+.++..
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~------------------------------------------------ 281 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ------------------------------------------------ 281 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH------------------------------------------------
T ss_pred cchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh------------------------------------------------
Confidence 999999999997 8999976554433333332
Q ss_pred hhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 214 LLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 214 ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+.++. +..+|+++++||.+||+.||++|||++|+++|
T Consensus 282 ----------------------~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 282 ----------------------NGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----------------------TTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------cCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2222211 23578999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-40 Score=319.44 Aligned_cols=231 Identities=19% Similarity=0.380 Sum_probs=161.4
Q ss_pred ccCCcEEEEec----cCCcHHHHHHHHHhhchhhHHhhh--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEec
Q psy3880 8 AHSRVVVRVKE----EGDDLKHLAAQVVDKGEAAVQDII--NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDD 81 (408)
Q Consensus 8 ~~~~~i~~~~~----~~~~~~~lv~e~~~~g~~~l~~~~--~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~ 81 (408)
.|+|+| ++.+ ......++|||||.+|+ |.... .++.+++.+++||+.||+|||++|||||||||+|||++.
T Consensus 88 ~hpnIv-~~~~~~~~~~~~~~~~v~e~~~~~~--L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~ 164 (328)
T d3bqca1 88 GGPNII-TLADIVKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164 (328)
T ss_dssp TSTTBC-CEEEEEECTTTCSEEEEEECCCSCB--GGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred CCCCCc-EEEEEEEecCCCceeEEEeecCCCc--HHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC
Confidence 477654 6554 23455789999999998 66543 467899999999999999999999999999999999986
Q ss_pred CC-CEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh-HHH
Q psy3880 82 QM-NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ-MVM 159 (408)
Q Consensus 82 ~~-~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~-~~~ 159 (408)
++ .+||+|||+|+...........+||+.|+|||++... ..|+.++|+||+||++|+|++|..||..... ...
T Consensus 165 ~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~ 239 (328)
T d3bqca1 165 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY-----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239 (328)
T ss_dssp TTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred CCCeeeecccccceeccCCCcccccccCccccCcccccCC-----CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH
Confidence 55 6999999999988776666778999999999998753 4578999999999999999999999976542 233
Q ss_pred HHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCC
Q psy3880 160 LRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYS 239 (408)
Q Consensus 160 ~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 239 (408)
...+......... .+.... +....+.. +.-..+..+.... ...
T Consensus 240 ~~~i~~~~g~~~~-----------~~~~~~--------~~~~~~~~------~~~~~~~~~~~~~------------~~~ 282 (328)
T d3bqca1 240 LVRIAKVLGTEDL-----------YDYIDK--------YNIELDPR------FNDILGRHSRKRW------------ERF 282 (328)
T ss_dssp HHHHHHHHCHHHH-----------HHHHHH--------TTCCCCGG------GGGTCCCCCCCCG------------GGG
T ss_pred HHHHHHHHCCchh-----------hhhhhh--------cccccCcc------cchhcccccccch------------hhc
Confidence 3333221000000 000000 00000000 0000011110000 001
Q ss_pred CCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 240 FSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 240 f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
+....+..+|++++|||++||++||++||||+|+|+||||+...
T Consensus 283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 22334566899999999999999999999999999999998643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=320.93 Aligned_cols=219 Identities=24% Similarity=0.405 Sum_probs=162.7
Q ss_pred ccccCCcEEEEeccC--------CcHHHHHHHHHhhchhhHHhhh----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q psy3880 6 MVAHSRVVVRVKEEG--------DDLKHLAAQVVDKGEAAVQDII----NSNPALRYIMRQLFEALEHVHNHSVVHRDLK 73 (408)
Q Consensus 6 ~~~~~~~i~~~~~~~--------~~~~~lv~e~~~~g~~~l~~~~----~~~~~~r~i~~qil~aL~~LH~~~IvHRDLK 73 (408)
.+.|+|+| ++.+.. ....|+||||| |+. |...+ .++..++.+++||+.||+|||++||||||||
T Consensus 73 ~l~hpniv-~l~~~~~~~~~~~~~~~~~lv~e~~-~~~--l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiK 148 (346)
T d1cm8a_ 73 HMRHENVI-GLLDVFTPDETLDDFTDFYLVMPFM-GTD--LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 148 (346)
T ss_dssp HCCBTTBC-CCSEEECSCSSTTTCCCCEEEEECC-SEE--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCCee-EEEEEeccCccccccceEEEEEecc-ccc--HHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence 47899855 555421 22458999999 443 44433 4668999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCC
Q psy3880 74 PENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 153 (408)
Q Consensus 74 p~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~ 153 (408)
|+|||++.++.+|++|||+|+.... .....+||+.|+|||++.+. ..++.++||||+||++|+|++|.+||.+
T Consensus 149 p~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 149 PGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNW-----MRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTT-----TCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcccccccccccccceeccCC--ccccccccccccCHHHHcCC-----CCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 9999999999999999999987643 34567899999999998753 3568899999999999999999999999
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+....+..+......+.. +..... .. ......
T Consensus 222 ~~~~~~~~~~~~~~~~~~~------------~~~~~~--------------------------------~~---~~~~~~ 254 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPA------------EFVQRL--------------------------------QS---DEAKNY 254 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCH------------HHHHTC--------------------------------SC---HHHHHH
T ss_pred CChHHHHHHHHhccCCCcH------------HHHhhh--------------------------------cc---hhhhhh
Confidence 9888877777654332211 100000 00 000011
Q ss_pred HhcCCCCCCC----cCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 234 MEGKYSFSSP----EWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 234 ~~~~~~f~~~----~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
.......... ....+|++++|||++||++||++||||+|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1111111111 224679999999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=322.18 Aligned_cols=201 Identities=32% Similarity=0.570 Sum_probs=155.1
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+++|+.+.+ +..+..++||||+.||+ |.+.+. .+..++.++.||+.||+|||++|||||||||+|||
T Consensus 84 ~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~--L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nil 161 (322)
T d1vzoa_ 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGE--LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161 (322)
T ss_dssp HHHTCTTBCCEEEEEEETTEEEEEECCCCSCB--HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hccCCCeEEEeeeeeccCCceeeeeecccccH--HHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcccee
Confidence 4678666767665 45567789999999998 877764 34889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccC--cccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKG--EKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~ 156 (408)
++.++.+||+|||+|+.+... ....+.+||+.|+|||.+... ...++.++||||+||++|+|++|..||.+.+.
T Consensus 162 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred ecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcC----CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999876432 233457899999999999753 23467789999999999999999999865432
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.... ..+.+.....
T Consensus 238 ~~~~------------------------------------------------------------------~~i~~~~~~~ 251 (322)
T d1vzoa_ 238 KNSQ------------------------------------------------------------------AEISRRILKS 251 (322)
T ss_dssp CCCH------------------------------------------------------------------HHHHHHHHHC
T ss_pred HHHH------------------------------------------------------------------HHHHHhcccC
Confidence 1110 0111122222
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRY-----SVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~-----ta~e~L~Hpwf~~~ 282 (408)
. .+....+|+++++||++||+.||++|| ||+|+|+||||++.
T Consensus 252 ~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 252 E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred C----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 2 222346899999999999999999999 58999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=315.25 Aligned_cols=227 Identities=25% Similarity=0.420 Sum_probs=158.4
Q ss_pred ccccCCcEEEEec--cCCcH----HHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE--EGDDL----KHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~----~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
+|.|+++| .+.. ..++. .+++++++.||+ |++.+. ++.+++.++.||+.||+|||++|||||||||+
T Consensus 62 ~l~hp~iv-~~~~~~~~~~~~~~~~~~l~~~~~~g~--L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~ 138 (345)
T d1pmea_ 62 RFRHENII-GINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 138 (345)
T ss_dssp HCCCTTBC-CCCEEECCSSTTTCCCEEEEEECCCEE--HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HcCCCCCC-cEEEEEeeccccccceEEEEEeecCCc--hhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcc
Confidence 47899865 4433 11111 233445567888 887763 56899999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
|||++.++.+||+|||+|....... .....+||+.|+|||++... ..|+.++|+||+||++|+|++|..||
T Consensus 139 NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-----KGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB-----CSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcC-----CCCCchhhhhccCceehHHhhCCCCC
Confidence 9999999999999999998654432 23457899999999998643 45789999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHH
Q psy3880 152 WHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLR 231 (408)
Q Consensus 152 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~ 231 (408)
.+.+.......+......+. ++... .....-.....-..|.....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~------------~~~~~-----------------~~~~~~~~~~~~~~~~~~~~------ 258 (345)
T d1pmea_ 214 PGKHYLDQLNHILGILGSPS------------QEDLN-----------------CIINLKARNYLLSLPHKNKV------ 258 (345)
T ss_dssp CCSSHHHHHHHHHHHHCSCC------------HHHHH-----------------TCCCHHHHHHHHTSCCCCCC------
T ss_pred CCCCHHHHHHHHhhhccCCC------------hhhhh-----------------hhhhhhhhcccccCCccCCC------
Confidence 98877666555443221110 01000 00000000000000000000
Q ss_pred HHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q psy3880 232 NIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPKL 283 (408)
Q Consensus 232 ~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~~ 283 (408)
.....+..+|++++|||++||++||++||||+|+|+||||+...
T Consensus 259 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 259 --------PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp --------CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred --------CHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00012356899999999999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=310.37 Aligned_cols=189 Identities=22% Similarity=0.285 Sum_probs=140.2
Q ss_pred ccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVH 63 (408)
Q Consensus 8 ~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH 63 (408)
.|+++|+.+.. +.++..++|||||++|+ |.+++ .+..++..++.||+.||+|||
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH 151 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCB--HHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCc--HHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 34444544443 34456789999999999 88776 345789999999999999999
Q ss_pred HCCCeeccCCCCcEEEecCCCEEEeccccchhcccCc---ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHH
Q psy3880 64 NHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGE---KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVI 140 (408)
Q Consensus 64 ~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvi 140 (408)
++|||||||||+|||++.++.+||+|||+|+...... .....+||+.|+|||++.. ..|+.++||||+||+
T Consensus 152 ~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~sDiwS~Gvi 225 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD------RVYTIQSDVWSFGVL 225 (299)
T ss_dssp HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH------CCCCHHHHHHHHHHH
T ss_pred hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc------CCCCcccceeehHHH
Confidence 9999999999999999999999999999998765432 2234689999999999975 357899999999999
Q ss_pred HHHHHhC-CCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCC
Q psy3880 141 MYTLLVG-CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 219 (408)
Q Consensus 141 l~~ll~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~ 219 (408)
+|+|++| .+||.+.+....+.++.
T Consensus 226 l~ellt~~~~p~~~~~~~~~~~~~~------------------------------------------------------- 250 (299)
T d1ywna1 226 LWEIFSLGASPYPGVKIDEEFCRRL------------------------------------------------------- 250 (299)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHH-------------------------------------------------------
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHH-------------------------------------------------------
Confidence 9999986 45675543222221111
Q ss_pred CCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 220 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+ ..+ +....+|+++++||.+||+.||++|||++|+++|
T Consensus 251 --------------~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 --------------KEG-TRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp --------------HHT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------hcC-CCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 111 1123578999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=305.90 Aligned_cols=193 Identities=22% Similarity=0.391 Sum_probs=150.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++.. ..++..|+|||||.+|. |.+.+. +..++..++.||+.||+|||+++|+||||||+||
T Consensus 64 ~l~HpnIv-~~~g~~~~~~~~iv~Ey~~~g~--L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NI 140 (272)
T d1qpca_ 64 QLQHQRLV-RLYAVVTQEPIYIITEYMENGS--LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140 (272)
T ss_dssp HCCCTTBC-CEEEEECSSSCEEEEECCTTCB--HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred hCCCCCEe-EEEeeeccCCeEEEEEeCCCCc--HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhe
Confidence 46799866 5544 34455689999999999 877664 3468899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCC-CCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~-~pf~~~ 154 (408)
|++.++.+||+|||+|+.+..... .....||+.|+|||++... .|+.++||||+||++|+|+||. +||...
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp EECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eeecccceeeccccceEEccCCccccccccCCcccccChHHHhCC------CCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999988765432 2346789999999999753 4778999999999999999854 444444
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+..
T Consensus 215 ~~~~~~~~i~~--------------------------------------------------------------------- 225 (272)
T d1qpca_ 215 TNPEVIQNLER--------------------------------------------------------------------- 225 (272)
T ss_dssp CHHHHHHHHHT---------------------------------------------------------------------
T ss_pred CHHHHHHHHHh---------------------------------------------------------------------
Confidence 33333333322
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc--CCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFFH 280 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~--Hpwf~ 280 (408)
+.. . +....+|+++++||.+||..||++|||++|+++ |+||+
T Consensus 226 -~~~-~--~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 -GYR-M--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -TCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCC-C--CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111 1 112357889999999999999999999999988 77774
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-39 Score=308.81 Aligned_cols=189 Identities=20% Similarity=0.383 Sum_probs=141.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.|.|+|+| ++.+ ..++..|+|||||.||. |.+.+. +..++..++.||+.||+|||++|||||||||+||
T Consensus 83 ~l~HpnIv-~l~g~~~~~~~~~iv~Ey~~~g~--L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 83 QFDHPNVI-HLEGVVTKSTPVMIITEFMENGS--LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159 (299)
T ss_dssp TCCCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hCCCCCCc-cEEEEEeeCCEEEEEEEecCCCc--ceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceE
Confidence 47899855 6655 45567899999999998 766543 4478899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCccc------ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEKL------MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPP 150 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~p 150 (408)
|++.++.+||+|||+|+.+...... ....||+.|+|||++.. ..|+.++|||||||++|||++ |..|
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY------RKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHS------CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc------CCCCcccccccchHHHHHHHhCCCCC
Confidence 9999999999999999876543321 12467899999999874 357889999999999999997 8888
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+..+.+..+..+.
T Consensus 234 f~~~~~~~~~~~i~~~~--------------------------------------------------------------- 250 (299)
T d1jpaa_ 234 YWDMTNQDVINAIEQDY--------------------------------------------------------------- 250 (299)
T ss_dssp TTTCCHHHHHHHHHTTC---------------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHcCC---------------------------------------------------------------
Confidence 87766555554443321
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. +.+..+++++++||.+||..||++|||+.|++++
T Consensus 251 --------~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 --------RL--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------CC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01 1123578899999999999999999999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=309.56 Aligned_cols=192 Identities=20% Similarity=0.327 Sum_probs=149.3
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILL 79 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl 79 (408)
.+.|+|+| ++.+ -.++..+||||||++|+ |.+++. ++.++..++.||+.||+|||++|||||||||+|||+
T Consensus 64 ~l~HpnIv-~~~g~~~~~~~~lvmE~~~~g~--L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill 140 (277)
T d1xbba_ 64 QLDNPYIV-RMIGICEAESWMLVMEMAELGP--LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140 (277)
T ss_dssp TCCCTTBC-CEEEEEESSSEEEEEECCTTEE--HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred hCCCCCCc-eEEEEeccCCEEEEEEcCCCCc--HHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence 46899866 5554 22334589999999998 777653 458899999999999999999999999999999999
Q ss_pred ecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 80 DDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 80 ~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
+.++.+||+|||+|+.+..... .....||+.|+|||++... .|+.++|||||||++|||++ |..||.+.
T Consensus 141 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC------CCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 9999999999999987654322 1235789999999999753 46789999999999999987 88888776
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....|..+.
T Consensus 215 ~~~~~~~~i~~~~------------------------------------------------------------------- 227 (277)
T d1xbba_ 215 KGSEVTAMLEKGE------------------------------------------------------------------- 227 (277)
T ss_dssp CHHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHHcCC-------------------------------------------------------------------
Confidence 5555444443321
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH---HcCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA---LNHSFF 279 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~---L~Hpwf 279 (408)
. . +....+|+++++||.+||..||++|||++|+ |+|+|+
T Consensus 228 ---~-~--~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 ---R-M--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ---C-C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---C-C--CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 0 0 1113578999999999999999999999887 566665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=309.19 Aligned_cols=193 Identities=20% Similarity=0.325 Sum_probs=153.9
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ -.++..|||||||+||. |.+++. +..++..++.||+.||+|||++|||||||||+|||
T Consensus 65 ~l~HpnIv-~l~g~~~~~~~~lvmE~~~~g~--L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 65 QLDNPYIV-RLIGVCQAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp HCCCTTBC-CEEEEEESSSEEEEEECCTTEE--HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hCCCCCEe-eEeeeeccCeEEEEEEeCCCCc--HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 47899865 5554 23345689999999999 877653 34789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
++.++.+||+|||+|+.+..... ....+||+.|+|||++... .|+.++|||||||++|||++ |..||.+
T Consensus 142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 142 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp EEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC------CCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 99999999999999987654322 2245789999999999753 47889999999999999998 8999977
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+....|..|.
T Consensus 216 ~~~~~~~~~i~~~~------------------------------------------------------------------ 229 (285)
T d1u59a_ 216 MKGPEVMAFIEQGK------------------------------------------------------------------ 229 (285)
T ss_dssp CCTHHHHHHHHTTC------------------------------------------------------------------
T ss_pred CCHHHHHHHHHcCC------------------------------------------------------------------
Confidence 66555544443321
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHH---HcCCCCC
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEA---LNHSFFH 280 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~---L~Hpwf~ 280 (408)
. . +....+|+++.+||.+||..||++|||+.++ |+|+|++
T Consensus 230 ----~-~--~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 ----R-M--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----C-C--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----C-C--CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 0 1113578999999999999999999998776 6778764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-39 Score=309.58 Aligned_cols=195 Identities=26% Similarity=0.452 Sum_probs=140.6
Q ss_pred ccccCCcEEEEecc----C--CcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE----G--DDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~--~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| ++.+. + ....|||||||+||+ |.+.+. ++.+++.++.||+.||+|||++|||||||||
T Consensus 63 ~~~hpniv-~~~~~~~~~~~~~~~~~lvmE~~~g~~--L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 63 ALNHPAIV-AVYDTGEAETPAGPLPYIVMEYVDGVT--LRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp TCCCTTBC-CEEEEEEEECSSSEEEEEEEECCCEEE--HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred hcCCCCCC-cccceeeeccCCCceEEEEEECCCCCE--ehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 47899866 44331 1 224689999999998 776653 4588999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCc----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGE----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 150 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p 150 (408)
+|||++.++.++++|||++....... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|.+|
T Consensus 140 ~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 140 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG------DSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp GGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT------CCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC------CCCCcceecccchHHHHHHHhCCCC
Confidence 99999999999999999987554322 2345789999999999864 3466777777777777777777776
Q ss_pred CCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 151 FWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 151 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
|.+.+ ..+.+
T Consensus 214 f~~~~----------------------------------------------------------------------~~~~~ 223 (277)
T d1o6ya_ 214 FTGDS----------------------------------------------------------------------PVSVA 223 (277)
T ss_dssp CCCSS----------------------------------------------------------------------HHHHH
T ss_pred CCCcC----------------------------------------------------------------------HHHHH
Confidence 65443 33334
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFF 279 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf 279 (408)
..+......++...+..+|+++++||.+||+.||++||+..+.|.|+|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 224 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 4444555555555677899999999999999999999944444445553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=304.27 Aligned_cols=189 Identities=24% Similarity=0.346 Sum_probs=141.4
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++++ -.++..|+|||||.+|. +.+.+ .+..+++.++.||+.||+|||+++||||||||+|||
T Consensus 64 ~l~HpnIv-~l~~~~~~~~~~iv~E~~~~g~--l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIl 140 (273)
T d1mp8a_ 64 QFDHPHIV-KLIGVITENPVWIIMELCTLGE--LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 140 (273)
T ss_dssp TCCCTTBC-CEEEEECSSSCEEEEECCTTEE--HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hCCCCCEe-eEEEEEecCeEEEEEEeccCCc--HHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhee
Confidence 46899865 5554 33466799999999998 66543 245789999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCch
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRK 155 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~~ 155 (408)
++.++.+||+|||+|+.+..... ....+||+.|+|||++.. ..|+.++||||+||++|+|++ |.+||.+.+
T Consensus 141 l~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 141 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF------RRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp EEETTEEEECC-------------------CCGGGCCHHHHHH------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc------CCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 99999999999999987654332 234678999999999975 357889999999999999987 888887765
Q ss_pred hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 156 QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 156 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
..+...++..+.
T Consensus 215 ~~~~~~~i~~~~-------------------------------------------------------------------- 226 (273)
T d1mp8a_ 215 NNDVIGRIENGE-------------------------------------------------------------------- 226 (273)
T ss_dssp GGGHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 554444443321
Q ss_pred cCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 236 GKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 236 ~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .+.+..+|+++++||.+||..||++|||++|+++|
T Consensus 227 --~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 --R---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --C---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 12234679999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-39 Score=301.47 Aligned_cols=189 Identities=21% Similarity=0.346 Sum_probs=140.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++++ ..++..|+|||||.+|. |.+.+. +.+.+..++.||+.||+|||+++|+||||||+||
T Consensus 56 ~l~HpnIv-~~~g~~~~~~~~~lv~E~~~~g~--L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Ni 132 (263)
T d1sm2a_ 56 KLSHPKLV-QLYGVCLEQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132 (263)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGE
T ss_pred hcCCCCcc-cccceeccCCceEEEEEecCCCc--HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhe
Confidence 46799855 6654 45667899999999998 877653 2477888999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||+|+....... .....||+.|+|||++.. ..|+.++||||+||++|||++ |.+||...
T Consensus 133 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF------SRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp EECGGGCEEECSCC------------------CTTSCCHHHHTT------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred eecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC------CCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 999999999999999987654332 234678999999999975 357889999999999999998 55666555
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+..+.
T Consensus 207 ~~~~~~~~i~~~~------------------------------------------------------------------- 219 (263)
T d1sm2a_ 207 SNSEVVEDISTGF------------------------------------------------------------------- 219 (263)
T ss_dssp CHHHHHHHHHHTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHHhcC-------------------------------------------------------------------
Confidence 5444444443321
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. ......|+++.+||.+||+.||++|||++|+++|
T Consensus 220 ---~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 ---RL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 11 1113468899999999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=303.14 Aligned_cols=224 Identities=24% Similarity=0.374 Sum_probs=163.8
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-----SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ +..+..++|++++.|+. +...+. ++.+++.++.|++.||+|||++|||||||||+|||
T Consensus 57 ~l~h~niv-~~~~~~~~~~~~~iv~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIl 133 (292)
T d1unla_ 57 ELKHKNIV-RLHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL 133 (292)
T ss_dssp TCCCTTBC-CEEEEEECSSEEEEEEECCSEEH--HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hcCcCCEE-eeccccccccceeEEeeeccccc--cccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccc
Confidence 47899865 5544 55566789999999988 655442 44889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCc-ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCC-Cchh
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGE-KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW-HRKQ 156 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~-~~~~ 156 (408)
++.++.+||+|||.|+...... ......+++.|+|||++... ..++.++||||+||++|+|++|..||. +.+.
T Consensus 134 i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTC-----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred cccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccC-----CCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 9999999999999998765443 23345678899999998753 346889999999999999999998854 5555
Q ss_pred HHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhc
Q psy3880 157 MVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEG 236 (408)
Q Consensus 157 ~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~ 236 (408)
.+.+.++......+....|....... ...++....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~----------- 243 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLP----------------------------------DYKPYPMYP----------- 243 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGST----------------------------------TCCCCCCCC-----------
T ss_pred HHHHHHHHhhcCCCChhhhhhhhhcc----------------------------------ccccccccc-----------
Confidence 66666666554443332222111000 000000000
Q ss_pred CCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 237 KYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 237 ~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
...........+|++++|||++||+.||.+||||+|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0001112234679999999999999999999999999999999764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=312.52 Aligned_cols=220 Identities=23% Similarity=0.427 Sum_probs=160.7
Q ss_pred ccccCCcEEEEecc-------CCcHHHHHHHHHhhchhhHHhhhC----CHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q psy3880 6 MVAHSRVVVRVKEE-------GDDLKHLAAQVVDKGEAAVQDIIN----SNPALRYIMRQLFEALEHVHNHSVVHRDLKP 74 (408)
Q Consensus 6 ~~~~~~~i~~~~~~-------~~~~~~lv~e~~~~g~~~l~~~~~----~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp 74 (408)
.+.|+|+| .+.+. .+...+++++++.||+ |.+++. ++.+++.++.||+.||+|||++|||||||||
T Consensus 73 ~l~h~~iv-~~~~~~~~~~~~~~~~~~~i~~~~~gg~--L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp 149 (348)
T d2gfsa1 73 HMKHENVI-GLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 149 (348)
T ss_dssp HCCCTTBC-CCSEEECSCSSTTTCCCCEEEEECCSEE--HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred hcCCCCee-eEEEEEeeccccccCceEEEEEeecCCc--hhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Confidence 46899866 44331 1223355667788998 888874 5589999999999999999999999999999
Q ss_pred CcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 75 ENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
+|||++.++.+|++|||+|..... ...+.+||+.|+|||++... ..++.++|+||+||++|+|++|.+||.+.
T Consensus 150 ~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~-----~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 150 SNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp GGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTC-----SCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccchhcccCc--ccccccccccccCchhhcCC-----ccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 999999999999999999876543 34567899999999998653 34688999999999999999999999999
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+.......|........ ++.... .++. ......
T Consensus 223 ~~~~~~~~i~~~~~~~~------------~~~~~~--------------~~~~---------------------~~~~~~ 255 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPG------------AELLKK--------------ISSE---------------------SARNYI 255 (348)
T ss_dssp SHHHHHHHHHHHHCCCC------------HHHHTT--------------CCCH---------------------HHHHHH
T ss_pred CHHHHHHHHHHhcCCCC------------hHHhhh--------------ccch---------------------hhhhhh
Confidence 98888888876543221 111000 0000 000111
Q ss_pred hcCCCCCC----CcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q psy3880 235 EGKYSFSS----PEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNHSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~----~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~Hpwf~~~ 282 (408)
........ ..+..+|++++|||++||++||++||||+|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 11111111 1235689999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-38 Score=302.20 Aligned_cols=189 Identities=22% Similarity=0.335 Sum_probs=147.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++++ ..++..|+|||||.+|. |.+.+. ++..+..++.||+.||+|||++|||||||||+|
T Consensus 69 ~l~HpnIv-~~~~~~~~~~~~~iv~E~~~~g~--l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~N 145 (287)
T d1opja_ 69 EIKHPNLV-QLLGVCTREPPFYIITEFMTYGN--LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145 (287)
T ss_dssp HCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hCCCCCEe-cCCccEeeCCeeEEEeecccCcc--hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCe
Confidence 46899855 5554 55567899999999998 777652 447889999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCccc--ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCc
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEKL--MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 154 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~ 154 (408)
||++.++.+||+|||+|+........ ....||+.|+|||++.. ..|+.++||||+||++|+|++|..||...
T Consensus 146 ILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY------NKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp EEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH------CCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC------CCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999877544322 23457899999999975 35789999999999999999976665433
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.....+.++. .
T Consensus 220 ~~~~~~~~~i---------------------------------------------------------------------~ 230 (287)
T d1opja_ 220 IDLSQVYELL---------------------------------------------------------------------E 230 (287)
T ss_dssp CCHHHHHHHH---------------------------------------------------------------------H
T ss_pred chHHHHHHHH---------------------------------------------------------------------h
Confidence 2222111111 1
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
..+.. +.+..+|+++++||.+||+.||++|||++|+++
T Consensus 231 -~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 -KDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCCCC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11111 223467899999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=294.50 Aligned_cols=189 Identities=22% Similarity=0.322 Sum_probs=152.4
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| +++. ..++..++||||+.+|. |.+.+. +.+.+..++.||+.||+|||++||+||||||+||
T Consensus 55 ~l~HpnIv-~~~g~~~~~~~~~iv~Ey~~~g~--l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni 131 (258)
T d1k2pa_ 55 NLSHEKLV-QLYGVCTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131 (258)
T ss_dssp TCCCTTBC-CEEEEECCSSSEEEEEECCTTEE--HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred hcCCCcee-eEEEEEeeCCceEEEEEccCCCc--HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence 56799855 6554 45567899999999998 666643 3378899999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|++.++.+||+|||+|+.+..... .....||+.|+|||++... .|+.++||||+||++|+|++ |..||.+.
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 132 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp EECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred EEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC------CCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 999999999999999987654432 2246789999999999753 57889999999999999997 78888777
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..++..+|.++.
T Consensus 206 ~~~~~~~~i~~~~------------------------------------------------------------------- 218 (258)
T d1k2pa_ 206 TNSETAEHIAQGL------------------------------------------------------------------- 218 (258)
T ss_dssp CHHHHHHHHHTTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHHhCC-------------------------------------------------------------------
Confidence 6666555554321
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. +.....++++++||++||+.||++|||++|+|+|
T Consensus 219 ---~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 ---RL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 10 1113567899999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=295.83 Aligned_cols=195 Identities=22% Similarity=0.337 Sum_probs=145.9
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| ++++ ..++..|+|||||.+|. |...+. +..++..++.||+.||+|||++||+||||||+||
T Consensus 68 ~l~h~nIv-~~~g~~~~~~~~lv~Ey~~~g~--l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 68 KLRHEKLV-QLYAVVSEEPIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp HCCCTTBC-CEEEEECSSSCEEEECCCTTCB--HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred hcccCCEe-EEEEEEecCCeEEEEEecCCCc--hhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 47888855 5553 34455789999999997 555543 4578999999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc--cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC-CCCc
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK--LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP-FWHR 154 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p-f~~~ 154 (408)
|++.++.+||+|||+|+.+..+.. ....+||+.|+|||++.. ..++.++||||+||++|+|++|..| +.+.
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY------GRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC------CCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654332 234679999999999975 3577899999999999999986544 4333
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+.+..+..
T Consensus 219 ~~~~~~~~i~~--------------------------------------------------------------------- 229 (285)
T d1fmka3 219 VNREVLDQVER--------------------------------------------------------------------- 229 (285)
T ss_dssp CHHHHHHHHHT---------------------------------------------------------------------
T ss_pred CHHHHHHHHHh---------------------------------------------------------------------
Confidence 33333333322
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc--CCCCCCC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN--HSFFHPK 282 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~--Hpwf~~~ 282 (408)
+. . .+....+|+++++||.+||+.||++|||++++++ |+||+..
T Consensus 230 -~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 -GY-R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -TC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -cC-C--CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 21 1 1123467899999999999999999999999988 8999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=291.83 Aligned_cols=186 Identities=20% Similarity=0.358 Sum_probs=149.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh---------------------CCHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII---------------------NSNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~---------------------~~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|+| ++.. ..++..++|||||.+|. |.+.+ .+..++..++.||+.||+|||+
T Consensus 77 ~HpnIv-~~~~~~~~~~~~~~v~e~~~~g~--l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 77 KHKNII-NLLGACTQDGPLYVIVEYASKGN--LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEECCCTTCB--HHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCeEE-ecccccccCCeEEEEEEccCCCc--HHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 588755 6554 45667899999999999 88877 3567899999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 141 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil 141 (408)
++||||||||+|||++.++.+||+|||+++....... ....+||+.|+|||.+.. ..|+.++|||||||++
T Consensus 154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~------~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD------RIYTHQSDVWSFGVLL 227 (299)
T ss_dssp TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH------CCCCHHHHHHHHHHHH
T ss_pred CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC------CCCCchhhhHHhHHHH
Confidence 9999999999999999999999999999987755432 234678999999999975 4578999999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCC
Q psy3880 142 YTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP 220 (408)
Q Consensus 142 ~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~P 220 (408)
|+|++ |.+||.+.+.......+..+
T Consensus 228 ~ell~~g~~p~~~~~~~~~~~~i~~~------------------------------------------------------ 253 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPVEELFKLLKEG------------------------------------------------------ 253 (299)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTT------------------------------------------------------
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHcC------------------------------------------------------
Confidence 99997 67787665554443333221
Q ss_pred CCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 221 FWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 221 f~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
+.++ ....+|+++++||.+||+.||++|||+.|+|+
T Consensus 254 -----------------~~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 254 -----------------HRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -----------------CCCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1111 12357899999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-37 Score=291.02 Aligned_cols=188 Identities=20% Similarity=0.365 Sum_probs=138.2
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
.+.|+|+| +++. ...+..++|||||.+|. +.+.+ .+..++..++.||+.||+|||+++||||||||+||
T Consensus 65 ~l~H~nIv-~~~g~~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 65 QFSHHNII-RLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141 (283)
T ss_dssp TCCCTTBC-CEEEEECSSSSEEEEEECCTTEE--HHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred hcCCCCEe-eeeEEEecCCceEEEEEecccCc--chhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence 46898855 6654 44566789999999997 65543 23478889999999999999999999999999999
Q ss_pred EEecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCC-CC
Q psy3880 78 LLDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPP-FW 152 (408)
Q Consensus 78 Ll~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~p-f~ 152 (408)
|++.++.+||+|||+|+.+..... .....||+.|+|||++.. ..|+.++|||||||++|||++|..| |.
T Consensus 142 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY------RKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS------CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc------CCCCCcccccccHHHHHHHHhCCCCccc
Confidence 999999999999999987654322 223578999999999875 3578899999999999999985444 43
Q ss_pred CchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 153 HRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 153 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..+..+.+..+.
T Consensus 216 ~~~~~~~~~~i~-------------------------------------------------------------------- 227 (283)
T d1mqba_ 216 ELSNHEVMKAIN-------------------------------------------------------------------- 227 (283)
T ss_dssp TCCHHHHHHHHH--------------------------------------------------------------------
T ss_pred cCCHHHHHHHHh--------------------------------------------------------------------
Confidence 333333333322
Q ss_pred HHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 233 IMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 233 i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.+. .. +....+++++++||.+||..||++|||+.|+++
T Consensus 228 --~~~-~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 228 --DGF-RL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --TTC-CC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --ccC-CC--CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 211 11 122357889999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=296.83 Aligned_cols=189 Identities=23% Similarity=0.316 Sum_probs=145.3
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhhC------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDIIN------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~~------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| ++.+ -.+...++++|++.+|. |.+.+. +...+..++.||+.||+|||++|||||||||+|||
T Consensus 67 ~l~HpnIv-~l~g~~~~~~~~~v~e~~~~~~--l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl 143 (317)
T d1xkka_ 67 SVDNPHVC-RLLGICLTSTVQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143 (317)
T ss_dssp HCCCTTBC-CEEEEEESSSEEEEEECCTTCB--HHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred hCCCCCEe-eEEEEEecCCeeEEEEeccCCc--ccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcce
Confidence 46899865 5543 23344578889999988 666543 34788999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCccc---ccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEKL---MDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
++.++.+||+|||+|+.+...... ....||+.|+|||++.. ..|+.++|||||||++|+|+| |.+||.+.
T Consensus 144 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH------RIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp EEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred eCCCCCeEeeccccceecccccccccccccccCccccChHHHhc------CCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999987543322 23568999999999975 357899999999999999998 78888665
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....+..+
T Consensus 218 ~~~~~~~~i~~~-------------------------------------------------------------------- 229 (317)
T d1xkka_ 218 PASEISSILEKG-------------------------------------------------------------------- 229 (317)
T ss_dssp CGGGHHHHHHHT--------------------------------------------------------------------
T ss_pred CHHHHHHHHHcC--------------------------------------------------------------------
Confidence 443333333221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
. .. +....+|+++++||.+||..||++|||+.|+++|
T Consensus 230 --~-~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 --E-RL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp --C-CC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --C-CC--CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1 11 1123578899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-37 Score=289.32 Aligned_cols=189 Identities=22% Similarity=0.333 Sum_probs=148.7
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENIL 78 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NIL 78 (408)
.+.|+|+| +++. -.+...++|||||.+|. +.+.+ .+...+..++.||+.||+|||++||+||||||+|||
T Consensus 67 ~l~H~nIv-~~~g~~~~~~~~lv~e~~~~~~--l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 67 SLDHRNLI-RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143 (273)
T ss_dssp HCCCTTBC-CEEEEECSSSCEEEEECCTTCB--HHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hCCCCCEE-EEEEEEeecchheeeeeecCcc--hhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhc
Confidence 46798855 5554 33345689999999998 66654 355889999999999999999999999999999999
Q ss_pred EecCCCEEEeccccchhcccCcc----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCC
Q psy3880 79 LDDQMNVKLTDFGFARVLKKGEK----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 153 (408)
Q Consensus 79 l~~~~~iKl~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~ 153 (408)
++.++.+||+|||+++.+..... .....|++.|+|||++... .|+.++|||||||++|||++ |..||.+
T Consensus 144 l~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC------CCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999987654322 1235678899999999763 47889999999999999998 8999977
Q ss_pred chhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHH
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNI 233 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i 233 (408)
.+..+.+.++...
T Consensus 218 ~~~~~~~~~i~~~------------------------------------------------------------------- 230 (273)
T d1u46a_ 218 LNGSQILHKIDKE------------------------------------------------------------------- 230 (273)
T ss_dssp CCHHHHHHHHHTS-------------------------------------------------------------------
T ss_pred cCHHHHHHHHHhC-------------------------------------------------------------------
Confidence 7666655555432
Q ss_pred HhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 234 MEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 234 ~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
...+ +.+..+|+++++||.+||..||++|||+.|+++
T Consensus 231 ---~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 ---GERL--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---CCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCC--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2111 123467899999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-36 Score=288.89 Aligned_cols=189 Identities=20% Similarity=0.291 Sum_probs=150.2
Q ss_pred ccccCCcEEEEec-cCCcHHHHHHHHHhhchhhHHhhh-----------------------------CCHHHHHHHHHHH
Q psy3880 6 MVAHSRVVVRVKE-EGDDLKHLAAQVVDKGEAAVQDII-----------------------------NSNPALRYIMRQL 55 (408)
Q Consensus 6 ~~~~~~~i~~~~~-~~~~~~~lv~e~~~~g~~~l~~~~-----------------------------~~~~~~r~i~~qi 55 (408)
.+.|+|+|..+.. ...+..++|||++.+|. |.+.+ .+..++..++.||
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD--LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCB--HHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred hcCCCCcccceeeeccCCceEEEEEecCCCc--HHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 4679986644332 45567889999999998 88776 2446789999999
Q ss_pred HHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcch
Q psy3880 56 FEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAV 132 (408)
Q Consensus 56 l~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~ 132 (408)
+.||+|||+++||||||||+|||++.++.+||+|||+|+.+..... ....+||+.|+|||++.. ..|+.++
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~t~ks 223 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY------NRYTTES 223 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH------CCCCHHH
T ss_pred HHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc------CCCChhh
Confidence 9999999999999999999999999999999999999987654322 234678999999999975 4578999
Q ss_pred hhhhhhHHHHHHHhCC-CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhH
Q psy3880 133 DVWACGVIMYTLLVGC-PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIM 211 (408)
Q Consensus 133 DiwSlGvil~~ll~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvil 211 (408)
|||||||++|||++|. +||.+.+..+.+..+..+.
T Consensus 224 DVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-------------------------------------------- 259 (301)
T d1lufa_ 224 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-------------------------------------------- 259 (301)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------------------------------------------
T ss_pred hhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC--------------------------------------------
Confidence 9999999999999885 5776666555555544332
Q ss_pred HHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 212 YTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 212 y~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. +....+++++.+||.+||..||++|||+.|+++
T Consensus 260 --------------------------~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 260 --------------------------IL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp --------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 112467889999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=291.92 Aligned_cols=187 Identities=21% Similarity=0.307 Sum_probs=147.9
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------------CHHHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------------SNPALRYIMRQLFEALEHVHN 64 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------------~~~~~r~i~~qil~aL~~LH~ 64 (408)
.|+|+| ++++ ...+..|+||||+.||. |.+.+. +...+..++.||+.||.|||+
T Consensus 69 ~HpnIv-~~~~~~~~~~~~~iV~ey~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 69 HHPNII-NLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp CCTTBC-CEEEEEEETTEEEEEECCCTTCB--HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEe-eEEEEEecCCeeEEEEEecCCCc--HHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence 588755 6554 44566799999999999 888773 346789999999999999999
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
++||||||||+|||++.++.+||+|||+|+...........+||+.|+|||.+.. ..|+.++|||||||++|+|
T Consensus 146 ~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY------SVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH------CEECHHHHHHHHHHHHHHH
T ss_pred CCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhcc------CCCCccceeehhHHHHHHH
Confidence 9999999999999999999999999999987655444445679999999999975 3578899999999999999
Q ss_pred HhCC-CCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 145 LVGC-PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 145 l~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
++|. +||.+.+..++...|.++.
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~-------------------------------------------------------- 243 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGY-------------------------------------------------------- 243 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTC--------------------------------------------------------
T ss_pred HhcCCCCCCCCCHHHHHHHHHhcC--------------------------------------------------------
Confidence 9864 5666655555444443321
Q ss_pred chhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 224 RKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 224 ~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
..+.+..+|+++++||.+||..||++|||++|+++|
T Consensus 244 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 -----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112234578999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-36 Score=280.94 Aligned_cols=187 Identities=19% Similarity=0.310 Sum_probs=142.0
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhC-------CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIIN-------SNPALRYIMRQLFEALEHVHNHSVVHRDLKPE 75 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~-------~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~ 75 (408)
.+.|+|+| ++.+ +.++..|+||||+.+|. |.+.+. +.+.+..++.||+.||+|||+++||||||||+
T Consensus 56 ~l~HpnIv-~~~g~~~~~~~~~~lv~ey~~~g~--L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~ 132 (262)
T d1byga_ 56 QLRHSNLV-QLLGVIVEEKGGLYIVTEYMAKGS--LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132 (262)
T ss_dssp TCCCTTBC-CEEEEECCC--CCEEEECCCTTEE--HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred hCCCCCEe-eEEEEEEecCCcEEEEEeccCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence 46899855 5554 33445789999999999 877763 44788999999999999999999999999999
Q ss_pred cEEEecCCCEEEeccccchhcccCcccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHh-CCCCCCCc
Q psy3880 76 NILLDDQMNVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 154 (408)
Q Consensus 76 NILl~~~~~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~-G~~pf~~~ 154 (408)
|||++.++.+|++|||+++..... .....+|+.|+|||++.. ..|+.++|||||||++|||++ |.+||...
T Consensus 133 Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~------~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 133 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE------KKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred hheecCCCCEeecccccceecCCC--CccccccccCCChHHHhC------CCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999876543 234678999999999975 357899999999999999998 78888665
Q ss_pred hhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 155 KQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 155 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
+..+....|..+.
T Consensus 205 ~~~~~~~~i~~~~------------------------------------------------------------------- 217 (262)
T d1byga_ 205 PLKDVVPRVEKGY------------------------------------------------------------------- 217 (262)
T ss_dssp CGGGHHHHHTTTC-------------------------------------------------------------------
T ss_pred CHHHHHHHHHcCC-------------------------------------------------------------------
Confidence 5544444443221
Q ss_pred hcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 235 EGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 235 ~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.. +....+++++++||++||..||++|||+.|+++|
T Consensus 218 ----~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ----KM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CC--CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 1113468899999999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=286.68 Aligned_cols=187 Identities=20% Similarity=0.325 Sum_probs=147.1
Q ss_pred ccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh-----------------------CCHHHHHHHHHHHHHHHHHH
Q psy3880 8 AHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII-----------------------NSNPALRYIMRQLFEALEHV 62 (408)
Q Consensus 8 ~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~-----------------------~~~~~~r~i~~qil~aL~~L 62 (408)
.|+|+| .+.. +..+..|+|||||.+|+ |.+++ .+...+..++.||+.||+||
T Consensus 85 ~HpnIv-~~~g~~~~~~~~~lvmE~~~~g~--l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 85 NHMNIV-NLLGACTIGGPTLVITEYCCYGD--LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp CCTTBC-CEEEEECSSSSCEEEEECCTTEE--HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEE-EEEEEEeeCCEEEEEEEcCCCCC--HHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 588755 6554 45566899999999998 77775 34578999999999999999
Q ss_pred HHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhH
Q psy3880 63 HNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGV 139 (408)
Q Consensus 63 H~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGv 139 (408)
|+++||||||||+|||++.++.+|++|||+++....... ....+||+.|+|||++.. ..++.++|||||||
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN------CVYTFESDVWSYGI 235 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH------CCCCHHHHHHHHHH
T ss_pred HhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC------CCCCCcccccchHH
Confidence 999999999999999999999999999999987654322 233678999999999975 35789999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC
Q psy3880 140 IMYTLLV-GCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC 218 (408)
Q Consensus 140 il~~ll~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~ 218 (408)
++|+|++ |.+||.+.+....+.++..
T Consensus 236 ~l~ellt~g~p~~~~~~~~~~~~~~i~----------------------------------------------------- 262 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDSKFYKMIK----------------------------------------------------- 262 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHH-----------------------------------------------------
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHh-----------------------------------------------------
Confidence 9999998 5666655443333333222
Q ss_pred CCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 219 PPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.......+ ..+|+++++||.+||..||++|||++|+|+
T Consensus 263 -----------------~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 -----------------EGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -----------------HTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------cCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11111111 346899999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-35 Score=280.19 Aligned_cols=188 Identities=20% Similarity=0.323 Sum_probs=150.3
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhhC---------------CHHHHHHHHHHHHHHHHHHHHCCCe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDIIN---------------SNPALRYIMRQLFEALEHVHNHSVV 68 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~~---------------~~~~~r~i~~qil~aL~~LH~~~Iv 68 (408)
.+.|+|+| .+.. ..++..++|||||.+|+ |.+++. +...+..++.|++.||.|||+++|+
T Consensus 79 ~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~g~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 79 EFNCHHVV-RLLGVVSQGQPTLVIMELMTRGD--LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp GCCCTTBC-CEEEEECSSSSCEEEEECCTTCB--HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HcCCCCEe-eeeeEEecCCceeEEEeecCCCC--HHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 46788855 5554 44566799999999998 877654 3356788999999999999999999
Q ss_pred eccCCCCcEEEecCCCEEEeccccchhcccCcc---cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHH
Q psy3880 69 HRDLKPENILLDDQMNVKLTDFGFARVLKKGEK---LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLL 145 (408)
Q Consensus 69 HRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll 145 (408)
||||||+|||++.++.+||+|||+|+.+..... ....+||+.|+|||.+.. ..|+.++|||||||++|+|+
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~------~~~~~~~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD------GVFTTYSDVWSFGVVLWEIA 229 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH------CCCCHHHHHHHHHHHHHHHH
T ss_pred eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc------CCCCcccccccHHHHHHHHH
Confidence 999999999999999999999999987654332 233578999999999975 35788999999999999999
Q ss_pred hC-CCCCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 146 VG-CPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 146 ~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
+| .+||.+.+..+.+..+..+.
T Consensus 230 t~~~~p~~~~~~~~~~~~i~~~~--------------------------------------------------------- 252 (308)
T d1p4oa_ 230 TLAEQPYQGLSNEQVLRFVMEGG--------------------------------------------------------- 252 (308)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTC---------------------------------------------------------
T ss_pred hCCCCCCCCCCHHHHHHHHHhCC---------------------------------------------------------
Confidence 98 46776666555555444321
Q ss_pred hhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 225 KQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 225 ~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
.. +....+|+++++||.+||+.||++|||++|+++
T Consensus 253 -------------~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 -------------LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 10 111357889999999999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=277.85 Aligned_cols=189 Identities=21% Similarity=0.329 Sum_probs=145.2
Q ss_pred ccccCCcEEEEec---cCCcHHHHHHHHHhhchhhHHhhhCC------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q psy3880 6 MVAHSRVVVRVKE---EGDDLKHLAAQVVDKGEAAVQDIINS------NPALRYIMRQLFEALEHVHNHSVVHRDLKPEN 76 (408)
Q Consensus 6 ~~~~~~~i~~~~~---~~~~~~~lv~e~~~~g~~~l~~~~~~------~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~N 76 (408)
.+.|+|+| ++.. +.+...++|||||.+|. |.+.+.. ...+..++.|++.||.|||+++|+||||||+|
T Consensus 84 ~l~HpnIv-~~~g~~~~~~~~~~lv~E~~~~g~--l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N 160 (311)
T d1r0pa_ 84 DFSHPNVL-SLLGICLRSEGSPLVVLPYMKHGD--LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 160 (311)
T ss_dssp TCCCTTBC-CCCEEEEETTTEEEEEEECCTTCB--HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hCCCCCEe-EEeEEEEecCCceEEEEEEeecCc--hhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence 47899866 5543 23446789999999998 7776543 26778999999999999999999999999999
Q ss_pred EEEecCCCEEEeccccchhcccCcc-----cccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCC
Q psy3880 77 ILLDDQMNVKLTDFGFARVLKKGEK-----LMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 151 (408)
Q Consensus 77 ILl~~~~~iKl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf 151 (408)
||+++++.+||+|||+++.+..... .....||+.|+|||.+.. ..++.++|||||||++|||++|..||
T Consensus 161 ILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT------QKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp EEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc------CCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 9999999999999999987654322 223568999999999875 35789999999999999999987777
Q ss_pred CCch-hHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 152 WHRK-QMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 152 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.... ..+...
T Consensus 235 ~~~~~~~~~~~--------------------------------------------------------------------- 245 (311)
T d1r0pa_ 235 YPDVNTFDITV--------------------------------------------------------------------- 245 (311)
T ss_dssp CC------CHH---------------------------------------------------------------------
T ss_pred CCCCCHHHHHH---------------------------------------------------------------------
Confidence 5432 111111
Q ss_pred HHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCHHHHHcC
Q psy3880 231 RNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSVKEALNH 276 (408)
Q Consensus 231 ~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta~e~L~H 276 (408)
.+..+... ..+ ..+++++++||.+||..||++|||+.|+++|
T Consensus 246 -~i~~g~~~-~~p--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 246 -YLLQGRRL-LQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -HHHTTCCC-CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHcCCCC-CCc--ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12222111 111 3468899999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=2.9e-34 Score=274.74 Aligned_cols=202 Identities=16% Similarity=0.223 Sum_probs=145.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhh---hCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEe
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDI---INSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLD 80 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~---~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~ 80 (408)
.+.|+++|+.+.. ...+..++||||+.++....... ..+..++..++.|++.||+|||++|||||||||+|||++
T Consensus 58 ~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp HSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred HccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 4678887766554 45566789999997664222111 235689999999999999999999999999999999985
Q ss_pred c---CCCEEEeccccchhcccCc--------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHHHhCCC
Q psy3880 81 D---QMNVKLTDFGFARVLKKGE--------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCP 149 (408)
Q Consensus 81 ~---~~~iKl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~ 149 (408)
. +..+||+|||+|+.+.... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|..
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG------IEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT------BCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC------CCCCChhhEEecCHHHHHHHhCCC
Confidence 3 4579999999998775432 1234689999999999875 457899999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccCCCCCCccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHH
Q psy3880 150 PFWHRKQMVMLRNIMEGKYSFSSPEWNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVM 229 (408)
Q Consensus 150 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~ 229 (408)
||.+.........+..
T Consensus 212 P~~~~~~~~~~~~~~~---------------------------------------------------------------- 227 (299)
T d1ckia_ 212 PWQGLKAATKRQKYER---------------------------------------------------------------- 227 (299)
T ss_dssp TTCCCC-------HHH----------------------------------------------------------------
T ss_pred cccccchHHHHHHHHH----------------------------------------------------------------
Confidence 9976543222111110
Q ss_pred HHHHHhcCCCCC-CCcCCCCCccHHHHHHHhcccCCCCCCCHH---HHHcCCCCC
Q psy3880 230 LRNIMEGKYSFS-SPEWNDISEDPKDLIRKLLIVTPEDRYSVK---EALNHSFFH 280 (408)
Q Consensus 230 ~~~i~~~~~~f~-~~~~~~iS~~~~dLI~klL~~dP~~R~ta~---e~L~Hpwf~ 280 (408)
........+ ...+..+|+++.+||.+||..||++|||+. ++|+|+|..
T Consensus 228 ---~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 228 ---ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000000000 011346789999999999999999999976 557787654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.7e-34 Score=276.07 Aligned_cols=145 Identities=22% Similarity=0.329 Sum_probs=114.5
Q ss_pred ccccCCcEEEEecc----CC--cHHHHHHHHHhhchhhHHhhhCC----HHHHHHHHHHHHHHHHHHHH--------CCC
Q psy3880 6 MVAHSRVVVRVKEE----GD--DLKHLAAQVVDKGEAAVQDIINS----NPALRYIMRQLFEALEHVHN--------HSV 67 (408)
Q Consensus 6 ~~~~~~~i~~~~~~----~~--~~~~lv~e~~~~g~~~l~~~~~~----~~~~r~i~~qil~aL~~LH~--------~~I 67 (408)
.+.|+|+| .++.. +. ...++|||||.+|+ |.+++.+ ......++.|++.||+|||+ +||
T Consensus 53 ~~~HpnIv-~~~~~~~~~~~~~~~~~lv~Ey~~~g~--L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I 129 (303)
T d1vjya_ 53 MLRHENIL-GFIAADNKDNGTWTQLWLVSDYHEHGS--LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129 (303)
T ss_dssp TCCCTTBC-CEEEEEEEECSSSEEEEEEEECCTTCB--HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred hCCCCcCc-ceEEEEEeCCCcceEEEEEEecccCCC--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCe
Confidence 46788866 54442 11 24689999999999 8888753 46778899999999999996 699
Q ss_pred eeccCCCCcEEEecCCCEEEeccccchhcccCc-----ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHH
Q psy3880 68 VHRDLKPENILLDDQMNVKLTDFGFARVLKKGE-----KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMY 142 (408)
Q Consensus 68 vHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~ 142 (408)
|||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++..........++.++|||||||++|
T Consensus 130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~ 209 (303)
T d1vjya_ 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred eccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence 999999999999999999999999998765432 123478999999999987543222234678999999999999
Q ss_pred HHHhCCCCCCC
Q psy3880 143 TLLVGCPPFWH 153 (408)
Q Consensus 143 ~ll~G~~pf~~ 153 (408)
||++|..||..
T Consensus 210 el~tg~~~~~~ 220 (303)
T d1vjya_ 210 EIARRCSIGGI 220 (303)
T ss_dssp HHHHTBCBTTB
T ss_pred HHhhCCCCCCc
Confidence 99999988744
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.9e-33 Score=275.28 Aligned_cols=200 Identities=23% Similarity=0.392 Sum_probs=129.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEecCC------CEEEeccccchhcccCcccccCCCCCcccChhh
Q psy3880 44 SNPALRYIMRQLFEALEHVHN-HSVVHRDLKPENILLDDQM------NVKLTDFGFARVLKKGEKLMDLCGTPGYLAPEV 116 (408)
Q Consensus 44 ~~~~~r~i~~qil~aL~~LH~-~~IvHRDLKp~NILl~~~~------~iKl~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 116 (408)
....++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||.|..... .....+||+.|+|||+
T Consensus 123 ~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~ 200 (362)
T d1q8ya_ 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEV 200 (362)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhh
Confidence 458899999999999999998 9999999999999998654 389999999876543 3356789999999999
Q ss_pred hhhccccCcCCCCcchhhhhhhHHHHHHHhCCCCCCCchhH------HHHHHHHhccccCCCCCCccCCCCCchHHHhhh
Q psy3880 117 LRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM------VMLRNIMEGKYSFSSPEWNDISGYLAPEVLRAN 190 (408)
Q Consensus 117 l~~~~~~~~~~~~~~~DiwSlGvil~~ll~G~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~PE~l~~~ 190 (408)
+.. ..|+.++|+||+||++++|++|+.||...+.. ..+..+...... ...+.....
T Consensus 201 ~~~------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~------------~~~~~~~~~ 262 (362)
T d1q8ya_ 201 LLG------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE------------LPSYLLRNG 262 (362)
T ss_dssp HHT------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS------------CCHHHHHHC
T ss_pred ccc------cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC------------CCHHHhhcc
Confidence 875 45789999999999999999999999754321 122221111000 011111110
Q ss_pred cccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHHHHHhcccCCCCCCCH
Q psy3880 191 MFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDLIRKLLIVTPEDRYSV 270 (408)
Q Consensus 191 ~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dLI~klL~~dP~~R~ta 270 (408)
... ....++.+.. ...... .... ...+....+.+ +...|++++|||.+||++||.+||||
T Consensus 263 ~~~-------~~~~~~~~~~-----~~~~~~-~~~~---~~~~~~~~~~~----~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 263 KYT-------RTFFNSRGLL-----RNISKL-KFWP---LEDVLTEKYKF----SKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp TTH-------HHHBCC--CB-----SSCCCC-CBCC---HHHHHHHTTCC----CHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred ccc-------ccccccchhh-----hccccc-cCCc---hhhhccccccc----CcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000 0000000000 000000 0000 11122222222 24568899999999999999999999
Q ss_pred HHHHcCCCCCCCC
Q psy3880 271 KEALNHSFFHPKL 283 (408)
Q Consensus 271 ~e~L~Hpwf~~~~ 283 (408)
+|||+||||+...
T Consensus 323 ~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 323 GGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHTCGGGTTCT
T ss_pred HHHhcCcccCCCC
Confidence 9999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=9.2e-33 Score=263.91 Aligned_cols=140 Identities=20% Similarity=0.329 Sum_probs=111.7
Q ss_pred ccccCCcEEEEec--cCCcHHHHHHHHHhhchhhHHhhh------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q psy3880 6 MVAHSRVVVRVKE--EGDDLKHLAAQVVDKGEAAVQDII------NSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENI 77 (408)
Q Consensus 6 ~~~~~~~i~~~~~--~~~~~~~lv~e~~~~g~~~l~~~~------~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NI 77 (408)
+|.|+++|+.+.+ +.+...++||||+. |. |.+.+ .+..++..++.|++.||+|||++|||||||||+||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~~-~~--l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni 132 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLG-PS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132 (293)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECCC-CB--HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HhcCCCCCCEEEEEeecCCccEEEEEecC-CC--HHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence 4666555655554 44556789999994 44 44443 34578999999999999999999999999999999
Q ss_pred EEec-----CCCEEEeccccchhcccCc--------ccccCCCCCcccChhhhhhccccCcCCCCcchhhhhhhHHHHHH
Q psy3880 78 LLDD-----QMNVKLTDFGFARVLKKGE--------KLMDLCGTPGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTL 144 (408)
Q Consensus 78 Ll~~-----~~~iKl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~DiwSlGvil~~l 144 (408)
|++. ++.+||+|||+|+.+.... .....+||+.|+|||++.+ ..|+.++|+||+||++|+|
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~------~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG------REQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT------CCCCHHHHHHHHHHHHHHH
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC------CCCChHHHHHHhhHHHHHH
Confidence 9974 5689999999998765321 2234689999999999874 4578999999999999999
Q ss_pred HhCCCCCCCc
Q psy3880 145 LVGCPPFWHR 154 (408)
Q Consensus 145 l~G~~pf~~~ 154 (408)
++|..||.+.
T Consensus 207 ltg~~Pf~~~ 216 (293)
T d1csna_ 207 LRGSLPWQGL 216 (293)
T ss_dssp HHSSCTTSSC
T ss_pred HhCCCcCCCc
Confidence 9999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.47 E-value=4.8e-16 Score=137.50 Aligned_cols=99 Identities=15% Similarity=0.237 Sum_probs=69.7
Q ss_pred HHHHHHHhhchhhHHhhhCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEecCCCEEEeccccchhcccCccccc
Q psy3880 25 HLAAQVVDKGEAAVQDIINSNPALRYIMRQLFEALEHVHNHSVVHRDLKPENILLDDQMNVKLTDFGFARVLKKGEKLMD 104 (408)
Q Consensus 25 ~lv~e~~~~g~~~l~~~~~~~~~~r~i~~qil~aL~~LH~~~IvHRDLKp~NILl~~~~~iKl~DFGla~~~~~~~~~~~ 104 (408)
+++|||+.++. +.+. +...++.++.|++.+|+|||++||+||||||+|||+++++ ++|+|||+|........
T Consensus 86 ~lvme~~~~~~--~~~l--~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~--- 157 (191)
T d1zara2 86 AVLMELIDAKE--LYRV--RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW--- 157 (191)
T ss_dssp EEEEECCCCEE--GGGC--CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH---
T ss_pred EEEEEeecccc--ccch--hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc---
Confidence 58899998876 4332 3355678999999999999999999999999999998654 89999999865432211
Q ss_pred CCCCCcccCh--hhhhhccccCcCCCCcchhhhhhh
Q psy3880 105 LCGTPGYLAP--EVLRANMFEDATGYGQAVDVWACG 138 (408)
Q Consensus 105 ~~gt~~y~aP--E~l~~~~~~~~~~~~~~~DiwSlG 138 (408)
..|... +.+. ..+ ...|+.++|+||..
T Consensus 158 ----~~~l~rd~~~~~-~~f--~r~y~~~~d~~s~~ 186 (191)
T d1zara2 158 ----REILERDVRNII-TYF--SRTYRTEKDINSAI 186 (191)
T ss_dssp ----HHHHHHHHHHHH-HHH--HHHHCCCCCHHHHH
T ss_pred ----HHHHHHHHHHHH-HHH--cCCCCCcccHHHHH
Confidence 112111 0010 011 13578899999965
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=9.9e-09 Score=95.86 Aligned_cols=57 Identities=28% Similarity=0.408 Sum_probs=48.2
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcC
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGK 237 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~ 237 (408)
..++..|+|||++... .|+.++||||+||++|+|++|.+||.+.+..+.+..|.+..
T Consensus 175 ~~gT~~Y~APE~~~~~------~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 175 VVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CCCCCTTCCHHHHTTC------CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccChhhcCcchhcCC------CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 3456789999998753 57889999999999999999999999998888877776543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=1.1e-08 Score=94.28 Aligned_cols=50 Identities=26% Similarity=0.551 Sum_probs=39.9
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
..++..|+|||++... .|+.++||||+||++|+|++|.+||.+.+..++.
T Consensus 174 ~~gt~~Y~APE~l~~~------~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~ 223 (269)
T d2java1 174 FVGTPYYMSPEQMNRM------SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223 (269)
T ss_dssp --CCCSCCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCCcccCCHHHHcCC------CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH
Confidence 3456789999999653 5788999999999999999999999776554443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=3.3e-08 Score=92.16 Aligned_cols=60 Identities=32% Similarity=0.394 Sum_probs=48.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSF 240 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f 240 (408)
.++..|+|||++... ..|+.++||||+||++|+|++|.+||.+.+..+++..|.+.....
T Consensus 161 ~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220 (299)
T ss_dssp CCCCTTCCHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ecChhhccHHHHccC-----CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCC
Confidence 356779999998643 347889999999999999999999999988888887776654433
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=2.7e-08 Score=92.64 Aligned_cols=58 Identities=24% Similarity=0.389 Sum_probs=45.0
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
.++..|+|||++..... ....|+.++||||+||++|+|++|.+||.+.+..+.+.++.
T Consensus 171 ~Gt~~y~APE~l~~~~~-~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~ 228 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETS-KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228 (288)
T ss_dssp CSCCTTCCHHHHTTCST-TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred ccccccCCHHHHhhccc-CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 45667999999864322 23468899999999999999999999998776655555544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=3.3e-08 Score=92.25 Aligned_cols=46 Identities=28% Similarity=0.734 Sum_probs=38.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQM 227 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~ 227 (408)
.++..|+|||++... .|+.++||||+||++|+|++|.+||.+.+..
T Consensus 177 ~gt~~Y~aPE~~~~~------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 222 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRK------AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (293)
T ss_dssp CSCGGGCCHHHHSSS------CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ccCCCccChhhhcCC------CCCchhceehHhHHHHHHhhCCCCCCCCCHH
Confidence 356679999999753 5788999999999999999999999766543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=8.9e-08 Score=90.31 Aligned_cols=46 Identities=24% Similarity=0.517 Sum_probs=39.4
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchh
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQ 226 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~ 226 (408)
..++..|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+.
T Consensus 163 ~~GT~~Y~APEvl~~~------~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGT------HYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -CCSSCCCCHHHHHCS------CCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccCCccccCchHHcCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3567789999999763 588999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.36 E-value=7.8e-08 Score=90.30 Aligned_cols=53 Identities=30% Similarity=0.508 Sum_probs=41.8
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
..++..|+|||++.... ...|+.++||||+||++|+|++|.+||.+.+....+
T Consensus 171 ~~GT~~Y~APE~~~~~~---~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~ 223 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMD---EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (309)
T ss_dssp CCSCGGGCCHHHHTTTT---SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cccCccccCHHHHhccC---CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 35667799999996432 235888999999999999999999999776554443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=1.1e-07 Score=89.17 Aligned_cols=64 Identities=25% Similarity=0.400 Sum_probs=50.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEW 245 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~ 245 (408)
.+..|++||++... ..|+.++||||+||++|+|++|.+||.+.+....+..+......+....+
T Consensus 183 gT~~Y~aPE~~~~~-----~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 183 VTLWYRPPELLLGE-----RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp SCGGGCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cCHHHhhHHHHcCC-----CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 56679999998653 35788999999999999999999999988887777777665555544433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=7.1e-08 Score=89.07 Aligned_cols=52 Identities=29% Similarity=0.544 Sum_probs=40.7
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVML 230 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~ 230 (408)
.++..|||||++... ....|+.++||||+||++|+|++|.+||.+.+....+
T Consensus 167 ~gt~~y~APE~l~~~---~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQ---DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp CCCGGGCCHHHHTTC---SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ccCcccCCHHHHhcc---cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence 345679999999643 2235788999999999999999999999876544433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=5.2e-08 Score=89.83 Aligned_cols=43 Identities=35% Similarity=0.765 Sum_probs=35.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
.++..|+|||++....+ ++.++||||+||++|+|++|.+||..
T Consensus 166 ~GT~~Y~APE~~~~~~~-----~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 166 CGTLPYVAPELLKRREF-----HAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CSCGGGSCTHHHHCSSB-----CHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred eeCcCccCHhHhcCCCC-----CCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 45678999999976432 46689999999999999999999954
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=1e-07 Score=87.67 Aligned_cols=42 Identities=26% Similarity=0.488 Sum_probs=36.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
.++..|+|||++.. +|+.++||||+||++|+|++|.+||...
T Consensus 174 ~GT~~Y~aPE~~~~-------~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 174 IGTPEFMAPEMYEE-------KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CSSCCCCCGGGGGT-------CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCccccCHHHhCC-------CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 45678999998853 4788999999999999999999999643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=1.2e-07 Score=89.57 Aligned_cols=41 Identities=27% Similarity=0.574 Sum_probs=35.1
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
+..|||||++... .|+.++||||+||++|+|++ |.+||.+.
T Consensus 229 t~~y~aPE~l~~~------~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 229 PVKWMAPESLFEG------IYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp CGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CCccCChHHHcCC------CCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 5569999999764 47889999999999999997 89999653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=98.27 E-value=2.1e-07 Score=85.88 Aligned_cols=67 Identities=25% Similarity=0.405 Sum_probs=52.4
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWND 247 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~ 247 (408)
.....|++||.+... ..|+.++|+||+||++|+|++|.+||.+.+..+.+.++...........|..
T Consensus 161 ~~~~~y~~pE~~~~~-----~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp -CCCTTCCHHHHTTC-----CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccchhhhHHHHhCC-----CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 355679999998653 3478899999999999999999999998888887777776655555555544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=2.3e-07 Score=86.30 Aligned_cols=62 Identities=24% Similarity=0.244 Sum_probs=48.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
...+..|++||++.... .++.++|+||+||++|+|++|++||.+.+....+.++........
T Consensus 162 ~~gt~~y~apE~~~~~~-----~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~ 223 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCK-----YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223 (298)
T ss_dssp CBCCCTTCCHHHHTTCS-----SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccceeeehhhhcccc-----CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 35667899999986543 357799999999999999999999998887777777665544433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=2.3e-07 Score=88.47 Aligned_cols=78 Identities=21% Similarity=0.276 Sum_probs=59.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCccHHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISEDPKDL 255 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~~~~dL 255 (408)
..+..|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+.......+...........|.......+++
T Consensus 179 ~~t~~y~aPE~l~~~------~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 179 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --CCTTCCHHHHTTC------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccChhhhcCC------CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 345679999999753 57889999999999999999999999988887777777665554444566666666666
Q ss_pred HHHh
Q psy3880 256 IRKL 259 (408)
Q Consensus 256 I~kl 259 (408)
....
T Consensus 253 ~~~~ 256 (355)
T d2b1pa1 253 VENR 256 (355)
T ss_dssp HHTS
T ss_pred hhcC
Confidence 6644
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.21 E-value=1.6e-07 Score=90.16 Aligned_cols=45 Identities=33% Similarity=0.683 Sum_probs=37.8
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..++..|+|||++... ..|+.++||||+||++|+|++|.+||.+.
T Consensus 165 ~~GT~~y~APE~~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 165 SVGTHGYMAPEVLQKG-----VAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CCSCGGGCCHHHHSTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccccchhHHhhcC-----CCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 3467789999998642 35888999999999999999999999653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=5.6e-08 Score=92.35 Aligned_cols=52 Identities=38% Similarity=0.737 Sum_probs=39.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHH
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRN 232 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~ 232 (408)
..++..|+|||++... .|+.++||||+||++|+|++|.+||.+.+.......
T Consensus 173 ~~gt~~y~aPE~~~~~------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~ 224 (335)
T d2ozaa1 173 PCYTPYYVAPEVLGPE------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224 (335)
T ss_dssp CSCCCSSCCCCCCCGG------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----
T ss_pred ccCCcccCCcHHHcCC------CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH
Confidence 3467789999998654 478899999999999999999999987655444433
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=2.5e-07 Score=85.77 Aligned_cols=48 Identities=27% Similarity=0.468 Sum_probs=38.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..++.
T Consensus 174 gt~~y~aPE~~~~~------~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~ 222 (285)
T d1u59a_ 174 WPLKWYAPECINFR------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222 (285)
T ss_dssp CCGGGCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred cCccccChHHHhCC------CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 34569999999764 46789999999999999997 99999765544443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.17 E-value=2.7e-07 Score=84.64 Aligned_cols=48 Identities=31% Similarity=0.555 Sum_probs=38.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..++.
T Consensus 171 gt~~y~apE~l~~~------~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~ 219 (273)
T d1mp8a_ 171 LPIKWMAPESINFR------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219 (273)
T ss_dssp CCGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred cCcccchhhHhccC------CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH
Confidence 34569999999764 47789999999999999987 89999766544333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=4.7e-07 Score=85.82 Aligned_cols=70 Identities=26% Similarity=0.346 Sum_probs=52.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCCCCcCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFSSPEWNDISE 250 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~~~~~~~iS~ 250 (408)
.....|++||++... ..++.++||||+||++|+|++|.+||.+.+....+..+.......+...|.....
T Consensus 179 ~~t~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 179 VVTRWYRAPEVILNW-----MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSCGGGCCTHHHHTT-----TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccccccCHHHHcCC-----CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 455679999998653 2467899999999999999999999999888777777766554444333333333
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=3.4e-07 Score=84.35 Aligned_cols=48 Identities=25% Similarity=0.451 Sum_probs=38.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..++.
T Consensus 172 gt~~y~APE~l~~~------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~ 220 (277)
T d1xbba_ 172 WPVKWYAPECINYY------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220 (277)
T ss_dssp CCGGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred CCceecCchhhcCC------CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH
Confidence 34569999999764 46779999999999999997 89999776554433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=5.3e-07 Score=82.85 Aligned_cols=46 Identities=26% Similarity=0.572 Sum_probs=37.7
Q ss_pred CCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 179 SGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 179 ~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
..|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..+.+
T Consensus 178 ~~~~aPE~~~~~------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~ 224 (273)
T d1u46a_ 178 FAWCAPESLKTR------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224 (273)
T ss_dssp GGGCCHHHHHHC------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred cccCCHHHHhCC------CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH
Confidence 468999999865 35678999999999999997 89999876655443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=1.9e-06 Score=79.75 Aligned_cols=17 Identities=29% Similarity=0.249 Sum_probs=10.3
Q ss_pred CcEEEecCCCEEEeccc
Q psy3880 75 ENILLDDQMNVKLTDFG 91 (408)
Q Consensus 75 ~NILl~~~~~iKl~DFG 91 (408)
.++-+.+-|..+..+.+
T Consensus 154 ~~vkl~DfG~a~~~~~~ 170 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFG 170 (293)
T ss_dssp CCEEECCCTTCEECTTS
T ss_pred cceEecchhhhhhcCCC
Confidence 35666666666665544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.07 E-value=6.2e-07 Score=83.49 Aligned_cols=48 Identities=25% Similarity=0.635 Sum_probs=38.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|+|||.+... .|+.++||||+||++|+|++ |.+||.+.+..+++
T Consensus 195 ~t~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~ 243 (299)
T d1jpaa_ 195 IPIRWTAPEAIQYR------KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243 (299)
T ss_dssp -CGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCccccCHHHHhcC------CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 34569999998753 47789999999999999997 89999876654443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.06 E-value=9.9e-07 Score=83.39 Aligned_cols=60 Identities=30% Similarity=0.403 Sum_probs=48.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHhcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIMEGKYSFS 241 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~~~~~f~ 241 (408)
....|++||++... ..++.++|+||+||++|+|++|.+||.+.+.......|........
T Consensus 180 g~~~y~apE~~~~~-----~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 180 ATRWYRAPEIMLNW-----MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp HHHHTSCHHHHTTC-----SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCchhhcCC-----ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 34459999987653 2467899999999999999999999999988888888877655443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.05 E-value=8.1e-07 Score=80.99 Aligned_cols=48 Identities=27% Similarity=0.547 Sum_probs=36.4
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVML 230 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~ 230 (408)
....|+|||++... .|+.++||||+||++|+|++ |.+||...+..+++
T Consensus 164 gt~~y~aPE~l~~~------~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~ 212 (263)
T d1sm2a_ 164 FPVKWASPEVFSFS------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212 (263)
T ss_dssp -CTTSCCHHHHTTC------CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH
T ss_pred cCcccCChHHhcCC------CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 45669999999754 47889999999999999998 57776555443333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.05 E-value=1.3e-06 Score=82.87 Aligned_cols=55 Identities=31% Similarity=0.506 Sum_probs=45.9
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHHh
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIME 235 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~~ 235 (408)
.....|++||++... ..|+.++||||+||++|+|++|.+||...+..+.+..|.+
T Consensus 183 ~gt~~y~aPE~~~~~-----~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 183 ICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp CSCTTSCCHHHHTTC-----SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred cccccccChHHhhcc-----cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 456679999988653 3578899999999999999999999998887777776654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=8.9e-07 Score=80.64 Aligned_cols=50 Identities=24% Similarity=0.421 Sum_probs=40.0
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQMVMLRN 232 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~~~~~~ 232 (408)
....|+|||++... .|+.++||||+||++|+|++ |.+||.+.+..++...
T Consensus 163 ~t~~y~aPE~~~~~------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~ 213 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYS------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213 (258)
T ss_dssp CCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH
T ss_pred CCCCcCCcHHhcCC------CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH
Confidence 34559999999864 46789999999999999998 8999987765554443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.03 E-value=2e-06 Score=80.34 Aligned_cols=24 Identities=21% Similarity=0.295 Sum_probs=8.0
Q ss_pred CCeeccCC-CCcEEEecCCCEEEec
Q psy3880 66 SVVHRDLK-PENILLDDQMNVKLTD 89 (408)
Q Consensus 66 ~IvHRDLK-p~NILl~~~~~iKl~D 89 (408)
+|.-.... ..++-+.+-|..+..+
T Consensus 137 Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 137 NLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp GEEESSSSTTCCEEECCC-------
T ss_pred ceeecccCCCceEEEeccceeEEcc
Confidence 55443322 2346666666555444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=1e-06 Score=82.51 Aligned_cols=43 Identities=26% Similarity=0.457 Sum_probs=35.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~ 224 (408)
..+..|+|||++... .|+.++||||+||++|+|++ |.+||.+.
T Consensus 174 ~gt~~y~APE~l~~~------~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 174 KVPIKWMALESILHR------IYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp -CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccCccccChHHHhcC------CCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 345679999999764 47889999999999999998 78888654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=1.2e-06 Score=79.94 Aligned_cols=44 Identities=25% Similarity=0.533 Sum_probs=35.8
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchh
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQ 226 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~ 226 (408)
....|+|||.+... .|+.++||||+||++|+|++ |.+||...+.
T Consensus 162 ~~~~y~aPE~l~~~------~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 162 LPVKWTAPEALREK------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp CCTTTSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred ccccCCChHHHhCC------CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 44569999998764 47889999999999999998 7888865443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=2.1e-06 Score=79.39 Aligned_cols=14 Identities=21% Similarity=0.235 Sum_probs=7.7
Q ss_pred cEEEecCCCEEEec
Q psy3880 76 NILLDDQMNVKLTD 89 (408)
Q Consensus 76 NILl~~~~~iKl~D 89 (408)
++-+.+-|..+..+
T Consensus 146 ~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 146 HIQITDFGTAKVLS 159 (288)
T ss_dssp CEEECCCTTCEECC
T ss_pred eEEecccccceecc
Confidence 45565656555543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=1.5e-06 Score=79.66 Aligned_cols=42 Identities=19% Similarity=0.389 Sum_probs=33.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~~ 223 (408)
.....|+|||++... .|+.++||||+||++|+|++| .|||..
T Consensus 171 ~gt~~y~APE~~~~~------~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 171 KFPIKWTAPEAINYG------TFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CCCTTTSCHHHHHHC------EECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCcccccChHHHhCC------CCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 345569999999764 467899999999999999995 555433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.95 E-value=1.7e-06 Score=80.35 Aligned_cols=49 Identities=22% Similarity=0.474 Sum_probs=38.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCCCchhHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFWHRKQMVMLR 231 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~~~~~~~~~~ 231 (408)
....|+|||.+... .|+.++||||+||++|+|++| .+||.+.+..++..
T Consensus 204 ~~~~y~aPE~~~~~------~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~ 253 (301)
T d1lufa_ 204 IPIRWMPPESIFYN------RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253 (301)
T ss_dssp BCGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred cCcCcCCHHHHccC------CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH
Confidence 44569999999764 477899999999999999998 57887665554443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=1.4e-06 Score=81.89 Aligned_cols=18 Identities=28% Similarity=0.665 Sum_probs=10.4
Q ss_pred chhHHHHHHHHhccccCC
Q psy3880 154 RKQMVMLRNIMEGKYSFS 171 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~ 171 (408)
.+..+.+.+|..+.+.+.
T Consensus 206 ~~~~~~~~~i~~~~~~~~ 223 (321)
T d1tkia_ 206 ETNQQIIENIMNAEYTFD 223 (321)
T ss_dssp SSHHHHHHHHHHTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCC
Confidence 345556666766665544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.94 E-value=1.5e-06 Score=80.34 Aligned_cols=45 Identities=13% Similarity=0.145 Sum_probs=38.2
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
..++..|+|||++.+. .|+.++|+||+||++|+|++|.+||....
T Consensus 173 ~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 173 LTGTARYASINTHLGI------EQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CCCCSSSCCHHHHTTB------CCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cCCCccccCHHHHhCC------CCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 3467789999998753 47889999999999999999999997644
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=3.2e-06 Score=77.02 Aligned_cols=10 Identities=0% Similarity=-0.286 Sum_probs=4.9
Q ss_pred cCCcHHHHHH
Q psy3880 19 EGDDLKHLAA 28 (408)
Q Consensus 19 ~~~~~~~lv~ 28 (408)
.+.++..++.
T Consensus 89 ~~g~L~~~l~ 98 (263)
T d2j4za1 89 PLGTVYRELQ 98 (263)
T ss_dssp TTCBHHHHHH
T ss_pred CCCcHHHHHh
Confidence 4455554443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.92 E-value=2.8e-06 Score=78.75 Aligned_cols=46 Identities=26% Similarity=0.489 Sum_probs=37.5
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCCchhH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWHRKQM 227 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~~~~~ 227 (408)
.....|++||.+... .|+.++||||+||++|+|++ |.+||.+.+..
T Consensus 198 ~~~~~y~aPE~l~~~------~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 198 RLPVKWMAPEALFDR------IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CCGGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCChhhhhhhHhcCC------CCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 445679999999764 57889999999999999997 79898665443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=97.92 E-value=3.4e-06 Score=80.22 Aligned_cols=23 Identities=9% Similarity=0.021 Sum_probs=11.7
Q ss_pred CCCeeccCCCCcEEEecCCCEEE
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKL 87 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl 87 (408)
.+|.-..-+..++-|.+-|..+.
T Consensus 156 ~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 156 ENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp GGEEESSTTCCCEEECCCTTCEE
T ss_pred ccccccccCCCeEEEeeccccee
Confidence 45554333445676666554443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.92 E-value=1.5e-06 Score=80.51 Aligned_cols=93 Identities=14% Similarity=0.058 Sum_probs=68.8
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch---hHHHHHHHHhcCCCCCC-CcCCCCCc
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK---QMVMLRNIMEGKYSFSS-PEWNDISE 250 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~---~~~~~~~i~~~~~~f~~-~~~~~iS~ 250 (408)
..++..|+|||++... .|+.++|+||+||++|+|++|.+||.+.. .......+.......+. .....+++
T Consensus 173 ~~GT~~y~aPE~~~~~------~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (293)
T d1csna_ 173 LSGTARYMSINTHLGR------EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246 (293)
T ss_dssp CCSCTTTCCHHHHTTC------CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred eEEchhhcCHHHhcCC------CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCH
Confidence 3467789999998753 57889999999999999999999997543 33333444333222211 11246789
Q ss_pred cHHHHHHHhcccCCCCCCCHHHH
Q psy3880 251 DPKDLIRKLLIVTPEDRYSVKEA 273 (408)
Q Consensus 251 ~~~dLI~klL~~dP~~R~ta~e~ 273 (408)
++.+++..|+..+|++||+.+.+
T Consensus 247 ~l~~ii~~~~~~~~~~rP~y~~l 269 (293)
T d1csna_ 247 EFYKYMHYARNLAFDATPDYDYL 269 (293)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHH
Confidence 99999999999999999986654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=1.7e-06 Score=80.14 Aligned_cols=42 Identities=24% Similarity=0.475 Sum_probs=34.1
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFWH 223 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~~ 223 (408)
.++..|+|||++... .|+.++||||+||++|+|++| .+||.+
T Consensus 197 ~gt~~y~APE~l~~~------~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 197 RLPLKWMAPETIFDR------VYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeCccccchhHhhcC------CCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 345679999999764 477899999999999999986 566643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.88 E-value=2.6e-06 Score=78.65 Aligned_cols=40 Identities=28% Similarity=0.437 Sum_probs=33.1
Q ss_pred CCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 178 ISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 178 ~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
...|+|||++... .|+.++||||+||++|+|++|..||+.
T Consensus 179 ~~~y~aPE~~~~~------~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 179 PIKWTAPESLAYN------KFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp CGGGCCHHHHHHC------CCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccccChHHHcCC------CCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 4559999999764 478899999999999999997666543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=2.5e-06 Score=78.46 Aligned_cols=39 Identities=23% Similarity=0.425 Sum_probs=31.9
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.+..|+|||++... .|+.++||||+||++|+|++|..||
T Consensus 175 gt~~Y~APE~l~~~------~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 175 IPIRWTAPEAISYR------KFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp CCGGGSCHHHHHSC------CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCccccCHHHHccC------CCCCcccccccHHHHHHHHhCCCCc
Confidence 45569999998754 5778999999999999999965544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=97.86 E-value=4.1e-06 Score=76.57 Aligned_cols=9 Identities=22% Similarity=0.608 Sum_probs=3.9
Q ss_pred cCCcHHHHH
Q psy3880 19 EGDDLKHLA 27 (408)
Q Consensus 19 ~~~~~~~lv 27 (408)
++.++...+
T Consensus 94 ~g~~L~~~~ 102 (277)
T d1o6ya_ 94 DGVTLRDIV 102 (277)
T ss_dssp CEEEHHHHH
T ss_pred CCCEehhhh
Confidence 344544333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=2.6e-06 Score=80.68 Aligned_cols=53 Identities=28% Similarity=0.592 Sum_probs=42.6
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCchhHHHHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRKQMVMLRNIM 234 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~~~~~~~~i~ 234 (408)
....|++||++... ..|+.++|+||+||++|+|++|.+||.+.+.......+.
T Consensus 174 gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 174 ATRWYRAPEIMLNS-----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp SCGGGCCGGGTTTB-----CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccceechHHHhhcC-----CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 45679999998653 347889999999999999999999998877665555443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=4.8e-06 Score=78.10 Aligned_cols=11 Identities=27% Similarity=0.304 Sum_probs=5.7
Q ss_pred cCCcHHHHHHH
Q psy3880 19 EGDDLKHLAAQ 29 (408)
Q Consensus 19 ~~~~~~~lv~e 29 (408)
++.++..++..
T Consensus 86 ~~g~L~~~i~~ 96 (320)
T d1xjda_ 86 NGGDLMYHIQS 96 (320)
T ss_dssp TTCBHHHHHHH
T ss_pred CCCcHHHHhhc
Confidence 45566555543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=97.83 E-value=5e-06 Score=79.01 Aligned_cols=23 Identities=9% Similarity=0.042 Sum_probs=10.3
Q ss_pred CCCeeccCCCCcEEEecCCCEEE
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKL 87 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl 87 (408)
.+|+-.+=+...+-+.+-|..+.
T Consensus 153 ~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 153 ENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp GGEEESSTTSCCEEECCCTTCEE
T ss_pred hHeeeccCCCCeEEEeecchhee
Confidence 34543322234565655554443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.82 E-value=6.4e-06 Score=77.05 Aligned_cols=14 Identities=21% Similarity=0.095 Sum_probs=7.9
Q ss_pred CcEEEecCCCEEEe
Q psy3880 75 ENILLDDQMNVKLT 88 (408)
Q Consensus 75 ~NILl~~~~~iKl~ 88 (408)
.++-|.+-|..+..
T Consensus 141 g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 141 GHIKITDFGFAKYV 154 (316)
T ss_dssp SCEEECCCSSCEEC
T ss_pred CCEEEecCccceEe
Confidence 35666666655544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=1.6e-06 Score=79.32 Aligned_cols=41 Identities=29% Similarity=0.656 Sum_probs=34.6
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCC
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPF 221 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf 221 (408)
.++..|+|||++.... .++.++||||+||++|+|++|.+||
T Consensus 170 ~GT~~y~aPE~~~~~~-----~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 170 DGTRVYSPPEWIRYHR-----YHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp CSCGGGSCHHHHHHSC-----BCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCCcCCHHHHcCCC-----CCCcccccccceeeehhHhhCCCCC
Confidence 4567799999997653 2466899999999999999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=6.4e-06 Score=77.81 Aligned_cols=10 Identities=20% Similarity=0.262 Sum_probs=4.9
Q ss_pred ccCCcHHHHH
Q psy3880 18 EEGDDLKHLA 27 (408)
Q Consensus 18 ~~~~~~~~lv 27 (408)
.++.++..++
T Consensus 87 ~~gg~L~~~~ 96 (337)
T d1o6la_ 87 ANGGELFFHL 96 (337)
T ss_dssp CTTCBHHHHH
T ss_pred cCCCchhhhh
Confidence 3555555443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=1.2e-06 Score=81.49 Aligned_cols=101 Identities=16% Similarity=0.198 Sum_probs=68.7
Q ss_pred CccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc---------------hhHHHHHHHHhcCCC
Q psy3880 175 WNDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR---------------KQMVMLRNIMEGKYS 239 (408)
Q Consensus 175 ~~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~---------------~~~~~~~~i~~~~~~ 239 (408)
..++..|+|||.+..........|+.++||||+||++|+|++|.+||... ........+......
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T d1vjya_ 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251 (303)
T ss_dssp CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred eecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC
Confidence 34567899999988754444445778999999999999999999887432 112222223332322
Q ss_pred CCC-CcCCC--CCccHHHHHHHhcccCCCCCCCHHHHHc
Q psy3880 240 FSS-PEWND--ISEDPKDLIRKLLIVTPEDRYSVKEALN 275 (408)
Q Consensus 240 f~~-~~~~~--iS~~~~dLI~klL~~dP~~R~ta~e~L~ 275 (408)
... ..|.. ...++.+|+.+||+.||++|||+.|+++
T Consensus 252 p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111 11211 2235789999999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.79 E-value=7e-06 Score=77.93 Aligned_cols=14 Identities=21% Similarity=-0.031 Sum_probs=7.6
Q ss_pred CcEEEecCCCEEEe
Q psy3880 75 ENILLDDQMNVKLT 88 (408)
Q Consensus 75 ~NILl~~~~~iKl~ 88 (408)
.++-|.+-|..+..
T Consensus 178 g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 178 GYIQVTDFGFAKRV 191 (350)
T ss_dssp SCEEECCCTTCEEC
T ss_pred CCEEeeeceeeeec
Confidence 35666665655543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=5.1e-06 Score=77.36 Aligned_cols=48 Identities=21% Similarity=0.365 Sum_probs=36.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCC-CCCCCchhHHH
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGC-PPFWHRKQMVM 229 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~-~Pf~~~~~~~~ 229 (408)
.....|++||.+... .|+.++||||+||++|+|++|. +||.+.+..++
T Consensus 187 ~gt~~y~aPE~l~~~------~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 187 RLPVRWMAIESLNYS------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp -CCTTTCCHHHHHHC------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ecCCcccchHHhccC------CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 345679999999764 4677999999999999999965 66765554443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.70 E-value=5.2e-06 Score=77.34 Aligned_cols=41 Identities=27% Similarity=0.545 Sum_probs=33.0
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhc-CCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLV-GCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~-g~~Pf~~ 223 (408)
....|+|||.+... .|+.++||||+||++|+|++ |.|||..
T Consensus 209 gt~~y~aPE~~~~~------~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 209 LPVKWMAPESIFNC------VYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp ECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cChHHcCHHHhcCC------CCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 34569999999754 46789999999999999998 5666543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.70 E-value=7.1e-06 Score=75.60 Aligned_cols=40 Identities=20% Similarity=0.286 Sum_probs=32.5
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFW 222 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~ 222 (408)
....|+|||.+... .|+.++||||+||++|+|++|..||.
T Consensus 176 gt~~y~aPE~~~~~------~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 176 FPIKWTAPEAALYG------RFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp CCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccChHHHhCC------CCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 45669999999764 46779999999999999999655543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.65 E-value=1.7e-05 Score=72.42 Aligned_cols=58 Identities=22% Similarity=0.325 Sum_probs=41.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC-chhHHHHHHHHhcCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH-RKQMVMLRNIMEGKYS 239 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~-~~~~~~~~~i~~~~~~ 239 (408)
....+.+||++.... .++.++||||+||++|+|++|..||.. .+..+.+..+......
T Consensus 163 ~~~~~~~pe~~~~~~-----~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 163 VTLWYRPPDVLFGAK-----LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp SCGGGCCHHHHTTCS-----CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhhhhHhccCC-----CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 345588999876542 357899999999999999999888654 4455555555544433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=97.63 E-value=2.1e-05 Score=72.06 Aligned_cols=21 Identities=71% Similarity=1.145 Sum_probs=12.0
Q ss_pred chhHHHHHHHHhccccCCCCC
Q psy3880 154 RKQMVMLRNIMEGKYSFSSPE 174 (408)
Q Consensus 154 ~~~~~~~~~i~~~~~~~~~~~ 174 (408)
.+.......|..+.+.+..+.
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 218 RKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp SSHHHHHHHHHHTCCCCCTTT
T ss_pred CCHHHHHHHHHhCCCCCCCcc
Confidence 345556666777666554443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=8.2e-06 Score=76.48 Aligned_cols=13 Identities=23% Similarity=0.077 Sum_probs=7.2
Q ss_pred cEEEecCCCEEEe
Q psy3880 76 NILLDDQMNVKLT 88 (408)
Q Consensus 76 NILl~~~~~iKl~ 88 (408)
++-+.+-|..+..
T Consensus 167 ~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 167 HVVLTDFGLSKEF 179 (322)
T ss_dssp CEEESCSSEEEEC
T ss_pred CEEEeeccchhhh
Confidence 4556666655543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=1.4e-05 Score=74.15 Aligned_cols=49 Identities=22% Similarity=0.439 Sum_probs=38.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcC-CCCCCCchhHHHHH
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVG-CPPFWHRKQMVMLR 231 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g-~~Pf~~~~~~~~~~ 231 (408)
....|++||.+... .|+.++|+||+||++|+|++| .+||.+.+..+.+.
T Consensus 197 ~t~~y~aPe~l~~~------~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 197 LPVRWMSPESLKDG------VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp ECGGGCCHHHHHHC------CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cccccCCHHHHccC------CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 34669999999765 467789999999999999998 57776665554443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=1.6e-05 Score=73.98 Aligned_cols=41 Identities=24% Similarity=0.507 Sum_probs=34.3
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCC
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWH 223 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~ 223 (408)
....|++||.+... .|+.++||||+||++|+|++|..||..
T Consensus 196 gt~~y~aPE~~~~~------~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 196 LPVKWMALESLQTQ------KFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCGGGSCHHHHHHC------CCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccccccChHHHhcC------CCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 45679999998764 478899999999999999998777754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.44 E-value=1.7e-05 Score=74.86 Aligned_cols=43 Identities=26% Similarity=0.512 Sum_probs=34.8
Q ss_pred ccCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCc
Q psy3880 176 NDISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHR 224 (408)
Q Consensus 176 ~~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~ 224 (408)
..+..|+|||++... .|+.++|+||+||++++|++|.+||...
T Consensus 190 ~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 190 IQTREYRSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp CSCGGGCCHHHHHTC------CCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cccccccChhhcccc------CCCccccccchHHHHHHHHHCCCCCCCC
Confidence 355679999998753 5788999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=97.34 E-value=4.2e-05 Score=71.26 Aligned_cols=44 Identities=23% Similarity=0.551 Sum_probs=36.7
Q ss_pred cCCCCCchHHHhhhcccccccCCCcccccchhhhHHHhhcCCCCCCCch
Q psy3880 177 DISGYLAPEVLRANMFEDATGYGQAVDVWACGVIMYTLLVGCPPFWHRK 225 (408)
Q Consensus 177 ~~~~~~~PE~l~~~~~~~~~~y~~~~DiWs~Gvily~ll~g~~Pf~~~~ 225 (408)
.+..|++||.+... ..|+.++|+||+||++|++++|.+||....
T Consensus 191 ~t~~y~aPE~~~~~-----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 191 ASRYFKGPELLVDY-----QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp SCGGGCCHHHHTTC-----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cCccccCcccccCC-----CCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 45569999998653 347889999999999999999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.57 E-value=0.0046 Score=54.42 Aligned_cols=28 Identities=29% Similarity=0.393 Sum_probs=24.3
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 6899999999999977666799998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.59 E-value=0.031 Score=50.46 Aligned_cols=30 Identities=33% Similarity=0.429 Sum_probs=26.7
Q ss_pred CCCeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 65 HSVVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 65 ~~IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
.|+||.|+.+.|++++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=84.82 E-value=0.13 Score=44.16 Aligned_cols=28 Identities=25% Similarity=0.266 Sum_probs=24.5
Q ss_pred CeeccCCCCcEEEecCCCEEEeccccch
Q psy3880 67 VVHRDLKPENILLDDQMNVKLTDFGFAR 94 (408)
Q Consensus 67 IvHRDLKp~NILl~~~~~iKl~DFGla~ 94 (408)
++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899998764
|